data_2n1k_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2n1k _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.066 0 N-CA-C 110.806 -0.072 . . . . 0.0 110.806 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -72.86 128.34 13.15 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.264 1.976 . . . . 0.0 111.476 174.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.551 ' HD2' ' O ' ' A' ' 31' ' ' SER . 89.2 Cg_exo -48.33 146.2 10.4 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.837 2.358 . . . . 0.0 111.933 174.178 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.422 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 9.1 p-10 -36.76 107.12 0.36 Allowed Pre-proline 0 N--CA 1.468 0.446 0 O-C-N 124.806 1.316 . . . . 0.0 112.74 -169.147 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.566 ' HG2' HG12 ' A' ' 91' ' ' VAL . 27.4 Cg_exo -66.86 152.3 80.71 Favored 'Trans proline' 0 C--O 1.233 0.273 0 C-N-CA 123.62 2.88 . . . . 0.0 112.643 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.8 m -107.05 130.62 54.63 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.987 -177.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.443 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 77.0 t -78.25 122.22 32.76 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-N 114.812 -1.085 . . . . 0.0 109.881 172.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -87.16 -42.08 13.27 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.918 -175.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -134.48 139.07 45.22 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.464 -175.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.424 ' HA ' HG12 ' A' ' 26' ' ' ILE . 61.2 t -130.88 123.78 54.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.472 178.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.424 ' HB3' ' H ' ' A' ' 23' ' ' ASP . 5.7 m-20 -133.59 -159.47 0.97 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.11 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.424 ' H ' ' HB3' ' A' ' 22' ' ' ASP . 17.7 p-10 -76.37 -57.68 3.72 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.199 0.524 . . . . 0.0 111.262 -178.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.612 HG23 ' O ' ' A' ' 69' ' ' LEU . 33.8 p -119.43 32.81 5.91 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.516 -172.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.62 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 68.4 m -168.07 130.47 1.5 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.201 -173.129 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.563 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 33.1 mt -145.08 141.71 22.86 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.888 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 175.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 40.6 t -116.69 132.93 64.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 C-N-CA 119.71 -0.796 . . . . 0.0 110.17 -175.271 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.583 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.7 OUTLIER -127.76 147.35 32.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 C-N-CA 120.397 -0.521 . . . . 0.0 110.052 -179.126 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.429 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 20.9 mtp180 -133.29 120.77 21.49 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.203 -174.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.523 ' CH2' HD12 ' A' ' 57' ' ' LEU . 41.3 p90 -113.23 149.65 33.48 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.343 -173.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.551 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 20.5 m -98.25 98.14 9.44 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.097 178.168 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.563 ' NE ' ' HB3' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -45.82 156.26 0.45 Allowed Pre-proline 0 CA--C 1.539 0.54 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 -173.49 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.69 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 2.9 Cg_exo -78.57 170.64 17.99 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 124.844 3.696 . . . . 0.0 113.496 -170.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -76.8 -20.96 55.81 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.832 -1.076 . . . . 0.0 109.218 173.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -70.19 137.77 86.91 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.856 175.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -73.5 114.93 4.17 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 121.468 1.446 . . . . 0.0 109.51 167.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.615 HG22 ' HB3' ' A' ' 81' ' ' ALA . 0.2 OUTLIER -111.8 160.44 11.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -174.121 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.4 p -93.23 -32.21 14.45 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.5 ' C ' HG11 ' A' ' 82' ' ' VAL . . . -167.85 -164.56 23.74 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.11 -1.043 . . . . 0.0 111.614 179.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.69 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 6.2 m-85 -140.33 135.52 32.27 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-N 117.111 0.456 . . . . 0.0 111.416 176.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.414 ' C ' HG13 ' A' ' 42' ' ' ILE . 25.1 mtp180 -103.48 151.09 23.24 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 167.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.867 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 29.3 mt -139.54 107.86 3.22 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 C-N-CA 120.312 -0.555 . . . . 0.0 112.112 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 71.2 t -106.3 110.24 30.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.151 0.5 . . . . 0.0 110.704 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.563 ' HA ' ' O ' ' A' ' 76' ' ' ASN . 0.8 OUTLIER -113.28 125.47 54.33 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.661 176.26 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 26.1 p -139.13 143.88 38.53 Favored Pre-proline 0 C--N 1.317 -0.817 0 CA-C-N 114.007 -1.451 . . . . 0.0 111.792 -173.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.527 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 4.7 Cg_exo . . . . . 0 C--O 1.234 0.284 0 C-N-CA 123.082 2.522 . . . . 0.0 111.467 175.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 8.4 p . . . . . 0 CA--C 1.518 -0.257 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.56 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 71.2 m -147.71 148.62 31.19 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.248 -0.581 . . . . 0.0 112.006 -179.161 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.867 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 41.6 tt0 -114.67 115.41 27.07 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.7 172.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.621 HD11 ' CG2' ' A' ' 64' ' ' VAL . 16.7 mt -96.44 157.97 15.65 Favored 'General case' 0 CA--C 1.513 -0.475 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.038 175.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.43 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 25.0 t-20 -120.21 115.73 24.2 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 178.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.523 HD12 ' CH2' ' A' ' 30' ' ' TRP . 2.5 mt -113.4 156.02 43.83 Favored Pre-proline 0 N--CA 1.443 -0.781 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 -177.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -63.65 150.87 87.43 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 121.687 1.591 . . . . 0.0 111.3 175.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -45.41 -28.54 0.89 Allowed 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 114.738 -1.119 . . . . 0.0 112.972 178.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 10.2 t -104.39 11.21 34.89 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.223 0.535 . . . . 0.0 111.126 -174.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.47 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -75.51 159.92 30.76 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 178.129 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.563 ' HB3' ' NE ' ' A' ' 32' ' ' ARG . 4.6 p-10 -146.41 17.53 1.34 Allowed 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 120.724 -0.391 . . . . 0.0 112.045 -177.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.583 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 39.3 p -171.4 134.37 0.87 Allowed 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.529 -0.469 . . . . 0.0 111.729 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.632 HG11 ' CD2' ' A' ' 66' ' ' LEU . 3.2 p -119.17 136.5 56.16 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 CA-C-N 116.358 -0.383 . . . . 0.0 109.992 174.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 63.0 m -95.67 100.47 12.19 Favored 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 168.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.632 ' CD2' HG11 ' A' ' 64' ' ' VAL . 0.3 OUTLIER -75.03 136.74 41.21 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.167 179.918 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 7.4 t -132.16 164.61 25.94 Favored 'General case' 0 C--N 1.316 -0.856 0 O-C-N 123.705 0.628 . . . . 0.0 109.458 -173.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 26.4 t0 58.71 50.72 8.47 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 123.81 0.694 . . . . 0.0 110.692 -177.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.612 ' O ' HG23 ' A' ' 24' ' ' THR . 11.9 mt -90.18 -176.24 4.79 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 172.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 57.6 tp60 -123.62 125.53 25.98 Favored Pre-proline 0 C--N 1.32 -0.691 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 174.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -62.01 140.77 86.32 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 123.05 2.5 . . . . 0.0 113.269 -178.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 75.57 29.6 59.46 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.918 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.418 ' CG1' ' HB3' ' A' ' 46' ' ' PRO . 61.0 t -131.42 148.09 32.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.276 0.56 . . . . 0.0 111.145 -176.041 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.527 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -82.81 127.79 33.79 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.412 179.18 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.528 ' CE2' HD22 ' A' ' 69' ' ' LEU . 3.8 m-85 -122.37 116.07 23.39 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.401 0.62 . . . . 0.0 112.521 -176.03 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.563 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 0.8 OUTLIER -85.92 112.91 21.61 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.597 172.927 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.554 ' HB ' HG13 ' A' ' 93' ' ' ILE . 5.0 mp -95.79 115.9 36.11 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.597 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 172.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.857 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 21.9 m -108.88 113.6 26.66 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.26 -178.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.512 HD11 HG22 ' A' ' 77' ' ' ILE . 12.8 mm -95.04 138.41 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.431 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 82.8 m-85 -124.67 111.29 15.42 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.161 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.615 ' HB3' HG22 ' A' ' 37' ' ' ILE . . . -81.05 111.24 17.34 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 171.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.5 HG11 ' C ' ' A' ' 39' ' ' GLY . 7.1 p -104.5 136.72 36.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 C-N-CA 120.021 -0.672 . . . . 0.0 110.717 -175.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -121.39 163.28 18.95 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -47.74 -46.59 30.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 118.341 0.519 . . . . 0.0 111.426 -178.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 -89.97 -34.6 15.95 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -170.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -150.77 171.84 16.54 Favored 'General case' 0 C--O 1.222 -0.347 0 C-N-CA 120.619 -0.432 . . . . 0.0 111.528 -168.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -114.57 129.06 56.63 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.321 175.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 17.1 m -66.95 169.33 8.39 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.075 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.5 p -57.76 151.13 43.92 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-O 120.968 0.413 . . . . 0.0 110.784 176.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -84.14 141.6 9.36 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 122.159 1.906 . . . . 0.0 113.989 -174.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.857 ' O ' ' HA ' ' A' ' 78' ' ' THR . 12.5 t -81.93 121.83 35.82 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.717 0 CA-C-N 114.855 -1.066 . . . . 0.0 108.196 168.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 5.9 t -117.87 105.72 18.48 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 C-N-CA 119.552 -0.859 . . . . 0.0 109.897 172.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.554 HG13 ' HB ' ' A' ' 77' ' ' ILE . 8.0 pt -123.26 115.48 45.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.379 176.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.507 ' HB2' ' OE1' ' A' ' 74' ' ' GLN . 5.1 pt20 -103.31 126.46 50.49 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.351 0.596 . . . . 0.0 111.103 -174.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -128.94 134.46 48.22 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.088 177.115 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.468 ' HG2' ' HG2' ' A' ' 74' ' ' GLN . 45.1 mt-10 -86.59 133.12 33.74 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 175.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.508 HG21 HD12 ' A' ' 26' ' ' ILE . 37.9 p -72.75 113.85 10.24 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.161 0.505 . . . . 0.0 110.724 -179.317 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 14.3 m . . . . . 0 C--N 1.326 -0.436 0 CA-C-O 121.421 0.629 . . . . 0.0 110.223 -177.776 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.515 ' HB1' ' O ' ' A' ' 89' ' ' THR . . . . . . . . 0 N--CA 1.451 -0.386 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -56.88 129.03 32.4 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.347 2.031 . . . . 0.0 112.079 174.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.43 ' HD2' ' O ' ' A' ' 31' ' ' SER . 85.5 Cg_exo -46.43 146.82 4.64 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.702 2.268 . . . . 0.0 111.422 171.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -36.79 106.17 0.32 Allowed Pre-proline 0 N--CA 1.472 0.628 0 O-C-N 124.654 1.221 . . . . 0.0 112.694 -168.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.559 ' HG2' HG11 ' A' ' 91' ' ' VAL . 37.9 Cg_exo -65.34 150.58 87.03 Favored 'Trans proline' 0 CA--C 1.52 -0.204 0 C-N-CA 123.501 2.8 . . . . 0.0 112.33 178.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 20.2 m -107.0 130.49 54.63 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.037 -176.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.486 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 82.1 t -83.33 121.37 36.09 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-N 114.435 -1.257 . . . . 0.0 109.908 174.288 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.515 ' OD1' ' HG3' ' A' ' 20' ' ' GLN . 13.5 t70 -80.96 -48.13 12.71 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.108 -174.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.515 ' HG3' ' OD1' ' A' ' 19' ' ' ASP . 27.5 mt-30 -136.07 140.73 44.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.694 -177.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.491 ' HA ' HG12 ' A' ' 26' ' ' ILE . 6.4 m -126.0 101.33 8.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.159 178.455 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -97.65 -160.12 0.78 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.151 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -78.86 -52.66 8.0 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.253 0.549 . . . . 0.0 110.622 177.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.748 HG22 ' O ' ' A' ' 69' ' ' LEU . 26.6 p -121.81 34.6 5.13 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.984 -172.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.647 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 66.1 m -169.19 130.43 1.14 Allowed 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.424 -172.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.539 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 20.5 mt -144.83 137.39 21.73 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.786 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 177.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.486 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 41.1 t -115.67 128.67 72.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 C-N-CA 119.632 -0.827 . . . . 0.0 110.438 -175.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.65 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.7 OUTLIER -125.12 144.65 34.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 C-N-CA 120.546 -0.461 . . . . 0.0 109.916 -177.55 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.541 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 23.0 mtm180 -129.88 121.0 25.82 Favored 'General case' 0 C--N 1.327 -0.393 0 O-C-N 123.239 0.337 . . . . 0.0 110.573 -176.194 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.523 ' CH2' HD12 ' A' ' 57' ' ' LEU . 33.8 p90 -107.88 144.58 34.91 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.176 -173.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.43 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 16.1 m -85.64 89.85 7.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.493 178.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.602 ' HD3' ' H ' ' A' ' 32' ' ' ARG . 0.4 OUTLIER -46.07 152.35 0.8 Allowed Pre-proline 0 CA--C 1.538 0.486 0 C-N-CA 124.189 0.996 . . . . 0.0 113.014 -175.549 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.67 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 2.2 Cg_endo -86.03 166.42 9.78 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 124.273 3.315 . . . . 0.0 113.318 -169.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -76.27 -20.86 56.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.319 172.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.32 136.24 91.56 Favored Pre-proline 0 N--CA 1.453 -0.311 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.754 175.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -70.21 113.19 3.37 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 121.072 1.181 . . . . 0.0 109.593 170.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.586 HG21 ' HB2' ' A' ' 81' ' ' ALA . 24.9 pt -117.9 153.42 19.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.797 -174.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.436 ' C ' ' HB3' ' A' ' 59' ' ' GLU . 9.1 p -94.88 -24.4 17.02 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.529 ' C ' HG11 ' A' ' 82' ' ' VAL . . . -174.8 -161.67 24.97 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 119.732 -1.223 . . . . 0.0 113.304 -179.063 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.67 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 41.8 m-85 -139.54 131.49 27.76 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 122.364 0.266 . . . . 0.0 111.25 174.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 14.3 mmm-85 -96.21 148.76 22.38 Favored 'General case' 0 CA--C 1.504 -0.812 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 165.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.871 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 28.4 mt -139.0 107.84 3.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 C-N-CA 119.74 -0.784 . . . . 0.0 112.439 -179.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 71.9 t -109.04 109.93 30.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.396 0.617 . . . . 0.0 110.719 179.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.686 ' CZ ' ' HB ' ' A' ' 53' ' ' THR . 0.6 OUTLIER -112.77 125.57 54.48 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.322 176.747 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.4 m -139.97 141.16 26.17 Favored Pre-proline 0 C--N 1.317 -0.842 0 CA-C-N 114.282 -1.326 . . . . 0.0 111.429 -173.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.686 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 59.9 Cg_endo . . . . . 0 C--O 1.232 0.191 0 C-N-CA 123.66 2.907 . . . . 0.0 112.01 177.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.493 ' HA ' ' O ' ' A' ' 44' ' ' TYR . 15.1 m . . . . . 0 CA--C 1.516 -0.333 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.686 ' HB ' ' CZ ' ' A' ' 44' ' ' TYR . 23.6 m -147.27 153.29 39.58 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 120.61 -0.436 . . . . 0.0 111.13 -179.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.871 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 30.8 tt0 -122.35 112.4 18.06 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 123.025 0.53 . . . . 0.0 109.673 175.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.632 HD11 ' CG2' ' A' ' 64' ' ' VAL . 15.8 mt -97.8 159.97 14.6 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.584 177.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -123.95 114.56 19.95 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.076 179.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.523 HD12 ' CH2' ' A' ' 30' ' ' TRP . 3.8 mt -113.69 154.65 45.68 Favored Pre-proline 0 C--N 1.318 -0.778 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -176.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -61.34 150.56 84.33 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 121.987 1.792 . . . . 0.0 111.18 176.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.436 ' HB3' ' C ' ' A' ' 38' ' ' THR . 11.4 pt-20 -46.26 -30.0 1.84 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.032 -0.985 . . . . 0.0 112.499 176.203 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 7.4 t -99.89 17.37 21.02 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.045 -175.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.46 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -88.48 151.46 22.53 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.165 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.541 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 24.6 p-10 -136.58 13.95 3.19 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.871 -177.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.65 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 71.6 p -167.51 134.39 2.25 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.336 -0.546 . . . . 0.0 111.678 -177.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.632 ' CG2' HD11 ' A' ' 55' ' ' LEU . 4.2 p -115.06 138.72 44.44 Favored 'Isoleucine or valine' 0 C--O 1.243 0.727 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.226 175.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 55.5 m -97.7 100.88 12.28 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.58 169.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.647 ' O ' ' HA ' ' A' ' 25' ' ' SER . 0.7 OUTLIER -76.46 144.46 39.88 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.2 177.415 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.1 p -141.85 164.74 29.38 Favored 'General case' 0 C--N 1.32 -0.675 0 O-C-N 123.501 0.501 . . . . 0.0 110.955 -172.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 28.8 t70 65.86 26.54 11.12 Favored 'General case' 0 N--CA 1.465 0.294 0 O-C-N 123.923 0.765 . . . . 0.0 110.824 -178.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.748 ' O ' HG22 ' A' ' 24' ' ' THR . 14.9 mt -70.65 -175.01 0.97 Allowed 'General case' 0 C--O 1.222 -0.349 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.948 176.335 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 16.8 mm-40 -129.27 133.28 24.97 Favored Pre-proline 0 C--N 1.319 -0.719 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 176.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -64.57 128.1 20.43 Favored 'Trans proline' 0 C--O 1.234 0.276 0 C-N-CA 122.921 2.414 . . . . 0.0 112.755 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 90.8 14.95 57.36 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.321 178.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 72.0 t -114.78 141.09 32.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.219 0.533 . . . . 0.0 111.602 -175.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.686 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -80.49 122.26 26.79 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.626 179.238 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.46 ' CE2' ' HB3' ' A' ' 69' ' ' LEU . 23.8 m-85 -118.17 113.71 21.96 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.377 0.608 . . . . 0.0 112.377 -176.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.53 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 20.5 m-80 -87.28 108.26 18.87 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.681 175.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.511 ' HB ' HG13 ' A' ' 93' ' ' ILE . 5.4 mp -92.55 115.29 31.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.298 0.571 . . . . 0.0 109.883 176.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.838 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 51.9 m -107.64 115.89 30.95 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.019 179.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.507 ' HB ' ' HB ' ' A' ' 91' ' ' VAL . 19.1 mm -95.91 143.04 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 -178.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.483 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 47.2 m-85 -128.35 111.83 13.77 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 178.091 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.586 ' HB2' HG21 ' A' ' 37' ' ' ILE . . . -79.82 107.96 13.0 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 173.036 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.529 HG11 ' C ' ' A' ' 39' ' ' GLY . 9.5 p -99.4 135.62 33.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 C-N-CA 120.132 -0.627 . . . . 0.0 110.678 -175.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.522 ' HG2' HG23 ' A' ' 37' ' ' ILE . 4.5 mt-10 -111.06 171.07 7.69 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 175.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -44.64 -47.09 10.47 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 123.797 0.686 . . . . 0.0 112.378 -178.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -106.14 -21.06 13.22 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -169.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -149.61 176.93 10.21 Favored 'General case' 0 C--O 1.219 -0.515 0 CA-C-N 118.696 0.68 . . . . 0.0 111.813 -174.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -117.6 134.36 54.97 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 177.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 10.7 m -73.84 -179.98 3.96 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.832 0.348 . . . . 0.0 111.223 -176.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.515 ' O ' ' HB1' ' A' ' 12' ' ' ALA . 0.8 OUTLIER -61.74 159.43 34.7 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.587 176.176 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -88.78 140.96 4.35 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 122.418 2.079 . . . . 0.0 114.361 -177.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.838 ' O ' ' HA ' ' A' ' 78' ' ' THR . 5.6 t -83.08 128.67 38.5 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.7 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 164.15 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 4.1 t -123.22 106.87 18.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 C-N-CA 119.987 -0.685 . . . . 0.0 110.113 171.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.511 HG13 ' HB ' ' A' ' 77' ' ' ILE . 6.7 pt -126.77 111.48 26.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.895 177.124 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -102.6 120.51 40.67 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.673 0.749 . . . . 0.0 111.524 -175.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.412 ' NE2' HG11 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -128.1 135.9 50.44 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.2 -179.1 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -87.04 146.46 26.09 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 176.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.408 ' CG2' HD12 ' A' ' 26' ' ' ILE . 20.7 p -81.38 120.08 24.51 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.104 178.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 85.7 m . . . . . 0 C--N 1.327 -0.388 0 CA-C-O 121.501 0.667 . . . . 0.0 110.58 178.691 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.287 0 N-CA-C 110.509 -0.182 . . . . 0.0 110.509 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -70.58 132.67 22.48 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.479 2.119 . . . . 0.0 111.45 174.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -53.81 159.52 6.92 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.687 2.258 . . . . 0.0 111.314 172.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -39.27 106.24 0.39 Allowed Pre-proline 0 N--CA 1.469 0.491 0 O-C-N 124.313 1.008 . . . . 0.0 111.918 -173.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.529 ' HG2' HG13 ' A' ' 91' ' ' VAL . 38.2 Cg_exo -65.22 144.82 82.45 Favored 'Trans proline' 0 CA--C 1.517 -0.339 0 C-N-CA 122.999 2.466 . . . . 0.0 111.925 178.245 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 39.6 m -97.91 124.72 42.47 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.665 -177.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 85.2 t -78.46 118.37 25.52 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-N 114.479 -1.237 . . . . 0.0 109.17 172.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -89.69 -37.13 14.81 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.283 -174.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -134.59 129.66 35.31 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.941 0.401 . . . . 0.0 110.66 -176.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.42 ' HA ' HG12 ' A' ' 26' ' ' ILE . 85.7 t -126.39 120.52 56.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.724 -178.253 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -125.41 -167.77 1.74 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.813 176.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.508 ' O ' ' HB2' ' A' ' 69' ' ' LEU . 4.1 p-10 -67.28 -59.16 3.65 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.173 0.511 . . . . 0.0 111.331 176.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.681 HG21 ' O ' ' A' ' 69' ' ' LEU . 36.0 p -117.32 36.83 4.08 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.991 -173.019 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.666 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 66.1 m -168.65 130.28 1.29 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.059 -176.229 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.606 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 34.1 mt -148.14 136.63 15.1 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.539 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 176.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.458 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 41.3 t -116.79 127.84 74.31 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.602 0 C-N-CA 120.054 -0.658 . . . . 0.0 110.693 -174.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.626 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.8 OUTLIER -122.52 143.5 35.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -176.97 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.478 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 63.8 mtp180 -130.14 121.01 25.49 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.912 0.387 . . . . 0.0 110.568 -175.349 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.502 ' CH2' HD11 ' A' ' 57' ' ' LEU . 34.9 p90 -110.69 141.49 43.89 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.504 -173.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 17.6 m -83.63 86.61 7.09 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.02 -0.537 . . . . 0.0 109.725 175.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.425 ' CD ' ' HB3' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -48.28 156.83 0.74 Allowed Pre-proline 0 CA--C 1.541 0.598 0 CA-C-N 114.87 -1.059 . . . . 0.0 113.267 -176.184 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.649 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 3.1 Cg_exo -81.03 169.85 15.8 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 124.341 3.361 . . . . 0.0 113.538 -171.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -91.35 -7.33 51.21 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.662 176.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -69.37 144.08 94.2 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.204 175.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -70.64 113.24 3.45 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 121.071 1.18 . . . . 0.0 109.766 171.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.586 HG22 ' HG3' ' A' ' 83' ' ' GLU . 3.5 pt -119.91 157.56 22.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.403 -173.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.464 ' C ' ' HB3' ' A' ' 59' ' ' GLU . 16.6 p -101.29 -22.85 14.51 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -176.136 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.555 ' C ' HG13 ' A' ' 82' ' ' VAL . . . -177.01 -165.43 32.38 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 119.6 -1.286 . . . . 0.0 112.371 179.017 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.649 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 6.3 m-85 -139.24 134.38 32.6 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.773 0.32 . . . . 0.0 110.875 173.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.7 mmm180 -100.97 148.07 25.44 Favored 'General case' 0 CA--C 1.501 -0.906 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 165.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.885 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 33.6 mt -138.25 109.53 5.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 C-N-CA 119.881 -0.728 . . . . 0.0 112.319 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 69.9 t -110.77 110.12 31.02 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.525 0 CA-C-O 121.391 0.615 . . . . 0.0 110.695 -179.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.709 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 0.8 OUTLIER -112.46 124.49 52.62 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.428 177.06 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.426 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 17.8 p -139.08 137.17 18.92 Favored Pre-proline 0 C--N 1.314 -0.975 0 CA-C-N 114.135 -1.393 . . . . 0.0 111.525 -173.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.553 ' HG3' ' CZ ' ' A' ' 75' ' ' TYR . 8.0 Cg_exo . . . . . 0 N--CA 1.462 -0.372 0 C-N-CA 122.978 2.452 . . . . 0.0 110.821 174.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.7 p . . . . . 0 CA--C 1.519 -0.239 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.709 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 29.1 m -146.0 150.23 35.63 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.655 -173.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.885 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 56.6 tt0 -114.93 118.35 33.23 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.935 173.238 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.613 HD13 ' CG2' ' A' ' 64' ' ' VAL . 21.9 mt -100.23 148.34 24.74 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.54 -0.464 . . . . 0.0 109.902 173.275 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -109.86 114.14 27.46 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 176.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.502 HD11 ' CH2' ' A' ' 30' ' ' TRP . 1.7 mt -109.96 152.51 43.07 Favored Pre-proline 0 N--CA 1.444 -0.766 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 -177.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -60.9 149.2 89.74 Favored 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 121.952 1.768 . . . . 0.0 111.389 176.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.464 ' HB3' ' C ' ' A' ' 38' ' ' THR . 9.6 pt-20 -46.92 -22.78 0.36 Allowed 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 114.848 -1.069 . . . . 0.0 113.019 176.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.2 t -107.3 15.84 24.6 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.135 -176.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.466 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -82.17 164.3 21.36 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.504 -0.317 . . . . 0.0 110.423 -179.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.478 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 4.6 p-10 -149.19 11.27 0.8 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -177.102 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.626 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 21.9 p -168.7 134.11 1.69 Allowed 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.346 -0.542 . . . . 0.0 111.996 -178.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.613 ' CG2' HD13 ' A' ' 55' ' ' LEU . 4.1 p -117.02 136.78 53.08 Favored 'Isoleucine or valine' 0 C--O 1.242 0.673 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.288 176.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 41.9 m -98.93 102.03 13.62 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-O 121.411 0.624 . . . . 0.0 109.795 170.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.666 ' O ' ' HA ' ' A' ' 25' ' ' SER . 0.2 OUTLIER -79.24 142.22 36.41 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.118 178.422 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.8 t -136.51 169.6 17.42 Favored 'General case' 0 C--N 1.32 -0.681 0 O-C-N 123.274 0.359 . . . . 0.0 110.559 -175.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 58.71 32.99 22.76 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.634 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.681 ' O ' HG21 ' A' ' 24' ' ' THR . 11.8 mt -71.88 -176.39 1.68 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.755 176.111 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -124.56 126.43 25.42 Favored Pre-proline 0 C--N 1.32 -0.714 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 175.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -63.58 132.44 35.48 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.183 2.589 . . . . 0.0 113.62 -176.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 87.92 21.58 45.85 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.311 177.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 18.7 t -125.53 148.2 30.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.328 0.585 . . . . 0.0 111.463 -176.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.454 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 15.0 tp60 -81.48 114.28 20.1 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.937 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.56 ' CE2' HD22 ' A' ' 69' ' ' LEU . 6.1 m-85 -104.83 115.19 29.87 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.291 0.567 . . . . 0.0 112.02 -178.024 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.538 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 14.2 m120 -87.72 105.42 17.36 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.64 175.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.536 HG21 HD11 ' A' ' 79' ' ' ILE . 5.2 mp -91.44 117.27 34.36 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.575 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 175.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.864 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 90.4 m -109.2 115.39 29.92 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.779 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.536 HD11 HG21 ' A' ' 77' ' ' ILE . 12.4 mm -96.16 121.07 46.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.915 -179.375 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -108.12 111.11 22.97 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 176.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -80.15 123.61 28.05 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 169.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.555 HG13 ' C ' ' A' ' 39' ' ' GLY . 12.7 p -115.67 134.47 58.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 C-N-CA 120.053 -0.659 . . . . 0.0 110.889 -176.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.586 ' HG3' HG22 ' A' ' 37' ' ' ILE . 8.6 mp0 -112.48 171.61 7.42 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -177.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -42.12 -44.93 3.83 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -174.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -125.66 -13.22 6.51 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.498 -0.481 . . . . 0.0 111.959 -176.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -128.39 173.73 9.94 Favored 'General case' 0 N--CA 1.443 -0.794 0 O-C-N 122.247 -0.283 . . . . 0.0 111.358 -171.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 20.4 mp0 -128.12 127.02 42.26 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.478 176.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 68.1 m -72.56 171.74 11.85 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.873 0.368 . . . . 0.0 111.797 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.2 p -60.61 150.24 75.75 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.327 177.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -85.17 141.2 8.02 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.421 2.08 . . . . 0.0 114.328 -175.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.864 ' O ' ' HA ' ' A' ' 78' ' ' THR . 7.0 t -82.65 129.39 37.53 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.641 0 CA-C-N 114.782 -1.099 . . . . 0.0 108.594 167.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 9.7 t -125.9 106.44 16.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 C-N-CA 120.196 -0.602 . . . . 0.0 110.057 171.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.527 HG13 ' HB ' ' A' ' 77' ' ' ILE . 5.8 pt -121.95 111.39 30.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.048 177.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.624 ' H ' ' NE2' ' A' ' 94' ' ' GLN . 0.7 OUTLIER -96.78 115.36 27.29 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.57 0.7 . . . . 0.0 111.184 -178.801 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.67 131.79 53.97 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.471 177.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -86.79 134.12 33.59 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.214 0.531 . . . . 0.0 110.135 179.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.507 HG23 HD11 ' A' ' 26' ' ' ILE . 24.1 p -66.08 120.86 13.92 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.437 178.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.6 m . . . . . 0 C--N 1.328 -0.335 0 CA-C-O 121.342 0.591 . . . . 0.0 110.247 -177.164 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 -0.179 0 CA-C-O 120.345 0.117 . . . . 0.0 110.882 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -71.27 129.65 16.32 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 122.35 2.033 . . . . 0.0 111.284 175.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.52 ' HD2' ' O ' ' A' ' 31' ' ' SER . 88.5 Cg_exo -49.31 151.44 6.61 Favored 'Trans proline' 0 C--O 1.234 0.316 0 C-N-CA 122.743 2.295 . . . . 0.0 111.936 173.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -36.63 106.61 0.34 Allowed Pre-proline 0 N--CA 1.469 0.51 0 O-C-N 124.728 1.268 . . . . 0.0 112.324 -171.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.58 ' HG2' HG11 ' A' ' 91' ' ' VAL . 28.1 Cg_exo -68.61 143.76 57.91 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 123.442 2.761 . . . . 0.0 113.046 179.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 94.6 m -96.62 127.7 42.86 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.199 -177.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.446 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 97.3 t -79.27 116.48 23.29 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-N 114.611 -1.177 . . . . 0.0 109.337 173.253 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -86.95 -37.02 17.97 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.085 -173.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -135.6 136.55 41.13 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.235 -176.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.443 ' HA ' HG12 ' A' ' 26' ' ' ILE . 42.0 t -133.52 115.44 22.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.109 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.423 ' HB3' ' H ' ' A' ' 23' ' ' ASP . 8.2 m-20 -132.41 -160.37 1.04 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.269 179.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.423 ' H ' ' HB3' ' A' ' 22' ' ' ASP . 6.3 p-10 -68.69 -66.59 0.55 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -177.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.584 HG23 ' O ' ' A' ' 69' ' ' LEU . 57.2 p -115.52 36.87 3.77 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.423 0.63 . . . . 0.0 110.582 -172.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.586 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 32.2 p -170.2 131.21 0.97 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.673 -174.253 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.493 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 42.4 mt -145.97 142.07 21.62 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.771 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 178.214 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.446 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 43.6 t -119.67 134.14 64.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 118.859 0.754 . . . . 0.0 110.338 -173.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.558 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.7 OUTLIER -129.11 148.55 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.524 -179.261 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.638 ' HG2' ' OG ' ' A' ' 63' ' ' SER . 29.7 mtm105 -131.36 120.3 22.92 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.554 -177.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.512 ' CH2' HD13 ' A' ' 57' ' ' LEU . 37.8 p90 -111.14 143.81 41.28 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.832 -175.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.52 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 17.3 t -91.17 96.44 10.58 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 177.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.468 ' CD ' ' H ' ' A' ' 32' ' ' ARG . 1.0 OUTLIER -49.54 158.12 0.86 Allowed Pre-proline 0 C--N 1.327 -0.372 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -173.854 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.666 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 5.1 Cg_exo -79.94 165.56 21.83 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 124.197 3.265 . . . . 0.0 112.534 -173.226 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -78.92 -10.43 59.81 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.13 -0.941 . . . . 0.0 108.933 172.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -72.23 138.42 81.54 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 114.779 -1.1 . . . . 0.0 111.315 177.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo -66.31 115.05 3.29 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 121.492 1.461 . . . . 0.0 109.738 166.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.569 HG21 ' HB2' ' A' ' 81' ' ' ALA . 0.6 OUTLIER -119.55 154.71 22.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 -177.901 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 9.5 p -95.74 -23.79 16.81 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -178.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.557 ' C ' HG13 ' A' ' 82' ' ' VAL . . . -173.61 -163.02 26.49 Favored Glycine 0 CA--C 1.502 -0.778 0 C-N-CA 119.919 -1.134 . . . . 0.0 111.887 178.458 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.666 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 6.8 m-85 -141.2 133.8 28.58 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 122.525 0.33 . . . . 0.0 111.156 174.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.5 mmm180 -104.61 149.87 25.16 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 167.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.889 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 33.7 mt -138.88 107.93 3.77 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 C-N-CA 120.123 -0.631 . . . . 0.0 112.106 -178.138 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 66.1 t -107.09 110.13 30.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.422 0.63 . . . . 0.0 110.572 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.639 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 0.5 OUTLIER -110.74 124.62 52.33 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.096 175.517 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 14.5 t -142.39 139.2 17.28 Favored Pre-proline 0 C--N 1.316 -0.89 0 CA-C-N 113.86 -1.518 . . . . 0.0 110.666 -172.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.684 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 37.2 Cg_exo . . . . . 0 C--N 1.343 0.244 0 C-N-CA 123.374 2.716 . . . . 0.0 112.585 176.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 32.7 p . . . . . 0 CA--C 1.52 -0.193 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.639 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 24.6 m -147.87 152.87 38.34 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.756 -0.377 . . . . 0.0 111.374 -178.149 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.889 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 34.1 tt0 -116.87 118.36 32.26 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 171.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.631 HD13 ' CG2' ' A' ' 64' ' ' VAL . 20.5 mt -97.13 157.13 16.08 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 174.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -122.35 113.48 19.45 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.512 HD13 ' CH2' ' A' ' 30' ' ' TRP . 3.6 mt -112.0 155.58 43.13 Favored Pre-proline 0 N--CA 1.443 -0.782 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 -175.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -64.36 149.65 89.73 Favored 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 121.656 1.57 . . . . 0.0 110.945 174.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -46.56 -25.94 0.79 Allowed 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 114.722 -1.126 . . . . 0.0 113.123 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 7.9 t -101.55 5.72 41.88 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.915 0.388 . . . . 0.0 111.358 -175.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.441 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -75.95 155.99 34.59 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.473 ' C ' ' HG ' ' A' ' 63' ' ' SER . 4.9 p-10 -141.3 12.46 2.17 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 120.55 -0.46 . . . . 0.0 112.181 -175.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.638 ' OG ' ' HG2' ' A' ' 29' ' ' ARG . 9.4 m -161.94 135.88 6.6 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.981 -0.288 . . . . 0.0 110.834 -178.051 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.631 ' CG2' HD13 ' A' ' 55' ' ' LEU . 4.2 p -121.26 135.12 62.45 Favored 'Isoleucine or valine' 0 C--O 1.24 0.605 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 172.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 55.2 m -97.67 100.91 12.31 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-O 121.528 0.68 . . . . 0.0 109.291 169.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.586 ' O ' ' HA ' ' A' ' 25' ' ' SER . 0.2 OUTLIER -77.52 141.38 39.65 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.22 -0.9 . . . . 0.0 108.958 179.824 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 22.5 t -141.42 169.63 17.25 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -174.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 34.1 t70 64.48 29.87 13.17 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 123.998 0.811 . . . . 0.0 110.307 -178.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.584 ' O ' HG23 ' A' ' 24' ' ' THR . 8.2 mt -75.42 -176.29 3.11 Favored 'General case' 0 N--CA 1.462 0.143 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 175.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -117.96 133.1 23.42 Favored Pre-proline 0 C--N 1.32 -0.689 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 174.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -64.55 128.71 21.85 Favored 'Trans proline' 0 C--O 1.233 0.269 0 C-N-CA 122.666 2.244 . . . . 0.0 112.392 177.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.63 37.52 19.81 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.04 179.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.519 ' CG1' ' HB3' ' A' ' 46' ' ' PRO . 71.5 t -134.82 138.35 49.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.121 0.486 . . . . 0.0 110.805 -178.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.684 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -75.7 121.28 22.27 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.564 -0.743 . . . . 0.0 109.549 -179.997 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.512 ' CE2' HD22 ' A' ' 69' ' ' LEU . 7.6 m-85 -113.92 114.62 26.47 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.308 0.575 . . . . 0.0 112.444 -176.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.462 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 12.2 m120 -88.28 109.21 19.78 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.321 172.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.537 ' HB ' HG13 ' A' ' 93' ' ' ILE . 4.9 mp -92.15 119.97 40.53 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.621 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 175.038 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.885 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 55.9 m -112.16 115.41 28.8 Favored 'General case' 0 N--CA 1.425 -1.687 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.613 -179.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.509 HD13 HG22 ' A' ' 77' ' ' ILE . 12.6 mm -95.94 136.91 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.406 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 57.7 m-85 -124.29 111.73 16.17 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.322 -0.399 . . . . 0.0 109.965 178.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.569 ' HB2' HG21 ' A' ' 37' ' ' ILE . . . -80.04 109.38 14.43 Favored 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 171.063 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.557 HG13 ' C ' ' A' ' 39' ' ' GLY . 10.4 p -100.13 139.73 20.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 C-N-CA 120.029 -0.668 . . . . 0.0 110.754 -174.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.636 ' HG2' ' H ' ' A' ' 84' ' ' GLU . 0.7 OUTLIER -117.56 167.56 11.2 Favored 'General case' 0 N--CA 1.447 -0.583 0 O-C-N 124.005 0.816 . . . . 0.0 108.935 179.265 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.636 ' H ' ' HG2' ' A' ' 83' ' ' GLU . 39.1 mt-10 -40.65 -52.51 2.9 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 28.5 m-80 -123.99 1.49 8.63 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.815 -174.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -134.98 172.02 13.6 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.332 -0.547 . . . . 0.0 111.596 -172.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -136.86 129.14 29.83 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.523 177.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 23.9 m -69.09 162.22 27.4 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.304 176.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.1 p -58.15 151.81 44.57 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.015 0.436 . . . . 0.0 110.265 174.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -82.39 140.6 10.9 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 121.978 1.786 . . . . 0.0 113.727 -173.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.885 ' O ' ' HA ' ' A' ' 78' ' ' THR . 10.7 t -82.27 123.72 38.52 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.728 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 167.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.4 t -121.82 106.71 18.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 C-N-CA 119.76 -0.776 . . . . 0.0 109.936 171.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.537 HG13 ' HB ' ' A' ' 77' ' ' ILE . 6.4 pt -120.47 115.7 47.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.612 177.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -103.83 123.0 46.3 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.467 0.651 . . . . 0.0 111.343 -174.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.34 135.25 42.6 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.711 177.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.48 ' HG3' ' HG2' ' A' ' 74' ' ' GLN . 1.6 mp0 -86.13 135.22 33.69 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.162 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.487 HG23 HD13 ' A' ' 26' ' ' ILE . 41.2 p -67.08 124.17 22.32 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.16 0.505 . . . . 0.0 110.303 178.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 14.2 m . . . . . 0 C--N 1.325 -0.491 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.142 -174.658 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.227 0 N-CA-C 110.343 -0.243 . . . . 0.0 110.343 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -71.82 130.11 16.4 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 122.446 2.097 . . . . 0.0 111.626 175.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.613 ' HD2' ' O ' ' A' ' 31' ' ' SER . 88.3 Cg_exo -48.54 154.83 2.57 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.963 2.442 . . . . 0.0 112.32 172.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -39.31 106.36 0.39 Allowed Pre-proline 0 N--CA 1.466 0.372 0 O-C-N 124.652 1.22 . . . . 0.0 112.621 -172.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.558 ' HG2' HG11 ' A' ' 91' ' ' VAL . 27.2 Cg_exo -68.92 149.25 72.0 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 123.444 2.763 . . . . 0.0 112.696 178.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.1 m -106.71 132.88 52.19 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.862 -177.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.424 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 81.9 t -85.14 121.56 37.16 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 114.63 -1.168 . . . . 0.0 109.78 174.379 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -94.28 -28.03 15.8 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.181 -174.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -135.79 126.51 27.3 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.406 -175.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.486 ' HA ' HG12 ' A' ' 26' ' ' ILE . 58.1 t -127.96 109.65 20.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.423 177.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.515 ' CG ' ' H ' ' A' ' 23' ' ' ASP . 13.7 t70 -118.68 -157.61 0.69 Allowed 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.515 ' H ' ' CG ' ' A' ' 22' ' ' ASP . 1.1 m-20 -84.23 -56.36 3.69 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.053 0.454 . . . . 0.0 110.286 -179.135 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.682 HG23 ' O ' ' A' ' 69' ' ' LEU . 22.8 p -114.43 34.5 4.69 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.669 -176.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.633 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 51.1 m -168.34 130.63 1.42 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.152 -172.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.573 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 45.3 mt -147.84 138.36 17.2 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.548 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 175.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 47.6 t -118.13 127.96 75.25 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.517 0 O-C-N 121.684 -0.635 . . . . 0.0 110.961 -174.293 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.602 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.6 OUTLIER -123.72 146.88 28.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.056 -176.61 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.506 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 28.7 mtm180 -133.35 121.88 23.0 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.313 -176.118 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.541 ' CH2' HD11 ' A' ' 57' ' ' LEU . 39.4 p90 -111.37 145.13 39.43 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.52 -174.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.613 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 25.4 m -90.83 94.74 9.8 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.311 178.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.572 ' NE ' ' HB3' ' A' ' 62' ' ' ASN . 0.1 OUTLIER -49.0 156.61 0.9 Allowed Pre-proline 0 CA--C 1.537 0.458 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -173.837 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.597 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 5.0 Cg_exo -80.12 167.88 19.36 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 124.126 3.217 . . . . 0.0 112.248 -173.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -83.14 -11.4 57.97 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 173.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -67.49 147.17 98.81 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 114.333 -1.303 . . . . 0.0 111.481 177.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -75.31 114.4 3.98 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 121.54 1.494 . . . . 0.0 110.283 170.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.554 HG22 ' HB3' ' A' ' 81' ' ' ALA . 1.2 pt -122.61 154.15 27.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -176.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.414 ' C ' ' HB3' ' A' ' 59' ' ' GLU . 19.3 p -99.14 -30.17 12.44 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -176.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.564 ' C ' HG12 ' A' ' 82' ' ' VAL . . . -165.73 -164.13 20.58 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.482 -0.866 . . . . 0.0 111.7 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.597 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 6.6 m-85 -141.95 134.89 28.78 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 117.145 0.473 . . . . 0.0 111.392 175.321 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 8.9 mmm180 -100.4 150.92 22.12 Favored 'General case' 0 CA--C 1.508 -0.656 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 166.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.884 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 30.4 mt -139.27 108.49 3.7 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 C-N-CA 120.452 -0.499 . . . . 0.0 112.215 177.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 72.7 t -108.69 110.34 31.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.464 0.649 . . . . 0.0 110.804 179.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.643 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 1.0 OUTLIER -112.35 125.67 54.44 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.374 175.773 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 12.4 p -137.79 139.24 25.99 Favored Pre-proline 0 C--N 1.317 -0.822 0 CA-C-N 114.093 -1.412 . . . . 0.0 112.02 -172.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.493 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 72.0 Cg_endo . . . . . 0 C--O 1.232 0.191 0 C-N-CA 123.482 2.788 . . . . 0.0 111.71 176.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.431 ' HA ' ' O ' ' A' ' 44' ' ' TYR . 22.0 p . . . . . 0 CA--C 1.514 -0.427 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.643 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 36.8 m -146.95 150.11 34.52 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 120.482 -0.487 . . . . 0.0 111.441 -174.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.884 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 52.5 tt0 -115.34 114.16 24.77 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.55 173.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.611 HD13 ' CG2' ' A' ' 64' ' ' VAL . 23.0 mt -97.08 151.64 19.56 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.46 -0.496 . . . . 0.0 109.667 175.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -116.54 115.81 26.45 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.541 HD11 ' CH2' ' A' ' 30' ' ' TRP . 3.9 mt -113.51 156.96 42.65 Favored Pre-proline 0 C--N 1.319 -0.723 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -176.273 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -66.16 151.37 83.82 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 121.712 1.608 . . . . 0.0 111.166 175.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.414 ' HB3' ' C ' ' A' ' 38' ' ' THR . 9.2 pt-20 -46.07 -28.01 1.09 Allowed 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.099 -0.955 . . . . 0.0 112.823 177.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.9 t -101.67 12.28 37.42 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.265 0.555 . . . . 0.0 111.246 -175.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.453 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -82.07 159.98 23.31 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.219 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.572 ' HB3' ' NE ' ' A' ' 32' ' ' ARG . 28.4 p-10 -146.73 17.19 1.27 Allowed 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -176.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.602 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 21.5 p -169.08 135.73 1.75 Allowed 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.17 -0.612 . . . . 0.0 111.846 -178.54 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.611 ' CG2' HD13 ' A' ' 55' ' ' LEU . 4.1 p -122.06 136.21 59.67 Favored 'Isoleucine or valine' 0 C--O 1.242 0.682 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.343 175.022 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 39.3 m -98.19 102.01 13.64 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-O 121.531 0.681 . . . . 0.0 109.55 170.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.633 ' O ' ' HA ' ' A' ' 25' ' ' SER . 0.2 OUTLIER -78.5 139.45 38.67 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.036 179.104 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 22.0 t -136.1 170.05 16.64 Favored 'General case' 0 C--N 1.317 -0.828 0 O-C-N 123.257 0.348 . . . . 0.0 110.224 -174.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 62.52 26.56 15.79 Favored 'General case' 0 C--N 1.331 -0.222 0 O-C-N 123.861 0.725 . . . . 0.0 111.457 -179.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.682 ' O ' HG23 ' A' ' 24' ' ' THR . 16.4 mt -68.17 -175.92 0.66 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.209 0.528 . . . . 0.0 109.887 177.175 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.567 ' N ' ' HH ' ' A' ' 75' ' ' TYR . 5.7 tp-100 -126.1 118.9 23.67 Favored Pre-proline 0 C--N 1.319 -0.738 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.149 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.545 ' HD2' ' OE1' ' A' ' 70' ' ' GLN . 19.2 Cg_endo -60.89 134.48 53.68 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.886 2.391 . . . . 0.0 113.033 -177.077 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.63 23.33 50.72 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.936 -0.65 . . . . 0.0 111.812 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 50.5 t -129.49 146.38 34.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.183 0.516 . . . . 0.0 110.804 -177.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.493 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -82.98 120.16 25.36 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.186 -0.916 . . . . 0.0 109.721 -178.696 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.567 ' HH ' ' N ' ' A' ' 70' ' ' GLN . 14.5 m-85 -115.06 113.92 24.68 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.254 0.55 . . . . 0.0 111.949 -176.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.549 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 0.8 OUTLIER -87.22 113.35 22.88 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.936 177.006 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.534 ' HB ' HG13 ' A' ' 93' ' ' ILE . 5.3 mp -94.68 114.94 32.28 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.615 0 CA-C-O 121.289 0.566 . . . . 0.0 109.618 175.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.821 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 48.4 m -108.52 116.15 31.43 Favored 'General case' 0 N--CA 1.427 -1.615 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.122 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.527 HD12 HG22 ' A' ' 77' ' ' ILE . 13.0 mm -95.22 143.49 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.412 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 64.7 m-85 -129.99 113.12 14.18 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.001 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.554 ' HB3' HG22 ' A' ' 37' ' ' ILE . . . -78.33 122.53 25.87 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 106.738 -1.578 . . . . 0.0 106.738 168.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.564 HG12 ' C ' ' A' ' 39' ' ' GLY . 7.5 p -110.49 135.37 49.78 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 C-N-CA 120.153 -0.619 . . . . 0.0 109.97 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.661 ' OE1' ' HG2' ' A' ' 86' ' ' GLN . 4.8 mp0 -115.34 169.87 8.82 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -37.76 -53.09 1.28 Allowed 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -171.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -126.24 7.23 7.12 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.726 -0.389 . . . . 0.0 111.947 -175.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.661 ' HG2' ' OE1' ' A' ' 83' ' ' GLU . 20.3 pm0 -143.79 176.73 9.02 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 120.688 -0.405 . . . . 0.0 111.289 -173.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -136.06 129.89 32.62 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.775 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 67.9 m -76.99 175.78 9.25 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.086 0.47 . . . . 0.0 111.622 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -60.93 152.94 68.02 Favored Pre-proline 0 N--CA 1.451 -0.38 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.283 179.065 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -85.99 141.83 7.4 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.433 2.089 . . . . 0.0 114.204 -177.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.821 ' O ' ' HA ' ' A' ' 78' ' ' THR . 11.8 t -82.51 124.88 39.74 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.718 0 CA-C-N 114.692 -1.14 . . . . 0.0 108.101 166.192 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 14.4 t -120.34 105.24 16.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 C-N-CA 119.385 -0.926 . . . . 0.0 109.904 171.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.534 HG13 ' HB ' ' A' ' 77' ' ' ILE . 10.4 pt -122.04 110.86 28.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.192 177.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.423 ' HB2' ' OE1' ' A' ' 74' ' ' GLN . 11.1 pt20 -100.86 114.6 28.59 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.783 0.801 . . . . 0.0 111.237 -174.093 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.28 126.44 52.16 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.988 -1.005 . . . . 0.0 109.756 178.38 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.447 ' HB2' ' HG2' ' A' ' 74' ' ' GLN . 39.1 tt0 -89.73 130.21 36.03 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 177.039 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.499 HG22 HD13 ' A' ' 26' ' ' ILE . 41.6 p -63.66 140.38 58.87 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.319 -177.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.6 m . . . . . 0 C--N 1.328 -0.366 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.633 -173.766 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.555 ' HB3' ' O ' ' A' ' 89' ' ' THR . . . . . . . . 0 N--CA 1.452 -0.34 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -62.22 132.68 39.93 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.412 2.074 . . . . 0.0 111.655 173.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -49.43 145.6 15.84 Favored 'Trans proline' 0 C--O 1.236 0.383 0 C-N-CA 122.588 2.192 . . . . 0.0 111.188 172.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -34.98 106.63 0.3 Allowed Pre-proline 0 N--CA 1.469 0.497 0 O-C-N 124.847 1.342 . . . . 0.0 112.693 -169.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.569 ' HG2' HG13 ' A' ' 91' ' ' VAL . 28.0 Cg_exo -66.68 151.51 82.5 Favored 'Trans proline' 0 CA--C 1.519 -0.273 0 C-N-CA 123.534 2.823 . . . . 0.0 112.108 178.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 8.2 m -113.13 131.62 55.77 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.635 -177.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.453 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 71.6 t -76.05 119.34 23.91 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-N 114.363 -1.29 . . . . 0.0 110.143 174.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -93.81 -28.05 16.11 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.073 -174.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -135.52 132.6 37.49 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.388 -178.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.442 ' HA ' HG12 ' A' ' 26' ' ' ILE . 11.5 t -131.95 104.84 8.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.77 179.312 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -111.75 -163.29 0.84 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.092 177.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.471 ' O ' ' HB2' ' A' ' 69' ' ' LEU . 4.0 p-10 -73.69 -62.42 1.5 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.349 0.595 . . . . 0.0 111.471 176.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.626 HG23 ' O ' ' A' ' 69' ' ' LEU . 35.1 p -111.49 33.43 4.72 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.447 -172.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.687 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 35.6 m -168.88 130.4 1.22 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.897 -171.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.572 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 40.5 mt -146.64 140.14 20.16 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.636 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 176.251 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 85.6 t -117.09 129.19 74.04 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.752 0 O-C-N 121.654 -0.654 . . . . 0.0 110.61 -175.082 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.652 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.8 OUTLIER -121.97 143.44 34.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 C-N-CA 120.32 -0.552 . . . . 0.0 109.608 -178.912 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.49 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 44.6 mtp180 -129.65 121.13 26.41 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.891 0.377 . . . . 0.0 110.5 -174.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.52 ' CH2' HD13 ' A' ' 57' ' ' LEU . 37.1 p90 -111.54 152.6 27.34 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.566 -174.411 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 11.7 m -96.81 97.46 9.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.965 178.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.548 ' NE ' ' HB3' ' A' ' 62' ' ' ASN . 0.1 OUTLIER -49.72 156.52 1.19 Allowed Pre-proline 0 CA--C 1.538 0.489 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -173.768 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.591 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 3.0 Cg_exo -84.1 165.55 13.06 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 124.303 3.335 . . . . 0.0 112.638 -173.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -77.91 -18.41 56.17 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.198 173.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.57 143.88 96.11 Favored Pre-proline 0 C--O 1.235 0.334 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.105 175.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.45 ' O ' ' HG2' ' A' ' 83' ' ' GLU . 57.2 Cg_endo -75.86 114.68 3.99 Favored 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 121.321 1.347 . . . . 0.0 109.934 170.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.569 HG21 ' HB3' ' A' ' 81' ' ' ALA . 1.3 pt -118.78 152.43 21.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -175.238 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.45 ' C ' ' HB3' ' A' ' 59' ' ' GLU . 7.7 p -92.15 -30.06 16.16 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.956 0.725 . . . . 0.0 112.956 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.589 ' C ' HG13 ' A' ' 82' ' ' VAL . . . -169.85 -162.14 21.58 Favored Glycine 0 CA--C 1.501 -0.818 0 C-N-CA 119.9 -1.143 . . . . 0.0 111.445 -178.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.591 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 7.2 m-85 -140.86 134.42 30.07 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 117.068 0.434 . . . . 0.0 110.888 173.324 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 -101.91 147.82 26.07 Favored 'General case' 0 CA--C 1.505 -0.762 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 166.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.887 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 34.4 mt -138.67 108.96 4.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 C-N-CA 120.238 -0.585 . . . . 0.0 112.367 -177.274 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 76.6 t -107.37 110.18 30.89 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.448 0 CA-C-O 121.27 0.557 . . . . 0.0 110.6 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.693 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 0.6 OUTLIER -112.62 125.05 53.86 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.34 175.969 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.425 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 13.5 t -140.22 136.03 16.64 Favored Pre-proline 0 C--N 1.31 -1.132 0 CA-C-N 113.941 -1.481 . . . . 0.0 110.297 -174.156 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.568 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 21.6 Cg_exo . . . . . 0 CA--C 1.518 -0.319 0 C-N-CA 123.014 2.476 . . . . 0.0 111.795 176.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.444 ' HA ' ' O ' ' A' ' 44' ' ' TYR . 6.1 m . . . . . 0 CA--C 1.517 -0.312 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.693 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 55.1 m -146.36 150.53 35.88 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.233 -175.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.887 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 46.7 tt0 -120.7 113.59 20.44 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.914 176.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.614 HD11 ' CG2' ' A' ' 64' ' ' VAL . 20.3 mt -97.17 157.84 15.74 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.461 177.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.478 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 27.4 t-20 -121.87 113.2 19.3 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.362 177.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.52 HD13 ' CH2' ' A' ' 30' ' ' TRP . 3.3 mt -109.98 155.56 41.44 Favored Pre-proline 0 C--N 1.318 -0.784 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -176.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -62.72 148.22 93.68 Favored 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 121.781 1.654 . . . . 0.0 110.959 176.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.45 ' HB3' ' C ' ' A' ' 38' ' ' THR . 8.8 pt-20 -44.96 -24.97 0.26 Allowed 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 114.986 -1.006 . . . . 0.0 113.468 178.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.5 t -105.85 9.07 32.94 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.04 0.447 . . . . 0.0 111.213 -174.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.434 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -76.09 157.28 33.07 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.548 ' HB3' ' NE ' ' A' ' 32' ' ' ARG . 27.9 p-10 -141.6 13.87 2.14 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.445 -0.502 . . . . 0.0 112.231 -178.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.652 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 16.6 m -162.17 133.88 5.4 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 121.951 -0.468 . . . . 0.0 110.698 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.614 ' CG2' HD11 ' A' ' 55' ' ' LEU . 4.3 p -115.27 135.47 55.14 Favored 'Isoleucine or valine' 0 C--O 1.242 0.708 0 CA-C-O 120.796 0.331 . . . . 0.0 110.184 173.211 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 55.0 m -96.27 101.19 12.8 Favored 'General case' 0 N--CA 1.434 -1.27 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.725 170.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.687 ' O ' ' HA ' ' A' ' 25' ' ' SER . 0.3 OUTLIER -77.82 142.02 38.83 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 177.664 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 10.1 t -138.2 167.97 20.71 Favored 'General case' 0 C--N 1.322 -0.597 0 O-C-N 123.282 0.364 . . . . 0.0 110.779 -173.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 63.96 25.12 13.83 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.574 -179.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.626 ' O ' HG23 ' A' ' 24' ' ' THR . 12.7 mt -69.58 -175.99 0.94 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.012 0.435 . . . . 0.0 110.142 177.297 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.403 ' N ' ' HH ' ' A' ' 75' ' ' TYR . 8.3 tt0 -129.41 127.23 23.08 Favored Pre-proline 0 C--N 1.319 -0.725 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 177.065 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -64.52 134.77 42.78 Favored 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 122.663 2.242 . . . . 0.0 112.599 -178.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 83.77 30.72 28.62 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.989 -0.625 . . . . 0.0 111.576 -178.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.474 ' CG1' ' HB3' ' A' ' 46' ' ' PRO . 95.6 t -133.23 141.98 43.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.7 0.286 . . . . 0.0 110.518 -177.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.575 ' OE1' ' HB2' ' A' ' 94' ' ' GLN . 1.5 tm0? -87.68 122.19 31.04 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.051 -179.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.454 ' CE1' ' HG3' ' A' ' 46' ' ' PRO . 13.4 m-85 -113.15 113.65 25.67 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.143 -174.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.511 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 13.3 m120 -86.34 106.42 17.38 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.937 177.116 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.518 HG23 HD11 ' A' ' 79' ' ' ILE . 5.3 mp -92.35 119.72 40.36 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.529 0 CA-C-O 121.201 0.524 . . . . 0.0 109.886 177.174 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.817 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 65.6 m -111.68 118.44 35.65 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.478 177.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.518 HD11 HG23 ' A' ' 77' ' ' ILE . 12.0 mm -96.12 140.05 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.407 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 67.8 m-85 -128.41 111.51 13.4 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 178.166 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.569 ' HB3' HG21 ' A' ' 37' ' ' ILE . . . -79.81 110.36 15.09 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 173.149 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.589 HG13 ' C ' ' A' ' 39' ' ' GLY . 10.8 p -99.44 141.53 16.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 C-N-CA 120.196 -0.602 . . . . 0.0 110.728 -173.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.45 ' HG2' ' O ' ' A' ' 36' ' ' PRO . 9.5 tm-20 -118.31 165.9 13.28 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 -176.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -45.17 -46.76 12.26 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -176.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -126.84 0.1 6.66 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.854 0.359 . . . . 0.0 111.426 -174.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -134.08 174.09 10.87 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 122.071 -0.393 . . . . 0.0 111.167 -173.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -136.9 133.67 35.99 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.433 175.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.7 m -75.9 174.59 9.72 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.495 -178.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.555 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 0.1 OUTLIER -60.48 159.43 24.01 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.704 176.525 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -88.66 134.79 2.84 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 122.243 1.962 . . . . 0.0 113.951 -178.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.817 ' O ' ' HA ' ' A' ' 78' ' ' THR . 10.5 t -82.67 126.58 40.04 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.627 0 CA-C-N 115.133 -0.939 . . . . 0.0 108.59 167.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.6 t -124.62 106.33 16.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 C-N-CA 120.115 -0.634 . . . . 0.0 110.276 174.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.484 HG13 ' HB ' ' A' ' 77' ' ' ILE . 8.3 pt -127.34 116.19 43.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.976 179.063 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.575 ' HB2' ' OE1' ' A' ' 74' ' ' GLN . 3.7 pt20 -99.5 131.41 45.52 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.261 0.553 . . . . 0.0 111.094 -177.5 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -140.43 129.11 22.98 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.137 178.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.44 ' HB2' ' HG2' ' A' ' 74' ' ' GLN . 38.7 tt0 -86.9 139.95 30.12 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.081 0.467 . . . . 0.0 110.305 177.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.467 HG21 HD13 ' A' ' 26' ' ' ILE . 18.7 p -70.56 119.44 14.73 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.314 -179.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 19.4 m . . . . . 0 C--N 1.325 -0.494 0 CA-C-O 121.247 0.546 . . . . 0.0 110.544 -179.369 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.319 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.402 ' HB3' ' O ' ' A' ' 31' ' ' SER . 15.6 Cg_exo -71.2 138.35 33.15 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.042 1.828 . . . . 0.0 110.788 174.14 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.559 ' HD2' ' O ' ' A' ' 31' ' ' SER . 18.1 Cg_endo -60.59 160.09 25.61 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 122.371 2.047 . . . . 0.0 110.518 176.147 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -42.15 107.69 0.55 Allowed Pre-proline 0 N--CA 1.468 0.449 0 O-C-N 124.126 0.891 . . . . 0.0 111.84 -170.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.548 ' HG2' HG11 ' A' ' 91' ' ' VAL . 24.3 Cg_exo -67.5 153.35 76.78 Favored 'Trans proline' 0 CA--C 1.518 -0.291 0 C-N-CA 122.953 2.436 . . . . 0.0 111.756 178.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 61.4 m -111.48 131.11 55.46 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 121.752 0.787 . . . . 0.0 110.87 -178.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 79.5 t -80.17 124.55 38.31 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 CA-C-N 114.119 -1.4 . . . . 0.0 110.06 174.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -83.41 -49.21 9.54 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.189 -176.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -136.84 141.94 42.84 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.794 -177.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.511 HG11 ' NE2' ' A' ' 95' ' ' GLN . 27.3 m -129.46 125.72 62.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.041 179.26 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -125.15 -167.9 1.75 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.057 176.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.512 ' O ' ' HB2' ' A' ' 69' ' ' LEU . 1.6 p-10 -62.54 -64.21 0.99 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.111 0.481 . . . . 0.0 111.824 178.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.645 HG23 ' O ' ' A' ' 69' ' ' LEU . 32.9 p -111.66 35.0 3.83 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.915 -172.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.604 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 52.4 p -169.16 139.38 2.23 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.277 -175.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.591 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 12.0 mt -149.89 140.2 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 176.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.434 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 44.0 t -116.21 128.63 73.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 O-C-N 121.486 -0.759 . . . . 0.0 110.519 -177.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.607 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.7 OUTLIER -124.63 146.05 30.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.072 -176.805 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.471 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 22.3 mtm180 -131.01 121.93 25.92 Favored 'General case' 0 C--N 1.328 -0.359 0 O-C-N 123.305 0.378 . . . . 0.0 110.804 -175.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.507 ' CH2' HD11 ' A' ' 57' ' ' LEU . 39.8 p90 -114.82 143.32 45.28 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.245 -175.083 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.559 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 15.9 t -88.95 98.77 11.93 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 177.211 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.529 ' CD ' ' H ' ' A' ' 32' ' ' ARG . 0.1 OUTLIER -51.9 159.26 1.43 Allowed Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 123.71 0.804 . . . . 0.0 113.06 -174.621 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.65 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 3.7 Cg_exo -82.21 166.11 16.51 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 124.116 3.211 . . . . 0.0 112.048 -176.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -87.43 -5.41 58.85 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.541 177.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -70.89 148.1 94.45 Favored Pre-proline 0 N--CA 1.453 -0.314 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.847 175.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.487 ' O ' ' HG3' ' A' ' 83' ' ' GLU . 10.9 Cg_exo -71.76 115.91 4.49 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 121.82 1.68 . . . . 0.0 110.101 169.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.444 HD12 ' HD2' ' A' ' 33' ' ' PRO . 2.4 pt -124.73 153.92 31.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -175.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 18.1 p -94.39 -32.67 13.46 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -176.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.559 ' C ' HG13 ' A' ' 82' ' ' VAL . . . -168.55 -162.79 21.35 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.314 -0.946 . . . . 0.0 111.796 -177.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.65 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 7.1 m-85 -141.78 135.23 29.48 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 122.573 0.349 . . . . 0.0 111.284 174.248 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.9 mmm180 -100.16 148.4 24.64 Favored 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 167.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.913 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 29.9 mt -139.19 107.74 3.42 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 C-N-CA 120.075 -0.65 . . . . 0.0 112.315 179.319 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 80.3 t -109.24 110.72 33.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.089 0.471 . . . . 0.0 110.859 -178.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.762 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 1.0 OUTLIER -115.22 128.73 56.34 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.215 178.372 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.429 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 29.8 p -143.11 145.16 31.65 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 114.051 -1.431 . . . . 0.0 112.027 -174.095 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.523 ' HG3' ' CZ ' ' A' ' 75' ' ' TYR . 2.1 Cg_endo . . . . . 0 C--N 1.347 0.468 0 C-N-CA 123.657 2.904 . . . . 0.0 111.172 175.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 13.1 m . . . . . 0 CA--C 1.516 -0.355 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.762 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 21.4 m -146.95 148.12 31.43 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 119.678 -0.809 . . . . 0.0 111.531 177.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.913 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 46.7 tt0 -116.16 117.98 31.58 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.97 172.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.637 HD12 ' CG2' ' A' ' 64' ' ' VAL . 17.9 mt -98.38 156.95 16.5 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.634 -0.426 . . . . 0.0 110.07 174.176 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -120.29 113.93 21.13 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 178.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.507 HD11 ' CH2' ' A' ' 30' ' ' TRP . 2.6 mt -111.27 157.74 38.09 Favored Pre-proline 0 C--N 1.318 -0.796 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -175.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -66.78 150.66 83.36 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 121.769 1.646 . . . . 0.0 111.512 175.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -43.17 -27.44 0.22 Allowed 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 114.435 -1.257 . . . . 0.0 113.397 177.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 5.7 t -104.38 4.89 33.92 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.148 0.499 . . . . 0.0 111.227 -172.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -75.14 152.42 38.49 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 -178.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.473 ' HB3' ' NE ' ' A' ' 32' ' ' ARG . 27.7 p-10 -135.6 16.28 3.37 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.816 -0.353 . . . . 0.0 111.831 -178.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.607 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 17.8 p -170.17 136.93 1.47 Allowed 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.27 -0.572 . . . . 0.0 112.078 -178.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.637 ' CG2' HD12 ' A' ' 55' ' ' LEU . 3.9 p -119.8 138.42 50.47 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.337 176.385 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 50.5 m -98.36 101.43 12.88 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-O 121.334 0.588 . . . . 0.0 109.692 170.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.624 ' CD2' HG12 ' A' ' 64' ' ' VAL . 0.2 OUTLIER -79.93 145.29 32.72 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.426 178.801 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.437 ' HA ' ' O ' ' A' ' 24' ' ' THR . 17.6 t -139.0 177.91 7.55 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -177.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 65.37 20.84 11.87 Favored 'General case' 0 N--CA 1.468 0.437 0 O-C-N 123.486 0.491 . . . . 0.0 111.977 -178.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.645 ' O ' HG23 ' A' ' 24' ' ' THR . 13.8 mt -72.19 -175.59 1.56 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.182 0.515 . . . . 0.0 110.339 178.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.426 ' N ' ' HH ' ' A' ' 75' ' ' TYR . 56.0 tp60 -128.72 128.82 23.5 Favored Pre-proline 0 C--N 1.319 -0.734 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 178.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.9 134.63 54.53 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.951 2.434 . . . . 0.0 113.391 -178.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.13 35.81 26.17 Favored Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 115.868 -0.605 . . . . 0.0 112.405 177.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 96' ' ' GLU . 42.5 t -134.37 150.43 30.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.04 0.448 . . . . 0.0 111.424 -175.327 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 8.0 tp60 -91.1 105.03 17.53 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.332 179.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.523 ' CZ ' ' HG3' ' A' ' 46' ' ' PRO . 9.9 m-85 -97.38 121.14 38.94 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.79 -178.091 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.529 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 55.7 m-20 -91.85 111.87 23.57 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.283 176.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.531 ' HB ' HG13 ' A' ' 93' ' ' ILE . 5.3 mp -94.82 118.4 40.83 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.623 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.971 176.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.889 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 29.5 m -107.91 115.4 30.07 Favored 'General case' 0 N--CA 1.425 -1.684 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.605 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.528 HD11 HG22 ' A' ' 77' ' ' ILE . 12.5 mm -96.1 137.58 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.41 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 75.4 m-85 -126.15 111.75 15.0 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.052 178.516 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -80.02 112.39 17.28 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 171.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.559 HG13 ' C ' ' A' ' 39' ' ' GLY . 10.9 p -103.64 136.4 36.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 C-N-CA 119.924 -0.711 . . . . 0.0 110.956 -175.123 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.659 ' HG2' ' N ' ' A' ' 84' ' ' GLU . 2.4 tt0 -117.73 166.91 11.87 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 177.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.659 ' N ' ' HG2' ' A' ' 83' ' ' GLU . 28.0 mt-10 -44.02 -48.38 8.78 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 178.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 19.9 m-80 -98.62 -33.87 10.79 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -170.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -145.81 169.49 18.42 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-O 120.904 0.383 . . . . 0.0 111.518 -167.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -114.72 145.78 41.68 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.289 175.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 17.8 m -76.15 169.78 17.55 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.738 178.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.2 p -58.73 146.11 75.87 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.079 173.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -78.26 138.91 16.31 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.134 1.889 . . . . 0.0 113.966 -174.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.889 ' O ' ' HA ' ' A' ' 78' ' ' THR . 9.7 t -81.74 126.5 39.88 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.745 0 CA-C-N 114.828 -1.078 . . . . 0.0 108.174 167.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 15.7 t -123.78 106.06 16.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 C-N-CA 119.766 -0.774 . . . . 0.0 109.912 170.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.531 HG13 ' HB ' ' A' ' 77' ' ' ILE . 6.9 pt -120.0 115.58 47.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.892 178.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -99.44 125.01 45.08 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.273 0.558 . . . . 0.0 111.372 -176.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.511 ' NE2' HG11 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -128.73 131.63 47.91 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.379 178.797 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.409 ' HA ' ' O ' ' A' ' 73' ' ' VAL . 44.1 mt-10 -85.71 127.31 34.48 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.049 0.452 . . . . 0.0 110.218 176.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.495 HG21 HD13 ' A' ' 26' ' ' ILE . 46.4 p -69.92 120.65 15.96 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.562 -179.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.9 m . . . . . 0 C--N 1.328 -0.351 0 CA-C-O 121.292 0.568 . . . . 0.0 110.588 -178.794 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.432 ' HB3' ' O ' ' A' ' 89' ' ' THR . . . . . . . . 0 CA--C 1.52 -0.192 0 N-CA-C 110.292 -0.262 . . . . 0.0 110.292 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.403 ' HB2' ' HB2' ' A' ' 30' ' ' TRP . 26.8 Cg_exo -64.54 128.45 21.25 Favored 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.365 2.044 . . . . 0.0 111.646 178.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -53.03 143.52 49.86 Favored 'Trans proline' 0 CA--C 1.512 -0.602 0 C-N-CA 122.517 2.145 . . . . 0.0 111.312 176.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -37.05 103.17 0.25 Allowed Pre-proline 0 CA--C 1.515 -0.39 0 O-C-N 125.145 1.528 . . . . 0.0 112.74 -163.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.712 ' CG ' HG11 ' A' ' 91' ' ' VAL . 3.1 Cg_endo -47.62 147.98 6.17 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 123.594 2.863 . . . . 0.0 113.526 169.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 18.4 m -107.6 131.6 54.19 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.021 -0.991 . . . . 0.0 109.789 177.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.454 HG13 ' O ' ' A' ' 27' ' ' VAL . 81.2 t -76.52 121.03 27.82 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.41 176.128 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -86.08 -39.06 17.16 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.526 -175.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -135.26 127.96 30.95 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.842 0.354 . . . . 0.0 110.683 -178.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.498 ' HA ' HG12 ' A' ' 26' ' ' ILE . 98.7 t -120.78 115.58 47.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.4 177.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -127.2 -164.17 1.33 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.338 178.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -68.55 -63.01 1.14 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.088 0.471 . . . . 0.0 112.149 -178.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.629 HG22 ' O ' ' A' ' 69' ' ' LEU . 38.7 p -117.81 35.08 4.85 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.812 -171.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.513 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 54.4 p -170.91 132.38 0.87 Allowed 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.496 -173.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.584 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 32.7 mt -145.91 140.82 21.67 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.781 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 178.214 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.454 ' O ' HG13 ' A' ' 18' ' ' VAL . 39.7 t -117.14 134.11 61.76 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.631 0 C-N-CA 120.064 -0.655 . . . . 0.0 110.084 -176.003 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.646 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.6 OUTLIER -127.06 146.93 32.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 C-N-CA 120.221 -0.591 . . . . 0.0 110.462 -178.643 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.56 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 18.4 mtp180 -128.54 118.94 23.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.549 -177.125 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.549 ' CH2' HD11 ' A' ' 57' ' ' LEU . 36.4 p90 -110.48 146.11 36.53 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.961 -176.08 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 20.8 m -92.21 99.92 12.62 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.078 177.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.549 ' NE ' ' HB3' ' A' ' 62' ' ' ASN . 0.1 OUTLIER -46.58 156.98 0.47 Allowed Pre-proline 0 CA--C 1.536 0.419 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -175.222 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.608 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 3.4 Cg_exo -83.34 169.0 12.84 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 124.179 3.253 . . . . 0.0 112.5 -172.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -87.2 -3.43 59.05 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.231 -0.895 . . . . 0.0 108.938 173.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.71 146.87 80.67 Favored Pre-proline 0 N--CA 1.451 -0.416 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.968 175.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -77.84 114.7 3.68 Favored 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 121.371 1.38 . . . . 0.0 110.043 170.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.556 HG23 ' HB3' ' A' ' 81' ' ' ALA . 0.7 OUTLIER -120.25 155.02 23.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.461 -174.494 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.1 p -97.51 -33.79 11.23 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -178.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.42 ' C ' ' HD1' ' A' ' 40' ' ' TYR . . . -164.74 -169.65 28.62 Favored Glycine 0 C--O 1.222 -0.642 0 C-N-CA 120.075 -1.059 . . . . 0.0 112.16 179.393 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.608 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 4.6 m-85 -136.56 131.38 33.76 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-N 117.302 0.551 . . . . 0.0 111.674 176.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 37.4 mtm180 -103.98 148.41 26.23 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.029 168.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.853 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 30.4 mt -139.0 109.32 4.37 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 C-N-CA 120.421 -0.511 . . . . 0.0 112.335 -176.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 95.6 t -110.43 110.74 33.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.42 0.629 . . . . 0.0 110.667 179.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.751 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 0.5 OUTLIER -108.17 125.09 51.22 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.191 175.358 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.411 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 6.3 p -144.03 138.4 14.98 Favored Pre-proline 0 C--N 1.315 -0.903 0 CA-C-N 113.864 -1.517 . . . . 0.0 111.301 -173.543 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.752 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 22.5 Cg_exo . . . . . 0 C--O 1.232 0.221 0 C-N-CA 123.349 2.699 . . . . 0.0 111.767 175.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.441 ' HA ' ' O ' ' A' ' 44' ' ' TYR . 15.0 m . . . . . 0 CA--C 1.517 -0.321 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.751 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 30.6 m -147.15 154.99 41.76 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.358 -176.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.853 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 33.0 tt0 -124.31 115.4 20.95 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 123.297 0.639 . . . . 0.0 109.902 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.629 HD11 ' CG2' ' A' ' 64' ' ' VAL . 18.4 mt -100.52 160.5 14.29 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 175.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.408 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 17.5 m120 -125.98 121.59 33.51 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 178.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.549 HD11 ' CH2' ' A' ' 30' ' ' TRP . 4.6 mt -118.33 158.9 45.48 Favored Pre-proline 0 C--N 1.318 -0.79 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -176.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -64.48 150.97 87.31 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 121.58 1.52 . . . . 0.0 111.21 175.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -46.0 -26.75 0.77 Allowed 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 114.924 -1.035 . . . . 0.0 112.77 177.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 7.8 t -103.76 8.21 37.22 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.318 -174.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.469 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -75.0 160.43 30.55 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -179.173 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.56 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 24.7 p-10 -142.58 10.92 1.86 Allowed 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.473 -0.491 . . . . 0.0 112.323 -179.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.646 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 14.6 m -161.43 133.82 5.94 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 118.476 0.58 . . . . 0.0 111.473 -178.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.629 ' CG2' HD11 ' A' ' 55' ' ' LEU . 4.1 p -119.56 136.87 55.31 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 173.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 40.4 m -97.44 100.97 12.4 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-O 121.426 0.631 . . . . 0.0 109.711 169.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.596 ' CD2' HG13 ' A' ' 64' ' ' VAL . 0.2 OUTLIER -78.52 145.14 35.06 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.008 178.045 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.1 t -142.31 173.56 11.42 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -175.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 67.02 23.04 9.86 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 123.907 0.755 . . . . 0.0 111.078 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.629 ' O ' HG22 ' A' ' 24' ' ' THR . 10.3 mt -72.37 -175.77 1.67 Allowed 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 177.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.437 ' N ' ' HH ' ' A' ' 75' ' ' TYR . 21.6 mm-40 -125.51 134.12 25.52 Favored Pre-proline 0 C--N 1.322 -0.613 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 176.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -65.8 126.01 15.25 Favored 'Trans proline' 0 CA--C 1.529 0.267 0 C-N-CA 122.502 2.135 . . . . 0.0 112.885 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 86.03 31.77 19.4 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.503 177.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 92.1 t -129.79 145.28 35.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.019 0.438 . . . . 0.0 110.698 -177.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.752 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -80.05 123.75 28.12 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.692 -179.274 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.437 ' HH ' ' N ' ' A' ' 70' ' ' GLN . 15.3 m-85 -120.45 114.03 21.2 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.164 0.507 . . . . 0.0 112.119 -176.232 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.437 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 11.5 m120 -90.33 110.65 21.71 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.371 176.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.533 HG21 HD13 ' A' ' 79' ' ' ILE . 5.1 mp -91.36 116.21 32.07 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.686 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 176.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.849 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 14.9 m -108.86 113.51 26.49 Favored 'General case' 0 N--CA 1.424 -1.751 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.359 -177.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.533 HD13 HG21 ' A' ' 77' ' ' ILE . 10.8 mm -95.13 134.23 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -122.33 111.55 17.04 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.75 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.556 ' HB3' HG23 ' A' ' 37' ' ' ILE . . . -81.25 131.17 35.28 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 170.07 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.4 HG12 ' C ' ' A' ' 39' ' ' GLY . 7.7 p -118.47 135.37 59.1 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.317 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.545 ' HG3' HG22 ' A' ' 37' ' ' ILE . 4.0 mp0 -115.21 169.95 8.74 Favored 'General case' 0 N--CA 1.448 -0.561 0 O-C-N 123.906 0.754 . . . . 0.0 109.482 -178.194 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -44.26 -47.88 9.43 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -174.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 30.3 p-10 -129.88 16.39 5.76 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.934 -0.306 . . . . 0.0 111.635 -177.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 77.2 mm-40 -144.65 173.99 11.36 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.763 0.316 . . . . 0.0 111.076 -176.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -140.54 119.9 13.06 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 174.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 66.7 m -65.57 167.42 8.97 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.832 0.349 . . . . 0.0 111.574 -177.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.432 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 1.2 p -57.4 160.61 6.84 Favored Pre-proline 0 CA--C 1.536 0.422 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.696 178.532 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -86.99 133.58 3.48 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 122.259 1.973 . . . . 0.0 113.766 -177.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.849 ' O ' ' HA ' ' A' ' 78' ' ' THR . 44.2 t -82.62 122.73 37.61 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.723 0 CA-C-N 114.936 -1.029 . . . . 0.0 108.622 170.028 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 10.8 t -120.38 106.6 19.07 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 C-N-CA 119.586 -0.846 . . . . 0.0 110.277 174.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.521 HG13 ' HB ' ' A' ' 77' ' ' ILE . 7.7 pt -122.29 113.7 39.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.733 176.394 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -100.4 131.25 46.43 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.395 0.616 . . . . 0.0 111.389 -174.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.71 132.35 34.75 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.572 177.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.48 ' HG2' ' HG2' ' A' ' 74' ' ' GLN . 45.3 mt-10 -89.13 131.8 35.1 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 175.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.485 HG22 HD11 ' A' ' 26' ' ' ILE . 31.4 p -68.5 121.17 15.8 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.47 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.3 m . . . . . 0 C--N 1.327 -0.397 0 CA-C-O 121.191 0.52 . . . . 0.0 110.305 -179.204 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.588 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.473 ' CB ' ' HB2' ' A' ' 30' ' ' TRP . 31.5 Cg_exo -62.47 128.14 22.8 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.017 1.811 . . . . 0.0 111.774 174.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -52.73 138.41 59.48 Favored 'Trans proline' 0 CA--C 1.509 -0.765 0 C-N-CA 122.288 1.992 . . . . 0.0 110.529 172.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.496 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 17.9 m-20 -36.52 102.78 0.24 Allowed Pre-proline 0 N--CA 1.465 0.296 0 O-C-N 125.373 1.671 . . . . 0.0 112.443 -161.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.722 ' CG ' HG11 ' A' ' 91' ' ' VAL . 2.8 Cg_endo -46.61 146.14 5.66 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 123.896 3.064 . . . . 0.0 113.855 172.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 11.2 m -104.0 129.97 51.62 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.111 -0.949 . . . . 0.0 110.414 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 89.3 t -79.46 121.74 33.29 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 114.458 -1.247 . . . . 0.0 109.997 174.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -86.18 -43.17 13.22 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.333 -175.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -135.86 139.35 43.33 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.907 0.384 . . . . 0.0 111.046 -179.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.443 HG21 HG12 ' A' ' 18' ' ' VAL . 40.3 t -129.02 111.49 23.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.327 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.433 ' CG ' ' H ' ' A' ' 23' ' ' ASP . 8.6 t70 -116.94 -157.46 0.66 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 -178.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.433 ' H ' ' CG ' ' A' ' 22' ' ' ASP . 7.0 m-20 -75.53 -64.02 1.16 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.231 0.539 . . . . 0.0 110.234 -179.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.667 HG22 ' O ' ' A' ' 69' ' ' LEU . 42.2 p -112.05 37.62 2.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.072 -175.02 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.62 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 69.6 m -168.43 131.97 1.52 Allowed 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 122.611 0.364 . . . . 0.0 110.834 -172.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.502 HD11 HG22 ' A' ' 97' ' ' THR . 39.8 mt -147.53 138.18 17.42 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.622 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 176.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 39.7 t -117.35 132.54 66.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 118.695 0.68 . . . . 0.0 110.629 -174.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.611 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.7 OUTLIER -127.64 146.07 33.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.544 -177.823 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.499 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 92.8 mtt180 -128.04 120.63 27.89 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 123.625 0.578 . . . . 0.0 110.519 -177.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.529 ' CH2' HD13 ' A' ' 57' ' ' LEU . 34.7 p90 -113.69 154.11 27.83 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.231 -175.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.435 ' O ' ' HA ' ' A' ' 13' ' ' PRO . 24.8 t -101.32 102.16 12.95 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 121.162 0.506 . . . . 0.0 110.5 178.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.518 ' CD ' ' H ' ' A' ' 32' ' ' ARG . 0.1 OUTLIER -53.89 160.46 2.18 Favored Pre-proline 0 CA--C 1.542 0.669 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -174.486 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.656 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 2.3 Cg_endo -84.87 169.44 10.41 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 124.581 3.521 . . . . 0.0 113.024 -175.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 -79.58 -22.25 44.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.609 173.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.427 ' HB1' ' OE2' ' A' ' 83' ' ' GLU . . . -58.77 136.7 86.86 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.171 179.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -66.52 113.45 2.71 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 121.317 1.345 . . . . 0.0 109.723 172.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.54 HG23 ' HG2' ' A' ' 83' ' ' GLU . 6.7 pt -123.55 157.3 29.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.855 -173.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.46 ' C ' ' HB3' ' A' ' 59' ' ' GLU . 18.3 p -101.19 -27.65 13.1 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -176.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.475 ' C ' HG11 ' A' ' 82' ' ' VAL . . . -171.04 -163.27 24.79 Favored Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 119.68 -1.247 . . . . 0.0 112.617 179.421 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.656 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 6.6 m-85 -141.05 135.64 31.23 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 122.858 0.463 . . . . 0.0 110.851 176.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 27.5 mtp180 -104.69 150.2 24.93 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 167.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.863 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 26.7 mt -139.0 107.94 3.65 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 C-N-CA 120.279 -0.568 . . . . 0.0 112.165 -178.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 69.2 t -105.93 110.78 32.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.323 0.582 . . . . 0.0 110.52 179.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.619 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 0.7 OUTLIER -112.35 125.73 54.51 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.341 176.008 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.403 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 16.1 t -142.75 138.1 15.77 Favored Pre-proline 0 C--N 1.317 -0.832 0 CA-C-N 113.968 -1.469 . . . . 0.0 110.785 -173.433 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.662 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 27.1 Cg_exo . . . . . 0 C--N 1.345 0.369 0 C-N-CA 123.473 2.782 . . . . 0.0 112.252 175.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.479 ' HA ' ' O ' ' A' ' 44' ' ' TYR . 6.2 p . . . . . 0 N--CA 1.449 -0.49 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.619 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 40.4 m -147.86 151.18 35.49 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 120.581 -0.447 . . . . 0.0 111.534 -177.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.863 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 39.6 tt0 -116.05 115.09 25.48 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 172.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.628 HD13 ' CG2' ' A' ' 64' ' ' VAL . 17.0 mt -96.58 153.49 17.82 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 175.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -117.37 118.95 33.63 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.529 HD13 ' CH2' ' A' ' 30' ' ' TRP . 3.5 mt -116.25 156.22 47.38 Favored Pre-proline 0 N--CA 1.444 -0.73 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 -176.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -64.31 151.44 85.42 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 122.009 1.806 . . . . 0.0 111.403 176.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.46 ' HB3' ' C ' ' A' ' 38' ' ' THR . 8.9 pt-20 -47.35 -25.06 0.9 Allowed 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 114.548 -1.205 . . . . 0.0 113.431 179.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.9 t -107.54 12.84 27.36 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.185 0.517 . . . . 0.0 111.013 -176.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.481 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -76.86 156.29 32.29 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 178.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.499 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 27.5 p-10 -141.71 14.61 2.13 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -177.507 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.611 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 13.8 p -168.78 135.12 1.8 Allowed 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.207 -0.597 . . . . 0.0 112.389 -177.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.628 ' CG2' HD13 ' A' ' 55' ' ' LEU . 4.8 p -120.03 134.2 64.31 Favored 'Isoleucine or valine' 0 C--O 1.24 0.591 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.309 176.002 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 25.8 m -96.74 101.2 12.76 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-O 121.526 0.679 . . . . 0.0 109.615 169.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.62 ' O ' ' HA ' ' A' ' 25' ' ' SER . 0.3 OUTLIER -78.71 144.39 35.34 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.105 179.239 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.402 ' HA ' ' O ' ' A' ' 24' ' ' THR . 12.4 p -141.68 168.58 19.41 Favored 'General case' 0 C--N 1.322 -0.601 0 O-C-N 123.338 0.399 . . . . 0.0 110.519 -173.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 64.04 27.82 14.25 Favored 'General case' 0 C--N 1.331 -0.238 0 O-C-N 123.804 0.69 . . . . 0.0 111.18 -178.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.667 ' O ' HG22 ' A' ' 24' ' ' THR . 15.3 mt -70.11 -175.5 0.97 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.181 0.515 . . . . 0.0 109.712 175.166 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.482 ' N ' ' HH ' ' A' ' 75' ' ' TYR . 56.2 tp60 -125.0 122.67 25.48 Favored Pre-proline 0 C--N 1.315 -0.896 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 176.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -63.12 129.53 26.01 Favored 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 122.891 2.394 . . . . 0.0 112.502 -177.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 86.09 33.37 15.01 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 121.098 -0.572 . . . . 0.0 111.949 -178.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.417 ' CG1' ' HB3' ' A' ' 46' ' ' PRO . 98.9 t -135.99 144.42 33.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.113 0.482 . . . . 0.0 110.93 -176.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.662 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -80.51 115.55 20.09 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.868 179.504 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.482 ' HH ' ' N ' ' A' ' 70' ' ' GLN . 13.0 m-85 -111.59 114.46 27.54 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.275 0.559 . . . . 0.0 111.961 -177.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.554 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 37.0 m-80 -87.2 113.47 22.96 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.946 175.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.53 ' HB ' HG13 ' A' ' 93' ' ' ILE . 5.1 mp -93.37 117.41 36.79 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.574 0 CA-C-O 121.226 0.536 . . . . 0.0 109.578 174.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.858 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 62.1 m -110.84 114.86 28.53 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.476 -179.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.521 HD12 HG21 ' A' ' 77' ' ' ILE . 11.5 mm -95.18 143.23 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 -179.319 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -129.66 111.7 12.94 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 178.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -82.39 121.93 27.35 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 172.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.475 HG11 ' C ' ' A' ' 39' ' ' GLY . 8.5 p -118.1 132.56 67.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 C-N-CA 119.758 -0.777 . . . . 0.0 112.179 -174.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.54 ' HG2' HG23 ' A' ' 37' ' ' ILE . 18.1 mt-10 -99.58 172.46 7.28 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 172.158 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -38.46 -42.8 0.78 Allowed 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -128.34 -20.15 3.74 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -178.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -98.07 167.76 10.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.145 0.497 . . . . 0.0 111.635 -173.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -145.16 121.49 10.92 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.364 175.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 10.6 m -67.38 169.77 8.44 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.325 -178.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 12.1 p -58.05 150.04 53.02 Favored Pre-proline 0 N--CA 1.451 -0.401 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.16 172.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -76.17 137.67 19.45 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 122.017 1.811 . . . . 0.0 113.06 -178.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.858 ' O ' ' HA ' ' A' ' 78' ' ' THR . 53.0 t -82.33 122.77 37.5 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.707 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 169.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.4 t -117.84 106.39 19.77 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 C-N-CA 119.374 -0.93 . . . . 0.0 110.676 174.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.53 HG13 ' HB ' ' A' ' 77' ' ' ILE . 7.5 pt -120.37 111.73 33.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.457 174.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.432 ' HB2' ' NE2' ' A' ' 74' ' ' GLN . 19.8 pt20 -99.88 121.6 41.55 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.479 0.657 . . . . 0.0 111.403 -174.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.35 130.12 47.27 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.452 179.123 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.452 ' CG ' ' HG2' ' A' ' 74' ' ' GLN . 37.2 mt-10 -85.97 134.17 33.88 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 176.206 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.502 HG22 HD11 ' A' ' 26' ' ' ILE . 21.6 p -69.13 114.26 7.24 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.355 0.598 . . . . 0.0 111.441 -177.102 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 6.9 m . . . . . 0 C--N 1.326 -0.436 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.838 179.43 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.258 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -64.4 128.54 21.62 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.186 1.924 . . . . 0.0 111.953 178.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_exo -51.53 147.2 23.65 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.57 2.18 . . . . 0.0 111.094 174.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -34.4 107.64 0.31 Allowed Pre-proline 0 N--CA 1.47 0.536 0 O-C-N 124.613 1.196 . . . . 0.0 113.016 -168.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.552 ' HG2' HG12 ' A' ' 91' ' ' VAL . 22.2 Cg_exo -68.72 153.34 73.36 Favored 'Trans proline' 0 CA--C 1.52 -0.207 0 C-N-CA 123.478 2.786 . . . . 0.0 111.829 177.218 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 26.3 m -112.63 133.41 54.68 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.566 0.698 . . . . 0.0 110.975 -177.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.452 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 79.6 t -76.21 121.39 28.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 114.437 -1.256 . . . . 0.0 110.231 175.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -76.55 -50.79 13.02 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.07 -175.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -141.12 142.23 34.12 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.799 -178.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.432 ' HA ' HG12 ' A' ' 26' ' ' ILE . 57.3 t -121.63 122.74 67.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.924 -177.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -125.58 -167.14 1.65 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.396 177.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.598 ' O ' ' HB2' ' A' ' 69' ' ' LEU . 2.0 p-10 -71.17 -65.17 0.78 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.089 0.471 . . . . 0.0 111.723 177.012 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.593 HG23 ' O ' ' A' ' 69' ' ' LEU . 42.1 p -111.23 34.63 3.96 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.561 -173.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.639 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 73.4 m -169.03 130.64 1.19 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.079 -173.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.577 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 45.0 mt -149.2 140.12 16.93 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.837 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 176.204 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.452 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 43.3 t -116.15 134.37 59.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 C-N-CA 119.834 -0.746 . . . . 0.0 110.166 -174.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.628 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.6 OUTLIER -127.33 146.23 33.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 C-N-CA 120.252 -0.579 . . . . 0.0 109.878 179.851 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.478 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 62.8 mtp180 -130.81 121.24 24.98 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 123.345 0.403 . . . . 0.0 110.472 -175.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.542 ' CH2' HD13 ' A' ' 57' ' ' LEU . 38.8 p90 -114.1 154.21 28.15 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.369 -173.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 19.7 m -100.01 100.81 11.74 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.469 178.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.557 ' NE ' ' HB3' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -51.19 157.93 1.42 Allowed Pre-proline 0 CA--C 1.537 0.463 0 C-N-CA 123.482 0.713 . . . . 0.0 112.854 -174.933 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.626 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 3.5 Cg_exo -83.25 163.7 15.08 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 124.244 3.296 . . . . 0.0 112.63 -175.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -73.76 -19.83 60.67 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.322 172.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.98 145.48 96.52 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 114.754 -1.112 . . . . 0.0 111.736 178.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -74.31 114.84 4.13 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 121.568 1.512 . . . . 0.0 110.085 168.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.544 HG21 ' HB2' ' A' ' 81' ' ' ALA . 0.7 OUTLIER -120.23 153.98 23.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -177.468 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.403 ' N ' ' O ' ' A' ' 82' ' ' VAL . 17.1 p -95.98 -25.31 15.99 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -177.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.551 ' C ' HG11 ' A' ' 82' ' ' VAL . . . -171.55 -164.87 27.92 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 119.944 -1.122 . . . . 0.0 112.235 179.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.626 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 5.8 m-85 -139.75 132.98 29.82 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 122.55 0.34 . . . . 0.0 111.18 173.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 10.8 mmm180 -99.82 151.15 21.61 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 166.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.882 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 37.6 mt -139.48 107.48 3.1 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 C-N-CA 120.134 -0.626 . . . . 0.0 112.162 178.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 71.5 t -108.56 110.33 31.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.392 0.615 . . . . 0.0 110.555 -179.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.631 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 0.6 OUTLIER -110.74 125.25 53.32 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.465 -0.788 . . . . 0.0 109.415 175.359 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.409 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 17.1 p -138.5 137.0 19.51 Favored Pre-proline 0 C--N 1.318 -0.772 0 CA-C-N 113.622 -1.626 . . . . 0.0 111.355 -173.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.633 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 22.0 Cg_exo . . . . . 0 C--O 1.231 0.17 0 C-N-CA 123.283 2.655 . . . . 0.0 112.224 175.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 14.8 m . . . . . 0 CA--C 1.516 -0.339 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.631 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 50.2 m -147.74 148.86 31.43 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.489 -0.484 . . . . 0.0 111.691 -178.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.882 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 45.5 tt0 -115.96 117.13 29.3 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.781 172.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.656 HD12 ' CG2' ' A' ' 64' ' ' VAL . 18.4 mt -97.92 163.43 12.79 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 174.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -128.96 110.51 12.14 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -178.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.542 HD13 ' CH2' ' A' ' 30' ' ' TRP . 3.3 mt -109.35 157.41 37.33 Favored Pre-proline 0 C--N 1.317 -0.844 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -175.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -64.06 149.09 91.18 Favored 'Trans proline' 0 N--CA 1.447 -1.212 0 C-N-CA 121.636 1.557 . . . . 0.0 110.99 175.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -44.02 -26.88 0.32 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.385 -1.279 . . . . 0.0 113.156 178.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 10.8 t -108.05 9.26 28.46 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.465 -173.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.402 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -75.07 161.18 29.65 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 178.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.557 ' HB3' ' NE ' ' A' ' 32' ' ' ARG . 28.3 p-10 -144.12 17.83 1.75 Allowed 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.465 0.542 . . . . 0.0 112.465 -178.207 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.628 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 17.2 p -169.62 133.76 1.33 Allowed 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.125 -0.63 . . . . 0.0 111.889 178.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.656 ' CG2' HD12 ' A' ' 55' ' ' LEU . 3.6 p -116.6 138.46 47.12 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.182 176.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 30.0 m -97.94 101.05 12.44 Favored 'General case' 0 N--CA 1.433 -1.299 0 CA-C-O 121.366 0.603 . . . . 0.0 109.457 169.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.639 ' O ' ' HA ' ' A' ' 25' ' ' SER . 0.3 OUTLIER -77.14 144.19 38.6 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.005 178.327 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 62.1 p -139.62 174.13 10.82 Favored 'General case' 0 C--N 1.319 -0.722 0 O-C-N 123.349 0.406 . . . . 0.0 110.147 -175.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 37.6 t70 61.62 28.52 17.68 Favored 'General case' 0 C--N 1.33 -0.258 0 O-C-N 123.777 0.673 . . . . 0.0 110.715 179.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.598 ' HB2' ' O ' ' A' ' 23' ' ' ASP . 13.9 mt -73.89 -176.2 2.39 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 176.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.584 ' OE1' ' HD2' ' A' ' 71' ' ' PRO . 5.8 tp-100 -132.24 121.31 17.54 Favored Pre-proline 0 C--N 1.318 -0.781 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.584 ' HD2' ' OE1' ' A' ' 70' ' ' GLN . 18.5 Cg_endo -60.62 137.06 71.01 Favored 'Trans proline' 0 C--O 1.235 0.346 0 C-N-CA 122.908 2.405 . . . . 0.0 112.896 -178.005 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.23 26.45 52.18 Favored Glycine 0 N--CA 1.449 -0.463 0 N-CA-C 111.435 -0.666 . . . . 0.0 111.435 -178.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.488 ' HB ' ' O ' ' A' ' 70' ' ' GLN . 77.8 t -131.55 136.02 58.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 120.899 0.38 . . . . 0.0 110.691 -177.207 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.633 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -80.82 117.53 21.55 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.937 -178.101 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.45 ' HH ' ' N ' ' A' ' 70' ' ' GLN . 18.9 m-85 -110.42 116.35 31.27 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.252 0.548 . . . . 0.0 112.184 -176.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.471 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 12.1 m120 -89.73 111.18 22.09 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.683 176.02 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.515 ' HB ' HG13 ' A' ' 93' ' ' ILE . 5.1 mp -92.0 118.82 38.29 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.632 0 CA-C-O 121.16 0.505 . . . . 0.0 109.836 178.057 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.852 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 21.7 m -110.45 115.3 29.4 Favored 'General case' 0 N--CA 1.428 -1.549 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.131 -179.235 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.51 HD11 HG23 ' A' ' 77' ' ' ILE . 14.1 mm -95.21 142.5 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.445 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 68.7 m-85 -129.6 112.37 13.64 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.335 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.544 ' HB2' HG21 ' A' ' 37' ' ' ILE . . . -78.95 122.88 26.7 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 168.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.551 HG11 ' C ' ' A' ' 39' ' ' GLY . 7.9 p -112.66 136.91 47.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.245 -178.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.479 ' OE1' ' HB2' ' A' ' 86' ' ' GLN . 1.8 mp0 -114.6 171.21 7.77 Favored 'General case' 0 N--CA 1.446 -0.626 0 O-C-N 123.695 0.622 . . . . 0.0 109.659 -177.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -45.3 -44.74 11.7 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -174.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -117.32 -16.73 10.28 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -175.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.479 ' HB2' ' OE1' ' A' ' 83' ' ' GLU . 45.2 mt-30 -128.4 176.05 8.02 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.474 -0.49 . . . . 0.0 111.625 -169.279 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -130.33 125.46 34.74 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.289 -0.869 . . . . 0.0 108.967 171.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 45.9 m -72.61 173.94 8.24 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.048 0.452 . . . . 0.0 111.705 -177.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -60.89 155.74 51.41 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.238 178.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -88.28 142.31 5.24 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 122.423 2.082 . . . . 0.0 114.482 -176.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.852 ' O ' ' HA ' ' A' ' 78' ' ' THR . 7.1 t -82.62 126.42 40.02 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.721 0 CA-C-N 114.662 -1.154 . . . . 0.0 108.175 166.002 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.6 t -120.26 106.73 19.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 C-N-CA 119.768 -0.773 . . . . 0.0 110.081 171.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.515 HG13 ' HB ' ' A' ' 77' ' ' ILE . 7.1 pt -123.5 113.35 37.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.54 176.021 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -99.0 126.02 44.61 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.502 0.667 . . . . 0.0 111.458 -175.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.67 127.92 33.93 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.151 -0.932 . . . . 0.0 109.56 176.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -87.26 138.17 31.72 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.076 0.465 . . . . 0.0 110.126 176.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.505 HG22 HD11 ' A' ' 26' ' ' ILE . 26.5 p -69.55 117.75 11.56 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.238 -177.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 14.3 m . . . . . 0 C--N 1.323 -0.573 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.354 -179.704 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.449 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.441 ' HA ' ' O ' ' A' ' 31' ' ' SER . 30.3 Cg_exo -64.52 126.74 17.45 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 121.886 1.724 . . . . 0.0 111.511 175.267 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.48 ' HD2' ' O ' ' A' ' 31' ' ' SER . 84.9 Cg_exo -47.14 146.95 5.83 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.634 2.223 . . . . 0.0 111.114 171.019 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -37.71 106.67 0.36 Allowed Pre-proline 0 N--CA 1.465 0.302 0 O-C-N 124.743 1.277 . . . . 0.0 112.594 -169.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.56 ' HG2' HG12 ' A' ' 91' ' ' VAL . 33.4 Cg_exo -65.59 152.28 82.23 Favored 'Trans proline' 0 CA--C 1.517 -0.329 0 C-N-CA 123.552 2.835 . . . . 0.0 112.015 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 25.8 m -109.45 128.78 55.41 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.898 -178.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.437 ' HA ' ' HA ' ' A' ' 28' ' ' VAL . 83.6 t -74.92 119.21 22.07 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-N 114.415 -1.266 . . . . 0.0 109.591 173.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -88.0 -40.25 14.02 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.184 -173.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 18.0 mm-40 -136.71 139.41 41.9 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.47 -177.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.452 HG13 ' NE2' ' A' ' 95' ' ' GLN . 33.6 m -130.55 133.75 63.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.15 0.5 . . . . 0.0 111.078 178.166 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -134.84 -162.72 1.28 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.064 178.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.42 ' CG ' ' H ' ' A' ' 24' ' ' THR . 4.5 p-10 -69.01 -68.41 0.4 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.105 0.479 . . . . 0.0 111.579 177.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.659 HG21 ' O ' ' A' ' 69' ' ' LEU . 68.2 p -111.87 39.64 2.34 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.905 -174.239 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.704 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 69.9 m -169.12 131.91 1.28 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.371 -0.832 . . . . 0.0 110.322 -171.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.601 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 17.9 mt -150.38 138.45 14.3 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.893 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 176.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.414 ' O ' HG11 ' A' ' 18' ' ' VAL . 37.7 t -116.35 131.94 67.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 119.002 0.819 . . . . 0.0 110.587 -173.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.63 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.7 OUTLIER -125.94 145.41 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.039 -178.412 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.508 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 77.3 mtt180 -127.13 121.87 32.61 Favored 'General case' 0 N--CA 1.465 0.293 0 O-C-N 123.629 0.581 . . . . 0.0 110.293 -177.333 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.482 ' CH2' HD11 ' A' ' 57' ' ' LEU . 28.1 p90 -112.83 146.8 38.23 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.835 -0.621 . . . . 0.0 112.05 -173.41 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.48 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 15.3 m -87.43 88.63 7.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.482 179.246 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.596 ' HD3' ' H ' ' A' ' 32' ' ' ARG . 0.4 OUTLIER -48.77 156.26 0.91 Allowed Pre-proline 0 CA--C 1.54 0.582 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -174.698 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.682 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 1.6 Cg_endo -85.7 169.26 9.37 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 124.307 3.338 . . . . 0.0 112.428 -173.409 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -93.86 -5.36 48.19 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.836 177.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -67.88 144.48 97.29 Favored Pre-proline 0 C--O 1.234 0.265 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.041 173.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_exo -70.76 112.72 3.32 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 121.272 1.314 . . . . 0.0 109.898 172.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.465 HD12 ' HD2' ' A' ' 33' ' ' PRO . 5.0 pt -121.36 151.93 24.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.08 -172.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.401 ' C ' ' HB3' ' A' ' 59' ' ' GLU . 16.8 p -98.33 -26.78 14.38 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -176.287 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.426 ' O ' HG12 ' A' ' 82' ' ' VAL . . . -173.36 -164.16 28.18 Favored Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 119.575 -1.298 . . . . 0.0 112.582 177.43 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.682 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 6.4 m-85 -138.88 135.4 34.44 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 120.975 0.417 . . . . 0.0 111.041 177.393 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 4.0 mtm105 -108.95 146.62 33.53 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 169.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.879 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 34.9 mt -138.76 109.58 4.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -174.227 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 75.3 t -109.67 110.54 32.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.297 0.57 . . . . 0.0 110.66 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.652 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 1.1 p90 -114.08 125.76 54.34 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.607 176.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.0 m -137.87 145.29 47.63 Favored Pre-proline 0 C--N 1.313 -1.014 0 CA-C-N 114.077 -1.419 . . . . 0.0 111.164 -173.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.546 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 55.7 Cg_endo . . . . . 0 N--CA 1.472 0.225 0 C-N-CA 123.443 2.762 . . . . 0.0 111.928 178.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 7.0 m . . . . . 0 CA--C 1.517 -0.296 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.652 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 86.4 m -147.02 151.05 36.31 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.332 -178.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.879 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 31.8 tt0 -119.82 122.86 42.29 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.496 175.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.661 HD13 ' CG2' ' A' ' 64' ' ' VAL . 16.9 mt -104.58 157.89 16.86 Favored 'General case' 0 CA--C 1.514 -0.406 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.129 175.529 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -122.02 114.68 21.29 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 177.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.482 HD11 ' CH2' ' A' ' 30' ' ' TRP . 2.1 mt -111.6 156.8 40.86 Favored Pre-proline 0 C--N 1.317 -0.843 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -175.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -63.24 150.16 89.36 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 121.912 1.742 . . . . 0.0 111.448 176.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.401 ' HB3' ' C ' ' A' ' 38' ' ' THR . 10.3 pt-20 -43.94 -28.74 0.49 Allowed 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 114.59 -1.186 . . . . 0.0 112.98 176.326 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.1 t -106.93 19.28 20.69 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.161 -175.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.47 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -82.15 152.78 26.34 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.181 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.508 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 28.5 p-10 -132.59 5.53 4.01 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -177.028 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.63 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 35.5 p -166.18 134.3 2.9 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 119.905 -0.718 . . . . 0.0 111.869 -175.125 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.661 ' CG2' HD13 ' A' ' 55' ' ' LEU . 4.7 p -114.53 135.3 54.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.259 175.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 54.3 m -97.4 99.41 10.84 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 121.572 0.701 . . . . 0.0 109.146 169.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.704 ' O ' ' HA ' ' A' ' 25' ' ' SER . 0.7 OUTLIER -73.96 144.54 45.2 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.094 -0.957 . . . . 0.0 108.907 179.05 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.431 ' HA ' ' O ' ' A' ' 24' ' ' THR . 10.6 t -142.35 167.46 22.04 Favored 'General case' 0 C--N 1.318 -0.791 0 O-C-N 123.56 0.537 . . . . 0.0 109.714 -173.527 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 62.77 27.48 16.1 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 123.881 0.738 . . . . 0.0 111.202 -178.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.659 ' O ' HG21 ' A' ' 24' ' ' THR . 13.6 mt -71.09 -174.92 1.05 Allowed 'General case' 0 C--O 1.225 -0.2 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 173.052 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 67.8 mm-40 -122.99 133.43 24.49 Favored Pre-proline 0 C--N 1.317 -0.846 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 175.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -63.71 126.19 16.98 Favored 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 122.513 2.142 . . . . 0.0 112.125 177.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 82.67 39.42 10.65 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.741 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 72.1 t -136.58 138.13 46.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.039 0.447 . . . . 0.0 110.843 -179.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.546 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -80.93 120.25 24.5 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.719 -179.841 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.528 ' CE2' ' HB3' ' A' ' 69' ' ' LEU . 30.1 m-85 -113.66 117.72 32.34 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.499 0.666 . . . . 0.0 112.44 -178.021 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.438 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 6.9 m120 -85.85 110.74 19.61 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.019 172.274 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.5 HG21 HD13 ' A' ' 79' ' ' ILE . 5.1 mp -92.21 121.89 43.18 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.562 0 CA-C-O 121.064 0.459 . . . . 0.0 109.866 176.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.879 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 48.2 m -111.73 114.57 27.65 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.861 179.53 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.5 HD13 HG21 ' A' ' 77' ' ' ILE . 13.5 mm -95.91 130.14 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -117.94 113.07 21.16 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 177.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -88.98 125.46 34.99 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 173.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.426 HG12 ' O ' ' A' ' 39' ' ' GLY . 8.1 p -118.6 133.5 65.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 C-N-CA 120.09 -0.644 . . . . 0.0 112.127 -173.396 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.438 ' HA ' ' HA ' ' A' ' 37' ' ' ILE . 8.9 mt-10 -100.58 173.6 6.47 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.127 172.529 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -34.93 -44.55 0.23 Allowed 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -176.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -135.03 2.77 3.12 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -176.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 26.3 pt20 -146.45 176.14 10.02 Favored 'General case' 0 C--O 1.218 -0.591 0 CA-C-N 118.939 0.791 . . . . 0.0 111.552 -179.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -126.67 154.95 43.38 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.768 -179.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 16.9 m -85.73 -175.27 5.55 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.453 176.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.4 p -62.65 158.69 49.04 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.449 173.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -87.33 140.08 5.33 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 122.065 1.843 . . . . 0.0 113.674 -178.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.879 ' O ' ' HA ' ' A' ' 78' ' ' THR . 8.6 t -83.29 125.68 40.09 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.744 0 CA-C-N 114.868 -1.06 . . . . 0.0 108.49 167.216 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 5.9 t -125.03 106.58 16.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 C-N-CA 119.958 -0.697 . . . . 0.0 110.078 171.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.497 HG13 ' HB ' ' A' ' 77' ' ' ILE . 5.9 pt -124.76 116.32 47.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.906 179.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -99.47 129.49 45.65 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.456 0.646 . . . . 0.0 111.332 -175.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.452 ' NE2' HG13 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -140.94 130.84 24.44 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.021 177.177 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -92.63 138.12 31.77 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.204 0.526 . . . . 0.0 110.745 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.466 HG21 HD13 ' A' ' 26' ' ' ILE . 34.1 p -68.81 124.64 24.24 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.741 -176.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 40.0 m . . . . . 0 C--N 1.329 -0.315 0 CA-C-O 121.503 0.668 . . . . 0.0 110.237 177.664 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.473 ' HB2' ' O ' ' A' ' 89' ' ' THR . . . . . . . . 0 N--CA 1.453 -0.298 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -62.23 128.45 23.92 Favored 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.295 1.997 . . . . 0.0 111.787 175.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.473 ' HD2' ' O ' ' A' ' 31' ' ' SER . 86.9 Cg_exo -47.12 140.24 14.37 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.71 2.274 . . . . 0.0 111.349 174.057 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.408 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 5.9 p-10 -33.85 106.96 0.28 Allowed Pre-proline 0 N--CA 1.467 0.396 0 O-C-N 124.929 1.393 . . . . 0.0 112.478 -168.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.557 ' HG2' HG13 ' A' ' 91' ' ' VAL . 39.1 Cg_exo -61.91 152.49 74.64 Favored 'Trans proline' 0 CA--C 1.517 -0.344 0 C-N-CA 123.727 2.951 . . . . 0.0 112.718 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.9 m -107.6 128.27 54.39 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.656 -178.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.468 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 69.5 t -78.46 117.12 23.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-N 114.337 -1.301 . . . . 0.0 109.725 173.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -83.63 -36.89 23.52 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.377 -173.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -135.6 138.38 42.87 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.471 -178.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.468 ' HA ' HG12 ' A' ' 26' ' ' ILE . 6.3 m -129.54 120.33 50.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.205 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -133.69 -165.33 1.62 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.46 -179.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.56 ' O ' ' HB2' ' A' ' 69' ' ' LEU . 3.3 p-10 -67.77 -65.13 0.73 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.971 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.665 HG23 ' O ' ' A' ' 69' ' ' LEU . 39.7 p -115.33 35.5 4.35 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.876 -172.038 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.674 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 18.6 p -169.79 130.7 1.03 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.787 -174.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.564 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 17.0 mt -146.95 135.97 16.11 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.608 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 177.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.468 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 39.9 t -115.1 129.81 70.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 C-N-CA 120.013 -0.675 . . . . 0.0 110.497 -174.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.664 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.8 OUTLIER -123.76 143.89 35.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.044 -177.544 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.536 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 85.8 mtt180 -128.03 121.63 30.22 Favored 'General case' 0 N--CA 1.465 0.297 0 O-C-N 123.79 0.681 . . . . 0.0 110.314 -177.13 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.514 ' CH2' HD13 ' A' ' 57' ' ' LEU . 30.2 p90 -111.39 140.5 45.93 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.189 -173.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.473 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 61.8 m -82.51 88.19 6.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.13 175.27 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.42 ' CZ ' ' HB3' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -49.08 156.46 0.96 Allowed Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -175.485 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.632 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 3.4 Cg_exo -80.36 169.26 17.47 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 123.886 3.057 . . . . 0.0 112.846 -174.378 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -86.57 -14.84 41.71 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.139 172.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -57.51 135.25 82.07 Favored Pre-proline 0 CA--C 1.517 -0.309 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.162 173.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -67.33 112.39 2.55 Favored 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 120.937 1.091 . . . . 0.0 109.774 172.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.553 HG23 ' HB2' ' A' ' 81' ' ' ALA . 1.6 pt -118.27 151.43 20.36 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -174.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.46 ' C ' ' HB3' ' A' ' 59' ' ' GLU . 11.0 p -98.56 -30.53 12.45 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -178.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.528 ' C ' HG12 ' A' ' 82' ' ' VAL . . . -162.86 -166.66 22.03 Favored Glycine 0 N--CA 1.438 -1.209 0 C-N-CA 120.153 -1.022 . . . . 0.0 112.044 -177.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.632 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 6.3 m-85 -141.54 134.46 28.9 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 122.613 0.365 . . . . 0.0 110.875 174.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.3 mmm180 -102.53 149.41 24.43 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 168.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.873 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 30.7 mt -139.55 108.4 3.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 C-N-CA 120.037 -0.665 . . . . 0.0 112.389 -179.297 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 71.7 t -107.53 110.57 32.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.182 0.515 . . . . 0.0 110.836 179.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.64 ' CZ ' ' HB ' ' A' ' 53' ' ' THR . 1.4 p90 -114.9 127.3 55.62 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.948 176.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.3 p -141.81 137.41 16.11 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 113.718 -1.583 . . . . 0.0 111.754 -175.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.589 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 58.1 Cg_endo . . . . . 0 C--N 1.342 0.2 0 C-N-CA 123.275 2.65 . . . . 0.0 111.9 176.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.425 ' HA ' ' O ' ' A' ' 44' ' ' TYR . 14.9 m . . . . . 0 CA--C 1.512 -0.492 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.64 ' HB ' ' CZ ' ' A' ' 44' ' ' TYR . 36.1 m -147.62 149.95 33.49 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 120.111 -0.636 . . . . 0.0 111.563 -179.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.873 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 26.4 tt0 -116.95 112.0 20.39 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.585 174.413 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.61 HD11 ' CG2' ' A' ' 64' ' ' VAL . 23.8 mt -96.09 159.04 15.17 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.072 177.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.445 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 24.7 t-20 -125.2 114.86 19.55 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -179.403 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.514 HD13 ' CH2' ' A' ' 30' ' ' TRP . 4.4 mt -112.1 157.68 39.1 Favored Pre-proline 0 C--N 1.317 -0.843 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 -176.369 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -68.3 152.54 75.66 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 121.749 1.632 . . . . 0.0 111.06 175.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.46 ' HB3' ' C ' ' A' ' 38' ' ' THR . 11.7 pt-20 -45.62 -27.07 0.71 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.796 -1.093 . . . . 0.0 112.758 176.01 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 11.1 t -101.44 18.74 19.36 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.277 0.561 . . . . 0.0 111.1 -174.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.42 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -93.04 157.92 16.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.394 179.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.536 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 26.6 p-10 -143.05 13.74 1.86 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -178.475 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.664 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 80.5 p -165.26 134.3 3.4 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 119.876 -0.729 . . . . 0.0 111.936 -177.042 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.61 ' CG2' HD11 ' A' ' 55' ' ' LEU . 3.8 p -117.43 134.81 59.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.346 175.082 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 35.1 m -96.57 101.22 12.8 Favored 'General case' 0 N--CA 1.434 -1.255 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.498 169.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.674 ' O ' ' HA ' ' A' ' 25' ' ' SER . 0.3 OUTLIER -78.3 144.57 35.98 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.1 178.33 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.2 p -138.47 166.58 23.92 Favored 'General case' 0 C--N 1.318 -0.783 0 O-C-N 123.514 0.508 . . . . 0.0 110.826 -173.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 64.2 27.1 13.92 Favored 'General case' 0 N--CA 1.463 0.2 0 O-C-N 123.757 0.661 . . . . 0.0 111.679 179.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.665 ' O ' HG23 ' A' ' 24' ' ' THR . 11.1 mt -70.31 -176.16 1.14 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 175.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 57.9 tp60 -127.44 124.05 23.43 Favored Pre-proline 0 C--N 1.32 -0.696 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 177.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -62.62 135.55 53.43 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 123.083 2.522 . . . . 0.0 113.31 -177.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.67 25.21 39.42 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.907 179.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 87.4 t -129.99 148.77 33.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.27 0.557 . . . . 0.0 111.289 -174.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.589 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -87.33 121.5 29.86 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.648 -179.588 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.402 ' CE2' HD21 ' A' ' 69' ' ' LEU . 7.4 m-85 -118.02 116.8 27.63 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.153 0.501 . . . . 0.0 112.24 -174.448 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.53 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 3.9 m-20 -89.96 113.13 24.72 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.376 176.474 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.511 HG22 HD12 ' A' ' 79' ' ' ILE . 5.1 mp -95.27 118.72 42.1 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.546 0 CA-C-O 121.057 0.455 . . . . 0.0 109.836 174.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.839 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 36.8 m -110.85 115.53 29.68 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.253 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.511 HD12 HG22 ' A' ' 77' ' ' ILE . 13.8 mm -95.89 145.27 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -179.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.426 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 53.0 m-85 -131.13 111.32 11.87 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 177.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.553 ' HB2' HG23 ' A' ' 37' ' ' ILE . . . -80.71 112.08 17.75 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 172.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.528 HG12 ' C ' ' A' ' 39' ' ' GLY . 7.4 p -106.68 135.54 44.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 C-N-CA 119.718 -0.793 . . . . 0.0 111.019 -174.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.473 ' HG2' HG22 ' A' ' 37' ' ' ILE . 4.8 mt-10 -109.05 172.06 7.07 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 177.433 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -44.67 -51.42 9.2 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 123.585 0.553 . . . . 0.0 112.136 178.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 -111.39 -14.19 13.79 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -171.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -135.43 172.81 12.47 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.32 -0.552 . . . . 0.0 111.882 -170.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -128.87 133.61 48.0 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 175.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 13.4 m -78.52 170.84 16.0 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.699 0.285 . . . . 0.0 110.914 -178.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.473 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 0.6 OUTLIER -57.9 158.24 13.24 Favored Pre-proline 0 N--CA 1.449 -0.51 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.767 174.758 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -87.07 138.79 5.04 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 122.067 1.844 . . . . 0.0 113.748 -177.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.839 ' O ' ' HA ' ' A' ' 78' ' ' THR . 5.0 t -82.38 124.26 39.09 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.795 0 CA-C-N 114.707 -1.133 . . . . 0.0 108.397 167.296 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 5.0 t -119.61 106.74 19.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 C-N-CA 119.689 -0.804 . . . . 0.0 109.99 171.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.488 HG13 ' HB ' ' A' ' 77' ' ' ILE . 5.9 pt -126.02 111.7 27.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.788 176.551 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.09 133.45 43.35 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.158 0.504 . . . . 0.0 110.499 -178.509 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.414 ' NE2' HG11 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -139.26 140.44 37.68 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.094 178.0 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.433 ' HG2' ' HG2' ' A' ' 74' ' ' GLN . 38.3 mt-10 -86.26 146.86 26.34 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.952 0.405 . . . . 0.0 110.427 177.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.481 HG22 HD13 ' A' ' 26' ' ' ILE . 40.0 p -82.81 114.86 21.42 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.339 177.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 26.7 m . . . . . 0 C--N 1.323 -0.545 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.907 -176.717 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.328 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -67.25 127.52 16.81 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.421 2.081 . . . . 0.0 111.999 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.571 ' HD2' ' O ' ' A' ' 31' ' ' SER . 80.0 Cg_exo -46.58 145.54 6.22 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 123.186 2.59 . . . . 0.0 112.174 174.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -35.27 105.37 0.28 Allowed Pre-proline 0 N--CA 1.468 0.44 0 O-C-N 124.884 1.365 . . . . 0.0 112.569 -169.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.559 ' HG2' HG13 ' A' ' 91' ' ' VAL . 23.7 Cg_exo -69.19 149.59 70.68 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 123.58 2.853 . . . . 0.0 112.796 -178.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.5 m -107.47 131.07 54.7 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.735 -177.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.527 HG12 ' O ' ' A' ' 27' ' ' VAL . 72.5 t -73.66 123.72 29.37 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.022 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.062 175.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -83.34 -47.67 11.22 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.845 -174.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -135.48 137.54 42.26 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.11 -178.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.46 HG23 HG11 ' A' ' 18' ' ' VAL . 30.3 t -121.52 115.13 45.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.642 177.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.504 ' HB2' ' HG ' ' A' ' 25' ' ' SER . 5.7 m-20 -123.09 -167.55 1.62 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.347 177.415 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.543 ' O ' ' HB2' ' A' ' 69' ' ' LEU . 1.7 p-10 -70.55 -68.41 0.43 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.145 -0.479 . . . . 0.0 112.043 178.117 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.593 HG21 ' O ' ' A' ' 69' ' ' LEU . 38.1 p -106.72 31.95 4.89 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.699 -172.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.628 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 11.6 p -171.24 132.51 0.81 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.502 -174.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.508 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 44.9 mt -145.86 145.0 20.61 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.742 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 177.341 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.527 ' O ' HG12 ' A' ' 18' ' ' VAL . 35.6 t -117.44 137.67 50.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 C-N-CA 120.03 -0.668 . . . . 0.0 109.782 -174.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.639 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.6 OUTLIER -130.68 146.39 34.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 C-N-CA 119.974 -0.69 . . . . 0.0 110.229 178.331 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.478 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 34.9 mtp180 -129.63 120.35 25.09 Favored 'General case' 0 C--N 1.327 -0.402 0 O-C-N 123.623 0.577 . . . . 0.0 110.045 -175.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.512 ' CH2' HD13 ' A' ' 57' ' ' LEU . 37.1 p90 -113.23 148.93 34.54 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.051 -174.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.571 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 13.6 m -93.7 100.4 12.63 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.936 178.498 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.625 ' NE ' ' HB3' ' A' ' 62' ' ' ASN . 0.1 OUTLIER -53.83 156.26 5.15 Favored Pre-proline 0 CA--C 1.538 0.482 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -174.314 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.624 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 2.4 Cg_endo -83.84 168.51 12.34 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 124.341 3.361 . . . . 0.0 112.474 -174.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -82.49 -16.32 49.22 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.019 172.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -59.62 141.65 88.34 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 114.621 -1.172 . . . . 0.0 111.304 177.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -69.75 112.76 3.16 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 121.035 1.156 . . . . 0.0 109.85 171.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.561 HG23 ' HB1' ' A' ' 81' ' ' ALA . 1.4 pt -121.42 147.33 25.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -176.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 17.4 p -97.39 -20.39 17.84 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -177.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.533 ' C ' HG11 ' A' ' 82' ' ' VAL . . . -173.63 -164.1 28.26 Favored Glycine 0 CA--C 1.501 -0.789 0 C-N-CA 119.877 -1.154 . . . . 0.0 111.957 177.19 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.624 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 6.5 m-85 -139.88 132.84 29.38 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-O 120.849 0.357 . . . . 0.0 111.069 173.644 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 8.7 mmm180 -103.49 149.31 24.97 Favored 'General case' 0 CA--C 1.503 -0.851 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 167.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.878 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 33.8 mt -138.73 108.25 4.11 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 C-N-CA 119.939 -0.705 . . . . 0.0 112.219 -178.512 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 72.0 t -107.94 110.38 31.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.299 0.571 . . . . 0.0 110.396 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.603 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 1.0 OUTLIER -110.64 125.42 53.41 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.328 176.071 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 39.9 p -140.01 135.47 16.43 Favored Pre-proline 0 C--N 1.316 -0.864 0 CA-C-N 113.922 -1.49 . . . . 0.0 111.217 -174.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.511 ' HG3' ' CE2' ' A' ' 75' ' ' TYR . 10.5 Cg_exo . . . . . 0 N--CA 1.462 -0.365 0 C-N-CA 122.815 2.344 . . . . 0.0 111.154 173.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.461 ' HA ' ' O ' ' A' ' 44' ' ' TYR . 16.5 m . . . . . 0 CA--C 1.515 -0.374 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.603 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 58.6 m -147.13 152.34 38.29 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.408 -177.048 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.878 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 33.2 tt0 -116.5 117.5 30.08 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.85 174.129 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.65 HD11 ' CG2' ' A' ' 64' ' ' VAL . 18.3 mt -97.3 158.06 15.65 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 174.684 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -123.45 111.06 15.88 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.607 -178.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.512 HD13 ' CH2' ' A' ' 30' ' ' TRP . 3.4 mt -109.59 155.55 41.16 Favored Pre-proline 0 N--CA 1.444 -0.771 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -177.152 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -64.35 148.83 90.93 Favored 'Trans proline' 0 N--CA 1.448 -1.172 0 C-N-CA 121.611 1.54 . . . . 0.0 110.635 175.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.42 ' HB2' HG13 ' A' ' 37' ' ' ILE . 8.4 pt-20 -44.04 -27.58 0.39 Allowed 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 114.729 -1.123 . . . . 0.0 113.197 178.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.8 t -103.35 6.99 38.23 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.44 -173.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.407 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -76.41 158.5 31.33 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 178.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.625 ' HB3' ' NE ' ' A' ' 32' ' ' ARG . 29.2 p-10 -141.98 18.29 2.12 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -177.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.639 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 25.5 p -169.76 134.2 1.33 Allowed 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.209 -0.597 . . . . 0.0 111.715 179.288 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.65 ' CG2' HD11 ' A' ' 55' ' ' LEU . 3.7 p -116.81 137.55 50.31 Favored 'Isoleucine or valine' 0 C--O 1.243 0.728 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.489 176.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 68.3 m -96.92 101.18 12.72 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.579 169.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.628 ' O ' ' HA ' ' A' ' 25' ' ' SER . 0.2 OUTLIER -80.19 145.38 32.31 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.474 -0.784 . . . . 0.0 108.928 178.647 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 8.8 t -141.06 174.14 10.8 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.27 -174.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 62.78 27.22 15.98 Favored 'General case' 0 C--N 1.329 -0.304 0 O-C-N 123.8 0.688 . . . . 0.0 111.272 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.593 ' O ' HG21 ' A' ' 24' ' ' THR . 10.9 mt -74.65 -176.36 2.77 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.275 -0.421 . . . . 0.0 109.883 177.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.439 ' N ' ' HH ' ' A' ' 75' ' ' TYR . 57.3 tp60 -130.35 123.27 20.44 Favored Pre-proline 0 C--N 1.32 -0.709 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.007 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -62.0 133.59 45.12 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.961 2.441 . . . . 0.0 113.035 -177.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 87.42 25.24 33.85 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.788 -178.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.485 ' CG1' ' HB3' ' A' ' 46' ' ' PRO . 94.9 t -131.02 142.81 42.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.027 0.441 . . . . 0.0 110.841 -176.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.484 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 10.3 tp60 -86.36 107.45 18.01 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.002 -177.339 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.511 ' CE2' ' HG3' ' A' ' 46' ' ' PRO . 18.8 m-85 -99.13 119.95 38.69 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.097 0.475 . . . . 0.0 111.69 -177.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.482 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 13.3 m120 -92.72 109.21 20.62 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.418 177.164 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.544 ' HB ' HG13 ' A' ' 93' ' ' ILE . 5.0 mp -91.76 116.72 33.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.246 0.546 . . . . 0.0 109.642 178.121 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.864 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 81.1 m -108.9 115.81 30.8 Favored 'General case' 0 N--CA 1.427 -1.605 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.441 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.533 HD11 HG21 ' A' ' 77' ' ' ILE . 13.5 mm -95.12 141.26 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 -179.285 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.406 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 64.0 m-85 -128.79 111.79 13.49 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.91 178.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.561 ' HB1' HG23 ' A' ' 37' ' ' ILE . . . -78.97 119.5 22.22 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 168.212 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.533 HG11 ' C ' ' A' ' 39' ' ' GLY . 7.6 p -106.77 133.87 50.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 C-N-CA 120.092 -0.643 . . . . 0.0 110.049 -178.206 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.406 ' HG3' HG22 ' A' ' 37' ' ' ILE . 1.4 mp0 -111.01 170.22 8.24 Favored 'General case' 0 N--CA 1.445 -0.68 0 O-C-N 123.579 0.549 . . . . 0.0 110.068 -178.12 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -43.68 -46.99 7.65 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.119 -0.946 . . . . 0.0 112.676 -174.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 -125.12 6.14 7.87 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -174.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -147.81 177.24 9.48 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.854 0.359 . . . . 0.0 111.762 -172.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -133.04 124.41 27.6 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.172 176.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.422 ' OG ' ' HB2' ' A' ' 81' ' ' ALA . 92.9 p -70.81 170.43 12.55 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.908 0.385 . . . . 0.0 111.569 -178.022 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 18.7 p -60.73 153.05 65.37 Favored Pre-proline 0 CA--C 1.531 0.218 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.772 175.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -83.38 144.55 11.59 Favored 'Trans proline' 0 CA--C 1.534 0.499 0 C-N-CA 122.31 2.007 . . . . 0.0 114.712 -175.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.864 ' O ' ' HA ' ' A' ' 78' ' ' THR . 11.7 t -83.49 129.38 37.61 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.581 0 CA-C-N 114.614 -1.176 . . . . 0.0 107.975 163.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.3 t -125.1 106.87 17.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 C-N-CA 120.046 -0.661 . . . . 0.0 110.13 173.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.544 HG13 ' HB ' ' A' ' 77' ' ' ILE . 9.7 pt -125.04 113.14 34.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.259 179.266 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.406 ' HB3' ' ND2' ' A' ' 76' ' ' ASN . 11.1 pt20 -98.72 125.33 44.01 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.558 0.694 . . . . 0.0 111.675 -176.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.98 127.3 35.99 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.389 176.285 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.404 ' HA ' ' HA ' ' A' ' 74' ' ' GLN . 28.8 tt0 -87.17 127.25 35.15 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.34 0.59 . . . . 0.0 109.851 178.564 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.505 HG21 HD11 ' A' ' 26' ' ' ILE . 22.7 p -59.79 116.88 4.39 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.851 -1.068 . . . . 0.0 111.719 -175.265 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.7 m . . . . . 0 C--N 1.324 -0.532 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.281 -178.476 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.163 0 N-CA-C 109.379 -0.601 . . . . 0.0 109.379 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -70.93 127.09 13.22 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 121.811 1.674 . . . . 0.0 111.166 176.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.492 ' HD2' ' O ' ' A' ' 31' ' ' SER . 84.6 Cg_exo -48.16 145.6 10.76 Favored 'Trans proline' 0 CA--C 1.515 -0.443 0 C-N-CA 122.874 2.382 . . . . 0.0 111.401 173.458 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -35.67 106.37 0.31 Allowed Pre-proline 0 N--CA 1.466 0.335 0 O-C-N 124.939 1.399 . . . . 0.0 111.993 -169.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.553 ' HG2' HG13 ' A' ' 91' ' ' VAL . 27.4 Cg_exo -67.03 146.13 76.05 Favored 'Trans proline' 0 CA--C 1.518 -0.305 0 C-N-CA 123.526 2.818 . . . . 0.0 112.045 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.8 m -105.57 131.46 52.93 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.894 -176.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 93.4 t -73.12 111.44 7.67 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-N 114.471 -1.24 . . . . 0.0 109.315 173.194 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -78.8 -45.0 21.91 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.277 -171.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -139.31 139.88 37.42 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.437 -178.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 60.5 t -129.12 132.6 66.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.868 -176.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.416 ' HB3' ' H ' ' A' ' 23' ' ' ASP . 4.6 m-20 -132.25 -161.86 1.18 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.765 174.149 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.416 ' H ' ' HB3' ' A' ' 22' ' ' ASP . 1.4 p-10 -71.75 -68.52 0.45 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.087 0.47 . . . . 0.0 112.109 177.188 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.617 HG23 ' O ' ' A' ' 69' ' ' LEU . 68.6 p -106.99 36.78 2.55 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.216 0.531 . . . . 0.0 111.176 -173.104 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.528 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 19.8 p -172.23 140.75 1.18 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.399 -174.108 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.453 HD12 ' CG2' ' A' ' 97' ' ' THR . 46.5 mt -149.38 155.91 7.87 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.699 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.32 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 39.7 t -128.17 133.48 66.93 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.572 0 CA-C-N 119.373 0.988 . . . . 0.0 110.206 179.159 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.663 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.7 OUTLIER -125.45 145.16 33.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 C-N-CA 120.197 -0.601 . . . . 0.0 109.924 179.45 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.472 ' HG2' ' OG ' ' A' ' 63' ' ' SER . 20.6 mtp180 -130.24 121.08 25.48 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 123.373 0.421 . . . . 0.0 110.563 -174.403 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.524 ' CH2' HD11 ' A' ' 57' ' ' LEU . 35.2 p90 -111.98 146.48 37.78 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.734 -175.169 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.492 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 33.0 t -89.99 88.68 7.4 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.333 174.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.493 ' HD3' ' H ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -49.55 155.55 1.33 Allowed Pre-proline 0 CA--C 1.541 0.597 0 CA-C-N 115.151 -0.931 . . . . 0.0 112.77 -174.32 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.697 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 2.8 Cg_exo -75.87 170.0 21.04 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.948 3.099 . . . . 0.0 113.953 -169.556 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 24.7 tt0 -80.35 -22.65 41.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.705 -1.134 . . . . 0.0 108.523 169.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.8 135.38 78.89 Favored Pre-proline 0 CA--C 1.517 -0.299 0 CA-C-N 114.804 -1.089 . . . . 0.0 111.054 177.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -69.83 113.13 3.29 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 121.099 1.2 . . . . 0.0 109.755 171.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.558 HG23 ' HB3' ' A' ' 81' ' ' ALA . 0.6 OUTLIER -118.44 154.2 20.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -174.409 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.425 ' N ' ' O ' ' A' ' 82' ' ' VAL . 7.3 p -94.4 -33.94 12.96 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -179.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.511 ' C ' HG13 ' A' ' 82' ' ' VAL . . . -162.39 -167.53 22.96 Favored Glycine 0 N--CA 1.438 -1.232 0 C-N-CA 120.036 -1.078 . . . . 0.0 112.419 -177.014 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.697 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 4.6 m-85 -137.9 134.07 34.58 Favored 'General case' 0 C--N 1.319 -0.729 0 O-C-N 123.745 0.321 . . . . 0.0 110.897 174.352 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.6 mmm180 -104.06 147.71 27.09 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 167.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.887 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 22.7 mt -138.66 108.23 4.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 C-N-CA 119.961 -0.696 . . . . 0.0 111.959 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 72.1 t -111.2 109.41 28.39 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.646 0 CA-C-O 121.364 0.602 . . . . 0.0 110.317 179.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.66 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 0.6 OUTLIER -111.58 125.07 53.54 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.549 177.598 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 23.1 t -141.98 137.44 15.96 Favored Pre-proline 0 C--N 1.316 -0.881 0 CA-C-N 114.158 -1.383 . . . . 0.0 111.192 -172.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.699 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 15.1 Cg_exo . . . . . 0 C--N 1.344 0.319 0 C-N-CA 123.276 2.651 . . . . 0.0 111.706 174.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.517 ' HA ' ' O ' ' A' ' 44' ' ' TYR . 17.7 m . . . . . 0 CA--C 1.515 -0.398 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.66 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 89.7 m -147.15 147.47 30.56 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.75 -175.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.887 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 33.4 tt0 -115.39 112.29 22.11 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.892 174.303 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.621 HD13 ' CG2' ' A' ' 64' ' ' VAL . 17.2 mt -98.0 152.99 18.7 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.561 -0.456 . . . . 0.0 109.8 174.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -116.7 118.35 32.31 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 177.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.524 HD11 ' CH2' ' A' ' 30' ' ' TRP . 3.2 mt -115.04 157.17 44.11 Favored Pre-proline 0 N--CA 1.444 -0.766 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -176.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -65.57 150.4 86.62 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 121.826 1.684 . . . . 0.0 110.991 174.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -47.12 -27.66 1.48 Allowed 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 115.217 -0.902 . . . . 0.0 112.48 177.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.8 t -102.59 15.08 30.3 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.138 -174.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.415 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -83.34 163.58 20.55 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 177.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.468 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 5.2 p-10 -150.08 12.97 0.77 Allowed 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.153 -0.619 . . . . 0.0 112.436 -176.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.663 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 20.1 m -162.89 134.92 5.27 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 117.634 0.197 . . . . 0.0 110.776 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.621 ' CG2' HD13 ' A' ' 55' ' ' LEU . 4.1 p -117.58 138.81 47.05 Favored 'Isoleucine or valine' 0 C--O 1.244 0.802 0 CA-C-O 120.662 0.267 . . . . 0.0 110.508 174.304 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 52.6 m -98.76 101.74 13.25 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-O 121.741 0.782 . . . . 0.0 110.162 171.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.599 HD21 HG13 ' A' ' 64' ' ' VAL . 0.5 OUTLIER -75.66 138.17 41.18 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.067 -0.969 . . . . 0.0 108.896 177.455 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 14.0 p -132.17 159.98 37.4 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 123.193 0.308 . . . . 0.0 111.502 -171.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 64.43 34.26 10.48 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.491 175.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.617 ' O ' HG23 ' A' ' 24' ' ' THR . 14.6 mt -74.34 -175.93 2.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.986 175.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -124.4 140.3 34.87 Favored Pre-proline 0 C--N 1.317 -0.822 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 172.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.14 125.5 14.19 Favored 'Trans proline' 0 CA--C 1.531 0.353 0 C-N-CA 122.362 2.041 . . . . 0.0 112.601 179.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 88.16 38.24 7.38 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.786 178.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 46.6 t -130.5 144.33 38.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 110.333 -0.247 . . . . 0.0 110.333 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.699 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 43.5 tt0 -88.83 125.42 34.9 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.032 178.195 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.517 ' O ' ' HA ' ' A' ' 94' ' ' GLN . 98.3 m-85 -117.44 121.79 42.01 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.917 0.389 . . . . 0.0 111.236 -179.451 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.523 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 4.1 m-20 -88.33 106.31 18.15 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 170.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.517 HG22 HD13 ' A' ' 79' ' ' ILE . 5.2 mp -90.1 115.56 29.79 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.768 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 177.26 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.891 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 29.0 m -103.83 113.79 27.57 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 114.779 -1.101 . . . . 0.0 110.222 -177.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.517 HD13 HG22 ' A' ' 77' ' ' ILE . 12.3 mm -95.34 134.43 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.411 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 62.8 m-85 -122.05 111.19 16.72 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.984 179.389 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.558 ' HB3' HG23 ' A' ' 37' ' ' ILE . . . -82.77 111.85 19.07 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 171.421 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.511 HG13 ' C ' ' A' ' 39' ' ' GLY . 7.8 p -107.73 133.05 53.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 C-N-CA 119.751 -0.779 . . . . 0.0 110.964 -173.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.534 ' HG2' HG22 ' A' ' 37' ' ' ILE . 6.8 mt-10 -107.22 171.11 7.56 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 175.613 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -43.77 -42.21 5.39 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 123.481 0.488 . . . . 0.0 112.14 178.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -123.01 -20.24 5.83 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -173.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.532 ' HB2' ' OE1' ' A' ' 83' ' ' GLU . 16.2 mm100 -123.77 176.33 6.33 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.789 -0.365 . . . . 0.0 111.632 -171.538 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -140.42 126.39 19.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.983 176.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.7 m -67.04 156.07 37.02 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.206 176.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 35.9 p -57.86 146.25 68.11 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.369 177.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -76.36 141.45 22.86 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 122.049 1.833 . . . . 0.0 114.118 -171.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.891 ' O ' ' HA ' ' A' ' 78' ' ' THR . 12.0 t -81.3 130.99 34.92 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.68 0 CA-C-N 114.444 -1.253 . . . . 0.0 108.201 169.392 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 19.0 t -127.52 106.85 15.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 C-N-CA 120.062 -0.655 . . . . 0.0 110.11 172.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.487 ' O ' HG13 ' A' ' 93' ' ' ILE . 43.0 pt -119.95 111.71 33.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.416 -179.44 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.517 ' HA ' ' O ' ' A' ' 75' ' ' TYR . 0.5 OUTLIER -95.59 126.31 40.79 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.297 0.57 . . . . 0.0 111.206 -177.456 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -137.42 131.57 32.18 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.625 179.446 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.47 ' HG2' ' HB2' ' A' ' 74' ' ' GLN . 43.4 mt-10 -92.04 122.02 34.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.695 -0.23 . . . . 0.0 110.842 178.422 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.453 ' CG2' HD12 ' A' ' 26' ' ' ILE . 1.8 p -56.38 126.11 24.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.189 0.519 . . . . 0.0 112.035 -177.524 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.0 m . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.44 -179.85 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.565 ' HB3' ' O ' ' A' ' 89' ' ' THR . . . . . . . . 0 C--O 1.233 0.225 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -62.91 133.46 41.7 Favored 'Trans proline' 0 C--O 1.235 0.344 0 C-N-CA 122.234 1.956 . . . . 0.0 111.618 175.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -50.82 145.97 22.37 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.424 2.082 . . . . 0.0 110.9 173.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -36.04 105.96 0.3 Allowed Pre-proline 0 N--CA 1.468 0.447 0 O-C-N 124.759 1.287 . . . . 0.0 112.206 -170.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.538 ' HG2' HG13 ' A' ' 91' ' ' VAL . 39.1 Cg_exo -65.23 147.21 87.86 Favored 'Trans proline' 0 CA--C 1.521 -0.173 0 C-N-CA 123.764 2.976 . . . . 0.0 112.517 -179.183 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 26.3 m -102.27 131.11 49.05 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.717 -177.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.493 HG13 ' O ' ' A' ' 27' ' ' VAL . 95.3 t -81.28 121.63 35.04 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 CA-C-N 114.379 -1.282 . . . . 0.0 110.224 177.118 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -88.13 -37.16 16.43 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.417 -174.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -135.62 135.61 40.36 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.343 -177.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.493 ' HA ' HG12 ' A' ' 26' ' ' ILE . 60.8 t -132.86 114.69 22.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.748 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -135.09 -172.22 3.0 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 177.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.529 ' O ' ' HB2' ' A' ' 69' ' ' LEU . 0.6 OUTLIER -57.18 -67.69 0.3 Allowed 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -178.131 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.642 HG23 ' O ' ' A' ' 69' ' ' LEU . 36.1 p -110.52 33.57 4.44 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.482 -172.335 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.613 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 58.4 m -168.04 130.06 1.47 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.544 -175.23 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.544 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 29.5 mt -144.48 141.53 23.96 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.733 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 175.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.493 ' O ' HG13 ' A' ' 18' ' ' VAL . 44.8 t -118.89 132.28 69.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.398 -175.16 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.608 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.6 OUTLIER -127.96 146.76 33.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 C-N-CA 119.928 -0.709 . . . . 0.0 110.605 -178.396 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.495 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 93.3 mtt180 -130.65 121.17 25.08 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.479 -176.267 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.53 ' CH2' HD11 ' A' ' 57' ' ' LEU . 37.7 p90 -112.98 152.97 28.77 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.202 -175.02 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 20.8 t -100.42 101.51 12.48 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.296 -0.411 . . . . 0.0 109.914 178.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.584 ' CD ' ' H ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -50.99 157.68 1.35 Allowed Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 123.99 0.916 . . . . 0.0 113.257 -174.364 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.665 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 2.5 Cg_endo -85.1 166.7 11.05 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 124.561 3.508 . . . . 0.0 113.572 -174.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -75.41 -23.64 57.03 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.845 -1.07 . . . . 0.0 109.369 171.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.39 135.92 76.17 Favored Pre-proline 0 C--O 1.236 0.348 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.292 175.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -68.38 113.9 3.27 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 121.192 1.262 . . . . 0.0 109.336 168.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.646 HG23 ' HG3' ' A' ' 83' ' ' GLU . 0.5 OUTLIER -117.98 152.31 20.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -175.662 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 12.5 p -95.54 -29.06 14.56 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -178.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.429 ' C ' HG12 ' A' ' 82' ' ' VAL . . . -168.58 -166.44 27.65 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 119.765 -1.207 . . . . 0.0 112.063 178.125 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.665 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 5.5 m-85 -137.81 131.94 31.9 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-N 117.056 0.428 . . . . 0.0 111.516 176.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 41.9 mtm180 -105.68 148.42 27.42 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 170.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.878 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 32.0 mt -139.6 108.92 3.62 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -176.027 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 78.3 t -109.03 110.58 32.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.24 0.543 . . . . 0.0 110.356 179.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.68 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 1.0 OUTLIER -111.86 124.76 53.04 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.392 177.055 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.3 m -134.95 137.7 27.81 Favored Pre-proline 0 C--N 1.315 -0.932 0 CA-C-N 114.318 -1.31 . . . . 0.0 111.639 -173.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.469 ' HD2' ' OG ' ' A' ' 52' ' ' SER . 73.3 Cg_endo . . . . . 0 C--O 1.23 0.125 0 C-N-CA 123.379 2.72 . . . . 0.0 111.566 174.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.469 ' OG ' ' HD2' ' A' ' 46' ' ' PRO . 6.7 m . . . . . 0 CA--C 1.519 -0.24 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.68 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 37.7 m -147.25 154.25 40.78 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.683 -0.407 . . . . 0.0 111.578 -176.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.878 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 44.3 tt0 -119.32 117.76 29.42 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.03 176.088 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.641 HD13 ' CG2' ' A' ' 64' ' ' VAL . 17.9 mt -99.67 164.67 11.96 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 173.429 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.482 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 8.0 t30 -135.91 115.83 13.17 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -178.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.53 HD11 ' CH2' ' A' ' 30' ' ' TRP . 5.7 mt -112.87 160.82 29.37 Favored Pre-proline 0 N--CA 1.444 -0.745 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -174.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -64.84 151.01 87.3 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 121.656 1.571 . . . . 0.0 110.841 174.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.404 ' HB2' HG13 ' A' ' 37' ' ' ILE . 10.4 pt-20 -45.49 -29.55 1.17 Allowed 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.095 0.958 . . . . 0.0 112.913 178.386 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 7.1 t -96.58 -0.17 49.11 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.398 -174.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.489 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -69.95 158.88 34.77 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 110.205 -0.295 . . . . 0.0 110.205 -177.51 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.551 ' HB3' ' NE ' ' A' ' 32' ' ' ARG . 3.8 p-10 -143.65 15.14 1.78 Allowed 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -177.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.608 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 36.1 p -168.45 133.63 1.72 Allowed 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.084 -0.646 . . . . 0.0 112.333 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.641 ' CG2' HD13 ' A' ' 55' ' ' LEU . 4.8 p -118.72 139.47 45.93 Favored 'Isoleucine or valine' 0 C--O 1.243 0.725 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.537 176.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 34.4 m -99.51 103.75 15.52 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.72 170.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.613 ' O ' ' HA ' ' A' ' 25' ' ' SER . 0.2 OUTLIER -83.38 144.45 29.63 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.465 179.112 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 9.6 t -138.97 170.64 15.61 Favored 'General case' 0 N--CA 1.448 -0.555 0 O-C-N 123.371 0.42 . . . . 0.0 110.296 -174.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 65.24 22.25 12.13 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.052 179.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.642 ' O ' HG23 ' A' ' 24' ' ' THR . 6.5 mt -68.66 -178.45 1.16 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 177.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -124.36 128.06 25.11 Favored Pre-proline 0 C--N 1.32 -0.696 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 176.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -62.16 135.22 53.37 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 123.003 2.468 . . . . 0.0 113.069 -177.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.54 29.34 30.12 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.217 178.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 47.8 t -130.55 147.27 33.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.157 0.503 . . . . 0.0 111.198 -177.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 7.6 tp60 -86.06 109.47 18.85 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.205 178.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.58 ' CE2' HD22 ' A' ' 69' ' ' LEU . 4.2 m-85 -98.97 117.39 33.36 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.144 0.497 . . . . 0.0 111.885 -177.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.429 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 78.4 m-20 -88.06 108.13 19.08 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.025 174.224 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.54 ' HB ' HG13 ' A' ' 93' ' ' ILE . 5.0 mp -92.12 113.55 27.6 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.692 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 175.11 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.869 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 25.8 m -105.07 113.8 27.61 Favored 'General case' 0 N--CA 1.425 -1.723 0 CA-C-N 114.915 -1.038 . . . . 0.0 109.996 -179.022 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.509 HD12 HG22 ' A' ' 77' ' ' ILE . 15.8 mm -95.05 143.3 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -130.85 111.94 12.56 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.96 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.566 ' HB3' HG21 ' A' ' 37' ' ' ILE . . . -81.28 125.53 30.45 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 167.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.429 HG12 ' C ' ' A' ' 39' ' ' GLY . 7.5 p -113.36 133.5 59.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 C-N-CA 120.384 -0.526 . . . . 0.0 110.233 -179.095 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.646 ' HG3' HG23 ' A' ' 37' ' ' ILE . 8.2 mp0 -109.07 170.85 7.79 Favored 'General case' 0 N--CA 1.443 -0.819 0 O-C-N 123.912 0.757 . . . . 0.0 108.988 -178.387 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -42.57 -45.24 4.48 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -172.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -131.16 0.9 4.19 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.029 -0.668 . . . . 0.0 112.624 -177.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.478 ' HG3' ' OE1' ' A' ' 83' ' ' GLU . 29.1 pt20 -136.07 176.04 9.05 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.961 -0.296 . . . . 0.0 110.772 -176.44 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -130.85 135.12 47.42 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.295 -0.412 . . . . 0.0 109.903 175.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.491 ' OG ' ' HB1' ' A' ' 81' ' ' ALA . 78.5 p -70.64 -178.36 1.8 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.955 0.407 . . . . 0.0 111.1 177.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.565 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 1.4 p -65.9 162.72 42.73 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.746 176.326 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -88.62 137.36 3.43 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 122.129 1.886 . . . . 0.0 113.753 179.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.869 ' O ' ' HA ' ' A' ' 78' ' ' THR . 6.4 t -82.53 126.07 39.97 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.72 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 166.619 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 10.5 t -124.14 106.77 17.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 C-N-CA 119.964 -0.694 . . . . 0.0 109.79 172.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.54 HG13 ' HB ' ' A' ' 77' ' ' ILE . 9.7 pt -122.98 111.88 31.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.354 178.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.409 ' HB3' ' OD1' ' A' ' 76' ' ' ASN . 3.6 pt20 -98.0 119.82 37.31 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.555 0.693 . . . . 0.0 111.591 -175.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.99 131.51 47.44 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.715 178.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -85.19 134.51 34.16 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.274 178.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.501 HG21 HD12 ' A' ' 26' ' ' ILE . 34.1 p -70.99 114.63 9.24 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.587 179.465 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 18.9 m . . . . . 0 C--N 1.323 -0.557 0 CA-C-O 121.443 0.64 . . . . 0.0 110.04 -177.999 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.394 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -63.89 130.24 27.04 Favored 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.119 1.879 . . . . 0.0 111.578 178.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.559 ' HD2' ' O ' ' A' ' 31' ' ' SER . 83.5 Cg_exo -47.74 149.74 4.86 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.827 2.351 . . . . 0.0 111.212 171.241 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -39.62 107.16 0.43 Allowed Pre-proline 0 N--CA 1.468 0.467 0 O-C-N 124.382 1.051 . . . . 0.0 112.336 -169.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.563 ' HG2' HG11 ' A' ' 91' ' ' VAL . 31.4 Cg_exo -65.22 148.17 88.6 Favored 'Trans proline' 0 CA--C 1.516 -0.42 0 C-N-CA 123.381 2.721 . . . . 0.0 112.134 179.071 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 24.9 m -107.41 132.01 53.64 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.655 -178.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.426 HG13 ' O ' ' A' ' 27' ' ' VAL . 77.9 t -79.35 123.26 36.04 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 CA-C-N 114.194 -1.366 . . . . 0.0 110.359 176.323 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.411 ' OD2' ' HG3' ' A' ' 20' ' ' GLN . 26.3 t70 -88.72 -35.83 16.51 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.252 -176.281 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.411 ' HG3' ' OD2' ' A' ' 19' ' ' ASP . 75.8 mt-30 -135.99 134.1 38.22 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.688 -176.303 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.48 ' HA ' HG12 ' A' ' 26' ' ' ILE . 78.7 t -129.97 113.68 27.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.444 178.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -127.2 -166.76 1.64 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.057 178.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.6 -68.33 0.37 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.197 0.522 . . . . 0.0 112.161 178.287 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.62 HG22 ' O ' ' A' ' 69' ' ' LEU . 69.6 p -109.56 36.85 2.81 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.51 -174.047 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.505 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 72.0 p -170.59 134.88 1.12 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.94 -176.391 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.619 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 42.4 mt -148.78 141.44 18.21 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.837 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 177.448 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.426 ' O ' HG13 ' A' ' 18' ' ' VAL . 47.3 t -118.21 132.24 68.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 118.897 0.771 . . . . 0.0 110.214 -176.275 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.619 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.7 OUTLIER -125.31 146.15 31.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 C-N-CA 119.917 -0.713 . . . . 0.0 110.411 -178.254 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.501 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 83.3 mtt180 -131.15 121.9 25.69 Favored 'General case' 0 C--N 1.329 -0.288 0 O-C-N 123.376 0.423 . . . . 0.0 110.778 -175.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.52 ' CH2' HD11 ' A' ' 57' ' ' LEU . 30.8 p90 -112.27 141.08 46.42 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.63 -0.713 . . . . 0.0 112.12 -172.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.559 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 62.6 m -80.28 86.11 5.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.848 172.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.502 ' HD3' ' H ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -47.59 151.5 1.45 Allowed Pre-proline 0 CA--C 1.538 0.509 0 CA-C-N 115.144 -0.935 . . . . 0.0 112.243 -177.551 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.662 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 3.3 Cg_exo -79.91 162.95 23.53 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.71 2.94 . . . . 0.0 112.714 -172.155 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -82.68 -13.0 57.19 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.218 172.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -58.82 145.83 77.48 Favored Pre-proline 0 CA--C 1.52 -0.204 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.043 175.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -69.56 114.42 3.67 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 121.458 1.439 . . . . 0.0 110.304 172.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.551 HG22 ' HB2' ' A' ' 81' ' ' ALA . 3.0 pt -127.73 147.95 32.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 109.381 -0.599 . . . . 0.0 109.381 -177.52 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.5 ' C ' ' HB3' ' A' ' 59' ' ' GLU . 16.3 p -96.92 -29.02 13.93 Favored 'General case' 0 N--CA 1.462 0.173 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -178.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.517 ' C ' HG11 ' A' ' 82' ' ' VAL . . . -165.3 -167.44 25.9 Favored Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 119.937 -1.125 . . . . 0.0 112.175 -178.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.662 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 5.3 m-85 -138.36 134.3 34.02 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 122.444 0.298 . . . . 0.0 111.341 174.225 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.6 mmm180 -103.91 149.76 24.81 Favored 'General case' 0 CA--C 1.504 -0.794 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 166.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.883 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 30.6 mt -139.09 108.58 3.89 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 C-N-CA 120.086 -0.646 . . . . 0.0 112.254 -179.339 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 78.8 t -109.44 110.33 31.69 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.432 0 CA-C-O 121.19 0.519 . . . . 0.0 110.797 -179.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.742 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 1.0 OUTLIER -113.57 126.34 55.18 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.783 176.647 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.9 m -137.4 141.88 35.43 Favored Pre-proline 0 C--N 1.319 -0.756 0 CA-C-N 114.203 -1.362 . . . . 0.0 111.98 -173.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo . . . . . 0 C--O 1.234 0.314 0 C-N-CA 123.581 2.854 . . . . 0.0 112.092 175.723 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 49.8 m . . . . . 0 CA--C 1.514 -0.413 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.742 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 26.1 m -146.56 148.08 31.79 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 119.834 -0.746 . . . . 0.0 111.763 -178.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.883 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 30.8 tt0 -120.19 113.74 20.88 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.921 175.201 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.633 HD12 ' CG2' ' A' ' 64' ' ' VAL . 19.9 mt -97.29 158.22 15.57 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.321 177.155 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -119.24 116.65 26.72 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 177.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.52 HD11 ' CH2' ' A' ' 30' ' ' TRP . 2.3 mt -114.11 156.23 44.41 Favored Pre-proline 0 C--N 1.317 -0.818 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -177.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -62.25 150.08 88.29 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 121.798 1.665 . . . . 0.0 111.644 176.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.5 ' HB3' ' C ' ' A' ' 38' ' ' THR . 9.4 pt-20 -45.49 -26.63 0.6 Allowed 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 114.573 -1.194 . . . . 0.0 113.102 176.572 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.2 t -109.32 16.02 22.68 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.333 0.587 . . . . 0.0 110.951 -175.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.493 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -75.59 162.91 27.87 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 177.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.501 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 30.4 p-10 -142.89 4.8 1.5 Allowed 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -176.5 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.619 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 59.4 p -167.31 133.96 2.26 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 119.861 -0.736 . . . . 0.0 111.928 -176.426 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.633 ' CG2' HD12 ' A' ' 55' ' ' LEU . 3.5 p -115.54 137.68 48.36 Favored 'Isoleucine or valine' 0 C--O 1.243 0.761 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.47 176.596 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 24.2 m -93.74 101.46 13.58 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.547 168.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.619 ' HG ' ' O ' ' A' ' 26' ' ' ILE . 0.2 OUTLIER -78.46 144.07 36.11 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 173.542 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.428 ' HA ' ' O ' ' A' ' 24' ' ' THR . 4.3 m -152.79 167.7 28.17 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -177.375 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 68.87 26.22 5.95 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 123.912 0.758 . . . . 0.0 110.394 -174.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.62 ' O ' HG22 ' A' ' 24' ' ' THR . 8.9 mt -72.97 -175.82 1.88 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.792 175.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -123.95 129.2 24.86 Favored Pre-proline 0 C--N 1.322 -0.611 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 174.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -62.54 133.96 45.33 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 123.204 2.603 . . . . 0.0 113.336 -177.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.54 34.88 24.27 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.897 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 58.7 t -134.94 138.95 48.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 120.999 0.428 . . . . 0.0 111.363 -176.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 18.3 tp60 -75.07 108.88 8.09 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.971 177.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.493 ' CE2' HD21 ' A' ' 69' ' ' LEU . 7.5 m-85 -101.63 113.57 26.83 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.311 0.577 . . . . 0.0 111.592 179.591 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.558 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 3.7 m-20 -86.91 110.12 19.79 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.437 175.59 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.524 HG22 HD11 ' A' ' 79' ' ' ILE . 5.3 mp -92.33 118.5 38.01 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.664 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.695 176.742 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.87 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 28.4 m -109.47 115.63 30.3 Favored 'General case' 0 N--CA 1.426 -1.675 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.397 179.55 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.524 HD11 HG22 ' A' ' 77' ' ' ILE . 13.3 mm -95.47 137.21 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 -179.637 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.471 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 74.2 m-85 -124.84 111.35 15.39 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 116.581 -0.282 . . . . 0.0 110.281 179.701 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.551 ' HB2' HG22 ' A' ' 37' ' ' ILE . . . -80.26 116.89 20.59 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 169.394 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.517 HG11 ' C ' ' A' ' 39' ' ' GLY . 7.7 p -109.12 133.34 54.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 C-N-CA 120.075 -0.65 . . . . 0.0 110.448 -176.457 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -112.98 170.15 8.41 Favored 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 123.258 0.349 . . . . 0.0 110.202 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -46.17 -40.66 11.49 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -175.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 24.2 p-10 -111.46 -21.03 12.0 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -171.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -142.6 175.97 9.39 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.372 -0.531 . . . . 0.0 111.653 -172.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -118.41 120.25 37.01 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.291 -0.868 . . . . 0.0 108.675 173.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 50.8 m -68.9 175.35 3.71 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.161 0.505 . . . . 0.0 112.067 -176.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -60.16 152.33 62.74 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.17 179.352 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -88.63 142.78 5.05 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 C-N-CA 122.261 1.974 . . . . 0.0 114.084 -177.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.87 ' O ' ' HA ' ' A' ' 78' ' ' THR . 6.9 t -82.57 128.11 39.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 114.366 -1.288 . . . . 0.0 108.001 165.404 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.7 t -123.49 105.68 16.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 C-N-CA 119.746 -0.782 . . . . 0.0 110.004 172.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.523 HG13 ' HB ' ' A' ' 77' ' ' ILE . 6.5 pt -122.85 111.79 31.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.935 177.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -95.92 117.51 30.75 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.533 0.683 . . . . 0.0 110.851 -177.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.58 127.51 46.47 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.155 176.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -87.15 135.05 33.44 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.147 0.499 . . . . 0.0 110.369 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.474 HG23 HD11 ' A' ' 26' ' ' ILE . 34.5 p -69.55 119.59 14.02 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.683 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 10.2 m . . . . . 0 C--N 1.324 -0.503 0 CA-C-O 121.437 0.637 . . . . 0.0 110.178 -179.059 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.679 ' HB1' ' O ' ' A' ' 89' ' ' THR . . . . . . . . 0 N--CA 1.452 -0.364 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.438 ' HB3' ' O ' ' A' ' 31' ' ' SER . 46.2 Cg_exo -58.49 135.68 69.25 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.381 2.054 . . . . 0.0 111.142 173.462 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.562 ' HD2' ' O ' ' A' ' 31' ' ' SER . 7.9 Cg_endo -53.39 147.09 38.48 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.072 1.848 . . . . 0.0 110.809 174.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -30.51 106.39 0.23 Allowed Pre-proline 0 N--CA 1.472 0.674 0 O-C-N 124.854 1.346 . . . . 0.0 113.267 -168.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.558 ' HG2' HG11 ' A' ' 91' ' ' VAL . 23.2 Cg_exo -70.25 147.22 59.27 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 123.192 2.595 . . . . 0.0 111.876 176.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 18.5 m -109.88 132.86 53.77 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.803 0.811 . . . . 0.0 110.953 -176.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.5 HG22 ' OE1' ' A' ' 95' ' ' GLN . 95.0 t -79.67 125.58 38.82 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-N 114.2 -1.363 . . . . 0.0 110.056 176.269 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -83.63 -52.51 6.39 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.067 -174.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -136.43 132.11 35.02 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.88 0.372 . . . . 0.0 110.505 -178.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.49 ' HA ' HG12 ' A' ' 26' ' ' ILE . 95.1 t -114.15 122.24 67.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.867 -178.365 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.412 ' HB3' ' H ' ' A' ' 23' ' ' ASP . 30.6 m-20 -124.14 -160.34 0.92 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.602 179.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.514 ' O ' ' HB2' ' A' ' 69' ' ' LEU . 1.8 p-10 -73.35 -77.03 0.11 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.129 178.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.644 HG21 ' O ' ' A' ' 69' ' ' LEU . 62.8 p -105.16 34.79 3.06 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.955 -174.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.67 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 75.3 m -168.12 131.01 1.53 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.042 -172.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.53 HG23 ' OE1' ' A' ' 95' ' ' GLN . 28.7 mt -149.2 148.28 15.84 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.89 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 177.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.47 ' O ' HG12 ' A' ' 18' ' ' VAL . 44.2 t -121.58 130.31 74.73 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.59 0 CA-C-N 119.367 0.985 . . . . 0.0 110.888 -176.329 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.62 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.6 OUTLIER -123.9 146.21 29.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 C-N-CA 120.3 -0.56 . . . . 0.0 109.965 -179.629 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.438 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 21.6 mtp180 -129.32 121.0 26.59 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 123.295 0.372 . . . . 0.0 110.602 -174.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.545 ' CH2' HD12 ' A' ' 57' ' ' LEU . 40.5 p90 -115.05 146.4 41.32 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.641 -174.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.562 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 24.0 t -93.89 97.88 10.68 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.635 177.649 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.521 ' NE ' ' HB3' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -46.8 155.67 0.59 Allowed Pre-proline 0 CA--C 1.539 0.533 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -175.445 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.678 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 2.8 Cg_endo -84.5 166.08 12.2 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 124.628 3.552 . . . . 0.0 112.634 -174.299 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -76.54 -22.11 54.81 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.257 -0.883 . . . . 0.0 108.957 170.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -55.22 133.23 69.21 Favored Pre-proline 0 CA--C 1.517 -0.297 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.663 176.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -61.8 116.32 3.37 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 121.554 1.503 . . . . 0.0 110.148 168.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.585 HG21 ' HB1' ' A' ' 81' ' ' ALA . 1.0 OUTLIER -126.76 148.49 31.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -177.544 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 19.0 p -98.07 -28.81 13.59 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -178.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.511 ' C ' HG11 ' A' ' 82' ' ' VAL . . . -162.83 -166.85 22.32 Favored Glycine 0 N--CA 1.443 -0.892 0 C-N-CA 120.347 -0.93 . . . . 0.0 111.766 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.678 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 5.9 m-85 -139.06 132.57 30.32 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 120.718 0.294 . . . . 0.0 110.932 173.183 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 10.4 mmm180 -102.51 149.91 23.91 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 167.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.878 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 34.0 mt -138.49 107.54 3.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 C-N-CA 120.022 -0.671 . . . . 0.0 111.925 -179.225 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 89.4 t -109.1 110.34 31.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.387 0.613 . . . . 0.0 110.551 -178.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.593 ' CE2' ' HB3' ' A' ' 66' ' ' LEU . 1.2 p90 -113.15 126.02 54.99 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.884 177.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 7.4 m -141.06 138.76 18.26 Favored Pre-proline 0 C--N 1.317 -0.827 0 CA-C-N 113.773 -1.558 . . . . 0.0 110.868 -175.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.458 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 59.5 Cg_endo . . . . . 0 C--O 1.232 0.196 0 C-N-CA 123.337 2.691 . . . . 0.0 111.749 175.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.0 m . . . . . 0 CA--C 1.516 -0.33 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.542 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 85.7 m -148.11 147.74 29.85 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.086 -0.645 . . . . 0.0 112.123 -178.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.878 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 30.3 tt0 -112.41 118.29 34.77 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.134 171.286 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.657 HD12 ' CG2' ' A' ' 64' ' ' VAL . 16.5 mt -97.42 160.54 14.26 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 173.209 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -124.77 113.95 18.62 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.728 -179.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.545 HD12 ' CH2' ' A' ' 30' ' ' TRP . 3.2 mt -112.96 157.99 39.07 Favored Pre-proline 0 C--N 1.317 -0.835 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -177.095 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -65.79 150.13 86.24 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 121.76 1.64 . . . . 0.0 111.413 174.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -44.44 -28.72 0.59 Allowed 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 114.887 -1.051 . . . . 0.0 112.859 176.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.8 t -105.29 14.44 28.92 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.251 0.548 . . . . 0.0 111.408 -174.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.423 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -80.02 158.79 26.43 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 176.207 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.521 ' HB3' ' NE ' ' A' ' 32' ' ' ARG . 31.0 p-10 -142.05 17.28 2.1 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 120.619 -0.432 . . . . 0.0 111.96 -177.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.62 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 19.2 p -171.35 134.01 0.86 Allowed 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.268 -0.573 . . . . 0.0 111.847 -179.549 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.657 ' CG2' HD12 ' A' ' 55' ' ' LEU . 3.5 p -117.11 136.3 54.71 Favored 'Isoleucine or valine' 0 C--O 1.242 0.7 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.414 176.367 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 20.8 m -95.13 101.36 13.1 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.386 167.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.67 ' O ' ' HA ' ' A' ' 25' ' ' SER . 0.3 OUTLIER -78.14 144.55 36.33 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.9 -1.045 . . . . 0.0 109.555 178.646 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.457 ' O ' ' HB2' ' A' ' 68' ' ' ASP . 14.2 t -140.39 170.17 16.31 Favored 'General case' 0 C--N 1.319 -0.745 0 O-C-N 123.76 0.663 . . . . 0.0 109.271 -176.482 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 67' ' ' SER . 3.2 m-20 71.89 20.0 4.6 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 123.803 0.69 . . . . 0.0 112.021 -179.28 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.644 ' O ' HG21 ' A' ' 24' ' ' THR . 6.8 mt -72.79 -177.81 2.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.125 0.488 . . . . 0.0 110.412 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 7.8 tp60 -125.38 122.72 25.07 Favored Pre-proline 0 C--N 1.321 -0.663 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 175.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.61 126.09 15.5 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.698 2.265 . . . . 0.0 112.833 -178.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 95.98 28.78 9.04 Favored Glycine 0 N--CA 1.45 -0.414 0 CA-C-N 115.949 -0.568 . . . . 0.0 112.181 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 36.9 t -134.64 152.17 32.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.048 0.451 . . . . 0.0 110.961 -177.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.458 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 11.6 tp60 -87.84 107.99 18.94 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.663 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.457 ' O ' ' HA ' ' A' ' 94' ' ' GLN . 7.1 m-85 -100.79 130.44 46.81 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.145 0.498 . . . . 0.0 111.876 -179.263 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.492 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 10.8 m120 -103.88 113.48 27.04 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.596 -1.184 . . . . 0.0 109.202 175.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.519 HG23 HD12 ' A' ' 79' ' ' ILE . 3.8 mp -95.07 120.27 44.26 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.814 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 176.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.918 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 25.6 m -109.03 113.46 26.34 Favored 'General case' 0 N--CA 1.424 -1.763 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.225 -179.12 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.519 HD12 HG23 ' A' ' 77' ' ' ILE . 12.9 mm -94.64 132.38 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -120.32 111.35 17.65 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.044 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.585 ' HB1' HG21 ' A' ' 37' ' ' ILE . . . -81.82 109.58 16.33 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 172.117 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.511 HG11 ' C ' ' A' ' 39' ' ' GLY . 7.2 p -104.66 143.09 16.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 C-N-CA 120.268 -0.573 . . . . 0.0 111.418 -172.069 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.546 ' HG2' ' N ' ' A' ' 84' ' ' GLU . 55.2 tt0 -121.11 168.17 11.85 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 170.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.546 ' N ' ' HG2' ' A' ' 83' ' ' GLU . 27.7 mt-10 -33.27 -50.97 0.32 Allowed 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -176.561 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 28.4 p-10 -111.96 -24.35 10.0 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -171.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -137.38 173.1 12.04 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.558 -170.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -121.36 152.05 39.43 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.968 178.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 9.8 m -80.51 179.61 7.65 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.62 175.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.679 ' O ' ' HB1' ' A' ' 12' ' ' ALA . 0.6 OUTLIER -60.02 159.41 20.91 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 173.081 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -88.16 138.7 4.16 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 121.921 1.747 . . . . 0.0 113.365 179.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.918 ' O ' ' HA ' ' A' ' 78' ' ' THR . 13.3 t -83.18 123.38 38.61 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.671 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 165.222 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.0 t -121.09 106.48 18.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 C-N-CA 119.856 -0.738 . . . . 0.0 109.981 172.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.431 ' O ' HG13 ' A' ' 93' ' ' ILE . 29.9 pt -121.63 117.63 53.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.976 179.033 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.457 ' HA ' ' O ' ' A' ' 75' ' ' TYR . 12.2 pt20 -108.1 128.67 54.89 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.159 0.504 . . . . 0.0 111.618 -175.422 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.53 ' OE1' HG23 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -136.74 153.03 50.97 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.772 171.927 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -97.31 126.14 42.35 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -179.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.517 HG22 HD13 ' A' ' 26' ' ' ILE . 20.1 p -61.12 112.73 2.22 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.417 0.627 . . . . 0.0 111.26 -176.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 11.0 m . . . . . 0 C--N 1.321 -0.633 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.864 -176.42 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.462 ' HB3' ' O ' ' A' ' 89' ' ' THR . . . . . . . . 0 N--CA 1.452 -0.327 0 N-CA-C 110.132 -0.322 . . . . 0.0 110.132 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -67.64 131.43 24.4 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.338 2.026 . . . . 0.0 111.415 175.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.408 ' HD2' ' O ' ' A' ' 31' ' ' SER . 74.6 Cg_exo -50.2 151.78 8.88 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.751 2.301 . . . . 0.0 111.214 172.454 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -36.83 106.37 0.33 Allowed Pre-proline 0 N--CA 1.472 0.658 0 O-C-N 124.443 1.089 . . . . 0.0 112.411 -171.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.557 ' HG2' HG13 ' A' ' 91' ' ' VAL . 37.8 Cg_exo -65.78 149.79 86.54 Favored 'Trans proline' 0 CA--C 1.517 -0.326 0 C-N-CA 123.141 2.561 . . . . 0.0 112.129 177.639 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 27.4 m -106.38 130.1 54.26 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.585 -178.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.46 HG11 ' O ' ' A' ' 27' ' ' VAL . 53.8 t -71.62 121.88 22.67 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-N 114.227 -1.351 . . . . 0.0 110.12 175.072 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -83.78 -46.26 12.42 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.258 -173.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -135.63 137.99 42.44 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.894 -178.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.489 ' HA ' HG12 ' A' ' 26' ' ' ILE . 23.7 t -123.26 121.37 62.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.892 -178.175 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -131.57 -163.05 1.28 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.443 176.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -72.88 -68.9 0.45 Allowed 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.311 0.485 . . . . 0.0 112.311 -178.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.546 HG22 ' O ' ' A' ' 69' ' ' LEU . 38.1 p -110.12 28.84 8.21 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.377 0.608 . . . . 0.0 110.87 -171.407 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.539 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 12.0 p -169.95 134.65 1.32 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.069 -175.477 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.526 ' HB ' HD11 ' A' ' 66' ' ' LEU . 29.0 mt -146.16 155.98 12.27 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.207 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.46 ' O ' HG11 ' A' ' 18' ' ' VAL . 54.4 t -121.48 140.21 46.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 119.859 1.209 . . . . 0.0 110.253 -177.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.567 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.8 OUTLIER -130.81 149.24 33.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 119.867 -0.733 . . . . 0.0 110.676 176.741 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.464 ' HG2' ' HB3' ' A' ' 63' ' ' SER . 60.8 mtp180 -132.1 120.61 22.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.265 -176.212 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.517 ' CH2' HD13 ' A' ' 57' ' ' LEU . 32.6 p90 -112.04 144.23 41.74 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.905 -173.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.408 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 21.4 m -85.04 86.55 7.37 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.697 174.535 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.498 ' HD3' ' H ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -52.03 152.87 5.15 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.035 -0.984 . . . . 0.0 112.231 -174.513 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.618 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 4.3 Cg_exo -78.13 160.69 29.78 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 123.615 2.877 . . . . 0.0 113.029 -172.229 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -79.29 -14.8 58.78 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.16 -0.927 . . . . 0.0 108.763 170.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.44 145.28 59.65 Favored Pre-proline 0 CA--C 1.517 -0.292 0 CA-C-N 114.879 -1.055 . . . . 0.0 111.441 175.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -67.45 115.77 3.87 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 121.463 1.442 . . . . 0.0 109.951 170.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.579 HG22 ' HB2' ' A' ' 81' ' ' ALA . 1.4 pt -128.18 146.76 33.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.507 ' C ' ' HB3' ' A' ' 59' ' ' GLU . 26.9 p -93.69 -28.86 15.72 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -178.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.559 ' C ' HG12 ' A' ' 82' ' ' VAL . . . -168.44 -164.04 23.45 Favored Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 120.338 -0.934 . . . . 0.0 111.532 -178.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.618 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 5.2 m-85 -140.3 133.98 30.32 Favored 'General case' 0 CA--C 1.513 -0.481 0 CA-C-N 116.929 0.364 . . . . 0.0 111.243 175.202 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.8 mmm180 -106.03 148.35 27.84 Favored 'General case' 0 CA--C 1.505 -0.757 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 167.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.876 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 28.8 mt -138.03 108.55 5.13 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 C-N-CA 120.006 -0.678 . . . . 0.0 112.489 -177.461 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 76.6 t -110.84 111.08 34.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.019 0.438 . . . . 0.0 110.717 -178.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.747 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 1.3 p90 -116.81 126.85 53.68 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.602 0.715 . . . . 0.0 110.474 178.453 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 25.1 p -149.81 143.93 17.21 Favored Pre-proline 0 C--N 1.319 -0.739 0 CA-C-N 113.698 -1.592 . . . . 0.0 111.183 -175.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.58 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 32.4 Cg_exo . . . . . 0 C--N 1.346 0.412 0 C-N-CA 123.128 2.552 . . . . 0.0 111.808 176.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.8 m . . . . . 0 CA--C 1.517 -0.317 0 N-CA-C 110.272 -0.27 . . . . 0.0 110.272 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.747 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 14.6 m -139.56 145.12 38.24 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.548 -0.461 . . . . 0.0 111.376 -177.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.876 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 74.3 tt0 -118.26 124.48 47.95 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 116.042 -0.527 . . . . 0.0 109.615 174.484 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.614 HD13 ' CG2' ' A' ' 64' ' ' VAL . 13.5 mt -106.42 156.79 18.17 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.153 173.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -119.29 115.58 24.46 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.577 178.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.517 HD13 ' CH2' ' A' ' 30' ' ' TRP . 3.5 mt -114.26 158.72 38.94 Favored Pre-proline 0 C--N 1.321 -0.636 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -177.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -69.15 150.0 71.43 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 121.599 1.532 . . . . 0.0 111.226 174.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.507 ' HB3' ' C ' ' A' ' 38' ' ' THR . 10.1 pt-20 -46.48 -25.1 0.61 Allowed 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 114.859 -1.064 . . . . 0.0 113.099 177.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 10.0 t -104.63 15.04 28.79 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.236 -174.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -84.69 162.32 19.73 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 178.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.46 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 27.8 p-10 -142.02 10.42 1.96 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -176.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.567 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 23.0 p -167.42 136.94 2.76 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.77 -177.315 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.638 HG11 ' CD2' ' A' ' 66' ' ' LEU . 2.8 p -120.64 137.49 54.22 Favored 'Isoleucine or valine' 0 C--O 1.247 0.96 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.801 177.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 42.3 m -90.57 100.94 13.69 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.22 166.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.638 ' CD2' HG11 ' A' ' 64' ' ' VAL . 0.5 OUTLIER -76.41 133.52 39.86 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.475 179.352 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 10.7 p -128.37 160.09 33.32 Favored 'General case' 0 N--CA 1.447 -0.583 0 O-C-N 123.878 0.736 . . . . 0.0 110.521 -174.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 65.13 52.03 1.56 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.202 -178.061 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.546 ' O ' HG22 ' A' ' 24' ' ' THR . 6.6 mt -95.1 -175.75 3.62 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 172.401 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.442 ' N ' ' HH ' ' A' ' 75' ' ' TYR . 18.6 mm-40 -127.45 132.77 24.49 Favored Pre-proline 0 C--N 1.321 -0.638 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 175.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -65.57 133.39 34.24 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.879 2.386 . . . . 0.0 112.878 -179.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 77.84 28.99 55.77 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.993 -0.622 . . . . 0.0 111.93 179.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.407 HG12 ' N ' ' A' ' 74' ' ' GLN . 97.5 t -132.01 141.55 45.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.998 0.428 . . . . 0.0 110.398 -178.099 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.58 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 7.7 tp60 -84.61 111.76 19.83 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.183 -175.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.442 ' HH ' ' N ' ' A' ' 70' ' ' GLN . 11.5 m-85 -103.01 127.58 50.2 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.303 0.573 . . . . 0.0 112.011 -176.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.562 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 14.4 m120 -95.72 111.14 23.16 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.278 176.194 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.582 ' HB ' HG13 ' A' ' 93' ' ' ILE . 5.0 mp -92.44 118.09 37.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 176.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.875 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 28.4 m -108.75 113.83 27.12 Favored 'General case' 0 N--CA 1.426 -1.629 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.176 -179.6 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.522 HD13 HG23 ' A' ' 77' ' ' ILE . 13.9 mm -95.12 133.5 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -179.688 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.406 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 71.2 m-85 -121.42 111.89 17.86 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.372 179.589 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.579 ' HB2' HG22 ' A' ' 37' ' ' ILE . . . -81.28 109.17 15.54 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 171.475 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.559 HG12 ' C ' ' A' ' 39' ' ' GLY . 7.4 p -101.09 137.69 27.82 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.604 0 C-N-CA 120.095 -0.642 . . . . 0.0 111.32 -172.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 11.5 tm-20 -117.05 167.41 11.17 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 179.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -46.27 -41.01 12.47 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -174.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 46.3 t-20 -109.38 -32.42 7.17 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -172.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 22.8 pt20 -133.81 176.97 8.09 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.098 -165.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -130.91 135.32 47.57 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 176.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 16.3 m -65.83 170.42 5.39 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.805 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.462 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 1.2 p -54.62 153.66 10.31 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.141 173.434 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -85.93 142.04 7.55 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 121.753 1.635 . . . . 0.0 113.724 -176.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.875 ' O ' ' HA ' ' A' ' 78' ' ' THR . 4.8 t -82.27 123.89 38.69 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.833 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 167.032 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.7 t -120.39 106.04 18.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 C-N-CA 119.862 -0.735 . . . . 0.0 109.961 172.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.582 HG13 ' HB ' ' A' ' 77' ' ' ILE . 7.8 pt -121.02 113.03 38.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.995 176.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.514 ' HB3' ' ND2' ' A' ' 76' ' ' ASN . 11.9 pt20 -99.56 117.66 34.43 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.408 0.623 . . . . 0.0 110.977 -176.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.31 130.63 43.01 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.457 ' HA ' ' HA ' ' A' ' 74' ' ' GLN . 40.4 tt0 -89.23 128.8 35.86 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.338 0.59 . . . . 0.0 111.021 -177.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.524 HG22 HD11 ' A' ' 26' ' ' ILE . 32.8 p -59.19 126.05 26.12 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.148 -178.349 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 10.9 m . . . . . 0 C--N 1.325 -0.468 0 CA-C-O 121.472 0.653 . . . . 0.0 109.875 179.363 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.25 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -69.47 128.89 16.96 Favored 'Trans proline' 0 C--O 1.235 0.367 0 C-N-CA 122.27 1.98 . . . . 0.0 111.472 174.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -52.45 142.12 49.18 Favored 'Trans proline' 0 CA--C 1.509 -0.736 0 C-N-CA 122.306 2.004 . . . . 0.0 110.806 173.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.467 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 2.4 m-20 -35.79 103.16 0.24 Allowed Pre-proline 0 N--CA 1.465 0.291 0 O-C-N 125.069 1.48 . . . . 0.0 112.674 -164.373 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.743 ' CG ' HG11 ' A' ' 91' ' ' VAL . 5.2 Cg_endo -49.7 145.72 17.03 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 123.584 2.856 . . . . 0.0 113.134 169.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.6 m -101.51 131.83 47.46 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.354 179.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.451 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 70.9 t -73.98 112.1 10.26 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 CA-C-N 114.835 -1.075 . . . . 0.0 109.284 172.572 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -86.51 -36.62 18.88 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.666 -172.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -135.03 140.83 45.92 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.973 -176.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 47.5 t -133.81 139.94 47.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.492 -179.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.474 ' CG ' ' H ' ' A' ' 23' ' ' ASP . 12.4 t70 -146.69 -157.69 0.83 Allowed 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -179.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.48 ' HB3' ' HB3' ' A' ' 71' ' ' PRO . 7.0 m-20 -79.5 -70.91 0.48 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.425 0.631 . . . . 0.0 109.935 178.14 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.57 HG22 ' O ' ' A' ' 69' ' ' LEU . 69.7 p -104.71 34.96 2.93 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.775 -174.757 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.518 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 29.9 m -167.83 137.52 2.65 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 123.139 0.576 . . . . 0.0 110.062 -172.321 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.534 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 29.2 mt -153.17 149.76 13.07 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.117 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 177.553 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 47.3 t -122.37 137.0 57.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 119.517 1.053 . . . . 0.0 110.186 -176.385 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.556 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.8 OUTLIER -130.19 149.83 33.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 C-N-CA 120.129 -0.629 . . . . 0.0 110.383 179.341 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.449 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 55.1 mtp180 -134.31 120.44 19.92 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.392 -175.142 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.53 ' CH2' HD12 ' A' ' 57' ' ' LEU . 36.9 p90 -112.56 146.8 37.89 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.742 -173.039 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 35.5 t -89.24 91.96 8.98 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 173.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.448 ' HD3' ' H ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -50.94 153.37 3.07 Favored Pre-proline 0 CA--C 1.54 0.584 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.785 -176.129 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.626 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 5.1 Cg_exo -78.07 162.52 28.85 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 123.879 3.053 . . . . 0.0 112.592 -174.527 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -83.25 -7.74 59.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.405 172.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.33 150.94 70.64 Favored Pre-proline 0 CA--C 1.518 -0.262 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.737 175.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.574 ' O ' ' HG3' ' A' ' 83' ' ' GLU . 12.2 Cg_exo -69.77 114.46 3.71 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 121.128 1.219 . . . . 0.0 109.559 169.439 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.584 HG21 ' HB3' ' A' ' 81' ' ' ALA . 2.0 pt -128.85 142.59 43.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.454 ' N ' ' O ' ' A' ' 82' ' ' VAL . 12.6 p -92.2 -31.42 15.46 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -178.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.552 ' C ' HG12 ' A' ' 82' ' ' VAL . . . -163.41 -163.95 17.36 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.12 -1.038 . . . . 0.0 111.919 -177.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.626 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 5.4 m-85 -141.05 133.31 28.12 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.785 0.326 . . . . 0.0 111.323 175.419 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 10.1 mmm180 -103.7 149.61 24.81 Favored 'General case' 0 CA--C 1.503 -0.832 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 167.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.866 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 32.0 mt -138.7 107.08 3.51 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 C-N-CA 119.734 -0.787 . . . . 0.0 112.318 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 74.1 t -108.88 110.18 31.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.19 0.519 . . . . 0.0 110.646 -178.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.772 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 0.5 OUTLIER -110.34 124.9 52.53 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.552 176.019 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 35.6 t -137.34 135.41 19.42 Favored Pre-proline 0 C--N 1.318 -0.8 0 CA-C-N 113.926 -1.488 . . . . 0.0 111.33 -173.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.65 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 50.7 Cg_endo . . . . . 0 CA--C 1.527 0.156 0 C-N-CA 123.472 2.781 . . . . 0.0 112.005 175.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.3 p . . . . . 0 C--O 1.233 0.236 0 N-CA-C 110.232 -0.285 . . . . 0.0 110.232 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.772 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 24.4 m -142.78 147.8 36.11 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.457 -0.497 . . . . 0.0 111.557 -174.588 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.866 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 21.8 tt0 -116.44 122.34 44.49 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.148 172.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.597 HD12 ' CG2' ' A' ' 64' ' ' VAL . 12.8 mt -99.8 160.54 14.23 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.613 -0.435 . . . . 0.0 109.882 172.153 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -122.54 117.66 26.43 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.53 HD12 ' CH2' ' A' ' 30' ' ' TRP . 3.9 mt -116.02 158.2 43.09 Favored Pre-proline 0 C--N 1.318 -0.796 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -177.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -70.71 152.17 64.18 Favored 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 121.298 1.332 . . . . 0.0 111.124 173.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.445 ' HG3' ' N ' ' A' ' 60' ' ' THR . 8.1 pt-20 -43.62 -39.65 3.65 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.548 0.69 . . . . 0.0 111.796 175.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.445 ' N ' ' HG3' ' A' ' 59' ' ' GLU . 9.7 t -88.24 19.07 3.92 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.467 -174.119 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -91.79 164.38 13.72 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 175.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.449 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 30.3 p-10 -149.28 16.08 0.92 Allowed 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -178.243 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.556 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 17.3 p -170.13 134.17 1.21 Allowed 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.446 -0.502 . . . . 0.0 112.017 -179.575 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.638 HG12 ' CD2' ' A' ' 66' ' ' LEU . 3.2 p -119.52 137.68 52.63 Favored 'Isoleucine or valine' 0 C--O 1.244 0.772 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.347 177.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 42.2 m -94.71 101.49 13.33 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-O 121.573 0.701 . . . . 0.0 109.332 167.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.638 ' CD2' HG12 ' A' ' 64' ' ' VAL . 0.2 OUTLIER -76.59 139.49 40.68 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.362 178.533 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 14.2 t -134.88 171.04 14.95 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -176.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 64.89 35.19 8.58 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 123.786 0.679 . . . . 0.0 110.795 -179.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.57 ' O ' HG22 ' A' ' 24' ' ' THR . 7.5 mt -85.08 -176.96 6.41 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 174.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 19.6 mm-40 -123.37 132.5 24.28 Favored Pre-proline 0 C--N 1.318 -0.782 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 173.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.48 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . 37.2 Cg_endo -66.74 128.01 18.15 Favored 'Trans proline' 0 C--O 1.234 0.311 0 C-N-CA 122.722 2.281 . . . . 0.0 112.517 179.47 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 83.49 33.8 21.44 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.991 -0.623 . . . . 0.0 111.851 -179.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 72.1 t -134.84 140.79 44.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.085 0.469 . . . . 0.0 111.047 -176.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.65 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -79.34 118.41 21.23 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.233 -178.481 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.467 ' CE2' HD21 ' A' ' 69' ' ' LEU . 9.2 m-85 -114.32 121.4 43.52 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.095 0.474 . . . . 0.0 112.143 -177.69 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.549 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 0.8 OUTLIER -88.47 113.38 24.0 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.418 170.669 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.551 ' HB ' HG13 ' A' ' 93' ' ' ILE . 4.9 mp -92.2 115.47 31.24 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.661 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 173.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.874 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 19.4 m -107.24 113.31 26.64 Favored 'General case' 0 N--CA 1.427 -1.615 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.421 -178.516 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.522 HD12 HG23 ' A' ' 77' ' ' ILE . 11.3 mm -94.78 136.09 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.022 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.433 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 80.7 m-85 -122.35 110.94 16.28 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.92 179.104 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.584 ' HB3' HG21 ' A' ' 37' ' ' ILE . . . -80.14 107.62 13.07 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 171.001 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.552 HG12 ' C ' ' A' ' 39' ' ' GLY . 7.3 p -99.96 137.61 26.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 C-N-CA 119.854 -0.738 . . . . 0.0 110.572 -173.464 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.643 ' HG2' ' N ' ' A' ' 84' ' ' GLU . 2.1 tt0 -111.85 166.8 10.89 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 124.014 0.821 . . . . 0.0 109.597 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.643 ' N ' ' HG2' ' A' ' 83' ' ' GLU . 34.3 mt-10 -41.23 -53.06 3.27 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 123.008 0.523 . . . . 0.0 111.955 177.107 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -124.53 8.26 8.33 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -173.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -140.41 174.22 10.73 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.025 0.441 . . . . 0.0 111.56 -176.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -136.8 122.26 19.52 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 172.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 32.6 m -64.72 168.69 5.82 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.712 0.292 . . . . 0.0 110.951 178.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.1 p -56.09 151.71 24.74 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.768 176.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -82.92 136.28 8.06 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 121.985 1.79 . . . . 0.0 113.139 -178.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.874 ' O ' ' HA ' ' A' ' 78' ' ' THR . 54.0 t -82.77 119.03 31.5 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.755 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 169.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.8 t -116.77 105.24 17.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 C-N-CA 119.249 -0.98 . . . . 0.0 109.965 173.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.551 HG13 ' HB ' ' A' ' 77' ' ' ILE . 7.4 pt -118.1 111.59 34.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.438 176.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -101.15 127.69 47.59 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.518 0.675 . . . . 0.0 111.04 -174.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -140.34 134.56 31.09 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.296 -0.866 . . . . 0.0 108.82 -179.224 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.587 ' CG ' ' HG2' ' A' ' 74' ' ' GLN . 47.0 mt-10 -86.61 126.56 34.59 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 120.81 0.338 . . . . 0.0 110.765 178.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.519 HG23 HD11 ' A' ' 26' ' ' ILE . 35.0 p -56.23 119.59 6.21 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.32 179.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 25.6 m . . . . . 0 CA--C 1.512 -0.506 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.591 -178.391 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.452 ' HB1' ' O ' ' A' ' 89' ' ' THR . . . . . . . . 0 N--CA 1.45 -0.44 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.41 ' HB2' ' HB2' ' A' ' 30' ' ' TRP . 17.4 Cg_exo -70.47 126.99 13.43 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 121.926 1.751 . . . . 0.0 111.062 172.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.689 ' HD2' ' O ' ' A' ' 31' ' ' SER . 95.4 Cg_exo -45.54 147.46 2.78 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.931 2.421 . . . . 0.0 111.858 172.504 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -32.74 105.36 0.24 Allowed Pre-proline 0 N--CA 1.468 0.456 0 O-C-N 125.016 1.448 . . . . 0.0 112.842 -170.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.534 ' HG2' HG12 ' A' ' 91' ' ' VAL . 20.8 Cg_exo -72.24 151.39 54.6 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 123.803 3.002 . . . . 0.0 112.113 177.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 24.0 m -119.68 135.06 54.98 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 121.72 0.771 . . . . 0.0 111.11 -176.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.45 ' HA ' ' HA ' ' A' ' 28' ' ' VAL . 71.9 t -77.64 125.41 37.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-N 114.16 -1.382 . . . . 0.0 109.864 174.59 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -88.05 -47.29 8.63 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.208 -174.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -136.88 145.83 44.82 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 120.978 0.418 . . . . 0.0 110.854 179.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 26.3 m -130.94 139.9 49.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.461 -179.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.445 ' HB2' ' HG ' ' A' ' 25' ' ' SER . 29.2 m-20 -135.34 -153.5 0.52 Allowed 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 175.374 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.452 ' CB ' ' HB3' ' A' ' 71' ' ' PRO . 5.5 m-20 -76.3 -73.47 0.27 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.546 0.689 . . . . 0.0 110.497 178.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.686 HG22 ' O ' ' A' ' 69' ' ' LEU . 35.0 p -102.07 37.01 1.95 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.698 -174.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.676 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 55.3 p -169.55 134.08 1.39 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.14 -173.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.613 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 13.3 mt -150.6 142.08 16.71 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.819 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.439 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 38.6 t -115.96 129.02 73.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 119.184 0.902 . . . . 0.0 110.906 -176.204 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.623 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.7 OUTLIER -123.27 145.71 29.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -177.742 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.443 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 59.5 mtp180 -131.78 122.4 25.74 Favored 'General case' 0 C--N 1.329 -0.298 0 O-C-N 123.254 0.346 . . . . 0.0 110.706 -174.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.547 ' CH2' HD13 ' A' ' 57' ' ' LEU . 34.5 p90 -114.36 148.42 37.65 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.674 -0.694 . . . . 0.0 112.004 -174.265 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.689 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 24.1 t -92.69 86.47 5.56 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.612 177.119 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.483 ' HD3' ' H ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -43.08 150.96 0.43 Allowed Pre-proline 0 CA--C 1.548 0.869 0 C-N-CA 124.011 0.924 . . . . 0.0 113.39 -176.043 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.72 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 6.3 Cg_exo -78.46 167.79 22.34 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 124.473 3.448 . . . . 0.0 114.9 -164.394 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -68.35 -28.62 67.29 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 114.308 -1.314 . . . . 0.0 109.642 170.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -61.87 137.43 95.32 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 114.99 -1.005 . . . . 0.0 111.403 -179.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_exo -70.66 115.03 4.04 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 121.394 1.396 . . . . 0.0 109.366 167.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.573 HG21 ' HB2' ' A' ' 81' ' ' ALA . 0.4 OUTLIER -118.64 159.35 19.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -174.745 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.404 ' N ' ' O ' ' A' ' 82' ' ' VAL . 16.7 p -101.47 -27.62 13.03 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -178.452 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -168.04 -168.9 30.83 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 119.879 -1.153 . . . . 0.0 112.365 177.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.72 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 5.0 m-85 -137.5 134.46 35.76 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 121.076 0.465 . . . . 0.0 111.438 177.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.8 mtm180 -112.95 147.54 36.9 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.103 170.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.884 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 27.1 mt -137.98 109.76 6.2 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 C-N-CA 119.886 -0.726 . . . . 0.0 112.841 -173.281 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 97.5 t -110.81 111.16 34.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.086 0.469 . . . . 0.0 110.941 -178.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.822 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 0.9 OUTLIER -115.69 126.65 54.39 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.267 177.366 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.6 p -136.67 138.25 25.88 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-N 113.922 -1.49 . . . . 0.0 111.889 -174.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo . . . . . 0 C--N 1.343 0.241 0 C-N-CA 123.611 2.874 . . . . 0.0 111.604 176.043 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 28.8 p . . . . . 0 CA--C 1.513 -0.457 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.822 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 12.4 m -140.01 148.72 42.28 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 119.535 -0.866 . . . . 0.0 111.595 -179.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.884 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 37.5 tt0 -122.68 112.15 17.6 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.557 177.269 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.6 HD12 ' CG2' ' A' ' 64' ' ' VAL . 11.7 mt -99.56 164.27 12.15 Favored 'General case' 0 CA--C 1.511 -0.531 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.633 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.404 ' O ' HD21 ' A' ' 57' ' ' LEU . 18.6 t-20 -126.27 118.86 25.99 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.586 179.475 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.547 HD13 ' CH2' ' A' ' 30' ' ' TRP . 5.3 mt -119.02 159.12 46.11 Favored Pre-proline 0 C--N 1.318 -0.801 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 -178.02 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -65.13 153.44 78.26 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 121.717 1.612 . . . . 0.0 111.258 174.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -49.98 -26.7 4.49 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.074 176.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 10.2 t -101.23 13.63 34.5 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.053 -175.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.5 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -80.34 161.53 24.99 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 178.274 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.443 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 27.7 p-10 -147.73 16.54 1.12 Allowed 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -178.16 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.623 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 19.7 p -171.49 134.42 0.86 Allowed 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.23 -0.588 . . . . 0.0 111.645 179.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.637 HG12 ' CD2' ' A' ' 66' ' ' LEU . 3.1 p -118.83 137.36 53.06 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.399 176.548 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 52.1 m -95.71 100.82 12.49 Favored 'General case' 0 N--CA 1.433 -1.301 0 CA-C-O 121.573 0.701 . . . . 0.0 109.18 169.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.715 ' HB3' ' CE2' ' A' ' 44' ' ' TYR . 0.3 OUTLIER -74.9 141.33 44.14 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.173 178.439 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.416 ' HA ' ' O ' ' A' ' 24' ' ' THR . 9.7 t -136.07 168.97 18.36 Favored 'General case' 0 N--CA 1.444 -0.75 0 O-C-N 123.605 0.566 . . . . 0.0 109.762 -178.126 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 62.92 34.34 14.25 Favored 'General case' 0 CA--C 1.519 -0.234 0 O-C-N 123.787 0.679 . . . . 0.0 111.252 -178.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.686 ' O ' HG22 ' A' ' 24' ' ' THR . 9.4 mt -79.62 -177.21 5.73 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 174.108 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 55.7 tp60 -123.33 125.01 26.24 Favored Pre-proline 0 C--N 1.314 -0.947 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 175.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.452 ' HB3' ' CB ' ' A' ' 23' ' ' ASP . 39.4 Cg_endo -65.28 133.97 37.21 Favored 'Trans proline' 0 CA--C 1.53 0.316 0 C-N-CA 123.019 2.48 . . . . 0.0 113.12 -175.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 82.48 35.49 19.83 Favored Glycine 0 N--CA 1.45 -0.386 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.901 -179.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 45.4 t -137.4 149.91 25.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.0 0.428 . . . . 0.0 111.026 -175.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 8.9 tp60 -87.98 111.34 21.38 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.433 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.508 ' CE2' HD22 ' A' ' 69' ' ' LEU . 4.7 m-85 -102.01 123.34 45.72 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.878 -177.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.522 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 74.9 m-20 -93.5 107.6 19.42 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.151 175.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.543 ' HB ' HG13 ' A' ' 93' ' ' ILE . 5.2 mp -92.69 118.67 38.81 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.596 0 CA-C-O 121.229 0.538 . . . . 0.0 109.717 176.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.826 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 30.0 m -110.16 116.19 31.08 Favored 'General case' 0 N--CA 1.428 -1.553 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.331 179.618 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.514 HD12 HG21 ' A' ' 77' ' ' ILE . 12.4 mm -95.5 130.79 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -117.53 112.14 20.2 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 177.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.573 ' HB2' HG21 ' A' ' 37' ' ' ILE . . . -82.69 127.61 33.56 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 169.588 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.404 ' O ' ' N ' ' A' ' 38' ' ' THR . 6.5 p -117.59 135.88 56.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 C-N-CA 120.194 -0.603 . . . . 0.0 110.804 -177.265 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.569 ' HG3' HG23 ' A' ' 37' ' ' ILE . 2.4 mp0 -113.37 170.17 8.43 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -38.65 -52.65 1.65 Allowed 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -174.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -131.09 17.31 5.05 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.943 -0.303 . . . . 0.0 110.814 -176.15 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 18.1 mm-40 -142.19 173.5 11.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.795 0.331 . . . . 0.0 110.915 -176.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -135.81 125.58 25.58 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 175.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 47.6 m -73.1 170.5 14.77 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.734 0.302 . . . . 0.0 111.079 178.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.452 ' O ' ' HB1' ' A' ' 12' ' ' ALA . 2.8 p -62.58 153.03 79.37 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 120.973 0.416 . . . . 0.0 111.096 178.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -86.03 140.92 6.97 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.516 2.144 . . . . 0.0 114.387 -177.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.826 ' O ' ' HA ' ' A' ' 78' ' ' THR . 21.0 t -82.33 127.4 39.67 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.624 0 CA-C-N 114.83 -1.077 . . . . 0.0 108.575 167.132 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 11.7 t -121.84 106.9 18.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 C-N-CA 119.935 -0.706 . . . . 0.0 109.884 170.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.543 HG13 ' HB ' ' A' ' 77' ' ' ILE . 8.6 pt -122.58 116.79 49.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.166 178.342 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -100.03 124.96 45.98 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.601 0.715 . . . . 0.0 110.953 -177.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.67 134.25 40.93 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.311 178.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -84.89 137.05 33.37 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.965 0.412 . . . . 0.0 110.037 178.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.481 HG21 HD12 ' A' ' 26' ' ' ILE . 25.5 p -71.13 113.0 7.73 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.778 176.13 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 33.1 m . . . . . 0 C--N 1.32 -0.706 0 CA-C-O 121.837 0.827 . . . . 0.0 109.638 -179.351 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.214 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.413 ' HB3' ' O ' ' A' ' 31' ' ' SER . 23.6 Cg_exo -68.28 130.91 22.18 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.507 2.138 . . . . 0.0 112.252 177.306 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -50.87 151.26 11.52 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.81 2.34 . . . . 0.0 111.572 172.899 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -38.88 106.13 0.37 Allowed Pre-proline 0 N--CA 1.47 0.573 0 O-C-N 124.493 1.121 . . . . 0.0 112.251 -170.552 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.56 ' HG2' HG12 ' A' ' 91' ' ' VAL . 34.3 Cg_exo -64.59 149.68 89.46 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 123.504 2.803 . . . . 0.0 112.691 179.594 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 28.0 m -105.24 129.39 53.62 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.988 -1.006 . . . . 0.0 110.71 -177.423 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.451 HG11 ' O ' ' A' ' 27' ' ' VAL . 70.6 t -81.02 123.31 37.49 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 CA-C-N 114.522 -1.217 . . . . 0.0 110.049 175.639 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -89.39 -37.39 14.88 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.435 -174.756 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -135.05 134.75 40.7 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.851 0.358 . . . . 0.0 110.601 -177.898 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.479 ' HA ' HG12 ' A' ' 26' ' ' ILE . 59.2 t -130.0 117.93 42.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.334 179.184 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -128.21 -160.76 1.04 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.84 175.405 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.552 ' O ' ' HB2' ' A' ' 69' ' ' LEU . 1.9 m-20 -77.19 -58.4 3.3 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.043 0.449 . . . . 0.0 110.91 -177.718 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.638 HG21 ' O ' ' A' ' 69' ' ' LEU . 34.9 p -113.11 34.42 4.47 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.131 -175.458 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.624 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 75.8 p -169.88 130.94 1.03 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.626 -176.583 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.582 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 43.4 mt -147.17 139.51 18.98 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.624 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 176.841 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.451 ' O ' HG11 ' A' ' 18' ' ' VAL . 39.9 t -118.17 130.13 73.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 118.697 0.681 . . . . 0.0 110.586 -175.702 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.678 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.6 OUTLIER -122.81 145.87 28.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 C-N-CA 120.496 -0.482 . . . . 0.0 110.009 -177.368 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.562 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 29.8 mtm180 -130.81 121.11 24.75 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 123.358 0.411 . . . . 0.0 110.68 -175.946 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.525 ' CH2' HD13 ' A' ' 57' ' ' LEU . 38.2 p90 -110.26 144.23 39.27 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.608 -173.994 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.413 ' O ' ' HB3' ' A' ' 13' ' ' PRO . 17.6 m -89.31 96.8 10.86 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.027 177.167 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.587 ' NE ' ' HB3' ' A' ' 62' ' ' ASN . 0.1 OUTLIER -45.73 155.85 0.46 Allowed Pre-proline 0 CA--C 1.538 0.515 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -175.105 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.672 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 4.6 Cg_exo -82.95 169.91 12.78 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 124.519 3.479 . . . . 0.0 112.623 -172.416 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -81.21 -18.0 47.65 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.181 174.518 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.18 142.08 98.21 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.499 177.863 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_exo -70.72 115.26 4.15 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 121.487 1.458 . . . . 0.0 109.614 168.432 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.609 HG21 ' HG3' ' A' ' 83' ' ' GLU . 0.8 OUTLIER -121.72 152.15 25.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -174.91 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 11.8 p -98.12 -31.65 12.01 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -177.637 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.448 ' C ' HG13 ' A' ' 82' ' ' VAL . . . -163.15 -164.39 18.09 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.267 -0.968 . . . . 0.0 111.698 177.977 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.672 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 6.4 m-85 -140.32 136.13 32.91 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.848 0.324 . . . . 0.0 111.124 175.162 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 21.6 mtp180 -104.69 151.38 23.77 Favored 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 166.393 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.882 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 32.6 mt -139.59 108.47 3.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 C-N-CA 120.617 -0.433 . . . . 0.0 111.977 -178.491 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 72.6 t -107.77 109.64 28.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.306 0.574 . . . . 0.0 110.194 178.322 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.7 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 0.6 OUTLIER -110.46 125.14 52.97 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.138 175.908 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.1 m -143.17 133.88 12.4 Favored Pre-proline 0 C--N 1.316 -0.874 0 CA-C-N 113.928 -1.487 . . . . 0.0 110.808 -175.379 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.528 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 57.6 Cg_endo . . . . . 0 C--N 1.333 -0.274 0 C-N-CA 123.108 2.539 . . . . 0.0 111.694 176.162 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 15.5 m . . . . . 0 CA--C 1.517 -0.318 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.7 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 23.5 m -144.77 151.93 39.59 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 120.443 -0.503 . . . . 0.0 111.476 -175.705 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.882 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 51.4 tt0 -121.61 112.44 18.46 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.619 176.251 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.617 HD11 ' CG2' ' A' ' 64' ' ' VAL . 18.1 mt -97.48 163.0 13.05 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.013 176.885 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.503 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 18.5 m120 -129.75 113.27 14.51 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.884 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.525 HD13 ' CH2' ' A' ' 30' ' ' TRP . 3.5 mt -110.98 157.62 38.14 Favored Pre-proline 0 C--N 1.317 -0.831 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -174.431 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -64.59 150.45 88.19 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 121.849 1.699 . . . . 0.0 111.157 175.484 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -48.31 -23.03 0.78 Allowed 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 115.177 -0.919 . . . . 0.0 112.852 177.908 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 5.1 t -99.86 1.6 43.07 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.215 -175.859 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.48 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -76.06 159.57 30.65 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 -176.951 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.587 ' HB3' ' NE ' ' A' ' 32' ' ' ARG . 28.6 p-10 -147.03 18.52 1.24 Allowed 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 120.554 -0.458 . . . . 0.0 112.231 -178.421 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.678 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 23.2 p -169.22 133.65 1.43 Allowed 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.164 -0.615 . . . . 0.0 112.155 -179.9 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.617 ' CG2' HD11 ' A' ' 55' ' ' LEU . 3.6 p -118.44 137.11 53.46 Favored 'Isoleucine or valine' 0 C--O 1.242 0.673 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.203 176.257 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 61.0 m -97.68 101.98 13.63 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.752 171.65 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.624 ' O ' ' HA ' ' A' ' 25' ' ' SER . 0.2 OUTLIER -80.59 140.22 35.87 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.362 179.397 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 22.0 t -134.11 168.23 19.21 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 123.438 0.461 . . . . 0.0 110.642 -173.455 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 58.75 31.34 21.09 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.991 -177.811 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.638 ' O ' HG21 ' A' ' 24' ' ' THR . 14.3 mt -69.16 -175.44 0.76 Allowed 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 175.19 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.45 ' N ' ' HH ' ' A' ' 75' ' ' TYR . 8.6 tt0 -126.87 125.53 24.28 Favored Pre-proline 0 C--N 1.318 -0.772 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 178.407 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.406 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . 27.0 Cg_endo -63.52 130.04 27.02 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 123.03 2.486 . . . . 0.0 113.418 -177.346 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 88.18 22.05 43.0 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.774 -179.917 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 86.6 t -127.38 144.26 37.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.145 0.498 . . . . 0.0 111.308 -173.35 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.528 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 15.8 tp60 -88.88 107.18 18.86 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.98 -176.566 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.45 ' HH ' ' N ' ' A' ' 70' ' ' GLN . 16.0 m-85 -98.09 117.79 33.24 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.224 0.535 . . . . 0.0 111.64 -178.079 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -90.4 107.9 19.44 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.127 177.629 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.527 HG21 HD13 ' A' ' 79' ' ' ILE . 5.3 mp -91.73 116.4 32.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.294 0.569 . . . . 0.0 109.684 178.988 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.834 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 30.8 m -108.47 115.26 29.77 Favored 'General case' 0 N--CA 1.428 -1.525 0 CA-C-N 115.294 -0.867 . . . . 0.0 110.404 -179.791 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.527 HD13 HG21 ' A' ' 77' ' ' ILE . 14.3 mm -95.46 144.23 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -179.255 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -131.17 112.12 12.55 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.233 179.374 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.562 ' HB3' HG22 ' A' ' 37' ' ' ILE . . . -79.02 123.69 27.55 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 169.117 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.448 HG13 ' C ' ' A' ' 39' ' ' GLY . 7.0 p -114.53 135.91 52.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 C-N-CA 120.149 -0.621 . . . . 0.0 110.685 -179.824 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.663 ' OE1' ' HG3' ' A' ' 86' ' ' GLN . 3.9 mp0 -112.28 170.68 8.0 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -179.164 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -38.76 -55.78 1.44 Allowed 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -174.09 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -125.23 9.85 8.01 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -176.233 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.663 ' HG3' ' OE1' ' A' ' 83' ' ' GLU . 3.3 pt20 -143.03 176.49 9.06 Favored 'General case' 0 N--CA 1.447 -0.623 0 O-C-N 122.336 -0.227 . . . . 0.0 111.0 -175.095 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -138.28 136.08 36.12 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.004 178.432 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 46.2 m -78.24 175.46 10.18 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.168 178.297 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -63.09 160.69 37.13 Favored Pre-proline 0 CA--C 1.534 0.344 0 CA-C-O 120.973 0.416 . . . . 0.0 111.523 178.614 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -87.85 140.46 5.01 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.302 2.002 . . . . 0.0 114.365 -178.497 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.834 ' O ' ' HA ' ' A' ' 78' ' ' THR . 6.9 t -82.72 127.65 39.47 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.688 0 CA-C-N 114.825 -1.08 . . . . 0.0 108.34 165.863 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.4 t -124.05 106.06 16.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 C-N-CA 120.027 -0.669 . . . . 0.0 109.596 172.476 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.506 HG13 ' HB ' ' A' ' 77' ' ' ILE . 7.7 pt -124.2 112.87 34.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.418 178.674 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -94.07 120.17 33.94 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.315 0.579 . . . . 0.0 111.05 -177.66 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.33 125.37 42.16 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.486 175.482 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.432 ' HA ' ' HA ' ' A' ' 74' ' ' GLN . 40.9 tt0 -90.0 128.08 36.18 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.18 0.514 . . . . 0.0 110.034 179.783 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.508 HG22 HD13 ' A' ' 26' ' ' ILE . 40.3 p -59.52 144.71 46.56 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.948 -176.524 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 16.4 m . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.342 -171.752 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.52 ' HB3' ' O ' ' A' ' 89' ' ' THR . . . . . . . . 0 CA--C 1.516 -0.34 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.455 ' CB ' ' HB2' ' A' ' 30' ' ' TRP . 27.0 Cg_exo -64.64 130.68 27.09 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 121.81 1.674 . . . . 0.0 111.055 171.806 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.546 ' HD2' ' O ' ' A' ' 31' ' ' SER . 71.5 Cg_exo -50.39 155.56 4.86 Favored 'Trans proline' 0 C--O 1.235 0.353 0 C-N-CA 122.524 2.149 . . . . 0.0 111.6 171.415 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -35.7 106.19 0.3 Allowed Pre-proline 0 N--CA 1.472 0.654 0 O-C-N 124.56 1.162 . . . . 0.0 112.437 -171.115 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.553 ' HG2' HG13 ' A' ' 91' ' ' VAL . 24.1 Cg_exo -70.5 145.1 51.94 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 123.162 2.575 . . . . 0.0 112.435 177.518 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.2 m -101.64 131.2 48.0 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.568 0.699 . . . . 0.0 110.814 -177.575 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.426 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 70.6 t -81.01 118.24 28.44 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 CA-C-N 114.658 -1.156 . . . . 0.0 110.061 175.226 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -78.05 -46.63 20.39 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.318 -175.568 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -136.74 140.67 42.77 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.679 -178.193 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.46 ' HA ' HG12 ' A' ' 26' ' ' ILE . 7.2 t -127.24 114.2 35.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.697 -178.063 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -124.63 -164.96 1.32 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 179.467 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.57 ' O ' ' HB2' ' A' ' 69' ' ' LEU . 4.0 p-10 -70.67 -67.1 0.53 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.073 0.463 . . . . 0.0 112.193 -178.109 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.678 HG22 ' O ' ' A' ' 69' ' ' LEU . 35.2 p -110.3 32.08 5.43 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.004 -173.381 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.703 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 42.3 m -167.71 129.99 1.57 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.194 -171.622 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.538 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 44.8 mt -147.37 145.57 18.99 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.924 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 177.398 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.426 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 43.7 t -118.67 131.4 71.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 119.22 0.918 . . . . 0.0 110.262 -176.803 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.639 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.6 OUTLIER -127.76 145.77 34.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 C-N-CA 120.096 -0.642 . . . . 0.0 110.318 -179.214 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.497 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 11.1 mtm180 -130.02 121.34 26.28 Favored 'General case' 0 CA--C 1.515 -0.379 0 O-C-N 123.397 0.436 . . . . 0.0 110.302 -175.584 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.515 ' CH2' HD13 ' A' ' 57' ' ' LEU . 34.6 p90 -111.53 145.8 38.43 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.419 -175.306 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.546 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 12.5 t -90.29 91.81 8.66 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 175.124 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.417 ' HD3' ' H ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -46.1 156.3 0.48 Allowed Pre-proline 0 CA--C 1.542 0.662 0 C-N-CA 124.14 0.976 . . . . 0.0 113.507 -174.426 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.657 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 4.2 Cg_exo -76.27 169.53 21.81 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 123.86 3.04 . . . . 0.0 112.939 -173.754 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -83.74 -15.59 48.03 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.344 174.378 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.98 144.87 99.14 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.122 -0.944 . . . . 0.0 111.423 177.233 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -68.6 115.45 3.92 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 121.612 1.542 . . . . 0.0 109.831 167.274 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.568 HG21 ' HB1' ' A' ' 81' ' ' ALA . 1.1 pt -121.11 155.74 24.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -177.683 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.502 ' C ' ' HB3' ' A' ' 59' ' ' GLU . 21.7 p -104.24 -29.32 10.88 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -177.858 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.511 ' C ' HG12 ' A' ' 82' ' ' VAL . . . -161.7 -167.87 22.77 Favored Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.252 -0.975 . . . . 0.0 111.829 179.853 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.657 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 5.5 m-85 -139.93 131.57 27.25 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 120.803 0.335 . . . . 0.0 111.301 174.347 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.583 ' CZ ' HG13 ' A' ' 82' ' ' VAL . 0.2 OUTLIER -99.55 147.79 24.96 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 168.792 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.882 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 33.0 mt -139.71 107.47 2.93 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 C-N-CA 119.875 -0.73 . . . . 0.0 112.435 -179.582 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 82.5 t -108.47 110.7 32.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.138 0.494 . . . . 0.0 110.825 -178.519 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.741 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 0.8 OUTLIER -113.43 125.56 54.37 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 121.503 0.668 . . . . 0.0 109.985 176.175 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.462 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 13.9 t -140.25 140.53 23.6 Favored Pre-proline 0 C--N 1.319 -0.751 0 CA-C-N 113.717 -1.583 . . . . 0.0 110.69 -174.505 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.629 ' HG3' ' CZ ' ' A' ' 75' ' ' TYR . 2.4 Cg_endo . . . . . 0 N--CA 1.462 -0.371 0 C-N-CA 123.605 2.87 . . . . 0.0 111.67 178.57 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 22.7 p . . . . . 0 CA--C 1.516 -0.339 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.741 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 62.7 m -146.92 145.6 29.86 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 119.922 -0.711 . . . . 0.0 111.588 176.919 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.882 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 41.8 tt0 -116.56 115.75 26.33 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.94 174.532 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.618 HD13 ' CG2' ' A' ' 64' ' ' VAL . 18.8 mt -97.52 161.55 13.72 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 175.855 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.477 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 36.9 t30 -126.12 119.44 27.56 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 177.651 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.515 HD13 ' CH2' ' A' ' 30' ' ' TRP . 4.7 mt -113.96 159.55 35.64 Favored Pre-proline 0 C--N 1.317 -0.822 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 -177.419 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -67.18 151.99 80.39 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 121.534 1.489 . . . . 0.0 111.005 174.66 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.502 ' HB3' ' C ' ' A' ' 38' ' ' THR . 7.0 pt-20 -47.8 -24.75 1.06 Allowed 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.092 -0.958 . . . . 0.0 112.632 177.468 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.9 t -104.6 15.87 27.17 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.09 -174.524 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.413 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -86.81 161.69 18.21 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 178.057 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.497 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 4.3 p-10 -145.31 15.37 1.48 Allowed 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.954 -178.092 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.639 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 26.4 p -168.83 133.88 1.6 Allowed 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.281 -0.568 . . . . 0.0 111.694 -179.016 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.625 HG12 ' CD2' ' A' ' 66' ' ' LEU . 3.3 p -117.33 139.83 42.72 Favored 'Isoleucine or valine' 0 C--O 1.244 0.81 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.47 177.237 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 47.7 m -97.23 101.14 12.64 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.579 168.391 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.703 ' O ' ' HA ' ' A' ' 25' ' ' SER . 0.3 OUTLIER -76.03 141.9 41.97 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.597 177.924 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.415 ' HA ' ' O ' ' A' ' 24' ' ' THR . 27.3 p -136.62 166.22 24.04 Favored 'General case' 0 N--CA 1.447 -0.595 0 O-C-N 123.819 0.7 . . . . 0.0 110.041 -174.955 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 61.93 38.54 14.32 Favored 'General case' 0 N--CA 1.464 0.227 0 O-C-N 123.688 0.617 . . . . 0.0 111.431 -179.214 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.678 ' O ' HG22 ' A' ' 24' ' ' THR . 8.1 mt -85.04 -176.26 6.12 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 175.459 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 58.4 tp60 -126.72 124.69 24.21 Favored Pre-proline 0 C--N 1.32 -0.704 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 176.479 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -62.24 134.54 49.35 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 123.188 2.592 . . . . 0.0 113.498 -178.072 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 86.53 24.27 40.0 Favored Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.363 176.977 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 17.9 t -130.53 149.23 33.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.236 0.541 . . . . 0.0 111.445 -176.232 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.48 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 14.8 tp60 -79.64 108.0 12.85 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.634 179.971 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.629 ' CZ ' ' HG3' ' A' ' 46' ' ' PRO . 4.2 m-85 -101.15 116.52 33.01 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.377 0.608 . . . . 0.0 111.868 -178.708 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.559 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 31.0 m-80 -89.2 109.02 19.94 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.448 177.037 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.587 ' HB ' HG13 ' A' ' 93' ' ' ILE . 5.2 mp -92.56 116.01 32.73 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.616 0 CA-C-O 121.332 0.586 . . . . 0.0 109.571 175.598 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.852 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 89.2 m -108.82 116.18 31.5 Favored 'General case' 0 N--CA 1.426 -1.639 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.243 179.954 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.514 HD13 HG21 ' A' ' 77' ' ' ILE . 15.6 mm -95.26 140.59 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 -178.959 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -127.87 113.04 15.4 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 178.776 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.568 ' HB1' HG21 ' A' ' 37' ' ' ILE . . . -84.12 119.65 25.23 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 171.173 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.583 HG13 ' CZ ' ' A' ' 41' ' ' ARG . 7.5 p -110.54 141.22 26.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 C-N-CA 120.237 -0.585 . . . . 0.0 110.204 -175.355 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.588 ' OE1' ' HB2' ' A' ' 86' ' ' GLN . 0.1 OUTLIER -123.28 170.88 9.84 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 123.37 0.419 . . . . 0.0 110.104 177.183 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -34.64 -55.83 0.55 Allowed 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 113.839 1.052 . . . . 0.0 113.839 -171.241 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -123.81 14.72 9.33 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 -174.627 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.588 ' HB2' ' OE1' ' A' ' 83' ' ' GLU . 25.4 mt-30 -146.18 170.81 15.96 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.368 0.604 . . . . 0.0 111.849 -177.298 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -127.38 124.63 39.02 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.113 173.704 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 15.4 m -76.2 -178.52 4.53 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.648 0.261 . . . . 0.0 111.088 -177.635 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.52 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 3.9 p -67.39 154.93 92.07 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-O 120.947 0.403 . . . . 0.0 111.438 -178.378 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -88.2 141.6 5.08 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 122.76 2.307 . . . . 0.0 115.031 179.747 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.852 ' O ' ' HA ' ' A' ' 78' ' ' THR . 8.8 t -83.34 131.59 33.43 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.538 0 CA-C-N 114.678 -1.146 . . . . 0.0 108.271 163.892 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 13.7 t -125.02 106.81 17.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 C-N-CA 119.94 -0.704 . . . . 0.0 110.172 170.178 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.587 HG13 ' HB ' ' A' ' 77' ' ' ILE . 8.2 pt -121.11 111.43 31.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.342 178.185 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -97.23 112.99 24.55 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.659 0.742 . . . . 0.0 111.6 -177.035 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.92 131.54 53.41 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.484 179.77 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -86.47 129.89 34.69 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.046 0.451 . . . . 0.0 110.519 -179.483 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.5 HG21 HD12 ' A' ' 26' ' ' ILE . 20.3 p -60.43 117.68 5.55 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.227 179.626 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 39.1 m . . . . . 0 C--N 1.325 -0.476 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.039 179.651 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.427 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.471 ' HA ' ' O ' ' A' ' 31' ' ' SER . 23.6 Cg_exo -67.35 126.16 14.54 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 121.364 1.376 . . . . 0.0 111.535 176.589 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -49.49 145.39 16.56 Favored 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.469 2.112 . . . . 0.0 110.634 171.486 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -35.95 105.62 0.29 Allowed Pre-proline 0 N--CA 1.47 0.55 0 O-C-N 124.701 1.251 . . . . 0.0 112.329 -169.394 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.56 ' HG2' HG11 ' A' ' 91' ' ' VAL . 31.3 Cg_exo -64.76 155.45 67.25 Favored 'Trans proline' 0 CA--C 1.514 -0.492 0 C-N-CA 123.747 2.965 . . . . 0.0 112.407 -179.81 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 31.6 m -113.77 131.03 56.36 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.806 -178.207 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.484 HG12 ' O ' ' A' ' 27' ' ' VAL . 71.4 t -73.26 122.81 26.9 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 114.054 -1.43 . . . . 0.0 109.884 175.051 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -84.47 -41.94 16.09 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.944 -173.847 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -136.22 140.62 43.65 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.163 178.574 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.462 HG23 HG11 ' A' ' 18' ' ' VAL . 39.8 t -123.72 119.46 57.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.468 178.191 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.409 ' HB2' ' O ' ' A' ' 25' ' ' SER . 23.6 m-20 -124.36 -159.06 0.85 Allowed 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 176.95 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.525 ' O ' ' HB2' ' A' ' 69' ' ' LEU . 17.8 p-10 -84.44 -54.41 4.78 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.3 0.571 . . . . 0.0 111.348 179.094 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.589 HG23 ' O ' ' A' ' 69' ' ' LEU . 29.9 p -119.61 29.73 7.44 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.192 -172.409 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.622 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 17.0 p -169.91 130.6 1.01 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.665 -1.152 . . . . 0.0 109.858 -176.097 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.593 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 48.0 mt -148.05 142.22 19.23 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.666 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.765 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.484 ' O ' HG12 ' A' ' 18' ' ' VAL . 44.9 t -115.96 136.21 53.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 C-N-CA 119.858 -0.737 . . . . 0.0 109.933 -175.701 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.641 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.6 OUTLIER -127.13 145.41 34.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 C-N-CA 120.122 -0.631 . . . . 0.0 110.162 179.105 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.446 ' HG2' ' HB3' ' A' ' 63' ' ' SER . 54.8 mtp180 -130.02 120.98 25.61 Favored 'General case' 0 C--N 1.327 -0.408 0 O-C-N 123.535 0.522 . . . . 0.0 110.497 -174.766 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.512 ' CH2' HD11 ' A' ' 57' ' ' LEU . 35.7 p90 -113.47 149.04 34.84 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.879 -174.052 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.471 ' O ' ' HA ' ' A' ' 13' ' ' PRO . 48.2 m -92.75 88.53 6.28 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.202 175.758 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.452 ' HD3' ' H ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -50.75 159.05 0.99 Allowed Pre-proline 0 CA--C 1.544 0.715 0 CA-C-N 114.99 -1.005 . . . . 0.0 113.404 -175.413 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.701 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 6.4 Cg_exo -74.08 169.33 22.69 Favored 'Trans proline' 0 C--N 1.358 1.032 0 C-N-CA 124.001 3.134 . . . . 0.0 113.332 -172.597 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -91.38 3.88 53.81 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.242 174.842 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -85.4 151.41 56.22 Favored Pre-proline 0 CA--C 1.515 -0.378 0 CA-C-N 114.683 -1.144 . . . . 0.0 110.532 178.686 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -75.85 114.76 4.01 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 121.446 1.431 . . . . 0.0 109.92 171.728 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.48 HG22 ' HG2' ' A' ' 83' ' ' GLU . 2.6 pt -123.06 157.52 28.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.728 -173.508 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.411 ' H ' ' HA ' ' A' ' 83' ' ' GLU . 6.8 p -91.91 -39.12 11.89 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -178.483 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.426 ' O ' HG11 ' A' ' 82' ' ' VAL . . . -169.45 -162.99 22.72 Favored Glycine 0 N--CA 1.439 -1.11 0 C-N-CA 119.542 -1.313 . . . . 0.0 112.687 -178.98 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.701 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 5.1 m-85 -137.71 135.64 36.63 Favored 'General case' 0 CA--C 1.506 -0.746 0 CA-C-O 120.897 0.38 . . . . 0.0 111.175 178.993 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.6 mtm105 -107.53 147.62 30.31 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 169.987 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.855 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 27.3 mt -139.22 109.74 4.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 C-N-CA 120.17 -0.612 . . . . 0.0 112.471 -174.758 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 78.4 t -111.11 110.34 31.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.578 179.011 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.784 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 0.7 OUTLIER -112.08 124.94 53.51 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.427 176.646 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.1 p -138.02 136.24 19.48 Favored Pre-proline 0 C--N 1.312 -1.039 0 CA-C-N 113.946 -1.479 . . . . 0.0 111.47 -172.394 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.458 ' HG3' ' CZ ' ' A' ' 75' ' ' TYR . 16.1 Cg_exo . . . . . 0 CA--C 1.519 -0.242 0 C-N-CA 122.929 2.419 . . . . 0.0 110.934 174.905 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.9 m . . . . . 0 CA--C 1.517 -0.303 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.784 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 26.3 m -145.67 154.99 42.71 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 120.53 -0.468 . . . . 0.0 111.493 -175.507 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.855 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 33.3 tt0 -127.46 112.92 15.52 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.603 -179.026 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.627 HD12 ' CG2' ' A' ' 64' ' ' VAL . 17.0 mt -100.86 162.35 12.96 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.455 178.183 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.549 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 2.3 m120 -128.65 115.89 18.74 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 176.837 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.512 HD11 ' CH2' ' A' ' 30' ' ' TRP . 4.6 mt -110.85 156.86 40.04 Favored Pre-proline 0 N--CA 1.441 -0.883 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -175.96 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -63.26 151.22 85.92 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 121.737 1.625 . . . . 0.0 110.989 175.902 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -45.84 -28.95 1.2 Allowed 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.344 176.707 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.5 t -101.2 19.53 17.44 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.148 -174.834 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.491 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -89.11 161.08 16.7 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 178.635 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.443 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 29.6 p-10 -147.85 15.94 1.09 Allowed 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -177.123 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.641 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 28.0 p -171.32 133.95 0.86 Allowed 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.226 -0.59 . . . . 0.0 111.779 -178.476 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.627 ' CG2' HD12 ' A' ' 55' ' ' LEU . 3.1 p -117.13 136.77 53.2 Favored 'Isoleucine or valine' 0 C--O 1.24 0.59 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.434 177.146 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 41.3 m -94.57 101.71 13.61 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.668 169.106 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.622 ' O ' ' HA ' ' A' ' 25' ' ' SER . 0.2 OUTLIER -78.8 141.04 38.09 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 177.551 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 10.9 t -137.3 172.65 12.67 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 -177.035 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 60.93 31.58 19.97 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.476 -179.287 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.589 ' O ' HG23 ' A' ' 24' ' ' THR . 10.7 mt -74.42 -176.99 2.89 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 176.917 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 7.7 tp60 -126.15 121.59 23.99 Favored Pre-proline 0 C--N 1.319 -0.741 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 177.5 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -60.29 135.06 59.33 Favored 'Trans proline' 0 C--O 1.235 0.366 0 C-N-CA 123.001 2.467 . . . . 0.0 113.372 -177.634 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 87.71 17.47 58.23 Favored Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.309 177.323 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.417 ' CG1' ' HB3' ' A' ' 46' ' ' PRO . 14.1 t -125.62 146.62 31.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 120.816 0.341 . . . . 0.0 110.841 -177.573 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.537 ' OE1' ' HB2' ' A' ' 96' ' ' GLU . 35.0 tp60 -81.05 122.69 27.63 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.782 178.744 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.589 ' CE2' HD23 ' A' ' 69' ' ' LEU . 5.4 m-85 -105.98 116.17 31.48 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 121.599 0.714 . . . . 0.0 111.725 -179.297 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.408 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 16.2 t-20 -90.14 104.1 16.7 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 114.487 -1.233 . . . . 0.0 109.113 177.01 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.514 HG21 HD13 ' A' ' 79' ' ' ILE . 5.3 mp -92.25 116.41 33.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.347 0.594 . . . . 0.0 109.758 177.722 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.825 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 62.1 m -108.3 116.13 31.39 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.09 179.094 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.514 HD13 HG21 ' A' ' 77' ' ' ILE . 15.5 mm -95.61 141.92 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.831 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -126.94 112.99 15.93 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 179.613 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -89.25 123.1 33.15 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 174.53 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.426 HG11 ' O ' ' A' ' 39' ' ' GLY . 7.3 p -120.63 134.67 63.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 120.02 -0.672 . . . . 0.0 112.258 -173.122 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.48 ' HG2' HG22 ' A' ' 37' ' ' ILE . 6.3 mt-10 -104.59 171.82 7.12 Favored 'General case' 0 N--CA 1.454 -0.261 0 O-C-N 124.146 0.904 . . . . 0.0 109.228 173.607 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -47.68 -39.51 17.56 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 179.081 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -113.36 -29.33 7.26 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -171.343 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -133.32 176.34 8.6 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.553 -0.459 . . . . 0.0 111.683 -170.011 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -134.61 137.78 43.98 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.789 177.717 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 17.7 m -77.64 173.47 12.01 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.828 -179.69 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 14.2 p -61.79 154.63 66.02 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-O 120.918 0.39 . . . . 0.0 110.623 176.567 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -81.64 142.6 12.97 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 122.067 1.845 . . . . 0.0 113.622 -175.463 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.825 ' O ' ' HA ' ' A' ' 78' ' ' THR . 7.1 t -83.18 129.41 37.5 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.771 0 CA-C-N 114.879 -1.055 . . . . 0.0 108.615 168.09 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.9 t -126.27 106.96 16.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.153 175.01 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.514 HG13 ' HB ' ' A' ' 77' ' ' ILE . 8.1 pt -128.17 118.9 49.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.47 178.794 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -103.39 129.93 50.59 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.402 0.62 . . . . 0.0 111.349 -176.877 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.06 130.03 23.19 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.96 176.517 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.537 ' HB2' ' OE1' ' A' ' 74' ' ' GLN . 34.5 tt0 -85.83 136.12 33.44 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.251 0.548 . . . . 0.0 110.093 179.959 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.502 HG22 HD11 ' A' ' 26' ' ' ILE . 25.4 p -65.92 124.5 22.67 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.55 179.709 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.4 m . . . . . 0 C--N 1.327 -0.395 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.228 -173.292 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.367 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -68.61 133.14 26.95 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.482 2.122 . . . . 0.0 111.678 175.005 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.77 154.24 21.65 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.321 2.014 . . . . 0.0 110.943 172.91 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -36.45 107.2 0.35 Allowed Pre-proline 0 N--CA 1.468 0.464 0 O-C-N 124.595 1.184 . . . . 0.0 112.445 -172.148 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.567 ' HG2' HG12 ' A' ' 91' ' ' VAL . 36.1 Cg_exo -66.69 150.93 83.53 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 123.09 2.526 . . . . 0.0 112.265 177.712 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 45.8 m -106.93 129.04 54.81 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.872 -179.07 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.443 HG11 HG22 ' A' ' 21' ' ' VAL . 78.2 t -76.99 123.29 33.27 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-N 114.509 -1.223 . . . . 0.0 109.891 173.75 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -91.59 -37.39 13.11 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.341 -174.813 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 13.9 mm-40 -136.17 132.74 36.36 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.788 -178.59 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.468 ' HA ' HG12 ' A' ' 26' ' ' ILE . 46.5 t -124.01 120.1 58.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.388 179.637 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -127.5 -159.98 0.98 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 178.809 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -74.48 -72.11 0.3 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 179.162 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.598 HG22 ' O ' ' A' ' 69' ' ' LEU . 69.9 p -105.41 33.57 3.64 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.211 -174.034 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.586 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 68.5 p -169.66 137.16 1.71 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.574 -173.628 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.569 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 35.9 mt -150.71 145.68 16.69 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.904 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.783 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.442 ' O ' HG12 ' A' ' 18' ' ' VAL . 41.0 t -118.36 131.85 69.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 119.255 0.934 . . . . 0.0 110.472 -176.062 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.59 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.6 OUTLIER -127.13 146.52 32.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.233 -178.119 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.478 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 20.2 mtm180 -130.69 121.27 25.2 Favored 'General case' 0 C--N 1.329 -0.303 0 O-C-N 123.244 0.34 . . . . 0.0 110.57 -175.856 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.526 ' CH2' HD12 ' A' ' 57' ' ' LEU . 39.5 p90 -112.06 146.74 37.41 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.103 -175.651 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 24.0 t -92.59 99.09 11.86 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.928 177.548 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.528 ' CD ' ' H ' ' A' ' 32' ' ' ARG . 0.2 OUTLIER -53.49 160.3 1.96 Allowed Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 115.098 -0.955 . . . . 0.0 113.189 -174.261 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.618 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 2.2 Cg_endo -84.93 163.52 11.81 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 124.307 3.338 . . . . 0.0 112.279 -177.254 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -82.73 -6.42 59.39 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.338 172.064 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -66.2 146.79 99.04 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.841 174.557 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -73.94 114.08 3.94 Favored 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 121.165 1.244 . . . . 0.0 109.857 170.213 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.546 HG22 ' HB1' ' A' ' 81' ' ' ALA . 0.8 OUTLIER -120.56 147.79 24.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 -177.455 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.422 ' N ' ' O ' ' A' ' 82' ' ' VAL . 25.4 p -88.89 -30.2 19.05 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -178.335 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.579 ' C ' HG12 ' A' ' 82' ' ' VAL . . . -171.09 -162.3 23.21 Favored Glycine 0 CA--C 1.499 -0.942 0 C-N-CA 120.116 -1.04 . . . . 0.0 111.551 -179.327 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.618 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 6.5 m-85 -140.06 132.6 28.69 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 117.01 0.405 . . . . 0.0 111.155 173.807 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.2 mmm180 -100.7 147.72 25.69 Favored 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 168.031 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.87 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 32.0 mt -138.29 108.21 4.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 C-N-CA 119.926 -0.71 . . . . 0.0 112.328 -178.395 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 93.1 t -110.41 111.52 36.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.088 0.47 . . . . 0.0 110.762 -178.154 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.734 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 0.6 OUTLIER -115.24 126.2 54.25 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.077 177.357 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 30.8 p -134.22 137.52 28.28 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 113.742 -1.572 . . . . 0.0 111.705 -174.696 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.601 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 92.9 Cg_endo . . . . . 0 N--CA 1.464 -0.231 0 C-N-CA 123.638 2.892 . . . . 0.0 111.937 178.488 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.0 p . . . . . 0 CA--C 1.514 -0.43 0 CA-C-O 120.421 0.153 . . . . 0.0 110.719 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.734 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 38.0 m -145.16 147.97 33.07 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 119.886 -0.725 . . . . 0.0 111.825 177.994 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.87 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 34.9 tt0 -118.54 114.1 22.3 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.957 176.014 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.627 HD12 ' CG2' ' A' ' 64' ' ' VAL . 16.8 mt -97.94 159.49 14.9 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.0 0.429 . . . . 0.0 110.318 176.564 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -123.43 113.63 19.05 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.59 179.253 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.526 HD12 ' CH2' ' A' ' 30' ' ' TRP . 2.6 mt -111.8 154.92 43.88 Favored Pre-proline 0 C--N 1.318 -0.796 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 -176.726 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -65.53 150.21 86.91 Favored 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 121.569 1.512 . . . . 0.0 110.958 175.955 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -45.11 -25.53 0.35 Allowed 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 114.618 -1.173 . . . . 0.0 113.186 178.981 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 5.4 t -103.9 5.01 35.42 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.44 -174.244 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.419 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -74.97 155.99 36.79 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 -179.677 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.478 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 26.6 p-10 -137.04 12.94 3.09 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.931 -177.32 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.59 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 23.3 p -169.1 133.79 1.49 Allowed 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 119.973 -0.691 . . . . 0.0 111.905 -177.525 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.644 HG11 ' CD2' ' A' ' 66' ' ' LEU . 3.6 p -116.14 137.16 50.75 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.122 176.744 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 42.8 m -95.84 101.16 12.82 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 168.56 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.644 ' CD2' HG11 ' A' ' 64' ' ' VAL . 0.2 OUTLIER -76.49 141.13 41.39 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.259 178.65 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.6 t -136.48 170.73 15.57 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -177.432 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 65.1 29.57 11.96 Favored 'General case' 0 C--N 1.327 -0.388 0 O-C-N 123.665 0.603 . . . . 0.0 111.549 -178.155 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.598 ' O ' HG22 ' A' ' 24' ' ' THR . 9.1 mt -78.73 -175.6 4.49 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 174.135 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.475 ' N ' ' HH ' ' A' ' 75' ' ' TYR . 14.7 mm100 -126.99 131.99 24.12 Favored Pre-proline 0 C--N 1.32 -0.702 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 177.876 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -64.49 133.65 38.08 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.87 2.38 . . . . 0.0 113.008 -178.214 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 74.92 34.37 53.0 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.947 -0.644 . . . . 0.0 111.649 179.758 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 70.1 t -134.62 139.79 46.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.209 0.528 . . . . 0.0 110.815 -177.042 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.601 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -81.05 121.13 25.69 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.047 -176.053 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.475 ' HH ' ' N ' ' A' ' 70' ' ' GLN . 12.9 m-85 -116.66 115.82 26.39 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -175.306 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.518 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 2.6 m-20 -85.55 111.47 20.05 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.547 -0.752 . . . . 0.0 109.752 174.345 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.534 ' HB ' HG13 ' A' ' 93' ' ' ILE . 5.1 mp -93.47 117.95 38.14 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.602 0 CA-C-O 121.164 0.507 . . . . 0.0 109.748 175.751 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.868 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 24.9 m -109.39 115.14 29.4 Favored 'General case' 0 N--CA 1.428 -1.573 0 CA-C-N 115.25 -0.887 . . . . 0.0 110.545 -179.693 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.516 HD11 HG23 ' A' ' 77' ' ' ILE . 12.4 mm -95.73 139.88 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 179.537 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.439 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 68.4 m-85 -128.46 112.39 14.32 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.624 -0.262 . . . . 0.0 110.343 179.085 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.546 ' HB1' HG22 ' A' ' 37' ' ' ILE . . . -79.42 109.32 13.67 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 170.874 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.579 HG12 ' C ' ' A' ' 39' ' ' GLY . 11.1 p -99.39 140.77 18.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.756 -173.927 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -122.93 165.2 17.1 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 -178.412 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -47.16 -47.87 23.7 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -176.716 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -130.1 17.63 5.56 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.37 -176.899 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 66.9 mm-40 -142.31 169.58 17.32 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.871 0.367 . . . . 0.0 111.328 -179.023 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -146.72 120.34 9.16 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.088 177.943 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 21.7 m -65.1 157.81 27.56 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.782 179.742 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 21.1 p -55.16 150.12 22.64 Favored Pre-proline 0 N--CA 1.453 -0.294 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.312 176.635 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -77.61 140.28 18.75 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 121.755 1.637 . . . . 0.0 113.548 -173.68 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.868 ' O ' ' HA ' ' A' ' 78' ' ' THR . 4.6 t -81.53 123.42 37.87 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.832 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 167.348 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 4.8 t -119.75 105.38 17.18 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 C-N-CA 119.53 -0.868 . . . . 0.0 109.857 172.452 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.534 HG13 ' HB ' ' A' ' 77' ' ' ILE . 6.4 pt -120.73 111.11 30.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.354 175.897 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.22 114.88 26.66 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.806 0.812 . . . . 0.0 110.76 -175.819 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.79 129.39 50.36 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.937 -1.028 . . . . 0.0 109.398 179.44 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -89.42 137.82 31.99 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.146 0.498 . . . . 0.0 110.433 179.148 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.505 HG22 HD11 ' A' ' 26' ' ' ILE . 41.7 p -71.46 121.61 18.93 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.928 -178.128 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.9 m . . . . . 0 C--N 1.323 -0.561 0 CA-C-O 121.344 0.592 . . . . 0.0 110.15 179.937 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.287 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -63.27 130.59 29.13 Favored 'Trans proline' 0 C--O 1.235 0.346 0 C-N-CA 122.324 2.016 . . . . 0.0 111.96 177.537 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.481 ' HD2' ' O ' ' A' ' 31' ' ' SER . 72.7 Cg_exo -49.54 146.07 15.5 Favored 'Trans proline' 0 C--O 1.237 0.426 0 C-N-CA 122.891 2.394 . . . . 0.0 111.091 172.856 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -35.76 106.66 0.32 Allowed Pre-proline 0 N--CA 1.466 0.366 0 O-C-N 124.837 1.336 . . . . 0.0 112.541 -169.276 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.583 ' HG2' HG12 ' A' ' 91' ' ' VAL . 34.6 Cg_exo -67.03 150.94 82.64 Favored 'Trans proline' 0 CA--C 1.517 -0.359 0 C-N-CA 123.368 2.712 . . . . 0.0 112.039 179.08 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.2 m -110.35 131.09 55.36 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.804 -178.387 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 76.0 t -75.67 119.87 24.38 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-N 114.446 -1.252 . . . . 0.0 109.653 173.756 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -86.97 -40.5 14.72 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.324 -174.809 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -136.03 138.5 42.26 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.995 0.426 . . . . 0.0 110.726 -179.776 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.428 HG21 HG13 ' A' ' 18' ' ' VAL . 17.0 t -125.98 125.16 67.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.005 179.825 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -130.58 -157.27 0.81 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.509 0.195 . . . . 0.0 110.475 -179.249 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.401 ' OD1' ' N ' ' A' ' 24' ' ' THR . 1.9 p30 -73.79 -69.43 0.44 Allowed 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 178.411 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.482 HG21 ' O ' ' A' ' 69' ' ' LEU . 67.7 p -114.39 37.12 3.48 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.483 0.659 . . . . 0.0 109.944 -174.335 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.642 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 55.1 m -167.97 131.49 1.64 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.807 -171.295 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.576 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 48.8 mt -149.86 140.8 16.81 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.905 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.522 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 36.5 t -116.52 132.12 67.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 119.135 0.879 . . . . 0.0 110.534 -173.822 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.571 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.7 OUTLIER -126.97 145.59 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.23 -178.996 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.464 ' HG2' ' HB3' ' A' ' 63' ' ' SER . 16.9 mtp180 -128.15 121.5 29.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.524 -175.685 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.507 ' CH2' HD12 ' A' ' 57' ' ' LEU . 38.7 p90 -114.41 148.56 37.53 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.355 -175.65 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.481 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 32.2 t -93.74 97.64 10.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.935 178.136 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.482 ' CD ' ' H ' ' A' ' 32' ' ' ARG . 0.8 OUTLIER -51.43 155.78 2.4 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.376 -0.829 . . . . 0.0 113.007 -175.497 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.65 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 1.5 Cg_endo -85.38 161.99 11.16 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 124.564 3.509 . . . . 0.0 112.656 -172.671 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -74.71 -18.76 60.46 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.6 173.102 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -59.43 138.69 89.04 Favored Pre-proline 0 CA--C 1.518 -0.276 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.041 175.867 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -69.62 113.86 3.49 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 121.008 1.139 . . . . 0.0 109.666 170.814 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.562 HG21 ' HB1' ' A' ' 81' ' ' ALA . 0.7 OUTLIER -118.63 155.11 20.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -176.222 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.458 ' C ' ' HB3' ' A' ' 59' ' ' GLU . 17.2 p -100.96 -26.02 13.87 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -176.921 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.53 ' C ' HG11 ' A' ' 82' ' ' VAL . . . -168.83 -168.59 31.11 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.33 -0.938 . . . . 0.0 111.675 179.432 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.65 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 5.6 m-85 -137.17 132.57 34.14 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 117.105 0.453 . . . . 0.0 111.378 173.359 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 10.0 mmm180 -99.28 148.68 23.89 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 167.807 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.867 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 31.6 mt -139.21 108.32 3.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 C-N-CA 120.065 -0.654 . . . . 0.0 112.043 178.848 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 75.2 t -110.03 110.42 32.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.325 0.584 . . . . 0.0 110.205 179.864 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.704 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 0.4 OUTLIER -111.87 124.47 52.43 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.377 176.338 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 23.1 t -139.4 135.74 17.31 Favored Pre-proline 0 C--N 1.314 -0.95 0 CA-C-N 113.692 -1.594 . . . . 0.0 110.383 -173.504 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.637 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 50.0 Cg_exo . . . . . 0 C--O 1.234 0.277 0 C-N-CA 123.362 2.708 . . . . 0.0 112.491 174.22 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 9.6 m . . . . . 0 C--O 1.233 0.214 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.704 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 23.3 m -145.61 148.7 33.4 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.876 -0.33 . . . . 0.0 111.5 -175.78 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.867 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 56.2 tt0 -119.16 118.36 31.14 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.235 173.301 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.635 HD12 ' CG2' ' A' ' 64' ' ' VAL . 19.4 mt -100.0 155.84 17.48 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 173.664 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -118.95 113.34 20.86 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 176.91 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.507 HD12 ' CH2' ' A' ' 30' ' ' TRP . 2.1 mt -108.51 156.25 39.03 Favored Pre-proline 0 C--N 1.317 -0.836 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 -177.32 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -54.77 147.07 52.2 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 121.824 1.683 . . . . 0.0 111.29 171.832 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.458 ' HB3' ' C ' ' A' ' 38' ' ' THR . 8.9 pt-20 -48.54 -27.38 2.7 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.959 173.153 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.4 t -96.69 -1.7 46.06 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.334 -175.572 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.439 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -71.41 152.29 43.26 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 -176.619 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.417 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 3.9 p-10 -132.32 11.32 4.54 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -176.21 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.571 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 53.4 p -169.3 133.67 1.41 Allowed 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 119.993 -0.683 . . . . 0.0 111.877 -177.171 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.635 ' CG2' HD12 ' A' ' 55' ' ' LEU . 3.7 p -114.61 136.37 51.46 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.148 176.034 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 83.1 m -96.14 100.0 11.68 Favored 'General case' 0 N--CA 1.429 -1.514 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 168.669 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.642 ' O ' ' HA ' ' A' ' 25' ' ' SER . 0.6 OUTLIER -74.13 144.19 45.01 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.143 178.922 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 8.6 t -144.56 166.16 25.95 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 -174.325 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 64.03 32.95 12.57 Favored 'General case' 0 C--N 1.327 -0.393 0 O-C-N 123.775 0.672 . . . . 0.0 110.936 -177.119 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.482 ' O ' HG21 ' A' ' 24' ' ' THR . 7.9 mt -78.42 -176.85 4.95 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 174.573 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -124.64 123.99 25.66 Favored Pre-proline 0 C--N 1.318 -0.793 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 176.812 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -60.53 135.91 63.93 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 122.778 2.319 . . . . 0.0 112.768 -179.328 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.2 33.91 31.09 Favored Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.683 -179.604 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.522 ' CG1' ' HB3' ' A' ' 46' ' ' PRO . 85.5 t -138.26 139.41 41.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 120.8 0.333 . . . . 0.0 110.82 -176.218 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.637 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 1.7 tm0? -82.39 127.53 33.35 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.025 179.348 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.469 ' CE2' HD23 ' A' ' 69' ' ' LEU . 6.1 m-85 -116.67 114.12 23.6 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -173.378 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.446 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 15.9 m120 -85.53 107.39 17.44 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.674 173.415 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.521 HG22 HD12 ' A' ' 79' ' ' ILE . 5.1 mp -91.01 117.07 33.51 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.733 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 176.644 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.882 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 26.1 m -109.15 114.77 28.77 Favored 'General case' 0 N--CA 1.424 -1.734 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.436 -179.146 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.521 HD12 HG22 ' A' ' 77' ' ' ILE . 13.5 mm -95.31 141.52 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -179.882 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.411 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 73.8 m-85 -129.34 111.99 13.4 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.229 179.624 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.562 ' HB1' HG21 ' A' ' 37' ' ' ILE . . . -79.81 114.47 18.76 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 169.761 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.53 HG11 ' C ' ' A' ' 39' ' ' GLY . 7.1 p -104.36 132.25 51.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 C-N-CA 120.048 -0.661 . . . . 0.0 109.565 -178.687 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.58 ' OE1' ' HB2' ' A' ' 86' ' ' GLN . 1.1 mp0 -113.6 171.33 7.64 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 123.178 0.299 . . . . 0.0 110.751 -177.655 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -45.22 -40.92 7.84 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.505 -0.771 . . . . 0.0 112.754 -176.107 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -112.42 -20.47 11.78 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -172.353 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.58 ' HB2' ' OE1' ' A' ' 83' ' ' GLU . 69.5 mt-30 -142.63 178.47 7.6 Favored 'General case' 0 C--N 1.328 -0.329 0 O-C-N 122.091 -0.381 . . . . 0.0 111.523 -170.095 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -123.17 120.35 32.93 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.449 -0.796 . . . . 0.0 108.976 171.09 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 50.9 m -70.0 178.03 2.9 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -172.625 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -59.31 152.83 51.41 Favored Pre-proline 0 N--CA 1.451 -0.413 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.539 179.028 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -87.0 138.47 4.97 Favored 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 122.53 2.153 . . . . 0.0 114.269 -177.42 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.882 ' O ' ' HA ' ' A' ' 78' ' ' THR . 7.1 t -82.28 125.78 39.88 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.746 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 165.929 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 4.5 t -122.16 107.08 18.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 C-N-CA 119.83 -0.748 . . . . 0.0 110.121 173.276 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.511 HG13 ' HB ' ' A' ' 77' ' ' ILE . 6.5 pt -124.96 114.94 42.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.878 177.449 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.551 ' HB2' ' OE1' ' A' ' 74' ' ' GLN . 11.3 pt20 -100.92 120.78 40.66 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.553 0.692 . . . . 0.0 111.598 -175.077 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.23 132.25 39.48 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.546 178.103 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.505 ' HB2' ' HG2' ' A' ' 74' ' ' GLN . 35.8 tt0 -87.0 142.3 28.04 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.016 0.436 . . . . 0.0 110.259 179.898 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.486 HG21 HD13 ' A' ' 26' ' ' ILE . 31.6 p -68.39 134.49 50.3 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.297 -178.102 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 11.8 m . . . . . 0 C--N 1.328 -0.361 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.665 -177.893 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.738 0 N-CA-C 111.88 -0.488 . . . . 0.0 111.88 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.5 m 60.43 57.29 2.88 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.152 0.501 . . . . 0.0 110.47 -178.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 49.1 t-80 -61.32 -35.83 78.46 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.382 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 85.0 mmm -98.9 38.63 1.35 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.168 178.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -108.37 25.07 20.99 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.268 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.9 p -71.36 -39.8 71.06 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.009 0.433 . . . . 0.0 111.309 -178.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.4 m -88.72 -4.17 58.6 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.628 0.728 . . . . 0.0 109.944 178.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 26.9 m -80.38 126.23 30.91 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.823 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -98.07 126.23 41.0 Favored Pre-proline 0 C--N 1.321 -0.634 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 176.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -65.28 145.81 84.61 Favored 'Trans proline' 0 C--O 1.234 0.289 0 C-N-CA 122.36 2.04 . . . . 0.0 112.498 -177.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.3 p-10 -95.94 164.55 12.67 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.268 -178.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -97.37 162.75 21.58 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.806 -179.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -72.86 128.34 13.15 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.264 1.976 . . . . 0.0 111.476 174.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.551 ' HD2' ' O ' ' A' ' 31' ' ' SER . 89.2 Cg_exo -48.33 146.2 10.4 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.837 2.358 . . . . 0.0 111.933 174.178 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.422 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 9.1 p-10 -36.76 107.12 0.36 Allowed Pre-proline 0 N--CA 1.468 0.446 0 O-C-N 124.806 1.316 . . . . 0.0 112.74 -169.147 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.566 ' HG2' HG12 ' A' ' 91' ' ' VAL . 27.4 Cg_exo -66.86 152.3 80.71 Favored 'Trans proline' 0 C--O 1.233 0.273 0 C-N-CA 123.62 2.88 . . . . 0.0 112.643 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.8 m -107.05 130.62 54.63 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.987 -177.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.443 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 77.0 t -78.25 122.22 32.76 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-N 114.812 -1.085 . . . . 0.0 109.881 172.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -87.16 -42.08 13.27 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.918 -175.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -134.48 139.07 45.22 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.464 -175.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.424 ' HA ' HG12 ' A' ' 26' ' ' ILE . 61.2 t -130.88 123.78 54.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.472 178.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.424 ' HB3' ' H ' ' A' ' 23' ' ' ASP . 5.7 m-20 -133.59 -159.47 0.97 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.11 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.424 ' H ' ' HB3' ' A' ' 22' ' ' ASP . 17.7 p-10 -76.37 -57.68 3.72 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.199 0.524 . . . . 0.0 111.262 -178.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.612 HG23 ' O ' ' A' ' 69' ' ' LEU . 33.8 p -119.43 32.81 5.91 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.516 -172.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.62 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 68.4 m -168.07 130.47 1.5 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.201 -173.129 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.563 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 33.1 mt -145.08 141.71 22.86 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.888 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 175.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 40.6 t -116.69 132.93 64.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 C-N-CA 119.71 -0.796 . . . . 0.0 110.17 -175.271 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.583 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.7 OUTLIER -127.76 147.35 32.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 C-N-CA 120.397 -0.521 . . . . 0.0 110.052 -179.126 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.429 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 20.9 mtp180 -133.29 120.77 21.49 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.203 -174.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.523 ' CH2' HD12 ' A' ' 57' ' ' LEU . 41.3 p90 -113.23 149.65 33.48 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.343 -173.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.551 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 20.5 m -98.25 98.14 9.44 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.097 178.168 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.563 ' NE ' ' HB3' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -45.82 156.26 0.45 Allowed Pre-proline 0 CA--C 1.539 0.54 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 -173.49 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.69 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 2.9 Cg_exo -78.57 170.64 17.99 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 124.844 3.696 . . . . 0.0 113.496 -170.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -76.8 -20.96 55.81 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.832 -1.076 . . . . 0.0 109.218 173.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -70.19 137.77 86.91 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.856 175.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -73.5 114.93 4.17 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 121.468 1.446 . . . . 0.0 109.51 167.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.615 HG22 ' HB3' ' A' ' 81' ' ' ALA . 0.2 OUTLIER -111.8 160.44 11.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -174.121 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.4 p -93.23 -32.21 14.45 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.5 ' C ' HG11 ' A' ' 82' ' ' VAL . . . -167.85 -164.56 23.74 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.11 -1.043 . . . . 0.0 111.614 179.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.69 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 6.2 m-85 -140.33 135.52 32.27 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-N 117.111 0.456 . . . . 0.0 111.416 176.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.414 ' C ' HG13 ' A' ' 42' ' ' ILE . 25.1 mtp180 -103.48 151.09 23.24 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 167.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.867 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 29.3 mt -139.54 107.86 3.22 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 C-N-CA 120.312 -0.555 . . . . 0.0 112.112 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 71.2 t -106.3 110.24 30.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.151 0.5 . . . . 0.0 110.704 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.563 ' HA ' ' O ' ' A' ' 76' ' ' ASN . 0.8 OUTLIER -113.28 125.47 54.33 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.661 176.26 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 26.1 p -139.13 143.88 38.53 Favored Pre-proline 0 C--N 1.317 -0.817 0 CA-C-N 114.007 -1.451 . . . . 0.0 111.792 -173.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.527 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 4.7 Cg_exo -74.03 137.43 24.07 Favored 'Trans proline' 0 C--O 1.234 0.284 0 C-N-CA 123.082 2.522 . . . . 0.0 111.467 175.206 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 7.3 m -65.71 -26.92 67.98 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.091 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 19.3 m -99.02 12.33 5.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.206 0.527 . . . . 0.0 110.522 175.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 68.7 157.1 0.14 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.629 -1.169 . . . . 0.0 111.829 -177.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 156.91 -125.46 1.59 Allowed Glycine 0 N--CA 1.445 -0.766 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 -176.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 23.0 m -86.97 117.09 25.46 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 117.228 0.514 . . . . 0.0 110.286 177.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 8.4 p -120.65 146.09 46.76 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.974 175.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.56 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 71.2 m -147.71 148.62 31.19 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.248 -0.581 . . . . 0.0 112.006 -179.161 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.867 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 41.6 tt0 -114.67 115.41 27.07 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.7 172.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.621 HD11 ' CG2' ' A' ' 64' ' ' VAL . 16.7 mt -96.44 157.97 15.65 Favored 'General case' 0 CA--C 1.513 -0.475 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.038 175.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.43 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 25.0 t-20 -120.21 115.73 24.2 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 178.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.523 HD12 ' CH2' ' A' ' 30' ' ' TRP . 2.5 mt -113.4 156.02 43.83 Favored Pre-proline 0 N--CA 1.443 -0.781 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 -177.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -63.65 150.87 87.43 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 121.687 1.591 . . . . 0.0 111.3 175.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -45.41 -28.54 0.89 Allowed 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 114.738 -1.119 . . . . 0.0 112.972 178.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 10.2 t -104.39 11.21 34.89 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.223 0.535 . . . . 0.0 111.126 -174.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.47 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -75.51 159.92 30.76 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 178.129 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.563 ' HB3' ' NE ' ' A' ' 32' ' ' ARG . 4.6 p-10 -146.41 17.53 1.34 Allowed 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 120.724 -0.391 . . . . 0.0 112.045 -177.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.583 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 39.3 p -171.4 134.37 0.87 Allowed 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.529 -0.469 . . . . 0.0 111.729 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.632 HG11 ' CD2' ' A' ' 66' ' ' LEU . 3.2 p -119.17 136.5 56.16 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 CA-C-N 116.358 -0.383 . . . . 0.0 109.992 174.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 63.0 m -95.67 100.47 12.19 Favored 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 168.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.632 ' CD2' HG11 ' A' ' 64' ' ' VAL . 0.3 OUTLIER -75.03 136.74 41.21 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.167 179.918 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 7.4 t -132.16 164.61 25.94 Favored 'General case' 0 C--N 1.316 -0.856 0 O-C-N 123.705 0.628 . . . . 0.0 109.458 -173.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 26.4 t0 58.71 50.72 8.47 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 123.81 0.694 . . . . 0.0 110.692 -177.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.612 ' O ' HG23 ' A' ' 24' ' ' THR . 11.9 mt -90.18 -176.24 4.79 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 172.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 57.6 tp60 -123.62 125.53 25.98 Favored Pre-proline 0 C--N 1.32 -0.691 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 174.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -62.01 140.77 86.32 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 123.05 2.5 . . . . 0.0 113.269 -178.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 75.57 29.6 59.46 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.918 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.418 ' CG1' ' HB3' ' A' ' 46' ' ' PRO . 61.0 t -131.42 148.09 32.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.276 0.56 . . . . 0.0 111.145 -176.041 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.527 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -82.81 127.79 33.79 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.412 179.18 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.528 ' CE2' HD22 ' A' ' 69' ' ' LEU . 3.8 m-85 -122.37 116.07 23.39 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.401 0.62 . . . . 0.0 112.521 -176.03 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.563 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 0.8 OUTLIER -85.92 112.91 21.61 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.597 172.927 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.554 ' HB ' HG13 ' A' ' 93' ' ' ILE . 5.0 mp -95.79 115.9 36.11 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.597 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 172.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.857 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 21.9 m -108.88 113.6 26.66 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.26 -178.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.512 HD11 HG22 ' A' ' 77' ' ' ILE . 12.8 mm -95.04 138.41 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.431 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 82.8 m-85 -124.67 111.29 15.42 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.161 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.615 ' HB3' HG22 ' A' ' 37' ' ' ILE . . . -81.05 111.24 17.34 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 171.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.5 HG11 ' C ' ' A' ' 39' ' ' GLY . 7.1 p -104.5 136.72 36.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 C-N-CA 120.021 -0.672 . . . . 0.0 110.717 -175.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -121.39 163.28 18.95 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -47.74 -46.59 30.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 118.341 0.519 . . . . 0.0 111.426 -178.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 -89.97 -34.6 15.95 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -170.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -150.77 171.84 16.54 Favored 'General case' 0 C--O 1.222 -0.347 0 C-N-CA 120.619 -0.432 . . . . 0.0 111.528 -168.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -114.57 129.06 56.63 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.321 175.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 17.1 m -66.95 169.33 8.39 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.075 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.5 p -57.76 151.13 43.92 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-O 120.968 0.413 . . . . 0.0 110.784 176.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -84.14 141.6 9.36 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 122.159 1.906 . . . . 0.0 113.989 -174.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.857 ' O ' ' HA ' ' A' ' 78' ' ' THR . 12.5 t -81.93 121.83 35.82 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.717 0 CA-C-N 114.855 -1.066 . . . . 0.0 108.196 168.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 5.9 t -117.87 105.72 18.48 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 C-N-CA 119.552 -0.859 . . . . 0.0 109.897 172.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.554 HG13 ' HB ' ' A' ' 77' ' ' ILE . 8.0 pt -123.26 115.48 45.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.379 176.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.507 ' HB2' ' OE1' ' A' ' 74' ' ' GLN . 5.1 pt20 -103.31 126.46 50.49 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.351 0.596 . . . . 0.0 111.103 -174.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -128.94 134.46 48.22 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.088 177.115 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.468 ' HG2' ' HG2' ' A' ' 74' ' ' GLN . 45.1 mt-10 -86.59 133.12 33.74 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 175.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.508 HG21 HD12 ' A' ' 26' ' ' ILE . 37.9 p -72.75 113.85 10.24 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.161 0.505 . . . . 0.0 110.724 -179.317 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 14.3 m -69.52 -32.19 70.88 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.421 0.629 . . . . 0.0 110.223 -177.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 103.27 -163.38 15.77 Favored Glycine 0 N--CA 1.442 -0.949 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.704 176.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 47.4 m -75.38 127.72 85.68 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 115.448 -0.376 . . . . 0.0 110.539 178.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -47.57 102.81 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 123.467 2.778 . . . . 0.0 113.18 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -102.08 112.51 25.19 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.814 177.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 16.2 m 58.24 42.55 21.72 Favored 'General case' 0 C--N 1.33 -0.245 0 O-C-N 123.776 0.672 . . . . 0.0 110.562 179.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -70.05 105.55 2.92 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.583 -178.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 109.35 119.81 4.24 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.119 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.8 m . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.799 -0.62 . . . . 0.0 110.324 178.855 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.644 0 N-CA-C 111.649 -0.581 . . . . 0.0 111.649 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.2 m -65.76 -45.34 82.93 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.015 0.436 . . . . 0.0 110.459 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 57.2 t60 -84.08 106.0 15.39 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.89 179.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 24.8 mmt -76.38 147.45 38.03 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.216 178.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 108.34 137.5 8.18 Favored Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 111.382 -0.687 . . . . 0.0 111.382 -176.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 84.0 m -147.21 114.1 6.12 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.875 0.369 . . . . 0.0 110.886 -178.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.5 p -99.97 -65.13 0.98 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.182 177.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 44.1 m 68.98 125.15 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.365 0 CA-C-O 121.399 0.619 . . . . 0.0 111.801 176.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -110.21 117.37 51.68 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.481 179.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -76.29 153.06 35.52 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 123.105 2.537 . . . . 0.0 112.466 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -103.69 144.42 31.48 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.462 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.515 ' HB1' ' O ' ' A' ' 89' ' ' THR . . . -74.02 151.83 88.48 Favored Pre-proline 0 C--N 1.319 -0.739 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.803 174.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -56.88 129.03 32.4 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.347 2.031 . . . . 0.0 112.079 174.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.43 ' HD2' ' O ' ' A' ' 31' ' ' SER . 85.5 Cg_exo -46.43 146.82 4.64 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.702 2.268 . . . . 0.0 111.422 171.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -36.79 106.17 0.32 Allowed Pre-proline 0 N--CA 1.472 0.628 0 O-C-N 124.654 1.221 . . . . 0.0 112.694 -168.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.559 ' HG2' HG11 ' A' ' 91' ' ' VAL . 37.9 Cg_exo -65.34 150.58 87.03 Favored 'Trans proline' 0 CA--C 1.52 -0.204 0 C-N-CA 123.501 2.8 . . . . 0.0 112.33 178.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 20.2 m -107.0 130.49 54.63 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.037 -176.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.486 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 82.1 t -83.33 121.37 36.09 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-N 114.435 -1.257 . . . . 0.0 109.908 174.288 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.515 ' OD1' ' HG3' ' A' ' 20' ' ' GLN . 13.5 t70 -80.96 -48.13 12.71 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.108 -174.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.515 ' HG3' ' OD1' ' A' ' 19' ' ' ASP . 27.5 mt-30 -136.07 140.73 44.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.694 -177.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.491 ' HA ' HG12 ' A' ' 26' ' ' ILE . 6.4 m -126.0 101.33 8.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.159 178.455 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -97.65 -160.12 0.78 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.151 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.519 ' CA ' ' HA2' ' A' ' 99' ' ' GLY . 11.5 p-10 -78.86 -52.66 8.0 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.253 0.549 . . . . 0.0 110.622 177.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.748 HG22 ' O ' ' A' ' 69' ' ' LEU . 26.6 p -121.81 34.6 5.13 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.984 -172.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.647 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 66.1 m -169.19 130.43 1.14 Allowed 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.424 -172.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.539 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 20.5 mt -144.83 137.39 21.73 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.786 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 177.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.486 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 41.1 t -115.67 128.67 72.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 C-N-CA 119.632 -0.827 . . . . 0.0 110.438 -175.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.65 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.7 OUTLIER -125.12 144.65 34.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 C-N-CA 120.546 -0.461 . . . . 0.0 109.916 -177.55 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.541 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 23.0 mtm180 -129.88 121.0 25.82 Favored 'General case' 0 C--N 1.327 -0.393 0 O-C-N 123.239 0.337 . . . . 0.0 110.573 -176.194 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.523 ' CH2' HD12 ' A' ' 57' ' ' LEU . 33.8 p90 -107.88 144.58 34.91 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.176 -173.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.43 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 16.1 m -85.64 89.85 7.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.493 178.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.602 ' HD3' ' H ' ' A' ' 32' ' ' ARG . 0.4 OUTLIER -46.07 152.35 0.8 Allowed Pre-proline 0 CA--C 1.538 0.486 0 C-N-CA 124.189 0.996 . . . . 0.0 113.014 -175.549 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.67 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 2.2 Cg_endo -86.03 166.42 9.78 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 124.273 3.315 . . . . 0.0 113.318 -169.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -76.27 -20.86 56.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.319 172.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.32 136.24 91.56 Favored Pre-proline 0 N--CA 1.453 -0.311 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.754 175.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -70.21 113.19 3.37 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 121.072 1.181 . . . . 0.0 109.593 170.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.586 HG21 ' HB2' ' A' ' 81' ' ' ALA . 24.9 pt -117.9 153.42 19.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.797 -174.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.436 ' C ' ' HB3' ' A' ' 59' ' ' GLU . 9.1 p -94.88 -24.4 17.02 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.529 ' C ' HG11 ' A' ' 82' ' ' VAL . . . -174.8 -161.67 24.97 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 119.732 -1.223 . . . . 0.0 113.304 -179.063 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.67 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 41.8 m-85 -139.54 131.49 27.76 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 122.364 0.266 . . . . 0.0 111.25 174.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 14.3 mmm-85 -96.21 148.76 22.38 Favored 'General case' 0 CA--C 1.504 -0.812 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 165.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.871 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 28.4 mt -139.0 107.84 3.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 C-N-CA 119.74 -0.784 . . . . 0.0 112.439 -179.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 71.9 t -109.04 109.93 30.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.396 0.617 . . . . 0.0 110.719 179.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.686 ' CZ ' ' HB ' ' A' ' 53' ' ' THR . 0.6 OUTLIER -112.77 125.57 54.48 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.322 176.747 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.4 m -139.97 141.16 26.17 Favored Pre-proline 0 C--N 1.317 -0.842 0 CA-C-N 114.282 -1.326 . . . . 0.0 111.429 -173.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.686 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 59.9 Cg_endo -68.89 156.29 65.84 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 123.66 2.907 . . . . 0.0 112.01 177.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 67.3 m -85.83 -29.71 23.54 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.724 -178.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 89.5 t -115.77 -42.21 3.28 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 C-N-CA 120.796 -0.361 . . . . 0.0 111.578 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -179.82 142.64 0.16 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.442 ' CA ' ' HG3' ' A' ' 46' ' ' PRO . . . 157.76 -160.18 30.48 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.866 -0.683 . . . . 0.0 111.963 -177.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.507 ' O ' ' HE1' ' A' ' 75' ' ' TYR . 19.4 m -94.83 121.6 36.6 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 -177.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.493 ' HA ' ' O ' ' A' ' 44' ' ' TYR . 15.1 m -102.77 139.94 37.69 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 172.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.686 ' HB ' ' CZ ' ' A' ' 44' ' ' TYR . 23.6 m -147.27 153.29 39.58 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 120.61 -0.436 . . . . 0.0 111.13 -179.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.871 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 30.8 tt0 -122.35 112.4 18.06 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 123.025 0.53 . . . . 0.0 109.673 175.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.632 HD11 ' CG2' ' A' ' 64' ' ' VAL . 15.8 mt -97.8 159.97 14.6 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.584 177.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -123.95 114.56 19.95 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.076 179.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.523 HD12 ' CH2' ' A' ' 30' ' ' TRP . 3.8 mt -113.69 154.65 45.68 Favored Pre-proline 0 C--N 1.318 -0.778 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -176.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -61.34 150.56 84.33 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 121.987 1.792 . . . . 0.0 111.18 176.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.436 ' HB3' ' C ' ' A' ' 38' ' ' THR . 11.4 pt-20 -46.26 -30.0 1.84 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.032 -0.985 . . . . 0.0 112.499 176.203 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 7.4 t -99.89 17.37 21.02 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.045 -175.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.46 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -88.48 151.46 22.53 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.165 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.541 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 24.6 p-10 -136.58 13.95 3.19 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.871 -177.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.65 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 71.6 p -167.51 134.39 2.25 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.336 -0.546 . . . . 0.0 111.678 -177.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.632 ' CG2' HD11 ' A' ' 55' ' ' LEU . 4.2 p -115.06 138.72 44.44 Favored 'Isoleucine or valine' 0 C--O 1.243 0.727 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.226 175.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 55.5 m -97.7 100.88 12.28 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.58 169.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.647 ' O ' ' HA ' ' A' ' 25' ' ' SER . 0.7 OUTLIER -76.46 144.46 39.88 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.2 177.415 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.1 p -141.85 164.74 29.38 Favored 'General case' 0 C--N 1.32 -0.675 0 O-C-N 123.501 0.501 . . . . 0.0 110.955 -172.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 28.8 t70 65.86 26.54 11.12 Favored 'General case' 0 N--CA 1.465 0.294 0 O-C-N 123.923 0.765 . . . . 0.0 110.824 -178.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.748 ' O ' HG22 ' A' ' 24' ' ' THR . 14.9 mt -70.65 -175.01 0.97 Allowed 'General case' 0 C--O 1.222 -0.349 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.948 176.335 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 16.8 mm-40 -129.27 133.28 24.97 Favored Pre-proline 0 C--N 1.319 -0.719 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 176.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -64.57 128.1 20.43 Favored 'Trans proline' 0 C--O 1.234 0.276 0 C-N-CA 122.921 2.414 . . . . 0.0 112.755 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 90.8 14.95 57.36 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.321 178.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 72.0 t -114.78 141.09 32.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.219 0.533 . . . . 0.0 111.602 -175.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.686 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -80.49 122.26 26.79 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.626 179.238 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.507 ' HE1' ' O ' ' A' ' 51' ' ' SER . 23.8 m-85 -118.17 113.71 21.96 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.377 0.608 . . . . 0.0 112.377 -176.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.53 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 20.5 m-80 -87.28 108.26 18.87 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.681 175.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.511 ' HB ' HG13 ' A' ' 93' ' ' ILE . 5.4 mp -92.55 115.29 31.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.298 0.571 . . . . 0.0 109.883 176.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.838 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 51.9 m -107.64 115.89 30.95 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.019 179.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.507 ' HB ' ' HB ' ' A' ' 91' ' ' VAL . 19.1 mm -95.91 143.04 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 -178.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.483 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 47.2 m-85 -128.35 111.83 13.77 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 178.091 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.586 ' HB2' HG21 ' A' ' 37' ' ' ILE . . . -79.82 107.96 13.0 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 173.036 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.529 HG11 ' C ' ' A' ' 39' ' ' GLY . 9.5 p -99.4 135.62 33.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 C-N-CA 120.132 -0.627 . . . . 0.0 110.678 -175.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.522 ' HG2' HG23 ' A' ' 37' ' ' ILE . 4.5 mt-10 -111.06 171.07 7.69 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 175.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -44.64 -47.09 10.47 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 123.797 0.686 . . . . 0.0 112.378 -178.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -106.14 -21.06 13.22 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -169.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -149.61 176.93 10.21 Favored 'General case' 0 C--O 1.219 -0.515 0 CA-C-N 118.696 0.68 . . . . 0.0 111.813 -174.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -117.6 134.36 54.97 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 177.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 10.7 m -73.84 -179.98 3.96 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.832 0.348 . . . . 0.0 111.223 -176.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.515 ' O ' ' HB1' ' A' ' 12' ' ' ALA . 0.8 OUTLIER -61.74 159.43 34.7 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.587 176.176 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -88.78 140.96 4.35 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 122.418 2.079 . . . . 0.0 114.361 -177.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.838 ' O ' ' HA ' ' A' ' 78' ' ' THR . 5.6 t -83.08 128.67 38.5 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.7 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 164.15 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 4.1 t -123.22 106.87 18.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 C-N-CA 119.987 -0.685 . . . . 0.0 110.113 171.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.511 HG13 ' HB ' ' A' ' 77' ' ' ILE . 6.7 pt -126.77 111.48 26.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.895 177.124 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -102.6 120.51 40.67 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.673 0.749 . . . . 0.0 111.524 -175.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.412 ' NE2' HG11 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -128.1 135.9 50.44 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.2 -179.1 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -87.04 146.46 26.09 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 176.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.408 ' CG2' HD12 ' A' ' 26' ' ' ILE . 20.7 p -81.38 120.08 24.51 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.104 178.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 85.7 m -70.17 -31.82 69.48 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.501 0.667 . . . . 0.0 110.58 178.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.519 ' HA2' ' CA ' ' A' ' 23' ' ' ASP . . . 83.59 -137.91 16.88 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.908 178.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 23.3 m -90.53 118.78 68.98 Favored Pre-proline 0 C--N 1.319 -0.748 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 175.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_exo -52.01 105.93 0.13 Allowed 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 123.117 2.545 . . . . 0.0 112.854 -178.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 32.2 tpt180 -148.27 87.9 1.62 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.694 179.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 50.6 m -87.25 62.45 7.26 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.964 -178.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -92.92 8.89 37.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.246 0.546 . . . . 0.0 109.708 177.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -73.51 100.87 1.11 Allowed Glycine 0 N--CA 1.444 -0.82 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.282 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 22.3 m . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.937 -0.554 . . . . 0.0 109.641 177.668 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.597 0 N-CA-C 111.997 -0.441 . . . . 0.0 111.997 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.1 p -84.06 -25.17 30.04 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.03 0.443 . . . . 0.0 110.827 -178.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 41.3 m-70 -85.82 95.49 9.44 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.667 179.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 25.2 ptm -156.86 43.37 0.37 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.483 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -63.05 -31.3 80.24 Favored Glycine 0 N--CA 1.453 -0.228 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.18 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.0 p -66.58 127.35 32.02 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.776 0.322 . . . . 0.0 111.226 177.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 37.6 m -70.97 112.26 6.99 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.445 178.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 53.7 m -73.79 128.97 36.95 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.081 -178.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -105.4 100.05 23.92 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.748 173.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -80.42 174.1 11.65 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.908 2.405 . . . . 0.0 112.741 -177.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -126.11 155.12 42.13 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.012 -178.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -95.91 160.78 29.34 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.509 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -70.58 132.67 22.48 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.479 2.119 . . . . 0.0 111.45 174.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -53.81 159.52 6.92 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.687 2.258 . . . . 0.0 111.314 172.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -39.27 106.24 0.39 Allowed Pre-proline 0 N--CA 1.469 0.491 0 O-C-N 124.313 1.008 . . . . 0.0 111.918 -173.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.529 ' HG2' HG13 ' A' ' 91' ' ' VAL . 38.2 Cg_exo -65.22 144.82 82.45 Favored 'Trans proline' 0 CA--C 1.517 -0.339 0 C-N-CA 122.999 2.466 . . . . 0.0 111.925 178.245 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 39.6 m -97.91 124.72 42.47 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.665 -177.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 85.2 t -78.46 118.37 25.52 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-N 114.479 -1.237 . . . . 0.0 109.17 172.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -89.69 -37.13 14.81 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.283 -174.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -134.59 129.66 35.31 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.941 0.401 . . . . 0.0 110.66 -176.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.42 ' HA ' HG12 ' A' ' 26' ' ' ILE . 85.7 t -126.39 120.52 56.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.724 -178.253 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -125.41 -167.77 1.74 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.813 176.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.508 ' O ' ' HB2' ' A' ' 69' ' ' LEU . 4.1 p-10 -67.28 -59.16 3.65 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.173 0.511 . . . . 0.0 111.331 176.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.681 HG21 ' O ' ' A' ' 69' ' ' LEU . 36.0 p -117.32 36.83 4.08 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.991 -173.019 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.666 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 66.1 m -168.65 130.28 1.29 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.059 -176.229 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.606 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 34.1 mt -148.14 136.63 15.1 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.539 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 176.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.458 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 41.3 t -116.79 127.84 74.31 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.602 0 C-N-CA 120.054 -0.658 . . . . 0.0 110.693 -174.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.626 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.8 OUTLIER -122.52 143.5 35.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -176.97 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.478 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 63.8 mtp180 -130.14 121.01 25.49 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.912 0.387 . . . . 0.0 110.568 -175.349 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.502 ' CH2' HD11 ' A' ' 57' ' ' LEU . 34.9 p90 -110.69 141.49 43.89 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.504 -173.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 17.6 m -83.63 86.61 7.09 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.02 -0.537 . . . . 0.0 109.725 175.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.425 ' CD ' ' HB3' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -48.28 156.83 0.74 Allowed Pre-proline 0 CA--C 1.541 0.598 0 CA-C-N 114.87 -1.059 . . . . 0.0 113.267 -176.184 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.649 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 3.1 Cg_exo -81.03 169.85 15.8 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 124.341 3.361 . . . . 0.0 113.538 -171.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -91.35 -7.33 51.21 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.662 176.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -69.37 144.08 94.2 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.204 175.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -70.64 113.24 3.45 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 121.071 1.18 . . . . 0.0 109.766 171.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.586 HG22 ' HG3' ' A' ' 83' ' ' GLU . 3.5 pt -119.91 157.56 22.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.403 -173.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.464 ' C ' ' HB3' ' A' ' 59' ' ' GLU . 16.6 p -101.29 -22.85 14.51 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -176.136 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.555 ' C ' HG13 ' A' ' 82' ' ' VAL . . . -177.01 -165.43 32.38 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 119.6 -1.286 . . . . 0.0 112.371 179.017 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.649 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 6.3 m-85 -139.24 134.38 32.6 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.773 0.32 . . . . 0.0 110.875 173.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.7 mmm180 -100.97 148.07 25.44 Favored 'General case' 0 CA--C 1.501 -0.906 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 165.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.885 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 33.6 mt -138.25 109.53 5.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 C-N-CA 119.881 -0.728 . . . . 0.0 112.319 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 69.9 t -110.77 110.12 31.02 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.525 0 CA-C-O 121.391 0.615 . . . . 0.0 110.695 -179.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.709 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 0.8 OUTLIER -112.46 124.49 52.62 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.428 177.06 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.426 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 17.8 p -139.08 137.17 18.92 Favored Pre-proline 0 C--N 1.314 -0.975 0 CA-C-N 114.135 -1.393 . . . . 0.0 111.525 -173.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.553 ' HG3' ' CZ ' ' A' ' 75' ' ' TYR . 8.0 Cg_exo -69.55 131.15 20.92 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.978 2.452 . . . . 0.0 110.821 174.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 12.6 m -55.39 -33.5 63.52 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.289 -0.869 . . . . 0.0 112.526 -173.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 12.7 m -109.89 -41.15 4.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -175.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 178.63 148.77 0.2 Allowed 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 -175.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.42 ' CA ' ' HG2' ' A' ' 46' ' ' PRO . . . 140.64 -160.61 26.57 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.47 178.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 20.2 m -84.69 122.98 29.85 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.524 0.202 . . . . 0.0 111.446 -177.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.7 p -117.31 140.38 49.63 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 175.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.709 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 29.1 m -146.0 150.23 35.63 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.655 -173.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.885 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 56.6 tt0 -114.93 118.35 33.23 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.935 173.238 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.613 HD13 ' CG2' ' A' ' 64' ' ' VAL . 21.9 mt -100.23 148.34 24.74 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.54 -0.464 . . . . 0.0 109.902 173.275 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -109.86 114.14 27.46 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 176.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.502 HD11 ' CH2' ' A' ' 30' ' ' TRP . 1.7 mt -109.96 152.51 43.07 Favored Pre-proline 0 N--CA 1.444 -0.766 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 -177.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -60.9 149.2 89.74 Favored 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 121.952 1.768 . . . . 0.0 111.389 176.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.464 ' HB3' ' C ' ' A' ' 38' ' ' THR . 9.6 pt-20 -46.92 -22.78 0.36 Allowed 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 114.848 -1.069 . . . . 0.0 113.019 176.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.2 t -107.3 15.84 24.6 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.135 -176.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.466 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -82.17 164.3 21.36 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.504 -0.317 . . . . 0.0 110.423 -179.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.478 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 4.6 p-10 -149.19 11.27 0.8 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -177.102 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.626 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 21.9 p -168.7 134.11 1.69 Allowed 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.346 -0.542 . . . . 0.0 111.996 -178.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.613 ' CG2' HD13 ' A' ' 55' ' ' LEU . 4.1 p -117.02 136.78 53.08 Favored 'Isoleucine or valine' 0 C--O 1.242 0.673 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.288 176.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 41.9 m -98.93 102.03 13.62 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-O 121.411 0.624 . . . . 0.0 109.795 170.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.666 ' O ' ' HA ' ' A' ' 25' ' ' SER . 0.2 OUTLIER -79.24 142.22 36.41 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.118 178.422 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.8 t -136.51 169.6 17.42 Favored 'General case' 0 C--N 1.32 -0.681 0 O-C-N 123.274 0.359 . . . . 0.0 110.559 -175.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 58.71 32.99 22.76 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.634 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.681 ' O ' HG21 ' A' ' 24' ' ' THR . 11.8 mt -71.88 -176.39 1.68 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.755 176.111 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -124.56 126.43 25.42 Favored Pre-proline 0 C--N 1.32 -0.714 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 175.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -63.58 132.44 35.48 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.183 2.589 . . . . 0.0 113.62 -176.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 87.92 21.58 45.85 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.311 177.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 18.7 t -125.53 148.2 30.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.328 0.585 . . . . 0.0 111.463 -176.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.454 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 15.0 tp60 -81.48 114.28 20.1 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.937 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.56 ' CE2' HD22 ' A' ' 69' ' ' LEU . 6.1 m-85 -104.83 115.19 29.87 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.291 0.567 . . . . 0.0 112.02 -178.024 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.538 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 14.2 m120 -87.72 105.42 17.36 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.64 175.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.536 HG21 HD11 ' A' ' 79' ' ' ILE . 5.2 mp -91.44 117.27 34.36 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.575 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 175.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.864 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 90.4 m -109.2 115.39 29.92 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.779 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.536 HD11 HG21 ' A' ' 77' ' ' ILE . 12.4 mm -96.16 121.07 46.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.915 -179.375 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -108.12 111.11 22.97 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 176.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -80.15 123.61 28.05 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 169.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.555 HG13 ' C ' ' A' ' 39' ' ' GLY . 12.7 p -115.67 134.47 58.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 C-N-CA 120.053 -0.659 . . . . 0.0 110.889 -176.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.586 ' HG3' HG22 ' A' ' 37' ' ' ILE . 8.6 mp0 -112.48 171.61 7.42 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -177.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -42.12 -44.93 3.83 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -174.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -125.66 -13.22 6.51 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.498 -0.481 . . . . 0.0 111.959 -176.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -128.39 173.73 9.94 Favored 'General case' 0 N--CA 1.443 -0.794 0 O-C-N 122.247 -0.283 . . . . 0.0 111.358 -171.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 20.4 mp0 -128.12 127.02 42.26 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.478 176.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 68.1 m -72.56 171.74 11.85 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.873 0.368 . . . . 0.0 111.797 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.2 p -60.61 150.24 75.75 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.327 177.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -85.17 141.2 8.02 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.421 2.08 . . . . 0.0 114.328 -175.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.864 ' O ' ' HA ' ' A' ' 78' ' ' THR . 7.0 t -82.65 129.39 37.53 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.641 0 CA-C-N 114.782 -1.099 . . . . 0.0 108.594 167.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 9.7 t -125.9 106.44 16.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 C-N-CA 120.196 -0.602 . . . . 0.0 110.057 171.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.527 HG13 ' HB ' ' A' ' 77' ' ' ILE . 5.8 pt -121.95 111.39 30.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.048 177.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.624 ' H ' ' NE2' ' A' ' 94' ' ' GLN . 0.7 OUTLIER -96.78 115.36 27.29 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.57 0.7 . . . . 0.0 111.184 -178.801 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.67 131.79 53.97 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.471 177.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -86.79 134.12 33.59 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.214 0.531 . . . . 0.0 110.135 179.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.507 HG23 HD11 ' A' ' 26' ' ' ILE . 24.1 p -66.08 120.86 13.92 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.437 178.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.6 m -68.29 -30.69 69.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.342 0.591 . . . . 0.0 110.247 -177.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.78 -150.99 20.28 Favored Glycine 0 N--CA 1.441 -0.985 0 CA-C-N 115.331 -0.849 . . . . 0.0 112.297 175.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.408 HG23 ' H ' ' A' ' 102' ' ' ARG . 40.2 m -106.07 128.76 25.74 Favored Pre-proline 0 C--N 1.316 -0.865 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -55.51 -26.82 56.34 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 123.253 2.635 . . . . 0.0 112.305 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.565 ' HB3' ' OD1' ' A' ' 104' ' ' ASP . 69.3 mtp180 -88.41 121.11 30.43 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.059 175.375 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 5.1 p -94.2 9.58 37.37 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.104 0.478 . . . . 0.0 111.024 -178.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . 0.565 ' OD1' ' HB3' ' A' ' 102' ' ' ARG . 6.7 p-10 -89.57 175.13 7.4 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.872 177.002 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 141.24 -54.32 0.63 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.911 -0.661 . . . . 0.0 111.93 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 20.7 m . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.828 -0.606 . . . . 0.0 109.818 177.092 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.642 0 N-CA-C 111.738 -0.545 . . . . 0.0 111.738 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 44.4 t 69.17 111.34 0.05 OUTLIER 'General case' 0 C--O 1.233 0.188 0 C-N-CA 123.081 0.552 . . . . 0.0 110.772 -179.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 41.8 m-70 60.42 57.23 2.9 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.486 -179.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.17 75.96 8.13 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.44 -179.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -79.67 -27.35 54.41 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.799 -176.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 13.9 m -88.93 62.12 6.21 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.43 0.633 . . . . 0.0 110.178 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.7 m -82.21 86.22 6.68 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.347 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 24.2 m -89.28 123.09 33.16 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.473 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -119.36 139.56 27.85 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.147 -177.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -67.06 136.94 42.7 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.231 1.954 . . . . 0.0 112.284 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -88.2 164.88 15.43 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.918 178.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -96.3 159.1 32.76 Favored Pre-proline 0 C--N 1.32 -0.687 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.882 -177.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -71.27 129.65 16.32 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 122.35 2.033 . . . . 0.0 111.284 175.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.52 ' HD2' ' O ' ' A' ' 31' ' ' SER . 88.5 Cg_exo -49.31 151.44 6.61 Favored 'Trans proline' 0 C--O 1.234 0.316 0 C-N-CA 122.743 2.295 . . . . 0.0 111.936 173.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -36.63 106.61 0.34 Allowed Pre-proline 0 N--CA 1.469 0.51 0 O-C-N 124.728 1.268 . . . . 0.0 112.324 -171.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.58 ' HG2' HG11 ' A' ' 91' ' ' VAL . 28.1 Cg_exo -68.61 143.76 57.91 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 123.442 2.761 . . . . 0.0 113.046 179.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 94.6 m -96.62 127.7 42.86 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.199 -177.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.446 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 97.3 t -79.27 116.48 23.29 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-N 114.611 -1.177 . . . . 0.0 109.337 173.253 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -86.95 -37.02 17.97 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.085 -173.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -135.6 136.55 41.13 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.235 -176.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.443 ' HA ' HG12 ' A' ' 26' ' ' ILE . 42.0 t -133.52 115.44 22.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.109 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.423 ' HB3' ' H ' ' A' ' 23' ' ' ASP . 8.2 m-20 -132.41 -160.37 1.04 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.269 179.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.423 ' H ' ' HB3' ' A' ' 22' ' ' ASP . 6.3 p-10 -68.69 -66.59 0.55 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -177.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.584 HG23 ' O ' ' A' ' 69' ' ' LEU . 57.2 p -115.52 36.87 3.77 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.423 0.63 . . . . 0.0 110.582 -172.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.586 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 32.2 p -170.2 131.21 0.97 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.673 -174.253 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.493 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 42.4 mt -145.97 142.07 21.62 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.771 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 178.214 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.446 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 43.6 t -119.67 134.14 64.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 118.859 0.754 . . . . 0.0 110.338 -173.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.558 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.7 OUTLIER -129.11 148.55 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.524 -179.261 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.638 ' HG2' ' OG ' ' A' ' 63' ' ' SER . 29.7 mtm105 -131.36 120.3 22.92 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.554 -177.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.512 ' CH2' HD13 ' A' ' 57' ' ' LEU . 37.8 p90 -111.14 143.81 41.28 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.832 -175.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.52 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 17.3 t -91.17 96.44 10.58 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 177.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.468 ' CD ' ' H ' ' A' ' 32' ' ' ARG . 1.0 OUTLIER -49.54 158.12 0.86 Allowed Pre-proline 0 C--N 1.327 -0.372 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -173.854 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.666 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 5.1 Cg_exo -79.94 165.56 21.83 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 124.197 3.265 . . . . 0.0 112.534 -173.226 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -78.92 -10.43 59.81 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.13 -0.941 . . . . 0.0 108.933 172.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -72.23 138.42 81.54 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 114.779 -1.1 . . . . 0.0 111.315 177.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo -66.31 115.05 3.29 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 121.492 1.461 . . . . 0.0 109.738 166.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.569 HG21 ' HB2' ' A' ' 81' ' ' ALA . 0.6 OUTLIER -119.55 154.71 22.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 -177.901 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 9.5 p -95.74 -23.79 16.81 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -178.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.557 ' C ' HG13 ' A' ' 82' ' ' VAL . . . -173.61 -163.02 26.49 Favored Glycine 0 CA--C 1.502 -0.778 0 C-N-CA 119.919 -1.134 . . . . 0.0 111.887 178.458 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.666 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 6.8 m-85 -141.2 133.8 28.58 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 122.525 0.33 . . . . 0.0 111.156 174.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.5 mmm180 -104.61 149.87 25.16 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 167.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.889 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 33.7 mt -138.88 107.93 3.77 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 C-N-CA 120.123 -0.631 . . . . 0.0 112.106 -178.138 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 66.1 t -107.09 110.13 30.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.422 0.63 . . . . 0.0 110.572 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.639 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 0.5 OUTLIER -110.74 124.62 52.33 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.096 175.517 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 14.5 t -142.39 139.2 17.28 Favored Pre-proline 0 C--N 1.316 -0.89 0 CA-C-N 113.86 -1.518 . . . . 0.0 110.666 -172.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.684 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 37.2 Cg_exo -63.1 153.49 73.5 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 123.374 2.716 . . . . 0.0 112.585 176.049 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 19.9 t -72.38 -30.76 64.98 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.44 -175.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.3 p -117.72 -42.51 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 120.242 -0.583 . . . . 0.0 112.163 177.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -179.76 152.23 0.48 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.635 0.255 . . . . 0.0 110.523 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.472 ' CA ' ' HG2' ' A' ' 46' ' ' PRO . . . 150.77 -156.26 26.59 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 111.494 -0.642 . . . . 0.0 111.494 -179.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 34.8 t -87.27 122.46 31.07 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.78 0.29 . . . . 0.0 110.809 -178.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 32.7 p -117.44 145.98 43.78 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 176.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.639 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 24.6 m -147.87 152.87 38.34 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.756 -0.377 . . . . 0.0 111.374 -178.149 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.889 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 34.1 tt0 -116.87 118.36 32.26 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 171.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.631 HD13 ' CG2' ' A' ' 64' ' ' VAL . 20.5 mt -97.13 157.13 16.08 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 174.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -122.35 113.48 19.45 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.512 HD13 ' CH2' ' A' ' 30' ' ' TRP . 3.6 mt -112.0 155.58 43.13 Favored Pre-proline 0 N--CA 1.443 -0.782 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 -175.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -64.36 149.65 89.73 Favored 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 121.656 1.57 . . . . 0.0 110.945 174.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -46.56 -25.94 0.79 Allowed 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 114.722 -1.126 . . . . 0.0 113.123 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 7.9 t -101.55 5.72 41.88 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.915 0.388 . . . . 0.0 111.358 -175.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.441 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -75.95 155.99 34.59 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.473 ' C ' ' HG ' ' A' ' 63' ' ' SER . 4.9 p-10 -141.3 12.46 2.17 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 120.55 -0.46 . . . . 0.0 112.181 -175.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.638 ' OG ' ' HG2' ' A' ' 29' ' ' ARG . 9.4 m -161.94 135.88 6.6 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.981 -0.288 . . . . 0.0 110.834 -178.051 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.631 ' CG2' HD13 ' A' ' 55' ' ' LEU . 4.2 p -121.26 135.12 62.45 Favored 'Isoleucine or valine' 0 C--O 1.24 0.605 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 172.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 55.2 m -97.67 100.91 12.31 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-O 121.528 0.68 . . . . 0.0 109.291 169.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.586 ' O ' ' HA ' ' A' ' 25' ' ' SER . 0.2 OUTLIER -77.52 141.38 39.65 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.22 -0.9 . . . . 0.0 108.958 179.824 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 22.5 t -141.42 169.63 17.25 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -174.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 34.1 t70 64.48 29.87 13.17 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 123.998 0.811 . . . . 0.0 110.307 -178.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.584 ' O ' HG23 ' A' ' 24' ' ' THR . 8.2 mt -75.42 -176.29 3.11 Favored 'General case' 0 N--CA 1.462 0.143 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 175.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -117.96 133.1 23.42 Favored Pre-proline 0 C--N 1.32 -0.689 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 174.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -64.55 128.71 21.85 Favored 'Trans proline' 0 C--O 1.233 0.269 0 C-N-CA 122.666 2.244 . . . . 0.0 112.392 177.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.63 37.52 19.81 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.04 179.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.519 ' CG1' ' HB3' ' A' ' 46' ' ' PRO . 71.5 t -134.82 138.35 49.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.121 0.486 . . . . 0.0 110.805 -178.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.684 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -75.7 121.28 22.27 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.564 -0.743 . . . . 0.0 109.549 -179.997 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.512 ' CE2' HD22 ' A' ' 69' ' ' LEU . 7.6 m-85 -113.92 114.62 26.47 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.308 0.575 . . . . 0.0 112.444 -176.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.462 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 12.2 m120 -88.28 109.21 19.78 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.321 172.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.537 ' HB ' HG13 ' A' ' 93' ' ' ILE . 4.9 mp -92.15 119.97 40.53 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.621 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 175.038 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.885 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 55.9 m -112.16 115.41 28.8 Favored 'General case' 0 N--CA 1.425 -1.687 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.613 -179.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.509 HD13 HG22 ' A' ' 77' ' ' ILE . 12.6 mm -95.94 136.91 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.406 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 57.7 m-85 -124.29 111.73 16.17 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.322 -0.399 . . . . 0.0 109.965 178.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.569 ' HB2' HG21 ' A' ' 37' ' ' ILE . . . -80.04 109.38 14.43 Favored 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 171.063 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.557 HG13 ' C ' ' A' ' 39' ' ' GLY . 10.4 p -100.13 139.73 20.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 C-N-CA 120.029 -0.668 . . . . 0.0 110.754 -174.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.636 ' HG2' ' H ' ' A' ' 84' ' ' GLU . 0.7 OUTLIER -117.56 167.56 11.2 Favored 'General case' 0 N--CA 1.447 -0.583 0 O-C-N 124.005 0.816 . . . . 0.0 108.935 179.265 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.636 ' H ' ' HG2' ' A' ' 83' ' ' GLU . 39.1 mt-10 -40.65 -52.51 2.9 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 28.5 m-80 -123.99 1.49 8.63 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.815 -174.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -134.98 172.02 13.6 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.332 -0.547 . . . . 0.0 111.596 -172.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -136.86 129.14 29.83 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.523 177.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 23.9 m -69.09 162.22 27.4 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.304 176.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.1 p -58.15 151.81 44.57 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.015 0.436 . . . . 0.0 110.265 174.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -82.39 140.6 10.9 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 121.978 1.786 . . . . 0.0 113.727 -173.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.885 ' O ' ' HA ' ' A' ' 78' ' ' THR . 10.7 t -82.27 123.72 38.52 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.728 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 167.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.4 t -121.82 106.71 18.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 C-N-CA 119.76 -0.776 . . . . 0.0 109.936 171.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.537 HG13 ' HB ' ' A' ' 77' ' ' ILE . 6.4 pt -120.47 115.7 47.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.612 177.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -103.83 123.0 46.3 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.467 0.651 . . . . 0.0 111.343 -174.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.34 135.25 42.6 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.711 177.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.48 ' HG3' ' HG2' ' A' ' 74' ' ' GLN . 1.6 mp0 -86.13 135.22 33.69 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.162 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.487 HG23 HD13 ' A' ' 26' ' ' ILE . 41.2 p -67.08 124.17 22.32 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.16 0.505 . . . . 0.0 110.303 178.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 14.2 m -69.39 -31.52 69.96 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.142 -174.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.32 -142.74 16.12 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.559 -0.829 . . . . 0.0 111.696 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 15.1 m -141.5 128.22 11.46 Favored Pre-proline 0 C--N 1.318 -0.789 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 178.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo -68.8 58.26 1.12 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.745 2.297 . . . . 0.0 111.576 171.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -91.69 137.81 32.07 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.451 -179.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 17.7 m 62.97 50.68 3.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.486 0.66 . . . . 0.0 109.696 -176.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -76.83 177.65 7.48 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.633 -177.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 86.87 -88.53 1.59 Allowed Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.389 -177.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 15.1 m . . . . . 0 C--O 1.247 0.953 0 CA-C-O 118.637 -0.697 . . . . 0.0 110.056 178.101 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.701 0 N-CA-C 111.9 -0.48 . . . . 0.0 111.9 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.5 m -67.34 -43.41 81.61 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.027 0.442 . . . . 0.0 110.703 -179.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 13.2 t60 -99.24 90.84 4.71 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 178.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 59.6 mtt -76.54 -24.57 53.64 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.864 -176.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 156.04 -102.5 0.22 Allowed Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.849 -0.691 . . . . 0.0 111.855 179.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 15.4 t -107.59 148.47 29.24 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.0 p -70.56 112.96 7.21 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.242 177.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 33.8 m -62.13 120.17 10.36 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 120.949 0.404 . . . . 0.0 110.262 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -146.9 110.98 4.11 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.743 -177.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -79.78 175.15 10.84 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.801 2.334 . . . . 0.0 111.681 175.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -127.24 164.39 21.8 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.328 -176.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -95.9 163.68 20.52 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.343 178.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -71.82 130.11 16.4 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 122.446 2.097 . . . . 0.0 111.626 175.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.613 ' HD2' ' O ' ' A' ' 31' ' ' SER . 88.3 Cg_exo -48.54 154.83 2.57 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.963 2.442 . . . . 0.0 112.32 172.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -39.31 106.36 0.39 Allowed Pre-proline 0 N--CA 1.466 0.372 0 O-C-N 124.652 1.22 . . . . 0.0 112.621 -172.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.558 ' HG2' HG11 ' A' ' 91' ' ' VAL . 27.2 Cg_exo -68.92 149.25 72.0 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 123.444 2.763 . . . . 0.0 112.696 178.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.1 m -106.71 132.88 52.19 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.862 -177.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.424 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 81.9 t -85.14 121.56 37.16 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 114.63 -1.168 . . . . 0.0 109.78 174.379 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -94.28 -28.03 15.8 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.181 -174.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -135.79 126.51 27.3 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.406 -175.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.486 ' HA ' HG12 ' A' ' 26' ' ' ILE . 58.1 t -127.96 109.65 20.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.423 177.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.515 ' CG ' ' H ' ' A' ' 23' ' ' ASP . 13.7 t70 -118.68 -157.61 0.69 Allowed 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.515 ' H ' ' CG ' ' A' ' 22' ' ' ASP . 1.1 m-20 -84.23 -56.36 3.69 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.053 0.454 . . . . 0.0 110.286 -179.135 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.682 HG23 ' O ' ' A' ' 69' ' ' LEU . 22.8 p -114.43 34.5 4.69 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.669 -176.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.633 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 51.1 m -168.34 130.63 1.42 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.152 -172.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.573 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 45.3 mt -147.84 138.36 17.2 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.548 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 175.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 47.6 t -118.13 127.96 75.25 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.517 0 O-C-N 121.684 -0.635 . . . . 0.0 110.961 -174.293 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.602 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.6 OUTLIER -123.72 146.88 28.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.056 -176.61 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.506 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 28.7 mtm180 -133.35 121.88 23.0 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.313 -176.118 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.541 ' CH2' HD11 ' A' ' 57' ' ' LEU . 39.4 p90 -111.37 145.13 39.43 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.52 -174.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.613 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 25.4 m -90.83 94.74 9.8 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.311 178.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.572 ' NE ' ' HB3' ' A' ' 62' ' ' ASN . 0.1 OUTLIER -49.0 156.61 0.9 Allowed Pre-proline 0 CA--C 1.537 0.458 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -173.837 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.597 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 5.0 Cg_exo -80.12 167.88 19.36 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 124.126 3.217 . . . . 0.0 112.248 -173.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -83.14 -11.4 57.97 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 173.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -67.49 147.17 98.81 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 114.333 -1.303 . . . . 0.0 111.481 177.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -75.31 114.4 3.98 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 121.54 1.494 . . . . 0.0 110.283 170.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.554 HG22 ' HB3' ' A' ' 81' ' ' ALA . 1.2 pt -122.61 154.15 27.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -176.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.414 ' C ' ' HB3' ' A' ' 59' ' ' GLU . 19.3 p -99.14 -30.17 12.44 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -176.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.564 ' C ' HG12 ' A' ' 82' ' ' VAL . . . -165.73 -164.13 20.58 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.482 -0.866 . . . . 0.0 111.7 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.597 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 6.6 m-85 -141.95 134.89 28.78 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 117.145 0.473 . . . . 0.0 111.392 175.321 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 8.9 mmm180 -100.4 150.92 22.12 Favored 'General case' 0 CA--C 1.508 -0.656 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 166.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.884 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 30.4 mt -139.27 108.49 3.7 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 C-N-CA 120.452 -0.499 . . . . 0.0 112.215 177.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 72.7 t -108.69 110.34 31.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.464 0.649 . . . . 0.0 110.804 179.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.643 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 1.0 OUTLIER -112.35 125.67 54.44 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.374 175.773 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 12.4 p -137.79 139.24 25.99 Favored Pre-proline 0 C--N 1.317 -0.822 0 CA-C-N 114.093 -1.412 . . . . 0.0 112.02 -172.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.493 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 72.0 Cg_endo -74.24 142.37 30.35 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 123.482 2.788 . . . . 0.0 111.71 176.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 18.4 m -71.46 -28.91 64.28 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.233 -176.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.7 m -116.94 -40.48 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -178.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -179.84 143.03 0.17 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -178.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.426 ' CA ' ' HG3' ' A' ' 46' ' ' PRO . . . 155.13 -159.88 29.39 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.971 -0.633 . . . . 0.0 111.664 178.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.457 ' O ' ' HE1' ' A' ' 75' ' ' TYR . 27.1 t -94.97 120.67 35.57 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.685 0.279 . . . . 0.0 110.625 -179.265 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.431 ' HA ' ' O ' ' A' ' 44' ' ' TYR . 22.0 p -107.55 139.5 41.98 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 173.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.643 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 36.8 m -146.95 150.11 34.52 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 120.482 -0.487 . . . . 0.0 111.441 -174.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.884 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 52.5 tt0 -115.34 114.16 24.77 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.55 173.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.611 HD13 ' CG2' ' A' ' 64' ' ' VAL . 23.0 mt -97.08 151.64 19.56 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.46 -0.496 . . . . 0.0 109.667 175.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -116.54 115.81 26.45 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.541 HD11 ' CH2' ' A' ' 30' ' ' TRP . 3.9 mt -113.51 156.96 42.65 Favored Pre-proline 0 C--N 1.319 -0.723 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -176.273 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -66.16 151.37 83.82 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 121.712 1.608 . . . . 0.0 111.166 175.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.414 ' HB3' ' C ' ' A' ' 38' ' ' THR . 9.2 pt-20 -46.07 -28.01 1.09 Allowed 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.099 -0.955 . . . . 0.0 112.823 177.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.9 t -101.67 12.28 37.42 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.265 0.555 . . . . 0.0 111.246 -175.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.453 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -82.07 159.98 23.31 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.219 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.572 ' HB3' ' NE ' ' A' ' 32' ' ' ARG . 28.4 p-10 -146.73 17.19 1.27 Allowed 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -176.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.602 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 21.5 p -169.08 135.73 1.75 Allowed 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.17 -0.612 . . . . 0.0 111.846 -178.54 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.611 ' CG2' HD13 ' A' ' 55' ' ' LEU . 4.1 p -122.06 136.21 59.67 Favored 'Isoleucine or valine' 0 C--O 1.242 0.682 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.343 175.022 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 39.3 m -98.19 102.01 13.64 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-O 121.531 0.681 . . . . 0.0 109.55 170.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.633 ' O ' ' HA ' ' A' ' 25' ' ' SER . 0.2 OUTLIER -78.5 139.45 38.67 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.036 179.104 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 22.0 t -136.1 170.05 16.64 Favored 'General case' 0 C--N 1.317 -0.828 0 O-C-N 123.257 0.348 . . . . 0.0 110.224 -174.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 62.52 26.56 15.79 Favored 'General case' 0 C--N 1.331 -0.222 0 O-C-N 123.861 0.725 . . . . 0.0 111.457 -179.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.682 ' O ' HG23 ' A' ' 24' ' ' THR . 16.4 mt -68.17 -175.92 0.66 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.209 0.528 . . . . 0.0 109.887 177.175 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.567 ' N ' ' HH ' ' A' ' 75' ' ' TYR . 5.7 tp-100 -126.1 118.9 23.67 Favored Pre-proline 0 C--N 1.319 -0.738 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.149 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.545 ' HD2' ' OE1' ' A' ' 70' ' ' GLN . 19.2 Cg_endo -60.89 134.48 53.68 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.886 2.391 . . . . 0.0 113.033 -177.077 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.63 23.33 50.72 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.936 -0.65 . . . . 0.0 111.812 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 50.5 t -129.49 146.38 34.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.183 0.516 . . . . 0.0 110.804 -177.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.493 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -82.98 120.16 25.36 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.186 -0.916 . . . . 0.0 109.721 -178.696 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.567 ' HH ' ' N ' ' A' ' 70' ' ' GLN . 14.5 m-85 -115.06 113.92 24.68 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.254 0.55 . . . . 0.0 111.949 -176.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.549 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 0.8 OUTLIER -87.22 113.35 22.88 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.936 177.006 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.534 ' HB ' HG13 ' A' ' 93' ' ' ILE . 5.3 mp -94.68 114.94 32.28 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.615 0 CA-C-O 121.289 0.566 . . . . 0.0 109.618 175.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.821 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 48.4 m -108.52 116.15 31.43 Favored 'General case' 0 N--CA 1.427 -1.615 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.122 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.527 HD12 HG22 ' A' ' 77' ' ' ILE . 13.0 mm -95.22 143.49 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.412 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 64.7 m-85 -129.99 113.12 14.18 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.001 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.554 ' HB3' HG22 ' A' ' 37' ' ' ILE . . . -78.33 122.53 25.87 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 106.738 -1.578 . . . . 0.0 106.738 168.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.564 HG12 ' C ' ' A' ' 39' ' ' GLY . 7.5 p -110.49 135.37 49.78 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 C-N-CA 120.153 -0.619 . . . . 0.0 109.97 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.661 ' OE1' ' HG2' ' A' ' 86' ' ' GLN . 4.8 mp0 -115.34 169.87 8.82 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -37.76 -53.09 1.28 Allowed 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -171.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -126.24 7.23 7.12 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.726 -0.389 . . . . 0.0 111.947 -175.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.661 ' HG2' ' OE1' ' A' ' 83' ' ' GLU . 20.3 pm0 -143.79 176.73 9.02 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 120.688 -0.405 . . . . 0.0 111.289 -173.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -136.06 129.89 32.62 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.775 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 67.9 m -76.99 175.78 9.25 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.086 0.47 . . . . 0.0 111.622 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -60.93 152.94 68.02 Favored Pre-proline 0 N--CA 1.451 -0.38 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.283 179.065 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -85.99 141.83 7.4 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.433 2.089 . . . . 0.0 114.204 -177.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.821 ' O ' ' HA ' ' A' ' 78' ' ' THR . 11.8 t -82.51 124.88 39.74 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.718 0 CA-C-N 114.692 -1.14 . . . . 0.0 108.101 166.192 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 14.4 t -120.34 105.24 16.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 C-N-CA 119.385 -0.926 . . . . 0.0 109.904 171.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.534 HG13 ' HB ' ' A' ' 77' ' ' ILE . 10.4 pt -122.04 110.86 28.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.192 177.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.423 ' HB2' ' OE1' ' A' ' 74' ' ' GLN . 11.1 pt20 -100.86 114.6 28.59 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.783 0.801 . . . . 0.0 111.237 -174.093 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.28 126.44 52.16 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.988 -1.005 . . . . 0.0 109.756 178.38 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.447 ' HB2' ' HG2' ' A' ' 74' ' ' GLN . 39.1 tt0 -89.73 130.21 36.03 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 177.039 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.499 HG22 HD13 ' A' ' 26' ' ' ILE . 41.6 p -63.66 140.38 58.87 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.319 -177.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.6 m -67.58 -30.74 70.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.633 -173.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 58.07 88.35 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 CA-C-N 115.948 -0.569 . . . . 0.0 113.088 172.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.4 m -81.77 118.52 72.45 Favored Pre-proline 0 C--N 1.313 -0.997 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 -179.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -51.01 111.41 0.55 Allowed 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 122.546 2.164 . . . . 0.0 111.364 178.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 70.3 mtt85 65.9 69.86 0.44 Allowed 'General case' 0 C--O 1.234 0.237 0 O-C-N 123.644 0.59 . . . . 0.0 110.05 -175.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.3 m -58.58 -47.36 84.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.809 -178.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -130.16 113.96 15.11 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.402 179.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 72.21 -112.03 3.85 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.982 -0.628 . . . . 0.0 111.756 -178.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.8 t . . . . . 0 C--O 1.253 1.238 0 CA-C-O 118.795 -0.621 . . . . 0.0 109.79 176.81 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.553 0 N-CA-C 112.126 -0.39 . . . . 0.0 112.126 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.3 m -75.74 -34.52 60.32 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.77 0.319 . . . . 0.0 111.272 -178.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 67.4 t60 -71.16 -38.82 72.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.916 0.389 . . . . 0.0 110.297 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 38.3 tpp -152.06 127.02 9.67 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.18 176.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -160.57 71.42 0.23 Allowed Glycine 0 N--CA 1.445 -0.764 0 N-CA-C 111.216 -0.753 . . . . 0.0 111.216 179.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.3 t -87.71 25.55 1.47 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.345 0.593 . . . . 0.0 111.077 -174.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.9 m -79.48 97.6 6.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.967 175.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.473 ' O ' ' HG3' ' A' ' 86' ' ' GLN . 23.5 m -69.22 133.86 48.48 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.015 -178.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -114.19 88.97 16.0 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-O 120.838 0.352 . . . . 0.0 110.276 175.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -81.52 159.2 19.49 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 122.476 2.117 . . . . 0.0 112.166 -178.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -106.02 152.61 23.14 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.822 -178.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.555 ' HB3' ' O ' ' A' ' 89' ' ' THR . . . -83.28 155.71 66.52 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.164 177.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -62.22 132.68 39.93 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.412 2.074 . . . . 0.0 111.655 173.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -49.43 145.6 15.84 Favored 'Trans proline' 0 C--O 1.236 0.383 0 C-N-CA 122.588 2.192 . . . . 0.0 111.188 172.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -34.98 106.63 0.3 Allowed Pre-proline 0 N--CA 1.469 0.497 0 O-C-N 124.847 1.342 . . . . 0.0 112.693 -169.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.569 ' HG2' HG13 ' A' ' 91' ' ' VAL . 28.0 Cg_exo -66.68 151.51 82.5 Favored 'Trans proline' 0 CA--C 1.519 -0.273 0 C-N-CA 123.534 2.823 . . . . 0.0 112.108 178.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 8.2 m -113.13 131.62 55.77 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.635 -177.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.453 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 71.6 t -76.05 119.34 23.91 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-N 114.363 -1.29 . . . . 0.0 110.143 174.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -93.81 -28.05 16.11 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.073 -174.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -135.52 132.6 37.49 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.388 -178.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.442 ' HA ' HG12 ' A' ' 26' ' ' ILE . 11.5 t -131.95 104.84 8.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.77 179.312 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -111.75 -163.29 0.84 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.092 177.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.471 ' O ' ' HB2' ' A' ' 69' ' ' LEU . 4.0 p-10 -73.69 -62.42 1.5 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.349 0.595 . . . . 0.0 111.471 176.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.626 HG23 ' O ' ' A' ' 69' ' ' LEU . 35.1 p -111.49 33.43 4.72 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.447 -172.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.687 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 35.6 m -168.88 130.4 1.22 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.897 -171.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.572 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 40.5 mt -146.64 140.14 20.16 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.636 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 176.251 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 85.6 t -117.09 129.19 74.04 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.752 0 O-C-N 121.654 -0.654 . . . . 0.0 110.61 -175.082 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.652 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.8 OUTLIER -121.97 143.44 34.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 C-N-CA 120.32 -0.552 . . . . 0.0 109.608 -178.912 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.49 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 44.6 mtp180 -129.65 121.13 26.41 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.891 0.377 . . . . 0.0 110.5 -174.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.52 ' CH2' HD13 ' A' ' 57' ' ' LEU . 37.1 p90 -111.54 152.6 27.34 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.566 -174.411 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 11.7 m -96.81 97.46 9.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.965 178.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.548 ' NE ' ' HB3' ' A' ' 62' ' ' ASN . 0.1 OUTLIER -49.72 156.52 1.19 Allowed Pre-proline 0 CA--C 1.538 0.489 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -173.768 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.591 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 3.0 Cg_exo -84.1 165.55 13.06 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 124.303 3.335 . . . . 0.0 112.638 -173.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -77.91 -18.41 56.17 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.198 173.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.57 143.88 96.11 Favored Pre-proline 0 C--O 1.235 0.334 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.105 175.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.45 ' O ' ' HG2' ' A' ' 83' ' ' GLU . 57.2 Cg_endo -75.86 114.68 3.99 Favored 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 121.321 1.347 . . . . 0.0 109.934 170.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.569 HG21 ' HB3' ' A' ' 81' ' ' ALA . 1.3 pt -118.78 152.43 21.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -175.238 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.45 ' C ' ' HB3' ' A' ' 59' ' ' GLU . 7.7 p -92.15 -30.06 16.16 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.956 0.725 . . . . 0.0 112.956 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.589 ' C ' HG13 ' A' ' 82' ' ' VAL . . . -169.85 -162.14 21.58 Favored Glycine 0 CA--C 1.501 -0.818 0 C-N-CA 119.9 -1.143 . . . . 0.0 111.445 -178.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.591 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 7.2 m-85 -140.86 134.42 30.07 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 117.068 0.434 . . . . 0.0 110.888 173.324 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 -101.91 147.82 26.07 Favored 'General case' 0 CA--C 1.505 -0.762 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 166.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.887 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 34.4 mt -138.67 108.96 4.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 C-N-CA 120.238 -0.585 . . . . 0.0 112.367 -177.274 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 76.6 t -107.37 110.18 30.89 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.448 0 CA-C-O 121.27 0.557 . . . . 0.0 110.6 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.693 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 0.6 OUTLIER -112.62 125.05 53.86 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.34 175.969 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.425 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 13.5 t -140.22 136.03 16.64 Favored Pre-proline 0 C--N 1.31 -1.132 0 CA-C-N 113.941 -1.481 . . . . 0.0 110.297 -174.156 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.568 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 21.6 Cg_exo -64.95 151.19 86.66 Favored 'Trans proline' 0 CA--C 1.518 -0.319 0 C-N-CA 123.014 2.476 . . . . 0.0 111.795 176.249 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 18.1 m -70.9 -35.75 72.42 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.145 -178.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 91.3 t -117.3 -42.98 3.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -176.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -171.31 142.11 1.67 Allowed 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.876 -0.33 . . . . 0.0 111.114 -175.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.474 ' CA ' ' HG2' ' A' ' 46' ' ' PRO . . . 151.54 -154.87 25.82 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.445 178.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.512 ' O ' ' HE1' ' A' ' 75' ' ' TYR . 29.5 m -95.13 121.82 37.16 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 111.616 0.228 . . . . 0.0 111.616 -177.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.444 ' HA ' ' O ' ' A' ' 44' ' ' TYR . 6.1 m -105.99 135.25 47.77 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 173.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.693 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 55.1 m -146.36 150.53 35.88 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.233 -175.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.887 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 46.7 tt0 -120.7 113.59 20.44 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.914 176.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.614 HD11 ' CG2' ' A' ' 64' ' ' VAL . 20.3 mt -97.17 157.84 15.74 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.461 177.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.478 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 27.4 t-20 -121.87 113.2 19.3 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.362 177.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.52 HD13 ' CH2' ' A' ' 30' ' ' TRP . 3.3 mt -109.98 155.56 41.44 Favored Pre-proline 0 C--N 1.318 -0.784 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -176.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -62.72 148.22 93.68 Favored 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 121.781 1.654 . . . . 0.0 110.959 176.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.45 ' HB3' ' C ' ' A' ' 38' ' ' THR . 8.8 pt-20 -44.96 -24.97 0.26 Allowed 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 114.986 -1.006 . . . . 0.0 113.468 178.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.5 t -105.85 9.07 32.94 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.04 0.447 . . . . 0.0 111.213 -174.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.434 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -76.09 157.28 33.07 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.548 ' HB3' ' NE ' ' A' ' 32' ' ' ARG . 27.9 p-10 -141.6 13.87 2.14 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.445 -0.502 . . . . 0.0 112.231 -178.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.652 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 16.6 m -162.17 133.88 5.4 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 121.951 -0.468 . . . . 0.0 110.698 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.614 ' CG2' HD11 ' A' ' 55' ' ' LEU . 4.3 p -115.27 135.47 55.14 Favored 'Isoleucine or valine' 0 C--O 1.242 0.708 0 CA-C-O 120.796 0.331 . . . . 0.0 110.184 173.211 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 55.0 m -96.27 101.19 12.8 Favored 'General case' 0 N--CA 1.434 -1.27 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.725 170.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.687 ' O ' ' HA ' ' A' ' 25' ' ' SER . 0.3 OUTLIER -77.82 142.02 38.83 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 177.664 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 10.1 t -138.2 167.97 20.71 Favored 'General case' 0 C--N 1.322 -0.597 0 O-C-N 123.282 0.364 . . . . 0.0 110.779 -173.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 63.96 25.12 13.83 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.574 -179.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.626 ' O ' HG23 ' A' ' 24' ' ' THR . 12.7 mt -69.58 -175.99 0.94 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.012 0.435 . . . . 0.0 110.142 177.297 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.403 ' N ' ' HH ' ' A' ' 75' ' ' TYR . 8.3 tt0 -129.41 127.23 23.08 Favored Pre-proline 0 C--N 1.319 -0.725 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 177.065 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -64.52 134.77 42.78 Favored 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 122.663 2.242 . . . . 0.0 112.599 -178.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 83.77 30.72 28.62 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.989 -0.625 . . . . 0.0 111.576 -178.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.474 ' CG1' ' HB3' ' A' ' 46' ' ' PRO . 95.6 t -133.23 141.98 43.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.7 0.286 . . . . 0.0 110.518 -177.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.575 ' OE1' ' HB2' ' A' ' 94' ' ' GLN . 1.5 tm0? -87.68 122.19 31.04 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.051 -179.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.512 ' HE1' ' O ' ' A' ' 51' ' ' SER . 13.4 m-85 -113.15 113.65 25.67 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.143 -174.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.511 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 13.3 m120 -86.34 106.42 17.38 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.937 177.116 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.518 HG23 HD11 ' A' ' 79' ' ' ILE . 5.3 mp -92.35 119.72 40.36 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.529 0 CA-C-O 121.201 0.524 . . . . 0.0 109.886 177.174 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.817 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 65.6 m -111.68 118.44 35.65 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.478 177.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.518 HD11 HG23 ' A' ' 77' ' ' ILE . 12.0 mm -96.12 140.05 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.407 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 67.8 m-85 -128.41 111.51 13.4 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 178.166 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.569 ' HB3' HG21 ' A' ' 37' ' ' ILE . . . -79.81 110.36 15.09 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 173.149 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.589 HG13 ' C ' ' A' ' 39' ' ' GLY . 10.8 p -99.44 141.53 16.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 C-N-CA 120.196 -0.602 . . . . 0.0 110.728 -173.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.45 ' HG2' ' O ' ' A' ' 36' ' ' PRO . 9.5 tm-20 -118.31 165.9 13.28 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 -176.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -45.17 -46.76 12.26 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -176.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -126.84 0.1 6.66 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.854 0.359 . . . . 0.0 111.426 -174.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.473 ' HG3' ' O ' ' A' ' 8' ' ' THR . 84.2 mm-40 -134.08 174.09 10.87 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 122.071 -0.393 . . . . 0.0 111.167 -173.073 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -136.9 133.67 35.99 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.433 175.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.7 m -75.9 174.59 9.72 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.495 -178.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.555 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 0.1 OUTLIER -60.48 159.43 24.01 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.704 176.525 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -88.66 134.79 2.84 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 122.243 1.962 . . . . 0.0 113.951 -178.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.817 ' O ' ' HA ' ' A' ' 78' ' ' THR . 10.5 t -82.67 126.58 40.04 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.627 0 CA-C-N 115.133 -0.939 . . . . 0.0 108.59 167.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.6 t -124.62 106.33 16.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 C-N-CA 120.115 -0.634 . . . . 0.0 110.276 174.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.484 HG13 ' HB ' ' A' ' 77' ' ' ILE . 8.3 pt -127.34 116.19 43.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.976 179.063 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.575 ' HB2' ' OE1' ' A' ' 74' ' ' GLN . 3.7 pt20 -99.5 131.41 45.52 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.261 0.553 . . . . 0.0 111.094 -177.5 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -140.43 129.11 22.98 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.137 178.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.44 ' HB2' ' HG2' ' A' ' 74' ' ' GLN . 38.7 tt0 -86.9 139.95 30.12 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.081 0.467 . . . . 0.0 110.305 177.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.467 HG21 HD13 ' A' ' 26' ' ' ILE . 18.7 p -70.56 119.44 14.73 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.314 -179.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 19.4 m -71.99 -32.0 66.79 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.247 0.546 . . . . 0.0 110.544 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 110.82 -174.32 16.95 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.099 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 22.2 m -74.88 126.52 88.24 Favored Pre-proline 0 C--N 1.322 -0.621 0 N-CA-C 110.258 -0.275 . . . . 0.0 110.258 178.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -67.95 65.97 0.94 Allowed 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 123.068 2.512 . . . . 0.0 112.469 176.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 43.3 ttp180 -72.57 -49.86 29.46 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.789 177.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 19.4 m 56.34 59.03 3.85 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.415 0.626 . . . . 0.0 110.879 177.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -91.81 -43.4 9.55 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.239 178.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -157.85 131.32 2.82 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 120.889 -0.672 . . . . 0.0 111.968 179.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 5.0 p . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.513 -0.756 . . . . 0.0 110.559 178.03 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.722 0 N-CA-C 111.804 -0.518 . . . . 0.0 111.804 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.1 t -112.53 125.81 54.65 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 13.5 t60 -74.86 -26.16 59.49 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.216 -177.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 90.9 mtp -93.14 177.69 5.98 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.566 178.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 142.64 169.47 12.29 Favored Glycine 0 N--CA 1.445 -0.759 0 N-CA-C 111.421 -0.672 . . . . 0.0 111.421 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 42.5 m -59.51 102.06 0.13 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.004 0.43 . . . . 0.0 110.389 178.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.0 m -83.74 84.58 7.5 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 121.104 0.478 . . . . 0.0 110.336 -179.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 88.7 m -79.48 130.01 35.01 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.219 178.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 65.95 88.44 0.11 Allowed Pre-proline 0 N--CA 1.463 0.186 0 O-C-N 123.796 0.685 . . . . 0.0 110.995 -179.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.54 156.21 66.58 Favored 'Trans proline' 0 C--O 1.238 0.493 0 C-N-CA 122.777 2.318 . . . . 0.0 112.647 -178.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -84.16 160.71 20.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.238 178.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -96.49 158.29 34.0 Favored Pre-proline 0 C--N 1.319 -0.735 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.8 175.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.402 ' HB3' ' O ' ' A' ' 31' ' ' SER . 15.6 Cg_exo -71.2 138.35 33.15 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.042 1.828 . . . . 0.0 110.788 174.14 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.559 ' HD2' ' O ' ' A' ' 31' ' ' SER . 18.1 Cg_endo -60.59 160.09 25.61 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 122.371 2.047 . . . . 0.0 110.518 176.147 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -42.15 107.69 0.55 Allowed Pre-proline 0 N--CA 1.468 0.449 0 O-C-N 124.126 0.891 . . . . 0.0 111.84 -170.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.548 ' HG2' HG11 ' A' ' 91' ' ' VAL . 24.3 Cg_exo -67.5 153.35 76.78 Favored 'Trans proline' 0 CA--C 1.518 -0.291 0 C-N-CA 122.953 2.436 . . . . 0.0 111.756 178.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 61.4 m -111.48 131.11 55.46 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 121.752 0.787 . . . . 0.0 110.87 -178.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 79.5 t -80.17 124.55 38.31 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 CA-C-N 114.119 -1.4 . . . . 0.0 110.06 174.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -83.41 -49.21 9.54 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.189 -176.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -136.84 141.94 42.84 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.794 -177.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.511 HG11 ' NE2' ' A' ' 95' ' ' GLN . 27.3 m -129.46 125.72 62.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.041 179.26 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -125.15 -167.9 1.75 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.057 176.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.512 ' O ' ' HB2' ' A' ' 69' ' ' LEU . 1.6 p-10 -62.54 -64.21 0.99 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.111 0.481 . . . . 0.0 111.824 178.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.645 HG23 ' O ' ' A' ' 69' ' ' LEU . 32.9 p -111.66 35.0 3.83 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.915 -172.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.604 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 52.4 p -169.16 139.38 2.23 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.277 -175.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.591 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 12.0 mt -149.89 140.2 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 176.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.434 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 44.0 t -116.21 128.63 73.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 O-C-N 121.486 -0.759 . . . . 0.0 110.519 -177.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.607 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.7 OUTLIER -124.63 146.05 30.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.072 -176.805 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.471 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 22.3 mtm180 -131.01 121.93 25.92 Favored 'General case' 0 C--N 1.328 -0.359 0 O-C-N 123.305 0.378 . . . . 0.0 110.804 -175.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.507 ' CH2' HD11 ' A' ' 57' ' ' LEU . 39.8 p90 -114.82 143.32 45.28 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.245 -175.083 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.559 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 15.9 t -88.95 98.77 11.93 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 177.211 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.529 ' CD ' ' H ' ' A' ' 32' ' ' ARG . 0.1 OUTLIER -51.9 159.26 1.43 Allowed Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 123.71 0.804 . . . . 0.0 113.06 -174.621 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.65 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 3.7 Cg_exo -82.21 166.11 16.51 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 124.116 3.211 . . . . 0.0 112.048 -176.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -87.43 -5.41 58.85 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.541 177.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -70.89 148.1 94.45 Favored Pre-proline 0 N--CA 1.453 -0.314 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.847 175.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.487 ' O ' ' HG3' ' A' ' 83' ' ' GLU . 10.9 Cg_exo -71.76 115.91 4.49 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 121.82 1.68 . . . . 0.0 110.101 169.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.444 HD12 ' HD2' ' A' ' 33' ' ' PRO . 2.4 pt -124.73 153.92 31.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -175.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 18.1 p -94.39 -32.67 13.46 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -176.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.559 ' C ' HG13 ' A' ' 82' ' ' VAL . . . -168.55 -162.79 21.35 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.314 -0.946 . . . . 0.0 111.796 -177.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.65 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 7.1 m-85 -141.78 135.23 29.48 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 122.573 0.349 . . . . 0.0 111.284 174.248 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.9 mmm180 -100.16 148.4 24.64 Favored 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 167.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.913 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 29.9 mt -139.19 107.74 3.42 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 C-N-CA 120.075 -0.65 . . . . 0.0 112.315 179.319 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 80.3 t -109.24 110.72 33.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.089 0.471 . . . . 0.0 110.859 -178.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.762 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 1.0 OUTLIER -115.22 128.73 56.34 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.215 178.372 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.429 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 29.8 p -143.11 145.16 31.65 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 114.051 -1.431 . . . . 0.0 112.027 -174.095 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.523 ' HG3' ' CZ ' ' A' ' 75' ' ' TYR . 2.1 Cg_endo -81.07 154.51 19.38 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 123.657 2.904 . . . . 0.0 111.172 175.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 23.2 t -84.61 -31.26 24.37 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.551 179.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 19.7 m -111.14 -33.93 2.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.43 ' HG3' HG21 ' A' ' 73' ' ' VAL . 21.3 mm-40 -91.62 -170.1 2.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.464 0.174 . . . . 0.0 110.746 -179.106 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -116.17 -29.37 2.36 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.022 -1.085 . . . . 0.0 115.535 -167.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.467 ' O ' ' HD3' ' A' ' 46' ' ' PRO . 9.6 t -64.8 113.49 3.83 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 118.974 1.387 . . . . 0.0 111.1 -170.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 13.1 m -123.62 146.48 48.14 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.778 176.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.762 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 21.4 m -146.95 148.12 31.43 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 119.678 -0.809 . . . . 0.0 111.531 177.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.913 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 46.7 tt0 -116.16 117.98 31.58 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.97 172.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.637 HD12 ' CG2' ' A' ' 64' ' ' VAL . 17.9 mt -98.38 156.95 16.5 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.634 -0.426 . . . . 0.0 110.07 174.176 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -120.29 113.93 21.13 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 178.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.507 HD11 ' CH2' ' A' ' 30' ' ' TRP . 2.6 mt -111.27 157.74 38.09 Favored Pre-proline 0 C--N 1.318 -0.796 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -175.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -66.78 150.66 83.36 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 121.769 1.646 . . . . 0.0 111.512 175.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -43.17 -27.44 0.22 Allowed 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 114.435 -1.257 . . . . 0.0 113.397 177.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 5.7 t -104.38 4.89 33.92 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.148 0.499 . . . . 0.0 111.227 -172.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -75.14 152.42 38.49 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 -178.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.473 ' HB3' ' NE ' ' A' ' 32' ' ' ARG . 27.7 p-10 -135.6 16.28 3.37 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.816 -0.353 . . . . 0.0 111.831 -178.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.607 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 17.8 p -170.17 136.93 1.47 Allowed 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.27 -0.572 . . . . 0.0 112.078 -178.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.637 ' CG2' HD12 ' A' ' 55' ' ' LEU . 3.9 p -119.8 138.42 50.47 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.337 176.385 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 50.5 m -98.36 101.43 12.88 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-O 121.334 0.588 . . . . 0.0 109.692 170.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.624 ' CD2' HG12 ' A' ' 64' ' ' VAL . 0.2 OUTLIER -79.93 145.29 32.72 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.426 178.801 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.437 ' HA ' ' O ' ' A' ' 24' ' ' THR . 17.6 t -139.0 177.91 7.55 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -177.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 65.37 20.84 11.87 Favored 'General case' 0 N--CA 1.468 0.437 0 O-C-N 123.486 0.491 . . . . 0.0 111.977 -178.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.645 ' O ' HG23 ' A' ' 24' ' ' THR . 13.8 mt -72.19 -175.59 1.56 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.182 0.515 . . . . 0.0 110.339 178.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.426 ' N ' ' HH ' ' A' ' 75' ' ' TYR . 56.0 tp60 -128.72 128.82 23.5 Favored Pre-proline 0 C--N 1.319 -0.734 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 178.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.9 134.63 54.53 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.951 2.434 . . . . 0.0 113.391 -178.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.13 35.81 26.17 Favored Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 115.868 -0.605 . . . . 0.0 112.405 177.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.43 HG21 ' HG3' ' A' ' 49' ' ' GLU . 42.5 t -134.37 150.43 30.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.04 0.448 . . . . 0.0 111.424 -175.327 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 8.0 tp60 -91.1 105.03 17.53 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.332 179.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.523 ' CZ ' ' HG3' ' A' ' 46' ' ' PRO . 9.9 m-85 -97.38 121.14 38.94 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.79 -178.091 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.529 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 55.7 m-20 -91.85 111.87 23.57 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.283 176.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.531 ' HB ' HG13 ' A' ' 93' ' ' ILE . 5.3 mp -94.82 118.4 40.83 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.623 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.971 176.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.889 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 29.5 m -107.91 115.4 30.07 Favored 'General case' 0 N--CA 1.425 -1.684 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.605 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.528 HD11 HG22 ' A' ' 77' ' ' ILE . 12.5 mm -96.1 137.58 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.41 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 75.4 m-85 -126.15 111.75 15.0 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.052 178.516 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -80.02 112.39 17.28 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 171.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.559 HG13 ' C ' ' A' ' 39' ' ' GLY . 10.9 p -103.64 136.4 36.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 C-N-CA 119.924 -0.711 . . . . 0.0 110.956 -175.123 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.659 ' HG2' ' N ' ' A' ' 84' ' ' GLU . 2.4 tt0 -117.73 166.91 11.87 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 177.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.659 ' N ' ' HG2' ' A' ' 83' ' ' GLU . 28.0 mt-10 -44.02 -48.38 8.78 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 178.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 19.9 m-80 -98.62 -33.87 10.79 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -170.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -145.81 169.49 18.42 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-O 120.904 0.383 . . . . 0.0 111.518 -167.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -114.72 145.78 41.68 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.289 175.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 17.8 m -76.15 169.78 17.55 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.738 178.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.2 p -58.73 146.11 75.87 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.079 173.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -78.26 138.91 16.31 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.134 1.889 . . . . 0.0 113.966 -174.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.889 ' O ' ' HA ' ' A' ' 78' ' ' THR . 9.7 t -81.74 126.5 39.88 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.745 0 CA-C-N 114.828 -1.078 . . . . 0.0 108.174 167.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 15.7 t -123.78 106.06 16.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 C-N-CA 119.766 -0.774 . . . . 0.0 109.912 170.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.531 HG13 ' HB ' ' A' ' 77' ' ' ILE . 6.9 pt -120.0 115.58 47.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.892 178.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -99.44 125.01 45.08 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.273 0.558 . . . . 0.0 111.372 -176.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.511 ' NE2' HG11 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -128.73 131.63 47.91 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.379 178.797 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.409 ' HA ' ' O ' ' A' ' 73' ' ' VAL . 44.1 mt-10 -85.71 127.31 34.48 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.049 0.452 . . . . 0.0 110.218 176.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.495 HG21 HD13 ' A' ' 26' ' ' ILE . 46.4 p -69.92 120.65 15.96 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.562 -179.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.9 m -69.71 -31.18 69.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.292 0.568 . . . . 0.0 110.588 -178.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 107.32 -162.5 13.36 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.218 176.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 28.8 m -86.17 122.67 72.37 Favored Pre-proline 0 C--N 1.321 -0.656 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 179.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -50.7 105.42 0.1 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.949 2.433 . . . . 0.0 111.964 178.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 29.6 ptt180 -80.41 149.1 30.28 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.323 -175.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 17.5 m -111.06 17.58 20.26 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.388 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -135.91 151.77 50.33 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.96 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 89.02 -90.94 1.68 Allowed Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.278 -177.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.5 m . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.145 -0.931 . . . . 0.0 109.384 175.309 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.793 0 N-CA-C 111.734 -0.547 . . . . 0.0 111.734 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.7 p -63.79 144.15 57.28 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.802 0.301 . . . . 0.0 110.37 177.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 20.1 t60 -85.82 58.36 5.0 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.229 0.538 . . . . 0.0 110.281 -176.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 15.7 tpt -98.96 97.84 8.96 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.649 177.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 155.39 -161.7 30.64 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.715 -0.755 . . . . 0.0 111.824 -178.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.7 m 62.03 66.15 0.84 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.536 0.684 . . . . 0.0 110.139 -178.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 35.2 m -73.84 105.29 5.05 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.253 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 22.5 m -66.58 122.68 18.14 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.162 -177.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -146.09 86.73 6.95 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.165 178.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.525 ' HG3' ' OE1' ' A' ' 83' ' ' GLU . 88.6 Cg_endo -79.96 -176.76 3.39 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.945 2.43 . . . . 0.0 112.689 -177.161 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -144.14 154.05 42.76 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.549 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.432 ' HB3' ' O ' ' A' ' 89' ' ' THR . . . -90.73 154.85 45.84 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.292 -178.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.403 ' HB2' ' HB2' ' A' ' 30' ' ' TRP . 26.8 Cg_exo -64.54 128.45 21.25 Favored 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.365 2.044 . . . . 0.0 111.646 178.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -53.03 143.52 49.86 Favored 'Trans proline' 0 CA--C 1.512 -0.602 0 C-N-CA 122.517 2.145 . . . . 0.0 111.312 176.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -37.05 103.17 0.25 Allowed Pre-proline 0 CA--C 1.515 -0.39 0 O-C-N 125.145 1.528 . . . . 0.0 112.74 -163.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.712 ' CG ' HG11 ' A' ' 91' ' ' VAL . 3.1 Cg_endo -47.62 147.98 6.17 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 123.594 2.863 . . . . 0.0 113.526 169.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 18.4 m -107.6 131.6 54.19 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.021 -0.991 . . . . 0.0 109.789 177.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.454 HG13 ' O ' ' A' ' 27' ' ' VAL . 81.2 t -76.52 121.03 27.82 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.41 176.128 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -86.08 -39.06 17.16 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.526 -175.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -135.26 127.96 30.95 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.842 0.354 . . . . 0.0 110.683 -178.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.498 ' HA ' HG12 ' A' ' 26' ' ' ILE . 98.7 t -120.78 115.58 47.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.4 177.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -127.2 -164.17 1.33 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.338 178.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -68.55 -63.01 1.14 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.088 0.471 . . . . 0.0 112.149 -178.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.629 HG22 ' O ' ' A' ' 69' ' ' LEU . 38.7 p -117.81 35.08 4.85 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.812 -171.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.513 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 54.4 p -170.91 132.38 0.87 Allowed 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.496 -173.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.584 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 32.7 mt -145.91 140.82 21.67 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.781 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 178.214 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.454 ' O ' HG13 ' A' ' 18' ' ' VAL . 39.7 t -117.14 134.11 61.76 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.631 0 C-N-CA 120.064 -0.655 . . . . 0.0 110.084 -176.003 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.646 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.6 OUTLIER -127.06 146.93 32.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 C-N-CA 120.221 -0.591 . . . . 0.0 110.462 -178.643 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.56 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 18.4 mtp180 -128.54 118.94 23.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.549 -177.125 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.549 ' CH2' HD11 ' A' ' 57' ' ' LEU . 36.4 p90 -110.48 146.11 36.53 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.961 -176.08 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 20.8 m -92.21 99.92 12.62 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.078 177.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.549 ' NE ' ' HB3' ' A' ' 62' ' ' ASN . 0.1 OUTLIER -46.58 156.98 0.47 Allowed Pre-proline 0 CA--C 1.536 0.419 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -175.222 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.608 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 3.4 Cg_exo -83.34 169.0 12.84 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 124.179 3.253 . . . . 0.0 112.5 -172.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -87.2 -3.43 59.05 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.231 -0.895 . . . . 0.0 108.938 173.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.71 146.87 80.67 Favored Pre-proline 0 N--CA 1.451 -0.416 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.968 175.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -77.84 114.7 3.68 Favored 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 121.371 1.38 . . . . 0.0 110.043 170.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.556 HG23 ' HB3' ' A' ' 81' ' ' ALA . 0.7 OUTLIER -120.25 155.02 23.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.461 -174.494 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.1 p -97.51 -33.79 11.23 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -178.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.42 ' C ' ' HD1' ' A' ' 40' ' ' TYR . . . -164.74 -169.65 28.62 Favored Glycine 0 C--O 1.222 -0.642 0 C-N-CA 120.075 -1.059 . . . . 0.0 112.16 179.393 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.608 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 4.6 m-85 -136.56 131.38 33.76 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-N 117.302 0.551 . . . . 0.0 111.674 176.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 37.4 mtm180 -103.98 148.41 26.23 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.029 168.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.853 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 30.4 mt -139.0 109.32 4.37 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 C-N-CA 120.421 -0.511 . . . . 0.0 112.335 -176.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 95.6 t -110.43 110.74 33.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.42 0.629 . . . . 0.0 110.667 179.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.751 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 0.5 OUTLIER -108.17 125.09 51.22 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.191 175.358 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.411 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 6.3 p -144.03 138.4 14.98 Favored Pre-proline 0 C--N 1.315 -0.903 0 CA-C-N 113.864 -1.517 . . . . 0.0 111.301 -173.543 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.752 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 22.5 Cg_exo -65.52 148.1 87.29 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 123.349 2.699 . . . . 0.0 111.767 175.174 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 10.0 m -69.56 -30.89 68.79 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.726 -177.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.488 ' O ' ' HB2' ' A' ' 49' ' ' GLU . 3.4 p -109.55 -41.82 4.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 120.745 -0.382 . . . . 0.0 111.982 -177.072 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.488 ' HB2' ' O ' ' A' ' 48' ' ' VAL . 34.6 tt0 169.56 148.74 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.328 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.547 ' CA ' ' HG2' ' A' ' 46' ' ' PRO . . . 159.21 -141.83 7.85 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 111.515 -0.634 . . . . 0.0 111.515 177.009 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.58 ' O ' ' HE1' ' A' ' 75' ' ' TYR . 16.5 m -93.95 120.56 34.37 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.873 0.368 . . . . 0.0 110.965 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.441 ' HA ' ' O ' ' A' ' 44' ' ' TYR . 15.0 m -115.19 137.57 51.88 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 176.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.751 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 30.6 m -147.15 154.99 41.76 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.358 -176.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.853 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 33.0 tt0 -124.31 115.4 20.95 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 123.297 0.639 . . . . 0.0 109.902 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.629 HD11 ' CG2' ' A' ' 64' ' ' VAL . 18.4 mt -100.52 160.5 14.29 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 175.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.408 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 17.5 m120 -125.98 121.59 33.51 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 178.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.549 HD11 ' CH2' ' A' ' 30' ' ' TRP . 4.6 mt -118.33 158.9 45.48 Favored Pre-proline 0 C--N 1.318 -0.79 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -176.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -64.48 150.97 87.31 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 121.58 1.52 . . . . 0.0 111.21 175.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -46.0 -26.75 0.77 Allowed 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 114.924 -1.035 . . . . 0.0 112.77 177.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 7.8 t -103.76 8.21 37.22 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.318 -174.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.469 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -75.0 160.43 30.55 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -179.173 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.56 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 24.7 p-10 -142.58 10.92 1.86 Allowed 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.473 -0.491 . . . . 0.0 112.323 -179.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.646 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 14.6 m -161.43 133.82 5.94 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 118.476 0.58 . . . . 0.0 111.473 -178.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.629 ' CG2' HD11 ' A' ' 55' ' ' LEU . 4.1 p -119.56 136.87 55.31 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 173.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 40.4 m -97.44 100.97 12.4 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-O 121.426 0.631 . . . . 0.0 109.711 169.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.596 ' CD2' HG13 ' A' ' 64' ' ' VAL . 0.2 OUTLIER -78.52 145.14 35.06 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.008 178.045 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.1 t -142.31 173.56 11.42 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -175.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 67.02 23.04 9.86 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 123.907 0.755 . . . . 0.0 111.078 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.629 ' O ' HG22 ' A' ' 24' ' ' THR . 10.3 mt -72.37 -175.77 1.67 Allowed 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 177.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.437 ' N ' ' HH ' ' A' ' 75' ' ' TYR . 21.6 mm-40 -125.51 134.12 25.52 Favored Pre-proline 0 C--N 1.322 -0.613 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 176.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -65.8 126.01 15.25 Favored 'Trans proline' 0 CA--C 1.529 0.267 0 C-N-CA 122.502 2.135 . . . . 0.0 112.885 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 86.03 31.77 19.4 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.503 177.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 92.1 t -129.79 145.28 35.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.019 0.438 . . . . 0.0 110.698 -177.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.752 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -80.05 123.75 28.12 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.692 -179.274 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.58 ' HE1' ' O ' ' A' ' 51' ' ' SER . 15.3 m-85 -120.45 114.03 21.2 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.164 0.507 . . . . 0.0 112.119 -176.232 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.437 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 11.5 m120 -90.33 110.65 21.71 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.371 176.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.533 HG21 HD13 ' A' ' 79' ' ' ILE . 5.1 mp -91.36 116.21 32.07 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.686 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 176.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.849 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 14.9 m -108.86 113.51 26.49 Favored 'General case' 0 N--CA 1.424 -1.751 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.359 -177.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.533 HD13 HG21 ' A' ' 77' ' ' ILE . 10.8 mm -95.13 134.23 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -122.33 111.55 17.04 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.75 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.556 ' HB3' HG23 ' A' ' 37' ' ' ILE . . . -81.25 131.17 35.28 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 170.07 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.4 HG12 ' C ' ' A' ' 39' ' ' GLY . 7.7 p -118.47 135.37 59.1 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.317 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.545 ' HG3' HG22 ' A' ' 37' ' ' ILE . 4.0 mp0 -115.21 169.95 8.74 Favored 'General case' 0 N--CA 1.448 -0.561 0 O-C-N 123.906 0.754 . . . . 0.0 109.482 -178.194 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -44.26 -47.88 9.43 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -174.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 30.3 p-10 -129.88 16.39 5.76 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.934 -0.306 . . . . 0.0 111.635 -177.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 77.2 mm-40 -144.65 173.99 11.36 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.763 0.316 . . . . 0.0 111.076 -176.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -140.54 119.9 13.06 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 174.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 66.7 m -65.57 167.42 8.97 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.832 0.349 . . . . 0.0 111.574 -177.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.432 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 1.2 p -57.4 160.61 6.84 Favored Pre-proline 0 CA--C 1.536 0.422 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.696 178.532 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -86.99 133.58 3.48 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 122.259 1.973 . . . . 0.0 113.766 -177.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.849 ' O ' ' HA ' ' A' ' 78' ' ' THR . 44.2 t -82.62 122.73 37.61 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.723 0 CA-C-N 114.936 -1.029 . . . . 0.0 108.622 170.028 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 10.8 t -120.38 106.6 19.07 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 C-N-CA 119.586 -0.846 . . . . 0.0 110.277 174.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.521 HG13 ' HB ' ' A' ' 77' ' ' ILE . 7.7 pt -122.29 113.7 39.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.733 176.394 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -100.4 131.25 46.43 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.395 0.616 . . . . 0.0 111.389 -174.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.71 132.35 34.75 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.572 177.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.48 ' HG2' ' HG2' ' A' ' 74' ' ' GLN . 45.3 mt-10 -89.13 131.8 35.1 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 175.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.485 HG22 HD11 ' A' ' 26' ' ' ILE . 31.4 p -68.5 121.17 15.8 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.47 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.3 m -69.33 -31.6 70.16 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.191 0.52 . . . . 0.0 110.305 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 95.59 -132.38 11.06 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.04 177.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 17.2 m -74.9 120.82 83.47 Favored Pre-proline 0 C--N 1.321 -0.632 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 177.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -50.4 136.97 40.0 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 123.307 2.671 . . . . 0.0 112.802 -177.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 85.0 mtt180 60.9 57.21 2.66 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.178 -177.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.5 m -64.4 -47.09 80.51 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.1 -0.955 . . . . 0.0 111.476 -175.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -66.94 126.04 27.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.943 0.401 . . . . 0.0 110.791 -176.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 143.46 134.13 2.83 Favored Glycine 0 N--CA 1.443 -0.855 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.541 -178.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 19.4 m . . . . . 0 C--O 1.247 0.936 0 CA-C-O 118.359 -0.829 . . . . 0.0 110.593 -179.302 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.685 0 N-CA-C 111.836 -0.505 . . . . 0.0 111.836 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.0 p -92.63 61.89 3.75 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.019 0.438 . . . . 0.0 111.595 -176.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 14.4 p80 -74.76 -24.17 58.65 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.862 0.363 . . . . 0.0 110.3 176.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 43.9 tpp -170.0 72.49 0.07 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.391 178.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 159.59 -152.32 23.23 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.097 -179.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 21.5 m -125.11 128.28 48.19 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.895 0.378 . . . . 0.0 111.362 -176.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.8 m -97.74 73.11 2.31 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 173.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.481 ' O ' ' HD3' ' A' ' 10' ' ' PRO . 5.3 m -63.26 151.19 41.24 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.609 -174.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -97.09 92.22 1.14 Allowed Pre-proline 0 C--N 1.323 -0.553 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 167.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.481 ' HD3' ' O ' ' A' ' 8' ' ' THR . 73.4 Cg_endo -78.69 137.95 14.73 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.33 2.02 . . . . 0.0 112.812 -171.427 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -86.12 162.11 18.55 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.91 175.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -96.06 155.57 38.08 Favored Pre-proline 0 C--N 1.314 -0.965 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 176.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.473 ' CB ' ' HB2' ' A' ' 30' ' ' TRP . 31.5 Cg_exo -62.47 128.14 22.8 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.017 1.811 . . . . 0.0 111.774 174.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -52.73 138.41 59.48 Favored 'Trans proline' 0 CA--C 1.509 -0.765 0 C-N-CA 122.288 1.992 . . . . 0.0 110.529 172.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.496 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 17.9 m-20 -36.52 102.78 0.24 Allowed Pre-proline 0 N--CA 1.465 0.296 0 O-C-N 125.373 1.671 . . . . 0.0 112.443 -161.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.722 ' CG ' HG11 ' A' ' 91' ' ' VAL . 2.8 Cg_endo -46.61 146.14 5.66 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 123.896 3.064 . . . . 0.0 113.855 172.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 11.2 m -104.0 129.97 51.62 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.111 -0.949 . . . . 0.0 110.414 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 89.3 t -79.46 121.74 33.29 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 114.458 -1.247 . . . . 0.0 109.997 174.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -86.18 -43.17 13.22 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.333 -175.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -135.86 139.35 43.33 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.907 0.384 . . . . 0.0 111.046 -179.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.443 HG21 HG12 ' A' ' 18' ' ' VAL . 40.3 t -129.02 111.49 23.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.327 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.433 ' CG ' ' H ' ' A' ' 23' ' ' ASP . 8.6 t70 -116.94 -157.46 0.66 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 -178.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.434 ' N ' ' HA2' ' A' ' 99' ' ' GLY . 7.0 m-20 -75.53 -64.02 1.16 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.231 0.539 . . . . 0.0 110.234 -179.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.667 HG22 ' O ' ' A' ' 69' ' ' LEU . 42.2 p -112.05 37.62 2.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.072 -175.02 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.62 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 69.6 m -168.43 131.97 1.52 Allowed 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 122.611 0.364 . . . . 0.0 110.834 -172.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.502 HD11 HG22 ' A' ' 97' ' ' THR . 39.8 mt -147.53 138.18 17.42 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.622 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 176.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 39.7 t -117.35 132.54 66.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 118.695 0.68 . . . . 0.0 110.629 -174.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.611 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.7 OUTLIER -127.64 146.07 33.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.544 -177.823 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.499 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 92.8 mtt180 -128.04 120.63 27.89 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 123.625 0.578 . . . . 0.0 110.519 -177.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.529 ' CH2' HD13 ' A' ' 57' ' ' LEU . 34.7 p90 -113.69 154.11 27.83 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.231 -175.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.435 ' O ' ' HA ' ' A' ' 13' ' ' PRO . 24.8 t -101.32 102.16 12.95 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 121.162 0.506 . . . . 0.0 110.5 178.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.518 ' CD ' ' H ' ' A' ' 32' ' ' ARG . 0.1 OUTLIER -53.89 160.46 2.18 Favored Pre-proline 0 CA--C 1.542 0.669 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -174.486 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.656 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 2.3 Cg_endo -84.87 169.44 10.41 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 124.581 3.521 . . . . 0.0 113.024 -175.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 -79.58 -22.25 44.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.609 173.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.427 ' HB1' ' OE2' ' A' ' 83' ' ' GLU . . . -58.77 136.7 86.86 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.171 179.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -66.52 113.45 2.71 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 121.317 1.345 . . . . 0.0 109.723 172.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.54 HG23 ' HG2' ' A' ' 83' ' ' GLU . 6.7 pt -123.55 157.3 29.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.855 -173.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.46 ' C ' ' HB3' ' A' ' 59' ' ' GLU . 18.3 p -101.19 -27.65 13.1 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -176.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.475 ' C ' HG11 ' A' ' 82' ' ' VAL . . . -171.04 -163.27 24.79 Favored Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 119.68 -1.247 . . . . 0.0 112.617 179.421 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.656 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 6.6 m-85 -141.05 135.64 31.23 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 122.858 0.463 . . . . 0.0 110.851 176.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 27.5 mtp180 -104.69 150.2 24.93 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 167.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.863 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 26.7 mt -139.0 107.94 3.65 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 C-N-CA 120.279 -0.568 . . . . 0.0 112.165 -178.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 69.2 t -105.93 110.78 32.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.323 0.582 . . . . 0.0 110.52 179.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.619 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 0.7 OUTLIER -112.35 125.73 54.51 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.341 176.008 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.403 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 16.1 t -142.75 138.1 15.77 Favored Pre-proline 0 C--N 1.317 -0.832 0 CA-C-N 113.968 -1.469 . . . . 0.0 110.785 -173.433 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.662 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 27.1 Cg_exo -62.91 151.94 81.74 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 123.473 2.782 . . . . 0.0 112.252 175.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 46.6 t -63.79 -31.93 73.26 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.014 -0.993 . . . . 0.0 111.985 -175.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 88.5 t -117.78 -42.77 2.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 C-N-CA 120.554 -0.458 . . . . 0.0 111.94 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 179.12 156.82 0.52 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.718 0.294 . . . . 0.0 110.719 -179.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.435 ' CA ' ' HG2' ' A' ' 46' ' ' PRO . . . 146.88 -144.62 12.85 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.061 -0.59 . . . . 0.0 111.756 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.538 ' O ' ' HE1' ' A' ' 75' ' ' TYR . 64.3 m -89.4 120.06 30.41 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.91 0.385 . . . . 0.0 111.101 -179.238 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.479 ' HA ' ' O ' ' A' ' 44' ' ' TYR . 6.2 p -118.06 140.23 50.06 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 174.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.619 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 40.4 m -147.86 151.18 35.49 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 120.581 -0.447 . . . . 0.0 111.534 -177.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.863 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 39.6 tt0 -116.05 115.09 25.48 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 172.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.628 HD13 ' CG2' ' A' ' 64' ' ' VAL . 17.0 mt -96.58 153.49 17.82 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 175.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -117.37 118.95 33.63 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.529 HD13 ' CH2' ' A' ' 30' ' ' TRP . 3.5 mt -116.25 156.22 47.38 Favored Pre-proline 0 N--CA 1.444 -0.73 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 -176.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -64.31 151.44 85.42 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 122.009 1.806 . . . . 0.0 111.403 176.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.46 ' HB3' ' C ' ' A' ' 38' ' ' THR . 8.9 pt-20 -47.35 -25.06 0.9 Allowed 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 114.548 -1.205 . . . . 0.0 113.431 179.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.9 t -107.54 12.84 27.36 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.185 0.517 . . . . 0.0 111.013 -176.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.481 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -76.86 156.29 32.29 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 178.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.499 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 27.5 p-10 -141.71 14.61 2.13 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -177.507 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.611 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 13.8 p -168.78 135.12 1.8 Allowed 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.207 -0.597 . . . . 0.0 112.389 -177.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.628 ' CG2' HD13 ' A' ' 55' ' ' LEU . 4.8 p -120.03 134.2 64.31 Favored 'Isoleucine or valine' 0 C--O 1.24 0.591 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.309 176.002 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 25.8 m -96.74 101.2 12.76 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-O 121.526 0.679 . . . . 0.0 109.615 169.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.62 ' O ' ' HA ' ' A' ' 25' ' ' SER . 0.3 OUTLIER -78.71 144.39 35.34 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.105 179.239 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.402 ' HA ' ' O ' ' A' ' 24' ' ' THR . 12.4 p -141.68 168.58 19.41 Favored 'General case' 0 C--N 1.322 -0.601 0 O-C-N 123.338 0.399 . . . . 0.0 110.519 -173.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 64.04 27.82 14.25 Favored 'General case' 0 C--N 1.331 -0.238 0 O-C-N 123.804 0.69 . . . . 0.0 111.18 -178.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.667 ' O ' HG22 ' A' ' 24' ' ' THR . 15.3 mt -70.11 -175.5 0.97 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.181 0.515 . . . . 0.0 109.712 175.166 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.482 ' N ' ' HH ' ' A' ' 75' ' ' TYR . 56.2 tp60 -125.0 122.67 25.48 Favored Pre-proline 0 C--N 1.315 -0.896 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 176.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -63.12 129.53 26.01 Favored 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 122.891 2.394 . . . . 0.0 112.502 -177.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 86.09 33.37 15.01 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 121.098 -0.572 . . . . 0.0 111.949 -178.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.417 ' CG1' ' HB3' ' A' ' 46' ' ' PRO . 98.9 t -135.99 144.42 33.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.113 0.482 . . . . 0.0 110.93 -176.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.662 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -80.51 115.55 20.09 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.868 179.504 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.538 ' HE1' ' O ' ' A' ' 51' ' ' SER . 13.0 m-85 -111.59 114.46 27.54 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.275 0.559 . . . . 0.0 111.961 -177.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.554 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 37.0 m-80 -87.2 113.47 22.96 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.946 175.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.53 ' HB ' HG13 ' A' ' 93' ' ' ILE . 5.1 mp -93.37 117.41 36.79 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.574 0 CA-C-O 121.226 0.536 . . . . 0.0 109.578 174.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.858 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 62.1 m -110.84 114.86 28.53 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.476 -179.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.521 HD12 HG21 ' A' ' 77' ' ' ILE . 11.5 mm -95.18 143.23 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 -179.319 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -129.66 111.7 12.94 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 178.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -82.39 121.93 27.35 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 172.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.475 HG11 ' C ' ' A' ' 39' ' ' GLY . 8.5 p -118.1 132.56 67.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 C-N-CA 119.758 -0.777 . . . . 0.0 112.179 -174.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.54 ' HG2' HG23 ' A' ' 37' ' ' ILE . 18.1 mt-10 -99.58 172.46 7.28 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 172.158 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -38.46 -42.8 0.78 Allowed 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -128.34 -20.15 3.74 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -178.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -98.07 167.76 10.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.145 0.497 . . . . 0.0 111.635 -173.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -145.16 121.49 10.92 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.364 175.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 10.6 m -67.38 169.77 8.44 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.325 -178.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 12.1 p -58.05 150.04 53.02 Favored Pre-proline 0 N--CA 1.451 -0.401 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.16 172.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -76.17 137.67 19.45 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 122.017 1.811 . . . . 0.0 113.06 -178.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.858 ' O ' ' HA ' ' A' ' 78' ' ' THR . 53.0 t -82.33 122.77 37.5 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.707 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 169.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.4 t -117.84 106.39 19.77 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 C-N-CA 119.374 -0.93 . . . . 0.0 110.676 174.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.53 HG13 ' HB ' ' A' ' 77' ' ' ILE . 7.5 pt -120.37 111.73 33.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.457 174.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.432 ' HB2' ' NE2' ' A' ' 74' ' ' GLN . 19.8 pt20 -99.88 121.6 41.55 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.479 0.657 . . . . 0.0 111.403 -174.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.35 130.12 47.27 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.452 179.123 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.452 ' CG ' ' HG2' ' A' ' 74' ' ' GLN . 37.2 mt-10 -85.97 134.17 33.88 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 176.206 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.502 HG22 HD11 ' A' ' 26' ' ' ILE . 21.6 p -69.13 114.26 7.24 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.355 0.598 . . . . 0.0 111.441 -177.102 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 6.9 m -69.65 -31.66 69.87 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.838 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.434 ' HA2' ' N ' ' A' ' 23' ' ' ASP . . . 60.46 -131.45 49.5 Favored Glycine 0 N--CA 1.441 -1.026 0 CA-C-N 114.622 -1.172 . . . . 0.0 113.164 177.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.402 ' HA ' ' HD3' ' A' ' 101' ' ' PRO . 22.8 m -90.51 123.45 65.31 Favored Pre-proline 0 C--N 1.318 -0.791 0 CA-C-N 115.689 -0.256 . . . . 0.0 110.661 -177.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 100' ' ' THR . 37.3 Cg_exo -60.74 95.15 0.11 Allowed 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.852 2.368 . . . . 0.0 112.485 179.053 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 81.8 mtm180 -89.27 -26.49 21.14 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.657 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 16.8 t -84.46 106.04 15.74 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 177.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -73.82 -28.03 61.41 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.085 -175.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 97.58 -127.07 9.09 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.879 -0.677 . . . . 0.0 111.619 -178.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 18.0 m . . . . . 0 C--O 1.247 0.962 0 CA-C-O 118.75 -0.643 . . . . 0.0 110.123 176.81 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.642 0 N-CA-C 112.051 -0.42 . . . . 0.0 112.051 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.6 p -106.08 -23.81 12.53 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.752 0.311 . . . . 0.0 111.225 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 56.6 m80 -78.77 116.97 19.46 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.569 178.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 24.4 mmt -90.13 -34.63 15.8 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.125 179.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -111.95 141.56 16.73 Favored Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 175.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.3 m -145.17 62.37 1.29 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.479 0.656 . . . . 0.0 110.427 -178.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 46.5 m -79.44 125.16 29.19 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.563 175.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 39.1 m -65.79 119.54 11.41 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.043 0.449 . . . . 0.0 110.535 -179.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -118.61 93.4 45.82 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.355 -177.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.415 ' HG3' ' OE1' ' A' ' 83' ' ' GLU . 66.1 Cg_endo -72.52 169.84 20.83 Favored 'Trans proline' 0 C--O 1.235 0.374 0 C-N-CA 123.015 2.477 . . . . 0.0 112.332 -179.172 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -121.22 158.28 28.42 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.96 -178.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -92.9 156.24 40.77 Favored Pre-proline 0 C--N 1.32 -0.683 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 176.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -64.4 128.54 21.62 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.186 1.924 . . . . 0.0 111.953 178.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_exo -51.53 147.2 23.65 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.57 2.18 . . . . 0.0 111.094 174.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -34.4 107.64 0.31 Allowed Pre-proline 0 N--CA 1.47 0.536 0 O-C-N 124.613 1.196 . . . . 0.0 113.016 -168.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.552 ' HG2' HG12 ' A' ' 91' ' ' VAL . 22.2 Cg_exo -68.72 153.34 73.36 Favored 'Trans proline' 0 CA--C 1.52 -0.207 0 C-N-CA 123.478 2.786 . . . . 0.0 111.829 177.218 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 26.3 m -112.63 133.41 54.68 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.566 0.698 . . . . 0.0 110.975 -177.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.452 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 79.6 t -76.21 121.39 28.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 114.437 -1.256 . . . . 0.0 110.231 175.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -76.55 -50.79 13.02 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.07 -175.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -141.12 142.23 34.12 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.799 -178.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.432 ' HA ' HG12 ' A' ' 26' ' ' ILE . 57.3 t -121.63 122.74 67.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.924 -177.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -125.58 -167.14 1.65 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.396 177.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.598 ' O ' ' HB2' ' A' ' 69' ' ' LEU . 2.0 p-10 -71.17 -65.17 0.78 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.089 0.471 . . . . 0.0 111.723 177.012 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.593 HG23 ' O ' ' A' ' 69' ' ' LEU . 42.1 p -111.23 34.63 3.96 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.561 -173.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.639 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 73.4 m -169.03 130.64 1.19 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.079 -173.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.577 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 45.0 mt -149.2 140.12 16.93 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.837 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 176.204 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.452 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 43.3 t -116.15 134.37 59.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 C-N-CA 119.834 -0.746 . . . . 0.0 110.166 -174.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.628 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.6 OUTLIER -127.33 146.23 33.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 C-N-CA 120.252 -0.579 . . . . 0.0 109.878 179.851 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.478 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 62.8 mtp180 -130.81 121.24 24.98 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 123.345 0.403 . . . . 0.0 110.472 -175.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.542 ' CH2' HD13 ' A' ' 57' ' ' LEU . 38.8 p90 -114.1 154.21 28.15 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.369 -173.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 19.7 m -100.01 100.81 11.74 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.469 178.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.557 ' NE ' ' HB3' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -51.19 157.93 1.42 Allowed Pre-proline 0 CA--C 1.537 0.463 0 C-N-CA 123.482 0.713 . . . . 0.0 112.854 -174.933 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.626 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 3.5 Cg_exo -83.25 163.7 15.08 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 124.244 3.296 . . . . 0.0 112.63 -175.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -73.76 -19.83 60.67 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.322 172.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.98 145.48 96.52 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 114.754 -1.112 . . . . 0.0 111.736 178.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -74.31 114.84 4.13 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 121.568 1.512 . . . . 0.0 110.085 168.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.544 HG21 ' HB2' ' A' ' 81' ' ' ALA . 0.7 OUTLIER -120.23 153.98 23.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -177.468 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.403 ' N ' ' O ' ' A' ' 82' ' ' VAL . 17.1 p -95.98 -25.31 15.99 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -177.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.551 ' C ' HG11 ' A' ' 82' ' ' VAL . . . -171.55 -164.87 27.92 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 119.944 -1.122 . . . . 0.0 112.235 179.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.626 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 5.8 m-85 -139.75 132.98 29.82 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 122.55 0.34 . . . . 0.0 111.18 173.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 10.8 mmm180 -99.82 151.15 21.61 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 166.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.882 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 37.6 mt -139.48 107.48 3.1 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 C-N-CA 120.134 -0.626 . . . . 0.0 112.162 178.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 71.5 t -108.56 110.33 31.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.392 0.615 . . . . 0.0 110.555 -179.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.631 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 0.6 OUTLIER -110.74 125.25 53.32 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.465 -0.788 . . . . 0.0 109.415 175.359 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.409 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 17.1 p -138.5 137.0 19.51 Favored Pre-proline 0 C--N 1.318 -0.772 0 CA-C-N 113.622 -1.626 . . . . 0.0 111.355 -173.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.633 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 22.0 Cg_exo -65.76 150.38 86.12 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 123.283 2.655 . . . . 0.0 112.224 175.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 23.2 t -70.75 -33.3 70.65 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.635 -175.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 18.1 m -118.32 -40.24 2.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 177.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -176.33 152.26 1.08 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.749 0.309 . . . . 0.0 111.422 -179.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.501 ' CA ' ' HG2' ' A' ' 46' ' ' PRO . . . 149.72 -159.27 28.01 Favored Glycine 0 N--CA 1.449 -0.497 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 -178.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.589 ' O ' ' HE1' ' A' ' 75' ' ' TYR . 31.8 t -94.41 120.63 34.94 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 117.297 0.549 . . . . 0.0 110.936 -178.312 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 14.8 m -104.13 143.83 32.4 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 176.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.631 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 50.2 m -147.74 148.86 31.43 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.489 -0.484 . . . . 0.0 111.691 -178.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.882 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 45.5 tt0 -115.96 117.13 29.3 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.781 172.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.656 HD12 ' CG2' ' A' ' 64' ' ' VAL . 18.4 mt -97.92 163.43 12.79 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 174.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -128.96 110.51 12.14 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -178.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.542 HD13 ' CH2' ' A' ' 30' ' ' TRP . 3.3 mt -109.35 157.41 37.33 Favored Pre-proline 0 C--N 1.317 -0.844 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -175.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -64.06 149.09 91.18 Favored 'Trans proline' 0 N--CA 1.447 -1.212 0 C-N-CA 121.636 1.557 . . . . 0.0 110.99 175.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -44.02 -26.88 0.32 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.385 -1.279 . . . . 0.0 113.156 178.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 10.8 t -108.05 9.26 28.46 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.465 -173.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.402 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -75.07 161.18 29.65 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 178.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.557 ' HB3' ' NE ' ' A' ' 32' ' ' ARG . 28.3 p-10 -144.12 17.83 1.75 Allowed 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.465 0.542 . . . . 0.0 112.465 -178.207 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.628 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 17.2 p -169.62 133.76 1.33 Allowed 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.125 -0.63 . . . . 0.0 111.889 178.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.656 ' CG2' HD12 ' A' ' 55' ' ' LEU . 3.6 p -116.6 138.46 47.12 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.182 176.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 30.0 m -97.94 101.05 12.44 Favored 'General case' 0 N--CA 1.433 -1.299 0 CA-C-O 121.366 0.603 . . . . 0.0 109.457 169.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.639 ' O ' ' HA ' ' A' ' 25' ' ' SER . 0.3 OUTLIER -77.14 144.19 38.6 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.005 178.327 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 62.1 p -139.62 174.13 10.82 Favored 'General case' 0 C--N 1.319 -0.722 0 O-C-N 123.349 0.406 . . . . 0.0 110.147 -175.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 37.6 t70 61.62 28.52 17.68 Favored 'General case' 0 C--N 1.33 -0.258 0 O-C-N 123.777 0.673 . . . . 0.0 110.715 179.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.598 ' HB2' ' O ' ' A' ' 23' ' ' ASP . 13.9 mt -73.89 -176.2 2.39 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 176.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.584 ' OE1' ' HD2' ' A' ' 71' ' ' PRO . 5.8 tp-100 -132.24 121.31 17.54 Favored Pre-proline 0 C--N 1.318 -0.781 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.584 ' HD2' ' OE1' ' A' ' 70' ' ' GLN . 18.5 Cg_endo -60.62 137.06 71.01 Favored 'Trans proline' 0 C--O 1.235 0.346 0 C-N-CA 122.908 2.405 . . . . 0.0 112.896 -178.005 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.23 26.45 52.18 Favored Glycine 0 N--CA 1.449 -0.463 0 N-CA-C 111.435 -0.666 . . . . 0.0 111.435 -178.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.488 ' HB ' ' O ' ' A' ' 70' ' ' GLN . 77.8 t -131.55 136.02 58.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 120.899 0.38 . . . . 0.0 110.691 -177.207 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.633 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -80.82 117.53 21.55 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.937 -178.101 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.589 ' HE1' ' O ' ' A' ' 51' ' ' SER . 18.9 m-85 -110.42 116.35 31.27 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.252 0.548 . . . . 0.0 112.184 -176.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.471 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 12.1 m120 -89.73 111.18 22.09 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.683 176.02 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.515 ' HB ' HG13 ' A' ' 93' ' ' ILE . 5.1 mp -92.0 118.82 38.29 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.632 0 CA-C-O 121.16 0.505 . . . . 0.0 109.836 178.057 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.852 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 21.7 m -110.45 115.3 29.4 Favored 'General case' 0 N--CA 1.428 -1.549 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.131 -179.235 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.51 HD11 HG23 ' A' ' 77' ' ' ILE . 14.1 mm -95.21 142.5 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.445 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 68.7 m-85 -129.6 112.37 13.64 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.335 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.544 ' HB2' HG21 ' A' ' 37' ' ' ILE . . . -78.95 122.88 26.7 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 168.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.551 HG11 ' C ' ' A' ' 39' ' ' GLY . 7.9 p -112.66 136.91 47.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.245 -178.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.479 ' OE1' ' HB2' ' A' ' 86' ' ' GLN . 1.8 mp0 -114.6 171.21 7.77 Favored 'General case' 0 N--CA 1.446 -0.626 0 O-C-N 123.695 0.622 . . . . 0.0 109.659 -177.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -45.3 -44.74 11.7 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -174.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -117.32 -16.73 10.28 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -175.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.479 ' HB2' ' OE1' ' A' ' 83' ' ' GLU . 45.2 mt-30 -128.4 176.05 8.02 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.474 -0.49 . . . . 0.0 111.625 -169.279 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -130.33 125.46 34.74 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.289 -0.869 . . . . 0.0 108.967 171.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 45.9 m -72.61 173.94 8.24 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.048 0.452 . . . . 0.0 111.705 -177.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -60.89 155.74 51.41 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.238 178.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -88.28 142.31 5.24 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 122.423 2.082 . . . . 0.0 114.482 -176.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.852 ' O ' ' HA ' ' A' ' 78' ' ' THR . 7.1 t -82.62 126.42 40.02 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.721 0 CA-C-N 114.662 -1.154 . . . . 0.0 108.175 166.002 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.6 t -120.26 106.73 19.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 C-N-CA 119.768 -0.773 . . . . 0.0 110.081 171.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.515 HG13 ' HB ' ' A' ' 77' ' ' ILE . 7.1 pt -123.5 113.35 37.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.54 176.021 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -99.0 126.02 44.61 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.502 0.667 . . . . 0.0 111.458 -175.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.67 127.92 33.93 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.151 -0.932 . . . . 0.0 109.56 176.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -87.26 138.17 31.72 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.076 0.465 . . . . 0.0 110.126 176.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.505 HG22 HD11 ' A' ' 26' ' ' ILE . 26.5 p -69.55 117.75 11.56 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.238 -177.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 14.3 m -69.81 -30.6 68.16 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.354 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 106.35 -157.08 16.04 Favored Glycine 0 N--CA 1.446 -0.666 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.29 175.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.44 ' O ' ' HG3' ' A' ' 102' ' ' ARG . 25.7 m -97.59 124.76 47.35 Favored Pre-proline 0 C--N 1.319 -0.734 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 176.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -62.0 -23.43 75.77 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.613 2.208 . . . . 0.0 112.127 179.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.44 ' HG3' ' O ' ' A' ' 100' ' ' THR . 34.9 mtp85 69.39 -160.52 0.17 Allowed 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.668 173.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 58.8 m 59.95 34.74 21.6 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-O 121.421 0.629 . . . . 0.0 110.48 -175.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -114.79 10.13 16.46 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.662 -178.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 126.44 -48.08 0.99 Allowed Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 -174.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 17.6 p . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.115 -0.945 . . . . 0.0 112.253 178.405 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.677 0 N-CA-C 111.87 -0.492 . . . . 0.0 111.87 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.7 p -82.77 -31.66 28.19 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 110.567 -0.16 . . . . 0.0 110.567 178.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 34.0 t-80 57.66 61.16 2.53 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.189 0.519 . . . . 0.0 110.073 176.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 66.4 mtt -106.96 41.72 1.42 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.682 -178.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -75.03 108.57 2.56 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.652 -0.785 . . . . 0.0 111.547 178.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 12.0 t -78.61 128.85 34.06 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.342 0.591 . . . . 0.0 110.779 -176.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.6 p -104.12 126.01 50.89 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.889 177.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.7 m -64.32 117.67 7.57 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.097 0.475 . . . . 0.0 111.07 -177.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -141.96 108.13 5.87 Favored Pre-proline 0 C--N 1.319 -0.753 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.336 -178.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.504 ' HD3' ' NE2' ' A' ' 86' ' ' GLN . 87.9 Cg_endo -88.91 170.44 5.1 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.877 2.384 . . . . 0.0 112.274 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -117.56 160.48 21.18 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.58 176.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -95.23 158.86 34.05 Favored Pre-proline 0 C--N 1.316 -0.855 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 177.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.441 ' HA ' ' O ' ' A' ' 31' ' ' SER . 30.3 Cg_exo -64.52 126.74 17.45 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 121.886 1.724 . . . . 0.0 111.511 175.267 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.48 ' HD2' ' O ' ' A' ' 31' ' ' SER . 84.9 Cg_exo -47.14 146.95 5.83 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.634 2.223 . . . . 0.0 111.114 171.019 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -37.71 106.67 0.36 Allowed Pre-proline 0 N--CA 1.465 0.302 0 O-C-N 124.743 1.277 . . . . 0.0 112.594 -169.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.56 ' HG2' HG12 ' A' ' 91' ' ' VAL . 33.4 Cg_exo -65.59 152.28 82.23 Favored 'Trans proline' 0 CA--C 1.517 -0.329 0 C-N-CA 123.552 2.835 . . . . 0.0 112.015 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 25.8 m -109.45 128.78 55.41 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.898 -178.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.437 ' HA ' ' HA ' ' A' ' 28' ' ' VAL . 83.6 t -74.92 119.21 22.07 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-N 114.415 -1.266 . . . . 0.0 109.591 173.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -88.0 -40.25 14.02 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.184 -173.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 18.0 mm-40 -136.71 139.41 41.9 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.47 -177.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.452 HG13 ' NE2' ' A' ' 95' ' ' GLN . 33.6 m -130.55 133.75 63.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.15 0.5 . . . . 0.0 111.078 178.166 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -134.84 -162.72 1.28 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.064 178.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.42 ' CG ' ' H ' ' A' ' 24' ' ' THR . 4.5 p-10 -69.01 -68.41 0.4 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.105 0.479 . . . . 0.0 111.579 177.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.659 HG21 ' O ' ' A' ' 69' ' ' LEU . 68.2 p -111.87 39.64 2.34 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.905 -174.239 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.704 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 69.9 m -169.12 131.91 1.28 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.371 -0.832 . . . . 0.0 110.322 -171.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.601 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 17.9 mt -150.38 138.45 14.3 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.893 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 176.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.414 ' O ' HG11 ' A' ' 18' ' ' VAL . 37.7 t -116.35 131.94 67.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 119.002 0.819 . . . . 0.0 110.587 -173.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.63 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.7 OUTLIER -125.94 145.41 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.039 -178.412 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.508 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 77.3 mtt180 -127.13 121.87 32.61 Favored 'General case' 0 N--CA 1.465 0.293 0 O-C-N 123.629 0.581 . . . . 0.0 110.293 -177.333 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.482 ' CH2' HD11 ' A' ' 57' ' ' LEU . 28.1 p90 -112.83 146.8 38.23 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.835 -0.621 . . . . 0.0 112.05 -173.41 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.48 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 15.3 m -87.43 88.63 7.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.482 179.246 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.596 ' HD3' ' H ' ' A' ' 32' ' ' ARG . 0.4 OUTLIER -48.77 156.26 0.91 Allowed Pre-proline 0 CA--C 1.54 0.582 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -174.698 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.682 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 1.6 Cg_endo -85.7 169.26 9.37 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 124.307 3.338 . . . . 0.0 112.428 -173.409 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -93.86 -5.36 48.19 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.836 177.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -67.88 144.48 97.29 Favored Pre-proline 0 C--O 1.234 0.265 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.041 173.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_exo -70.76 112.72 3.32 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 121.272 1.314 . . . . 0.0 109.898 172.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.465 HD12 ' HD2' ' A' ' 33' ' ' PRO . 5.0 pt -121.36 151.93 24.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.08 -172.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.401 ' C ' ' HB3' ' A' ' 59' ' ' GLU . 16.8 p -98.33 -26.78 14.38 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -176.287 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.426 ' O ' HG12 ' A' ' 82' ' ' VAL . . . -173.36 -164.16 28.18 Favored Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 119.575 -1.298 . . . . 0.0 112.582 177.43 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.682 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 6.4 m-85 -138.88 135.4 34.44 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 120.975 0.417 . . . . 0.0 111.041 177.393 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 4.0 mtm105 -108.95 146.62 33.53 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 169.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.879 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 34.9 mt -138.76 109.58 4.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -174.227 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 75.3 t -109.67 110.54 32.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.297 0.57 . . . . 0.0 110.66 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.652 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 1.1 p90 -114.08 125.76 54.34 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.607 176.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.0 m -137.87 145.29 47.63 Favored Pre-proline 0 C--N 1.313 -1.014 0 CA-C-N 114.077 -1.419 . . . . 0.0 111.164 -173.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.546 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 55.7 Cg_endo -66.42 153.74 76.88 Favored 'Trans proline' 0 N--CA 1.472 0.225 0 C-N-CA 123.443 2.762 . . . . 0.0 111.928 178.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 29.3 t -77.76 -37.65 48.59 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.952 179.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 94.7 t -117.67 -42.37 2.79 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -178.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -171.05 137.21 1.15 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.576 0.227 . . . . 0.0 110.531 -177.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 158.31 -169.12 34.82 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.169 -178.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.427 ' O ' ' HE1' ' A' ' 75' ' ' TYR . 22.9 m -94.74 121.3 36.18 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.633 0.254 . . . . 0.0 111.56 -176.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 7.0 m -97.34 141.89 29.88 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 176.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.652 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 86.4 m -147.02 151.05 36.31 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.332 -178.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.879 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 31.8 tt0 -119.82 122.86 42.29 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.496 175.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.661 HD13 ' CG2' ' A' ' 64' ' ' VAL . 16.9 mt -104.58 157.89 16.86 Favored 'General case' 0 CA--C 1.514 -0.406 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.129 175.529 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -122.02 114.68 21.29 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 177.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.482 HD11 ' CH2' ' A' ' 30' ' ' TRP . 2.1 mt -111.6 156.8 40.86 Favored Pre-proline 0 C--N 1.317 -0.843 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -175.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -63.24 150.16 89.36 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 121.912 1.742 . . . . 0.0 111.448 176.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.401 ' HB3' ' C ' ' A' ' 38' ' ' THR . 10.3 pt-20 -43.94 -28.74 0.49 Allowed 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 114.59 -1.186 . . . . 0.0 112.98 176.326 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.1 t -106.93 19.28 20.69 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.161 -175.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.47 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -82.15 152.78 26.34 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.181 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.508 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 28.5 p-10 -132.59 5.53 4.01 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -177.028 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.63 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 35.5 p -166.18 134.3 2.9 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 119.905 -0.718 . . . . 0.0 111.869 -175.125 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.661 ' CG2' HD13 ' A' ' 55' ' ' LEU . 4.7 p -114.53 135.3 54.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.259 175.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 54.3 m -97.4 99.41 10.84 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 121.572 0.701 . . . . 0.0 109.146 169.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.704 ' O ' ' HA ' ' A' ' 25' ' ' SER . 0.7 OUTLIER -73.96 144.54 45.2 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.094 -0.957 . . . . 0.0 108.907 179.05 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.431 ' HA ' ' O ' ' A' ' 24' ' ' THR . 10.6 t -142.35 167.46 22.04 Favored 'General case' 0 C--N 1.318 -0.791 0 O-C-N 123.56 0.537 . . . . 0.0 109.714 -173.527 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 62.77 27.48 16.1 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 123.881 0.738 . . . . 0.0 111.202 -178.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.659 ' O ' HG21 ' A' ' 24' ' ' THR . 13.6 mt -71.09 -174.92 1.05 Allowed 'General case' 0 C--O 1.225 -0.2 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 173.052 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 67.8 mm-40 -122.99 133.43 24.49 Favored Pre-proline 0 C--N 1.317 -0.846 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 175.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -63.71 126.19 16.98 Favored 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 122.513 2.142 . . . . 0.0 112.125 177.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 82.67 39.42 10.65 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.741 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 72.1 t -136.58 138.13 46.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.039 0.447 . . . . 0.0 110.843 -179.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.546 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -80.93 120.25 24.5 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.719 -179.841 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.528 ' CE2' ' HB3' ' A' ' 69' ' ' LEU . 30.1 m-85 -113.66 117.72 32.34 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.499 0.666 . . . . 0.0 112.44 -178.021 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.438 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 6.9 m120 -85.85 110.74 19.61 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.019 172.274 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.5 HG21 HD13 ' A' ' 79' ' ' ILE . 5.1 mp -92.21 121.89 43.18 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.562 0 CA-C-O 121.064 0.459 . . . . 0.0 109.866 176.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.879 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 48.2 m -111.73 114.57 27.65 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.861 179.53 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.5 HD13 HG21 ' A' ' 77' ' ' ILE . 13.5 mm -95.91 130.14 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -117.94 113.07 21.16 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 177.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -88.98 125.46 34.99 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 173.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.426 HG12 ' O ' ' A' ' 39' ' ' GLY . 8.1 p -118.6 133.5 65.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 C-N-CA 120.09 -0.644 . . . . 0.0 112.127 -173.396 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.438 ' HA ' ' HA ' ' A' ' 37' ' ' ILE . 8.9 mt-10 -100.58 173.6 6.47 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.127 172.529 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -34.93 -44.55 0.23 Allowed 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -176.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -135.03 2.77 3.12 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -176.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.504 ' NE2' ' HD3' ' A' ' 10' ' ' PRO . 26.3 pt20 -146.45 176.14 10.02 Favored 'General case' 0 C--O 1.218 -0.591 0 CA-C-N 118.939 0.791 . . . . 0.0 111.552 -179.087 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -126.67 154.95 43.38 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.768 -179.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 16.9 m -85.73 -175.27 5.55 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.453 176.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.4 p -62.65 158.69 49.04 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.449 173.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -87.33 140.08 5.33 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 122.065 1.843 . . . . 0.0 113.674 -178.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.879 ' O ' ' HA ' ' A' ' 78' ' ' THR . 8.6 t -83.29 125.68 40.09 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.744 0 CA-C-N 114.868 -1.06 . . . . 0.0 108.49 167.216 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 5.9 t -125.03 106.58 16.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 C-N-CA 119.958 -0.697 . . . . 0.0 110.078 171.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.497 HG13 ' HB ' ' A' ' 77' ' ' ILE . 5.9 pt -124.76 116.32 47.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.906 179.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -99.47 129.49 45.65 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.456 0.646 . . . . 0.0 111.332 -175.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.452 ' NE2' HG13 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -140.94 130.84 24.44 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.021 177.177 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -92.63 138.12 31.77 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.204 0.526 . . . . 0.0 110.745 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.466 HG21 HD13 ' A' ' 26' ' ' ILE . 34.1 p -68.81 124.64 24.24 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.741 -176.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 40.0 m -69.28 -30.05 68.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.503 0.668 . . . . 0.0 110.237 177.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 104.47 -160.42 15.7 Favored Glycine 0 N--CA 1.444 -0.819 0 CA-C-N 115.419 -0.81 . . . . 0.0 112.454 175.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 4.2 m -75.47 130.83 78.71 Favored Pre-proline 0 C--N 1.317 -0.807 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 178.177 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -61.54 121.35 9.46 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 122.096 1.864 . . . . 0.0 111.388 177.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.407 ' HD3' ' N ' ' A' ' 102' ' ' ARG . 0.0 OUTLIER -127.23 -171.3 2.39 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.304 -179.064 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 10.9 t 67.11 26.56 8.84 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.342 0.591 . . . . 0.0 110.151 -179.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -105.57 4.62 30.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.638 177.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 159.38 -149.92 20.04 Favored Glycine 0 N--CA 1.443 -0.843 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.182 -179.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.5 p . . . . . 0 C--O 1.247 0.922 0 CA-C-O 118.376 -0.821 . . . . 0.0 110.667 178.019 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.633 0 N-CA-C 111.88 -0.488 . . . . 0.0 111.88 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 39.2 m -68.62 142.73 55.04 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.481 0.182 . . . . 0.0 110.741 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 25.3 m-70 63.0 40.89 8.82 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.095 -179.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 16.2 tpt -94.53 126.93 40.12 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.596 175.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -87.77 162.16 32.64 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.471 -178.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 14.9 t -80.73 129.43 34.52 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 178.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.8 t -159.06 147.11 17.85 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.374 -176.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 57.2 m -138.4 129.22 26.69 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.064 0.459 . . . . 0.0 110.793 -178.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -111.23 128.55 25.18 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.816 176.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.46 ' HB3' ' OE2' ' A' ' 83' ' ' GLU . 65.9 Cg_endo -73.91 160.31 43.47 Favored 'Trans proline' 0 C--O 1.233 0.272 0 C-N-CA 122.635 2.224 . . . . 0.0 111.693 178.359 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -109.44 145.58 35.94 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.473 ' HB2' ' O ' ' A' ' 89' ' ' THR . . . -79.45 153.88 76.44 Favored Pre-proline 0 C--N 1.319 -0.759 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 175.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -62.23 128.45 23.92 Favored 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.295 1.997 . . . . 0.0 111.787 175.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.473 ' HD2' ' O ' ' A' ' 31' ' ' SER . 86.9 Cg_exo -47.12 140.24 14.37 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.71 2.274 . . . . 0.0 111.349 174.057 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.408 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 5.9 p-10 -33.85 106.96 0.28 Allowed Pre-proline 0 N--CA 1.467 0.396 0 O-C-N 124.929 1.393 . . . . 0.0 112.478 -168.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.557 ' HG2' HG13 ' A' ' 91' ' ' VAL . 39.1 Cg_exo -61.91 152.49 74.64 Favored 'Trans proline' 0 CA--C 1.517 -0.344 0 C-N-CA 123.727 2.951 . . . . 0.0 112.718 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.9 m -107.6 128.27 54.39 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.656 -178.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.468 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 69.5 t -78.46 117.12 23.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-N 114.337 -1.301 . . . . 0.0 109.725 173.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -83.63 -36.89 23.52 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.377 -173.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -135.6 138.38 42.87 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.471 -178.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.468 ' HA ' HG12 ' A' ' 26' ' ' ILE . 6.3 m -129.54 120.33 50.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.205 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -133.69 -165.33 1.62 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.46 -179.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.56 ' O ' ' HB2' ' A' ' 69' ' ' LEU . 3.3 p-10 -67.77 -65.13 0.73 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.971 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.665 HG23 ' O ' ' A' ' 69' ' ' LEU . 39.7 p -115.33 35.5 4.35 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.876 -172.038 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.674 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 18.6 p -169.79 130.7 1.03 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.787 -174.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.564 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 17.0 mt -146.95 135.97 16.11 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.608 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 177.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.468 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 39.9 t -115.1 129.81 70.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 C-N-CA 120.013 -0.675 . . . . 0.0 110.497 -174.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.664 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.8 OUTLIER -123.76 143.89 35.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.044 -177.544 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.536 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 85.8 mtt180 -128.03 121.63 30.22 Favored 'General case' 0 N--CA 1.465 0.297 0 O-C-N 123.79 0.681 . . . . 0.0 110.314 -177.13 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.514 ' CH2' HD13 ' A' ' 57' ' ' LEU . 30.2 p90 -111.39 140.5 45.93 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.189 -173.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.473 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 61.8 m -82.51 88.19 6.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.13 175.27 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.42 ' CZ ' ' HB3' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -49.08 156.46 0.96 Allowed Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -175.485 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.632 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 3.4 Cg_exo -80.36 169.26 17.47 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 123.886 3.057 . . . . 0.0 112.846 -174.378 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -86.57 -14.84 41.71 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.139 172.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -57.51 135.25 82.07 Favored Pre-proline 0 CA--C 1.517 -0.309 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.162 173.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -67.33 112.39 2.55 Favored 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 120.937 1.091 . . . . 0.0 109.774 172.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.553 HG23 ' HB2' ' A' ' 81' ' ' ALA . 1.6 pt -118.27 151.43 20.36 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -174.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.46 ' C ' ' HB3' ' A' ' 59' ' ' GLU . 11.0 p -98.56 -30.53 12.45 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -178.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.528 ' C ' HG12 ' A' ' 82' ' ' VAL . . . -162.86 -166.66 22.03 Favored Glycine 0 N--CA 1.438 -1.209 0 C-N-CA 120.153 -1.022 . . . . 0.0 112.044 -177.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.632 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 6.3 m-85 -141.54 134.46 28.9 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 122.613 0.365 . . . . 0.0 110.875 174.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.3 mmm180 -102.53 149.41 24.43 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 168.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.873 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 30.7 mt -139.55 108.4 3.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 C-N-CA 120.037 -0.665 . . . . 0.0 112.389 -179.297 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 71.7 t -107.53 110.57 32.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.182 0.515 . . . . 0.0 110.836 179.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.64 ' CZ ' ' HB ' ' A' ' 53' ' ' THR . 1.4 p90 -114.9 127.3 55.62 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.948 176.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.3 p -141.81 137.41 16.11 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 113.718 -1.583 . . . . 0.0 111.754 -175.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.589 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 58.1 Cg_endo -73.88 137.26 24.18 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 123.275 2.65 . . . . 0.0 111.9 176.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 32.5 t -66.7 -22.34 66.07 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.75 -176.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 16.6 m -108.55 20.45 5.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.702 0.287 . . . . 0.0 111.533 -179.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 74.58 144.34 0.08 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.118 178.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 162.36 -128.94 1.96 Allowed Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 -177.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.45 ' O ' ' HD3' ' A' ' 46' ' ' PRO . 27.4 m -90.84 119.64 31.22 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 117.177 0.489 . . . . 0.0 110.77 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.425 ' HA ' ' O ' ' A' ' 44' ' ' TYR . 14.9 m -117.5 141.19 48.65 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 173.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.64 ' HB ' ' CZ ' ' A' ' 44' ' ' TYR . 36.1 m -147.62 149.95 33.49 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 120.111 -0.636 . . . . 0.0 111.563 -179.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.873 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 26.4 tt0 -116.95 112.0 20.39 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.585 174.413 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.61 HD11 ' CG2' ' A' ' 64' ' ' VAL . 23.8 mt -96.09 159.04 15.17 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.072 177.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.445 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 24.7 t-20 -125.2 114.86 19.55 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -179.403 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.514 HD13 ' CH2' ' A' ' 30' ' ' TRP . 4.4 mt -112.1 157.68 39.1 Favored Pre-proline 0 C--N 1.317 -0.843 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 -176.369 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -68.3 152.54 75.66 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 121.749 1.632 . . . . 0.0 111.06 175.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.46 ' HB3' ' C ' ' A' ' 38' ' ' THR . 11.7 pt-20 -45.62 -27.07 0.71 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.796 -1.093 . . . . 0.0 112.758 176.01 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 11.1 t -101.44 18.74 19.36 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.277 0.561 . . . . 0.0 111.1 -174.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.42 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -93.04 157.92 16.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.394 179.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.536 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 26.6 p-10 -143.05 13.74 1.86 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -178.475 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.664 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 80.5 p -165.26 134.3 3.4 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 119.876 -0.729 . . . . 0.0 111.936 -177.042 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.61 ' CG2' HD11 ' A' ' 55' ' ' LEU . 3.8 p -117.43 134.81 59.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.346 175.082 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 35.1 m -96.57 101.22 12.8 Favored 'General case' 0 N--CA 1.434 -1.255 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.498 169.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.674 ' O ' ' HA ' ' A' ' 25' ' ' SER . 0.3 OUTLIER -78.3 144.57 35.98 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.1 178.33 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.2 p -138.47 166.58 23.92 Favored 'General case' 0 C--N 1.318 -0.783 0 O-C-N 123.514 0.508 . . . . 0.0 110.826 -173.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 64.2 27.1 13.92 Favored 'General case' 0 N--CA 1.463 0.2 0 O-C-N 123.757 0.661 . . . . 0.0 111.679 179.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.665 ' O ' HG23 ' A' ' 24' ' ' THR . 11.1 mt -70.31 -176.16 1.14 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 175.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 57.9 tp60 -127.44 124.05 23.43 Favored Pre-proline 0 C--N 1.32 -0.696 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 177.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -62.62 135.55 53.43 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 123.083 2.522 . . . . 0.0 113.31 -177.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.67 25.21 39.42 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.907 179.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 87.4 t -129.99 148.77 33.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.27 0.557 . . . . 0.0 111.289 -174.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.589 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -87.33 121.5 29.86 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.648 -179.588 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.402 ' CE2' HD21 ' A' ' 69' ' ' LEU . 7.4 m-85 -118.02 116.8 27.63 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.153 0.501 . . . . 0.0 112.24 -174.448 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.53 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 3.9 m-20 -89.96 113.13 24.72 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.376 176.474 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.511 HG22 HD12 ' A' ' 79' ' ' ILE . 5.1 mp -95.27 118.72 42.1 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.546 0 CA-C-O 121.057 0.455 . . . . 0.0 109.836 174.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.839 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 36.8 m -110.85 115.53 29.68 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.253 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.511 HD12 HG22 ' A' ' 77' ' ' ILE . 13.8 mm -95.89 145.27 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -179.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.426 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 53.0 m-85 -131.13 111.32 11.87 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 177.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.553 ' HB2' HG23 ' A' ' 37' ' ' ILE . . . -80.71 112.08 17.75 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 172.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.528 HG12 ' C ' ' A' ' 39' ' ' GLY . 7.4 p -106.68 135.54 44.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 C-N-CA 119.718 -0.793 . . . . 0.0 111.019 -174.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.473 ' HG2' HG22 ' A' ' 37' ' ' ILE . 4.8 mt-10 -109.05 172.06 7.07 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 177.433 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -44.67 -51.42 9.2 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 123.585 0.553 . . . . 0.0 112.136 178.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 -111.39 -14.19 13.79 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -171.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -135.43 172.81 12.47 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.32 -0.552 . . . . 0.0 111.882 -170.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -128.87 133.61 48.0 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 175.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 13.4 m -78.52 170.84 16.0 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.699 0.285 . . . . 0.0 110.914 -178.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.473 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 0.6 OUTLIER -57.9 158.24 13.24 Favored Pre-proline 0 N--CA 1.449 -0.51 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.767 174.758 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -87.07 138.79 5.04 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 122.067 1.844 . . . . 0.0 113.748 -177.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.839 ' O ' ' HA ' ' A' ' 78' ' ' THR . 5.0 t -82.38 124.26 39.09 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.795 0 CA-C-N 114.707 -1.133 . . . . 0.0 108.397 167.296 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 5.0 t -119.61 106.74 19.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 C-N-CA 119.689 -0.804 . . . . 0.0 109.99 171.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.488 HG13 ' HB ' ' A' ' 77' ' ' ILE . 5.9 pt -126.02 111.7 27.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.788 176.551 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.09 133.45 43.35 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.158 0.504 . . . . 0.0 110.499 -178.509 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.414 ' NE2' HG11 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -139.26 140.44 37.68 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.094 178.0 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.433 ' HG2' ' HG2' ' A' ' 74' ' ' GLN . 38.3 mt-10 -86.26 146.86 26.34 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.952 0.405 . . . . 0.0 110.427 177.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.481 HG22 HD13 ' A' ' 26' ' ' ILE . 40.0 p -82.81 114.86 21.42 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.339 177.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 26.7 m -70.45 -31.43 68.58 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.907 -176.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 104.45 -171.55 19.51 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.469 -0.872 . . . . 0.0 112.535 175.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 86.3 m -79.21 124.34 84.44 Favored Pre-proline 0 C--N 1.32 -0.707 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 178.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -53.55 -38.93 84.1 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 123.025 2.484 . . . . 0.0 111.799 177.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 58.5 ttp180 54.03 67.17 1.05 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.685 174.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 23.1 m -92.26 46.44 1.26 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.308 0.575 . . . . 0.0 110.035 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -83.46 -19.23 36.22 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.718 -177.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -89.48 37.55 3.32 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.62 -176.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 37.3 m . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.313 -0.851 . . . . 0.0 109.566 176.321 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.528 0 N-CA-C 111.918 -0.473 . . . . 0.0 111.918 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.5 m -94.97 -9.45 33.95 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.104 0.478 . . . . 0.0 110.888 -179.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 28.5 m-70 -102.28 45.97 0.94 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.488 -179.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 14.2 tpt -67.39 -39.97 85.64 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.525 -178.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -83.4 82.45 1.67 Allowed Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.051 179.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 43.8 m -137.27 91.83 2.65 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 -179.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.9 m -79.71 87.7 5.22 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.296 0.57 . . . . 0.0 110.879 -178.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 13.3 t -115.6 -6.75 12.21 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.388 0.613 . . . . 0.0 110.351 178.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -78.67 119.15 76.24 Favored Pre-proline 0 C--N 1.315 -0.934 0 CA-C-N 114.783 -1.098 . . . . 0.0 110.862 -179.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.502 ' HG3' ' OE1' ' A' ' 83' ' ' GLU . 98.1 Cg_endo -82.47 175.94 8.41 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 123.113 2.542 . . . . 0.0 112.377 178.31 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -132.55 161.33 34.1 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.792 179.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -95.23 156.81 37.33 Favored Pre-proline 0 C--N 1.32 -0.71 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.638 176.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -67.25 127.52 16.81 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.421 2.081 . . . . 0.0 111.999 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.571 ' HD2' ' O ' ' A' ' 31' ' ' SER . 80.0 Cg_exo -46.58 145.54 6.22 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 123.186 2.59 . . . . 0.0 112.174 174.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -35.27 105.37 0.28 Allowed Pre-proline 0 N--CA 1.468 0.44 0 O-C-N 124.884 1.365 . . . . 0.0 112.569 -169.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.559 ' HG2' HG13 ' A' ' 91' ' ' VAL . 23.7 Cg_exo -69.19 149.59 70.68 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 123.58 2.853 . . . . 0.0 112.796 -178.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.5 m -107.47 131.07 54.7 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.735 -177.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.527 HG12 ' O ' ' A' ' 27' ' ' VAL . 72.5 t -73.66 123.72 29.37 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.022 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.062 175.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -83.34 -47.67 11.22 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.845 -174.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -135.48 137.54 42.26 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.11 -178.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.46 HG23 HG11 ' A' ' 18' ' ' VAL . 30.3 t -121.52 115.13 45.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.642 177.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.504 ' HB2' ' HG ' ' A' ' 25' ' ' SER . 5.7 m-20 -123.09 -167.55 1.62 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.347 177.415 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.543 ' O ' ' HB2' ' A' ' 69' ' ' LEU . 1.7 p-10 -70.55 -68.41 0.43 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.145 -0.479 . . . . 0.0 112.043 178.117 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.593 HG21 ' O ' ' A' ' 69' ' ' LEU . 38.1 p -106.72 31.95 4.89 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.699 -172.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.628 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 11.6 p -171.24 132.51 0.81 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.502 -174.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.508 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 44.9 mt -145.86 145.0 20.61 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.742 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 177.341 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.527 ' O ' HG12 ' A' ' 18' ' ' VAL . 35.6 t -117.44 137.67 50.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 C-N-CA 120.03 -0.668 . . . . 0.0 109.782 -174.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.639 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.6 OUTLIER -130.68 146.39 34.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 C-N-CA 119.974 -0.69 . . . . 0.0 110.229 178.331 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.478 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 34.9 mtp180 -129.63 120.35 25.09 Favored 'General case' 0 C--N 1.327 -0.402 0 O-C-N 123.623 0.577 . . . . 0.0 110.045 -175.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.512 ' CH2' HD13 ' A' ' 57' ' ' LEU . 37.1 p90 -113.23 148.93 34.54 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.051 -174.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.571 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 13.6 m -93.7 100.4 12.63 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.936 178.498 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.625 ' NE ' ' HB3' ' A' ' 62' ' ' ASN . 0.1 OUTLIER -53.83 156.26 5.15 Favored Pre-proline 0 CA--C 1.538 0.482 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -174.314 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.624 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 2.4 Cg_endo -83.84 168.51 12.34 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 124.341 3.361 . . . . 0.0 112.474 -174.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -82.49 -16.32 49.22 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.019 172.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -59.62 141.65 88.34 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 114.621 -1.172 . . . . 0.0 111.304 177.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -69.75 112.76 3.16 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 121.035 1.156 . . . . 0.0 109.85 171.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.561 HG23 ' HB1' ' A' ' 81' ' ' ALA . 1.4 pt -121.42 147.33 25.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -176.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 17.4 p -97.39 -20.39 17.84 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -177.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.533 ' C ' HG11 ' A' ' 82' ' ' VAL . . . -173.63 -164.1 28.26 Favored Glycine 0 CA--C 1.501 -0.789 0 C-N-CA 119.877 -1.154 . . . . 0.0 111.957 177.19 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.624 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 6.5 m-85 -139.88 132.84 29.38 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-O 120.849 0.357 . . . . 0.0 111.069 173.644 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 8.7 mmm180 -103.49 149.31 24.97 Favored 'General case' 0 CA--C 1.503 -0.851 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 167.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.878 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 33.8 mt -138.73 108.25 4.11 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 C-N-CA 119.939 -0.705 . . . . 0.0 112.219 -178.512 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 72.0 t -107.94 110.38 31.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.299 0.571 . . . . 0.0 110.396 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.603 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 1.0 OUTLIER -110.64 125.42 53.41 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.328 176.071 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 39.9 p -140.01 135.47 16.43 Favored Pre-proline 0 C--N 1.316 -0.864 0 CA-C-N 113.922 -1.49 . . . . 0.0 111.217 -174.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.521 ' HG2' ' CA ' ' A' ' 50' ' ' GLY . 10.5 Cg_exo -69.71 132.48 23.5 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.815 2.344 . . . . 0.0 111.154 173.577 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 5.8 p -76.01 -9.22 58.44 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 121.077 -0.249 . . . . 0.0 111.547 -178.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.424 ' O ' ' HB2' ' A' ' 49' ' ' GLU . 15.7 m -117.24 -41.65 2.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 179.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.424 ' HB2' ' O ' ' A' ' 48' ' ' VAL . 45.7 tt0 169.86 138.36 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 122.498 0.319 . . . . 0.0 110.21 -177.3 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.521 ' CA ' ' HG2' ' A' ' 46' ' ' PRO . . . 152.44 -154.22 25.38 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.655 176.447 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.558 ' O ' ' HE2' ' A' ' 75' ' ' TYR . 39.9 t -93.94 121.61 35.59 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.799 0.333 . . . . 0.0 111.343 -176.325 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.461 ' HA ' ' O ' ' A' ' 44' ' ' TYR . 16.5 m -107.2 135.84 48.04 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 174.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.603 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 58.6 m -147.13 152.34 38.29 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.408 -177.048 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.878 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 33.2 tt0 -116.5 117.5 30.08 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.85 174.129 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.65 HD11 ' CG2' ' A' ' 64' ' ' VAL . 18.3 mt -97.3 158.06 15.65 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 174.684 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -123.45 111.06 15.88 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.607 -178.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.512 HD13 ' CH2' ' A' ' 30' ' ' TRP . 3.4 mt -109.59 155.55 41.16 Favored Pre-proline 0 N--CA 1.444 -0.771 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -177.152 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -64.35 148.83 90.93 Favored 'Trans proline' 0 N--CA 1.448 -1.172 0 C-N-CA 121.611 1.54 . . . . 0.0 110.635 175.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.42 ' HB2' HG13 ' A' ' 37' ' ' ILE . 8.4 pt-20 -44.04 -27.58 0.39 Allowed 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 114.729 -1.123 . . . . 0.0 113.197 178.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.8 t -103.35 6.99 38.23 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.44 -173.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.407 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -76.41 158.5 31.33 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 178.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.625 ' HB3' ' NE ' ' A' ' 32' ' ' ARG . 29.2 p-10 -141.98 18.29 2.12 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -177.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.639 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 25.5 p -169.76 134.2 1.33 Allowed 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.209 -0.597 . . . . 0.0 111.715 179.288 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.65 ' CG2' HD11 ' A' ' 55' ' ' LEU . 3.7 p -116.81 137.55 50.31 Favored 'Isoleucine or valine' 0 C--O 1.243 0.728 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.489 176.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 68.3 m -96.92 101.18 12.72 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.579 169.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.628 ' O ' ' HA ' ' A' ' 25' ' ' SER . 0.2 OUTLIER -80.19 145.38 32.31 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.474 -0.784 . . . . 0.0 108.928 178.647 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 8.8 t -141.06 174.14 10.8 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.27 -174.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 62.78 27.22 15.98 Favored 'General case' 0 C--N 1.329 -0.304 0 O-C-N 123.8 0.688 . . . . 0.0 111.272 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.593 ' O ' HG21 ' A' ' 24' ' ' THR . 10.9 mt -74.65 -176.36 2.77 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.275 -0.421 . . . . 0.0 109.883 177.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.439 ' N ' ' HH ' ' A' ' 75' ' ' TYR . 57.3 tp60 -130.35 123.27 20.44 Favored Pre-proline 0 C--N 1.32 -0.709 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.007 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -62.0 133.59 45.12 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.961 2.441 . . . . 0.0 113.035 -177.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 87.42 25.24 33.85 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.788 -178.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.485 ' CG1' ' HB3' ' A' ' 46' ' ' PRO . 94.9 t -131.02 142.81 42.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.027 0.441 . . . . 0.0 110.841 -176.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.484 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 10.3 tp60 -86.36 107.45 18.01 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.002 -177.339 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.558 ' HE2' ' O ' ' A' ' 51' ' ' SER . 18.8 m-85 -99.13 119.95 38.69 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.097 0.475 . . . . 0.0 111.69 -177.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.482 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 13.3 m120 -92.72 109.21 20.62 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.418 177.164 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.544 ' HB ' HG13 ' A' ' 93' ' ' ILE . 5.0 mp -91.76 116.72 33.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.246 0.546 . . . . 0.0 109.642 178.121 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.864 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 81.1 m -108.9 115.81 30.8 Favored 'General case' 0 N--CA 1.427 -1.605 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.441 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.533 HD11 HG21 ' A' ' 77' ' ' ILE . 13.5 mm -95.12 141.26 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 -179.285 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.406 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 64.0 m-85 -128.79 111.79 13.49 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.91 178.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.561 ' HB1' HG23 ' A' ' 37' ' ' ILE . . . -78.97 119.5 22.22 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 168.212 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.533 HG11 ' C ' ' A' ' 39' ' ' GLY . 7.6 p -106.77 133.87 50.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 C-N-CA 120.092 -0.643 . . . . 0.0 110.049 -178.206 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.502 ' OE1' ' HG3' ' A' ' 10' ' ' PRO . 1.4 mp0 -111.01 170.22 8.24 Favored 'General case' 0 N--CA 1.445 -0.68 0 O-C-N 123.579 0.549 . . . . 0.0 110.068 -178.12 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -43.68 -46.99 7.65 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.119 -0.946 . . . . 0.0 112.676 -174.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 -125.12 6.14 7.87 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -174.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -147.81 177.24 9.48 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.854 0.359 . . . . 0.0 111.762 -172.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -133.04 124.41 27.6 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.172 176.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.422 ' OG ' ' HB2' ' A' ' 81' ' ' ALA . 92.9 p -70.81 170.43 12.55 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.908 0.385 . . . . 0.0 111.569 -178.022 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 18.7 p -60.73 153.05 65.37 Favored Pre-proline 0 CA--C 1.531 0.218 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.772 175.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -83.38 144.55 11.59 Favored 'Trans proline' 0 CA--C 1.534 0.499 0 C-N-CA 122.31 2.007 . . . . 0.0 114.712 -175.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.864 ' O ' ' HA ' ' A' ' 78' ' ' THR . 11.7 t -83.49 129.38 37.61 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.581 0 CA-C-N 114.614 -1.176 . . . . 0.0 107.975 163.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.3 t -125.1 106.87 17.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 C-N-CA 120.046 -0.661 . . . . 0.0 110.13 173.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.544 HG13 ' HB ' ' A' ' 77' ' ' ILE . 9.7 pt -125.04 113.14 34.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.259 179.266 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.406 ' HB3' ' ND2' ' A' ' 76' ' ' ASN . 11.1 pt20 -98.72 125.33 44.01 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.558 0.694 . . . . 0.0 111.675 -176.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.98 127.3 35.99 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.389 176.285 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.404 ' HA ' ' HA ' ' A' ' 74' ' ' GLN . 28.8 tt0 -87.17 127.25 35.15 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.34 0.59 . . . . 0.0 109.851 178.564 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.505 HG21 HD11 ' A' ' 26' ' ' ILE . 22.7 p -59.79 116.88 4.39 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.851 -1.068 . . . . 0.0 111.719 -175.265 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.7 m -69.26 -30.88 69.09 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.281 -178.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 107.88 -169.75 14.75 Favored Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.669 178.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 39.8 m -73.47 120.75 82.77 Favored Pre-proline 0 C--N 1.319 -0.751 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 175.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -56.18 92.81 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 123.047 2.498 . . . . 0.0 113.088 -176.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 75.2 ttt180 -85.27 -32.57 22.49 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.062 175.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 43.6 t -95.9 146.45 24.57 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.496 176.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -132.25 5.16 4.09 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.429 -179.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -166.2 31.35 0.21 Allowed Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.382 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 97.1 m . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.734 -0.65 . . . . 0.0 110.217 178.514 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.655 0 N-CA-C 111.892 -0.483 . . . . 0.0 111.892 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.4 m -118.41 75.16 1.0 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.067 0.46 . . . . 0.0 110.568 -178.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 23.8 m-70 -136.64 112.61 9.64 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.139 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 95.0 mmm -70.01 104.25 2.5 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 175.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 87.11 61.19 1.6 Allowed Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 -172.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 23.6 m -61.87 124.94 22.15 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.342 -0.429 . . . . 0.0 111.046 -176.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.7 t -84.35 151.03 24.98 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.136 177.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 27.7 m -148.75 118.74 7.16 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.029 0.443 . . . . 0.0 110.205 177.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -148.35 124.32 5.26 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.599 -178.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.471 ' HB3' ' CD ' ' A' ' 83' ' ' GLU . 56.4 Cg_endo -70.47 134.47 26.54 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.229 1.952 . . . . 0.0 112.757 -176.297 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -84.86 154.46 22.26 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.328 174.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -96.85 162.26 23.65 Favored Pre-proline 0 C--N 1.319 -0.756 0 N-CA-C 109.379 -0.601 . . . . 0.0 109.379 177.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -70.93 127.09 13.22 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 121.811 1.674 . . . . 0.0 111.166 176.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.492 ' HD2' ' O ' ' A' ' 31' ' ' SER . 84.6 Cg_exo -48.16 145.6 10.76 Favored 'Trans proline' 0 CA--C 1.515 -0.443 0 C-N-CA 122.874 2.382 . . . . 0.0 111.401 173.458 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -35.67 106.37 0.31 Allowed Pre-proline 0 N--CA 1.466 0.335 0 O-C-N 124.939 1.399 . . . . 0.0 111.993 -169.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.553 ' HG2' HG13 ' A' ' 91' ' ' VAL . 27.4 Cg_exo -67.03 146.13 76.05 Favored 'Trans proline' 0 CA--C 1.518 -0.305 0 C-N-CA 123.526 2.818 . . . . 0.0 112.045 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.8 m -105.57 131.46 52.93 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.894 -176.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 93.4 t -73.12 111.44 7.67 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-N 114.471 -1.24 . . . . 0.0 109.315 173.194 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -78.8 -45.0 21.91 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.277 -171.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -139.31 139.88 37.42 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.437 -178.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 60.5 t -129.12 132.6 66.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.868 -176.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.416 ' HB3' ' H ' ' A' ' 23' ' ' ASP . 4.6 m-20 -132.25 -161.86 1.18 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.765 174.149 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.416 ' H ' ' HB3' ' A' ' 22' ' ' ASP . 1.4 p-10 -71.75 -68.52 0.45 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.087 0.47 . . . . 0.0 112.109 177.188 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.617 HG23 ' O ' ' A' ' 69' ' ' LEU . 68.6 p -106.99 36.78 2.55 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.216 0.531 . . . . 0.0 111.176 -173.104 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.528 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 19.8 p -172.23 140.75 1.18 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.399 -174.108 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.453 HD12 ' CG2' ' A' ' 97' ' ' THR . 46.5 mt -149.38 155.91 7.87 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.699 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.32 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 39.7 t -128.17 133.48 66.93 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.572 0 CA-C-N 119.373 0.988 . . . . 0.0 110.206 179.159 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.663 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.7 OUTLIER -125.45 145.16 33.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 C-N-CA 120.197 -0.601 . . . . 0.0 109.924 179.45 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.472 ' HG2' ' OG ' ' A' ' 63' ' ' SER . 20.6 mtp180 -130.24 121.08 25.48 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 123.373 0.421 . . . . 0.0 110.563 -174.403 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.524 ' CH2' HD11 ' A' ' 57' ' ' LEU . 35.2 p90 -111.98 146.48 37.78 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.734 -175.169 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.492 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 33.0 t -89.99 88.68 7.4 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.333 174.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.493 ' HD3' ' H ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -49.55 155.55 1.33 Allowed Pre-proline 0 CA--C 1.541 0.597 0 CA-C-N 115.151 -0.931 . . . . 0.0 112.77 -174.32 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.697 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 2.8 Cg_exo -75.87 170.0 21.04 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.948 3.099 . . . . 0.0 113.953 -169.556 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 24.7 tt0 -80.35 -22.65 41.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.705 -1.134 . . . . 0.0 108.523 169.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.8 135.38 78.89 Favored Pre-proline 0 CA--C 1.517 -0.299 0 CA-C-N 114.804 -1.089 . . . . 0.0 111.054 177.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -69.83 113.13 3.29 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 121.099 1.2 . . . . 0.0 109.755 171.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.558 HG23 ' HB3' ' A' ' 81' ' ' ALA . 0.6 OUTLIER -118.44 154.2 20.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -174.409 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.425 ' N ' ' O ' ' A' ' 82' ' ' VAL . 7.3 p -94.4 -33.94 12.96 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -179.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.511 ' C ' HG13 ' A' ' 82' ' ' VAL . . . -162.39 -167.53 22.96 Favored Glycine 0 N--CA 1.438 -1.232 0 C-N-CA 120.036 -1.078 . . . . 0.0 112.419 -177.014 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.697 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 4.6 m-85 -137.9 134.07 34.58 Favored 'General case' 0 C--N 1.319 -0.729 0 O-C-N 123.745 0.321 . . . . 0.0 110.897 174.352 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.6 mmm180 -104.06 147.71 27.09 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 167.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.887 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 22.7 mt -138.66 108.23 4.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 C-N-CA 119.961 -0.696 . . . . 0.0 111.959 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 72.1 t -111.2 109.41 28.39 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.646 0 CA-C-O 121.364 0.602 . . . . 0.0 110.317 179.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.66 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 0.6 OUTLIER -111.58 125.07 53.54 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.549 177.598 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 23.1 t -141.98 137.44 15.96 Favored Pre-proline 0 C--N 1.316 -0.881 0 CA-C-N 114.158 -1.383 . . . . 0.0 111.192 -172.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.699 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 15.1 Cg_exo -67.69 153.91 74.75 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 123.276 2.651 . . . . 0.0 111.706 174.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 16.3 m -79.07 -26.13 43.07 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.82 -176.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 94.0 t -117.05 -41.86 2.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -178.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 179.32 146.36 0.19 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.566 0.222 . . . . 0.0 110.634 -178.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.438 ' CA ' ' HG2' ' A' ' 46' ' ' PRO . . . 150.31 -149.32 21.18 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.452 -0.88 . . . . 0.0 112.79 176.556 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 19.9 m -92.58 121.45 34.03 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.744 0.307 . . . . 0.0 111.163 -176.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.517 ' HA ' ' O ' ' A' ' 44' ' ' TYR . 17.7 m -114.87 136.21 53.35 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 174.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.66 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 89.7 m -147.15 147.47 30.56 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.75 -175.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.887 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 33.4 tt0 -115.39 112.29 22.11 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.892 174.303 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.621 HD13 ' CG2' ' A' ' 64' ' ' VAL . 17.2 mt -98.0 152.99 18.7 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.561 -0.456 . . . . 0.0 109.8 174.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -116.7 118.35 32.31 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 177.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.524 HD11 ' CH2' ' A' ' 30' ' ' TRP . 3.2 mt -115.04 157.17 44.11 Favored Pre-proline 0 N--CA 1.444 -0.766 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -176.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -65.57 150.4 86.62 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 121.826 1.684 . . . . 0.0 110.991 174.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -47.12 -27.66 1.48 Allowed 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 115.217 -0.902 . . . . 0.0 112.48 177.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.8 t -102.59 15.08 30.3 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.138 -174.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.415 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -83.34 163.58 20.55 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 177.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.468 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 5.2 p-10 -150.08 12.97 0.77 Allowed 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.153 -0.619 . . . . 0.0 112.436 -176.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.663 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 20.1 m -162.89 134.92 5.27 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 117.634 0.197 . . . . 0.0 110.776 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.621 ' CG2' HD13 ' A' ' 55' ' ' LEU . 4.1 p -117.58 138.81 47.05 Favored 'Isoleucine or valine' 0 C--O 1.244 0.802 0 CA-C-O 120.662 0.267 . . . . 0.0 110.508 174.304 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 52.6 m -98.76 101.74 13.25 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-O 121.741 0.782 . . . . 0.0 110.162 171.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.599 HD21 HG13 ' A' ' 64' ' ' VAL . 0.5 OUTLIER -75.66 138.17 41.18 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.067 -0.969 . . . . 0.0 108.896 177.455 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 14.0 p -132.17 159.98 37.4 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 123.193 0.308 . . . . 0.0 111.502 -171.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 64.43 34.26 10.48 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.491 175.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.617 ' O ' HG23 ' A' ' 24' ' ' THR . 14.6 mt -74.34 -175.93 2.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.986 175.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.41 ' NE2' ' HA2' ' A' ' 50' ' ' GLY . 21.3 mt-30 -124.4 140.3 34.87 Favored Pre-proline 0 C--N 1.317 -0.822 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 172.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.14 125.5 14.19 Favored 'Trans proline' 0 CA--C 1.531 0.353 0 C-N-CA 122.362 2.041 . . . . 0.0 112.601 179.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 88.16 38.24 7.38 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.786 178.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 46.6 t -130.5 144.33 38.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 110.333 -0.247 . . . . 0.0 110.333 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.699 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 43.5 tt0 -88.83 125.42 34.9 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.032 178.195 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.517 ' O ' ' HA ' ' A' ' 94' ' ' GLN . 98.3 m-85 -117.44 121.79 42.01 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.917 0.389 . . . . 0.0 111.236 -179.451 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.523 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 4.1 m-20 -88.33 106.31 18.15 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 170.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.517 HG22 HD13 ' A' ' 79' ' ' ILE . 5.2 mp -90.1 115.56 29.79 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.768 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 177.26 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.891 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 29.0 m -103.83 113.79 27.57 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 114.779 -1.101 . . . . 0.0 110.222 -177.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.517 HD13 HG22 ' A' ' 77' ' ' ILE . 12.3 mm -95.34 134.43 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.411 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 62.8 m-85 -122.05 111.19 16.72 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.984 179.389 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.558 ' HB3' HG23 ' A' ' 37' ' ' ILE . . . -82.77 111.85 19.07 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 171.421 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.511 HG13 ' C ' ' A' ' 39' ' ' GLY . 7.8 p -107.73 133.05 53.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 C-N-CA 119.751 -0.779 . . . . 0.0 110.964 -173.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.534 ' HG2' HG22 ' A' ' 37' ' ' ILE . 6.8 mt-10 -107.22 171.11 7.56 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 175.613 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -43.77 -42.21 5.39 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 123.481 0.488 . . . . 0.0 112.14 178.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -123.01 -20.24 5.83 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -173.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.532 ' HB2' ' OE1' ' A' ' 83' ' ' GLU . 16.2 mm100 -123.77 176.33 6.33 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.789 -0.365 . . . . 0.0 111.632 -171.538 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -140.42 126.39 19.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.983 176.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.419 ' OG ' ' HB2' ' A' ' 10' ' ' PRO . 19.7 m -67.04 156.07 37.02 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.206 176.437 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 35.9 p -57.86 146.25 68.11 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.369 177.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -76.36 141.45 22.86 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 122.049 1.833 . . . . 0.0 114.118 -171.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.891 ' O ' ' HA ' ' A' ' 78' ' ' THR . 12.0 t -81.3 130.99 34.92 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.68 0 CA-C-N 114.444 -1.253 . . . . 0.0 108.201 169.392 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 19.0 t -127.52 106.85 15.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 C-N-CA 120.062 -0.655 . . . . 0.0 110.11 172.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.487 ' O ' HG13 ' A' ' 93' ' ' ILE . 43.0 pt -119.95 111.71 33.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.416 -179.44 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.517 ' HA ' ' O ' ' A' ' 75' ' ' TYR . 0.5 OUTLIER -95.59 126.31 40.79 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.297 0.57 . . . . 0.0 111.206 -177.456 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -137.42 131.57 32.18 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.625 179.446 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.47 ' HG2' ' HB2' ' A' ' 74' ' ' GLN . 43.4 mt-10 -92.04 122.02 34.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.695 -0.23 . . . . 0.0 110.842 178.422 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.453 ' CG2' HD12 ' A' ' 26' ' ' ILE . 1.8 p -56.38 126.11 24.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.189 0.519 . . . . 0.0 112.035 -177.524 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.0 m -69.36 -30.97 69.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.44 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 100.54 -155.43 19.39 Favored Glycine 0 N--CA 1.443 -0.889 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.429 176.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 25.0 m -103.47 123.9 39.94 Favored Pre-proline 0 C--N 1.32 -0.716 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 178.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -55.94 121.86 10.74 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.51 2.14 . . . . 0.0 111.338 175.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 79.6 mtm180 -85.8 73.73 10.33 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.155 0.503 . . . . 0.0 110.575 -178.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 5.8 p -85.69 -12.41 51.29 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.193 178.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -108.13 150.24 27.46 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.939 178.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -161.5 -54.12 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.142 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.1 p . . . . . 0 C--O 1.248 1.024 0 CA-C-O 119.133 -0.46 . . . . 0.0 110.916 178.975 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.568 0 N-CA-C 112.0 -0.44 . . . . 0.0 112.0 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.3 m -151.27 51.2 0.84 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.015 0.436 . . . . 0.0 110.22 177.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 51.0 t-80 -99.94 72.5 1.7 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.141 -179.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 21.2 ptp -119.23 -21.0 7.74 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.631 179.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -137.74 -56.5 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 177.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.8 p 43.74 65.67 0.97 Allowed 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.846 0.859 . . . . 0.0 113.108 175.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.3 m -74.14 -17.33 60.94 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.156 175.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 25.6 m -67.98 141.05 56.38 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.542 177.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 65.19 72.66 0.46 Allowed Pre-proline 0 N--CA 1.466 0.337 0 O-C-N 123.704 0.627 . . . . 0.0 111.539 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -81.44 153.44 18.16 Favored 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 123.103 2.535 . . . . 0.0 111.45 178.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.471 ' O ' ' HB3' ' A' ' 33' ' ' PRO . 7.3 p-10 -106.03 141.83 36.75 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.295 -0.562 . . . . 0.0 110.507 -177.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.565 ' HB3' ' O ' ' A' ' 89' ' ' THR . . . -72.84 163.43 68.3 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.271 178.399 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -62.91 133.46 41.7 Favored 'Trans proline' 0 C--O 1.235 0.344 0 C-N-CA 122.234 1.956 . . . . 0.0 111.618 175.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -50.82 145.97 22.37 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.424 2.082 . . . . 0.0 110.9 173.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -36.04 105.96 0.3 Allowed Pre-proline 0 N--CA 1.468 0.447 0 O-C-N 124.759 1.287 . . . . 0.0 112.206 -170.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.538 ' HG2' HG13 ' A' ' 91' ' ' VAL . 39.1 Cg_exo -65.23 147.21 87.86 Favored 'Trans proline' 0 CA--C 1.521 -0.173 0 C-N-CA 123.764 2.976 . . . . 0.0 112.517 -179.183 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 26.3 m -102.27 131.11 49.05 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.717 -177.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.493 HG13 ' O ' ' A' ' 27' ' ' VAL . 95.3 t -81.28 121.63 35.04 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 CA-C-N 114.379 -1.282 . . . . 0.0 110.224 177.118 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -88.13 -37.16 16.43 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.417 -174.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -135.62 135.61 40.36 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.343 -177.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.493 ' HA ' HG12 ' A' ' 26' ' ' ILE . 60.8 t -132.86 114.69 22.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.748 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -135.09 -172.22 3.0 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 177.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.529 ' O ' ' HB2' ' A' ' 69' ' ' LEU . 0.6 OUTLIER -57.18 -67.69 0.3 Allowed 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -178.131 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.642 HG23 ' O ' ' A' ' 69' ' ' LEU . 36.1 p -110.52 33.57 4.44 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.482 -172.335 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.613 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 58.4 m -168.04 130.06 1.47 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.544 -175.23 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.544 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 29.5 mt -144.48 141.53 23.96 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.733 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 175.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.493 ' O ' HG13 ' A' ' 18' ' ' VAL . 44.8 t -118.89 132.28 69.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.398 -175.16 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.608 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.6 OUTLIER -127.96 146.76 33.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 C-N-CA 119.928 -0.709 . . . . 0.0 110.605 -178.396 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.495 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 93.3 mtt180 -130.65 121.17 25.08 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.479 -176.267 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.53 ' CH2' HD11 ' A' ' 57' ' ' LEU . 37.7 p90 -112.98 152.97 28.77 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.202 -175.02 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 20.8 t -100.42 101.51 12.48 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.296 -0.411 . . . . 0.0 109.914 178.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.584 ' CD ' ' H ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -50.99 157.68 1.35 Allowed Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 123.99 0.916 . . . . 0.0 113.257 -174.364 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.665 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 2.5 Cg_endo -85.1 166.7 11.05 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 124.561 3.508 . . . . 0.0 113.572 -174.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -75.41 -23.64 57.03 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.845 -1.07 . . . . 0.0 109.369 171.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.39 135.92 76.17 Favored Pre-proline 0 C--O 1.236 0.348 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.292 175.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -68.38 113.9 3.27 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 121.192 1.262 . . . . 0.0 109.336 168.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.646 HG23 ' HG3' ' A' ' 83' ' ' GLU . 0.5 OUTLIER -117.98 152.31 20.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -175.662 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 12.5 p -95.54 -29.06 14.56 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -178.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.429 ' C ' HG12 ' A' ' 82' ' ' VAL . . . -168.58 -166.44 27.65 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 119.765 -1.207 . . . . 0.0 112.063 178.125 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.665 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 5.5 m-85 -137.81 131.94 31.9 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-N 117.056 0.428 . . . . 0.0 111.516 176.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 41.9 mtm180 -105.68 148.42 27.42 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 170.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.878 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 32.0 mt -139.6 108.92 3.62 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -176.027 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 78.3 t -109.03 110.58 32.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.24 0.543 . . . . 0.0 110.356 179.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.68 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 1.0 OUTLIER -111.86 124.76 53.04 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.392 177.055 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.3 m -134.95 137.7 27.81 Favored Pre-proline 0 C--N 1.315 -0.932 0 CA-C-N 114.318 -1.31 . . . . 0.0 111.639 -173.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.469 ' HD2' ' OG ' ' A' ' 52' ' ' SER . 73.3 Cg_endo -73.04 134.38 21.31 Favored 'Trans proline' 0 C--O 1.23 0.125 0 C-N-CA 123.379 2.72 . . . . 0.0 111.566 174.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 28.1 t -65.0 -34.98 79.73 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.657 -177.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 16.0 m -115.6 -39.42 2.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -175.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.511 ' O ' HG11 ' A' ' 73' ' ' VAL . 10.1 tp10 -173.71 146.58 1.29 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 117.885 0.311 . . . . 0.0 110.515 -178.284 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.441 ' C ' ' HG3' ' A' ' 46' ' ' PRO . . . 139.4 -165.3 25.8 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.235 -179.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 20.3 m -92.79 127.84 38.44 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 111.565 0.209 . . . . 0.0 111.565 -177.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.469 ' OG ' ' HD2' ' A' ' 46' ' ' PRO . 6.7 m -103.22 138.07 40.51 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 170.297 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.68 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 37.7 m -147.25 154.25 40.78 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.683 -0.407 . . . . 0.0 111.578 -176.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.878 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 44.3 tt0 -119.32 117.76 29.42 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.03 176.088 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.641 HD13 ' CG2' ' A' ' 64' ' ' VAL . 17.9 mt -99.67 164.67 11.96 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 173.429 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.482 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 8.0 t30 -135.91 115.83 13.17 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -178.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.53 HD11 ' CH2' ' A' ' 30' ' ' TRP . 5.7 mt -112.87 160.82 29.37 Favored Pre-proline 0 N--CA 1.444 -0.745 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -174.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -64.84 151.01 87.3 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 121.656 1.571 . . . . 0.0 110.841 174.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.404 ' HB2' HG13 ' A' ' 37' ' ' ILE . 10.4 pt-20 -45.49 -29.55 1.17 Allowed 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.095 0.958 . . . . 0.0 112.913 178.386 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 7.1 t -96.58 -0.17 49.11 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.398 -174.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.489 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -69.95 158.88 34.77 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 110.205 -0.295 . . . . 0.0 110.205 -177.51 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.551 ' HB3' ' NE ' ' A' ' 32' ' ' ARG . 3.8 p-10 -143.65 15.14 1.78 Allowed 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -177.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.608 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 36.1 p -168.45 133.63 1.72 Allowed 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.084 -0.646 . . . . 0.0 112.333 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.641 ' CG2' HD13 ' A' ' 55' ' ' LEU . 4.8 p -118.72 139.47 45.93 Favored 'Isoleucine or valine' 0 C--O 1.243 0.725 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.537 176.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 34.4 m -99.51 103.75 15.52 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.72 170.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.613 ' O ' ' HA ' ' A' ' 25' ' ' SER . 0.2 OUTLIER -83.38 144.45 29.63 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.465 179.112 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 9.6 t -138.97 170.64 15.61 Favored 'General case' 0 N--CA 1.448 -0.555 0 O-C-N 123.371 0.42 . . . . 0.0 110.296 -174.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 65.24 22.25 12.13 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.052 179.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.642 ' O ' HG23 ' A' ' 24' ' ' THR . 6.5 mt -68.66 -178.45 1.16 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 177.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -124.36 128.06 25.11 Favored Pre-proline 0 C--N 1.32 -0.696 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 176.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -62.16 135.22 53.37 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 123.003 2.468 . . . . 0.0 113.069 -177.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.54 29.34 30.12 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.217 178.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.511 HG11 ' O ' ' A' ' 49' ' ' GLU . 47.8 t -130.55 147.27 33.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.157 0.503 . . . . 0.0 111.198 -177.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 7.6 tp60 -86.06 109.47 18.85 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.205 178.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.58 ' CE2' HD22 ' A' ' 69' ' ' LEU . 4.2 m-85 -98.97 117.39 33.36 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.144 0.497 . . . . 0.0 111.885 -177.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.429 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 78.4 m-20 -88.06 108.13 19.08 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.025 174.224 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.54 ' HB ' HG13 ' A' ' 93' ' ' ILE . 5.0 mp -92.12 113.55 27.6 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.692 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 175.11 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.869 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 25.8 m -105.07 113.8 27.61 Favored 'General case' 0 N--CA 1.425 -1.723 0 CA-C-N 114.915 -1.038 . . . . 0.0 109.996 -179.022 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.509 HD12 HG22 ' A' ' 77' ' ' ILE . 15.8 mm -95.05 143.3 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -130.85 111.94 12.56 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.96 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.566 ' HB3' HG21 ' A' ' 37' ' ' ILE . . . -81.28 125.53 30.45 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 167.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.429 HG12 ' C ' ' A' ' 39' ' ' GLY . 7.5 p -113.36 133.5 59.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 C-N-CA 120.384 -0.526 . . . . 0.0 110.233 -179.095 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.646 ' HG3' HG23 ' A' ' 37' ' ' ILE . 8.2 mp0 -109.07 170.85 7.79 Favored 'General case' 0 N--CA 1.443 -0.819 0 O-C-N 123.912 0.757 . . . . 0.0 108.988 -178.387 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -42.57 -45.24 4.48 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -172.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -131.16 0.9 4.19 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.029 -0.668 . . . . 0.0 112.624 -177.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.478 ' HG3' ' OE1' ' A' ' 83' ' ' GLU . 29.1 pt20 -136.07 176.04 9.05 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.961 -0.296 . . . . 0.0 110.772 -176.44 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -130.85 135.12 47.42 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.295 -0.412 . . . . 0.0 109.903 175.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.491 ' OG ' ' HB1' ' A' ' 81' ' ' ALA . 78.5 p -70.64 -178.36 1.8 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.955 0.407 . . . . 0.0 111.1 177.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.565 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 1.4 p -65.9 162.72 42.73 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.746 176.326 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -88.62 137.36 3.43 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 122.129 1.886 . . . . 0.0 113.753 179.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.869 ' O ' ' HA ' ' A' ' 78' ' ' THR . 6.4 t -82.53 126.07 39.97 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.72 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 166.619 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 10.5 t -124.14 106.77 17.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 C-N-CA 119.964 -0.694 . . . . 0.0 109.79 172.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.54 HG13 ' HB ' ' A' ' 77' ' ' ILE . 9.7 pt -122.98 111.88 31.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.354 178.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.409 ' HB3' ' OD1' ' A' ' 76' ' ' ASN . 3.6 pt20 -98.0 119.82 37.31 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.555 0.693 . . . . 0.0 111.591 -175.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.99 131.51 47.44 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.715 178.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -85.19 134.51 34.16 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.274 178.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.501 HG21 HD12 ' A' ' 26' ' ' ILE . 34.1 p -70.99 114.63 9.24 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.587 179.465 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 18.9 m -68.72 -30.77 69.49 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.443 0.64 . . . . 0.0 110.04 -177.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.435 ' HA2' ' HB3' ' A' ' 23' ' ' ASP . . . 94.68 -120.96 6.58 Favored Glycine 0 N--CA 1.441 -1.016 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.421 174.554 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 24.1 m -125.37 124.41 25.15 Favored Pre-proline 0 C--N 1.318 -0.789 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.2 92.06 0.06 OUTLIER 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 123.092 2.528 . . . . 0.0 112.73 179.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 66.0 ttt180 66.64 -80.43 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.797 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 18.6 m -132.07 -48.02 0.93 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.751 0.31 . . . . 0.0 111.016 -176.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -92.11 163.96 13.76 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.693 179.456 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 109.73 47.51 0.84 Allowed Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.675 -0.774 . . . . 0.0 111.196 -177.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.9 t . . . . . 0 C--O 1.252 1.197 0 CA-C-O 119.276 -0.392 . . . . 0.0 109.944 -179.721 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.821 0 N-CA-C 112.068 -0.413 . . . . 0.0 112.068 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 44.2 m -82.84 126.17 32.14 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.95 0.405 . . . . 0.0 110.616 179.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 38.5 t-80 -116.47 -53.95 2.49 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.238 179.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 50.1 ttm -162.13 126.24 3.19 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.473 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 166.97 -115.63 0.64 Allowed Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.079 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 7.5 p -78.45 -19.21 53.63 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.082 0.468 . . . . 0.0 110.935 178.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.5 p -99.67 117.49 34.14 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.048 178.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 28.1 m -73.32 143.77 46.81 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 175.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -85.03 112.86 46.41 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-O 120.692 0.282 . . . . 0.0 110.393 179.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.07 172.22 16.79 Favored 'Trans proline' 0 C--O 1.235 0.343 0 C-N-CA 122.886 2.391 . . . . 0.0 111.59 -179.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -120.02 158.6 26.46 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.838 0.352 . . . . 0.0 110.366 -179.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -95.83 160.75 29.5 Favored Pre-proline 0 C--N 1.318 -0.784 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.348 175.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -63.89 130.24 27.04 Favored 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.119 1.879 . . . . 0.0 111.578 178.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.559 ' HD2' ' O ' ' A' ' 31' ' ' SER . 83.5 Cg_exo -47.74 149.74 4.86 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.827 2.351 . . . . 0.0 111.212 171.241 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -39.62 107.16 0.43 Allowed Pre-proline 0 N--CA 1.468 0.467 0 O-C-N 124.382 1.051 . . . . 0.0 112.336 -169.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.563 ' HG2' HG11 ' A' ' 91' ' ' VAL . 31.4 Cg_exo -65.22 148.17 88.6 Favored 'Trans proline' 0 CA--C 1.516 -0.42 0 C-N-CA 123.381 2.721 . . . . 0.0 112.134 179.071 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 24.9 m -107.41 132.01 53.64 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.655 -178.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.426 HG13 ' O ' ' A' ' 27' ' ' VAL . 77.9 t -79.35 123.26 36.04 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 CA-C-N 114.194 -1.366 . . . . 0.0 110.359 176.323 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.411 ' OD2' ' HG3' ' A' ' 20' ' ' GLN . 26.3 t70 -88.72 -35.83 16.51 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.252 -176.281 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.411 ' HG3' ' OD2' ' A' ' 19' ' ' ASP . 75.8 mt-30 -135.99 134.1 38.22 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.688 -176.303 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.48 ' HA ' HG12 ' A' ' 26' ' ' ILE . 78.7 t -129.97 113.68 27.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.444 178.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -127.2 -166.76 1.64 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.057 178.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.6 -68.33 0.37 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.197 0.522 . . . . 0.0 112.161 178.287 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.62 HG22 ' O ' ' A' ' 69' ' ' LEU . 69.6 p -109.56 36.85 2.81 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.51 -174.047 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.505 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 72.0 p -170.59 134.88 1.12 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.94 -176.391 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.619 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 42.4 mt -148.78 141.44 18.21 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.837 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 177.448 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.426 ' O ' HG13 ' A' ' 18' ' ' VAL . 47.3 t -118.21 132.24 68.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 118.897 0.771 . . . . 0.0 110.214 -176.275 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.619 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.7 OUTLIER -125.31 146.15 31.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 C-N-CA 119.917 -0.713 . . . . 0.0 110.411 -178.254 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.501 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 83.3 mtt180 -131.15 121.9 25.69 Favored 'General case' 0 C--N 1.329 -0.288 0 O-C-N 123.376 0.423 . . . . 0.0 110.778 -175.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.52 ' CH2' HD11 ' A' ' 57' ' ' LEU . 30.8 p90 -112.27 141.08 46.42 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.63 -0.713 . . . . 0.0 112.12 -172.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.559 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 62.6 m -80.28 86.11 5.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.848 172.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.502 ' HD3' ' H ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -47.59 151.5 1.45 Allowed Pre-proline 0 CA--C 1.538 0.509 0 CA-C-N 115.144 -0.935 . . . . 0.0 112.243 -177.551 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.662 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 3.3 Cg_exo -79.91 162.95 23.53 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.71 2.94 . . . . 0.0 112.714 -172.155 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -82.68 -13.0 57.19 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.218 172.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -58.82 145.83 77.48 Favored Pre-proline 0 CA--C 1.52 -0.204 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.043 175.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -69.56 114.42 3.67 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 121.458 1.439 . . . . 0.0 110.304 172.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.551 HG22 ' HB2' ' A' ' 81' ' ' ALA . 3.0 pt -127.73 147.95 32.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 109.381 -0.599 . . . . 0.0 109.381 -177.52 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.5 ' C ' ' HB3' ' A' ' 59' ' ' GLU . 16.3 p -96.92 -29.02 13.93 Favored 'General case' 0 N--CA 1.462 0.173 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -178.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.517 ' C ' HG11 ' A' ' 82' ' ' VAL . . . -165.3 -167.44 25.9 Favored Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 119.937 -1.125 . . . . 0.0 112.175 -178.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.662 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 5.3 m-85 -138.36 134.3 34.02 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 122.444 0.298 . . . . 0.0 111.341 174.225 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.6 mmm180 -103.91 149.76 24.81 Favored 'General case' 0 CA--C 1.504 -0.794 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 166.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.883 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 30.6 mt -139.09 108.58 3.89 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 C-N-CA 120.086 -0.646 . . . . 0.0 112.254 -179.339 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 78.8 t -109.44 110.33 31.69 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.432 0 CA-C-O 121.19 0.519 . . . . 0.0 110.797 -179.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.742 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 1.0 OUTLIER -113.57 126.34 55.18 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.783 176.647 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.9 m -137.4 141.88 35.43 Favored Pre-proline 0 C--N 1.319 -0.756 0 CA-C-N 114.203 -1.362 . . . . 0.0 111.98 -173.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.437 ' HD3' ' O ' ' A' ' 51' ' ' SER . 72.6 Cg_endo -76.78 133.48 14.03 Favored 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 123.581 2.854 . . . . 0.0 112.092 175.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 34.1 t -64.73 -27.37 68.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.455 -177.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.416 ' O ' ' HB2' ' A' ' 49' ' ' GLU . 18.9 m -100.67 17.92 3.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.778 0.323 . . . . 0.0 111.603 -179.502 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.416 ' HB2' ' O ' ' A' ' 48' ' ' VAL . 47.1 mm-40 73.91 157.95 0.2 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.241 -179.445 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 144.49 -135.26 6.06 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 121.025 -0.607 . . . . 0.0 111.779 -177.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.437 ' O ' ' HD3' ' A' ' 46' ' ' PRO . 16.2 m -83.3 119.31 24.43 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.753 0.276 . . . . 0.0 111.091 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 49.8 m -118.44 146.44 44.46 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 173.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.742 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 26.1 m -146.56 148.08 31.79 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 119.834 -0.746 . . . . 0.0 111.763 -178.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.883 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 30.8 tt0 -120.19 113.74 20.88 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.921 175.201 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.633 HD12 ' CG2' ' A' ' 64' ' ' VAL . 19.9 mt -97.29 158.22 15.57 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.321 177.155 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -119.24 116.65 26.72 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 177.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.52 HD11 ' CH2' ' A' ' 30' ' ' TRP . 2.3 mt -114.11 156.23 44.41 Favored Pre-proline 0 C--N 1.317 -0.818 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -177.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -62.25 150.08 88.29 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 121.798 1.665 . . . . 0.0 111.644 176.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.5 ' HB3' ' C ' ' A' ' 38' ' ' THR . 9.4 pt-20 -45.49 -26.63 0.6 Allowed 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 114.573 -1.194 . . . . 0.0 113.102 176.572 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.2 t -109.32 16.02 22.68 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.333 0.587 . . . . 0.0 110.951 -175.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.493 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -75.59 162.91 27.87 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 177.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.501 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 30.4 p-10 -142.89 4.8 1.5 Allowed 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -176.5 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.619 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 59.4 p -167.31 133.96 2.26 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 119.861 -0.736 . . . . 0.0 111.928 -176.426 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.633 ' CG2' HD12 ' A' ' 55' ' ' LEU . 3.5 p -115.54 137.68 48.36 Favored 'Isoleucine or valine' 0 C--O 1.243 0.761 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.47 176.596 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 24.2 m -93.74 101.46 13.58 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.547 168.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.619 ' HG ' ' O ' ' A' ' 26' ' ' ILE . 0.2 OUTLIER -78.46 144.07 36.11 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 173.542 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.428 ' HA ' ' O ' ' A' ' 24' ' ' THR . 4.3 m -152.79 167.7 28.17 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -177.375 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 68.87 26.22 5.95 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 123.912 0.758 . . . . 0.0 110.394 -174.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.62 ' O ' HG22 ' A' ' 24' ' ' THR . 8.9 mt -72.97 -175.82 1.88 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.792 175.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -123.95 129.2 24.86 Favored Pre-proline 0 C--N 1.322 -0.611 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 174.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -62.54 133.96 45.33 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 123.204 2.603 . . . . 0.0 113.336 -177.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.54 34.88 24.27 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.897 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 58.7 t -134.94 138.95 48.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 120.999 0.428 . . . . 0.0 111.363 -176.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 18.3 tp60 -75.07 108.88 8.09 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.971 177.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.493 ' CE2' HD21 ' A' ' 69' ' ' LEU . 7.5 m-85 -101.63 113.57 26.83 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.311 0.577 . . . . 0.0 111.592 179.591 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.558 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 3.7 m-20 -86.91 110.12 19.79 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.437 175.59 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.524 HG22 HD11 ' A' ' 79' ' ' ILE . 5.3 mp -92.33 118.5 38.01 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.664 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.695 176.742 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.87 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 28.4 m -109.47 115.63 30.3 Favored 'General case' 0 N--CA 1.426 -1.675 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.397 179.55 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.524 HD11 HG22 ' A' ' 77' ' ' ILE . 13.3 mm -95.47 137.21 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 -179.637 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.471 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 74.2 m-85 -124.84 111.35 15.39 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 116.581 -0.282 . . . . 0.0 110.281 179.701 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.551 ' HB2' HG22 ' A' ' 37' ' ' ILE . . . -80.26 116.89 20.59 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 169.394 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.517 HG11 ' C ' ' A' ' 39' ' ' GLY . 7.7 p -109.12 133.34 54.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 C-N-CA 120.075 -0.65 . . . . 0.0 110.448 -176.457 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -112.98 170.15 8.41 Favored 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 123.258 0.349 . . . . 0.0 110.202 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -46.17 -40.66 11.49 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -175.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 24.2 p-10 -111.46 -21.03 12.0 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -171.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -142.6 175.97 9.39 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.372 -0.531 . . . . 0.0 111.653 -172.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -118.41 120.25 37.01 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.291 -0.868 . . . . 0.0 108.675 173.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 50.8 m -68.9 175.35 3.71 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.161 0.505 . . . . 0.0 112.067 -176.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -60.16 152.33 62.74 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.17 179.352 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -88.63 142.78 5.05 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 C-N-CA 122.261 1.974 . . . . 0.0 114.084 -177.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.87 ' O ' ' HA ' ' A' ' 78' ' ' THR . 6.9 t -82.57 128.11 39.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 114.366 -1.288 . . . . 0.0 108.001 165.404 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.7 t -123.49 105.68 16.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 C-N-CA 119.746 -0.782 . . . . 0.0 110.004 172.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.523 HG13 ' HB ' ' A' ' 77' ' ' ILE . 6.5 pt -122.85 111.79 31.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.935 177.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -95.92 117.51 30.75 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.533 0.683 . . . . 0.0 110.851 -177.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.58 127.51 46.47 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.155 176.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -87.15 135.05 33.44 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.147 0.499 . . . . 0.0 110.369 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.474 HG23 HD11 ' A' ' 26' ' ' ILE . 34.5 p -69.55 119.59 14.02 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.683 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 10.2 m -69.06 -31.4 70.14 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.437 0.637 . . . . 0.0 110.178 -179.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 108.15 -165.14 12.78 Favored Glycine 0 N--CA 1.442 -0.935 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.279 176.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 56.5 m -82.51 126.06 74.64 Favored Pre-proline 0 C--N 1.32 -0.714 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 178.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -61.52 87.65 0.1 OUTLIER 'Trans proline' 0 C--O 1.233 0.255 0 C-N-CA 122.721 2.281 . . . . 0.0 111.48 175.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 -130.57 17.29 5.33 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.319 -176.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 48.1 t -127.26 95.55 4.31 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.265 -178.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -82.63 146.18 29.26 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.077 178.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.28 -36.79 3.55 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.091 -178.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.5 t . . . . . 0 C--O 1.249 1.038 0 CA-C-O 119.342 -0.361 . . . . 0.0 110.148 -179.945 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.557 0 N-CA-C 111.982 -0.447 . . . . 0.0 111.982 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.6 m -68.09 -28.68 67.56 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 122.852 -0.205 . . . . 0.0 111.368 -179.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 58.9 m-70 54.73 38.63 30.43 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.48 0.657 . . . . 0.0 110.338 -176.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 24.2 ptt? -83.45 -12.82 55.92 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.064 -178.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -163.05 167.51 37.43 Favored Glycine 0 N--CA 1.442 -0.943 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.231 177.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 19.0 m -152.96 80.61 1.21 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.081 0.467 . . . . 0.0 109.752 177.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.0 m -73.25 -37.79 66.22 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.318 -178.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 51.1 m -100.68 121.17 41.19 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.292 178.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -142.96 99.86 5.48 Favored Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.179 -178.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.475 ' HB2' ' OG ' ' A' ' 88' ' ' SER . 66.6 Cg_endo -76.3 144.65 26.35 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.662 2.241 . . . . 0.0 112.121 -179.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -104.74 150.12 25.02 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.755 0.312 . . . . 0.0 110.591 -178.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.679 ' HB1' ' O ' ' A' ' 89' ' ' THR . . . -72.43 153.45 91.95 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.238 175.254 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.438 ' HB3' ' O ' ' A' ' 31' ' ' SER . 46.2 Cg_exo -58.49 135.68 69.25 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.381 2.054 . . . . 0.0 111.142 173.462 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.562 ' HD2' ' O ' ' A' ' 31' ' ' SER . 7.9 Cg_endo -53.39 147.09 38.48 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.072 1.848 . . . . 0.0 110.809 174.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -30.51 106.39 0.23 Allowed Pre-proline 0 N--CA 1.472 0.674 0 O-C-N 124.854 1.346 . . . . 0.0 113.267 -168.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.558 ' HG2' HG11 ' A' ' 91' ' ' VAL . 23.2 Cg_exo -70.25 147.22 59.27 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 123.192 2.595 . . . . 0.0 111.876 176.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 18.5 m -109.88 132.86 53.77 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.803 0.811 . . . . 0.0 110.953 -176.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.5 HG22 ' OE1' ' A' ' 95' ' ' GLN . 95.0 t -79.67 125.58 38.82 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-N 114.2 -1.363 . . . . 0.0 110.056 176.269 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -83.63 -52.51 6.39 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.067 -174.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -136.43 132.11 35.02 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.88 0.372 . . . . 0.0 110.505 -178.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.49 ' HA ' HG12 ' A' ' 26' ' ' ILE . 95.1 t -114.15 122.24 67.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.867 -178.365 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.412 ' HB3' ' H ' ' A' ' 23' ' ' ASP . 30.6 m-20 -124.14 -160.34 0.92 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.602 179.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.514 ' O ' ' HB2' ' A' ' 69' ' ' LEU . 1.8 p-10 -73.35 -77.03 0.11 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.129 178.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.644 HG21 ' O ' ' A' ' 69' ' ' LEU . 62.8 p -105.16 34.79 3.06 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.955 -174.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.67 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 75.3 m -168.12 131.01 1.53 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.042 -172.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.53 HG23 ' OE1' ' A' ' 95' ' ' GLN . 28.7 mt -149.2 148.28 15.84 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.89 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 177.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.47 ' O ' HG12 ' A' ' 18' ' ' VAL . 44.2 t -121.58 130.31 74.73 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.59 0 CA-C-N 119.367 0.985 . . . . 0.0 110.888 -176.329 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.62 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.6 OUTLIER -123.9 146.21 29.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 C-N-CA 120.3 -0.56 . . . . 0.0 109.965 -179.629 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.438 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 21.6 mtp180 -129.32 121.0 26.59 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 123.295 0.372 . . . . 0.0 110.602 -174.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.545 ' CH2' HD12 ' A' ' 57' ' ' LEU . 40.5 p90 -115.05 146.4 41.32 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.641 -174.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.562 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 24.0 t -93.89 97.88 10.68 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.635 177.649 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.521 ' NE ' ' HB3' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -46.8 155.67 0.59 Allowed Pre-proline 0 CA--C 1.539 0.533 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -175.445 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.678 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 2.8 Cg_endo -84.5 166.08 12.2 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 124.628 3.552 . . . . 0.0 112.634 -174.299 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -76.54 -22.11 54.81 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.257 -0.883 . . . . 0.0 108.957 170.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -55.22 133.23 69.21 Favored Pre-proline 0 CA--C 1.517 -0.297 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.663 176.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -61.8 116.32 3.37 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 121.554 1.503 . . . . 0.0 110.148 168.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.585 HG21 ' HB1' ' A' ' 81' ' ' ALA . 1.0 OUTLIER -126.76 148.49 31.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -177.544 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 19.0 p -98.07 -28.81 13.59 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -178.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.511 ' C ' HG11 ' A' ' 82' ' ' VAL . . . -162.83 -166.85 22.32 Favored Glycine 0 N--CA 1.443 -0.892 0 C-N-CA 120.347 -0.93 . . . . 0.0 111.766 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.678 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 5.9 m-85 -139.06 132.57 30.32 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 120.718 0.294 . . . . 0.0 110.932 173.183 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 10.4 mmm180 -102.51 149.91 23.91 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 167.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.878 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 34.0 mt -138.49 107.54 3.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 C-N-CA 120.022 -0.671 . . . . 0.0 111.925 -179.225 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 89.4 t -109.1 110.34 31.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.387 0.613 . . . . 0.0 110.551 -178.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.593 ' CE2' ' HB3' ' A' ' 66' ' ' LEU . 1.2 p90 -113.15 126.02 54.99 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.884 177.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 7.4 m -141.06 138.76 18.26 Favored Pre-proline 0 C--N 1.317 -0.827 0 CA-C-N 113.773 -1.558 . . . . 0.0 110.868 -175.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.458 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 59.5 Cg_endo -71.99 143.95 41.76 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 123.337 2.691 . . . . 0.0 111.749 175.208 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 33.3 m -71.94 -31.79 66.67 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.265 -176.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.489 ' O ' ' HB2' ' A' ' 49' ' ' GLU . 27.7 m -100.69 -40.59 8.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -174.668 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.489 ' HB2' ' O ' ' A' ' 48' ' ' VAL . 39.4 tt0 168.75 148.4 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -178.25 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 142.64 -174.32 23.54 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.206 178.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.44 ' HB2' ' O ' ' A' ' 68' ' ' ASP . 51.0 m -73.46 133.36 43.66 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.844 0.354 . . . . 0.0 111.741 -176.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.0 m -116.53 145.73 43.12 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 174.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.542 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 85.7 m -148.11 147.74 29.85 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.086 -0.645 . . . . 0.0 112.123 -178.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.878 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 30.3 tt0 -112.41 118.29 34.77 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.134 171.286 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.657 HD12 ' CG2' ' A' ' 64' ' ' VAL . 16.5 mt -97.42 160.54 14.26 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 173.209 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -124.77 113.95 18.62 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.728 -179.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.545 HD12 ' CH2' ' A' ' 30' ' ' TRP . 3.2 mt -112.96 157.99 39.07 Favored Pre-proline 0 C--N 1.317 -0.835 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -177.095 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -65.79 150.13 86.24 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 121.76 1.64 . . . . 0.0 111.413 174.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -44.44 -28.72 0.59 Allowed 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 114.887 -1.051 . . . . 0.0 112.859 176.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.8 t -105.29 14.44 28.92 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.251 0.548 . . . . 0.0 111.408 -174.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.423 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -80.02 158.79 26.43 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 176.207 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.521 ' HB3' ' NE ' ' A' ' 32' ' ' ARG . 31.0 p-10 -142.05 17.28 2.1 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 120.619 -0.432 . . . . 0.0 111.96 -177.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.62 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 19.2 p -171.35 134.01 0.86 Allowed 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.268 -0.573 . . . . 0.0 111.847 -179.549 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.657 ' CG2' HD12 ' A' ' 55' ' ' LEU . 3.5 p -117.11 136.3 54.71 Favored 'Isoleucine or valine' 0 C--O 1.242 0.7 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.414 176.367 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 20.8 m -95.13 101.36 13.1 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.386 167.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.67 ' O ' ' HA ' ' A' ' 25' ' ' SER . 0.3 OUTLIER -78.14 144.55 36.33 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.9 -1.045 . . . . 0.0 109.555 178.646 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.457 ' O ' ' HB2' ' A' ' 68' ' ' ASP . 14.2 t -140.39 170.17 16.31 Favored 'General case' 0 C--N 1.319 -0.745 0 O-C-N 123.76 0.663 . . . . 0.0 109.271 -176.482 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 67' ' ' SER . 3.2 m-20 71.89 20.0 4.6 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 123.803 0.69 . . . . 0.0 112.021 -179.28 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.644 ' O ' HG21 ' A' ' 24' ' ' THR . 6.8 mt -72.79 -177.81 2.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.125 0.488 . . . . 0.0 110.412 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 7.8 tp60 -125.38 122.72 25.07 Favored Pre-proline 0 C--N 1.321 -0.663 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 175.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.61 126.09 15.5 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.698 2.265 . . . . 0.0 112.833 -178.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 95.98 28.78 9.04 Favored Glycine 0 N--CA 1.45 -0.414 0 CA-C-N 115.949 -0.568 . . . . 0.0 112.181 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 36.9 t -134.64 152.17 32.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.048 0.451 . . . . 0.0 110.961 -177.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.458 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 11.6 tp60 -87.84 107.99 18.94 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.663 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.457 ' O ' ' HA ' ' A' ' 94' ' ' GLN . 7.1 m-85 -100.79 130.44 46.81 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.145 0.498 . . . . 0.0 111.876 -179.263 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.492 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 10.8 m120 -103.88 113.48 27.04 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.596 -1.184 . . . . 0.0 109.202 175.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.519 HG23 HD12 ' A' ' 79' ' ' ILE . 3.8 mp -95.07 120.27 44.26 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.814 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 176.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.918 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 25.6 m -109.03 113.46 26.34 Favored 'General case' 0 N--CA 1.424 -1.763 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.225 -179.12 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.519 HD12 HG23 ' A' ' 77' ' ' ILE . 12.9 mm -94.64 132.38 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -120.32 111.35 17.65 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.044 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.585 ' HB1' HG21 ' A' ' 37' ' ' ILE . . . -81.82 109.58 16.33 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 172.117 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.511 HG11 ' C ' ' A' ' 39' ' ' GLY . 7.2 p -104.66 143.09 16.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 C-N-CA 120.268 -0.573 . . . . 0.0 111.418 -172.069 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.546 ' HG2' ' N ' ' A' ' 84' ' ' GLU . 55.2 tt0 -121.11 168.17 11.85 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 170.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.546 ' N ' ' HG2' ' A' ' 83' ' ' GLU . 27.7 mt-10 -33.27 -50.97 0.32 Allowed 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -176.561 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 28.4 p-10 -111.96 -24.35 10.0 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -171.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -137.38 173.1 12.04 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.558 -170.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -121.36 152.05 39.43 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.968 178.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.475 ' OG ' ' HB2' ' A' ' 10' ' ' PRO . 9.8 m -80.51 179.61 7.65 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.62 175.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.679 ' O ' ' HB1' ' A' ' 12' ' ' ALA . 0.6 OUTLIER -60.02 159.41 20.91 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 173.081 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -88.16 138.7 4.16 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 121.921 1.747 . . . . 0.0 113.365 179.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.918 ' O ' ' HA ' ' A' ' 78' ' ' THR . 13.3 t -83.18 123.38 38.61 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.671 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 165.222 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.0 t -121.09 106.48 18.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 C-N-CA 119.856 -0.738 . . . . 0.0 109.981 172.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.431 ' O ' HG13 ' A' ' 93' ' ' ILE . 29.9 pt -121.63 117.63 53.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.976 179.033 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.457 ' HA ' ' O ' ' A' ' 75' ' ' TYR . 12.2 pt20 -108.1 128.67 54.89 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.159 0.504 . . . . 0.0 111.618 -175.422 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.53 ' OE1' HG23 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -136.74 153.03 50.97 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.772 171.927 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -97.31 126.14 42.35 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -179.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.517 HG22 HD13 ' A' ' 26' ' ' ILE . 20.1 p -61.12 112.73 2.22 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.417 0.627 . . . . 0.0 111.26 -176.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 11.0 m -70.04 -30.79 68.16 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.864 -176.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 107.64 -168.26 13.93 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.093 177.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 18.3 m -81.19 128.78 69.42 Favored Pre-proline 0 C--N 1.321 -0.665 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 177.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -58.66 92.12 0.07 OUTLIER 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.672 2.248 . . . . 0.0 111.988 176.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 15.1 ptp180 -129.41 19.7 5.76 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.366 -178.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 44.9 m -69.68 -19.48 63.58 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.909 -177.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -109.64 13.6 23.76 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.71 0.767 . . . . 0.0 109.837 178.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -125.42 108.46 1.07 Allowed Glycine 0 N--CA 1.45 -0.369 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.055 -179.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 20.3 m . . . . . 0 C--O 1.251 1.143 0 CA-C-O 118.741 -0.647 . . . . 0.0 110.617 -178.285 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.571 0 N-CA-C 111.835 -0.506 . . . . 0.0 111.835 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.0 p -71.11 -57.48 4.48 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.842 0.353 . . . . 0.0 110.686 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 38.8 m-70 -91.48 124.27 35.52 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.405 -178.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 19.8 ptm -123.2 67.64 0.99 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.987 -176.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -73.75 -77.43 0.63 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.801 -0.714 . . . . 0.0 111.71 178.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.2 p -80.31 59.68 3.5 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.191 0.519 . . . . 0.0 110.577 176.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.5 t -73.47 -20.51 60.68 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.215 -177.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 22.7 m -110.8 125.25 53.37 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.124 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -103.63 119.5 54.53 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.199 179.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -78.17 144.53 21.0 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 122.428 2.085 . . . . 0.0 112.065 -179.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -93.39 164.86 13.04 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.986 179.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.462 ' HB3' ' O ' ' A' ' 89' ' ' THR . . . -97.03 159.84 30.45 Favored Pre-proline 0 C--N 1.32 -0.714 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.132 177.039 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -67.64 131.43 24.4 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.338 2.026 . . . . 0.0 111.415 175.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.408 ' HD2' ' O ' ' A' ' 31' ' ' SER . 74.6 Cg_exo -50.2 151.78 8.88 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.751 2.301 . . . . 0.0 111.214 172.454 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -36.83 106.37 0.33 Allowed Pre-proline 0 N--CA 1.472 0.658 0 O-C-N 124.443 1.089 . . . . 0.0 112.411 -171.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.557 ' HG2' HG13 ' A' ' 91' ' ' VAL . 37.8 Cg_exo -65.78 149.79 86.54 Favored 'Trans proline' 0 CA--C 1.517 -0.326 0 C-N-CA 123.141 2.561 . . . . 0.0 112.129 177.639 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 27.4 m -106.38 130.1 54.26 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.585 -178.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.46 HG11 ' O ' ' A' ' 27' ' ' VAL . 53.8 t -71.62 121.88 22.67 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-N 114.227 -1.351 . . . . 0.0 110.12 175.072 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -83.78 -46.26 12.42 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.258 -173.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -135.63 137.99 42.44 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.894 -178.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.489 ' HA ' HG12 ' A' ' 26' ' ' ILE . 23.7 t -123.26 121.37 62.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.892 -178.175 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -131.57 -163.05 1.28 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.443 176.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -72.88 -68.9 0.45 Allowed 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.311 0.485 . . . . 0.0 112.311 -178.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.546 HG22 ' O ' ' A' ' 69' ' ' LEU . 38.1 p -110.12 28.84 8.21 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.377 0.608 . . . . 0.0 110.87 -171.407 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.539 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 12.0 p -169.95 134.65 1.32 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.069 -175.477 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.526 ' HB ' HD11 ' A' ' 66' ' ' LEU . 29.0 mt -146.16 155.98 12.27 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.207 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.46 ' O ' HG11 ' A' ' 18' ' ' VAL . 54.4 t -121.48 140.21 46.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 119.859 1.209 . . . . 0.0 110.253 -177.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.567 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.8 OUTLIER -130.81 149.24 33.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 119.867 -0.733 . . . . 0.0 110.676 176.741 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.464 ' HG2' ' HB3' ' A' ' 63' ' ' SER . 60.8 mtp180 -132.1 120.61 22.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.265 -176.212 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.517 ' CH2' HD13 ' A' ' 57' ' ' LEU . 32.6 p90 -112.04 144.23 41.74 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.905 -173.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.408 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 21.4 m -85.04 86.55 7.37 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.697 174.535 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.498 ' HD3' ' H ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -52.03 152.87 5.15 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.035 -0.984 . . . . 0.0 112.231 -174.513 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.618 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 4.3 Cg_exo -78.13 160.69 29.78 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 123.615 2.877 . . . . 0.0 113.029 -172.229 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -79.29 -14.8 58.78 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.16 -0.927 . . . . 0.0 108.763 170.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.44 145.28 59.65 Favored Pre-proline 0 CA--C 1.517 -0.292 0 CA-C-N 114.879 -1.055 . . . . 0.0 111.441 175.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -67.45 115.77 3.87 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 121.463 1.442 . . . . 0.0 109.951 170.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.579 HG22 ' HB2' ' A' ' 81' ' ' ALA . 1.4 pt -128.18 146.76 33.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.507 ' C ' ' HB3' ' A' ' 59' ' ' GLU . 26.9 p -93.69 -28.86 15.72 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -178.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.559 ' C ' HG12 ' A' ' 82' ' ' VAL . . . -168.44 -164.04 23.45 Favored Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 120.338 -0.934 . . . . 0.0 111.532 -178.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.618 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 5.2 m-85 -140.3 133.98 30.32 Favored 'General case' 0 CA--C 1.513 -0.481 0 CA-C-N 116.929 0.364 . . . . 0.0 111.243 175.202 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.8 mmm180 -106.03 148.35 27.84 Favored 'General case' 0 CA--C 1.505 -0.757 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 167.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.876 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 28.8 mt -138.03 108.55 5.13 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 C-N-CA 120.006 -0.678 . . . . 0.0 112.489 -177.461 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 76.6 t -110.84 111.08 34.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.019 0.438 . . . . 0.0 110.717 -178.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.747 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 1.3 p90 -116.81 126.85 53.68 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.602 0.715 . . . . 0.0 110.474 178.453 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 25.1 p -149.81 143.93 17.21 Favored Pre-proline 0 C--N 1.319 -0.739 0 CA-C-N 113.698 -1.592 . . . . 0.0 111.183 -175.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.58 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 32.4 Cg_exo -59.11 148.78 83.96 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 123.128 2.552 . . . . 0.0 111.808 176.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 20.1 m -61.89 -23.18 66.14 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.466 -0.788 . . . . 0.0 112.534 -172.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 5.5 p -116.08 -42.32 3.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 120.345 -0.542 . . . . 0.0 112.347 -178.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 173.99 147.51 0.06 Allowed 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 110.067 -0.345 . . . . 0.0 110.067 -176.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.476 ' HA3' ' HG2' ' A' ' 46' ' ' PRO . . . 149.42 -162.2 28.98 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.204 174.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 16.1 m -63.45 120.7 12.17 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.932 0.396 . . . . 0.0 111.096 -177.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.8 m -118.77 139.63 51.26 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.272 178.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.747 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 14.6 m -139.56 145.12 38.24 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.548 -0.461 . . . . 0.0 111.376 -177.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.876 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 74.3 tt0 -118.26 124.48 47.95 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 116.042 -0.527 . . . . 0.0 109.615 174.484 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.614 HD13 ' CG2' ' A' ' 64' ' ' VAL . 13.5 mt -106.42 156.79 18.17 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.153 173.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -119.29 115.58 24.46 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.577 178.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.517 HD13 ' CH2' ' A' ' 30' ' ' TRP . 3.5 mt -114.26 158.72 38.94 Favored Pre-proline 0 C--N 1.321 -0.636 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -177.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -69.15 150.0 71.43 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 121.599 1.532 . . . . 0.0 111.226 174.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.507 ' HB3' ' C ' ' A' ' 38' ' ' THR . 10.1 pt-20 -46.48 -25.1 0.61 Allowed 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 114.859 -1.064 . . . . 0.0 113.099 177.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 10.0 t -104.63 15.04 28.79 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.236 -174.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -84.69 162.32 19.73 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 178.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.46 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 27.8 p-10 -142.02 10.42 1.96 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -176.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.567 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 23.0 p -167.42 136.94 2.76 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.77 -177.315 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.638 HG11 ' CD2' ' A' ' 66' ' ' LEU . 2.8 p -120.64 137.49 54.22 Favored 'Isoleucine or valine' 0 C--O 1.247 0.96 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.801 177.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 42.3 m -90.57 100.94 13.69 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.22 166.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.638 ' CD2' HG11 ' A' ' 64' ' ' VAL . 0.5 OUTLIER -76.41 133.52 39.86 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.475 179.352 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 10.7 p -128.37 160.09 33.32 Favored 'General case' 0 N--CA 1.447 -0.583 0 O-C-N 123.878 0.736 . . . . 0.0 110.521 -174.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 65.13 52.03 1.56 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.202 -178.061 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.546 ' O ' HG22 ' A' ' 24' ' ' THR . 6.6 mt -95.1 -175.75 3.62 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 172.401 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.442 ' N ' ' HH ' ' A' ' 75' ' ' TYR . 18.6 mm-40 -127.45 132.77 24.49 Favored Pre-proline 0 C--N 1.321 -0.638 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 175.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -65.57 133.39 34.24 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.879 2.386 . . . . 0.0 112.878 -179.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 77.84 28.99 55.77 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.993 -0.622 . . . . 0.0 111.93 179.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.407 HG12 ' N ' ' A' ' 74' ' ' GLN . 97.5 t -132.01 141.55 45.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.998 0.428 . . . . 0.0 110.398 -178.099 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.58 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 7.7 tp60 -84.61 111.76 19.83 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.183 -175.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.442 ' HH ' ' N ' ' A' ' 70' ' ' GLN . 11.5 m-85 -103.01 127.58 50.2 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.303 0.573 . . . . 0.0 112.011 -176.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.562 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 14.4 m120 -95.72 111.14 23.16 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.278 176.194 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.582 ' HB ' HG13 ' A' ' 93' ' ' ILE . 5.0 mp -92.44 118.09 37.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 176.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.875 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 28.4 m -108.75 113.83 27.12 Favored 'General case' 0 N--CA 1.426 -1.629 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.176 -179.6 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.522 HD13 HG23 ' A' ' 77' ' ' ILE . 13.9 mm -95.12 133.5 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -179.688 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.406 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 71.2 m-85 -121.42 111.89 17.86 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.372 179.589 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.579 ' HB2' HG22 ' A' ' 37' ' ' ILE . . . -81.28 109.17 15.54 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 171.475 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.559 HG12 ' C ' ' A' ' 39' ' ' GLY . 7.4 p -101.09 137.69 27.82 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.604 0 C-N-CA 120.095 -0.642 . . . . 0.0 111.32 -172.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 11.5 tm-20 -117.05 167.41 11.17 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 179.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -46.27 -41.01 12.47 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -174.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 46.3 t-20 -109.38 -32.42 7.17 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -172.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 22.8 pt20 -133.81 176.97 8.09 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.098 -165.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -130.91 135.32 47.57 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 176.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 16.3 m -65.83 170.42 5.39 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.805 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.462 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 1.2 p -54.62 153.66 10.31 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.141 173.434 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -85.93 142.04 7.55 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 121.753 1.635 . . . . 0.0 113.724 -176.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.875 ' O ' ' HA ' ' A' ' 78' ' ' THR . 4.8 t -82.27 123.89 38.69 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.833 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 167.032 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.7 t -120.39 106.04 18.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 C-N-CA 119.862 -0.735 . . . . 0.0 109.961 172.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.582 HG13 ' HB ' ' A' ' 77' ' ' ILE . 7.8 pt -121.02 113.03 38.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.995 176.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.514 ' HB3' ' ND2' ' A' ' 76' ' ' ASN . 11.9 pt20 -99.56 117.66 34.43 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.408 0.623 . . . . 0.0 110.977 -176.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.31 130.63 43.01 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.457 ' HA ' ' HA ' ' A' ' 74' ' ' GLN . 40.4 tt0 -89.23 128.8 35.86 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.338 0.59 . . . . 0.0 111.021 -177.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.524 HG22 HD11 ' A' ' 26' ' ' ILE . 32.8 p -59.19 126.05 26.12 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.148 -178.349 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 10.9 m -69.69 -30.95 68.72 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.472 0.653 . . . . 0.0 109.875 179.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 89.2 -137.31 14.09 Favored Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.86 178.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 21.1 m -130.53 122.14 19.65 Favored Pre-proline 0 C--N 1.317 -0.82 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 178.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_exo -42.97 -63.95 0.29 Allowed 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 123.232 2.622 . . . . 0.0 112.747 -175.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 26.3 ttm180 -148.72 118.51 7.07 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.382 178.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 42.9 m 64.3 -89.94 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.587 179.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -124.88 10.9 8.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.204 0.526 . . . . 0.0 110.349 179.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 142.11 -83.51 0.21 Allowed Glycine 0 N--CA 1.444 -0.787 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.11 179.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.8 t . . . . . 0 C--O 1.248 0.983 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.859 177.77 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.659 0 N-CA-C 111.792 -0.523 . . . . 0.0 111.792 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 31.1 m -83.68 108.53 16.81 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.791 0.329 . . . . 0.0 110.556 -179.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 32.8 m-70 -80.21 81.01 6.56 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.629 -179.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 84.2 mtp -93.36 -0.69 56.52 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.138 -177.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -88.22 -33.53 10.56 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.383 -0.913 . . . . 0.0 112.319 -179.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 13.3 t -88.42 -7.16 57.06 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 111.599 0.222 . . . . 0.0 111.599 -176.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.2 t -158.06 145.66 18.35 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.99 0.424 . . . . 0.0 110.805 -178.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 24.0 m -119.28 127.78 53.54 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.315 179.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -100.39 110.35 59.8 Favored Pre-proline 0 C--N 1.327 -0.396 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 176.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.494 ' HB2' ' OG ' ' A' ' 88' ' ' SER . 48.1 Cg_endo -76.37 135.87 17.1 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 122.282 1.988 . . . . 0.0 112.897 -176.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -87.97 162.38 16.89 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.879 178.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -96.92 163.0 21.05 Favored Pre-proline 0 C--N 1.322 -0.608 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 174.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -69.47 128.89 16.96 Favored 'Trans proline' 0 C--O 1.235 0.367 0 C-N-CA 122.27 1.98 . . . . 0.0 111.472 174.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -52.45 142.12 49.18 Favored 'Trans proline' 0 CA--C 1.509 -0.736 0 C-N-CA 122.306 2.004 . . . . 0.0 110.806 173.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.467 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 2.4 m-20 -35.79 103.16 0.24 Allowed Pre-proline 0 N--CA 1.465 0.291 0 O-C-N 125.069 1.48 . . . . 0.0 112.674 -164.373 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.743 ' CG ' HG11 ' A' ' 91' ' ' VAL . 5.2 Cg_endo -49.7 145.72 17.03 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 123.584 2.856 . . . . 0.0 113.134 169.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.6 m -101.51 131.83 47.46 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.354 179.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.451 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 70.9 t -73.98 112.1 10.26 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 CA-C-N 114.835 -1.075 . . . . 0.0 109.284 172.572 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -86.51 -36.62 18.88 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.666 -172.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -135.03 140.83 45.92 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.973 -176.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 47.5 t -133.81 139.94 47.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.492 -179.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.474 ' CG ' ' H ' ' A' ' 23' ' ' ASP . 12.4 t70 -146.69 -157.69 0.83 Allowed 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -179.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.48 ' HB3' ' HB3' ' A' ' 71' ' ' PRO . 7.0 m-20 -79.5 -70.91 0.48 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.425 0.631 . . . . 0.0 109.935 178.14 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.57 HG22 ' O ' ' A' ' 69' ' ' LEU . 69.7 p -104.71 34.96 2.93 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.775 -174.757 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.518 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 29.9 m -167.83 137.52 2.65 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 123.139 0.576 . . . . 0.0 110.062 -172.321 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.534 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 29.2 mt -153.17 149.76 13.07 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.117 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 177.553 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 47.3 t -122.37 137.0 57.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 119.517 1.053 . . . . 0.0 110.186 -176.385 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.556 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.8 OUTLIER -130.19 149.83 33.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 C-N-CA 120.129 -0.629 . . . . 0.0 110.383 179.341 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.449 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 55.1 mtp180 -134.31 120.44 19.92 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.392 -175.142 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.53 ' CH2' HD12 ' A' ' 57' ' ' LEU . 36.9 p90 -112.56 146.8 37.89 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.742 -173.039 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 35.5 t -89.24 91.96 8.98 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 173.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.448 ' HD3' ' H ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -50.94 153.37 3.07 Favored Pre-proline 0 CA--C 1.54 0.584 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.785 -176.129 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.626 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 5.1 Cg_exo -78.07 162.52 28.85 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 123.879 3.053 . . . . 0.0 112.592 -174.527 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -83.25 -7.74 59.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.405 172.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.33 150.94 70.64 Favored Pre-proline 0 CA--C 1.518 -0.262 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.737 175.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.574 ' O ' ' HG3' ' A' ' 83' ' ' GLU . 12.2 Cg_exo -69.77 114.46 3.71 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 121.128 1.219 . . . . 0.0 109.559 169.439 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.584 HG21 ' HB3' ' A' ' 81' ' ' ALA . 2.0 pt -128.85 142.59 43.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.454 ' N ' ' O ' ' A' ' 82' ' ' VAL . 12.6 p -92.2 -31.42 15.46 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -178.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.552 ' C ' HG12 ' A' ' 82' ' ' VAL . . . -163.41 -163.95 17.36 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.12 -1.038 . . . . 0.0 111.919 -177.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.626 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 5.4 m-85 -141.05 133.31 28.12 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.785 0.326 . . . . 0.0 111.323 175.419 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 10.1 mmm180 -103.7 149.61 24.81 Favored 'General case' 0 CA--C 1.503 -0.832 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 167.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.866 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 32.0 mt -138.7 107.08 3.51 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 C-N-CA 119.734 -0.787 . . . . 0.0 112.318 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 74.1 t -108.88 110.18 31.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.19 0.519 . . . . 0.0 110.646 -178.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.772 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 0.5 OUTLIER -110.34 124.9 52.53 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.552 176.019 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 35.6 t -137.34 135.41 19.42 Favored Pre-proline 0 C--N 1.318 -0.8 0 CA-C-N 113.926 -1.488 . . . . 0.0 111.33 -173.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.65 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 50.7 Cg_endo -70.19 130.89 19.57 Favored 'Trans proline' 0 CA--C 1.527 0.156 0 C-N-CA 123.472 2.781 . . . . 0.0 112.005 175.557 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 14.5 m -70.31 -16.81 63.05 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.035 0.445 . . . . 0.0 111.303 -178.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.419 ' O ' ' HB2' ' A' ' 49' ' ' GLU . 15.8 m -105.86 16.62 6.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.59 177.601 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.419 ' HB2' ' O ' ' A' ' 48' ' ' VAL . 24.3 mm-40 71.26 161.37 0.23 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.861 -1.063 . . . . 0.0 111.912 -178.379 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 145.3 -134.98 5.76 Favored Glycine 0 N--CA 1.446 -0.64 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 -176.043 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 27.2 t -93.59 121.26 34.82 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.957 0.379 . . . . 0.0 110.817 179.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.3 p -117.92 143.06 46.67 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.232 176.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.772 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 24.4 m -142.78 147.8 36.11 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.457 -0.497 . . . . 0.0 111.557 -174.588 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.866 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 21.8 tt0 -116.44 122.34 44.49 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.148 172.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.597 HD12 ' CG2' ' A' ' 64' ' ' VAL . 12.8 mt -99.8 160.54 14.23 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.613 -0.435 . . . . 0.0 109.882 172.153 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -122.54 117.66 26.43 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.53 HD12 ' CH2' ' A' ' 30' ' ' TRP . 3.9 mt -116.02 158.2 43.09 Favored Pre-proline 0 C--N 1.318 -0.796 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -177.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -70.71 152.17 64.18 Favored 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 121.298 1.332 . . . . 0.0 111.124 173.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.445 ' HG3' ' N ' ' A' ' 60' ' ' THR . 8.1 pt-20 -43.62 -39.65 3.65 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.548 0.69 . . . . 0.0 111.796 175.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.445 ' N ' ' HG3' ' A' ' 59' ' ' GLU . 9.7 t -88.24 19.07 3.92 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.467 -174.119 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -91.79 164.38 13.72 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 175.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.449 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 30.3 p-10 -149.28 16.08 0.92 Allowed 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -178.243 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.556 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 17.3 p -170.13 134.17 1.21 Allowed 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.446 -0.502 . . . . 0.0 112.017 -179.575 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.638 HG12 ' CD2' ' A' ' 66' ' ' LEU . 3.2 p -119.52 137.68 52.63 Favored 'Isoleucine or valine' 0 C--O 1.244 0.772 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.347 177.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 42.2 m -94.71 101.49 13.33 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-O 121.573 0.701 . . . . 0.0 109.332 167.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.638 ' CD2' HG12 ' A' ' 64' ' ' VAL . 0.2 OUTLIER -76.59 139.49 40.68 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.362 178.533 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 14.2 t -134.88 171.04 14.95 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -176.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 64.89 35.19 8.58 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 123.786 0.679 . . . . 0.0 110.795 -179.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.57 ' O ' HG22 ' A' ' 24' ' ' THR . 7.5 mt -85.08 -176.96 6.41 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 174.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 19.6 mm-40 -123.37 132.5 24.28 Favored Pre-proline 0 C--N 1.318 -0.782 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 173.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.48 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . 37.2 Cg_endo -66.74 128.01 18.15 Favored 'Trans proline' 0 C--O 1.234 0.311 0 C-N-CA 122.722 2.281 . . . . 0.0 112.517 179.47 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 83.49 33.8 21.44 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.991 -0.623 . . . . 0.0 111.851 -179.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 72.1 t -134.84 140.79 44.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.085 0.469 . . . . 0.0 111.047 -176.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.65 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -79.34 118.41 21.23 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.233 -178.481 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.467 ' CE2' HD21 ' A' ' 69' ' ' LEU . 9.2 m-85 -114.32 121.4 43.52 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.095 0.474 . . . . 0.0 112.143 -177.69 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.549 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 0.8 OUTLIER -88.47 113.38 24.0 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.418 170.669 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.551 ' HB ' HG13 ' A' ' 93' ' ' ILE . 4.9 mp -92.2 115.47 31.24 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.661 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 173.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.874 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 19.4 m -107.24 113.31 26.64 Favored 'General case' 0 N--CA 1.427 -1.615 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.421 -178.516 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.522 HD12 HG23 ' A' ' 77' ' ' ILE . 11.3 mm -94.78 136.09 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.022 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.433 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 80.7 m-85 -122.35 110.94 16.28 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.92 179.104 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.584 ' HB3' HG21 ' A' ' 37' ' ' ILE . . . -80.14 107.62 13.07 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 171.001 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.552 HG12 ' C ' ' A' ' 39' ' ' GLY . 7.3 p -99.96 137.61 26.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 C-N-CA 119.854 -0.738 . . . . 0.0 110.572 -173.464 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.643 ' HG2' ' N ' ' A' ' 84' ' ' GLU . 2.1 tt0 -111.85 166.8 10.89 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 124.014 0.821 . . . . 0.0 109.597 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.643 ' N ' ' HG2' ' A' ' 83' ' ' GLU . 34.3 mt-10 -41.23 -53.06 3.27 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 123.008 0.523 . . . . 0.0 111.955 177.107 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -124.53 8.26 8.33 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -173.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -140.41 174.22 10.73 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.025 0.441 . . . . 0.0 111.56 -176.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -136.8 122.26 19.52 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 172.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.494 ' OG ' ' HB2' ' A' ' 10' ' ' PRO . 32.6 m -64.72 168.69 5.82 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.712 0.292 . . . . 0.0 110.951 178.579 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.1 p -56.09 151.71 24.74 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.768 176.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -82.92 136.28 8.06 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 121.985 1.79 . . . . 0.0 113.139 -178.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.874 ' O ' ' HA ' ' A' ' 78' ' ' THR . 54.0 t -82.77 119.03 31.5 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.755 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 169.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.8 t -116.77 105.24 17.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 C-N-CA 119.249 -0.98 . . . . 0.0 109.965 173.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.551 HG13 ' HB ' ' A' ' 77' ' ' ILE . 7.4 pt -118.1 111.59 34.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.438 176.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -101.15 127.69 47.59 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.518 0.675 . . . . 0.0 111.04 -174.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -140.34 134.56 31.09 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.296 -0.866 . . . . 0.0 108.82 -179.224 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.587 ' CG ' ' HG2' ' A' ' 74' ' ' GLN . 47.0 mt-10 -86.61 126.56 34.59 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 120.81 0.338 . . . . 0.0 110.765 178.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.519 HG23 HD11 ' A' ' 26' ' ' ILE . 35.0 p -56.23 119.59 6.21 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.32 179.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 25.6 m -67.93 -30.29 69.57 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.591 -178.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 89.51 -138.42 14.62 Favored Glycine 0 N--CA 1.432 -1.602 0 CA-C-N 114.794 -1.093 . . . . 0.0 111.016 -179.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 18.2 m -84.27 118.69 71.82 Favored Pre-proline 0 C--N 1.314 -0.941 0 N-CA-C 110.266 -0.272 . . . . 0.0 110.266 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -59.9 100.31 0.14 Allowed 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 123.044 2.496 . . . . 0.0 112.336 -178.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 87.4 mtt180 -85.29 -58.54 2.64 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.902 -179.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 10.0 t 54.98 78.02 0.19 Allowed 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.531 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -112.71 158.34 20.17 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.304 -179.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -78.49 81.52 1.34 Allowed Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.143 178.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 34.7 p . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.236 -0.888 . . . . 0.0 112.037 -179.215 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.539 0 N-CA-C 111.841 -0.504 . . . . 0.0 111.841 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.2 m -87.78 70.96 9.63 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.139 0.495 . . . . 0.0 110.483 179.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 22.4 t60 -82.01 65.94 7.37 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.458 0.647 . . . . 0.0 109.708 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 21.6 ptp -124.42 37.83 4.32 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.269 -177.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 85.78 -58.52 4.81 Favored Glycine 0 N--CA 1.45 -0.403 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 -174.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 16.7 p -79.21 78.71 5.67 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 121.133 0.492 . . . . 0.0 110.357 175.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.407 ' O ' ' HB ' ' A' ' 8' ' ' THR . 31.4 p -68.89 160.02 31.49 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.065 -178.104 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.407 ' HB ' ' O ' ' A' ' 7' ' ' THR . 63.4 m 71.89 122.44 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.205 0.526 . . . . 0.0 110.926 -176.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -137.43 120.98 11.73 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.174 179.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -78.28 176.48 9.89 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.241 1.961 . . . . 0.0 112.097 179.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.42 ' H ' ' HB1' ' A' ' 35' ' ' ALA . 23.5 m-20 -138.93 161.36 37.52 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -175.079 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.452 ' HB1' ' O ' ' A' ' 89' ' ' THR . . . -96.32 164.41 18.46 Favored Pre-proline 0 C--N 1.313 -0.997 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 175.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.41 ' HB2' ' HB2' ' A' ' 30' ' ' TRP . 17.4 Cg_exo -70.47 126.99 13.43 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 121.926 1.751 . . . . 0.0 111.062 172.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.689 ' HD2' ' O ' ' A' ' 31' ' ' SER . 95.4 Cg_exo -45.54 147.46 2.78 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.931 2.421 . . . . 0.0 111.858 172.504 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -32.74 105.36 0.24 Allowed Pre-proline 0 N--CA 1.468 0.456 0 O-C-N 125.016 1.448 . . . . 0.0 112.842 -170.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.534 ' HG2' HG12 ' A' ' 91' ' ' VAL . 20.8 Cg_exo -72.24 151.39 54.6 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 123.803 3.002 . . . . 0.0 112.113 177.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 24.0 m -119.68 135.06 54.98 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 121.72 0.771 . . . . 0.0 111.11 -176.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.45 ' HA ' ' HA ' ' A' ' 28' ' ' VAL . 71.9 t -77.64 125.41 37.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-N 114.16 -1.382 . . . . 0.0 109.864 174.59 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -88.05 -47.29 8.63 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.208 -174.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -136.88 145.83 44.82 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 120.978 0.418 . . . . 0.0 110.854 179.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 26.3 m -130.94 139.9 49.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.461 -179.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.445 ' HB2' ' HG ' ' A' ' 25' ' ' SER . 29.2 m-20 -135.34 -153.5 0.52 Allowed 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 175.374 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.452 ' CB ' ' HB3' ' A' ' 71' ' ' PRO . 5.5 m-20 -76.3 -73.47 0.27 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.546 0.689 . . . . 0.0 110.497 178.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.686 HG22 ' O ' ' A' ' 69' ' ' LEU . 35.0 p -102.07 37.01 1.95 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.698 -174.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.676 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 55.3 p -169.55 134.08 1.39 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.14 -173.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.613 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 13.3 mt -150.6 142.08 16.71 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.819 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.439 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 38.6 t -115.96 129.02 73.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 119.184 0.902 . . . . 0.0 110.906 -176.204 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.623 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.7 OUTLIER -123.27 145.71 29.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -177.742 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.443 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 59.5 mtp180 -131.78 122.4 25.74 Favored 'General case' 0 C--N 1.329 -0.298 0 O-C-N 123.254 0.346 . . . . 0.0 110.706 -174.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.547 ' CH2' HD13 ' A' ' 57' ' ' LEU . 34.5 p90 -114.36 148.42 37.65 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.674 -0.694 . . . . 0.0 112.004 -174.265 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.689 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 24.1 t -92.69 86.47 5.56 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.612 177.119 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.483 ' HD3' ' H ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -43.08 150.96 0.43 Allowed Pre-proline 0 CA--C 1.548 0.869 0 C-N-CA 124.011 0.924 . . . . 0.0 113.39 -176.043 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.72 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 6.3 Cg_exo -78.46 167.79 22.34 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 124.473 3.448 . . . . 0.0 114.9 -164.394 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -68.35 -28.62 67.29 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 114.308 -1.314 . . . . 0.0 109.642 170.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.42 ' HB1' ' H ' ' A' ' 11' ' ' ASP . . . -61.87 137.43 95.32 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 114.99 -1.005 . . . . 0.0 111.403 -179.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_exo -70.66 115.03 4.04 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 121.394 1.396 . . . . 0.0 109.366 167.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.573 HG21 ' HB2' ' A' ' 81' ' ' ALA . 0.4 OUTLIER -118.64 159.35 19.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -174.745 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.404 ' N ' ' O ' ' A' ' 82' ' ' VAL . 16.7 p -101.47 -27.62 13.03 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -178.452 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -168.04 -168.9 30.83 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 119.879 -1.153 . . . . 0.0 112.365 177.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.72 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 5.0 m-85 -137.5 134.46 35.76 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 121.076 0.465 . . . . 0.0 111.438 177.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.8 mtm180 -112.95 147.54 36.9 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.103 170.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.884 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 27.1 mt -137.98 109.76 6.2 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 C-N-CA 119.886 -0.726 . . . . 0.0 112.841 -173.281 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 97.5 t -110.81 111.16 34.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.086 0.469 . . . . 0.0 110.941 -178.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.822 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 0.9 OUTLIER -115.69 126.65 54.39 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.267 177.366 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.6 p -136.67 138.25 25.88 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-N 113.922 -1.49 . . . . 0.0 111.889 -174.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.466 ' HD3' ' O ' ' A' ' 51' ' ' SER . 94.6 Cg_endo -80.44 143.21 15.23 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 123.611 2.874 . . . . 0.0 111.604 176.043 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 16.4 t -71.02 -28.61 64.52 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.851 -175.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.7 m -114.69 -34.81 2.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -177.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.497 ' CG ' HG22 ' A' ' 73' ' ' VAL . 31.1 mm-40 -87.09 -172.75 4.11 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.753 0.311 . . . . 0.0 111.106 -177.227 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -119.94 -11.82 6.8 Favored Glycine 0 N--CA 1.443 -0.889 0 C-N-CA 120.359 -0.924 . . . . 0.0 114.773 -171.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.466 ' O ' ' HD3' ' A' ' 46' ' ' PRO . 7.7 m -78.21 111.4 14.11 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 118.992 1.396 . . . . 0.0 110.168 -178.639 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 28.8 p -123.31 147.21 47.24 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.576 176.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.822 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 12.4 m -140.01 148.72 42.28 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 119.535 -0.866 . . . . 0.0 111.595 -179.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.884 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 37.5 tt0 -122.68 112.15 17.6 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.557 177.269 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.6 HD12 ' CG2' ' A' ' 64' ' ' VAL . 11.7 mt -99.56 164.27 12.15 Favored 'General case' 0 CA--C 1.511 -0.531 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.633 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.404 ' O ' HD21 ' A' ' 57' ' ' LEU . 18.6 t-20 -126.27 118.86 25.99 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.586 179.475 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.547 HD13 ' CH2' ' A' ' 30' ' ' TRP . 5.3 mt -119.02 159.12 46.11 Favored Pre-proline 0 C--N 1.318 -0.801 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 -178.02 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -65.13 153.44 78.26 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 121.717 1.612 . . . . 0.0 111.258 174.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -49.98 -26.7 4.49 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.074 176.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 10.2 t -101.23 13.63 34.5 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.053 -175.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.5 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -80.34 161.53 24.99 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 178.274 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.443 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 27.7 p-10 -147.73 16.54 1.12 Allowed 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -178.16 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.623 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 19.7 p -171.49 134.42 0.86 Allowed 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.23 -0.588 . . . . 0.0 111.645 179.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.637 HG12 ' CD2' ' A' ' 66' ' ' LEU . 3.1 p -118.83 137.36 53.06 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.399 176.548 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 52.1 m -95.71 100.82 12.49 Favored 'General case' 0 N--CA 1.433 -1.301 0 CA-C-O 121.573 0.701 . . . . 0.0 109.18 169.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.715 ' HB3' ' CE2' ' A' ' 44' ' ' TYR . 0.3 OUTLIER -74.9 141.33 44.14 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.173 178.439 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.416 ' HA ' ' O ' ' A' ' 24' ' ' THR . 9.7 t -136.07 168.97 18.36 Favored 'General case' 0 N--CA 1.444 -0.75 0 O-C-N 123.605 0.566 . . . . 0.0 109.762 -178.126 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 62.92 34.34 14.25 Favored 'General case' 0 CA--C 1.519 -0.234 0 O-C-N 123.787 0.679 . . . . 0.0 111.252 -178.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.686 ' O ' HG22 ' A' ' 24' ' ' THR . 9.4 mt -79.62 -177.21 5.73 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 174.108 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.466 ' HG2' ' HG3' ' A' ' 49' ' ' GLU . 55.7 tp60 -123.33 125.01 26.24 Favored Pre-proline 0 C--N 1.314 -0.947 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 175.597 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.452 ' HB3' ' CB ' ' A' ' 23' ' ' ASP . 39.4 Cg_endo -65.28 133.97 37.21 Favored 'Trans proline' 0 CA--C 1.53 0.316 0 C-N-CA 123.019 2.48 . . . . 0.0 113.12 -175.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 82.48 35.49 19.83 Favored Glycine 0 N--CA 1.45 -0.386 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.901 -179.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.497 HG22 ' CG ' ' A' ' 49' ' ' GLU . 45.4 t -137.4 149.91 25.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.0 0.428 . . . . 0.0 111.026 -175.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 8.9 tp60 -87.98 111.34 21.38 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.433 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.508 ' CE2' HD22 ' A' ' 69' ' ' LEU . 4.7 m-85 -102.01 123.34 45.72 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.878 -177.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.522 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 74.9 m-20 -93.5 107.6 19.42 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.151 175.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.543 ' HB ' HG13 ' A' ' 93' ' ' ILE . 5.2 mp -92.69 118.67 38.81 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.596 0 CA-C-O 121.229 0.538 . . . . 0.0 109.717 176.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.826 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 30.0 m -110.16 116.19 31.08 Favored 'General case' 0 N--CA 1.428 -1.553 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.331 179.618 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.514 HD12 HG21 ' A' ' 77' ' ' ILE . 12.4 mm -95.5 130.79 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -117.53 112.14 20.2 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 177.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.573 ' HB2' HG21 ' A' ' 37' ' ' ILE . . . -82.69 127.61 33.56 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 169.588 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.404 ' O ' ' N ' ' A' ' 38' ' ' THR . 6.5 p -117.59 135.88 56.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 C-N-CA 120.194 -0.603 . . . . 0.0 110.804 -177.265 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.569 ' HG3' HG23 ' A' ' 37' ' ' ILE . 2.4 mp0 -113.37 170.17 8.43 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -38.65 -52.65 1.65 Allowed 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -174.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -131.09 17.31 5.05 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.943 -0.303 . . . . 0.0 110.814 -176.15 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 18.1 mm-40 -142.19 173.5 11.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.795 0.331 . . . . 0.0 110.915 -176.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -135.81 125.58 25.58 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 175.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 47.6 m -73.1 170.5 14.77 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.734 0.302 . . . . 0.0 111.079 178.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.452 ' O ' ' HB1' ' A' ' 12' ' ' ALA . 2.8 p -62.58 153.03 79.37 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 120.973 0.416 . . . . 0.0 111.096 178.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -86.03 140.92 6.97 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.516 2.144 . . . . 0.0 114.387 -177.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.826 ' O ' ' HA ' ' A' ' 78' ' ' THR . 21.0 t -82.33 127.4 39.67 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.624 0 CA-C-N 114.83 -1.077 . . . . 0.0 108.575 167.132 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 11.7 t -121.84 106.9 18.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 C-N-CA 119.935 -0.706 . . . . 0.0 109.884 170.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.543 HG13 ' HB ' ' A' ' 77' ' ' ILE . 8.6 pt -122.58 116.79 49.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.166 178.342 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -100.03 124.96 45.98 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.601 0.715 . . . . 0.0 110.953 -177.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.67 134.25 40.93 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.311 178.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -84.89 137.05 33.37 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.965 0.412 . . . . 0.0 110.037 178.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.481 HG21 HD12 ' A' ' 26' ' ' ILE . 25.5 p -71.13 113.0 7.73 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.778 176.13 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 33.1 m -69.01 -28.91 67.01 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.837 0.827 . . . . 0.0 109.638 -179.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 87.46 -148.09 21.04 Favored Glycine 0 N--CA 1.436 -1.339 0 CA-C-N 114.7 -1.137 . . . . 0.0 111.877 176.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 4.7 m -68.91 120.16 74.39 Favored Pre-proline 0 C--N 1.316 -0.868 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 178.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -42.2 108.09 0.09 OUTLIER 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 123.787 2.991 . . . . 0.0 113.262 -176.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 7.5 ptm180 -81.7 122.59 27.84 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.768 -178.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 19.6 m -71.69 143.17 49.78 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.559 176.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 62.74 48.51 4.16 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.614 0.721 . . . . 0.0 109.851 -174.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -176.85 -44.82 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.041 -0.981 . . . . 0.0 111.279 -179.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 65.4 m . . . . . 0 C--O 1.248 0.984 0 CA-C-O 118.917 -0.563 . . . . 0.0 109.713 174.594 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.655 0 N-CA-C 111.572 -0.611 . . . . 0.0 111.572 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.0 m 55.65 42.81 29.05 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 120.891 0.377 . . . . 0.0 111.443 178.938 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 45.0 m170 -75.54 128.43 35.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.454 -179.393 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 14.7 tpt 58.49 70.83 0.62 Allowed 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.813 0.816 . . . . 0.0 110.102 -176.704 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 164.95 58.02 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.619 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.93 -177.682 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.8 t -66.77 117.75 9.33 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.338 0.589 . . . . 0.0 111.737 -175.788 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.1 m -82.75 74.47 9.71 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 172.093 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 32.1 m -65.03 123.33 19.21 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.382 -0.826 . . . . 0.0 112.233 -172.33 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -93.83 146.44 31.71 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.906 178.652 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.438 ' HB2' ' OG ' ' A' ' 88' ' ' SER . 74.0 Cg_endo -73.21 150.91 48.33 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 122.515 2.143 . . . . 0.0 111.991 179.899 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.439 ' H ' ' HB1' ' A' ' 35' ' ' ALA . 13.8 p-10 -110.72 157.4 19.79 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.185 -178.622 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -96.39 161.07 28.14 Favored Pre-proline 0 C--N 1.32 -0.716 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.196 177.302 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.413 ' HB3' ' O ' ' A' ' 31' ' ' SER . 23.6 Cg_exo -68.28 130.91 22.18 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.507 2.138 . . . . 0.0 112.252 177.306 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -50.87 151.26 11.52 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.81 2.34 . . . . 0.0 111.572 172.899 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -38.88 106.13 0.37 Allowed Pre-proline 0 N--CA 1.47 0.573 0 O-C-N 124.493 1.121 . . . . 0.0 112.251 -170.552 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.56 ' HG2' HG12 ' A' ' 91' ' ' VAL . 34.3 Cg_exo -64.59 149.68 89.46 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 123.504 2.803 . . . . 0.0 112.691 179.594 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 28.0 m -105.24 129.39 53.62 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.988 -1.006 . . . . 0.0 110.71 -177.423 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.451 HG11 ' O ' ' A' ' 27' ' ' VAL . 70.6 t -81.02 123.31 37.49 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 CA-C-N 114.522 -1.217 . . . . 0.0 110.049 175.639 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -89.39 -37.39 14.88 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.435 -174.756 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -135.05 134.75 40.7 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.851 0.358 . . . . 0.0 110.601 -177.898 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.479 ' HA ' HG12 ' A' ' 26' ' ' ILE . 59.2 t -130.0 117.93 42.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.334 179.184 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -128.21 -160.76 1.04 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.84 175.405 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.552 ' O ' ' HB2' ' A' ' 69' ' ' LEU . 1.9 m-20 -77.19 -58.4 3.3 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.043 0.449 . . . . 0.0 110.91 -177.718 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.638 HG21 ' O ' ' A' ' 69' ' ' LEU . 34.9 p -113.11 34.42 4.47 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.131 -175.458 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.624 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 75.8 p -169.88 130.94 1.03 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.626 -176.583 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.582 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 43.4 mt -147.17 139.51 18.98 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.624 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 176.841 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.451 ' O ' HG11 ' A' ' 18' ' ' VAL . 39.9 t -118.17 130.13 73.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 118.697 0.681 . . . . 0.0 110.586 -175.702 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.678 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.6 OUTLIER -122.81 145.87 28.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 C-N-CA 120.496 -0.482 . . . . 0.0 110.009 -177.368 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.562 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 29.8 mtm180 -130.81 121.11 24.75 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 123.358 0.411 . . . . 0.0 110.68 -175.946 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.525 ' CH2' HD13 ' A' ' 57' ' ' LEU . 38.2 p90 -110.26 144.23 39.27 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.608 -173.994 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.413 ' O ' ' HB3' ' A' ' 13' ' ' PRO . 17.6 m -89.31 96.8 10.86 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.027 177.167 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.587 ' NE ' ' HB3' ' A' ' 62' ' ' ASN . 0.1 OUTLIER -45.73 155.85 0.46 Allowed Pre-proline 0 CA--C 1.538 0.515 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -175.105 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.672 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 4.6 Cg_exo -82.95 169.91 12.78 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 124.519 3.479 . . . . 0.0 112.623 -172.416 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -81.21 -18.0 47.65 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.181 174.518 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.439 ' HB1' ' H ' ' A' ' 11' ' ' ASP . . . -64.18 142.08 98.21 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.499 177.863 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_exo -70.72 115.26 4.15 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 121.487 1.458 . . . . 0.0 109.614 168.432 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.609 HG21 ' HG3' ' A' ' 83' ' ' GLU . 0.8 OUTLIER -121.72 152.15 25.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -174.91 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 11.8 p -98.12 -31.65 12.01 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -177.637 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.448 ' C ' HG13 ' A' ' 82' ' ' VAL . . . -163.15 -164.39 18.09 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.267 -0.968 . . . . 0.0 111.698 177.977 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.672 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 6.4 m-85 -140.32 136.13 32.91 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.848 0.324 . . . . 0.0 111.124 175.162 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 21.6 mtp180 -104.69 151.38 23.77 Favored 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 166.393 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.882 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 32.6 mt -139.59 108.47 3.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 C-N-CA 120.617 -0.433 . . . . 0.0 111.977 -178.491 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 72.6 t -107.77 109.64 28.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.306 0.574 . . . . 0.0 110.194 178.322 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.7 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 0.6 OUTLIER -110.46 125.14 52.97 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.138 175.908 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.1 m -143.17 133.88 12.4 Favored Pre-proline 0 C--N 1.316 -0.874 0 CA-C-N 113.928 -1.487 . . . . 0.0 110.808 -175.379 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.528 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 57.6 Cg_endo -73.95 130.92 14.98 Favored 'Trans proline' 0 C--N 1.333 -0.274 0 C-N-CA 123.108 2.539 . . . . 0.0 111.694 176.162 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 41.7 t -64.02 -24.11 67.59 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.309 -178.621 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 13.7 m -99.59 16.04 3.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.852 0.358 . . . . 0.0 111.167 178.783 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 74.36 152.75 0.13 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.919 -1.037 . . . . 0.0 111.381 178.121 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 155.73 -131.12 2.96 Favored Glycine 0 N--CA 1.448 -0.505 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 -176.366 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.518 ' O ' ' HE2' ' A' ' 75' ' ' TYR . 19.8 m -92.28 119.85 32.26 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 117.245 0.523 . . . . 0.0 110.74 179.705 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 15.5 m -117.98 137.26 52.98 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 176.531 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.7 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 23.5 m -144.77 151.93 39.59 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 120.443 -0.503 . . . . 0.0 111.476 -175.705 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.882 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 51.4 tt0 -121.61 112.44 18.46 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.619 176.251 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.617 HD11 ' CG2' ' A' ' 64' ' ' VAL . 18.1 mt -97.48 163.0 13.05 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.013 176.885 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.503 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 18.5 m120 -129.75 113.27 14.51 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.884 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.525 HD13 ' CH2' ' A' ' 30' ' ' TRP . 3.5 mt -110.98 157.62 38.14 Favored Pre-proline 0 C--N 1.317 -0.831 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -174.431 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -64.59 150.45 88.19 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 121.849 1.699 . . . . 0.0 111.157 175.484 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -48.31 -23.03 0.78 Allowed 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 115.177 -0.919 . . . . 0.0 112.852 177.908 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 5.1 t -99.86 1.6 43.07 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.215 -175.859 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.48 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -76.06 159.57 30.65 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 -176.951 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.587 ' HB3' ' NE ' ' A' ' 32' ' ' ARG . 28.6 p-10 -147.03 18.52 1.24 Allowed 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 120.554 -0.458 . . . . 0.0 112.231 -178.421 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.678 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 23.2 p -169.22 133.65 1.43 Allowed 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.164 -0.615 . . . . 0.0 112.155 -179.9 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.617 ' CG2' HD11 ' A' ' 55' ' ' LEU . 3.6 p -118.44 137.11 53.46 Favored 'Isoleucine or valine' 0 C--O 1.242 0.673 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.203 176.257 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 61.0 m -97.68 101.98 13.63 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.752 171.65 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.624 ' O ' ' HA ' ' A' ' 25' ' ' SER . 0.2 OUTLIER -80.59 140.22 35.87 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.362 179.397 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 22.0 t -134.11 168.23 19.21 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 123.438 0.461 . . . . 0.0 110.642 -173.455 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 58.75 31.34 21.09 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.991 -177.811 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.638 ' O ' HG21 ' A' ' 24' ' ' THR . 14.3 mt -69.16 -175.44 0.76 Allowed 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 175.19 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.45 ' N ' ' HH ' ' A' ' 75' ' ' TYR . 8.6 tt0 -126.87 125.53 24.28 Favored Pre-proline 0 C--N 1.318 -0.772 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 178.407 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.406 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . 27.0 Cg_endo -63.52 130.04 27.02 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 123.03 2.486 . . . . 0.0 113.418 -177.346 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 88.18 22.05 43.0 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.774 -179.917 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 86.6 t -127.38 144.26 37.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.145 0.498 . . . . 0.0 111.308 -173.35 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.528 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 15.8 tp60 -88.88 107.18 18.86 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.98 -176.566 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.518 ' HE2' ' O ' ' A' ' 51' ' ' SER . 16.0 m-85 -98.09 117.79 33.24 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.224 0.535 . . . . 0.0 111.64 -178.079 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -90.4 107.9 19.44 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.127 177.629 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.527 HG21 HD13 ' A' ' 79' ' ' ILE . 5.3 mp -91.73 116.4 32.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.294 0.569 . . . . 0.0 109.684 178.988 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.834 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 30.8 m -108.47 115.26 29.77 Favored 'General case' 0 N--CA 1.428 -1.525 0 CA-C-N 115.294 -0.867 . . . . 0.0 110.404 -179.791 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.527 HD13 HG21 ' A' ' 77' ' ' ILE . 14.3 mm -95.46 144.23 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -179.255 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -131.17 112.12 12.55 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.233 179.374 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.562 ' HB3' HG22 ' A' ' 37' ' ' ILE . . . -79.02 123.69 27.55 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 169.117 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.448 HG13 ' C ' ' A' ' 39' ' ' GLY . 7.0 p -114.53 135.91 52.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 C-N-CA 120.149 -0.621 . . . . 0.0 110.685 -179.824 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.663 ' OE1' ' HG3' ' A' ' 86' ' ' GLN . 3.9 mp0 -112.28 170.68 8.0 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -179.164 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -38.76 -55.78 1.44 Allowed 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -174.09 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -125.23 9.85 8.01 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -176.233 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.663 ' HG3' ' OE1' ' A' ' 83' ' ' GLU . 3.3 pt20 -143.03 176.49 9.06 Favored 'General case' 0 N--CA 1.447 -0.623 0 O-C-N 122.336 -0.227 . . . . 0.0 111.0 -175.095 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -138.28 136.08 36.12 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.004 178.432 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.438 ' OG ' ' HB2' ' A' ' 10' ' ' PRO . 46.2 m -78.24 175.46 10.18 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.168 178.297 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -63.09 160.69 37.13 Favored Pre-proline 0 CA--C 1.534 0.344 0 CA-C-O 120.973 0.416 . . . . 0.0 111.523 178.614 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -87.85 140.46 5.01 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.302 2.002 . . . . 0.0 114.365 -178.497 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.834 ' O ' ' HA ' ' A' ' 78' ' ' THR . 6.9 t -82.72 127.65 39.47 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.688 0 CA-C-N 114.825 -1.08 . . . . 0.0 108.34 165.863 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.4 t -124.05 106.06 16.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 C-N-CA 120.027 -0.669 . . . . 0.0 109.596 172.476 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.506 HG13 ' HB ' ' A' ' 77' ' ' ILE . 7.7 pt -124.2 112.87 34.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.418 178.674 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -94.07 120.17 33.94 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.315 0.579 . . . . 0.0 111.05 -177.66 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.33 125.37 42.16 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.486 175.482 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.432 ' HA ' ' HA ' ' A' ' 74' ' ' GLN . 40.9 tt0 -90.0 128.08 36.18 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.18 0.514 . . . . 0.0 110.034 179.783 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.508 HG22 HD13 ' A' ' 26' ' ' ILE . 40.3 p -59.52 144.71 46.56 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.948 -176.524 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 16.4 m -68.63 -31.98 71.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.342 -171.752 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 58.85 75.3 0.27 Allowed Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.686 -0.769 . . . . 0.0 111.832 178.366 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.412 ' HA ' ' HD3' ' A' ' 101' ' ' PRO . 3.5 m -66.08 131.0 94.41 Favored Pre-proline 0 C--N 1.314 -0.944 0 CA-C-N 114.838 -0.681 . . . . 0.0 110.687 -176.474 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 100' ' ' THR . 21.3 Cg_exo -66.07 74.34 0.35 Allowed 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.796 2.33 . . . . 0.0 112.195 177.369 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.448 ' HA ' ' HE ' ' A' ' 102' ' ' ARG . 3.1 tpm_? -85.54 -53.48 5.15 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.156 -179.13 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 47.4 t -171.27 -48.86 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.137 178.63 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -152.08 -30.99 0.15 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.559 179.215 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 81.97 -84.77 1.47 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.752 175.946 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.447 HG22 ' CG ' ' A' ' 70' ' ' GLN . 8.9 t . . . . . 0 C--O 1.248 0.989 0 CA-C-O 118.51 -0.757 . . . . 0.0 109.953 -176.813 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.814 0 N-CA-C 111.86 -0.496 . . . . 0.0 111.86 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.1 t -155.93 155.54 33.0 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 -179.239 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -125.11 176.85 6.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.875 0.369 . . . . 0.0 110.349 -179.82 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 26.0 ttt -135.67 54.25 1.92 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 176.369 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.39 89.66 1.12 Allowed Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.306 -0.861 . . . . 0.0 112.014 -178.723 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.6 m -85.02 78.42 9.91 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.199 0.523 . . . . 0.0 110.528 -178.76 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.4 p -83.28 -7.15 59.64 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.024 -178.625 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 12.9 t -74.9 -6.82 51.28 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 122.093 0.949 . . . . 0.0 109.703 174.074 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -112.86 88.33 11.56 Favored Pre-proline 0 C--N 1.313 -0.992 0 CA-C-N 114.043 -1.435 . . . . 0.0 109.112 173.834 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.471 ' HG3' ' CD ' ' A' ' 83' ' ' GLU . 87.5 Cg_endo -79.08 158.37 26.89 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 122.953 2.435 . . . . 0.0 112.427 -174.67 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -116.01 171.07 8.02 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -179.708 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.52 ' HB3' ' O ' ' A' ' 89' ' ' THR . . . -96.34 165.48 16.13 Favored Pre-proline 0 C--N 1.316 -0.858 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 178.997 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.455 ' CB ' ' HB2' ' A' ' 30' ' ' TRP . 27.0 Cg_exo -64.64 130.68 27.09 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 121.81 1.674 . . . . 0.0 111.055 171.806 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.546 ' HD2' ' O ' ' A' ' 31' ' ' SER . 71.5 Cg_exo -50.39 155.56 4.86 Favored 'Trans proline' 0 C--O 1.235 0.353 0 C-N-CA 122.524 2.149 . . . . 0.0 111.6 171.415 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -35.7 106.19 0.3 Allowed Pre-proline 0 N--CA 1.472 0.654 0 O-C-N 124.56 1.162 . . . . 0.0 112.437 -171.115 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.553 ' HG2' HG13 ' A' ' 91' ' ' VAL . 24.1 Cg_exo -70.5 145.1 51.94 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 123.162 2.575 . . . . 0.0 112.435 177.518 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.2 m -101.64 131.2 48.0 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.568 0.699 . . . . 0.0 110.814 -177.575 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.426 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 70.6 t -81.01 118.24 28.44 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 CA-C-N 114.658 -1.156 . . . . 0.0 110.061 175.226 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -78.05 -46.63 20.39 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.318 -175.568 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -136.74 140.67 42.77 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.679 -178.193 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.46 ' HA ' HG12 ' A' ' 26' ' ' ILE . 7.2 t -127.24 114.2 35.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.697 -178.063 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -124.63 -164.96 1.32 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 179.467 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.57 ' O ' ' HB2' ' A' ' 69' ' ' LEU . 4.0 p-10 -70.67 -67.1 0.53 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.073 0.463 . . . . 0.0 112.193 -178.109 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.678 HG22 ' O ' ' A' ' 69' ' ' LEU . 35.2 p -110.3 32.08 5.43 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.004 -173.381 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.703 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 42.3 m -167.71 129.99 1.57 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.194 -171.622 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.538 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 44.8 mt -147.37 145.57 18.99 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.924 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 177.398 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.426 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 43.7 t -118.67 131.4 71.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 119.22 0.918 . . . . 0.0 110.262 -176.803 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.639 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.6 OUTLIER -127.76 145.77 34.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 C-N-CA 120.096 -0.642 . . . . 0.0 110.318 -179.214 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.497 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 11.1 mtm180 -130.02 121.34 26.28 Favored 'General case' 0 CA--C 1.515 -0.379 0 O-C-N 123.397 0.436 . . . . 0.0 110.302 -175.584 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.515 ' CH2' HD13 ' A' ' 57' ' ' LEU . 34.6 p90 -111.53 145.8 38.43 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.419 -175.306 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.546 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 12.5 t -90.29 91.81 8.66 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 175.124 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.417 ' HD3' ' H ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -46.1 156.3 0.48 Allowed Pre-proline 0 CA--C 1.542 0.662 0 C-N-CA 124.14 0.976 . . . . 0.0 113.507 -174.426 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.657 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 4.2 Cg_exo -76.27 169.53 21.81 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 123.86 3.04 . . . . 0.0 112.939 -173.754 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -83.74 -15.59 48.03 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.344 174.378 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.98 144.87 99.14 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.122 -0.944 . . . . 0.0 111.423 177.233 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -68.6 115.45 3.92 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 121.612 1.542 . . . . 0.0 109.831 167.274 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.568 HG21 ' HB1' ' A' ' 81' ' ' ALA . 1.1 pt -121.11 155.74 24.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -177.683 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.502 ' C ' ' HB3' ' A' ' 59' ' ' GLU . 21.7 p -104.24 -29.32 10.88 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -177.858 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.511 ' C ' HG12 ' A' ' 82' ' ' VAL . . . -161.7 -167.87 22.77 Favored Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.252 -0.975 . . . . 0.0 111.829 179.853 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.657 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 5.5 m-85 -139.93 131.57 27.25 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 120.803 0.335 . . . . 0.0 111.301 174.347 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.583 ' CZ ' HG13 ' A' ' 82' ' ' VAL . 0.2 OUTLIER -99.55 147.79 24.96 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 168.792 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.882 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 33.0 mt -139.71 107.47 2.93 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 C-N-CA 119.875 -0.73 . . . . 0.0 112.435 -179.582 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 82.5 t -108.47 110.7 32.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.138 0.494 . . . . 0.0 110.825 -178.519 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.741 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 0.8 OUTLIER -113.43 125.56 54.37 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 121.503 0.668 . . . . 0.0 109.985 176.175 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.462 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 13.9 t -140.25 140.53 23.6 Favored Pre-proline 0 C--N 1.319 -0.751 0 CA-C-N 113.717 -1.583 . . . . 0.0 110.69 -174.505 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.629 ' HG3' ' CZ ' ' A' ' 75' ' ' TYR . 2.4 Cg_endo -80.46 148.3 18.34 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 123.605 2.87 . . . . 0.0 111.67 178.57 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 15.0 m -71.35 -30.11 65.78 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.584 179.87 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.9 p -118.18 -40.25 2.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 179.345 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.494 ' HG2' ' CB ' ' A' ' 70' ' ' GLN . 10.2 tp10 -76.77 166.54 23.22 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.598 -0.273 . . . . 0.0 110.31 -179.344 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -115.88 17.64 15.23 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.389 -0.91 . . . . 0.0 114.581 -174.792 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.7 t -93.06 111.72 23.44 Favored 'General case' 0 C--N 1.334 -0.088 0 CA-C-N 118.954 1.377 . . . . 0.0 109.054 174.334 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 22.7 p -123.08 148.16 45.93 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.076 179.576 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.741 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 62.7 m -146.92 145.6 29.86 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 119.922 -0.711 . . . . 0.0 111.588 176.919 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.882 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 41.8 tt0 -116.56 115.75 26.33 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.94 174.532 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.618 HD13 ' CG2' ' A' ' 64' ' ' VAL . 18.8 mt -97.52 161.55 13.72 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 175.855 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.477 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 36.9 t30 -126.12 119.44 27.56 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 177.651 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.515 HD13 ' CH2' ' A' ' 30' ' ' TRP . 4.7 mt -113.96 159.55 35.64 Favored Pre-proline 0 C--N 1.317 -0.822 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 -177.419 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -67.18 151.99 80.39 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 121.534 1.489 . . . . 0.0 111.005 174.66 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.502 ' HB3' ' C ' ' A' ' 38' ' ' THR . 7.0 pt-20 -47.8 -24.75 1.06 Allowed 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.092 -0.958 . . . . 0.0 112.632 177.468 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.9 t -104.6 15.87 27.17 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.09 -174.524 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.413 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -86.81 161.69 18.21 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 178.057 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.497 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 4.3 p-10 -145.31 15.37 1.48 Allowed 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.954 -178.092 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.639 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 26.4 p -168.83 133.88 1.6 Allowed 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.281 -0.568 . . . . 0.0 111.694 -179.016 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.625 HG12 ' CD2' ' A' ' 66' ' ' LEU . 3.3 p -117.33 139.83 42.72 Favored 'Isoleucine or valine' 0 C--O 1.244 0.81 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.47 177.237 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 47.7 m -97.23 101.14 12.64 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.579 168.391 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.703 ' O ' ' HA ' ' A' ' 25' ' ' SER . 0.3 OUTLIER -76.03 141.9 41.97 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.597 177.924 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.415 ' HA ' ' O ' ' A' ' 24' ' ' THR . 27.3 p -136.62 166.22 24.04 Favored 'General case' 0 N--CA 1.447 -0.595 0 O-C-N 123.819 0.7 . . . . 0.0 110.041 -174.955 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 61.93 38.54 14.32 Favored 'General case' 0 N--CA 1.464 0.227 0 O-C-N 123.688 0.617 . . . . 0.0 111.431 -179.214 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.678 ' O ' HG22 ' A' ' 24' ' ' THR . 8.1 mt -85.04 -176.26 6.12 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 175.459 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.494 ' CB ' ' HG2' ' A' ' 49' ' ' GLU . 58.4 tp60 -126.72 124.69 24.21 Favored Pre-proline 0 C--N 1.32 -0.704 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 176.479 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -62.24 134.54 49.35 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 123.188 2.592 . . . . 0.0 113.498 -178.072 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 86.53 24.27 40.0 Favored Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.363 176.977 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 17.9 t -130.53 149.23 33.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.236 0.541 . . . . 0.0 111.445 -176.232 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.48 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 14.8 tp60 -79.64 108.0 12.85 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.634 179.971 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.629 ' CZ ' ' HG3' ' A' ' 46' ' ' PRO . 4.2 m-85 -101.15 116.52 33.01 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.377 0.608 . . . . 0.0 111.868 -178.708 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.559 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 31.0 m-80 -89.2 109.02 19.94 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.448 177.037 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.587 ' HB ' HG13 ' A' ' 93' ' ' ILE . 5.2 mp -92.56 116.01 32.73 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.616 0 CA-C-O 121.332 0.586 . . . . 0.0 109.571 175.598 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.852 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 89.2 m -108.82 116.18 31.5 Favored 'General case' 0 N--CA 1.426 -1.639 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.243 179.954 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.514 HD13 HG21 ' A' ' 77' ' ' ILE . 15.6 mm -95.26 140.59 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 -178.959 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -127.87 113.04 15.4 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 178.776 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.568 ' HB1' HG21 ' A' ' 37' ' ' ILE . . . -84.12 119.65 25.23 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 171.173 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.583 HG13 ' CZ ' ' A' ' 41' ' ' ARG . 7.5 p -110.54 141.22 26.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 C-N-CA 120.237 -0.585 . . . . 0.0 110.204 -175.355 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.588 ' OE1' ' HB2' ' A' ' 86' ' ' GLN . 0.1 OUTLIER -123.28 170.88 9.84 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 123.37 0.419 . . . . 0.0 110.104 177.183 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -34.64 -55.83 0.55 Allowed 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 113.839 1.052 . . . . 0.0 113.839 -171.241 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -123.81 14.72 9.33 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 -174.627 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.588 ' HB2' ' OE1' ' A' ' 83' ' ' GLU . 25.4 mt-30 -146.18 170.81 15.96 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.368 0.604 . . . . 0.0 111.849 -177.298 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -127.38 124.63 39.02 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.113 173.704 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 15.4 m -76.2 -178.52 4.53 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.648 0.261 . . . . 0.0 111.088 -177.635 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.52 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 3.9 p -67.39 154.93 92.07 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-O 120.947 0.403 . . . . 0.0 111.438 -178.378 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -88.2 141.6 5.08 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 122.76 2.307 . . . . 0.0 115.031 179.747 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.852 ' O ' ' HA ' ' A' ' 78' ' ' THR . 8.8 t -83.34 131.59 33.43 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.538 0 CA-C-N 114.678 -1.146 . . . . 0.0 108.271 163.892 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 13.7 t -125.02 106.81 17.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 C-N-CA 119.94 -0.704 . . . . 0.0 110.172 170.178 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.587 HG13 ' HB ' ' A' ' 77' ' ' ILE . 8.2 pt -121.11 111.43 31.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.342 178.185 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -97.23 112.99 24.55 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.659 0.742 . . . . 0.0 111.6 -177.035 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.92 131.54 53.41 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.484 179.77 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -86.47 129.89 34.69 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.046 0.451 . . . . 0.0 110.519 -179.483 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.5 HG21 HD12 ' A' ' 26' ' ' ILE . 20.3 p -60.43 117.68 5.55 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.227 179.626 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 39.1 m -70.9 -31.5 68.16 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.039 179.651 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.468 ' HA2' ' CA ' ' A' ' 23' ' ' ASP . . . 66.79 -115.6 7.43 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.193 -0.912 . . . . 0.0 112.678 176.711 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 21.1 m -93.28 121.34 65.51 Favored Pre-proline 0 C--N 1.319 -0.751 0 N-CA-C 110.347 -0.242 . . . . 0.0 110.347 179.0 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -56.23 130.7 41.55 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.532 2.155 . . . . 0.0 111.139 176.207 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 36.5 mmt180 -83.36 49.4 1.56 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.858 0.361 . . . . 0.0 110.895 -175.978 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 17.6 m -67.46 -38.38 84.39 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.316 179.211 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -95.84 167.15 11.43 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.071 177.879 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 78.25 34.1 37.92 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.287 -179.973 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 24.5 m . . . . . 0 C--O 1.25 1.131 0 CA-C-O 118.419 -0.801 . . . . 0.0 110.597 -178.798 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.654 0 N-CA-C 111.849 -0.501 . . . . 0.0 111.849 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 40.1 m -142.24 39.67 1.6 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.84 0.352 . . . . 0.0 110.907 -178.798 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 33.0 t60 -71.43 -43.19 67.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.899 0.38 . . . . 0.0 110.001 177.616 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 52.5 tpp -94.43 -56.53 2.78 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.225 178.333 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -87.97 74.38 2.19 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.009 -179.846 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 12.9 t -99.12 -7.99 25.85 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.407 0.623 . . . . 0.0 110.083 179.604 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.6 m 64.47 63.56 0.74 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 114.649 -1.16 . . . . 0.0 111.047 179.07 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 17.1 m -63.09 128.25 34.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.25 177.873 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 66.2 92.42 0.06 OUTLIER Pre-proline 0 C--O 1.235 0.304 0 O-C-N 123.751 0.657 . . . . 0.0 110.383 -175.719 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.408 ' HG3' ' OE1' ' A' ' 83' ' ' GLU . 55.4 Cg_endo -69.07 151.31 73.0 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 122.927 2.418 . . . . 0.0 112.371 -175.425 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.455 ' HB2' ' HB3' ' A' ' 33' ' ' PRO . 1.0 OUTLIER -80.99 153.66 27.33 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.454 178.263 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -96.75 158.79 32.98 Favored Pre-proline 0 C--N 1.312 -1.058 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 163.559 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.471 ' HA ' ' O ' ' A' ' 31' ' ' SER . 23.6 Cg_exo -67.35 126.16 14.54 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 121.364 1.376 . . . . 0.0 111.535 176.589 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -49.49 145.39 16.56 Favored 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.469 2.112 . . . . 0.0 110.634 171.486 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -35.95 105.62 0.29 Allowed Pre-proline 0 N--CA 1.47 0.55 0 O-C-N 124.701 1.251 . . . . 0.0 112.329 -169.394 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.56 ' HG2' HG11 ' A' ' 91' ' ' VAL . 31.3 Cg_exo -64.76 155.45 67.25 Favored 'Trans proline' 0 CA--C 1.514 -0.492 0 C-N-CA 123.747 2.965 . . . . 0.0 112.407 -179.81 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 31.6 m -113.77 131.03 56.36 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.806 -178.207 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.484 HG12 ' O ' ' A' ' 27' ' ' VAL . 71.4 t -73.26 122.81 26.9 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 114.054 -1.43 . . . . 0.0 109.884 175.051 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -84.47 -41.94 16.09 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.944 -173.847 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -136.22 140.62 43.65 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.163 178.574 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.462 HG23 HG11 ' A' ' 18' ' ' VAL . 39.8 t -123.72 119.46 57.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.468 178.191 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.409 ' HB2' ' O ' ' A' ' 25' ' ' SER . 23.6 m-20 -124.36 -159.06 0.85 Allowed 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 176.95 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.551 ' HB3' ' C ' ' A' ' 99' ' ' GLY . 17.8 p-10 -84.44 -54.41 4.78 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.3 0.571 . . . . 0.0 111.348 179.094 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.589 HG23 ' O ' ' A' ' 69' ' ' LEU . 29.9 p -119.61 29.73 7.44 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.192 -172.409 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.622 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 17.0 p -169.91 130.6 1.01 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.665 -1.152 . . . . 0.0 109.858 -176.097 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.593 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 48.0 mt -148.05 142.22 19.23 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.666 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.765 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.484 ' O ' HG12 ' A' ' 18' ' ' VAL . 44.9 t -115.96 136.21 53.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 C-N-CA 119.858 -0.737 . . . . 0.0 109.933 -175.701 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.641 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.6 OUTLIER -127.13 145.41 34.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 C-N-CA 120.122 -0.631 . . . . 0.0 110.162 179.105 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.446 ' HG2' ' HB3' ' A' ' 63' ' ' SER . 54.8 mtp180 -130.02 120.98 25.61 Favored 'General case' 0 C--N 1.327 -0.408 0 O-C-N 123.535 0.522 . . . . 0.0 110.497 -174.766 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.512 ' CH2' HD11 ' A' ' 57' ' ' LEU . 35.7 p90 -113.47 149.04 34.84 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.879 -174.052 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.471 ' O ' ' HA ' ' A' ' 13' ' ' PRO . 48.2 m -92.75 88.53 6.28 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.202 175.758 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.452 ' HD3' ' H ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -50.75 159.05 0.99 Allowed Pre-proline 0 CA--C 1.544 0.715 0 CA-C-N 114.99 -1.005 . . . . 0.0 113.404 -175.413 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.701 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 6.4 Cg_exo -74.08 169.33 22.69 Favored 'Trans proline' 0 C--N 1.358 1.032 0 C-N-CA 124.001 3.134 . . . . 0.0 113.332 -172.597 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -91.38 3.88 53.81 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.242 174.842 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -85.4 151.41 56.22 Favored Pre-proline 0 CA--C 1.515 -0.378 0 CA-C-N 114.683 -1.144 . . . . 0.0 110.532 178.686 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -75.85 114.76 4.01 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 121.446 1.431 . . . . 0.0 109.92 171.728 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.48 HG22 ' HG2' ' A' ' 83' ' ' GLU . 2.6 pt -123.06 157.52 28.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.728 -173.508 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.411 ' H ' ' HA ' ' A' ' 83' ' ' GLU . 6.8 p -91.91 -39.12 11.89 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -178.483 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.426 ' O ' HG11 ' A' ' 82' ' ' VAL . . . -169.45 -162.99 22.72 Favored Glycine 0 N--CA 1.439 -1.11 0 C-N-CA 119.542 -1.313 . . . . 0.0 112.687 -178.98 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.701 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 5.1 m-85 -137.71 135.64 36.63 Favored 'General case' 0 CA--C 1.506 -0.746 0 CA-C-O 120.897 0.38 . . . . 0.0 111.175 178.993 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.6 mtm105 -107.53 147.62 30.31 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 169.987 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.855 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 27.3 mt -139.22 109.74 4.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 C-N-CA 120.17 -0.612 . . . . 0.0 112.471 -174.758 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 78.4 t -111.11 110.34 31.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.578 179.011 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.784 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 0.7 OUTLIER -112.08 124.94 53.51 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.427 176.646 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.1 p -138.02 136.24 19.48 Favored Pre-proline 0 C--N 1.312 -1.039 0 CA-C-N 113.946 -1.479 . . . . 0.0 111.47 -172.394 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.458 ' HG3' ' CZ ' ' A' ' 75' ' ' TYR . 16.1 Cg_exo -64.78 129.46 23.49 Favored 'Trans proline' 0 CA--C 1.519 -0.242 0 C-N-CA 122.929 2.419 . . . . 0.0 110.934 174.905 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 13.6 m -60.31 -26.6 66.66 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.683 -0.689 . . . . 0.0 112.453 -173.538 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.483 ' O ' ' HB3' ' A' ' 49' ' ' GLU . 17.7 m -105.54 -41.94 6.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 120.546 -0.462 . . . . 0.0 111.805 179.675 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.483 ' HB3' ' O ' ' A' ' 48' ' ' VAL . 12.1 pt-20 165.31 157.18 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.534 0.734 . . . . 0.0 109.654 177.212 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 147.05 -143.82 11.83 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.95 178.481 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 45.4 m -91.04 121.64 33.02 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.743 0.271 . . . . 0.0 110.987 -179.709 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.9 m -116.07 145.58 42.9 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 176.021 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.784 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 26.3 m -145.67 154.99 42.71 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 120.53 -0.468 . . . . 0.0 111.493 -175.507 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.855 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 33.3 tt0 -127.46 112.92 15.52 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.603 -179.026 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.627 HD12 ' CG2' ' A' ' 64' ' ' VAL . 17.0 mt -100.86 162.35 12.96 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.455 178.183 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.549 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 2.3 m120 -128.65 115.89 18.74 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 176.837 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.512 HD11 ' CH2' ' A' ' 30' ' ' TRP . 4.6 mt -110.85 156.86 40.04 Favored Pre-proline 0 N--CA 1.441 -0.883 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -175.96 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -63.26 151.22 85.92 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 121.737 1.625 . . . . 0.0 110.989 175.902 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -45.84 -28.95 1.2 Allowed 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.344 176.707 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.5 t -101.2 19.53 17.44 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.148 -174.834 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.491 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -89.11 161.08 16.7 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 178.635 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.443 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 29.6 p-10 -147.85 15.94 1.09 Allowed 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -177.123 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.641 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 28.0 p -171.32 133.95 0.86 Allowed 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.226 -0.59 . . . . 0.0 111.779 -178.476 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.627 ' CG2' HD12 ' A' ' 55' ' ' LEU . 3.1 p -117.13 136.77 53.2 Favored 'Isoleucine or valine' 0 C--O 1.24 0.59 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.434 177.146 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 41.3 m -94.57 101.71 13.61 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.668 169.106 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.622 ' O ' ' HA ' ' A' ' 25' ' ' SER . 0.2 OUTLIER -78.8 141.04 38.09 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 177.551 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 10.9 t -137.3 172.65 12.67 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 -177.035 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 60.93 31.58 19.97 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.476 -179.287 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.589 ' O ' HG23 ' A' ' 24' ' ' THR . 10.7 mt -74.42 -176.99 2.89 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 176.917 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 7.7 tp60 -126.15 121.59 23.99 Favored Pre-proline 0 C--N 1.319 -0.741 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 177.5 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.406 ' HB3' ' HA2' ' A' ' 99' ' ' GLY . 12.0 Cg_endo -60.29 135.06 59.33 Favored 'Trans proline' 0 C--O 1.235 0.366 0 C-N-CA 123.001 2.467 . . . . 0.0 113.372 -177.634 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 87.71 17.47 58.23 Favored Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.309 177.323 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.417 ' CG1' ' HB3' ' A' ' 46' ' ' PRO . 14.1 t -125.62 146.62 31.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 120.816 0.341 . . . . 0.0 110.841 -177.573 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.537 ' OE1' ' HB2' ' A' ' 96' ' ' GLU . 35.0 tp60 -81.05 122.69 27.63 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.782 178.744 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.589 ' CE2' HD23 ' A' ' 69' ' ' LEU . 5.4 m-85 -105.98 116.17 31.48 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 121.599 0.714 . . . . 0.0 111.725 -179.297 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.408 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 16.2 t-20 -90.14 104.1 16.7 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 114.487 -1.233 . . . . 0.0 109.113 177.01 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.514 HG21 HD13 ' A' ' 79' ' ' ILE . 5.3 mp -92.25 116.41 33.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.347 0.594 . . . . 0.0 109.758 177.722 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.825 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 62.1 m -108.3 116.13 31.39 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.09 179.094 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.514 HD13 HG21 ' A' ' 77' ' ' ILE . 15.5 mm -95.61 141.92 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.831 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -126.94 112.99 15.93 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 179.613 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -89.25 123.1 33.15 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 174.53 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.426 HG11 ' O ' ' A' ' 39' ' ' GLY . 7.3 p -120.63 134.67 63.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 120.02 -0.672 . . . . 0.0 112.258 -173.122 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.48 ' HG2' HG22 ' A' ' 37' ' ' ILE . 6.3 mt-10 -104.59 171.82 7.12 Favored 'General case' 0 N--CA 1.454 -0.261 0 O-C-N 124.146 0.904 . . . . 0.0 109.228 173.607 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -47.68 -39.51 17.56 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 179.081 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -113.36 -29.33 7.26 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -171.343 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -133.32 176.34 8.6 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.553 -0.459 . . . . 0.0 111.683 -170.011 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -134.61 137.78 43.98 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.789 177.717 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 17.7 m -77.64 173.47 12.01 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.828 -179.69 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 14.2 p -61.79 154.63 66.02 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-O 120.918 0.39 . . . . 0.0 110.623 176.567 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -81.64 142.6 12.97 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 122.067 1.845 . . . . 0.0 113.622 -175.463 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.825 ' O ' ' HA ' ' A' ' 78' ' ' THR . 7.1 t -83.18 129.41 37.5 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.771 0 CA-C-N 114.879 -1.055 . . . . 0.0 108.615 168.09 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.9 t -126.27 106.96 16.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.153 175.01 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.514 HG13 ' HB ' ' A' ' 77' ' ' ILE . 8.1 pt -128.17 118.9 49.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.47 178.794 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -103.39 129.93 50.59 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.402 0.62 . . . . 0.0 111.349 -176.877 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.06 130.03 23.19 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.96 176.517 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.537 ' HB2' ' OE1' ' A' ' 74' ' ' GLN . 34.5 tt0 -85.83 136.12 33.44 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.251 0.548 . . . . 0.0 110.093 179.959 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.502 HG22 HD11 ' A' ' 26' ' ' ILE . 25.4 p -65.92 124.5 22.67 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.55 179.709 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.4 m -68.57 -31.71 71.1 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.228 -173.292 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.551 ' C ' ' HB3' ' A' ' 23' ' ' ASP . . . 119.56 166.68 13.41 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.001 177.697 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.476 ' N ' ' HB3' ' A' ' 23' ' ' ASP . 24.1 m -68.37 123.11 86.78 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-O 120.379 0.133 . . . . 0.0 110.96 -176.172 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -58.31 101.27 0.12 Allowed 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.974 2.449 . . . . 0.0 112.235 178.826 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 7.8 ptp180 -145.15 171.15 14.93 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.872 -179.96 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 35.8 t -145.25 135.95 24.44 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 177.771 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 71.3 -64.56 0.38 Allowed 'General case' 0 N--CA 1.467 0.391 0 O-C-N 123.911 0.757 . . . . 0.0 112.034 175.508 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -121.15 177.62 16.39 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.339 -178.632 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.7 t . . . . . 0 C--O 1.249 1.041 0 CA-C-O 119.058 -0.496 . . . . 0.0 110.401 -179.814 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.82 0 N-CA-C 111.708 -0.557 . . . . 0.0 111.708 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 28.2 m -79.49 -178.21 6.18 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 178.35 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 62.22 40.39 11.64 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.321 0.581 . . . . 0.0 109.626 -176.665 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 23.0 ptt? -107.03 169.5 8.51 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.106 -175.295 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 104.22 -169.58 17.71 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.952 -0.642 . . . . 0.0 111.632 -179.37 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.0 m -78.62 71.58 5.09 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.279 0.562 . . . . 0.0 110.24 179.279 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.1 p -73.21 -12.91 61.04 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.839 -176.823 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 13.0 t -79.99 -4.48 52.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.734 0.778 . . . . 0.0 110.387 176.189 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -129.37 88.28 51.0 Favored Pre-proline 0 C--N 1.311 -1.084 0 CA-C-N 114.7 -1.137 . . . . 0.0 109.377 175.411 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -64.04 142.36 80.8 Favored 'Trans proline' 0 C--O 1.235 0.372 0 C-N-CA 122.654 2.236 . . . . 0.0 113.337 -173.342 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -90.02 162.82 15.17 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.797 175.646 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -97.04 159.68 30.84 Favored Pre-proline 0 C--N 1.316 -0.854 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.249 177.317 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -68.61 133.14 26.95 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.482 2.122 . . . . 0.0 111.678 175.005 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.77 154.24 21.65 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.321 2.014 . . . . 0.0 110.943 172.91 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -36.45 107.2 0.35 Allowed Pre-proline 0 N--CA 1.468 0.464 0 O-C-N 124.595 1.184 . . . . 0.0 112.445 -172.148 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.567 ' HG2' HG12 ' A' ' 91' ' ' VAL . 36.1 Cg_exo -66.69 150.93 83.53 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 123.09 2.526 . . . . 0.0 112.265 177.712 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 45.8 m -106.93 129.04 54.81 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.872 -179.07 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.443 HG11 HG22 ' A' ' 21' ' ' VAL . 78.2 t -76.99 123.29 33.27 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-N 114.509 -1.223 . . . . 0.0 109.891 173.75 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -91.59 -37.39 13.11 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.341 -174.813 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 13.9 mm-40 -136.17 132.74 36.36 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.788 -178.59 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.468 ' HA ' HG12 ' A' ' 26' ' ' ILE . 46.5 t -124.01 120.1 58.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.388 179.637 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -127.5 -159.98 0.98 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 178.809 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -74.48 -72.11 0.3 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 179.162 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.598 HG22 ' O ' ' A' ' 69' ' ' LEU . 69.9 p -105.41 33.57 3.64 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.211 -174.034 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.586 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 68.5 p -169.66 137.16 1.71 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.574 -173.628 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.569 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 35.9 mt -150.71 145.68 16.69 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.904 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.783 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.442 ' O ' HG12 ' A' ' 18' ' ' VAL . 41.0 t -118.36 131.85 69.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 119.255 0.934 . . . . 0.0 110.472 -176.062 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.59 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.6 OUTLIER -127.13 146.52 32.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.233 -178.119 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.478 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 20.2 mtm180 -130.69 121.27 25.2 Favored 'General case' 0 C--N 1.329 -0.303 0 O-C-N 123.244 0.34 . . . . 0.0 110.57 -175.856 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.526 ' CH2' HD12 ' A' ' 57' ' ' LEU . 39.5 p90 -112.06 146.74 37.41 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.103 -175.651 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 24.0 t -92.59 99.09 11.86 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.928 177.548 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.528 ' CD ' ' H ' ' A' ' 32' ' ' ARG . 0.2 OUTLIER -53.49 160.3 1.96 Allowed Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 115.098 -0.955 . . . . 0.0 113.189 -174.261 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.618 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 2.2 Cg_endo -84.93 163.52 11.81 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 124.307 3.338 . . . . 0.0 112.279 -177.254 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -82.73 -6.42 59.39 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.338 172.064 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -66.2 146.79 99.04 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.841 174.557 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -73.94 114.08 3.94 Favored 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 121.165 1.244 . . . . 0.0 109.857 170.213 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.546 HG22 ' HB1' ' A' ' 81' ' ' ALA . 0.8 OUTLIER -120.56 147.79 24.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 -177.455 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.422 ' N ' ' O ' ' A' ' 82' ' ' VAL . 25.4 p -88.89 -30.2 19.05 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -178.335 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.579 ' C ' HG12 ' A' ' 82' ' ' VAL . . . -171.09 -162.3 23.21 Favored Glycine 0 CA--C 1.499 -0.942 0 C-N-CA 120.116 -1.04 . . . . 0.0 111.551 -179.327 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.618 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 6.5 m-85 -140.06 132.6 28.69 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 117.01 0.405 . . . . 0.0 111.155 173.807 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.2 mmm180 -100.7 147.72 25.69 Favored 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 168.031 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.87 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 32.0 mt -138.29 108.21 4.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 C-N-CA 119.926 -0.71 . . . . 0.0 112.328 -178.395 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 93.1 t -110.41 111.52 36.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.088 0.47 . . . . 0.0 110.762 -178.154 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.734 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 0.6 OUTLIER -115.24 126.2 54.25 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.077 177.357 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 30.8 p -134.22 137.52 28.28 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 113.742 -1.572 . . . . 0.0 111.705 -174.696 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.601 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 92.9 Cg_endo -80.52 130.6 7.98 Favored 'Trans proline' 0 N--CA 1.464 -0.231 0 C-N-CA 123.638 2.892 . . . . 0.0 111.937 178.488 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 23.1 t -72.72 -28.0 62.4 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.017 -178.325 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.2 m -117.48 16.48 7.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.173 0.511 . . . . 0.0 112.177 -176.187 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -149.83 -166.01 2.43 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.239 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -137.4 17.73 3.51 Favored Glycine 0 N--CA 1.443 -0.843 0 C-N-CA 119.283 -1.437 . . . . 0.0 115.034 -174.208 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.589 ' O ' ' HD3' ' A' ' 46' ' ' PRO . 7.7 t -93.37 111.19 22.79 Favored 'General case' 0 C--O 1.225 -0.197 0 CA-C-N 119.265 1.532 . . . . 0.0 109.386 174.278 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.0 p -123.41 148.83 45.73 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.719 -179.341 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.734 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 38.0 m -145.16 147.97 33.07 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 119.886 -0.725 . . . . 0.0 111.825 177.994 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.87 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 34.9 tt0 -118.54 114.1 22.3 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.957 176.014 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.627 HD12 ' CG2' ' A' ' 64' ' ' VAL . 16.8 mt -97.94 159.49 14.9 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.0 0.429 . . . . 0.0 110.318 176.564 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -123.43 113.63 19.05 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.59 179.253 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.526 HD12 ' CH2' ' A' ' 30' ' ' TRP . 2.6 mt -111.8 154.92 43.88 Favored Pre-proline 0 C--N 1.318 -0.796 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 -176.726 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -65.53 150.21 86.91 Favored 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 121.569 1.512 . . . . 0.0 110.958 175.955 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -45.11 -25.53 0.35 Allowed 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 114.618 -1.173 . . . . 0.0 113.186 178.981 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 5.4 t -103.9 5.01 35.42 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.44 -174.244 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.419 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -74.97 155.99 36.79 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 -179.677 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.478 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 26.6 p-10 -137.04 12.94 3.09 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.931 -177.32 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.59 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 23.3 p -169.1 133.79 1.49 Allowed 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 119.973 -0.691 . . . . 0.0 111.905 -177.525 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.644 HG11 ' CD2' ' A' ' 66' ' ' LEU . 3.6 p -116.14 137.16 50.75 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.122 176.744 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 42.8 m -95.84 101.16 12.82 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 168.56 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.644 ' CD2' HG11 ' A' ' 64' ' ' VAL . 0.2 OUTLIER -76.49 141.13 41.39 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.259 178.65 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.6 t -136.48 170.73 15.57 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -177.432 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 65.1 29.57 11.96 Favored 'General case' 0 C--N 1.327 -0.388 0 O-C-N 123.665 0.603 . . . . 0.0 111.549 -178.155 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.598 ' O ' HG22 ' A' ' 24' ' ' THR . 9.1 mt -78.73 -175.6 4.49 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 174.135 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.475 ' N ' ' HH ' ' A' ' 75' ' ' TYR . 14.7 mm100 -126.99 131.99 24.12 Favored Pre-proline 0 C--N 1.32 -0.702 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 177.876 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -64.49 133.65 38.08 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.87 2.38 . . . . 0.0 113.008 -178.214 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 74.92 34.37 53.0 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.947 -0.644 . . . . 0.0 111.649 179.758 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 70.1 t -134.62 139.79 46.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.209 0.528 . . . . 0.0 110.815 -177.042 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.601 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -81.05 121.13 25.69 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.047 -176.053 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.475 ' HH ' ' N ' ' A' ' 70' ' ' GLN . 12.9 m-85 -116.66 115.82 26.39 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -175.306 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.518 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 2.6 m-20 -85.55 111.47 20.05 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.547 -0.752 . . . . 0.0 109.752 174.345 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.534 ' HB ' HG13 ' A' ' 93' ' ' ILE . 5.1 mp -93.47 117.95 38.14 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.602 0 CA-C-O 121.164 0.507 . . . . 0.0 109.748 175.751 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.868 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 24.9 m -109.39 115.14 29.4 Favored 'General case' 0 N--CA 1.428 -1.573 0 CA-C-N 115.25 -0.887 . . . . 0.0 110.545 -179.693 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.516 HD11 HG23 ' A' ' 77' ' ' ILE . 12.4 mm -95.73 139.88 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 179.537 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.439 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 68.4 m-85 -128.46 112.39 14.32 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.624 -0.262 . . . . 0.0 110.343 179.085 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.546 ' HB1' HG22 ' A' ' 37' ' ' ILE . . . -79.42 109.32 13.67 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 170.874 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.579 HG12 ' C ' ' A' ' 39' ' ' GLY . 11.1 p -99.39 140.77 18.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.756 -173.927 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -122.93 165.2 17.1 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 -178.412 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -47.16 -47.87 23.7 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -176.716 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -130.1 17.63 5.56 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.37 -176.899 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 66.9 mm-40 -142.31 169.58 17.32 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.871 0.367 . . . . 0.0 111.328 -179.023 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -146.72 120.34 9.16 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.088 177.943 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 21.7 m -65.1 157.81 27.56 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.782 179.742 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 21.1 p -55.16 150.12 22.64 Favored Pre-proline 0 N--CA 1.453 -0.294 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.312 176.635 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -77.61 140.28 18.75 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 121.755 1.637 . . . . 0.0 113.548 -173.68 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.868 ' O ' ' HA ' ' A' ' 78' ' ' THR . 4.6 t -81.53 123.42 37.87 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.832 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 167.348 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 4.8 t -119.75 105.38 17.18 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 C-N-CA 119.53 -0.868 . . . . 0.0 109.857 172.452 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.534 HG13 ' HB ' ' A' ' 77' ' ' ILE . 6.4 pt -120.73 111.11 30.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.354 175.897 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.22 114.88 26.66 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.806 0.812 . . . . 0.0 110.76 -175.819 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.79 129.39 50.36 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.937 -1.028 . . . . 0.0 109.398 179.44 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -89.42 137.82 31.99 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.146 0.498 . . . . 0.0 110.433 179.148 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.505 HG22 HD11 ' A' ' 26' ' ' ILE . 41.7 p -71.46 121.61 18.93 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.928 -178.128 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.9 m -69.43 -30.87 68.9 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.344 0.592 . . . . 0.0 110.15 179.937 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.59 -114.47 3.84 Favored Glycine 0 N--CA 1.443 -0.898 0 CA-C-N 115.187 -0.915 . . . . 0.0 112.237 177.776 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 4.1 m -98.02 146.52 31.64 Favored Pre-proline 0 C--N 1.316 -0.849 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 177.459 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_exo -64.59 55.65 0.24 Allowed 'Trans proline' 0 C--N 1.356 0.95 0 C-N-CA 123.205 2.603 . . . . 0.0 112.786 176.566 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 17.0 ptp180 -169.8 42.25 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 179.385 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 8.9 m -59.73 -35.35 74.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.108 -174.686 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -104.55 23.74 12.82 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.096 0.474 . . . . 0.0 110.268 177.118 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -82.75 68.05 3.62 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.092 -179.731 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 3.5 t . . . . . 0 C--O 1.245 0.865 0 CA-C-O 119.382 -0.342 . . . . 0.0 110.29 179.362 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.643 0 N-CA-C 111.686 -0.566 . . . . 0.0 111.686 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.1 m -82.84 -19.39 37.67 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.801 0.334 . . . . 0.0 111.395 -177.132 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 49.1 m80 -101.79 -60.51 1.52 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.152 179.577 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 23.7 mmt -78.74 92.24 4.78 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.122 0.487 . . . . 0.0 111.071 -177.009 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.43 ' HA2' ' CB ' ' A' ' 9' ' ' ALA . . . -83.25 61.19 4.81 Favored Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.807 177.068 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 12.8 p -61.48 106.22 0.62 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.634 0.254 . . . . 0.0 110.842 -179.765 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 62.1 p 49.25 52.16 14.95 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.793 -175.41 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 19.4 m 75.99 123.54 0.04 OUTLIER 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.217 -178.186 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.43 ' CB ' ' HA2' ' A' ' 5' ' ' GLY . . . -129.78 94.72 31.01 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.2 175.988 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.578 ' HG3' ' OE1' ' A' ' 83' ' ' GLU . 98.3 Cg_endo -75.97 -178.33 4.28 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 122.981 2.454 . . . . 0.0 112.109 -179.265 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -130.51 154.44 47.78 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.128 -178.203 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -91.11 158.24 41.75 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.76 176.229 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -63.27 130.59 29.13 Favored 'Trans proline' 0 C--O 1.235 0.346 0 C-N-CA 122.324 2.016 . . . . 0.0 111.96 177.537 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.481 ' HD2' ' O ' ' A' ' 31' ' ' SER . 72.7 Cg_exo -49.54 146.07 15.5 Favored 'Trans proline' 0 C--O 1.237 0.426 0 C-N-CA 122.891 2.394 . . . . 0.0 111.091 172.856 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -35.76 106.66 0.32 Allowed Pre-proline 0 N--CA 1.466 0.366 0 O-C-N 124.837 1.336 . . . . 0.0 112.541 -169.276 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.583 ' HG2' HG12 ' A' ' 91' ' ' VAL . 34.6 Cg_exo -67.03 150.94 82.64 Favored 'Trans proline' 0 CA--C 1.517 -0.359 0 C-N-CA 123.368 2.712 . . . . 0.0 112.039 179.08 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.2 m -110.35 131.09 55.36 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.804 -178.387 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 76.0 t -75.67 119.87 24.38 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-N 114.446 -1.252 . . . . 0.0 109.653 173.756 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -86.97 -40.5 14.72 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.324 -174.809 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -136.03 138.5 42.26 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.995 0.426 . . . . 0.0 110.726 -179.776 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.428 HG21 HG13 ' A' ' 18' ' ' VAL . 17.0 t -125.98 125.16 67.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.005 179.825 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -130.58 -157.27 0.81 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.509 0.195 . . . . 0.0 110.475 -179.249 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.406 ' HA ' ' HA3' ' A' ' 99' ' ' GLY . 1.9 p30 -73.79 -69.43 0.44 Allowed 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 178.411 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.482 HG21 ' O ' ' A' ' 69' ' ' LEU . 67.7 p -114.39 37.12 3.48 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.483 0.659 . . . . 0.0 109.944 -174.335 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.642 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 55.1 m -167.97 131.49 1.64 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.807 -171.295 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.576 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 48.8 mt -149.86 140.8 16.81 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.905 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.522 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 36.5 t -116.52 132.12 67.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 119.135 0.879 . . . . 0.0 110.534 -173.822 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.571 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.7 OUTLIER -126.97 145.59 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.23 -178.996 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.464 ' HG2' ' HB3' ' A' ' 63' ' ' SER . 16.9 mtp180 -128.15 121.5 29.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.524 -175.685 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.507 ' CH2' HD12 ' A' ' 57' ' ' LEU . 38.7 p90 -114.41 148.56 37.53 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.355 -175.65 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.481 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 32.2 t -93.74 97.64 10.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.935 178.136 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.482 ' CD ' ' H ' ' A' ' 32' ' ' ARG . 0.8 OUTLIER -51.43 155.78 2.4 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.376 -0.829 . . . . 0.0 113.007 -175.497 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.65 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 1.5 Cg_endo -85.38 161.99 11.16 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 124.564 3.509 . . . . 0.0 112.656 -172.671 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -74.71 -18.76 60.46 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.6 173.102 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -59.43 138.69 89.04 Favored Pre-proline 0 CA--C 1.518 -0.276 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.041 175.867 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -69.62 113.86 3.49 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 121.008 1.139 . . . . 0.0 109.666 170.814 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.562 HG21 ' HB1' ' A' ' 81' ' ' ALA . 0.7 OUTLIER -118.63 155.11 20.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -176.222 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.458 ' C ' ' HB3' ' A' ' 59' ' ' GLU . 17.2 p -100.96 -26.02 13.87 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -176.921 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.53 ' C ' HG11 ' A' ' 82' ' ' VAL . . . -168.83 -168.59 31.11 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.33 -0.938 . . . . 0.0 111.675 179.432 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.65 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 5.6 m-85 -137.17 132.57 34.14 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 117.105 0.453 . . . . 0.0 111.378 173.359 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 10.0 mmm180 -99.28 148.68 23.89 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 167.807 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.867 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 31.6 mt -139.21 108.32 3.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 C-N-CA 120.065 -0.654 . . . . 0.0 112.043 178.848 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 75.2 t -110.03 110.42 32.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.325 0.584 . . . . 0.0 110.205 179.864 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.704 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 0.4 OUTLIER -111.87 124.47 52.43 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.377 176.338 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 23.1 t -139.4 135.74 17.31 Favored Pre-proline 0 C--N 1.314 -0.95 0 CA-C-N 113.692 -1.594 . . . . 0.0 110.383 -173.504 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.637 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 50.0 Cg_exo -55.61 148.26 55.0 Favored 'Trans proline' 0 C--O 1.234 0.277 0 C-N-CA 123.362 2.708 . . . . 0.0 112.491 174.22 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 31.4 t -61.8 -42.03 98.49 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.412 -176.75 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.9 m -114.73 -39.24 2.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -178.531 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -176.52 145.36 0.56 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.666 0.269 . . . . 0.0 110.994 -176.948 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.491 ' CA ' ' HG2' ' A' ' 46' ' ' PRO . . . 154.45 -151.68 23.33 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 121.168 -0.539 . . . . 0.0 111.953 176.828 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 39.5 t -92.3 121.87 34.22 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.576 0.188 . . . . 0.0 110.657 -177.745 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 9.6 m -112.07 144.63 41.11 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 178.447 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.704 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 23.3 m -145.61 148.7 33.4 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.876 -0.33 . . . . 0.0 111.5 -175.78 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.867 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 56.2 tt0 -119.16 118.36 31.14 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.235 173.301 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.635 HD12 ' CG2' ' A' ' 64' ' ' VAL . 19.4 mt -100.0 155.84 17.48 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 173.664 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -118.95 113.34 20.86 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 176.91 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.507 HD12 ' CH2' ' A' ' 30' ' ' TRP . 2.1 mt -108.51 156.25 39.03 Favored Pre-proline 0 C--N 1.317 -0.836 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 -177.32 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -54.77 147.07 52.2 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 121.824 1.683 . . . . 0.0 111.29 171.832 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.458 ' HB3' ' C ' ' A' ' 38' ' ' THR . 8.9 pt-20 -48.54 -27.38 2.7 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.959 173.153 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.4 t -96.69 -1.7 46.06 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.334 -175.572 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.439 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -71.41 152.29 43.26 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 -176.619 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.417 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 3.9 p-10 -132.32 11.32 4.54 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -176.21 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.571 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 53.4 p -169.3 133.67 1.41 Allowed 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 119.993 -0.683 . . . . 0.0 111.877 -177.171 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.635 ' CG2' HD12 ' A' ' 55' ' ' LEU . 3.7 p -114.61 136.37 51.46 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.148 176.034 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 83.1 m -96.14 100.0 11.68 Favored 'General case' 0 N--CA 1.429 -1.514 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 168.669 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.642 ' O ' ' HA ' ' A' ' 25' ' ' SER . 0.6 OUTLIER -74.13 144.19 45.01 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.143 178.922 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 8.6 t -144.56 166.16 25.95 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 -174.325 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 64.03 32.95 12.57 Favored 'General case' 0 C--N 1.327 -0.393 0 O-C-N 123.775 0.672 . . . . 0.0 110.936 -177.119 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.482 ' O ' HG21 ' A' ' 24' ' ' THR . 7.9 mt -78.42 -176.85 4.95 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 174.573 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -124.64 123.99 25.66 Favored Pre-proline 0 C--N 1.318 -0.793 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 176.812 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -60.53 135.91 63.93 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 122.778 2.319 . . . . 0.0 112.768 -179.328 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.2 33.91 31.09 Favored Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.683 -179.604 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.522 ' CG1' ' HB3' ' A' ' 46' ' ' PRO . 85.5 t -138.26 139.41 41.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 120.8 0.333 . . . . 0.0 110.82 -176.218 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.637 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 1.7 tm0? -82.39 127.53 33.35 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.025 179.348 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.469 ' CE2' HD23 ' A' ' 69' ' ' LEU . 6.1 m-85 -116.67 114.12 23.6 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -173.378 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.446 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 15.9 m120 -85.53 107.39 17.44 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.674 173.415 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.521 HG22 HD12 ' A' ' 79' ' ' ILE . 5.1 mp -91.01 117.07 33.51 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.733 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 176.644 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.882 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 26.1 m -109.15 114.77 28.77 Favored 'General case' 0 N--CA 1.424 -1.734 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.436 -179.146 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.521 HD12 HG22 ' A' ' 77' ' ' ILE . 13.5 mm -95.31 141.52 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -179.882 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.411 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 73.8 m-85 -129.34 111.99 13.4 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.229 179.624 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.562 ' HB1' HG21 ' A' ' 37' ' ' ILE . . . -79.81 114.47 18.76 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 169.761 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.53 HG11 ' C ' ' A' ' 39' ' ' GLY . 7.1 p -104.36 132.25 51.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 C-N-CA 120.048 -0.661 . . . . 0.0 109.565 -178.687 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.58 ' OE1' ' HB2' ' A' ' 86' ' ' GLN . 1.1 mp0 -113.6 171.33 7.64 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 123.178 0.299 . . . . 0.0 110.751 -177.655 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -45.22 -40.92 7.84 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.505 -0.771 . . . . 0.0 112.754 -176.107 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -112.42 -20.47 11.78 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -172.353 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.58 ' HB2' ' OE1' ' A' ' 83' ' ' GLU . 69.5 mt-30 -142.63 178.47 7.6 Favored 'General case' 0 C--N 1.328 -0.329 0 O-C-N 122.091 -0.381 . . . . 0.0 111.523 -170.095 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -123.17 120.35 32.93 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.449 -0.796 . . . . 0.0 108.976 171.09 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 50.9 m -70.0 178.03 2.9 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -172.625 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -59.31 152.83 51.41 Favored Pre-proline 0 N--CA 1.451 -0.413 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.539 179.028 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -87.0 138.47 4.97 Favored 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 122.53 2.153 . . . . 0.0 114.269 -177.42 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.882 ' O ' ' HA ' ' A' ' 78' ' ' THR . 7.1 t -82.28 125.78 39.88 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.746 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 165.929 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 4.5 t -122.16 107.08 18.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 C-N-CA 119.83 -0.748 . . . . 0.0 110.121 173.276 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.511 HG13 ' HB ' ' A' ' 77' ' ' ILE . 6.5 pt -124.96 114.94 42.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.878 177.449 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.551 ' HB2' ' OE1' ' A' ' 74' ' ' GLN . 11.3 pt20 -100.92 120.78 40.66 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.553 0.692 . . . . 0.0 111.598 -175.077 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.23 132.25 39.48 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.546 178.103 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.505 ' HB2' ' HG2' ' A' ' 74' ' ' GLN . 35.8 tt0 -87.0 142.3 28.04 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.016 0.436 . . . . 0.0 110.259 179.898 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.486 HG21 HD13 ' A' ' 26' ' ' ILE . 31.6 p -68.39 134.49 50.3 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.297 -178.102 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 11.8 m -70.49 -29.25 65.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.665 -177.893 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.406 ' HA3' ' HA ' ' A' ' 23' ' ' ASP . . . -47.68 128.7 15.39 Favored Glycine 0 N--CA 1.452 -0.285 0 CA-C-N 115.156 -0.929 . . . . 0.0 113.812 -179.423 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 84.9 m -89.82 122.17 68.24 Favored Pre-proline 0 C--N 1.32 -0.696 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 172.819 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -54.67 110.4 0.52 Allowed 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.802 2.335 . . . . 0.0 111.883 179.381 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 44.0 ttp180 -149.73 108.93 3.93 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.913 -175.41 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 58.8 p -110.81 -173.03 2.15 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.753 175.433 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 65.94 57.25 0.81 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.184 0.516 . . . . 0.0 111.34 174.333 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -100.41 43.81 1.7 Allowed Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 175.134 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 23.8 p . . . . . 0 C--O 1.25 1.112 0 C-N-CA 123.542 0.737 . . . . 0.0 111.36 -175.203 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.066 0 N-CA-C 110.806 -0.072 . . . . 0.0 110.806 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -72.86 128.34 13.15 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.264 1.976 . . . . 0.0 111.476 174.058 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.568 ' HD2' ' O ' ' A' ' 31' ' ' SER . 89.2 Cg_exo -48.33 146.2 10.4 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.837 2.358 . . . . 0.0 111.933 174.178 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.456 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 9.1 p-10 -36.76 107.12 0.36 Allowed Pre-proline 0 N--CA 1.468 0.446 0 O-C-N 124.806 1.316 . . . . 0.0 112.74 -169.147 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.634 ' HG2' HG11 ' A' ' 91' ' ' VAL . 27.4 Cg_exo -66.86 152.3 80.71 Favored 'Trans proline' 0 C--O 1.233 0.273 0 C-N-CA 123.62 2.88 . . . . 0.0 112.643 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.8 m -107.05 130.62 54.63 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.987 -177.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.475 HG22 HG12 ' A' ' 28' ' ' VAL . 77.0 t -78.25 122.22 32.76 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-N 114.812 -1.085 . . . . 0.0 109.881 172.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -87.16 -42.08 13.27 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.918 -175.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -134.48 139.07 45.22 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.464 -175.458 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.447 ' HA ' HG12 ' A' ' 26' ' ' ILE . 61.2 t -130.88 123.78 54.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.472 178.748 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -133.59 -159.47 0.97 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.11 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 17.7 p-10 -76.37 -57.68 3.72 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.199 0.524 . . . . 0.0 111.262 -178.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.62 HG22 ' O ' ' A' ' 69' ' ' LEU . 33.8 p -119.43 32.81 5.91 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.516 -172.239 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.627 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 68.4 m -168.07 130.47 1.5 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.201 -173.129 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.626 ' HB ' HD12 ' A' ' 66' ' ' LEU . 33.1 mt -145.08 141.71 22.86 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.888 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 175.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 40.6 t -116.69 132.93 64.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 C-N-CA 119.71 -0.796 . . . . 0.0 110.17 -175.271 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.584 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.7 OUTLIER -127.76 147.35 32.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 C-N-CA 120.397 -0.521 . . . . 0.0 110.052 -179.126 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.44 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 20.9 mtp180 -133.29 120.77 21.49 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.203 -174.466 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.814 ' HZ3' HG12 ' A' ' 64' ' ' VAL . 41.3 p90 -113.23 149.65 33.48 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.343 -173.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.568 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 20.5 m -98.25 98.14 9.44 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.097 178.168 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.645 ' H ' ' CD ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -45.82 156.26 0.45 Allowed Pre-proline 0 CA--C 1.539 0.54 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 -173.49 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.708 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 2.9 Cg_exo -78.57 170.64 17.99 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 124.844 3.696 . . . . 0.0 113.496 -170.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -76.8 -20.96 55.81 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.832 -1.076 . . . . 0.0 109.218 173.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -70.19 137.77 86.91 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.856 175.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.405 ' O ' ' HG2' ' A' ' 83' ' ' GLU . 6.7 Cg_exo -73.5 114.93 4.17 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 121.468 1.446 . . . . 0.0 109.51 167.638 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.563 HG21 ' HB1' ' A' ' 81' ' ' ALA . 0.2 OUTLIER -111.8 160.44 11.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -174.121 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.4 p -93.23 -32.21 14.45 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.497 ' C ' HG12 ' A' ' 82' ' ' VAL . . . -167.85 -164.56 23.74 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.11 -1.043 . . . . 0.0 111.614 179.344 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.708 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 6.2 m-85 -140.33 135.52 32.27 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-N 117.111 0.456 . . . . 0.0 111.416 176.219 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.435 ' C ' HG13 ' A' ' 42' ' ' ILE . 25.1 mtp180 -103.48 151.09 23.24 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 167.053 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.865 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 29.3 mt -139.54 107.86 3.22 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 C-N-CA 120.312 -0.555 . . . . 0.0 112.112 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 71.2 t -106.3 110.24 30.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.151 0.5 . . . . 0.0 110.704 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.583 ' HA ' ' O ' ' A' ' 76' ' ' ASN . 0.8 OUTLIER -113.28 125.47 54.33 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.661 176.26 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.412 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 26.1 p -139.13 143.88 38.53 Favored Pre-proline 0 C--N 1.317 -0.817 0 CA-C-N 114.007 -1.451 . . . . 0.0 111.792 -173.253 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.564 ' HB3' HG11 ' A' ' 73' ' ' VAL . 4.7 Cg_exo . . . . . 0 C--O 1.234 0.284 0 C-N-CA 123.082 2.522 . . . . 0.0 111.467 175.206 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 8.4 p . . . . . 0 CA--C 1.518 -0.257 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.565 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 71.2 m -147.71 148.62 31.19 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.248 -0.581 . . . . 0.0 112.006 -179.161 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.865 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 41.6 tt0 -114.67 115.41 27.07 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.7 172.186 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.676 HD12 ' CG2' ' A' ' 64' ' ' VAL . 16.7 mt -96.44 157.97 15.65 Favored 'General case' 0 CA--C 1.513 -0.475 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.038 175.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.438 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 25.0 t-20 -120.21 115.73 24.2 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 178.404 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.571 HD12 ' CH2' ' A' ' 30' ' ' TRP . 2.5 mt -113.4 156.02 43.83 Favored Pre-proline 0 N--CA 1.443 -0.781 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 -177.362 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -63.65 150.87 87.43 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 121.687 1.591 . . . . 0.0 111.3 175.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -45.41 -28.54 0.89 Allowed 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 114.738 -1.119 . . . . 0.0 112.972 178.013 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 10.2 t -104.39 11.21 34.89 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.223 0.535 . . . . 0.0 111.126 -174.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.486 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -75.51 159.92 30.76 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 178.129 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.572 ' HB3' ' NE ' ' A' ' 32' ' ' ARG . 4.6 p-10 -146.41 17.53 1.34 Allowed 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 120.724 -0.391 . . . . 0.0 112.045 -177.301 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.584 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 39.3 p -171.4 134.37 0.87 Allowed 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.529 -0.469 . . . . 0.0 111.729 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.814 HG12 ' HZ3' ' A' ' 30' ' ' TRP . 3.2 p -119.17 136.5 56.16 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 CA-C-N 116.358 -0.383 . . . . 0.0 109.992 174.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 63.0 m -95.67 100.47 12.19 Favored 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 168.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.726 HD11 HG12 ' A' ' 77' ' ' ILE . 0.3 OUTLIER -75.03 136.74 41.21 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.167 179.918 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 7.4 t -132.16 164.61 25.94 Favored 'General case' 0 C--N 1.316 -0.856 0 O-C-N 123.705 0.628 . . . . 0.0 109.458 -173.209 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 26.4 t0 58.71 50.72 8.47 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 123.81 0.694 . . . . 0.0 110.692 -177.11 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.62 ' O ' HG22 ' A' ' 24' ' ' THR . 11.9 mt -90.18 -176.24 4.79 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 172.442 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 57.6 tp60 -123.62 125.53 25.98 Favored Pre-proline 0 C--N 1.32 -0.691 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 174.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -62.01 140.77 86.32 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 123.05 2.5 . . . . 0.0 113.269 -178.476 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 75.57 29.6 59.46 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.918 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.564 HG11 ' HB3' ' A' ' 46' ' ' PRO . 61.0 t -131.42 148.09 32.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.276 0.56 . . . . 0.0 111.145 -176.041 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.554 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -82.81 127.79 33.79 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.412 179.18 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.432 ' CZ ' ' HG3' ' A' ' 46' ' ' PRO . 3.8 m-85 -122.37 116.07 23.39 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.401 0.62 . . . . 0.0 112.521 -176.03 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.583 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 4.0 m-20 -85.92 112.91 21.61 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.597 172.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.726 HG12 HD11 ' A' ' 66' ' ' LEU . 5.0 mp -95.79 115.9 36.11 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.597 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 172.553 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.879 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 21.9 m -108.88 113.6 26.66 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.26 -178.674 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.542 ' HB ' ' HB ' ' A' ' 91' ' ' VAL . 12.8 mm -95.04 138.41 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.412 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 82.8 m-85 -124.67 111.29 15.42 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.161 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.563 ' HB1' HG21 ' A' ' 37' ' ' ILE . . . -81.05 111.24 17.34 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 171.264 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.497 HG12 ' C ' ' A' ' 39' ' ' GLY . 7.1 p -104.5 136.72 36.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 C-N-CA 120.021 -0.672 . . . . 0.0 110.717 -175.474 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.405 ' HG2' ' O ' ' A' ' 36' ' ' PRO . 4.3 tm-20 -121.39 163.28 18.95 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -47.74 -46.59 30.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 118.341 0.519 . . . . 0.0 111.426 -178.136 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 -89.97 -34.6 15.95 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -170.477 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -150.77 171.84 16.54 Favored 'General case' 0 C--O 1.222 -0.347 0 C-N-CA 120.619 -0.432 . . . . 0.0 111.528 -168.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -114.57 129.06 56.63 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.321 175.034 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 17.1 m -66.95 169.33 8.39 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.075 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.5 p -57.76 151.13 43.92 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-O 120.968 0.413 . . . . 0.0 110.784 176.694 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -84.14 141.6 9.36 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 122.159 1.906 . . . . 0.0 113.989 -174.536 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.879 ' O ' ' HA ' ' A' ' 78' ' ' THR . 12.5 t -81.93 121.83 35.82 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.717 0 CA-C-N 114.855 -1.066 . . . . 0.0 108.196 168.678 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 5.9 t -117.87 105.72 18.48 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 C-N-CA 119.552 -0.859 . . . . 0.0 109.897 172.25 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.588 HG13 ' HB ' ' A' ' 77' ' ' ILE . 8.0 pt -123.26 115.48 45.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.379 176.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.515 ' HB2' ' OE1' ' A' ' 74' ' ' GLN . 5.1 pt20 -103.31 126.46 50.49 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.351 0.596 . . . . 0.0 111.103 -174.567 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -128.94 134.46 48.22 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.088 177.115 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.5 ' HG2' ' HG2' ' A' ' 74' ' ' GLN . 45.1 mt-10 -86.59 133.12 33.74 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 175.014 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 37.9 p -72.75 113.85 10.24 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.161 0.505 . . . . 0.0 110.724 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 14.3 m . . . . . 0 C--N 1.326 -0.436 0 CA-C-O 121.421 0.629 . . . . 0.0 110.223 -177.776 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.538 ' HB2' ' O ' ' A' ' 89' ' ' THR . . . . . . . . 0 N--CA 1.451 -0.386 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -56.88 129.03 32.4 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.347 2.031 . . . . 0.0 112.079 174.462 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.449 ' HD2' ' O ' ' A' ' 31' ' ' SER . 85.5 Cg_exo -46.43 146.82 4.64 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.702 2.268 . . . . 0.0 111.422 171.189 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -36.79 106.17 0.32 Allowed Pre-proline 0 N--CA 1.472 0.628 0 O-C-N 124.654 1.221 . . . . 0.0 112.694 -168.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.634 ' HG2' HG11 ' A' ' 91' ' ' VAL . 37.9 Cg_exo -65.34 150.58 87.03 Favored 'Trans proline' 0 CA--C 1.52 -0.204 0 C-N-CA 123.501 2.8 . . . . 0.0 112.33 178.718 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 20.2 m -107.0 130.49 54.63 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.037 -176.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.488 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 82.1 t -83.33 121.37 36.09 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-N 114.435 -1.257 . . . . 0.0 109.908 174.288 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.532 ' OD1' ' HG3' ' A' ' 20' ' ' GLN . 13.5 t70 -80.96 -48.13 12.71 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.108 -174.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.532 ' HG3' ' OD1' ' A' ' 19' ' ' ASP . 94.8 mt-30 -136.07 140.73 44.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.694 -177.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.525 ' HA ' HG12 ' A' ' 26' ' ' ILE . 6.4 m -126.0 101.33 8.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.159 178.455 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.406 ' HB3' ' H ' ' A' ' 23' ' ' ASP . 12.3 m-20 -97.65 -160.12 0.78 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.151 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.406 ' H ' ' HB3' ' A' ' 22' ' ' ASP . 11.5 p-10 -78.86 -52.66 8.0 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.253 0.549 . . . . 0.0 110.622 177.637 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.747 HG22 ' O ' ' A' ' 69' ' ' LEU . 26.6 p -121.81 34.6 5.13 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.984 -172.45 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.651 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 66.1 m -169.19 130.43 1.14 Allowed 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.424 -172.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.578 ' HB ' HD12 ' A' ' 66' ' ' LEU . 20.5 mt -144.83 137.39 21.73 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.786 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 177.628 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 41.1 t -115.67 128.67 72.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 C-N-CA 119.632 -0.827 . . . . 0.0 110.438 -175.651 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.65 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.7 OUTLIER -125.12 144.65 34.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 C-N-CA 120.546 -0.461 . . . . 0.0 109.916 -177.55 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.531 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 23.0 mtm180 -129.88 121.0 25.82 Favored 'General case' 0 C--N 1.327 -0.393 0 O-C-N 123.239 0.337 . . . . 0.0 110.573 -176.194 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.734 ' HZ3' HG12 ' A' ' 64' ' ' VAL . 33.8 p90 -107.88 144.58 34.91 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.176 -173.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.449 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 16.1 m -85.64 89.85 7.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.493 178.406 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.705 ' HD3' ' H ' ' A' ' 32' ' ' ARG . 0.4 OUTLIER -46.07 152.35 0.8 Allowed Pre-proline 0 CA--C 1.538 0.486 0 C-N-CA 124.189 0.996 . . . . 0.0 113.014 -175.549 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.687 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 2.2 Cg_endo -86.03 166.42 9.78 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 124.273 3.315 . . . . 0.0 113.318 -169.456 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -76.27 -20.86 56.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.319 172.214 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.32 136.24 91.56 Favored Pre-proline 0 N--CA 1.453 -0.311 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.754 175.634 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -70.21 113.19 3.37 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 121.072 1.181 . . . . 0.0 109.593 170.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.505 HG22 ' HG2' ' A' ' 83' ' ' GLU . 24.9 pt -117.9 153.42 19.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.797 -174.621 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.448 ' C ' ' HB3' ' A' ' 59' ' ' GLU . 9.1 p -94.88 -24.4 17.02 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.547 ' C ' HG12 ' A' ' 82' ' ' VAL . . . -174.8 -161.67 24.97 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 119.732 -1.223 . . . . 0.0 113.304 -179.063 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.687 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 41.8 m-85 -139.54 131.49 27.76 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 122.364 0.266 . . . . 0.0 111.25 174.807 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.408 ' HB2' ' CD1' ' A' ' 80' ' ' TYR . 14.3 mmm-85 -96.21 148.76 22.38 Favored 'General case' 0 CA--C 1.504 -0.812 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 165.533 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.876 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 28.4 mt -139.0 107.84 3.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 C-N-CA 119.74 -0.784 . . . . 0.0 112.439 -179.567 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 71.9 t -109.04 109.93 30.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.396 0.617 . . . . 0.0 110.719 179.181 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.697 ' CZ ' ' HB ' ' A' ' 53' ' ' THR . 0.6 OUTLIER -112.77 125.57 54.48 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.322 176.747 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.4 m -139.97 141.16 26.17 Favored Pre-proline 0 C--N 1.317 -0.842 0 CA-C-N 114.282 -1.326 . . . . 0.0 111.429 -173.663 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.684 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 59.9 Cg_endo . . . . . 0 C--O 1.232 0.191 0 C-N-CA 123.66 2.907 . . . . 0.0 112.01 177.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.505 ' HA ' ' O ' ' A' ' 44' ' ' TYR . 15.1 m . . . . . 0 CA--C 1.516 -0.333 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.697 ' HB ' ' CZ ' ' A' ' 44' ' ' TYR . 23.6 m -147.27 153.29 39.58 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 120.61 -0.436 . . . . 0.0 111.13 -179.399 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.876 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 30.8 tt0 -122.35 112.4 18.06 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 123.025 0.53 . . . . 0.0 109.673 175.663 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.682 HD12 ' CG2' ' A' ' 64' ' ' VAL . 15.8 mt -97.8 159.97 14.6 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.584 177.737 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -123.95 114.56 19.95 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.076 179.031 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.588 HD12 ' CH2' ' A' ' 30' ' ' TRP . 3.8 mt -113.69 154.65 45.68 Favored Pre-proline 0 C--N 1.318 -0.778 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -176.715 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -61.34 150.56 84.33 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 121.987 1.792 . . . . 0.0 111.18 176.193 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.448 ' HB3' ' C ' ' A' ' 38' ' ' THR . 11.4 pt-20 -46.26 -30.0 1.84 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.032 -0.985 . . . . 0.0 112.499 176.203 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 7.4 t -99.89 17.37 21.02 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.045 -175.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.476 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -88.48 151.46 22.53 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.165 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.531 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 24.6 p-10 -136.58 13.95 3.19 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.871 -177.865 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.65 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 71.6 p -167.51 134.39 2.25 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.336 -0.546 . . . . 0.0 111.678 -177.85 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.734 HG12 ' HZ3' ' A' ' 30' ' ' TRP . 4.2 p -115.06 138.72 44.44 Favored 'Isoleucine or valine' 0 C--O 1.243 0.727 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.226 175.71 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 55.5 m -97.7 100.88 12.28 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.58 169.497 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.721 HD11 HG12 ' A' ' 77' ' ' ILE . 0.7 OUTLIER -76.46 144.46 39.88 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.2 177.415 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.1 p -141.85 164.74 29.38 Favored 'General case' 0 C--N 1.32 -0.675 0 O-C-N 123.501 0.501 . . . . 0.0 110.955 -172.12 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 28.8 t70 65.86 26.54 11.12 Favored 'General case' 0 N--CA 1.465 0.294 0 O-C-N 123.923 0.765 . . . . 0.0 110.824 -178.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.747 ' O ' HG22 ' A' ' 24' ' ' THR . 14.9 mt -70.65 -175.01 0.97 Allowed 'General case' 0 C--O 1.222 -0.349 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.948 176.335 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.456 ' HB2' HG21 ' A' ' 73' ' ' VAL . 16.8 mm-40 -129.27 133.28 24.97 Favored Pre-proline 0 C--N 1.319 -0.719 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 176.686 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -64.57 128.1 20.43 Favored 'Trans proline' 0 C--O 1.234 0.276 0 C-N-CA 122.921 2.414 . . . . 0.0 112.755 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 90.8 14.95 57.36 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.321 178.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.456 HG21 ' HB2' ' A' ' 70' ' ' GLN . 72.0 t -114.78 141.09 32.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.219 0.533 . . . . 0.0 111.602 -175.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.684 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -80.49 122.26 26.79 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.626 179.238 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.466 ' CE2' ' HB3' ' A' ' 69' ' ' LEU . 23.8 m-85 -118.17 113.71 21.96 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.377 0.608 . . . . 0.0 112.377 -176.651 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.552 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 20.5 m-80 -87.28 108.26 18.87 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.681 175.768 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.721 HG12 HD11 ' A' ' 66' ' ' LEU . 5.4 mp -92.55 115.29 31.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.298 0.571 . . . . 0.0 109.883 176.658 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.858 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 51.9 m -107.64 115.89 30.95 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.019 179.445 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.624 ' HB ' ' HB ' ' A' ' 91' ' ' VAL . 19.1 mm -95.91 143.04 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 -178.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.473 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 47.2 m-85 -128.35 111.83 13.77 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 178.091 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.489 ' HB1' HG21 ' A' ' 37' ' ' ILE . . . -79.82 107.96 13.0 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 173.036 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.547 HG12 ' C ' ' A' ' 39' ' ' GLY . 9.5 p -99.4 135.62 33.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 C-N-CA 120.132 -0.627 . . . . 0.0 110.678 -175.555 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.505 ' HG2' HG22 ' A' ' 37' ' ' ILE . 4.5 mt-10 -111.06 171.07 7.69 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 175.535 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -44.64 -47.09 10.47 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 123.797 0.686 . . . . 0.0 112.378 -178.56 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -106.14 -21.06 13.22 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -169.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -149.61 176.93 10.21 Favored 'General case' 0 C--O 1.219 -0.515 0 CA-C-N 118.696 0.68 . . . . 0.0 111.813 -174.143 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -117.6 134.36 54.97 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 177.456 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 10.7 m -73.84 -179.98 3.96 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.832 0.348 . . . . 0.0 111.223 -176.669 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.538 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 0.8 OUTLIER -61.74 159.43 34.7 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.587 176.176 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -88.78 140.96 4.35 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 122.418 2.079 . . . . 0.0 114.361 -177.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.858 ' O ' ' HA ' ' A' ' 78' ' ' THR . 5.6 t -83.08 128.67 38.5 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.7 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 164.15 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 4.1 t -123.22 106.87 18.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 C-N-CA 119.987 -0.685 . . . . 0.0 110.113 171.684 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.539 HG13 ' HB ' ' A' ' 77' ' ' ILE . 6.7 pt -126.77 111.48 26.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.895 177.124 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.401 ' HB2' HE22 ' A' ' 74' ' ' GLN . 17.9 pt20 -102.6 120.51 40.67 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.673 0.749 . . . . 0.0 111.524 -175.613 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -128.1 135.9 50.44 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.2 -179.1 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -87.04 146.46 26.09 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 176.672 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 20.7 p -81.38 120.08 24.51 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.104 178.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 85.7 m . . . . . 0 C--N 1.327 -0.388 0 CA-C-O 121.501 0.667 . . . . 0.0 110.58 178.691 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.287 0 N-CA-C 110.509 -0.182 . . . . 0.0 110.509 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -70.58 132.67 22.48 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.479 2.119 . . . . 0.0 111.45 174.765 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -53.81 159.52 6.92 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.687 2.258 . . . . 0.0 111.314 172.467 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -39.27 106.24 0.39 Allowed Pre-proline 0 N--CA 1.469 0.491 0 O-C-N 124.313 1.008 . . . . 0.0 111.918 -173.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.556 ' HG2' HG11 ' A' ' 91' ' ' VAL . 38.2 Cg_exo -65.22 144.82 82.45 Favored 'Trans proline' 0 CA--C 1.517 -0.339 0 C-N-CA 122.999 2.466 . . . . 0.0 111.925 178.245 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 39.6 m -97.91 124.72 42.47 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.665 -177.535 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.452 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 85.2 t -78.46 118.37 25.52 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-N 114.479 -1.237 . . . . 0.0 109.17 172.438 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -89.69 -37.13 14.81 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.283 -174.047 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 24.8 mm-40 -134.59 129.66 35.31 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.941 0.401 . . . . 0.0 110.66 -176.215 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.439 ' HA ' HG12 ' A' ' 26' ' ' ILE . 85.7 t -126.39 120.52 56.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.724 -178.253 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -125.41 -167.77 1.74 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.813 176.355 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.521 ' O ' ' HB2' ' A' ' 69' ' ' LEU . 4.1 p-10 -67.28 -59.16 3.65 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.173 0.511 . . . . 0.0 111.331 176.596 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.688 HG22 ' O ' ' A' ' 69' ' ' LEU . 36.0 p -117.32 36.83 4.08 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.991 -173.019 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.666 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 66.1 m -168.65 130.28 1.29 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.059 -176.229 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.618 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 34.1 mt -148.14 136.63 15.1 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.539 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 176.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.452 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 41.3 t -116.79 127.84 74.31 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.602 0 C-N-CA 120.054 -0.658 . . . . 0.0 110.693 -174.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.626 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.8 OUTLIER -122.52 143.5 35.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -176.97 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.477 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 63.8 mtp180 -130.14 121.01 25.49 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.912 0.387 . . . . 0.0 110.568 -175.349 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.707 ' HZ3' HG12 ' A' ' 64' ' ' VAL . 34.9 p90 -110.69 141.49 43.89 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.504 -173.66 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 17.6 m -83.63 86.61 7.09 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.02 -0.537 . . . . 0.0 109.725 175.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.442 ' CD ' ' HB3' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -48.28 156.83 0.74 Allowed Pre-proline 0 CA--C 1.541 0.598 0 CA-C-N 114.87 -1.059 . . . . 0.0 113.267 -176.184 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.674 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 3.1 Cg_exo -81.03 169.85 15.8 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 124.341 3.361 . . . . 0.0 113.538 -171.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 19.0 mp0 -91.35 -7.33 51.21 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.662 176.617 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -69.37 144.08 94.2 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.204 175.25 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -70.64 113.24 3.45 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 121.071 1.18 . . . . 0.0 109.766 171.009 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.913 HG22 ' HG3' ' A' ' 83' ' ' GLU . 3.5 pt -119.91 157.56 22.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.403 -173.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.485 HG21 ' HA ' ' A' ' 84' ' ' GLU . 16.6 p -101.29 -22.85 14.51 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -176.136 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.578 ' C ' HG12 ' A' ' 82' ' ' VAL . . . -177.01 -165.43 32.38 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 119.6 -1.286 . . . . 0.0 112.371 179.017 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.674 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 6.3 m-85 -139.24 134.38 32.6 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.773 0.32 . . . . 0.0 110.875 173.512 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.7 mmm180 -100.97 148.07 25.44 Favored 'General case' 0 CA--C 1.501 -0.906 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 165.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.892 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 33.6 mt -138.25 109.53 5.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 C-N-CA 119.881 -0.728 . . . . 0.0 112.319 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 69.9 t -110.77 110.12 31.02 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.525 0 CA-C-O 121.391 0.615 . . . . 0.0 110.695 -179.2 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.712 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 0.8 OUTLIER -112.46 124.49 52.62 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.428 177.06 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.455 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 17.8 p -139.08 137.17 18.92 Favored Pre-proline 0 C--N 1.314 -0.975 0 CA-C-N 114.135 -1.393 . . . . 0.0 111.525 -173.678 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.56 ' HG3' ' CZ ' ' A' ' 75' ' ' TYR . 8.0 Cg_exo . . . . . 0 N--CA 1.462 -0.372 0 C-N-CA 122.978 2.452 . . . . 0.0 110.821 174.635 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.7 p . . . . . 0 CA--C 1.519 -0.239 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.712 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 29.1 m -146.0 150.23 35.63 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.655 -173.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.892 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 56.6 tt0 -114.93 118.35 33.23 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.935 173.238 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.73 HD12 ' CG2' ' A' ' 64' ' ' VAL . 21.9 mt -100.23 148.34 24.74 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.54 -0.464 . . . . 0.0 109.902 173.275 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -109.86 114.14 27.46 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 176.5 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.563 HD12 ' CH2' ' A' ' 30' ' ' TRP . 1.7 mt -109.96 152.51 43.07 Favored Pre-proline 0 N--CA 1.444 -0.766 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 -177.66 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -60.9 149.2 89.74 Favored 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 121.952 1.768 . . . . 0.0 111.389 176.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.476 ' HB3' ' C ' ' A' ' 38' ' ' THR . 9.6 pt-20 -46.92 -22.78 0.36 Allowed 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 114.848 -1.069 . . . . 0.0 113.019 176.586 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.2 t -107.3 15.84 24.6 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.135 -176.133 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.48 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -82.17 164.3 21.36 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.504 -0.317 . . . . 0.0 110.423 -179.642 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.477 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 4.6 p-10 -149.19 11.27 0.8 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -177.102 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.626 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 21.9 p -168.7 134.11 1.69 Allowed 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.346 -0.542 . . . . 0.0 111.996 -178.689 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.73 ' CG2' HD12 ' A' ' 55' ' ' LEU . 4.1 p -117.02 136.78 53.08 Favored 'Isoleucine or valine' 0 C--O 1.242 0.673 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.288 176.488 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 41.9 m -98.93 102.03 13.62 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-O 121.411 0.624 . . . . 0.0 109.795 170.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.667 HD11 HG12 ' A' ' 77' ' ' ILE . 0.2 OUTLIER -79.24 142.22 36.41 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.118 178.422 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.8 t -136.51 169.6 17.42 Favored 'General case' 0 C--N 1.32 -0.681 0 O-C-N 123.274 0.359 . . . . 0.0 110.559 -175.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 58.71 32.99 22.76 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.634 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.688 ' O ' HG22 ' A' ' 24' ' ' THR . 11.8 mt -71.88 -176.39 1.68 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.755 176.111 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -124.56 126.43 25.42 Favored Pre-proline 0 C--N 1.32 -0.714 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 175.158 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -63.58 132.44 35.48 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.183 2.589 . . . . 0.0 113.62 -176.509 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 87.92 21.58 45.85 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.311 177.421 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.495 HG11 ' HB3' ' A' ' 46' ' ' PRO . 18.7 t -125.53 148.2 30.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.328 0.585 . . . . 0.0 111.463 -176.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.48 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 4.3 tp-100 -81.48 114.28 20.1 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.937 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.56 ' CZ ' ' HG3' ' A' ' 46' ' ' PRO . 6.1 m-85 -104.83 115.19 29.87 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.291 0.567 . . . . 0.0 112.02 -178.024 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.556 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 23.1 m-80 -87.72 105.42 17.36 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.64 175.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.667 HG12 HD11 ' A' ' 66' ' ' LEU . 5.2 mp -91.44 117.27 34.36 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.575 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 175.699 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.88 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 90.4 m -109.2 115.39 29.92 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.779 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.555 ' HB ' ' HB ' ' A' ' 91' ' ' VAL . 12.4 mm -96.16 121.07 46.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.915 -179.375 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -108.12 111.11 22.97 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 176.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -80.15 123.61 28.05 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 169.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.578 HG12 ' C ' ' A' ' 39' ' ' GLY . 12.7 p -115.67 134.47 58.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 C-N-CA 120.053 -0.659 . . . . 0.0 110.889 -176.436 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.913 ' HG3' HG22 ' A' ' 37' ' ' ILE . 8.6 mp0 -112.48 171.61 7.42 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -177.843 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.485 ' HA ' HG21 ' A' ' 38' ' ' THR . 39.1 mt-10 -42.12 -44.93 3.83 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -174.15 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -125.66 -13.22 6.51 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.498 -0.481 . . . . 0.0 111.959 -176.331 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -128.39 173.73 9.94 Favored 'General case' 0 N--CA 1.443 -0.794 0 O-C-N 122.247 -0.283 . . . . 0.0 111.358 -171.523 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 20.4 mp0 -128.12 127.02 42.26 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.478 176.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 68.1 m -72.56 171.74 11.85 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.873 0.368 . . . . 0.0 111.797 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.2 p -60.61 150.24 75.75 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.327 177.55 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -85.17 141.2 8.02 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.421 2.08 . . . . 0.0 114.328 -175.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.88 ' O ' ' HA ' ' A' ' 78' ' ' THR . 7.0 t -82.65 129.39 37.53 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.641 0 CA-C-N 114.782 -1.099 . . . . 0.0 108.594 167.436 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 9.7 t -125.9 106.44 16.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 C-N-CA 120.196 -0.602 . . . . 0.0 110.057 171.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.552 HG13 ' HB ' ' A' ' 77' ' ' ILE . 5.8 pt -121.95 111.39 30.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.048 177.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.451 ' HA ' ' O ' ' A' ' 75' ' ' TYR . 0.4 OUTLIER -96.78 115.36 27.29 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.57 0.7 . . . . 0.0 111.184 -178.801 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -122.67 131.79 53.97 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.471 177.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -86.79 134.12 33.59 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.214 0.531 . . . . 0.0 110.135 179.003 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 24.1 p -66.08 120.86 13.92 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.437 178.244 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.6 m . . . . . 0 C--N 1.328 -0.335 0 CA-C-O 121.342 0.591 . . . . 0.0 110.247 -177.164 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 -0.179 0 CA-C-O 120.345 0.117 . . . . 0.0 110.882 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -71.27 129.65 16.32 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 122.35 2.033 . . . . 0.0 111.284 175.166 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.54 ' HD2' ' O ' ' A' ' 31' ' ' SER . 88.5 Cg_exo -49.31 151.44 6.61 Favored 'Trans proline' 0 C--O 1.234 0.316 0 C-N-CA 122.743 2.295 . . . . 0.0 111.936 173.746 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -36.63 106.61 0.34 Allowed Pre-proline 0 N--CA 1.469 0.51 0 O-C-N 124.728 1.268 . . . . 0.0 112.324 -171.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.666 ' HG2' HG11 ' A' ' 91' ' ' VAL . 28.1 Cg_exo -68.61 143.76 57.91 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 123.442 2.761 . . . . 0.0 113.046 179.44 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 94.6 m -96.62 127.7 42.86 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.199 -177.17 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.44 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 97.3 t -79.27 116.48 23.29 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-N 114.611 -1.177 . . . . 0.0 109.337 173.253 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -86.95 -37.02 17.97 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.085 -173.499 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -135.6 136.55 41.13 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.235 -176.496 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.467 ' HA ' HG12 ' A' ' 26' ' ' ILE . 42.0 t -133.52 115.44 22.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.109 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.401 ' HB3' ' H ' ' A' ' 23' ' ' ASP . 8.2 m-20 -132.41 -160.37 1.04 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.269 179.392 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.401 ' H ' ' HB3' ' A' ' 22' ' ' ASP . 6.3 p-10 -68.69 -66.59 0.55 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -177.557 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.609 HG22 ' O ' ' A' ' 69' ' ' LEU . 57.2 p -115.52 36.87 3.77 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.423 0.63 . . . . 0.0 110.582 -172.523 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.602 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 32.2 p -170.2 131.21 0.97 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.673 -174.253 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.586 ' HB ' HD12 ' A' ' 66' ' ' LEU . 42.4 mt -145.97 142.07 21.62 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.771 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 178.214 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 43.6 t -119.67 134.14 64.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 118.859 0.754 . . . . 0.0 110.338 -173.697 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.544 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.7 OUTLIER -129.11 148.55 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.524 -179.261 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.639 ' HG2' ' OG ' ' A' ' 63' ' ' SER . 29.7 mtm105 -131.36 120.3 22.92 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.554 -177.752 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.749 ' HZ3' HG12 ' A' ' 64' ' ' VAL . 37.8 p90 -111.14 143.81 41.28 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.832 -175.687 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.54 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 17.3 t -91.17 96.44 10.58 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 177.219 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.543 ' H ' ' CD ' ' A' ' 32' ' ' ARG . 1.0 OUTLIER -49.54 158.12 0.86 Allowed Pre-proline 0 C--N 1.327 -0.372 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -173.854 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.692 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 5.1 Cg_exo -79.94 165.56 21.83 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 124.197 3.265 . . . . 0.0 112.534 -173.226 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -78.92 -10.43 59.81 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.13 -0.941 . . . . 0.0 108.933 172.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -72.23 138.42 81.54 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 114.779 -1.1 . . . . 0.0 111.315 177.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo -66.31 115.05 3.29 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 121.492 1.461 . . . . 0.0 109.738 166.643 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.54 HD12 ' HE1' ' A' ' 40' ' ' TYR . 0.6 OUTLIER -119.55 154.71 22.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 -177.901 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.412 ' N ' ' O ' ' A' ' 82' ' ' VAL . 9.5 p -95.74 -23.79 16.81 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -178.25 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.574 ' C ' HG12 ' A' ' 82' ' ' VAL . . . -173.61 -163.02 26.49 Favored Glycine 0 CA--C 1.502 -0.778 0 C-N-CA 119.919 -1.134 . . . . 0.0 111.887 178.458 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.692 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 6.8 m-85 -141.2 133.8 28.58 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 122.525 0.33 . . . . 0.0 111.156 174.667 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.5 mmm180 -104.61 149.87 25.16 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 167.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.888 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 33.7 mt -138.88 107.93 3.77 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 C-N-CA 120.123 -0.631 . . . . 0.0 112.106 -178.138 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 66.1 t -107.09 110.13 30.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.422 0.63 . . . . 0.0 110.572 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.645 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 0.5 OUTLIER -110.74 124.62 52.33 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.096 175.517 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.412 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 14.5 t -142.39 139.2 17.28 Favored Pre-proline 0 C--N 1.316 -0.89 0 CA-C-N 113.86 -1.518 . . . . 0.0 110.666 -172.085 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.704 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 37.2 Cg_exo . . . . . 0 C--N 1.343 0.244 0 C-N-CA 123.374 2.716 . . . . 0.0 112.585 176.049 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 32.7 p . . . . . 0 CA--C 1.52 -0.193 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.645 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 24.6 m -147.87 152.87 38.34 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.756 -0.377 . . . . 0.0 111.374 -178.149 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.888 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 34.1 tt0 -116.87 118.36 32.26 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 171.467 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.7 HD12 ' CG2' ' A' ' 64' ' ' VAL . 20.5 mt -97.13 157.13 16.08 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 174.481 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -122.35 113.48 19.45 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.564 HD12 ' CH2' ' A' ' 30' ' ' TRP . 3.6 mt -112.0 155.58 43.13 Favored Pre-proline 0 N--CA 1.443 -0.782 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 -175.74 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -64.36 149.65 89.73 Favored 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 121.656 1.57 . . . . 0.0 110.945 174.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -46.56 -25.94 0.79 Allowed 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 114.722 -1.126 . . . . 0.0 113.123 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 7.9 t -101.55 5.72 41.88 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.915 0.388 . . . . 0.0 111.358 -175.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.455 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -75.95 155.99 34.59 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.433 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 4.9 p-10 -141.3 12.46 2.17 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 120.55 -0.46 . . . . 0.0 112.181 -175.722 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.639 ' OG ' ' HG2' ' A' ' 29' ' ' ARG . 9.4 m -161.94 135.88 6.6 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.981 -0.288 . . . . 0.0 110.834 -178.051 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.749 HG12 ' HZ3' ' A' ' 30' ' ' TRP . 4.2 p -121.26 135.12 62.45 Favored 'Isoleucine or valine' 0 C--O 1.24 0.605 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 172.488 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 55.2 m -97.67 100.91 12.31 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-O 121.528 0.68 . . . . 0.0 109.291 169.444 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.741 HD11 HG12 ' A' ' 77' ' ' ILE . 0.2 OUTLIER -77.52 141.38 39.65 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.22 -0.9 . . . . 0.0 108.958 179.824 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 22.5 t -141.42 169.63 17.25 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -174.627 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 34.1 t70 64.48 29.87 13.17 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 123.998 0.811 . . . . 0.0 110.307 -178.524 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.609 ' O ' HG22 ' A' ' 24' ' ' THR . 8.2 mt -75.42 -176.29 3.11 Favored 'General case' 0 N--CA 1.462 0.143 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 175.768 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -117.96 133.1 23.42 Favored Pre-proline 0 C--N 1.32 -0.689 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 174.437 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -64.55 128.71 21.85 Favored 'Trans proline' 0 C--O 1.233 0.269 0 C-N-CA 122.666 2.244 . . . . 0.0 112.392 177.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.63 37.52 19.81 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.04 179.407 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.526 ' CG1' ' HB3' ' A' ' 46' ' ' PRO . 71.5 t -134.82 138.35 49.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.121 0.486 . . . . 0.0 110.805 -178.557 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.704 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -75.7 121.28 22.27 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.564 -0.743 . . . . 0.0 109.549 -179.997 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.439 ' CE2' HD22 ' A' ' 69' ' ' LEU . 7.6 m-85 -113.92 114.62 26.47 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.308 0.575 . . . . 0.0 112.444 -176.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.482 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 12.2 m120 -88.28 109.21 19.78 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.321 172.472 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.741 HG12 HD11 ' A' ' 66' ' ' LEU . 4.9 mp -92.15 119.97 40.53 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.621 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 175.038 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.897 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 55.9 m -112.16 115.41 28.8 Favored 'General case' 0 N--CA 1.425 -1.687 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.613 -179.552 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.53 ' H ' ' HB ' ' A' ' 91' ' ' VAL . 12.6 mm -95.94 136.91 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -124.29 111.73 16.17 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.322 -0.399 . . . . 0.0 109.965 178.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.445 ' HB1' HG21 ' A' ' 37' ' ' ILE . . . -80.04 109.38 14.43 Favored 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 171.063 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.574 HG12 ' C ' ' A' ' 39' ' ' GLY . 10.4 p -100.13 139.73 20.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 C-N-CA 120.029 -0.668 . . . . 0.0 110.754 -174.303 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.632 ' HG2' ' H ' ' A' ' 84' ' ' GLU . 0.7 OUTLIER -117.56 167.56 11.2 Favored 'General case' 0 N--CA 1.447 -0.583 0 O-C-N 124.005 0.816 . . . . 0.0 108.935 179.265 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.632 ' H ' ' HG2' ' A' ' 83' ' ' GLU . 39.1 mt-10 -40.65 -52.51 2.9 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 28.5 m-80 -123.99 1.49 8.63 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.815 -174.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -134.98 172.02 13.6 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.332 -0.547 . . . . 0.0 111.596 -172.202 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -136.86 129.14 29.83 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.523 177.227 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 23.9 m -69.09 162.22 27.4 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.304 176.482 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.1 p -58.15 151.81 44.57 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.015 0.436 . . . . 0.0 110.265 174.65 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -82.39 140.6 10.9 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 121.978 1.786 . . . . 0.0 113.727 -173.09 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.897 ' O ' ' HA ' ' A' ' 78' ' ' THR . 10.7 t -82.27 123.72 38.52 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.728 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 167.591 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.4 t -121.82 106.71 18.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 C-N-CA 119.76 -0.776 . . . . 0.0 109.936 171.363 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.574 HG13 ' HB ' ' A' ' 77' ' ' ILE . 6.4 pt -120.47 115.7 47.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.612 177.077 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -103.83 123.0 46.3 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.467 0.651 . . . . 0.0 111.343 -174.476 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -134.34 135.25 42.6 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.711 177.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.49 ' HG3' ' HG2' ' A' ' 74' ' ' GLN . 1.6 mp0 -86.13 135.22 33.69 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.162 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 41.2 p -67.08 124.17 22.32 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.16 0.505 . . . . 0.0 110.303 178.653 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 14.2 m . . . . . 0 C--N 1.325 -0.491 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.142 -174.658 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.227 0 N-CA-C 110.343 -0.243 . . . . 0.0 110.343 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -71.82 130.11 16.4 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 122.446 2.097 . . . . 0.0 111.626 175.706 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.629 ' HD2' ' O ' ' A' ' 31' ' ' SER . 88.3 Cg_exo -48.54 154.83 2.57 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.963 2.442 . . . . 0.0 112.32 172.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.423 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 24.5 t70 -39.31 106.36 0.39 Allowed Pre-proline 0 N--CA 1.466 0.372 0 O-C-N 124.652 1.22 . . . . 0.0 112.621 -172.088 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.693 ' HG2' HG11 ' A' ' 91' ' ' VAL . 27.2 Cg_exo -68.92 149.25 72.0 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 123.444 2.763 . . . . 0.0 112.696 178.536 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.1 m -106.71 132.88 52.19 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.862 -177.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 81.9 t -85.14 121.56 37.16 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 114.63 -1.168 . . . . 0.0 109.78 174.379 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -94.28 -28.03 15.8 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.181 -174.549 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -135.79 126.51 27.3 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.406 -175.365 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.514 ' HA ' HG12 ' A' ' 26' ' ' ILE . 58.1 t -127.96 109.65 20.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.423 177.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.477 ' CG ' ' H ' ' A' ' 23' ' ' ASP . 13.7 t70 -118.68 -157.61 0.69 Allowed 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.477 ' H ' ' CG ' ' A' ' 22' ' ' ASP . 1.1 m-20 -84.23 -56.36 3.69 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.053 0.454 . . . . 0.0 110.286 -179.135 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.688 HG22 ' O ' ' A' ' 69' ' ' LEU . 22.8 p -114.43 34.5 4.69 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.669 -176.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.634 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 51.1 m -168.34 130.63 1.42 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.152 -172.811 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.585 ' HB ' HD12 ' A' ' 66' ' ' LEU . 45.3 mt -147.84 138.36 17.2 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.548 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 175.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 47.6 t -118.13 127.96 75.25 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.517 0 O-C-N 121.684 -0.635 . . . . 0.0 110.961 -174.293 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.602 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.6 OUTLIER -123.72 146.88 28.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.056 -176.61 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.498 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 28.7 mtm180 -133.35 121.88 23.0 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.313 -176.118 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.721 ' HZ3' HG12 ' A' ' 64' ' ' VAL . 39.4 p90 -111.37 145.13 39.43 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.52 -174.718 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.629 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 25.4 m -90.83 94.74 9.8 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.311 178.29 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.584 ' NE ' ' HB3' ' A' ' 62' ' ' ASN . 0.1 OUTLIER -49.0 156.61 0.9 Allowed Pre-proline 0 CA--C 1.537 0.458 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -173.837 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.618 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 5.0 Cg_exo -80.12 167.88 19.36 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 124.126 3.217 . . . . 0.0 112.248 -173.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 24.8 mp0 -83.14 -11.4 57.97 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 173.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -67.49 147.17 98.81 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 114.333 -1.303 . . . . 0.0 111.481 177.457 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -75.31 114.4 3.98 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 121.54 1.494 . . . . 0.0 110.283 170.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.582 HG22 ' HG3' ' A' ' 83' ' ' GLU . 1.2 pt -122.61 154.15 27.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -176.659 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.424 ' C ' ' HB3' ' A' ' 59' ' ' GLU . 19.3 p -99.14 -30.17 12.44 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -176.654 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.576 ' C ' HG12 ' A' ' 82' ' ' VAL . . . -165.73 -164.13 20.58 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.482 -0.866 . . . . 0.0 111.7 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.618 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 6.6 m-85 -141.95 134.89 28.78 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 117.145 0.473 . . . . 0.0 111.392 175.321 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 8.9 mmm180 -100.4 150.92 22.12 Favored 'General case' 0 CA--C 1.508 -0.656 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 166.234 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.89 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 30.4 mt -139.27 108.49 3.7 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 C-N-CA 120.452 -0.499 . . . . 0.0 112.215 177.572 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 72.7 t -108.69 110.34 31.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.464 0.649 . . . . 0.0 110.804 179.307 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.648 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 1.0 OUTLIER -112.35 125.67 54.44 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.374 175.773 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 12.4 p -137.79 139.24 25.99 Favored Pre-proline 0 C--N 1.317 -0.822 0 CA-C-N 114.093 -1.412 . . . . 0.0 112.02 -172.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.521 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 72.0 Cg_endo . . . . . 0 C--O 1.232 0.191 0 C-N-CA 123.482 2.788 . . . . 0.0 111.71 176.47 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.448 ' HA ' ' O ' ' A' ' 44' ' ' TYR . 22.0 p . . . . . 0 CA--C 1.514 -0.427 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.648 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 36.8 m -146.95 150.11 34.52 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 120.482 -0.487 . . . . 0.0 111.441 -174.396 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.89 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 52.5 tt0 -115.34 114.16 24.77 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.55 173.503 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.682 HD12 ' CG2' ' A' ' 64' ' ' VAL . 23.0 mt -97.08 151.64 19.56 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.46 -0.496 . . . . 0.0 109.667 175.228 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -116.54 115.81 26.45 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.61 HD12 ' CH2' ' A' ' 30' ' ' TRP . 3.9 mt -113.51 156.96 42.65 Favored Pre-proline 0 C--N 1.319 -0.723 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -176.273 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -66.16 151.37 83.82 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 121.712 1.608 . . . . 0.0 111.166 175.11 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.424 ' HB3' ' C ' ' A' ' 38' ' ' THR . 9.2 pt-20 -46.07 -28.01 1.09 Allowed 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.099 -0.955 . . . . 0.0 112.823 177.437 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.9 t -101.67 12.28 37.42 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.265 0.555 . . . . 0.0 111.246 -175.278 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.467 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -82.07 159.98 23.31 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.219 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.584 ' HB3' ' NE ' ' A' ' 32' ' ' ARG . 28.4 p-10 -146.73 17.19 1.27 Allowed 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -176.766 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.602 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 21.5 p -169.08 135.73 1.75 Allowed 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.17 -0.612 . . . . 0.0 111.846 -178.54 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.721 HG12 ' HZ3' ' A' ' 30' ' ' TRP . 4.1 p -122.06 136.21 59.67 Favored 'Isoleucine or valine' 0 C--O 1.242 0.682 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.343 175.022 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 39.3 m -98.19 102.01 13.64 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-O 121.531 0.681 . . . . 0.0 109.55 170.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.701 HD11 HG12 ' A' ' 77' ' ' ILE . 0.2 OUTLIER -78.5 139.45 38.67 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.036 179.104 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 22.0 t -136.1 170.05 16.64 Favored 'General case' 0 C--N 1.317 -0.828 0 O-C-N 123.257 0.348 . . . . 0.0 110.224 -174.647 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 62.52 26.56 15.79 Favored 'General case' 0 C--N 1.331 -0.222 0 O-C-N 123.861 0.725 . . . . 0.0 111.457 -179.053 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.688 ' O ' HG22 ' A' ' 24' ' ' THR . 16.4 mt -68.17 -175.92 0.66 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.209 0.528 . . . . 0.0 109.887 177.175 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.55 ' OE1' ' HD2' ' A' ' 71' ' ' PRO . 5.7 tp-100 -126.1 118.9 23.67 Favored Pre-proline 0 C--N 1.319 -0.738 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.149 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.55 ' HD2' ' OE1' ' A' ' 70' ' ' GLN . 19.2 Cg_endo -60.89 134.48 53.68 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.886 2.391 . . . . 0.0 113.033 -177.077 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.63 23.33 50.72 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.936 -0.65 . . . . 0.0 111.812 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 50.5 t -129.49 146.38 34.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.183 0.516 . . . . 0.0 110.804 -177.629 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.521 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -82.98 120.16 25.36 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.186 -0.916 . . . . 0.0 109.721 -178.696 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -115.06 113.92 24.68 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.254 0.55 . . . . 0.0 111.949 -176.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.576 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 2.7 m-20 -87.22 113.35 22.88 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.936 177.006 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.701 HG12 HD11 ' A' ' 66' ' ' LEU . 5.3 mp -94.68 114.94 32.28 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.615 0 CA-C-O 121.289 0.566 . . . . 0.0 109.618 175.468 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.843 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 48.4 m -108.52 116.15 31.43 Favored 'General case' 0 N--CA 1.427 -1.615 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.122 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.547 ' HB ' ' HB ' ' A' ' 91' ' ' VAL . 13.0 mm -95.22 143.49 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -129.99 113.12 14.18 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.001 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.33 122.53 25.87 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 106.738 -1.578 . . . . 0.0 106.738 168.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.576 HG12 ' C ' ' A' ' 39' ' ' GLY . 7.5 p -110.49 135.37 49.78 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 C-N-CA 120.153 -0.619 . . . . 0.0 109.97 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.679 ' OE1' ' HG2' ' A' ' 86' ' ' GLN . 4.8 mp0 -115.34 169.87 8.82 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -37.76 -53.09 1.28 Allowed 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -171.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -126.24 7.23 7.12 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.726 -0.389 . . . . 0.0 111.947 -175.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.679 ' HG2' ' OE1' ' A' ' 83' ' ' GLU . 20.3 pm0 -143.79 176.73 9.02 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 120.688 -0.405 . . . . 0.0 111.289 -173.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -136.06 129.89 32.62 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.775 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 67.9 m -76.99 175.78 9.25 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.086 0.47 . . . . 0.0 111.622 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -60.93 152.94 68.02 Favored Pre-proline 0 N--CA 1.451 -0.38 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.283 179.065 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -85.99 141.83 7.4 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.433 2.089 . . . . 0.0 114.204 -177.319 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.843 ' O ' ' HA ' ' A' ' 78' ' ' THR . 11.8 t -82.51 124.88 39.74 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.718 0 CA-C-N 114.692 -1.14 . . . . 0.0 108.101 166.192 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 14.4 t -120.34 105.24 16.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 C-N-CA 119.385 -0.926 . . . . 0.0 109.904 171.452 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.57 HG13 ' HB ' ' A' ' 77' ' ' ILE . 10.4 pt -122.04 110.86 28.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.192 177.241 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.431 ' HB2' ' OE1' ' A' ' 74' ' ' GLN . 11.1 pt20 -100.86 114.6 28.59 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.783 0.801 . . . . 0.0 111.237 -174.093 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -118.28 126.44 52.16 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.988 -1.005 . . . . 0.0 109.756 178.38 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.457 ' HB2' ' HG2' ' A' ' 74' ' ' GLN . 39.1 tt0 -89.73 130.21 36.03 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 177.039 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 41.6 p -63.66 140.38 58.87 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.319 -177.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.6 m . . . . . 0 C--N 1.328 -0.366 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.633 -173.766 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.582 ' HB2' ' O ' ' A' ' 89' ' ' THR . . . . . . . . 0 N--CA 1.452 -0.34 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -62.22 132.68 39.93 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.412 2.074 . . . . 0.0 111.655 173.366 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.42 ' HD2' ' O ' ' A' ' 31' ' ' SER . 89.0 Cg_exo -49.43 145.6 15.84 Favored 'Trans proline' 0 C--O 1.236 0.383 0 C-N-CA 122.588 2.192 . . . . 0.0 111.188 172.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.425 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 5.5 m-20 -34.98 106.63 0.3 Allowed Pre-proline 0 N--CA 1.469 0.497 0 O-C-N 124.847 1.342 . . . . 0.0 112.693 -169.187 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.604 ' HG2' HG11 ' A' ' 91' ' ' VAL . 28.0 Cg_exo -66.68 151.51 82.5 Favored 'Trans proline' 0 CA--C 1.519 -0.273 0 C-N-CA 123.534 2.823 . . . . 0.0 112.108 178.621 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 8.2 m -113.13 131.62 55.77 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.635 -177.261 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.458 ' HA ' ' HA ' ' A' ' 28' ' ' VAL . 71.6 t -76.05 119.34 23.91 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-N 114.363 -1.29 . . . . 0.0 110.143 174.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -93.81 -28.05 16.11 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.073 -174.34 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -135.52 132.6 37.49 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.388 -178.452 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.456 ' HA ' HG12 ' A' ' 26' ' ' ILE . 11.5 t -131.95 104.84 8.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.77 179.312 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -111.75 -163.29 0.84 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.092 177.189 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.482 ' O ' ' HB2' ' A' ' 69' ' ' LEU . 4.0 p-10 -73.69 -62.42 1.5 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.349 0.595 . . . . 0.0 111.471 176.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.635 HG22 ' O ' ' A' ' 69' ' ' LEU . 35.1 p -111.49 33.43 4.72 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.447 -172.751 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.691 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 35.6 m -168.88 130.4 1.22 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.897 -171.432 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.594 ' HB ' HD12 ' A' ' 66' ' ' LEU . 40.5 mt -146.64 140.14 20.16 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.636 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 176.251 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 85.6 t -117.09 129.19 74.04 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.752 0 O-C-N 121.654 -0.654 . . . . 0.0 110.61 -175.082 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.639 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.8 OUTLIER -121.97 143.44 34.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 C-N-CA 120.32 -0.552 . . . . 0.0 109.608 -178.912 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.496 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 44.6 mtp180 -129.65 121.13 26.41 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.891 0.377 . . . . 0.0 110.5 -174.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.723 ' HZ3' HG12 ' A' ' 64' ' ' VAL . 37.1 p90 -111.54 152.6 27.34 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.566 -174.411 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.42 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 11.7 m -96.81 97.46 9.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.965 178.492 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.562 ' NE ' ' HB3' ' A' ' 62' ' ' ASN . 0.1 OUTLIER -49.72 156.52 1.19 Allowed Pre-proline 0 CA--C 1.538 0.489 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -173.768 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.613 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 3.0 Cg_exo -84.1 165.55 13.06 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 124.303 3.335 . . . . 0.0 112.638 -173.509 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -77.91 -18.41 56.17 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.198 173.057 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.57 143.88 96.11 Favored Pre-proline 0 C--O 1.235 0.334 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.105 175.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.475 ' O ' ' HG2' ' A' ' 83' ' ' GLU . 57.2 Cg_endo -75.86 114.68 3.99 Favored 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 121.321 1.347 . . . . 0.0 109.934 170.489 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.558 HD12 ' CE1' ' A' ' 40' ' ' TYR . 1.3 pt -118.78 152.43 21.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -175.238 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.46 ' C ' ' HB3' ' A' ' 59' ' ' GLU . 7.7 p -92.15 -30.06 16.16 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.956 0.725 . . . . 0.0 112.956 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.593 ' C ' HG12 ' A' ' 82' ' ' VAL . . . -169.85 -162.14 21.58 Favored Glycine 0 CA--C 1.501 -0.818 0 C-N-CA 119.9 -1.143 . . . . 0.0 111.445 -178.282 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.613 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 7.2 m-85 -140.86 134.42 30.07 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 117.068 0.434 . . . . 0.0 110.888 173.324 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 -101.91 147.82 26.07 Favored 'General case' 0 CA--C 1.505 -0.762 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 166.213 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.897 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 34.4 mt -138.67 108.96 4.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 C-N-CA 120.238 -0.585 . . . . 0.0 112.367 -177.274 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 76.6 t -107.37 110.18 30.89 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.448 0 CA-C-O 121.27 0.557 . . . . 0.0 110.6 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.698 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 0.6 OUTLIER -112.62 125.05 53.86 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.34 175.969 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.461 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 13.5 t -140.22 136.03 16.64 Favored Pre-proline 0 C--N 1.31 -1.132 0 CA-C-N 113.941 -1.481 . . . . 0.0 110.297 -174.156 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.586 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 21.6 Cg_exo . . . . . 0 CA--C 1.518 -0.319 0 C-N-CA 123.014 2.476 . . . . 0.0 111.795 176.249 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.454 ' HA ' ' O ' ' A' ' 44' ' ' TYR . 6.1 m . . . . . 0 CA--C 1.517 -0.312 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.698 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 55.1 m -146.36 150.53 35.88 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.233 -175.857 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.897 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 46.7 tt0 -120.7 113.59 20.44 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.914 176.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.707 HD12 ' CG2' ' A' ' 64' ' ' VAL . 20.3 mt -97.17 157.84 15.74 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.461 177.657 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.484 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 7.1 t30 -121.87 113.2 19.3 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.362 177.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.56 HD12 ' CH2' ' A' ' 30' ' ' TRP . 3.3 mt -109.98 155.56 41.44 Favored Pre-proline 0 C--N 1.318 -0.784 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -176.529 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -62.72 148.22 93.68 Favored 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 121.781 1.654 . . . . 0.0 110.959 176.23 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.46 ' HB3' ' C ' ' A' ' 38' ' ' THR . 8.8 pt-20 -44.96 -24.97 0.26 Allowed 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 114.986 -1.006 . . . . 0.0 113.468 178.776 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.5 t -105.85 9.07 32.94 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.04 0.447 . . . . 0.0 111.213 -174.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.448 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -76.09 157.28 33.07 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.562 ' HB3' ' NE ' ' A' ' 32' ' ' ARG . 27.9 p-10 -141.6 13.87 2.14 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.445 -0.502 . . . . 0.0 112.231 -178.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.639 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 16.6 m -162.17 133.88 5.4 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 121.951 -0.468 . . . . 0.0 110.698 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.723 HG12 ' HZ3' ' A' ' 30' ' ' TRP . 4.3 p -115.27 135.47 55.14 Favored 'Isoleucine or valine' 0 C--O 1.242 0.708 0 CA-C-O 120.796 0.331 . . . . 0.0 110.184 173.211 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 55.0 m -96.27 101.19 12.8 Favored 'General case' 0 N--CA 1.434 -1.27 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.725 170.183 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.691 ' O ' ' HA ' ' A' ' 25' ' ' SER . 0.3 OUTLIER -77.82 142.02 38.83 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 177.664 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 10.1 t -138.2 167.97 20.71 Favored 'General case' 0 C--N 1.322 -0.597 0 O-C-N 123.282 0.364 . . . . 0.0 110.779 -173.105 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 63.96 25.12 13.83 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.574 -179.043 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.635 ' O ' HG22 ' A' ' 24' ' ' THR . 12.7 mt -69.58 -175.99 0.94 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.012 0.435 . . . . 0.0 110.142 177.297 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -129.41 127.23 23.08 Favored Pre-proline 0 C--N 1.319 -0.725 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 177.065 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -64.52 134.77 42.78 Favored 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 122.663 2.242 . . . . 0.0 112.599 -178.587 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 83.77 30.72 28.62 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.989 -0.625 . . . . 0.0 111.576 -178.277 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.489 ' CG1' ' HB3' ' A' ' 46' ' ' PRO . 95.6 t -133.23 141.98 43.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.7 0.286 . . . . 0.0 110.518 -177.73 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.586 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 1.5 tm0? -87.68 122.19 31.04 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.051 -179.428 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.454 ' CE1' ' HG3' ' A' ' 46' ' ' PRO . 13.4 m-85 -113.15 113.65 25.67 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.143 -174.293 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.531 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 19.8 m-80 -86.34 106.42 17.38 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.937 177.116 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.654 HG12 HD11 ' A' ' 66' ' ' LEU . 5.3 mp -92.35 119.72 40.36 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.529 0 CA-C-O 121.201 0.524 . . . . 0.0 109.886 177.174 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.829 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 65.6 m -111.68 118.44 35.65 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.478 177.723 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.565 ' HB ' ' HB ' ' A' ' 91' ' ' VAL . 12.0 mm -96.12 140.05 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 -128.41 111.51 13.4 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 178.166 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.432 ' HB1' HG21 ' A' ' 37' ' ' ILE . . . -79.81 110.36 15.09 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 173.149 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.593 HG12 ' C ' ' A' ' 39' ' ' GLY . 10.8 p -99.44 141.53 16.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 C-N-CA 120.196 -0.602 . . . . 0.0 110.728 -173.722 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.475 ' HG2' ' O ' ' A' ' 36' ' ' PRO . 9.5 tm-20 -118.31 165.9 13.28 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 -176.646 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -45.17 -46.76 12.26 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -176.559 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -126.84 0.1 6.66 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.854 0.359 . . . . 0.0 111.426 -174.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -134.08 174.09 10.87 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 122.071 -0.393 . . . . 0.0 111.167 -173.073 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -136.9 133.67 35.99 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.433 175.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.7 m -75.9 174.59 9.72 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.495 -178.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.582 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 0.1 OUTLIER -60.48 159.43 24.01 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.704 176.525 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -88.66 134.79 2.84 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 122.243 1.962 . . . . 0.0 113.951 -178.528 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.829 ' O ' ' HA ' ' A' ' 78' ' ' THR . 10.5 t -82.67 126.58 40.04 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.627 0 CA-C-N 115.133 -0.939 . . . . 0.0 108.59 167.7 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.6 t -124.62 106.33 16.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 C-N-CA 120.115 -0.634 . . . . 0.0 110.276 174.026 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.511 HG13 ' HB ' ' A' ' 77' ' ' ILE . 8.3 pt -127.34 116.19 43.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.976 179.063 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.579 ' HB2' ' OE1' ' A' ' 74' ' ' GLN . 14.0 pt20 -99.5 131.41 45.52 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.261 0.553 . . . . 0.0 111.094 -177.5 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -140.43 129.11 22.98 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.137 178.617 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.453 ' HB2' ' HG2' ' A' ' 74' ' ' GLN . 38.7 tt0 -86.9 139.95 30.12 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.081 0.467 . . . . 0.0 110.305 177.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 18.7 p -70.56 119.44 14.73 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.314 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.406 ' H ' HG12 ' A' ' 21' ' ' VAL . 19.4 m . . . . . 0 C--N 1.325 -0.494 0 CA-C-O 121.247 0.546 . . . . 0.0 110.544 -179.369 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.319 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -71.2 138.35 33.15 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.042 1.828 . . . . 0.0 110.788 174.14 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.571 ' HD2' ' O ' ' A' ' 31' ' ' SER . 18.1 Cg_endo -60.59 160.09 25.61 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 122.371 2.047 . . . . 0.0 110.518 176.147 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.407 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 7.5 p-10 -42.15 107.69 0.55 Allowed Pre-proline 0 N--CA 1.468 0.449 0 O-C-N 124.126 0.891 . . . . 0.0 111.84 -170.832 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.593 ' HG2' HG11 ' A' ' 91' ' ' VAL . 24.3 Cg_exo -67.5 153.35 76.78 Favored 'Trans proline' 0 CA--C 1.518 -0.291 0 C-N-CA 122.953 2.436 . . . . 0.0 111.756 178.32 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 61.4 m -111.48 131.11 55.46 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 121.752 0.787 . . . . 0.0 110.87 -178.547 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.446 ' HA ' ' HA ' ' A' ' 28' ' ' VAL . 79.5 t -80.17 124.55 38.31 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 CA-C-N 114.119 -1.4 . . . . 0.0 110.06 174.637 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -83.41 -49.21 9.54 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.189 -176.228 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -136.84 141.94 42.84 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.794 -177.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.3 m -129.46 125.72 62.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.041 179.26 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -125.15 -167.9 1.75 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.057 176.486 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.518 ' O ' ' HB2' ' A' ' 69' ' ' LEU . 1.6 p-10 -62.54 -64.21 0.99 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.111 0.481 . . . . 0.0 111.824 178.734 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.655 HG22 ' O ' ' A' ' 69' ' ' LEU . 32.9 p -111.66 35.0 3.83 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.915 -172.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.617 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 52.4 p -169.16 139.38 2.23 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.277 -175.371 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.616 ' HB ' HD12 ' A' ' 66' ' ' LEU . 12.0 mt -149.89 140.2 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 176.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.435 ' O ' HG13 ' A' ' 18' ' ' VAL . 44.0 t -116.21 128.63 73.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 O-C-N 121.486 -0.759 . . . . 0.0 110.519 -177.545 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.606 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.7 OUTLIER -124.63 146.05 30.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.072 -176.805 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.467 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 22.3 mtm180 -131.01 121.93 25.92 Favored 'General case' 0 C--N 1.328 -0.359 0 O-C-N 123.305 0.378 . . . . 0.0 110.804 -175.173 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.781 ' HZ3' HG12 ' A' ' 64' ' ' VAL . 39.8 p90 -114.82 143.32 45.28 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.245 -175.083 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.571 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 15.9 t -88.95 98.77 11.93 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 177.211 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.604 ' H ' ' CD ' ' A' ' 32' ' ' ARG . 0.1 OUTLIER -51.9 159.26 1.43 Allowed Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 123.71 0.804 . . . . 0.0 113.06 -174.621 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.677 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 3.7 Cg_exo -82.21 166.11 16.51 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 124.116 3.211 . . . . 0.0 112.048 -176.704 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -87.43 -5.41 58.85 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.541 177.03 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.409 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . . . -70.89 148.1 94.45 Favored Pre-proline 0 N--CA 1.453 -0.314 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.847 175.02 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.496 ' O ' ' HG3' ' A' ' 83' ' ' GLU . 10.9 Cg_exo -71.76 115.91 4.49 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 121.82 1.68 . . . . 0.0 110.101 169.407 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.498 HD12 ' HE1' ' A' ' 40' ' ' TYR . 2.4 pt -124.73 153.92 31.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -175.723 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 18.1 p -94.39 -32.67 13.46 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -176.381 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.579 ' C ' HG12 ' A' ' 82' ' ' VAL . . . -168.55 -162.79 21.35 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.314 -0.946 . . . . 0.0 111.796 -177.684 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.677 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 7.1 m-85 -141.78 135.23 29.48 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 122.573 0.349 . . . . 0.0 111.284 174.248 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.9 mmm180 -100.16 148.4 24.64 Favored 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 167.011 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.916 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 29.9 mt -139.19 107.74 3.42 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 C-N-CA 120.075 -0.65 . . . . 0.0 112.315 179.319 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 80.3 t -109.24 110.72 33.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.089 0.471 . . . . 0.0 110.859 -178.65 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.772 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 1.0 OUTLIER -115.22 128.73 56.34 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.215 178.372 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.454 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 29.8 p -143.11 145.16 31.65 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 114.051 -1.431 . . . . 0.0 112.027 -174.095 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.547 ' HB3' HG11 ' A' ' 73' ' ' VAL . 2.1 Cg_endo . . . . . 0 C--N 1.347 0.468 0 C-N-CA 123.657 2.904 . . . . 0.0 111.172 175.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 13.1 m . . . . . 0 CA--C 1.516 -0.355 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.772 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 21.4 m -146.95 148.12 31.43 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 119.678 -0.809 . . . . 0.0 111.531 177.583 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.916 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 46.7 tt0 -116.16 117.98 31.58 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.97 172.562 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.717 HD12 ' CG2' ' A' ' 64' ' ' VAL . 17.9 mt -98.38 156.95 16.5 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.634 -0.426 . . . . 0.0 110.07 174.176 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -120.29 113.93 21.13 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 178.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.566 HD12 ' CH2' ' A' ' 30' ' ' TRP . 2.6 mt -111.27 157.74 38.09 Favored Pre-proline 0 C--N 1.318 -0.796 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -175.646 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -66.78 150.66 83.36 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 121.769 1.646 . . . . 0.0 111.512 175.692 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -43.17 -27.44 0.22 Allowed 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 114.435 -1.257 . . . . 0.0 113.397 177.007 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 5.7 t -104.38 4.89 33.92 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.148 0.499 . . . . 0.0 111.227 -172.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.408 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -75.14 152.42 38.49 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 -178.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.484 ' HB3' ' NE ' ' A' ' 32' ' ' ARG . 27.7 p-10 -135.6 16.28 3.37 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.816 -0.353 . . . . 0.0 111.831 -178.337 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.606 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 17.8 p -170.17 136.93 1.47 Allowed 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.27 -0.572 . . . . 0.0 112.078 -178.786 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.781 HG12 ' HZ3' ' A' ' 30' ' ' TRP . 3.9 p -119.8 138.42 50.47 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.337 176.385 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 50.5 m -98.36 101.43 12.88 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-O 121.334 0.588 . . . . 0.0 109.692 170.009 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.687 HD11 HG12 ' A' ' 77' ' ' ILE . 0.2 OUTLIER -79.93 145.29 32.72 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.426 178.801 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.468 ' HA ' ' O ' ' A' ' 24' ' ' THR . 17.6 t -139.0 177.91 7.55 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -177.805 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 65.37 20.84 11.87 Favored 'General case' 0 N--CA 1.468 0.437 0 O-C-N 123.486 0.491 . . . . 0.0 111.977 -178.14 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.655 ' O ' HG22 ' A' ' 24' ' ' THR . 13.8 mt -72.19 -175.59 1.56 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.182 0.515 . . . . 0.0 110.339 178.608 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 56.0 tp60 -128.72 128.82 23.5 Favored Pre-proline 0 C--N 1.319 -0.734 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 178.5 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.9 134.63 54.53 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.951 2.434 . . . . 0.0 113.391 -178.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.13 35.81 26.17 Favored Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 115.868 -0.605 . . . . 0.0 112.405 177.555 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.547 HG11 ' HB3' ' A' ' 46' ' ' PRO . 42.5 t -134.37 150.43 30.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.04 0.448 . . . . 0.0 111.424 -175.327 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.1 tp-100 -91.1 105.03 17.53 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.332 179.077 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.527 ' CZ ' ' HG3' ' A' ' 46' ' ' PRO . 9.9 m-85 -97.38 121.14 38.94 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.79 -178.091 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.553 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 55.7 m-20 -91.85 111.87 23.57 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.283 176.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.687 HG12 HD11 ' A' ' 66' ' ' LEU . 5.3 mp -94.82 118.4 40.83 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.623 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.971 176.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.905 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 29.5 m -107.91 115.4 30.07 Favored 'General case' 0 N--CA 1.425 -1.684 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.605 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.533 ' HB ' ' HB ' ' A' ' 91' ' ' VAL . 12.5 mm -96.1 137.58 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -126.15 111.75 15.0 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.052 178.516 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -80.02 112.39 17.28 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 171.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.579 HG12 ' C ' ' A' ' 39' ' ' GLY . 10.9 p -103.64 136.4 36.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 C-N-CA 119.924 -0.711 . . . . 0.0 110.956 -175.123 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.66 ' HG2' ' N ' ' A' ' 84' ' ' GLU . 2.4 tt0 -117.73 166.91 11.87 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 177.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.66 ' N ' ' HG2' ' A' ' 83' ' ' GLU . 28.0 mt-10 -44.02 -48.38 8.78 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 178.139 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 19.9 m-80 -98.62 -33.87 10.79 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -170.333 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -145.81 169.49 18.42 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-O 120.904 0.383 . . . . 0.0 111.518 -167.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -114.72 145.78 41.68 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.289 175.419 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 17.8 m -76.15 169.78 17.55 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.738 178.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.2 p -58.73 146.11 75.87 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.079 173.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -78.26 138.91 16.31 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.134 1.889 . . . . 0.0 113.966 -174.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.905 ' O ' ' HA ' ' A' ' 78' ' ' THR . 9.7 t -81.74 126.5 39.88 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.745 0 CA-C-N 114.828 -1.078 . . . . 0.0 108.174 167.532 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 15.7 t -123.78 106.06 16.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 C-N-CA 119.766 -0.774 . . . . 0.0 109.912 170.261 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.565 HG13 ' HB ' ' A' ' 77' ' ' ILE . 6.9 pt -120.0 115.58 47.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.892 178.667 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -99.44 125.01 45.08 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.273 0.558 . . . . 0.0 111.372 -176.107 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -128.73 131.63 47.91 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.379 178.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.41 ' HA ' ' O ' ' A' ' 73' ' ' VAL . 44.1 mt-10 -85.71 127.31 34.48 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.049 0.452 . . . . 0.0 110.218 176.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 46.4 p -69.92 120.65 15.96 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.562 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.9 m . . . . . 0 C--N 1.328 -0.351 0 CA-C-O 121.292 0.568 . . . . 0.0 110.588 -178.794 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.446 ' HB2' ' O ' ' A' ' 89' ' ' THR . . . . . . . . 0 CA--C 1.52 -0.192 0 N-CA-C 110.292 -0.262 . . . . 0.0 110.292 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.448 ' HB2' ' HB2' ' A' ' 30' ' ' TRP . 26.8 Cg_exo -64.54 128.45 21.25 Favored 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.365 2.044 . . . . 0.0 111.646 178.578 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.415 ' HD2' ' O ' ' A' ' 31' ' ' SER . 53.5 Cg_exo -53.03 143.52 49.86 Favored 'Trans proline' 0 CA--C 1.512 -0.602 0 C-N-CA 122.517 2.145 . . . . 0.0 111.312 176.169 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -37.05 103.17 0.25 Allowed Pre-proline 0 CA--C 1.515 -0.39 0 O-C-N 125.145 1.528 . . . . 0.0 112.74 -163.605 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.709 ' CG ' HG11 ' A' ' 91' ' ' VAL . 3.1 Cg_endo -47.62 147.98 6.17 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 123.594 2.863 . . . . 0.0 113.526 169.775 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 18.4 m -107.6 131.6 54.19 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.021 -0.991 . . . . 0.0 109.789 177.514 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.483 HG11 HG22 ' A' ' 21' ' ' VAL . 81.2 t -76.52 121.03 27.82 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.41 176.128 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -86.08 -39.06 17.16 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.526 -175.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -135.26 127.96 30.95 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.842 0.354 . . . . 0.0 110.683 -178.257 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.516 ' HA ' HG12 ' A' ' 26' ' ' ILE . 98.7 t -120.78 115.58 47.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.4 177.642 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -127.2 -164.17 1.33 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.338 178.568 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -68.55 -63.01 1.14 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.088 0.471 . . . . 0.0 112.149 -178.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.642 HG22 ' O ' ' A' ' 69' ' ' LEU . 38.7 p -117.81 35.08 4.85 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.812 -171.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.531 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 54.4 p -170.91 132.38 0.87 Allowed 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.496 -173.805 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.595 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 32.7 mt -145.91 140.82 21.67 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.781 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 178.214 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.433 ' O ' HG13 ' A' ' 18' ' ' VAL . 39.7 t -117.14 134.11 61.76 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.631 0 C-N-CA 120.064 -0.655 . . . . 0.0 110.084 -176.003 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.638 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.6 OUTLIER -127.06 146.93 32.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 C-N-CA 120.221 -0.591 . . . . 0.0 110.462 -178.643 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.564 ' HG2' ' OG ' ' A' ' 63' ' ' SER . 18.4 mtp180 -128.54 118.94 23.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.549 -177.125 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.764 ' HZ3' HG12 ' A' ' 64' ' ' VAL . 36.4 p90 -110.48 146.11 36.53 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.961 -176.08 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.415 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 20.8 m -92.21 99.92 12.62 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.078 177.702 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.56 ' NE ' ' HB3' ' A' ' 62' ' ' ASN . 0.1 OUTLIER -46.58 156.98 0.47 Allowed Pre-proline 0 CA--C 1.536 0.419 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -175.222 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.628 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 3.4 Cg_exo -83.34 169.0 12.84 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 124.179 3.253 . . . . 0.0 112.5 -172.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -87.2 -3.43 59.05 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.231 -0.895 . . . . 0.0 108.938 173.494 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.71 146.87 80.67 Favored Pre-proline 0 N--CA 1.451 -0.416 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.968 175.032 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -77.84 114.7 3.68 Favored 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 121.371 1.38 . . . . 0.0 110.043 170.084 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.641 HG22 ' HG3' ' A' ' 83' ' ' GLU . 0.7 OUTLIER -120.25 155.02 23.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.461 -174.494 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.1 p -97.51 -33.79 11.23 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -178.416 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.414 ' C ' HG12 ' A' ' 82' ' ' VAL . . . -164.74 -169.65 28.62 Favored Glycine 0 C--O 1.222 -0.642 0 C-N-CA 120.075 -1.059 . . . . 0.0 112.16 179.393 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.628 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 4.6 m-85 -136.56 131.38 33.76 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-N 117.302 0.551 . . . . 0.0 111.674 176.603 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 37.4 mtm180 -103.98 148.41 26.23 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.029 168.018 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.867 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 30.4 mt -139.0 109.32 4.37 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 C-N-CA 120.421 -0.511 . . . . 0.0 112.335 -176.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 95.6 t -110.43 110.74 33.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.42 0.629 . . . . 0.0 110.667 179.429 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.755 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 0.5 OUTLIER -108.17 125.09 51.22 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.191 175.358 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.443 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 6.3 p -144.03 138.4 14.98 Favored Pre-proline 0 C--N 1.315 -0.903 0 CA-C-N 113.864 -1.517 . . . . 0.0 111.301 -173.543 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.742 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 22.5 Cg_exo . . . . . 0 C--O 1.232 0.221 0 C-N-CA 123.349 2.699 . . . . 0.0 111.767 175.174 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.457 ' HA ' ' O ' ' A' ' 44' ' ' TYR . 15.0 m . . . . . 0 CA--C 1.517 -0.321 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.755 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 30.6 m -147.15 154.99 41.76 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.358 -176.722 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.867 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 33.0 tt0 -124.31 115.4 20.95 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 123.297 0.639 . . . . 0.0 109.902 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.687 HD12 ' CG2' ' A' ' 64' ' ' VAL . 18.4 mt -100.52 160.5 14.29 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 175.838 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.423 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 17.5 m120 -125.98 121.59 33.51 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 178.637 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.603 HD12 ' CH2' ' A' ' 30' ' ' TRP . 4.6 mt -118.33 158.9 45.48 Favored Pre-proline 0 C--N 1.318 -0.79 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -176.469 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -64.48 150.97 87.31 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 121.58 1.52 . . . . 0.0 111.21 175.33 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.402 ' HB2' HG13 ' A' ' 37' ' ' ILE . 12.8 pt-20 -46.0 -26.75 0.77 Allowed 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 114.924 -1.035 . . . . 0.0 112.77 177.722 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 7.8 t -103.76 8.21 37.22 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.318 -174.067 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.484 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -75.0 160.43 30.55 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -179.173 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.56 ' HB3' ' NE ' ' A' ' 32' ' ' ARG . 24.7 p-10 -142.58 10.92 1.86 Allowed 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.473 -0.491 . . . . 0.0 112.323 -179.2 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.638 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 14.6 m -161.43 133.82 5.94 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 118.476 0.58 . . . . 0.0 111.473 -178.466 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.764 HG12 ' HZ3' ' A' ' 30' ' ' TRP . 4.1 p -119.56 136.87 55.31 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 173.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 40.4 m -97.44 100.97 12.4 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-O 121.426 0.631 . . . . 0.0 109.711 169.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.7 HD11 HG12 ' A' ' 77' ' ' ILE . 0.2 OUTLIER -78.52 145.14 35.06 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.008 178.045 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.1 t -142.31 173.56 11.42 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -175.245 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 67.02 23.04 9.86 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 123.907 0.755 . . . . 0.0 111.078 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.642 ' O ' HG22 ' A' ' 24' ' ' THR . 10.3 mt -72.37 -175.77 1.67 Allowed 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 177.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 21.6 mm-40 -125.51 134.12 25.52 Favored Pre-proline 0 C--N 1.322 -0.613 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 176.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -65.8 126.01 15.25 Favored 'Trans proline' 0 CA--C 1.529 0.267 0 C-N-CA 122.502 2.135 . . . . 0.0 112.885 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 86.03 31.77 19.4 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.503 177.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 92.1 t -129.79 145.28 35.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.019 0.438 . . . . 0.0 110.698 -177.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.742 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -80.05 123.75 28.12 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.692 -179.274 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.427 ' CE1' ' HG3' ' A' ' 46' ' ' PRO . 15.3 m-85 -120.45 114.03 21.2 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.164 0.507 . . . . 0.0 112.119 -176.232 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.457 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 15.6 m-80 -90.33 110.65 21.71 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.371 176.442 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.7 HG12 HD11 ' A' ' 66' ' ' LEU . 5.1 mp -91.36 116.21 32.07 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.686 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 176.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.868 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 14.9 m -108.86 113.51 26.49 Favored 'General case' 0 N--CA 1.424 -1.751 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.359 -177.732 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.576 ' H ' ' HB ' ' A' ' 91' ' ' VAL . 10.8 mm -95.13 134.23 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -122.33 111.55 17.04 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.75 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.404 ' HB3' ' HB2' ' A' ' 88' ' ' SER . . . -81.25 131.17 35.28 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 170.07 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.414 HG12 ' C ' ' A' ' 39' ' ' GLY . 7.7 p -118.47 135.37 59.1 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.317 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.641 ' HG3' HG22 ' A' ' 37' ' ' ILE . 4.0 mp0 -115.21 169.95 8.74 Favored 'General case' 0 N--CA 1.448 -0.561 0 O-C-N 123.906 0.754 . . . . 0.0 109.482 -178.194 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -44.26 -47.88 9.43 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -174.471 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 30.3 p-10 -129.88 16.39 5.76 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.934 -0.306 . . . . 0.0 111.635 -177.263 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 77.2 mm-40 -144.65 173.99 11.36 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.763 0.316 . . . . 0.0 111.076 -176.186 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -140.54 119.9 13.06 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 174.106 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.404 ' HB2' ' HB3' ' A' ' 81' ' ' ALA . 66.7 m -65.57 167.42 8.97 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.832 0.349 . . . . 0.0 111.574 -177.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.446 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 1.2 p -57.4 160.61 6.84 Favored Pre-proline 0 CA--C 1.536 0.422 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.696 178.532 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -86.99 133.58 3.48 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 122.259 1.973 . . . . 0.0 113.766 -177.588 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.868 ' O ' ' HA ' ' A' ' 78' ' ' THR . 44.2 t -82.62 122.73 37.61 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.723 0 CA-C-N 114.936 -1.029 . . . . 0.0 108.622 170.028 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 10.8 t -120.38 106.6 19.07 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 C-N-CA 119.586 -0.846 . . . . 0.0 110.277 174.189 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.553 HG13 ' HB ' ' A' ' 77' ' ' ILE . 7.7 pt -122.29 113.7 39.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.733 176.394 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -100.4 131.25 46.43 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.395 0.616 . . . . 0.0 111.389 -174.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -136.71 132.35 34.75 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.572 177.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.491 ' HG2' ' HG2' ' A' ' 74' ' ' GLN . 45.3 mt-10 -89.13 131.8 35.1 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 175.846 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.402 HG22 HD11 ' A' ' 26' ' ' ILE . 31.4 p -68.5 121.17 15.8 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.47 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.3 m . . . . . 0 C--N 1.327 -0.397 0 CA-C-O 121.191 0.52 . . . . 0.0 110.305 -179.204 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.588 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.479 ' CB ' ' HB2' ' A' ' 30' ' ' TRP . 31.5 Cg_exo -62.47 128.14 22.8 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.017 1.811 . . . . 0.0 111.774 174.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -52.73 138.41 59.48 Favored 'Trans proline' 0 CA--C 1.509 -0.765 0 C-N-CA 122.288 1.992 . . . . 0.0 110.529 172.613 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -36.52 102.78 0.24 Allowed Pre-proline 0 N--CA 1.465 0.296 0 O-C-N 125.373 1.671 . . . . 0.0 112.443 -161.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.737 ' CG ' HG11 ' A' ' 91' ' ' VAL . 2.8 Cg_endo -46.61 146.14 5.66 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 123.896 3.064 . . . . 0.0 113.855 172.626 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 11.2 m -104.0 129.97 51.62 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.111 -0.949 . . . . 0.0 110.414 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.475 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 89.3 t -79.46 121.74 33.29 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 114.458 -1.247 . . . . 0.0 109.997 174.673 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -86.18 -43.17 13.22 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.333 -175.036 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -135.86 139.35 43.33 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.907 0.384 . . . . 0.0 111.046 -179.295 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.474 HG22 HG11 ' A' ' 18' ' ' VAL . 40.3 t -129.02 111.49 23.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.327 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -116.94 -157.46 0.66 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 -178.41 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.402 ' OD2' ' HB3' ' A' ' 71' ' ' PRO . 7.0 m-20 -75.53 -64.02 1.16 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.231 0.539 . . . . 0.0 110.234 -179.54 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.673 HG22 ' O ' ' A' ' 69' ' ' LEU . 42.2 p -112.05 37.62 2.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.072 -175.02 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.625 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 69.6 m -168.43 131.97 1.52 Allowed 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 122.611 0.364 . . . . 0.0 110.834 -172.782 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.591 ' HB ' HD12 ' A' ' 66' ' ' LEU . 39.8 mt -147.53 138.18 17.42 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.622 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 176.824 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 39.7 t -117.35 132.54 66.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 118.695 0.68 . . . . 0.0 110.629 -174.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.612 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.7 OUTLIER -127.64 146.07 33.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.544 -177.823 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.531 ' HG2' ' HB3' ' A' ' 63' ' ' SER . 92.8 mtt180 -128.04 120.63 27.89 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 123.625 0.578 . . . . 0.0 110.519 -177.702 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.692 ' HZ3' HG12 ' A' ' 64' ' ' VAL . 34.7 p90 -113.69 154.11 27.83 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.231 -175.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 24.8 t -101.32 102.16 12.95 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 121.162 0.506 . . . . 0.0 110.5 178.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.587 ' H ' ' CD ' ' A' ' 32' ' ' ARG . 0.1 OUTLIER -53.89 160.46 2.18 Favored Pre-proline 0 CA--C 1.542 0.669 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -174.486 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.673 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 2.3 Cg_endo -84.87 169.44 10.41 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 124.581 3.521 . . . . 0.0 113.024 -175.564 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 -79.58 -22.25 44.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.609 173.247 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.502 ' HB1' ' OE2' ' A' ' 83' ' ' GLU . . . -58.77 136.7 86.86 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.171 179.346 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -66.52 113.45 2.71 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 121.317 1.345 . . . . 0.0 109.723 172.189 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.684 HG22 ' HG2' ' A' ' 83' ' ' GLU . 6.7 pt -123.55 157.3 29.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.855 -173.559 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.467 ' C ' ' HB3' ' A' ' 59' ' ' GLU . 18.3 p -101.19 -27.65 13.1 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -176.558 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.493 ' C ' HG12 ' A' ' 82' ' ' VAL . . . -171.04 -163.27 24.79 Favored Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 119.68 -1.247 . . . . 0.0 112.617 179.421 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.673 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 6.6 m-85 -141.05 135.64 31.23 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 122.858 0.463 . . . . 0.0 110.851 176.509 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 27.5 mtp180 -104.69 150.2 24.93 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 167.479 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.863 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 26.7 mt -139.0 107.94 3.65 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 C-N-CA 120.279 -0.568 . . . . 0.0 112.165 -178.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 69.2 t -105.93 110.78 32.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.323 0.582 . . . . 0.0 110.52 179.219 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.622 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 0.7 OUTLIER -112.35 125.73 54.51 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.341 176.008 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.438 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 16.1 t -142.75 138.1 15.77 Favored Pre-proline 0 C--N 1.317 -0.832 0 CA-C-N 113.968 -1.469 . . . . 0.0 110.785 -173.433 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.68 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 27.1 Cg_exo . . . . . 0 C--N 1.345 0.369 0 C-N-CA 123.473 2.782 . . . . 0.0 112.252 175.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.496 ' HA ' ' O ' ' A' ' 44' ' ' TYR . 6.2 p . . . . . 0 N--CA 1.449 -0.49 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.622 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 40.4 m -147.86 151.18 35.49 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 120.581 -0.447 . . . . 0.0 111.534 -177.202 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.863 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 39.6 tt0 -116.05 115.09 25.48 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 172.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.688 HD12 ' CG2' ' A' ' 64' ' ' VAL . 17.0 mt -96.58 153.49 17.82 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 175.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -117.37 118.95 33.63 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.492 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.592 HD12 ' CH2' ' A' ' 30' ' ' TRP . 3.5 mt -116.25 156.22 47.38 Favored Pre-proline 0 N--CA 1.444 -0.73 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 -176.485 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -64.31 151.44 85.42 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 122.009 1.806 . . . . 0.0 111.403 176.146 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.467 ' HB3' ' C ' ' A' ' 38' ' ' THR . 8.9 pt-20 -47.35 -25.06 0.9 Allowed 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 114.548 -1.205 . . . . 0.0 113.431 179.438 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.9 t -107.54 12.84 27.36 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.185 0.517 . . . . 0.0 111.013 -176.096 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.496 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -76.86 156.29 32.29 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 178.777 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.486 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 27.5 p-10 -141.71 14.61 2.13 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -177.507 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.612 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 13.8 p -168.78 135.12 1.8 Allowed 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.207 -0.597 . . . . 0.0 112.389 -177.52 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.692 HG12 ' HZ3' ' A' ' 30' ' ' TRP . 4.8 p -120.03 134.2 64.31 Favored 'Isoleucine or valine' 0 C--O 1.24 0.591 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.309 176.002 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 25.8 m -96.74 101.2 12.76 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-O 121.526 0.679 . . . . 0.0 109.615 169.148 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.724 HD11 HG12 ' A' ' 77' ' ' ILE . 0.3 OUTLIER -78.71 144.39 35.34 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.105 179.239 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.423 ' HA ' ' O ' ' A' ' 24' ' ' THR . 12.4 p -141.68 168.58 19.41 Favored 'General case' 0 C--N 1.322 -0.601 0 O-C-N 123.338 0.399 . . . . 0.0 110.519 -173.787 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 64.04 27.82 14.25 Favored 'General case' 0 C--N 1.331 -0.238 0 O-C-N 123.804 0.69 . . . . 0.0 111.18 -178.289 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.673 ' O ' HG22 ' A' ' 24' ' ' THR . 15.3 mt -70.11 -175.5 0.97 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.181 0.515 . . . . 0.0 109.712 175.166 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 56.2 tp60 -125.0 122.67 25.48 Favored Pre-proline 0 C--N 1.315 -0.896 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 176.405 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.402 ' HB3' ' OD2' ' A' ' 23' ' ' ASP . 32.8 Cg_endo -63.12 129.53 26.01 Favored 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 122.891 2.394 . . . . 0.0 112.502 -177.489 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 86.09 33.37 15.01 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 121.098 -0.572 . . . . 0.0 111.949 -178.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.428 ' CG1' ' HB3' ' A' ' 46' ' ' PRO . 98.9 t -135.99 144.42 33.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.113 0.482 . . . . 0.0 110.93 -176.646 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.68 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -80.51 115.55 20.09 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.868 179.504 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.406 ' CZ ' ' HG3' ' A' ' 46' ' ' PRO . 13.0 m-85 -111.59 114.46 27.54 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.275 0.559 . . . . 0.0 111.961 -177.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.571 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 37.0 m-80 -87.2 113.47 22.96 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.946 175.581 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.724 HG12 HD11 ' A' ' 66' ' ' LEU . 5.1 mp -93.37 117.41 36.79 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.574 0 CA-C-O 121.226 0.536 . . . . 0.0 109.578 174.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.877 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 62.1 m -110.84 114.86 28.53 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.476 -179.314 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.565 ' H ' ' HB ' ' A' ' 91' ' ' VAL . 11.5 mm -95.18 143.23 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 -179.319 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -129.66 111.7 12.94 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 178.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -82.39 121.93 27.35 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 172.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.493 HG12 ' C ' ' A' ' 39' ' ' GLY . 8.5 p -118.1 132.56 67.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 C-N-CA 119.758 -0.777 . . . . 0.0 112.179 -174.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.684 ' HG2' HG22 ' A' ' 37' ' ' ILE . 18.1 mt-10 -99.58 172.46 7.28 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 172.158 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -38.46 -42.8 0.78 Allowed 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -128.34 -20.15 3.74 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -178.537 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -98.07 167.76 10.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.145 0.497 . . . . 0.0 111.635 -173.734 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -145.16 121.49 10.92 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.364 175.239 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 10.6 m -67.38 169.77 8.44 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.325 -178.26 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 12.1 p -58.05 150.04 53.02 Favored Pre-proline 0 N--CA 1.451 -0.401 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.16 172.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -76.17 137.67 19.45 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 122.017 1.811 . . . . 0.0 113.06 -178.227 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.877 ' O ' ' HA ' ' A' ' 78' ' ' THR . 53.0 t -82.33 122.77 37.5 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.707 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 169.311 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.4 t -117.84 106.39 19.77 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 C-N-CA 119.374 -0.93 . . . . 0.0 110.676 174.416 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.563 HG13 ' HB ' ' A' ' 77' ' ' ILE . 7.5 pt -120.37 111.73 33.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.457 174.835 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.44 ' HB2' ' NE2' ' A' ' 74' ' ' GLN . 19.8 pt20 -99.88 121.6 41.55 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.479 0.657 . . . . 0.0 111.403 -174.488 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -128.35 130.12 47.27 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.452 179.123 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.458 ' CG ' ' HG2' ' A' ' 74' ' ' GLN . 37.2 mt-10 -85.97 134.17 33.88 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 176.206 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 21.6 p -69.13 114.26 7.24 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.355 0.598 . . . . 0.0 111.441 -177.102 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.424 ' H ' HG12 ' A' ' 21' ' ' VAL . 6.9 m . . . . . 0 C--N 1.326 -0.436 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.838 179.43 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.258 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -64.4 128.54 21.62 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.186 1.924 . . . . 0.0 111.953 178.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_exo -51.53 147.2 23.65 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.57 2.18 . . . . 0.0 111.094 174.643 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.43 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 6.9 m-20 -34.4 107.64 0.31 Allowed Pre-proline 0 N--CA 1.47 0.536 0 O-C-N 124.613 1.196 . . . . 0.0 113.016 -168.279 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.603 ' HG2' HG11 ' A' ' 91' ' ' VAL . 22.2 Cg_exo -68.72 153.34 73.36 Favored 'Trans proline' 0 CA--C 1.52 -0.207 0 C-N-CA 123.478 2.786 . . . . 0.0 111.829 177.218 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 26.3 m -112.63 133.41 54.68 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.566 0.698 . . . . 0.0 110.975 -177.575 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.456 HG11 HG22 ' A' ' 21' ' ' VAL . 79.6 t -76.21 121.39 28.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 114.437 -1.256 . . . . 0.0 110.231 175.667 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -76.55 -50.79 13.02 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.07 -175.689 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -141.12 142.23 34.12 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.799 -178.369 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.456 HG22 HG11 ' A' ' 18' ' ' VAL . 57.3 t -121.63 122.74 67.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.924 -177.545 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -125.58 -167.14 1.65 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.396 177.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.608 ' O ' ' HB2' ' A' ' 69' ' ' LEU . 2.0 p-10 -71.17 -65.17 0.78 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.089 0.471 . . . . 0.0 111.723 177.012 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.599 HG22 ' O ' ' A' ' 69' ' ' LEU . 42.1 p -111.23 34.63 3.96 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.561 -173.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.644 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 73.4 m -169.03 130.64 1.19 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.079 -173.626 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.585 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 45.0 mt -149.2 140.12 16.93 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.837 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 176.204 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.455 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 43.3 t -116.15 134.37 59.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 C-N-CA 119.834 -0.746 . . . . 0.0 110.166 -174.797 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.629 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.6 OUTLIER -127.33 146.23 33.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 C-N-CA 120.252 -0.579 . . . . 0.0 109.878 179.851 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.481 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 62.8 mtp180 -130.81 121.24 24.98 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 123.345 0.403 . . . . 0.0 110.472 -175.363 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.755 ' HZ3' HG12 ' A' ' 64' ' ' VAL . 38.8 p90 -114.1 154.21 28.15 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.369 -173.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 19.7 m -100.01 100.81 11.74 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.469 178.18 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.604 ' H ' ' CD ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -51.19 157.93 1.42 Allowed Pre-proline 0 CA--C 1.537 0.463 0 C-N-CA 123.482 0.713 . . . . 0.0 112.854 -174.933 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.646 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 3.5 Cg_exo -83.25 163.7 15.08 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 124.244 3.296 . . . . 0.0 112.63 -175.488 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -73.76 -19.83 60.67 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.322 172.567 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.415 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . . . -62.98 145.48 96.52 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 114.754 -1.112 . . . . 0.0 111.736 178.47 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 35' ' ' ALA . 3.1 Cg_exo -74.31 114.84 4.13 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 121.568 1.512 . . . . 0.0 110.085 168.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.532 HD12 ' HE1' ' A' ' 40' ' ' TYR . 0.7 OUTLIER -120.23 153.98 23.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -177.468 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.403 ' N ' ' O ' ' A' ' 82' ' ' VAL . 17.1 p -95.98 -25.31 15.99 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -177.699 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.561 ' C ' HG12 ' A' ' 82' ' ' VAL . . . -171.55 -164.87 27.92 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 119.944 -1.122 . . . . 0.0 112.235 179.523 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.646 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 5.8 m-85 -139.75 132.98 29.82 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 122.55 0.34 . . . . 0.0 111.18 173.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 10.8 mmm180 -99.82 151.15 21.61 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 166.582 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.885 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 37.6 mt -139.48 107.48 3.1 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 C-N-CA 120.134 -0.626 . . . . 0.0 112.162 178.692 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 71.5 t -108.56 110.33 31.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.392 0.615 . . . . 0.0 110.555 -179.377 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.635 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 0.6 OUTLIER -110.74 125.25 53.32 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.465 -0.788 . . . . 0.0 109.415 175.359 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.441 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 17.1 p -138.5 137.0 19.51 Favored Pre-proline 0 C--N 1.318 -0.772 0 CA-C-N 113.622 -1.626 . . . . 0.0 111.355 -173.655 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.657 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 22.0 Cg_exo . . . . . 0 C--O 1.231 0.17 0 C-N-CA 123.283 2.655 . . . . 0.0 112.224 175.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 14.8 m . . . . . 0 CA--C 1.516 -0.339 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.635 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 50.2 m -147.74 148.86 31.43 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.489 -0.484 . . . . 0.0 111.691 -178.546 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.885 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 45.5 tt0 -115.96 117.13 29.3 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.781 172.45 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.701 HD12 ' CG2' ' A' ' 64' ' ' VAL . 18.4 mt -97.92 163.43 12.79 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 174.181 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.404 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 26.3 t-20 -128.96 110.51 12.14 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -178.019 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.585 HD12 ' CH2' ' A' ' 30' ' ' TRP . 3.3 mt -109.35 157.41 37.33 Favored Pre-proline 0 C--N 1.317 -0.844 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -175.798 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -64.06 149.09 91.18 Favored 'Trans proline' 0 N--CA 1.447 -1.212 0 C-N-CA 121.636 1.557 . . . . 0.0 110.99 175.265 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -44.02 -26.88 0.32 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.385 -1.279 . . . . 0.0 113.156 178.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 10.8 t -108.05 9.26 28.46 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.465 -173.276 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.417 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -75.07 161.18 29.65 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 178.597 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.566 ' HB3' ' NE ' ' A' ' 32' ' ' ARG . 28.3 p-10 -144.12 17.83 1.75 Allowed 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.465 0.542 . . . . 0.0 112.465 -178.207 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.629 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 17.2 p -169.62 133.76 1.33 Allowed 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.125 -0.63 . . . . 0.0 111.889 178.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.755 HG12 ' HZ3' ' A' ' 30' ' ' TRP . 3.6 p -116.6 138.46 47.12 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.182 176.626 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 30.0 m -97.94 101.05 12.44 Favored 'General case' 0 N--CA 1.433 -1.299 0 CA-C-O 121.366 0.603 . . . . 0.0 109.457 169.289 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.688 HD11 HG12 ' A' ' 77' ' ' ILE . 0.3 OUTLIER -77.14 144.19 38.6 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.005 178.327 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 62.1 p -139.62 174.13 10.82 Favored 'General case' 0 C--N 1.319 -0.722 0 O-C-N 123.349 0.406 . . . . 0.0 110.147 -175.419 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 37.6 t70 61.62 28.52 17.68 Favored 'General case' 0 C--N 1.33 -0.258 0 O-C-N 123.777 0.673 . . . . 0.0 110.715 179.06 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.608 ' HB2' ' O ' ' A' ' 23' ' ' ASP . 13.9 mt -73.89 -176.2 2.39 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 176.785 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.584 ' OE1' ' HD2' ' A' ' 71' ' ' PRO . 5.8 tp-100 -132.24 121.31 17.54 Favored Pre-proline 0 C--N 1.318 -0.781 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.584 ' HD2' ' OE1' ' A' ' 70' ' ' GLN . 18.5 Cg_endo -60.62 137.06 71.01 Favored 'Trans proline' 0 C--O 1.235 0.346 0 C-N-CA 122.908 2.405 . . . . 0.0 112.896 -178.005 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.23 26.45 52.18 Favored Glycine 0 N--CA 1.449 -0.463 0 N-CA-C 111.435 -0.666 . . . . 0.0 111.435 -178.356 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.492 ' HB ' ' O ' ' A' ' 70' ' ' GLN . 77.8 t -131.55 136.02 58.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 120.899 0.38 . . . . 0.0 110.691 -177.207 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.657 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -80.82 117.53 21.55 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.937 -178.101 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.426 ' CE1' ' HG3' ' A' ' 46' ' ' PRO . 18.9 m-85 -110.42 116.35 31.27 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.252 0.548 . . . . 0.0 112.184 -176.553 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.496 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 16.7 m-80 -89.73 111.18 22.09 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.683 176.02 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.688 HG12 HD11 ' A' ' 66' ' ' LEU . 5.1 mp -92.0 118.82 38.29 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.632 0 CA-C-O 121.16 0.505 . . . . 0.0 109.836 178.057 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.872 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 21.7 m -110.45 115.3 29.4 Favored 'General case' 0 N--CA 1.428 -1.549 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.131 -179.235 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.56 ' HB ' ' HB ' ' A' ' 91' ' ' VAL . 14.1 mm -95.21 142.5 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.43 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 68.7 m-85 -129.6 112.37 13.64 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.335 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.95 122.88 26.7 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 168.665 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.561 HG12 ' C ' ' A' ' 39' ' ' GLY . 7.9 p -112.66 136.91 47.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.245 -178.798 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.512 ' HG3' HG22 ' A' ' 37' ' ' ILE . 1.8 mp0 -114.6 171.21 7.77 Favored 'General case' 0 N--CA 1.446 -0.626 0 O-C-N 123.695 0.622 . . . . 0.0 109.659 -177.826 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -45.3 -44.74 11.7 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -174.053 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -117.32 -16.73 10.28 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -175.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.499 ' HB2' ' OE1' ' A' ' 83' ' ' GLU . 45.2 mt-30 -128.4 176.05 8.02 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.474 -0.49 . . . . 0.0 111.625 -169.279 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.443 ' HG2' HG23 ' A' ' 82' ' ' VAL . 45.8 mt-10 -130.33 125.46 34.74 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.289 -0.869 . . . . 0.0 108.967 171.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 45.9 m -72.61 173.94 8.24 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.048 0.452 . . . . 0.0 111.705 -177.121 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -60.89 155.74 51.41 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.238 178.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -88.28 142.31 5.24 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 122.423 2.082 . . . . 0.0 114.482 -176.522 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.872 ' O ' ' HA ' ' A' ' 78' ' ' THR . 7.1 t -82.62 126.42 40.02 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.721 0 CA-C-N 114.662 -1.154 . . . . 0.0 108.175 166.002 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.6 t -120.26 106.73 19.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 C-N-CA 119.768 -0.773 . . . . 0.0 110.081 171.284 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.545 HG13 ' HB ' ' A' ' 77' ' ' ILE . 7.1 pt -123.5 113.35 37.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.54 176.021 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.584 ' HB2' HE22 ' A' ' 74' ' ' GLN . 14.0 pt20 -99.0 126.02 44.61 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.502 0.667 . . . . 0.0 111.458 -175.177 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -133.67 127.92 33.93 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.151 -0.932 . . . . 0.0 109.56 176.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.421 ' HA ' ' HA ' ' A' ' 74' ' ' GLN . 37.4 tt0 -87.26 138.17 31.72 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.076 0.465 . . . . 0.0 110.126 176.79 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 26.5 p -69.55 117.75 11.56 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.238 -177.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 14.3 m . . . . . 0 C--N 1.323 -0.573 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.354 -179.704 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.408 ' HB2' ' O ' ' A' ' 89' ' ' THR . . . . . . . . 0 N--CA 1.45 -0.449 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.413 ' CB ' ' HB2' ' A' ' 30' ' ' TRP . 30.3 Cg_exo -64.52 126.74 17.45 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 121.886 1.724 . . . . 0.0 111.511 175.267 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.505 ' HD2' ' O ' ' A' ' 31' ' ' SER . 84.9 Cg_exo -47.14 146.95 5.83 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.634 2.223 . . . . 0.0 111.114 171.019 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.419 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 10.2 p-10 -37.71 106.67 0.36 Allowed Pre-proline 0 N--CA 1.465 0.302 0 O-C-N 124.743 1.277 . . . . 0.0 112.594 -169.104 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.583 ' HG2' HG11 ' A' ' 91' ' ' VAL . 33.4 Cg_exo -65.59 152.28 82.23 Favored 'Trans proline' 0 CA--C 1.517 -0.329 0 C-N-CA 123.552 2.835 . . . . 0.0 112.015 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 25.8 m -109.45 128.78 55.41 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.898 -178.741 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.463 ' HA ' ' HA ' ' A' ' 28' ' ' VAL . 83.6 t -74.92 119.21 22.07 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-N 114.415 -1.266 . . . . 0.0 109.591 173.651 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -88.0 -40.25 14.02 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.184 -173.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 18.0 mm-40 -136.71 139.41 41.9 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.47 -177.648 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.6 m -130.55 133.75 63.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.15 0.5 . . . . 0.0 111.078 178.166 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -134.84 -162.72 1.28 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.064 178.355 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -69.01 -68.41 0.4 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.105 0.479 . . . . 0.0 111.579 177.574 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.685 HG22 ' O ' ' A' ' 69' ' ' LEU . 68.2 p -111.87 39.64 2.34 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.905 -174.239 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.711 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 69.9 m -169.12 131.91 1.28 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.371 -0.832 . . . . 0.0 110.322 -171.626 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.613 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 17.9 mt -150.38 138.45 14.3 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.893 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 176.613 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 37.7 t -116.35 131.94 67.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 119.002 0.819 . . . . 0.0 110.587 -173.825 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.631 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.7 OUTLIER -125.94 145.41 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.039 -178.412 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.499 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 77.3 mtt180 -127.13 121.87 32.61 Favored 'General case' 0 N--CA 1.465 0.293 0 O-C-N 123.629 0.581 . . . . 0.0 110.293 -177.333 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.757 ' HZ3' HG12 ' A' ' 64' ' ' VAL . 28.1 p90 -112.83 146.8 38.23 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.835 -0.621 . . . . 0.0 112.05 -173.41 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.505 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 15.3 m -87.43 88.63 7.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.482 179.246 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.675 ' HD3' ' H ' ' A' ' 32' ' ' ARG . 0.4 OUTLIER -48.77 156.26 0.91 Allowed Pre-proline 0 CA--C 1.54 0.582 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -174.698 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.706 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 1.6 Cg_endo -85.7 169.26 9.37 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 124.307 3.338 . . . . 0.0 112.428 -173.409 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -93.86 -5.36 48.19 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.836 177.537 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -67.88 144.48 97.29 Favored Pre-proline 0 C--O 1.234 0.265 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.041 173.664 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_exo -70.76 112.72 3.32 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 121.272 1.314 . . . . 0.0 109.898 172.575 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.611 HD12 ' HE1' ' A' ' 40' ' ' TYR . 5.0 pt -121.36 151.93 24.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.08 -172.55 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.45 HG21 ' HA ' ' A' ' 84' ' ' GLU . 16.8 p -98.33 -26.78 14.38 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -176.287 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.436 ' O ' HG12 ' A' ' 82' ' ' VAL . . . -173.36 -164.16 28.18 Favored Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 119.575 -1.298 . . . . 0.0 112.582 177.43 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.706 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 6.4 m-85 -138.88 135.4 34.44 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 120.975 0.417 . . . . 0.0 111.041 177.393 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 4.0 mtm105 -108.95 146.62 33.53 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 169.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.891 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 34.9 mt -138.76 109.58 4.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -174.227 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 75.3 t -109.67 110.54 32.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.297 0.57 . . . . 0.0 110.66 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.662 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 1.1 p90 -114.08 125.76 54.34 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.607 176.832 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.0 m -137.87 145.29 47.63 Favored Pre-proline 0 C--N 1.313 -1.014 0 CA-C-N 114.077 -1.419 . . . . 0.0 111.164 -173.185 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.576 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 55.7 Cg_endo . . . . . 0 N--CA 1.472 0.225 0 C-N-CA 123.443 2.762 . . . . 0.0 111.928 178.804 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 7.0 m . . . . . 0 CA--C 1.517 -0.296 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.662 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 86.4 m -147.02 151.05 36.31 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.332 -178.841 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.891 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 31.8 tt0 -119.82 122.86 42.29 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.496 175.898 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.736 HD12 ' CG2' ' A' ' 64' ' ' VAL . 16.9 mt -104.58 157.89 16.86 Favored 'General case' 0 CA--C 1.514 -0.406 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.129 175.529 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -122.02 114.68 21.29 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 177.579 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.531 HD12 ' CH2' ' A' ' 30' ' ' TRP . 2.1 mt -111.6 156.8 40.86 Favored Pre-proline 0 C--N 1.317 -0.843 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -175.68 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -63.24 150.16 89.36 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 121.912 1.742 . . . . 0.0 111.448 176.008 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.414 ' HB3' ' C ' ' A' ' 38' ' ' THR . 10.3 pt-20 -43.94 -28.74 0.49 Allowed 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 114.59 -1.186 . . . . 0.0 112.98 176.326 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.1 t -106.93 19.28 20.69 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.161 -175.043 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.486 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -82.15 152.78 26.34 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.181 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.499 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 28.5 p-10 -132.59 5.53 4.01 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -177.028 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.631 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 35.5 p -166.18 134.3 2.9 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 119.905 -0.718 . . . . 0.0 111.869 -175.125 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.757 HG12 ' HZ3' ' A' ' 30' ' ' TRP . 4.7 p -114.53 135.3 54.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.259 175.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 54.3 m -97.4 99.41 10.84 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 121.572 0.701 . . . . 0.0 109.146 169.485 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.711 ' O ' ' HA ' ' A' ' 25' ' ' SER . 0.7 OUTLIER -73.96 144.54 45.2 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.094 -0.957 . . . . 0.0 108.907 179.05 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.452 ' HA ' ' O ' ' A' ' 24' ' ' THR . 10.6 t -142.35 167.46 22.04 Favored 'General case' 0 C--N 1.318 -0.791 0 O-C-N 123.56 0.537 . . . . 0.0 109.714 -173.527 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 62.77 27.48 16.1 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 123.881 0.738 . . . . 0.0 111.202 -178.163 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.685 ' O ' HG22 ' A' ' 24' ' ' THR . 13.6 mt -71.09 -174.92 1.05 Allowed 'General case' 0 C--O 1.225 -0.2 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 173.052 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.498 ' HB2' HG21 ' A' ' 73' ' ' VAL . 67.8 mm-40 -122.99 133.43 24.49 Favored Pre-proline 0 C--N 1.317 -0.846 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 175.703 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -63.71 126.19 16.98 Favored 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 122.513 2.142 . . . . 0.0 112.125 177.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 82.67 39.42 10.65 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.741 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.498 HG21 ' HB2' ' A' ' 70' ' ' GLN . 72.1 t -136.58 138.13 46.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.039 0.447 . . . . 0.0 110.843 -179.288 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.617 HE22 ' HB2' ' A' ' 94' ' ' GLN . 0.0 OUTLIER -80.93 120.25 24.5 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.719 -179.841 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.526 ' CE2' ' HB3' ' A' ' 69' ' ' LEU . 30.1 m-85 -113.66 117.72 32.34 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.499 0.666 . . . . 0.0 112.44 -178.021 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.463 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 7.3 m-80 -85.85 110.74 19.61 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.019 172.274 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.69 HG12 HD11 ' A' ' 66' ' ' LEU . 5.1 mp -92.21 121.89 43.18 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.562 0 CA-C-O 121.064 0.459 . . . . 0.0 109.866 176.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.896 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 48.2 m -111.73 114.57 27.65 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.861 179.53 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.577 ' HB ' ' HB ' ' A' ' 91' ' ' VAL . 13.5 mm -95.91 130.14 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -117.94 113.07 21.16 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 177.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -88.98 125.46 34.99 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 173.614 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.436 HG12 ' O ' ' A' ' 39' ' ' GLY . 8.1 p -118.6 133.5 65.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 C-N-CA 120.09 -0.644 . . . . 0.0 112.127 -173.396 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.536 ' HG2' HG22 ' A' ' 37' ' ' ILE . 8.9 mt-10 -100.58 173.6 6.47 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.127 172.529 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.45 ' HA ' HG21 ' A' ' 38' ' ' THR . 26.0 mt-10 -34.93 -44.55 0.23 Allowed 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -176.578 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -135.03 2.77 3.12 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -176.691 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 26.3 pt20 -146.45 176.14 10.02 Favored 'General case' 0 C--O 1.218 -0.591 0 CA-C-N 118.939 0.791 . . . . 0.0 111.552 -179.087 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -126.67 154.95 43.38 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.768 -179.495 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 16.9 m -85.73 -175.27 5.55 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.453 176.486 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.408 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 1.4 p -62.65 158.69 49.04 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.449 173.219 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -87.33 140.08 5.33 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 122.065 1.843 . . . . 0.0 113.674 -178.752 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.896 ' O ' ' HA ' ' A' ' 78' ' ' THR . 8.6 t -83.29 125.68 40.09 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.744 0 CA-C-N 114.868 -1.06 . . . . 0.0 108.49 167.216 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 5.9 t -125.03 106.58 16.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 C-N-CA 119.958 -0.697 . . . . 0.0 110.078 171.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.528 HG13 ' HB ' ' A' ' 77' ' ' ILE . 5.9 pt -124.76 116.32 47.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.906 179.461 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.617 ' HB2' HE22 ' A' ' 74' ' ' GLN . 12.6 pt20 -99.47 129.49 45.65 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.456 0.646 . . . . 0.0 111.332 -175.562 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -140.94 130.84 24.44 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.021 177.177 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.41 ' HA ' ' HA ' ' A' ' 74' ' ' GLN . 39.6 tt0 -92.63 138.12 31.77 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.204 0.526 . . . . 0.0 110.745 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 34.1 p -68.81 124.64 24.24 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.741 -176.491 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 40.0 m . . . . . 0 C--N 1.329 -0.315 0 CA-C-O 121.503 0.668 . . . . 0.0 110.237 177.664 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.483 ' HB2' ' O ' ' A' ' 89' ' ' THR . . . . . . . . 0 N--CA 1.453 -0.298 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -62.23 128.45 23.92 Favored 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.295 1.997 . . . . 0.0 111.787 175.292 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.496 ' HD2' ' O ' ' A' ' 31' ' ' SER . 86.9 Cg_exo -47.12 140.24 14.37 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.71 2.274 . . . . 0.0 111.349 174.057 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.44 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 5.9 p-10 -33.85 106.96 0.28 Allowed Pre-proline 0 N--CA 1.467 0.396 0 O-C-N 124.929 1.393 . . . . 0.0 112.478 -168.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.564 ' HG2' HG11 ' A' ' 91' ' ' VAL . 39.1 Cg_exo -61.91 152.49 74.64 Favored 'Trans proline' 0 CA--C 1.517 -0.344 0 C-N-CA 123.727 2.951 . . . . 0.0 112.718 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.9 m -107.6 128.27 54.39 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.656 -178.559 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.468 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 69.5 t -78.46 117.12 23.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-N 114.337 -1.301 . . . . 0.0 109.725 173.706 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -83.63 -36.89 23.52 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.377 -173.769 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -135.6 138.38 42.87 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.471 -178.713 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.495 ' HA ' HG12 ' A' ' 26' ' ' ILE . 6.3 m -129.54 120.33 50.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.205 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.407 ' HB3' ' H ' ' A' ' 23' ' ' ASP . 8.4 m-20 -133.69 -165.33 1.62 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.46 -179.368 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.571 ' O ' ' HB2' ' A' ' 69' ' ' LEU . 3.3 p-10 -67.77 -65.13 0.73 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.971 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.672 HG22 ' O ' ' A' ' 69' ' ' LEU . 39.7 p -115.33 35.5 4.35 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.876 -172.038 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.689 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 18.6 p -169.79 130.7 1.03 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.787 -174.708 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.573 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 17.0 mt -146.95 135.97 16.11 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.608 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 177.686 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.468 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 39.9 t -115.1 129.81 70.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 C-N-CA 120.013 -0.675 . . . . 0.0 110.497 -174.51 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.663 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.8 OUTLIER -123.76 143.89 35.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.044 -177.544 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.534 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 85.8 mtt180 -128.03 121.63 30.22 Favored 'General case' 0 N--CA 1.465 0.297 0 O-C-N 123.79 0.681 . . . . 0.0 110.314 -177.13 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.674 ' HZ3' HG12 ' A' ' 64' ' ' VAL . 30.2 p90 -111.39 140.5 45.93 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.189 -173.883 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.496 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 61.8 m -82.51 88.19 6.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.13 175.27 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.437 ' HD3' ' H ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -49.08 156.46 0.96 Allowed Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -175.485 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.658 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 3.4 Cg_exo -80.36 169.26 17.47 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 123.886 3.057 . . . . 0.0 112.846 -174.378 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -86.57 -14.84 41.71 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.139 172.25 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -57.51 135.25 82.07 Favored Pre-proline 0 CA--C 1.517 -0.309 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.162 173.276 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -67.33 112.39 2.55 Favored 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 120.937 1.091 . . . . 0.0 109.774 172.554 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.674 HD12 ' HE1' ' A' ' 40' ' ' TYR . 1.6 pt -118.27 151.43 20.36 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -174.662 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.466 ' C ' ' HB3' ' A' ' 59' ' ' GLU . 11.0 p -98.56 -30.53 12.45 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -178.632 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.537 ' C ' HG12 ' A' ' 82' ' ' VAL . . . -162.86 -166.66 22.03 Favored Glycine 0 N--CA 1.438 -1.209 0 C-N-CA 120.153 -1.022 . . . . 0.0 112.044 -177.861 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.674 ' HE1' HD12 ' A' ' 37' ' ' ILE . 6.3 m-85 -141.54 134.46 28.9 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 122.613 0.365 . . . . 0.0 110.875 174.78 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.3 mmm180 -102.53 149.41 24.43 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 168.152 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.879 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 30.7 mt -139.55 108.4 3.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 C-N-CA 120.037 -0.665 . . . . 0.0 112.389 -179.297 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 71.7 t -107.53 110.57 32.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.182 0.515 . . . . 0.0 110.836 179.02 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.656 ' CZ ' ' HB ' ' A' ' 53' ' ' THR . 1.4 p90 -114.9 127.3 55.62 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.948 176.832 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.3 p -141.81 137.41 16.11 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 113.718 -1.583 . . . . 0.0 111.754 -175.05 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.595 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 58.1 Cg_endo . . . . . 0 C--N 1.342 0.2 0 C-N-CA 123.275 2.65 . . . . 0.0 111.9 176.553 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.431 ' HA ' ' O ' ' A' ' 44' ' ' TYR . 14.9 m . . . . . 0 CA--C 1.512 -0.492 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.656 ' HB ' ' CZ ' ' A' ' 44' ' ' TYR . 36.1 m -147.62 149.95 33.49 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 120.111 -0.636 . . . . 0.0 111.563 -179.537 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.879 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 26.4 tt0 -116.95 112.0 20.39 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.585 174.413 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.709 HD12 ' CG2' ' A' ' 64' ' ' VAL . 23.8 mt -96.09 159.04 15.17 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.072 177.785 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.455 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 24.7 t-20 -125.2 114.86 19.55 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -179.403 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.575 HD12 ' CH2' ' A' ' 30' ' ' TRP . 4.4 mt -112.1 157.68 39.1 Favored Pre-proline 0 C--N 1.317 -0.843 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 -176.369 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -68.3 152.54 75.66 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 121.749 1.632 . . . . 0.0 111.06 175.501 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.466 ' HB3' ' C ' ' A' ' 38' ' ' THR . 11.7 pt-20 -45.62 -27.07 0.71 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.796 -1.093 . . . . 0.0 112.758 176.01 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 11.1 t -101.44 18.74 19.36 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.277 0.561 . . . . 0.0 111.1 -174.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.432 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -93.04 157.92 16.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.394 179.581 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.534 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 26.6 p-10 -143.05 13.74 1.86 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -178.475 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.663 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 80.5 p -165.26 134.3 3.4 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 119.876 -0.729 . . . . 0.0 111.936 -177.042 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.709 ' CG2' HD12 ' A' ' 55' ' ' LEU . 3.8 p -117.43 134.81 59.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.346 175.082 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 35.1 m -96.57 101.22 12.8 Favored 'General case' 0 N--CA 1.434 -1.255 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.498 169.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.691 HD11 HG12 ' A' ' 77' ' ' ILE . 0.3 OUTLIER -78.3 144.57 35.98 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.1 178.33 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.405 ' HA ' ' O ' ' A' ' 24' ' ' THR . 13.2 p -138.47 166.58 23.92 Favored 'General case' 0 C--N 1.318 -0.783 0 O-C-N 123.514 0.508 . . . . 0.0 110.826 -173.241 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 64.2 27.1 13.92 Favored 'General case' 0 N--CA 1.463 0.2 0 O-C-N 123.757 0.661 . . . . 0.0 111.679 179.071 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.672 ' O ' HG22 ' A' ' 24' ' ' THR . 11.1 mt -70.31 -176.16 1.14 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 175.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 57.9 tp60 -127.44 124.05 23.43 Favored Pre-proline 0 C--N 1.32 -0.696 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 177.618 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -62.62 135.55 53.43 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 123.083 2.522 . . . . 0.0 113.31 -177.499 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.67 25.21 39.42 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.907 179.659 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 87.4 t -129.99 148.77 33.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.27 0.557 . . . . 0.0 111.289 -174.233 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.595 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -87.33 121.5 29.86 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.648 -179.588 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -118.02 116.8 27.63 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.153 0.501 . . . . 0.0 112.24 -174.448 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.555 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 3.9 m-20 -89.96 113.13 24.72 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.376 176.474 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.691 HG12 HD11 ' A' ' 66' ' ' LEU . 5.1 mp -95.27 118.72 42.1 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.546 0 CA-C-O 121.057 0.455 . . . . 0.0 109.836 174.905 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.856 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 36.8 m -110.85 115.53 29.68 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.253 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.565 ' HB ' ' HB ' ' A' ' 91' ' ' VAL . 13.8 mm -95.89 145.27 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -179.556 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.414 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 53.0 m-85 -131.13 111.32 11.87 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 177.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.42 ' HB1' HG21 ' A' ' 37' ' ' ILE . . . -80.71 112.08 17.75 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 172.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.537 HG12 ' C ' ' A' ' 39' ' ' GLY . 7.4 p -106.68 135.54 44.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 C-N-CA 119.718 -0.793 . . . . 0.0 111.019 -174.818 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.416 ' HG2' HG22 ' A' ' 37' ' ' ILE . 4.8 mt-10 -109.05 172.06 7.07 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 177.433 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -44.67 -51.42 9.2 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 123.585 0.553 . . . . 0.0 112.136 178.68 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 -111.39 -14.19 13.79 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -171.852 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -135.43 172.81 12.47 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.32 -0.552 . . . . 0.0 111.882 -170.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -128.87 133.61 48.0 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 175.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 13.4 m -78.52 170.84 16.0 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.699 0.285 . . . . 0.0 110.914 -178.132 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.483 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 0.6 OUTLIER -57.9 158.24 13.24 Favored Pre-proline 0 N--CA 1.449 -0.51 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.767 174.758 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -87.07 138.79 5.04 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 122.067 1.844 . . . . 0.0 113.748 -177.759 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.856 ' O ' ' HA ' ' A' ' 78' ' ' THR . 5.0 t -82.38 124.26 39.09 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.795 0 CA-C-N 114.707 -1.133 . . . . 0.0 108.397 167.296 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 5.0 t -119.61 106.74 19.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 C-N-CA 119.689 -0.804 . . . . 0.0 109.99 171.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.514 HG13 ' HB ' ' A' ' 77' ' ' ILE . 5.9 pt -126.02 111.7 27.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.788 176.551 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.7 pm0 -99.09 133.45 43.35 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.158 0.504 . . . . 0.0 110.499 -178.509 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -139.26 140.44 37.68 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.094 178.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.469 ' HG2' ' HG2' ' A' ' 74' ' ' GLN . 38.3 mt-10 -86.26 146.86 26.34 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.952 0.405 . . . . 0.0 110.427 177.833 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 40.0 p -82.81 114.86 21.42 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.339 177.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 26.7 m . . . . . 0 C--N 1.323 -0.545 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.907 -176.717 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.328 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.418 ' HB2' ' HB2' ' A' ' 30' ' ' TRP . 23.0 Cg_exo -67.25 127.52 16.81 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.421 2.081 . . . . 0.0 111.999 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.587 ' HD2' ' O ' ' A' ' 31' ' ' SER . 80.0 Cg_exo -46.58 145.54 6.22 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 123.186 2.59 . . . . 0.0 112.174 174.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.426 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 24.2 t70 -35.27 105.37 0.28 Allowed Pre-proline 0 N--CA 1.468 0.44 0 O-C-N 124.884 1.365 . . . . 0.0 112.569 -169.854 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.651 ' HG2' HG11 ' A' ' 91' ' ' VAL . 23.7 Cg_exo -69.19 149.59 70.68 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 123.58 2.853 . . . . 0.0 112.796 -178.757 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.5 m -107.47 131.07 54.7 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.735 -177.632 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.512 HG11 HG22 ' A' ' 21' ' ' VAL . 72.5 t -73.66 123.72 29.37 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.022 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.062 175.679 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -83.34 -47.67 11.22 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.845 -174.503 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -135.48 137.54 42.26 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.11 -178.45 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.512 HG22 HG11 ' A' ' 18' ' ' VAL . 30.3 t -121.52 115.13 45.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.642 177.834 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -123.09 -167.55 1.62 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.347 177.415 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.552 ' O ' ' HB2' ' A' ' 69' ' ' LEU . 1.7 p-10 -70.55 -68.41 0.43 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.145 -0.479 . . . . 0.0 112.043 178.117 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.604 HG22 ' O ' ' A' ' 69' ' ' LEU . 38.1 p -106.72 31.95 4.89 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.699 -172.87 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.648 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 11.6 p -171.24 132.51 0.81 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.502 -174.484 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.579 ' HB ' HD12 ' A' ' 66' ' ' LEU . 44.9 mt -145.86 145.0 20.61 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.742 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 177.341 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.512 ' O ' HG13 ' A' ' 18' ' ' VAL . 35.6 t -117.44 137.67 50.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 C-N-CA 120.03 -0.668 . . . . 0.0 109.782 -174.886 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.64 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.6 OUTLIER -130.68 146.39 34.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 C-N-CA 119.974 -0.69 . . . . 0.0 110.229 178.331 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.481 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 34.9 mtp180 -129.63 120.35 25.09 Favored 'General case' 0 C--N 1.327 -0.402 0 O-C-N 123.623 0.577 . . . . 0.0 110.045 -175.488 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.753 ' HZ3' HG12 ' A' ' 64' ' ' VAL . 37.1 p90 -113.23 148.93 34.54 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.051 -174.823 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.587 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 13.6 m -93.7 100.4 12.63 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.936 178.498 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.638 ' NE ' ' HB3' ' A' ' 62' ' ' ASN . 0.1 OUTLIER -53.83 156.26 5.15 Favored Pre-proline 0 CA--C 1.538 0.482 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -174.314 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.65 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 2.4 Cg_endo -83.84 168.51 12.34 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 124.341 3.361 . . . . 0.0 112.474 -174.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -82.49 -16.32 49.22 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.019 172.586 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -59.62 141.65 88.34 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 114.621 -1.172 . . . . 0.0 111.304 177.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -69.75 112.76 3.16 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 121.035 1.156 . . . . 0.0 109.85 171.562 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.609 HD12 ' HE1' ' A' ' 40' ' ' TYR . 1.4 pt -121.42 147.33 25.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -176.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 17.4 p -97.39 -20.39 17.84 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -177.252 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.546 ' C ' HG12 ' A' ' 82' ' ' VAL . . . -173.63 -164.1 28.26 Favored Glycine 0 CA--C 1.501 -0.789 0 C-N-CA 119.877 -1.154 . . . . 0.0 111.957 177.19 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.65 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 6.5 m-85 -139.88 132.84 29.38 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-O 120.849 0.357 . . . . 0.0 111.069 173.644 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 8.7 mmm180 -103.49 149.31 24.97 Favored 'General case' 0 CA--C 1.503 -0.851 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 167.854 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.885 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 33.8 mt -138.73 108.25 4.11 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 C-N-CA 119.939 -0.705 . . . . 0.0 112.219 -178.512 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 72.0 t -107.94 110.38 31.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.299 0.571 . . . . 0.0 110.396 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.612 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 1.0 OUTLIER -110.64 125.42 53.41 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.328 176.071 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 39.9 p -140.01 135.47 16.43 Favored Pre-proline 0 C--N 1.316 -0.864 0 CA-C-N 113.922 -1.49 . . . . 0.0 111.217 -174.549 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.514 ' HG3' ' CE2' ' A' ' 75' ' ' TYR . 10.5 Cg_exo . . . . . 0 N--CA 1.462 -0.365 0 C-N-CA 122.815 2.344 . . . . 0.0 111.154 173.577 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.477 ' HA ' ' O ' ' A' ' 44' ' ' TYR . 16.5 m . . . . . 0 CA--C 1.515 -0.374 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.612 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 58.6 m -147.13 152.34 38.29 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.408 -177.048 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.885 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 33.2 tt0 -116.5 117.5 30.08 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.85 174.129 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.703 HD12 ' CG2' ' A' ' 64' ' ' VAL . 18.3 mt -97.3 158.06 15.65 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 174.684 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -123.45 111.06 15.88 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.607 -178.608 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.569 HD12 ' CH2' ' A' ' 30' ' ' TRP . 3.4 mt -109.59 155.55 41.16 Favored Pre-proline 0 N--CA 1.444 -0.771 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -177.152 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -64.35 148.83 90.93 Favored 'Trans proline' 0 N--CA 1.448 -1.172 0 C-N-CA 121.611 1.54 . . . . 0.0 110.635 175.108 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.467 ' HB2' HG13 ' A' ' 37' ' ' ILE . 8.4 pt-20 -44.04 -27.58 0.39 Allowed 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 114.729 -1.123 . . . . 0.0 113.197 178.818 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.8 t -103.35 6.99 38.23 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.44 -173.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.421 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -76.41 158.5 31.33 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 178.598 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.638 ' HB3' ' NE ' ' A' ' 32' ' ' ARG . 29.2 p-10 -141.98 18.29 2.12 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -177.595 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.64 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 25.5 p -169.76 134.2 1.33 Allowed 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.209 -0.597 . . . . 0.0 111.715 179.288 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.753 HG12 ' HZ3' ' A' ' 30' ' ' TRP . 3.7 p -116.81 137.55 50.31 Favored 'Isoleucine or valine' 0 C--O 1.243 0.728 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.489 176.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 68.3 m -96.92 101.18 12.72 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.579 169.403 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.678 HD11 HG12 ' A' ' 77' ' ' ILE . 0.2 OUTLIER -80.19 145.38 32.31 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.474 -0.784 . . . . 0.0 108.928 178.647 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 8.8 t -141.06 174.14 10.8 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.27 -174.34 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 62.78 27.22 15.98 Favored 'General case' 0 C--N 1.329 -0.304 0 O-C-N 123.8 0.688 . . . . 0.0 111.272 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.604 ' O ' HG22 ' A' ' 24' ' ' THR . 10.9 mt -74.65 -176.36 2.77 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.275 -0.421 . . . . 0.0 109.883 177.242 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 57.3 tp60 -130.35 123.27 20.44 Favored Pre-proline 0 C--N 1.32 -0.709 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.007 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -62.0 133.59 45.12 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.961 2.441 . . . . 0.0 113.035 -177.861 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 87.42 25.24 33.85 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.788 -178.62 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.505 ' CG1' ' HB3' ' A' ' 46' ' ' PRO . 94.9 t -131.02 142.81 42.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.027 0.441 . . . . 0.0 110.841 -176.772 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.493 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 10.3 tp60 -86.36 107.45 18.01 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.002 -177.339 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.514 ' CE2' ' HG3' ' A' ' 46' ' ' PRO . 18.8 m-85 -99.13 119.95 38.69 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.097 0.475 . . . . 0.0 111.69 -177.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.507 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 20.2 m-80 -92.72 109.21 20.62 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.418 177.164 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.678 HG12 HD11 ' A' ' 66' ' ' LEU . 5.0 mp -91.76 116.72 33.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.246 0.546 . . . . 0.0 109.642 178.121 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.884 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 81.1 m -108.9 115.81 30.8 Favored 'General case' 0 N--CA 1.427 -1.605 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.441 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.544 ' HB ' ' HB ' ' A' ' 91' ' ' VAL . 13.5 mm -95.12 141.26 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 -179.285 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -128.79 111.79 13.49 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.91 178.781 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.444 ' HB3' ' OG ' ' A' ' 88' ' ' SER . . . -78.97 119.5 22.22 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 168.212 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.546 HG12 ' C ' ' A' ' 39' ' ' GLY . 7.6 p -106.77 133.87 50.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 C-N-CA 120.092 -0.643 . . . . 0.0 110.049 -178.206 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.467 ' HG3' HG22 ' A' ' 37' ' ' ILE . 1.4 mp0 -111.01 170.22 8.24 Favored 'General case' 0 N--CA 1.445 -0.68 0 O-C-N 123.579 0.549 . . . . 0.0 110.068 -178.12 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.441 ' H ' ' HG3' ' A' ' 84' ' ' GLU . 30.7 mt-10 -43.68 -46.99 7.65 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.119 -0.946 . . . . 0.0 112.676 -174.566 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 -125.12 6.14 7.87 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -174.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -147.81 177.24 9.48 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.854 0.359 . . . . 0.0 111.762 -172.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -133.04 124.41 27.6 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.172 176.376 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.444 ' OG ' ' HB3' ' A' ' 81' ' ' ALA . 92.9 p -70.81 170.43 12.55 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.908 0.385 . . . . 0.0 111.569 -178.022 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 18.7 p -60.73 153.05 65.37 Favored Pre-proline 0 CA--C 1.531 0.218 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.772 175.834 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -83.38 144.55 11.59 Favored 'Trans proline' 0 CA--C 1.534 0.499 0 C-N-CA 122.31 2.007 . . . . 0.0 114.712 -175.405 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.884 ' O ' ' HA ' ' A' ' 78' ' ' THR . 11.7 t -83.49 129.38 37.61 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.581 0 CA-C-N 114.614 -1.176 . . . . 0.0 107.975 163.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.3 t -125.1 106.87 17.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 C-N-CA 120.046 -0.661 . . . . 0.0 110.13 173.248 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.574 HG13 ' HB ' ' A' ' 77' ' ' ILE . 9.7 pt -125.04 113.14 34.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.259 179.266 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -98.72 125.33 44.01 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.558 0.694 . . . . 0.0 111.675 -176.551 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -131.98 127.3 35.99 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.389 176.285 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.437 ' HA ' ' HA ' ' A' ' 74' ' ' GLN . 28.8 tt0 -87.17 127.25 35.15 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.34 0.59 . . . . 0.0 109.851 178.564 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.405 HG22 HD11 ' A' ' 26' ' ' ILE . 22.7 p -59.79 116.88 4.39 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.851 -1.068 . . . . 0.0 111.719 -175.265 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.7 m . . . . . 0 C--N 1.324 -0.532 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.281 -178.476 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.163 0 N-CA-C 109.379 -0.601 . . . . 0.0 109.379 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -70.93 127.09 13.22 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 121.811 1.674 . . . . 0.0 111.166 176.089 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.518 ' HD2' ' O ' ' A' ' 31' ' ' SER . 84.6 Cg_exo -48.16 145.6 10.76 Favored 'Trans proline' 0 CA--C 1.515 -0.443 0 C-N-CA 122.874 2.382 . . . . 0.0 111.401 173.458 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.429 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 17.3 t70 -35.67 106.37 0.31 Allowed Pre-proline 0 N--CA 1.466 0.335 0 O-C-N 124.939 1.399 . . . . 0.0 111.993 -169.422 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.589 ' HG2' HG11 ' A' ' 91' ' ' VAL . 27.4 Cg_exo -67.03 146.13 76.05 Favored 'Trans proline' 0 CA--C 1.518 -0.305 0 C-N-CA 123.526 2.818 . . . . 0.0 112.045 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.8 m -105.57 131.46 52.93 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.894 -176.095 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.407 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 93.4 t -73.12 111.44 7.67 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-N 114.471 -1.24 . . . . 0.0 109.315 173.194 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -78.8 -45.0 21.91 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.277 -171.539 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -139.31 139.88 37.42 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.437 -178.008 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.416 HG13 HG12 ' A' ' 26' ' ' ILE . 60.5 t -129.12 132.6 66.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.868 -176.36 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -132.25 -161.86 1.18 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.765 174.149 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -71.75 -68.52 0.45 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.087 0.47 . . . . 0.0 112.109 177.188 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.625 HG22 ' O ' ' A' ' 69' ' ' LEU . 68.6 p -106.99 36.78 2.55 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.216 0.531 . . . . 0.0 111.176 -173.104 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.543 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 19.8 p -172.23 140.75 1.18 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.399 -174.108 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.578 ' HB ' HD12 ' A' ' 66' ' ' LEU . 46.5 mt -149.38 155.91 7.87 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.699 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.32 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 39.7 t -128.17 133.48 66.93 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.572 0 CA-C-N 119.373 0.988 . . . . 0.0 110.206 179.159 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.651 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.7 OUTLIER -125.45 145.16 33.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 C-N-CA 120.197 -0.601 . . . . 0.0 109.924 179.45 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.471 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 20.6 mtp180 -130.24 121.08 25.48 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 123.373 0.421 . . . . 0.0 110.563 -174.403 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.629 ' HZ3' HG12 ' A' ' 64' ' ' VAL . 35.2 p90 -111.98 146.48 37.78 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.734 -175.169 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.518 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 33.0 t -89.99 88.68 7.4 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.333 174.834 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.579 ' HD3' ' H ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -49.55 155.55 1.33 Allowed Pre-proline 0 CA--C 1.541 0.597 0 CA-C-N 115.151 -0.931 . . . . 0.0 112.77 -174.32 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.717 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 2.8 Cg_exo -75.87 170.0 21.04 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.948 3.099 . . . . 0.0 113.953 -169.556 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 24.7 tt0 -80.35 -22.65 41.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.705 -1.134 . . . . 0.0 108.523 169.792 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.8 135.38 78.89 Favored Pre-proline 0 CA--C 1.517 -0.299 0 CA-C-N 114.804 -1.089 . . . . 0.0 111.054 177.109 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -69.83 113.13 3.29 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 121.099 1.2 . . . . 0.0 109.755 171.579 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.559 HD12 ' HE1' ' A' ' 40' ' ' TYR . 0.6 OUTLIER -118.44 154.2 20.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -174.409 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.425 ' N ' ' O ' ' A' ' 82' ' ' VAL . 7.3 p -94.4 -33.94 12.96 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -179.726 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.514 ' C ' HG12 ' A' ' 82' ' ' VAL . . . -162.39 -167.53 22.96 Favored Glycine 0 N--CA 1.438 -1.232 0 C-N-CA 120.036 -1.078 . . . . 0.0 112.419 -177.014 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.717 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 4.6 m-85 -137.9 134.07 34.58 Favored 'General case' 0 C--N 1.319 -0.729 0 O-C-N 123.745 0.321 . . . . 0.0 110.897 174.352 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.6 mmm180 -104.06 147.71 27.09 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 167.795 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.887 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 22.7 mt -138.66 108.23 4.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 C-N-CA 119.961 -0.696 . . . . 0.0 111.959 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 72.1 t -111.2 109.41 28.39 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.646 0 CA-C-O 121.364 0.602 . . . . 0.0 110.317 179.166 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.665 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 0.6 OUTLIER -111.58 125.07 53.54 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.549 177.598 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.428 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 23.1 t -141.98 137.44 15.96 Favored Pre-proline 0 C--N 1.316 -0.881 0 CA-C-N 114.158 -1.383 . . . . 0.0 111.192 -172.624 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.68 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 15.1 Cg_exo . . . . . 0 C--N 1.344 0.319 0 C-N-CA 123.276 2.651 . . . . 0.0 111.706 174.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.524 ' HA ' ' O ' ' A' ' 44' ' ' TYR . 17.7 m . . . . . 0 CA--C 1.515 -0.398 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.665 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 89.7 m -147.15 147.47 30.56 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.75 -175.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.887 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 33.4 tt0 -115.39 112.29 22.11 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.892 174.303 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.714 HD12 ' CG2' ' A' ' 64' ' ' VAL . 17.2 mt -98.0 152.99 18.7 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.561 -0.456 . . . . 0.0 109.8 174.816 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -116.7 118.35 32.31 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 177.791 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.582 HD12 ' CH2' ' A' ' 30' ' ' TRP . 3.2 mt -115.04 157.17 44.11 Favored Pre-proline 0 N--CA 1.444 -0.766 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -176.809 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -65.57 150.4 86.62 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 121.826 1.684 . . . . 0.0 110.991 174.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.408 ' HB2' HG13 ' A' ' 37' ' ' ILE . 10.0 pt-20 -47.12 -27.66 1.48 Allowed 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 115.217 -0.902 . . . . 0.0 112.48 177.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.8 t -102.59 15.08 30.3 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.138 -174.799 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.43 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -83.34 163.58 20.55 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 177.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.471 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 5.2 p-10 -150.08 12.97 0.77 Allowed 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.153 -0.619 . . . . 0.0 112.436 -176.656 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.651 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 20.1 m -162.89 134.92 5.27 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 117.634 0.197 . . . . 0.0 110.776 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.714 ' CG2' HD12 ' A' ' 55' ' ' LEU . 4.1 p -117.58 138.81 47.05 Favored 'Isoleucine or valine' 0 C--O 1.244 0.802 0 CA-C-O 120.662 0.267 . . . . 0.0 110.508 174.304 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 52.6 m -98.76 101.74 13.25 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-O 121.741 0.782 . . . . 0.0 110.162 171.797 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.594 HD11 HG12 ' A' ' 77' ' ' ILE . 0.5 OUTLIER -75.66 138.17 41.18 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.067 -0.969 . . . . 0.0 108.896 177.455 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 14.0 p -132.17 159.98 37.4 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 123.193 0.308 . . . . 0.0 111.502 -171.25 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 64.43 34.26 10.48 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.491 175.314 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.625 ' O ' HG22 ' A' ' 24' ' ' THR . 14.6 mt -74.34 -175.93 2.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.986 175.655 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.471 ' HB2' HG21 ' A' ' 73' ' ' VAL . 21.3 mt-30 -124.4 140.3 34.87 Favored Pre-proline 0 C--N 1.317 -0.822 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 172.828 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.14 125.5 14.19 Favored 'Trans proline' 0 CA--C 1.531 0.353 0 C-N-CA 122.362 2.041 . . . . 0.0 112.601 179.506 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 88.16 38.24 7.38 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.786 178.139 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.471 HG21 ' HB2' ' A' ' 70' ' ' GLN . 46.6 t -130.5 144.33 38.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 110.333 -0.247 . . . . 0.0 110.333 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.68 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 43.5 tt0 -88.83 125.42 34.9 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.032 178.195 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.526 ' O ' ' HA ' ' A' ' 94' ' ' GLN . 98.3 m-85 -117.44 121.79 42.01 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.917 0.389 . . . . 0.0 111.236 -179.451 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.543 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 4.1 m-20 -88.33 106.31 18.15 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 170.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.594 HG12 HD11 ' A' ' 66' ' ' LEU . 5.2 mp -90.1 115.56 29.79 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.768 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 177.26 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.902 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 29.0 m -103.83 113.79 27.57 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 114.779 -1.101 . . . . 0.0 110.222 -177.849 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.541 ' HB ' ' HB ' ' A' ' 91' ' ' VAL . 12.3 mm -95.34 134.43 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -122.05 111.19 16.72 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.984 179.389 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.479 ' HB1' HG21 ' A' ' 37' ' ' ILE . . . -82.77 111.85 19.07 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 171.421 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.514 HG12 ' C ' ' A' ' 39' ' ' GLY . 7.8 p -107.73 133.05 53.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 C-N-CA 119.751 -0.779 . . . . 0.0 110.964 -173.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.543 ' OE1' ' HB2' ' A' ' 86' ' ' GLN . 6.8 mt-10 -107.22 171.11 7.56 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 175.613 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -43.77 -42.21 5.39 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 123.481 0.488 . . . . 0.0 112.14 178.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -123.01 -20.24 5.83 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -173.679 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.543 ' HB2' ' OE1' ' A' ' 83' ' ' GLU . 16.2 mm100 -123.77 176.33 6.33 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.789 -0.365 . . . . 0.0 111.632 -171.538 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -140.42 126.39 19.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.983 176.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.7 m -67.04 156.07 37.02 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.206 176.437 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 35.9 p -57.86 146.25 68.11 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.369 177.266 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -76.36 141.45 22.86 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 122.049 1.833 . . . . 0.0 114.118 -171.257 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.902 ' O ' ' HA ' ' A' ' 78' ' ' THR . 12.0 t -81.3 130.99 34.92 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.68 0 CA-C-N 114.444 -1.253 . . . . 0.0 108.201 169.392 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 19.0 t -127.52 106.85 15.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 C-N-CA 120.062 -0.655 . . . . 0.0 110.11 172.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.502 HG13 ' O ' ' A' ' 93' ' ' ILE . 43.0 pt -119.95 111.71 33.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.416 -179.44 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.526 ' HA ' ' O ' ' A' ' 75' ' ' TYR . 0.5 OUTLIER -95.59 126.31 40.79 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.297 0.57 . . . . 0.0 111.206 -177.456 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 17.9 tm0? -137.42 131.57 32.18 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.625 179.446 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.483 ' HG2' ' HB2' ' A' ' 74' ' ' GLN . 43.4 mt-10 -92.04 122.02 34.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.695 -0.23 . . . . 0.0 110.842 178.422 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.425 ' CG2' HD11 ' A' ' 26' ' ' ILE . 1.8 p -56.38 126.11 24.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.189 0.519 . . . . 0.0 112.035 -177.524 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.0 m . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.44 -179.85 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.582 ' HB2' ' O ' ' A' ' 89' ' ' THR . . . . . . . . 0 C--O 1.233 0.225 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -62.91 133.46 41.7 Favored 'Trans proline' 0 C--O 1.235 0.344 0 C-N-CA 122.234 1.956 . . . . 0.0 111.618 175.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -50.82 145.97 22.37 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.424 2.082 . . . . 0.0 110.9 173.623 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.404 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 13.1 m-20 -36.04 105.96 0.3 Allowed Pre-proline 0 N--CA 1.468 0.447 0 O-C-N 124.759 1.287 . . . . 0.0 112.206 -170.343 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.552 ' HG2' HG11 ' A' ' 91' ' ' VAL . 39.1 Cg_exo -65.23 147.21 87.86 Favored 'Trans proline' 0 CA--C 1.521 -0.173 0 C-N-CA 123.764 2.976 . . . . 0.0 112.517 -179.183 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 26.3 m -102.27 131.11 49.05 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.717 -177.185 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.469 HG13 ' O ' ' A' ' 27' ' ' VAL . 95.3 t -81.28 121.63 35.04 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 CA-C-N 114.379 -1.282 . . . . 0.0 110.224 177.118 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -88.13 -37.16 16.43 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.417 -174.421 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -135.62 135.61 40.36 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.343 -177.805 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.514 ' HA ' HG12 ' A' ' 26' ' ' ILE . 60.8 t -132.86 114.69 22.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.748 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -135.09 -172.22 3.0 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 177.803 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.542 ' O ' ' HB2' ' A' ' 69' ' ' LEU . 0.6 OUTLIER -57.18 -67.69 0.3 Allowed 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -178.131 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.648 HG22 ' O ' ' A' ' 69' ' ' LEU . 36.1 p -110.52 33.57 4.44 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.482 -172.335 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.616 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 58.4 m -168.04 130.06 1.47 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.544 -175.23 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.578 ' HB ' HD12 ' A' ' 66' ' ' LEU . 29.5 mt -144.48 141.53 23.96 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.733 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 175.817 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.469 ' O ' HG13 ' A' ' 18' ' ' VAL . 44.8 t -118.89 132.28 69.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.398 -175.16 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.609 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.6 OUTLIER -127.96 146.76 33.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 C-N-CA 119.928 -0.709 . . . . 0.0 110.605 -178.396 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.511 ' HG2' ' HB3' ' A' ' 63' ' ' SER . 93.3 mtt180 -130.65 121.17 25.08 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.479 -176.267 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.724 ' HZ3' HG12 ' A' ' 64' ' ' VAL . 37.7 p90 -112.98 152.97 28.77 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.202 -175.02 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 20.8 t -100.42 101.51 12.48 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.296 -0.411 . . . . 0.0 109.914 178.59 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.666 ' H ' ' CD ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -50.99 157.68 1.35 Allowed Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 123.99 0.916 . . . . 0.0 113.257 -174.364 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.687 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 2.5 Cg_endo -85.1 166.7 11.05 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 124.561 3.508 . . . . 0.0 113.572 -174.646 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -75.41 -23.64 57.03 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.845 -1.07 . . . . 0.0 109.369 171.117 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.39 135.92 76.17 Favored Pre-proline 0 C--O 1.236 0.348 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.292 175.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -68.38 113.9 3.27 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 121.192 1.262 . . . . 0.0 109.336 168.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.596 HG22 ' HG3' ' A' ' 83' ' ' GLU . 0.5 OUTLIER -117.98 152.31 20.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -175.662 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.401 HG21 ' HA ' ' A' ' 84' ' ' GLU . 12.5 p -95.54 -29.06 14.56 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -178.403 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.432 ' C ' HG12 ' A' ' 82' ' ' VAL . . . -168.58 -166.44 27.65 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 119.765 -1.207 . . . . 0.0 112.063 178.125 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.687 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 5.5 m-85 -137.81 131.94 31.9 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-N 117.056 0.428 . . . . 0.0 111.516 176.632 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 41.9 mtm180 -105.68 148.42 27.42 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 170.536 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.888 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 32.0 mt -139.6 108.92 3.62 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -176.027 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 78.3 t -109.03 110.58 32.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.24 0.543 . . . . 0.0 110.356 179.054 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.69 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 1.0 OUTLIER -111.86 124.76 53.04 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.392 177.055 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.3 m -134.95 137.7 27.81 Favored Pre-proline 0 C--N 1.315 -0.932 0 CA-C-N 114.318 -1.31 . . . . 0.0 111.639 -173.552 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.491 ' HD2' ' OG ' ' A' ' 52' ' ' SER . 73.3 Cg_endo . . . . . 0 C--O 1.23 0.125 0 C-N-CA 123.379 2.72 . . . . 0.0 111.566 174.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.491 ' OG ' ' HD2' ' A' ' 46' ' ' PRO . 6.7 m . . . . . 0 CA--C 1.519 -0.24 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.69 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 37.7 m -147.25 154.25 40.78 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.683 -0.407 . . . . 0.0 111.578 -176.798 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.888 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 44.3 tt0 -119.32 117.76 29.42 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.03 176.088 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.7 HD12 ' CG2' ' A' ' 64' ' ' VAL . 17.9 mt -99.67 164.67 11.96 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 173.429 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.508 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 8.0 t30 -135.91 115.83 13.17 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -178.699 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.561 HD12 ' CH2' ' A' ' 30' ' ' TRP . 5.7 mt -112.87 160.82 29.37 Favored Pre-proline 0 N--CA 1.444 -0.745 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -174.184 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -64.84 151.01 87.3 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 121.656 1.571 . . . . 0.0 110.841 174.474 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.446 ' HB2' HG13 ' A' ' 37' ' ' ILE . 10.4 pt-20 -45.49 -29.55 1.17 Allowed 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.095 0.958 . . . . 0.0 112.913 178.386 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 7.1 t -96.58 -0.17 49.11 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.398 -174.225 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.504 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -69.95 158.88 34.77 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 110.205 -0.295 . . . . 0.0 110.205 -177.51 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.561 ' HB3' ' NE ' ' A' ' 32' ' ' ARG . 3.8 p-10 -143.65 15.14 1.78 Allowed 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -177.709 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.609 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 36.1 p -168.45 133.63 1.72 Allowed 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.084 -0.646 . . . . 0.0 112.333 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.724 HG12 ' HZ3' ' A' ' 30' ' ' TRP . 4.8 p -118.72 139.47 45.93 Favored 'Isoleucine or valine' 0 C--O 1.243 0.725 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.537 176.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 34.4 m -99.51 103.75 15.52 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.72 170.256 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.708 HD11 HG12 ' A' ' 77' ' ' ILE . 0.2 OUTLIER -83.38 144.45 29.63 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.465 179.112 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 9.6 t -138.97 170.64 15.61 Favored 'General case' 0 N--CA 1.448 -0.555 0 O-C-N 123.371 0.42 . . . . 0.0 110.296 -174.158 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 65.24 22.25 12.13 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.052 179.271 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.648 ' O ' HG22 ' A' ' 24' ' ' THR . 6.5 mt -68.66 -178.45 1.16 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 177.513 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -124.36 128.06 25.11 Favored Pre-proline 0 C--N 1.32 -0.696 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 176.11 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -62.16 135.22 53.37 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 123.003 2.468 . . . . 0.0 113.069 -177.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.54 29.34 30.12 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.217 178.735 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 47.8 t -130.55 147.27 33.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.157 0.503 . . . . 0.0 111.198 -177.655 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 7.6 tp60 -86.06 109.47 18.85 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.205 178.713 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.448 ' CE2' HD22 ' A' ' 69' ' ' LEU . 4.2 m-85 -98.97 117.39 33.36 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.144 0.497 . . . . 0.0 111.885 -177.826 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.446 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 78.4 m-20 -88.06 108.13 19.08 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.025 174.224 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.708 HG12 HD11 ' A' ' 66' ' ' LEU . 5.0 mp -92.12 113.55 27.6 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.692 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 175.11 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.889 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 25.8 m -105.07 113.8 27.61 Favored 'General case' 0 N--CA 1.425 -1.723 0 CA-C-N 114.915 -1.038 . . . . 0.0 109.996 -179.022 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.574 ' H ' ' HB ' ' A' ' 91' ' ' VAL . 15.8 mm -95.05 143.3 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -130.85 111.94 12.56 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.96 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.501 ' HB3' ' OG ' ' A' ' 88' ' ' SER . . . -81.28 125.53 30.45 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 167.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.432 HG12 ' C ' ' A' ' 39' ' ' GLY . 7.5 p -113.36 133.5 59.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 C-N-CA 120.384 -0.526 . . . . 0.0 110.233 -179.095 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.596 ' HG3' HG22 ' A' ' 37' ' ' ILE . 8.2 mp0 -109.07 170.85 7.79 Favored 'General case' 0 N--CA 1.443 -0.819 0 O-C-N 123.912 0.757 . . . . 0.0 108.988 -178.387 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.401 ' HA ' HG21 ' A' ' 38' ' ' THR . 46.8 mt-10 -42.57 -45.24 4.48 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -172.885 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -131.16 0.9 4.19 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.029 -0.668 . . . . 0.0 112.624 -177.274 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.491 ' HG3' ' OE1' ' A' ' 83' ' ' GLU . 29.1 pt20 -136.07 176.04 9.05 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.961 -0.296 . . . . 0.0 110.772 -176.44 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -130.85 135.12 47.42 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.295 -0.412 . . . . 0.0 109.903 175.104 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.501 ' OG ' ' HB3' ' A' ' 81' ' ' ALA . 78.5 p -70.64 -178.36 1.8 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.955 0.407 . . . . 0.0 111.1 177.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.582 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 1.4 p -65.9 162.72 42.73 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.746 176.326 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -88.62 137.36 3.43 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 122.129 1.886 . . . . 0.0 113.753 179.075 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.889 ' O ' ' HA ' ' A' ' 78' ' ' THR . 6.4 t -82.53 126.07 39.97 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.72 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 166.619 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 10.5 t -124.14 106.77 17.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 C-N-CA 119.964 -0.694 . . . . 0.0 109.79 172.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.575 HG13 ' HB ' ' A' ' 77' ' ' ILE . 9.7 pt -122.98 111.88 31.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.354 178.531 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.426 ' HB3' ' OD1' ' A' ' 76' ' ' ASN . 11.3 pt20 -98.0 119.82 37.31 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.555 0.693 . . . . 0.0 111.591 -175.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -128.99 131.51 47.44 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.715 178.442 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -85.19 134.51 34.16 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.274 178.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.407 HG22 HD11 ' A' ' 26' ' ' ILE . 34.1 p -70.99 114.63 9.24 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.587 179.465 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 18.9 m . . . . . 0 C--N 1.323 -0.557 0 CA-C-O 121.443 0.64 . . . . 0.0 110.04 -177.999 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.403 ' HB2' ' O ' ' A' ' 89' ' ' THR . . . . . . . . 0 N--CA 1.451 -0.394 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -63.89 130.24 27.04 Favored 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.119 1.879 . . . . 0.0 111.578 178.729 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.579 ' HD2' ' O ' ' A' ' 31' ' ' SER . 83.5 Cg_exo -47.74 149.74 4.86 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.827 2.351 . . . . 0.0 111.212 171.241 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.421 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 8.1 p-10 -39.62 107.16 0.43 Allowed Pre-proline 0 N--CA 1.468 0.467 0 O-C-N 124.382 1.051 . . . . 0.0 112.336 -169.785 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.602 ' HG2' HG11 ' A' ' 91' ' ' VAL . 31.4 Cg_exo -65.22 148.17 88.6 Favored 'Trans proline' 0 CA--C 1.516 -0.42 0 C-N-CA 123.381 2.721 . . . . 0.0 112.134 179.071 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 24.9 m -107.41 132.01 53.64 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.655 -178.606 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 77.9 t -79.35 123.26 36.04 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 CA-C-N 114.194 -1.366 . . . . 0.0 110.359 176.323 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.423 ' OD2' ' HG3' ' A' ' 20' ' ' GLN . 26.3 t70 -88.72 -35.83 16.51 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.252 -176.281 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.423 ' HG3' ' OD2' ' A' ' 19' ' ' ASP . 75.8 mt-30 -135.99 134.1 38.22 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.688 -176.303 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.504 ' HA ' HG12 ' A' ' 26' ' ' ILE . 78.7 t -129.97 113.68 27.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.444 178.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -127.2 -166.76 1.64 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.057 178.857 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.6 -68.33 0.37 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.197 0.522 . . . . 0.0 112.161 178.287 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.633 HG22 ' O ' ' A' ' 69' ' ' LEU . 69.6 p -109.56 36.85 2.81 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.51 -174.047 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.517 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 72.0 p -170.59 134.88 1.12 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.94 -176.391 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.628 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 42.4 mt -148.78 141.44 18.21 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.837 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 177.448 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 47.3 t -118.21 132.24 68.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 118.897 0.771 . . . . 0.0 110.214 -176.275 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.622 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.7 OUTLIER -125.31 146.15 31.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 C-N-CA 119.917 -0.713 . . . . 0.0 110.411 -178.254 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.501 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 83.3 mtt180 -131.15 121.9 25.69 Favored 'General case' 0 C--N 1.329 -0.288 0 O-C-N 123.376 0.423 . . . . 0.0 110.778 -175.655 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.718 ' HZ3' HG12 ' A' ' 64' ' ' VAL . 30.8 p90 -112.27 141.08 46.42 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.63 -0.713 . . . . 0.0 112.12 -172.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.579 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 62.6 m -80.28 86.11 5.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.848 172.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.586 ' HD3' ' H ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -47.59 151.5 1.45 Allowed Pre-proline 0 CA--C 1.538 0.509 0 CA-C-N 115.144 -0.935 . . . . 0.0 112.243 -177.551 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.688 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 3.3 Cg_exo -79.91 162.95 23.53 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.71 2.94 . . . . 0.0 112.714 -172.155 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -82.68 -13.0 57.19 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.218 172.578 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.408 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . . . -58.82 145.83 77.48 Favored Pre-proline 0 CA--C 1.52 -0.204 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.043 175.398 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 35' ' ' ALA . 12.4 Cg_exo -69.56 114.42 3.67 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 121.458 1.439 . . . . 0.0 110.304 172.506 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.67 HD12 ' HE1' ' A' ' 40' ' ' TYR . 3.0 pt -127.73 147.95 32.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 109.381 -0.599 . . . . 0.0 109.381 -177.52 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.512 ' C ' ' HB3' ' A' ' 59' ' ' GLU . 16.3 p -96.92 -29.02 13.93 Favored 'General case' 0 N--CA 1.462 0.173 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -178.666 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.521 ' C ' HG12 ' A' ' 82' ' ' VAL . . . -165.3 -167.44 25.9 Favored Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 119.937 -1.125 . . . . 0.0 112.175 -178.567 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.688 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 5.3 m-85 -138.36 134.3 34.02 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 122.444 0.298 . . . . 0.0 111.341 174.225 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.6 mmm180 -103.91 149.76 24.81 Favored 'General case' 0 CA--C 1.504 -0.794 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 166.539 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.886 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 30.6 mt -139.09 108.58 3.89 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 C-N-CA 120.086 -0.646 . . . . 0.0 112.254 -179.339 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 78.8 t -109.44 110.33 31.69 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.432 0 CA-C-O 121.19 0.519 . . . . 0.0 110.797 -179.349 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.745 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 1.0 OUTLIER -113.57 126.34 55.18 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.783 176.647 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.9 m -137.4 141.88 35.43 Favored Pre-proline 0 C--N 1.319 -0.756 0 CA-C-N 114.203 -1.362 . . . . 0.0 111.98 -173.875 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.421 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 72.6 Cg_endo . . . . . 0 C--O 1.234 0.314 0 C-N-CA 123.581 2.854 . . . . 0.0 112.092 175.723 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 49.8 m . . . . . 0 CA--C 1.514 -0.413 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.745 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 26.1 m -146.56 148.08 31.79 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 119.834 -0.746 . . . . 0.0 111.763 -178.745 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.886 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 30.8 tt0 -120.19 113.74 20.88 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.921 175.201 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.715 HD12 ' CG2' ' A' ' 64' ' ' VAL . 19.9 mt -97.29 158.22 15.57 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.321 177.155 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -119.24 116.65 26.72 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 177.556 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.572 HD12 ' CH2' ' A' ' 30' ' ' TRP . 2.3 mt -114.11 156.23 44.41 Favored Pre-proline 0 C--N 1.317 -0.818 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -177.876 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -62.25 150.08 88.29 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 121.798 1.665 . . . . 0.0 111.644 176.321 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.512 ' HB3' ' C ' ' A' ' 38' ' ' THR . 9.4 pt-20 -45.49 -26.63 0.6 Allowed 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 114.573 -1.194 . . . . 0.0 113.102 176.572 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.2 t -109.32 16.02 22.68 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.333 0.587 . . . . 0.0 110.951 -175.731 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.509 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -75.59 162.91 27.87 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 177.765 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.501 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 30.4 p-10 -142.89 4.8 1.5 Allowed 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -176.5 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.622 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 59.4 p -167.31 133.96 2.26 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 119.861 -0.736 . . . . 0.0 111.928 -176.426 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.718 HG12 ' HZ3' ' A' ' 30' ' ' TRP . 3.5 p -115.54 137.68 48.36 Favored 'Isoleucine or valine' 0 C--O 1.243 0.761 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.47 176.596 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 24.2 m -93.74 101.46 13.58 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.547 168.124 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.701 HD11 HG12 ' A' ' 77' ' ' ILE . 0.2 OUTLIER -78.46 144.07 36.11 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 173.542 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.461 ' HA ' ' O ' ' A' ' 24' ' ' THR . 4.3 m -152.79 167.7 28.17 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -177.375 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 68.87 26.22 5.95 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 123.912 0.758 . . . . 0.0 110.394 -174.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.633 ' O ' HG22 ' A' ' 24' ' ' THR . 8.9 mt -72.97 -175.82 1.88 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.792 175.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -123.95 129.2 24.86 Favored Pre-proline 0 C--N 1.322 -0.611 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 174.588 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -62.54 133.96 45.33 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 123.204 2.603 . . . . 0.0 113.336 -177.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.54 34.88 24.27 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.897 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.414 HG11 ' HB3' ' A' ' 46' ' ' PRO . 58.7 t -134.94 138.95 48.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 120.999 0.428 . . . . 0.0 111.363 -176.84 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.421 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 4.6 tp-100 -75.07 108.88 8.09 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.971 177.466 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -101.63 113.57 26.83 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.311 0.577 . . . . 0.0 111.592 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.581 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 3.7 m-20 -86.91 110.12 19.79 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.437 175.59 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.701 HG12 HD11 ' A' ' 66' ' ' LEU . 5.3 mp -92.33 118.5 38.01 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.664 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.695 176.742 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.885 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 28.4 m -109.47 115.63 30.3 Favored 'General case' 0 N--CA 1.426 -1.675 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.397 179.55 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.577 ' HB ' ' HB ' ' A' ' 91' ' ' VAL . 13.3 mm -95.47 137.21 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 -179.637 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.449 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 74.2 m-85 -124.84 111.35 15.39 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 116.581 -0.282 . . . . 0.0 110.281 179.701 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.416 ' HB1' HG21 ' A' ' 37' ' ' ILE . . . -80.26 116.89 20.59 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 169.394 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.521 HG12 ' C ' ' A' ' 39' ' ' GLY . 7.7 p -109.12 133.34 54.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 C-N-CA 120.075 -0.65 . . . . 0.0 110.448 -176.457 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -112.98 170.15 8.41 Favored 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 123.258 0.349 . . . . 0.0 110.202 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -46.17 -40.66 11.49 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -175.789 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 24.2 p-10 -111.46 -21.03 12.0 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -171.178 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -142.6 175.97 9.39 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.372 -0.531 . . . . 0.0 111.653 -172.464 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -118.41 120.25 37.01 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.291 -0.868 . . . . 0.0 108.675 173.66 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 50.8 m -68.9 175.35 3.71 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.161 0.505 . . . . 0.0 112.067 -176.252 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.403 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 1.0 OUTLIER -60.16 152.33 62.74 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.17 179.352 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -88.63 142.78 5.05 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 C-N-CA 122.261 1.974 . . . . 0.0 114.084 -177.614 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.885 ' O ' ' HA ' ' A' ' 78' ' ' THR . 6.9 t -82.57 128.11 39.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 114.366 -1.288 . . . . 0.0 108.001 165.404 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.7 t -123.49 105.68 16.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 C-N-CA 119.746 -0.782 . . . . 0.0 110.004 172.226 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.556 HG13 ' HB ' ' A' ' 77' ' ' ILE . 6.5 pt -122.85 111.79 31.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.935 177.871 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 29.7 pt20 -95.92 117.51 30.75 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.533 0.683 . . . . 0.0 110.851 -177.144 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -125.58 127.51 46.47 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.155 176.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -87.15 135.05 33.44 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.147 0.499 . . . . 0.0 110.369 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 34.5 p -69.55 119.59 14.02 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.683 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 10.2 m . . . . . 0 C--N 1.324 -0.503 0 CA-C-O 121.437 0.637 . . . . 0.0 110.178 -179.059 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.698 ' HB2' ' O ' ' A' ' 89' ' ' THR . . . . . . . . 0 N--CA 1.452 -0.364 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.426 ' HB3' ' O ' ' A' ' 31' ' ' SER . 46.2 Cg_exo -58.49 135.68 69.25 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.381 2.054 . . . . 0.0 111.142 173.462 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.564 ' HD2' ' O ' ' A' ' 31' ' ' SER . 7.9 Cg_endo -53.39 147.09 38.48 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.072 1.848 . . . . 0.0 110.809 174.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -30.51 106.39 0.23 Allowed Pre-proline 0 N--CA 1.472 0.674 0 O-C-N 124.854 1.346 . . . . 0.0 113.267 -168.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.654 ' HG2' HG11 ' A' ' 91' ' ' VAL . 23.2 Cg_exo -70.25 147.22 59.27 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 123.192 2.595 . . . . 0.0 111.876 176.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 18.5 m -109.88 132.86 53.77 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.803 0.811 . . . . 0.0 110.953 -176.342 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.513 HG21 ' OE1' ' A' ' 95' ' ' GLN . 95.0 t -79.67 125.58 38.82 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-N 114.2 -1.363 . . . . 0.0 110.056 176.269 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -83.63 -52.51 6.39 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.067 -174.287 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -136.43 132.11 35.02 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.88 0.372 . . . . 0.0 110.505 -178.593 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.502 ' HA ' HG12 ' A' ' 26' ' ' ILE . 95.1 t -114.15 122.24 67.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.867 -178.365 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -124.14 -160.34 0.92 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.602 179.632 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.525 ' O ' ' HB2' ' A' ' 69' ' ' LEU . 1.8 p-10 -73.35 -77.03 0.11 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.129 178.788 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.652 HG22 ' O ' ' A' ' 69' ' ' LEU . 62.8 p -105.16 34.79 3.06 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.955 -174.762 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.675 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 75.3 m -168.12 131.01 1.53 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.042 -172.844 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.579 ' HB ' HD12 ' A' ' 66' ' ' LEU . 28.7 mt -149.2 148.28 15.84 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.89 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 177.519 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.447 ' O ' HG13 ' A' ' 18' ' ' VAL . 44.2 t -121.58 130.31 74.73 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.59 0 CA-C-N 119.367 0.985 . . . . 0.0 110.888 -176.329 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.622 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.6 OUTLIER -123.9 146.21 29.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 C-N-CA 120.3 -0.56 . . . . 0.0 109.965 -179.629 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.438 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 21.6 mtp180 -129.32 121.0 26.59 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 123.295 0.372 . . . . 0.0 110.602 -174.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.815 ' HZ3' HG12 ' A' ' 64' ' ' VAL . 40.5 p90 -115.05 146.4 41.32 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.641 -174.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.564 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 24.0 t -93.89 97.88 10.68 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.635 177.649 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.597 ' H ' ' CD ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -46.8 155.67 0.59 Allowed Pre-proline 0 CA--C 1.539 0.533 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -175.445 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.696 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 2.8 Cg_endo -84.5 166.08 12.2 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 124.628 3.552 . . . . 0.0 112.634 -174.299 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -76.54 -22.11 54.81 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.257 -0.883 . . . . 0.0 108.957 170.772 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -55.22 133.23 69.21 Favored Pre-proline 0 CA--C 1.517 -0.297 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.663 176.68 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -61.8 116.32 3.37 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 121.554 1.503 . . . . 0.0 110.148 168.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.572 HD12 ' HE1' ' A' ' 40' ' ' TYR . 1.0 OUTLIER -126.76 148.49 31.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -177.544 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.42 ' H ' ' HA ' ' A' ' 83' ' ' GLU . 19.0 p -98.07 -28.81 13.59 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -178.763 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.52 ' C ' HG12 ' A' ' 82' ' ' VAL . . . -162.83 -166.85 22.32 Favored Glycine 0 N--CA 1.443 -0.892 0 C-N-CA 120.347 -0.93 . . . . 0.0 111.766 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.696 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 5.9 m-85 -139.06 132.57 30.32 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 120.718 0.294 . . . . 0.0 110.932 173.183 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 10.4 mmm180 -102.51 149.91 23.91 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 167.534 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.878 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 34.0 mt -138.49 107.54 3.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 C-N-CA 120.022 -0.671 . . . . 0.0 111.925 -179.225 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.441 HG22 ' HB2' ' A' ' 54' ' ' GLU . 89.4 t -109.1 110.34 31.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.387 0.613 . . . . 0.0 110.551 -178.79 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.608 ' CE2' ' HB3' ' A' ' 66' ' ' LEU . 1.2 p90 -113.15 126.02 54.99 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.884 177.603 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 7.4 m -141.06 138.76 18.26 Favored Pre-proline 0 C--N 1.317 -0.827 0 CA-C-N 113.773 -1.558 . . . . 0.0 110.868 -175.152 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.477 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 59.5 Cg_endo . . . . . 0 C--O 1.232 0.196 0 C-N-CA 123.337 2.691 . . . . 0.0 111.749 175.208 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.0 m . . . . . 0 CA--C 1.516 -0.33 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.551 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 85.7 m -148.11 147.74 29.85 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.086 -0.645 . . . . 0.0 112.123 -178.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.878 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 30.3 tt0 -112.41 118.29 34.77 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.134 171.286 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.708 HD12 ' CG2' ' A' ' 64' ' ' VAL . 16.5 mt -97.42 160.54 14.26 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 173.209 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -124.77 113.95 18.62 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.728 -179.472 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.594 HD12 ' CH2' ' A' ' 30' ' ' TRP . 3.2 mt -112.96 157.99 39.07 Favored Pre-proline 0 C--N 1.317 -0.835 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -177.095 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -65.79 150.13 86.24 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 121.76 1.64 . . . . 0.0 111.413 174.807 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -44.44 -28.72 0.59 Allowed 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 114.887 -1.051 . . . . 0.0 112.859 176.345 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.8 t -105.29 14.44 28.92 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.251 0.548 . . . . 0.0 111.408 -174.789 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.437 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -80.02 158.79 26.43 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 176.207 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.531 ' HB3' ' NE ' ' A' ' 32' ' ' ARG . 31.0 p-10 -142.05 17.28 2.1 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 120.619 -0.432 . . . . 0.0 111.96 -177.718 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.622 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 19.2 p -171.35 134.01 0.86 Allowed 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.268 -0.573 . . . . 0.0 111.847 -179.549 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.815 HG12 ' HZ3' ' A' ' 30' ' ' TRP . 3.5 p -117.11 136.3 54.71 Favored 'Isoleucine or valine' 0 C--O 1.242 0.7 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.414 176.367 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 20.8 m -95.13 101.36 13.1 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.386 167.706 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.675 ' O ' ' HA ' ' A' ' 25' ' ' SER . 0.3 OUTLIER -78.14 144.55 36.33 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.9 -1.045 . . . . 0.0 109.555 178.646 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.461 ' O ' ' HB2' ' A' ' 68' ' ' ASP . 14.2 t -140.39 170.17 16.31 Favored 'General case' 0 C--N 1.319 -0.745 0 O-C-N 123.76 0.663 . . . . 0.0 109.271 -176.482 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.461 ' HB2' ' O ' ' A' ' 67' ' ' SER . 3.2 m-20 71.89 20.0 4.6 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 123.803 0.69 . . . . 0.0 112.021 -179.28 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.652 ' O ' HG22 ' A' ' 24' ' ' THR . 6.8 mt -72.79 -177.81 2.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.125 0.488 . . . . 0.0 110.412 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 7.8 tp60 -125.38 122.72 25.07 Favored Pre-proline 0 C--N 1.321 -0.663 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 175.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.61 126.09 15.5 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.698 2.265 . . . . 0.0 112.833 -178.09 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 95.98 28.78 9.04 Favored Glycine 0 N--CA 1.45 -0.414 0 CA-C-N 115.949 -0.568 . . . . 0.0 112.181 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 36.9 t -134.64 152.17 32.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.048 0.451 . . . . 0.0 110.961 -177.1 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.477 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 11.6 tp60 -87.84 107.99 18.94 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.663 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.469 ' O ' ' HA ' ' A' ' 94' ' ' GLN . 7.1 m-85 -100.79 130.44 46.81 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.145 0.498 . . . . 0.0 111.876 -179.263 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.52 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 13.9 m-80 -103.88 113.48 27.04 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.596 -1.184 . . . . 0.0 109.202 175.519 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.61 HG12 HD11 ' A' ' 66' ' ' LEU . 3.8 mp -95.07 120.27 44.26 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.814 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 176.717 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.937 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 25.6 m -109.03 113.46 26.34 Favored 'General case' 0 N--CA 1.424 -1.763 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.225 -179.12 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.54 ' HB ' ' HB ' ' A' ' 91' ' ' VAL . 12.9 mm -94.64 132.38 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -120.32 111.35 17.65 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.044 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.484 ' HB1' HG21 ' A' ' 37' ' ' ILE . . . -81.82 109.58 16.33 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 172.117 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.52 HG12 ' C ' ' A' ' 39' ' ' GLY . 7.2 p -104.66 143.09 16.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 C-N-CA 120.268 -0.573 . . . . 0.0 111.418 -172.069 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.557 ' HG2' ' N ' ' A' ' 84' ' ' GLU . 55.2 tt0 -121.11 168.17 11.85 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 170.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.557 ' N ' ' HG2' ' A' ' 83' ' ' GLU . 27.7 mt-10 -33.27 -50.97 0.32 Allowed 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -176.561 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 28.4 p-10 -111.96 -24.35 10.0 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -171.188 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -137.38 173.1 12.04 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.558 -170.61 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -121.36 152.05 39.43 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.968 178.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 9.8 m -80.51 179.61 7.65 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.62 175.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.698 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 0.6 OUTLIER -60.02 159.41 20.91 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 173.081 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -88.16 138.7 4.16 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 121.921 1.747 . . . . 0.0 113.365 179.298 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.937 ' O ' ' HA ' ' A' ' 78' ' ' THR . 13.3 t -83.18 123.38 38.61 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.671 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 165.222 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.0 t -121.09 106.48 18.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 C-N-CA 119.856 -0.738 . . . . 0.0 109.981 172.731 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.449 HG13 ' HB ' ' A' ' 77' ' ' ILE . 29.9 pt -121.63 117.63 53.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.976 179.033 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.469 ' HA ' ' O ' ' A' ' 75' ' ' TYR . 4.0 pt20 -108.1 128.67 54.89 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.159 0.504 . . . . 0.0 111.618 -175.422 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.545 ' OE1' HG21 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -136.74 153.03 50.97 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.772 171.927 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -97.31 126.14 42.35 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -179.282 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.436 HG22 HD11 ' A' ' 26' ' ' ILE . 20.1 p -61.12 112.73 2.22 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.417 0.627 . . . . 0.0 111.26 -176.925 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 11.0 m . . . . . 0 C--N 1.321 -0.633 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.864 -176.42 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.496 ' HB2' ' O ' ' A' ' 89' ' ' THR . . . . . . . . 0 N--CA 1.452 -0.327 0 N-CA-C 110.132 -0.322 . . . . 0.0 110.132 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.41 ' HB2' ' HB2' ' A' ' 30' ' ' TRP . 19.9 Cg_exo -67.64 131.43 24.4 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.338 2.026 . . . . 0.0 111.415 175.883 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.429 ' HD2' ' O ' ' A' ' 31' ' ' SER . 74.6 Cg_exo -50.2 151.78 8.88 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.751 2.301 . . . . 0.0 111.214 172.454 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -36.83 106.37 0.33 Allowed Pre-proline 0 N--CA 1.472 0.658 0 O-C-N 124.443 1.089 . . . . 0.0 112.411 -171.176 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.587 ' HG2' HG11 ' A' ' 91' ' ' VAL . 37.8 Cg_exo -65.78 149.79 86.54 Favored 'Trans proline' 0 CA--C 1.517 -0.326 0 C-N-CA 123.141 2.561 . . . . 0.0 112.129 177.639 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 27.4 m -106.38 130.1 54.26 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.585 -178.701 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.515 HG22 HG12 ' A' ' 28' ' ' VAL . 53.8 t -71.62 121.88 22.67 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-N 114.227 -1.351 . . . . 0.0 110.12 175.072 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -83.78 -46.26 12.42 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.258 -173.466 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -135.63 137.99 42.44 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.894 -178.425 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.499 HG22 HG11 ' A' ' 18' ' ' VAL . 23.7 t -123.26 121.37 62.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.892 -178.175 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -131.57 -163.05 1.28 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.443 176.687 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -72.88 -68.9 0.45 Allowed 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.311 0.485 . . . . 0.0 112.311 -178.67 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.555 HG22 ' O ' ' A' ' 69' ' ' LEU . 38.1 p -110.12 28.84 8.21 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.377 0.608 . . . . 0.0 110.87 -171.407 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.559 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 12.0 p -169.95 134.65 1.32 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.069 -175.477 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.546 ' HB ' HD12 ' A' ' 66' ' ' LEU . 29.0 mt -146.16 155.98 12.27 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.207 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 54.4 t -121.48 140.21 46.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 119.859 1.209 . . . . 0.0 110.253 -177.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.57 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.8 OUTLIER -130.81 149.24 33.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 119.867 -0.733 . . . . 0.0 110.676 176.741 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.505 ' HG2' ' HB3' ' A' ' 63' ' ' SER . 60.8 mtp180 -132.1 120.61 22.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.265 -176.212 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.785 ' HZ3' HG12 ' A' ' 64' ' ' VAL . 32.6 p90 -112.04 144.23 41.74 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.905 -173.512 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.429 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 21.4 m -85.04 86.55 7.37 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.697 174.535 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.582 ' HD3' ' H ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -52.03 152.87 5.15 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.035 -0.984 . . . . 0.0 112.231 -174.513 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.648 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 4.3 Cg_exo -78.13 160.69 29.78 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 123.615 2.877 . . . . 0.0 113.029 -172.229 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -79.29 -14.8 58.78 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.16 -0.927 . . . . 0.0 108.763 170.581 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.44 145.28 59.65 Favored Pre-proline 0 CA--C 1.517 -0.292 0 CA-C-N 114.879 -1.055 . . . . 0.0 111.441 175.19 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -67.45 115.77 3.87 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 121.463 1.442 . . . . 0.0 109.951 170.457 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.65 HD12 ' HE1' ' A' ' 40' ' ' TYR . 1.4 pt -128.18 146.76 33.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.513 ' C ' ' HB3' ' A' ' 59' ' ' GLU . 26.9 p -93.69 -28.86 15.72 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -178.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.557 ' C ' HG12 ' A' ' 82' ' ' VAL . . . -168.44 -164.04 23.45 Favored Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 120.338 -0.934 . . . . 0.0 111.532 -178.88 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.65 ' HE1' HD12 ' A' ' 37' ' ' ILE . 5.2 m-85 -140.3 133.98 30.32 Favored 'General case' 0 CA--C 1.513 -0.481 0 CA-C-N 116.929 0.364 . . . . 0.0 111.243 175.202 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.8 mmm180 -106.03 148.35 27.84 Favored 'General case' 0 CA--C 1.505 -0.757 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 167.088 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.881 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 28.8 mt -138.03 108.55 5.13 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 C-N-CA 120.006 -0.678 . . . . 0.0 112.489 -177.461 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 76.6 t -110.84 111.08 34.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.019 0.438 . . . . 0.0 110.717 -178.244 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.752 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 1.3 p90 -116.81 126.85 53.68 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.602 0.715 . . . . 0.0 110.474 178.453 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.416 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 25.1 p -149.81 143.93 17.21 Favored Pre-proline 0 C--N 1.319 -0.739 0 CA-C-N 113.698 -1.592 . . . . 0.0 111.183 -175.171 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.593 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 32.4 Cg_exo . . . . . 0 C--N 1.346 0.412 0 C-N-CA 123.128 2.552 . . . . 0.0 111.808 176.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.8 m . . . . . 0 CA--C 1.517 -0.317 0 N-CA-C 110.272 -0.27 . . . . 0.0 110.272 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.752 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 14.6 m -139.56 145.12 38.24 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.548 -0.461 . . . . 0.0 111.376 -177.724 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.881 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 74.3 tt0 -118.26 124.48 47.95 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 116.042 -0.527 . . . . 0.0 109.615 174.484 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.67 HD12 ' CG2' ' A' ' 64' ' ' VAL . 13.5 mt -106.42 156.79 18.17 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.153 173.856 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -119.29 115.58 24.46 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.577 178.71 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.58 HD12 ' CH2' ' A' ' 30' ' ' TRP . 3.5 mt -114.26 158.72 38.94 Favored Pre-proline 0 C--N 1.321 -0.636 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -177.789 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -69.15 150.0 71.43 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 121.599 1.532 . . . . 0.0 111.226 174.359 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.513 ' HB3' ' C ' ' A' ' 38' ' ' THR . 10.1 pt-20 -46.48 -25.1 0.61 Allowed 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 114.859 -1.064 . . . . 0.0 113.099 177.891 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 10.0 t -104.63 15.04 28.79 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.236 -174.77 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -84.69 162.32 19.73 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 178.27 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.469 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 27.8 p-10 -142.02 10.42 1.96 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -176.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.57 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 23.0 p -167.42 136.94 2.76 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.77 -177.315 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.785 HG12 ' HZ3' ' A' ' 30' ' ' TRP . 2.8 p -120.64 137.49 54.22 Favored 'Isoleucine or valine' 0 C--O 1.247 0.96 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.801 177.792 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 42.3 m -90.57 100.94 13.69 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.22 166.799 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.58 ' HB3' ' CE2' ' A' ' 44' ' ' TYR . 0.5 OUTLIER -76.41 133.52 39.86 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.475 179.352 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 10.7 p -128.37 160.09 33.32 Favored 'General case' 0 N--CA 1.447 -0.583 0 O-C-N 123.878 0.736 . . . . 0.0 110.521 -174.211 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 65.13 52.03 1.56 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.202 -178.061 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.555 ' O ' HG22 ' A' ' 24' ' ' THR . 6.6 mt -95.1 -175.75 3.62 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 172.401 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 18.6 mm-40 -127.45 132.77 24.49 Favored Pre-proline 0 C--N 1.321 -0.638 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 175.769 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -65.57 133.39 34.24 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.879 2.386 . . . . 0.0 112.878 -179.426 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 77.84 28.99 55.77 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.993 -0.622 . . . . 0.0 111.93 179.523 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 97.5 t -132.01 141.55 45.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.998 0.428 . . . . 0.0 110.398 -178.099 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.593 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 1.5 tp-100 -84.61 111.76 19.83 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.183 -175.769 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.405 ' CZ ' ' HG3' ' A' ' 46' ' ' PRO . 11.5 m-85 -103.01 127.58 50.2 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.303 0.573 . . . . 0.0 112.011 -176.805 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.584 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 18.0 m-80 -95.72 111.14 23.16 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.278 176.194 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.616 ' HB ' HG13 ' A' ' 93' ' ' ILE . 5.0 mp -92.44 118.09 37.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 176.518 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.891 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 28.4 m -108.75 113.83 27.12 Favored 'General case' 0 N--CA 1.426 -1.629 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.176 -179.6 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.58 ' HB ' ' HB ' ' A' ' 91' ' ' VAL . 13.9 mm -95.12 133.5 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -179.688 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -121.42 111.89 17.86 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.372 179.589 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.473 ' HB1' HG21 ' A' ' 37' ' ' ILE . . . -81.28 109.17 15.54 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 171.475 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.557 HG12 ' C ' ' A' ' 39' ' ' GLY . 7.4 p -101.09 137.69 27.82 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.604 0 C-N-CA 120.095 -0.642 . . . . 0.0 111.32 -172.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 11.5 tm-20 -117.05 167.41 11.17 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 179.57 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -46.27 -41.01 12.47 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -174.643 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 46.3 t-20 -109.38 -32.42 7.17 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -172.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 22.8 pt20 -133.81 176.97 8.09 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.098 -165.816 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -130.91 135.32 47.57 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 176.678 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 16.3 m -65.83 170.42 5.39 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.805 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.496 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 1.2 p -54.62 153.66 10.31 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.141 173.434 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -85.93 142.04 7.55 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 121.753 1.635 . . . . 0.0 113.724 -176.103 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.891 ' O ' ' HA ' ' A' ' 78' ' ' THR . 4.8 t -82.27 123.89 38.69 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.833 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 167.032 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.7 t -120.39 106.04 18.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 C-N-CA 119.862 -0.735 . . . . 0.0 109.961 172.623 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.616 HG13 ' HB ' ' A' ' 77' ' ' ILE . 7.8 pt -121.02 113.03 38.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.995 176.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -99.56 117.66 34.43 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.408 0.623 . . . . 0.0 110.977 -176.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 3.3 tm0? -131.31 130.63 43.01 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.476 ' HA ' ' HA ' ' A' ' 74' ' ' GLN . 40.4 tt0 -89.23 128.8 35.86 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.338 0.59 . . . . 0.0 111.021 -177.847 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.452 HG22 HD11 ' A' ' 26' ' ' ILE . 32.8 p -59.19 126.05 26.12 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.148 -178.349 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 10.9 m . . . . . 0 C--N 1.325 -0.468 0 CA-C-O 121.472 0.653 . . . . 0.0 109.875 179.363 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.423 ' HB2' ' O ' ' A' ' 89' ' ' THR . . . . . . . . 0 C--O 1.234 0.25 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.429 ' HB2' ' HB2' ' A' ' 30' ' ' TRP . 19.3 Cg_exo -69.47 128.89 16.96 Favored 'Trans proline' 0 C--O 1.235 0.367 0 C-N-CA 122.27 1.98 . . . . 0.0 111.472 174.628 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.42 ' HD2' ' O ' ' A' ' 31' ' ' SER . 52.3 Cg_exo -52.45 142.12 49.18 Favored 'Trans proline' 0 CA--C 1.509 -0.736 0 C-N-CA 122.306 2.004 . . . . 0.0 110.806 173.316 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.506 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 2.4 m-20 -35.79 103.16 0.24 Allowed Pre-proline 0 N--CA 1.465 0.291 0 O-C-N 125.069 1.48 . . . . 0.0 112.674 -164.373 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.752 ' CG ' HG11 ' A' ' 91' ' ' VAL . 5.2 Cg_endo -49.7 145.72 17.03 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 123.584 2.856 . . . . 0.0 113.134 169.777 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.6 m -101.51 131.83 47.46 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.354 179.506 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.533 HG22 HG12 ' A' ' 28' ' ' VAL . 70.9 t -73.98 112.1 10.26 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 CA-C-N 114.835 -1.075 . . . . 0.0 109.284 172.572 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -86.51 -36.62 18.88 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.666 -172.736 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -135.03 140.83 45.92 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.973 -176.453 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.418 ' HA ' HG12 ' A' ' 26' ' ' ILE . 47.5 t -133.81 139.94 47.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.492 -179.22 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.435 ' CG ' ' H ' ' A' ' 23' ' ' ASP . 12.4 t70 -146.69 -157.69 0.83 Allowed 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -179.655 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.458 ' HB3' ' HB3' ' A' ' 71' ' ' PRO . 7.0 m-20 -79.5 -70.91 0.48 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.425 0.631 . . . . 0.0 109.935 178.14 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.58 HG22 ' O ' ' A' ' 69' ' ' LEU . 69.7 p -104.71 34.96 2.93 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.775 -174.757 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.521 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 29.9 m -167.83 137.52 2.65 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 123.139 0.576 . . . . 0.0 110.062 -172.321 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.579 ' HB ' HD12 ' A' ' 66' ' ' LEU . 29.2 mt -153.17 149.76 13.07 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.117 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 177.553 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.446 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 47.3 t -122.37 137.0 57.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 119.517 1.053 . . . . 0.0 110.186 -176.385 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.56 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.8 OUTLIER -130.19 149.83 33.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 C-N-CA 120.129 -0.629 . . . . 0.0 110.383 179.341 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.453 ' HG2' ' HB3' ' A' ' 63' ' ' SER . 55.1 mtp180 -134.31 120.44 19.92 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.392 -175.142 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.749 ' HZ3' HG12 ' A' ' 64' ' ' VAL . 36.9 p90 -112.56 146.8 37.89 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.742 -173.039 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.42 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 35.5 t -89.24 91.96 8.98 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 173.306 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.508 ' HD3' ' H ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -50.94 153.37 3.07 Favored Pre-proline 0 CA--C 1.54 0.584 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.785 -176.129 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.653 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 5.1 Cg_exo -78.07 162.52 28.85 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 123.879 3.053 . . . . 0.0 112.592 -174.527 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -83.25 -7.74 59.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.405 172.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.33 150.94 70.64 Favored Pre-proline 0 CA--C 1.518 -0.262 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.737 175.236 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.581 ' O ' ' HG3' ' A' ' 83' ' ' GLU . 12.2 Cg_exo -69.77 114.46 3.71 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 121.128 1.219 . . . . 0.0 109.559 169.439 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.583 HD12 ' HE1' ' A' ' 40' ' ' TYR . 2.0 pt -128.85 142.59 43.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.454 ' N ' ' O ' ' A' ' 82' ' ' VAL . 12.6 p -92.2 -31.42 15.46 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -178.835 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.558 ' C ' HG12 ' A' ' 82' ' ' VAL . . . -163.41 -163.95 17.36 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.12 -1.038 . . . . 0.0 111.919 -177.911 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.653 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 5.4 m-85 -141.05 133.31 28.12 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.785 0.326 . . . . 0.0 111.323 175.419 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.41 ' C ' HG13 ' A' ' 42' ' ' ILE . 10.1 mmm180 -103.7 149.61 24.81 Favored 'General case' 0 CA--C 1.503 -0.832 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 167.128 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.866 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 32.0 mt -138.7 107.08 3.51 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 C-N-CA 119.734 -0.787 . . . . 0.0 112.318 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.418 HG22 ' HB2' ' A' ' 54' ' ' GLU . 74.1 t -108.88 110.18 31.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.19 0.519 . . . . 0.0 110.646 -178.648 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.778 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 0.5 OUTLIER -110.34 124.9 52.53 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.552 176.019 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 35.6 t -137.34 135.41 19.42 Favored Pre-proline 0 C--N 1.318 -0.8 0 CA-C-N 113.926 -1.488 . . . . 0.0 111.33 -173.737 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.672 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 50.7 Cg_endo . . . . . 0 CA--C 1.527 0.156 0 C-N-CA 123.472 2.781 . . . . 0.0 112.005 175.557 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.3 p . . . . . 0 C--O 1.233 0.236 0 N-CA-C 110.232 -0.285 . . . . 0.0 110.232 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.778 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 24.4 m -142.78 147.8 36.11 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.457 -0.497 . . . . 0.0 111.557 -174.588 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.866 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 21.8 tt0 -116.44 122.34 44.49 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.148 172.903 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.658 HD12 ' CG2' ' A' ' 64' ' ' VAL . 12.8 mt -99.8 160.54 14.23 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.613 -0.435 . . . . 0.0 109.882 172.153 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -122.54 117.66 26.43 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.107 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.597 HD12 ' CH2' ' A' ' 30' ' ' TRP . 3.9 mt -116.02 158.2 43.09 Favored Pre-proline 0 C--N 1.318 -0.796 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -177.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -70.71 152.17 64.18 Favored 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 121.298 1.332 . . . . 0.0 111.124 173.581 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.487 ' HB2' HG13 ' A' ' 37' ' ' ILE . 8.1 pt-20 -43.62 -39.65 3.65 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.548 0.69 . . . . 0.0 111.796 175.859 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.454 ' N ' ' HG3' ' A' ' 59' ' ' GLU . 9.7 t -88.24 19.07 3.92 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.467 -174.119 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -91.79 164.38 13.72 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 175.281 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.45 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 30.3 p-10 -149.28 16.08 0.92 Allowed 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -178.243 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.56 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 17.3 p -170.13 134.17 1.21 Allowed 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.446 -0.502 . . . . 0.0 112.017 -179.575 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.749 HG12 ' HZ3' ' A' ' 30' ' ' TRP . 3.2 p -119.52 137.68 52.63 Favored 'Isoleucine or valine' 0 C--O 1.244 0.772 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.347 177.751 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 42.2 m -94.71 101.49 13.33 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-O 121.573 0.701 . . . . 0.0 109.332 167.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.624 HD11 HG12 ' A' ' 77' ' ' ILE . 0.2 OUTLIER -76.59 139.49 40.68 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.362 178.533 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 14.2 t -134.88 171.04 14.95 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -176.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 64.89 35.19 8.58 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 123.786 0.679 . . . . 0.0 110.795 -179.432 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.58 ' O ' HG22 ' A' ' 24' ' ' THR . 7.5 mt -85.08 -176.96 6.41 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 174.831 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 19.6 mm-40 -123.37 132.5 24.28 Favored Pre-proline 0 C--N 1.318 -0.782 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 173.762 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.458 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . 37.2 Cg_endo -66.74 128.01 18.15 Favored 'Trans proline' 0 C--O 1.234 0.311 0 C-N-CA 122.722 2.281 . . . . 0.0 112.517 179.47 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 83.49 33.8 21.44 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.991 -0.623 . . . . 0.0 111.851 -179.169 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 72.1 t -134.84 140.79 44.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.085 0.469 . . . . 0.0 111.047 -176.671 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.672 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -79.34 118.41 21.23 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.233 -178.481 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -114.32 121.4 43.52 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.095 0.474 . . . . 0.0 112.143 -177.69 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.574 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 3.7 m-20 -88.47 113.38 24.0 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.418 170.669 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.624 HG12 HD11 ' A' ' 66' ' ' LEU . 4.9 mp -92.2 115.47 31.24 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.661 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 173.802 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.895 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 19.4 m -107.24 113.31 26.64 Favored 'General case' 0 N--CA 1.427 -1.615 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.421 -178.516 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.574 ' H ' ' HB ' ' A' ' 91' ' ' VAL . 11.3 mm -94.78 136.09 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.022 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.418 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 80.7 m-85 -122.35 110.94 16.28 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.92 179.104 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.481 ' HB1' HG21 ' A' ' 37' ' ' ILE . . . -80.14 107.62 13.07 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 171.001 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.558 HG12 ' C ' ' A' ' 39' ' ' GLY . 7.3 p -99.96 137.61 26.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 C-N-CA 119.854 -0.738 . . . . 0.0 110.572 -173.464 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.644 ' HG2' ' N ' ' A' ' 84' ' ' GLU . 2.1 tt0 -111.85 166.8 10.89 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 124.014 0.821 . . . . 0.0 109.597 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.644 ' N ' ' HG2' ' A' ' 83' ' ' GLU . 34.3 mt-10 -41.23 -53.06 3.27 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 123.008 0.523 . . . . 0.0 111.955 177.107 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -124.53 8.26 8.33 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -173.687 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -140.41 174.22 10.73 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.025 0.441 . . . . 0.0 111.56 -176.305 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -136.8 122.26 19.52 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 172.573 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 32.6 m -64.72 168.69 5.82 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.712 0.292 . . . . 0.0 110.951 178.579 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.423 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 1.1 p -56.09 151.71 24.74 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.768 176.195 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -82.92 136.28 8.06 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 121.985 1.79 . . . . 0.0 113.139 -178.246 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.895 ' O ' ' HA ' ' A' ' 78' ' ' THR . 54.0 t -82.77 119.03 31.5 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.755 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 169.764 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.8 t -116.77 105.24 17.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 C-N-CA 119.249 -0.98 . . . . 0.0 109.965 173.477 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.59 HG13 ' HB ' ' A' ' 77' ' ' ILE . 7.4 pt -118.1 111.59 34.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.438 176.65 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -101.15 127.69 47.59 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.518 0.675 . . . . 0.0 111.04 -174.465 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 14.4 tm0? -140.34 134.56 31.09 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.296 -0.866 . . . . 0.0 108.82 -179.224 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.597 ' HG2' ' HG2' ' A' ' 74' ' ' GLN . 47.0 mt-10 -86.61 126.56 34.59 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 120.81 0.338 . . . . 0.0 110.765 178.77 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.468 HG22 HD11 ' A' ' 26' ' ' ILE . 35.0 p -56.23 119.59 6.21 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.32 179.721 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 25.6 m . . . . . 0 CA--C 1.512 -0.506 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.591 -178.391 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.46 ' HB2' ' O ' ' A' ' 89' ' ' THR . . . . . . . . 0 N--CA 1.45 -0.44 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.458 ' HB2' ' HB2' ' A' ' 30' ' ' TRP . 17.4 Cg_exo -70.47 126.99 13.43 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 121.926 1.751 . . . . 0.0 111.062 172.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.709 ' HD2' ' O ' ' A' ' 31' ' ' SER . 95.4 Cg_exo -45.54 147.46 2.78 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.931 2.421 . . . . 0.0 111.858 172.504 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.43 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 29.8 t70 -32.74 105.36 0.24 Allowed Pre-proline 0 N--CA 1.468 0.456 0 O-C-N 125.016 1.448 . . . . 0.0 112.842 -170.759 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.659 ' HG2' HG11 ' A' ' 91' ' ' VAL . 20.8 Cg_exo -72.24 151.39 54.6 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 123.803 3.002 . . . . 0.0 112.113 177.864 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 24.0 m -119.68 135.06 54.98 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 121.72 0.771 . . . . 0.0 111.11 -176.644 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.48 HG22 HG12 ' A' ' 28' ' ' VAL . 71.9 t -77.64 125.41 37.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-N 114.16 -1.382 . . . . 0.0 109.864 174.59 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -88.05 -47.29 8.63 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.208 -174.451 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -136.88 145.83 44.82 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 120.978 0.418 . . . . 0.0 110.854 179.226 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 26.3 m -130.94 139.9 49.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.461 -179.026 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.411 ' HB3' ' H ' ' A' ' 23' ' ' ASP . 29.2 m-20 -135.34 -153.5 0.52 Allowed 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 175.374 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.448 ' CB ' ' HB3' ' A' ' 71' ' ' PRO . 5.5 m-20 -76.3 -73.47 0.27 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.546 0.689 . . . . 0.0 110.497 178.892 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.684 HG22 ' O ' ' A' ' 69' ' ' LEU . 35.0 p -102.07 37.01 1.95 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.698 -174.767 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.689 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 55.3 p -169.55 134.08 1.39 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.14 -173.776 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.627 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 13.3 mt -150.6 142.08 16.71 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.819 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.522 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.441 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 38.6 t -115.96 129.02 73.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 119.184 0.902 . . . . 0.0 110.906 -176.204 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.624 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.7 OUTLIER -123.27 145.71 29.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -177.742 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.445 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 59.5 mtp180 -131.78 122.4 25.74 Favored 'General case' 0 C--N 1.329 -0.298 0 O-C-N 123.254 0.346 . . . . 0.0 110.706 -174.609 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.72 ' HZ3' HG12 ' A' ' 64' ' ' VAL . 34.5 p90 -114.36 148.42 37.65 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.674 -0.694 . . . . 0.0 112.004 -174.265 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.709 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 24.1 t -92.69 86.47 5.56 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.612 177.119 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.564 ' HD3' ' H ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -43.08 150.96 0.43 Allowed Pre-proline 0 CA--C 1.548 0.869 0 C-N-CA 124.011 0.924 . . . . 0.0 113.39 -176.043 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.746 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 6.3 Cg_exo -78.46 167.79 22.34 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 124.473 3.448 . . . . 0.0 114.9 -164.394 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -68.35 -28.62 67.29 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 114.308 -1.314 . . . . 0.0 109.642 170.737 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -61.87 137.43 95.32 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 114.99 -1.005 . . . . 0.0 111.403 -179.65 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_exo -70.66 115.03 4.04 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 121.394 1.396 . . . . 0.0 109.366 167.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.609 HG22 ' HG3' ' A' ' 83' ' ' GLU . 0.4 OUTLIER -118.64 159.35 19.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -174.745 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.404 ' N ' ' O ' ' A' ' 82' ' ' VAL . 16.7 p -101.47 -27.62 13.03 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -178.452 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -168.04 -168.9 30.83 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 119.879 -1.153 . . . . 0.0 112.365 177.633 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.746 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 5.0 m-85 -137.5 134.46 35.76 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 121.076 0.465 . . . . 0.0 111.438 177.835 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.8 mtm180 -112.95 147.54 36.9 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.103 170.168 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.894 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 27.1 mt -137.98 109.76 6.2 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 C-N-CA 119.886 -0.726 . . . . 0.0 112.841 -173.281 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 97.5 t -110.81 111.16 34.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.086 0.469 . . . . 0.0 110.941 -178.627 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.829 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 0.9 OUTLIER -115.69 126.65 54.39 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.267 177.366 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.6 p -136.67 138.25 25.88 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-N 113.922 -1.49 . . . . 0.0 111.889 -174.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo . . . . . 0 C--N 1.343 0.241 0 C-N-CA 123.611 2.874 . . . . 0.0 111.604 176.043 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 28.8 p . . . . . 0 CA--C 1.513 -0.457 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.829 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 12.4 m -140.01 148.72 42.28 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 119.535 -0.866 . . . . 0.0 111.595 -179.723 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.894 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 37.5 tt0 -122.68 112.15 17.6 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.557 177.269 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.663 HD12 ' CG2' ' A' ' 64' ' ' VAL . 11.7 mt -99.56 164.27 12.15 Favored 'General case' 0 CA--C 1.511 -0.531 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.633 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.417 ' O ' HD23 ' A' ' 57' ' ' LEU . 18.6 t-20 -126.27 118.86 25.99 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.586 179.475 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.638 HD12 ' CH2' ' A' ' 30' ' ' TRP . 5.3 mt -119.02 159.12 46.11 Favored Pre-proline 0 C--N 1.318 -0.801 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 -178.02 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -65.13 153.44 78.26 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 121.717 1.612 . . . . 0.0 111.258 174.701 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -49.98 -26.7 4.49 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.074 176.528 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 10.2 t -101.23 13.63 34.5 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.053 -175.589 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.514 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -80.34 161.53 24.99 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 178.274 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.445 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 27.7 p-10 -147.73 16.54 1.12 Allowed 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -178.16 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.624 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 19.7 p -171.49 134.42 0.86 Allowed 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.23 -0.588 . . . . 0.0 111.645 179.774 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.72 HG12 ' HZ3' ' A' ' 30' ' ' TRP . 3.1 p -118.83 137.36 53.06 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.399 176.548 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 52.1 m -95.71 100.82 12.49 Favored 'General case' 0 N--CA 1.433 -1.301 0 CA-C-O 121.573 0.701 . . . . 0.0 109.18 169.035 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.725 ' HB3' ' CE2' ' A' ' 44' ' ' TYR . 0.3 OUTLIER -74.9 141.33 44.14 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.173 178.439 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.438 ' HA ' ' O ' ' A' ' 24' ' ' THR . 9.7 t -136.07 168.97 18.36 Favored 'General case' 0 N--CA 1.444 -0.75 0 O-C-N 123.605 0.566 . . . . 0.0 109.762 -178.126 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 62.92 34.34 14.25 Favored 'General case' 0 CA--C 1.519 -0.234 0 O-C-N 123.787 0.679 . . . . 0.0 111.252 -178.191 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.684 ' O ' HG22 ' A' ' 24' ' ' THR . 9.4 mt -79.62 -177.21 5.73 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 174.108 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 55.7 tp60 -123.33 125.01 26.24 Favored Pre-proline 0 C--N 1.314 -0.947 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 175.597 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.448 ' HB3' ' CB ' ' A' ' 23' ' ' ASP . 39.4 Cg_endo -65.28 133.97 37.21 Favored 'Trans proline' 0 CA--C 1.53 0.316 0 C-N-CA 123.019 2.48 . . . . 0.0 113.12 -175.632 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 82.48 35.49 19.83 Favored Glycine 0 N--CA 1.45 -0.386 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.901 -179.364 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 45.4 t -137.4 149.91 25.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.0 0.428 . . . . 0.0 111.026 -175.633 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 8.9 tp60 -87.98 111.34 21.38 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.433 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -102.01 123.34 45.72 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.878 -177.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.545 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 74.9 m-20 -93.5 107.6 19.42 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.151 175.937 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.641 HG12 HD11 ' A' ' 66' ' ' LEU . 5.2 mp -92.69 118.67 38.81 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.596 0 CA-C-O 121.229 0.538 . . . . 0.0 109.717 176.89 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.844 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 30.0 m -110.16 116.19 31.08 Favored 'General case' 0 N--CA 1.428 -1.553 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.331 179.618 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.539 ' HB ' ' HB ' ' A' ' 91' ' ' VAL . 12.4 mm -95.5 130.79 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -117.53 112.14 20.2 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 177.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.417 ' HB1' HG21 ' A' ' 37' ' ' ILE . . . -82.69 127.61 33.56 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 169.588 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.404 ' O ' ' N ' ' A' ' 38' ' ' THR . 6.5 p -117.59 135.88 56.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 C-N-CA 120.194 -0.603 . . . . 0.0 110.804 -177.265 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.609 ' HG3' HG22 ' A' ' 37' ' ' ILE . 2.4 mp0 -113.37 170.17 8.43 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.403 ' HG3' ' H ' ' A' ' 84' ' ' GLU . 40.6 mt-10 -38.65 -52.65 1.65 Allowed 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -174.102 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -131.09 17.31 5.05 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.943 -0.303 . . . . 0.0 110.814 -176.15 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 18.1 mm-40 -142.19 173.5 11.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.795 0.331 . . . . 0.0 110.915 -176.434 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -135.81 125.58 25.58 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 175.071 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.4 ' HB2' ' HB3' ' A' ' 81' ' ' ALA . 47.6 m -73.1 170.5 14.77 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.734 0.302 . . . . 0.0 111.079 178.923 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.46 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 2.8 p -62.58 153.03 79.37 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 120.973 0.416 . . . . 0.0 111.096 178.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -86.03 140.92 6.97 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.516 2.144 . . . . 0.0 114.387 -177.169 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.844 ' O ' ' HA ' ' A' ' 78' ' ' THR . 21.0 t -82.33 127.4 39.67 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.624 0 CA-C-N 114.83 -1.077 . . . . 0.0 108.575 167.132 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 11.7 t -121.84 106.9 18.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 C-N-CA 119.935 -0.706 . . . . 0.0 109.884 170.776 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.579 HG13 ' HB ' ' A' ' 77' ' ' ILE . 8.6 pt -122.58 116.79 49.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.166 178.342 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -100.03 124.96 45.98 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.601 0.715 . . . . 0.0 110.953 -177.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -134.67 134.25 40.93 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.311 178.789 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -84.89 137.05 33.37 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.965 0.412 . . . . 0.0 110.037 178.282 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 25.5 p -71.13 113.0 7.73 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.778 176.13 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 33.1 m . . . . . 0 C--N 1.32 -0.706 0 CA-C-O 121.837 0.827 . . . . 0.0 109.638 -179.351 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.214 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -68.28 130.91 22.18 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.507 2.138 . . . . 0.0 112.252 177.306 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.401 ' HD2' ' O ' ' A' ' 31' ' ' SER . 74.0 Cg_exo -50.87 151.26 11.52 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.81 2.34 . . . . 0.0 111.572 172.899 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -38.88 106.13 0.37 Allowed Pre-proline 0 N--CA 1.47 0.573 0 O-C-N 124.493 1.121 . . . . 0.0 112.251 -170.552 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.603 ' HG2' HG11 ' A' ' 91' ' ' VAL . 34.3 Cg_exo -64.59 149.68 89.46 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 123.504 2.803 . . . . 0.0 112.691 179.594 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 28.0 m -105.24 129.39 53.62 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.988 -1.006 . . . . 0.0 110.71 -177.423 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.452 ' HA ' ' HA ' ' A' ' 28' ' ' VAL . 70.6 t -81.02 123.31 37.49 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 CA-C-N 114.522 -1.217 . . . . 0.0 110.049 175.639 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -89.39 -37.39 14.88 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.435 -174.756 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -135.05 134.75 40.7 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.851 0.358 . . . . 0.0 110.601 -177.898 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.504 ' HA ' HG12 ' A' ' 26' ' ' ILE . 59.2 t -130.0 117.93 42.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.334 179.184 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.415 ' HB3' ' H ' ' A' ' 23' ' ' ASP . 8.8 m-20 -128.21 -160.76 1.04 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.84 175.405 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.56 ' O ' ' HB2' ' A' ' 69' ' ' LEU . 1.9 m-20 -77.19 -58.4 3.3 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.043 0.449 . . . . 0.0 110.91 -177.718 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.646 HG22 ' O ' ' A' ' 69' ' ' LEU . 34.9 p -113.11 34.42 4.47 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.131 -175.458 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.637 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 75.8 p -169.88 130.94 1.03 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.626 -176.583 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.592 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 43.4 mt -147.17 139.51 18.98 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.624 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 176.841 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.445 ' O ' HG13 ' A' ' 18' ' ' VAL . 39.9 t -118.17 130.13 73.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 118.697 0.681 . . . . 0.0 110.586 -175.702 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.675 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.6 OUTLIER -122.81 145.87 28.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 C-N-CA 120.496 -0.482 . . . . 0.0 110.009 -177.368 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.556 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 29.8 mtm180 -130.81 121.11 24.75 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 123.358 0.411 . . . . 0.0 110.68 -175.946 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.746 ' HZ3' HG12 ' A' ' 64' ' ' VAL . 38.2 p90 -110.26 144.23 39.27 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.608 -173.994 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.401 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 17.6 m -89.31 96.8 10.86 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.027 177.167 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.596 ' NE ' ' HB3' ' A' ' 62' ' ' ASN . 0.1 OUTLIER -45.73 155.85 0.46 Allowed Pre-proline 0 CA--C 1.538 0.515 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -175.105 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.693 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 4.6 Cg_exo -82.95 169.91 12.78 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 124.519 3.479 . . . . 0.0 112.623 -172.416 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -81.21 -18.0 47.65 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.181 174.518 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.18 142.08 98.21 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.499 177.863 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_exo -70.72 115.26 4.15 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 121.487 1.458 . . . . 0.0 109.614 168.432 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.6 HG22 ' HG3' ' A' ' 83' ' ' GLU . 0.8 OUTLIER -121.72 152.15 25.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -174.91 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 11.8 p -98.12 -31.65 12.01 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -177.637 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.452 ' C ' HG12 ' A' ' 82' ' ' VAL . . . -163.15 -164.39 18.09 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.267 -0.968 . . . . 0.0 111.698 177.977 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.693 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 6.4 m-85 -140.32 136.13 32.91 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.848 0.324 . . . . 0.0 111.124 175.162 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 21.6 mtp180 -104.69 151.38 23.77 Favored 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 166.393 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.889 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 32.6 mt -139.59 108.47 3.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 C-N-CA 120.617 -0.433 . . . . 0.0 111.977 -178.491 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 72.6 t -107.77 109.64 28.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.306 0.574 . . . . 0.0 110.194 178.322 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.703 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 0.6 OUTLIER -110.46 125.14 52.97 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.138 175.908 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.1 m -143.17 133.88 12.4 Favored Pre-proline 0 C--N 1.316 -0.874 0 CA-C-N 113.928 -1.487 . . . . 0.0 110.808 -175.379 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.524 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 57.6 Cg_endo . . . . . 0 C--N 1.333 -0.274 0 C-N-CA 123.108 2.539 . . . . 0.0 111.694 176.162 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 15.5 m . . . . . 0 CA--C 1.517 -0.318 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.703 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 23.5 m -144.77 151.93 39.59 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 120.443 -0.503 . . . . 0.0 111.476 -175.705 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.889 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 51.4 tt0 -121.61 112.44 18.46 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.619 176.251 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.713 HD12 ' CG2' ' A' ' 64' ' ' VAL . 18.1 mt -97.48 163.0 13.05 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.013 176.885 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.513 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 18.5 m120 -129.75 113.27 14.51 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.884 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.556 HD12 ' CH2' ' A' ' 30' ' ' TRP . 3.5 mt -110.98 157.62 38.14 Favored Pre-proline 0 C--N 1.317 -0.831 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -174.431 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -64.59 150.45 88.19 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 121.849 1.699 . . . . 0.0 111.157 175.484 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -48.31 -23.03 0.78 Allowed 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 115.177 -0.919 . . . . 0.0 112.852 177.908 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 5.1 t -99.86 1.6 43.07 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.215 -175.859 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.496 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -76.06 159.57 30.65 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 -176.951 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.596 ' HB3' ' NE ' ' A' ' 32' ' ' ARG . 28.6 p-10 -147.03 18.52 1.24 Allowed 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 120.554 -0.458 . . . . 0.0 112.231 -178.421 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.675 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 23.2 p -169.22 133.65 1.43 Allowed 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.164 -0.615 . . . . 0.0 112.155 -179.9 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.746 HG12 ' HZ3' ' A' ' 30' ' ' TRP . 3.6 p -118.44 137.11 53.46 Favored 'Isoleucine or valine' 0 C--O 1.242 0.673 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.203 176.257 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 61.0 m -97.68 101.98 13.63 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.752 171.65 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.68 HD11 HG12 ' A' ' 77' ' ' ILE . 0.2 OUTLIER -80.59 140.22 35.87 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.362 179.397 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 22.0 t -134.11 168.23 19.21 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 123.438 0.461 . . . . 0.0 110.642 -173.455 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 58.75 31.34 21.09 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.991 -177.811 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.646 ' O ' HG22 ' A' ' 24' ' ' THR . 14.3 mt -69.16 -175.44 0.76 Allowed 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 175.19 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -126.87 125.53 24.28 Favored Pre-proline 0 C--N 1.318 -0.772 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 178.407 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -63.52 130.04 27.02 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 123.03 2.486 . . . . 0.0 113.418 -177.346 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 88.18 22.05 43.0 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.774 -179.917 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 86.6 t -127.38 144.26 37.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.145 0.498 . . . . 0.0 111.308 -173.35 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.524 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 2.8 tp-100 -88.88 107.18 18.86 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.98 -176.566 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -98.09 117.79 33.24 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.224 0.535 . . . . 0.0 111.64 -178.079 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 -90.4 107.9 19.44 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.127 177.629 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.68 HG12 HD11 ' A' ' 66' ' ' LEU . 5.3 mp -91.73 116.4 32.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.294 0.569 . . . . 0.0 109.684 178.988 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.854 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 30.8 m -108.47 115.26 29.77 Favored 'General case' 0 N--CA 1.428 -1.525 0 CA-C-N 115.294 -0.867 . . . . 0.0 110.404 -179.791 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.566 ' HB ' ' HB ' ' A' ' 91' ' ' VAL . 14.3 mm -95.46 144.23 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -179.255 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -131.17 112.12 12.55 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.233 179.374 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -79.02 123.69 27.55 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 169.117 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.452 HG12 ' C ' ' A' ' 39' ' ' GLY . 7.0 p -114.53 135.91 52.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 C-N-CA 120.149 -0.621 . . . . 0.0 110.685 -179.824 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.666 ' OE1' ' HG3' ' A' ' 86' ' ' GLN . 3.9 mp0 -112.28 170.68 8.0 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -179.164 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -38.76 -55.78 1.44 Allowed 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -174.09 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -125.23 9.85 8.01 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -176.233 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.666 ' HG3' ' OE1' ' A' ' 83' ' ' GLU . 12.7 pt20 -143.03 176.49 9.06 Favored 'General case' 0 N--CA 1.447 -0.623 0 O-C-N 122.336 -0.227 . . . . 0.0 111.0 -175.095 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -138.28 136.08 36.12 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.004 178.432 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 46.2 m -78.24 175.46 10.18 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.168 178.297 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -63.09 160.69 37.13 Favored Pre-proline 0 CA--C 1.534 0.344 0 CA-C-O 120.973 0.416 . . . . 0.0 111.523 178.614 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -87.85 140.46 5.01 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.302 2.002 . . . . 0.0 114.365 -178.497 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.854 ' O ' ' HA ' ' A' ' 78' ' ' THR . 6.9 t -82.72 127.65 39.47 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.688 0 CA-C-N 114.825 -1.08 . . . . 0.0 108.34 165.863 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.4 t -124.05 106.06 16.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 C-N-CA 120.027 -0.669 . . . . 0.0 109.596 172.476 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.537 HG13 ' HB ' ' A' ' 77' ' ' ILE . 7.7 pt -124.2 112.87 34.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.418 178.674 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -94.07 120.17 33.94 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.315 0.579 . . . . 0.0 111.05 -177.66 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -126.33 125.37 42.16 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.486 175.482 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.447 ' HA ' ' HA ' ' A' ' 74' ' ' GLN . 40.9 tt0 -90.0 128.08 36.18 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.18 0.514 . . . . 0.0 110.034 179.783 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 40.3 p -59.52 144.71 46.56 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.948 -176.524 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 16.4 m . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.342 -171.752 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.576 ' HB2' ' O ' ' A' ' 89' ' ' THR . . . . . . . . 0 CA--C 1.516 -0.34 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.469 ' HB2' ' HB2' ' A' ' 30' ' ' TRP . 27.0 Cg_exo -64.64 130.68 27.09 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 121.81 1.674 . . . . 0.0 111.055 171.806 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.567 ' HD2' ' O ' ' A' ' 31' ' ' SER . 71.5 Cg_exo -50.39 155.56 4.86 Favored 'Trans proline' 0 C--O 1.235 0.353 0 C-N-CA 122.524 2.149 . . . . 0.0 111.6 171.415 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -35.7 106.19 0.3 Allowed Pre-proline 0 N--CA 1.472 0.654 0 O-C-N 124.56 1.162 . . . . 0.0 112.437 -171.115 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.628 ' HG2' HG11 ' A' ' 91' ' ' VAL . 24.1 Cg_exo -70.5 145.1 51.94 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 123.162 2.575 . . . . 0.0 112.435 177.518 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.2 m -101.64 131.2 48.0 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.568 0.699 . . . . 0.0 110.814 -177.575 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.498 HG11 HG22 ' A' ' 21' ' ' VAL . 70.6 t -81.01 118.24 28.44 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 CA-C-N 114.658 -1.156 . . . . 0.0 110.061 175.226 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -78.05 -46.63 20.39 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.318 -175.568 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -136.74 140.67 42.77 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.679 -178.193 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.498 HG22 HG11 ' A' ' 18' ' ' VAL . 7.2 t -127.24 114.2 35.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.697 -178.063 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -124.63 -164.96 1.32 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 179.467 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.581 ' O ' ' HB2' ' A' ' 69' ' ' LEU . 4.0 p-10 -70.67 -67.1 0.53 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.073 0.463 . . . . 0.0 112.193 -178.109 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.678 HG22 ' O ' ' A' ' 69' ' ' LEU . 35.2 p -110.3 32.08 5.43 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.004 -173.381 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.706 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 42.3 m -167.71 129.99 1.57 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.194 -171.622 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.732 ' HB ' HD12 ' A' ' 66' ' ' LEU . 44.8 mt -147.37 145.57 18.99 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.924 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 177.398 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 43.7 t -118.67 131.4 71.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 119.22 0.918 . . . . 0.0 110.262 -176.803 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.64 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.6 OUTLIER -127.76 145.77 34.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 C-N-CA 120.096 -0.642 . . . . 0.0 110.318 -179.214 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.48 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 11.1 mtm180 -130.02 121.34 26.28 Favored 'General case' 0 CA--C 1.515 -0.379 0 O-C-N 123.397 0.436 . . . . 0.0 110.302 -175.584 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.733 ' HZ3' HG12 ' A' ' 64' ' ' VAL . 34.6 p90 -111.53 145.8 38.43 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.419 -175.306 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.567 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 12.5 t -90.29 91.81 8.66 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 175.124 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.473 ' HD3' ' H ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -46.1 156.3 0.48 Allowed Pre-proline 0 CA--C 1.542 0.662 0 C-N-CA 124.14 0.976 . . . . 0.0 113.507 -174.426 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.684 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 4.2 Cg_exo -76.27 169.53 21.81 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 123.86 3.04 . . . . 0.0 112.939 -173.754 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -83.74 -15.59 48.03 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.344 174.378 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.98 144.87 99.14 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.122 -0.944 . . . . 0.0 111.423 177.233 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -68.6 115.45 3.92 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 121.612 1.542 . . . . 0.0 109.831 167.274 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.638 HD12 ' HE1' ' A' ' 40' ' ' TYR . 1.1 pt -121.11 155.74 24.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -177.683 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.51 ' C ' ' HB3' ' A' ' 59' ' ' GLU . 21.7 p -104.24 -29.32 10.88 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -177.858 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.522 ' C ' HG12 ' A' ' 82' ' ' VAL . . . -161.7 -167.87 22.77 Favored Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.252 -0.975 . . . . 0.0 111.829 179.853 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.684 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 5.5 m-85 -139.93 131.57 27.25 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 120.803 0.335 . . . . 0.0 111.301 174.347 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.593 ' CZ ' HG11 ' A' ' 82' ' ' VAL . 0.2 OUTLIER -99.55 147.79 24.96 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 168.792 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.891 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 33.0 mt -139.71 107.47 2.93 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 C-N-CA 119.875 -0.73 . . . . 0.0 112.435 -179.582 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 82.5 t -108.47 110.7 32.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.138 0.494 . . . . 0.0 110.825 -178.519 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.751 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 0.8 OUTLIER -113.43 125.56 54.37 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 121.503 0.668 . . . . 0.0 109.985 176.175 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.495 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 13.9 t -140.25 140.53 23.6 Favored Pre-proline 0 C--N 1.319 -0.751 0 CA-C-N 113.717 -1.583 . . . . 0.0 110.69 -174.505 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.633 ' HG3' ' CZ ' ' A' ' 75' ' ' TYR . 2.4 Cg_endo . . . . . 0 N--CA 1.462 -0.371 0 C-N-CA 123.605 2.87 . . . . 0.0 111.67 178.57 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 22.7 p . . . . . 0 CA--C 1.516 -0.339 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.751 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 62.7 m -146.92 145.6 29.86 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 119.922 -0.711 . . . . 0.0 111.588 176.919 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.891 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 41.8 tt0 -116.56 115.75 26.33 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.94 174.532 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.684 HD12 ' CG2' ' A' ' 64' ' ' VAL . 18.8 mt -97.52 161.55 13.72 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 175.855 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.486 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 36.9 t30 -126.12 119.44 27.56 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 177.651 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.573 HD12 ' CH2' ' A' ' 30' ' ' TRP . 4.7 mt -113.96 159.55 35.64 Favored Pre-proline 0 C--N 1.317 -0.822 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 -177.419 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -67.18 151.99 80.39 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 121.534 1.489 . . . . 0.0 111.005 174.66 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.51 ' HB3' ' C ' ' A' ' 38' ' ' THR . 7.0 pt-20 -47.8 -24.75 1.06 Allowed 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.092 -0.958 . . . . 0.0 112.632 177.468 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.9 t -104.6 15.87 27.17 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.09 -174.524 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.428 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -86.81 161.69 18.21 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 178.057 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.48 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 4.3 p-10 -145.31 15.37 1.48 Allowed 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.954 -178.092 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.64 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 26.4 p -168.83 133.88 1.6 Allowed 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.281 -0.568 . . . . 0.0 111.694 -179.016 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.733 HG12 ' HZ3' ' A' ' 30' ' ' TRP . 3.3 p -117.33 139.83 42.72 Favored 'Isoleucine or valine' 0 C--O 1.244 0.81 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.47 177.237 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 47.7 m -97.23 101.14 12.64 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.579 168.391 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.732 HD12 ' HB ' ' A' ' 26' ' ' ILE . 0.3 OUTLIER -76.03 141.9 41.97 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.597 177.924 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.436 ' HA ' ' O ' ' A' ' 24' ' ' THR . 27.3 p -136.62 166.22 24.04 Favored 'General case' 0 N--CA 1.447 -0.595 0 O-C-N 123.819 0.7 . . . . 0.0 110.041 -174.955 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 61.93 38.54 14.32 Favored 'General case' 0 N--CA 1.464 0.227 0 O-C-N 123.688 0.617 . . . . 0.0 111.431 -179.214 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.678 ' O ' HG22 ' A' ' 24' ' ' THR . 8.1 mt -85.04 -176.26 6.12 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 175.459 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 58.4 tp60 -126.72 124.69 24.21 Favored Pre-proline 0 C--N 1.32 -0.704 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 176.479 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -62.24 134.54 49.35 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 123.188 2.592 . . . . 0.0 113.498 -178.072 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 86.53 24.27 40.0 Favored Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.363 176.977 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 17.9 t -130.53 149.23 33.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.236 0.541 . . . . 0.0 111.445 -176.232 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.494 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 4.4 tp-100 -79.64 108.0 12.85 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.634 179.971 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.633 ' CZ ' ' HG3' ' A' ' 46' ' ' PRO . 4.2 m-85 -101.15 116.52 33.01 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.377 0.608 . . . . 0.0 111.868 -178.708 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.585 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 31.0 m-80 -89.2 109.02 19.94 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.448 177.037 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.678 HG12 HD11 ' A' ' 66' ' ' LEU . 5.2 mp -92.56 116.01 32.73 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.616 0 CA-C-O 121.332 0.586 . . . . 0.0 109.571 175.598 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.874 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 89.2 m -108.82 116.18 31.5 Favored 'General case' 0 N--CA 1.426 -1.639 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.243 179.954 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.558 ' HB ' ' HB ' ' A' ' 91' ' ' VAL . 15.6 mm -95.26 140.59 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 -178.959 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -127.87 113.04 15.4 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 178.776 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.458 ' HB1' HG21 ' A' ' 37' ' ' ILE . . . -84.12 119.65 25.23 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 171.173 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.593 HG11 ' CZ ' ' A' ' 41' ' ' ARG . 7.5 p -110.54 141.22 26.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 C-N-CA 120.237 -0.585 . . . . 0.0 110.204 -175.355 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.604 ' OE1' ' HB2' ' A' ' 86' ' ' GLN . 0.1 OUTLIER -123.28 170.88 9.84 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 123.37 0.419 . . . . 0.0 110.104 177.183 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -34.64 -55.83 0.55 Allowed 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 113.839 1.052 . . . . 0.0 113.839 -171.241 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -123.81 14.72 9.33 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 -174.627 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.604 ' HB2' ' OE1' ' A' ' 83' ' ' GLU . 25.4 mt-30 -146.18 170.81 15.96 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.368 0.604 . . . . 0.0 111.849 -177.298 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -127.38 124.63 39.02 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.113 173.704 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 15.4 m -76.2 -178.52 4.53 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.648 0.261 . . . . 0.0 111.088 -177.635 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.576 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 3.9 p -67.39 154.93 92.07 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-O 120.947 0.403 . . . . 0.0 111.438 -178.378 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -88.2 141.6 5.08 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 122.76 2.307 . . . . 0.0 115.031 179.747 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.874 ' O ' ' HA ' ' A' ' 78' ' ' THR . 8.8 t -83.34 131.59 33.43 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.538 0 CA-C-N 114.678 -1.146 . . . . 0.0 108.271 163.892 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 13.7 t -125.02 106.81 17.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 C-N-CA 119.94 -0.704 . . . . 0.0 110.172 170.178 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.623 HG13 ' HB ' ' A' ' 77' ' ' ILE . 8.2 pt -121.11 111.43 31.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.342 178.185 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -97.23 112.99 24.55 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.659 0.742 . . . . 0.0 111.6 -177.035 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -124.92 131.54 53.41 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.484 179.77 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -86.47 129.89 34.69 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.046 0.451 . . . . 0.0 110.519 -179.483 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.443 HG22 HD11 ' A' ' 26' ' ' ILE . 20.3 p -60.43 117.68 5.55 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.227 179.626 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.424 ' H ' HG12 ' A' ' 21' ' ' VAL . 39.1 m . . . . . 0 C--N 1.325 -0.476 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.039 179.651 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.427 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.456 ' CB ' ' HB2' ' A' ' 30' ' ' TRP . 23.6 Cg_exo -67.35 126.16 14.54 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 121.364 1.376 . . . . 0.0 111.535 176.589 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.42 ' HD2' ' O ' ' A' ' 31' ' ' SER . 76.6 Cg_exo -49.49 145.39 16.56 Favored 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.469 2.112 . . . . 0.0 110.634 171.486 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.402 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 10.1 m-20 -35.95 105.62 0.29 Allowed Pre-proline 0 N--CA 1.47 0.55 0 O-C-N 124.701 1.251 . . . . 0.0 112.329 -169.394 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.597 ' HG2' HG11 ' A' ' 91' ' ' VAL . 31.3 Cg_exo -64.76 155.45 67.25 Favored 'Trans proline' 0 CA--C 1.514 -0.492 0 C-N-CA 123.747 2.965 . . . . 0.0 112.407 -179.81 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 31.6 m -113.77 131.03 56.36 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.806 -178.207 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.511 HG11 HG22 ' A' ' 21' ' ' VAL . 71.4 t -73.26 122.81 26.9 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 114.054 -1.43 . . . . 0.0 109.884 175.051 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -84.47 -41.94 16.09 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.944 -173.847 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -136.22 140.62 43.65 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.163 178.574 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.511 HG22 HG11 ' A' ' 18' ' ' VAL . 39.8 t -123.72 119.46 57.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.468 178.191 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.406 ' HB2' ' O ' ' A' ' 25' ' ' SER . 23.6 m-20 -124.36 -159.06 0.85 Allowed 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 176.95 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.536 ' O ' ' HB2' ' A' ' 69' ' ' LEU . 17.8 p-10 -84.44 -54.41 4.78 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.3 0.571 . . . . 0.0 111.348 179.094 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.599 HG22 ' O ' ' A' ' 69' ' ' LEU . 29.9 p -119.61 29.73 7.44 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.192 -172.409 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.636 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 17.0 p -169.91 130.6 1.01 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.665 -1.152 . . . . 0.0 109.858 -176.097 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.606 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 48.0 mt -148.05 142.22 19.23 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.666 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.765 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.458 ' O ' HG13 ' A' ' 18' ' ' VAL . 44.9 t -115.96 136.21 53.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 C-N-CA 119.858 -0.737 . . . . 0.0 109.933 -175.701 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.642 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.6 OUTLIER -127.13 145.41 34.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 C-N-CA 120.122 -0.631 . . . . 0.0 110.162 179.105 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.48 ' HG2' ' HB3' ' A' ' 63' ' ' SER . 54.8 mtp180 -130.02 120.98 25.61 Favored 'General case' 0 C--N 1.327 -0.408 0 O-C-N 123.535 0.522 . . . . 0.0 110.497 -174.766 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.708 ' HZ3' HG12 ' A' ' 64' ' ' VAL . 35.7 p90 -113.47 149.04 34.84 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.879 -174.052 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.433 ' O ' ' HA ' ' A' ' 13' ' ' PRO . 48.2 m -92.75 88.53 6.28 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.202 175.758 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.526 ' HD3' ' H ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -50.75 159.05 0.99 Allowed Pre-proline 0 CA--C 1.544 0.715 0 CA-C-N 114.99 -1.005 . . . . 0.0 113.404 -175.413 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.729 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 6.4 Cg_exo -74.08 169.33 22.69 Favored 'Trans proline' 0 C--N 1.358 1.032 0 C-N-CA 124.001 3.134 . . . . 0.0 113.332 -172.597 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -91.38 3.88 53.81 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.242 174.842 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -85.4 151.41 56.22 Favored Pre-proline 0 CA--C 1.515 -0.378 0 CA-C-N 114.683 -1.144 . . . . 0.0 110.532 178.686 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -75.85 114.76 4.01 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 121.446 1.431 . . . . 0.0 109.92 171.728 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.614 HD12 ' HE1' ' A' ' 40' ' ' TYR . 2.6 pt -123.06 157.52 28.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.728 -173.508 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.407 ' H ' ' HA ' ' A' ' 83' ' ' GLU . 6.8 p -91.91 -39.12 11.89 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -178.483 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.436 ' O ' HG12 ' A' ' 82' ' ' VAL . . . -169.45 -162.99 22.72 Favored Glycine 0 N--CA 1.439 -1.11 0 C-N-CA 119.542 -1.313 . . . . 0.0 112.687 -178.98 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.729 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 5.1 m-85 -137.71 135.64 36.63 Favored 'General case' 0 CA--C 1.506 -0.746 0 CA-C-O 120.897 0.38 . . . . 0.0 111.175 178.993 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.6 mtm105 -107.53 147.62 30.31 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 169.987 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.875 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 27.3 mt -139.22 109.74 4.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 C-N-CA 120.17 -0.612 . . . . 0.0 112.471 -174.758 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 78.4 t -111.11 110.34 31.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.578 179.011 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.784 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 0.7 OUTLIER -112.08 124.94 53.51 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.427 176.646 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.431 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 8.1 p -138.02 136.24 19.48 Favored Pre-proline 0 C--N 1.312 -1.039 0 CA-C-N 113.946 -1.479 . . . . 0.0 111.47 -172.394 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.595 ' HB3' HG11 ' A' ' 73' ' ' VAL . 16.1 Cg_exo . . . . . 0 CA--C 1.519 -0.242 0 C-N-CA 122.929 2.419 . . . . 0.0 110.934 174.905 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.9 m . . . . . 0 CA--C 1.517 -0.303 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.784 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 26.3 m -145.67 154.99 42.71 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 120.53 -0.468 . . . . 0.0 111.493 -175.507 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.875 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 33.3 tt0 -127.46 112.92 15.52 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.603 -179.026 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.708 HD12 ' CG2' ' A' ' 64' ' ' VAL . 17.0 mt -100.86 162.35 12.96 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.455 178.183 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.555 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 2.3 m120 -128.65 115.89 18.74 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 176.837 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.57 HD12 ' CH2' ' A' ' 30' ' ' TRP . 4.6 mt -110.85 156.86 40.04 Favored Pre-proline 0 N--CA 1.441 -0.883 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -175.96 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -63.26 151.22 85.92 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 121.737 1.625 . . . . 0.0 110.989 175.902 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.437 ' HB2' HG13 ' A' ' 37' ' ' ILE . 9.8 pt-20 -45.84 -28.95 1.2 Allowed 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.344 176.707 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.5 t -101.2 19.53 17.44 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.148 -174.834 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.506 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -89.11 161.08 16.7 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 178.635 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.446 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 29.6 p-10 -147.85 15.94 1.09 Allowed 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -177.123 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.642 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 28.0 p -171.32 133.95 0.86 Allowed 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.226 -0.59 . . . . 0.0 111.779 -178.476 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.716 HG11 HG21 ' A' ' 42' ' ' ILE . 3.1 p -117.13 136.77 53.2 Favored 'Isoleucine or valine' 0 C--O 1.24 0.59 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.434 177.146 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 41.3 m -94.57 101.71 13.61 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.668 169.106 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.636 ' O ' ' HA ' ' A' ' 25' ' ' SER . 0.2 OUTLIER -78.8 141.04 38.09 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 177.551 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 10.9 t -137.3 172.65 12.67 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 -177.035 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 60.93 31.58 19.97 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.476 -179.287 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.599 ' O ' HG22 ' A' ' 24' ' ' THR . 10.7 mt -74.42 -176.99 2.89 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 176.917 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 7.7 tp60 -126.15 121.59 23.99 Favored Pre-proline 0 C--N 1.319 -0.741 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 177.5 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -60.29 135.06 59.33 Favored 'Trans proline' 0 C--O 1.235 0.366 0 C-N-CA 123.001 2.467 . . . . 0.0 113.372 -177.634 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 87.71 17.47 58.23 Favored Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.309 177.323 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.595 HG11 ' HB3' ' A' ' 46' ' ' PRO . 14.1 t -125.62 146.62 31.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 120.816 0.341 . . . . 0.0 110.841 -177.573 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.553 ' OE1' ' HB2' ' A' ' 96' ' ' GLU . 35.0 tp60 -81.05 122.69 27.63 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.782 178.744 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.463 ' CE2' HD22 ' A' ' 69' ' ' LEU . 5.4 m-85 -105.98 116.17 31.48 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 121.599 0.714 . . . . 0.0 111.725 -179.297 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.423 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 16.2 t-20 -90.14 104.1 16.7 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 114.487 -1.233 . . . . 0.0 109.113 177.01 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.623 HG12 HD11 ' A' ' 66' ' ' LEU . 5.3 mp -92.25 116.41 33.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.347 0.594 . . . . 0.0 109.758 177.722 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.84 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 62.1 m -108.3 116.13 31.39 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.09 179.094 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.612 ' HB ' ' HB ' ' A' ' 91' ' ' VAL . 15.5 mm -95.61 141.92 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.831 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -126.94 112.99 15.93 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 179.613 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -89.25 123.1 33.15 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 174.53 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.436 HG12 ' O ' ' A' ' 39' ' ' GLY . 7.3 p -120.63 134.67 63.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 120.02 -0.672 . . . . 0.0 112.258 -173.122 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.611 ' HG2' HG22 ' A' ' 37' ' ' ILE . 6.3 mt-10 -104.59 171.82 7.12 Favored 'General case' 0 N--CA 1.454 -0.261 0 O-C-N 124.146 0.904 . . . . 0.0 109.228 173.607 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -47.68 -39.51 17.56 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 179.081 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -113.36 -29.33 7.26 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -171.343 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -133.32 176.34 8.6 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.553 -0.459 . . . . 0.0 111.683 -170.011 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -134.61 137.78 43.98 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.789 177.717 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 17.7 m -77.64 173.47 12.01 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.828 -179.69 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 14.2 p -61.79 154.63 66.02 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-O 120.918 0.39 . . . . 0.0 110.623 176.567 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -81.64 142.6 12.97 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 122.067 1.845 . . . . 0.0 113.622 -175.463 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.84 ' O ' ' HA ' ' A' ' 78' ' ' THR . 7.1 t -83.18 129.41 37.5 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.771 0 CA-C-N 114.879 -1.055 . . . . 0.0 108.615 168.09 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.9 t -126.27 106.96 16.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.153 175.01 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.547 HG13 ' HB ' ' A' ' 77' ' ' ILE . 8.1 pt -128.17 118.9 49.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.47 178.794 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -103.39 129.93 50.59 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.402 0.62 . . . . 0.0 111.349 -176.877 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -141.06 130.03 23.19 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.96 176.517 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.553 ' HB2' ' OE1' ' A' ' 74' ' ' GLN . 34.5 tt0 -85.83 136.12 33.44 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.251 0.548 . . . . 0.0 110.093 179.959 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 25.4 p -65.92 124.5 22.67 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.55 179.709 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.4 m . . . . . 0 C--N 1.327 -0.395 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.228 -173.292 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.367 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -68.61 133.14 26.95 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.482 2.122 . . . . 0.0 111.678 175.005 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.77 154.24 21.65 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.321 2.014 . . . . 0.0 110.943 172.91 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -36.45 107.2 0.35 Allowed Pre-proline 0 N--CA 1.468 0.464 0 O-C-N 124.595 1.184 . . . . 0.0 112.445 -172.148 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.622 ' HG2' HG11 ' A' ' 91' ' ' VAL . 36.1 Cg_exo -66.69 150.93 83.53 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 123.09 2.526 . . . . 0.0 112.265 177.712 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 45.8 m -106.93 129.04 54.81 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.872 -179.07 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.473 HG11 HG22 ' A' ' 21' ' ' VAL . 78.2 t -76.99 123.29 33.27 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-N 114.509 -1.223 . . . . 0.0 109.891 173.75 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -91.59 -37.39 13.11 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.341 -174.813 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 13.9 mm-40 -136.17 132.74 36.36 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.788 -178.59 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.485 ' HA ' HG12 ' A' ' 26' ' ' ILE . 46.5 t -124.01 120.1 58.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.388 179.637 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -127.5 -159.98 0.98 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 178.809 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -74.48 -72.11 0.3 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 179.162 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.608 HG22 ' O ' ' A' ' 69' ' ' LEU . 69.9 p -105.41 33.57 3.64 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.211 -174.034 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.601 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 68.5 p -169.66 137.16 1.71 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.574 -173.628 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.618 ' HB ' HD12 ' A' ' 66' ' ' LEU . 35.9 mt -150.71 145.68 16.69 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.904 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.783 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.432 ' O ' HG13 ' A' ' 18' ' ' VAL . 41.0 t -118.36 131.85 69.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 119.255 0.934 . . . . 0.0 110.472 -176.062 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.59 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.6 OUTLIER -127.13 146.52 32.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.233 -178.119 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.47 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 20.2 mtm180 -130.69 121.27 25.2 Favored 'General case' 0 C--N 1.329 -0.303 0 O-C-N 123.244 0.34 . . . . 0.0 110.57 -175.856 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.823 ' HZ3' HG12 ' A' ' 64' ' ' VAL . 39.5 p90 -112.06 146.74 37.41 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.103 -175.651 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 24.0 t -92.59 99.09 11.86 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.928 177.548 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.605 ' H ' ' CD ' ' A' ' 32' ' ' ARG . 0.2 OUTLIER -53.49 160.3 1.96 Allowed Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 115.098 -0.955 . . . . 0.0 113.189 -174.261 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.645 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 2.2 Cg_endo -84.93 163.52 11.81 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 124.307 3.338 . . . . 0.0 112.279 -177.254 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -82.73 -6.42 59.39 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.338 172.064 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -66.2 146.79 99.04 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.841 174.557 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -73.94 114.08 3.94 Favored 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 121.165 1.244 . . . . 0.0 109.857 170.213 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.583 HD12 ' HE1' ' A' ' 40' ' ' TYR . 0.8 OUTLIER -120.56 147.79 24.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 -177.455 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.422 ' N ' ' O ' ' A' ' 82' ' ' VAL . 25.4 p -88.89 -30.2 19.05 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -178.335 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.59 ' C ' HG12 ' A' ' 82' ' ' VAL . . . -171.09 -162.3 23.21 Favored Glycine 0 CA--C 1.499 -0.942 0 C-N-CA 120.116 -1.04 . . . . 0.0 111.551 -179.327 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.645 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 6.5 m-85 -140.06 132.6 28.69 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 117.01 0.405 . . . . 0.0 111.155 173.807 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.2 mmm180 -100.7 147.72 25.69 Favored 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 168.031 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.881 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 32.0 mt -138.29 108.21 4.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 C-N-CA 119.926 -0.71 . . . . 0.0 112.328 -178.395 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 93.1 t -110.41 111.52 36.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.088 0.47 . . . . 0.0 110.762 -178.154 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.742 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 0.6 OUTLIER -115.24 126.2 54.25 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.077 177.357 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 30.8 p -134.22 137.52 28.28 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 113.742 -1.572 . . . . 0.0 111.705 -174.696 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.617 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 92.9 Cg_endo . . . . . 0 N--CA 1.464 -0.231 0 C-N-CA 123.638 2.892 . . . . 0.0 111.937 178.488 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.0 p . . . . . 0 CA--C 1.514 -0.43 0 CA-C-O 120.421 0.153 . . . . 0.0 110.719 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.742 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 38.0 m -145.16 147.97 33.07 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 119.886 -0.725 . . . . 0.0 111.825 177.994 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.881 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 34.9 tt0 -118.54 114.1 22.3 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.957 176.014 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.697 HD12 ' CG2' ' A' ' 64' ' ' VAL . 16.8 mt -97.94 159.49 14.9 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.0 0.429 . . . . 0.0 110.318 176.564 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 22.1 m-80 -123.43 113.63 19.05 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.59 179.253 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.557 HD12 ' CH2' ' A' ' 30' ' ' TRP . 2.6 mt -111.8 154.92 43.88 Favored Pre-proline 0 C--N 1.318 -0.796 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 -176.726 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -65.53 150.21 86.91 Favored 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 121.569 1.512 . . . . 0.0 110.958 175.955 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -45.11 -25.53 0.35 Allowed 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 114.618 -1.173 . . . . 0.0 113.186 178.981 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 5.4 t -103.9 5.01 35.42 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.44 -174.244 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.434 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -74.97 155.99 36.79 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 -179.677 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.493 ' HB3' ' NE ' ' A' ' 32' ' ' ARG . 26.6 p-10 -137.04 12.94 3.09 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.931 -177.32 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.59 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 23.3 p -169.1 133.79 1.49 Allowed 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 119.973 -0.691 . . . . 0.0 111.905 -177.525 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.823 HG12 ' HZ3' ' A' ' 30' ' ' TRP . 3.6 p -116.14 137.16 50.75 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.122 176.744 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 42.8 m -95.84 101.16 12.82 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 168.56 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.666 HD11 HG12 ' A' ' 77' ' ' ILE . 0.2 OUTLIER -76.49 141.13 41.39 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.259 178.65 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.6 t -136.48 170.73 15.57 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -177.432 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 65.1 29.57 11.96 Favored 'General case' 0 C--N 1.327 -0.388 0 O-C-N 123.665 0.603 . . . . 0.0 111.549 -178.155 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.608 ' O ' HG22 ' A' ' 24' ' ' THR . 9.1 mt -78.73 -175.6 4.49 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 174.135 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -126.99 131.99 24.12 Favored Pre-proline 0 C--N 1.32 -0.702 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 177.876 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -64.49 133.65 38.08 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.87 2.38 . . . . 0.0 113.008 -178.214 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 74.92 34.37 53.0 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.947 -0.644 . . . . 0.0 111.649 179.758 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 70.1 t -134.62 139.79 46.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.209 0.528 . . . . 0.0 110.815 -177.042 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.617 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -81.05 121.13 25.69 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.047 -176.053 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -116.66 115.82 26.39 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -175.306 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.544 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 2.6 m-20 -85.55 111.47 20.05 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.547 -0.752 . . . . 0.0 109.752 174.345 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.666 HG12 HD11 ' A' ' 66' ' ' LEU . 5.1 mp -93.47 117.95 38.14 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.602 0 CA-C-O 121.164 0.507 . . . . 0.0 109.748 175.751 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.883 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 24.9 m -109.39 115.14 29.4 Favored 'General case' 0 N--CA 1.428 -1.573 0 CA-C-N 115.25 -0.887 . . . . 0.0 110.545 -179.693 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.546 ' HB ' ' HB ' ' A' ' 91' ' ' VAL . 12.4 mm -95.73 139.88 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 179.537 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.427 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 68.4 m-85 -128.46 112.39 14.32 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.624 -0.262 . . . . 0.0 110.343 179.085 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.401 ' HB1' HG21 ' A' ' 37' ' ' ILE . . . -79.42 109.32 13.67 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 170.874 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.59 HG12 ' C ' ' A' ' 39' ' ' GLY . 11.1 p -99.39 140.77 18.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.756 -173.927 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -122.93 165.2 17.1 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 -178.412 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -47.16 -47.87 23.7 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -176.716 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -130.1 17.63 5.56 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.37 -176.899 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 66.9 mm-40 -142.31 169.58 17.32 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.871 0.367 . . . . 0.0 111.328 -179.023 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -146.72 120.34 9.16 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.088 177.943 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 21.7 m -65.1 157.81 27.56 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.782 179.742 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 21.1 p -55.16 150.12 22.64 Favored Pre-proline 0 N--CA 1.453 -0.294 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.312 176.635 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -77.61 140.28 18.75 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 121.755 1.637 . . . . 0.0 113.548 -173.68 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.883 ' O ' ' HA ' ' A' ' 78' ' ' THR . 4.6 t -81.53 123.42 37.87 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.832 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 167.348 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 4.8 t -119.75 105.38 17.18 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 C-N-CA 119.53 -0.868 . . . . 0.0 109.857 172.452 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.569 HG13 ' HB ' ' A' ' 77' ' ' ILE . 6.4 pt -120.73 111.11 30.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.354 175.897 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.41 ' CD ' ' H ' ' A' ' 94' ' ' GLN . 4.5 pm0 -97.22 114.88 26.66 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.806 0.812 . . . . 0.0 110.76 -175.819 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -124.79 129.39 50.36 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.937 -1.028 . . . . 0.0 109.398 179.44 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.411 ' HA ' ' HA ' ' A' ' 74' ' ' GLN . 36.2 tt0 -89.42 137.82 31.99 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.146 0.498 . . . . 0.0 110.433 179.148 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 41.7 p -71.46 121.61 18.93 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.928 -178.128 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.9 m . . . . . 0 C--N 1.323 -0.561 0 CA-C-O 121.344 0.592 . . . . 0.0 110.15 179.937 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.287 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -63.27 130.59 29.13 Favored 'Trans proline' 0 C--O 1.235 0.346 0 C-N-CA 122.324 2.016 . . . . 0.0 111.96 177.537 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.506 ' HD2' ' O ' ' A' ' 31' ' ' SER . 72.7 Cg_exo -49.54 146.07 15.5 Favored 'Trans proline' 0 C--O 1.237 0.426 0 C-N-CA 122.891 2.394 . . . . 0.0 111.091 172.856 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.429 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 9.4 p-10 -35.76 106.66 0.32 Allowed Pre-proline 0 N--CA 1.466 0.366 0 O-C-N 124.837 1.336 . . . . 0.0 112.541 -169.276 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.65 ' HG2' HG11 ' A' ' 91' ' ' VAL . 34.6 Cg_exo -67.03 150.94 82.64 Favored 'Trans proline' 0 CA--C 1.517 -0.359 0 C-N-CA 123.368 2.712 . . . . 0.0 112.039 179.08 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.2 m -110.35 131.09 55.36 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.804 -178.387 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.465 HG11 HG22 ' A' ' 21' ' ' VAL . 76.0 t -75.67 119.87 24.38 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-N 114.446 -1.252 . . . . 0.0 109.653 173.756 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -86.97 -40.5 14.72 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.324 -174.809 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -136.03 138.5 42.26 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.995 0.426 . . . . 0.0 110.726 -179.776 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.465 HG22 HG11 ' A' ' 18' ' ' VAL . 17.0 t -125.98 125.16 67.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.005 179.825 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -130.58 -157.27 0.81 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.509 0.195 . . . . 0.0 110.475 -179.249 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.439 ' OD1' ' N ' ' A' ' 24' ' ' THR . 1.9 p30 -73.79 -69.43 0.44 Allowed 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 178.411 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.5 HG22 ' O ' ' A' ' 69' ' ' LEU . 67.7 p -114.39 37.12 3.48 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.483 0.659 . . . . 0.0 109.944 -174.335 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.652 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 55.1 m -167.97 131.49 1.64 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.807 -171.295 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.61 ' HB ' HD12 ' A' ' 66' ' ' LEU . 48.8 mt -149.86 140.8 16.81 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.905 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.522 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 36.5 t -116.52 132.12 67.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 119.135 0.879 . . . . 0.0 110.534 -173.822 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.572 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.7 OUTLIER -126.97 145.59 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.23 -178.996 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.505 ' HG2' ' HB3' ' A' ' 63' ' ' SER . 16.9 mtp180 -128.15 121.5 29.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.524 -175.685 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.834 ' HZ3' HG12 ' A' ' 64' ' ' VAL . 38.7 p90 -114.41 148.56 37.53 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.355 -175.65 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.506 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 32.2 t -93.74 97.64 10.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.935 178.136 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.569 ' H ' ' CD ' ' A' ' 32' ' ' ARG . 0.8 OUTLIER -51.43 155.78 2.4 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.376 -0.829 . . . . 0.0 113.007 -175.497 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.676 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 1.5 Cg_endo -85.38 161.99 11.16 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 124.564 3.509 . . . . 0.0 112.656 -172.671 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -74.71 -18.76 60.46 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.6 173.102 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -59.43 138.69 89.04 Favored Pre-proline 0 CA--C 1.518 -0.276 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.041 175.867 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -69.62 113.86 3.49 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 121.008 1.139 . . . . 0.0 109.666 170.814 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.567 HD12 ' HE1' ' A' ' 40' ' ' TYR . 0.7 OUTLIER -118.63 155.11 20.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -176.222 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.466 ' C ' ' HB3' ' A' ' 59' ' ' GLU . 17.2 p -100.96 -26.02 13.87 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -176.921 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.53 ' C ' HG12 ' A' ' 82' ' ' VAL . . . -168.83 -168.59 31.11 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.33 -0.938 . . . . 0.0 111.675 179.432 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.676 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 5.6 m-85 -137.17 132.57 34.14 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 117.105 0.453 . . . . 0.0 111.378 173.359 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 10.0 mmm180 -99.28 148.68 23.89 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 167.807 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.869 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 31.6 mt -139.21 108.32 3.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 C-N-CA 120.065 -0.654 . . . . 0.0 112.043 178.848 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 75.2 t -110.03 110.42 32.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.325 0.584 . . . . 0.0 110.205 179.864 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.71 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 0.4 OUTLIER -111.87 124.47 52.43 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.377 176.338 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.422 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 23.1 t -139.4 135.74 17.31 Favored Pre-proline 0 C--N 1.314 -0.95 0 CA-C-N 113.692 -1.594 . . . . 0.0 110.383 -173.504 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.658 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 50.0 Cg_exo . . . . . 0 C--O 1.234 0.277 0 C-N-CA 123.362 2.708 . . . . 0.0 112.491 174.22 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 9.6 m . . . . . 0 C--O 1.233 0.214 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.71 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 23.3 m -145.61 148.7 33.4 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.876 -0.33 . . . . 0.0 111.5 -175.78 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.869 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 56.2 tt0 -119.16 118.36 31.14 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.235 173.301 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.698 HD12 ' CG2' ' A' ' 64' ' ' VAL . 19.4 mt -100.0 155.84 17.48 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 173.664 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -118.95 113.34 20.86 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 176.91 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.544 HD12 ' CH2' ' A' ' 30' ' ' TRP . 2.1 mt -108.51 156.25 39.03 Favored Pre-proline 0 C--N 1.317 -0.836 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 -177.32 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -54.77 147.07 52.2 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 121.824 1.683 . . . . 0.0 111.29 171.832 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.477 ' HB2' HG13 ' A' ' 37' ' ' ILE . 8.9 pt-20 -48.54 -27.38 2.7 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.959 173.153 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.4 t -96.69 -1.7 46.06 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.334 -175.572 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.454 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -71.41 152.29 43.26 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 -176.619 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.412 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 3.9 p-10 -132.32 11.32 4.54 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -176.21 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.572 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 53.4 p -169.3 133.67 1.41 Allowed 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 119.993 -0.683 . . . . 0.0 111.877 -177.171 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.834 HG12 ' HZ3' ' A' ' 30' ' ' TRP . 3.7 p -114.61 136.37 51.46 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.148 176.034 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 83.1 m -96.14 100.0 11.68 Favored 'General case' 0 N--CA 1.429 -1.514 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 168.669 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.728 HD11 HG12 ' A' ' 77' ' ' ILE . 0.6 OUTLIER -74.13 144.19 45.01 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.143 178.922 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 8.6 t -144.56 166.16 25.95 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 -174.325 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 64.03 32.95 12.57 Favored 'General case' 0 C--N 1.327 -0.393 0 O-C-N 123.775 0.672 . . . . 0.0 110.936 -177.119 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.5 ' O ' HG22 ' A' ' 24' ' ' THR . 7.9 mt -78.42 -176.85 4.95 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 174.573 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -124.64 123.99 25.66 Favored Pre-proline 0 C--N 1.318 -0.793 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 176.812 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -60.53 135.91 63.93 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 122.778 2.319 . . . . 0.0 112.768 -179.328 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.2 33.91 31.09 Favored Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.683 -179.604 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.527 ' CG1' ' HB3' ' A' ' 46' ' ' PRO . 85.5 t -138.26 139.41 41.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 120.8 0.333 . . . . 0.0 110.82 -176.218 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.658 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 1.7 tm0? -82.39 127.53 33.35 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.025 179.348 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -116.67 114.12 23.6 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -173.378 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.465 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 27.3 m-80 -85.53 107.39 17.44 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.674 173.415 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.728 HG12 HD11 ' A' ' 66' ' ' LEU . 5.1 mp -91.01 117.07 33.51 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.733 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 176.644 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.895 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 26.1 m -109.15 114.77 28.77 Favored 'General case' 0 N--CA 1.424 -1.734 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.436 -179.146 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.549 ' HB ' ' HB ' ' A' ' 91' ' ' VAL . 13.5 mm -95.31 141.52 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -179.882 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -129.34 111.99 13.4 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.229 179.624 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.404 ' HB1' HG21 ' A' ' 37' ' ' ILE . . . -79.81 114.47 18.76 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 169.761 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.543 HG23 ' HG2' ' A' ' 87' ' ' GLU . 7.1 p -104.36 132.25 51.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 C-N-CA 120.048 -0.661 . . . . 0.0 109.565 -178.687 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.592 ' OE1' ' HB2' ' A' ' 86' ' ' GLN . 1.1 mp0 -113.6 171.33 7.64 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 123.178 0.299 . . . . 0.0 110.751 -177.655 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.418 ' H ' ' HG3' ' A' ' 84' ' ' GLU . 28.8 mt-10 -45.22 -40.92 7.84 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.505 -0.771 . . . . 0.0 112.754 -176.107 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -112.42 -20.47 11.78 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -172.353 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.592 ' HB2' ' OE1' ' A' ' 83' ' ' GLU . 69.5 mt-30 -142.63 178.47 7.6 Favored 'General case' 0 C--N 1.328 -0.329 0 O-C-N 122.091 -0.381 . . . . 0.0 111.523 -170.095 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.543 ' HG2' HG23 ' A' ' 82' ' ' VAL . 50.4 mt-10 -123.17 120.35 32.93 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.449 -0.796 . . . . 0.0 108.976 171.09 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 50.9 m -70.0 178.03 2.9 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -172.625 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -59.31 152.83 51.41 Favored Pre-proline 0 N--CA 1.451 -0.413 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.539 179.028 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -87.0 138.47 4.97 Favored 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 122.53 2.153 . . . . 0.0 114.269 -177.42 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.895 ' O ' ' HA ' ' A' ' 78' ' ' THR . 7.1 t -82.28 125.78 39.88 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.746 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 165.929 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 4.5 t -122.16 107.08 18.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 C-N-CA 119.83 -0.748 . . . . 0.0 110.121 173.276 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.542 HG13 ' HB ' ' A' ' 77' ' ' ILE . 6.5 pt -124.96 114.94 42.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.878 177.449 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.558 ' HB2' ' OE1' ' A' ' 74' ' ' GLN . 11.3 pt20 -100.92 120.78 40.66 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.553 0.692 . . . . 0.0 111.598 -175.077 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -134.23 132.25 39.48 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.546 178.103 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.51 ' HB2' ' HG2' ' A' ' 74' ' ' GLN . 35.8 tt0 -87.0 142.3 28.04 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.016 0.436 . . . . 0.0 110.259 179.898 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 31.6 p -68.39 134.49 50.3 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.297 -178.102 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 11.8 m . . . . . 0 C--N 1.328 -0.361 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.665 -177.893 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.738 0 N-CA-C 111.88 -0.488 . . . . 0.0 111.88 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.5 m 60.43 57.29 2.88 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.152 0.501 . . . . 0.0 110.47 -178.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 49.1 t-80 -61.32 -35.83 78.46 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.382 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 85.0 mmm -98.9 38.63 1.35 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.168 178.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -108.37 25.07 20.99 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.268 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.9 p -71.36 -39.8 71.06 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.009 0.433 . . . . 0.0 111.309 -178.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.4 m -88.72 -4.17 58.6 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.628 0.728 . . . . 0.0 109.944 178.194 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 26.9 m -80.38 126.23 30.91 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.823 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -98.07 126.23 41.0 Favored Pre-proline 0 C--N 1.321 -0.634 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 176.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -65.28 145.81 84.61 Favored 'Trans proline' 0 C--O 1.234 0.289 0 C-N-CA 122.36 2.04 . . . . 0.0 112.498 -177.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.3 p-10 -95.94 164.55 12.67 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.268 -178.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -97.37 162.75 21.58 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.806 -179.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -72.86 128.34 13.15 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.264 1.976 . . . . 0.0 111.476 174.058 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.568 ' HD2' ' O ' ' A' ' 31' ' ' SER . 89.2 Cg_exo -48.33 146.2 10.4 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.837 2.358 . . . . 0.0 111.933 174.178 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.456 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 9.1 p-10 -36.76 107.12 0.36 Allowed Pre-proline 0 N--CA 1.468 0.446 0 O-C-N 124.806 1.316 . . . . 0.0 112.74 -169.147 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.634 ' HG2' HG11 ' A' ' 91' ' ' VAL . 27.4 Cg_exo -66.86 152.3 80.71 Favored 'Trans proline' 0 C--O 1.233 0.273 0 C-N-CA 123.62 2.88 . . . . 0.0 112.643 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.8 m -107.05 130.62 54.63 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.987 -177.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.475 HG22 HG12 ' A' ' 28' ' ' VAL . 77.0 t -78.25 122.22 32.76 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-N 114.812 -1.085 . . . . 0.0 109.881 172.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -87.16 -42.08 13.27 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.918 -175.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -134.48 139.07 45.22 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.464 -175.458 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.447 ' HA ' HG12 ' A' ' 26' ' ' ILE . 61.2 t -130.88 123.78 54.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.472 178.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -133.59 -159.47 0.97 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.11 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 17.7 p-10 -76.37 -57.68 3.72 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.199 0.524 . . . . 0.0 111.262 -178.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.62 HG22 ' O ' ' A' ' 69' ' ' LEU . 33.8 p -119.43 32.81 5.91 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.516 -172.239 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.627 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 68.4 m -168.07 130.47 1.5 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.201 -173.129 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.626 ' HB ' HD12 ' A' ' 66' ' ' LEU . 33.1 mt -145.08 141.71 22.86 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.888 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 175.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 40.6 t -116.69 132.93 64.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 C-N-CA 119.71 -0.796 . . . . 0.0 110.17 -175.271 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.584 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.7 OUTLIER -127.76 147.35 32.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 C-N-CA 120.397 -0.521 . . . . 0.0 110.052 -179.126 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.44 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 20.9 mtp180 -133.29 120.77 21.49 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.203 -174.466 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.814 ' HZ3' HG12 ' A' ' 64' ' ' VAL . 41.3 p90 -113.23 149.65 33.48 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.343 -173.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.568 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 20.5 m -98.25 98.14 9.44 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.097 178.168 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.645 ' H ' ' CD ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -45.82 156.26 0.45 Allowed Pre-proline 0 CA--C 1.539 0.54 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 -173.49 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.708 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 2.9 Cg_exo -78.57 170.64 17.99 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 124.844 3.696 . . . . 0.0 113.496 -170.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -76.8 -20.96 55.81 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.832 -1.076 . . . . 0.0 109.218 173.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -70.19 137.77 86.91 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.856 175.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.405 ' O ' ' HG2' ' A' ' 83' ' ' GLU . 6.7 Cg_exo -73.5 114.93 4.17 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 121.468 1.446 . . . . 0.0 109.51 167.638 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.563 HG21 ' HB1' ' A' ' 81' ' ' ALA . 0.2 OUTLIER -111.8 160.44 11.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -174.121 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.4 p -93.23 -32.21 14.45 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.497 ' C ' HG12 ' A' ' 82' ' ' VAL . . . -167.85 -164.56 23.74 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.11 -1.043 . . . . 0.0 111.614 179.344 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.708 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 6.2 m-85 -140.33 135.52 32.27 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-N 117.111 0.456 . . . . 0.0 111.416 176.219 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.435 ' C ' HG13 ' A' ' 42' ' ' ILE . 25.1 mtp180 -103.48 151.09 23.24 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 167.053 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.865 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 29.3 mt -139.54 107.86 3.22 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 C-N-CA 120.312 -0.555 . . . . 0.0 112.112 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 71.2 t -106.3 110.24 30.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.151 0.5 . . . . 0.0 110.704 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.583 ' HA ' ' O ' ' A' ' 76' ' ' ASN . 0.8 OUTLIER -113.28 125.47 54.33 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.661 176.26 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.412 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 26.1 p -139.13 143.88 38.53 Favored Pre-proline 0 C--N 1.317 -0.817 0 CA-C-N 114.007 -1.451 . . . . 0.0 111.792 -173.253 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.564 ' HB3' HG11 ' A' ' 73' ' ' VAL . 4.7 Cg_exo -74.03 137.43 24.07 Favored 'Trans proline' 0 C--O 1.234 0.284 0 C-N-CA 123.082 2.522 . . . . 0.0 111.467 175.206 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 7.3 m -65.71 -26.92 67.98 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.091 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 19.3 m -99.02 12.33 5.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.206 0.527 . . . . 0.0 110.522 175.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 68.7 157.1 0.14 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.629 -1.169 . . . . 0.0 111.829 -177.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 156.91 -125.46 1.59 Allowed Glycine 0 N--CA 1.445 -0.766 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 -176.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 23.0 m -86.97 117.09 25.46 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 117.228 0.514 . . . . 0.0 110.286 177.348 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 8.4 p -120.65 146.09 46.76 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.974 175.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.565 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 71.2 m -147.71 148.62 31.19 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.248 -0.581 . . . . 0.0 112.006 -179.161 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.865 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 41.6 tt0 -114.67 115.41 27.07 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.7 172.186 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.676 HD12 ' CG2' ' A' ' 64' ' ' VAL . 16.7 mt -96.44 157.97 15.65 Favored 'General case' 0 CA--C 1.513 -0.475 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.038 175.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.438 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 25.0 t-20 -120.21 115.73 24.2 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 178.404 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.571 HD12 ' CH2' ' A' ' 30' ' ' TRP . 2.5 mt -113.4 156.02 43.83 Favored Pre-proline 0 N--CA 1.443 -0.781 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 -177.362 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -63.65 150.87 87.43 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 121.687 1.591 . . . . 0.0 111.3 175.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -45.41 -28.54 0.89 Allowed 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 114.738 -1.119 . . . . 0.0 112.972 178.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 10.2 t -104.39 11.21 34.89 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.223 0.535 . . . . 0.0 111.126 -174.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.486 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -75.51 159.92 30.76 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 178.129 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.572 ' HB3' ' NE ' ' A' ' 32' ' ' ARG . 4.6 p-10 -146.41 17.53 1.34 Allowed 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 120.724 -0.391 . . . . 0.0 112.045 -177.301 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.584 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 39.3 p -171.4 134.37 0.87 Allowed 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.529 -0.469 . . . . 0.0 111.729 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.814 HG12 ' HZ3' ' A' ' 30' ' ' TRP . 3.2 p -119.17 136.5 56.16 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 CA-C-N 116.358 -0.383 . . . . 0.0 109.992 174.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 63.0 m -95.67 100.47 12.19 Favored 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 168.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.726 HD11 HG12 ' A' ' 77' ' ' ILE . 0.3 OUTLIER -75.03 136.74 41.21 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.167 179.918 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 7.4 t -132.16 164.61 25.94 Favored 'General case' 0 C--N 1.316 -0.856 0 O-C-N 123.705 0.628 . . . . 0.0 109.458 -173.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 26.4 t0 58.71 50.72 8.47 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 123.81 0.694 . . . . 0.0 110.692 -177.11 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.62 ' O ' HG22 ' A' ' 24' ' ' THR . 11.9 mt -90.18 -176.24 4.79 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 172.442 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 57.6 tp60 -123.62 125.53 25.98 Favored Pre-proline 0 C--N 1.32 -0.691 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 174.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -62.01 140.77 86.32 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 123.05 2.5 . . . . 0.0 113.269 -178.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 75.57 29.6 59.46 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.918 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.564 HG11 ' HB3' ' A' ' 46' ' ' PRO . 61.0 t -131.42 148.09 32.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.276 0.56 . . . . 0.0 111.145 -176.041 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.554 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -82.81 127.79 33.79 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.412 179.18 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.432 ' CZ ' ' HG3' ' A' ' 46' ' ' PRO . 3.8 m-85 -122.37 116.07 23.39 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.401 0.62 . . . . 0.0 112.521 -176.03 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.583 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 4.0 m-20 -85.92 112.91 21.61 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.597 172.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.726 HG12 HD11 ' A' ' 66' ' ' LEU . 5.0 mp -95.79 115.9 36.11 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.597 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 172.553 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.879 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 21.9 m -108.88 113.6 26.66 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.26 -178.674 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.542 ' HB ' ' HB ' ' A' ' 91' ' ' VAL . 12.8 mm -95.04 138.41 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.412 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 82.8 m-85 -124.67 111.29 15.42 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.161 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.563 ' HB1' HG21 ' A' ' 37' ' ' ILE . . . -81.05 111.24 17.34 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 171.264 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.497 HG12 ' C ' ' A' ' 39' ' ' GLY . 7.1 p -104.5 136.72 36.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 C-N-CA 120.021 -0.672 . . . . 0.0 110.717 -175.474 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.405 ' HG2' ' O ' ' A' ' 36' ' ' PRO . 4.3 tm-20 -121.39 163.28 18.95 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -47.74 -46.59 30.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 118.341 0.519 . . . . 0.0 111.426 -178.136 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 -89.97 -34.6 15.95 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -170.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -150.77 171.84 16.54 Favored 'General case' 0 C--O 1.222 -0.347 0 C-N-CA 120.619 -0.432 . . . . 0.0 111.528 -168.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -114.57 129.06 56.63 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.321 175.034 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 17.1 m -66.95 169.33 8.39 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.075 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.5 p -57.76 151.13 43.92 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-O 120.968 0.413 . . . . 0.0 110.784 176.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -84.14 141.6 9.36 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 122.159 1.906 . . . . 0.0 113.989 -174.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.879 ' O ' ' HA ' ' A' ' 78' ' ' THR . 12.5 t -81.93 121.83 35.82 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.717 0 CA-C-N 114.855 -1.066 . . . . 0.0 108.196 168.678 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 5.9 t -117.87 105.72 18.48 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 C-N-CA 119.552 -0.859 . . . . 0.0 109.897 172.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.588 HG13 ' HB ' ' A' ' 77' ' ' ILE . 8.0 pt -123.26 115.48 45.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.379 176.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.515 ' HB2' ' OE1' ' A' ' 74' ' ' GLN . 5.1 pt20 -103.31 126.46 50.49 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.351 0.596 . . . . 0.0 111.103 -174.567 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -128.94 134.46 48.22 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.088 177.115 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.5 ' HG2' ' HG2' ' A' ' 74' ' ' GLN . 45.1 mt-10 -86.59 133.12 33.74 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 175.014 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 37.9 p -72.75 113.85 10.24 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.161 0.505 . . . . 0.0 110.724 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 14.3 m -69.52 -32.19 70.88 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.421 0.629 . . . . 0.0 110.223 -177.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 103.27 -163.38 15.77 Favored Glycine 0 N--CA 1.442 -0.949 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.704 176.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 47.4 m -75.38 127.72 85.68 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 115.448 -0.376 . . . . 0.0 110.539 178.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -47.57 102.81 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 123.467 2.778 . . . . 0.0 113.18 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -102.08 112.51 25.19 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.814 177.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 16.2 m 58.24 42.55 21.72 Favored 'General case' 0 C--N 1.33 -0.245 0 O-C-N 123.776 0.672 . . . . 0.0 110.562 179.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -70.05 105.55 2.92 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.583 -178.144 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 109.35 119.81 4.24 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.119 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.8 m . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.799 -0.62 . . . . 0.0 110.324 178.855 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.644 0 N-CA-C 111.649 -0.581 . . . . 0.0 111.649 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.2 m -65.76 -45.34 82.93 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.015 0.436 . . . . 0.0 110.459 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 57.2 t60 -84.08 106.0 15.39 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.89 179.002 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 24.8 mmt -76.38 147.45 38.03 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.216 178.305 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 108.34 137.5 8.18 Favored Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 111.382 -0.687 . . . . 0.0 111.382 -176.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 84.0 m -147.21 114.1 6.12 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.875 0.369 . . . . 0.0 110.886 -178.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.5 p -99.97 -65.13 0.98 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.182 177.17 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 44.1 m 68.98 125.15 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.365 0 CA-C-O 121.399 0.619 . . . . 0.0 111.801 176.579 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -110.21 117.37 51.68 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.481 179.359 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -76.29 153.06 35.52 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 123.105 2.537 . . . . 0.0 112.466 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -103.69 144.42 31.48 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.462 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.538 ' HB2' ' O ' ' A' ' 89' ' ' THR . . . -74.02 151.83 88.48 Favored Pre-proline 0 C--N 1.319 -0.739 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.803 174.365 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -56.88 129.03 32.4 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.347 2.031 . . . . 0.0 112.079 174.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.449 ' HD2' ' O ' ' A' ' 31' ' ' SER . 85.5 Cg_exo -46.43 146.82 4.64 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.702 2.268 . . . . 0.0 111.422 171.189 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -36.79 106.17 0.32 Allowed Pre-proline 0 N--CA 1.472 0.628 0 O-C-N 124.654 1.221 . . . . 0.0 112.694 -168.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.634 ' HG2' HG11 ' A' ' 91' ' ' VAL . 37.9 Cg_exo -65.34 150.58 87.03 Favored 'Trans proline' 0 CA--C 1.52 -0.204 0 C-N-CA 123.501 2.8 . . . . 0.0 112.33 178.718 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 20.2 m -107.0 130.49 54.63 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.037 -176.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.488 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 82.1 t -83.33 121.37 36.09 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-N 114.435 -1.257 . . . . 0.0 109.908 174.288 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.532 ' OD1' ' HG3' ' A' ' 20' ' ' GLN . 13.5 t70 -80.96 -48.13 12.71 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.108 -174.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.532 ' HG3' ' OD1' ' A' ' 19' ' ' ASP . 94.8 mt-30 -136.07 140.73 44.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.694 -177.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.525 ' HA ' HG12 ' A' ' 26' ' ' ILE . 6.4 m -126.0 101.33 8.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.159 178.455 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.406 ' HB3' ' H ' ' A' ' 23' ' ' ASP . 12.3 m-20 -97.65 -160.12 0.78 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.151 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.531 ' CA ' ' HA2' ' A' ' 99' ' ' GLY . 11.5 p-10 -78.86 -52.66 8.0 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.253 0.549 . . . . 0.0 110.622 177.637 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.747 HG22 ' O ' ' A' ' 69' ' ' LEU . 26.6 p -121.81 34.6 5.13 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.984 -172.45 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.651 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 66.1 m -169.19 130.43 1.14 Allowed 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.424 -172.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.578 ' HB ' HD12 ' A' ' 66' ' ' LEU . 20.5 mt -144.83 137.39 21.73 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.786 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 177.628 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 41.1 t -115.67 128.67 72.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 C-N-CA 119.632 -0.827 . . . . 0.0 110.438 -175.651 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.65 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.7 OUTLIER -125.12 144.65 34.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 C-N-CA 120.546 -0.461 . . . . 0.0 109.916 -177.55 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.531 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 23.0 mtm180 -129.88 121.0 25.82 Favored 'General case' 0 C--N 1.327 -0.393 0 O-C-N 123.239 0.337 . . . . 0.0 110.573 -176.194 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.734 ' HZ3' HG12 ' A' ' 64' ' ' VAL . 33.8 p90 -107.88 144.58 34.91 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.176 -173.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.449 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 16.1 m -85.64 89.85 7.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.493 178.406 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.705 ' HD3' ' H ' ' A' ' 32' ' ' ARG . 0.4 OUTLIER -46.07 152.35 0.8 Allowed Pre-proline 0 CA--C 1.538 0.486 0 C-N-CA 124.189 0.996 . . . . 0.0 113.014 -175.549 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.687 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 2.2 Cg_endo -86.03 166.42 9.78 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 124.273 3.315 . . . . 0.0 113.318 -169.456 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -76.27 -20.86 56.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.319 172.214 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.32 136.24 91.56 Favored Pre-proline 0 N--CA 1.453 -0.311 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.754 175.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -70.21 113.19 3.37 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 121.072 1.181 . . . . 0.0 109.593 170.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.505 HG22 ' HG2' ' A' ' 83' ' ' GLU . 24.9 pt -117.9 153.42 19.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.797 -174.621 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.448 ' C ' ' HB3' ' A' ' 59' ' ' GLU . 9.1 p -94.88 -24.4 17.02 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.547 ' C ' HG12 ' A' ' 82' ' ' VAL . . . -174.8 -161.67 24.97 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 119.732 -1.223 . . . . 0.0 113.304 -179.063 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.687 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 41.8 m-85 -139.54 131.49 27.76 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 122.364 0.266 . . . . 0.0 111.25 174.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.408 ' HB2' ' CD1' ' A' ' 80' ' ' TYR . 14.3 mmm-85 -96.21 148.76 22.38 Favored 'General case' 0 CA--C 1.504 -0.812 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 165.533 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.876 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 28.4 mt -139.0 107.84 3.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 C-N-CA 119.74 -0.784 . . . . 0.0 112.439 -179.567 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 71.9 t -109.04 109.93 30.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.396 0.617 . . . . 0.0 110.719 179.181 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.697 ' CZ ' ' HB ' ' A' ' 53' ' ' THR . 0.6 OUTLIER -112.77 125.57 54.48 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.322 176.747 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.4 m -139.97 141.16 26.17 Favored Pre-proline 0 C--N 1.317 -0.842 0 CA-C-N 114.282 -1.326 . . . . 0.0 111.429 -173.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.684 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 59.9 Cg_endo -68.89 156.29 65.84 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 123.66 2.907 . . . . 0.0 112.01 177.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 67.3 m -85.83 -29.71 23.54 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.724 -178.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 89.5 t -115.77 -42.21 3.28 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 C-N-CA 120.796 -0.361 . . . . 0.0 111.578 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -179.82 142.64 0.16 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.446 ' CA ' ' HG3' ' A' ' 46' ' ' PRO . . . 157.76 -160.18 30.48 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.866 -0.683 . . . . 0.0 111.963 -177.741 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.508 ' O ' ' HE1' ' A' ' 75' ' ' TYR . 19.4 m -94.83 121.6 36.6 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 -177.369 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.505 ' HA ' ' O ' ' A' ' 44' ' ' TYR . 15.1 m -102.77 139.94 37.69 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 172.53 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.697 ' HB ' ' CZ ' ' A' ' 44' ' ' TYR . 23.6 m -147.27 153.29 39.58 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 120.61 -0.436 . . . . 0.0 111.13 -179.399 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.876 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 30.8 tt0 -122.35 112.4 18.06 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 123.025 0.53 . . . . 0.0 109.673 175.663 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.682 HD12 ' CG2' ' A' ' 64' ' ' VAL . 15.8 mt -97.8 159.97 14.6 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.584 177.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -123.95 114.56 19.95 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.076 179.031 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.588 HD12 ' CH2' ' A' ' 30' ' ' TRP . 3.8 mt -113.69 154.65 45.68 Favored Pre-proline 0 C--N 1.318 -0.778 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -176.715 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -61.34 150.56 84.33 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 121.987 1.792 . . . . 0.0 111.18 176.193 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.448 ' HB3' ' C ' ' A' ' 38' ' ' THR . 11.4 pt-20 -46.26 -30.0 1.84 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.032 -0.985 . . . . 0.0 112.499 176.203 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 7.4 t -99.89 17.37 21.02 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.045 -175.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.476 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -88.48 151.46 22.53 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.165 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.531 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 24.6 p-10 -136.58 13.95 3.19 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.871 -177.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.65 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 71.6 p -167.51 134.39 2.25 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.336 -0.546 . . . . 0.0 111.678 -177.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.734 HG12 ' HZ3' ' A' ' 30' ' ' TRP . 4.2 p -115.06 138.72 44.44 Favored 'Isoleucine or valine' 0 C--O 1.243 0.727 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.226 175.71 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 55.5 m -97.7 100.88 12.28 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.58 169.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.721 HD11 HG12 ' A' ' 77' ' ' ILE . 0.7 OUTLIER -76.46 144.46 39.88 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.2 177.415 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.1 p -141.85 164.74 29.38 Favored 'General case' 0 C--N 1.32 -0.675 0 O-C-N 123.501 0.501 . . . . 0.0 110.955 -172.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 28.8 t70 65.86 26.54 11.12 Favored 'General case' 0 N--CA 1.465 0.294 0 O-C-N 123.923 0.765 . . . . 0.0 110.824 -178.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.747 ' O ' HG22 ' A' ' 24' ' ' THR . 14.9 mt -70.65 -175.01 0.97 Allowed 'General case' 0 C--O 1.222 -0.349 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.948 176.335 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.456 ' HB2' HG21 ' A' ' 73' ' ' VAL . 16.8 mm-40 -129.27 133.28 24.97 Favored Pre-proline 0 C--N 1.319 -0.719 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 176.686 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -64.57 128.1 20.43 Favored 'Trans proline' 0 C--O 1.234 0.276 0 C-N-CA 122.921 2.414 . . . . 0.0 112.755 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 90.8 14.95 57.36 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.321 178.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.456 HG21 ' HB2' ' A' ' 70' ' ' GLN . 72.0 t -114.78 141.09 32.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.219 0.533 . . . . 0.0 111.602 -175.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.684 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -80.49 122.26 26.79 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.626 179.238 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.508 ' HE1' ' O ' ' A' ' 51' ' ' SER . 23.8 m-85 -118.17 113.71 21.96 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.377 0.608 . . . . 0.0 112.377 -176.651 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.552 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 20.5 m-80 -87.28 108.26 18.87 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.681 175.768 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.721 HG12 HD11 ' A' ' 66' ' ' LEU . 5.4 mp -92.55 115.29 31.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.298 0.571 . . . . 0.0 109.883 176.658 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.858 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 51.9 m -107.64 115.89 30.95 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.019 179.445 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.624 ' HB ' ' HB ' ' A' ' 91' ' ' VAL . 19.1 mm -95.91 143.04 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 -178.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.473 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 47.2 m-85 -128.35 111.83 13.77 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 178.091 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.489 ' HB1' HG21 ' A' ' 37' ' ' ILE . . . -79.82 107.96 13.0 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 173.036 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.547 HG12 ' C ' ' A' ' 39' ' ' GLY . 9.5 p -99.4 135.62 33.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 C-N-CA 120.132 -0.627 . . . . 0.0 110.678 -175.555 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.505 ' HG2' HG22 ' A' ' 37' ' ' ILE . 4.5 mt-10 -111.06 171.07 7.69 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 175.535 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -44.64 -47.09 10.47 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 123.797 0.686 . . . . 0.0 112.378 -178.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -106.14 -21.06 13.22 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -169.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -149.61 176.93 10.21 Favored 'General case' 0 C--O 1.219 -0.515 0 CA-C-N 118.696 0.68 . . . . 0.0 111.813 -174.143 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -117.6 134.36 54.97 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 177.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 10.7 m -73.84 -179.98 3.96 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.832 0.348 . . . . 0.0 111.223 -176.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.538 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 0.8 OUTLIER -61.74 159.43 34.7 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.587 176.176 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -88.78 140.96 4.35 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 122.418 2.079 . . . . 0.0 114.361 -177.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.858 ' O ' ' HA ' ' A' ' 78' ' ' THR . 5.6 t -83.08 128.67 38.5 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.7 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 164.15 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 4.1 t -123.22 106.87 18.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 C-N-CA 119.987 -0.685 . . . . 0.0 110.113 171.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.539 HG13 ' HB ' ' A' ' 77' ' ' ILE . 6.7 pt -126.77 111.48 26.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.895 177.124 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.499 ' HB2' HE22 ' A' ' 74' ' ' GLN . 17.9 pt20 -102.6 120.51 40.67 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.673 0.749 . . . . 0.0 111.524 -175.613 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -128.1 135.9 50.44 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.2 -179.1 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -87.04 146.46 26.09 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 176.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 20.7 p -81.38 120.08 24.51 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.104 178.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 85.7 m -70.17 -31.82 69.48 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.501 0.667 . . . . 0.0 110.58 178.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.531 ' HA2' ' CA ' ' A' ' 23' ' ' ASP . . . 83.59 -137.91 16.88 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.908 178.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 23.3 m -90.53 118.78 68.98 Favored Pre-proline 0 C--N 1.319 -0.748 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 175.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_exo -52.01 105.93 0.13 Allowed 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 123.117 2.545 . . . . 0.0 112.854 -178.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 32.2 tpt180 -148.27 87.9 1.62 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.694 179.198 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 50.6 m -87.25 62.45 7.26 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.964 -178.271 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -92.92 8.89 37.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.246 0.546 . . . . 0.0 109.708 177.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -73.51 100.87 1.11 Allowed Glycine 0 N--CA 1.444 -0.82 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.282 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 22.3 m . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.937 -0.554 . . . . 0.0 109.641 177.668 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.597 0 N-CA-C 111.997 -0.441 . . . . 0.0 111.997 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.1 p -84.06 -25.17 30.04 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.03 0.443 . . . . 0.0 110.827 -178.114 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 41.3 m-70 -85.82 95.49 9.44 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.667 179.111 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 25.2 ptm -156.86 43.37 0.37 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.483 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -63.05 -31.3 80.24 Favored Glycine 0 N--CA 1.453 -0.228 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.18 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.0 p -66.58 127.35 32.02 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.776 0.322 . . . . 0.0 111.226 177.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 37.6 m -70.97 112.26 6.99 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.445 178.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 53.7 m -73.79 128.97 36.95 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.081 -178.384 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -105.4 100.05 23.92 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.748 173.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -80.42 174.1 11.65 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.908 2.405 . . . . 0.0 112.741 -177.239 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -126.11 155.12 42.13 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.012 -178.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -95.91 160.78 29.34 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.509 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -70.58 132.67 22.48 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.479 2.119 . . . . 0.0 111.45 174.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -53.81 159.52 6.92 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.687 2.258 . . . . 0.0 111.314 172.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -39.27 106.24 0.39 Allowed Pre-proline 0 N--CA 1.469 0.491 0 O-C-N 124.313 1.008 . . . . 0.0 111.918 -173.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.556 ' HG2' HG11 ' A' ' 91' ' ' VAL . 38.2 Cg_exo -65.22 144.82 82.45 Favored 'Trans proline' 0 CA--C 1.517 -0.339 0 C-N-CA 122.999 2.466 . . . . 0.0 111.925 178.245 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 39.6 m -97.91 124.72 42.47 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.665 -177.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.452 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 85.2 t -78.46 118.37 25.52 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-N 114.479 -1.237 . . . . 0.0 109.17 172.438 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -89.69 -37.13 14.81 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.283 -174.047 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 24.8 mm-40 -134.59 129.66 35.31 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.941 0.401 . . . . 0.0 110.66 -176.215 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.439 ' HA ' HG12 ' A' ' 26' ' ' ILE . 85.7 t -126.39 120.52 56.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.724 -178.253 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -125.41 -167.77 1.74 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.813 176.355 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.521 ' O ' ' HB2' ' A' ' 69' ' ' LEU . 4.1 p-10 -67.28 -59.16 3.65 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.173 0.511 . . . . 0.0 111.331 176.596 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.688 HG22 ' O ' ' A' ' 69' ' ' LEU . 36.0 p -117.32 36.83 4.08 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.991 -173.019 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.666 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 66.1 m -168.65 130.28 1.29 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.059 -176.229 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.618 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 34.1 mt -148.14 136.63 15.1 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.539 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 176.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.452 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 41.3 t -116.79 127.84 74.31 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.602 0 C-N-CA 120.054 -0.658 . . . . 0.0 110.693 -174.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.626 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.8 OUTLIER -122.52 143.5 35.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -176.97 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.477 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 63.8 mtp180 -130.14 121.01 25.49 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.912 0.387 . . . . 0.0 110.568 -175.349 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.707 ' HZ3' HG12 ' A' ' 64' ' ' VAL . 34.9 p90 -110.69 141.49 43.89 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.504 -173.66 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 17.6 m -83.63 86.61 7.09 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.02 -0.537 . . . . 0.0 109.725 175.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.442 ' CD ' ' HB3' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -48.28 156.83 0.74 Allowed Pre-proline 0 CA--C 1.541 0.598 0 CA-C-N 114.87 -1.059 . . . . 0.0 113.267 -176.184 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.674 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 3.1 Cg_exo -81.03 169.85 15.8 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 124.341 3.361 . . . . 0.0 113.538 -171.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 19.0 mp0 -91.35 -7.33 51.21 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.662 176.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -69.37 144.08 94.2 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.204 175.25 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -70.64 113.24 3.45 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 121.071 1.18 . . . . 0.0 109.766 171.009 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.913 HG22 ' HG3' ' A' ' 83' ' ' GLU . 3.5 pt -119.91 157.56 22.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.403 -173.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.485 HG21 ' HA ' ' A' ' 84' ' ' GLU . 16.6 p -101.29 -22.85 14.51 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -176.136 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.578 ' C ' HG12 ' A' ' 82' ' ' VAL . . . -177.01 -165.43 32.38 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 119.6 -1.286 . . . . 0.0 112.371 179.017 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.674 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 6.3 m-85 -139.24 134.38 32.6 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.773 0.32 . . . . 0.0 110.875 173.512 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.7 mmm180 -100.97 148.07 25.44 Favored 'General case' 0 CA--C 1.501 -0.906 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 165.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.892 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 33.6 mt -138.25 109.53 5.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 C-N-CA 119.881 -0.728 . . . . 0.0 112.319 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 69.9 t -110.77 110.12 31.02 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.525 0 CA-C-O 121.391 0.615 . . . . 0.0 110.695 -179.2 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.712 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 0.8 OUTLIER -112.46 124.49 52.62 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.428 177.06 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.455 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 17.8 p -139.08 137.17 18.92 Favored Pre-proline 0 C--N 1.314 -0.975 0 CA-C-N 114.135 -1.393 . . . . 0.0 111.525 -173.678 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.56 ' HG3' ' CZ ' ' A' ' 75' ' ' TYR . 8.0 Cg_exo -69.55 131.15 20.92 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.978 2.452 . . . . 0.0 110.821 174.635 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 12.6 m -55.39 -33.5 63.52 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.289 -0.869 . . . . 0.0 112.526 -173.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 12.7 m -109.89 -41.15 4.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -175.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 178.63 148.77 0.2 Allowed 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 -175.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.437 ' CA ' ' HG2' ' A' ' 46' ' ' PRO . . . 140.64 -160.61 26.57 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.47 178.611 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 20.2 m -84.69 122.98 29.85 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.524 0.202 . . . . 0.0 111.446 -177.107 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.7 p -117.31 140.38 49.63 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 175.016 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.712 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 29.1 m -146.0 150.23 35.63 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.655 -173.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.892 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 56.6 tt0 -114.93 118.35 33.23 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.935 173.238 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.73 HD12 ' CG2' ' A' ' 64' ' ' VAL . 21.9 mt -100.23 148.34 24.74 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.54 -0.464 . . . . 0.0 109.902 173.275 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -109.86 114.14 27.46 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 176.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.563 HD12 ' CH2' ' A' ' 30' ' ' TRP . 1.7 mt -109.96 152.51 43.07 Favored Pre-proline 0 N--CA 1.444 -0.766 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 -177.66 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -60.9 149.2 89.74 Favored 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 121.952 1.768 . . . . 0.0 111.389 176.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.476 ' HB3' ' C ' ' A' ' 38' ' ' THR . 9.6 pt-20 -46.92 -22.78 0.36 Allowed 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 114.848 -1.069 . . . . 0.0 113.019 176.586 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.2 t -107.3 15.84 24.6 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.135 -176.133 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.48 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -82.17 164.3 21.36 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.504 -0.317 . . . . 0.0 110.423 -179.642 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.477 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 4.6 p-10 -149.19 11.27 0.8 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -177.102 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.626 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 21.9 p -168.7 134.11 1.69 Allowed 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.346 -0.542 . . . . 0.0 111.996 -178.689 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.73 ' CG2' HD12 ' A' ' 55' ' ' LEU . 4.1 p -117.02 136.78 53.08 Favored 'Isoleucine or valine' 0 C--O 1.242 0.673 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.288 176.488 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 41.9 m -98.93 102.03 13.62 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-O 121.411 0.624 . . . . 0.0 109.795 170.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.667 HD11 HG12 ' A' ' 77' ' ' ILE . 0.2 OUTLIER -79.24 142.22 36.41 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.118 178.422 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.8 t -136.51 169.6 17.42 Favored 'General case' 0 C--N 1.32 -0.681 0 O-C-N 123.274 0.359 . . . . 0.0 110.559 -175.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 58.71 32.99 22.76 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.634 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.688 ' O ' HG22 ' A' ' 24' ' ' THR . 11.8 mt -71.88 -176.39 1.68 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.755 176.111 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -124.56 126.43 25.42 Favored Pre-proline 0 C--N 1.32 -0.714 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 175.158 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -63.58 132.44 35.48 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.183 2.589 . . . . 0.0 113.62 -176.509 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 87.92 21.58 45.85 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.311 177.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.495 HG11 ' HB3' ' A' ' 46' ' ' PRO . 18.7 t -125.53 148.2 30.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.328 0.585 . . . . 0.0 111.463 -176.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.48 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 4.3 tp-100 -81.48 114.28 20.1 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.937 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.56 ' CZ ' ' HG3' ' A' ' 46' ' ' PRO . 6.1 m-85 -104.83 115.19 29.87 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.291 0.567 . . . . 0.0 112.02 -178.024 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.556 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 14.2 m120 -87.72 105.42 17.36 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.64 175.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.667 HG12 HD11 ' A' ' 66' ' ' LEU . 5.2 mp -91.44 117.27 34.36 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.575 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 175.699 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.88 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 90.4 m -109.2 115.39 29.92 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.779 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.555 ' HB ' ' HB ' ' A' ' 91' ' ' VAL . 12.4 mm -96.16 121.07 46.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.915 -179.375 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -108.12 111.11 22.97 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 176.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -80.15 123.61 28.05 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 169.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.578 HG12 ' C ' ' A' ' 39' ' ' GLY . 12.7 p -115.67 134.47 58.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 C-N-CA 120.053 -0.659 . . . . 0.0 110.889 -176.436 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.913 ' HG3' HG22 ' A' ' 37' ' ' ILE . 8.6 mp0 -112.48 171.61 7.42 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -177.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.485 ' HA ' HG21 ' A' ' 38' ' ' THR . 39.1 mt-10 -42.12 -44.93 3.83 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -174.15 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -125.66 -13.22 6.51 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.498 -0.481 . . . . 0.0 111.959 -176.331 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -128.39 173.73 9.94 Favored 'General case' 0 N--CA 1.443 -0.794 0 O-C-N 122.247 -0.283 . . . . 0.0 111.358 -171.523 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 20.4 mp0 -128.12 127.02 42.26 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.478 176.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 68.1 m -72.56 171.74 11.85 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.873 0.368 . . . . 0.0 111.797 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.2 p -60.61 150.24 75.75 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.327 177.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -85.17 141.2 8.02 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.421 2.08 . . . . 0.0 114.328 -175.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.88 ' O ' ' HA ' ' A' ' 78' ' ' THR . 7.0 t -82.65 129.39 37.53 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.641 0 CA-C-N 114.782 -1.099 . . . . 0.0 108.594 167.436 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 9.7 t -125.9 106.44 16.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 C-N-CA 120.196 -0.602 . . . . 0.0 110.057 171.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.552 HG13 ' HB ' ' A' ' 77' ' ' ILE . 5.8 pt -121.95 111.39 30.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.048 177.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.451 ' HA ' ' O ' ' A' ' 75' ' ' TYR . 0.4 OUTLIER -96.78 115.36 27.29 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.57 0.7 . . . . 0.0 111.184 -178.801 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -122.67 131.79 53.97 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.471 177.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -86.79 134.12 33.59 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.214 0.531 . . . . 0.0 110.135 179.003 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 24.1 p -66.08 120.86 13.92 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.437 178.244 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.6 m -68.29 -30.69 69.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.342 0.591 . . . . 0.0 110.247 -177.164 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.78 -150.99 20.28 Favored Glycine 0 N--CA 1.441 -0.985 0 CA-C-N 115.331 -0.849 . . . . 0.0 112.297 175.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.496 HG22 ' H ' ' A' ' 102' ' ' ARG . 40.2 m -106.07 128.76 25.74 Favored Pre-proline 0 C--N 1.316 -0.865 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 100' ' ' THR . 52.0 Cg_exo -55.51 -26.82 56.34 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 123.253 2.635 . . . . 0.0 112.305 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.57 ' HB3' ' OD1' ' A' ' 104' ' ' ASP . 69.3 mtp180 -88.41 121.11 30.43 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.059 175.375 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 5.1 p -94.2 9.58 37.37 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.104 0.478 . . . . 0.0 111.024 -178.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.57 ' OD1' ' HB3' ' A' ' 102' ' ' ARG . 6.7 p-10 -89.57 175.13 7.4 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.872 177.002 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 141.24 -54.32 0.63 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.911 -0.661 . . . . 0.0 111.93 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 20.7 m . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.828 -0.606 . . . . 0.0 109.818 177.092 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.642 0 N-CA-C 111.738 -0.545 . . . . 0.0 111.738 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 44.4 t 69.17 111.34 0.05 OUTLIER 'General case' 0 C--O 1.233 0.188 0 C-N-CA 123.081 0.552 . . . . 0.0 110.772 -179.287 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 41.8 m-70 60.42 57.23 2.9 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.486 -179.185 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.17 75.96 8.13 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.44 -179.486 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -79.67 -27.35 54.41 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.799 -176.259 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 13.9 m -88.93 62.12 6.21 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.43 0.633 . . . . 0.0 110.178 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.7 m -82.21 86.22 6.68 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.347 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 24.2 m -89.28 123.09 33.16 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.473 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -119.36 139.56 27.85 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.147 -177.038 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -67.06 136.94 42.7 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.231 1.954 . . . . 0.0 112.284 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -88.2 164.88 15.43 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.918 178.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -96.3 159.1 32.76 Favored Pre-proline 0 C--N 1.32 -0.687 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.882 -177.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -71.27 129.65 16.32 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 122.35 2.033 . . . . 0.0 111.284 175.166 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.54 ' HD2' ' O ' ' A' ' 31' ' ' SER . 88.5 Cg_exo -49.31 151.44 6.61 Favored 'Trans proline' 0 C--O 1.234 0.316 0 C-N-CA 122.743 2.295 . . . . 0.0 111.936 173.746 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -36.63 106.61 0.34 Allowed Pre-proline 0 N--CA 1.469 0.51 0 O-C-N 124.728 1.268 . . . . 0.0 112.324 -171.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.666 ' HG2' HG11 ' A' ' 91' ' ' VAL . 28.1 Cg_exo -68.61 143.76 57.91 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 123.442 2.761 . . . . 0.0 113.046 179.44 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 94.6 m -96.62 127.7 42.86 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.199 -177.17 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.44 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 97.3 t -79.27 116.48 23.29 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-N 114.611 -1.177 . . . . 0.0 109.337 173.253 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -86.95 -37.02 17.97 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.085 -173.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -135.6 136.55 41.13 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.235 -176.496 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.467 ' HA ' HG12 ' A' ' 26' ' ' ILE . 42.0 t -133.52 115.44 22.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.109 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.401 ' HB3' ' H ' ' A' ' 23' ' ' ASP . 8.2 m-20 -132.41 -160.37 1.04 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.269 179.392 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.401 ' H ' ' HB3' ' A' ' 22' ' ' ASP . 6.3 p-10 -68.69 -66.59 0.55 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -177.557 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.609 HG22 ' O ' ' A' ' 69' ' ' LEU . 57.2 p -115.52 36.87 3.77 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.423 0.63 . . . . 0.0 110.582 -172.523 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.602 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 32.2 p -170.2 131.21 0.97 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.673 -174.253 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.586 ' HB ' HD12 ' A' ' 66' ' ' LEU . 42.4 mt -145.97 142.07 21.62 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.771 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 178.214 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 43.6 t -119.67 134.14 64.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 118.859 0.754 . . . . 0.0 110.338 -173.697 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.544 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.7 OUTLIER -129.11 148.55 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.524 -179.261 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.639 ' HG2' ' OG ' ' A' ' 63' ' ' SER . 29.7 mtm105 -131.36 120.3 22.92 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.554 -177.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.749 ' HZ3' HG12 ' A' ' 64' ' ' VAL . 37.8 p90 -111.14 143.81 41.28 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.832 -175.687 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.54 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 17.3 t -91.17 96.44 10.58 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 177.219 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.543 ' H ' ' CD ' ' A' ' 32' ' ' ARG . 1.0 OUTLIER -49.54 158.12 0.86 Allowed Pre-proline 0 C--N 1.327 -0.372 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -173.854 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.692 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 5.1 Cg_exo -79.94 165.56 21.83 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 124.197 3.265 . . . . 0.0 112.534 -173.226 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -78.92 -10.43 59.81 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.13 -0.941 . . . . 0.0 108.933 172.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -72.23 138.42 81.54 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 114.779 -1.1 . . . . 0.0 111.315 177.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo -66.31 115.05 3.29 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 121.492 1.461 . . . . 0.0 109.738 166.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.54 HD12 ' HE1' ' A' ' 40' ' ' TYR . 0.6 OUTLIER -119.55 154.71 22.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 -177.901 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.412 ' N ' ' O ' ' A' ' 82' ' ' VAL . 9.5 p -95.74 -23.79 16.81 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -178.25 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.574 ' C ' HG12 ' A' ' 82' ' ' VAL . . . -173.61 -163.02 26.49 Favored Glycine 0 CA--C 1.502 -0.778 0 C-N-CA 119.919 -1.134 . . . . 0.0 111.887 178.458 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.692 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 6.8 m-85 -141.2 133.8 28.58 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 122.525 0.33 . . . . 0.0 111.156 174.667 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.5 mmm180 -104.61 149.87 25.16 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 167.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.888 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 33.7 mt -138.88 107.93 3.77 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 C-N-CA 120.123 -0.631 . . . . 0.0 112.106 -178.138 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 66.1 t -107.09 110.13 30.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.422 0.63 . . . . 0.0 110.572 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.645 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 0.5 OUTLIER -110.74 124.62 52.33 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.096 175.517 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.412 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 14.5 t -142.39 139.2 17.28 Favored Pre-proline 0 C--N 1.316 -0.89 0 CA-C-N 113.86 -1.518 . . . . 0.0 110.666 -172.085 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.704 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 37.2 Cg_exo -63.1 153.49 73.5 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 123.374 2.716 . . . . 0.0 112.585 176.049 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 19.9 t -72.38 -30.76 64.98 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.44 -175.431 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.3 p -117.72 -42.51 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 120.242 -0.583 . . . . 0.0 112.163 177.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -179.76 152.23 0.48 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.635 0.255 . . . . 0.0 110.523 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.492 ' CA ' ' HG2' ' A' ' 46' ' ' PRO . . . 150.77 -156.26 26.59 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 111.494 -0.642 . . . . 0.0 111.494 -179.614 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 34.8 t -87.27 122.46 31.07 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.78 0.29 . . . . 0.0 110.809 -178.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 32.7 p -117.44 145.98 43.78 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 176.241 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.645 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 24.6 m -147.87 152.87 38.34 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.756 -0.377 . . . . 0.0 111.374 -178.149 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.888 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 34.1 tt0 -116.87 118.36 32.26 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 171.467 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.7 HD12 ' CG2' ' A' ' 64' ' ' VAL . 20.5 mt -97.13 157.13 16.08 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 174.481 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -122.35 113.48 19.45 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.564 HD12 ' CH2' ' A' ' 30' ' ' TRP . 3.6 mt -112.0 155.58 43.13 Favored Pre-proline 0 N--CA 1.443 -0.782 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 -175.74 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -64.36 149.65 89.73 Favored 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 121.656 1.57 . . . . 0.0 110.945 174.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -46.56 -25.94 0.79 Allowed 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 114.722 -1.126 . . . . 0.0 113.123 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 7.9 t -101.55 5.72 41.88 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.915 0.388 . . . . 0.0 111.358 -175.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.455 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -75.95 155.99 34.59 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.433 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 4.9 p-10 -141.3 12.46 2.17 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 120.55 -0.46 . . . . 0.0 112.181 -175.722 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.639 ' OG ' ' HG2' ' A' ' 29' ' ' ARG . 9.4 m -161.94 135.88 6.6 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.981 -0.288 . . . . 0.0 110.834 -178.051 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.749 HG12 ' HZ3' ' A' ' 30' ' ' TRP . 4.2 p -121.26 135.12 62.45 Favored 'Isoleucine or valine' 0 C--O 1.24 0.605 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 172.488 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 55.2 m -97.67 100.91 12.31 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-O 121.528 0.68 . . . . 0.0 109.291 169.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.741 HD11 HG12 ' A' ' 77' ' ' ILE . 0.2 OUTLIER -77.52 141.38 39.65 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.22 -0.9 . . . . 0.0 108.958 179.824 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 22.5 t -141.42 169.63 17.25 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -174.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 34.1 t70 64.48 29.87 13.17 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 123.998 0.811 . . . . 0.0 110.307 -178.524 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.609 ' O ' HG22 ' A' ' 24' ' ' THR . 8.2 mt -75.42 -176.29 3.11 Favored 'General case' 0 N--CA 1.462 0.143 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 175.768 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -117.96 133.1 23.42 Favored Pre-proline 0 C--N 1.32 -0.689 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 174.437 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -64.55 128.71 21.85 Favored 'Trans proline' 0 C--O 1.233 0.269 0 C-N-CA 122.666 2.244 . . . . 0.0 112.392 177.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.63 37.52 19.81 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.04 179.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.526 ' CG1' ' HB3' ' A' ' 46' ' ' PRO . 71.5 t -134.82 138.35 49.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.121 0.486 . . . . 0.0 110.805 -178.557 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.704 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -75.7 121.28 22.27 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.564 -0.743 . . . . 0.0 109.549 -179.997 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.439 ' CE2' HD22 ' A' ' 69' ' ' LEU . 7.6 m-85 -113.92 114.62 26.47 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.308 0.575 . . . . 0.0 112.444 -176.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.482 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 12.2 m120 -88.28 109.21 19.78 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.321 172.472 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.741 HG12 HD11 ' A' ' 66' ' ' LEU . 4.9 mp -92.15 119.97 40.53 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.621 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 175.038 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.897 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 55.9 m -112.16 115.41 28.8 Favored 'General case' 0 N--CA 1.425 -1.687 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.613 -179.552 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.53 ' H ' ' HB ' ' A' ' 91' ' ' VAL . 12.6 mm -95.94 136.91 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -124.29 111.73 16.17 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.322 -0.399 . . . . 0.0 109.965 178.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.445 ' HB1' HG21 ' A' ' 37' ' ' ILE . . . -80.04 109.38 14.43 Favored 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 171.063 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.574 HG12 ' C ' ' A' ' 39' ' ' GLY . 10.4 p -100.13 139.73 20.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 C-N-CA 120.029 -0.668 . . . . 0.0 110.754 -174.303 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.632 ' HG2' ' H ' ' A' ' 84' ' ' GLU . 0.7 OUTLIER -117.56 167.56 11.2 Favored 'General case' 0 N--CA 1.447 -0.583 0 O-C-N 124.005 0.816 . . . . 0.0 108.935 179.265 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.632 ' H ' ' HG2' ' A' ' 83' ' ' GLU . 39.1 mt-10 -40.65 -52.51 2.9 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 28.5 m-80 -123.99 1.49 8.63 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.815 -174.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -134.98 172.02 13.6 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.332 -0.547 . . . . 0.0 111.596 -172.202 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -136.86 129.14 29.83 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.523 177.227 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 23.9 m -69.09 162.22 27.4 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.304 176.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.1 p -58.15 151.81 44.57 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.015 0.436 . . . . 0.0 110.265 174.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -82.39 140.6 10.9 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 121.978 1.786 . . . . 0.0 113.727 -173.09 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.897 ' O ' ' HA ' ' A' ' 78' ' ' THR . 10.7 t -82.27 123.72 38.52 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.728 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 167.591 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.4 t -121.82 106.71 18.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 C-N-CA 119.76 -0.776 . . . . 0.0 109.936 171.363 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.574 HG13 ' HB ' ' A' ' 77' ' ' ILE . 6.4 pt -120.47 115.7 47.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.612 177.077 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -103.83 123.0 46.3 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.467 0.651 . . . . 0.0 111.343 -174.476 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -134.34 135.25 42.6 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.711 177.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.49 ' HG3' ' HG2' ' A' ' 74' ' ' GLN . 1.6 mp0 -86.13 135.22 33.69 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.162 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 41.2 p -67.08 124.17 22.32 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.16 0.505 . . . . 0.0 110.303 178.653 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 14.2 m -69.39 -31.52 69.96 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.142 -174.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.32 -142.74 16.12 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.559 -0.829 . . . . 0.0 111.696 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 15.1 m -141.5 128.22 11.46 Favored Pre-proline 0 C--N 1.318 -0.789 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 178.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo -68.8 58.26 1.12 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.745 2.297 . . . . 0.0 111.576 171.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -91.69 137.81 32.07 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.451 -179.473 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 17.7 m 62.97 50.68 3.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.486 0.66 . . . . 0.0 109.696 -176.059 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -76.83 177.65 7.48 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.633 -177.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 86.87 -88.53 1.59 Allowed Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.389 -177.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 15.1 m . . . . . 0 C--O 1.247 0.953 0 CA-C-O 118.637 -0.697 . . . . 0.0 110.056 178.101 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.701 0 N-CA-C 111.9 -0.48 . . . . 0.0 111.9 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.5 m -67.34 -43.41 81.61 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.027 0.442 . . . . 0.0 110.703 -179.122 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 13.2 t60 -99.24 90.84 4.71 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 178.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 59.6 mtt -76.54 -24.57 53.64 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.864 -176.432 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 156.04 -102.5 0.22 Allowed Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.849 -0.691 . . . . 0.0 111.855 179.065 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 15.4 t -107.59 148.47 29.24 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.038 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.0 p -70.56 112.96 7.21 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.242 177.41 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 33.8 m -62.13 120.17 10.36 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 120.949 0.404 . . . . 0.0 110.262 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -146.9 110.98 4.11 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.743 -177.012 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -79.78 175.15 10.84 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.801 2.334 . . . . 0.0 111.681 175.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -127.24 164.39 21.8 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.328 -176.323 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -95.9 163.68 20.52 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.343 178.242 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -71.82 130.11 16.4 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 122.446 2.097 . . . . 0.0 111.626 175.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.629 ' HD2' ' O ' ' A' ' 31' ' ' SER . 88.3 Cg_exo -48.54 154.83 2.57 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.963 2.442 . . . . 0.0 112.32 172.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.423 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 24.5 t70 -39.31 106.36 0.39 Allowed Pre-proline 0 N--CA 1.466 0.372 0 O-C-N 124.652 1.22 . . . . 0.0 112.621 -172.088 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.693 ' HG2' HG11 ' A' ' 91' ' ' VAL . 27.2 Cg_exo -68.92 149.25 72.0 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 123.444 2.763 . . . . 0.0 112.696 178.536 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.1 m -106.71 132.88 52.19 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.862 -177.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 81.9 t -85.14 121.56 37.16 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 114.63 -1.168 . . . . 0.0 109.78 174.379 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -94.28 -28.03 15.8 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.181 -174.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -135.79 126.51 27.3 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.406 -175.365 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.514 ' HA ' HG12 ' A' ' 26' ' ' ILE . 58.1 t -127.96 109.65 20.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.423 177.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.477 ' CG ' ' H ' ' A' ' 23' ' ' ASP . 13.7 t70 -118.68 -157.61 0.69 Allowed 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.477 ' H ' ' CG ' ' A' ' 22' ' ' ASP . 1.1 m-20 -84.23 -56.36 3.69 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.053 0.454 . . . . 0.0 110.286 -179.135 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.688 HG22 ' O ' ' A' ' 69' ' ' LEU . 22.8 p -114.43 34.5 4.69 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.669 -176.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.634 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 51.1 m -168.34 130.63 1.42 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.152 -172.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.585 ' HB ' HD12 ' A' ' 66' ' ' LEU . 45.3 mt -147.84 138.36 17.2 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.548 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 175.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 47.6 t -118.13 127.96 75.25 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.517 0 O-C-N 121.684 -0.635 . . . . 0.0 110.961 -174.293 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.602 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.6 OUTLIER -123.72 146.88 28.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.056 -176.61 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.498 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 28.7 mtm180 -133.35 121.88 23.0 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.313 -176.118 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.721 ' HZ3' HG12 ' A' ' 64' ' ' VAL . 39.4 p90 -111.37 145.13 39.43 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.52 -174.718 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.629 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 25.4 m -90.83 94.74 9.8 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.311 178.29 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.584 ' NE ' ' HB3' ' A' ' 62' ' ' ASN . 0.1 OUTLIER -49.0 156.61 0.9 Allowed Pre-proline 0 CA--C 1.537 0.458 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -173.837 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.618 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 5.0 Cg_exo -80.12 167.88 19.36 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 124.126 3.217 . . . . 0.0 112.248 -173.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 24.8 mp0 -83.14 -11.4 57.97 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 173.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -67.49 147.17 98.81 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 114.333 -1.303 . . . . 0.0 111.481 177.457 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -75.31 114.4 3.98 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 121.54 1.494 . . . . 0.0 110.283 170.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.582 HG22 ' HG3' ' A' ' 83' ' ' GLU . 1.2 pt -122.61 154.15 27.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -176.659 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.424 ' C ' ' HB3' ' A' ' 59' ' ' GLU . 19.3 p -99.14 -30.17 12.44 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -176.654 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.576 ' C ' HG12 ' A' ' 82' ' ' VAL . . . -165.73 -164.13 20.58 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.482 -0.866 . . . . 0.0 111.7 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.618 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 6.6 m-85 -141.95 134.89 28.78 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 117.145 0.473 . . . . 0.0 111.392 175.321 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 8.9 mmm180 -100.4 150.92 22.12 Favored 'General case' 0 CA--C 1.508 -0.656 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 166.234 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.89 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 30.4 mt -139.27 108.49 3.7 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 C-N-CA 120.452 -0.499 . . . . 0.0 112.215 177.572 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 72.7 t -108.69 110.34 31.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.464 0.649 . . . . 0.0 110.804 179.307 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.648 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 1.0 OUTLIER -112.35 125.67 54.44 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.374 175.773 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 12.4 p -137.79 139.24 25.99 Favored Pre-proline 0 C--N 1.317 -0.822 0 CA-C-N 114.093 -1.412 . . . . 0.0 112.02 -172.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.521 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 72.0 Cg_endo -74.24 142.37 30.35 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 123.482 2.788 . . . . 0.0 111.71 176.47 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 18.4 m -71.46 -28.91 64.28 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.233 -176.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.7 m -116.94 -40.48 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -178.348 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -179.84 143.03 0.17 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -178.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.439 ' CA ' ' HG3' ' A' ' 46' ' ' PRO . . . 155.13 -159.88 29.39 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.971 -0.633 . . . . 0.0 111.664 178.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.459 ' O ' ' HE1' ' A' ' 75' ' ' TYR . 27.1 t -94.97 120.67 35.57 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.685 0.279 . . . . 0.0 110.625 -179.265 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.448 ' HA ' ' O ' ' A' ' 44' ' ' TYR . 22.0 p -107.55 139.5 41.98 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 173.455 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.648 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 36.8 m -146.95 150.11 34.52 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 120.482 -0.487 . . . . 0.0 111.441 -174.396 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.89 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 52.5 tt0 -115.34 114.16 24.77 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.55 173.503 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.682 HD12 ' CG2' ' A' ' 64' ' ' VAL . 23.0 mt -97.08 151.64 19.56 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.46 -0.496 . . . . 0.0 109.667 175.228 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -116.54 115.81 26.45 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.61 HD12 ' CH2' ' A' ' 30' ' ' TRP . 3.9 mt -113.51 156.96 42.65 Favored Pre-proline 0 C--N 1.319 -0.723 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -176.273 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -66.16 151.37 83.82 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 121.712 1.608 . . . . 0.0 111.166 175.11 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.424 ' HB3' ' C ' ' A' ' 38' ' ' THR . 9.2 pt-20 -46.07 -28.01 1.09 Allowed 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.099 -0.955 . . . . 0.0 112.823 177.437 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.9 t -101.67 12.28 37.42 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.265 0.555 . . . . 0.0 111.246 -175.278 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.467 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -82.07 159.98 23.31 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.219 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.584 ' HB3' ' NE ' ' A' ' 32' ' ' ARG . 28.4 p-10 -146.73 17.19 1.27 Allowed 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -176.766 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.602 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 21.5 p -169.08 135.73 1.75 Allowed 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.17 -0.612 . . . . 0.0 111.846 -178.54 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.721 HG12 ' HZ3' ' A' ' 30' ' ' TRP . 4.1 p -122.06 136.21 59.67 Favored 'Isoleucine or valine' 0 C--O 1.242 0.682 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.343 175.022 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 39.3 m -98.19 102.01 13.64 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-O 121.531 0.681 . . . . 0.0 109.55 170.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.701 HD11 HG12 ' A' ' 77' ' ' ILE . 0.2 OUTLIER -78.5 139.45 38.67 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.036 179.104 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 22.0 t -136.1 170.05 16.64 Favored 'General case' 0 C--N 1.317 -0.828 0 O-C-N 123.257 0.348 . . . . 0.0 110.224 -174.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 62.52 26.56 15.79 Favored 'General case' 0 C--N 1.331 -0.222 0 O-C-N 123.861 0.725 . . . . 0.0 111.457 -179.053 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.688 ' O ' HG22 ' A' ' 24' ' ' THR . 16.4 mt -68.17 -175.92 0.66 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.209 0.528 . . . . 0.0 109.887 177.175 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.55 ' OE1' ' HD2' ' A' ' 71' ' ' PRO . 5.7 tp-100 -126.1 118.9 23.67 Favored Pre-proline 0 C--N 1.319 -0.738 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.149 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.55 ' HD2' ' OE1' ' A' ' 70' ' ' GLN . 19.2 Cg_endo -60.89 134.48 53.68 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.886 2.391 . . . . 0.0 113.033 -177.077 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.63 23.33 50.72 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.936 -0.65 . . . . 0.0 111.812 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 50.5 t -129.49 146.38 34.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.183 0.516 . . . . 0.0 110.804 -177.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.521 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -82.98 120.16 25.36 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.186 -0.916 . . . . 0.0 109.721 -178.696 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.459 ' HE1' ' O ' ' A' ' 51' ' ' SER . 14.5 m-85 -115.06 113.92 24.68 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.254 0.55 . . . . 0.0 111.949 -176.632 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.576 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 2.7 m-20 -87.22 113.35 22.88 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.936 177.006 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.701 HG12 HD11 ' A' ' 66' ' ' LEU . 5.3 mp -94.68 114.94 32.28 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.615 0 CA-C-O 121.289 0.566 . . . . 0.0 109.618 175.468 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.843 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 48.4 m -108.52 116.15 31.43 Favored 'General case' 0 N--CA 1.427 -1.615 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.122 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.547 ' HB ' ' HB ' ' A' ' 91' ' ' VAL . 13.0 mm -95.22 143.49 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -129.99 113.12 14.18 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.001 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.33 122.53 25.87 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 106.738 -1.578 . . . . 0.0 106.738 168.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.576 HG12 ' C ' ' A' ' 39' ' ' GLY . 7.5 p -110.49 135.37 49.78 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 C-N-CA 120.153 -0.619 . . . . 0.0 109.97 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.679 ' OE1' ' HG2' ' A' ' 86' ' ' GLN . 4.8 mp0 -115.34 169.87 8.82 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -37.76 -53.09 1.28 Allowed 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -171.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -126.24 7.23 7.12 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.726 -0.389 . . . . 0.0 111.947 -175.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.679 ' HG2' ' OE1' ' A' ' 83' ' ' GLU . 20.3 pm0 -143.79 176.73 9.02 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 120.688 -0.405 . . . . 0.0 111.289 -173.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -136.06 129.89 32.62 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.775 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 67.9 m -76.99 175.78 9.25 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.086 0.47 . . . . 0.0 111.622 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -60.93 152.94 68.02 Favored Pre-proline 0 N--CA 1.451 -0.38 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.283 179.065 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -85.99 141.83 7.4 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.433 2.089 . . . . 0.0 114.204 -177.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.843 ' O ' ' HA ' ' A' ' 78' ' ' THR . 11.8 t -82.51 124.88 39.74 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.718 0 CA-C-N 114.692 -1.14 . . . . 0.0 108.101 166.192 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 14.4 t -120.34 105.24 16.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 C-N-CA 119.385 -0.926 . . . . 0.0 109.904 171.452 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.57 HG13 ' HB ' ' A' ' 77' ' ' ILE . 10.4 pt -122.04 110.86 28.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.192 177.241 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.431 ' HB2' ' OE1' ' A' ' 74' ' ' GLN . 11.1 pt20 -100.86 114.6 28.59 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.783 0.801 . . . . 0.0 111.237 -174.093 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -118.28 126.44 52.16 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.988 -1.005 . . . . 0.0 109.756 178.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.457 ' HB2' ' HG2' ' A' ' 74' ' ' GLN . 39.1 tt0 -89.73 130.21 36.03 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 177.039 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 41.6 p -63.66 140.38 58.87 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.319 -177.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.6 m -67.58 -30.74 70.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.633 -173.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 58.07 88.35 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 CA-C-N 115.948 -0.569 . . . . 0.0 113.088 172.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.4 m -81.77 118.52 72.45 Favored Pre-proline 0 C--N 1.313 -0.997 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 -179.095 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -51.01 111.41 0.55 Allowed 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 122.546 2.164 . . . . 0.0 111.364 178.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 70.3 mtt85 65.9 69.86 0.44 Allowed 'General case' 0 C--O 1.234 0.237 0 O-C-N 123.644 0.59 . . . . 0.0 110.05 -175.304 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.3 m -58.58 -47.36 84.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.809 -178.14 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -130.16 113.96 15.11 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.402 179.047 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 72.21 -112.03 3.85 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.982 -0.628 . . . . 0.0 111.756 -178.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.8 t . . . . . 0 C--O 1.253 1.238 0 CA-C-O 118.795 -0.621 . . . . 0.0 109.79 176.81 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.553 0 N-CA-C 112.126 -0.39 . . . . 0.0 112.126 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.3 m -75.74 -34.52 60.32 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.77 0.319 . . . . 0.0 111.272 -178.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 67.4 t60 -71.16 -38.82 72.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.916 0.389 . . . . 0.0 110.297 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 38.3 tpp -152.06 127.02 9.67 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.18 176.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -160.57 71.42 0.23 Allowed Glycine 0 N--CA 1.445 -0.764 0 N-CA-C 111.216 -0.753 . . . . 0.0 111.216 179.223 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.3 t -87.71 25.55 1.47 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.345 0.593 . . . . 0.0 111.077 -174.011 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.9 m -79.48 97.6 6.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.967 175.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.466 ' O ' ' HG3' ' A' ' 86' ' ' GLN . 23.5 m -69.22 133.86 48.48 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.015 -178.705 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -114.19 88.97 16.0 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-O 120.838 0.352 . . . . 0.0 110.276 175.414 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -81.52 159.2 19.49 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 122.476 2.117 . . . . 0.0 112.166 -178.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -106.02 152.61 23.14 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.822 -178.188 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.582 ' HB2' ' O ' ' A' ' 89' ' ' THR . . . -83.28 155.71 66.52 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.164 177.295 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -62.22 132.68 39.93 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.412 2.074 . . . . 0.0 111.655 173.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.42 ' HD2' ' O ' ' A' ' 31' ' ' SER . 89.0 Cg_exo -49.43 145.6 15.84 Favored 'Trans proline' 0 C--O 1.236 0.383 0 C-N-CA 122.588 2.192 . . . . 0.0 111.188 172.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.425 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 5.5 m-20 -34.98 106.63 0.3 Allowed Pre-proline 0 N--CA 1.469 0.497 0 O-C-N 124.847 1.342 . . . . 0.0 112.693 -169.187 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.604 ' HG2' HG11 ' A' ' 91' ' ' VAL . 28.0 Cg_exo -66.68 151.51 82.5 Favored 'Trans proline' 0 CA--C 1.519 -0.273 0 C-N-CA 123.534 2.823 . . . . 0.0 112.108 178.621 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 8.2 m -113.13 131.62 55.77 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.635 -177.261 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.458 ' HA ' ' HA ' ' A' ' 28' ' ' VAL . 71.6 t -76.05 119.34 23.91 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-N 114.363 -1.29 . . . . 0.0 110.143 174.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -93.81 -28.05 16.11 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.073 -174.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -135.52 132.6 37.49 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.388 -178.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.456 ' HA ' HG12 ' A' ' 26' ' ' ILE . 11.5 t -131.95 104.84 8.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.77 179.312 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -111.75 -163.29 0.84 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.092 177.189 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.482 ' O ' ' HB2' ' A' ' 69' ' ' LEU . 4.0 p-10 -73.69 -62.42 1.5 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.349 0.595 . . . . 0.0 111.471 176.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.635 HG22 ' O ' ' A' ' 69' ' ' LEU . 35.1 p -111.49 33.43 4.72 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.447 -172.751 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.691 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 35.6 m -168.88 130.4 1.22 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.897 -171.432 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.594 ' HB ' HD12 ' A' ' 66' ' ' LEU . 40.5 mt -146.64 140.14 20.16 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.636 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 176.251 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 85.6 t -117.09 129.19 74.04 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.752 0 O-C-N 121.654 -0.654 . . . . 0.0 110.61 -175.082 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.639 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.8 OUTLIER -121.97 143.44 34.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 C-N-CA 120.32 -0.552 . . . . 0.0 109.608 -178.912 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.496 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 44.6 mtp180 -129.65 121.13 26.41 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.891 0.377 . . . . 0.0 110.5 -174.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.723 ' HZ3' HG12 ' A' ' 64' ' ' VAL . 37.1 p90 -111.54 152.6 27.34 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.566 -174.411 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.42 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 11.7 m -96.81 97.46 9.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.965 178.492 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.562 ' NE ' ' HB3' ' A' ' 62' ' ' ASN . 0.1 OUTLIER -49.72 156.52 1.19 Allowed Pre-proline 0 CA--C 1.538 0.489 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -173.768 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.613 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 3.0 Cg_exo -84.1 165.55 13.06 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 124.303 3.335 . . . . 0.0 112.638 -173.509 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -77.91 -18.41 56.17 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.198 173.057 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.57 143.88 96.11 Favored Pre-proline 0 C--O 1.235 0.334 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.105 175.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.475 ' O ' ' HG2' ' A' ' 83' ' ' GLU . 57.2 Cg_endo -75.86 114.68 3.99 Favored 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 121.321 1.347 . . . . 0.0 109.934 170.489 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.558 HD12 ' CE1' ' A' ' 40' ' ' TYR . 1.3 pt -118.78 152.43 21.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -175.238 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.46 ' C ' ' HB3' ' A' ' 59' ' ' GLU . 7.7 p -92.15 -30.06 16.16 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.956 0.725 . . . . 0.0 112.956 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.593 ' C ' HG12 ' A' ' 82' ' ' VAL . . . -169.85 -162.14 21.58 Favored Glycine 0 CA--C 1.501 -0.818 0 C-N-CA 119.9 -1.143 . . . . 0.0 111.445 -178.282 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.613 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 7.2 m-85 -140.86 134.42 30.07 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 117.068 0.434 . . . . 0.0 110.888 173.324 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 -101.91 147.82 26.07 Favored 'General case' 0 CA--C 1.505 -0.762 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 166.213 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.897 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 34.4 mt -138.67 108.96 4.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 C-N-CA 120.238 -0.585 . . . . 0.0 112.367 -177.274 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 76.6 t -107.37 110.18 30.89 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.448 0 CA-C-O 121.27 0.557 . . . . 0.0 110.6 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.698 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 0.6 OUTLIER -112.62 125.05 53.86 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.34 175.969 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.461 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 13.5 t -140.22 136.03 16.64 Favored Pre-proline 0 C--N 1.31 -1.132 0 CA-C-N 113.941 -1.481 . . . . 0.0 110.297 -174.156 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.586 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 21.6 Cg_exo -64.95 151.19 86.66 Favored 'Trans proline' 0 CA--C 1.518 -0.319 0 C-N-CA 123.014 2.476 . . . . 0.0 111.795 176.249 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 18.1 m -70.9 -35.75 72.42 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.145 -178.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 91.3 t -117.3 -42.98 3.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -176.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -171.31 142.11 1.67 Allowed 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.876 -0.33 . . . . 0.0 111.114 -175.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.498 ' CA ' ' HG2' ' A' ' 46' ' ' PRO . . . 151.54 -154.87 25.82 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.445 178.507 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.512 ' O ' ' HE1' ' A' ' 75' ' ' TYR . 29.5 m -95.13 121.82 37.16 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 111.616 0.228 . . . . 0.0 111.616 -177.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.454 ' HA ' ' O ' ' A' ' 44' ' ' TYR . 6.1 m -105.99 135.25 47.77 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 173.433 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.698 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 55.1 m -146.36 150.53 35.88 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.233 -175.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.897 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 46.7 tt0 -120.7 113.59 20.44 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.914 176.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.707 HD12 ' CG2' ' A' ' 64' ' ' VAL . 20.3 mt -97.17 157.84 15.74 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.461 177.657 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.484 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 7.1 t30 -121.87 113.2 19.3 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.362 177.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.56 HD12 ' CH2' ' A' ' 30' ' ' TRP . 3.3 mt -109.98 155.56 41.44 Favored Pre-proline 0 C--N 1.318 -0.784 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -176.529 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -62.72 148.22 93.68 Favored 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 121.781 1.654 . . . . 0.0 110.959 176.23 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.46 ' HB3' ' C ' ' A' ' 38' ' ' THR . 8.8 pt-20 -44.96 -24.97 0.26 Allowed 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 114.986 -1.006 . . . . 0.0 113.468 178.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.5 t -105.85 9.07 32.94 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.04 0.447 . . . . 0.0 111.213 -174.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.448 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -76.09 157.28 33.07 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.562 ' HB3' ' NE ' ' A' ' 32' ' ' ARG . 27.9 p-10 -141.6 13.87 2.14 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.445 -0.502 . . . . 0.0 112.231 -178.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.639 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 16.6 m -162.17 133.88 5.4 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 121.951 -0.468 . . . . 0.0 110.698 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.723 HG12 ' HZ3' ' A' ' 30' ' ' TRP . 4.3 p -115.27 135.47 55.14 Favored 'Isoleucine or valine' 0 C--O 1.242 0.708 0 CA-C-O 120.796 0.331 . . . . 0.0 110.184 173.211 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 55.0 m -96.27 101.19 12.8 Favored 'General case' 0 N--CA 1.434 -1.27 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.725 170.183 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.691 ' O ' ' HA ' ' A' ' 25' ' ' SER . 0.3 OUTLIER -77.82 142.02 38.83 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 177.664 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 10.1 t -138.2 167.97 20.71 Favored 'General case' 0 C--N 1.322 -0.597 0 O-C-N 123.282 0.364 . . . . 0.0 110.779 -173.105 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 63.96 25.12 13.83 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.574 -179.043 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.635 ' O ' HG22 ' A' ' 24' ' ' THR . 12.7 mt -69.58 -175.99 0.94 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.012 0.435 . . . . 0.0 110.142 177.297 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -129.41 127.23 23.08 Favored Pre-proline 0 C--N 1.319 -0.725 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 177.065 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -64.52 134.77 42.78 Favored 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 122.663 2.242 . . . . 0.0 112.599 -178.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 83.77 30.72 28.62 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.989 -0.625 . . . . 0.0 111.576 -178.277 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.489 ' CG1' ' HB3' ' A' ' 46' ' ' PRO . 95.6 t -133.23 141.98 43.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.7 0.286 . . . . 0.0 110.518 -177.73 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.586 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 1.5 tm0? -87.68 122.19 31.04 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.051 -179.428 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.512 ' HE1' ' O ' ' A' ' 51' ' ' SER . 13.4 m-85 -113.15 113.65 25.67 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.143 -174.293 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.531 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 13.3 m120 -86.34 106.42 17.38 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.937 177.116 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.654 HG12 HD11 ' A' ' 66' ' ' LEU . 5.3 mp -92.35 119.72 40.36 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.529 0 CA-C-O 121.201 0.524 . . . . 0.0 109.886 177.174 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.829 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 65.6 m -111.68 118.44 35.65 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.478 177.723 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.565 ' HB ' ' HB ' ' A' ' 91' ' ' VAL . 12.0 mm -96.12 140.05 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 -128.41 111.51 13.4 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 178.166 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.432 ' HB1' HG21 ' A' ' 37' ' ' ILE . . . -79.81 110.36 15.09 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 173.149 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.593 HG12 ' C ' ' A' ' 39' ' ' GLY . 10.8 p -99.44 141.53 16.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 C-N-CA 120.196 -0.602 . . . . 0.0 110.728 -173.722 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.475 ' HG2' ' O ' ' A' ' 36' ' ' PRO . 9.5 tm-20 -118.31 165.9 13.28 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 -176.646 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -45.17 -46.76 12.26 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -176.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -126.84 0.1 6.66 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.854 0.359 . . . . 0.0 111.426 -174.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.466 ' HG3' ' O ' ' A' ' 8' ' ' THR . 84.2 mm-40 -134.08 174.09 10.87 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 122.071 -0.393 . . . . 0.0 111.167 -173.073 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -136.9 133.67 35.99 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.433 175.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.7 m -75.9 174.59 9.72 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.495 -178.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.582 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 0.1 OUTLIER -60.48 159.43 24.01 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.704 176.525 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -88.66 134.79 2.84 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 122.243 1.962 . . . . 0.0 113.951 -178.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.829 ' O ' ' HA ' ' A' ' 78' ' ' THR . 10.5 t -82.67 126.58 40.04 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.627 0 CA-C-N 115.133 -0.939 . . . . 0.0 108.59 167.7 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.6 t -124.62 106.33 16.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 C-N-CA 120.115 -0.634 . . . . 0.0 110.276 174.026 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.511 HG13 ' HB ' ' A' ' 77' ' ' ILE . 8.3 pt -127.34 116.19 43.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.976 179.063 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.579 ' HB2' ' OE1' ' A' ' 74' ' ' GLN . 14.0 pt20 -99.5 131.41 45.52 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.261 0.553 . . . . 0.0 111.094 -177.5 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -140.43 129.11 22.98 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.137 178.617 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.453 ' HB2' ' HG2' ' A' ' 74' ' ' GLN . 38.7 tt0 -86.9 139.95 30.12 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.081 0.467 . . . . 0.0 110.305 177.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 18.7 p -70.56 119.44 14.73 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.314 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.406 ' H ' HG12 ' A' ' 21' ' ' VAL . 19.4 m -71.99 -32.0 66.79 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.247 0.546 . . . . 0.0 110.544 -179.369 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 110.82 -174.32 16.95 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.099 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 22.2 m -74.88 126.52 88.24 Favored Pre-proline 0 C--N 1.322 -0.621 0 N-CA-C 110.258 -0.275 . . . . 0.0 110.258 178.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -67.95 65.97 0.94 Allowed 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 123.068 2.512 . . . . 0.0 112.469 176.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 43.3 ttp180 -72.57 -49.86 29.46 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.789 177.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 19.4 m 56.34 59.03 3.85 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.415 0.626 . . . . 0.0 110.879 177.214 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -91.81 -43.4 9.55 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.239 178.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -157.85 131.32 2.82 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 120.889 -0.672 . . . . 0.0 111.968 179.157 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 5.0 p . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.513 -0.756 . . . . 0.0 110.559 178.03 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.722 0 N-CA-C 111.804 -0.518 . . . . 0.0 111.804 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.1 t -112.53 125.81 54.65 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 13.5 t60 -74.86 -26.16 59.49 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.216 -177.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 90.9 mtp -93.14 177.69 5.98 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.566 178.288 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 142.64 169.47 12.29 Favored Glycine 0 N--CA 1.445 -0.759 0 N-CA-C 111.421 -0.672 . . . . 0.0 111.421 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 42.5 m -59.51 102.06 0.13 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.004 0.43 . . . . 0.0 110.389 178.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.0 m -83.74 84.58 7.5 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 121.104 0.478 . . . . 0.0 110.336 -179.247 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 88.7 m -79.48 130.01 35.01 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.219 178.276 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.405 ' HA ' ' HD2' ' A' ' 10' ' ' PRO . . . 65.95 88.44 0.11 Allowed Pre-proline 0 N--CA 1.463 0.186 0 O-C-N 123.796 0.685 . . . . 0.0 110.995 -179.137 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 9' ' ' ALA . 37.3 Cg_endo -66.54 156.21 66.58 Favored 'Trans proline' 0 C--O 1.238 0.493 0 C-N-CA 122.777 2.318 . . . . 0.0 112.647 -178.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -84.16 160.71 20.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.238 178.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -96.49 158.29 34.0 Favored Pre-proline 0 C--N 1.319 -0.735 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.8 175.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -71.2 138.35 33.15 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.042 1.828 . . . . 0.0 110.788 174.14 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.571 ' HD2' ' O ' ' A' ' 31' ' ' SER . 18.1 Cg_endo -60.59 160.09 25.61 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 122.371 2.047 . . . . 0.0 110.518 176.147 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.407 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 7.5 p-10 -42.15 107.69 0.55 Allowed Pre-proline 0 N--CA 1.468 0.449 0 O-C-N 124.126 0.891 . . . . 0.0 111.84 -170.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.593 ' HG2' HG11 ' A' ' 91' ' ' VAL . 24.3 Cg_exo -67.5 153.35 76.78 Favored 'Trans proline' 0 CA--C 1.518 -0.291 0 C-N-CA 122.953 2.436 . . . . 0.0 111.756 178.32 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 61.4 m -111.48 131.11 55.46 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 121.752 0.787 . . . . 0.0 110.87 -178.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.446 ' HA ' ' HA ' ' A' ' 28' ' ' VAL . 79.5 t -80.17 124.55 38.31 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 CA-C-N 114.119 -1.4 . . . . 0.0 110.06 174.637 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -83.41 -49.21 9.54 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.189 -176.228 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -136.84 141.94 42.84 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.794 -177.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.3 m -129.46 125.72 62.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.041 179.26 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -125.15 -167.9 1.75 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.057 176.486 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.518 ' O ' ' HB2' ' A' ' 69' ' ' LEU . 1.6 p-10 -62.54 -64.21 0.99 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.111 0.481 . . . . 0.0 111.824 178.734 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.655 HG22 ' O ' ' A' ' 69' ' ' LEU . 32.9 p -111.66 35.0 3.83 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.915 -172.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.617 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 52.4 p -169.16 139.38 2.23 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.277 -175.371 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.616 ' HB ' HD12 ' A' ' 66' ' ' LEU . 12.0 mt -149.89 140.2 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 176.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.435 ' O ' HG13 ' A' ' 18' ' ' VAL . 44.0 t -116.21 128.63 73.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 O-C-N 121.486 -0.759 . . . . 0.0 110.519 -177.545 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.606 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.7 OUTLIER -124.63 146.05 30.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.072 -176.805 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.467 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 22.3 mtm180 -131.01 121.93 25.92 Favored 'General case' 0 C--N 1.328 -0.359 0 O-C-N 123.305 0.378 . . . . 0.0 110.804 -175.173 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.781 ' HZ3' HG12 ' A' ' 64' ' ' VAL . 39.8 p90 -114.82 143.32 45.28 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.245 -175.083 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.571 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 15.9 t -88.95 98.77 11.93 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 177.211 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.604 ' H ' ' CD ' ' A' ' 32' ' ' ARG . 0.1 OUTLIER -51.9 159.26 1.43 Allowed Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 123.71 0.804 . . . . 0.0 113.06 -174.621 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.677 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 3.7 Cg_exo -82.21 166.11 16.51 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 124.116 3.211 . . . . 0.0 112.048 -176.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -87.43 -5.41 58.85 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.541 177.03 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.409 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . . . -70.89 148.1 94.45 Favored Pre-proline 0 N--CA 1.453 -0.314 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.847 175.02 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.496 ' O ' ' HG3' ' A' ' 83' ' ' GLU . 10.9 Cg_exo -71.76 115.91 4.49 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 121.82 1.68 . . . . 0.0 110.101 169.407 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.498 HD12 ' HE1' ' A' ' 40' ' ' TYR . 2.4 pt -124.73 153.92 31.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -175.723 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 18.1 p -94.39 -32.67 13.46 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -176.381 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.579 ' C ' HG12 ' A' ' 82' ' ' VAL . . . -168.55 -162.79 21.35 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.314 -0.946 . . . . 0.0 111.796 -177.684 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.677 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 7.1 m-85 -141.78 135.23 29.48 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 122.573 0.349 . . . . 0.0 111.284 174.248 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.9 mmm180 -100.16 148.4 24.64 Favored 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 167.011 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.916 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 29.9 mt -139.19 107.74 3.42 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 C-N-CA 120.075 -0.65 . . . . 0.0 112.315 179.319 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 80.3 t -109.24 110.72 33.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.089 0.471 . . . . 0.0 110.859 -178.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.772 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 1.0 OUTLIER -115.22 128.73 56.34 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.215 178.372 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.454 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 29.8 p -143.11 145.16 31.65 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 114.051 -1.431 . . . . 0.0 112.027 -174.095 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.547 ' HB3' HG11 ' A' ' 73' ' ' VAL . 2.1 Cg_endo -81.07 154.51 19.38 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 123.657 2.904 . . . . 0.0 111.172 175.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 23.2 t -84.61 -31.26 24.37 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.551 179.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 19.7 m -111.14 -33.93 2.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -91.62 -170.1 2.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.464 0.174 . . . . 0.0 110.746 -179.106 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -116.17 -29.37 2.36 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.022 -1.085 . . . . 0.0 115.535 -167.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.467 ' O ' ' HD3' ' A' ' 46' ' ' PRO . 9.6 t -64.8 113.49 3.83 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 118.974 1.387 . . . . 0.0 111.1 -170.481 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 13.1 m -123.62 146.48 48.14 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.778 176.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.772 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 21.4 m -146.95 148.12 31.43 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 119.678 -0.809 . . . . 0.0 111.531 177.583 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.916 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 46.7 tt0 -116.16 117.98 31.58 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.97 172.562 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.717 HD12 ' CG2' ' A' ' 64' ' ' VAL . 17.9 mt -98.38 156.95 16.5 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.634 -0.426 . . . . 0.0 110.07 174.176 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -120.29 113.93 21.13 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 178.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.566 HD12 ' CH2' ' A' ' 30' ' ' TRP . 2.6 mt -111.27 157.74 38.09 Favored Pre-proline 0 C--N 1.318 -0.796 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -175.646 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -66.78 150.66 83.36 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 121.769 1.646 . . . . 0.0 111.512 175.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -43.17 -27.44 0.22 Allowed 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 114.435 -1.257 . . . . 0.0 113.397 177.007 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 5.7 t -104.38 4.89 33.92 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.148 0.499 . . . . 0.0 111.227 -172.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.408 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -75.14 152.42 38.49 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 -178.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.484 ' HB3' ' NE ' ' A' ' 32' ' ' ARG . 27.7 p-10 -135.6 16.28 3.37 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.816 -0.353 . . . . 0.0 111.831 -178.337 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.606 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 17.8 p -170.17 136.93 1.47 Allowed 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.27 -0.572 . . . . 0.0 112.078 -178.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.781 HG12 ' HZ3' ' A' ' 30' ' ' TRP . 3.9 p -119.8 138.42 50.47 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.337 176.385 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 50.5 m -98.36 101.43 12.88 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-O 121.334 0.588 . . . . 0.0 109.692 170.009 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.687 HD11 HG12 ' A' ' 77' ' ' ILE . 0.2 OUTLIER -79.93 145.29 32.72 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.426 178.801 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.468 ' HA ' ' O ' ' A' ' 24' ' ' THR . 17.6 t -139.0 177.91 7.55 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -177.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 65.37 20.84 11.87 Favored 'General case' 0 N--CA 1.468 0.437 0 O-C-N 123.486 0.491 . . . . 0.0 111.977 -178.14 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.655 ' O ' HG22 ' A' ' 24' ' ' THR . 13.8 mt -72.19 -175.59 1.56 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.182 0.515 . . . . 0.0 110.339 178.608 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 56.0 tp60 -128.72 128.82 23.5 Favored Pre-proline 0 C--N 1.319 -0.734 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 178.5 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.9 134.63 54.53 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.951 2.434 . . . . 0.0 113.391 -178.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.13 35.81 26.17 Favored Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 115.868 -0.605 . . . . 0.0 112.405 177.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.547 HG11 ' HB3' ' A' ' 46' ' ' PRO . 42.5 t -134.37 150.43 30.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.04 0.448 . . . . 0.0 111.424 -175.327 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.1 tp-100 -91.1 105.03 17.53 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.332 179.077 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.527 ' CZ ' ' HG3' ' A' ' 46' ' ' PRO . 9.9 m-85 -97.38 121.14 38.94 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.79 -178.091 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.553 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 55.7 m-20 -91.85 111.87 23.57 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.283 176.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.687 HG12 HD11 ' A' ' 66' ' ' LEU . 5.3 mp -94.82 118.4 40.83 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.623 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.971 176.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.905 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 29.5 m -107.91 115.4 30.07 Favored 'General case' 0 N--CA 1.425 -1.684 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.605 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.533 ' HB ' ' HB ' ' A' ' 91' ' ' VAL . 12.5 mm -96.1 137.58 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -126.15 111.75 15.0 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.052 178.516 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -80.02 112.39 17.28 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 171.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.579 HG12 ' C ' ' A' ' 39' ' ' GLY . 10.9 p -103.64 136.4 36.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 C-N-CA 119.924 -0.711 . . . . 0.0 110.956 -175.123 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.66 ' HG2' ' N ' ' A' ' 84' ' ' GLU . 2.4 tt0 -117.73 166.91 11.87 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 177.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.66 ' N ' ' HG2' ' A' ' 83' ' ' GLU . 28.0 mt-10 -44.02 -48.38 8.78 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 178.139 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 19.9 m-80 -98.62 -33.87 10.79 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -170.333 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -145.81 169.49 18.42 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-O 120.904 0.383 . . . . 0.0 111.518 -167.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -114.72 145.78 41.68 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.289 175.419 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 17.8 m -76.15 169.78 17.55 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.738 178.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.2 p -58.73 146.11 75.87 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.079 173.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -78.26 138.91 16.31 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.134 1.889 . . . . 0.0 113.966 -174.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.905 ' O ' ' HA ' ' A' ' 78' ' ' THR . 9.7 t -81.74 126.5 39.88 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.745 0 CA-C-N 114.828 -1.078 . . . . 0.0 108.174 167.532 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 15.7 t -123.78 106.06 16.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 C-N-CA 119.766 -0.774 . . . . 0.0 109.912 170.261 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.565 HG13 ' HB ' ' A' ' 77' ' ' ILE . 6.9 pt -120.0 115.58 47.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.892 178.667 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -99.44 125.01 45.08 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.273 0.558 . . . . 0.0 111.372 -176.107 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -128.73 131.63 47.91 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.379 178.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.41 ' HA ' ' O ' ' A' ' 73' ' ' VAL . 44.1 mt-10 -85.71 127.31 34.48 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.049 0.452 . . . . 0.0 110.218 176.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 46.4 p -69.92 120.65 15.96 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.562 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.9 m -69.71 -31.18 69.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.292 0.568 . . . . 0.0 110.588 -178.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 107.32 -162.5 13.36 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.218 176.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 28.8 m -86.17 122.67 72.37 Favored Pre-proline 0 C--N 1.321 -0.656 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 179.219 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -50.7 105.42 0.1 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.949 2.433 . . . . 0.0 111.964 178.434 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 29.6 ptt180 -80.41 149.1 30.28 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.323 -175.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 17.5 m -111.06 17.58 20.26 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.388 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -135.91 151.77 50.33 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.96 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 89.02 -90.94 1.68 Allowed Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.278 -177.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.5 m . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.145 -0.931 . . . . 0.0 109.384 175.309 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.793 0 N-CA-C 111.734 -0.547 . . . . 0.0 111.734 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.7 p -63.79 144.15 57.28 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.802 0.301 . . . . 0.0 110.37 177.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 20.1 t60 -85.82 58.36 5.0 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.229 0.538 . . . . 0.0 110.281 -176.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 15.7 tpt -98.96 97.84 8.96 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.649 177.182 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 155.39 -161.7 30.64 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.715 -0.755 . . . . 0.0 111.824 -178.349 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.7 m 62.03 66.15 0.84 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.536 0.684 . . . . 0.0 110.139 -178.424 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 35.2 m -73.84 105.29 5.05 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.253 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 22.5 m -66.58 122.68 18.14 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.162 -177.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -146.09 86.73 6.95 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.165 178.168 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.547 ' HG3' ' OE1' ' A' ' 83' ' ' GLU . 88.6 Cg_endo -79.96 -176.76 3.39 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.945 2.43 . . . . 0.0 112.689 -177.161 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -144.14 154.05 42.76 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.549 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.446 ' HB2' ' O ' ' A' ' 89' ' ' THR . . . -90.73 154.85 45.84 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.292 -178.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.448 ' HB2' ' HB2' ' A' ' 30' ' ' TRP . 26.8 Cg_exo -64.54 128.45 21.25 Favored 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.365 2.044 . . . . 0.0 111.646 178.578 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.415 ' HD2' ' O ' ' A' ' 31' ' ' SER . 53.5 Cg_exo -53.03 143.52 49.86 Favored 'Trans proline' 0 CA--C 1.512 -0.602 0 C-N-CA 122.517 2.145 . . . . 0.0 111.312 176.169 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -37.05 103.17 0.25 Allowed Pre-proline 0 CA--C 1.515 -0.39 0 O-C-N 125.145 1.528 . . . . 0.0 112.74 -163.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.709 ' CG ' HG11 ' A' ' 91' ' ' VAL . 3.1 Cg_endo -47.62 147.98 6.17 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 123.594 2.863 . . . . 0.0 113.526 169.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 18.4 m -107.6 131.6 54.19 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.021 -0.991 . . . . 0.0 109.789 177.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.483 HG11 HG22 ' A' ' 21' ' ' VAL . 81.2 t -76.52 121.03 27.82 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.41 176.128 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -86.08 -39.06 17.16 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.526 -175.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -135.26 127.96 30.95 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.842 0.354 . . . . 0.0 110.683 -178.257 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.516 ' HA ' HG12 ' A' ' 26' ' ' ILE . 98.7 t -120.78 115.58 47.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.4 177.642 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -127.2 -164.17 1.33 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.338 178.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -68.55 -63.01 1.14 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.088 0.471 . . . . 0.0 112.149 -178.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.642 HG22 ' O ' ' A' ' 69' ' ' LEU . 38.7 p -117.81 35.08 4.85 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.812 -171.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.531 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 54.4 p -170.91 132.38 0.87 Allowed 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.496 -173.805 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.595 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 32.7 mt -145.91 140.82 21.67 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.781 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 178.214 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.433 ' O ' HG13 ' A' ' 18' ' ' VAL . 39.7 t -117.14 134.11 61.76 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.631 0 C-N-CA 120.064 -0.655 . . . . 0.0 110.084 -176.003 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.638 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.6 OUTLIER -127.06 146.93 32.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 C-N-CA 120.221 -0.591 . . . . 0.0 110.462 -178.643 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.564 ' HG2' ' OG ' ' A' ' 63' ' ' SER . 18.4 mtp180 -128.54 118.94 23.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.549 -177.125 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.764 ' HZ3' HG12 ' A' ' 64' ' ' VAL . 36.4 p90 -110.48 146.11 36.53 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.961 -176.08 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.415 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 20.8 m -92.21 99.92 12.62 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.078 177.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.56 ' NE ' ' HB3' ' A' ' 62' ' ' ASN . 0.1 OUTLIER -46.58 156.98 0.47 Allowed Pre-proline 0 CA--C 1.536 0.419 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -175.222 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.628 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 3.4 Cg_exo -83.34 169.0 12.84 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 124.179 3.253 . . . . 0.0 112.5 -172.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -87.2 -3.43 59.05 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.231 -0.895 . . . . 0.0 108.938 173.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.71 146.87 80.67 Favored Pre-proline 0 N--CA 1.451 -0.416 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.968 175.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -77.84 114.7 3.68 Favored 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 121.371 1.38 . . . . 0.0 110.043 170.084 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.641 HG22 ' HG3' ' A' ' 83' ' ' GLU . 0.7 OUTLIER -120.25 155.02 23.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.461 -174.494 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.1 p -97.51 -33.79 11.23 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -178.416 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.414 ' C ' HG12 ' A' ' 82' ' ' VAL . . . -164.74 -169.65 28.62 Favored Glycine 0 C--O 1.222 -0.642 0 C-N-CA 120.075 -1.059 . . . . 0.0 112.16 179.393 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.628 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 4.6 m-85 -136.56 131.38 33.76 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-N 117.302 0.551 . . . . 0.0 111.674 176.603 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 37.4 mtm180 -103.98 148.41 26.23 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.029 168.018 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.867 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 30.4 mt -139.0 109.32 4.37 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 C-N-CA 120.421 -0.511 . . . . 0.0 112.335 -176.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 95.6 t -110.43 110.74 33.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.42 0.629 . . . . 0.0 110.667 179.429 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.755 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 0.5 OUTLIER -108.17 125.09 51.22 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.191 175.358 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.443 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 6.3 p -144.03 138.4 14.98 Favored Pre-proline 0 C--N 1.315 -0.903 0 CA-C-N 113.864 -1.517 . . . . 0.0 111.301 -173.543 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.742 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 22.5 Cg_exo -65.52 148.1 87.29 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 123.349 2.699 . . . . 0.0 111.767 175.174 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 10.0 m -69.56 -30.89 68.79 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.726 -177.078 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.497 ' O ' ' HB2' ' A' ' 49' ' ' GLU . 3.4 p -109.55 -41.82 4.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 120.745 -0.382 . . . . 0.0 111.982 -177.072 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.497 ' HB2' ' O ' ' A' ' 48' ' ' VAL . 34.6 tt0 169.56 148.74 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.328 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.566 ' CA ' ' HG2' ' A' ' 46' ' ' PRO . . . 159.21 -141.83 7.85 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 111.515 -0.634 . . . . 0.0 111.515 177.009 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.58 ' O ' ' HE1' ' A' ' 75' ' ' TYR . 16.5 m -93.95 120.56 34.37 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.873 0.368 . . . . 0.0 110.965 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.457 ' HA ' ' O ' ' A' ' 44' ' ' TYR . 15.0 m -115.19 137.57 51.88 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 176.433 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.755 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 30.6 m -147.15 154.99 41.76 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.358 -176.722 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.867 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 33.0 tt0 -124.31 115.4 20.95 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 123.297 0.639 . . . . 0.0 109.902 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.687 HD12 ' CG2' ' A' ' 64' ' ' VAL . 18.4 mt -100.52 160.5 14.29 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 175.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.423 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 17.5 m120 -125.98 121.59 33.51 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 178.637 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.603 HD12 ' CH2' ' A' ' 30' ' ' TRP . 4.6 mt -118.33 158.9 45.48 Favored Pre-proline 0 C--N 1.318 -0.79 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -176.469 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -64.48 150.97 87.31 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 121.58 1.52 . . . . 0.0 111.21 175.33 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.402 ' HB2' HG13 ' A' ' 37' ' ' ILE . 12.8 pt-20 -46.0 -26.75 0.77 Allowed 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 114.924 -1.035 . . . . 0.0 112.77 177.722 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 7.8 t -103.76 8.21 37.22 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.318 -174.067 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.484 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -75.0 160.43 30.55 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -179.173 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.56 ' HB3' ' NE ' ' A' ' 32' ' ' ARG . 24.7 p-10 -142.58 10.92 1.86 Allowed 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.473 -0.491 . . . . 0.0 112.323 -179.2 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.638 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 14.6 m -161.43 133.82 5.94 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 118.476 0.58 . . . . 0.0 111.473 -178.466 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.764 HG12 ' HZ3' ' A' ' 30' ' ' TRP . 4.1 p -119.56 136.87 55.31 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 173.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 40.4 m -97.44 100.97 12.4 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-O 121.426 0.631 . . . . 0.0 109.711 169.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.7 HD11 HG12 ' A' ' 77' ' ' ILE . 0.2 OUTLIER -78.52 145.14 35.06 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.008 178.045 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.1 t -142.31 173.56 11.42 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -175.245 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 67.02 23.04 9.86 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 123.907 0.755 . . . . 0.0 111.078 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.642 ' O ' HG22 ' A' ' 24' ' ' THR . 10.3 mt -72.37 -175.77 1.67 Allowed 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 177.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 21.6 mm-40 -125.51 134.12 25.52 Favored Pre-proline 0 C--N 1.322 -0.613 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 176.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -65.8 126.01 15.25 Favored 'Trans proline' 0 CA--C 1.529 0.267 0 C-N-CA 122.502 2.135 . . . . 0.0 112.885 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 86.03 31.77 19.4 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.503 177.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 92.1 t -129.79 145.28 35.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.019 0.438 . . . . 0.0 110.698 -177.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.742 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -80.05 123.75 28.12 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.692 -179.274 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.58 ' HE1' ' O ' ' A' ' 51' ' ' SER . 15.3 m-85 -120.45 114.03 21.2 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.164 0.507 . . . . 0.0 112.119 -176.232 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.457 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 15.6 m-80 -90.33 110.65 21.71 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.371 176.442 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.7 HG12 HD11 ' A' ' 66' ' ' LEU . 5.1 mp -91.36 116.21 32.07 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.686 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 176.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.868 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 14.9 m -108.86 113.51 26.49 Favored 'General case' 0 N--CA 1.424 -1.751 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.359 -177.732 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.576 ' H ' ' HB ' ' A' ' 91' ' ' VAL . 10.8 mm -95.13 134.23 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -122.33 111.55 17.04 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.75 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.404 ' HB3' ' HB2' ' A' ' 88' ' ' SER . . . -81.25 131.17 35.28 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 170.07 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.414 HG12 ' C ' ' A' ' 39' ' ' GLY . 7.7 p -118.47 135.37 59.1 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.317 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.641 ' HG3' HG22 ' A' ' 37' ' ' ILE . 4.0 mp0 -115.21 169.95 8.74 Favored 'General case' 0 N--CA 1.448 -0.561 0 O-C-N 123.906 0.754 . . . . 0.0 109.482 -178.194 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -44.26 -47.88 9.43 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -174.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 30.3 p-10 -129.88 16.39 5.76 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.934 -0.306 . . . . 0.0 111.635 -177.263 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 77.2 mm-40 -144.65 173.99 11.36 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.763 0.316 . . . . 0.0 111.076 -176.186 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -140.54 119.9 13.06 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 174.106 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.404 ' HB2' ' HB3' ' A' ' 81' ' ' ALA . 66.7 m -65.57 167.42 8.97 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.832 0.349 . . . . 0.0 111.574 -177.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.446 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 1.2 p -57.4 160.61 6.84 Favored Pre-proline 0 CA--C 1.536 0.422 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.696 178.532 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -86.99 133.58 3.48 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 122.259 1.973 . . . . 0.0 113.766 -177.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.868 ' O ' ' HA ' ' A' ' 78' ' ' THR . 44.2 t -82.62 122.73 37.61 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.723 0 CA-C-N 114.936 -1.029 . . . . 0.0 108.622 170.028 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 10.8 t -120.38 106.6 19.07 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 C-N-CA 119.586 -0.846 . . . . 0.0 110.277 174.189 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.553 HG13 ' HB ' ' A' ' 77' ' ' ILE . 7.7 pt -122.29 113.7 39.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.733 176.394 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -100.4 131.25 46.43 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.395 0.616 . . . . 0.0 111.389 -174.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -136.71 132.35 34.75 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.572 177.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.491 ' HG2' ' HG2' ' A' ' 74' ' ' GLN . 45.3 mt-10 -89.13 131.8 35.1 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 175.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.402 HG22 HD11 ' A' ' 26' ' ' ILE . 31.4 p -68.5 121.17 15.8 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.47 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.3 m -69.33 -31.6 70.16 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.191 0.52 . . . . 0.0 110.305 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 95.59 -132.38 11.06 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.04 177.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 17.2 m -74.9 120.82 83.47 Favored Pre-proline 0 C--N 1.321 -0.632 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 177.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -50.4 136.97 40.0 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 123.307 2.671 . . . . 0.0 112.802 -177.112 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 85.0 mtt180 60.9 57.21 2.66 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.178 -177.437 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.5 m -64.4 -47.09 80.51 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.1 -0.955 . . . . 0.0 111.476 -175.207 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -66.94 126.04 27.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.943 0.401 . . . . 0.0 110.791 -176.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 143.46 134.13 2.83 Favored Glycine 0 N--CA 1.443 -0.855 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.541 -178.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 19.4 m . . . . . 0 C--O 1.247 0.936 0 CA-C-O 118.359 -0.829 . . . . 0.0 110.593 -179.302 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.685 0 N-CA-C 111.836 -0.505 . . . . 0.0 111.836 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.0 p -92.63 61.89 3.75 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.019 0.438 . . . . 0.0 111.595 -176.24 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 14.4 p80 -74.76 -24.17 58.65 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.862 0.363 . . . . 0.0 110.3 176.456 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 43.9 tpp -170.0 72.49 0.07 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.391 178.182 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 159.59 -152.32 23.23 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.097 -179.004 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 21.5 m -125.11 128.28 48.19 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.895 0.378 . . . . 0.0 111.362 -176.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.8 m -97.74 73.11 2.31 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 173.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.511 ' O ' ' HD3' ' A' ' 10' ' ' PRO . 5.3 m -63.26 151.19 41.24 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.609 -174.671 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -97.09 92.22 1.14 Allowed Pre-proline 0 C--N 1.323 -0.553 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 167.432 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.511 ' HD3' ' O ' ' A' ' 8' ' ' THR . 73.4 Cg_endo -78.69 137.95 14.73 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.33 2.02 . . . . 0.0 112.812 -171.427 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -86.12 162.11 18.55 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.91 175.252 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -96.06 155.57 38.08 Favored Pre-proline 0 C--N 1.314 -0.965 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 176.145 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.479 ' CB ' ' HB2' ' A' ' 30' ' ' TRP . 31.5 Cg_exo -62.47 128.14 22.8 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.017 1.811 . . . . 0.0 111.774 174.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -52.73 138.41 59.48 Favored 'Trans proline' 0 CA--C 1.509 -0.765 0 C-N-CA 122.288 1.992 . . . . 0.0 110.529 172.613 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -36.52 102.78 0.24 Allowed Pre-proline 0 N--CA 1.465 0.296 0 O-C-N 125.373 1.671 . . . . 0.0 112.443 -161.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.737 ' CG ' HG11 ' A' ' 91' ' ' VAL . 2.8 Cg_endo -46.61 146.14 5.66 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 123.896 3.064 . . . . 0.0 113.855 172.626 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 11.2 m -104.0 129.97 51.62 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.111 -0.949 . . . . 0.0 110.414 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.475 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 89.3 t -79.46 121.74 33.29 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 114.458 -1.247 . . . . 0.0 109.997 174.673 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -86.18 -43.17 13.22 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.333 -175.036 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -135.86 139.35 43.33 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.907 0.384 . . . . 0.0 111.046 -179.295 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.474 HG22 HG11 ' A' ' 18' ' ' VAL . 40.3 t -129.02 111.49 23.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.327 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -116.94 -157.46 0.66 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 -178.41 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.445 ' N ' ' HA2' ' A' ' 99' ' ' GLY . 7.0 m-20 -75.53 -64.02 1.16 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.231 0.539 . . . . 0.0 110.234 -179.54 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.673 HG22 ' O ' ' A' ' 69' ' ' LEU . 42.2 p -112.05 37.62 2.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.072 -175.02 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.625 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 69.6 m -168.43 131.97 1.52 Allowed 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 122.611 0.364 . . . . 0.0 110.834 -172.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.591 ' HB ' HD12 ' A' ' 66' ' ' LEU . 39.8 mt -147.53 138.18 17.42 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.622 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 176.824 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 39.7 t -117.35 132.54 66.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 118.695 0.68 . . . . 0.0 110.629 -174.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.612 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.7 OUTLIER -127.64 146.07 33.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.544 -177.823 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.531 ' HG2' ' HB3' ' A' ' 63' ' ' SER . 92.8 mtt180 -128.04 120.63 27.89 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 123.625 0.578 . . . . 0.0 110.519 -177.702 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.692 ' HZ3' HG12 ' A' ' 64' ' ' VAL . 34.7 p90 -113.69 154.11 27.83 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.231 -175.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 24.8 t -101.32 102.16 12.95 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 121.162 0.506 . . . . 0.0 110.5 178.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.587 ' H ' ' CD ' ' A' ' 32' ' ' ARG . 0.1 OUTLIER -53.89 160.46 2.18 Favored Pre-proline 0 CA--C 1.542 0.669 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -174.486 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.673 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 2.3 Cg_endo -84.87 169.44 10.41 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 124.581 3.521 . . . . 0.0 113.024 -175.564 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 -79.58 -22.25 44.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.609 173.247 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.502 ' HB1' ' OE2' ' A' ' 83' ' ' GLU . . . -58.77 136.7 86.86 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.171 179.346 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -66.52 113.45 2.71 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 121.317 1.345 . . . . 0.0 109.723 172.189 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.684 HG22 ' HG2' ' A' ' 83' ' ' GLU . 6.7 pt -123.55 157.3 29.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.855 -173.559 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.467 ' C ' ' HB3' ' A' ' 59' ' ' GLU . 18.3 p -101.19 -27.65 13.1 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -176.558 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.493 ' C ' HG12 ' A' ' 82' ' ' VAL . . . -171.04 -163.27 24.79 Favored Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 119.68 -1.247 . . . . 0.0 112.617 179.421 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.673 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 6.6 m-85 -141.05 135.64 31.23 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 122.858 0.463 . . . . 0.0 110.851 176.509 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 27.5 mtp180 -104.69 150.2 24.93 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 167.479 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.863 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 26.7 mt -139.0 107.94 3.65 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 C-N-CA 120.279 -0.568 . . . . 0.0 112.165 -178.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 69.2 t -105.93 110.78 32.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.323 0.582 . . . . 0.0 110.52 179.219 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.622 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 0.7 OUTLIER -112.35 125.73 54.51 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.341 176.008 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.438 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 16.1 t -142.75 138.1 15.77 Favored Pre-proline 0 C--N 1.317 -0.832 0 CA-C-N 113.968 -1.469 . . . . 0.0 110.785 -173.433 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.68 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 27.1 Cg_exo -62.91 151.94 81.74 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 123.473 2.782 . . . . 0.0 112.252 175.725 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 46.6 t -63.79 -31.93 73.26 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.014 -0.993 . . . . 0.0 111.985 -175.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 88.5 t -117.78 -42.77 2.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 C-N-CA 120.554 -0.458 . . . . 0.0 111.94 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 179.12 156.82 0.52 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.718 0.294 . . . . 0.0 110.719 -179.385 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.451 ' CA ' ' HG2' ' A' ' 46' ' ' PRO . . . 146.88 -144.62 12.85 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.061 -0.59 . . . . 0.0 111.756 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.54 ' O ' ' HE1' ' A' ' 75' ' ' TYR . 64.3 m -89.4 120.06 30.41 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.91 0.385 . . . . 0.0 111.101 -179.238 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.496 ' HA ' ' O ' ' A' ' 44' ' ' TYR . 6.2 p -118.06 140.23 50.06 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 174.439 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.622 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 40.4 m -147.86 151.18 35.49 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 120.581 -0.447 . . . . 0.0 111.534 -177.202 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.863 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 39.6 tt0 -116.05 115.09 25.48 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 172.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.688 HD12 ' CG2' ' A' ' 64' ' ' VAL . 17.0 mt -96.58 153.49 17.82 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 175.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -117.37 118.95 33.63 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.592 HD12 ' CH2' ' A' ' 30' ' ' TRP . 3.5 mt -116.25 156.22 47.38 Favored Pre-proline 0 N--CA 1.444 -0.73 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 -176.485 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -64.31 151.44 85.42 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 122.009 1.806 . . . . 0.0 111.403 176.146 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.467 ' HB3' ' C ' ' A' ' 38' ' ' THR . 8.9 pt-20 -47.35 -25.06 0.9 Allowed 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 114.548 -1.205 . . . . 0.0 113.431 179.438 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.9 t -107.54 12.84 27.36 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.185 0.517 . . . . 0.0 111.013 -176.096 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.496 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -76.86 156.29 32.29 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 178.777 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.486 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 27.5 p-10 -141.71 14.61 2.13 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -177.507 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.612 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 13.8 p -168.78 135.12 1.8 Allowed 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.207 -0.597 . . . . 0.0 112.389 -177.52 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.692 HG12 ' HZ3' ' A' ' 30' ' ' TRP . 4.8 p -120.03 134.2 64.31 Favored 'Isoleucine or valine' 0 C--O 1.24 0.591 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.309 176.002 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 25.8 m -96.74 101.2 12.76 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-O 121.526 0.679 . . . . 0.0 109.615 169.148 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.724 HD11 HG12 ' A' ' 77' ' ' ILE . 0.3 OUTLIER -78.71 144.39 35.34 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.105 179.239 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.423 ' HA ' ' O ' ' A' ' 24' ' ' THR . 12.4 p -141.68 168.58 19.41 Favored 'General case' 0 C--N 1.322 -0.601 0 O-C-N 123.338 0.399 . . . . 0.0 110.519 -173.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 64.04 27.82 14.25 Favored 'General case' 0 C--N 1.331 -0.238 0 O-C-N 123.804 0.69 . . . . 0.0 111.18 -178.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.673 ' O ' HG22 ' A' ' 24' ' ' THR . 15.3 mt -70.11 -175.5 0.97 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.181 0.515 . . . . 0.0 109.712 175.166 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 56.2 tp60 -125.0 122.67 25.48 Favored Pre-proline 0 C--N 1.315 -0.896 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 176.405 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.402 ' HB3' ' OD2' ' A' ' 23' ' ' ASP . 32.8 Cg_endo -63.12 129.53 26.01 Favored 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 122.891 2.394 . . . . 0.0 112.502 -177.489 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 86.09 33.37 15.01 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 121.098 -0.572 . . . . 0.0 111.949 -178.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.428 ' CG1' ' HB3' ' A' ' 46' ' ' PRO . 98.9 t -135.99 144.42 33.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.113 0.482 . . . . 0.0 110.93 -176.646 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.68 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -80.51 115.55 20.09 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.868 179.504 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.54 ' HE1' ' O ' ' A' ' 51' ' ' SER . 13.0 m-85 -111.59 114.46 27.54 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.275 0.559 . . . . 0.0 111.961 -177.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.571 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 37.0 m-80 -87.2 113.47 22.96 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.946 175.581 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.724 HG12 HD11 ' A' ' 66' ' ' LEU . 5.1 mp -93.37 117.41 36.79 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.574 0 CA-C-O 121.226 0.536 . . . . 0.0 109.578 174.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.877 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 62.1 m -110.84 114.86 28.53 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.476 -179.314 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.565 ' H ' ' HB ' ' A' ' 91' ' ' VAL . 11.5 mm -95.18 143.23 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 -179.319 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -129.66 111.7 12.94 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 178.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -82.39 121.93 27.35 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 172.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.493 HG12 ' C ' ' A' ' 39' ' ' GLY . 8.5 p -118.1 132.56 67.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 C-N-CA 119.758 -0.777 . . . . 0.0 112.179 -174.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.684 ' HG2' HG22 ' A' ' 37' ' ' ILE . 18.1 mt-10 -99.58 172.46 7.28 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 172.158 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -38.46 -42.8 0.78 Allowed 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -128.34 -20.15 3.74 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -178.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -98.07 167.76 10.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.145 0.497 . . . . 0.0 111.635 -173.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -145.16 121.49 10.92 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.364 175.239 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 10.6 m -67.38 169.77 8.44 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.325 -178.26 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 12.1 p -58.05 150.04 53.02 Favored Pre-proline 0 N--CA 1.451 -0.401 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.16 172.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -76.17 137.67 19.45 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 122.017 1.811 . . . . 0.0 113.06 -178.227 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.877 ' O ' ' HA ' ' A' ' 78' ' ' THR . 53.0 t -82.33 122.77 37.5 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.707 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 169.311 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.4 t -117.84 106.39 19.77 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 C-N-CA 119.374 -0.93 . . . . 0.0 110.676 174.416 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.563 HG13 ' HB ' ' A' ' 77' ' ' ILE . 7.5 pt -120.37 111.73 33.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.457 174.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.44 ' HB2' ' NE2' ' A' ' 74' ' ' GLN . 19.8 pt20 -99.88 121.6 41.55 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.479 0.657 . . . . 0.0 111.403 -174.488 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -128.35 130.12 47.27 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.452 179.123 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.458 ' CG ' ' HG2' ' A' ' 74' ' ' GLN . 37.2 mt-10 -85.97 134.17 33.88 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 176.206 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 21.6 p -69.13 114.26 7.24 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.355 0.598 . . . . 0.0 111.441 -177.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.424 ' H ' HG12 ' A' ' 21' ' ' VAL . 6.9 m -69.65 -31.66 69.87 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.838 179.43 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.445 ' HA2' ' N ' ' A' ' 23' ' ' ASP . . . 60.46 -131.45 49.5 Favored Glycine 0 N--CA 1.441 -1.026 0 CA-C-N 114.622 -1.172 . . . . 0.0 113.164 177.602 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.439 ' HA ' ' HD3' ' A' ' 101' ' ' PRO . 22.8 m -90.51 123.45 65.31 Favored Pre-proline 0 C--N 1.318 -0.791 0 CA-C-N 115.689 -0.256 . . . . 0.0 110.661 -177.567 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 100' ' ' THR . 37.3 Cg_exo -60.74 95.15 0.11 Allowed 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.852 2.368 . . . . 0.0 112.485 179.053 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 81.8 mtm180 -89.27 -26.49 21.14 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.657 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 16.8 t -84.46 106.04 15.74 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 177.006 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -73.82 -28.03 61.41 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.085 -175.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 97.58 -127.07 9.09 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.879 -0.677 . . . . 0.0 111.619 -178.61 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 18.0 m . . . . . 0 C--O 1.247 0.962 0 CA-C-O 118.75 -0.643 . . . . 0.0 110.123 176.81 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.642 0 N-CA-C 112.051 -0.42 . . . . 0.0 112.051 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.6 p -106.08 -23.81 12.53 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.752 0.311 . . . . 0.0 111.225 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 56.6 m80 -78.77 116.97 19.46 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.569 178.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 24.4 mmt -90.13 -34.63 15.8 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.125 179.289 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -111.95 141.56 16.73 Favored Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 175.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.3 m -145.17 62.37 1.29 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.479 0.656 . . . . 0.0 110.427 -178.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 46.5 m -79.44 125.16 29.19 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.563 175.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 39.1 m -65.79 119.54 11.41 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.043 0.449 . . . . 0.0 110.535 -179.007 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -118.61 93.4 45.82 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.355 -177.149 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.446 ' HG3' ' OE1' ' A' ' 83' ' ' GLU . 66.1 Cg_endo -72.52 169.84 20.83 Favored 'Trans proline' 0 C--O 1.235 0.374 0 C-N-CA 123.015 2.477 . . . . 0.0 112.332 -179.172 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -121.22 158.28 28.42 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.96 -178.345 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -92.9 156.24 40.77 Favored Pre-proline 0 C--N 1.32 -0.683 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 176.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -64.4 128.54 21.62 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.186 1.924 . . . . 0.0 111.953 178.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_exo -51.53 147.2 23.65 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.57 2.18 . . . . 0.0 111.094 174.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.43 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 6.9 m-20 -34.4 107.64 0.31 Allowed Pre-proline 0 N--CA 1.47 0.536 0 O-C-N 124.613 1.196 . . . . 0.0 113.016 -168.279 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.603 ' HG2' HG11 ' A' ' 91' ' ' VAL . 22.2 Cg_exo -68.72 153.34 73.36 Favored 'Trans proline' 0 CA--C 1.52 -0.207 0 C-N-CA 123.478 2.786 . . . . 0.0 111.829 177.218 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 26.3 m -112.63 133.41 54.68 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.566 0.698 . . . . 0.0 110.975 -177.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.456 HG11 HG22 ' A' ' 21' ' ' VAL . 79.6 t -76.21 121.39 28.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 114.437 -1.256 . . . . 0.0 110.231 175.667 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -76.55 -50.79 13.02 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.07 -175.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -141.12 142.23 34.12 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.799 -178.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.456 HG22 HG11 ' A' ' 18' ' ' VAL . 57.3 t -121.63 122.74 67.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.924 -177.545 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -125.58 -167.14 1.65 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.396 177.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.608 ' O ' ' HB2' ' A' ' 69' ' ' LEU . 2.0 p-10 -71.17 -65.17 0.78 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.089 0.471 . . . . 0.0 111.723 177.012 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.599 HG22 ' O ' ' A' ' 69' ' ' LEU . 42.1 p -111.23 34.63 3.96 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.561 -173.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.644 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 73.4 m -169.03 130.64 1.19 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.079 -173.626 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.585 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 45.0 mt -149.2 140.12 16.93 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.837 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 176.204 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.455 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 43.3 t -116.15 134.37 59.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 C-N-CA 119.834 -0.746 . . . . 0.0 110.166 -174.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.629 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.6 OUTLIER -127.33 146.23 33.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 C-N-CA 120.252 -0.579 . . . . 0.0 109.878 179.851 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.481 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 62.8 mtp180 -130.81 121.24 24.98 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 123.345 0.403 . . . . 0.0 110.472 -175.363 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.755 ' HZ3' HG12 ' A' ' 64' ' ' VAL . 38.8 p90 -114.1 154.21 28.15 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.369 -173.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 19.7 m -100.01 100.81 11.74 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.469 178.18 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.604 ' H ' ' CD ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -51.19 157.93 1.42 Allowed Pre-proline 0 CA--C 1.537 0.463 0 C-N-CA 123.482 0.713 . . . . 0.0 112.854 -174.933 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.646 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 3.5 Cg_exo -83.25 163.7 15.08 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 124.244 3.296 . . . . 0.0 112.63 -175.488 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -73.76 -19.83 60.67 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.322 172.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.415 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . . . -62.98 145.48 96.52 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 114.754 -1.112 . . . . 0.0 111.736 178.47 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 35' ' ' ALA . 3.1 Cg_exo -74.31 114.84 4.13 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 121.568 1.512 . . . . 0.0 110.085 168.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.532 HD12 ' HE1' ' A' ' 40' ' ' TYR . 0.7 OUTLIER -120.23 153.98 23.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -177.468 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.403 ' N ' ' O ' ' A' ' 82' ' ' VAL . 17.1 p -95.98 -25.31 15.99 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -177.699 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.561 ' C ' HG12 ' A' ' 82' ' ' VAL . . . -171.55 -164.87 27.92 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 119.944 -1.122 . . . . 0.0 112.235 179.523 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.646 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 5.8 m-85 -139.75 132.98 29.82 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 122.55 0.34 . . . . 0.0 111.18 173.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 10.8 mmm180 -99.82 151.15 21.61 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 166.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.885 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 37.6 mt -139.48 107.48 3.1 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 C-N-CA 120.134 -0.626 . . . . 0.0 112.162 178.692 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 71.5 t -108.56 110.33 31.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.392 0.615 . . . . 0.0 110.555 -179.377 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.635 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 0.6 OUTLIER -110.74 125.25 53.32 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.465 -0.788 . . . . 0.0 109.415 175.359 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.441 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 17.1 p -138.5 137.0 19.51 Favored Pre-proline 0 C--N 1.318 -0.772 0 CA-C-N 113.622 -1.626 . . . . 0.0 111.355 -173.655 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.657 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 22.0 Cg_exo -65.76 150.38 86.12 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 123.283 2.655 . . . . 0.0 112.224 175.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 23.2 t -70.75 -33.3 70.65 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.635 -175.154 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 18.1 m -118.32 -40.24 2.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 177.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -176.33 152.26 1.08 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.749 0.309 . . . . 0.0 111.422 -179.222 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.523 ' CA ' ' HG2' ' A' ' 46' ' ' PRO . . . 149.72 -159.27 28.01 Favored Glycine 0 N--CA 1.449 -0.497 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 -178.637 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.591 ' O ' ' HE1' ' A' ' 75' ' ' TYR . 31.8 t -94.41 120.63 34.94 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 117.297 0.549 . . . . 0.0 110.936 -178.312 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 14.8 m -104.13 143.83 32.4 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 176.181 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.635 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 50.2 m -147.74 148.86 31.43 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.489 -0.484 . . . . 0.0 111.691 -178.546 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.885 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 45.5 tt0 -115.96 117.13 29.3 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.781 172.45 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.701 HD12 ' CG2' ' A' ' 64' ' ' VAL . 18.4 mt -97.92 163.43 12.79 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 174.181 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.404 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 26.3 t-20 -128.96 110.51 12.14 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -178.019 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.585 HD12 ' CH2' ' A' ' 30' ' ' TRP . 3.3 mt -109.35 157.41 37.33 Favored Pre-proline 0 C--N 1.317 -0.844 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -175.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -64.06 149.09 91.18 Favored 'Trans proline' 0 N--CA 1.447 -1.212 0 C-N-CA 121.636 1.557 . . . . 0.0 110.99 175.265 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -44.02 -26.88 0.32 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.385 -1.279 . . . . 0.0 113.156 178.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 10.8 t -108.05 9.26 28.46 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.465 -173.276 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.417 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -75.07 161.18 29.65 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 178.597 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.566 ' HB3' ' NE ' ' A' ' 32' ' ' ARG . 28.3 p-10 -144.12 17.83 1.75 Allowed 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.465 0.542 . . . . 0.0 112.465 -178.207 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.629 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 17.2 p -169.62 133.76 1.33 Allowed 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.125 -0.63 . . . . 0.0 111.889 178.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.755 HG12 ' HZ3' ' A' ' 30' ' ' TRP . 3.6 p -116.6 138.46 47.12 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.182 176.626 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 30.0 m -97.94 101.05 12.44 Favored 'General case' 0 N--CA 1.433 -1.299 0 CA-C-O 121.366 0.603 . . . . 0.0 109.457 169.289 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.688 HD11 HG12 ' A' ' 77' ' ' ILE . 0.3 OUTLIER -77.14 144.19 38.6 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.005 178.327 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 62.1 p -139.62 174.13 10.82 Favored 'General case' 0 C--N 1.319 -0.722 0 O-C-N 123.349 0.406 . . . . 0.0 110.147 -175.419 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 37.6 t70 61.62 28.52 17.68 Favored 'General case' 0 C--N 1.33 -0.258 0 O-C-N 123.777 0.673 . . . . 0.0 110.715 179.06 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.608 ' HB2' ' O ' ' A' ' 23' ' ' ASP . 13.9 mt -73.89 -176.2 2.39 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 176.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.584 ' OE1' ' HD2' ' A' ' 71' ' ' PRO . 5.8 tp-100 -132.24 121.31 17.54 Favored Pre-proline 0 C--N 1.318 -0.781 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.584 ' HD2' ' OE1' ' A' ' 70' ' ' GLN . 18.5 Cg_endo -60.62 137.06 71.01 Favored 'Trans proline' 0 C--O 1.235 0.346 0 C-N-CA 122.908 2.405 . . . . 0.0 112.896 -178.005 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.23 26.45 52.18 Favored Glycine 0 N--CA 1.449 -0.463 0 N-CA-C 111.435 -0.666 . . . . 0.0 111.435 -178.356 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.492 ' HB ' ' O ' ' A' ' 70' ' ' GLN . 77.8 t -131.55 136.02 58.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 120.899 0.38 . . . . 0.0 110.691 -177.207 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.657 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -80.82 117.53 21.55 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.937 -178.101 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.591 ' HE1' ' O ' ' A' ' 51' ' ' SER . 18.9 m-85 -110.42 116.35 31.27 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.252 0.548 . . . . 0.0 112.184 -176.553 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.496 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 16.7 m-80 -89.73 111.18 22.09 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.683 176.02 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.688 HG12 HD11 ' A' ' 66' ' ' LEU . 5.1 mp -92.0 118.82 38.29 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.632 0 CA-C-O 121.16 0.505 . . . . 0.0 109.836 178.057 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.872 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 21.7 m -110.45 115.3 29.4 Favored 'General case' 0 N--CA 1.428 -1.549 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.131 -179.235 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.56 ' HB ' ' HB ' ' A' ' 91' ' ' VAL . 14.1 mm -95.21 142.5 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.43 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 68.7 m-85 -129.6 112.37 13.64 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.335 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.95 122.88 26.7 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 168.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.561 HG12 ' C ' ' A' ' 39' ' ' GLY . 7.9 p -112.66 136.91 47.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.245 -178.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.512 ' HG3' HG22 ' A' ' 37' ' ' ILE . 1.8 mp0 -114.6 171.21 7.77 Favored 'General case' 0 N--CA 1.446 -0.626 0 O-C-N 123.695 0.622 . . . . 0.0 109.659 -177.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -45.3 -44.74 11.7 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -174.053 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -117.32 -16.73 10.28 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -175.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.499 ' HB2' ' OE1' ' A' ' 83' ' ' GLU . 45.2 mt-30 -128.4 176.05 8.02 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.474 -0.49 . . . . 0.0 111.625 -169.279 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.443 ' HG2' HG23 ' A' ' 82' ' ' VAL . 45.8 mt-10 -130.33 125.46 34.74 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.289 -0.869 . . . . 0.0 108.967 171.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 45.9 m -72.61 173.94 8.24 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.048 0.452 . . . . 0.0 111.705 -177.121 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -60.89 155.74 51.41 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.238 178.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -88.28 142.31 5.24 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 122.423 2.082 . . . . 0.0 114.482 -176.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.872 ' O ' ' HA ' ' A' ' 78' ' ' THR . 7.1 t -82.62 126.42 40.02 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.721 0 CA-C-N 114.662 -1.154 . . . . 0.0 108.175 166.002 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.6 t -120.26 106.73 19.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 C-N-CA 119.768 -0.773 . . . . 0.0 110.081 171.284 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.545 HG13 ' HB ' ' A' ' 77' ' ' ILE . 7.1 pt -123.5 113.35 37.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.54 176.021 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.584 ' HB2' HE22 ' A' ' 74' ' ' GLN . 14.0 pt20 -99.0 126.02 44.61 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.502 0.667 . . . . 0.0 111.458 -175.177 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -133.67 127.92 33.93 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.151 -0.932 . . . . 0.0 109.56 176.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.421 ' HA ' ' HA ' ' A' ' 74' ' ' GLN . 37.4 tt0 -87.26 138.17 31.72 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.076 0.465 . . . . 0.0 110.126 176.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 26.5 p -69.55 117.75 11.56 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.238 -177.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 14.3 m -69.81 -30.6 68.16 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.354 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.4 ' HA2' ' HB3' ' A' ' 71' ' ' PRO . . . 106.35 -157.08 16.04 Favored Glycine 0 N--CA 1.446 -0.666 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.29 175.483 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.471 HG22 ' H ' ' A' ' 102' ' ' ARG . 25.7 m -97.59 124.76 47.35 Favored Pre-proline 0 C--N 1.319 -0.734 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 176.448 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -62.0 -23.43 75.77 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.613 2.208 . . . . 0.0 112.127 179.328 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.471 ' H ' HG22 ' A' ' 100' ' ' THR . 34.9 mtp85 69.39 -160.52 0.17 Allowed 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.668 173.56 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 58.8 m 59.95 34.74 21.6 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-O 121.421 0.629 . . . . 0.0 110.48 -175.191 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -114.79 10.13 16.46 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.662 -178.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 126.44 -48.08 0.99 Allowed Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 -174.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 17.6 p . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.115 -0.945 . . . . 0.0 112.253 178.405 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.677 0 N-CA-C 111.87 -0.492 . . . . 0.0 111.87 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.7 p -82.77 -31.66 28.19 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 110.567 -0.16 . . . . 0.0 110.567 178.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 34.0 t-80 57.66 61.16 2.53 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.189 0.519 . . . . 0.0 110.073 176.245 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 66.4 mtt -106.96 41.72 1.42 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.682 -178.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -75.03 108.57 2.56 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.652 -0.785 . . . . 0.0 111.547 178.376 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 12.0 t -78.61 128.85 34.06 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.342 0.591 . . . . 0.0 110.779 -176.407 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.6 p -104.12 126.01 50.89 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.889 177.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.7 m -64.32 117.67 7.57 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.097 0.475 . . . . 0.0 111.07 -177.286 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -141.96 108.13 5.87 Favored Pre-proline 0 C--N 1.319 -0.753 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.336 -178.117 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.528 ' HD3' ' NE2' ' A' ' 86' ' ' GLN . 87.9 Cg_endo -88.91 170.44 5.1 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.877 2.384 . . . . 0.0 112.274 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -117.56 160.48 21.18 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.58 176.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.408 ' HB2' ' O ' ' A' ' 89' ' ' THR . . . -95.23 158.86 34.05 Favored Pre-proline 0 C--N 1.316 -0.855 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 177.346 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.413 ' CB ' ' HB2' ' A' ' 30' ' ' TRP . 30.3 Cg_exo -64.52 126.74 17.45 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 121.886 1.724 . . . . 0.0 111.511 175.267 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.505 ' HD2' ' O ' ' A' ' 31' ' ' SER . 84.9 Cg_exo -47.14 146.95 5.83 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.634 2.223 . . . . 0.0 111.114 171.019 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.419 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 10.2 p-10 -37.71 106.67 0.36 Allowed Pre-proline 0 N--CA 1.465 0.302 0 O-C-N 124.743 1.277 . . . . 0.0 112.594 -169.104 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.583 ' HG2' HG11 ' A' ' 91' ' ' VAL . 33.4 Cg_exo -65.59 152.28 82.23 Favored 'Trans proline' 0 CA--C 1.517 -0.329 0 C-N-CA 123.552 2.835 . . . . 0.0 112.015 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 25.8 m -109.45 128.78 55.41 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.898 -178.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.463 ' HA ' ' HA ' ' A' ' 28' ' ' VAL . 83.6 t -74.92 119.21 22.07 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-N 114.415 -1.266 . . . . 0.0 109.591 173.651 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -88.0 -40.25 14.02 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.184 -173.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 18.0 mm-40 -136.71 139.41 41.9 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.47 -177.648 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.6 m -130.55 133.75 63.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.15 0.5 . . . . 0.0 111.078 178.166 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -134.84 -162.72 1.28 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.064 178.355 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -69.01 -68.41 0.4 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.105 0.479 . . . . 0.0 111.579 177.574 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.685 HG22 ' O ' ' A' ' 69' ' ' LEU . 68.2 p -111.87 39.64 2.34 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.905 -174.239 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.711 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 69.9 m -169.12 131.91 1.28 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.371 -0.832 . . . . 0.0 110.322 -171.626 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.613 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 17.9 mt -150.38 138.45 14.3 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.893 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 176.613 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 37.7 t -116.35 131.94 67.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 119.002 0.819 . . . . 0.0 110.587 -173.825 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.631 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.7 OUTLIER -125.94 145.41 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.039 -178.412 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.499 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 77.3 mtt180 -127.13 121.87 32.61 Favored 'General case' 0 N--CA 1.465 0.293 0 O-C-N 123.629 0.581 . . . . 0.0 110.293 -177.333 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.757 ' HZ3' HG12 ' A' ' 64' ' ' VAL . 28.1 p90 -112.83 146.8 38.23 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.835 -0.621 . . . . 0.0 112.05 -173.41 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.505 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 15.3 m -87.43 88.63 7.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.482 179.246 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.675 ' HD3' ' H ' ' A' ' 32' ' ' ARG . 0.4 OUTLIER -48.77 156.26 0.91 Allowed Pre-proline 0 CA--C 1.54 0.582 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -174.698 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.706 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 1.6 Cg_endo -85.7 169.26 9.37 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 124.307 3.338 . . . . 0.0 112.428 -173.409 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -93.86 -5.36 48.19 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.836 177.537 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -67.88 144.48 97.29 Favored Pre-proline 0 C--O 1.234 0.265 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.041 173.664 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_exo -70.76 112.72 3.32 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 121.272 1.314 . . . . 0.0 109.898 172.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.611 HD12 ' HE1' ' A' ' 40' ' ' TYR . 5.0 pt -121.36 151.93 24.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.08 -172.55 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.45 HG21 ' HA ' ' A' ' 84' ' ' GLU . 16.8 p -98.33 -26.78 14.38 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -176.287 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.436 ' O ' HG12 ' A' ' 82' ' ' VAL . . . -173.36 -164.16 28.18 Favored Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 119.575 -1.298 . . . . 0.0 112.582 177.43 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.706 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 6.4 m-85 -138.88 135.4 34.44 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 120.975 0.417 . . . . 0.0 111.041 177.393 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 4.0 mtm105 -108.95 146.62 33.53 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 169.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.891 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 34.9 mt -138.76 109.58 4.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -174.227 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 75.3 t -109.67 110.54 32.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.297 0.57 . . . . 0.0 110.66 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.662 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 1.1 p90 -114.08 125.76 54.34 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.607 176.832 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.0 m -137.87 145.29 47.63 Favored Pre-proline 0 C--N 1.313 -1.014 0 CA-C-N 114.077 -1.419 . . . . 0.0 111.164 -173.185 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.576 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 55.7 Cg_endo -66.42 153.74 76.88 Favored 'Trans proline' 0 N--CA 1.472 0.225 0 C-N-CA 123.443 2.762 . . . . 0.0 111.928 178.804 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 29.3 t -77.76 -37.65 48.59 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.952 179.425 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 94.7 t -117.67 -42.37 2.79 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -178.503 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -171.05 137.21 1.15 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.576 0.227 . . . . 0.0 110.531 -177.516 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 158.31 -169.12 34.82 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.169 -178.221 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.427 ' O ' ' HE1' ' A' ' 75' ' ' TYR . 22.9 m -94.74 121.3 36.18 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.633 0.254 . . . . 0.0 111.56 -176.473 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 7.0 m -97.34 141.89 29.88 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 176.694 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.662 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 86.4 m -147.02 151.05 36.31 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.332 -178.841 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.891 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 31.8 tt0 -119.82 122.86 42.29 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.496 175.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.736 HD12 ' CG2' ' A' ' 64' ' ' VAL . 16.9 mt -104.58 157.89 16.86 Favored 'General case' 0 CA--C 1.514 -0.406 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.129 175.529 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -122.02 114.68 21.29 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 177.579 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.531 HD12 ' CH2' ' A' ' 30' ' ' TRP . 2.1 mt -111.6 156.8 40.86 Favored Pre-proline 0 C--N 1.317 -0.843 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -175.68 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -63.24 150.16 89.36 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 121.912 1.742 . . . . 0.0 111.448 176.008 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.414 ' HB3' ' C ' ' A' ' 38' ' ' THR . 10.3 pt-20 -43.94 -28.74 0.49 Allowed 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 114.59 -1.186 . . . . 0.0 112.98 176.326 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.1 t -106.93 19.28 20.69 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.161 -175.043 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.486 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -82.15 152.78 26.34 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.181 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.499 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 28.5 p-10 -132.59 5.53 4.01 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -177.028 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.631 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 35.5 p -166.18 134.3 2.9 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 119.905 -0.718 . . . . 0.0 111.869 -175.125 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.757 HG12 ' HZ3' ' A' ' 30' ' ' TRP . 4.7 p -114.53 135.3 54.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.259 175.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 54.3 m -97.4 99.41 10.84 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 121.572 0.701 . . . . 0.0 109.146 169.485 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.711 ' O ' ' HA ' ' A' ' 25' ' ' SER . 0.7 OUTLIER -73.96 144.54 45.2 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.094 -0.957 . . . . 0.0 108.907 179.05 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.452 ' HA ' ' O ' ' A' ' 24' ' ' THR . 10.6 t -142.35 167.46 22.04 Favored 'General case' 0 C--N 1.318 -0.791 0 O-C-N 123.56 0.537 . . . . 0.0 109.714 -173.527 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 62.77 27.48 16.1 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 123.881 0.738 . . . . 0.0 111.202 -178.163 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.685 ' O ' HG22 ' A' ' 24' ' ' THR . 13.6 mt -71.09 -174.92 1.05 Allowed 'General case' 0 C--O 1.225 -0.2 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 173.052 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.498 ' HB2' HG21 ' A' ' 73' ' ' VAL . 67.8 mm-40 -122.99 133.43 24.49 Favored Pre-proline 0 C--N 1.317 -0.846 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 175.703 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -63.71 126.19 16.98 Favored 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 122.513 2.142 . . . . 0.0 112.125 177.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 82.67 39.42 10.65 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.741 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.498 HG21 ' HB2' ' A' ' 70' ' ' GLN . 72.1 t -136.58 138.13 46.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.039 0.447 . . . . 0.0 110.843 -179.288 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.617 HE22 ' HB2' ' A' ' 94' ' ' GLN . 0.0 OUTLIER -80.93 120.25 24.5 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.719 -179.841 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.526 ' CE2' ' HB3' ' A' ' 69' ' ' LEU . 30.1 m-85 -113.66 117.72 32.34 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.499 0.666 . . . . 0.0 112.44 -178.021 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.463 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 7.3 m-80 -85.85 110.74 19.61 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.019 172.274 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.69 HG12 HD11 ' A' ' 66' ' ' LEU . 5.1 mp -92.21 121.89 43.18 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.562 0 CA-C-O 121.064 0.459 . . . . 0.0 109.866 176.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.896 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 48.2 m -111.73 114.57 27.65 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.861 179.53 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.577 ' HB ' ' HB ' ' A' ' 91' ' ' VAL . 13.5 mm -95.91 130.14 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -117.94 113.07 21.16 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 177.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -88.98 125.46 34.99 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 173.614 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.436 HG12 ' O ' ' A' ' 39' ' ' GLY . 8.1 p -118.6 133.5 65.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 C-N-CA 120.09 -0.644 . . . . 0.0 112.127 -173.396 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.536 ' HG2' HG22 ' A' ' 37' ' ' ILE . 8.9 mt-10 -100.58 173.6 6.47 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.127 172.529 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.45 ' HA ' HG21 ' A' ' 38' ' ' THR . 26.0 mt-10 -34.93 -44.55 0.23 Allowed 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -176.578 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -135.03 2.77 3.12 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -176.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.528 ' NE2' ' HD3' ' A' ' 10' ' ' PRO . 26.3 pt20 -146.45 176.14 10.02 Favored 'General case' 0 C--O 1.218 -0.591 0 CA-C-N 118.939 0.791 . . . . 0.0 111.552 -179.087 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -126.67 154.95 43.38 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.768 -179.495 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 16.9 m -85.73 -175.27 5.55 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.453 176.486 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.408 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 1.4 p -62.65 158.69 49.04 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.449 173.219 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -87.33 140.08 5.33 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 122.065 1.843 . . . . 0.0 113.674 -178.752 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.896 ' O ' ' HA ' ' A' ' 78' ' ' THR . 8.6 t -83.29 125.68 40.09 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.744 0 CA-C-N 114.868 -1.06 . . . . 0.0 108.49 167.216 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 5.9 t -125.03 106.58 16.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 C-N-CA 119.958 -0.697 . . . . 0.0 110.078 171.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.528 HG13 ' HB ' ' A' ' 77' ' ' ILE . 5.9 pt -124.76 116.32 47.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.906 179.461 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.617 ' HB2' HE22 ' A' ' 74' ' ' GLN . 12.6 pt20 -99.47 129.49 45.65 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.456 0.646 . . . . 0.0 111.332 -175.562 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -140.94 130.84 24.44 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.021 177.177 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.41 ' HA ' ' HA ' ' A' ' 74' ' ' GLN . 39.6 tt0 -92.63 138.12 31.77 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.204 0.526 . . . . 0.0 110.745 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 34.1 p -68.81 124.64 24.24 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.741 -176.491 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 40.0 m -69.28 -30.05 68.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.503 0.668 . . . . 0.0 110.237 177.664 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 104.47 -160.42 15.7 Favored Glycine 0 N--CA 1.444 -0.819 0 CA-C-N 115.419 -0.81 . . . . 0.0 112.454 175.154 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 4.2 m -75.47 130.83 78.71 Favored Pre-proline 0 C--N 1.317 -0.807 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 178.177 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -61.54 121.35 9.46 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 122.096 1.864 . . . . 0.0 111.388 177.447 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.409 ' HD3' ' N ' ' A' ' 102' ' ' ARG . 0.0 OUTLIER -127.23 -171.3 2.39 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.304 -179.064 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 10.9 t 67.11 26.56 8.84 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.342 0.591 . . . . 0.0 110.151 -179.243 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -105.57 4.62 30.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.638 177.332 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 159.38 -149.92 20.04 Favored Glycine 0 N--CA 1.443 -0.843 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.182 -179.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.5 p . . . . . 0 C--O 1.247 0.922 0 CA-C-O 118.376 -0.821 . . . . 0.0 110.667 178.019 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.633 0 N-CA-C 111.88 -0.488 . . . . 0.0 111.88 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 39.2 m -68.62 142.73 55.04 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.481 0.182 . . . . 0.0 110.741 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 25.3 m-70 63.0 40.89 8.82 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.095 -179.04 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 16.2 tpt -94.53 126.93 40.12 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.596 175.184 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -87.77 162.16 32.64 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.471 -178.135 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 14.9 t -80.73 129.43 34.52 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 178.585 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.8 t -159.06 147.11 17.85 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.374 -176.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 57.2 m -138.4 129.22 26.69 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.064 0.459 . . . . 0.0 110.793 -178.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -111.23 128.55 25.18 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.816 176.525 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.477 ' HB3' ' OE2' ' A' ' 83' ' ' GLU . 65.9 Cg_endo -73.91 160.31 43.47 Favored 'Trans proline' 0 C--O 1.233 0.272 0 C-N-CA 122.635 2.224 . . . . 0.0 111.693 178.359 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -109.44 145.58 35.94 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.483 ' HB2' ' O ' ' A' ' 89' ' ' THR . . . -79.45 153.88 76.44 Favored Pre-proline 0 C--N 1.319 -0.759 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 175.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -62.23 128.45 23.92 Favored 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.295 1.997 . . . . 0.0 111.787 175.292 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.496 ' HD2' ' O ' ' A' ' 31' ' ' SER . 86.9 Cg_exo -47.12 140.24 14.37 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.71 2.274 . . . . 0.0 111.349 174.057 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.44 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 5.9 p-10 -33.85 106.96 0.28 Allowed Pre-proline 0 N--CA 1.467 0.396 0 O-C-N 124.929 1.393 . . . . 0.0 112.478 -168.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.564 ' HG2' HG11 ' A' ' 91' ' ' VAL . 39.1 Cg_exo -61.91 152.49 74.64 Favored 'Trans proline' 0 CA--C 1.517 -0.344 0 C-N-CA 123.727 2.951 . . . . 0.0 112.718 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.9 m -107.6 128.27 54.39 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.656 -178.559 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.468 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 69.5 t -78.46 117.12 23.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-N 114.337 -1.301 . . . . 0.0 109.725 173.706 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -83.63 -36.89 23.52 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.377 -173.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -135.6 138.38 42.87 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.471 -178.713 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.495 ' HA ' HG12 ' A' ' 26' ' ' ILE . 6.3 m -129.54 120.33 50.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.205 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.407 ' HB3' ' H ' ' A' ' 23' ' ' ASP . 8.4 m-20 -133.69 -165.33 1.62 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.46 -179.368 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.571 ' O ' ' HB2' ' A' ' 69' ' ' LEU . 3.3 p-10 -67.77 -65.13 0.73 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.971 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.672 HG22 ' O ' ' A' ' 69' ' ' LEU . 39.7 p -115.33 35.5 4.35 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.876 -172.038 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.689 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 18.6 p -169.79 130.7 1.03 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.787 -174.708 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.573 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 17.0 mt -146.95 135.97 16.11 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.608 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 177.686 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.468 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 39.9 t -115.1 129.81 70.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 C-N-CA 120.013 -0.675 . . . . 0.0 110.497 -174.51 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.663 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.8 OUTLIER -123.76 143.89 35.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.044 -177.544 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.534 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 85.8 mtt180 -128.03 121.63 30.22 Favored 'General case' 0 N--CA 1.465 0.297 0 O-C-N 123.79 0.681 . . . . 0.0 110.314 -177.13 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.674 ' HZ3' HG12 ' A' ' 64' ' ' VAL . 30.2 p90 -111.39 140.5 45.93 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.189 -173.883 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.496 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 61.8 m -82.51 88.19 6.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.13 175.27 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.437 ' HD3' ' H ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -49.08 156.46 0.96 Allowed Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -175.485 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.658 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 3.4 Cg_exo -80.36 169.26 17.47 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 123.886 3.057 . . . . 0.0 112.846 -174.378 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -86.57 -14.84 41.71 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.139 172.25 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -57.51 135.25 82.07 Favored Pre-proline 0 CA--C 1.517 -0.309 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.162 173.276 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -67.33 112.39 2.55 Favored 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 120.937 1.091 . . . . 0.0 109.774 172.554 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.674 HD12 ' HE1' ' A' ' 40' ' ' TYR . 1.6 pt -118.27 151.43 20.36 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -174.662 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.466 ' C ' ' HB3' ' A' ' 59' ' ' GLU . 11.0 p -98.56 -30.53 12.45 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -178.632 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.537 ' C ' HG12 ' A' ' 82' ' ' VAL . . . -162.86 -166.66 22.03 Favored Glycine 0 N--CA 1.438 -1.209 0 C-N-CA 120.153 -1.022 . . . . 0.0 112.044 -177.861 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.674 ' HE1' HD12 ' A' ' 37' ' ' ILE . 6.3 m-85 -141.54 134.46 28.9 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 122.613 0.365 . . . . 0.0 110.875 174.78 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.3 mmm180 -102.53 149.41 24.43 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 168.152 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.879 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 30.7 mt -139.55 108.4 3.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 C-N-CA 120.037 -0.665 . . . . 0.0 112.389 -179.297 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 71.7 t -107.53 110.57 32.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.182 0.515 . . . . 0.0 110.836 179.02 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.656 ' CZ ' ' HB ' ' A' ' 53' ' ' THR . 1.4 p90 -114.9 127.3 55.62 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.948 176.832 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.3 p -141.81 137.41 16.11 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 113.718 -1.583 . . . . 0.0 111.754 -175.05 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.595 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 58.1 Cg_endo -73.88 137.26 24.18 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 123.275 2.65 . . . . 0.0 111.9 176.553 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 32.5 t -66.7 -22.34 66.07 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.75 -176.091 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.403 ' O ' ' HB3' ' A' ' 49' ' ' GLU . 16.6 m -108.55 20.45 5.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.702 0.287 . . . . 0.0 111.533 -179.339 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.403 ' HB3' ' O ' ' A' ' 48' ' ' VAL . 45.4 tt0 74.58 144.34 0.08 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.118 178.727 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 162.36 -128.94 1.96 Allowed Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 -177.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.47 ' O ' ' HD3' ' A' ' 46' ' ' PRO . 27.4 m -90.84 119.64 31.22 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 117.177 0.489 . . . . 0.0 110.77 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.431 ' HA ' ' O ' ' A' ' 44' ' ' TYR . 14.9 m -117.5 141.19 48.65 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 173.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.656 ' HB ' ' CZ ' ' A' ' 44' ' ' TYR . 36.1 m -147.62 149.95 33.49 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 120.111 -0.636 . . . . 0.0 111.563 -179.537 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.879 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 26.4 tt0 -116.95 112.0 20.39 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.585 174.413 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.709 HD12 ' CG2' ' A' ' 64' ' ' VAL . 23.8 mt -96.09 159.04 15.17 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.072 177.785 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.455 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 24.7 t-20 -125.2 114.86 19.55 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -179.403 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.575 HD12 ' CH2' ' A' ' 30' ' ' TRP . 4.4 mt -112.1 157.68 39.1 Favored Pre-proline 0 C--N 1.317 -0.843 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 -176.369 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -68.3 152.54 75.66 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 121.749 1.632 . . . . 0.0 111.06 175.501 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.466 ' HB3' ' C ' ' A' ' 38' ' ' THR . 11.7 pt-20 -45.62 -27.07 0.71 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.796 -1.093 . . . . 0.0 112.758 176.01 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 11.1 t -101.44 18.74 19.36 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.277 0.561 . . . . 0.0 111.1 -174.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.432 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -93.04 157.92 16.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.394 179.581 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.534 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 26.6 p-10 -143.05 13.74 1.86 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -178.475 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.663 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 80.5 p -165.26 134.3 3.4 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 119.876 -0.729 . . . . 0.0 111.936 -177.042 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.709 ' CG2' HD12 ' A' ' 55' ' ' LEU . 3.8 p -117.43 134.81 59.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.346 175.082 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 35.1 m -96.57 101.22 12.8 Favored 'General case' 0 N--CA 1.434 -1.255 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.498 169.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.691 HD11 HG12 ' A' ' 77' ' ' ILE . 0.3 OUTLIER -78.3 144.57 35.98 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.1 178.33 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.405 ' HA ' ' O ' ' A' ' 24' ' ' THR . 13.2 p -138.47 166.58 23.92 Favored 'General case' 0 C--N 1.318 -0.783 0 O-C-N 123.514 0.508 . . . . 0.0 110.826 -173.241 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 64.2 27.1 13.92 Favored 'General case' 0 N--CA 1.463 0.2 0 O-C-N 123.757 0.661 . . . . 0.0 111.679 179.071 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.672 ' O ' HG22 ' A' ' 24' ' ' THR . 11.1 mt -70.31 -176.16 1.14 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 175.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 57.9 tp60 -127.44 124.05 23.43 Favored Pre-proline 0 C--N 1.32 -0.696 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 177.618 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -62.62 135.55 53.43 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 123.083 2.522 . . . . 0.0 113.31 -177.499 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.67 25.21 39.42 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.907 179.659 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 87.4 t -129.99 148.77 33.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.27 0.557 . . . . 0.0 111.289 -174.233 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.595 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -87.33 121.5 29.86 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.648 -179.588 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -118.02 116.8 27.63 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.153 0.501 . . . . 0.0 112.24 -174.448 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.555 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 3.9 m-20 -89.96 113.13 24.72 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.376 176.474 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.691 HG12 HD11 ' A' ' 66' ' ' LEU . 5.1 mp -95.27 118.72 42.1 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.546 0 CA-C-O 121.057 0.455 . . . . 0.0 109.836 174.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.856 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 36.8 m -110.85 115.53 29.68 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.253 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.565 ' HB ' ' HB ' ' A' ' 91' ' ' VAL . 13.8 mm -95.89 145.27 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -179.556 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.414 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 53.0 m-85 -131.13 111.32 11.87 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 177.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.42 ' HB1' HG21 ' A' ' 37' ' ' ILE . . . -80.71 112.08 17.75 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 172.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.537 HG12 ' C ' ' A' ' 39' ' ' GLY . 7.4 p -106.68 135.54 44.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 C-N-CA 119.718 -0.793 . . . . 0.0 111.019 -174.818 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.477 ' OE2' ' HB3' ' A' ' 10' ' ' PRO . 4.8 mt-10 -109.05 172.06 7.07 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 177.433 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -44.67 -51.42 9.2 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 123.585 0.553 . . . . 0.0 112.136 178.68 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 -111.39 -14.19 13.79 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -171.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -135.43 172.81 12.47 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.32 -0.552 . . . . 0.0 111.882 -170.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -128.87 133.61 48.0 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 175.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 13.4 m -78.52 170.84 16.0 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.699 0.285 . . . . 0.0 110.914 -178.132 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.483 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 0.6 OUTLIER -57.9 158.24 13.24 Favored Pre-proline 0 N--CA 1.449 -0.51 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.767 174.758 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -87.07 138.79 5.04 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 122.067 1.844 . . . . 0.0 113.748 -177.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.856 ' O ' ' HA ' ' A' ' 78' ' ' THR . 5.0 t -82.38 124.26 39.09 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.795 0 CA-C-N 114.707 -1.133 . . . . 0.0 108.397 167.296 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 5.0 t -119.61 106.74 19.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 C-N-CA 119.689 -0.804 . . . . 0.0 109.99 171.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.514 HG13 ' HB ' ' A' ' 77' ' ' ILE . 5.9 pt -126.02 111.7 27.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.788 176.551 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.7 pm0 -99.09 133.45 43.35 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.158 0.504 . . . . 0.0 110.499 -178.509 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -139.26 140.44 37.68 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.094 178.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.469 ' HG2' ' HG2' ' A' ' 74' ' ' GLN . 38.3 mt-10 -86.26 146.86 26.34 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.952 0.405 . . . . 0.0 110.427 177.833 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 40.0 p -82.81 114.86 21.42 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.339 177.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 26.7 m -70.45 -31.43 68.58 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.907 -176.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 104.45 -171.55 19.51 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.469 -0.872 . . . . 0.0 112.535 175.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 86.3 m -79.21 124.34 84.44 Favored Pre-proline 0 C--N 1.32 -0.707 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 178.584 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -53.55 -38.93 84.1 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 123.025 2.484 . . . . 0.0 111.799 177.075 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 58.5 ttp180 54.03 67.17 1.05 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.685 174.136 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 23.1 m -92.26 46.44 1.26 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.308 0.575 . . . . 0.0 110.035 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -83.46 -19.23 36.22 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.718 -177.015 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -89.48 37.55 3.32 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.62 -176.238 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 37.3 m . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.313 -0.851 . . . . 0.0 109.566 176.321 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.528 0 N-CA-C 111.918 -0.473 . . . . 0.0 111.918 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.5 m -94.97 -9.45 33.95 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.104 0.478 . . . . 0.0 110.888 -179.287 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 28.5 m-70 -102.28 45.97 0.94 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.488 -179.555 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 14.2 tpt -67.39 -39.97 85.64 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.525 -178.281 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -83.4 82.45 1.67 Allowed Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.051 179.473 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 43.8 m -137.27 91.83 2.65 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 -179.688 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.9 m -79.71 87.7 5.22 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.296 0.57 . . . . 0.0 110.879 -178.434 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 13.3 t -115.6 -6.75 12.21 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.388 0.613 . . . . 0.0 110.351 178.261 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -78.67 119.15 76.24 Favored Pre-proline 0 C--N 1.315 -0.934 0 CA-C-N 114.783 -1.098 . . . . 0.0 110.862 -179.283 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.528 ' HG3' ' OE1' ' A' ' 83' ' ' GLU . 98.1 Cg_endo -82.47 175.94 8.41 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 123.113 2.542 . . . . 0.0 112.377 178.31 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -132.55 161.33 34.1 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.792 179.02 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -95.23 156.81 37.33 Favored Pre-proline 0 C--N 1.32 -0.71 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.638 176.496 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.418 ' HB2' ' HB2' ' A' ' 30' ' ' TRP . 23.0 Cg_exo -67.25 127.52 16.81 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.421 2.081 . . . . 0.0 111.999 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.587 ' HD2' ' O ' ' A' ' 31' ' ' SER . 80.0 Cg_exo -46.58 145.54 6.22 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 123.186 2.59 . . . . 0.0 112.174 174.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.426 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 24.2 t70 -35.27 105.37 0.28 Allowed Pre-proline 0 N--CA 1.468 0.44 0 O-C-N 124.884 1.365 . . . . 0.0 112.569 -169.854 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.651 ' HG2' HG11 ' A' ' 91' ' ' VAL . 23.7 Cg_exo -69.19 149.59 70.68 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 123.58 2.853 . . . . 0.0 112.796 -178.757 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.5 m -107.47 131.07 54.7 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.735 -177.632 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.512 HG11 HG22 ' A' ' 21' ' ' VAL . 72.5 t -73.66 123.72 29.37 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.022 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.062 175.679 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -83.34 -47.67 11.22 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.845 -174.503 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -135.48 137.54 42.26 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.11 -178.45 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.512 HG22 HG11 ' A' ' 18' ' ' VAL . 30.3 t -121.52 115.13 45.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.642 177.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -123.09 -167.55 1.62 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.347 177.415 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.552 ' O ' ' HB2' ' A' ' 69' ' ' LEU . 1.7 p-10 -70.55 -68.41 0.43 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.145 -0.479 . . . . 0.0 112.043 178.117 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.604 HG22 ' O ' ' A' ' 69' ' ' LEU . 38.1 p -106.72 31.95 4.89 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.699 -172.87 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.648 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 11.6 p -171.24 132.51 0.81 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.502 -174.484 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.579 ' HB ' HD12 ' A' ' 66' ' ' LEU . 44.9 mt -145.86 145.0 20.61 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.742 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 177.341 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.512 ' O ' HG13 ' A' ' 18' ' ' VAL . 35.6 t -117.44 137.67 50.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 C-N-CA 120.03 -0.668 . . . . 0.0 109.782 -174.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.64 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.6 OUTLIER -130.68 146.39 34.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 C-N-CA 119.974 -0.69 . . . . 0.0 110.229 178.331 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.481 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 34.9 mtp180 -129.63 120.35 25.09 Favored 'General case' 0 C--N 1.327 -0.402 0 O-C-N 123.623 0.577 . . . . 0.0 110.045 -175.488 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.753 ' HZ3' HG12 ' A' ' 64' ' ' VAL . 37.1 p90 -113.23 148.93 34.54 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.051 -174.823 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.587 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 13.6 m -93.7 100.4 12.63 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.936 178.498 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.638 ' NE ' ' HB3' ' A' ' 62' ' ' ASN . 0.1 OUTLIER -53.83 156.26 5.15 Favored Pre-proline 0 CA--C 1.538 0.482 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -174.314 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.65 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 2.4 Cg_endo -83.84 168.51 12.34 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 124.341 3.361 . . . . 0.0 112.474 -174.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -82.49 -16.32 49.22 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.019 172.586 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -59.62 141.65 88.34 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 114.621 -1.172 . . . . 0.0 111.304 177.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -69.75 112.76 3.16 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 121.035 1.156 . . . . 0.0 109.85 171.562 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.609 HD12 ' HE1' ' A' ' 40' ' ' TYR . 1.4 pt -121.42 147.33 25.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -176.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 17.4 p -97.39 -20.39 17.84 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -177.252 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.546 ' C ' HG12 ' A' ' 82' ' ' VAL . . . -173.63 -164.1 28.26 Favored Glycine 0 CA--C 1.501 -0.789 0 C-N-CA 119.877 -1.154 . . . . 0.0 111.957 177.19 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.65 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 6.5 m-85 -139.88 132.84 29.38 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-O 120.849 0.357 . . . . 0.0 111.069 173.644 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 8.7 mmm180 -103.49 149.31 24.97 Favored 'General case' 0 CA--C 1.503 -0.851 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 167.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.885 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 33.8 mt -138.73 108.25 4.11 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 C-N-CA 119.939 -0.705 . . . . 0.0 112.219 -178.512 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 72.0 t -107.94 110.38 31.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.299 0.571 . . . . 0.0 110.396 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.612 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 1.0 OUTLIER -110.64 125.42 53.41 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.328 176.071 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 39.9 p -140.01 135.47 16.43 Favored Pre-proline 0 C--N 1.316 -0.864 0 CA-C-N 113.922 -1.49 . . . . 0.0 111.217 -174.549 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.543 ' HG2' ' CA ' ' A' ' 50' ' ' GLY . 10.5 Cg_exo -69.71 132.48 23.5 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.815 2.344 . . . . 0.0 111.154 173.577 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 5.8 p -76.01 -9.22 58.44 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 121.077 -0.249 . . . . 0.0 111.547 -178.465 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.433 ' O ' ' HB2' ' A' ' 49' ' ' GLU . 15.7 m -117.24 -41.65 2.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 179.625 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.433 ' HB2' ' O ' ' A' ' 48' ' ' VAL . 45.7 tt0 169.86 138.36 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 122.498 0.319 . . . . 0.0 110.21 -177.3 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.543 ' CA ' ' HG2' ' A' ' 46' ' ' PRO . . . 152.44 -154.22 25.38 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.655 176.447 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.556 ' O ' ' HE2' ' A' ' 75' ' ' TYR . 39.9 t -93.94 121.61 35.59 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.799 0.333 . . . . 0.0 111.343 -176.325 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.477 ' HA ' ' O ' ' A' ' 44' ' ' TYR . 16.5 m -107.2 135.84 48.04 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 174.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.612 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 58.6 m -147.13 152.34 38.29 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.408 -177.048 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.885 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 33.2 tt0 -116.5 117.5 30.08 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.85 174.129 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.703 HD12 ' CG2' ' A' ' 64' ' ' VAL . 18.3 mt -97.3 158.06 15.65 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 174.684 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -123.45 111.06 15.88 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.607 -178.608 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.569 HD12 ' CH2' ' A' ' 30' ' ' TRP . 3.4 mt -109.59 155.55 41.16 Favored Pre-proline 0 N--CA 1.444 -0.771 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -177.152 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -64.35 148.83 90.93 Favored 'Trans proline' 0 N--CA 1.448 -1.172 0 C-N-CA 121.611 1.54 . . . . 0.0 110.635 175.108 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.467 ' HB2' HG13 ' A' ' 37' ' ' ILE . 8.4 pt-20 -44.04 -27.58 0.39 Allowed 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 114.729 -1.123 . . . . 0.0 113.197 178.818 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.8 t -103.35 6.99 38.23 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.44 -173.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.421 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -76.41 158.5 31.33 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 178.598 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.638 ' HB3' ' NE ' ' A' ' 32' ' ' ARG . 29.2 p-10 -141.98 18.29 2.12 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -177.595 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.64 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 25.5 p -169.76 134.2 1.33 Allowed 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.209 -0.597 . . . . 0.0 111.715 179.288 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.753 HG12 ' HZ3' ' A' ' 30' ' ' TRP . 3.7 p -116.81 137.55 50.31 Favored 'Isoleucine or valine' 0 C--O 1.243 0.728 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.489 176.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 68.3 m -96.92 101.18 12.72 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.579 169.403 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.678 HD11 HG12 ' A' ' 77' ' ' ILE . 0.2 OUTLIER -80.19 145.38 32.31 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.474 -0.784 . . . . 0.0 108.928 178.647 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 8.8 t -141.06 174.14 10.8 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.27 -174.34 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 62.78 27.22 15.98 Favored 'General case' 0 C--N 1.329 -0.304 0 O-C-N 123.8 0.688 . . . . 0.0 111.272 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.604 ' O ' HG22 ' A' ' 24' ' ' THR . 10.9 mt -74.65 -176.36 2.77 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.275 -0.421 . . . . 0.0 109.883 177.242 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 57.3 tp60 -130.35 123.27 20.44 Favored Pre-proline 0 C--N 1.32 -0.709 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.007 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -62.0 133.59 45.12 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.961 2.441 . . . . 0.0 113.035 -177.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 87.42 25.24 33.85 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.788 -178.62 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.505 ' CG1' ' HB3' ' A' ' 46' ' ' PRO . 94.9 t -131.02 142.81 42.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.027 0.441 . . . . 0.0 110.841 -176.772 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.493 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 10.3 tp60 -86.36 107.45 18.01 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.002 -177.339 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.556 ' HE2' ' O ' ' A' ' 51' ' ' SER . 18.8 m-85 -99.13 119.95 38.69 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.097 0.475 . . . . 0.0 111.69 -177.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.507 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 13.3 m120 -92.72 109.21 20.62 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.418 177.164 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.678 HG12 HD11 ' A' ' 66' ' ' LEU . 5.0 mp -91.76 116.72 33.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.246 0.546 . . . . 0.0 109.642 178.121 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.884 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 81.1 m -108.9 115.81 30.8 Favored 'General case' 0 N--CA 1.427 -1.605 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.441 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.544 ' HB ' ' HB ' ' A' ' 91' ' ' VAL . 13.5 mm -95.12 141.26 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 -179.285 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -128.79 111.79 13.49 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.91 178.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.444 ' HB3' ' OG ' ' A' ' 88' ' ' SER . . . -78.97 119.5 22.22 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 168.212 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.546 HG12 ' C ' ' A' ' 39' ' ' GLY . 7.6 p -106.77 133.87 50.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 C-N-CA 120.092 -0.643 . . . . 0.0 110.049 -178.206 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.528 ' OE1' ' HG3' ' A' ' 10' ' ' PRO . 1.4 mp0 -111.01 170.22 8.24 Favored 'General case' 0 N--CA 1.445 -0.68 0 O-C-N 123.579 0.549 . . . . 0.0 110.068 -178.12 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.441 ' H ' ' HG3' ' A' ' 84' ' ' GLU . 30.7 mt-10 -43.68 -46.99 7.65 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.119 -0.946 . . . . 0.0 112.676 -174.566 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 -125.12 6.14 7.87 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -174.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -147.81 177.24 9.48 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.854 0.359 . . . . 0.0 111.762 -172.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -133.04 124.41 27.6 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.172 176.376 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.444 ' OG ' ' HB3' ' A' ' 81' ' ' ALA . 92.9 p -70.81 170.43 12.55 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.908 0.385 . . . . 0.0 111.569 -178.022 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 18.7 p -60.73 153.05 65.37 Favored Pre-proline 0 CA--C 1.531 0.218 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.772 175.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -83.38 144.55 11.59 Favored 'Trans proline' 0 CA--C 1.534 0.499 0 C-N-CA 122.31 2.007 . . . . 0.0 114.712 -175.405 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.884 ' O ' ' HA ' ' A' ' 78' ' ' THR . 11.7 t -83.49 129.38 37.61 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.581 0 CA-C-N 114.614 -1.176 . . . . 0.0 107.975 163.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.3 t -125.1 106.87 17.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 C-N-CA 120.046 -0.661 . . . . 0.0 110.13 173.248 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.574 HG13 ' HB ' ' A' ' 77' ' ' ILE . 9.7 pt -125.04 113.14 34.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.259 179.266 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.423 ' HB3' ' ND2' ' A' ' 76' ' ' ASN . 11.1 pt20 -98.72 125.33 44.01 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.558 0.694 . . . . 0.0 111.675 -176.551 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -131.98 127.3 35.99 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.389 176.285 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.437 ' HA ' ' HA ' ' A' ' 74' ' ' GLN . 28.8 tt0 -87.17 127.25 35.15 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.34 0.59 . . . . 0.0 109.851 178.564 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.405 HG22 HD11 ' A' ' 26' ' ' ILE . 22.7 p -59.79 116.88 4.39 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.851 -1.068 . . . . 0.0 111.719 -175.265 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.7 m -69.26 -30.88 69.09 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.281 -178.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 107.88 -169.75 14.75 Favored Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.669 178.474 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.402 ' HA ' ' HD3' ' A' ' 101' ' ' PRO . 39.8 m -73.47 120.75 82.77 Favored Pre-proline 0 C--N 1.319 -0.751 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 175.785 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 100' ' ' THR . 48.5 Cg_exo -56.18 92.81 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 123.047 2.498 . . . . 0.0 113.088 -176.283 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 75.2 ttt180 -85.27 -32.57 22.49 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.062 175.702 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 43.6 t -95.9 146.45 24.57 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.496 176.179 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -132.25 5.16 4.09 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.429 -179.526 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -166.2 31.35 0.21 Allowed Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.382 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 97.1 m . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.734 -0.65 . . . . 0.0 110.217 178.514 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.655 0 N-CA-C 111.892 -0.483 . . . . 0.0 111.892 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.4 m -118.41 75.16 1.0 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.067 0.46 . . . . 0.0 110.568 -178.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 23.8 m-70 -136.64 112.61 9.64 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.139 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 95.0 mmm -70.01 104.25 2.5 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 175.144 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 87.11 61.19 1.6 Allowed Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 -172.244 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 23.6 m -61.87 124.94 22.15 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.342 -0.429 . . . . 0.0 111.046 -176.311 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.7 t -84.35 151.03 24.98 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.136 177.605 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 27.7 m -148.75 118.74 7.16 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.029 0.443 . . . . 0.0 110.205 177.092 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -148.35 124.32 5.26 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.599 -178.105 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.491 ' HB3' ' CD ' ' A' ' 83' ' ' GLU . 56.4 Cg_endo -70.47 134.47 26.54 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.229 1.952 . . . . 0.0 112.757 -176.297 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.409 ' O ' ' HB3' ' A' ' 33' ' ' PRO . 7.3 p-10 -84.86 154.46 22.26 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.328 174.686 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -96.85 162.26 23.65 Favored Pre-proline 0 C--N 1.319 -0.756 0 N-CA-C 109.379 -0.601 . . . . 0.0 109.379 177.671 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -70.93 127.09 13.22 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 121.811 1.674 . . . . 0.0 111.166 176.089 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.518 ' HD2' ' O ' ' A' ' 31' ' ' SER . 84.6 Cg_exo -48.16 145.6 10.76 Favored 'Trans proline' 0 CA--C 1.515 -0.443 0 C-N-CA 122.874 2.382 . . . . 0.0 111.401 173.458 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.429 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 17.3 t70 -35.67 106.37 0.31 Allowed Pre-proline 0 N--CA 1.466 0.335 0 O-C-N 124.939 1.399 . . . . 0.0 111.993 -169.422 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.589 ' HG2' HG11 ' A' ' 91' ' ' VAL . 27.4 Cg_exo -67.03 146.13 76.05 Favored 'Trans proline' 0 CA--C 1.518 -0.305 0 C-N-CA 123.526 2.818 . . . . 0.0 112.045 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.8 m -105.57 131.46 52.93 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.894 -176.095 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.407 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 93.4 t -73.12 111.44 7.67 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-N 114.471 -1.24 . . . . 0.0 109.315 173.194 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -78.8 -45.0 21.91 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.277 -171.539 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -139.31 139.88 37.42 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.437 -178.008 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.416 HG13 HG12 ' A' ' 26' ' ' ILE . 60.5 t -129.12 132.6 66.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.868 -176.36 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -132.25 -161.86 1.18 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.765 174.149 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -71.75 -68.52 0.45 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.087 0.47 . . . . 0.0 112.109 177.188 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.625 HG22 ' O ' ' A' ' 69' ' ' LEU . 68.6 p -106.99 36.78 2.55 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.216 0.531 . . . . 0.0 111.176 -173.104 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.543 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 19.8 p -172.23 140.75 1.18 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.399 -174.108 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.578 ' HB ' HD12 ' A' ' 66' ' ' LEU . 46.5 mt -149.38 155.91 7.87 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.699 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.32 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 39.7 t -128.17 133.48 66.93 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.572 0 CA-C-N 119.373 0.988 . . . . 0.0 110.206 179.159 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.651 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.7 OUTLIER -125.45 145.16 33.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 C-N-CA 120.197 -0.601 . . . . 0.0 109.924 179.45 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.471 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 20.6 mtp180 -130.24 121.08 25.48 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 123.373 0.421 . . . . 0.0 110.563 -174.403 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.629 ' HZ3' HG12 ' A' ' 64' ' ' VAL . 35.2 p90 -111.98 146.48 37.78 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.734 -175.169 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.518 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 33.0 t -89.99 88.68 7.4 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.333 174.834 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.579 ' HD3' ' H ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -49.55 155.55 1.33 Allowed Pre-proline 0 CA--C 1.541 0.597 0 CA-C-N 115.151 -0.931 . . . . 0.0 112.77 -174.32 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.717 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 2.8 Cg_exo -75.87 170.0 21.04 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.948 3.099 . . . . 0.0 113.953 -169.556 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 24.7 tt0 -80.35 -22.65 41.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.705 -1.134 . . . . 0.0 108.523 169.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.8 135.38 78.89 Favored Pre-proline 0 CA--C 1.517 -0.299 0 CA-C-N 114.804 -1.089 . . . . 0.0 111.054 177.109 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -69.83 113.13 3.29 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 121.099 1.2 . . . . 0.0 109.755 171.579 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.559 HD12 ' HE1' ' A' ' 40' ' ' TYR . 0.6 OUTLIER -118.44 154.2 20.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -174.409 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.425 ' N ' ' O ' ' A' ' 82' ' ' VAL . 7.3 p -94.4 -33.94 12.96 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -179.726 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.514 ' C ' HG12 ' A' ' 82' ' ' VAL . . . -162.39 -167.53 22.96 Favored Glycine 0 N--CA 1.438 -1.232 0 C-N-CA 120.036 -1.078 . . . . 0.0 112.419 -177.014 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.717 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 4.6 m-85 -137.9 134.07 34.58 Favored 'General case' 0 C--N 1.319 -0.729 0 O-C-N 123.745 0.321 . . . . 0.0 110.897 174.352 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.6 mmm180 -104.06 147.71 27.09 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 167.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.887 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 22.7 mt -138.66 108.23 4.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 C-N-CA 119.961 -0.696 . . . . 0.0 111.959 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 72.1 t -111.2 109.41 28.39 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.646 0 CA-C-O 121.364 0.602 . . . . 0.0 110.317 179.166 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.665 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 0.6 OUTLIER -111.58 125.07 53.54 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.549 177.598 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.428 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 23.1 t -141.98 137.44 15.96 Favored Pre-proline 0 C--N 1.316 -0.881 0 CA-C-N 114.158 -1.383 . . . . 0.0 111.192 -172.624 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.68 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 15.1 Cg_exo -67.69 153.91 74.75 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 123.276 2.651 . . . . 0.0 111.706 174.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 16.3 m -79.07 -26.13 43.07 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.82 -176.128 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 94.0 t -117.05 -41.86 2.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -178.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 179.32 146.36 0.19 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.566 0.222 . . . . 0.0 110.634 -178.012 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.461 ' CA ' ' HG2' ' A' ' 46' ' ' PRO . . . 150.31 -149.32 21.18 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.452 -0.88 . . . . 0.0 112.79 176.556 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 19.9 m -92.58 121.45 34.03 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.744 0.307 . . . . 0.0 111.163 -176.699 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.524 ' HA ' ' O ' ' A' ' 44' ' ' TYR . 17.7 m -114.87 136.21 53.35 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 174.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.665 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 89.7 m -147.15 147.47 30.56 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.75 -175.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.887 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 33.4 tt0 -115.39 112.29 22.11 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.892 174.303 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.714 HD12 ' CG2' ' A' ' 64' ' ' VAL . 17.2 mt -98.0 152.99 18.7 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.561 -0.456 . . . . 0.0 109.8 174.816 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -116.7 118.35 32.31 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 177.791 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.582 HD12 ' CH2' ' A' ' 30' ' ' TRP . 3.2 mt -115.04 157.17 44.11 Favored Pre-proline 0 N--CA 1.444 -0.766 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -176.809 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -65.57 150.4 86.62 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 121.826 1.684 . . . . 0.0 110.991 174.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.408 ' HB2' HG13 ' A' ' 37' ' ' ILE . 10.0 pt-20 -47.12 -27.66 1.48 Allowed 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 115.217 -0.902 . . . . 0.0 112.48 177.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.8 t -102.59 15.08 30.3 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.138 -174.799 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.43 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -83.34 163.58 20.55 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 177.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.471 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 5.2 p-10 -150.08 12.97 0.77 Allowed 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.153 -0.619 . . . . 0.0 112.436 -176.656 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.651 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 20.1 m -162.89 134.92 5.27 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 117.634 0.197 . . . . 0.0 110.776 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.714 ' CG2' HD12 ' A' ' 55' ' ' LEU . 4.1 p -117.58 138.81 47.05 Favored 'Isoleucine or valine' 0 C--O 1.244 0.802 0 CA-C-O 120.662 0.267 . . . . 0.0 110.508 174.304 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 52.6 m -98.76 101.74 13.25 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-O 121.741 0.782 . . . . 0.0 110.162 171.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.594 HD11 HG12 ' A' ' 77' ' ' ILE . 0.5 OUTLIER -75.66 138.17 41.18 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.067 -0.969 . . . . 0.0 108.896 177.455 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 14.0 p -132.17 159.98 37.4 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 123.193 0.308 . . . . 0.0 111.502 -171.25 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 64.43 34.26 10.48 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.491 175.314 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.625 ' O ' HG22 ' A' ' 24' ' ' THR . 14.6 mt -74.34 -175.93 2.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.986 175.655 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.471 ' HB2' HG21 ' A' ' 73' ' ' VAL . 20.3 mt-30 -124.4 140.3 34.87 Favored Pre-proline 0 C--N 1.317 -0.822 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 172.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.14 125.5 14.19 Favored 'Trans proline' 0 CA--C 1.531 0.353 0 C-N-CA 122.362 2.041 . . . . 0.0 112.601 179.506 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 88.16 38.24 7.38 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.786 178.139 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.471 HG21 ' HB2' ' A' ' 70' ' ' GLN . 46.6 t -130.5 144.33 38.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 110.333 -0.247 . . . . 0.0 110.333 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.68 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 43.5 tt0 -88.83 125.42 34.9 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.032 178.195 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.526 ' O ' ' HA ' ' A' ' 94' ' ' GLN . 98.3 m-85 -117.44 121.79 42.01 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.917 0.389 . . . . 0.0 111.236 -179.451 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.543 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 4.1 m-20 -88.33 106.31 18.15 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 170.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.594 HG12 HD11 ' A' ' 66' ' ' LEU . 5.2 mp -90.1 115.56 29.79 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.768 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 177.26 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.902 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 29.0 m -103.83 113.79 27.57 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 114.779 -1.101 . . . . 0.0 110.222 -177.849 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.541 ' HB ' ' HB ' ' A' ' 91' ' ' VAL . 12.3 mm -95.34 134.43 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -122.05 111.19 16.72 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.984 179.389 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.479 ' HB1' HG21 ' A' ' 37' ' ' ILE . . . -82.77 111.85 19.07 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 171.421 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.514 HG12 ' C ' ' A' ' 39' ' ' GLY . 7.8 p -107.73 133.05 53.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 C-N-CA 119.751 -0.779 . . . . 0.0 110.964 -173.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.543 ' OE1' ' HB2' ' A' ' 86' ' ' GLN . 6.8 mt-10 -107.22 171.11 7.56 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 175.613 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -43.77 -42.21 5.39 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 123.481 0.488 . . . . 0.0 112.14 178.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -123.01 -20.24 5.83 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -173.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.543 ' HB2' ' OE1' ' A' ' 83' ' ' GLU . 16.2 mm100 -123.77 176.33 6.33 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.789 -0.365 . . . . 0.0 111.632 -171.538 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -140.42 126.39 19.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.983 176.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.425 ' OG ' ' HB2' ' A' ' 10' ' ' PRO . 19.7 m -67.04 156.07 37.02 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.206 176.437 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 35.9 p -57.86 146.25 68.11 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.369 177.266 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -76.36 141.45 22.86 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 122.049 1.833 . . . . 0.0 114.118 -171.257 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.902 ' O ' ' HA ' ' A' ' 78' ' ' THR . 12.0 t -81.3 130.99 34.92 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.68 0 CA-C-N 114.444 -1.253 . . . . 0.0 108.201 169.392 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 19.0 t -127.52 106.85 15.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 C-N-CA 120.062 -0.655 . . . . 0.0 110.11 172.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.502 HG13 ' O ' ' A' ' 93' ' ' ILE . 43.0 pt -119.95 111.71 33.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.416 -179.44 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.526 ' HA ' ' O ' ' A' ' 75' ' ' TYR . 0.5 OUTLIER -95.59 126.31 40.79 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.297 0.57 . . . . 0.0 111.206 -177.456 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 17.9 tm0? -137.42 131.57 32.18 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.625 179.446 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.483 ' HG2' ' HB2' ' A' ' 74' ' ' GLN . 43.4 mt-10 -92.04 122.02 34.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.695 -0.23 . . . . 0.0 110.842 178.422 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.425 ' CG2' HD11 ' A' ' 26' ' ' ILE . 1.8 p -56.38 126.11 24.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.189 0.519 . . . . 0.0 112.035 -177.524 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.0 m -69.36 -30.97 69.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.44 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 100.54 -155.43 19.39 Favored Glycine 0 N--CA 1.443 -0.889 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.429 176.37 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 25.0 m -103.47 123.9 39.94 Favored Pre-proline 0 C--N 1.32 -0.716 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 178.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -55.94 121.86 10.74 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.51 2.14 . . . . 0.0 111.338 175.622 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 79.6 mtm180 -85.8 73.73 10.33 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.155 0.503 . . . . 0.0 110.575 -178.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 5.8 p -85.69 -12.41 51.29 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.193 178.459 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -108.13 150.24 27.46 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.939 178.615 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -161.5 -54.12 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.142 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.1 p . . . . . 0 C--O 1.248 1.024 0 CA-C-O 119.133 -0.46 . . . . 0.0 110.916 178.975 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.568 0 N-CA-C 112.0 -0.44 . . . . 0.0 112.0 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.3 m -151.27 51.2 0.84 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.015 0.436 . . . . 0.0 110.22 177.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 51.0 t-80 -99.94 72.5 1.7 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.141 -179.418 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 21.2 ptp -119.23 -21.0 7.74 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.631 179.069 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -137.74 -56.5 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 177.223 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.8 p 43.74 65.67 0.97 Allowed 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.846 0.859 . . . . 0.0 113.108 175.75 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.3 m -74.14 -17.33 60.94 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.156 175.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 25.6 m -67.98 141.05 56.38 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.542 177.014 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 65.19 72.66 0.46 Allowed Pre-proline 0 N--CA 1.466 0.337 0 O-C-N 123.704 0.627 . . . . 0.0 111.539 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -81.44 153.44 18.16 Favored 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 123.103 2.535 . . . . 0.0 111.45 178.081 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.489 ' O ' ' HB3' ' A' ' 33' ' ' PRO . 7.3 p-10 -106.03 141.83 36.75 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.295 -0.562 . . . . 0.0 110.507 -177.699 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.582 ' HB2' ' O ' ' A' ' 89' ' ' THR . . . -72.84 163.43 68.3 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.271 178.399 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -62.91 133.46 41.7 Favored 'Trans proline' 0 C--O 1.235 0.344 0 C-N-CA 122.234 1.956 . . . . 0.0 111.618 175.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -50.82 145.97 22.37 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.424 2.082 . . . . 0.0 110.9 173.623 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.404 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 13.1 m-20 -36.04 105.96 0.3 Allowed Pre-proline 0 N--CA 1.468 0.447 0 O-C-N 124.759 1.287 . . . . 0.0 112.206 -170.343 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.552 ' HG2' HG11 ' A' ' 91' ' ' VAL . 39.1 Cg_exo -65.23 147.21 87.86 Favored 'Trans proline' 0 CA--C 1.521 -0.173 0 C-N-CA 123.764 2.976 . . . . 0.0 112.517 -179.183 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 26.3 m -102.27 131.11 49.05 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.717 -177.185 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.469 HG13 ' O ' ' A' ' 27' ' ' VAL . 95.3 t -81.28 121.63 35.04 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 CA-C-N 114.379 -1.282 . . . . 0.0 110.224 177.118 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -88.13 -37.16 16.43 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.417 -174.421 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -135.62 135.61 40.36 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.343 -177.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.514 ' HA ' HG12 ' A' ' 26' ' ' ILE . 60.8 t -132.86 114.69 22.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.748 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -135.09 -172.22 3.0 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 177.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.542 ' O ' ' HB2' ' A' ' 69' ' ' LEU . 0.6 OUTLIER -57.18 -67.69 0.3 Allowed 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -178.131 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.648 HG22 ' O ' ' A' ' 69' ' ' LEU . 36.1 p -110.52 33.57 4.44 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.482 -172.335 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.616 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 58.4 m -168.04 130.06 1.47 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.544 -175.23 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.578 ' HB ' HD12 ' A' ' 66' ' ' LEU . 29.5 mt -144.48 141.53 23.96 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.733 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 175.817 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.469 ' O ' HG13 ' A' ' 18' ' ' VAL . 44.8 t -118.89 132.28 69.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.398 -175.16 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.609 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.6 OUTLIER -127.96 146.76 33.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 C-N-CA 119.928 -0.709 . . . . 0.0 110.605 -178.396 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.511 ' HG2' ' HB3' ' A' ' 63' ' ' SER . 93.3 mtt180 -130.65 121.17 25.08 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.479 -176.267 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.724 ' HZ3' HG12 ' A' ' 64' ' ' VAL . 37.7 p90 -112.98 152.97 28.77 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.202 -175.02 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 20.8 t -100.42 101.51 12.48 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.296 -0.411 . . . . 0.0 109.914 178.59 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.666 ' H ' ' CD ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -50.99 157.68 1.35 Allowed Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 123.99 0.916 . . . . 0.0 113.257 -174.364 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.687 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 2.5 Cg_endo -85.1 166.7 11.05 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 124.561 3.508 . . . . 0.0 113.572 -174.646 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -75.41 -23.64 57.03 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.845 -1.07 . . . . 0.0 109.369 171.117 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.39 135.92 76.17 Favored Pre-proline 0 C--O 1.236 0.348 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.292 175.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -68.38 113.9 3.27 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 121.192 1.262 . . . . 0.0 109.336 168.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.596 HG22 ' HG3' ' A' ' 83' ' ' GLU . 0.5 OUTLIER -117.98 152.31 20.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -175.662 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.401 HG21 ' HA ' ' A' ' 84' ' ' GLU . 12.5 p -95.54 -29.06 14.56 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -178.403 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.432 ' C ' HG12 ' A' ' 82' ' ' VAL . . . -168.58 -166.44 27.65 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 119.765 -1.207 . . . . 0.0 112.063 178.125 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.687 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 5.5 m-85 -137.81 131.94 31.9 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-N 117.056 0.428 . . . . 0.0 111.516 176.632 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 41.9 mtm180 -105.68 148.42 27.42 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 170.536 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.888 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 32.0 mt -139.6 108.92 3.62 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -176.027 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 78.3 t -109.03 110.58 32.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.24 0.543 . . . . 0.0 110.356 179.054 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.69 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 1.0 OUTLIER -111.86 124.76 53.04 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.392 177.055 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.3 m -134.95 137.7 27.81 Favored Pre-proline 0 C--N 1.315 -0.932 0 CA-C-N 114.318 -1.31 . . . . 0.0 111.639 -173.552 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.491 ' HD2' ' OG ' ' A' ' 52' ' ' SER . 73.3 Cg_endo -73.04 134.38 21.31 Favored 'Trans proline' 0 C--O 1.23 0.125 0 C-N-CA 123.379 2.72 . . . . 0.0 111.566 174.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 28.1 t -65.0 -34.98 79.73 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.657 -177.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 16.0 m -115.6 -39.42 2.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -175.025 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -173.71 146.58 1.29 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 117.885 0.311 . . . . 0.0 110.515 -178.284 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.456 ' C ' ' HG3' ' A' ' 46' ' ' PRO . . . 139.4 -165.3 25.8 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.235 -179.691 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 20.3 m -92.79 127.84 38.44 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 111.565 0.209 . . . . 0.0 111.565 -177.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.491 ' OG ' ' HD2' ' A' ' 46' ' ' PRO . 6.7 m -103.22 138.07 40.51 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 170.297 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.69 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 37.7 m -147.25 154.25 40.78 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.683 -0.407 . . . . 0.0 111.578 -176.798 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.888 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 44.3 tt0 -119.32 117.76 29.42 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.03 176.088 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.7 HD12 ' CG2' ' A' ' 64' ' ' VAL . 17.9 mt -99.67 164.67 11.96 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 173.429 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.508 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 8.0 t30 -135.91 115.83 13.17 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -178.699 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.561 HD12 ' CH2' ' A' ' 30' ' ' TRP . 5.7 mt -112.87 160.82 29.37 Favored Pre-proline 0 N--CA 1.444 -0.745 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -174.184 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -64.84 151.01 87.3 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 121.656 1.571 . . . . 0.0 110.841 174.474 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.446 ' HB2' HG13 ' A' ' 37' ' ' ILE . 10.4 pt-20 -45.49 -29.55 1.17 Allowed 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.095 0.958 . . . . 0.0 112.913 178.386 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 7.1 t -96.58 -0.17 49.11 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.398 -174.225 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.504 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -69.95 158.88 34.77 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 110.205 -0.295 . . . . 0.0 110.205 -177.51 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.561 ' HB3' ' NE ' ' A' ' 32' ' ' ARG . 3.8 p-10 -143.65 15.14 1.78 Allowed 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -177.709 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.609 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 36.1 p -168.45 133.63 1.72 Allowed 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.084 -0.646 . . . . 0.0 112.333 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.724 HG12 ' HZ3' ' A' ' 30' ' ' TRP . 4.8 p -118.72 139.47 45.93 Favored 'Isoleucine or valine' 0 C--O 1.243 0.725 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.537 176.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 34.4 m -99.51 103.75 15.52 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.72 170.256 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.708 HD11 HG12 ' A' ' 77' ' ' ILE . 0.2 OUTLIER -83.38 144.45 29.63 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.465 179.112 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 9.6 t -138.97 170.64 15.61 Favored 'General case' 0 N--CA 1.448 -0.555 0 O-C-N 123.371 0.42 . . . . 0.0 110.296 -174.158 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 65.24 22.25 12.13 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.052 179.271 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.648 ' O ' HG22 ' A' ' 24' ' ' THR . 6.5 mt -68.66 -178.45 1.16 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 177.513 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -124.36 128.06 25.11 Favored Pre-proline 0 C--N 1.32 -0.696 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 176.11 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -62.16 135.22 53.37 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 123.003 2.468 . . . . 0.0 113.069 -177.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.54 29.34 30.12 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.217 178.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 47.8 t -130.55 147.27 33.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.157 0.503 . . . . 0.0 111.198 -177.655 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 7.6 tp60 -86.06 109.47 18.85 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.205 178.713 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.448 ' CE2' HD22 ' A' ' 69' ' ' LEU . 4.2 m-85 -98.97 117.39 33.36 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.144 0.497 . . . . 0.0 111.885 -177.826 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.446 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 78.4 m-20 -88.06 108.13 19.08 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.025 174.224 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.708 HG12 HD11 ' A' ' 66' ' ' LEU . 5.0 mp -92.12 113.55 27.6 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.692 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 175.11 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.889 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 25.8 m -105.07 113.8 27.61 Favored 'General case' 0 N--CA 1.425 -1.723 0 CA-C-N 114.915 -1.038 . . . . 0.0 109.996 -179.022 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.574 ' H ' ' HB ' ' A' ' 91' ' ' VAL . 15.8 mm -95.05 143.3 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -130.85 111.94 12.56 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.96 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.501 ' HB3' ' OG ' ' A' ' 88' ' ' SER . . . -81.28 125.53 30.45 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 167.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.432 HG12 ' C ' ' A' ' 39' ' ' GLY . 7.5 p -113.36 133.5 59.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 C-N-CA 120.384 -0.526 . . . . 0.0 110.233 -179.095 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.596 ' HG3' HG22 ' A' ' 37' ' ' ILE . 8.2 mp0 -109.07 170.85 7.79 Favored 'General case' 0 N--CA 1.443 -0.819 0 O-C-N 123.912 0.757 . . . . 0.0 108.988 -178.387 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.401 ' HA ' HG21 ' A' ' 38' ' ' THR . 46.8 mt-10 -42.57 -45.24 4.48 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -172.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -131.16 0.9 4.19 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.029 -0.668 . . . . 0.0 112.624 -177.274 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.491 ' HG3' ' OE1' ' A' ' 83' ' ' GLU . 29.1 pt20 -136.07 176.04 9.05 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.961 -0.296 . . . . 0.0 110.772 -176.44 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -130.85 135.12 47.42 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.295 -0.412 . . . . 0.0 109.903 175.104 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.501 ' OG ' ' HB3' ' A' ' 81' ' ' ALA . 78.5 p -70.64 -178.36 1.8 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.955 0.407 . . . . 0.0 111.1 177.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.582 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 1.4 p -65.9 162.72 42.73 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.746 176.326 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -88.62 137.36 3.43 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 122.129 1.886 . . . . 0.0 113.753 179.075 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.889 ' O ' ' HA ' ' A' ' 78' ' ' THR . 6.4 t -82.53 126.07 39.97 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.72 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 166.619 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 10.5 t -124.14 106.77 17.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 C-N-CA 119.964 -0.694 . . . . 0.0 109.79 172.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.575 HG13 ' HB ' ' A' ' 77' ' ' ILE . 9.7 pt -122.98 111.88 31.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.354 178.531 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.426 ' HB3' ' OD1' ' A' ' 76' ' ' ASN . 11.3 pt20 -98.0 119.82 37.31 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.555 0.693 . . . . 0.0 111.591 -175.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -128.99 131.51 47.44 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.715 178.442 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -85.19 134.51 34.16 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.274 178.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.407 HG22 HD11 ' A' ' 26' ' ' ILE . 34.1 p -70.99 114.63 9.24 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.587 179.465 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 18.9 m -68.72 -30.77 69.49 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.443 0.64 . . . . 0.0 110.04 -177.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.449 ' HA2' ' HB3' ' A' ' 23' ' ' ASP . . . 94.68 -120.96 6.58 Favored Glycine 0 N--CA 1.441 -1.016 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.421 174.554 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 24.1 m -125.37 124.41 25.15 Favored Pre-proline 0 C--N 1.318 -0.789 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.2 92.06 0.06 OUTLIER 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 123.092 2.528 . . . . 0.0 112.73 179.547 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 66.0 ttt180 66.64 -80.43 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.797 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 18.6 m -132.07 -48.02 0.93 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.751 0.31 . . . . 0.0 111.016 -176.181 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -92.11 163.96 13.76 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.693 179.456 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 109.73 47.51 0.84 Allowed Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.675 -0.774 . . . . 0.0 111.196 -177.06 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.9 t . . . . . 0 C--O 1.252 1.197 0 CA-C-O 119.276 -0.392 . . . . 0.0 109.944 -179.721 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.821 0 N-CA-C 112.068 -0.413 . . . . 0.0 112.068 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 44.2 m -82.84 126.17 32.14 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.95 0.405 . . . . 0.0 110.616 179.447 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 38.5 t-80 -116.47 -53.95 2.49 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.238 179.518 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 50.1 ttm -162.13 126.24 3.19 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.473 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 166.97 -115.63 0.64 Allowed Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.079 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 7.5 p -78.45 -19.21 53.63 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.082 0.468 . . . . 0.0 110.935 178.134 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.5 p -99.67 117.49 34.14 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.048 178.642 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 28.1 m -73.32 143.77 46.81 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 175.502 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -85.03 112.86 46.41 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-O 120.692 0.282 . . . . 0.0 110.393 179.37 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.07 172.22 16.79 Favored 'Trans proline' 0 C--O 1.235 0.343 0 C-N-CA 122.886 2.391 . . . . 0.0 111.59 -179.038 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -120.02 158.6 26.46 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.838 0.352 . . . . 0.0 110.366 -179.524 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.403 ' HB2' ' O ' ' A' ' 89' ' ' THR . . . -95.83 160.75 29.5 Favored Pre-proline 0 C--N 1.318 -0.784 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.348 175.079 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -63.89 130.24 27.04 Favored 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.119 1.879 . . . . 0.0 111.578 178.729 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.579 ' HD2' ' O ' ' A' ' 31' ' ' SER . 83.5 Cg_exo -47.74 149.74 4.86 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.827 2.351 . . . . 0.0 111.212 171.241 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.421 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 8.1 p-10 -39.62 107.16 0.43 Allowed Pre-proline 0 N--CA 1.468 0.467 0 O-C-N 124.382 1.051 . . . . 0.0 112.336 -169.785 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.602 ' HG2' HG11 ' A' ' 91' ' ' VAL . 31.4 Cg_exo -65.22 148.17 88.6 Favored 'Trans proline' 0 CA--C 1.516 -0.42 0 C-N-CA 123.381 2.721 . . . . 0.0 112.134 179.071 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 24.9 m -107.41 132.01 53.64 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.655 -178.606 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 77.9 t -79.35 123.26 36.04 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 CA-C-N 114.194 -1.366 . . . . 0.0 110.359 176.323 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.423 ' OD2' ' HG3' ' A' ' 20' ' ' GLN . 26.3 t70 -88.72 -35.83 16.51 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.252 -176.281 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.423 ' HG3' ' OD2' ' A' ' 19' ' ' ASP . 75.8 mt-30 -135.99 134.1 38.22 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.688 -176.303 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.504 ' HA ' HG12 ' A' ' 26' ' ' ILE . 78.7 t -129.97 113.68 27.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.444 178.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -127.2 -166.76 1.64 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.057 178.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.6 -68.33 0.37 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.197 0.522 . . . . 0.0 112.161 178.287 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.633 HG22 ' O ' ' A' ' 69' ' ' LEU . 69.6 p -109.56 36.85 2.81 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.51 -174.047 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.517 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 72.0 p -170.59 134.88 1.12 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.94 -176.391 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.628 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 42.4 mt -148.78 141.44 18.21 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.837 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 177.448 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 47.3 t -118.21 132.24 68.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 118.897 0.771 . . . . 0.0 110.214 -176.275 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.622 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.7 OUTLIER -125.31 146.15 31.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 C-N-CA 119.917 -0.713 . . . . 0.0 110.411 -178.254 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.501 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 83.3 mtt180 -131.15 121.9 25.69 Favored 'General case' 0 C--N 1.329 -0.288 0 O-C-N 123.376 0.423 . . . . 0.0 110.778 -175.655 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.718 ' HZ3' HG12 ' A' ' 64' ' ' VAL . 30.8 p90 -112.27 141.08 46.42 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.63 -0.713 . . . . 0.0 112.12 -172.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.579 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 62.6 m -80.28 86.11 5.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.848 172.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.586 ' HD3' ' H ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -47.59 151.5 1.45 Allowed Pre-proline 0 CA--C 1.538 0.509 0 CA-C-N 115.144 -0.935 . . . . 0.0 112.243 -177.551 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.688 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 3.3 Cg_exo -79.91 162.95 23.53 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.71 2.94 . . . . 0.0 112.714 -172.155 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -82.68 -13.0 57.19 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.218 172.578 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.408 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . . . -58.82 145.83 77.48 Favored Pre-proline 0 CA--C 1.52 -0.204 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.043 175.398 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 35' ' ' ALA . 12.4 Cg_exo -69.56 114.42 3.67 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 121.458 1.439 . . . . 0.0 110.304 172.506 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.67 HD12 ' HE1' ' A' ' 40' ' ' TYR . 3.0 pt -127.73 147.95 32.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 109.381 -0.599 . . . . 0.0 109.381 -177.52 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.512 ' C ' ' HB3' ' A' ' 59' ' ' GLU . 16.3 p -96.92 -29.02 13.93 Favored 'General case' 0 N--CA 1.462 0.173 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -178.666 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.521 ' C ' HG12 ' A' ' 82' ' ' VAL . . . -165.3 -167.44 25.9 Favored Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 119.937 -1.125 . . . . 0.0 112.175 -178.567 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.688 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 5.3 m-85 -138.36 134.3 34.02 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 122.444 0.298 . . . . 0.0 111.341 174.225 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.6 mmm180 -103.91 149.76 24.81 Favored 'General case' 0 CA--C 1.504 -0.794 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 166.539 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.886 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 30.6 mt -139.09 108.58 3.89 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 C-N-CA 120.086 -0.646 . . . . 0.0 112.254 -179.339 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 78.8 t -109.44 110.33 31.69 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.432 0 CA-C-O 121.19 0.519 . . . . 0.0 110.797 -179.349 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.745 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 1.0 OUTLIER -113.57 126.34 55.18 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.783 176.647 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.9 m -137.4 141.88 35.43 Favored Pre-proline 0 C--N 1.319 -0.756 0 CA-C-N 114.203 -1.362 . . . . 0.0 111.98 -173.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.447 ' HD3' ' O ' ' A' ' 51' ' ' SER . 72.6 Cg_endo -76.78 133.48 14.03 Favored 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 123.581 2.854 . . . . 0.0 112.092 175.723 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 34.1 t -64.73 -27.37 68.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.455 -177.421 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.407 ' O ' ' HB2' ' A' ' 49' ' ' GLU . 18.9 m -100.67 17.92 3.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.778 0.323 . . . . 0.0 111.603 -179.502 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.407 ' HB2' ' O ' ' A' ' 48' ' ' VAL . 47.1 mm-40 73.91 157.95 0.2 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.241 -179.445 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 144.49 -135.26 6.06 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 121.025 -0.607 . . . . 0.0 111.779 -177.407 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.447 ' O ' ' HD3' ' A' ' 46' ' ' PRO . 16.2 m -83.3 119.31 24.43 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.753 0.276 . . . . 0.0 111.091 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 49.8 m -118.44 146.44 44.46 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 173.666 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.745 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 26.1 m -146.56 148.08 31.79 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 119.834 -0.746 . . . . 0.0 111.763 -178.745 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.886 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 30.8 tt0 -120.19 113.74 20.88 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.921 175.201 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.715 HD12 ' CG2' ' A' ' 64' ' ' VAL . 19.9 mt -97.29 158.22 15.57 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.321 177.155 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -119.24 116.65 26.72 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 177.556 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.572 HD12 ' CH2' ' A' ' 30' ' ' TRP . 2.3 mt -114.11 156.23 44.41 Favored Pre-proline 0 C--N 1.317 -0.818 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -177.876 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -62.25 150.08 88.29 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 121.798 1.665 . . . . 0.0 111.644 176.321 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.512 ' HB3' ' C ' ' A' ' 38' ' ' THR . 9.4 pt-20 -45.49 -26.63 0.6 Allowed 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 114.573 -1.194 . . . . 0.0 113.102 176.572 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.2 t -109.32 16.02 22.68 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.333 0.587 . . . . 0.0 110.951 -175.731 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.509 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -75.59 162.91 27.87 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 177.765 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.501 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 30.4 p-10 -142.89 4.8 1.5 Allowed 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -176.5 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.622 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 59.4 p -167.31 133.96 2.26 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 119.861 -0.736 . . . . 0.0 111.928 -176.426 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.718 HG12 ' HZ3' ' A' ' 30' ' ' TRP . 3.5 p -115.54 137.68 48.36 Favored 'Isoleucine or valine' 0 C--O 1.243 0.761 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.47 176.596 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 24.2 m -93.74 101.46 13.58 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.547 168.124 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.701 HD11 HG12 ' A' ' 77' ' ' ILE . 0.2 OUTLIER -78.46 144.07 36.11 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 173.542 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.461 ' HA ' ' O ' ' A' ' 24' ' ' THR . 4.3 m -152.79 167.7 28.17 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -177.375 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 68.87 26.22 5.95 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 123.912 0.758 . . . . 0.0 110.394 -174.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.633 ' O ' HG22 ' A' ' 24' ' ' THR . 8.9 mt -72.97 -175.82 1.88 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.792 175.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -123.95 129.2 24.86 Favored Pre-proline 0 C--N 1.322 -0.611 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 174.588 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -62.54 133.96 45.33 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 123.204 2.603 . . . . 0.0 113.336 -177.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.54 34.88 24.27 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.897 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.414 HG11 ' HB3' ' A' ' 46' ' ' PRO . 58.7 t -134.94 138.95 48.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 120.999 0.428 . . . . 0.0 111.363 -176.84 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.421 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 4.6 tp-100 -75.07 108.88 8.09 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.971 177.466 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -101.63 113.57 26.83 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.311 0.577 . . . . 0.0 111.592 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.581 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 3.7 m-20 -86.91 110.12 19.79 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.437 175.59 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.701 HG12 HD11 ' A' ' 66' ' ' LEU . 5.3 mp -92.33 118.5 38.01 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.664 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.695 176.742 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.885 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 28.4 m -109.47 115.63 30.3 Favored 'General case' 0 N--CA 1.426 -1.675 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.397 179.55 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.577 ' HB ' ' HB ' ' A' ' 91' ' ' VAL . 13.3 mm -95.47 137.21 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 -179.637 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.449 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 74.2 m-85 -124.84 111.35 15.39 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 116.581 -0.282 . . . . 0.0 110.281 179.701 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.416 ' HB1' HG21 ' A' ' 37' ' ' ILE . . . -80.26 116.89 20.59 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 169.394 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.521 HG12 ' C ' ' A' ' 39' ' ' GLY . 7.7 p -109.12 133.34 54.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 C-N-CA 120.075 -0.65 . . . . 0.0 110.448 -176.457 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -112.98 170.15 8.41 Favored 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 123.258 0.349 . . . . 0.0 110.202 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -46.17 -40.66 11.49 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -175.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 24.2 p-10 -111.46 -21.03 12.0 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -171.178 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -142.6 175.97 9.39 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.372 -0.531 . . . . 0.0 111.653 -172.464 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -118.41 120.25 37.01 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.291 -0.868 . . . . 0.0 108.675 173.66 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 50.8 m -68.9 175.35 3.71 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.161 0.505 . . . . 0.0 112.067 -176.252 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.403 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 1.0 OUTLIER -60.16 152.33 62.74 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.17 179.352 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -88.63 142.78 5.05 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 C-N-CA 122.261 1.974 . . . . 0.0 114.084 -177.614 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.885 ' O ' ' HA ' ' A' ' 78' ' ' THR . 6.9 t -82.57 128.11 39.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 114.366 -1.288 . . . . 0.0 108.001 165.404 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.7 t -123.49 105.68 16.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 C-N-CA 119.746 -0.782 . . . . 0.0 110.004 172.226 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.556 HG13 ' HB ' ' A' ' 77' ' ' ILE . 6.5 pt -122.85 111.79 31.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.935 177.871 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 29.7 pt20 -95.92 117.51 30.75 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.533 0.683 . . . . 0.0 110.851 -177.144 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -125.58 127.51 46.47 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.155 176.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -87.15 135.05 33.44 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.147 0.499 . . . . 0.0 110.369 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 34.5 p -69.55 119.59 14.02 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.683 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 10.2 m -69.06 -31.4 70.14 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.437 0.637 . . . . 0.0 110.178 -179.059 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 108.15 -165.14 12.78 Favored Glycine 0 N--CA 1.442 -0.935 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.279 176.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 56.5 m -82.51 126.06 74.64 Favored Pre-proline 0 C--N 1.32 -0.714 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 178.492 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -61.52 87.65 0.1 OUTLIER 'Trans proline' 0 C--O 1.233 0.255 0 C-N-CA 122.721 2.281 . . . . 0.0 111.48 175.459 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 -130.57 17.29 5.33 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.319 -176.16 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 48.1 t -127.26 95.55 4.31 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.265 -178.592 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -82.63 146.18 29.26 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.077 178.452 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.28 -36.79 3.55 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.091 -178.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.5 t . . . . . 0 C--O 1.249 1.038 0 CA-C-O 119.342 -0.361 . . . . 0.0 110.148 -179.945 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.557 0 N-CA-C 111.982 -0.447 . . . . 0.0 111.982 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.6 m -68.09 -28.68 67.56 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 122.852 -0.205 . . . . 0.0 111.368 -179.362 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 58.9 m-70 54.73 38.63 30.43 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.48 0.657 . . . . 0.0 110.338 -176.053 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 24.2 ptt? -83.45 -12.82 55.92 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.064 -178.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -163.05 167.51 37.43 Favored Glycine 0 N--CA 1.442 -0.943 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.231 177.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 19.0 m -152.96 80.61 1.21 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.081 0.467 . . . . 0.0 109.752 177.093 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.0 m -73.25 -37.79 66.22 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.318 -178.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 51.1 m -100.68 121.17 41.19 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.292 178.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -142.96 99.86 5.48 Favored Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.179 -178.753 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.481 ' HB2' ' OG ' ' A' ' 88' ' ' SER . 66.6 Cg_endo -76.3 144.65 26.35 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.662 2.241 . . . . 0.0 112.121 -179.658 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -104.74 150.12 25.02 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.755 0.312 . . . . 0.0 110.591 -178.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.698 ' HB2' ' O ' ' A' ' 89' ' ' THR . . . -72.43 153.45 91.95 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.238 175.254 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.426 ' HB3' ' O ' ' A' ' 31' ' ' SER . 46.2 Cg_exo -58.49 135.68 69.25 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.381 2.054 . . . . 0.0 111.142 173.462 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.564 ' HD2' ' O ' ' A' ' 31' ' ' SER . 7.9 Cg_endo -53.39 147.09 38.48 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.072 1.848 . . . . 0.0 110.809 174.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -30.51 106.39 0.23 Allowed Pre-proline 0 N--CA 1.472 0.674 0 O-C-N 124.854 1.346 . . . . 0.0 113.267 -168.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.654 ' HG2' HG11 ' A' ' 91' ' ' VAL . 23.2 Cg_exo -70.25 147.22 59.27 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 123.192 2.595 . . . . 0.0 111.876 176.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 18.5 m -109.88 132.86 53.77 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.803 0.811 . . . . 0.0 110.953 -176.342 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.513 HG21 ' OE1' ' A' ' 95' ' ' GLN . 95.0 t -79.67 125.58 38.82 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-N 114.2 -1.363 . . . . 0.0 110.056 176.269 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -83.63 -52.51 6.39 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.067 -174.287 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -136.43 132.11 35.02 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.88 0.372 . . . . 0.0 110.505 -178.593 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.502 ' HA ' HG12 ' A' ' 26' ' ' ILE . 95.1 t -114.15 122.24 67.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.867 -178.365 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -124.14 -160.34 0.92 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.602 179.632 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.525 ' O ' ' HB2' ' A' ' 69' ' ' LEU . 1.8 p-10 -73.35 -77.03 0.11 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.129 178.788 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.652 HG22 ' O ' ' A' ' 69' ' ' LEU . 62.8 p -105.16 34.79 3.06 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.955 -174.762 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.675 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 75.3 m -168.12 131.01 1.53 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.042 -172.844 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.579 ' HB ' HD12 ' A' ' 66' ' ' LEU . 28.7 mt -149.2 148.28 15.84 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.89 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 177.519 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.447 ' O ' HG13 ' A' ' 18' ' ' VAL . 44.2 t -121.58 130.31 74.73 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.59 0 CA-C-N 119.367 0.985 . . . . 0.0 110.888 -176.329 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.622 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.6 OUTLIER -123.9 146.21 29.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 C-N-CA 120.3 -0.56 . . . . 0.0 109.965 -179.629 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.438 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 21.6 mtp180 -129.32 121.0 26.59 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 123.295 0.372 . . . . 0.0 110.602 -174.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.815 ' HZ3' HG12 ' A' ' 64' ' ' VAL . 40.5 p90 -115.05 146.4 41.32 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.641 -174.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.564 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 24.0 t -93.89 97.88 10.68 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.635 177.649 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.597 ' H ' ' CD ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -46.8 155.67 0.59 Allowed Pre-proline 0 CA--C 1.539 0.533 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -175.445 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.696 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 2.8 Cg_endo -84.5 166.08 12.2 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 124.628 3.552 . . . . 0.0 112.634 -174.299 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -76.54 -22.11 54.81 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.257 -0.883 . . . . 0.0 108.957 170.772 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -55.22 133.23 69.21 Favored Pre-proline 0 CA--C 1.517 -0.297 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.663 176.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -61.8 116.32 3.37 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 121.554 1.503 . . . . 0.0 110.148 168.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.572 HD12 ' HE1' ' A' ' 40' ' ' TYR . 1.0 OUTLIER -126.76 148.49 31.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -177.544 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.42 ' H ' ' HA ' ' A' ' 83' ' ' GLU . 19.0 p -98.07 -28.81 13.59 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -178.763 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.52 ' C ' HG12 ' A' ' 82' ' ' VAL . . . -162.83 -166.85 22.32 Favored Glycine 0 N--CA 1.443 -0.892 0 C-N-CA 120.347 -0.93 . . . . 0.0 111.766 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.696 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 5.9 m-85 -139.06 132.57 30.32 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 120.718 0.294 . . . . 0.0 110.932 173.183 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 10.4 mmm180 -102.51 149.91 23.91 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 167.534 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.878 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 34.0 mt -138.49 107.54 3.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 C-N-CA 120.022 -0.671 . . . . 0.0 111.925 -179.225 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.441 HG22 ' HB2' ' A' ' 54' ' ' GLU . 89.4 t -109.1 110.34 31.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.387 0.613 . . . . 0.0 110.551 -178.79 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.608 ' CE2' ' HB3' ' A' ' 66' ' ' LEU . 1.2 p90 -113.15 126.02 54.99 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.884 177.603 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 7.4 m -141.06 138.76 18.26 Favored Pre-proline 0 C--N 1.317 -0.827 0 CA-C-N 113.773 -1.558 . . . . 0.0 110.868 -175.152 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.477 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 59.5 Cg_endo -71.99 143.95 41.76 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 123.337 2.691 . . . . 0.0 111.749 175.208 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 33.3 m -71.94 -31.79 66.67 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.265 -176.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.498 ' O ' ' HB2' ' A' ' 49' ' ' GLU . 27.7 m -100.69 -40.59 8.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -174.668 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.498 ' HB2' ' O ' ' A' ' 48' ' ' VAL . 39.4 tt0 168.75 148.4 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -178.25 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 142.64 -174.32 23.54 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.206 178.384 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.444 ' HB2' ' O ' ' A' ' 68' ' ' ASP . 51.0 m -73.46 133.36 43.66 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.844 0.354 . . . . 0.0 111.741 -176.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.0 m -116.53 145.73 43.12 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 174.774 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.551 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 85.7 m -148.11 147.74 29.85 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.086 -0.645 . . . . 0.0 112.123 -178.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.878 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 30.3 tt0 -112.41 118.29 34.77 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.134 171.286 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.708 HD12 ' CG2' ' A' ' 64' ' ' VAL . 16.5 mt -97.42 160.54 14.26 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 173.209 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -124.77 113.95 18.62 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.728 -179.472 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.594 HD12 ' CH2' ' A' ' 30' ' ' TRP . 3.2 mt -112.96 157.99 39.07 Favored Pre-proline 0 C--N 1.317 -0.835 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -177.095 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -65.79 150.13 86.24 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 121.76 1.64 . . . . 0.0 111.413 174.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -44.44 -28.72 0.59 Allowed 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 114.887 -1.051 . . . . 0.0 112.859 176.345 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.8 t -105.29 14.44 28.92 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.251 0.548 . . . . 0.0 111.408 -174.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.437 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -80.02 158.79 26.43 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 176.207 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.531 ' HB3' ' NE ' ' A' ' 32' ' ' ARG . 31.0 p-10 -142.05 17.28 2.1 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 120.619 -0.432 . . . . 0.0 111.96 -177.718 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.622 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 19.2 p -171.35 134.01 0.86 Allowed 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.268 -0.573 . . . . 0.0 111.847 -179.549 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.815 HG12 ' HZ3' ' A' ' 30' ' ' TRP . 3.5 p -117.11 136.3 54.71 Favored 'Isoleucine or valine' 0 C--O 1.242 0.7 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.414 176.367 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 20.8 m -95.13 101.36 13.1 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.386 167.706 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.675 ' O ' ' HA ' ' A' ' 25' ' ' SER . 0.3 OUTLIER -78.14 144.55 36.33 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.9 -1.045 . . . . 0.0 109.555 178.646 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.461 ' O ' ' HB2' ' A' ' 68' ' ' ASP . 14.2 t -140.39 170.17 16.31 Favored 'General case' 0 C--N 1.319 -0.745 0 O-C-N 123.76 0.663 . . . . 0.0 109.271 -176.482 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.461 ' HB2' ' O ' ' A' ' 67' ' ' SER . 3.2 m-20 71.89 20.0 4.6 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 123.803 0.69 . . . . 0.0 112.021 -179.28 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.652 ' O ' HG22 ' A' ' 24' ' ' THR . 6.8 mt -72.79 -177.81 2.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.125 0.488 . . . . 0.0 110.412 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 7.8 tp60 -125.38 122.72 25.07 Favored Pre-proline 0 C--N 1.321 -0.663 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 175.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.61 126.09 15.5 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.698 2.265 . . . . 0.0 112.833 -178.09 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 95.98 28.78 9.04 Favored Glycine 0 N--CA 1.45 -0.414 0 CA-C-N 115.949 -0.568 . . . . 0.0 112.181 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 36.9 t -134.64 152.17 32.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.048 0.451 . . . . 0.0 110.961 -177.1 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.477 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 11.6 tp60 -87.84 107.99 18.94 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.663 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.469 ' O ' ' HA ' ' A' ' 94' ' ' GLN . 7.1 m-85 -100.79 130.44 46.81 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.145 0.498 . . . . 0.0 111.876 -179.263 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.52 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 13.9 m-80 -103.88 113.48 27.04 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.596 -1.184 . . . . 0.0 109.202 175.519 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.61 HG12 HD11 ' A' ' 66' ' ' LEU . 3.8 mp -95.07 120.27 44.26 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.814 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 176.717 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.937 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 25.6 m -109.03 113.46 26.34 Favored 'General case' 0 N--CA 1.424 -1.763 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.225 -179.12 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.54 ' HB ' ' HB ' ' A' ' 91' ' ' VAL . 12.9 mm -94.64 132.38 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -120.32 111.35 17.65 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.044 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.484 ' HB1' HG21 ' A' ' 37' ' ' ILE . . . -81.82 109.58 16.33 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 172.117 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.52 HG12 ' C ' ' A' ' 39' ' ' GLY . 7.2 p -104.66 143.09 16.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 C-N-CA 120.268 -0.573 . . . . 0.0 111.418 -172.069 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.557 ' HG2' ' N ' ' A' ' 84' ' ' GLU . 55.2 tt0 -121.11 168.17 11.85 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 170.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.557 ' N ' ' HG2' ' A' ' 83' ' ' GLU . 27.7 mt-10 -33.27 -50.97 0.32 Allowed 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -176.561 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 28.4 p-10 -111.96 -24.35 10.0 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -171.188 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -137.38 173.1 12.04 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.558 -170.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -121.36 152.05 39.43 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.968 178.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.481 ' OG ' ' HB2' ' A' ' 10' ' ' PRO . 9.8 m -80.51 179.61 7.65 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.62 175.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.698 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 0.6 OUTLIER -60.02 159.41 20.91 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 173.081 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -88.16 138.7 4.16 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 121.921 1.747 . . . . 0.0 113.365 179.298 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.937 ' O ' ' HA ' ' A' ' 78' ' ' THR . 13.3 t -83.18 123.38 38.61 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.671 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 165.222 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.0 t -121.09 106.48 18.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 C-N-CA 119.856 -0.738 . . . . 0.0 109.981 172.731 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.449 HG13 ' HB ' ' A' ' 77' ' ' ILE . 29.9 pt -121.63 117.63 53.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.976 179.033 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.469 ' HA ' ' O ' ' A' ' 75' ' ' TYR . 4.0 pt20 -108.1 128.67 54.89 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.159 0.504 . . . . 0.0 111.618 -175.422 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.545 ' OE1' HG21 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -136.74 153.03 50.97 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.772 171.927 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -97.31 126.14 42.35 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -179.282 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.436 HG22 HD11 ' A' ' 26' ' ' ILE . 20.1 p -61.12 112.73 2.22 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.417 0.627 . . . . 0.0 111.26 -176.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 11.0 m -70.04 -30.79 68.16 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.864 -176.42 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 107.64 -168.26 13.93 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.093 177.076 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 18.3 m -81.19 128.78 69.42 Favored Pre-proline 0 C--N 1.321 -0.665 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 177.138 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -58.66 92.12 0.07 OUTLIER 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.672 2.248 . . . . 0.0 111.988 176.081 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 15.1 ptp180 -129.41 19.7 5.76 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.366 -178.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 44.9 m -69.68 -19.48 63.58 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.909 -177.04 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -109.64 13.6 23.76 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.71 0.767 . . . . 0.0 109.837 178.294 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -125.42 108.46 1.07 Allowed Glycine 0 N--CA 1.45 -0.369 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.055 -179.508 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 20.3 m . . . . . 0 C--O 1.251 1.143 0 CA-C-O 118.741 -0.647 . . . . 0.0 110.617 -178.285 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.571 0 N-CA-C 111.835 -0.506 . . . . 0.0 111.835 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.0 p -71.11 -57.48 4.48 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.842 0.353 . . . . 0.0 110.686 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 38.8 m-70 -91.48 124.27 35.52 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.405 -178.719 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 19.8 ptm -123.2 67.64 0.99 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.987 -176.364 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -73.75 -77.43 0.63 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.801 -0.714 . . . . 0.0 111.71 178.254 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.2 p -80.31 59.68 3.5 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.191 0.519 . . . . 0.0 110.577 176.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.5 t -73.47 -20.51 60.68 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.215 -177.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 22.7 m -110.8 125.25 53.37 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.124 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -103.63 119.5 54.53 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.199 179.027 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -78.17 144.53 21.0 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 122.428 2.085 . . . . 0.0 112.065 -179.473 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -93.39 164.86 13.04 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.986 179.5 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.496 ' HB2' ' O ' ' A' ' 89' ' ' THR . . . -97.03 159.84 30.45 Favored Pre-proline 0 C--N 1.32 -0.714 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.132 177.039 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.41 ' HB2' ' HB2' ' A' ' 30' ' ' TRP . 19.9 Cg_exo -67.64 131.43 24.4 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.338 2.026 . . . . 0.0 111.415 175.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.429 ' HD2' ' O ' ' A' ' 31' ' ' SER . 74.6 Cg_exo -50.2 151.78 8.88 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.751 2.301 . . . . 0.0 111.214 172.454 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -36.83 106.37 0.33 Allowed Pre-proline 0 N--CA 1.472 0.658 0 O-C-N 124.443 1.089 . . . . 0.0 112.411 -171.176 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.587 ' HG2' HG11 ' A' ' 91' ' ' VAL . 37.8 Cg_exo -65.78 149.79 86.54 Favored 'Trans proline' 0 CA--C 1.517 -0.326 0 C-N-CA 123.141 2.561 . . . . 0.0 112.129 177.639 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 27.4 m -106.38 130.1 54.26 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.585 -178.701 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.515 HG22 HG12 ' A' ' 28' ' ' VAL . 53.8 t -71.62 121.88 22.67 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-N 114.227 -1.351 . . . . 0.0 110.12 175.072 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -83.78 -46.26 12.42 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.258 -173.466 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -135.63 137.99 42.44 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.894 -178.425 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.499 HG22 HG11 ' A' ' 18' ' ' VAL . 23.7 t -123.26 121.37 62.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.892 -178.175 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -131.57 -163.05 1.28 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.443 176.687 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -72.88 -68.9 0.45 Allowed 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.311 0.485 . . . . 0.0 112.311 -178.67 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.555 HG22 ' O ' ' A' ' 69' ' ' LEU . 38.1 p -110.12 28.84 8.21 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.377 0.608 . . . . 0.0 110.87 -171.407 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.559 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 12.0 p -169.95 134.65 1.32 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.069 -175.477 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.546 ' HB ' HD12 ' A' ' 66' ' ' LEU . 29.0 mt -146.16 155.98 12.27 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.207 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 54.4 t -121.48 140.21 46.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 119.859 1.209 . . . . 0.0 110.253 -177.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.57 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.8 OUTLIER -130.81 149.24 33.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 119.867 -0.733 . . . . 0.0 110.676 176.741 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.505 ' HG2' ' HB3' ' A' ' 63' ' ' SER . 60.8 mtp180 -132.1 120.61 22.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.265 -176.212 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.785 ' HZ3' HG12 ' A' ' 64' ' ' VAL . 32.6 p90 -112.04 144.23 41.74 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.905 -173.512 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.429 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 21.4 m -85.04 86.55 7.37 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.697 174.535 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.582 ' HD3' ' H ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -52.03 152.87 5.15 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.035 -0.984 . . . . 0.0 112.231 -174.513 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.648 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 4.3 Cg_exo -78.13 160.69 29.78 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 123.615 2.877 . . . . 0.0 113.029 -172.229 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -79.29 -14.8 58.78 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.16 -0.927 . . . . 0.0 108.763 170.581 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.44 145.28 59.65 Favored Pre-proline 0 CA--C 1.517 -0.292 0 CA-C-N 114.879 -1.055 . . . . 0.0 111.441 175.19 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -67.45 115.77 3.87 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 121.463 1.442 . . . . 0.0 109.951 170.457 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.65 HD12 ' HE1' ' A' ' 40' ' ' TYR . 1.4 pt -128.18 146.76 33.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.513 ' C ' ' HB3' ' A' ' 59' ' ' GLU . 26.9 p -93.69 -28.86 15.72 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -178.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.557 ' C ' HG12 ' A' ' 82' ' ' VAL . . . -168.44 -164.04 23.45 Favored Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 120.338 -0.934 . . . . 0.0 111.532 -178.88 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.65 ' HE1' HD12 ' A' ' 37' ' ' ILE . 5.2 m-85 -140.3 133.98 30.32 Favored 'General case' 0 CA--C 1.513 -0.481 0 CA-C-N 116.929 0.364 . . . . 0.0 111.243 175.202 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.8 mmm180 -106.03 148.35 27.84 Favored 'General case' 0 CA--C 1.505 -0.757 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 167.088 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.881 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 28.8 mt -138.03 108.55 5.13 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 C-N-CA 120.006 -0.678 . . . . 0.0 112.489 -177.461 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 76.6 t -110.84 111.08 34.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.019 0.438 . . . . 0.0 110.717 -178.244 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.752 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 1.3 p90 -116.81 126.85 53.68 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.602 0.715 . . . . 0.0 110.474 178.453 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.416 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 25.1 p -149.81 143.93 17.21 Favored Pre-proline 0 C--N 1.319 -0.739 0 CA-C-N 113.698 -1.592 . . . . 0.0 111.183 -175.171 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.593 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 32.4 Cg_exo -59.11 148.78 83.96 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 123.128 2.552 . . . . 0.0 111.808 176.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 20.1 m -61.89 -23.18 66.14 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.466 -0.788 . . . . 0.0 112.534 -172.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 5.5 p -116.08 -42.32 3.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 120.345 -0.542 . . . . 0.0 112.347 -178.506 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 173.99 147.51 0.06 Allowed 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 110.067 -0.345 . . . . 0.0 110.067 -176.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.487 ' HA3' ' HG2' ' A' ' 46' ' ' PRO . . . 149.42 -162.2 28.98 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.204 174.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 16.1 m -63.45 120.7 12.17 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.932 0.396 . . . . 0.0 111.096 -177.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.8 m -118.77 139.63 51.26 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.272 178.19 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.752 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 14.6 m -139.56 145.12 38.24 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.548 -0.461 . . . . 0.0 111.376 -177.724 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.881 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 74.3 tt0 -118.26 124.48 47.95 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 116.042 -0.527 . . . . 0.0 109.615 174.484 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.67 HD12 ' CG2' ' A' ' 64' ' ' VAL . 13.5 mt -106.42 156.79 18.17 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.153 173.856 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -119.29 115.58 24.46 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.577 178.71 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.58 HD12 ' CH2' ' A' ' 30' ' ' TRP . 3.5 mt -114.26 158.72 38.94 Favored Pre-proline 0 C--N 1.321 -0.636 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -177.789 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -69.15 150.0 71.43 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 121.599 1.532 . . . . 0.0 111.226 174.359 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.513 ' HB3' ' C ' ' A' ' 38' ' ' THR . 10.1 pt-20 -46.48 -25.1 0.61 Allowed 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 114.859 -1.064 . . . . 0.0 113.099 177.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 10.0 t -104.63 15.04 28.79 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.236 -174.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -84.69 162.32 19.73 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 178.27 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.469 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 27.8 p-10 -142.02 10.42 1.96 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -176.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.57 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 23.0 p -167.42 136.94 2.76 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.77 -177.315 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.785 HG12 ' HZ3' ' A' ' 30' ' ' TRP . 2.8 p -120.64 137.49 54.22 Favored 'Isoleucine or valine' 0 C--O 1.247 0.96 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.801 177.792 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 42.3 m -90.57 100.94 13.69 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.22 166.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.58 ' HB3' ' CE2' ' A' ' 44' ' ' TYR . 0.5 OUTLIER -76.41 133.52 39.86 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.475 179.352 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 10.7 p -128.37 160.09 33.32 Favored 'General case' 0 N--CA 1.447 -0.583 0 O-C-N 123.878 0.736 . . . . 0.0 110.521 -174.211 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 65.13 52.03 1.56 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.202 -178.061 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.555 ' O ' HG22 ' A' ' 24' ' ' THR . 6.6 mt -95.1 -175.75 3.62 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 172.401 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 18.6 mm-40 -127.45 132.77 24.49 Favored Pre-proline 0 C--N 1.321 -0.638 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 175.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -65.57 133.39 34.24 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.879 2.386 . . . . 0.0 112.878 -179.426 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 77.84 28.99 55.77 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.993 -0.622 . . . . 0.0 111.93 179.523 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 97.5 t -132.01 141.55 45.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.998 0.428 . . . . 0.0 110.398 -178.099 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.593 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 1.5 tp-100 -84.61 111.76 19.83 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.183 -175.769 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.405 ' CZ ' ' HG3' ' A' ' 46' ' ' PRO . 11.5 m-85 -103.01 127.58 50.2 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.303 0.573 . . . . 0.0 112.011 -176.805 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.584 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 14.4 m120 -95.72 111.14 23.16 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.278 176.194 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.616 ' HB ' HG13 ' A' ' 93' ' ' ILE . 5.0 mp -92.44 118.09 37.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 176.518 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.891 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 28.4 m -108.75 113.83 27.12 Favored 'General case' 0 N--CA 1.426 -1.629 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.176 -179.6 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.58 ' HB ' ' HB ' ' A' ' 91' ' ' VAL . 13.9 mm -95.12 133.5 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -179.688 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -121.42 111.89 17.86 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.372 179.589 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.473 ' HB1' HG21 ' A' ' 37' ' ' ILE . . . -81.28 109.17 15.54 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 171.475 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.557 HG12 ' C ' ' A' ' 39' ' ' GLY . 7.4 p -101.09 137.69 27.82 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.604 0 C-N-CA 120.095 -0.642 . . . . 0.0 111.32 -172.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 11.5 tm-20 -117.05 167.41 11.17 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 179.57 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -46.27 -41.01 12.47 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -174.643 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 46.3 t-20 -109.38 -32.42 7.17 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -172.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 22.8 pt20 -133.81 176.97 8.09 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.098 -165.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -130.91 135.32 47.57 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 176.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 16.3 m -65.83 170.42 5.39 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.805 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.496 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 1.2 p -54.62 153.66 10.31 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.141 173.434 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -85.93 142.04 7.55 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 121.753 1.635 . . . . 0.0 113.724 -176.103 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.891 ' O ' ' HA ' ' A' ' 78' ' ' THR . 4.8 t -82.27 123.89 38.69 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.833 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 167.032 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.7 t -120.39 106.04 18.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 C-N-CA 119.862 -0.735 . . . . 0.0 109.961 172.623 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.616 HG13 ' HB ' ' A' ' 77' ' ' ILE . 7.8 pt -121.02 113.03 38.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.995 176.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.528 ' HB3' ' ND2' ' A' ' 76' ' ' ASN . 11.9 pt20 -99.56 117.66 34.43 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.408 0.623 . . . . 0.0 110.977 -176.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 3.3 tm0? -131.31 130.63 43.01 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.476 ' HA ' ' HA ' ' A' ' 74' ' ' GLN . 40.4 tt0 -89.23 128.8 35.86 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.338 0.59 . . . . 0.0 111.021 -177.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.452 HG22 HD11 ' A' ' 26' ' ' ILE . 32.8 p -59.19 126.05 26.12 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.148 -178.349 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 10.9 m -69.69 -30.95 68.72 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.472 0.653 . . . . 0.0 109.875 179.363 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 89.2 -137.31 14.09 Favored Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.86 178.48 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 21.1 m -130.53 122.14 19.65 Favored Pre-proline 0 C--N 1.317 -0.82 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 178.505 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_exo -42.97 -63.95 0.29 Allowed 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 123.232 2.622 . . . . 0.0 112.747 -175.637 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 26.3 ttm180 -148.72 118.51 7.07 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.382 178.325 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 42.9 m 64.3 -89.94 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.587 179.335 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -124.88 10.9 8.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.204 0.526 . . . . 0.0 110.349 179.558 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 142.11 -83.51 0.21 Allowed Glycine 0 N--CA 1.444 -0.787 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.11 179.133 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.8 t . . . . . 0 C--O 1.248 0.983 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.859 177.77 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.659 0 N-CA-C 111.792 -0.523 . . . . 0.0 111.792 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 31.1 m -83.68 108.53 16.81 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.791 0.329 . . . . 0.0 110.556 -179.406 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 32.8 m-70 -80.21 81.01 6.56 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.629 -179.369 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 84.2 mtp -93.36 -0.69 56.52 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.138 -177.609 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -88.22 -33.53 10.56 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.383 -0.913 . . . . 0.0 112.319 -179.442 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 13.3 t -88.42 -7.16 57.06 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 111.599 0.222 . . . . 0.0 111.599 -176.125 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.2 t -158.06 145.66 18.35 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.99 0.424 . . . . 0.0 110.805 -178.517 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 24.0 m -119.28 127.78 53.54 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.315 179.635 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -100.39 110.35 59.8 Favored Pre-proline 0 C--N 1.327 -0.396 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 176.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.502 ' HB2' ' OG ' ' A' ' 88' ' ' SER . 48.1 Cg_endo -76.37 135.87 17.1 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 122.282 1.988 . . . . 0.0 112.897 -176.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -87.97 162.38 16.89 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.879 178.122 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.423 ' HB2' ' O ' ' A' ' 89' ' ' THR . . . -96.92 163.0 21.05 Favored Pre-proline 0 C--N 1.322 -0.608 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 174.193 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.429 ' HB2' ' HB2' ' A' ' 30' ' ' TRP . 19.3 Cg_exo -69.47 128.89 16.96 Favored 'Trans proline' 0 C--O 1.235 0.367 0 C-N-CA 122.27 1.98 . . . . 0.0 111.472 174.628 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.42 ' HD2' ' O ' ' A' ' 31' ' ' SER . 52.3 Cg_exo -52.45 142.12 49.18 Favored 'Trans proline' 0 CA--C 1.509 -0.736 0 C-N-CA 122.306 2.004 . . . . 0.0 110.806 173.316 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.506 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 2.4 m-20 -35.79 103.16 0.24 Allowed Pre-proline 0 N--CA 1.465 0.291 0 O-C-N 125.069 1.48 . . . . 0.0 112.674 -164.373 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.752 ' CG ' HG11 ' A' ' 91' ' ' VAL . 5.2 Cg_endo -49.7 145.72 17.03 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 123.584 2.856 . . . . 0.0 113.134 169.777 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.6 m -101.51 131.83 47.46 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.354 179.506 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.533 HG22 HG12 ' A' ' 28' ' ' VAL . 70.9 t -73.98 112.1 10.26 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 CA-C-N 114.835 -1.075 . . . . 0.0 109.284 172.572 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -86.51 -36.62 18.88 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.666 -172.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -135.03 140.83 45.92 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.973 -176.453 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.418 ' HA ' HG12 ' A' ' 26' ' ' ILE . 47.5 t -133.81 139.94 47.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.492 -179.22 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.435 ' CG ' ' H ' ' A' ' 23' ' ' ASP . 12.4 t70 -146.69 -157.69 0.83 Allowed 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -179.655 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.458 ' HB3' ' HB3' ' A' ' 71' ' ' PRO . 7.0 m-20 -79.5 -70.91 0.48 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.425 0.631 . . . . 0.0 109.935 178.14 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.58 HG22 ' O ' ' A' ' 69' ' ' LEU . 69.7 p -104.71 34.96 2.93 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.775 -174.757 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.521 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 29.9 m -167.83 137.52 2.65 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 123.139 0.576 . . . . 0.0 110.062 -172.321 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.579 ' HB ' HD12 ' A' ' 66' ' ' LEU . 29.2 mt -153.17 149.76 13.07 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.117 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 177.553 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.446 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 47.3 t -122.37 137.0 57.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 119.517 1.053 . . . . 0.0 110.186 -176.385 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.56 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.8 OUTLIER -130.19 149.83 33.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 C-N-CA 120.129 -0.629 . . . . 0.0 110.383 179.341 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.453 ' HG2' ' HB3' ' A' ' 63' ' ' SER . 55.1 mtp180 -134.31 120.44 19.92 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.392 -175.142 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.749 ' HZ3' HG12 ' A' ' 64' ' ' VAL . 36.9 p90 -112.56 146.8 37.89 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.742 -173.039 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.42 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 35.5 t -89.24 91.96 8.98 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 173.306 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.508 ' HD3' ' H ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -50.94 153.37 3.07 Favored Pre-proline 0 CA--C 1.54 0.584 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.785 -176.129 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.653 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 5.1 Cg_exo -78.07 162.52 28.85 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 123.879 3.053 . . . . 0.0 112.592 -174.527 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -83.25 -7.74 59.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.405 172.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.33 150.94 70.64 Favored Pre-proline 0 CA--C 1.518 -0.262 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.737 175.236 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.581 ' O ' ' HG3' ' A' ' 83' ' ' GLU . 12.2 Cg_exo -69.77 114.46 3.71 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 121.128 1.219 . . . . 0.0 109.559 169.439 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.583 HD12 ' HE1' ' A' ' 40' ' ' TYR . 2.0 pt -128.85 142.59 43.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.454 ' N ' ' O ' ' A' ' 82' ' ' VAL . 12.6 p -92.2 -31.42 15.46 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -178.835 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.558 ' C ' HG12 ' A' ' 82' ' ' VAL . . . -163.41 -163.95 17.36 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.12 -1.038 . . . . 0.0 111.919 -177.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.653 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 5.4 m-85 -141.05 133.31 28.12 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.785 0.326 . . . . 0.0 111.323 175.419 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.41 ' C ' HG13 ' A' ' 42' ' ' ILE . 10.1 mmm180 -103.7 149.61 24.81 Favored 'General case' 0 CA--C 1.503 -0.832 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 167.128 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.866 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 32.0 mt -138.7 107.08 3.51 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 C-N-CA 119.734 -0.787 . . . . 0.0 112.318 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.418 HG22 ' HB2' ' A' ' 54' ' ' GLU . 74.1 t -108.88 110.18 31.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.19 0.519 . . . . 0.0 110.646 -178.648 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.778 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 0.5 OUTLIER -110.34 124.9 52.53 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.552 176.019 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 35.6 t -137.34 135.41 19.42 Favored Pre-proline 0 C--N 1.318 -0.8 0 CA-C-N 113.926 -1.488 . . . . 0.0 111.33 -173.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.672 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 50.7 Cg_endo -70.19 130.89 19.57 Favored 'Trans proline' 0 CA--C 1.527 0.156 0 C-N-CA 123.472 2.781 . . . . 0.0 112.005 175.557 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 14.5 m -70.31 -16.81 63.05 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.035 0.445 . . . . 0.0 111.303 -178.519 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.431 ' CG2' HG13 ' A' ' 73' ' ' VAL . 15.8 m -105.86 16.62 6.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.59 177.601 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.42 ' HB2' ' O ' ' A' ' 48' ' ' VAL . 24.3 mm-40 71.26 161.37 0.23 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.861 -1.063 . . . . 0.0 111.912 -178.379 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 145.3 -134.98 5.76 Favored Glycine 0 N--CA 1.446 -0.64 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 -176.043 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 27.2 t -93.59 121.26 34.82 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.957 0.379 . . . . 0.0 110.817 179.564 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.3 p -117.92 143.06 46.67 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.232 176.134 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.778 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 24.4 m -142.78 147.8 36.11 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.457 -0.497 . . . . 0.0 111.557 -174.588 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.866 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 21.8 tt0 -116.44 122.34 44.49 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.148 172.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.658 HD12 ' CG2' ' A' ' 64' ' ' VAL . 12.8 mt -99.8 160.54 14.23 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.613 -0.435 . . . . 0.0 109.882 172.153 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -122.54 117.66 26.43 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.107 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.597 HD12 ' CH2' ' A' ' 30' ' ' TRP . 3.9 mt -116.02 158.2 43.09 Favored Pre-proline 0 C--N 1.318 -0.796 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -177.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -70.71 152.17 64.18 Favored 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 121.298 1.332 . . . . 0.0 111.124 173.581 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.487 ' HB2' HG13 ' A' ' 37' ' ' ILE . 8.1 pt-20 -43.62 -39.65 3.65 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.548 0.69 . . . . 0.0 111.796 175.859 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.454 ' N ' ' HG3' ' A' ' 59' ' ' GLU . 9.7 t -88.24 19.07 3.92 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.467 -174.119 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -91.79 164.38 13.72 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 175.281 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.45 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 30.3 p-10 -149.28 16.08 0.92 Allowed 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -178.243 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.56 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 17.3 p -170.13 134.17 1.21 Allowed 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.446 -0.502 . . . . 0.0 112.017 -179.575 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.749 HG12 ' HZ3' ' A' ' 30' ' ' TRP . 3.2 p -119.52 137.68 52.63 Favored 'Isoleucine or valine' 0 C--O 1.244 0.772 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.347 177.751 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 42.2 m -94.71 101.49 13.33 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-O 121.573 0.701 . . . . 0.0 109.332 167.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.624 HD11 HG12 ' A' ' 77' ' ' ILE . 0.2 OUTLIER -76.59 139.49 40.68 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.362 178.533 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 14.2 t -134.88 171.04 14.95 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -176.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 64.89 35.19 8.58 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 123.786 0.679 . . . . 0.0 110.795 -179.432 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.58 ' O ' HG22 ' A' ' 24' ' ' THR . 7.5 mt -85.08 -176.96 6.41 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 174.831 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 19.6 mm-40 -123.37 132.5 24.28 Favored Pre-proline 0 C--N 1.318 -0.782 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 173.762 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.458 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . 37.2 Cg_endo -66.74 128.01 18.15 Favored 'Trans proline' 0 C--O 1.234 0.311 0 C-N-CA 122.722 2.281 . . . . 0.0 112.517 179.47 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 83.49 33.8 21.44 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.991 -0.623 . . . . 0.0 111.851 -179.169 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.431 HG13 ' CG2' ' A' ' 48' ' ' VAL . 72.1 t -134.84 140.79 44.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.085 0.469 . . . . 0.0 111.047 -176.671 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.672 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -79.34 118.41 21.23 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.233 -178.481 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -114.32 121.4 43.52 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.095 0.474 . . . . 0.0 112.143 -177.69 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.574 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 3.7 m-20 -88.47 113.38 24.0 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.418 170.669 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.624 HG12 HD11 ' A' ' 66' ' ' LEU . 4.9 mp -92.2 115.47 31.24 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.661 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 173.802 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.895 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 19.4 m -107.24 113.31 26.64 Favored 'General case' 0 N--CA 1.427 -1.615 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.421 -178.516 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.574 ' H ' ' HB ' ' A' ' 91' ' ' VAL . 11.3 mm -94.78 136.09 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.022 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.418 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 80.7 m-85 -122.35 110.94 16.28 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.92 179.104 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.481 ' HB1' HG21 ' A' ' 37' ' ' ILE . . . -80.14 107.62 13.07 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 171.001 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.558 HG12 ' C ' ' A' ' 39' ' ' GLY . 7.3 p -99.96 137.61 26.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 C-N-CA 119.854 -0.738 . . . . 0.0 110.572 -173.464 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.644 ' HG2' ' N ' ' A' ' 84' ' ' GLU . 2.1 tt0 -111.85 166.8 10.89 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 124.014 0.821 . . . . 0.0 109.597 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.644 ' N ' ' HG2' ' A' ' 83' ' ' GLU . 34.3 mt-10 -41.23 -53.06 3.27 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 123.008 0.523 . . . . 0.0 111.955 177.107 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -124.53 8.26 8.33 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -173.687 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -140.41 174.22 10.73 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.025 0.441 . . . . 0.0 111.56 -176.305 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -136.8 122.26 19.52 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 172.573 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.502 ' OG ' ' HB2' ' A' ' 10' ' ' PRO . 32.6 m -64.72 168.69 5.82 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.712 0.292 . . . . 0.0 110.951 178.579 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.423 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 1.1 p -56.09 151.71 24.74 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.768 176.195 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -82.92 136.28 8.06 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 121.985 1.79 . . . . 0.0 113.139 -178.246 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.895 ' O ' ' HA ' ' A' ' 78' ' ' THR . 54.0 t -82.77 119.03 31.5 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.755 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 169.764 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.8 t -116.77 105.24 17.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 C-N-CA 119.249 -0.98 . . . . 0.0 109.965 173.477 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.59 HG13 ' HB ' ' A' ' 77' ' ' ILE . 7.4 pt -118.1 111.59 34.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.438 176.65 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -101.15 127.69 47.59 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.518 0.675 . . . . 0.0 111.04 -174.465 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 14.4 tm0? -140.34 134.56 31.09 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.296 -0.866 . . . . 0.0 108.82 -179.224 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.597 ' HG2' ' HG2' ' A' ' 74' ' ' GLN . 47.0 mt-10 -86.61 126.56 34.59 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 120.81 0.338 . . . . 0.0 110.765 178.77 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.468 HG22 HD11 ' A' ' 26' ' ' ILE . 35.0 p -56.23 119.59 6.21 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.32 179.721 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 25.6 m -67.93 -30.29 69.57 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.591 -178.391 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.41 ' HA2' ' HA ' ' A' ' 23' ' ' ASP . . . 89.51 -138.42 14.62 Favored Glycine 0 N--CA 1.432 -1.602 0 CA-C-N 114.794 -1.093 . . . . 0.0 111.016 -179.448 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.406 ' HA ' ' HD3' ' A' ' 101' ' ' PRO . 18.2 m -84.27 118.69 71.82 Favored Pre-proline 0 C--N 1.314 -0.941 0 N-CA-C 110.266 -0.272 . . . . 0.0 110.266 179.689 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 100' ' ' THR . 35.2 Cg_exo -59.9 100.31 0.14 Allowed 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 123.044 2.496 . . . . 0.0 112.336 -178.222 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 87.4 mtt180 -85.29 -58.54 2.64 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.902 -179.233 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 10.0 t 54.98 78.02 0.19 Allowed 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.531 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -112.71 158.34 20.17 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.304 -179.113 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -78.49 81.52 1.34 Allowed Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.143 178.505 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 34.7 p . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.236 -0.888 . . . . 0.0 112.037 -179.215 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.539 0 N-CA-C 111.841 -0.504 . . . . 0.0 111.841 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.2 m -87.78 70.96 9.63 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.139 0.495 . . . . 0.0 110.483 179.352 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 22.4 t60 -82.01 65.94 7.37 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.458 0.647 . . . . 0.0 109.708 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 21.6 ptp -124.42 37.83 4.32 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.269 -177.158 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 85.78 -58.52 4.81 Favored Glycine 0 N--CA 1.45 -0.403 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 -174.495 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 16.7 p -79.21 78.71 5.67 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 121.133 0.492 . . . . 0.0 110.357 175.337 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.413 ' O ' ' HB ' ' A' ' 8' ' ' THR . 31.4 p -68.89 160.02 31.49 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.065 -178.104 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.413 ' HB ' ' O ' ' A' ' 7' ' ' THR . 63.4 m 71.89 122.44 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.205 0.526 . . . . 0.0 110.926 -176.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -137.43 120.98 11.73 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.174 179.304 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.518 ' HA ' ' HB2' ' A' ' 35' ' ' ALA . 83.9 Cg_endo -78.28 176.48 9.89 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.241 1.961 . . . . 0.0 112.097 179.287 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -138.93 161.36 37.52 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -175.079 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.46 ' HB2' ' O ' ' A' ' 89' ' ' THR . . . -96.32 164.41 18.46 Favored Pre-proline 0 C--N 1.313 -0.997 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 175.578 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.458 ' HB2' ' HB2' ' A' ' 30' ' ' TRP . 17.4 Cg_exo -70.47 126.99 13.43 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 121.926 1.751 . . . . 0.0 111.062 172.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.709 ' HD2' ' O ' ' A' ' 31' ' ' SER . 95.4 Cg_exo -45.54 147.46 2.78 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.931 2.421 . . . . 0.0 111.858 172.504 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.43 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 29.8 t70 -32.74 105.36 0.24 Allowed Pre-proline 0 N--CA 1.468 0.456 0 O-C-N 125.016 1.448 . . . . 0.0 112.842 -170.759 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.659 ' HG2' HG11 ' A' ' 91' ' ' VAL . 20.8 Cg_exo -72.24 151.39 54.6 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 123.803 3.002 . . . . 0.0 112.113 177.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 24.0 m -119.68 135.06 54.98 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 121.72 0.771 . . . . 0.0 111.11 -176.644 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.48 HG22 HG12 ' A' ' 28' ' ' VAL . 71.9 t -77.64 125.41 37.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-N 114.16 -1.382 . . . . 0.0 109.864 174.59 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -88.05 -47.29 8.63 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.208 -174.451 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -136.88 145.83 44.82 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 120.978 0.418 . . . . 0.0 110.854 179.226 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 26.3 m -130.94 139.9 49.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.461 -179.026 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.411 ' HB3' ' H ' ' A' ' 23' ' ' ASP . 29.2 m-20 -135.34 -153.5 0.52 Allowed 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 175.374 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.448 ' CB ' ' HB3' ' A' ' 71' ' ' PRO . 5.5 m-20 -76.3 -73.47 0.27 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.546 0.689 . . . . 0.0 110.497 178.892 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.684 HG22 ' O ' ' A' ' 69' ' ' LEU . 35.0 p -102.07 37.01 1.95 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.698 -174.767 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.689 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 55.3 p -169.55 134.08 1.39 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.14 -173.776 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.627 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 13.3 mt -150.6 142.08 16.71 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.819 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.522 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.441 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 38.6 t -115.96 129.02 73.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 119.184 0.902 . . . . 0.0 110.906 -176.204 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.624 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.7 OUTLIER -123.27 145.71 29.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -177.742 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.445 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 59.5 mtp180 -131.78 122.4 25.74 Favored 'General case' 0 C--N 1.329 -0.298 0 O-C-N 123.254 0.346 . . . . 0.0 110.706 -174.609 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.72 ' HZ3' HG12 ' A' ' 64' ' ' VAL . 34.5 p90 -114.36 148.42 37.65 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.674 -0.694 . . . . 0.0 112.004 -174.265 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.709 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 24.1 t -92.69 86.47 5.56 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.612 177.119 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.564 ' HD3' ' H ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -43.08 150.96 0.43 Allowed Pre-proline 0 CA--C 1.548 0.869 0 C-N-CA 124.011 0.924 . . . . 0.0 113.39 -176.043 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.746 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 6.3 Cg_exo -78.46 167.79 22.34 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 124.473 3.448 . . . . 0.0 114.9 -164.394 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -68.35 -28.62 67.29 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 114.308 -1.314 . . . . 0.0 109.642 170.737 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.518 ' HB2' ' HA ' ' A' ' 10' ' ' PRO . . . -61.87 137.43 95.32 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 114.99 -1.005 . . . . 0.0 111.403 -179.65 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_exo -70.66 115.03 4.04 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 121.394 1.396 . . . . 0.0 109.366 167.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.609 HG22 ' HG3' ' A' ' 83' ' ' GLU . 0.4 OUTLIER -118.64 159.35 19.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -174.745 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.404 ' N ' ' O ' ' A' ' 82' ' ' VAL . 16.7 p -101.47 -27.62 13.03 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -178.452 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -168.04 -168.9 30.83 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 119.879 -1.153 . . . . 0.0 112.365 177.633 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.746 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 5.0 m-85 -137.5 134.46 35.76 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 121.076 0.465 . . . . 0.0 111.438 177.835 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.8 mtm180 -112.95 147.54 36.9 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.103 170.168 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.894 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 27.1 mt -137.98 109.76 6.2 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 C-N-CA 119.886 -0.726 . . . . 0.0 112.841 -173.281 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 97.5 t -110.81 111.16 34.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.086 0.469 . . . . 0.0 110.941 -178.627 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.829 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 0.9 OUTLIER -115.69 126.65 54.39 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.267 177.366 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.6 p -136.67 138.25 25.88 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-N 113.922 -1.49 . . . . 0.0 111.889 -174.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.48 ' HD3' ' O ' ' A' ' 51' ' ' SER . 94.6 Cg_endo -80.44 143.21 15.23 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 123.611 2.874 . . . . 0.0 111.604 176.043 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 16.4 t -71.02 -28.61 64.52 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.851 -175.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.7 m -114.69 -34.81 2.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -177.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.485 ' HG3' ' HG2' ' A' ' 70' ' ' GLN . 31.1 mm-40 -87.09 -172.75 4.11 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.753 0.311 . . . . 0.0 111.106 -177.227 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -119.94 -11.82 6.8 Favored Glycine 0 N--CA 1.443 -0.889 0 C-N-CA 120.359 -0.924 . . . . 0.0 114.773 -171.351 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.48 ' O ' ' HD3' ' A' ' 46' ' ' PRO . 7.7 m -78.21 111.4 14.11 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 118.992 1.396 . . . . 0.0 110.168 -178.639 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 28.8 p -123.31 147.21 47.24 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.576 176.405 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.829 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 12.4 m -140.01 148.72 42.28 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 119.535 -0.866 . . . . 0.0 111.595 -179.723 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.894 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 37.5 tt0 -122.68 112.15 17.6 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.557 177.269 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.663 HD12 ' CG2' ' A' ' 64' ' ' VAL . 11.7 mt -99.56 164.27 12.15 Favored 'General case' 0 CA--C 1.511 -0.531 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.633 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.417 ' O ' HD23 ' A' ' 57' ' ' LEU . 18.6 t-20 -126.27 118.86 25.99 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.586 179.475 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.638 HD12 ' CH2' ' A' ' 30' ' ' TRP . 5.3 mt -119.02 159.12 46.11 Favored Pre-proline 0 C--N 1.318 -0.801 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 -178.02 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -65.13 153.44 78.26 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 121.717 1.612 . . . . 0.0 111.258 174.701 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -49.98 -26.7 4.49 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.074 176.528 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 10.2 t -101.23 13.63 34.5 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.053 -175.589 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.514 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -80.34 161.53 24.99 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 178.274 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.445 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 27.7 p-10 -147.73 16.54 1.12 Allowed 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -178.16 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.624 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 19.7 p -171.49 134.42 0.86 Allowed 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.23 -0.588 . . . . 0.0 111.645 179.774 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.72 HG12 ' HZ3' ' A' ' 30' ' ' TRP . 3.1 p -118.83 137.36 53.06 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.399 176.548 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 52.1 m -95.71 100.82 12.49 Favored 'General case' 0 N--CA 1.433 -1.301 0 CA-C-O 121.573 0.701 . . . . 0.0 109.18 169.035 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.725 ' HB3' ' CE2' ' A' ' 44' ' ' TYR . 0.3 OUTLIER -74.9 141.33 44.14 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.173 178.439 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.438 ' HA ' ' O ' ' A' ' 24' ' ' THR . 9.7 t -136.07 168.97 18.36 Favored 'General case' 0 N--CA 1.444 -0.75 0 O-C-N 123.605 0.566 . . . . 0.0 109.762 -178.126 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 62.92 34.34 14.25 Favored 'General case' 0 CA--C 1.519 -0.234 0 O-C-N 123.787 0.679 . . . . 0.0 111.252 -178.191 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.684 ' O ' HG22 ' A' ' 24' ' ' THR . 9.4 mt -79.62 -177.21 5.73 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 174.108 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.485 ' HG2' ' HG3' ' A' ' 49' ' ' GLU . 55.7 tp60 -123.33 125.01 26.24 Favored Pre-proline 0 C--N 1.314 -0.947 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 175.597 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.448 ' HB3' ' CB ' ' A' ' 23' ' ' ASP . 39.4 Cg_endo -65.28 133.97 37.21 Favored 'Trans proline' 0 CA--C 1.53 0.316 0 C-N-CA 123.019 2.48 . . . . 0.0 113.12 -175.632 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 82.48 35.49 19.83 Favored Glycine 0 N--CA 1.45 -0.386 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.901 -179.364 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.448 HG21 ' HG3' ' A' ' 49' ' ' GLU . 45.4 t -137.4 149.91 25.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.0 0.428 . . . . 0.0 111.026 -175.633 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 8.9 tp60 -87.98 111.34 21.38 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.433 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -102.01 123.34 45.72 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.878 -177.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.545 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 74.9 m-20 -93.5 107.6 19.42 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.151 175.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.641 HG12 HD11 ' A' ' 66' ' ' LEU . 5.2 mp -92.69 118.67 38.81 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.596 0 CA-C-O 121.229 0.538 . . . . 0.0 109.717 176.89 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.844 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 30.0 m -110.16 116.19 31.08 Favored 'General case' 0 N--CA 1.428 -1.553 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.331 179.618 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.539 ' HB ' ' HB ' ' A' ' 91' ' ' VAL . 12.4 mm -95.5 130.79 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -117.53 112.14 20.2 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 177.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.417 ' HB1' HG21 ' A' ' 37' ' ' ILE . . . -82.69 127.61 33.56 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 169.588 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.404 ' O ' ' N ' ' A' ' 38' ' ' THR . 6.5 p -117.59 135.88 56.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 C-N-CA 120.194 -0.603 . . . . 0.0 110.804 -177.265 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.609 ' HG3' HG22 ' A' ' 37' ' ' ILE . 2.4 mp0 -113.37 170.17 8.43 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.403 ' HG3' ' H ' ' A' ' 84' ' ' GLU . 40.6 mt-10 -38.65 -52.65 1.65 Allowed 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -174.102 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -131.09 17.31 5.05 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.943 -0.303 . . . . 0.0 110.814 -176.15 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 18.1 mm-40 -142.19 173.5 11.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.795 0.331 . . . . 0.0 110.915 -176.434 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -135.81 125.58 25.58 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 175.071 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.4 ' HB2' ' HB3' ' A' ' 81' ' ' ALA . 47.6 m -73.1 170.5 14.77 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.734 0.302 . . . . 0.0 111.079 178.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.46 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 2.8 p -62.58 153.03 79.37 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 120.973 0.416 . . . . 0.0 111.096 178.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -86.03 140.92 6.97 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.516 2.144 . . . . 0.0 114.387 -177.169 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.844 ' O ' ' HA ' ' A' ' 78' ' ' THR . 21.0 t -82.33 127.4 39.67 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.624 0 CA-C-N 114.83 -1.077 . . . . 0.0 108.575 167.132 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 11.7 t -121.84 106.9 18.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 C-N-CA 119.935 -0.706 . . . . 0.0 109.884 170.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.579 HG13 ' HB ' ' A' ' 77' ' ' ILE . 8.6 pt -122.58 116.79 49.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.166 178.342 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -100.03 124.96 45.98 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.601 0.715 . . . . 0.0 110.953 -177.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -134.67 134.25 40.93 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.311 178.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -84.89 137.05 33.37 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.965 0.412 . . . . 0.0 110.037 178.282 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 25.5 p -71.13 113.0 7.73 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.778 176.13 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 33.1 m -69.01 -28.91 67.01 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.837 0.827 . . . . 0.0 109.638 -179.351 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.41 ' HA2' ' HA ' ' A' ' 23' ' ' ASP . . . 87.46 -148.09 21.04 Favored Glycine 0 N--CA 1.436 -1.339 0 CA-C-N 114.7 -1.137 . . . . 0.0 111.877 176.713 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 4.7 m -68.91 120.16 74.39 Favored Pre-proline 0 C--N 1.316 -0.868 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 178.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -42.2 108.09 0.09 OUTLIER 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 123.787 2.991 . . . . 0.0 113.262 -176.093 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 7.5 ptm180 -81.7 122.59 27.84 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.768 -178.23 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 19.6 m -71.69 143.17 49.78 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.559 176.741 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 62.74 48.51 4.16 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.614 0.721 . . . . 0.0 109.851 -174.53 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -176.85 -44.82 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.041 -0.981 . . . . 0.0 111.279 -179.347 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 65.4 m . . . . . 0 C--O 1.248 0.984 0 CA-C-O 118.917 -0.563 . . . . 0.0 109.713 174.594 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.655 0 N-CA-C 111.572 -0.611 . . . . 0.0 111.572 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.0 m 55.65 42.81 29.05 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 120.891 0.377 . . . . 0.0 111.443 178.938 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 45.0 m170 -75.54 128.43 35.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.454 -179.393 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 14.7 tpt 58.49 70.83 0.62 Allowed 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.813 0.816 . . . . 0.0 110.102 -176.704 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 164.95 58.02 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.619 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.93 -177.682 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.8 t -66.77 117.75 9.33 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.338 0.589 . . . . 0.0 111.737 -175.788 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.1 m -82.75 74.47 9.71 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 172.093 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 32.1 m -65.03 123.33 19.21 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.382 -0.826 . . . . 0.0 112.233 -172.33 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -93.83 146.44 31.71 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.906 178.652 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.446 ' HB2' ' OG ' ' A' ' 88' ' ' SER . 74.0 Cg_endo -73.21 150.91 48.33 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 122.515 2.143 . . . . 0.0 111.991 179.899 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.423 ' O ' ' HB3' ' A' ' 33' ' ' PRO . 13.8 p-10 -110.72 157.4 19.79 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.185 -178.622 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -96.39 161.07 28.14 Favored Pre-proline 0 C--N 1.32 -0.716 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.196 177.302 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -68.28 130.91 22.18 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.507 2.138 . . . . 0.0 112.252 177.306 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.401 ' HD2' ' O ' ' A' ' 31' ' ' SER . 74.0 Cg_exo -50.87 151.26 11.52 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.81 2.34 . . . . 0.0 111.572 172.899 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -38.88 106.13 0.37 Allowed Pre-proline 0 N--CA 1.47 0.573 0 O-C-N 124.493 1.121 . . . . 0.0 112.251 -170.552 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.603 ' HG2' HG11 ' A' ' 91' ' ' VAL . 34.3 Cg_exo -64.59 149.68 89.46 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 123.504 2.803 . . . . 0.0 112.691 179.594 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 28.0 m -105.24 129.39 53.62 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.988 -1.006 . . . . 0.0 110.71 -177.423 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.452 ' HA ' ' HA ' ' A' ' 28' ' ' VAL . 70.6 t -81.02 123.31 37.49 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 CA-C-N 114.522 -1.217 . . . . 0.0 110.049 175.639 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -89.39 -37.39 14.88 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.435 -174.756 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -135.05 134.75 40.7 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.851 0.358 . . . . 0.0 110.601 -177.898 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.504 ' HA ' HG12 ' A' ' 26' ' ' ILE . 59.2 t -130.0 117.93 42.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.334 179.184 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.415 ' HB3' ' H ' ' A' ' 23' ' ' ASP . 8.8 m-20 -128.21 -160.76 1.04 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.84 175.405 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.56 ' O ' ' HB2' ' A' ' 69' ' ' LEU . 1.9 m-20 -77.19 -58.4 3.3 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.043 0.449 . . . . 0.0 110.91 -177.718 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.646 HG22 ' O ' ' A' ' 69' ' ' LEU . 34.9 p -113.11 34.42 4.47 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.131 -175.458 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.637 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 75.8 p -169.88 130.94 1.03 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.626 -176.583 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.592 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 43.4 mt -147.17 139.51 18.98 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.624 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 176.841 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.445 ' O ' HG13 ' A' ' 18' ' ' VAL . 39.9 t -118.17 130.13 73.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 118.697 0.681 . . . . 0.0 110.586 -175.702 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.675 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.6 OUTLIER -122.81 145.87 28.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 C-N-CA 120.496 -0.482 . . . . 0.0 110.009 -177.368 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.556 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 29.8 mtm180 -130.81 121.11 24.75 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 123.358 0.411 . . . . 0.0 110.68 -175.946 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.746 ' HZ3' HG12 ' A' ' 64' ' ' VAL . 38.2 p90 -110.26 144.23 39.27 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.608 -173.994 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.401 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 17.6 m -89.31 96.8 10.86 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.027 177.167 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.596 ' NE ' ' HB3' ' A' ' 62' ' ' ASN . 0.1 OUTLIER -45.73 155.85 0.46 Allowed Pre-proline 0 CA--C 1.538 0.515 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -175.105 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.693 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 4.6 Cg_exo -82.95 169.91 12.78 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 124.519 3.479 . . . . 0.0 112.623 -172.416 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -81.21 -18.0 47.65 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.181 174.518 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.417 ' HB2' ' HA ' ' A' ' 10' ' ' PRO . . . -64.18 142.08 98.21 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.499 177.863 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_exo -70.72 115.26 4.15 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 121.487 1.458 . . . . 0.0 109.614 168.432 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.6 HG22 ' HG3' ' A' ' 83' ' ' GLU . 0.8 OUTLIER -121.72 152.15 25.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -174.91 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 11.8 p -98.12 -31.65 12.01 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -177.637 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.452 ' C ' HG12 ' A' ' 82' ' ' VAL . . . -163.15 -164.39 18.09 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.267 -0.968 . . . . 0.0 111.698 177.977 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.693 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 6.4 m-85 -140.32 136.13 32.91 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.848 0.324 . . . . 0.0 111.124 175.162 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 21.6 mtp180 -104.69 151.38 23.77 Favored 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 166.393 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.889 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 32.6 mt -139.59 108.47 3.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 C-N-CA 120.617 -0.433 . . . . 0.0 111.977 -178.491 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 72.6 t -107.77 109.64 28.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.306 0.574 . . . . 0.0 110.194 178.322 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.703 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 0.6 OUTLIER -110.46 125.14 52.97 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.138 175.908 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.1 m -143.17 133.88 12.4 Favored Pre-proline 0 C--N 1.316 -0.874 0 CA-C-N 113.928 -1.487 . . . . 0.0 110.808 -175.379 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.524 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 57.6 Cg_endo -73.95 130.92 14.98 Favored 'Trans proline' 0 C--N 1.333 -0.274 0 C-N-CA 123.108 2.539 . . . . 0.0 111.694 176.162 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 41.7 t -64.02 -24.11 67.59 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.309 -178.621 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.464 ' CG2' HG13 ' A' ' 73' ' ' VAL . 13.7 m -99.59 16.04 3.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.852 0.358 . . . . 0.0 111.167 178.783 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 74.36 152.75 0.13 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.919 -1.037 . . . . 0.0 111.381 178.121 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 155.73 -131.12 2.96 Favored Glycine 0 N--CA 1.448 -0.505 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 -176.366 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.517 ' O ' ' HE2' ' A' ' 75' ' ' TYR . 19.8 m -92.28 119.85 32.26 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 117.245 0.523 . . . . 0.0 110.74 179.705 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 15.5 m -117.98 137.26 52.98 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 176.531 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.703 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 23.5 m -144.77 151.93 39.59 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 120.443 -0.503 . . . . 0.0 111.476 -175.705 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.889 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 51.4 tt0 -121.61 112.44 18.46 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.619 176.251 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.713 HD12 ' CG2' ' A' ' 64' ' ' VAL . 18.1 mt -97.48 163.0 13.05 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.013 176.885 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.513 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 18.5 m120 -129.75 113.27 14.51 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.884 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.556 HD12 ' CH2' ' A' ' 30' ' ' TRP . 3.5 mt -110.98 157.62 38.14 Favored Pre-proline 0 C--N 1.317 -0.831 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -174.431 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -64.59 150.45 88.19 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 121.849 1.699 . . . . 0.0 111.157 175.484 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -48.31 -23.03 0.78 Allowed 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 115.177 -0.919 . . . . 0.0 112.852 177.908 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 5.1 t -99.86 1.6 43.07 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.215 -175.859 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.496 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -76.06 159.57 30.65 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 -176.951 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.596 ' HB3' ' NE ' ' A' ' 32' ' ' ARG . 28.6 p-10 -147.03 18.52 1.24 Allowed 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 120.554 -0.458 . . . . 0.0 112.231 -178.421 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.675 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 23.2 p -169.22 133.65 1.43 Allowed 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.164 -0.615 . . . . 0.0 112.155 -179.9 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.746 HG12 ' HZ3' ' A' ' 30' ' ' TRP . 3.6 p -118.44 137.11 53.46 Favored 'Isoleucine or valine' 0 C--O 1.242 0.673 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.203 176.257 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 61.0 m -97.68 101.98 13.63 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.752 171.65 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.68 HD11 HG12 ' A' ' 77' ' ' ILE . 0.2 OUTLIER -80.59 140.22 35.87 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.362 179.397 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 22.0 t -134.11 168.23 19.21 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 123.438 0.461 . . . . 0.0 110.642 -173.455 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 58.75 31.34 21.09 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.991 -177.811 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.646 ' O ' HG22 ' A' ' 24' ' ' THR . 14.3 mt -69.16 -175.44 0.76 Allowed 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 175.19 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.462 ' CG ' HG21 ' A' ' 106' ' ' THR . 50.2 tt0 -126.87 125.53 24.28 Favored Pre-proline 0 C--N 1.318 -0.772 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 178.407 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -63.52 130.04 27.02 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 123.03 2.486 . . . . 0.0 113.418 -177.346 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 88.18 22.05 43.0 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.774 -179.917 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.464 HG13 ' CG2' ' A' ' 48' ' ' VAL . 86.6 t -127.38 144.26 37.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.145 0.498 . . . . 0.0 111.308 -173.35 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.524 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 2.8 tp-100 -88.88 107.18 18.86 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.98 -176.566 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.517 ' HE2' ' O ' ' A' ' 51' ' ' SER . 16.0 m-85 -98.09 117.79 33.24 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.224 0.535 . . . . 0.0 111.64 -178.079 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -90.4 107.9 19.44 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.127 177.629 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.68 HG12 HD11 ' A' ' 66' ' ' LEU . 5.3 mp -91.73 116.4 32.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.294 0.569 . . . . 0.0 109.684 178.988 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.854 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 30.8 m -108.47 115.26 29.77 Favored 'General case' 0 N--CA 1.428 -1.525 0 CA-C-N 115.294 -0.867 . . . . 0.0 110.404 -179.791 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.566 ' HB ' ' HB ' ' A' ' 91' ' ' VAL . 14.3 mm -95.46 144.23 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -179.255 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -131.17 112.12 12.55 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.233 179.374 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -79.02 123.69 27.55 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 169.117 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.452 HG12 ' C ' ' A' ' 39' ' ' GLY . 7.0 p -114.53 135.91 52.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 C-N-CA 120.149 -0.621 . . . . 0.0 110.685 -179.824 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.666 ' OE1' ' HG3' ' A' ' 86' ' ' GLN . 3.9 mp0 -112.28 170.68 8.0 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -179.164 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -38.76 -55.78 1.44 Allowed 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -174.09 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -125.23 9.85 8.01 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -176.233 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.666 ' HG3' ' OE1' ' A' ' 83' ' ' GLU . 3.3 pt20 -143.03 176.49 9.06 Favored 'General case' 0 N--CA 1.447 -0.623 0 O-C-N 122.336 -0.227 . . . . 0.0 111.0 -175.095 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -138.28 136.08 36.12 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.004 178.432 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.446 ' OG ' ' HB2' ' A' ' 10' ' ' PRO . 46.2 m -78.24 175.46 10.18 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.168 178.297 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -63.09 160.69 37.13 Favored Pre-proline 0 CA--C 1.534 0.344 0 CA-C-O 120.973 0.416 . . . . 0.0 111.523 178.614 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -87.85 140.46 5.01 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.302 2.002 . . . . 0.0 114.365 -178.497 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.854 ' O ' ' HA ' ' A' ' 78' ' ' THR . 6.9 t -82.72 127.65 39.47 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.688 0 CA-C-N 114.825 -1.08 . . . . 0.0 108.34 165.863 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.4 t -124.05 106.06 16.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 C-N-CA 120.027 -0.669 . . . . 0.0 109.596 172.476 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.537 HG13 ' HB ' ' A' ' 77' ' ' ILE . 7.7 pt -124.2 112.87 34.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.418 178.674 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -94.07 120.17 33.94 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.315 0.579 . . . . 0.0 111.05 -177.66 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -126.33 125.37 42.16 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.486 175.482 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.447 ' HA ' ' HA ' ' A' ' 74' ' ' GLN . 40.9 tt0 -90.0 128.08 36.18 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.18 0.514 . . . . 0.0 110.034 179.783 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 40.3 p -59.52 144.71 46.56 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.948 -176.524 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 16.4 m -68.63 -31.98 71.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.342 -171.752 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 58.85 75.3 0.27 Allowed Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.686 -0.769 . . . . 0.0 111.832 178.366 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.448 ' HA ' ' HD3' ' A' ' 101' ' ' PRO . 3.5 m -66.08 131.0 94.41 Favored Pre-proline 0 C--N 1.314 -0.944 0 CA-C-N 114.838 -0.681 . . . . 0.0 110.687 -176.474 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 100' ' ' THR . 21.3 Cg_exo -66.07 74.34 0.35 Allowed 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.796 2.33 . . . . 0.0 112.195 177.369 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.492 ' HE ' ' HA ' ' A' ' 102' ' ' ARG . 3.1 tpm_? -85.54 -53.48 5.15 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.156 -179.13 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 47.4 t -171.27 -48.86 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.137 178.63 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -152.08 -30.99 0.15 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.559 179.215 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 81.97 -84.77 1.47 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.752 175.946 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.462 HG21 ' CG ' ' A' ' 70' ' ' GLN . 8.9 t . . . . . 0 C--O 1.248 0.989 0 CA-C-O 118.51 -0.757 . . . . 0.0 109.953 -176.813 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.814 0 N-CA-C 111.86 -0.496 . . . . 0.0 111.86 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.1 t -155.93 155.54 33.0 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 -179.239 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -125.11 176.85 6.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.875 0.369 . . . . 0.0 110.349 -179.82 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 26.0 ttt -135.67 54.25 1.92 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 176.369 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.39 89.66 1.12 Allowed Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.306 -0.861 . . . . 0.0 112.014 -178.723 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.6 m -85.02 78.42 9.91 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.199 0.523 . . . . 0.0 110.528 -178.76 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.4 p -83.28 -7.15 59.64 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.024 -178.625 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 12.9 t -74.9 -6.82 51.28 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 122.093 0.949 . . . . 0.0 109.703 174.074 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -112.86 88.33 11.56 Favored Pre-proline 0 C--N 1.313 -0.992 0 CA-C-N 114.043 -1.435 . . . . 0.0 109.112 173.834 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.485 ' HG3' ' CD ' ' A' ' 83' ' ' GLU . 87.5 Cg_endo -79.08 158.37 26.89 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 122.953 2.435 . . . . 0.0 112.427 -174.67 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -116.01 171.07 8.02 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -179.708 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.576 ' HB2' ' O ' ' A' ' 89' ' ' THR . . . -96.34 165.48 16.13 Favored Pre-proline 0 C--N 1.316 -0.858 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 178.997 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.469 ' HB2' ' HB2' ' A' ' 30' ' ' TRP . 27.0 Cg_exo -64.64 130.68 27.09 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 121.81 1.674 . . . . 0.0 111.055 171.806 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.567 ' HD2' ' O ' ' A' ' 31' ' ' SER . 71.5 Cg_exo -50.39 155.56 4.86 Favored 'Trans proline' 0 C--O 1.235 0.353 0 C-N-CA 122.524 2.149 . . . . 0.0 111.6 171.415 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -35.7 106.19 0.3 Allowed Pre-proline 0 N--CA 1.472 0.654 0 O-C-N 124.56 1.162 . . . . 0.0 112.437 -171.115 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.628 ' HG2' HG11 ' A' ' 91' ' ' VAL . 24.1 Cg_exo -70.5 145.1 51.94 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 123.162 2.575 . . . . 0.0 112.435 177.518 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.2 m -101.64 131.2 48.0 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.568 0.699 . . . . 0.0 110.814 -177.575 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.498 HG11 HG22 ' A' ' 21' ' ' VAL . 70.6 t -81.01 118.24 28.44 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 CA-C-N 114.658 -1.156 . . . . 0.0 110.061 175.226 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -78.05 -46.63 20.39 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.318 -175.568 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -136.74 140.67 42.77 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.679 -178.193 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.498 HG22 HG11 ' A' ' 18' ' ' VAL . 7.2 t -127.24 114.2 35.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.697 -178.063 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -124.63 -164.96 1.32 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 179.467 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.581 ' O ' ' HB2' ' A' ' 69' ' ' LEU . 4.0 p-10 -70.67 -67.1 0.53 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.073 0.463 . . . . 0.0 112.193 -178.109 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.678 HG22 ' O ' ' A' ' 69' ' ' LEU . 35.2 p -110.3 32.08 5.43 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.004 -173.381 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.706 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 42.3 m -167.71 129.99 1.57 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.194 -171.622 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.732 ' HB ' HD12 ' A' ' 66' ' ' LEU . 44.8 mt -147.37 145.57 18.99 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.924 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 177.398 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 43.7 t -118.67 131.4 71.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 119.22 0.918 . . . . 0.0 110.262 -176.803 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.64 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.6 OUTLIER -127.76 145.77 34.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 C-N-CA 120.096 -0.642 . . . . 0.0 110.318 -179.214 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.48 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 11.1 mtm180 -130.02 121.34 26.28 Favored 'General case' 0 CA--C 1.515 -0.379 0 O-C-N 123.397 0.436 . . . . 0.0 110.302 -175.584 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.733 ' HZ3' HG12 ' A' ' 64' ' ' VAL . 34.6 p90 -111.53 145.8 38.43 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.419 -175.306 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.567 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 12.5 t -90.29 91.81 8.66 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 175.124 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.473 ' HD3' ' H ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -46.1 156.3 0.48 Allowed Pre-proline 0 CA--C 1.542 0.662 0 C-N-CA 124.14 0.976 . . . . 0.0 113.507 -174.426 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.684 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 4.2 Cg_exo -76.27 169.53 21.81 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 123.86 3.04 . . . . 0.0 112.939 -173.754 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -83.74 -15.59 48.03 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.344 174.378 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.98 144.87 99.14 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.122 -0.944 . . . . 0.0 111.423 177.233 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -68.6 115.45 3.92 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 121.612 1.542 . . . . 0.0 109.831 167.274 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.638 HD12 ' HE1' ' A' ' 40' ' ' TYR . 1.1 pt -121.11 155.74 24.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -177.683 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.51 ' C ' ' HB3' ' A' ' 59' ' ' GLU . 21.7 p -104.24 -29.32 10.88 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -177.858 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.522 ' C ' HG12 ' A' ' 82' ' ' VAL . . . -161.7 -167.87 22.77 Favored Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.252 -0.975 . . . . 0.0 111.829 179.853 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.684 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 5.5 m-85 -139.93 131.57 27.25 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 120.803 0.335 . . . . 0.0 111.301 174.347 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.593 ' CZ ' HG11 ' A' ' 82' ' ' VAL . 0.2 OUTLIER -99.55 147.79 24.96 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 168.792 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.891 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 33.0 mt -139.71 107.47 2.93 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 C-N-CA 119.875 -0.73 . . . . 0.0 112.435 -179.582 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 82.5 t -108.47 110.7 32.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.138 0.494 . . . . 0.0 110.825 -178.519 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.751 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 0.8 OUTLIER -113.43 125.56 54.37 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 121.503 0.668 . . . . 0.0 109.985 176.175 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.495 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 13.9 t -140.25 140.53 23.6 Favored Pre-proline 0 C--N 1.319 -0.751 0 CA-C-N 113.717 -1.583 . . . . 0.0 110.69 -174.505 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.633 ' HG3' ' CZ ' ' A' ' 75' ' ' TYR . 2.4 Cg_endo -80.46 148.3 18.34 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 123.605 2.87 . . . . 0.0 111.67 178.57 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 15.0 m -71.35 -30.11 65.78 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.584 179.87 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.9 p -118.18 -40.25 2.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 179.345 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.504 ' HG2' ' CB ' ' A' ' 70' ' ' GLN . 10.2 tp10 -76.77 166.54 23.22 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.598 -0.273 . . . . 0.0 110.31 -179.344 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -115.88 17.64 15.23 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.389 -0.91 . . . . 0.0 114.581 -174.792 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.7 t -93.06 111.72 23.44 Favored 'General case' 0 C--N 1.334 -0.088 0 CA-C-N 118.954 1.377 . . . . 0.0 109.054 174.334 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 22.7 p -123.08 148.16 45.93 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.076 179.576 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.751 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 62.7 m -146.92 145.6 29.86 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 119.922 -0.711 . . . . 0.0 111.588 176.919 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.891 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 41.8 tt0 -116.56 115.75 26.33 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.94 174.532 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.684 HD12 ' CG2' ' A' ' 64' ' ' VAL . 18.8 mt -97.52 161.55 13.72 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 175.855 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.486 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 36.9 t30 -126.12 119.44 27.56 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 177.651 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.573 HD12 ' CH2' ' A' ' 30' ' ' TRP . 4.7 mt -113.96 159.55 35.64 Favored Pre-proline 0 C--N 1.317 -0.822 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 -177.419 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -67.18 151.99 80.39 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 121.534 1.489 . . . . 0.0 111.005 174.66 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.51 ' HB3' ' C ' ' A' ' 38' ' ' THR . 7.0 pt-20 -47.8 -24.75 1.06 Allowed 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.092 -0.958 . . . . 0.0 112.632 177.468 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.9 t -104.6 15.87 27.17 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.09 -174.524 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.428 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -86.81 161.69 18.21 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 178.057 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.48 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 4.3 p-10 -145.31 15.37 1.48 Allowed 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.954 -178.092 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.64 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 26.4 p -168.83 133.88 1.6 Allowed 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.281 -0.568 . . . . 0.0 111.694 -179.016 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.733 HG12 ' HZ3' ' A' ' 30' ' ' TRP . 3.3 p -117.33 139.83 42.72 Favored 'Isoleucine or valine' 0 C--O 1.244 0.81 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.47 177.237 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 47.7 m -97.23 101.14 12.64 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.579 168.391 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.732 HD12 ' HB ' ' A' ' 26' ' ' ILE . 0.3 OUTLIER -76.03 141.9 41.97 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.597 177.924 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.436 ' HA ' ' O ' ' A' ' 24' ' ' THR . 27.3 p -136.62 166.22 24.04 Favored 'General case' 0 N--CA 1.447 -0.595 0 O-C-N 123.819 0.7 . . . . 0.0 110.041 -174.955 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 61.93 38.54 14.32 Favored 'General case' 0 N--CA 1.464 0.227 0 O-C-N 123.688 0.617 . . . . 0.0 111.431 -179.214 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.678 ' O ' HG22 ' A' ' 24' ' ' THR . 8.1 mt -85.04 -176.26 6.12 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 175.459 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.504 ' CB ' ' HG2' ' A' ' 49' ' ' GLU . 58.4 tp60 -126.72 124.69 24.21 Favored Pre-proline 0 C--N 1.32 -0.704 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 176.479 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -62.24 134.54 49.35 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 123.188 2.592 . . . . 0.0 113.498 -178.072 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 86.53 24.27 40.0 Favored Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.363 176.977 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 17.9 t -130.53 149.23 33.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.236 0.541 . . . . 0.0 111.445 -176.232 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.494 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 4.4 tp-100 -79.64 108.0 12.85 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.634 179.971 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.633 ' CZ ' ' HG3' ' A' ' 46' ' ' PRO . 4.2 m-85 -101.15 116.52 33.01 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.377 0.608 . . . . 0.0 111.868 -178.708 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.585 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 31.0 m-80 -89.2 109.02 19.94 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.448 177.037 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.678 HG12 HD11 ' A' ' 66' ' ' LEU . 5.2 mp -92.56 116.01 32.73 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.616 0 CA-C-O 121.332 0.586 . . . . 0.0 109.571 175.598 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.874 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 89.2 m -108.82 116.18 31.5 Favored 'General case' 0 N--CA 1.426 -1.639 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.243 179.954 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.558 ' HB ' ' HB ' ' A' ' 91' ' ' VAL . 15.6 mm -95.26 140.59 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 -178.959 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -127.87 113.04 15.4 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 178.776 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.458 ' HB1' HG21 ' A' ' 37' ' ' ILE . . . -84.12 119.65 25.23 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 171.173 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.593 HG11 ' CZ ' ' A' ' 41' ' ' ARG . 7.5 p -110.54 141.22 26.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 C-N-CA 120.237 -0.585 . . . . 0.0 110.204 -175.355 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.604 ' OE1' ' HB2' ' A' ' 86' ' ' GLN . 0.1 OUTLIER -123.28 170.88 9.84 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 123.37 0.419 . . . . 0.0 110.104 177.183 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -34.64 -55.83 0.55 Allowed 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 113.839 1.052 . . . . 0.0 113.839 -171.241 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -123.81 14.72 9.33 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 -174.627 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.604 ' HB2' ' OE1' ' A' ' 83' ' ' GLU . 25.4 mt-30 -146.18 170.81 15.96 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.368 0.604 . . . . 0.0 111.849 -177.298 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -127.38 124.63 39.02 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.113 173.704 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 15.4 m -76.2 -178.52 4.53 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.648 0.261 . . . . 0.0 111.088 -177.635 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.576 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 3.9 p -67.39 154.93 92.07 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-O 120.947 0.403 . . . . 0.0 111.438 -178.378 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -88.2 141.6 5.08 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 122.76 2.307 . . . . 0.0 115.031 179.747 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.874 ' O ' ' HA ' ' A' ' 78' ' ' THR . 8.8 t -83.34 131.59 33.43 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.538 0 CA-C-N 114.678 -1.146 . . . . 0.0 108.271 163.892 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 13.7 t -125.02 106.81 17.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 C-N-CA 119.94 -0.704 . . . . 0.0 110.172 170.178 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.623 HG13 ' HB ' ' A' ' 77' ' ' ILE . 8.2 pt -121.11 111.43 31.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.342 178.185 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -97.23 112.99 24.55 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.659 0.742 . . . . 0.0 111.6 -177.035 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -124.92 131.54 53.41 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.484 179.77 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -86.47 129.89 34.69 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.046 0.451 . . . . 0.0 110.519 -179.483 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.443 HG22 HD11 ' A' ' 26' ' ' ILE . 20.3 p -60.43 117.68 5.55 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.227 179.626 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.424 ' H ' HG12 ' A' ' 21' ' ' VAL . 39.1 m -70.9 -31.5 68.16 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.039 179.651 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.486 ' HA2' ' CA ' ' A' ' 23' ' ' ASP . . . 66.79 -115.6 7.43 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.193 -0.912 . . . . 0.0 112.678 176.711 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 21.1 m -93.28 121.34 65.51 Favored Pre-proline 0 C--N 1.319 -0.751 0 N-CA-C 110.347 -0.242 . . . . 0.0 110.347 179.0 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -56.23 130.7 41.55 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.532 2.155 . . . . 0.0 111.139 176.207 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 36.5 mmt180 -83.36 49.4 1.56 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.858 0.361 . . . . 0.0 110.895 -175.978 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 17.6 m -67.46 -38.38 84.39 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.316 179.211 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -95.84 167.15 11.43 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.071 177.879 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 78.25 34.1 37.92 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.287 -179.973 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 24.5 m . . . . . 0 C--O 1.25 1.131 0 CA-C-O 118.419 -0.801 . . . . 0.0 110.597 -178.798 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.654 0 N-CA-C 111.849 -0.501 . . . . 0.0 111.849 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 40.1 m -142.24 39.67 1.6 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.84 0.352 . . . . 0.0 110.907 -178.798 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 33.0 t60 -71.43 -43.19 67.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.899 0.38 . . . . 0.0 110.001 177.616 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 52.5 tpp -94.43 -56.53 2.78 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.225 178.333 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -87.97 74.38 2.19 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.009 -179.846 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 12.9 t -99.12 -7.99 25.85 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.407 0.623 . . . . 0.0 110.083 179.604 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.4 HG21 ' HA ' ' A' ' 35' ' ' ALA . 2.6 m 64.47 63.56 0.74 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 114.649 -1.16 . . . . 0.0 111.047 179.07 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 17.1 m -63.09 128.25 34.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.25 177.873 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 66.2 92.42 0.06 OUTLIER Pre-proline 0 C--O 1.235 0.304 0 O-C-N 123.751 0.657 . . . . 0.0 110.383 -175.719 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.402 ' HG3' ' OE1' ' A' ' 83' ' ' GLU . 55.4 Cg_endo -69.07 151.31 73.0 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 122.927 2.418 . . . . 0.0 112.371 -175.425 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.442 ' HB2' ' HB3' ' A' ' 33' ' ' PRO . 1.0 OUTLIER -80.99 153.66 27.33 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.454 178.263 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -96.75 158.79 32.98 Favored Pre-proline 0 C--N 1.312 -1.058 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 163.559 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.456 ' CB ' ' HB2' ' A' ' 30' ' ' TRP . 23.6 Cg_exo -67.35 126.16 14.54 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 121.364 1.376 . . . . 0.0 111.535 176.589 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.42 ' HD2' ' O ' ' A' ' 31' ' ' SER . 76.6 Cg_exo -49.49 145.39 16.56 Favored 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.469 2.112 . . . . 0.0 110.634 171.486 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.402 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 10.1 m-20 -35.95 105.62 0.29 Allowed Pre-proline 0 N--CA 1.47 0.55 0 O-C-N 124.701 1.251 . . . . 0.0 112.329 -169.394 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.597 ' HG2' HG11 ' A' ' 91' ' ' VAL . 31.3 Cg_exo -64.76 155.45 67.25 Favored 'Trans proline' 0 CA--C 1.514 -0.492 0 C-N-CA 123.747 2.965 . . . . 0.0 112.407 -179.81 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 31.6 m -113.77 131.03 56.36 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.806 -178.207 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.511 HG11 HG22 ' A' ' 21' ' ' VAL . 71.4 t -73.26 122.81 26.9 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 114.054 -1.43 . . . . 0.0 109.884 175.051 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -84.47 -41.94 16.09 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.944 -173.847 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -136.22 140.62 43.65 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.163 178.574 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.511 HG22 HG11 ' A' ' 18' ' ' VAL . 39.8 t -123.72 119.46 57.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.468 178.191 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.406 ' HB2' ' O ' ' A' ' 25' ' ' SER . 23.6 m-20 -124.36 -159.06 0.85 Allowed 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 176.95 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.569 ' HB3' ' C ' ' A' ' 99' ' ' GLY . 17.8 p-10 -84.44 -54.41 4.78 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.3 0.571 . . . . 0.0 111.348 179.094 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.599 HG22 ' O ' ' A' ' 69' ' ' LEU . 29.9 p -119.61 29.73 7.44 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.192 -172.409 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.636 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 17.0 p -169.91 130.6 1.01 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.665 -1.152 . . . . 0.0 109.858 -176.097 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.606 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 48.0 mt -148.05 142.22 19.23 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.666 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.765 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.458 ' O ' HG13 ' A' ' 18' ' ' VAL . 44.9 t -115.96 136.21 53.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 C-N-CA 119.858 -0.737 . . . . 0.0 109.933 -175.701 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.642 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.6 OUTLIER -127.13 145.41 34.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 C-N-CA 120.122 -0.631 . . . . 0.0 110.162 179.105 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.48 ' HG2' ' HB3' ' A' ' 63' ' ' SER . 54.8 mtp180 -130.02 120.98 25.61 Favored 'General case' 0 C--N 1.327 -0.408 0 O-C-N 123.535 0.522 . . . . 0.0 110.497 -174.766 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.708 ' HZ3' HG12 ' A' ' 64' ' ' VAL . 35.7 p90 -113.47 149.04 34.84 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.879 -174.052 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.433 ' O ' ' HA ' ' A' ' 13' ' ' PRO . 48.2 m -92.75 88.53 6.28 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.202 175.758 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.526 ' HD3' ' H ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -50.75 159.05 0.99 Allowed Pre-proline 0 CA--C 1.544 0.715 0 CA-C-N 114.99 -1.005 . . . . 0.0 113.404 -175.413 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.729 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 6.4 Cg_exo -74.08 169.33 22.69 Favored 'Trans proline' 0 C--N 1.358 1.032 0 C-N-CA 124.001 3.134 . . . . 0.0 113.332 -172.597 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -91.38 3.88 53.81 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.242 174.842 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.4 ' HA ' HG21 ' A' ' 7' ' ' THR . . . -85.4 151.41 56.22 Favored Pre-proline 0 CA--C 1.515 -0.378 0 CA-C-N 114.683 -1.144 . . . . 0.0 110.532 178.686 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -75.85 114.76 4.01 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 121.446 1.431 . . . . 0.0 109.92 171.728 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.614 HD12 ' HE1' ' A' ' 40' ' ' TYR . 2.6 pt -123.06 157.52 28.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.728 -173.508 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.407 ' H ' ' HA ' ' A' ' 83' ' ' GLU . 6.8 p -91.91 -39.12 11.89 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -178.483 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.436 ' O ' HG12 ' A' ' 82' ' ' VAL . . . -169.45 -162.99 22.72 Favored Glycine 0 N--CA 1.439 -1.11 0 C-N-CA 119.542 -1.313 . . . . 0.0 112.687 -178.98 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.729 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 5.1 m-85 -137.71 135.64 36.63 Favored 'General case' 0 CA--C 1.506 -0.746 0 CA-C-O 120.897 0.38 . . . . 0.0 111.175 178.993 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.6 mtm105 -107.53 147.62 30.31 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 169.987 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.875 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 27.3 mt -139.22 109.74 4.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 C-N-CA 120.17 -0.612 . . . . 0.0 112.471 -174.758 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 78.4 t -111.11 110.34 31.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.578 179.011 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.784 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 0.7 OUTLIER -112.08 124.94 53.51 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.427 176.646 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.431 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 8.1 p -138.02 136.24 19.48 Favored Pre-proline 0 C--N 1.312 -1.039 0 CA-C-N 113.946 -1.479 . . . . 0.0 111.47 -172.394 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.595 ' HB3' HG11 ' A' ' 73' ' ' VAL . 16.1 Cg_exo -64.78 129.46 23.49 Favored 'Trans proline' 0 CA--C 1.519 -0.242 0 C-N-CA 122.929 2.419 . . . . 0.0 110.934 174.905 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 13.6 m -60.31 -26.6 66.66 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.683 -0.689 . . . . 0.0 112.453 -173.538 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.475 ' O ' ' HB3' ' A' ' 49' ' ' GLU . 17.7 m -105.54 -41.94 6.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 120.546 -0.462 . . . . 0.0 111.805 179.675 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.475 ' HB3' ' O ' ' A' ' 48' ' ' VAL . 12.1 pt-20 165.31 157.18 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.534 0.734 . . . . 0.0 109.654 177.212 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 147.05 -143.82 11.83 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.95 178.481 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 45.4 m -91.04 121.64 33.02 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.743 0.271 . . . . 0.0 110.987 -179.709 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.9 m -116.07 145.58 42.9 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 176.021 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.784 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 26.3 m -145.67 154.99 42.71 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 120.53 -0.468 . . . . 0.0 111.493 -175.507 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.875 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 33.3 tt0 -127.46 112.92 15.52 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.603 -179.026 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.708 HD12 ' CG2' ' A' ' 64' ' ' VAL . 17.0 mt -100.86 162.35 12.96 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.455 178.183 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.555 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 2.3 m120 -128.65 115.89 18.74 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 176.837 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.57 HD12 ' CH2' ' A' ' 30' ' ' TRP . 4.6 mt -110.85 156.86 40.04 Favored Pre-proline 0 N--CA 1.441 -0.883 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -175.96 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -63.26 151.22 85.92 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 121.737 1.625 . . . . 0.0 110.989 175.902 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.437 ' HB2' HG13 ' A' ' 37' ' ' ILE . 9.8 pt-20 -45.84 -28.95 1.2 Allowed 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.344 176.707 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.5 t -101.2 19.53 17.44 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.148 -174.834 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.506 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -89.11 161.08 16.7 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 178.635 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.446 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 29.6 p-10 -147.85 15.94 1.09 Allowed 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -177.123 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.642 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 28.0 p -171.32 133.95 0.86 Allowed 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.226 -0.59 . . . . 0.0 111.779 -178.476 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.716 HG11 HG21 ' A' ' 42' ' ' ILE . 3.1 p -117.13 136.77 53.2 Favored 'Isoleucine or valine' 0 C--O 1.24 0.59 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.434 177.146 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 41.3 m -94.57 101.71 13.61 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.668 169.106 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.636 ' O ' ' HA ' ' A' ' 25' ' ' SER . 0.2 OUTLIER -78.8 141.04 38.09 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 177.551 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 10.9 t -137.3 172.65 12.67 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 -177.035 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 60.93 31.58 19.97 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.476 -179.287 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.599 ' O ' HG22 ' A' ' 24' ' ' THR . 10.7 mt -74.42 -176.99 2.89 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 176.917 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 7.7 tp60 -126.15 121.59 23.99 Favored Pre-proline 0 C--N 1.319 -0.741 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 177.5 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.426 ' HB3' ' HA2' ' A' ' 99' ' ' GLY . 12.0 Cg_endo -60.29 135.06 59.33 Favored 'Trans proline' 0 C--O 1.235 0.366 0 C-N-CA 123.001 2.467 . . . . 0.0 113.372 -177.634 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 87.71 17.47 58.23 Favored Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.309 177.323 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.595 HG11 ' HB3' ' A' ' 46' ' ' PRO . 14.1 t -125.62 146.62 31.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 120.816 0.341 . . . . 0.0 110.841 -177.573 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.553 ' OE1' ' HB2' ' A' ' 96' ' ' GLU . 35.0 tp60 -81.05 122.69 27.63 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.782 178.744 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.463 ' CE2' HD22 ' A' ' 69' ' ' LEU . 5.4 m-85 -105.98 116.17 31.48 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 121.599 0.714 . . . . 0.0 111.725 -179.297 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.423 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 16.2 t-20 -90.14 104.1 16.7 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 114.487 -1.233 . . . . 0.0 109.113 177.01 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.623 HG12 HD11 ' A' ' 66' ' ' LEU . 5.3 mp -92.25 116.41 33.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.347 0.594 . . . . 0.0 109.758 177.722 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.84 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 62.1 m -108.3 116.13 31.39 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.09 179.094 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.612 ' HB ' ' HB ' ' A' ' 91' ' ' VAL . 15.5 mm -95.61 141.92 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.831 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -126.94 112.99 15.93 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 179.613 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -89.25 123.1 33.15 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 174.53 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.436 HG12 ' O ' ' A' ' 39' ' ' GLY . 7.3 p -120.63 134.67 63.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 120.02 -0.672 . . . . 0.0 112.258 -173.122 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.611 ' HG2' HG22 ' A' ' 37' ' ' ILE . 6.3 mt-10 -104.59 171.82 7.12 Favored 'General case' 0 N--CA 1.454 -0.261 0 O-C-N 124.146 0.904 . . . . 0.0 109.228 173.607 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -47.68 -39.51 17.56 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 179.081 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -113.36 -29.33 7.26 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -171.343 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -133.32 176.34 8.6 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.553 -0.459 . . . . 0.0 111.683 -170.011 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -134.61 137.78 43.98 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.789 177.717 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 17.7 m -77.64 173.47 12.01 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.828 -179.69 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 14.2 p -61.79 154.63 66.02 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-O 120.918 0.39 . . . . 0.0 110.623 176.567 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -81.64 142.6 12.97 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 122.067 1.845 . . . . 0.0 113.622 -175.463 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.84 ' O ' ' HA ' ' A' ' 78' ' ' THR . 7.1 t -83.18 129.41 37.5 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.771 0 CA-C-N 114.879 -1.055 . . . . 0.0 108.615 168.09 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.9 t -126.27 106.96 16.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.153 175.01 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.547 HG13 ' HB ' ' A' ' 77' ' ' ILE . 8.1 pt -128.17 118.9 49.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.47 178.794 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -103.39 129.93 50.59 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.402 0.62 . . . . 0.0 111.349 -176.877 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -141.06 130.03 23.19 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.96 176.517 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.553 ' HB2' ' OE1' ' A' ' 74' ' ' GLN . 34.5 tt0 -85.83 136.12 33.44 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.251 0.548 . . . . 0.0 110.093 179.959 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 25.4 p -65.92 124.5 22.67 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.55 179.709 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.4 m -68.57 -31.71 71.1 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.228 -173.292 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.569 ' C ' ' HB3' ' A' ' 23' ' ' ASP . . . 119.56 166.68 13.41 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.001 177.697 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.496 ' N ' ' HB3' ' A' ' 23' ' ' ASP . 24.1 m -68.37 123.11 86.78 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-O 120.379 0.133 . . . . 0.0 110.96 -176.172 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 100' ' ' THR . 35.9 Cg_exo -58.31 101.27 0.12 Allowed 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.974 2.449 . . . . 0.0 112.235 178.826 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 7.8 ptp180 -145.15 171.15 14.93 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.872 -179.96 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 35.8 t -145.25 135.95 24.44 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 177.771 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 71.3 -64.56 0.38 Allowed 'General case' 0 N--CA 1.467 0.391 0 O-C-N 123.911 0.757 . . . . 0.0 112.034 175.508 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -121.15 177.62 16.39 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.339 -178.632 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.7 t . . . . . 0 C--O 1.249 1.041 0 CA-C-O 119.058 -0.496 . . . . 0.0 110.401 -179.814 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.82 0 N-CA-C 111.708 -0.557 . . . . 0.0 111.708 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 28.2 m -79.49 -178.21 6.18 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 178.35 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 62.22 40.39 11.64 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.321 0.581 . . . . 0.0 109.626 -176.665 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 23.0 ptt? -107.03 169.5 8.51 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.106 -175.295 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 104.22 -169.58 17.71 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.952 -0.642 . . . . 0.0 111.632 -179.37 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.0 m -78.62 71.58 5.09 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.279 0.562 . . . . 0.0 110.24 179.279 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.1 p -73.21 -12.91 61.04 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.839 -176.823 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 13.0 t -79.99 -4.48 52.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.734 0.778 . . . . 0.0 110.387 176.189 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -129.37 88.28 51.0 Favored Pre-proline 0 C--N 1.311 -1.084 0 CA-C-N 114.7 -1.137 . . . . 0.0 109.377 175.411 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -64.04 142.36 80.8 Favored 'Trans proline' 0 C--O 1.235 0.372 0 C-N-CA 122.654 2.236 . . . . 0.0 113.337 -173.342 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -90.02 162.82 15.17 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.797 175.646 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -97.04 159.68 30.84 Favored Pre-proline 0 C--N 1.316 -0.854 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.249 177.317 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -68.61 133.14 26.95 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.482 2.122 . . . . 0.0 111.678 175.005 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.77 154.24 21.65 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.321 2.014 . . . . 0.0 110.943 172.91 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -36.45 107.2 0.35 Allowed Pre-proline 0 N--CA 1.468 0.464 0 O-C-N 124.595 1.184 . . . . 0.0 112.445 -172.148 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.622 ' HG2' HG11 ' A' ' 91' ' ' VAL . 36.1 Cg_exo -66.69 150.93 83.53 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 123.09 2.526 . . . . 0.0 112.265 177.712 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 45.8 m -106.93 129.04 54.81 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.872 -179.07 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.473 HG11 HG22 ' A' ' 21' ' ' VAL . 78.2 t -76.99 123.29 33.27 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-N 114.509 -1.223 . . . . 0.0 109.891 173.75 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -91.59 -37.39 13.11 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.341 -174.813 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 13.9 mm-40 -136.17 132.74 36.36 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.788 -178.59 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.485 ' HA ' HG12 ' A' ' 26' ' ' ILE . 46.5 t -124.01 120.1 58.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.388 179.637 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -127.5 -159.98 0.98 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 178.809 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.402 ' HB3' ' HA2' ' A' ' 99' ' ' GLY . 1.8 p-10 -74.48 -72.11 0.3 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 179.162 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.608 HG22 ' O ' ' A' ' 69' ' ' LEU . 69.9 p -105.41 33.57 3.64 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.211 -174.034 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.601 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 68.5 p -169.66 137.16 1.71 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.574 -173.628 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.618 ' HB ' HD12 ' A' ' 66' ' ' LEU . 35.9 mt -150.71 145.68 16.69 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.904 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.783 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.432 ' O ' HG13 ' A' ' 18' ' ' VAL . 41.0 t -118.36 131.85 69.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 119.255 0.934 . . . . 0.0 110.472 -176.062 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.59 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.6 OUTLIER -127.13 146.52 32.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.233 -178.119 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.47 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 20.2 mtm180 -130.69 121.27 25.2 Favored 'General case' 0 C--N 1.329 -0.303 0 O-C-N 123.244 0.34 . . . . 0.0 110.57 -175.856 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.823 ' HZ3' HG12 ' A' ' 64' ' ' VAL . 39.5 p90 -112.06 146.74 37.41 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.103 -175.651 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 24.0 t -92.59 99.09 11.86 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.928 177.548 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.605 ' H ' ' CD ' ' A' ' 32' ' ' ARG . 0.2 OUTLIER -53.49 160.3 1.96 Allowed Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 115.098 -0.955 . . . . 0.0 113.189 -174.261 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.645 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 2.2 Cg_endo -84.93 163.52 11.81 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 124.307 3.338 . . . . 0.0 112.279 -177.254 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -82.73 -6.42 59.39 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.338 172.064 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -66.2 146.79 99.04 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.841 174.557 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -73.94 114.08 3.94 Favored 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 121.165 1.244 . . . . 0.0 109.857 170.213 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.583 HD12 ' HE1' ' A' ' 40' ' ' TYR . 0.8 OUTLIER -120.56 147.79 24.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 -177.455 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.422 ' N ' ' O ' ' A' ' 82' ' ' VAL . 25.4 p -88.89 -30.2 19.05 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -178.335 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.59 ' C ' HG12 ' A' ' 82' ' ' VAL . . . -171.09 -162.3 23.21 Favored Glycine 0 CA--C 1.499 -0.942 0 C-N-CA 120.116 -1.04 . . . . 0.0 111.551 -179.327 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.645 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 6.5 m-85 -140.06 132.6 28.69 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 117.01 0.405 . . . . 0.0 111.155 173.807 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.2 mmm180 -100.7 147.72 25.69 Favored 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 168.031 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.881 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 32.0 mt -138.29 108.21 4.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 C-N-CA 119.926 -0.71 . . . . 0.0 112.328 -178.395 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 93.1 t -110.41 111.52 36.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.088 0.47 . . . . 0.0 110.762 -178.154 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.742 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 0.6 OUTLIER -115.24 126.2 54.25 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.077 177.357 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 30.8 p -134.22 137.52 28.28 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 113.742 -1.572 . . . . 0.0 111.705 -174.696 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.617 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 92.9 Cg_endo -80.52 130.6 7.98 Favored 'Trans proline' 0 N--CA 1.464 -0.231 0 C-N-CA 123.638 2.892 . . . . 0.0 111.937 178.488 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 23.1 t -72.72 -28.0 62.4 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.017 -178.325 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.2 m -117.48 16.48 7.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.173 0.511 . . . . 0.0 112.177 -176.187 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.546 ' HB2' HG11 ' A' ' 73' ' ' VAL . 1.2 tm-20 -149.83 -166.01 2.43 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.239 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -137.4 17.73 3.51 Favored Glycine 0 N--CA 1.443 -0.843 0 C-N-CA 119.283 -1.437 . . . . 0.0 115.034 -174.208 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.598 ' O ' ' HD3' ' A' ' 46' ' ' PRO . 7.7 t -93.37 111.19 22.79 Favored 'General case' 0 C--O 1.225 -0.197 0 CA-C-N 119.265 1.532 . . . . 0.0 109.386 174.278 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.0 p -123.41 148.83 45.73 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.719 -179.341 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.742 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 38.0 m -145.16 147.97 33.07 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 119.886 -0.725 . . . . 0.0 111.825 177.994 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.881 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 34.9 tt0 -118.54 114.1 22.3 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.957 176.014 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.697 HD12 ' CG2' ' A' ' 64' ' ' VAL . 16.8 mt -97.94 159.49 14.9 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.0 0.429 . . . . 0.0 110.318 176.564 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 22.1 m-80 -123.43 113.63 19.05 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.59 179.253 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.557 HD12 ' CH2' ' A' ' 30' ' ' TRP . 2.6 mt -111.8 154.92 43.88 Favored Pre-proline 0 C--N 1.318 -0.796 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 -176.726 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -65.53 150.21 86.91 Favored 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 121.569 1.512 . . . . 0.0 110.958 175.955 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -45.11 -25.53 0.35 Allowed 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 114.618 -1.173 . . . . 0.0 113.186 178.981 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 5.4 t -103.9 5.01 35.42 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.44 -174.244 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.434 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -74.97 155.99 36.79 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 -179.677 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.493 ' HB3' ' NE ' ' A' ' 32' ' ' ARG . 26.6 p-10 -137.04 12.94 3.09 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.931 -177.32 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.59 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 23.3 p -169.1 133.79 1.49 Allowed 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 119.973 -0.691 . . . . 0.0 111.905 -177.525 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.823 HG12 ' HZ3' ' A' ' 30' ' ' TRP . 3.6 p -116.14 137.16 50.75 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.122 176.744 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 42.8 m -95.84 101.16 12.82 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 168.56 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.666 HD11 HG12 ' A' ' 77' ' ' ILE . 0.2 OUTLIER -76.49 141.13 41.39 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.259 178.65 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.6 t -136.48 170.73 15.57 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -177.432 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 65.1 29.57 11.96 Favored 'General case' 0 C--N 1.327 -0.388 0 O-C-N 123.665 0.603 . . . . 0.0 111.549 -178.155 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.608 ' O ' HG22 ' A' ' 24' ' ' THR . 9.1 mt -78.73 -175.6 4.49 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 174.135 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -126.99 131.99 24.12 Favored Pre-proline 0 C--N 1.32 -0.702 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 177.876 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -64.49 133.65 38.08 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.87 2.38 . . . . 0.0 113.008 -178.214 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 74.92 34.37 53.0 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.947 -0.644 . . . . 0.0 111.649 179.758 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.546 HG11 ' HB2' ' A' ' 49' ' ' GLU . 70.1 t -134.62 139.79 46.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.209 0.528 . . . . 0.0 110.815 -177.042 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.617 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -81.05 121.13 25.69 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.047 -176.053 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -116.66 115.82 26.39 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -175.306 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.544 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 2.6 m-20 -85.55 111.47 20.05 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.547 -0.752 . . . . 0.0 109.752 174.345 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.666 HG12 HD11 ' A' ' 66' ' ' LEU . 5.1 mp -93.47 117.95 38.14 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.602 0 CA-C-O 121.164 0.507 . . . . 0.0 109.748 175.751 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.883 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 24.9 m -109.39 115.14 29.4 Favored 'General case' 0 N--CA 1.428 -1.573 0 CA-C-N 115.25 -0.887 . . . . 0.0 110.545 -179.693 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.546 ' HB ' ' HB ' ' A' ' 91' ' ' VAL . 12.4 mm -95.73 139.88 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 179.537 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.427 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 68.4 m-85 -128.46 112.39 14.32 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.624 -0.262 . . . . 0.0 110.343 179.085 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.401 ' HB1' HG21 ' A' ' 37' ' ' ILE . . . -79.42 109.32 13.67 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 170.874 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.59 HG12 ' C ' ' A' ' 39' ' ' GLY . 11.1 p -99.39 140.77 18.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.756 -173.927 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -122.93 165.2 17.1 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 -178.412 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -47.16 -47.87 23.7 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -176.716 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -130.1 17.63 5.56 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.37 -176.899 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 66.9 mm-40 -142.31 169.58 17.32 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.871 0.367 . . . . 0.0 111.328 -179.023 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -146.72 120.34 9.16 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.088 177.943 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 21.7 m -65.1 157.81 27.56 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.782 179.742 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 21.1 p -55.16 150.12 22.64 Favored Pre-proline 0 N--CA 1.453 -0.294 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.312 176.635 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -77.61 140.28 18.75 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 121.755 1.637 . . . . 0.0 113.548 -173.68 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.883 ' O ' ' HA ' ' A' ' 78' ' ' THR . 4.6 t -81.53 123.42 37.87 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.832 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 167.348 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 4.8 t -119.75 105.38 17.18 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 C-N-CA 119.53 -0.868 . . . . 0.0 109.857 172.452 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.569 HG13 ' HB ' ' A' ' 77' ' ' ILE . 6.4 pt -120.73 111.11 30.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.354 175.897 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.41 ' CD ' ' H ' ' A' ' 94' ' ' GLN . 4.5 pm0 -97.22 114.88 26.66 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.806 0.812 . . . . 0.0 110.76 -175.819 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -124.79 129.39 50.36 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.937 -1.028 . . . . 0.0 109.398 179.44 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.411 ' HA ' ' HA ' ' A' ' 74' ' ' GLN . 36.2 tt0 -89.42 137.82 31.99 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.146 0.498 . . . . 0.0 110.433 179.148 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 41.7 p -71.46 121.61 18.93 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.928 -178.128 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.9 m -69.43 -30.87 68.9 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.344 0.592 . . . . 0.0 110.15 179.937 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.402 ' HA2' ' HB3' ' A' ' 23' ' ' ASP . . . 82.59 -114.47 3.84 Favored Glycine 0 N--CA 1.443 -0.898 0 CA-C-N 115.187 -0.915 . . . . 0.0 112.237 177.776 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 4.1 m -98.02 146.52 31.64 Favored Pre-proline 0 C--N 1.316 -0.849 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 177.459 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_exo -64.59 55.65 0.24 Allowed 'Trans proline' 0 C--N 1.356 0.95 0 C-N-CA 123.205 2.603 . . . . 0.0 112.786 176.566 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 17.0 ptp180 -169.8 42.25 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 179.385 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 8.9 m -59.73 -35.35 74.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.108 -174.686 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -104.55 23.74 12.82 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.096 0.474 . . . . 0.0 110.268 177.118 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -82.75 68.05 3.62 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.092 -179.731 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 3.5 t . . . . . 0 C--O 1.245 0.865 0 CA-C-O 119.382 -0.342 . . . . 0.0 110.29 179.362 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.643 0 N-CA-C 111.686 -0.566 . . . . 0.0 111.686 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.1 m -82.84 -19.39 37.67 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.801 0.334 . . . . 0.0 111.395 -177.132 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 49.1 m80 -101.79 -60.51 1.52 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.152 179.577 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 23.7 mmt -78.74 92.24 4.78 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.122 0.487 . . . . 0.0 111.071 -177.009 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.445 ' HA2' ' CB ' ' A' ' 9' ' ' ALA . . . -83.25 61.19 4.81 Favored Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.807 177.068 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 12.8 p -61.48 106.22 0.62 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.634 0.254 . . . . 0.0 110.842 -179.765 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 62.1 p 49.25 52.16 14.95 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.793 -175.41 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 19.4 m 75.99 123.54 0.04 OUTLIER 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.217 -178.186 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.445 ' CB ' ' HA2' ' A' ' 5' ' ' GLY . . . -129.78 94.72 31.01 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.2 175.988 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.603 ' HG3' ' OE1' ' A' ' 83' ' ' GLU . 98.3 Cg_endo -75.97 -178.33 4.28 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 122.981 2.454 . . . . 0.0 112.109 -179.265 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -130.51 154.44 47.78 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.128 -178.203 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -91.11 158.24 41.75 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.76 176.229 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -63.27 130.59 29.13 Favored 'Trans proline' 0 C--O 1.235 0.346 0 C-N-CA 122.324 2.016 . . . . 0.0 111.96 177.537 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.506 ' HD2' ' O ' ' A' ' 31' ' ' SER . 72.7 Cg_exo -49.54 146.07 15.5 Favored 'Trans proline' 0 C--O 1.237 0.426 0 C-N-CA 122.891 2.394 . . . . 0.0 111.091 172.856 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.429 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 9.4 p-10 -35.76 106.66 0.32 Allowed Pre-proline 0 N--CA 1.466 0.366 0 O-C-N 124.837 1.336 . . . . 0.0 112.541 -169.276 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.65 ' HG2' HG11 ' A' ' 91' ' ' VAL . 34.6 Cg_exo -67.03 150.94 82.64 Favored 'Trans proline' 0 CA--C 1.517 -0.359 0 C-N-CA 123.368 2.712 . . . . 0.0 112.039 179.08 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.2 m -110.35 131.09 55.36 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.804 -178.387 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.465 HG11 HG22 ' A' ' 21' ' ' VAL . 76.0 t -75.67 119.87 24.38 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-N 114.446 -1.252 . . . . 0.0 109.653 173.756 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -86.97 -40.5 14.72 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.324 -174.809 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -136.03 138.5 42.26 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.995 0.426 . . . . 0.0 110.726 -179.776 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.465 HG22 HG11 ' A' ' 18' ' ' VAL . 17.0 t -125.98 125.16 67.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.005 179.825 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -130.58 -157.27 0.81 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.509 0.195 . . . . 0.0 110.475 -179.249 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.439 ' OD1' ' N ' ' A' ' 24' ' ' THR . 1.9 p30 -73.79 -69.43 0.44 Allowed 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 178.411 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.5 HG22 ' O ' ' A' ' 69' ' ' LEU . 67.7 p -114.39 37.12 3.48 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.483 0.659 . . . . 0.0 109.944 -174.335 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.652 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 55.1 m -167.97 131.49 1.64 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.807 -171.295 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.61 ' HB ' HD12 ' A' ' 66' ' ' LEU . 48.8 mt -149.86 140.8 16.81 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.905 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.522 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 36.5 t -116.52 132.12 67.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 119.135 0.879 . . . . 0.0 110.534 -173.822 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.572 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.7 OUTLIER -126.97 145.59 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.23 -178.996 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.505 ' HG2' ' HB3' ' A' ' 63' ' ' SER . 16.9 mtp180 -128.15 121.5 29.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.524 -175.685 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.834 ' HZ3' HG12 ' A' ' 64' ' ' VAL . 38.7 p90 -114.41 148.56 37.53 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.355 -175.65 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.506 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 32.2 t -93.74 97.64 10.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.935 178.136 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.569 ' H ' ' CD ' ' A' ' 32' ' ' ARG . 0.8 OUTLIER -51.43 155.78 2.4 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.376 -0.829 . . . . 0.0 113.007 -175.497 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.676 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 1.5 Cg_endo -85.38 161.99 11.16 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 124.564 3.509 . . . . 0.0 112.656 -172.671 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -74.71 -18.76 60.46 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.6 173.102 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -59.43 138.69 89.04 Favored Pre-proline 0 CA--C 1.518 -0.276 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.041 175.867 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -69.62 113.86 3.49 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 121.008 1.139 . . . . 0.0 109.666 170.814 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.567 HD12 ' HE1' ' A' ' 40' ' ' TYR . 0.7 OUTLIER -118.63 155.11 20.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -176.222 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.466 ' C ' ' HB3' ' A' ' 59' ' ' GLU . 17.2 p -100.96 -26.02 13.87 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -176.921 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.53 ' C ' HG12 ' A' ' 82' ' ' VAL . . . -168.83 -168.59 31.11 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.33 -0.938 . . . . 0.0 111.675 179.432 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.676 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 5.6 m-85 -137.17 132.57 34.14 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 117.105 0.453 . . . . 0.0 111.378 173.359 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 10.0 mmm180 -99.28 148.68 23.89 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 167.807 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.869 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 31.6 mt -139.21 108.32 3.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 C-N-CA 120.065 -0.654 . . . . 0.0 112.043 178.848 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 75.2 t -110.03 110.42 32.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.325 0.584 . . . . 0.0 110.205 179.864 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.71 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 0.4 OUTLIER -111.87 124.47 52.43 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.377 176.338 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.422 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 23.1 t -139.4 135.74 17.31 Favored Pre-proline 0 C--N 1.314 -0.95 0 CA-C-N 113.692 -1.594 . . . . 0.0 110.383 -173.504 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.658 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 50.0 Cg_exo -55.61 148.26 55.0 Favored 'Trans proline' 0 C--O 1.234 0.277 0 C-N-CA 123.362 2.708 . . . . 0.0 112.491 174.22 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 31.4 t -61.8 -42.03 98.49 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.412 -176.75 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.9 m -114.73 -39.24 2.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -178.531 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -176.52 145.36 0.56 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.666 0.269 . . . . 0.0 110.994 -176.948 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.51 ' CA ' ' HG2' ' A' ' 46' ' ' PRO . . . 154.45 -151.68 23.33 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 121.168 -0.539 . . . . 0.0 111.953 176.828 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 39.5 t -92.3 121.87 34.22 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.576 0.188 . . . . 0.0 110.657 -177.745 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 9.6 m -112.07 144.63 41.11 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 178.447 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.71 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 23.3 m -145.61 148.7 33.4 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.876 -0.33 . . . . 0.0 111.5 -175.78 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.869 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 56.2 tt0 -119.16 118.36 31.14 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.235 173.301 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.698 HD12 ' CG2' ' A' ' 64' ' ' VAL . 19.4 mt -100.0 155.84 17.48 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 173.664 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -118.95 113.34 20.86 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 176.91 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.544 HD12 ' CH2' ' A' ' 30' ' ' TRP . 2.1 mt -108.51 156.25 39.03 Favored Pre-proline 0 C--N 1.317 -0.836 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 -177.32 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -54.77 147.07 52.2 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 121.824 1.683 . . . . 0.0 111.29 171.832 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.477 ' HB2' HG13 ' A' ' 37' ' ' ILE . 8.9 pt-20 -48.54 -27.38 2.7 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.959 173.153 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.4 t -96.69 -1.7 46.06 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.334 -175.572 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.454 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -71.41 152.29 43.26 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 -176.619 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.412 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 3.9 p-10 -132.32 11.32 4.54 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -176.21 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.572 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 53.4 p -169.3 133.67 1.41 Allowed 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 119.993 -0.683 . . . . 0.0 111.877 -177.171 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.834 HG12 ' HZ3' ' A' ' 30' ' ' TRP . 3.7 p -114.61 136.37 51.46 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.148 176.034 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 83.1 m -96.14 100.0 11.68 Favored 'General case' 0 N--CA 1.429 -1.514 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 168.669 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.728 HD11 HG12 ' A' ' 77' ' ' ILE . 0.6 OUTLIER -74.13 144.19 45.01 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.143 178.922 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 8.6 t -144.56 166.16 25.95 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 -174.325 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 64.03 32.95 12.57 Favored 'General case' 0 C--N 1.327 -0.393 0 O-C-N 123.775 0.672 . . . . 0.0 110.936 -177.119 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.5 ' O ' HG22 ' A' ' 24' ' ' THR . 7.9 mt -78.42 -176.85 4.95 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 174.573 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -124.64 123.99 25.66 Favored Pre-proline 0 C--N 1.318 -0.793 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 176.812 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -60.53 135.91 63.93 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 122.778 2.319 . . . . 0.0 112.768 -179.328 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.2 33.91 31.09 Favored Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.683 -179.604 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.527 ' CG1' ' HB3' ' A' ' 46' ' ' PRO . 85.5 t -138.26 139.41 41.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 120.8 0.333 . . . . 0.0 110.82 -176.218 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.658 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 1.7 tm0? -82.39 127.53 33.35 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.025 179.348 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -116.67 114.12 23.6 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -173.378 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.465 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 27.3 m-80 -85.53 107.39 17.44 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.674 173.415 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.728 HG12 HD11 ' A' ' 66' ' ' LEU . 5.1 mp -91.01 117.07 33.51 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.733 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 176.644 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.895 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 26.1 m -109.15 114.77 28.77 Favored 'General case' 0 N--CA 1.424 -1.734 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.436 -179.146 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.549 ' HB ' ' HB ' ' A' ' 91' ' ' VAL . 13.5 mm -95.31 141.52 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -179.882 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -129.34 111.99 13.4 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.229 179.624 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.404 ' HB1' HG21 ' A' ' 37' ' ' ILE . . . -79.81 114.47 18.76 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 169.761 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.543 HG23 ' HG2' ' A' ' 87' ' ' GLU . 7.1 p -104.36 132.25 51.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 C-N-CA 120.048 -0.661 . . . . 0.0 109.565 -178.687 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.603 ' OE1' ' HG3' ' A' ' 10' ' ' PRO . 1.1 mp0 -113.6 171.33 7.64 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 123.178 0.299 . . . . 0.0 110.751 -177.655 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.418 ' H ' ' HG3' ' A' ' 84' ' ' GLU . 28.8 mt-10 -45.22 -40.92 7.84 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.505 -0.771 . . . . 0.0 112.754 -176.107 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -112.42 -20.47 11.78 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -172.353 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.592 ' HB2' ' OE1' ' A' ' 83' ' ' GLU . 69.5 mt-30 -142.63 178.47 7.6 Favored 'General case' 0 C--N 1.328 -0.329 0 O-C-N 122.091 -0.381 . . . . 0.0 111.523 -170.095 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.543 ' HG2' HG23 ' A' ' 82' ' ' VAL . 50.4 mt-10 -123.17 120.35 32.93 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.449 -0.796 . . . . 0.0 108.976 171.09 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 50.9 m -70.0 178.03 2.9 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -172.625 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -59.31 152.83 51.41 Favored Pre-proline 0 N--CA 1.451 -0.413 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.539 179.028 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -87.0 138.47 4.97 Favored 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 122.53 2.153 . . . . 0.0 114.269 -177.42 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.895 ' O ' ' HA ' ' A' ' 78' ' ' THR . 7.1 t -82.28 125.78 39.88 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.746 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 165.929 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 4.5 t -122.16 107.08 18.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 C-N-CA 119.83 -0.748 . . . . 0.0 110.121 173.276 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.542 HG13 ' HB ' ' A' ' 77' ' ' ILE . 6.5 pt -124.96 114.94 42.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.878 177.449 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.558 ' HB2' ' OE1' ' A' ' 74' ' ' GLN . 11.3 pt20 -100.92 120.78 40.66 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.553 0.692 . . . . 0.0 111.598 -175.077 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -134.23 132.25 39.48 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.546 178.103 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.51 ' HB2' ' HG2' ' A' ' 74' ' ' GLN . 35.8 tt0 -87.0 142.3 28.04 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.016 0.436 . . . . 0.0 110.259 179.898 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 31.6 p -68.39 134.49 50.3 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.297 -178.102 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 11.8 m -70.49 -29.25 65.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.665 -177.893 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.407 ' HA3' ' HA ' ' A' ' 23' ' ' ASP . . . -47.68 128.7 15.39 Favored Glycine 0 N--CA 1.452 -0.285 0 CA-C-N 115.156 -0.929 . . . . 0.0 113.812 -179.423 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 84.9 m -89.82 122.17 68.24 Favored Pre-proline 0 C--N 1.32 -0.696 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 172.819 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -54.67 110.4 0.52 Allowed 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.802 2.335 . . . . 0.0 111.883 179.381 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 44.0 ttp180 -149.73 108.93 3.93 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.913 -175.41 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 58.8 p -110.81 -173.03 2.15 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.753 175.433 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 65.94 57.25 0.81 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.184 0.516 . . . . 0.0 111.34 174.333 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -100.41 43.81 1.7 Allowed Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 175.134 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 23.8 p . . . . . 0 C--O 1.25 1.112 0 C-N-CA 123.542 0.737 . . . . 0.0 111.36 -175.203 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.066 0 N-CA-C 110.806 -0.072 . . . . 0.0 110.806 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -72.86 128.34 13.15 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.264 1.976 . . . . 0.0 111.476 174.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.568 ' HD2' ' O ' ' A' ' 31' ' ' SER . 89.2 Cg_exo -48.33 146.2 10.4 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.837 2.358 . . . . 0.0 111.933 174.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.456 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 9.1 p-10 -36.76 107.12 0.36 Allowed Pre-proline 0 N--CA 1.468 0.446 0 O-C-N 124.806 1.316 . . . . 0.0 112.74 -169.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.634 ' HG2' HG11 ' A' ' 91' ' ' VAL . 27.4 Cg_exo -66.86 152.3 80.71 Favored 'Trans proline' 0 C--O 1.233 0.273 0 C-N-CA 123.62 2.88 . . . . 0.0 112.643 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.8 m -107.05 130.62 54.63 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.987 -177.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.475 HG22 HG12 ' A' ' 28' ' ' VAL . 77.0 t -78.25 122.22 32.76 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-N 114.812 -1.085 . . . . 0.0 109.881 172.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -87.16 -42.08 13.27 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.918 -175.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -134.48 139.07 45.22 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.464 -175.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.447 ' HA ' HG12 ' A' ' 26' ' ' ILE . 61.2 t -130.88 123.78 54.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.472 178.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -133.59 -159.47 0.97 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.11 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 17.7 p-10 -76.37 -57.68 3.72 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.199 0.524 . . . . 0.0 111.262 -178.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.62 HG22 ' O ' ' A' ' 69' ' ' LEU . 33.8 p -119.43 32.81 5.91 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.516 -172.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.627 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 68.4 m -168.07 130.47 1.5 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.201 -173.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.626 ' HB ' HD12 ' A' ' 66' ' ' LEU . 33.1 mt -145.08 141.71 22.86 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.888 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 175.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 40.6 t -116.69 132.93 64.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 C-N-CA 119.71 -0.796 . . . . 0.0 110.17 -175.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.584 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.7 OUTLIER -127.76 147.35 32.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 C-N-CA 120.397 -0.521 . . . . 0.0 110.052 -179.126 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.44 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 20.9 mtp180 -133.29 120.77 21.49 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.203 -174.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.814 ' HZ3' HG12 ' A' ' 64' ' ' VAL . 41.3 p90 -113.23 149.65 33.48 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.343 -173.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.568 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 20.5 m -98.25 98.14 9.44 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.097 178.168 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.645 ' CD ' ' H ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -45.82 156.26 0.45 Allowed Pre-proline 0 CA--C 1.539 0.54 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 -173.49 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.708 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 2.9 Cg_exo -78.57 170.64 17.99 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 124.844 3.696 . . . . 0.0 113.496 -170.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -76.8 -20.96 55.81 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.832 -1.076 . . . . 0.0 109.218 173.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -70.19 137.77 86.91 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.856 175.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.405 ' O ' ' HG2' ' A' ' 83' ' ' GLU . 6.7 Cg_exo -73.5 114.93 4.17 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 121.468 1.446 . . . . 0.0 109.51 167.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.563 HG21 ' HB1' ' A' ' 81' ' ' ALA . 0.2 OUTLIER -111.8 160.44 11.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -174.121 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.4 p -93.23 -32.21 14.45 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.497 ' C ' HG12 ' A' ' 82' ' ' VAL . . . -167.85 -164.56 23.74 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.11 -1.043 . . . . 0.0 111.614 179.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.708 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 6.2 m-85 -140.33 135.52 32.27 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-N 117.111 0.456 . . . . 0.0 111.416 176.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.435 ' C ' HG13 ' A' ' 42' ' ' ILE . 25.1 mtp180 -103.48 151.09 23.24 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 167.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.865 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 29.3 mt -139.54 107.86 3.22 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 C-N-CA 120.312 -0.555 . . . . 0.0 112.112 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 71.2 t -106.3 110.24 30.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.151 0.5 . . . . 0.0 110.704 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.583 ' HA ' ' O ' ' A' ' 76' ' ' ASN . 0.8 OUTLIER -113.28 125.47 54.33 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.661 176.26 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.412 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 26.1 p -139.13 143.88 38.53 Favored Pre-proline 0 C--N 1.317 -0.817 0 CA-C-N 114.007 -1.451 . . . . 0.0 111.792 -173.253 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.564 ' HB3' HG11 ' A' ' 73' ' ' VAL . 4.7 Cg_exo . . . . . 0 C--O 1.234 0.284 0 C-N-CA 123.082 2.522 . . . . 0.0 111.467 175.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 8.4 p . . . . . 0 CA--C 1.518 -0.257 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.565 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 71.2 m -147.71 148.62 31.19 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.248 -0.581 . . . . 0.0 112.006 -179.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.865 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 41.6 tt0 -114.67 115.41 27.07 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.7 172.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.676 HD12 ' CG2' ' A' ' 64' ' ' VAL . 16.7 mt -96.44 157.97 15.65 Favored 'General case' 0 CA--C 1.513 -0.475 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.038 175.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.438 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 25.0 t-20 -120.21 115.73 24.2 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 178.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.571 HD12 ' CH2' ' A' ' 30' ' ' TRP . 2.5 mt -113.4 156.02 43.83 Favored Pre-proline 0 N--CA 1.443 -0.781 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 -177.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -63.65 150.87 87.43 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 121.687 1.591 . . . . 0.0 111.3 175.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -45.41 -28.54 0.89 Allowed 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 114.738 -1.119 . . . . 0.0 112.972 178.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 10.2 t -104.39 11.21 34.89 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.223 0.535 . . . . 0.0 111.126 -174.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.486 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -75.51 159.92 30.76 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 178.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.572 ' HB3' ' NE ' ' A' ' 32' ' ' ARG . 4.6 p-10 -146.41 17.53 1.34 Allowed 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 120.724 -0.391 . . . . 0.0 112.045 -177.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.584 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 39.3 p -171.4 134.37 0.87 Allowed 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.529 -0.469 . . . . 0.0 111.729 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.814 HG12 ' HZ3' ' A' ' 30' ' ' TRP . 3.2 p -119.17 136.5 56.16 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 CA-C-N 116.358 -0.383 . . . . 0.0 109.992 174.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 63.0 m -95.67 100.47 12.19 Favored 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 168.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.726 HD11 HG12 ' A' ' 77' ' ' ILE . 0.3 OUTLIER -75.03 136.74 41.21 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.167 179.918 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 7.4 t -132.16 164.61 25.94 Favored 'General case' 0 C--N 1.316 -0.856 0 O-C-N 123.705 0.628 . . . . 0.0 109.458 -173.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 26.4 t0 58.71 50.72 8.47 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 123.81 0.694 . . . . 0.0 110.692 -177.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.62 ' O ' HG22 ' A' ' 24' ' ' THR . 11.9 mt -90.18 -176.24 4.79 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 172.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 57.6 tp60 -123.62 125.53 25.98 Favored Pre-proline 0 C--N 1.32 -0.691 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 174.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -62.01 140.77 86.32 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 123.05 2.5 . . . . 0.0 113.269 -178.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 75.57 29.6 59.46 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.918 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.564 HG11 ' HB3' ' A' ' 46' ' ' PRO . 61.0 t -131.42 148.09 32.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.276 0.56 . . . . 0.0 111.145 -176.041 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.554 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -82.81 127.79 33.79 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.412 179.18 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.432 ' CZ ' ' HG3' ' A' ' 46' ' ' PRO . 3.8 m-85 -122.37 116.07 23.39 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.401 0.62 . . . . 0.0 112.521 -176.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.583 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 0.8 OUTLIER -85.92 112.91 21.61 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.597 172.927 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.726 HG12 HD11 ' A' ' 66' ' ' LEU . 5.0 mp -95.79 115.9 36.11 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.597 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 172.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.879 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 21.9 m -108.88 113.6 26.66 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.26 -178.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.542 ' HB ' ' HB ' ' A' ' 91' ' ' VAL . 12.8 mm -95.04 138.41 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.412 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 82.8 m-85 -124.67 111.29 15.42 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.161 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.563 ' HB1' HG21 ' A' ' 37' ' ' ILE . . . -81.05 111.24 17.34 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 171.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.497 HG12 ' C ' ' A' ' 39' ' ' GLY . 7.1 p -104.5 136.72 36.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 C-N-CA 120.021 -0.672 . . . . 0.0 110.717 -175.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.405 ' HG2' ' O ' ' A' ' 36' ' ' PRO . 4.3 tm-20 -121.39 163.28 18.95 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -47.74 -46.59 30.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 118.341 0.519 . . . . 0.0 111.426 -178.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 -89.97 -34.6 15.95 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -170.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -150.77 171.84 16.54 Favored 'General case' 0 C--O 1.222 -0.347 0 C-N-CA 120.619 -0.432 . . . . 0.0 111.528 -168.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -114.57 129.06 56.63 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.321 175.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 17.1 m -66.95 169.33 8.39 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.075 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.5 p -57.76 151.13 43.92 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-O 120.968 0.413 . . . . 0.0 110.784 176.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -84.14 141.6 9.36 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 122.159 1.906 . . . . 0.0 113.989 -174.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.879 ' O ' ' HA ' ' A' ' 78' ' ' THR . 12.5 t -81.93 121.83 35.82 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.717 0 CA-C-N 114.855 -1.066 . . . . 0.0 108.196 168.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 5.9 t -117.87 105.72 18.48 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 C-N-CA 119.552 -0.859 . . . . 0.0 109.897 172.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.588 HG13 ' HB ' ' A' ' 77' ' ' ILE . 8.0 pt -123.26 115.48 45.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.379 176.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.515 ' HB2' ' OE1' ' A' ' 74' ' ' GLN . 5.1 pt20 -103.31 126.46 50.49 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.351 0.596 . . . . 0.0 111.103 -174.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -128.94 134.46 48.22 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.088 177.115 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.5 ' HG2' ' HG2' ' A' ' 74' ' ' GLN . 45.1 mt-10 -86.59 133.12 33.74 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 175.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 37.9 p -72.75 113.85 10.24 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.161 0.505 . . . . 0.0 110.724 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 14.3 m . . . . . 0 C--N 1.326 -0.436 0 CA-C-O 121.421 0.629 . . . . 0.0 110.223 -177.776 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.538 ' HB2' ' O ' ' A' ' 89' ' ' THR . . . . . . . . 0 N--CA 1.451 -0.386 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -56.88 129.03 32.4 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.347 2.031 . . . . 0.0 112.079 174.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.449 ' HD2' ' O ' ' A' ' 31' ' ' SER . 85.5 Cg_exo -46.43 146.82 4.64 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.702 2.268 . . . . 0.0 111.422 171.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -36.79 106.17 0.32 Allowed Pre-proline 0 N--CA 1.472 0.628 0 O-C-N 124.654 1.221 . . . . 0.0 112.694 -168.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.634 ' HG2' HG11 ' A' ' 91' ' ' VAL . 37.9 Cg_exo -65.34 150.58 87.03 Favored 'Trans proline' 0 CA--C 1.52 -0.204 0 C-N-CA 123.501 2.8 . . . . 0.0 112.33 178.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 20.2 m -107.0 130.49 54.63 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.037 -176.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.488 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 82.1 t -83.33 121.37 36.09 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-N 114.435 -1.257 . . . . 0.0 109.908 174.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.532 ' OD1' ' HG3' ' A' ' 20' ' ' GLN . 13.5 t70 -80.96 -48.13 12.71 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.108 -174.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.532 ' HG3' ' OD1' ' A' ' 19' ' ' ASP . 27.5 mt-30 -136.07 140.73 44.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.694 -177.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.525 ' HA ' HG12 ' A' ' 26' ' ' ILE . 6.4 m -126.0 101.33 8.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.159 178.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.406 ' HB3' ' H ' ' A' ' 23' ' ' ASP . 12.3 m-20 -97.65 -160.12 0.78 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.151 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.406 ' H ' ' HB3' ' A' ' 22' ' ' ASP . 11.5 p-10 -78.86 -52.66 8.0 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.253 0.549 . . . . 0.0 110.622 177.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.747 HG22 ' O ' ' A' ' 69' ' ' LEU . 26.6 p -121.81 34.6 5.13 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.984 -172.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.651 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 66.1 m -169.19 130.43 1.14 Allowed 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.424 -172.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.578 ' HB ' HD12 ' A' ' 66' ' ' LEU . 20.5 mt -144.83 137.39 21.73 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.786 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 177.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 41.1 t -115.67 128.67 72.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 C-N-CA 119.632 -0.827 . . . . 0.0 110.438 -175.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.65 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.7 OUTLIER -125.12 144.65 34.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 C-N-CA 120.546 -0.461 . . . . 0.0 109.916 -177.55 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.531 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 23.0 mtm180 -129.88 121.0 25.82 Favored 'General case' 0 C--N 1.327 -0.393 0 O-C-N 123.239 0.337 . . . . 0.0 110.573 -176.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.734 ' HZ3' HG12 ' A' ' 64' ' ' VAL . 33.8 p90 -107.88 144.58 34.91 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.176 -173.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.449 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 16.1 m -85.64 89.85 7.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.493 178.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.705 ' HD3' ' H ' ' A' ' 32' ' ' ARG . 0.4 OUTLIER -46.07 152.35 0.8 Allowed Pre-proline 0 CA--C 1.538 0.486 0 C-N-CA 124.189 0.996 . . . . 0.0 113.014 -175.549 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.687 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 2.2 Cg_endo -86.03 166.42 9.78 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 124.273 3.315 . . . . 0.0 113.318 -169.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -76.27 -20.86 56.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.319 172.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.32 136.24 91.56 Favored Pre-proline 0 N--CA 1.453 -0.311 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.754 175.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -70.21 113.19 3.37 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 121.072 1.181 . . . . 0.0 109.593 170.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.505 HG22 ' HG2' ' A' ' 83' ' ' GLU . 24.9 pt -117.9 153.42 19.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.797 -174.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.448 ' C ' ' HB3' ' A' ' 59' ' ' GLU . 9.1 p -94.88 -24.4 17.02 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.547 ' C ' HG12 ' A' ' 82' ' ' VAL . . . -174.8 -161.67 24.97 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 119.732 -1.223 . . . . 0.0 113.304 -179.063 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.687 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 41.8 m-85 -139.54 131.49 27.76 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 122.364 0.266 . . . . 0.0 111.25 174.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.408 ' HB2' ' CD1' ' A' ' 80' ' ' TYR . 14.3 mmm-85 -96.21 148.76 22.38 Favored 'General case' 0 CA--C 1.504 -0.812 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 165.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.876 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 28.4 mt -139.0 107.84 3.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 C-N-CA 119.74 -0.784 . . . . 0.0 112.439 -179.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 71.9 t -109.04 109.93 30.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.396 0.617 . . . . 0.0 110.719 179.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.697 ' CZ ' ' HB ' ' A' ' 53' ' ' THR . 0.6 OUTLIER -112.77 125.57 54.48 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.322 176.747 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.4 m -139.97 141.16 26.17 Favored Pre-proline 0 C--N 1.317 -0.842 0 CA-C-N 114.282 -1.326 . . . . 0.0 111.429 -173.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.684 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 59.9 Cg_endo . . . . . 0 C--O 1.232 0.191 0 C-N-CA 123.66 2.907 . . . . 0.0 112.01 177.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.505 ' HA ' ' O ' ' A' ' 44' ' ' TYR . 15.1 m . . . . . 0 CA--C 1.516 -0.333 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.697 ' HB ' ' CZ ' ' A' ' 44' ' ' TYR . 23.6 m -147.27 153.29 39.58 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 120.61 -0.436 . . . . 0.0 111.13 -179.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.876 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 30.8 tt0 -122.35 112.4 18.06 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 123.025 0.53 . . . . 0.0 109.673 175.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.682 HD12 ' CG2' ' A' ' 64' ' ' VAL . 15.8 mt -97.8 159.97 14.6 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.584 177.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -123.95 114.56 19.95 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.076 179.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.588 HD12 ' CH2' ' A' ' 30' ' ' TRP . 3.8 mt -113.69 154.65 45.68 Favored Pre-proline 0 C--N 1.318 -0.778 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -176.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -61.34 150.56 84.33 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 121.987 1.792 . . . . 0.0 111.18 176.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.448 ' HB3' ' C ' ' A' ' 38' ' ' THR . 11.4 pt-20 -46.26 -30.0 1.84 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.032 -0.985 . . . . 0.0 112.499 176.203 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 7.4 t -99.89 17.37 21.02 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.045 -175.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.476 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -88.48 151.46 22.53 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.531 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 24.6 p-10 -136.58 13.95 3.19 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.871 -177.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.65 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 71.6 p -167.51 134.39 2.25 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.336 -0.546 . . . . 0.0 111.678 -177.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.734 HG12 ' HZ3' ' A' ' 30' ' ' TRP . 4.2 p -115.06 138.72 44.44 Favored 'Isoleucine or valine' 0 C--O 1.243 0.727 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.226 175.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 55.5 m -97.7 100.88 12.28 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.58 169.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.721 HD11 HG12 ' A' ' 77' ' ' ILE . 0.7 OUTLIER -76.46 144.46 39.88 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.2 177.415 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.1 p -141.85 164.74 29.38 Favored 'General case' 0 C--N 1.32 -0.675 0 O-C-N 123.501 0.501 . . . . 0.0 110.955 -172.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 28.8 t70 65.86 26.54 11.12 Favored 'General case' 0 N--CA 1.465 0.294 0 O-C-N 123.923 0.765 . . . . 0.0 110.824 -178.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.747 ' O ' HG22 ' A' ' 24' ' ' THR . 14.9 mt -70.65 -175.01 0.97 Allowed 'General case' 0 C--O 1.222 -0.349 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.948 176.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.456 ' HB2' HG21 ' A' ' 73' ' ' VAL . 16.8 mm-40 -129.27 133.28 24.97 Favored Pre-proline 0 C--N 1.319 -0.719 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 176.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -64.57 128.1 20.43 Favored 'Trans proline' 0 C--O 1.234 0.276 0 C-N-CA 122.921 2.414 . . . . 0.0 112.755 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 90.8 14.95 57.36 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.321 178.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.456 HG21 ' HB2' ' A' ' 70' ' ' GLN . 72.0 t -114.78 141.09 32.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.219 0.533 . . . . 0.0 111.602 -175.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.684 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -80.49 122.26 26.79 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.626 179.238 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.466 ' CE2' ' HB3' ' A' ' 69' ' ' LEU . 23.8 m-85 -118.17 113.71 21.96 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.377 0.608 . . . . 0.0 112.377 -176.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.552 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 20.5 m-80 -87.28 108.26 18.87 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.681 175.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.721 HG12 HD11 ' A' ' 66' ' ' LEU . 5.4 mp -92.55 115.29 31.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.298 0.571 . . . . 0.0 109.883 176.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.858 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 51.9 m -107.64 115.89 30.95 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.019 179.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.624 ' HB ' ' HB ' ' A' ' 91' ' ' VAL . 19.1 mm -95.91 143.04 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 -178.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.473 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 47.2 m-85 -128.35 111.83 13.77 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 178.091 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.489 ' HB1' HG21 ' A' ' 37' ' ' ILE . . . -79.82 107.96 13.0 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 173.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.547 HG12 ' C ' ' A' ' 39' ' ' GLY . 9.5 p -99.4 135.62 33.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 C-N-CA 120.132 -0.627 . . . . 0.0 110.678 -175.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.505 ' HG2' HG22 ' A' ' 37' ' ' ILE . 4.5 mt-10 -111.06 171.07 7.69 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 175.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -44.64 -47.09 10.47 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 123.797 0.686 . . . . 0.0 112.378 -178.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -106.14 -21.06 13.22 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -169.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -149.61 176.93 10.21 Favored 'General case' 0 C--O 1.219 -0.515 0 CA-C-N 118.696 0.68 . . . . 0.0 111.813 -174.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -117.6 134.36 54.97 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 177.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 10.7 m -73.84 -179.98 3.96 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.832 0.348 . . . . 0.0 111.223 -176.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.538 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 0.8 OUTLIER -61.74 159.43 34.7 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.587 176.176 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -88.78 140.96 4.35 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 122.418 2.079 . . . . 0.0 114.361 -177.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.858 ' O ' ' HA ' ' A' ' 78' ' ' THR . 5.6 t -83.08 128.67 38.5 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.7 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 164.15 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 4.1 t -123.22 106.87 18.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 C-N-CA 119.987 -0.685 . . . . 0.0 110.113 171.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.539 HG13 ' HB ' ' A' ' 77' ' ' ILE . 6.7 pt -126.77 111.48 26.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.895 177.124 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.401 ' HB2' HE22 ' A' ' 74' ' ' GLN . 17.9 pt20 -102.6 120.51 40.67 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.673 0.749 . . . . 0.0 111.524 -175.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.429 ' NE2' HG11 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -128.1 135.9 50.44 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.2 -179.1 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -87.04 146.46 26.09 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 176.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 20.7 p -81.38 120.08 24.51 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.104 178.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 85.7 m . . . . . 0 C--N 1.327 -0.388 0 CA-C-O 121.501 0.667 . . . . 0.0 110.58 178.691 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.287 0 N-CA-C 110.509 -0.182 . . . . 0.0 110.509 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -70.58 132.67 22.48 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.479 2.119 . . . . 0.0 111.45 174.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -53.81 159.52 6.92 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.687 2.258 . . . . 0.0 111.314 172.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -39.27 106.24 0.39 Allowed Pre-proline 0 N--CA 1.469 0.491 0 O-C-N 124.313 1.008 . . . . 0.0 111.918 -173.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.556 ' HG2' HG11 ' A' ' 91' ' ' VAL . 38.2 Cg_exo -65.22 144.82 82.45 Favored 'Trans proline' 0 CA--C 1.517 -0.339 0 C-N-CA 122.999 2.466 . . . . 0.0 111.925 178.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 39.6 m -97.91 124.72 42.47 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.665 -177.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.452 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 85.2 t -78.46 118.37 25.52 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-N 114.479 -1.237 . . . . 0.0 109.17 172.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -89.69 -37.13 14.81 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.283 -174.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -134.59 129.66 35.31 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.941 0.401 . . . . 0.0 110.66 -176.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.439 ' HA ' HG12 ' A' ' 26' ' ' ILE . 85.7 t -126.39 120.52 56.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.724 -178.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -125.41 -167.77 1.74 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.813 176.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.521 ' O ' ' HB2' ' A' ' 69' ' ' LEU . 4.1 p-10 -67.28 -59.16 3.65 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.173 0.511 . . . . 0.0 111.331 176.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.688 HG22 ' O ' ' A' ' 69' ' ' LEU . 36.0 p -117.32 36.83 4.08 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.991 -173.019 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.666 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 66.1 m -168.65 130.28 1.29 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.059 -176.229 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.618 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 34.1 mt -148.14 136.63 15.1 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.539 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 176.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.452 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 41.3 t -116.79 127.84 74.31 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.602 0 C-N-CA 120.054 -0.658 . . . . 0.0 110.693 -174.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.626 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.8 OUTLIER -122.52 143.5 35.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -176.97 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.477 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 63.8 mtp180 -130.14 121.01 25.49 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.912 0.387 . . . . 0.0 110.568 -175.349 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.707 ' HZ3' HG12 ' A' ' 64' ' ' VAL . 34.9 p90 -110.69 141.49 43.89 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.504 -173.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 17.6 m -83.63 86.61 7.09 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.02 -0.537 . . . . 0.0 109.725 175.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.442 ' CD ' ' HB3' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -48.28 156.83 0.74 Allowed Pre-proline 0 CA--C 1.541 0.598 0 CA-C-N 114.87 -1.059 . . . . 0.0 113.267 -176.184 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.674 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 3.1 Cg_exo -81.03 169.85 15.8 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 124.341 3.361 . . . . 0.0 113.538 -171.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -91.35 -7.33 51.21 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.662 176.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -69.37 144.08 94.2 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.204 175.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -70.64 113.24 3.45 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 121.071 1.18 . . . . 0.0 109.766 171.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.913 HG22 ' HG3' ' A' ' 83' ' ' GLU . 3.5 pt -119.91 157.56 22.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.403 -173.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.485 HG21 ' HA ' ' A' ' 84' ' ' GLU . 16.6 p -101.29 -22.85 14.51 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -176.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.578 ' C ' HG12 ' A' ' 82' ' ' VAL . . . -177.01 -165.43 32.38 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 119.6 -1.286 . . . . 0.0 112.371 179.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.674 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 6.3 m-85 -139.24 134.38 32.6 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.773 0.32 . . . . 0.0 110.875 173.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.7 mmm180 -100.97 148.07 25.44 Favored 'General case' 0 CA--C 1.501 -0.906 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 165.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.892 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 33.6 mt -138.25 109.53 5.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 C-N-CA 119.881 -0.728 . . . . 0.0 112.319 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 69.9 t -110.77 110.12 31.02 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.525 0 CA-C-O 121.391 0.615 . . . . 0.0 110.695 -179.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.712 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 0.8 OUTLIER -112.46 124.49 52.62 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.428 177.06 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.455 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 17.8 p -139.08 137.17 18.92 Favored Pre-proline 0 C--N 1.314 -0.975 0 CA-C-N 114.135 -1.393 . . . . 0.0 111.525 -173.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.56 ' HG3' ' CZ ' ' A' ' 75' ' ' TYR . 8.0 Cg_exo . . . . . 0 N--CA 1.462 -0.372 0 C-N-CA 122.978 2.452 . . . . 0.0 110.821 174.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.7 p . . . . . 0 CA--C 1.519 -0.239 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.712 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 29.1 m -146.0 150.23 35.63 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.655 -173.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.892 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 56.6 tt0 -114.93 118.35 33.23 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.935 173.238 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.73 HD12 ' CG2' ' A' ' 64' ' ' VAL . 21.9 mt -100.23 148.34 24.74 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.54 -0.464 . . . . 0.0 109.902 173.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -109.86 114.14 27.46 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 176.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.563 HD12 ' CH2' ' A' ' 30' ' ' TRP . 1.7 mt -109.96 152.51 43.07 Favored Pre-proline 0 N--CA 1.444 -0.766 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 -177.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -60.9 149.2 89.74 Favored 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 121.952 1.768 . . . . 0.0 111.389 176.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.476 ' HB3' ' C ' ' A' ' 38' ' ' THR . 9.6 pt-20 -46.92 -22.78 0.36 Allowed 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 114.848 -1.069 . . . . 0.0 113.019 176.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.2 t -107.3 15.84 24.6 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.135 -176.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.48 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -82.17 164.3 21.36 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.504 -0.317 . . . . 0.0 110.423 -179.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.477 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 4.6 p-10 -149.19 11.27 0.8 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -177.102 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.626 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 21.9 p -168.7 134.11 1.69 Allowed 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.346 -0.542 . . . . 0.0 111.996 -178.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.73 ' CG2' HD12 ' A' ' 55' ' ' LEU . 4.1 p -117.02 136.78 53.08 Favored 'Isoleucine or valine' 0 C--O 1.242 0.673 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.288 176.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 41.9 m -98.93 102.03 13.62 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-O 121.411 0.624 . . . . 0.0 109.795 170.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.667 HD11 HG12 ' A' ' 77' ' ' ILE . 0.2 OUTLIER -79.24 142.22 36.41 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.118 178.422 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.8 t -136.51 169.6 17.42 Favored 'General case' 0 C--N 1.32 -0.681 0 O-C-N 123.274 0.359 . . . . 0.0 110.559 -175.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 58.71 32.99 22.76 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.634 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.688 ' O ' HG22 ' A' ' 24' ' ' THR . 11.8 mt -71.88 -176.39 1.68 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.755 176.111 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -124.56 126.43 25.42 Favored Pre-proline 0 C--N 1.32 -0.714 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 175.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -63.58 132.44 35.48 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.183 2.589 . . . . 0.0 113.62 -176.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 87.92 21.58 45.85 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.311 177.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.495 HG11 ' HB3' ' A' ' 46' ' ' PRO . 18.7 t -125.53 148.2 30.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.328 0.585 . . . . 0.0 111.463 -176.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.48 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 15.0 tp60 -81.48 114.28 20.1 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.937 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.56 ' CZ ' ' HG3' ' A' ' 46' ' ' PRO . 6.1 m-85 -104.83 115.19 29.87 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.291 0.567 . . . . 0.0 112.02 -178.024 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.556 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 14.2 m120 -87.72 105.42 17.36 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.64 175.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.667 HG12 HD11 ' A' ' 66' ' ' LEU . 5.2 mp -91.44 117.27 34.36 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.575 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 175.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.88 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 90.4 m -109.2 115.39 29.92 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.779 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.555 ' HB ' ' HB ' ' A' ' 91' ' ' VAL . 12.4 mm -96.16 121.07 46.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.915 -179.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -108.12 111.11 22.97 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 176.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -80.15 123.61 28.05 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 169.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.578 HG12 ' C ' ' A' ' 39' ' ' GLY . 12.7 p -115.67 134.47 58.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 C-N-CA 120.053 -0.659 . . . . 0.0 110.889 -176.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.913 ' HG3' HG22 ' A' ' 37' ' ' ILE . 8.6 mp0 -112.48 171.61 7.42 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -177.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.485 ' HA ' HG21 ' A' ' 38' ' ' THR . 39.1 mt-10 -42.12 -44.93 3.83 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -174.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -125.66 -13.22 6.51 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.498 -0.481 . . . . 0.0 111.959 -176.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -128.39 173.73 9.94 Favored 'General case' 0 N--CA 1.443 -0.794 0 O-C-N 122.247 -0.283 . . . . 0.0 111.358 -171.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 20.4 mp0 -128.12 127.02 42.26 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.478 176.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 68.1 m -72.56 171.74 11.85 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.873 0.368 . . . . 0.0 111.797 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.2 p -60.61 150.24 75.75 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.327 177.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -85.17 141.2 8.02 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.421 2.08 . . . . 0.0 114.328 -175.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.88 ' O ' ' HA ' ' A' ' 78' ' ' THR . 7.0 t -82.65 129.39 37.53 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.641 0 CA-C-N 114.782 -1.099 . . . . 0.0 108.594 167.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 9.7 t -125.9 106.44 16.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 C-N-CA 120.196 -0.602 . . . . 0.0 110.057 171.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.552 HG13 ' HB ' ' A' ' 77' ' ' ILE . 5.8 pt -121.95 111.39 30.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.048 177.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.687 ' H ' ' NE2' ' A' ' 94' ' ' GLN . 0.7 OUTLIER -96.78 115.36 27.29 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.57 0.7 . . . . 0.0 111.184 -178.801 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.67 131.79 53.97 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.471 177.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -86.79 134.12 33.59 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.214 0.531 . . . . 0.0 110.135 179.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 24.1 p -66.08 120.86 13.92 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.437 178.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.6 m . . . . . 0 C--N 1.328 -0.335 0 CA-C-O 121.342 0.591 . . . . 0.0 110.247 -177.164 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 -0.179 0 CA-C-O 120.345 0.117 . . . . 0.0 110.882 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -71.27 129.65 16.32 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 122.35 2.033 . . . . 0.0 111.284 175.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.54 ' HD2' ' O ' ' A' ' 31' ' ' SER . 88.5 Cg_exo -49.31 151.44 6.61 Favored 'Trans proline' 0 C--O 1.234 0.316 0 C-N-CA 122.743 2.295 . . . . 0.0 111.936 173.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -36.63 106.61 0.34 Allowed Pre-proline 0 N--CA 1.469 0.51 0 O-C-N 124.728 1.268 . . . . 0.0 112.324 -171.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.666 ' HG2' HG11 ' A' ' 91' ' ' VAL . 28.1 Cg_exo -68.61 143.76 57.91 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 123.442 2.761 . . . . 0.0 113.046 179.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 94.6 m -96.62 127.7 42.86 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.199 -177.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.44 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 97.3 t -79.27 116.48 23.29 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-N 114.611 -1.177 . . . . 0.0 109.337 173.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -86.95 -37.02 17.97 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.085 -173.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -135.6 136.55 41.13 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.235 -176.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.467 ' HA ' HG12 ' A' ' 26' ' ' ILE . 42.0 t -133.52 115.44 22.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.109 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.401 ' HB3' ' H ' ' A' ' 23' ' ' ASP . 8.2 m-20 -132.41 -160.37 1.04 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.269 179.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.401 ' H ' ' HB3' ' A' ' 22' ' ' ASP . 6.3 p-10 -68.69 -66.59 0.55 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -177.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.609 HG22 ' O ' ' A' ' 69' ' ' LEU . 57.2 p -115.52 36.87 3.77 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.423 0.63 . . . . 0.0 110.582 -172.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.602 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 32.2 p -170.2 131.21 0.97 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.673 -174.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.586 ' HB ' HD12 ' A' ' 66' ' ' LEU . 42.4 mt -145.97 142.07 21.62 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.771 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 178.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 43.6 t -119.67 134.14 64.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 118.859 0.754 . . . . 0.0 110.338 -173.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.544 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.7 OUTLIER -129.11 148.55 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.524 -179.261 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.639 ' HG2' ' OG ' ' A' ' 63' ' ' SER . 29.7 mtm105 -131.36 120.3 22.92 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.554 -177.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.749 ' HZ3' HG12 ' A' ' 64' ' ' VAL . 37.8 p90 -111.14 143.81 41.28 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.832 -175.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.54 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 17.3 t -91.17 96.44 10.58 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 177.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.543 ' CD ' ' H ' ' A' ' 32' ' ' ARG . 1.0 OUTLIER -49.54 158.12 0.86 Allowed Pre-proline 0 C--N 1.327 -0.372 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -173.854 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.692 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 5.1 Cg_exo -79.94 165.56 21.83 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 124.197 3.265 . . . . 0.0 112.534 -173.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -78.92 -10.43 59.81 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.13 -0.941 . . . . 0.0 108.933 172.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -72.23 138.42 81.54 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 114.779 -1.1 . . . . 0.0 111.315 177.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo -66.31 115.05 3.29 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 121.492 1.461 . . . . 0.0 109.738 166.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.54 HD12 ' HE1' ' A' ' 40' ' ' TYR . 0.6 OUTLIER -119.55 154.71 22.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 -177.901 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.412 ' N ' ' O ' ' A' ' 82' ' ' VAL . 9.5 p -95.74 -23.79 16.81 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -178.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.574 ' C ' HG12 ' A' ' 82' ' ' VAL . . . -173.61 -163.02 26.49 Favored Glycine 0 CA--C 1.502 -0.778 0 C-N-CA 119.919 -1.134 . . . . 0.0 111.887 178.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.692 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 6.8 m-85 -141.2 133.8 28.58 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 122.525 0.33 . . . . 0.0 111.156 174.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.5 mmm180 -104.61 149.87 25.16 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 167.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.888 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 33.7 mt -138.88 107.93 3.77 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 C-N-CA 120.123 -0.631 . . . . 0.0 112.106 -178.138 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 66.1 t -107.09 110.13 30.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.422 0.63 . . . . 0.0 110.572 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.645 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 0.5 OUTLIER -110.74 124.62 52.33 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.096 175.517 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.412 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 14.5 t -142.39 139.2 17.28 Favored Pre-proline 0 C--N 1.316 -0.89 0 CA-C-N 113.86 -1.518 . . . . 0.0 110.666 -172.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.704 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 37.2 Cg_exo . . . . . 0 C--N 1.343 0.244 0 C-N-CA 123.374 2.716 . . . . 0.0 112.585 176.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 32.7 p . . . . . 0 CA--C 1.52 -0.193 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.645 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 24.6 m -147.87 152.87 38.34 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.756 -0.377 . . . . 0.0 111.374 -178.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.888 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 34.1 tt0 -116.87 118.36 32.26 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 171.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.7 HD12 ' CG2' ' A' ' 64' ' ' VAL . 20.5 mt -97.13 157.13 16.08 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 174.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -122.35 113.48 19.45 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.564 HD12 ' CH2' ' A' ' 30' ' ' TRP . 3.6 mt -112.0 155.58 43.13 Favored Pre-proline 0 N--CA 1.443 -0.782 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 -175.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -64.36 149.65 89.73 Favored 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 121.656 1.57 . . . . 0.0 110.945 174.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -46.56 -25.94 0.79 Allowed 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 114.722 -1.126 . . . . 0.0 113.123 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 7.9 t -101.55 5.72 41.88 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.915 0.388 . . . . 0.0 111.358 -175.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.455 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -75.95 155.99 34.59 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.433 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 4.9 p-10 -141.3 12.46 2.17 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 120.55 -0.46 . . . . 0.0 112.181 -175.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.639 ' OG ' ' HG2' ' A' ' 29' ' ' ARG . 9.4 m -161.94 135.88 6.6 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.981 -0.288 . . . . 0.0 110.834 -178.051 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.749 HG12 ' HZ3' ' A' ' 30' ' ' TRP . 4.2 p -121.26 135.12 62.45 Favored 'Isoleucine or valine' 0 C--O 1.24 0.605 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 172.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 55.2 m -97.67 100.91 12.31 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-O 121.528 0.68 . . . . 0.0 109.291 169.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.741 HD11 HG12 ' A' ' 77' ' ' ILE . 0.2 OUTLIER -77.52 141.38 39.65 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.22 -0.9 . . . . 0.0 108.958 179.824 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 22.5 t -141.42 169.63 17.25 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -174.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 34.1 t70 64.48 29.87 13.17 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 123.998 0.811 . . . . 0.0 110.307 -178.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.609 ' O ' HG22 ' A' ' 24' ' ' THR . 8.2 mt -75.42 -176.29 3.11 Favored 'General case' 0 N--CA 1.462 0.143 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 175.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -117.96 133.1 23.42 Favored Pre-proline 0 C--N 1.32 -0.689 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 174.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -64.55 128.71 21.85 Favored 'Trans proline' 0 C--O 1.233 0.269 0 C-N-CA 122.666 2.244 . . . . 0.0 112.392 177.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.63 37.52 19.81 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.04 179.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.526 ' CG1' ' HB3' ' A' ' 46' ' ' PRO . 71.5 t -134.82 138.35 49.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.121 0.486 . . . . 0.0 110.805 -178.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.704 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -75.7 121.28 22.27 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.564 -0.743 . . . . 0.0 109.549 -179.997 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.439 ' CE2' HD22 ' A' ' 69' ' ' LEU . 7.6 m-85 -113.92 114.62 26.47 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.308 0.575 . . . . 0.0 112.444 -176.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.482 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 12.2 m120 -88.28 109.21 19.78 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.321 172.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.741 HG12 HD11 ' A' ' 66' ' ' LEU . 4.9 mp -92.15 119.97 40.53 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.621 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 175.038 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.897 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 55.9 m -112.16 115.41 28.8 Favored 'General case' 0 N--CA 1.425 -1.687 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.613 -179.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.53 ' H ' ' HB ' ' A' ' 91' ' ' VAL . 12.6 mm -95.94 136.91 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -124.29 111.73 16.17 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.322 -0.399 . . . . 0.0 109.965 178.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.445 ' HB1' HG21 ' A' ' 37' ' ' ILE . . . -80.04 109.38 14.43 Favored 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 171.063 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.574 HG12 ' C ' ' A' ' 39' ' ' GLY . 10.4 p -100.13 139.73 20.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 C-N-CA 120.029 -0.668 . . . . 0.0 110.754 -174.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.632 ' HG2' ' H ' ' A' ' 84' ' ' GLU . 0.7 OUTLIER -117.56 167.56 11.2 Favored 'General case' 0 N--CA 1.447 -0.583 0 O-C-N 124.005 0.816 . . . . 0.0 108.935 179.265 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.632 ' H ' ' HG2' ' A' ' 83' ' ' GLU . 39.1 mt-10 -40.65 -52.51 2.9 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 28.5 m-80 -123.99 1.49 8.63 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.815 -174.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -134.98 172.02 13.6 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.332 -0.547 . . . . 0.0 111.596 -172.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -136.86 129.14 29.83 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.523 177.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 23.9 m -69.09 162.22 27.4 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.304 176.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.1 p -58.15 151.81 44.57 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.015 0.436 . . . . 0.0 110.265 174.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -82.39 140.6 10.9 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 121.978 1.786 . . . . 0.0 113.727 -173.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.897 ' O ' ' HA ' ' A' ' 78' ' ' THR . 10.7 t -82.27 123.72 38.52 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.728 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 167.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.4 t -121.82 106.71 18.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 C-N-CA 119.76 -0.776 . . . . 0.0 109.936 171.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.574 HG13 ' HB ' ' A' ' 77' ' ' ILE . 6.4 pt -120.47 115.7 47.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.612 177.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -103.83 123.0 46.3 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.467 0.651 . . . . 0.0 111.343 -174.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.34 135.25 42.6 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.711 177.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.49 ' HG3' ' HG2' ' A' ' 74' ' ' GLN . 1.6 mp0 -86.13 135.22 33.69 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.162 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 41.2 p -67.08 124.17 22.32 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.16 0.505 . . . . 0.0 110.303 178.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 14.2 m . . . . . 0 C--N 1.325 -0.491 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.142 -174.658 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.227 0 N-CA-C 110.343 -0.243 . . . . 0.0 110.343 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -71.82 130.11 16.4 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 122.446 2.097 . . . . 0.0 111.626 175.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.629 ' HD2' ' O ' ' A' ' 31' ' ' SER . 88.3 Cg_exo -48.54 154.83 2.57 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.963 2.442 . . . . 0.0 112.32 172.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.423 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 24.5 t70 -39.31 106.36 0.39 Allowed Pre-proline 0 N--CA 1.466 0.372 0 O-C-N 124.652 1.22 . . . . 0.0 112.621 -172.088 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.693 ' HG2' HG11 ' A' ' 91' ' ' VAL . 27.2 Cg_exo -68.92 149.25 72.0 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 123.444 2.763 . . . . 0.0 112.696 178.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.1 m -106.71 132.88 52.19 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.862 -177.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 81.9 t -85.14 121.56 37.16 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 114.63 -1.168 . . . . 0.0 109.78 174.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -94.28 -28.03 15.8 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.181 -174.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -135.79 126.51 27.3 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.406 -175.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.514 ' HA ' HG12 ' A' ' 26' ' ' ILE . 58.1 t -127.96 109.65 20.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.423 177.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.477 ' CG ' ' H ' ' A' ' 23' ' ' ASP . 13.7 t70 -118.68 -157.61 0.69 Allowed 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.477 ' H ' ' CG ' ' A' ' 22' ' ' ASP . 1.1 m-20 -84.23 -56.36 3.69 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.053 0.454 . . . . 0.0 110.286 -179.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.688 HG22 ' O ' ' A' ' 69' ' ' LEU . 22.8 p -114.43 34.5 4.69 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.669 -176.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.634 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 51.1 m -168.34 130.63 1.42 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.152 -172.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.585 ' HB ' HD12 ' A' ' 66' ' ' LEU . 45.3 mt -147.84 138.36 17.2 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.548 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 175.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 47.6 t -118.13 127.96 75.25 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.517 0 O-C-N 121.684 -0.635 . . . . 0.0 110.961 -174.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.602 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.6 OUTLIER -123.72 146.88 28.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.056 -176.61 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.498 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 28.7 mtm180 -133.35 121.88 23.0 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.313 -176.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.721 ' HZ3' HG12 ' A' ' 64' ' ' VAL . 39.4 p90 -111.37 145.13 39.43 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.52 -174.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.629 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 25.4 m -90.83 94.74 9.8 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.311 178.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.584 ' NE ' ' HB3' ' A' ' 62' ' ' ASN . 0.1 OUTLIER -49.0 156.61 0.9 Allowed Pre-proline 0 CA--C 1.537 0.458 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -173.837 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.618 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 5.0 Cg_exo -80.12 167.88 19.36 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 124.126 3.217 . . . . 0.0 112.248 -173.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.438 ' H ' ' NE2' ' A' ' 34' ' ' GLN . 1.9 mp0 -83.14 -11.4 57.97 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 173.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -67.49 147.17 98.81 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 114.333 -1.303 . . . . 0.0 111.481 177.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -75.31 114.4 3.98 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 121.54 1.494 . . . . 0.0 110.283 170.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.582 HG22 ' HG3' ' A' ' 83' ' ' GLU . 1.2 pt -122.61 154.15 27.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -176.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.424 ' C ' ' HB3' ' A' ' 59' ' ' GLU . 19.3 p -99.14 -30.17 12.44 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -176.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.576 ' C ' HG12 ' A' ' 82' ' ' VAL . . . -165.73 -164.13 20.58 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.482 -0.866 . . . . 0.0 111.7 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.618 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 6.6 m-85 -141.95 134.89 28.78 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 117.145 0.473 . . . . 0.0 111.392 175.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 8.9 mmm180 -100.4 150.92 22.12 Favored 'General case' 0 CA--C 1.508 -0.656 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 166.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.89 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 30.4 mt -139.27 108.49 3.7 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 C-N-CA 120.452 -0.499 . . . . 0.0 112.215 177.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 72.7 t -108.69 110.34 31.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.464 0.649 . . . . 0.0 110.804 179.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.648 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 1.0 OUTLIER -112.35 125.67 54.44 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.374 175.773 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 12.4 p -137.79 139.24 25.99 Favored Pre-proline 0 C--N 1.317 -0.822 0 CA-C-N 114.093 -1.412 . . . . 0.0 112.02 -172.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.521 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 72.0 Cg_endo . . . . . 0 C--O 1.232 0.191 0 C-N-CA 123.482 2.788 . . . . 0.0 111.71 176.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.448 ' HA ' ' O ' ' A' ' 44' ' ' TYR . 22.0 p . . . . . 0 CA--C 1.514 -0.427 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.648 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 36.8 m -146.95 150.11 34.52 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 120.482 -0.487 . . . . 0.0 111.441 -174.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.89 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 52.5 tt0 -115.34 114.16 24.77 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.55 173.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.682 HD12 ' CG2' ' A' ' 64' ' ' VAL . 23.0 mt -97.08 151.64 19.56 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.46 -0.496 . . . . 0.0 109.667 175.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -116.54 115.81 26.45 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.61 HD12 ' CH2' ' A' ' 30' ' ' TRP . 3.9 mt -113.51 156.96 42.65 Favored Pre-proline 0 C--N 1.319 -0.723 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -176.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -66.16 151.37 83.82 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 121.712 1.608 . . . . 0.0 111.166 175.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.424 ' HB3' ' C ' ' A' ' 38' ' ' THR . 9.2 pt-20 -46.07 -28.01 1.09 Allowed 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.099 -0.955 . . . . 0.0 112.823 177.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.9 t -101.67 12.28 37.42 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.265 0.555 . . . . 0.0 111.246 -175.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.467 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -82.07 159.98 23.31 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.584 ' HB3' ' NE ' ' A' ' 32' ' ' ARG . 28.4 p-10 -146.73 17.19 1.27 Allowed 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -176.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.602 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 21.5 p -169.08 135.73 1.75 Allowed 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.17 -0.612 . . . . 0.0 111.846 -178.54 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.721 HG12 ' HZ3' ' A' ' 30' ' ' TRP . 4.1 p -122.06 136.21 59.67 Favored 'Isoleucine or valine' 0 C--O 1.242 0.682 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.343 175.022 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 39.3 m -98.19 102.01 13.64 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-O 121.531 0.681 . . . . 0.0 109.55 170.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.701 HD11 HG12 ' A' ' 77' ' ' ILE . 0.2 OUTLIER -78.5 139.45 38.67 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.036 179.104 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 22.0 t -136.1 170.05 16.64 Favored 'General case' 0 C--N 1.317 -0.828 0 O-C-N 123.257 0.348 . . . . 0.0 110.224 -174.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 62.52 26.56 15.79 Favored 'General case' 0 C--N 1.331 -0.222 0 O-C-N 123.861 0.725 . . . . 0.0 111.457 -179.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.688 ' O ' HG22 ' A' ' 24' ' ' THR . 16.4 mt -68.17 -175.92 0.66 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.209 0.528 . . . . 0.0 109.887 177.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.55 ' OE1' ' HD2' ' A' ' 71' ' ' PRO . 5.7 tp-100 -126.1 118.9 23.67 Favored Pre-proline 0 C--N 1.319 -0.738 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.149 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.55 ' HD2' ' OE1' ' A' ' 70' ' ' GLN . 19.2 Cg_endo -60.89 134.48 53.68 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.886 2.391 . . . . 0.0 113.033 -177.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.63 23.33 50.72 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.936 -0.65 . . . . 0.0 111.812 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 50.5 t -129.49 146.38 34.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.183 0.516 . . . . 0.0 110.804 -177.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.521 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -82.98 120.16 25.36 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.186 -0.916 . . . . 0.0 109.721 -178.696 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -115.06 113.92 24.68 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.254 0.55 . . . . 0.0 111.949 -176.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.576 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 0.8 OUTLIER -87.22 113.35 22.88 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.936 177.006 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.701 HG12 HD11 ' A' ' 66' ' ' LEU . 5.3 mp -94.68 114.94 32.28 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.615 0 CA-C-O 121.289 0.566 . . . . 0.0 109.618 175.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.843 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 48.4 m -108.52 116.15 31.43 Favored 'General case' 0 N--CA 1.427 -1.615 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.122 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.547 ' HB ' ' HB ' ' A' ' 91' ' ' VAL . 13.0 mm -95.22 143.49 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -129.99 113.12 14.18 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.001 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.33 122.53 25.87 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 106.738 -1.578 . . . . 0.0 106.738 168.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.576 HG12 ' C ' ' A' ' 39' ' ' GLY . 7.5 p -110.49 135.37 49.78 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 C-N-CA 120.153 -0.619 . . . . 0.0 109.97 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.679 ' OE1' ' HG2' ' A' ' 86' ' ' GLN . 4.8 mp0 -115.34 169.87 8.82 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -37.76 -53.09 1.28 Allowed 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -171.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -126.24 7.23 7.12 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.726 -0.389 . . . . 0.0 111.947 -175.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.679 ' HG2' ' OE1' ' A' ' 83' ' ' GLU . 20.3 pm0 -143.79 176.73 9.02 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 120.688 -0.405 . . . . 0.0 111.289 -173.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -136.06 129.89 32.62 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.775 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 67.9 m -76.99 175.78 9.25 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.086 0.47 . . . . 0.0 111.622 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -60.93 152.94 68.02 Favored Pre-proline 0 N--CA 1.451 -0.38 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.283 179.065 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -85.99 141.83 7.4 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.433 2.089 . . . . 0.0 114.204 -177.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.843 ' O ' ' HA ' ' A' ' 78' ' ' THR . 11.8 t -82.51 124.88 39.74 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.718 0 CA-C-N 114.692 -1.14 . . . . 0.0 108.101 166.192 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 14.4 t -120.34 105.24 16.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 C-N-CA 119.385 -0.926 . . . . 0.0 109.904 171.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.57 HG13 ' HB ' ' A' ' 77' ' ' ILE . 10.4 pt -122.04 110.86 28.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.192 177.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.431 ' HB2' ' OE1' ' A' ' 74' ' ' GLN . 11.1 pt20 -100.86 114.6 28.59 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.783 0.801 . . . . 0.0 111.237 -174.093 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.28 126.44 52.16 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.988 -1.005 . . . . 0.0 109.756 178.38 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.457 ' HB2' ' HG2' ' A' ' 74' ' ' GLN . 39.1 tt0 -89.73 130.21 36.03 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 177.039 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 41.6 p -63.66 140.38 58.87 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.319 -177.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.6 m . . . . . 0 C--N 1.328 -0.366 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.633 -173.766 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.582 ' HB2' ' O ' ' A' ' 89' ' ' THR . . . . . . . . 0 N--CA 1.452 -0.34 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -62.22 132.68 39.93 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.412 2.074 . . . . 0.0 111.655 173.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.42 ' HD2' ' O ' ' A' ' 31' ' ' SER . 89.0 Cg_exo -49.43 145.6 15.84 Favored 'Trans proline' 0 C--O 1.236 0.383 0 C-N-CA 122.588 2.192 . . . . 0.0 111.188 172.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.425 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 5.5 m-20 -34.98 106.63 0.3 Allowed Pre-proline 0 N--CA 1.469 0.497 0 O-C-N 124.847 1.342 . . . . 0.0 112.693 -169.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.604 ' HG2' HG11 ' A' ' 91' ' ' VAL . 28.0 Cg_exo -66.68 151.51 82.5 Favored 'Trans proline' 0 CA--C 1.519 -0.273 0 C-N-CA 123.534 2.823 . . . . 0.0 112.108 178.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 8.2 m -113.13 131.62 55.77 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.635 -177.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.458 ' HA ' ' HA ' ' A' ' 28' ' ' VAL . 71.6 t -76.05 119.34 23.91 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-N 114.363 -1.29 . . . . 0.0 110.143 174.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -93.81 -28.05 16.11 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.073 -174.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -135.52 132.6 37.49 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.388 -178.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.456 ' HA ' HG12 ' A' ' 26' ' ' ILE . 11.5 t -131.95 104.84 8.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.77 179.312 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -111.75 -163.29 0.84 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.092 177.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.482 ' O ' ' HB2' ' A' ' 69' ' ' LEU . 4.0 p-10 -73.69 -62.42 1.5 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.349 0.595 . . . . 0.0 111.471 176.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.635 HG22 ' O ' ' A' ' 69' ' ' LEU . 35.1 p -111.49 33.43 4.72 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.447 -172.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.691 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 35.6 m -168.88 130.4 1.22 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.897 -171.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.594 ' HB ' HD12 ' A' ' 66' ' ' LEU . 40.5 mt -146.64 140.14 20.16 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.636 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 176.251 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 85.6 t -117.09 129.19 74.04 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.752 0 O-C-N 121.654 -0.654 . . . . 0.0 110.61 -175.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.639 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.8 OUTLIER -121.97 143.44 34.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 C-N-CA 120.32 -0.552 . . . . 0.0 109.608 -178.912 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.496 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 44.6 mtp180 -129.65 121.13 26.41 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.891 0.377 . . . . 0.0 110.5 -174.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.723 ' HZ3' HG12 ' A' ' 64' ' ' VAL . 37.1 p90 -111.54 152.6 27.34 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.566 -174.411 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.42 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 11.7 m -96.81 97.46 9.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.965 178.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.562 ' NE ' ' HB3' ' A' ' 62' ' ' ASN . 0.1 OUTLIER -49.72 156.52 1.19 Allowed Pre-proline 0 CA--C 1.538 0.489 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -173.768 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.613 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 3.0 Cg_exo -84.1 165.55 13.06 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 124.303 3.335 . . . . 0.0 112.638 -173.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -77.91 -18.41 56.17 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.198 173.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.57 143.88 96.11 Favored Pre-proline 0 C--O 1.235 0.334 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.105 175.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.475 ' O ' ' HG2' ' A' ' 83' ' ' GLU . 57.2 Cg_endo -75.86 114.68 3.99 Favored 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 121.321 1.347 . . . . 0.0 109.934 170.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.558 HD12 ' CE1' ' A' ' 40' ' ' TYR . 1.3 pt -118.78 152.43 21.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -175.238 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.46 ' C ' ' HB3' ' A' ' 59' ' ' GLU . 7.7 p -92.15 -30.06 16.16 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.956 0.725 . . . . 0.0 112.956 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.593 ' C ' HG12 ' A' ' 82' ' ' VAL . . . -169.85 -162.14 21.58 Favored Glycine 0 CA--C 1.501 -0.818 0 C-N-CA 119.9 -1.143 . . . . 0.0 111.445 -178.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.613 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 7.2 m-85 -140.86 134.42 30.07 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 117.068 0.434 . . . . 0.0 110.888 173.324 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 -101.91 147.82 26.07 Favored 'General case' 0 CA--C 1.505 -0.762 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 166.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.897 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 34.4 mt -138.67 108.96 4.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 C-N-CA 120.238 -0.585 . . . . 0.0 112.367 -177.274 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 76.6 t -107.37 110.18 30.89 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.448 0 CA-C-O 121.27 0.557 . . . . 0.0 110.6 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.698 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 0.6 OUTLIER -112.62 125.05 53.86 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.34 175.969 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.461 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 13.5 t -140.22 136.03 16.64 Favored Pre-proline 0 C--N 1.31 -1.132 0 CA-C-N 113.941 -1.481 . . . . 0.0 110.297 -174.156 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.586 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 21.6 Cg_exo . . . . . 0 CA--C 1.518 -0.319 0 C-N-CA 123.014 2.476 . . . . 0.0 111.795 176.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.454 ' HA ' ' O ' ' A' ' 44' ' ' TYR . 6.1 m . . . . . 0 CA--C 1.517 -0.312 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.698 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 55.1 m -146.36 150.53 35.88 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.233 -175.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.897 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 46.7 tt0 -120.7 113.59 20.44 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.914 176.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.707 HD12 ' CG2' ' A' ' 64' ' ' VAL . 20.3 mt -97.17 157.84 15.74 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.461 177.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.484 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 27.4 t-20 -121.87 113.2 19.3 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.362 177.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.56 HD12 ' CH2' ' A' ' 30' ' ' TRP . 3.3 mt -109.98 155.56 41.44 Favored Pre-proline 0 C--N 1.318 -0.784 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -176.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -62.72 148.22 93.68 Favored 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 121.781 1.654 . . . . 0.0 110.959 176.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.46 ' HB3' ' C ' ' A' ' 38' ' ' THR . 8.8 pt-20 -44.96 -24.97 0.26 Allowed 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 114.986 -1.006 . . . . 0.0 113.468 178.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.5 t -105.85 9.07 32.94 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.04 0.447 . . . . 0.0 111.213 -174.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.448 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -76.09 157.28 33.07 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.562 ' HB3' ' NE ' ' A' ' 32' ' ' ARG . 27.9 p-10 -141.6 13.87 2.14 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.445 -0.502 . . . . 0.0 112.231 -178.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.639 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 16.6 m -162.17 133.88 5.4 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 121.951 -0.468 . . . . 0.0 110.698 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.723 HG12 ' HZ3' ' A' ' 30' ' ' TRP . 4.3 p -115.27 135.47 55.14 Favored 'Isoleucine or valine' 0 C--O 1.242 0.708 0 CA-C-O 120.796 0.331 . . . . 0.0 110.184 173.211 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 55.0 m -96.27 101.19 12.8 Favored 'General case' 0 N--CA 1.434 -1.27 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.725 170.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.691 ' O ' ' HA ' ' A' ' 25' ' ' SER . 0.3 OUTLIER -77.82 142.02 38.83 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 177.664 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 10.1 t -138.2 167.97 20.71 Favored 'General case' 0 C--N 1.322 -0.597 0 O-C-N 123.282 0.364 . . . . 0.0 110.779 -173.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 63.96 25.12 13.83 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.574 -179.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.635 ' O ' HG22 ' A' ' 24' ' ' THR . 12.7 mt -69.58 -175.99 0.94 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.012 0.435 . . . . 0.0 110.142 177.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -129.41 127.23 23.08 Favored Pre-proline 0 C--N 1.319 -0.725 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 177.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -64.52 134.77 42.78 Favored 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 122.663 2.242 . . . . 0.0 112.599 -178.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 83.77 30.72 28.62 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.989 -0.625 . . . . 0.0 111.576 -178.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.489 ' CG1' ' HB3' ' A' ' 46' ' ' PRO . 95.6 t -133.23 141.98 43.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.7 0.286 . . . . 0.0 110.518 -177.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.586 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 1.5 tm0? -87.68 122.19 31.04 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.051 -179.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.454 ' CE1' ' HG3' ' A' ' 46' ' ' PRO . 13.4 m-85 -113.15 113.65 25.67 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.143 -174.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.531 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 13.3 m120 -86.34 106.42 17.38 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.937 177.116 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.654 HG12 HD11 ' A' ' 66' ' ' LEU . 5.3 mp -92.35 119.72 40.36 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.529 0 CA-C-O 121.201 0.524 . . . . 0.0 109.886 177.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.829 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 65.6 m -111.68 118.44 35.65 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.478 177.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.565 ' HB ' ' HB ' ' A' ' 91' ' ' VAL . 12.0 mm -96.12 140.05 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 -128.41 111.51 13.4 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 178.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.432 ' HB1' HG21 ' A' ' 37' ' ' ILE . . . -79.81 110.36 15.09 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 173.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.593 HG12 ' C ' ' A' ' 39' ' ' GLY . 10.8 p -99.44 141.53 16.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 C-N-CA 120.196 -0.602 . . . . 0.0 110.728 -173.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.475 ' HG2' ' O ' ' A' ' 36' ' ' PRO . 9.5 tm-20 -118.31 165.9 13.28 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 -176.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -45.17 -46.76 12.26 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -176.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -126.84 0.1 6.66 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.854 0.359 . . . . 0.0 111.426 -174.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -134.08 174.09 10.87 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 122.071 -0.393 . . . . 0.0 111.167 -173.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -136.9 133.67 35.99 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.433 175.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.7 m -75.9 174.59 9.72 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.495 -178.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.582 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 0.1 OUTLIER -60.48 159.43 24.01 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.704 176.525 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -88.66 134.79 2.84 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 122.243 1.962 . . . . 0.0 113.951 -178.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.829 ' O ' ' HA ' ' A' ' 78' ' ' THR . 10.5 t -82.67 126.58 40.04 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.627 0 CA-C-N 115.133 -0.939 . . . . 0.0 108.59 167.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.6 t -124.62 106.33 16.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 C-N-CA 120.115 -0.634 . . . . 0.0 110.276 174.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.511 HG13 ' HB ' ' A' ' 77' ' ' ILE . 8.3 pt -127.34 116.19 43.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.976 179.063 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.579 ' HB2' ' OE1' ' A' ' 74' ' ' GLN . 3.7 pt20 -99.5 131.41 45.52 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.261 0.553 . . . . 0.0 111.094 -177.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -140.43 129.11 22.98 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.137 178.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.453 ' HB2' ' HG2' ' A' ' 74' ' ' GLN . 38.7 tt0 -86.9 139.95 30.12 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.081 0.467 . . . . 0.0 110.305 177.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 18.7 p -70.56 119.44 14.73 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.314 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.406 ' H ' HG12 ' A' ' 21' ' ' VAL . 19.4 m . . . . . 0 C--N 1.325 -0.494 0 CA-C-O 121.247 0.546 . . . . 0.0 110.544 -179.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.319 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -71.2 138.35 33.15 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.042 1.828 . . . . 0.0 110.788 174.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.571 ' HD2' ' O ' ' A' ' 31' ' ' SER . 18.1 Cg_endo -60.59 160.09 25.61 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 122.371 2.047 . . . . 0.0 110.518 176.147 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.407 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 7.5 p-10 -42.15 107.69 0.55 Allowed Pre-proline 0 N--CA 1.468 0.449 0 O-C-N 124.126 0.891 . . . . 0.0 111.84 -170.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.593 ' HG2' HG11 ' A' ' 91' ' ' VAL . 24.3 Cg_exo -67.5 153.35 76.78 Favored 'Trans proline' 0 CA--C 1.518 -0.291 0 C-N-CA 122.953 2.436 . . . . 0.0 111.756 178.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 61.4 m -111.48 131.11 55.46 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 121.752 0.787 . . . . 0.0 110.87 -178.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.446 ' HA ' ' HA ' ' A' ' 28' ' ' VAL . 79.5 t -80.17 124.55 38.31 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 CA-C-N 114.119 -1.4 . . . . 0.0 110.06 174.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -83.41 -49.21 9.54 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.189 -176.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -136.84 141.94 42.84 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.794 -177.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.521 HG11 ' NE2' ' A' ' 95' ' ' GLN . 27.3 m -129.46 125.72 62.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.041 179.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -125.15 -167.9 1.75 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.057 176.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.518 ' O ' ' HB2' ' A' ' 69' ' ' LEU . 1.6 p-10 -62.54 -64.21 0.99 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.111 0.481 . . . . 0.0 111.824 178.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.655 HG22 ' O ' ' A' ' 69' ' ' LEU . 32.9 p -111.66 35.0 3.83 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.915 -172.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.617 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 52.4 p -169.16 139.38 2.23 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.277 -175.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.616 ' HB ' HD12 ' A' ' 66' ' ' LEU . 12.0 mt -149.89 140.2 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 176.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.435 ' O ' HG13 ' A' ' 18' ' ' VAL . 44.0 t -116.21 128.63 73.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 O-C-N 121.486 -0.759 . . . . 0.0 110.519 -177.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.606 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.7 OUTLIER -124.63 146.05 30.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.072 -176.805 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.467 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 22.3 mtm180 -131.01 121.93 25.92 Favored 'General case' 0 C--N 1.328 -0.359 0 O-C-N 123.305 0.378 . . . . 0.0 110.804 -175.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.781 ' HZ3' HG12 ' A' ' 64' ' ' VAL . 39.8 p90 -114.82 143.32 45.28 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.245 -175.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.571 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 15.9 t -88.95 98.77 11.93 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 177.211 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.604 ' CD ' ' H ' ' A' ' 32' ' ' ARG . 0.1 OUTLIER -51.9 159.26 1.43 Allowed Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 123.71 0.804 . . . . 0.0 113.06 -174.621 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.677 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 3.7 Cg_exo -82.21 166.11 16.51 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 124.116 3.211 . . . . 0.0 112.048 -176.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -87.43 -5.41 58.85 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.541 177.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.409 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . . . -70.89 148.1 94.45 Favored Pre-proline 0 N--CA 1.453 -0.314 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.847 175.02 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.496 ' O ' ' HG3' ' A' ' 83' ' ' GLU . 10.9 Cg_exo -71.76 115.91 4.49 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 121.82 1.68 . . . . 0.0 110.101 169.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.498 HD12 ' HE1' ' A' ' 40' ' ' TYR . 2.4 pt -124.73 153.92 31.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -175.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 18.1 p -94.39 -32.67 13.46 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -176.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.579 ' C ' HG12 ' A' ' 82' ' ' VAL . . . -168.55 -162.79 21.35 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.314 -0.946 . . . . 0.0 111.796 -177.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.677 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 7.1 m-85 -141.78 135.23 29.48 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 122.573 0.349 . . . . 0.0 111.284 174.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.9 mmm180 -100.16 148.4 24.64 Favored 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 167.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.916 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 29.9 mt -139.19 107.74 3.42 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 C-N-CA 120.075 -0.65 . . . . 0.0 112.315 179.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 80.3 t -109.24 110.72 33.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.089 0.471 . . . . 0.0 110.859 -178.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.772 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 1.0 OUTLIER -115.22 128.73 56.34 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.215 178.372 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.454 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 29.8 p -143.11 145.16 31.65 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 114.051 -1.431 . . . . 0.0 112.027 -174.095 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.547 ' HB3' HG11 ' A' ' 73' ' ' VAL . 2.1 Cg_endo . . . . . 0 C--N 1.347 0.468 0 C-N-CA 123.657 2.904 . . . . 0.0 111.172 175.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 13.1 m . . . . . 0 CA--C 1.516 -0.355 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.772 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 21.4 m -146.95 148.12 31.43 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 119.678 -0.809 . . . . 0.0 111.531 177.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.916 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 46.7 tt0 -116.16 117.98 31.58 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.97 172.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.717 HD12 ' CG2' ' A' ' 64' ' ' VAL . 17.9 mt -98.38 156.95 16.5 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.634 -0.426 . . . . 0.0 110.07 174.176 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -120.29 113.93 21.13 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 178.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.566 HD12 ' CH2' ' A' ' 30' ' ' TRP . 2.6 mt -111.27 157.74 38.09 Favored Pre-proline 0 C--N 1.318 -0.796 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -175.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -66.78 150.66 83.36 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 121.769 1.646 . . . . 0.0 111.512 175.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -43.17 -27.44 0.22 Allowed 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 114.435 -1.257 . . . . 0.0 113.397 177.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 5.7 t -104.38 4.89 33.92 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.148 0.499 . . . . 0.0 111.227 -172.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.408 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -75.14 152.42 38.49 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 -178.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.484 ' HB3' ' NE ' ' A' ' 32' ' ' ARG . 27.7 p-10 -135.6 16.28 3.37 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.816 -0.353 . . . . 0.0 111.831 -178.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.606 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 17.8 p -170.17 136.93 1.47 Allowed 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.27 -0.572 . . . . 0.0 112.078 -178.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.781 HG12 ' HZ3' ' A' ' 30' ' ' TRP . 3.9 p -119.8 138.42 50.47 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.337 176.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 50.5 m -98.36 101.43 12.88 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-O 121.334 0.588 . . . . 0.0 109.692 170.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.687 HD11 HG12 ' A' ' 77' ' ' ILE . 0.2 OUTLIER -79.93 145.29 32.72 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.426 178.801 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.468 ' HA ' ' O ' ' A' ' 24' ' ' THR . 17.6 t -139.0 177.91 7.55 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -177.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 65.37 20.84 11.87 Favored 'General case' 0 N--CA 1.468 0.437 0 O-C-N 123.486 0.491 . . . . 0.0 111.977 -178.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.655 ' O ' HG22 ' A' ' 24' ' ' THR . 13.8 mt -72.19 -175.59 1.56 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.182 0.515 . . . . 0.0 110.339 178.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 56.0 tp60 -128.72 128.82 23.5 Favored Pre-proline 0 C--N 1.319 -0.734 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 178.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.9 134.63 54.53 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.951 2.434 . . . . 0.0 113.391 -178.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.13 35.81 26.17 Favored Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 115.868 -0.605 . . . . 0.0 112.405 177.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.547 HG11 ' HB3' ' A' ' 46' ' ' PRO . 42.5 t -134.37 150.43 30.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.04 0.448 . . . . 0.0 111.424 -175.327 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 8.0 tp60 -91.1 105.03 17.53 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.332 179.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.527 ' CZ ' ' HG3' ' A' ' 46' ' ' PRO . 9.9 m-85 -97.38 121.14 38.94 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.79 -178.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.553 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 55.7 m-20 -91.85 111.87 23.57 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.283 176.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.687 HG12 HD11 ' A' ' 66' ' ' LEU . 5.3 mp -94.82 118.4 40.83 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.623 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.971 176.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.905 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 29.5 m -107.91 115.4 30.07 Favored 'General case' 0 N--CA 1.425 -1.684 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.605 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.533 ' HB ' ' HB ' ' A' ' 91' ' ' VAL . 12.5 mm -96.1 137.58 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -126.15 111.75 15.0 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.052 178.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -80.02 112.39 17.28 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 171.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.579 HG12 ' C ' ' A' ' 39' ' ' GLY . 10.9 p -103.64 136.4 36.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 C-N-CA 119.924 -0.711 . . . . 0.0 110.956 -175.123 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.66 ' HG2' ' N ' ' A' ' 84' ' ' GLU . 2.4 tt0 -117.73 166.91 11.87 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 177.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.66 ' N ' ' HG2' ' A' ' 83' ' ' GLU . 28.0 mt-10 -44.02 -48.38 8.78 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 178.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 19.9 m-80 -98.62 -33.87 10.79 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -170.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -145.81 169.49 18.42 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-O 120.904 0.383 . . . . 0.0 111.518 -167.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -114.72 145.78 41.68 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.289 175.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 17.8 m -76.15 169.78 17.55 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.738 178.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.2 p -58.73 146.11 75.87 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.079 173.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -78.26 138.91 16.31 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.134 1.889 . . . . 0.0 113.966 -174.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.905 ' O ' ' HA ' ' A' ' 78' ' ' THR . 9.7 t -81.74 126.5 39.88 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.745 0 CA-C-N 114.828 -1.078 . . . . 0.0 108.174 167.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 15.7 t -123.78 106.06 16.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 C-N-CA 119.766 -0.774 . . . . 0.0 109.912 170.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.565 HG13 ' HB ' ' A' ' 77' ' ' ILE . 6.9 pt -120.0 115.58 47.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.892 178.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -99.44 125.01 45.08 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.273 0.558 . . . . 0.0 111.372 -176.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.521 ' NE2' HG11 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -128.73 131.63 47.91 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.379 178.797 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.41 ' HA ' ' O ' ' A' ' 73' ' ' VAL . 44.1 mt-10 -85.71 127.31 34.48 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.049 0.452 . . . . 0.0 110.218 176.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 46.4 p -69.92 120.65 15.96 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.562 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.9 m . . . . . 0 C--N 1.328 -0.351 0 CA-C-O 121.292 0.568 . . . . 0.0 110.588 -178.794 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.446 ' HB2' ' O ' ' A' ' 89' ' ' THR . . . . . . . . 0 CA--C 1.52 -0.192 0 N-CA-C 110.292 -0.262 . . . . 0.0 110.292 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.448 ' HB2' ' HB2' ' A' ' 30' ' ' TRP . 26.8 Cg_exo -64.54 128.45 21.25 Favored 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.365 2.044 . . . . 0.0 111.646 178.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.415 ' HD2' ' O ' ' A' ' 31' ' ' SER . 53.5 Cg_exo -53.03 143.52 49.86 Favored 'Trans proline' 0 CA--C 1.512 -0.602 0 C-N-CA 122.517 2.145 . . . . 0.0 111.312 176.169 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -37.05 103.17 0.25 Allowed Pre-proline 0 CA--C 1.515 -0.39 0 O-C-N 125.145 1.528 . . . . 0.0 112.74 -163.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.709 ' CG ' HG11 ' A' ' 91' ' ' VAL . 3.1 Cg_endo -47.62 147.98 6.17 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 123.594 2.863 . . . . 0.0 113.526 169.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 18.4 m -107.6 131.6 54.19 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.021 -0.991 . . . . 0.0 109.789 177.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.483 HG11 HG22 ' A' ' 21' ' ' VAL . 81.2 t -76.52 121.03 27.82 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.41 176.128 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -86.08 -39.06 17.16 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.526 -175.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -135.26 127.96 30.95 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.842 0.354 . . . . 0.0 110.683 -178.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.516 ' HA ' HG12 ' A' ' 26' ' ' ILE . 98.7 t -120.78 115.58 47.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.4 177.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -127.2 -164.17 1.33 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.338 178.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -68.55 -63.01 1.14 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.088 0.471 . . . . 0.0 112.149 -178.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.642 HG22 ' O ' ' A' ' 69' ' ' LEU . 38.7 p -117.81 35.08 4.85 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.812 -171.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.531 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 54.4 p -170.91 132.38 0.87 Allowed 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.496 -173.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.595 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 32.7 mt -145.91 140.82 21.67 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.781 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 178.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.433 ' O ' HG13 ' A' ' 18' ' ' VAL . 39.7 t -117.14 134.11 61.76 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.631 0 C-N-CA 120.064 -0.655 . . . . 0.0 110.084 -176.003 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.638 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.6 OUTLIER -127.06 146.93 32.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 C-N-CA 120.221 -0.591 . . . . 0.0 110.462 -178.643 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.564 ' HG2' ' OG ' ' A' ' 63' ' ' SER . 18.4 mtp180 -128.54 118.94 23.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.549 -177.125 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.764 ' HZ3' HG12 ' A' ' 64' ' ' VAL . 36.4 p90 -110.48 146.11 36.53 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.961 -176.08 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.415 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 20.8 m -92.21 99.92 12.62 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.078 177.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.56 ' NE ' ' HB3' ' A' ' 62' ' ' ASN . 0.1 OUTLIER -46.58 156.98 0.47 Allowed Pre-proline 0 CA--C 1.536 0.419 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -175.222 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.628 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 3.4 Cg_exo -83.34 169.0 12.84 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 124.179 3.253 . . . . 0.0 112.5 -172.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -87.2 -3.43 59.05 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.231 -0.895 . . . . 0.0 108.938 173.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.71 146.87 80.67 Favored Pre-proline 0 N--CA 1.451 -0.416 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.968 175.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -77.84 114.7 3.68 Favored 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 121.371 1.38 . . . . 0.0 110.043 170.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.641 HG22 ' HG3' ' A' ' 83' ' ' GLU . 0.7 OUTLIER -120.25 155.02 23.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.461 -174.494 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.1 p -97.51 -33.79 11.23 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -178.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.414 ' C ' HG12 ' A' ' 82' ' ' VAL . . . -164.74 -169.65 28.62 Favored Glycine 0 C--O 1.222 -0.642 0 C-N-CA 120.075 -1.059 . . . . 0.0 112.16 179.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.628 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 4.6 m-85 -136.56 131.38 33.76 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-N 117.302 0.551 . . . . 0.0 111.674 176.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 37.4 mtm180 -103.98 148.41 26.23 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.029 168.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.867 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 30.4 mt -139.0 109.32 4.37 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 C-N-CA 120.421 -0.511 . . . . 0.0 112.335 -176.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 95.6 t -110.43 110.74 33.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.42 0.629 . . . . 0.0 110.667 179.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.755 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 0.5 OUTLIER -108.17 125.09 51.22 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.191 175.358 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.443 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 6.3 p -144.03 138.4 14.98 Favored Pre-proline 0 C--N 1.315 -0.903 0 CA-C-N 113.864 -1.517 . . . . 0.0 111.301 -173.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.742 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 22.5 Cg_exo . . . . . 0 C--O 1.232 0.221 0 C-N-CA 123.349 2.699 . . . . 0.0 111.767 175.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.457 ' HA ' ' O ' ' A' ' 44' ' ' TYR . 15.0 m . . . . . 0 CA--C 1.517 -0.321 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.755 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 30.6 m -147.15 154.99 41.76 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.358 -176.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.867 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 33.0 tt0 -124.31 115.4 20.95 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 123.297 0.639 . . . . 0.0 109.902 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.687 HD12 ' CG2' ' A' ' 64' ' ' VAL . 18.4 mt -100.52 160.5 14.29 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 175.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.423 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 17.5 m120 -125.98 121.59 33.51 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 178.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.603 HD12 ' CH2' ' A' ' 30' ' ' TRP . 4.6 mt -118.33 158.9 45.48 Favored Pre-proline 0 C--N 1.318 -0.79 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -176.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -64.48 150.97 87.31 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 121.58 1.52 . . . . 0.0 111.21 175.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.402 ' HB2' HG13 ' A' ' 37' ' ' ILE . 12.8 pt-20 -46.0 -26.75 0.77 Allowed 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 114.924 -1.035 . . . . 0.0 112.77 177.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 7.8 t -103.76 8.21 37.22 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.318 -174.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.484 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -75.0 160.43 30.55 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -179.173 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.56 ' HB3' ' NE ' ' A' ' 32' ' ' ARG . 24.7 p-10 -142.58 10.92 1.86 Allowed 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.473 -0.491 . . . . 0.0 112.323 -179.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.638 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 14.6 m -161.43 133.82 5.94 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 118.476 0.58 . . . . 0.0 111.473 -178.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.764 HG12 ' HZ3' ' A' ' 30' ' ' TRP . 4.1 p -119.56 136.87 55.31 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 173.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 40.4 m -97.44 100.97 12.4 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-O 121.426 0.631 . . . . 0.0 109.711 169.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.7 HD11 HG12 ' A' ' 77' ' ' ILE . 0.2 OUTLIER -78.52 145.14 35.06 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.008 178.045 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.1 t -142.31 173.56 11.42 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -175.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 67.02 23.04 9.86 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 123.907 0.755 . . . . 0.0 111.078 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.642 ' O ' HG22 ' A' ' 24' ' ' THR . 10.3 mt -72.37 -175.77 1.67 Allowed 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 177.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 21.6 mm-40 -125.51 134.12 25.52 Favored Pre-proline 0 C--N 1.322 -0.613 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 176.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -65.8 126.01 15.25 Favored 'Trans proline' 0 CA--C 1.529 0.267 0 C-N-CA 122.502 2.135 . . . . 0.0 112.885 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 86.03 31.77 19.4 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.503 177.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 92.1 t -129.79 145.28 35.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.019 0.438 . . . . 0.0 110.698 -177.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.742 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -80.05 123.75 28.12 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.692 -179.274 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.427 ' CE1' ' HG3' ' A' ' 46' ' ' PRO . 15.3 m-85 -120.45 114.03 21.2 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.164 0.507 . . . . 0.0 112.119 -176.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.457 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 11.5 m120 -90.33 110.65 21.71 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.371 176.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.7 HG12 HD11 ' A' ' 66' ' ' LEU . 5.1 mp -91.36 116.21 32.07 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.686 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 176.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.868 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 14.9 m -108.86 113.51 26.49 Favored 'General case' 0 N--CA 1.424 -1.751 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.359 -177.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.576 ' H ' ' HB ' ' A' ' 91' ' ' VAL . 10.8 mm -95.13 134.23 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -122.33 111.55 17.04 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.75 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.404 ' HB3' ' HB2' ' A' ' 88' ' ' SER . . . -81.25 131.17 35.28 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 170.07 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.414 HG12 ' C ' ' A' ' 39' ' ' GLY . 7.7 p -118.47 135.37 59.1 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.317 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.641 ' HG3' HG22 ' A' ' 37' ' ' ILE . 4.0 mp0 -115.21 169.95 8.74 Favored 'General case' 0 N--CA 1.448 -0.561 0 O-C-N 123.906 0.754 . . . . 0.0 109.482 -178.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -44.26 -47.88 9.43 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -174.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 30.3 p-10 -129.88 16.39 5.76 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.934 -0.306 . . . . 0.0 111.635 -177.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 77.2 mm-40 -144.65 173.99 11.36 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.763 0.316 . . . . 0.0 111.076 -176.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -140.54 119.9 13.06 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 174.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.404 ' HB2' ' HB3' ' A' ' 81' ' ' ALA . 66.7 m -65.57 167.42 8.97 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.832 0.349 . . . . 0.0 111.574 -177.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.446 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 1.2 p -57.4 160.61 6.84 Favored Pre-proline 0 CA--C 1.536 0.422 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.696 178.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -86.99 133.58 3.48 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 122.259 1.973 . . . . 0.0 113.766 -177.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.868 ' O ' ' HA ' ' A' ' 78' ' ' THR . 44.2 t -82.62 122.73 37.61 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.723 0 CA-C-N 114.936 -1.029 . . . . 0.0 108.622 170.028 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 10.8 t -120.38 106.6 19.07 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 C-N-CA 119.586 -0.846 . . . . 0.0 110.277 174.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.553 HG13 ' HB ' ' A' ' 77' ' ' ILE . 7.7 pt -122.29 113.7 39.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.733 176.394 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -100.4 131.25 46.43 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.395 0.616 . . . . 0.0 111.389 -174.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.71 132.35 34.75 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.572 177.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.491 ' HG2' ' HG2' ' A' ' 74' ' ' GLN . 45.3 mt-10 -89.13 131.8 35.1 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 175.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.402 HG22 HD11 ' A' ' 26' ' ' ILE . 31.4 p -68.5 121.17 15.8 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.47 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.3 m . . . . . 0 C--N 1.327 -0.397 0 CA-C-O 121.191 0.52 . . . . 0.0 110.305 -179.204 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.588 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.479 ' CB ' ' HB2' ' A' ' 30' ' ' TRP . 31.5 Cg_exo -62.47 128.14 22.8 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.017 1.811 . . . . 0.0 111.774 174.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -52.73 138.41 59.48 Favored 'Trans proline' 0 CA--C 1.509 -0.765 0 C-N-CA 122.288 1.992 . . . . 0.0 110.529 172.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -36.52 102.78 0.24 Allowed Pre-proline 0 N--CA 1.465 0.296 0 O-C-N 125.373 1.671 . . . . 0.0 112.443 -161.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.737 ' CG ' HG11 ' A' ' 91' ' ' VAL . 2.8 Cg_endo -46.61 146.14 5.66 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 123.896 3.064 . . . . 0.0 113.855 172.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 11.2 m -104.0 129.97 51.62 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.111 -0.949 . . . . 0.0 110.414 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.475 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 89.3 t -79.46 121.74 33.29 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 114.458 -1.247 . . . . 0.0 109.997 174.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -86.18 -43.17 13.22 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.333 -175.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -135.86 139.35 43.33 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.907 0.384 . . . . 0.0 111.046 -179.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.474 HG22 HG11 ' A' ' 18' ' ' VAL . 40.3 t -129.02 111.49 23.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.327 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -116.94 -157.46 0.66 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 -178.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.402 ' OD2' ' HB3' ' A' ' 71' ' ' PRO . 7.0 m-20 -75.53 -64.02 1.16 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.231 0.539 . . . . 0.0 110.234 -179.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.673 HG22 ' O ' ' A' ' 69' ' ' LEU . 42.2 p -112.05 37.62 2.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.072 -175.02 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.625 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 69.6 m -168.43 131.97 1.52 Allowed 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 122.611 0.364 . . . . 0.0 110.834 -172.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.591 ' HB ' HD12 ' A' ' 66' ' ' LEU . 39.8 mt -147.53 138.18 17.42 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.622 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 176.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 39.7 t -117.35 132.54 66.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 118.695 0.68 . . . . 0.0 110.629 -174.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.612 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.7 OUTLIER -127.64 146.07 33.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.544 -177.823 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.531 ' HG2' ' HB3' ' A' ' 63' ' ' SER . 92.8 mtt180 -128.04 120.63 27.89 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 123.625 0.578 . . . . 0.0 110.519 -177.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.692 ' HZ3' HG12 ' A' ' 64' ' ' VAL . 34.7 p90 -113.69 154.11 27.83 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.231 -175.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 24.8 t -101.32 102.16 12.95 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 121.162 0.506 . . . . 0.0 110.5 178.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.587 ' CD ' ' H ' ' A' ' 32' ' ' ARG . 0.1 OUTLIER -53.89 160.46 2.18 Favored Pre-proline 0 CA--C 1.542 0.669 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -174.486 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.673 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 2.3 Cg_endo -84.87 169.44 10.41 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 124.581 3.521 . . . . 0.0 113.024 -175.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 -79.58 -22.25 44.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.609 173.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.502 ' HB1' ' OE2' ' A' ' 83' ' ' GLU . . . -58.77 136.7 86.86 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.171 179.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -66.52 113.45 2.71 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 121.317 1.345 . . . . 0.0 109.723 172.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.684 HG22 ' HG2' ' A' ' 83' ' ' GLU . 6.7 pt -123.55 157.3 29.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.855 -173.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.467 ' C ' ' HB3' ' A' ' 59' ' ' GLU . 18.3 p -101.19 -27.65 13.1 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -176.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.493 ' C ' HG12 ' A' ' 82' ' ' VAL . . . -171.04 -163.27 24.79 Favored Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 119.68 -1.247 . . . . 0.0 112.617 179.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.673 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 6.6 m-85 -141.05 135.64 31.23 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 122.858 0.463 . . . . 0.0 110.851 176.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 27.5 mtp180 -104.69 150.2 24.93 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 167.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.863 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 26.7 mt -139.0 107.94 3.65 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 C-N-CA 120.279 -0.568 . . . . 0.0 112.165 -178.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 69.2 t -105.93 110.78 32.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.323 0.582 . . . . 0.0 110.52 179.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.622 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 0.7 OUTLIER -112.35 125.73 54.51 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.341 176.008 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.438 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 16.1 t -142.75 138.1 15.77 Favored Pre-proline 0 C--N 1.317 -0.832 0 CA-C-N 113.968 -1.469 . . . . 0.0 110.785 -173.433 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.68 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 27.1 Cg_exo . . . . . 0 C--N 1.345 0.369 0 C-N-CA 123.473 2.782 . . . . 0.0 112.252 175.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.496 ' HA ' ' O ' ' A' ' 44' ' ' TYR . 6.2 p . . . . . 0 N--CA 1.449 -0.49 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.622 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 40.4 m -147.86 151.18 35.49 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 120.581 -0.447 . . . . 0.0 111.534 -177.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.863 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 39.6 tt0 -116.05 115.09 25.48 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 172.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.688 HD12 ' CG2' ' A' ' 64' ' ' VAL . 17.0 mt -96.58 153.49 17.82 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 175.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -117.37 118.95 33.63 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.592 HD12 ' CH2' ' A' ' 30' ' ' TRP . 3.5 mt -116.25 156.22 47.38 Favored Pre-proline 0 N--CA 1.444 -0.73 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 -176.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -64.31 151.44 85.42 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 122.009 1.806 . . . . 0.0 111.403 176.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.467 ' HB3' ' C ' ' A' ' 38' ' ' THR . 8.9 pt-20 -47.35 -25.06 0.9 Allowed 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 114.548 -1.205 . . . . 0.0 113.431 179.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.9 t -107.54 12.84 27.36 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.185 0.517 . . . . 0.0 111.013 -176.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.496 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -76.86 156.29 32.29 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 178.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.486 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 27.5 p-10 -141.71 14.61 2.13 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -177.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.612 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 13.8 p -168.78 135.12 1.8 Allowed 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.207 -0.597 . . . . 0.0 112.389 -177.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.692 HG12 ' HZ3' ' A' ' 30' ' ' TRP . 4.8 p -120.03 134.2 64.31 Favored 'Isoleucine or valine' 0 C--O 1.24 0.591 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.309 176.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 25.8 m -96.74 101.2 12.76 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-O 121.526 0.679 . . . . 0.0 109.615 169.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.724 HD11 HG12 ' A' ' 77' ' ' ILE . 0.3 OUTLIER -78.71 144.39 35.34 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.105 179.239 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.423 ' HA ' ' O ' ' A' ' 24' ' ' THR . 12.4 p -141.68 168.58 19.41 Favored 'General case' 0 C--N 1.322 -0.601 0 O-C-N 123.338 0.399 . . . . 0.0 110.519 -173.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 64.04 27.82 14.25 Favored 'General case' 0 C--N 1.331 -0.238 0 O-C-N 123.804 0.69 . . . . 0.0 111.18 -178.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.673 ' O ' HG22 ' A' ' 24' ' ' THR . 15.3 mt -70.11 -175.5 0.97 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.181 0.515 . . . . 0.0 109.712 175.166 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 56.2 tp60 -125.0 122.67 25.48 Favored Pre-proline 0 C--N 1.315 -0.896 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 176.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.402 ' HB3' ' OD2' ' A' ' 23' ' ' ASP . 32.8 Cg_endo -63.12 129.53 26.01 Favored 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 122.891 2.394 . . . . 0.0 112.502 -177.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 86.09 33.37 15.01 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 121.098 -0.572 . . . . 0.0 111.949 -178.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.428 ' CG1' ' HB3' ' A' ' 46' ' ' PRO . 98.9 t -135.99 144.42 33.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.113 0.482 . . . . 0.0 110.93 -176.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.68 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -80.51 115.55 20.09 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.868 179.504 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.406 ' CZ ' ' HG3' ' A' ' 46' ' ' PRO . 13.0 m-85 -111.59 114.46 27.54 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.275 0.559 . . . . 0.0 111.961 -177.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.571 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 37.0 m-80 -87.2 113.47 22.96 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.946 175.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.724 HG12 HD11 ' A' ' 66' ' ' LEU . 5.1 mp -93.37 117.41 36.79 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.574 0 CA-C-O 121.226 0.536 . . . . 0.0 109.578 174.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.877 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 62.1 m -110.84 114.86 28.53 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.476 -179.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.565 ' H ' ' HB ' ' A' ' 91' ' ' VAL . 11.5 mm -95.18 143.23 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 -179.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -129.66 111.7 12.94 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 178.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -82.39 121.93 27.35 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 172.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.493 HG12 ' C ' ' A' ' 39' ' ' GLY . 8.5 p -118.1 132.56 67.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 C-N-CA 119.758 -0.777 . . . . 0.0 112.179 -174.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.684 ' HG2' HG22 ' A' ' 37' ' ' ILE . 18.1 mt-10 -99.58 172.46 7.28 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 172.158 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -38.46 -42.8 0.78 Allowed 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -128.34 -20.15 3.74 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -178.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -98.07 167.76 10.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.145 0.497 . . . . 0.0 111.635 -173.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -145.16 121.49 10.92 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.364 175.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 10.6 m -67.38 169.77 8.44 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.325 -178.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 12.1 p -58.05 150.04 53.02 Favored Pre-proline 0 N--CA 1.451 -0.401 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.16 172.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -76.17 137.67 19.45 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 122.017 1.811 . . . . 0.0 113.06 -178.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.877 ' O ' ' HA ' ' A' ' 78' ' ' THR . 53.0 t -82.33 122.77 37.5 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.707 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 169.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.4 t -117.84 106.39 19.77 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 C-N-CA 119.374 -0.93 . . . . 0.0 110.676 174.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.563 HG13 ' HB ' ' A' ' 77' ' ' ILE . 7.5 pt -120.37 111.73 33.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.457 174.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.44 ' HB2' ' NE2' ' A' ' 74' ' ' GLN . 19.8 pt20 -99.88 121.6 41.55 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.479 0.657 . . . . 0.0 111.403 -174.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.35 130.12 47.27 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.452 179.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.458 ' CG ' ' HG2' ' A' ' 74' ' ' GLN . 37.2 mt-10 -85.97 134.17 33.88 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 176.206 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 21.6 p -69.13 114.26 7.24 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.355 0.598 . . . . 0.0 111.441 -177.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.424 ' H ' HG12 ' A' ' 21' ' ' VAL . 6.9 m . . . . . 0 C--N 1.326 -0.436 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.838 179.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.258 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -64.4 128.54 21.62 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.186 1.924 . . . . 0.0 111.953 178.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_exo -51.53 147.2 23.65 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.57 2.18 . . . . 0.0 111.094 174.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.43 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 6.9 m-20 -34.4 107.64 0.31 Allowed Pre-proline 0 N--CA 1.47 0.536 0 O-C-N 124.613 1.196 . . . . 0.0 113.016 -168.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.603 ' HG2' HG11 ' A' ' 91' ' ' VAL . 22.2 Cg_exo -68.72 153.34 73.36 Favored 'Trans proline' 0 CA--C 1.52 -0.207 0 C-N-CA 123.478 2.786 . . . . 0.0 111.829 177.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 26.3 m -112.63 133.41 54.68 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.566 0.698 . . . . 0.0 110.975 -177.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.456 HG11 HG22 ' A' ' 21' ' ' VAL . 79.6 t -76.21 121.39 28.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 114.437 -1.256 . . . . 0.0 110.231 175.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -76.55 -50.79 13.02 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.07 -175.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -141.12 142.23 34.12 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.799 -178.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.456 HG22 HG11 ' A' ' 18' ' ' VAL . 57.3 t -121.63 122.74 67.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.924 -177.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -125.58 -167.14 1.65 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.396 177.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.608 ' O ' ' HB2' ' A' ' 69' ' ' LEU . 2.0 p-10 -71.17 -65.17 0.78 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.089 0.471 . . . . 0.0 111.723 177.012 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.599 HG22 ' O ' ' A' ' 69' ' ' LEU . 42.1 p -111.23 34.63 3.96 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.561 -173.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.644 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 73.4 m -169.03 130.64 1.19 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.079 -173.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.585 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 45.0 mt -149.2 140.12 16.93 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.837 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 176.204 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.455 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 43.3 t -116.15 134.37 59.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 C-N-CA 119.834 -0.746 . . . . 0.0 110.166 -174.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.629 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.6 OUTLIER -127.33 146.23 33.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 C-N-CA 120.252 -0.579 . . . . 0.0 109.878 179.851 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.481 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 62.8 mtp180 -130.81 121.24 24.98 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 123.345 0.403 . . . . 0.0 110.472 -175.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.755 ' HZ3' HG12 ' A' ' 64' ' ' VAL . 38.8 p90 -114.1 154.21 28.15 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.369 -173.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 19.7 m -100.01 100.81 11.74 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.469 178.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.604 ' CD ' ' H ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -51.19 157.93 1.42 Allowed Pre-proline 0 CA--C 1.537 0.463 0 C-N-CA 123.482 0.713 . . . . 0.0 112.854 -174.933 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.646 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 3.5 Cg_exo -83.25 163.7 15.08 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 124.244 3.296 . . . . 0.0 112.63 -175.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -73.76 -19.83 60.67 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.322 172.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.415 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . . . -62.98 145.48 96.52 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 114.754 -1.112 . . . . 0.0 111.736 178.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 35' ' ' ALA . 3.1 Cg_exo -74.31 114.84 4.13 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 121.568 1.512 . . . . 0.0 110.085 168.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.532 HD12 ' HE1' ' A' ' 40' ' ' TYR . 0.7 OUTLIER -120.23 153.98 23.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -177.468 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.403 ' N ' ' O ' ' A' ' 82' ' ' VAL . 17.1 p -95.98 -25.31 15.99 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -177.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.561 ' C ' HG12 ' A' ' 82' ' ' VAL . . . -171.55 -164.87 27.92 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 119.944 -1.122 . . . . 0.0 112.235 179.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.646 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 5.8 m-85 -139.75 132.98 29.82 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 122.55 0.34 . . . . 0.0 111.18 173.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 10.8 mmm180 -99.82 151.15 21.61 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 166.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.885 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 37.6 mt -139.48 107.48 3.1 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 C-N-CA 120.134 -0.626 . . . . 0.0 112.162 178.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 71.5 t -108.56 110.33 31.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.392 0.615 . . . . 0.0 110.555 -179.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.635 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 0.6 OUTLIER -110.74 125.25 53.32 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.465 -0.788 . . . . 0.0 109.415 175.359 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.441 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 17.1 p -138.5 137.0 19.51 Favored Pre-proline 0 C--N 1.318 -0.772 0 CA-C-N 113.622 -1.626 . . . . 0.0 111.355 -173.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.657 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 22.0 Cg_exo . . . . . 0 C--O 1.231 0.17 0 C-N-CA 123.283 2.655 . . . . 0.0 112.224 175.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 14.8 m . . . . . 0 CA--C 1.516 -0.339 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.635 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 50.2 m -147.74 148.86 31.43 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.489 -0.484 . . . . 0.0 111.691 -178.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.885 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 45.5 tt0 -115.96 117.13 29.3 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.781 172.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.701 HD12 ' CG2' ' A' ' 64' ' ' VAL . 18.4 mt -97.92 163.43 12.79 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 174.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.404 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 26.3 t-20 -128.96 110.51 12.14 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -178.019 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.585 HD12 ' CH2' ' A' ' 30' ' ' TRP . 3.3 mt -109.35 157.41 37.33 Favored Pre-proline 0 C--N 1.317 -0.844 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -175.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -64.06 149.09 91.18 Favored 'Trans proline' 0 N--CA 1.447 -1.212 0 C-N-CA 121.636 1.557 . . . . 0.0 110.99 175.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -44.02 -26.88 0.32 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.385 -1.279 . . . . 0.0 113.156 178.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 10.8 t -108.05 9.26 28.46 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.465 -173.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.417 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -75.07 161.18 29.65 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 178.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.566 ' HB3' ' NE ' ' A' ' 32' ' ' ARG . 28.3 p-10 -144.12 17.83 1.75 Allowed 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.465 0.542 . . . . 0.0 112.465 -178.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.629 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 17.2 p -169.62 133.76 1.33 Allowed 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.125 -0.63 . . . . 0.0 111.889 178.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.755 HG12 ' HZ3' ' A' ' 30' ' ' TRP . 3.6 p -116.6 138.46 47.12 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.182 176.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 30.0 m -97.94 101.05 12.44 Favored 'General case' 0 N--CA 1.433 -1.299 0 CA-C-O 121.366 0.603 . . . . 0.0 109.457 169.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.688 HD11 HG12 ' A' ' 77' ' ' ILE . 0.3 OUTLIER -77.14 144.19 38.6 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.005 178.327 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 62.1 p -139.62 174.13 10.82 Favored 'General case' 0 C--N 1.319 -0.722 0 O-C-N 123.349 0.406 . . . . 0.0 110.147 -175.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 37.6 t70 61.62 28.52 17.68 Favored 'General case' 0 C--N 1.33 -0.258 0 O-C-N 123.777 0.673 . . . . 0.0 110.715 179.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.608 ' HB2' ' O ' ' A' ' 23' ' ' ASP . 13.9 mt -73.89 -176.2 2.39 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 176.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.584 ' OE1' ' HD2' ' A' ' 71' ' ' PRO . 5.8 tp-100 -132.24 121.31 17.54 Favored Pre-proline 0 C--N 1.318 -0.781 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.584 ' HD2' ' OE1' ' A' ' 70' ' ' GLN . 18.5 Cg_endo -60.62 137.06 71.01 Favored 'Trans proline' 0 C--O 1.235 0.346 0 C-N-CA 122.908 2.405 . . . . 0.0 112.896 -178.005 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.23 26.45 52.18 Favored Glycine 0 N--CA 1.449 -0.463 0 N-CA-C 111.435 -0.666 . . . . 0.0 111.435 -178.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.492 ' HB ' ' O ' ' A' ' 70' ' ' GLN . 77.8 t -131.55 136.02 58.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 120.899 0.38 . . . . 0.0 110.691 -177.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.657 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -80.82 117.53 21.55 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.937 -178.101 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.426 ' CE1' ' HG3' ' A' ' 46' ' ' PRO . 18.9 m-85 -110.42 116.35 31.27 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.252 0.548 . . . . 0.0 112.184 -176.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.496 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 12.1 m120 -89.73 111.18 22.09 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.683 176.02 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.688 HG12 HD11 ' A' ' 66' ' ' LEU . 5.1 mp -92.0 118.82 38.29 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.632 0 CA-C-O 121.16 0.505 . . . . 0.0 109.836 178.057 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.872 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 21.7 m -110.45 115.3 29.4 Favored 'General case' 0 N--CA 1.428 -1.549 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.131 -179.235 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.56 ' HB ' ' HB ' ' A' ' 91' ' ' VAL . 14.1 mm -95.21 142.5 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.43 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 68.7 m-85 -129.6 112.37 13.64 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.335 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.95 122.88 26.7 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 168.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.561 HG12 ' C ' ' A' ' 39' ' ' GLY . 7.9 p -112.66 136.91 47.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.245 -178.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.512 ' HG3' HG22 ' A' ' 37' ' ' ILE . 1.8 mp0 -114.6 171.21 7.77 Favored 'General case' 0 N--CA 1.446 -0.626 0 O-C-N 123.695 0.622 . . . . 0.0 109.659 -177.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -45.3 -44.74 11.7 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -174.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -117.32 -16.73 10.28 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -175.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.499 ' HB2' ' OE1' ' A' ' 83' ' ' GLU . 45.2 mt-30 -128.4 176.05 8.02 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.474 -0.49 . . . . 0.0 111.625 -169.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.443 ' HG2' HG23 ' A' ' 82' ' ' VAL . 45.8 mt-10 -130.33 125.46 34.74 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.289 -0.869 . . . . 0.0 108.967 171.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 45.9 m -72.61 173.94 8.24 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.048 0.452 . . . . 0.0 111.705 -177.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -60.89 155.74 51.41 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.238 178.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -88.28 142.31 5.24 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 122.423 2.082 . . . . 0.0 114.482 -176.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.872 ' O ' ' HA ' ' A' ' 78' ' ' THR . 7.1 t -82.62 126.42 40.02 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.721 0 CA-C-N 114.662 -1.154 . . . . 0.0 108.175 166.002 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.6 t -120.26 106.73 19.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 C-N-CA 119.768 -0.773 . . . . 0.0 110.081 171.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.545 HG13 ' HB ' ' A' ' 77' ' ' ILE . 7.1 pt -123.5 113.35 37.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.54 176.021 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -99.0 126.02 44.61 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.502 0.667 . . . . 0.0 111.458 -175.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.67 127.92 33.93 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.151 -0.932 . . . . 0.0 109.56 176.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.421 ' HA ' ' HA ' ' A' ' 74' ' ' GLN . 37.4 tt0 -87.26 138.17 31.72 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.076 0.465 . . . . 0.0 110.126 176.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 26.5 p -69.55 117.75 11.56 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.238 -177.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 14.3 m . . . . . 0 C--N 1.323 -0.573 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.354 -179.704 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.408 ' HB2' ' O ' ' A' ' 89' ' ' THR . . . . . . . . 0 N--CA 1.45 -0.449 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.413 ' CB ' ' HB2' ' A' ' 30' ' ' TRP . 30.3 Cg_exo -64.52 126.74 17.45 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 121.886 1.724 . . . . 0.0 111.511 175.267 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.505 ' HD2' ' O ' ' A' ' 31' ' ' SER . 84.9 Cg_exo -47.14 146.95 5.83 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.634 2.223 . . . . 0.0 111.114 171.019 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.419 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 10.2 p-10 -37.71 106.67 0.36 Allowed Pre-proline 0 N--CA 1.465 0.302 0 O-C-N 124.743 1.277 . . . . 0.0 112.594 -169.104 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.583 ' HG2' HG11 ' A' ' 91' ' ' VAL . 33.4 Cg_exo -65.59 152.28 82.23 Favored 'Trans proline' 0 CA--C 1.517 -0.329 0 C-N-CA 123.552 2.835 . . . . 0.0 112.015 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 25.8 m -109.45 128.78 55.41 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.898 -178.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.463 ' HA ' ' HA ' ' A' ' 28' ' ' VAL . 83.6 t -74.92 119.21 22.07 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-N 114.415 -1.266 . . . . 0.0 109.591 173.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -88.0 -40.25 14.02 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.184 -173.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 18.0 mm-40 -136.71 139.41 41.9 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.47 -177.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.47 HG11 ' NE2' ' A' ' 95' ' ' GLN . 33.6 m -130.55 133.75 63.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.15 0.5 . . . . 0.0 111.078 178.166 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -134.84 -162.72 1.28 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.064 178.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -69.01 -68.41 0.4 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.105 0.479 . . . . 0.0 111.579 177.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.685 HG22 ' O ' ' A' ' 69' ' ' LEU . 68.2 p -111.87 39.64 2.34 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.905 -174.239 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.711 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 69.9 m -169.12 131.91 1.28 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.371 -0.832 . . . . 0.0 110.322 -171.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.613 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 17.9 mt -150.38 138.45 14.3 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.893 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 176.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 37.7 t -116.35 131.94 67.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 119.002 0.819 . . . . 0.0 110.587 -173.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.631 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.7 OUTLIER -125.94 145.41 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.039 -178.412 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.499 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 77.3 mtt180 -127.13 121.87 32.61 Favored 'General case' 0 N--CA 1.465 0.293 0 O-C-N 123.629 0.581 . . . . 0.0 110.293 -177.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.757 ' HZ3' HG12 ' A' ' 64' ' ' VAL . 28.1 p90 -112.83 146.8 38.23 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.835 -0.621 . . . . 0.0 112.05 -173.41 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.505 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 15.3 m -87.43 88.63 7.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.482 179.246 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.675 ' HD3' ' H ' ' A' ' 32' ' ' ARG . 0.4 OUTLIER -48.77 156.26 0.91 Allowed Pre-proline 0 CA--C 1.54 0.582 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -174.698 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.706 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 1.6 Cg_endo -85.7 169.26 9.37 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 124.307 3.338 . . . . 0.0 112.428 -173.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -93.86 -5.36 48.19 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.836 177.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -67.88 144.48 97.29 Favored Pre-proline 0 C--O 1.234 0.265 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.041 173.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_exo -70.76 112.72 3.32 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 121.272 1.314 . . . . 0.0 109.898 172.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.611 HD12 ' HE1' ' A' ' 40' ' ' TYR . 5.0 pt -121.36 151.93 24.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.08 -172.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.45 HG21 ' HA ' ' A' ' 84' ' ' GLU . 16.8 p -98.33 -26.78 14.38 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -176.287 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.436 ' O ' HG12 ' A' ' 82' ' ' VAL . . . -173.36 -164.16 28.18 Favored Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 119.575 -1.298 . . . . 0.0 112.582 177.43 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.706 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 6.4 m-85 -138.88 135.4 34.44 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 120.975 0.417 . . . . 0.0 111.041 177.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 4.0 mtm105 -108.95 146.62 33.53 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 169.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.891 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 34.9 mt -138.76 109.58 4.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -174.227 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 75.3 t -109.67 110.54 32.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.297 0.57 . . . . 0.0 110.66 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.662 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 1.1 p90 -114.08 125.76 54.34 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.607 176.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.0 m -137.87 145.29 47.63 Favored Pre-proline 0 C--N 1.313 -1.014 0 CA-C-N 114.077 -1.419 . . . . 0.0 111.164 -173.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.576 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 55.7 Cg_endo . . . . . 0 N--CA 1.472 0.225 0 C-N-CA 123.443 2.762 . . . . 0.0 111.928 178.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 7.0 m . . . . . 0 CA--C 1.517 -0.296 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.662 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 86.4 m -147.02 151.05 36.31 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.332 -178.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.891 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 31.8 tt0 -119.82 122.86 42.29 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.496 175.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.736 HD12 ' CG2' ' A' ' 64' ' ' VAL . 16.9 mt -104.58 157.89 16.86 Favored 'General case' 0 CA--C 1.514 -0.406 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.129 175.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -122.02 114.68 21.29 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 177.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.531 HD12 ' CH2' ' A' ' 30' ' ' TRP . 2.1 mt -111.6 156.8 40.86 Favored Pre-proline 0 C--N 1.317 -0.843 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -175.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -63.24 150.16 89.36 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 121.912 1.742 . . . . 0.0 111.448 176.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.414 ' HB3' ' C ' ' A' ' 38' ' ' THR . 10.3 pt-20 -43.94 -28.74 0.49 Allowed 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 114.59 -1.186 . . . . 0.0 112.98 176.326 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.1 t -106.93 19.28 20.69 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.161 -175.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.486 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -82.15 152.78 26.34 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.181 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.499 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 28.5 p-10 -132.59 5.53 4.01 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -177.028 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.631 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 35.5 p -166.18 134.3 2.9 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 119.905 -0.718 . . . . 0.0 111.869 -175.125 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.757 HG12 ' HZ3' ' A' ' 30' ' ' TRP . 4.7 p -114.53 135.3 54.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.259 175.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 54.3 m -97.4 99.41 10.84 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 121.572 0.701 . . . . 0.0 109.146 169.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.711 ' O ' ' HA ' ' A' ' 25' ' ' SER . 0.7 OUTLIER -73.96 144.54 45.2 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.094 -0.957 . . . . 0.0 108.907 179.05 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.452 ' HA ' ' O ' ' A' ' 24' ' ' THR . 10.6 t -142.35 167.46 22.04 Favored 'General case' 0 C--N 1.318 -0.791 0 O-C-N 123.56 0.537 . . . . 0.0 109.714 -173.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 62.77 27.48 16.1 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 123.881 0.738 . . . . 0.0 111.202 -178.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.685 ' O ' HG22 ' A' ' 24' ' ' THR . 13.6 mt -71.09 -174.92 1.05 Allowed 'General case' 0 C--O 1.225 -0.2 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 173.052 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.498 ' HB2' HG21 ' A' ' 73' ' ' VAL . 67.8 mm-40 -122.99 133.43 24.49 Favored Pre-proline 0 C--N 1.317 -0.846 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 175.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -63.71 126.19 16.98 Favored 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 122.513 2.142 . . . . 0.0 112.125 177.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 82.67 39.42 10.65 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.741 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.498 HG21 ' HB2' ' A' ' 70' ' ' GLN . 72.1 t -136.58 138.13 46.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.039 0.447 . . . . 0.0 110.843 -179.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.576 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -80.93 120.25 24.5 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.719 -179.841 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.526 ' CE2' ' HB3' ' A' ' 69' ' ' LEU . 30.1 m-85 -113.66 117.72 32.34 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.499 0.666 . . . . 0.0 112.44 -178.021 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.463 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 6.9 m120 -85.85 110.74 19.61 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.019 172.274 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.69 HG12 HD11 ' A' ' 66' ' ' LEU . 5.1 mp -92.21 121.89 43.18 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.562 0 CA-C-O 121.064 0.459 . . . . 0.0 109.866 176.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.896 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 48.2 m -111.73 114.57 27.65 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.861 179.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.577 ' HB ' ' HB ' ' A' ' 91' ' ' VAL . 13.5 mm -95.91 130.14 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -117.94 113.07 21.16 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 177.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -88.98 125.46 34.99 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 173.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.436 HG12 ' O ' ' A' ' 39' ' ' GLY . 8.1 p -118.6 133.5 65.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 C-N-CA 120.09 -0.644 . . . . 0.0 112.127 -173.396 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.536 ' HG2' HG22 ' A' ' 37' ' ' ILE . 8.9 mt-10 -100.58 173.6 6.47 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.127 172.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.45 ' HA ' HG21 ' A' ' 38' ' ' THR . 26.0 mt-10 -34.93 -44.55 0.23 Allowed 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -176.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -135.03 2.77 3.12 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -176.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 26.3 pt20 -146.45 176.14 10.02 Favored 'General case' 0 C--O 1.218 -0.591 0 CA-C-N 118.939 0.791 . . . . 0.0 111.552 -179.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -126.67 154.95 43.38 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.768 -179.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 16.9 m -85.73 -175.27 5.55 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.453 176.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.408 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 1.4 p -62.65 158.69 49.04 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.449 173.219 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -87.33 140.08 5.33 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 122.065 1.843 . . . . 0.0 113.674 -178.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.896 ' O ' ' HA ' ' A' ' 78' ' ' THR . 8.6 t -83.29 125.68 40.09 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.744 0 CA-C-N 114.868 -1.06 . . . . 0.0 108.49 167.216 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 5.9 t -125.03 106.58 16.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 C-N-CA 119.958 -0.697 . . . . 0.0 110.078 171.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.528 HG13 ' HB ' ' A' ' 77' ' ' ILE . 5.9 pt -124.76 116.32 47.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.906 179.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.406 ' HB2' HE22 ' A' ' 74' ' ' GLN . 3.8 pt20 -99.47 129.49 45.65 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.456 0.646 . . . . 0.0 111.332 -175.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.47 ' NE2' HG11 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -140.94 130.84 24.44 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.021 177.177 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.41 ' HA ' ' HA ' ' A' ' 74' ' ' GLN . 39.6 tt0 -92.63 138.12 31.77 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.204 0.526 . . . . 0.0 110.745 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 34.1 p -68.81 124.64 24.24 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.741 -176.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 40.0 m . . . . . 0 C--N 1.329 -0.315 0 CA-C-O 121.503 0.668 . . . . 0.0 110.237 177.664 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.483 ' HB2' ' O ' ' A' ' 89' ' ' THR . . . . . . . . 0 N--CA 1.453 -0.298 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -62.23 128.45 23.92 Favored 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.295 1.997 . . . . 0.0 111.787 175.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.496 ' HD2' ' O ' ' A' ' 31' ' ' SER . 86.9 Cg_exo -47.12 140.24 14.37 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.71 2.274 . . . . 0.0 111.349 174.057 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.44 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 5.9 p-10 -33.85 106.96 0.28 Allowed Pre-proline 0 N--CA 1.467 0.396 0 O-C-N 124.929 1.393 . . . . 0.0 112.478 -168.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.564 ' HG2' HG11 ' A' ' 91' ' ' VAL . 39.1 Cg_exo -61.91 152.49 74.64 Favored 'Trans proline' 0 CA--C 1.517 -0.344 0 C-N-CA 123.727 2.951 . . . . 0.0 112.718 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.9 m -107.6 128.27 54.39 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.656 -178.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.468 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 69.5 t -78.46 117.12 23.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-N 114.337 -1.301 . . . . 0.0 109.725 173.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -83.63 -36.89 23.52 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.377 -173.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -135.6 138.38 42.87 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.471 -178.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.495 ' HA ' HG12 ' A' ' 26' ' ' ILE . 6.3 m -129.54 120.33 50.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.205 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.407 ' HB3' ' H ' ' A' ' 23' ' ' ASP . 8.4 m-20 -133.69 -165.33 1.62 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.46 -179.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.571 ' O ' ' HB2' ' A' ' 69' ' ' LEU . 3.3 p-10 -67.77 -65.13 0.73 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.971 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.672 HG22 ' O ' ' A' ' 69' ' ' LEU . 39.7 p -115.33 35.5 4.35 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.876 -172.038 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.689 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 18.6 p -169.79 130.7 1.03 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.787 -174.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.573 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 17.0 mt -146.95 135.97 16.11 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.608 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 177.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.468 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 39.9 t -115.1 129.81 70.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 C-N-CA 120.013 -0.675 . . . . 0.0 110.497 -174.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.663 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.8 OUTLIER -123.76 143.89 35.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.044 -177.544 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.534 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 85.8 mtt180 -128.03 121.63 30.22 Favored 'General case' 0 N--CA 1.465 0.297 0 O-C-N 123.79 0.681 . . . . 0.0 110.314 -177.13 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.674 ' HZ3' HG12 ' A' ' 64' ' ' VAL . 30.2 p90 -111.39 140.5 45.93 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.189 -173.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.496 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 61.8 m -82.51 88.19 6.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.13 175.27 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.437 ' HD3' ' H ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -49.08 156.46 0.96 Allowed Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -175.485 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.658 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 3.4 Cg_exo -80.36 169.26 17.47 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 123.886 3.057 . . . . 0.0 112.846 -174.378 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -86.57 -14.84 41.71 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.139 172.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -57.51 135.25 82.07 Favored Pre-proline 0 CA--C 1.517 -0.309 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.162 173.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -67.33 112.39 2.55 Favored 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 120.937 1.091 . . . . 0.0 109.774 172.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.674 HD12 ' HE1' ' A' ' 40' ' ' TYR . 1.6 pt -118.27 151.43 20.36 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -174.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.466 ' C ' ' HB3' ' A' ' 59' ' ' GLU . 11.0 p -98.56 -30.53 12.45 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -178.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.537 ' C ' HG12 ' A' ' 82' ' ' VAL . . . -162.86 -166.66 22.03 Favored Glycine 0 N--CA 1.438 -1.209 0 C-N-CA 120.153 -1.022 . . . . 0.0 112.044 -177.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.674 ' HE1' HD12 ' A' ' 37' ' ' ILE . 6.3 m-85 -141.54 134.46 28.9 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 122.613 0.365 . . . . 0.0 110.875 174.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.3 mmm180 -102.53 149.41 24.43 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 168.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.879 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 30.7 mt -139.55 108.4 3.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 C-N-CA 120.037 -0.665 . . . . 0.0 112.389 -179.297 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 71.7 t -107.53 110.57 32.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.182 0.515 . . . . 0.0 110.836 179.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.656 ' CZ ' ' HB ' ' A' ' 53' ' ' THR . 1.4 p90 -114.9 127.3 55.62 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.948 176.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.3 p -141.81 137.41 16.11 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 113.718 -1.583 . . . . 0.0 111.754 -175.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.595 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 58.1 Cg_endo . . . . . 0 C--N 1.342 0.2 0 C-N-CA 123.275 2.65 . . . . 0.0 111.9 176.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.431 ' HA ' ' O ' ' A' ' 44' ' ' TYR . 14.9 m . . . . . 0 CA--C 1.512 -0.492 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.656 ' HB ' ' CZ ' ' A' ' 44' ' ' TYR . 36.1 m -147.62 149.95 33.49 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 120.111 -0.636 . . . . 0.0 111.563 -179.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.879 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 26.4 tt0 -116.95 112.0 20.39 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.585 174.413 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.709 HD12 ' CG2' ' A' ' 64' ' ' VAL . 23.8 mt -96.09 159.04 15.17 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.072 177.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.455 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 24.7 t-20 -125.2 114.86 19.55 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -179.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.575 HD12 ' CH2' ' A' ' 30' ' ' TRP . 4.4 mt -112.1 157.68 39.1 Favored Pre-proline 0 C--N 1.317 -0.843 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 -176.369 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -68.3 152.54 75.66 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 121.749 1.632 . . . . 0.0 111.06 175.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.466 ' HB3' ' C ' ' A' ' 38' ' ' THR . 11.7 pt-20 -45.62 -27.07 0.71 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.796 -1.093 . . . . 0.0 112.758 176.01 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 11.1 t -101.44 18.74 19.36 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.277 0.561 . . . . 0.0 111.1 -174.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.432 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -93.04 157.92 16.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.394 179.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.534 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 26.6 p-10 -143.05 13.74 1.86 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -178.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.663 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 80.5 p -165.26 134.3 3.4 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 119.876 -0.729 . . . . 0.0 111.936 -177.042 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.709 ' CG2' HD12 ' A' ' 55' ' ' LEU . 3.8 p -117.43 134.81 59.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.346 175.082 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 35.1 m -96.57 101.22 12.8 Favored 'General case' 0 N--CA 1.434 -1.255 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.498 169.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.691 HD11 HG12 ' A' ' 77' ' ' ILE . 0.3 OUTLIER -78.3 144.57 35.98 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.1 178.33 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.405 ' HA ' ' O ' ' A' ' 24' ' ' THR . 13.2 p -138.47 166.58 23.92 Favored 'General case' 0 C--N 1.318 -0.783 0 O-C-N 123.514 0.508 . . . . 0.0 110.826 -173.241 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 64.2 27.1 13.92 Favored 'General case' 0 N--CA 1.463 0.2 0 O-C-N 123.757 0.661 . . . . 0.0 111.679 179.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.672 ' O ' HG22 ' A' ' 24' ' ' THR . 11.1 mt -70.31 -176.16 1.14 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 175.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 57.9 tp60 -127.44 124.05 23.43 Favored Pre-proline 0 C--N 1.32 -0.696 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 177.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -62.62 135.55 53.43 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 123.083 2.522 . . . . 0.0 113.31 -177.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.67 25.21 39.42 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.907 179.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 87.4 t -129.99 148.77 33.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.27 0.557 . . . . 0.0 111.289 -174.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.595 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -87.33 121.5 29.86 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.648 -179.588 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -118.02 116.8 27.63 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.153 0.501 . . . . 0.0 112.24 -174.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.555 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 3.9 m-20 -89.96 113.13 24.72 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.376 176.474 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.691 HG12 HD11 ' A' ' 66' ' ' LEU . 5.1 mp -95.27 118.72 42.1 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.546 0 CA-C-O 121.057 0.455 . . . . 0.0 109.836 174.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.856 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 36.8 m -110.85 115.53 29.68 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.253 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.565 ' HB ' ' HB ' ' A' ' 91' ' ' VAL . 13.8 mm -95.89 145.27 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -179.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.414 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 53.0 m-85 -131.13 111.32 11.87 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 177.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.42 ' HB1' HG21 ' A' ' 37' ' ' ILE . . . -80.71 112.08 17.75 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 172.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.537 HG12 ' C ' ' A' ' 39' ' ' GLY . 7.4 p -106.68 135.54 44.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 C-N-CA 119.718 -0.793 . . . . 0.0 111.019 -174.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.416 ' HG2' HG22 ' A' ' 37' ' ' ILE . 4.8 mt-10 -109.05 172.06 7.07 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 177.433 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -44.67 -51.42 9.2 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 123.585 0.553 . . . . 0.0 112.136 178.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 -111.39 -14.19 13.79 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -171.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -135.43 172.81 12.47 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.32 -0.552 . . . . 0.0 111.882 -170.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -128.87 133.61 48.0 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 175.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 13.4 m -78.52 170.84 16.0 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.699 0.285 . . . . 0.0 110.914 -178.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.483 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 0.6 OUTLIER -57.9 158.24 13.24 Favored Pre-proline 0 N--CA 1.449 -0.51 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.767 174.758 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -87.07 138.79 5.04 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 122.067 1.844 . . . . 0.0 113.748 -177.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.856 ' O ' ' HA ' ' A' ' 78' ' ' THR . 5.0 t -82.38 124.26 39.09 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.795 0 CA-C-N 114.707 -1.133 . . . . 0.0 108.397 167.296 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 5.0 t -119.61 106.74 19.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 C-N-CA 119.689 -0.804 . . . . 0.0 109.99 171.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.514 HG13 ' HB ' ' A' ' 77' ' ' ILE . 5.9 pt -126.02 111.7 27.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.788 176.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.09 133.45 43.35 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.158 0.504 . . . . 0.0 110.499 -178.509 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.438 ' NE2' HG11 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -139.26 140.44 37.68 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.094 178.0 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.469 ' HG2' ' HG2' ' A' ' 74' ' ' GLN . 38.3 mt-10 -86.26 146.86 26.34 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.952 0.405 . . . . 0.0 110.427 177.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 40.0 p -82.81 114.86 21.42 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.339 177.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 26.7 m . . . . . 0 C--N 1.323 -0.545 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.907 -176.717 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.328 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.418 ' HB2' ' HB2' ' A' ' 30' ' ' TRP . 23.0 Cg_exo -67.25 127.52 16.81 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.421 2.081 . . . . 0.0 111.999 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.587 ' HD2' ' O ' ' A' ' 31' ' ' SER . 80.0 Cg_exo -46.58 145.54 6.22 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 123.186 2.59 . . . . 0.0 112.174 174.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.426 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 24.2 t70 -35.27 105.37 0.28 Allowed Pre-proline 0 N--CA 1.468 0.44 0 O-C-N 124.884 1.365 . . . . 0.0 112.569 -169.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.651 ' HG2' HG11 ' A' ' 91' ' ' VAL . 23.7 Cg_exo -69.19 149.59 70.68 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 123.58 2.853 . . . . 0.0 112.796 -178.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.5 m -107.47 131.07 54.7 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.735 -177.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.512 HG13 ' O ' ' A' ' 27' ' ' VAL . 72.5 t -73.66 123.72 29.37 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.022 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.062 175.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -83.34 -47.67 11.22 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.845 -174.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -135.48 137.54 42.26 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.11 -178.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.512 HG22 HG11 ' A' ' 18' ' ' VAL . 30.3 t -121.52 115.13 45.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.642 177.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -123.09 -167.55 1.62 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.347 177.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.552 ' O ' ' HB2' ' A' ' 69' ' ' LEU . 1.7 p-10 -70.55 -68.41 0.43 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.145 -0.479 . . . . 0.0 112.043 178.117 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.604 HG22 ' O ' ' A' ' 69' ' ' LEU . 38.1 p -106.72 31.95 4.89 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.699 -172.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.648 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 11.6 p -171.24 132.51 0.81 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.502 -174.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.579 ' HB ' HD12 ' A' ' 66' ' ' LEU . 44.9 mt -145.86 145.0 20.61 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.742 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 177.341 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.512 ' O ' HG13 ' A' ' 18' ' ' VAL . 35.6 t -117.44 137.67 50.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 C-N-CA 120.03 -0.668 . . . . 0.0 109.782 -174.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.64 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.6 OUTLIER -130.68 146.39 34.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 C-N-CA 119.974 -0.69 . . . . 0.0 110.229 178.331 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.481 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 34.9 mtp180 -129.63 120.35 25.09 Favored 'General case' 0 C--N 1.327 -0.402 0 O-C-N 123.623 0.577 . . . . 0.0 110.045 -175.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.753 ' HZ3' HG12 ' A' ' 64' ' ' VAL . 37.1 p90 -113.23 148.93 34.54 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.051 -174.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.587 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 13.6 m -93.7 100.4 12.63 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.936 178.498 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.638 ' NE ' ' HB3' ' A' ' 62' ' ' ASN . 0.1 OUTLIER -53.83 156.26 5.15 Favored Pre-proline 0 CA--C 1.538 0.482 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -174.314 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.65 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 2.4 Cg_endo -83.84 168.51 12.34 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 124.341 3.361 . . . . 0.0 112.474 -174.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -82.49 -16.32 49.22 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.019 172.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -59.62 141.65 88.34 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 114.621 -1.172 . . . . 0.0 111.304 177.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -69.75 112.76 3.16 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 121.035 1.156 . . . . 0.0 109.85 171.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.609 HD12 ' HE1' ' A' ' 40' ' ' TYR . 1.4 pt -121.42 147.33 25.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -176.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 17.4 p -97.39 -20.39 17.84 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -177.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.546 ' C ' HG12 ' A' ' 82' ' ' VAL . . . -173.63 -164.1 28.26 Favored Glycine 0 CA--C 1.501 -0.789 0 C-N-CA 119.877 -1.154 . . . . 0.0 111.957 177.19 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.65 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 6.5 m-85 -139.88 132.84 29.38 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-O 120.849 0.357 . . . . 0.0 111.069 173.644 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 8.7 mmm180 -103.49 149.31 24.97 Favored 'General case' 0 CA--C 1.503 -0.851 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 167.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.885 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 33.8 mt -138.73 108.25 4.11 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 C-N-CA 119.939 -0.705 . . . . 0.0 112.219 -178.512 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 72.0 t -107.94 110.38 31.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.299 0.571 . . . . 0.0 110.396 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.612 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 1.0 OUTLIER -110.64 125.42 53.41 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.328 176.071 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 39.9 p -140.01 135.47 16.43 Favored Pre-proline 0 C--N 1.316 -0.864 0 CA-C-N 113.922 -1.49 . . . . 0.0 111.217 -174.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.514 ' HG3' ' CE2' ' A' ' 75' ' ' TYR . 10.5 Cg_exo . . . . . 0 N--CA 1.462 -0.365 0 C-N-CA 122.815 2.344 . . . . 0.0 111.154 173.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.477 ' HA ' ' O ' ' A' ' 44' ' ' TYR . 16.5 m . . . . . 0 CA--C 1.515 -0.374 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.612 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 58.6 m -147.13 152.34 38.29 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.408 -177.048 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.885 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 33.2 tt0 -116.5 117.5 30.08 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.85 174.129 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.703 HD12 ' CG2' ' A' ' 64' ' ' VAL . 18.3 mt -97.3 158.06 15.65 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 174.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -123.45 111.06 15.88 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.607 -178.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.569 HD12 ' CH2' ' A' ' 30' ' ' TRP . 3.4 mt -109.59 155.55 41.16 Favored Pre-proline 0 N--CA 1.444 -0.771 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -177.152 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -64.35 148.83 90.93 Favored 'Trans proline' 0 N--CA 1.448 -1.172 0 C-N-CA 121.611 1.54 . . . . 0.0 110.635 175.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.467 ' HB2' HG13 ' A' ' 37' ' ' ILE . 8.4 pt-20 -44.04 -27.58 0.39 Allowed 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 114.729 -1.123 . . . . 0.0 113.197 178.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.8 t -103.35 6.99 38.23 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.44 -173.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.421 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -76.41 158.5 31.33 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 178.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.638 ' HB3' ' NE ' ' A' ' 32' ' ' ARG . 29.2 p-10 -141.98 18.29 2.12 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -177.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.64 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 25.5 p -169.76 134.2 1.33 Allowed 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.209 -0.597 . . . . 0.0 111.715 179.288 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.753 HG12 ' HZ3' ' A' ' 30' ' ' TRP . 3.7 p -116.81 137.55 50.31 Favored 'Isoleucine or valine' 0 C--O 1.243 0.728 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.489 176.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 68.3 m -96.92 101.18 12.72 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.579 169.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.678 HD11 HG12 ' A' ' 77' ' ' ILE . 0.2 OUTLIER -80.19 145.38 32.31 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.474 -0.784 . . . . 0.0 108.928 178.647 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 8.8 t -141.06 174.14 10.8 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.27 -174.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 62.78 27.22 15.98 Favored 'General case' 0 C--N 1.329 -0.304 0 O-C-N 123.8 0.688 . . . . 0.0 111.272 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.604 ' O ' HG22 ' A' ' 24' ' ' THR . 10.9 mt -74.65 -176.36 2.77 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.275 -0.421 . . . . 0.0 109.883 177.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 57.3 tp60 -130.35 123.27 20.44 Favored Pre-proline 0 C--N 1.32 -0.709 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -62.0 133.59 45.12 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.961 2.441 . . . . 0.0 113.035 -177.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 87.42 25.24 33.85 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.788 -178.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.505 ' CG1' ' HB3' ' A' ' 46' ' ' PRO . 94.9 t -131.02 142.81 42.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.027 0.441 . . . . 0.0 110.841 -176.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.493 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 10.3 tp60 -86.36 107.45 18.01 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.002 -177.339 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.514 ' CE2' ' HG3' ' A' ' 46' ' ' PRO . 18.8 m-85 -99.13 119.95 38.69 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.097 0.475 . . . . 0.0 111.69 -177.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.507 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 13.3 m120 -92.72 109.21 20.62 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.418 177.164 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.678 HG12 HD11 ' A' ' 66' ' ' LEU . 5.0 mp -91.76 116.72 33.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.246 0.546 . . . . 0.0 109.642 178.121 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.884 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 81.1 m -108.9 115.81 30.8 Favored 'General case' 0 N--CA 1.427 -1.605 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.441 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.544 ' HB ' ' HB ' ' A' ' 91' ' ' VAL . 13.5 mm -95.12 141.26 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 -179.285 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -128.79 111.79 13.49 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.91 178.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.444 ' HB3' ' OG ' ' A' ' 88' ' ' SER . . . -78.97 119.5 22.22 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 168.212 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.546 HG12 ' C ' ' A' ' 39' ' ' GLY . 7.6 p -106.77 133.87 50.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 C-N-CA 120.092 -0.643 . . . . 0.0 110.049 -178.206 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.467 ' HG3' HG22 ' A' ' 37' ' ' ILE . 1.4 mp0 -111.01 170.22 8.24 Favored 'General case' 0 N--CA 1.445 -0.68 0 O-C-N 123.579 0.549 . . . . 0.0 110.068 -178.12 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.441 ' H ' ' HG3' ' A' ' 84' ' ' GLU . 30.7 mt-10 -43.68 -46.99 7.65 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.119 -0.946 . . . . 0.0 112.676 -174.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 -125.12 6.14 7.87 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -174.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -147.81 177.24 9.48 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.854 0.359 . . . . 0.0 111.762 -172.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -133.04 124.41 27.6 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.172 176.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.444 ' OG ' ' HB3' ' A' ' 81' ' ' ALA . 92.9 p -70.81 170.43 12.55 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.908 0.385 . . . . 0.0 111.569 -178.022 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 18.7 p -60.73 153.05 65.37 Favored Pre-proline 0 CA--C 1.531 0.218 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.772 175.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -83.38 144.55 11.59 Favored 'Trans proline' 0 CA--C 1.534 0.499 0 C-N-CA 122.31 2.007 . . . . 0.0 114.712 -175.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.884 ' O ' ' HA ' ' A' ' 78' ' ' THR . 11.7 t -83.49 129.38 37.61 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.581 0 CA-C-N 114.614 -1.176 . . . . 0.0 107.975 163.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.3 t -125.1 106.87 17.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 C-N-CA 120.046 -0.661 . . . . 0.0 110.13 173.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.574 HG13 ' HB ' ' A' ' 77' ' ' ILE . 9.7 pt -125.04 113.14 34.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.259 179.266 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.423 ' HB3' ' ND2' ' A' ' 76' ' ' ASN . 11.1 pt20 -98.72 125.33 44.01 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.558 0.694 . . . . 0.0 111.675 -176.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.98 127.3 35.99 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.389 176.285 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.437 ' HA ' ' HA ' ' A' ' 74' ' ' GLN . 28.8 tt0 -87.17 127.25 35.15 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.34 0.59 . . . . 0.0 109.851 178.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.405 HG22 HD11 ' A' ' 26' ' ' ILE . 22.7 p -59.79 116.88 4.39 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.851 -1.068 . . . . 0.0 111.719 -175.265 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.7 m . . . . . 0 C--N 1.324 -0.532 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.281 -178.476 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.163 0 N-CA-C 109.379 -0.601 . . . . 0.0 109.379 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -70.93 127.09 13.22 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 121.811 1.674 . . . . 0.0 111.166 176.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.518 ' HD2' ' O ' ' A' ' 31' ' ' SER . 84.6 Cg_exo -48.16 145.6 10.76 Favored 'Trans proline' 0 CA--C 1.515 -0.443 0 C-N-CA 122.874 2.382 . . . . 0.0 111.401 173.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.429 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 17.3 t70 -35.67 106.37 0.31 Allowed Pre-proline 0 N--CA 1.466 0.335 0 O-C-N 124.939 1.399 . . . . 0.0 111.993 -169.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.589 ' HG2' HG11 ' A' ' 91' ' ' VAL . 27.4 Cg_exo -67.03 146.13 76.05 Favored 'Trans proline' 0 CA--C 1.518 -0.305 0 C-N-CA 123.526 2.818 . . . . 0.0 112.045 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.8 m -105.57 131.46 52.93 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.894 -176.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.407 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 93.4 t -73.12 111.44 7.67 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-N 114.471 -1.24 . . . . 0.0 109.315 173.194 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -78.8 -45.0 21.91 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.277 -171.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -139.31 139.88 37.42 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.437 -178.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.416 HG13 HG12 ' A' ' 26' ' ' ILE . 60.5 t -129.12 132.6 66.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.868 -176.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -132.25 -161.86 1.18 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.765 174.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -71.75 -68.52 0.45 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.087 0.47 . . . . 0.0 112.109 177.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.625 HG22 ' O ' ' A' ' 69' ' ' LEU . 68.6 p -106.99 36.78 2.55 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.216 0.531 . . . . 0.0 111.176 -173.104 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.543 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 19.8 p -172.23 140.75 1.18 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.399 -174.108 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.578 ' HB ' HD12 ' A' ' 66' ' ' LEU . 46.5 mt -149.38 155.91 7.87 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.699 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.32 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 39.7 t -128.17 133.48 66.93 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.572 0 CA-C-N 119.373 0.988 . . . . 0.0 110.206 179.159 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.651 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.7 OUTLIER -125.45 145.16 33.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 C-N-CA 120.197 -0.601 . . . . 0.0 109.924 179.45 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.471 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 20.6 mtp180 -130.24 121.08 25.48 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 123.373 0.421 . . . . 0.0 110.563 -174.403 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.629 ' HZ3' HG12 ' A' ' 64' ' ' VAL . 35.2 p90 -111.98 146.48 37.78 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.734 -175.169 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.518 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 33.0 t -89.99 88.68 7.4 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.333 174.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.579 ' HD3' ' H ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -49.55 155.55 1.33 Allowed Pre-proline 0 CA--C 1.541 0.597 0 CA-C-N 115.151 -0.931 . . . . 0.0 112.77 -174.32 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.717 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 2.8 Cg_exo -75.87 170.0 21.04 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.948 3.099 . . . . 0.0 113.953 -169.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 24.7 tt0 -80.35 -22.65 41.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.705 -1.134 . . . . 0.0 108.523 169.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.8 135.38 78.89 Favored Pre-proline 0 CA--C 1.517 -0.299 0 CA-C-N 114.804 -1.089 . . . . 0.0 111.054 177.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -69.83 113.13 3.29 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 121.099 1.2 . . . . 0.0 109.755 171.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.559 HD12 ' HE1' ' A' ' 40' ' ' TYR . 0.6 OUTLIER -118.44 154.2 20.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -174.409 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.425 ' N ' ' O ' ' A' ' 82' ' ' VAL . 7.3 p -94.4 -33.94 12.96 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -179.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.514 ' C ' HG12 ' A' ' 82' ' ' VAL . . . -162.39 -167.53 22.96 Favored Glycine 0 N--CA 1.438 -1.232 0 C-N-CA 120.036 -1.078 . . . . 0.0 112.419 -177.014 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.717 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 4.6 m-85 -137.9 134.07 34.58 Favored 'General case' 0 C--N 1.319 -0.729 0 O-C-N 123.745 0.321 . . . . 0.0 110.897 174.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.6 mmm180 -104.06 147.71 27.09 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 167.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.887 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 22.7 mt -138.66 108.23 4.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 C-N-CA 119.961 -0.696 . . . . 0.0 111.959 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 72.1 t -111.2 109.41 28.39 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.646 0 CA-C-O 121.364 0.602 . . . . 0.0 110.317 179.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.665 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 0.6 OUTLIER -111.58 125.07 53.54 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.549 177.598 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.428 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 23.1 t -141.98 137.44 15.96 Favored Pre-proline 0 C--N 1.316 -0.881 0 CA-C-N 114.158 -1.383 . . . . 0.0 111.192 -172.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.68 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 15.1 Cg_exo . . . . . 0 C--N 1.344 0.319 0 C-N-CA 123.276 2.651 . . . . 0.0 111.706 174.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.524 ' HA ' ' O ' ' A' ' 44' ' ' TYR . 17.7 m . . . . . 0 CA--C 1.515 -0.398 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.665 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 89.7 m -147.15 147.47 30.56 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.75 -175.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.887 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 33.4 tt0 -115.39 112.29 22.11 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.892 174.303 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.714 HD12 ' CG2' ' A' ' 64' ' ' VAL . 17.2 mt -98.0 152.99 18.7 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.561 -0.456 . . . . 0.0 109.8 174.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -116.7 118.35 32.31 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 177.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.582 HD12 ' CH2' ' A' ' 30' ' ' TRP . 3.2 mt -115.04 157.17 44.11 Favored Pre-proline 0 N--CA 1.444 -0.766 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -176.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -65.57 150.4 86.62 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 121.826 1.684 . . . . 0.0 110.991 174.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.408 ' HB2' HG13 ' A' ' 37' ' ' ILE . 10.0 pt-20 -47.12 -27.66 1.48 Allowed 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 115.217 -0.902 . . . . 0.0 112.48 177.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.8 t -102.59 15.08 30.3 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.138 -174.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.43 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -83.34 163.58 20.55 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 177.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.471 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 5.2 p-10 -150.08 12.97 0.77 Allowed 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.153 -0.619 . . . . 0.0 112.436 -176.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.651 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 20.1 m -162.89 134.92 5.27 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 117.634 0.197 . . . . 0.0 110.776 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.714 ' CG2' HD12 ' A' ' 55' ' ' LEU . 4.1 p -117.58 138.81 47.05 Favored 'Isoleucine or valine' 0 C--O 1.244 0.802 0 CA-C-O 120.662 0.267 . . . . 0.0 110.508 174.304 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 52.6 m -98.76 101.74 13.25 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-O 121.741 0.782 . . . . 0.0 110.162 171.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.594 HD11 HG12 ' A' ' 77' ' ' ILE . 0.5 OUTLIER -75.66 138.17 41.18 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.067 -0.969 . . . . 0.0 108.896 177.455 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 14.0 p -132.17 159.98 37.4 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 123.193 0.308 . . . . 0.0 111.502 -171.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 64.43 34.26 10.48 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.491 175.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.625 ' O ' HG22 ' A' ' 24' ' ' THR . 14.6 mt -74.34 -175.93 2.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.986 175.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.471 ' HB2' HG21 ' A' ' 73' ' ' VAL . 21.3 mt-30 -124.4 140.3 34.87 Favored Pre-proline 0 C--N 1.317 -0.822 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 172.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.14 125.5 14.19 Favored 'Trans proline' 0 CA--C 1.531 0.353 0 C-N-CA 122.362 2.041 . . . . 0.0 112.601 179.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 88.16 38.24 7.38 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.786 178.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.471 HG21 ' HB2' ' A' ' 70' ' ' GLN . 46.6 t -130.5 144.33 38.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 110.333 -0.247 . . . . 0.0 110.333 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.68 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 43.5 tt0 -88.83 125.42 34.9 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.032 178.195 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.526 ' O ' ' HA ' ' A' ' 94' ' ' GLN . 98.3 m-85 -117.44 121.79 42.01 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.917 0.389 . . . . 0.0 111.236 -179.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.543 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 4.1 m-20 -88.33 106.31 18.15 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 170.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.594 HG12 HD11 ' A' ' 66' ' ' LEU . 5.2 mp -90.1 115.56 29.79 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.768 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 177.26 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.902 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 29.0 m -103.83 113.79 27.57 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 114.779 -1.101 . . . . 0.0 110.222 -177.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.541 ' HB ' ' HB ' ' A' ' 91' ' ' VAL . 12.3 mm -95.34 134.43 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -122.05 111.19 16.72 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.984 179.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.479 ' HB1' HG21 ' A' ' 37' ' ' ILE . . . -82.77 111.85 19.07 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 171.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.514 HG12 ' C ' ' A' ' 39' ' ' GLY . 7.8 p -107.73 133.05 53.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 C-N-CA 119.751 -0.779 . . . . 0.0 110.964 -173.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.543 ' OE1' ' HB2' ' A' ' 86' ' ' GLN . 6.8 mt-10 -107.22 171.11 7.56 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 175.613 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -43.77 -42.21 5.39 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 123.481 0.488 . . . . 0.0 112.14 178.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -123.01 -20.24 5.83 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -173.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.543 ' HB2' ' OE1' ' A' ' 83' ' ' GLU . 16.2 mm100 -123.77 176.33 6.33 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.789 -0.365 . . . . 0.0 111.632 -171.538 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -140.42 126.39 19.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.983 176.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.7 m -67.04 156.07 37.02 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.206 176.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 35.9 p -57.86 146.25 68.11 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.369 177.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -76.36 141.45 22.86 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 122.049 1.833 . . . . 0.0 114.118 -171.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.902 ' O ' ' HA ' ' A' ' 78' ' ' THR . 12.0 t -81.3 130.99 34.92 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.68 0 CA-C-N 114.444 -1.253 . . . . 0.0 108.201 169.392 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 19.0 t -127.52 106.85 15.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 C-N-CA 120.062 -0.655 . . . . 0.0 110.11 172.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.502 ' O ' HG13 ' A' ' 93' ' ' ILE . 43.0 pt -119.95 111.71 33.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.416 -179.44 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.526 ' HA ' ' O ' ' A' ' 75' ' ' TYR . 0.5 OUTLIER -95.59 126.31 40.79 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.297 0.57 . . . . 0.0 111.206 -177.456 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -137.42 131.57 32.18 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.625 179.446 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.483 ' HG2' ' HB2' ' A' ' 74' ' ' GLN . 43.4 mt-10 -92.04 122.02 34.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.695 -0.23 . . . . 0.0 110.842 178.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.425 ' CG2' HD11 ' A' ' 26' ' ' ILE . 1.8 p -56.38 126.11 24.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.189 0.519 . . . . 0.0 112.035 -177.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.0 m . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.44 -179.85 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.582 ' HB2' ' O ' ' A' ' 89' ' ' THR . . . . . . . . 0 C--O 1.233 0.225 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -62.91 133.46 41.7 Favored 'Trans proline' 0 C--O 1.235 0.344 0 C-N-CA 122.234 1.956 . . . . 0.0 111.618 175.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -50.82 145.97 22.37 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.424 2.082 . . . . 0.0 110.9 173.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.404 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 13.1 m-20 -36.04 105.96 0.3 Allowed Pre-proline 0 N--CA 1.468 0.447 0 O-C-N 124.759 1.287 . . . . 0.0 112.206 -170.343 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.552 ' HG2' HG11 ' A' ' 91' ' ' VAL . 39.1 Cg_exo -65.23 147.21 87.86 Favored 'Trans proline' 0 CA--C 1.521 -0.173 0 C-N-CA 123.764 2.976 . . . . 0.0 112.517 -179.183 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 26.3 m -102.27 131.11 49.05 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.717 -177.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.469 HG13 ' O ' ' A' ' 27' ' ' VAL . 95.3 t -81.28 121.63 35.04 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 CA-C-N 114.379 -1.282 . . . . 0.0 110.224 177.118 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -88.13 -37.16 16.43 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.417 -174.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -135.62 135.61 40.36 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.343 -177.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.514 ' HA ' HG12 ' A' ' 26' ' ' ILE . 60.8 t -132.86 114.69 22.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.748 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -135.09 -172.22 3.0 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 177.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.542 ' O ' ' HB2' ' A' ' 69' ' ' LEU . 0.6 OUTLIER -57.18 -67.69 0.3 Allowed 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -178.131 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.648 HG22 ' O ' ' A' ' 69' ' ' LEU . 36.1 p -110.52 33.57 4.44 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.482 -172.335 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.616 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 58.4 m -168.04 130.06 1.47 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.544 -175.23 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.578 ' HB ' HD12 ' A' ' 66' ' ' LEU . 29.5 mt -144.48 141.53 23.96 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.733 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 175.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.469 ' O ' HG13 ' A' ' 18' ' ' VAL . 44.8 t -118.89 132.28 69.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.398 -175.16 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.609 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.6 OUTLIER -127.96 146.76 33.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 C-N-CA 119.928 -0.709 . . . . 0.0 110.605 -178.396 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.511 ' HG2' ' HB3' ' A' ' 63' ' ' SER . 93.3 mtt180 -130.65 121.17 25.08 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.479 -176.267 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.724 ' HZ3' HG12 ' A' ' 64' ' ' VAL . 37.7 p90 -112.98 152.97 28.77 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.202 -175.02 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 20.8 t -100.42 101.51 12.48 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.296 -0.411 . . . . 0.0 109.914 178.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.666 ' CD ' ' H ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -50.99 157.68 1.35 Allowed Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 123.99 0.916 . . . . 0.0 113.257 -174.364 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.687 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 2.5 Cg_endo -85.1 166.7 11.05 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 124.561 3.508 . . . . 0.0 113.572 -174.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -75.41 -23.64 57.03 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.845 -1.07 . . . . 0.0 109.369 171.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.39 135.92 76.17 Favored Pre-proline 0 C--O 1.236 0.348 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.292 175.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -68.38 113.9 3.27 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 121.192 1.262 . . . . 0.0 109.336 168.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.596 HG22 ' HG3' ' A' ' 83' ' ' GLU . 0.5 OUTLIER -117.98 152.31 20.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -175.662 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.401 HG21 ' HA ' ' A' ' 84' ' ' GLU . 12.5 p -95.54 -29.06 14.56 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -178.403 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.432 ' C ' HG12 ' A' ' 82' ' ' VAL . . . -168.58 -166.44 27.65 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 119.765 -1.207 . . . . 0.0 112.063 178.125 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.687 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 5.5 m-85 -137.81 131.94 31.9 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-N 117.056 0.428 . . . . 0.0 111.516 176.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 41.9 mtm180 -105.68 148.42 27.42 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 170.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.888 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 32.0 mt -139.6 108.92 3.62 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -176.027 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 78.3 t -109.03 110.58 32.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.24 0.543 . . . . 0.0 110.356 179.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.69 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 1.0 OUTLIER -111.86 124.76 53.04 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.392 177.055 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.3 m -134.95 137.7 27.81 Favored Pre-proline 0 C--N 1.315 -0.932 0 CA-C-N 114.318 -1.31 . . . . 0.0 111.639 -173.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.491 ' HD2' ' OG ' ' A' ' 52' ' ' SER . 73.3 Cg_endo . . . . . 0 C--O 1.23 0.125 0 C-N-CA 123.379 2.72 . . . . 0.0 111.566 174.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.491 ' OG ' ' HD2' ' A' ' 46' ' ' PRO . 6.7 m . . . . . 0 CA--C 1.519 -0.24 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.69 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 37.7 m -147.25 154.25 40.78 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.683 -0.407 . . . . 0.0 111.578 -176.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.888 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 44.3 tt0 -119.32 117.76 29.42 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.03 176.088 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.7 HD12 ' CG2' ' A' ' 64' ' ' VAL . 17.9 mt -99.67 164.67 11.96 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 173.429 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.508 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 8.0 t30 -135.91 115.83 13.17 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -178.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.561 HD12 ' CH2' ' A' ' 30' ' ' TRP . 5.7 mt -112.87 160.82 29.37 Favored Pre-proline 0 N--CA 1.444 -0.745 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -174.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -64.84 151.01 87.3 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 121.656 1.571 . . . . 0.0 110.841 174.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.446 ' HB2' HG13 ' A' ' 37' ' ' ILE . 10.4 pt-20 -45.49 -29.55 1.17 Allowed 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.095 0.958 . . . . 0.0 112.913 178.386 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 7.1 t -96.58 -0.17 49.11 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.398 -174.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.504 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -69.95 158.88 34.77 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 110.205 -0.295 . . . . 0.0 110.205 -177.51 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.561 ' HB3' ' NE ' ' A' ' 32' ' ' ARG . 3.8 p-10 -143.65 15.14 1.78 Allowed 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -177.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.609 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 36.1 p -168.45 133.63 1.72 Allowed 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.084 -0.646 . . . . 0.0 112.333 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.724 HG12 ' HZ3' ' A' ' 30' ' ' TRP . 4.8 p -118.72 139.47 45.93 Favored 'Isoleucine or valine' 0 C--O 1.243 0.725 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.537 176.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 34.4 m -99.51 103.75 15.52 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.72 170.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.708 HD11 HG12 ' A' ' 77' ' ' ILE . 0.2 OUTLIER -83.38 144.45 29.63 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.465 179.112 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 9.6 t -138.97 170.64 15.61 Favored 'General case' 0 N--CA 1.448 -0.555 0 O-C-N 123.371 0.42 . . . . 0.0 110.296 -174.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 65.24 22.25 12.13 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.052 179.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.648 ' O ' HG22 ' A' ' 24' ' ' THR . 6.5 mt -68.66 -178.45 1.16 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 177.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -124.36 128.06 25.11 Favored Pre-proline 0 C--N 1.32 -0.696 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 176.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -62.16 135.22 53.37 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 123.003 2.468 . . . . 0.0 113.069 -177.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.54 29.34 30.12 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.217 178.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 47.8 t -130.55 147.27 33.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.157 0.503 . . . . 0.0 111.198 -177.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 7.6 tp60 -86.06 109.47 18.85 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.205 178.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.448 ' CE2' HD22 ' A' ' 69' ' ' LEU . 4.2 m-85 -98.97 117.39 33.36 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.144 0.497 . . . . 0.0 111.885 -177.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.446 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 78.4 m-20 -88.06 108.13 19.08 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.025 174.224 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.708 HG12 HD11 ' A' ' 66' ' ' LEU . 5.0 mp -92.12 113.55 27.6 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.692 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 175.11 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.889 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 25.8 m -105.07 113.8 27.61 Favored 'General case' 0 N--CA 1.425 -1.723 0 CA-C-N 114.915 -1.038 . . . . 0.0 109.996 -179.022 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.574 ' H ' ' HB ' ' A' ' 91' ' ' VAL . 15.8 mm -95.05 143.3 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -130.85 111.94 12.56 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.96 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.501 ' HB3' ' OG ' ' A' ' 88' ' ' SER . . . -81.28 125.53 30.45 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 167.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.432 HG12 ' C ' ' A' ' 39' ' ' GLY . 7.5 p -113.36 133.5 59.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 C-N-CA 120.384 -0.526 . . . . 0.0 110.233 -179.095 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.596 ' HG3' HG22 ' A' ' 37' ' ' ILE . 8.2 mp0 -109.07 170.85 7.79 Favored 'General case' 0 N--CA 1.443 -0.819 0 O-C-N 123.912 0.757 . . . . 0.0 108.988 -178.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.401 ' HA ' HG21 ' A' ' 38' ' ' THR . 46.8 mt-10 -42.57 -45.24 4.48 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -172.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -131.16 0.9 4.19 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.029 -0.668 . . . . 0.0 112.624 -177.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.491 ' HG3' ' OE1' ' A' ' 83' ' ' GLU . 29.1 pt20 -136.07 176.04 9.05 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.961 -0.296 . . . . 0.0 110.772 -176.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -130.85 135.12 47.42 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.295 -0.412 . . . . 0.0 109.903 175.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.501 ' OG ' ' HB3' ' A' ' 81' ' ' ALA . 78.5 p -70.64 -178.36 1.8 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.955 0.407 . . . . 0.0 111.1 177.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.582 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 1.4 p -65.9 162.72 42.73 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.746 176.326 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -88.62 137.36 3.43 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 122.129 1.886 . . . . 0.0 113.753 179.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.889 ' O ' ' HA ' ' A' ' 78' ' ' THR . 6.4 t -82.53 126.07 39.97 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.72 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 166.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 10.5 t -124.14 106.77 17.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 C-N-CA 119.964 -0.694 . . . . 0.0 109.79 172.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.575 HG13 ' HB ' ' A' ' 77' ' ' ILE . 9.7 pt -122.98 111.88 31.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.354 178.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.426 ' HB3' ' OD1' ' A' ' 76' ' ' ASN . 3.6 pt20 -98.0 119.82 37.31 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.555 0.693 . . . . 0.0 111.591 -175.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.99 131.51 47.44 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.715 178.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -85.19 134.51 34.16 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.274 178.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.407 HG22 HD11 ' A' ' 26' ' ' ILE . 34.1 p -70.99 114.63 9.24 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.587 179.465 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 18.9 m . . . . . 0 C--N 1.323 -0.557 0 CA-C-O 121.443 0.64 . . . . 0.0 110.04 -177.999 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.403 ' HB2' ' O ' ' A' ' 89' ' ' THR . . . . . . . . 0 N--CA 1.451 -0.394 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -63.89 130.24 27.04 Favored 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.119 1.879 . . . . 0.0 111.578 178.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.579 ' HD2' ' O ' ' A' ' 31' ' ' SER . 83.5 Cg_exo -47.74 149.74 4.86 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.827 2.351 . . . . 0.0 111.212 171.241 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.421 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 8.1 p-10 -39.62 107.16 0.43 Allowed Pre-proline 0 N--CA 1.468 0.467 0 O-C-N 124.382 1.051 . . . . 0.0 112.336 -169.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.602 ' HG2' HG11 ' A' ' 91' ' ' VAL . 31.4 Cg_exo -65.22 148.17 88.6 Favored 'Trans proline' 0 CA--C 1.516 -0.42 0 C-N-CA 123.381 2.721 . . . . 0.0 112.134 179.071 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 24.9 m -107.41 132.01 53.64 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.655 -178.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.429 HG13 ' O ' ' A' ' 27' ' ' VAL . 77.9 t -79.35 123.26 36.04 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 CA-C-N 114.194 -1.366 . . . . 0.0 110.359 176.323 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.423 ' OD2' ' HG3' ' A' ' 20' ' ' GLN . 26.3 t70 -88.72 -35.83 16.51 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.252 -176.281 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.423 ' HG3' ' OD2' ' A' ' 19' ' ' ASP . 75.8 mt-30 -135.99 134.1 38.22 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.688 -176.303 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.504 ' HA ' HG12 ' A' ' 26' ' ' ILE . 78.7 t -129.97 113.68 27.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.444 178.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -127.2 -166.76 1.64 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.057 178.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.6 -68.33 0.37 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.197 0.522 . . . . 0.0 112.161 178.287 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.633 HG22 ' O ' ' A' ' 69' ' ' LEU . 69.6 p -109.56 36.85 2.81 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.51 -174.047 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.517 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 72.0 p -170.59 134.88 1.12 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.94 -176.391 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.628 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 42.4 mt -148.78 141.44 18.21 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.837 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 177.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.429 ' O ' HG13 ' A' ' 18' ' ' VAL . 47.3 t -118.21 132.24 68.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 118.897 0.771 . . . . 0.0 110.214 -176.275 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.622 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.7 OUTLIER -125.31 146.15 31.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 C-N-CA 119.917 -0.713 . . . . 0.0 110.411 -178.254 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.501 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 83.3 mtt180 -131.15 121.9 25.69 Favored 'General case' 0 C--N 1.329 -0.288 0 O-C-N 123.376 0.423 . . . . 0.0 110.778 -175.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.718 ' HZ3' HG12 ' A' ' 64' ' ' VAL . 30.8 p90 -112.27 141.08 46.42 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.63 -0.713 . . . . 0.0 112.12 -172.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.579 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 62.6 m -80.28 86.11 5.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.848 172.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.586 ' HD3' ' H ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -47.59 151.5 1.45 Allowed Pre-proline 0 CA--C 1.538 0.509 0 CA-C-N 115.144 -0.935 . . . . 0.0 112.243 -177.551 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.688 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 3.3 Cg_exo -79.91 162.95 23.53 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.71 2.94 . . . . 0.0 112.714 -172.155 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -82.68 -13.0 57.19 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.218 172.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.408 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . . . -58.82 145.83 77.48 Favored Pre-proline 0 CA--C 1.52 -0.204 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.043 175.398 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 35' ' ' ALA . 12.4 Cg_exo -69.56 114.42 3.67 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 121.458 1.439 . . . . 0.0 110.304 172.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.67 HD12 ' HE1' ' A' ' 40' ' ' TYR . 3.0 pt -127.73 147.95 32.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 109.381 -0.599 . . . . 0.0 109.381 -177.52 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.512 ' C ' ' HB3' ' A' ' 59' ' ' GLU . 16.3 p -96.92 -29.02 13.93 Favored 'General case' 0 N--CA 1.462 0.173 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -178.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.521 ' C ' HG12 ' A' ' 82' ' ' VAL . . . -165.3 -167.44 25.9 Favored Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 119.937 -1.125 . . . . 0.0 112.175 -178.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.688 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 5.3 m-85 -138.36 134.3 34.02 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 122.444 0.298 . . . . 0.0 111.341 174.225 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.6 mmm180 -103.91 149.76 24.81 Favored 'General case' 0 CA--C 1.504 -0.794 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 166.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.886 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 30.6 mt -139.09 108.58 3.89 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 C-N-CA 120.086 -0.646 . . . . 0.0 112.254 -179.339 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 78.8 t -109.44 110.33 31.69 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.432 0 CA-C-O 121.19 0.519 . . . . 0.0 110.797 -179.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.745 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 1.0 OUTLIER -113.57 126.34 55.18 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.783 176.647 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.9 m -137.4 141.88 35.43 Favored Pre-proline 0 C--N 1.319 -0.756 0 CA-C-N 114.203 -1.362 . . . . 0.0 111.98 -173.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.421 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 72.6 Cg_endo . . . . . 0 C--O 1.234 0.314 0 C-N-CA 123.581 2.854 . . . . 0.0 112.092 175.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 49.8 m . . . . . 0 CA--C 1.514 -0.413 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.745 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 26.1 m -146.56 148.08 31.79 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 119.834 -0.746 . . . . 0.0 111.763 -178.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.886 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 30.8 tt0 -120.19 113.74 20.88 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.921 175.201 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.715 HD12 ' CG2' ' A' ' 64' ' ' VAL . 19.9 mt -97.29 158.22 15.57 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.321 177.155 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -119.24 116.65 26.72 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 177.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.572 HD12 ' CH2' ' A' ' 30' ' ' TRP . 2.3 mt -114.11 156.23 44.41 Favored Pre-proline 0 C--N 1.317 -0.818 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -177.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -62.25 150.08 88.29 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 121.798 1.665 . . . . 0.0 111.644 176.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.512 ' HB3' ' C ' ' A' ' 38' ' ' THR . 9.4 pt-20 -45.49 -26.63 0.6 Allowed 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 114.573 -1.194 . . . . 0.0 113.102 176.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.2 t -109.32 16.02 22.68 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.333 0.587 . . . . 0.0 110.951 -175.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.509 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -75.59 162.91 27.87 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 177.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.501 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 30.4 p-10 -142.89 4.8 1.5 Allowed 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -176.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.622 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 59.4 p -167.31 133.96 2.26 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 119.861 -0.736 . . . . 0.0 111.928 -176.426 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.718 HG12 ' HZ3' ' A' ' 30' ' ' TRP . 3.5 p -115.54 137.68 48.36 Favored 'Isoleucine or valine' 0 C--O 1.243 0.761 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.47 176.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 24.2 m -93.74 101.46 13.58 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.547 168.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.701 HD11 HG12 ' A' ' 77' ' ' ILE . 0.2 OUTLIER -78.46 144.07 36.11 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 173.542 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.461 ' HA ' ' O ' ' A' ' 24' ' ' THR . 4.3 m -152.79 167.7 28.17 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -177.375 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 68.87 26.22 5.95 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 123.912 0.758 . . . . 0.0 110.394 -174.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.633 ' O ' HG22 ' A' ' 24' ' ' THR . 8.9 mt -72.97 -175.82 1.88 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.792 175.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -123.95 129.2 24.86 Favored Pre-proline 0 C--N 1.322 -0.611 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 174.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -62.54 133.96 45.33 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 123.204 2.603 . . . . 0.0 113.336 -177.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.54 34.88 24.27 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.897 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.414 HG11 ' HB3' ' A' ' 46' ' ' PRO . 58.7 t -134.94 138.95 48.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 120.999 0.428 . . . . 0.0 111.363 -176.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.421 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 18.3 tp60 -75.07 108.88 8.09 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.971 177.466 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -101.63 113.57 26.83 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.311 0.577 . . . . 0.0 111.592 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.581 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 3.7 m-20 -86.91 110.12 19.79 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.437 175.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.701 HG12 HD11 ' A' ' 66' ' ' LEU . 5.3 mp -92.33 118.5 38.01 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.664 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.695 176.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.885 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 28.4 m -109.47 115.63 30.3 Favored 'General case' 0 N--CA 1.426 -1.675 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.397 179.55 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.577 ' HB ' ' HB ' ' A' ' 91' ' ' VAL . 13.3 mm -95.47 137.21 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 -179.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.449 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 74.2 m-85 -124.84 111.35 15.39 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 116.581 -0.282 . . . . 0.0 110.281 179.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.416 ' HB1' HG21 ' A' ' 37' ' ' ILE . . . -80.26 116.89 20.59 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 169.394 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.521 HG12 ' C ' ' A' ' 39' ' ' GLY . 7.7 p -109.12 133.34 54.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 C-N-CA 120.075 -0.65 . . . . 0.0 110.448 -176.457 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -112.98 170.15 8.41 Favored 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 123.258 0.349 . . . . 0.0 110.202 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -46.17 -40.66 11.49 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -175.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 24.2 p-10 -111.46 -21.03 12.0 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -171.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -142.6 175.97 9.39 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.372 -0.531 . . . . 0.0 111.653 -172.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -118.41 120.25 37.01 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.291 -0.868 . . . . 0.0 108.675 173.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 50.8 m -68.9 175.35 3.71 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.161 0.505 . . . . 0.0 112.067 -176.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.403 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 1.0 OUTLIER -60.16 152.33 62.74 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.17 179.352 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -88.63 142.78 5.05 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 C-N-CA 122.261 1.974 . . . . 0.0 114.084 -177.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.885 ' O ' ' HA ' ' A' ' 78' ' ' THR . 6.9 t -82.57 128.11 39.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 114.366 -1.288 . . . . 0.0 108.001 165.404 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.7 t -123.49 105.68 16.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 C-N-CA 119.746 -0.782 . . . . 0.0 110.004 172.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.556 HG13 ' HB ' ' A' ' 77' ' ' ILE . 6.5 pt -122.85 111.79 31.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.935 177.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -95.92 117.51 30.75 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.533 0.683 . . . . 0.0 110.851 -177.144 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.58 127.51 46.47 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.155 176.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -87.15 135.05 33.44 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.147 0.499 . . . . 0.0 110.369 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 34.5 p -69.55 119.59 14.02 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.683 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 10.2 m . . . . . 0 C--N 1.324 -0.503 0 CA-C-O 121.437 0.637 . . . . 0.0 110.178 -179.059 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.698 ' HB2' ' O ' ' A' ' 89' ' ' THR . . . . . . . . 0 N--CA 1.452 -0.364 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.426 ' HB3' ' O ' ' A' ' 31' ' ' SER . 46.2 Cg_exo -58.49 135.68 69.25 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.381 2.054 . . . . 0.0 111.142 173.462 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.564 ' HD2' ' O ' ' A' ' 31' ' ' SER . 7.9 Cg_endo -53.39 147.09 38.48 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.072 1.848 . . . . 0.0 110.809 174.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -30.51 106.39 0.23 Allowed Pre-proline 0 N--CA 1.472 0.674 0 O-C-N 124.854 1.346 . . . . 0.0 113.267 -168.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.654 ' HG2' HG11 ' A' ' 91' ' ' VAL . 23.2 Cg_exo -70.25 147.22 59.27 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 123.192 2.595 . . . . 0.0 111.876 176.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 18.5 m -109.88 132.86 53.77 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.803 0.811 . . . . 0.0 110.953 -176.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.513 HG21 ' OE1' ' A' ' 95' ' ' GLN . 95.0 t -79.67 125.58 38.82 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-N 114.2 -1.363 . . . . 0.0 110.056 176.269 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -83.63 -52.51 6.39 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.067 -174.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -136.43 132.11 35.02 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.88 0.372 . . . . 0.0 110.505 -178.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.502 ' HA ' HG12 ' A' ' 26' ' ' ILE . 95.1 t -114.15 122.24 67.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.867 -178.365 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -124.14 -160.34 0.92 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.602 179.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.525 ' O ' ' HB2' ' A' ' 69' ' ' LEU . 1.8 p-10 -73.35 -77.03 0.11 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.129 178.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.652 HG22 ' O ' ' A' ' 69' ' ' LEU . 62.8 p -105.16 34.79 3.06 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.955 -174.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.675 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 75.3 m -168.12 131.01 1.53 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.042 -172.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.579 ' HB ' HD12 ' A' ' 66' ' ' LEU . 28.7 mt -149.2 148.28 15.84 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.89 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 177.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.447 ' O ' HG13 ' A' ' 18' ' ' VAL . 44.2 t -121.58 130.31 74.73 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.59 0 CA-C-N 119.367 0.985 . . . . 0.0 110.888 -176.329 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.622 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.6 OUTLIER -123.9 146.21 29.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 C-N-CA 120.3 -0.56 . . . . 0.0 109.965 -179.629 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.438 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 21.6 mtp180 -129.32 121.0 26.59 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 123.295 0.372 . . . . 0.0 110.602 -174.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.815 ' HZ3' HG12 ' A' ' 64' ' ' VAL . 40.5 p90 -115.05 146.4 41.32 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.641 -174.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.564 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 24.0 t -93.89 97.88 10.68 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.635 177.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.597 ' CD ' ' H ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -46.8 155.67 0.59 Allowed Pre-proline 0 CA--C 1.539 0.533 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -175.445 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.696 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 2.8 Cg_endo -84.5 166.08 12.2 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 124.628 3.552 . . . . 0.0 112.634 -174.299 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -76.54 -22.11 54.81 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.257 -0.883 . . . . 0.0 108.957 170.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -55.22 133.23 69.21 Favored Pre-proline 0 CA--C 1.517 -0.297 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.663 176.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -61.8 116.32 3.37 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 121.554 1.503 . . . . 0.0 110.148 168.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.572 HD12 ' HE1' ' A' ' 40' ' ' TYR . 1.0 OUTLIER -126.76 148.49 31.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -177.544 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.42 ' H ' ' HA ' ' A' ' 83' ' ' GLU . 19.0 p -98.07 -28.81 13.59 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -178.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.52 ' C ' HG12 ' A' ' 82' ' ' VAL . . . -162.83 -166.85 22.32 Favored Glycine 0 N--CA 1.443 -0.892 0 C-N-CA 120.347 -0.93 . . . . 0.0 111.766 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.696 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 5.9 m-85 -139.06 132.57 30.32 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 120.718 0.294 . . . . 0.0 110.932 173.183 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 10.4 mmm180 -102.51 149.91 23.91 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 167.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.878 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 34.0 mt -138.49 107.54 3.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 C-N-CA 120.022 -0.671 . . . . 0.0 111.925 -179.225 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.441 HG22 ' HB2' ' A' ' 54' ' ' GLU . 89.4 t -109.1 110.34 31.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.387 0.613 . . . . 0.0 110.551 -178.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.608 ' CE2' ' HB3' ' A' ' 66' ' ' LEU . 1.2 p90 -113.15 126.02 54.99 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.884 177.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 7.4 m -141.06 138.76 18.26 Favored Pre-proline 0 C--N 1.317 -0.827 0 CA-C-N 113.773 -1.558 . . . . 0.0 110.868 -175.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.477 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 59.5 Cg_endo . . . . . 0 C--O 1.232 0.196 0 C-N-CA 123.337 2.691 . . . . 0.0 111.749 175.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.0 m . . . . . 0 CA--C 1.516 -0.33 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.551 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 85.7 m -148.11 147.74 29.85 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.086 -0.645 . . . . 0.0 112.123 -178.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.878 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 30.3 tt0 -112.41 118.29 34.77 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.134 171.286 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.708 HD12 ' CG2' ' A' ' 64' ' ' VAL . 16.5 mt -97.42 160.54 14.26 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 173.209 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -124.77 113.95 18.62 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.728 -179.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.594 HD12 ' CH2' ' A' ' 30' ' ' TRP . 3.2 mt -112.96 157.99 39.07 Favored Pre-proline 0 C--N 1.317 -0.835 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -177.095 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -65.79 150.13 86.24 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 121.76 1.64 . . . . 0.0 111.413 174.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -44.44 -28.72 0.59 Allowed 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 114.887 -1.051 . . . . 0.0 112.859 176.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.8 t -105.29 14.44 28.92 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.251 0.548 . . . . 0.0 111.408 -174.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.437 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -80.02 158.79 26.43 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 176.207 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.531 ' HB3' ' NE ' ' A' ' 32' ' ' ARG . 31.0 p-10 -142.05 17.28 2.1 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 120.619 -0.432 . . . . 0.0 111.96 -177.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.622 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 19.2 p -171.35 134.01 0.86 Allowed 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.268 -0.573 . . . . 0.0 111.847 -179.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.815 HG12 ' HZ3' ' A' ' 30' ' ' TRP . 3.5 p -117.11 136.3 54.71 Favored 'Isoleucine or valine' 0 C--O 1.242 0.7 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.414 176.367 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 20.8 m -95.13 101.36 13.1 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.386 167.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.675 ' O ' ' HA ' ' A' ' 25' ' ' SER . 0.3 OUTLIER -78.14 144.55 36.33 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.9 -1.045 . . . . 0.0 109.555 178.646 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.461 ' O ' ' HB2' ' A' ' 68' ' ' ASP . 14.2 t -140.39 170.17 16.31 Favored 'General case' 0 C--N 1.319 -0.745 0 O-C-N 123.76 0.663 . . . . 0.0 109.271 -176.482 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.461 ' HB2' ' O ' ' A' ' 67' ' ' SER . 3.2 m-20 71.89 20.0 4.6 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 123.803 0.69 . . . . 0.0 112.021 -179.28 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.652 ' O ' HG22 ' A' ' 24' ' ' THR . 6.8 mt -72.79 -177.81 2.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.125 0.488 . . . . 0.0 110.412 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 7.8 tp60 -125.38 122.72 25.07 Favored Pre-proline 0 C--N 1.321 -0.663 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 175.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.61 126.09 15.5 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.698 2.265 . . . . 0.0 112.833 -178.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 95.98 28.78 9.04 Favored Glycine 0 N--CA 1.45 -0.414 0 CA-C-N 115.949 -0.568 . . . . 0.0 112.181 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 36.9 t -134.64 152.17 32.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.048 0.451 . . . . 0.0 110.961 -177.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.477 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 11.6 tp60 -87.84 107.99 18.94 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.663 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.469 ' O ' ' HA ' ' A' ' 94' ' ' GLN . 7.1 m-85 -100.79 130.44 46.81 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.145 0.498 . . . . 0.0 111.876 -179.263 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.52 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 10.8 m120 -103.88 113.48 27.04 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.596 -1.184 . . . . 0.0 109.202 175.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.61 HG12 HD11 ' A' ' 66' ' ' LEU . 3.8 mp -95.07 120.27 44.26 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.814 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 176.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.937 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 25.6 m -109.03 113.46 26.34 Favored 'General case' 0 N--CA 1.424 -1.763 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.225 -179.12 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.54 ' HB ' ' HB ' ' A' ' 91' ' ' VAL . 12.9 mm -94.64 132.38 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -120.32 111.35 17.65 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.044 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.484 ' HB1' HG21 ' A' ' 37' ' ' ILE . . . -81.82 109.58 16.33 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 172.117 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.52 HG12 ' C ' ' A' ' 39' ' ' GLY . 7.2 p -104.66 143.09 16.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 C-N-CA 120.268 -0.573 . . . . 0.0 111.418 -172.069 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.557 ' HG2' ' N ' ' A' ' 84' ' ' GLU . 55.2 tt0 -121.11 168.17 11.85 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 170.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.557 ' N ' ' HG2' ' A' ' 83' ' ' GLU . 27.7 mt-10 -33.27 -50.97 0.32 Allowed 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -176.561 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 28.4 p-10 -111.96 -24.35 10.0 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -171.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -137.38 173.1 12.04 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.558 -170.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -121.36 152.05 39.43 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.968 178.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 9.8 m -80.51 179.61 7.65 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.62 175.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.698 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 0.6 OUTLIER -60.02 159.41 20.91 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 173.081 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -88.16 138.7 4.16 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 121.921 1.747 . . . . 0.0 113.365 179.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.937 ' O ' ' HA ' ' A' ' 78' ' ' THR . 13.3 t -83.18 123.38 38.61 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.671 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 165.222 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.0 t -121.09 106.48 18.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 C-N-CA 119.856 -0.738 . . . . 0.0 109.981 172.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.449 HG13 ' HB ' ' A' ' 77' ' ' ILE . 29.9 pt -121.63 117.63 53.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.976 179.033 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.469 ' HA ' ' O ' ' A' ' 75' ' ' TYR . 12.2 pt20 -108.1 128.67 54.89 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.159 0.504 . . . . 0.0 111.618 -175.422 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.545 ' OE1' HG21 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -136.74 153.03 50.97 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.772 171.927 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -97.31 126.14 42.35 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -179.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.436 HG22 HD11 ' A' ' 26' ' ' ILE . 20.1 p -61.12 112.73 2.22 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.417 0.627 . . . . 0.0 111.26 -176.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 11.0 m . . . . . 0 C--N 1.321 -0.633 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.864 -176.42 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.496 ' HB2' ' O ' ' A' ' 89' ' ' THR . . . . . . . . 0 N--CA 1.452 -0.327 0 N-CA-C 110.132 -0.322 . . . . 0.0 110.132 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.41 ' HB2' ' HB2' ' A' ' 30' ' ' TRP . 19.9 Cg_exo -67.64 131.43 24.4 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.338 2.026 . . . . 0.0 111.415 175.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.429 ' HD2' ' O ' ' A' ' 31' ' ' SER . 74.6 Cg_exo -50.2 151.78 8.88 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.751 2.301 . . . . 0.0 111.214 172.454 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -36.83 106.37 0.33 Allowed Pre-proline 0 N--CA 1.472 0.658 0 O-C-N 124.443 1.089 . . . . 0.0 112.411 -171.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.587 ' HG2' HG11 ' A' ' 91' ' ' VAL . 37.8 Cg_exo -65.78 149.79 86.54 Favored 'Trans proline' 0 CA--C 1.517 -0.326 0 C-N-CA 123.141 2.561 . . . . 0.0 112.129 177.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 27.4 m -106.38 130.1 54.26 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.585 -178.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.515 HG22 HG12 ' A' ' 28' ' ' VAL . 53.8 t -71.62 121.88 22.67 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-N 114.227 -1.351 . . . . 0.0 110.12 175.072 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -83.78 -46.26 12.42 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.258 -173.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -135.63 137.99 42.44 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.894 -178.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.499 ' HA ' HG12 ' A' ' 26' ' ' ILE . 23.7 t -123.26 121.37 62.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.892 -178.175 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -131.57 -163.05 1.28 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.443 176.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -72.88 -68.9 0.45 Allowed 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.311 0.485 . . . . 0.0 112.311 -178.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.555 HG22 ' O ' ' A' ' 69' ' ' LEU . 38.1 p -110.12 28.84 8.21 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.377 0.608 . . . . 0.0 110.87 -171.407 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.559 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 12.0 p -169.95 134.65 1.32 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.069 -175.477 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.546 ' HB ' HD12 ' A' ' 66' ' ' LEU . 29.0 mt -146.16 155.98 12.27 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.207 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 54.4 t -121.48 140.21 46.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 119.859 1.209 . . . . 0.0 110.253 -177.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.57 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.8 OUTLIER -130.81 149.24 33.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 119.867 -0.733 . . . . 0.0 110.676 176.741 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.505 ' HG2' ' HB3' ' A' ' 63' ' ' SER . 60.8 mtp180 -132.1 120.61 22.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.265 -176.212 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.785 ' HZ3' HG12 ' A' ' 64' ' ' VAL . 32.6 p90 -112.04 144.23 41.74 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.905 -173.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.429 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 21.4 m -85.04 86.55 7.37 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.697 174.535 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.582 ' HD3' ' H ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -52.03 152.87 5.15 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.035 -0.984 . . . . 0.0 112.231 -174.513 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.648 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 4.3 Cg_exo -78.13 160.69 29.78 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 123.615 2.877 . . . . 0.0 113.029 -172.229 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -79.29 -14.8 58.78 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.16 -0.927 . . . . 0.0 108.763 170.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.44 145.28 59.65 Favored Pre-proline 0 CA--C 1.517 -0.292 0 CA-C-N 114.879 -1.055 . . . . 0.0 111.441 175.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -67.45 115.77 3.87 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 121.463 1.442 . . . . 0.0 109.951 170.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.65 HD12 ' HE1' ' A' ' 40' ' ' TYR . 1.4 pt -128.18 146.76 33.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.513 ' C ' ' HB3' ' A' ' 59' ' ' GLU . 26.9 p -93.69 -28.86 15.72 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -178.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.557 ' C ' HG12 ' A' ' 82' ' ' VAL . . . -168.44 -164.04 23.45 Favored Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 120.338 -0.934 . . . . 0.0 111.532 -178.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.65 ' HE1' HD12 ' A' ' 37' ' ' ILE . 5.2 m-85 -140.3 133.98 30.32 Favored 'General case' 0 CA--C 1.513 -0.481 0 CA-C-N 116.929 0.364 . . . . 0.0 111.243 175.202 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.8 mmm180 -106.03 148.35 27.84 Favored 'General case' 0 CA--C 1.505 -0.757 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 167.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.881 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 28.8 mt -138.03 108.55 5.13 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 C-N-CA 120.006 -0.678 . . . . 0.0 112.489 -177.461 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 76.6 t -110.84 111.08 34.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.019 0.438 . . . . 0.0 110.717 -178.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.752 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 1.3 p90 -116.81 126.85 53.68 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.602 0.715 . . . . 0.0 110.474 178.453 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.416 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 25.1 p -149.81 143.93 17.21 Favored Pre-proline 0 C--N 1.319 -0.739 0 CA-C-N 113.698 -1.592 . . . . 0.0 111.183 -175.171 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.593 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 32.4 Cg_exo . . . . . 0 C--N 1.346 0.412 0 C-N-CA 123.128 2.552 . . . . 0.0 111.808 176.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.8 m . . . . . 0 CA--C 1.517 -0.317 0 N-CA-C 110.272 -0.27 . . . . 0.0 110.272 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.752 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 14.6 m -139.56 145.12 38.24 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.548 -0.461 . . . . 0.0 111.376 -177.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.881 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 74.3 tt0 -118.26 124.48 47.95 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 116.042 -0.527 . . . . 0.0 109.615 174.484 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.67 HD12 ' CG2' ' A' ' 64' ' ' VAL . 13.5 mt -106.42 156.79 18.17 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.153 173.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -119.29 115.58 24.46 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.577 178.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.58 HD12 ' CH2' ' A' ' 30' ' ' TRP . 3.5 mt -114.26 158.72 38.94 Favored Pre-proline 0 C--N 1.321 -0.636 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -177.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -69.15 150.0 71.43 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 121.599 1.532 . . . . 0.0 111.226 174.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.513 ' HB3' ' C ' ' A' ' 38' ' ' THR . 10.1 pt-20 -46.48 -25.1 0.61 Allowed 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 114.859 -1.064 . . . . 0.0 113.099 177.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 10.0 t -104.63 15.04 28.79 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.236 -174.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -84.69 162.32 19.73 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 178.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.469 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 27.8 p-10 -142.02 10.42 1.96 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -176.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.57 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 23.0 p -167.42 136.94 2.76 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.77 -177.315 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.785 HG12 ' HZ3' ' A' ' 30' ' ' TRP . 2.8 p -120.64 137.49 54.22 Favored 'Isoleucine or valine' 0 C--O 1.247 0.96 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.801 177.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 42.3 m -90.57 100.94 13.69 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.22 166.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.58 ' HB3' ' CE2' ' A' ' 44' ' ' TYR . 0.5 OUTLIER -76.41 133.52 39.86 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.475 179.352 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 10.7 p -128.37 160.09 33.32 Favored 'General case' 0 N--CA 1.447 -0.583 0 O-C-N 123.878 0.736 . . . . 0.0 110.521 -174.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 65.13 52.03 1.56 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.202 -178.061 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.555 ' O ' HG22 ' A' ' 24' ' ' THR . 6.6 mt -95.1 -175.75 3.62 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 172.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 18.6 mm-40 -127.45 132.77 24.49 Favored Pre-proline 0 C--N 1.321 -0.638 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 175.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -65.57 133.39 34.24 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.879 2.386 . . . . 0.0 112.878 -179.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 77.84 28.99 55.77 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.993 -0.622 . . . . 0.0 111.93 179.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 97.5 t -132.01 141.55 45.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.998 0.428 . . . . 0.0 110.398 -178.099 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.593 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 7.7 tp60 -84.61 111.76 19.83 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.183 -175.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.405 ' CZ ' ' HG3' ' A' ' 46' ' ' PRO . 11.5 m-85 -103.01 127.58 50.2 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.303 0.573 . . . . 0.0 112.011 -176.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.584 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 14.4 m120 -95.72 111.14 23.16 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.278 176.194 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.616 ' HB ' HG13 ' A' ' 93' ' ' ILE . 5.0 mp -92.44 118.09 37.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 176.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.891 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 28.4 m -108.75 113.83 27.12 Favored 'General case' 0 N--CA 1.426 -1.629 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.176 -179.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.58 ' HB ' ' HB ' ' A' ' 91' ' ' VAL . 13.9 mm -95.12 133.5 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -179.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -121.42 111.89 17.86 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.372 179.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.473 ' HB1' HG21 ' A' ' 37' ' ' ILE . . . -81.28 109.17 15.54 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 171.475 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.557 HG12 ' C ' ' A' ' 39' ' ' GLY . 7.4 p -101.09 137.69 27.82 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.604 0 C-N-CA 120.095 -0.642 . . . . 0.0 111.32 -172.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 11.5 tm-20 -117.05 167.41 11.17 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 179.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -46.27 -41.01 12.47 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -174.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 46.3 t-20 -109.38 -32.42 7.17 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -172.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 22.8 pt20 -133.81 176.97 8.09 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.098 -165.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -130.91 135.32 47.57 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 176.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 16.3 m -65.83 170.42 5.39 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.805 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.496 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 1.2 p -54.62 153.66 10.31 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.141 173.434 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -85.93 142.04 7.55 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 121.753 1.635 . . . . 0.0 113.724 -176.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.891 ' O ' ' HA ' ' A' ' 78' ' ' THR . 4.8 t -82.27 123.89 38.69 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.833 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 167.032 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.7 t -120.39 106.04 18.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 C-N-CA 119.862 -0.735 . . . . 0.0 109.961 172.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.616 HG13 ' HB ' ' A' ' 77' ' ' ILE . 7.8 pt -121.02 113.03 38.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.995 176.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.528 ' HB3' ' ND2' ' A' ' 76' ' ' ASN . 11.9 pt20 -99.56 117.66 34.43 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.408 0.623 . . . . 0.0 110.977 -176.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.31 130.63 43.01 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.476 ' HA ' ' HA ' ' A' ' 74' ' ' GLN . 40.4 tt0 -89.23 128.8 35.86 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.338 0.59 . . . . 0.0 111.021 -177.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.452 HG22 HD11 ' A' ' 26' ' ' ILE . 32.8 p -59.19 126.05 26.12 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.148 -178.349 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 10.9 m . . . . . 0 C--N 1.325 -0.468 0 CA-C-O 121.472 0.653 . . . . 0.0 109.875 179.363 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.423 ' HB2' ' O ' ' A' ' 89' ' ' THR . . . . . . . . 0 C--O 1.234 0.25 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.429 ' HB2' ' HB2' ' A' ' 30' ' ' TRP . 19.3 Cg_exo -69.47 128.89 16.96 Favored 'Trans proline' 0 C--O 1.235 0.367 0 C-N-CA 122.27 1.98 . . . . 0.0 111.472 174.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.42 ' HD2' ' O ' ' A' ' 31' ' ' SER . 52.3 Cg_exo -52.45 142.12 49.18 Favored 'Trans proline' 0 CA--C 1.509 -0.736 0 C-N-CA 122.306 2.004 . . . . 0.0 110.806 173.316 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.506 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 2.4 m-20 -35.79 103.16 0.24 Allowed Pre-proline 0 N--CA 1.465 0.291 0 O-C-N 125.069 1.48 . . . . 0.0 112.674 -164.373 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.752 ' CG ' HG11 ' A' ' 91' ' ' VAL . 5.2 Cg_endo -49.7 145.72 17.03 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 123.584 2.856 . . . . 0.0 113.134 169.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.6 m -101.51 131.83 47.46 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.354 179.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.533 HG22 HG12 ' A' ' 28' ' ' VAL . 70.9 t -73.98 112.1 10.26 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 CA-C-N 114.835 -1.075 . . . . 0.0 109.284 172.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -86.51 -36.62 18.88 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.666 -172.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -135.03 140.83 45.92 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.973 -176.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.418 ' HA ' HG12 ' A' ' 26' ' ' ILE . 47.5 t -133.81 139.94 47.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.492 -179.22 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.435 ' CG ' ' H ' ' A' ' 23' ' ' ASP . 12.4 t70 -146.69 -157.69 0.83 Allowed 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -179.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.458 ' HB3' ' HB3' ' A' ' 71' ' ' PRO . 7.0 m-20 -79.5 -70.91 0.48 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.425 0.631 . . . . 0.0 109.935 178.14 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.58 HG22 ' O ' ' A' ' 69' ' ' LEU . 69.7 p -104.71 34.96 2.93 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.775 -174.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.521 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 29.9 m -167.83 137.52 2.65 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 123.139 0.576 . . . . 0.0 110.062 -172.321 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.579 ' HB ' HD12 ' A' ' 66' ' ' LEU . 29.2 mt -153.17 149.76 13.07 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.117 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 177.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.446 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 47.3 t -122.37 137.0 57.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 119.517 1.053 . . . . 0.0 110.186 -176.385 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.56 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.8 OUTLIER -130.19 149.83 33.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 C-N-CA 120.129 -0.629 . . . . 0.0 110.383 179.341 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.453 ' HG2' ' HB3' ' A' ' 63' ' ' SER . 55.1 mtp180 -134.31 120.44 19.92 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.392 -175.142 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.749 ' HZ3' HG12 ' A' ' 64' ' ' VAL . 36.9 p90 -112.56 146.8 37.89 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.742 -173.039 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.42 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 35.5 t -89.24 91.96 8.98 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 173.306 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.508 ' HD3' ' H ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -50.94 153.37 3.07 Favored Pre-proline 0 CA--C 1.54 0.584 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.785 -176.129 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.653 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 5.1 Cg_exo -78.07 162.52 28.85 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 123.879 3.053 . . . . 0.0 112.592 -174.527 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -83.25 -7.74 59.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.405 172.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.33 150.94 70.64 Favored Pre-proline 0 CA--C 1.518 -0.262 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.737 175.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.581 ' O ' ' HG3' ' A' ' 83' ' ' GLU . 12.2 Cg_exo -69.77 114.46 3.71 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 121.128 1.219 . . . . 0.0 109.559 169.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.583 HD12 ' HE1' ' A' ' 40' ' ' TYR . 2.0 pt -128.85 142.59 43.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.454 ' N ' ' O ' ' A' ' 82' ' ' VAL . 12.6 p -92.2 -31.42 15.46 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -178.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.558 ' C ' HG12 ' A' ' 82' ' ' VAL . . . -163.41 -163.95 17.36 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.12 -1.038 . . . . 0.0 111.919 -177.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.653 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 5.4 m-85 -141.05 133.31 28.12 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.785 0.326 . . . . 0.0 111.323 175.419 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.41 ' C ' HG13 ' A' ' 42' ' ' ILE . 10.1 mmm180 -103.7 149.61 24.81 Favored 'General case' 0 CA--C 1.503 -0.832 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 167.128 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.866 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 32.0 mt -138.7 107.08 3.51 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 C-N-CA 119.734 -0.787 . . . . 0.0 112.318 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.418 HG22 ' HB2' ' A' ' 54' ' ' GLU . 74.1 t -108.88 110.18 31.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.19 0.519 . . . . 0.0 110.646 -178.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.778 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 0.5 OUTLIER -110.34 124.9 52.53 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.552 176.019 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 35.6 t -137.34 135.41 19.42 Favored Pre-proline 0 C--N 1.318 -0.8 0 CA-C-N 113.926 -1.488 . . . . 0.0 111.33 -173.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.672 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 50.7 Cg_endo . . . . . 0 CA--C 1.527 0.156 0 C-N-CA 123.472 2.781 . . . . 0.0 112.005 175.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.3 p . . . . . 0 C--O 1.233 0.236 0 N-CA-C 110.232 -0.285 . . . . 0.0 110.232 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.778 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 24.4 m -142.78 147.8 36.11 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.457 -0.497 . . . . 0.0 111.557 -174.588 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.866 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 21.8 tt0 -116.44 122.34 44.49 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.148 172.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.658 HD12 ' CG2' ' A' ' 64' ' ' VAL . 12.8 mt -99.8 160.54 14.23 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.613 -0.435 . . . . 0.0 109.882 172.153 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -122.54 117.66 26.43 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.597 HD12 ' CH2' ' A' ' 30' ' ' TRP . 3.9 mt -116.02 158.2 43.09 Favored Pre-proline 0 C--N 1.318 -0.796 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -177.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -70.71 152.17 64.18 Favored 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 121.298 1.332 . . . . 0.0 111.124 173.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.487 ' HB2' HG13 ' A' ' 37' ' ' ILE . 8.1 pt-20 -43.62 -39.65 3.65 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.548 0.69 . . . . 0.0 111.796 175.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.454 ' N ' ' HG3' ' A' ' 59' ' ' GLU . 9.7 t -88.24 19.07 3.92 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.467 -174.119 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -91.79 164.38 13.72 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 175.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.45 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 30.3 p-10 -149.28 16.08 0.92 Allowed 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -178.243 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.56 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 17.3 p -170.13 134.17 1.21 Allowed 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.446 -0.502 . . . . 0.0 112.017 -179.575 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.749 HG12 ' HZ3' ' A' ' 30' ' ' TRP . 3.2 p -119.52 137.68 52.63 Favored 'Isoleucine or valine' 0 C--O 1.244 0.772 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.347 177.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 42.2 m -94.71 101.49 13.33 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-O 121.573 0.701 . . . . 0.0 109.332 167.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.624 HD11 HG12 ' A' ' 77' ' ' ILE . 0.2 OUTLIER -76.59 139.49 40.68 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.362 178.533 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 14.2 t -134.88 171.04 14.95 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -176.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 64.89 35.19 8.58 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 123.786 0.679 . . . . 0.0 110.795 -179.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.58 ' O ' HG22 ' A' ' 24' ' ' THR . 7.5 mt -85.08 -176.96 6.41 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 174.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 19.6 mm-40 -123.37 132.5 24.28 Favored Pre-proline 0 C--N 1.318 -0.782 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 173.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.458 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . 37.2 Cg_endo -66.74 128.01 18.15 Favored 'Trans proline' 0 C--O 1.234 0.311 0 C-N-CA 122.722 2.281 . . . . 0.0 112.517 179.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 83.49 33.8 21.44 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.991 -0.623 . . . . 0.0 111.851 -179.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 72.1 t -134.84 140.79 44.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.085 0.469 . . . . 0.0 111.047 -176.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.672 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -79.34 118.41 21.23 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.233 -178.481 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -114.32 121.4 43.52 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.095 0.474 . . . . 0.0 112.143 -177.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.574 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 0.8 OUTLIER -88.47 113.38 24.0 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.418 170.669 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.624 HG12 HD11 ' A' ' 66' ' ' LEU . 4.9 mp -92.2 115.47 31.24 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.661 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 173.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.895 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 19.4 m -107.24 113.31 26.64 Favored 'General case' 0 N--CA 1.427 -1.615 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.421 -178.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.574 ' H ' ' HB ' ' A' ' 91' ' ' VAL . 11.3 mm -94.78 136.09 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.022 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.418 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 80.7 m-85 -122.35 110.94 16.28 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.92 179.104 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.481 ' HB1' HG21 ' A' ' 37' ' ' ILE . . . -80.14 107.62 13.07 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 171.001 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.558 HG12 ' C ' ' A' ' 39' ' ' GLY . 7.3 p -99.96 137.61 26.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 C-N-CA 119.854 -0.738 . . . . 0.0 110.572 -173.464 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.644 ' HG2' ' N ' ' A' ' 84' ' ' GLU . 2.1 tt0 -111.85 166.8 10.89 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 124.014 0.821 . . . . 0.0 109.597 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.644 ' N ' ' HG2' ' A' ' 83' ' ' GLU . 34.3 mt-10 -41.23 -53.06 3.27 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 123.008 0.523 . . . . 0.0 111.955 177.107 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -124.53 8.26 8.33 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -173.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -140.41 174.22 10.73 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.025 0.441 . . . . 0.0 111.56 -176.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -136.8 122.26 19.52 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 172.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 32.6 m -64.72 168.69 5.82 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.712 0.292 . . . . 0.0 110.951 178.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.423 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 1.1 p -56.09 151.71 24.74 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.768 176.195 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -82.92 136.28 8.06 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 121.985 1.79 . . . . 0.0 113.139 -178.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.895 ' O ' ' HA ' ' A' ' 78' ' ' THR . 54.0 t -82.77 119.03 31.5 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.755 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 169.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.8 t -116.77 105.24 17.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 C-N-CA 119.249 -0.98 . . . . 0.0 109.965 173.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.59 HG13 ' HB ' ' A' ' 77' ' ' ILE . 7.4 pt -118.1 111.59 34.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.438 176.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -101.15 127.69 47.59 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.518 0.675 . . . . 0.0 111.04 -174.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -140.34 134.56 31.09 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.296 -0.866 . . . . 0.0 108.82 -179.224 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.597 ' HG2' ' HG2' ' A' ' 74' ' ' GLN . 47.0 mt-10 -86.61 126.56 34.59 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 120.81 0.338 . . . . 0.0 110.765 178.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.468 HG22 HD11 ' A' ' 26' ' ' ILE . 35.0 p -56.23 119.59 6.21 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.32 179.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 25.6 m . . . . . 0 CA--C 1.512 -0.506 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.591 -178.391 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.46 ' HB2' ' O ' ' A' ' 89' ' ' THR . . . . . . . . 0 N--CA 1.45 -0.44 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.458 ' HB2' ' HB2' ' A' ' 30' ' ' TRP . 17.4 Cg_exo -70.47 126.99 13.43 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 121.926 1.751 . . . . 0.0 111.062 172.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.709 ' HD2' ' O ' ' A' ' 31' ' ' SER . 95.4 Cg_exo -45.54 147.46 2.78 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.931 2.421 . . . . 0.0 111.858 172.504 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.43 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 29.8 t70 -32.74 105.36 0.24 Allowed Pre-proline 0 N--CA 1.468 0.456 0 O-C-N 125.016 1.448 . . . . 0.0 112.842 -170.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.659 ' HG2' HG11 ' A' ' 91' ' ' VAL . 20.8 Cg_exo -72.24 151.39 54.6 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 123.803 3.002 . . . . 0.0 112.113 177.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 24.0 m -119.68 135.06 54.98 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 121.72 0.771 . . . . 0.0 111.11 -176.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.48 HG22 HG12 ' A' ' 28' ' ' VAL . 71.9 t -77.64 125.41 37.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-N 114.16 -1.382 . . . . 0.0 109.864 174.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -88.05 -47.29 8.63 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.208 -174.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -136.88 145.83 44.82 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 120.978 0.418 . . . . 0.0 110.854 179.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 26.3 m -130.94 139.9 49.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.461 -179.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.411 ' HB3' ' H ' ' A' ' 23' ' ' ASP . 29.2 m-20 -135.34 -153.5 0.52 Allowed 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 175.374 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.448 ' CB ' ' HB3' ' A' ' 71' ' ' PRO . 5.5 m-20 -76.3 -73.47 0.27 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.546 0.689 . . . . 0.0 110.497 178.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.684 HG22 ' O ' ' A' ' 69' ' ' LEU . 35.0 p -102.07 37.01 1.95 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.698 -174.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.689 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 55.3 p -169.55 134.08 1.39 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.14 -173.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.627 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 13.3 mt -150.6 142.08 16.71 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.819 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.441 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 38.6 t -115.96 129.02 73.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 119.184 0.902 . . . . 0.0 110.906 -176.204 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.624 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.7 OUTLIER -123.27 145.71 29.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -177.742 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.445 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 59.5 mtp180 -131.78 122.4 25.74 Favored 'General case' 0 C--N 1.329 -0.298 0 O-C-N 123.254 0.346 . . . . 0.0 110.706 -174.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.72 ' HZ3' HG12 ' A' ' 64' ' ' VAL . 34.5 p90 -114.36 148.42 37.65 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.674 -0.694 . . . . 0.0 112.004 -174.265 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.709 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 24.1 t -92.69 86.47 5.56 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.612 177.119 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.564 ' HD3' ' H ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -43.08 150.96 0.43 Allowed Pre-proline 0 CA--C 1.548 0.869 0 C-N-CA 124.011 0.924 . . . . 0.0 113.39 -176.043 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.746 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 6.3 Cg_exo -78.46 167.79 22.34 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 124.473 3.448 . . . . 0.0 114.9 -164.394 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -68.35 -28.62 67.29 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 114.308 -1.314 . . . . 0.0 109.642 170.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -61.87 137.43 95.32 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 114.99 -1.005 . . . . 0.0 111.403 -179.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_exo -70.66 115.03 4.04 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 121.394 1.396 . . . . 0.0 109.366 167.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.609 HG22 ' HG3' ' A' ' 83' ' ' GLU . 0.4 OUTLIER -118.64 159.35 19.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -174.745 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.404 ' N ' ' O ' ' A' ' 82' ' ' VAL . 16.7 p -101.47 -27.62 13.03 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -178.452 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -168.04 -168.9 30.83 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 119.879 -1.153 . . . . 0.0 112.365 177.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.746 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 5.0 m-85 -137.5 134.46 35.76 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 121.076 0.465 . . . . 0.0 111.438 177.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.8 mtm180 -112.95 147.54 36.9 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.103 170.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.894 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 27.1 mt -137.98 109.76 6.2 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 C-N-CA 119.886 -0.726 . . . . 0.0 112.841 -173.281 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 97.5 t -110.81 111.16 34.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.086 0.469 . . . . 0.0 110.941 -178.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.829 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 0.9 OUTLIER -115.69 126.65 54.39 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.267 177.366 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.6 p -136.67 138.25 25.88 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-N 113.922 -1.49 . . . . 0.0 111.889 -174.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo . . . . . 0 C--N 1.343 0.241 0 C-N-CA 123.611 2.874 . . . . 0.0 111.604 176.043 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 28.8 p . . . . . 0 CA--C 1.513 -0.457 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.829 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 12.4 m -140.01 148.72 42.28 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 119.535 -0.866 . . . . 0.0 111.595 -179.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.894 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 37.5 tt0 -122.68 112.15 17.6 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.557 177.269 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.663 HD12 ' CG2' ' A' ' 64' ' ' VAL . 11.7 mt -99.56 164.27 12.15 Favored 'General case' 0 CA--C 1.511 -0.531 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.633 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.417 ' O ' HD23 ' A' ' 57' ' ' LEU . 18.6 t-20 -126.27 118.86 25.99 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.586 179.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.638 HD12 ' CH2' ' A' ' 30' ' ' TRP . 5.3 mt -119.02 159.12 46.11 Favored Pre-proline 0 C--N 1.318 -0.801 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 -178.02 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -65.13 153.44 78.26 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 121.717 1.612 . . . . 0.0 111.258 174.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -49.98 -26.7 4.49 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.074 176.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 10.2 t -101.23 13.63 34.5 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.053 -175.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.514 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -80.34 161.53 24.99 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 178.274 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.445 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 27.7 p-10 -147.73 16.54 1.12 Allowed 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -178.16 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.624 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 19.7 p -171.49 134.42 0.86 Allowed 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.23 -0.588 . . . . 0.0 111.645 179.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.72 HG12 ' HZ3' ' A' ' 30' ' ' TRP . 3.1 p -118.83 137.36 53.06 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.399 176.548 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 52.1 m -95.71 100.82 12.49 Favored 'General case' 0 N--CA 1.433 -1.301 0 CA-C-O 121.573 0.701 . . . . 0.0 109.18 169.035 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.725 ' HB3' ' CE2' ' A' ' 44' ' ' TYR . 0.3 OUTLIER -74.9 141.33 44.14 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.173 178.439 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.438 ' HA ' ' O ' ' A' ' 24' ' ' THR . 9.7 t -136.07 168.97 18.36 Favored 'General case' 0 N--CA 1.444 -0.75 0 O-C-N 123.605 0.566 . . . . 0.0 109.762 -178.126 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 62.92 34.34 14.25 Favored 'General case' 0 CA--C 1.519 -0.234 0 O-C-N 123.787 0.679 . . . . 0.0 111.252 -178.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.684 ' O ' HG22 ' A' ' 24' ' ' THR . 9.4 mt -79.62 -177.21 5.73 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 174.108 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 55.7 tp60 -123.33 125.01 26.24 Favored Pre-proline 0 C--N 1.314 -0.947 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 175.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.448 ' HB3' ' CB ' ' A' ' 23' ' ' ASP . 39.4 Cg_endo -65.28 133.97 37.21 Favored 'Trans proline' 0 CA--C 1.53 0.316 0 C-N-CA 123.019 2.48 . . . . 0.0 113.12 -175.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 82.48 35.49 19.83 Favored Glycine 0 N--CA 1.45 -0.386 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.901 -179.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 45.4 t -137.4 149.91 25.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.0 0.428 . . . . 0.0 111.026 -175.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 8.9 tp60 -87.98 111.34 21.38 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.433 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -102.01 123.34 45.72 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.878 -177.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.545 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 74.9 m-20 -93.5 107.6 19.42 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.151 175.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.641 HG12 HD11 ' A' ' 66' ' ' LEU . 5.2 mp -92.69 118.67 38.81 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.596 0 CA-C-O 121.229 0.538 . . . . 0.0 109.717 176.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.844 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 30.0 m -110.16 116.19 31.08 Favored 'General case' 0 N--CA 1.428 -1.553 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.331 179.618 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.539 ' HB ' ' HB ' ' A' ' 91' ' ' VAL . 12.4 mm -95.5 130.79 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -117.53 112.14 20.2 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 177.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.417 ' HB1' HG21 ' A' ' 37' ' ' ILE . . . -82.69 127.61 33.56 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 169.588 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.404 ' O ' ' N ' ' A' ' 38' ' ' THR . 6.5 p -117.59 135.88 56.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 C-N-CA 120.194 -0.603 . . . . 0.0 110.804 -177.265 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.609 ' HG3' HG22 ' A' ' 37' ' ' ILE . 2.4 mp0 -113.37 170.17 8.43 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.403 ' HG3' ' H ' ' A' ' 84' ' ' GLU . 40.6 mt-10 -38.65 -52.65 1.65 Allowed 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -174.102 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -131.09 17.31 5.05 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.943 -0.303 . . . . 0.0 110.814 -176.15 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 18.1 mm-40 -142.19 173.5 11.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.795 0.331 . . . . 0.0 110.915 -176.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -135.81 125.58 25.58 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 175.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.4 ' HB2' ' HB3' ' A' ' 81' ' ' ALA . 47.6 m -73.1 170.5 14.77 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.734 0.302 . . . . 0.0 111.079 178.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.46 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 2.8 p -62.58 153.03 79.37 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 120.973 0.416 . . . . 0.0 111.096 178.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -86.03 140.92 6.97 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.516 2.144 . . . . 0.0 114.387 -177.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.844 ' O ' ' HA ' ' A' ' 78' ' ' THR . 21.0 t -82.33 127.4 39.67 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.624 0 CA-C-N 114.83 -1.077 . . . . 0.0 108.575 167.132 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 11.7 t -121.84 106.9 18.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 C-N-CA 119.935 -0.706 . . . . 0.0 109.884 170.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.579 HG13 ' HB ' ' A' ' 77' ' ' ILE . 8.6 pt -122.58 116.79 49.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.166 178.342 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -100.03 124.96 45.98 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.601 0.715 . . . . 0.0 110.953 -177.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.67 134.25 40.93 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.311 178.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -84.89 137.05 33.37 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.965 0.412 . . . . 0.0 110.037 178.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 25.5 p -71.13 113.0 7.73 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.778 176.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 33.1 m . . . . . 0 C--N 1.32 -0.706 0 CA-C-O 121.837 0.827 . . . . 0.0 109.638 -179.351 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.214 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -68.28 130.91 22.18 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.507 2.138 . . . . 0.0 112.252 177.306 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.401 ' HD2' ' O ' ' A' ' 31' ' ' SER . 74.0 Cg_exo -50.87 151.26 11.52 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.81 2.34 . . . . 0.0 111.572 172.899 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -38.88 106.13 0.37 Allowed Pre-proline 0 N--CA 1.47 0.573 0 O-C-N 124.493 1.121 . . . . 0.0 112.251 -170.552 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.603 ' HG2' HG11 ' A' ' 91' ' ' VAL . 34.3 Cg_exo -64.59 149.68 89.46 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 123.504 2.803 . . . . 0.0 112.691 179.594 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 28.0 m -105.24 129.39 53.62 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.988 -1.006 . . . . 0.0 110.71 -177.423 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.452 ' HA ' ' HA ' ' A' ' 28' ' ' VAL . 70.6 t -81.02 123.31 37.49 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 CA-C-N 114.522 -1.217 . . . . 0.0 110.049 175.639 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -89.39 -37.39 14.88 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.435 -174.756 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -135.05 134.75 40.7 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.851 0.358 . . . . 0.0 110.601 -177.898 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.504 ' HA ' HG12 ' A' ' 26' ' ' ILE . 59.2 t -130.0 117.93 42.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.334 179.184 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.415 ' HB3' ' H ' ' A' ' 23' ' ' ASP . 8.8 m-20 -128.21 -160.76 1.04 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.84 175.405 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.56 ' O ' ' HB2' ' A' ' 69' ' ' LEU . 1.9 m-20 -77.19 -58.4 3.3 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.043 0.449 . . . . 0.0 110.91 -177.718 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.646 HG22 ' O ' ' A' ' 69' ' ' LEU . 34.9 p -113.11 34.42 4.47 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.131 -175.458 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.637 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 75.8 p -169.88 130.94 1.03 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.626 -176.583 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.592 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 43.4 mt -147.17 139.51 18.98 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.624 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 176.841 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.445 ' O ' HG13 ' A' ' 18' ' ' VAL . 39.9 t -118.17 130.13 73.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 118.697 0.681 . . . . 0.0 110.586 -175.702 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.675 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.6 OUTLIER -122.81 145.87 28.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 C-N-CA 120.496 -0.482 . . . . 0.0 110.009 -177.368 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.556 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 29.8 mtm180 -130.81 121.11 24.75 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 123.358 0.411 . . . . 0.0 110.68 -175.946 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.746 ' HZ3' HG12 ' A' ' 64' ' ' VAL . 38.2 p90 -110.26 144.23 39.27 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.608 -173.994 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.401 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 17.6 m -89.31 96.8 10.86 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.027 177.167 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.596 ' NE ' ' HB3' ' A' ' 62' ' ' ASN . 0.1 OUTLIER -45.73 155.85 0.46 Allowed Pre-proline 0 CA--C 1.538 0.515 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -175.105 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.693 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 4.6 Cg_exo -82.95 169.91 12.78 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 124.519 3.479 . . . . 0.0 112.623 -172.416 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -81.21 -18.0 47.65 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.181 174.518 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.18 142.08 98.21 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.499 177.863 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_exo -70.72 115.26 4.15 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 121.487 1.458 . . . . 0.0 109.614 168.432 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.6 HG22 ' HG3' ' A' ' 83' ' ' GLU . 0.8 OUTLIER -121.72 152.15 25.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -174.91 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 11.8 p -98.12 -31.65 12.01 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -177.637 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.452 ' C ' HG12 ' A' ' 82' ' ' VAL . . . -163.15 -164.39 18.09 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.267 -0.968 . . . . 0.0 111.698 177.977 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.693 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 6.4 m-85 -140.32 136.13 32.91 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.848 0.324 . . . . 0.0 111.124 175.162 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 21.6 mtp180 -104.69 151.38 23.77 Favored 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 166.393 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.889 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 32.6 mt -139.59 108.47 3.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 C-N-CA 120.617 -0.433 . . . . 0.0 111.977 -178.491 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 72.6 t -107.77 109.64 28.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.306 0.574 . . . . 0.0 110.194 178.322 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.703 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 0.6 OUTLIER -110.46 125.14 52.97 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.138 175.908 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.1 m -143.17 133.88 12.4 Favored Pre-proline 0 C--N 1.316 -0.874 0 CA-C-N 113.928 -1.487 . . . . 0.0 110.808 -175.379 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.524 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 57.6 Cg_endo . . . . . 0 C--N 1.333 -0.274 0 C-N-CA 123.108 2.539 . . . . 0.0 111.694 176.162 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 15.5 m . . . . . 0 CA--C 1.517 -0.318 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.703 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 23.5 m -144.77 151.93 39.59 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 120.443 -0.503 . . . . 0.0 111.476 -175.705 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.889 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 51.4 tt0 -121.61 112.44 18.46 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.619 176.251 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.713 HD12 ' CG2' ' A' ' 64' ' ' VAL . 18.1 mt -97.48 163.0 13.05 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.013 176.885 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.513 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 18.5 m120 -129.75 113.27 14.51 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.884 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.556 HD12 ' CH2' ' A' ' 30' ' ' TRP . 3.5 mt -110.98 157.62 38.14 Favored Pre-proline 0 C--N 1.317 -0.831 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -174.431 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -64.59 150.45 88.19 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 121.849 1.699 . . . . 0.0 111.157 175.484 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -48.31 -23.03 0.78 Allowed 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 115.177 -0.919 . . . . 0.0 112.852 177.908 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 5.1 t -99.86 1.6 43.07 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.215 -175.859 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.496 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -76.06 159.57 30.65 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 -176.951 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.596 ' HB3' ' NE ' ' A' ' 32' ' ' ARG . 28.6 p-10 -147.03 18.52 1.24 Allowed 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 120.554 -0.458 . . . . 0.0 112.231 -178.421 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.675 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 23.2 p -169.22 133.65 1.43 Allowed 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.164 -0.615 . . . . 0.0 112.155 -179.9 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.746 HG12 ' HZ3' ' A' ' 30' ' ' TRP . 3.6 p -118.44 137.11 53.46 Favored 'Isoleucine or valine' 0 C--O 1.242 0.673 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.203 176.257 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 61.0 m -97.68 101.98 13.63 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.752 171.65 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.68 HD11 HG12 ' A' ' 77' ' ' ILE . 0.2 OUTLIER -80.59 140.22 35.87 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.362 179.397 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 22.0 t -134.11 168.23 19.21 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 123.438 0.461 . . . . 0.0 110.642 -173.455 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 58.75 31.34 21.09 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.991 -177.811 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.646 ' O ' HG22 ' A' ' 24' ' ' THR . 14.3 mt -69.16 -175.44 0.76 Allowed 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 175.19 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -126.87 125.53 24.28 Favored Pre-proline 0 C--N 1.318 -0.772 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 178.407 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -63.52 130.04 27.02 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 123.03 2.486 . . . . 0.0 113.418 -177.346 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 88.18 22.05 43.0 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.774 -179.917 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 86.6 t -127.38 144.26 37.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.145 0.498 . . . . 0.0 111.308 -173.35 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.524 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 15.8 tp60 -88.88 107.18 18.86 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.98 -176.566 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -98.09 117.79 33.24 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.224 0.535 . . . . 0.0 111.64 -178.079 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -90.4 107.9 19.44 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.127 177.629 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.68 HG12 HD11 ' A' ' 66' ' ' LEU . 5.3 mp -91.73 116.4 32.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.294 0.569 . . . . 0.0 109.684 178.988 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.854 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 30.8 m -108.47 115.26 29.77 Favored 'General case' 0 N--CA 1.428 -1.525 0 CA-C-N 115.294 -0.867 . . . . 0.0 110.404 -179.791 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.566 ' HB ' ' HB ' ' A' ' 91' ' ' VAL . 14.3 mm -95.46 144.23 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -179.255 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -131.17 112.12 12.55 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.233 179.374 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -79.02 123.69 27.55 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 169.117 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.452 HG12 ' C ' ' A' ' 39' ' ' GLY . 7.0 p -114.53 135.91 52.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 C-N-CA 120.149 -0.621 . . . . 0.0 110.685 -179.824 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.666 ' OE1' ' HG3' ' A' ' 86' ' ' GLN . 3.9 mp0 -112.28 170.68 8.0 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -179.164 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -38.76 -55.78 1.44 Allowed 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -174.09 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -125.23 9.85 8.01 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -176.233 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.666 ' HG3' ' OE1' ' A' ' 83' ' ' GLU . 3.3 pt20 -143.03 176.49 9.06 Favored 'General case' 0 N--CA 1.447 -0.623 0 O-C-N 122.336 -0.227 . . . . 0.0 111.0 -175.095 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -138.28 136.08 36.12 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.004 178.432 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 46.2 m -78.24 175.46 10.18 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.168 178.297 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -63.09 160.69 37.13 Favored Pre-proline 0 CA--C 1.534 0.344 0 CA-C-O 120.973 0.416 . . . . 0.0 111.523 178.614 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -87.85 140.46 5.01 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.302 2.002 . . . . 0.0 114.365 -178.497 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.854 ' O ' ' HA ' ' A' ' 78' ' ' THR . 6.9 t -82.72 127.65 39.47 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.688 0 CA-C-N 114.825 -1.08 . . . . 0.0 108.34 165.863 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.4 t -124.05 106.06 16.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 C-N-CA 120.027 -0.669 . . . . 0.0 109.596 172.476 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.537 HG13 ' HB ' ' A' ' 77' ' ' ILE . 7.7 pt -124.2 112.87 34.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.418 178.674 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -94.07 120.17 33.94 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.315 0.579 . . . . 0.0 111.05 -177.66 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.33 125.37 42.16 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.486 175.482 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.447 ' HA ' ' HA ' ' A' ' 74' ' ' GLN . 40.9 tt0 -90.0 128.08 36.18 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.18 0.514 . . . . 0.0 110.034 179.783 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 40.3 p -59.52 144.71 46.56 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.948 -176.524 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 16.4 m . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.342 -171.752 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.576 ' HB2' ' O ' ' A' ' 89' ' ' THR . . . . . . . . 0 CA--C 1.516 -0.34 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.469 ' HB2' ' HB2' ' A' ' 30' ' ' TRP . 27.0 Cg_exo -64.64 130.68 27.09 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 121.81 1.674 . . . . 0.0 111.055 171.806 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.567 ' HD2' ' O ' ' A' ' 31' ' ' SER . 71.5 Cg_exo -50.39 155.56 4.86 Favored 'Trans proline' 0 C--O 1.235 0.353 0 C-N-CA 122.524 2.149 . . . . 0.0 111.6 171.415 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -35.7 106.19 0.3 Allowed Pre-proline 0 N--CA 1.472 0.654 0 O-C-N 124.56 1.162 . . . . 0.0 112.437 -171.115 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.628 ' HG2' HG11 ' A' ' 91' ' ' VAL . 24.1 Cg_exo -70.5 145.1 51.94 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 123.162 2.575 . . . . 0.0 112.435 177.518 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.2 m -101.64 131.2 48.0 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.568 0.699 . . . . 0.0 110.814 -177.575 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.498 HG11 HG22 ' A' ' 21' ' ' VAL . 70.6 t -81.01 118.24 28.44 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 CA-C-N 114.658 -1.156 . . . . 0.0 110.061 175.226 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -78.05 -46.63 20.39 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.318 -175.568 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -136.74 140.67 42.77 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.679 -178.193 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.498 HG22 HG11 ' A' ' 18' ' ' VAL . 7.2 t -127.24 114.2 35.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.697 -178.063 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -124.63 -164.96 1.32 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 179.467 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.581 ' O ' ' HB2' ' A' ' 69' ' ' LEU . 4.0 p-10 -70.67 -67.1 0.53 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.073 0.463 . . . . 0.0 112.193 -178.109 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.678 HG22 ' O ' ' A' ' 69' ' ' LEU . 35.2 p -110.3 32.08 5.43 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.004 -173.381 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.706 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 42.3 m -167.71 129.99 1.57 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.194 -171.622 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.732 ' HB ' HD12 ' A' ' 66' ' ' LEU . 44.8 mt -147.37 145.57 18.99 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.924 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 177.398 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 43.7 t -118.67 131.4 71.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 119.22 0.918 . . . . 0.0 110.262 -176.803 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.64 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.6 OUTLIER -127.76 145.77 34.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 C-N-CA 120.096 -0.642 . . . . 0.0 110.318 -179.214 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.48 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 11.1 mtm180 -130.02 121.34 26.28 Favored 'General case' 0 CA--C 1.515 -0.379 0 O-C-N 123.397 0.436 . . . . 0.0 110.302 -175.584 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.733 ' HZ3' HG12 ' A' ' 64' ' ' VAL . 34.6 p90 -111.53 145.8 38.43 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.419 -175.306 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.567 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 12.5 t -90.29 91.81 8.66 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 175.124 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.473 ' HD3' ' H ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -46.1 156.3 0.48 Allowed Pre-proline 0 CA--C 1.542 0.662 0 C-N-CA 124.14 0.976 . . . . 0.0 113.507 -174.426 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.684 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 4.2 Cg_exo -76.27 169.53 21.81 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 123.86 3.04 . . . . 0.0 112.939 -173.754 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -83.74 -15.59 48.03 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.344 174.378 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.98 144.87 99.14 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.122 -0.944 . . . . 0.0 111.423 177.233 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -68.6 115.45 3.92 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 121.612 1.542 . . . . 0.0 109.831 167.274 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.638 HD12 ' HE1' ' A' ' 40' ' ' TYR . 1.1 pt -121.11 155.74 24.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -177.683 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.51 ' C ' ' HB3' ' A' ' 59' ' ' GLU . 21.7 p -104.24 -29.32 10.88 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -177.858 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.522 ' C ' HG12 ' A' ' 82' ' ' VAL . . . -161.7 -167.87 22.77 Favored Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.252 -0.975 . . . . 0.0 111.829 179.853 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.684 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 5.5 m-85 -139.93 131.57 27.25 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 120.803 0.335 . . . . 0.0 111.301 174.347 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.593 ' CZ ' HG11 ' A' ' 82' ' ' VAL . 0.2 OUTLIER -99.55 147.79 24.96 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 168.792 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.891 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 33.0 mt -139.71 107.47 2.93 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 C-N-CA 119.875 -0.73 . . . . 0.0 112.435 -179.582 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 82.5 t -108.47 110.7 32.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.138 0.494 . . . . 0.0 110.825 -178.519 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.751 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 0.8 OUTLIER -113.43 125.56 54.37 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 121.503 0.668 . . . . 0.0 109.985 176.175 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.495 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 13.9 t -140.25 140.53 23.6 Favored Pre-proline 0 C--N 1.319 -0.751 0 CA-C-N 113.717 -1.583 . . . . 0.0 110.69 -174.505 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.633 ' HG3' ' CZ ' ' A' ' 75' ' ' TYR . 2.4 Cg_endo . . . . . 0 N--CA 1.462 -0.371 0 C-N-CA 123.605 2.87 . . . . 0.0 111.67 178.57 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 22.7 p . . . . . 0 CA--C 1.516 -0.339 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.751 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 62.7 m -146.92 145.6 29.86 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 119.922 -0.711 . . . . 0.0 111.588 176.919 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.891 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 41.8 tt0 -116.56 115.75 26.33 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.94 174.532 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.684 HD12 ' CG2' ' A' ' 64' ' ' VAL . 18.8 mt -97.52 161.55 13.72 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 175.855 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.486 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 36.9 t30 -126.12 119.44 27.56 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 177.651 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.573 HD12 ' CH2' ' A' ' 30' ' ' TRP . 4.7 mt -113.96 159.55 35.64 Favored Pre-proline 0 C--N 1.317 -0.822 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 -177.419 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -67.18 151.99 80.39 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 121.534 1.489 . . . . 0.0 111.005 174.66 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.51 ' HB3' ' C ' ' A' ' 38' ' ' THR . 7.0 pt-20 -47.8 -24.75 1.06 Allowed 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.092 -0.958 . . . . 0.0 112.632 177.468 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.9 t -104.6 15.87 27.17 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.09 -174.524 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.428 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -86.81 161.69 18.21 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 178.057 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.48 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 4.3 p-10 -145.31 15.37 1.48 Allowed 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.954 -178.092 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.64 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 26.4 p -168.83 133.88 1.6 Allowed 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.281 -0.568 . . . . 0.0 111.694 -179.016 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.733 HG12 ' HZ3' ' A' ' 30' ' ' TRP . 3.3 p -117.33 139.83 42.72 Favored 'Isoleucine or valine' 0 C--O 1.244 0.81 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.47 177.237 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 47.7 m -97.23 101.14 12.64 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.579 168.391 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.732 HD12 ' HB ' ' A' ' 26' ' ' ILE . 0.3 OUTLIER -76.03 141.9 41.97 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.597 177.924 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.436 ' HA ' ' O ' ' A' ' 24' ' ' THR . 27.3 p -136.62 166.22 24.04 Favored 'General case' 0 N--CA 1.447 -0.595 0 O-C-N 123.819 0.7 . . . . 0.0 110.041 -174.955 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 61.93 38.54 14.32 Favored 'General case' 0 N--CA 1.464 0.227 0 O-C-N 123.688 0.617 . . . . 0.0 111.431 -179.214 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.678 ' O ' HG22 ' A' ' 24' ' ' THR . 8.1 mt -85.04 -176.26 6.12 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 175.459 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 58.4 tp60 -126.72 124.69 24.21 Favored Pre-proline 0 C--N 1.32 -0.704 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 176.479 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -62.24 134.54 49.35 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 123.188 2.592 . . . . 0.0 113.498 -178.072 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 86.53 24.27 40.0 Favored Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.363 176.977 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 17.9 t -130.53 149.23 33.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.236 0.541 . . . . 0.0 111.445 -176.232 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.494 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 14.8 tp60 -79.64 108.0 12.85 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.634 179.971 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.633 ' CZ ' ' HG3' ' A' ' 46' ' ' PRO . 4.2 m-85 -101.15 116.52 33.01 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.377 0.608 . . . . 0.0 111.868 -178.708 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.585 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 31.0 m-80 -89.2 109.02 19.94 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.448 177.037 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.678 HG12 HD11 ' A' ' 66' ' ' LEU . 5.2 mp -92.56 116.01 32.73 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.616 0 CA-C-O 121.332 0.586 . . . . 0.0 109.571 175.598 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.874 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 89.2 m -108.82 116.18 31.5 Favored 'General case' 0 N--CA 1.426 -1.639 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.243 179.954 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.558 ' HB ' ' HB ' ' A' ' 91' ' ' VAL . 15.6 mm -95.26 140.59 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 -178.959 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -127.87 113.04 15.4 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 178.776 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.458 ' HB1' HG21 ' A' ' 37' ' ' ILE . . . -84.12 119.65 25.23 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 171.173 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.593 HG11 ' CZ ' ' A' ' 41' ' ' ARG . 7.5 p -110.54 141.22 26.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 C-N-CA 120.237 -0.585 . . . . 0.0 110.204 -175.355 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.604 ' OE1' ' HB2' ' A' ' 86' ' ' GLN . 0.1 OUTLIER -123.28 170.88 9.84 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 123.37 0.419 . . . . 0.0 110.104 177.183 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -34.64 -55.83 0.55 Allowed 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 113.839 1.052 . . . . 0.0 113.839 -171.241 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -123.81 14.72 9.33 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 -174.627 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.604 ' HB2' ' OE1' ' A' ' 83' ' ' GLU . 25.4 mt-30 -146.18 170.81 15.96 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.368 0.604 . . . . 0.0 111.849 -177.298 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -127.38 124.63 39.02 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.113 173.704 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 15.4 m -76.2 -178.52 4.53 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.648 0.261 . . . . 0.0 111.088 -177.635 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.576 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 3.9 p -67.39 154.93 92.07 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-O 120.947 0.403 . . . . 0.0 111.438 -178.378 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -88.2 141.6 5.08 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 122.76 2.307 . . . . 0.0 115.031 179.747 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.874 ' O ' ' HA ' ' A' ' 78' ' ' THR . 8.8 t -83.34 131.59 33.43 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.538 0 CA-C-N 114.678 -1.146 . . . . 0.0 108.271 163.892 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 13.7 t -125.02 106.81 17.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 C-N-CA 119.94 -0.704 . . . . 0.0 110.172 170.178 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.623 HG13 ' HB ' ' A' ' 77' ' ' ILE . 8.2 pt -121.11 111.43 31.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.342 178.185 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -97.23 112.99 24.55 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.659 0.742 . . . . 0.0 111.6 -177.035 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.92 131.54 53.41 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.484 179.77 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -86.47 129.89 34.69 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.046 0.451 . . . . 0.0 110.519 -179.483 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.443 HG22 HD11 ' A' ' 26' ' ' ILE . 20.3 p -60.43 117.68 5.55 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.227 179.626 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.424 ' H ' HG12 ' A' ' 21' ' ' VAL . 39.1 m . . . . . 0 C--N 1.325 -0.476 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.039 179.651 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.427 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.456 ' CB ' ' HB2' ' A' ' 30' ' ' TRP . 23.6 Cg_exo -67.35 126.16 14.54 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 121.364 1.376 . . . . 0.0 111.535 176.589 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.42 ' HD2' ' O ' ' A' ' 31' ' ' SER . 76.6 Cg_exo -49.49 145.39 16.56 Favored 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.469 2.112 . . . . 0.0 110.634 171.486 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.402 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 10.1 m-20 -35.95 105.62 0.29 Allowed Pre-proline 0 N--CA 1.47 0.55 0 O-C-N 124.701 1.251 . . . . 0.0 112.329 -169.394 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.597 ' HG2' HG11 ' A' ' 91' ' ' VAL . 31.3 Cg_exo -64.76 155.45 67.25 Favored 'Trans proline' 0 CA--C 1.514 -0.492 0 C-N-CA 123.747 2.965 . . . . 0.0 112.407 -179.81 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 31.6 m -113.77 131.03 56.36 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.806 -178.207 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.511 HG11 HG22 ' A' ' 21' ' ' VAL . 71.4 t -73.26 122.81 26.9 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 114.054 -1.43 . . . . 0.0 109.884 175.051 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -84.47 -41.94 16.09 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.944 -173.847 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -136.22 140.62 43.65 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.163 178.574 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.511 HG22 HG11 ' A' ' 18' ' ' VAL . 39.8 t -123.72 119.46 57.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.468 178.191 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.406 ' HB2' ' O ' ' A' ' 25' ' ' SER . 23.6 m-20 -124.36 -159.06 0.85 Allowed 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 176.95 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.536 ' O ' ' HB2' ' A' ' 69' ' ' LEU . 17.8 p-10 -84.44 -54.41 4.78 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.3 0.571 . . . . 0.0 111.348 179.094 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.599 HG22 ' O ' ' A' ' 69' ' ' LEU . 29.9 p -119.61 29.73 7.44 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.192 -172.409 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.636 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 17.0 p -169.91 130.6 1.01 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.665 -1.152 . . . . 0.0 109.858 -176.097 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.606 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 48.0 mt -148.05 142.22 19.23 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.666 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.765 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.458 ' O ' HG13 ' A' ' 18' ' ' VAL . 44.9 t -115.96 136.21 53.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 C-N-CA 119.858 -0.737 . . . . 0.0 109.933 -175.701 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.642 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.6 OUTLIER -127.13 145.41 34.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 C-N-CA 120.122 -0.631 . . . . 0.0 110.162 179.105 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.48 ' HG2' ' HB3' ' A' ' 63' ' ' SER . 54.8 mtp180 -130.02 120.98 25.61 Favored 'General case' 0 C--N 1.327 -0.408 0 O-C-N 123.535 0.522 . . . . 0.0 110.497 -174.766 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.708 ' HZ3' HG12 ' A' ' 64' ' ' VAL . 35.7 p90 -113.47 149.04 34.84 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.879 -174.052 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.433 ' O ' ' HA ' ' A' ' 13' ' ' PRO . 48.2 m -92.75 88.53 6.28 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.202 175.758 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.526 ' HD3' ' H ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -50.75 159.05 0.99 Allowed Pre-proline 0 CA--C 1.544 0.715 0 CA-C-N 114.99 -1.005 . . . . 0.0 113.404 -175.413 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.729 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 6.4 Cg_exo -74.08 169.33 22.69 Favored 'Trans proline' 0 C--N 1.358 1.032 0 C-N-CA 124.001 3.134 . . . . 0.0 113.332 -172.597 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -91.38 3.88 53.81 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.242 174.842 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -85.4 151.41 56.22 Favored Pre-proline 0 CA--C 1.515 -0.378 0 CA-C-N 114.683 -1.144 . . . . 0.0 110.532 178.686 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -75.85 114.76 4.01 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 121.446 1.431 . . . . 0.0 109.92 171.728 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.614 HD12 ' HE1' ' A' ' 40' ' ' TYR . 2.6 pt -123.06 157.52 28.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.728 -173.508 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.407 ' H ' ' HA ' ' A' ' 83' ' ' GLU . 6.8 p -91.91 -39.12 11.89 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -178.483 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.436 ' O ' HG12 ' A' ' 82' ' ' VAL . . . -169.45 -162.99 22.72 Favored Glycine 0 N--CA 1.439 -1.11 0 C-N-CA 119.542 -1.313 . . . . 0.0 112.687 -178.98 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.729 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 5.1 m-85 -137.71 135.64 36.63 Favored 'General case' 0 CA--C 1.506 -0.746 0 CA-C-O 120.897 0.38 . . . . 0.0 111.175 178.993 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.6 mtm105 -107.53 147.62 30.31 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 169.987 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.875 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 27.3 mt -139.22 109.74 4.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 C-N-CA 120.17 -0.612 . . . . 0.0 112.471 -174.758 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 78.4 t -111.11 110.34 31.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.578 179.011 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.784 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 0.7 OUTLIER -112.08 124.94 53.51 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.427 176.646 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.431 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 8.1 p -138.02 136.24 19.48 Favored Pre-proline 0 C--N 1.312 -1.039 0 CA-C-N 113.946 -1.479 . . . . 0.0 111.47 -172.394 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.595 ' HB3' HG11 ' A' ' 73' ' ' VAL . 16.1 Cg_exo . . . . . 0 CA--C 1.519 -0.242 0 C-N-CA 122.929 2.419 . . . . 0.0 110.934 174.905 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.9 m . . . . . 0 CA--C 1.517 -0.303 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.784 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 26.3 m -145.67 154.99 42.71 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 120.53 -0.468 . . . . 0.0 111.493 -175.507 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.875 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 33.3 tt0 -127.46 112.92 15.52 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.603 -179.026 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.708 HD12 ' CG2' ' A' ' 64' ' ' VAL . 17.0 mt -100.86 162.35 12.96 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.455 178.183 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.555 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 2.3 m120 -128.65 115.89 18.74 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 176.837 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.57 HD12 ' CH2' ' A' ' 30' ' ' TRP . 4.6 mt -110.85 156.86 40.04 Favored Pre-proline 0 N--CA 1.441 -0.883 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -175.96 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -63.26 151.22 85.92 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 121.737 1.625 . . . . 0.0 110.989 175.902 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.437 ' HB2' HG13 ' A' ' 37' ' ' ILE . 9.8 pt-20 -45.84 -28.95 1.2 Allowed 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.344 176.707 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.5 t -101.2 19.53 17.44 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.148 -174.834 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.506 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -89.11 161.08 16.7 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 178.635 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.446 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 29.6 p-10 -147.85 15.94 1.09 Allowed 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -177.123 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.642 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 28.0 p -171.32 133.95 0.86 Allowed 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.226 -0.59 . . . . 0.0 111.779 -178.476 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.716 HG11 HG21 ' A' ' 42' ' ' ILE . 3.1 p -117.13 136.77 53.2 Favored 'Isoleucine or valine' 0 C--O 1.24 0.59 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.434 177.146 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 41.3 m -94.57 101.71 13.61 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.668 169.106 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.636 ' O ' ' HA ' ' A' ' 25' ' ' SER . 0.2 OUTLIER -78.8 141.04 38.09 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 177.551 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 10.9 t -137.3 172.65 12.67 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 -177.035 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 60.93 31.58 19.97 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.476 -179.287 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.599 ' O ' HG22 ' A' ' 24' ' ' THR . 10.7 mt -74.42 -176.99 2.89 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 176.917 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 7.7 tp60 -126.15 121.59 23.99 Favored Pre-proline 0 C--N 1.319 -0.741 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 177.5 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -60.29 135.06 59.33 Favored 'Trans proline' 0 C--O 1.235 0.366 0 C-N-CA 123.001 2.467 . . . . 0.0 113.372 -177.634 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 87.71 17.47 58.23 Favored Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.309 177.323 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.595 HG11 ' HB3' ' A' ' 46' ' ' PRO . 14.1 t -125.62 146.62 31.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 120.816 0.341 . . . . 0.0 110.841 -177.573 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.553 ' OE1' ' HB2' ' A' ' 96' ' ' GLU . 35.0 tp60 -81.05 122.69 27.63 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.782 178.744 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.463 ' CE2' HD22 ' A' ' 69' ' ' LEU . 5.4 m-85 -105.98 116.17 31.48 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 121.599 0.714 . . . . 0.0 111.725 -179.297 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.423 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 16.2 t-20 -90.14 104.1 16.7 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 114.487 -1.233 . . . . 0.0 109.113 177.01 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.623 HG12 HD11 ' A' ' 66' ' ' LEU . 5.3 mp -92.25 116.41 33.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.347 0.594 . . . . 0.0 109.758 177.722 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.84 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 62.1 m -108.3 116.13 31.39 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.09 179.094 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.612 ' HB ' ' HB ' ' A' ' 91' ' ' VAL . 15.5 mm -95.61 141.92 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.831 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -126.94 112.99 15.93 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 179.613 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -89.25 123.1 33.15 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 174.53 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.436 HG12 ' O ' ' A' ' 39' ' ' GLY . 7.3 p -120.63 134.67 63.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 120.02 -0.672 . . . . 0.0 112.258 -173.122 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.611 ' HG2' HG22 ' A' ' 37' ' ' ILE . 6.3 mt-10 -104.59 171.82 7.12 Favored 'General case' 0 N--CA 1.454 -0.261 0 O-C-N 124.146 0.904 . . . . 0.0 109.228 173.607 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -47.68 -39.51 17.56 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 179.081 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -113.36 -29.33 7.26 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -171.343 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -133.32 176.34 8.6 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.553 -0.459 . . . . 0.0 111.683 -170.011 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -134.61 137.78 43.98 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.789 177.717 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 17.7 m -77.64 173.47 12.01 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.828 -179.69 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 14.2 p -61.79 154.63 66.02 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-O 120.918 0.39 . . . . 0.0 110.623 176.567 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -81.64 142.6 12.97 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 122.067 1.845 . . . . 0.0 113.622 -175.463 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.84 ' O ' ' HA ' ' A' ' 78' ' ' THR . 7.1 t -83.18 129.41 37.5 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.771 0 CA-C-N 114.879 -1.055 . . . . 0.0 108.615 168.09 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.9 t -126.27 106.96 16.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.153 175.01 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.547 HG13 ' HB ' ' A' ' 77' ' ' ILE . 8.1 pt -128.17 118.9 49.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.47 178.794 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -103.39 129.93 50.59 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.402 0.62 . . . . 0.0 111.349 -176.877 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.06 130.03 23.19 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.96 176.517 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.553 ' HB2' ' OE1' ' A' ' 74' ' ' GLN . 34.5 tt0 -85.83 136.12 33.44 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.251 0.548 . . . . 0.0 110.093 179.959 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 25.4 p -65.92 124.5 22.67 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.55 179.709 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.4 m . . . . . 0 C--N 1.327 -0.395 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.228 -173.292 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.367 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -68.61 133.14 26.95 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.482 2.122 . . . . 0.0 111.678 175.005 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.77 154.24 21.65 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.321 2.014 . . . . 0.0 110.943 172.91 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -36.45 107.2 0.35 Allowed Pre-proline 0 N--CA 1.468 0.464 0 O-C-N 124.595 1.184 . . . . 0.0 112.445 -172.148 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.622 ' HG2' HG11 ' A' ' 91' ' ' VAL . 36.1 Cg_exo -66.69 150.93 83.53 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 123.09 2.526 . . . . 0.0 112.265 177.712 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 45.8 m -106.93 129.04 54.81 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.872 -179.07 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.473 HG11 HG22 ' A' ' 21' ' ' VAL . 78.2 t -76.99 123.29 33.27 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-N 114.509 -1.223 . . . . 0.0 109.891 173.75 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -91.59 -37.39 13.11 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.341 -174.813 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 13.9 mm-40 -136.17 132.74 36.36 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.788 -178.59 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.485 ' HA ' HG12 ' A' ' 26' ' ' ILE . 46.5 t -124.01 120.1 58.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.388 179.637 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -127.5 -159.98 0.98 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 178.809 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -74.48 -72.11 0.3 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 179.162 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.608 HG22 ' O ' ' A' ' 69' ' ' LEU . 69.9 p -105.41 33.57 3.64 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.211 -174.034 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.601 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 68.5 p -169.66 137.16 1.71 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.574 -173.628 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.618 ' HB ' HD12 ' A' ' 66' ' ' LEU . 35.9 mt -150.71 145.68 16.69 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.904 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.783 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.432 ' O ' HG13 ' A' ' 18' ' ' VAL . 41.0 t -118.36 131.85 69.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 119.255 0.934 . . . . 0.0 110.472 -176.062 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.59 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.6 OUTLIER -127.13 146.52 32.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.233 -178.119 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.47 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 20.2 mtm180 -130.69 121.27 25.2 Favored 'General case' 0 C--N 1.329 -0.303 0 O-C-N 123.244 0.34 . . . . 0.0 110.57 -175.856 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.823 ' HZ3' HG12 ' A' ' 64' ' ' VAL . 39.5 p90 -112.06 146.74 37.41 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.103 -175.651 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 24.0 t -92.59 99.09 11.86 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.928 177.548 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.605 ' CD ' ' H ' ' A' ' 32' ' ' ARG . 0.2 OUTLIER -53.49 160.3 1.96 Allowed Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 115.098 -0.955 . . . . 0.0 113.189 -174.261 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.645 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 2.2 Cg_endo -84.93 163.52 11.81 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 124.307 3.338 . . . . 0.0 112.279 -177.254 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -82.73 -6.42 59.39 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.338 172.064 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -66.2 146.79 99.04 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.841 174.557 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -73.94 114.08 3.94 Favored 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 121.165 1.244 . . . . 0.0 109.857 170.213 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.583 HD12 ' HE1' ' A' ' 40' ' ' TYR . 0.8 OUTLIER -120.56 147.79 24.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 -177.455 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.422 ' N ' ' O ' ' A' ' 82' ' ' VAL . 25.4 p -88.89 -30.2 19.05 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -178.335 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.59 ' C ' HG12 ' A' ' 82' ' ' VAL . . . -171.09 -162.3 23.21 Favored Glycine 0 CA--C 1.499 -0.942 0 C-N-CA 120.116 -1.04 . . . . 0.0 111.551 -179.327 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.645 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 6.5 m-85 -140.06 132.6 28.69 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 117.01 0.405 . . . . 0.0 111.155 173.807 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.2 mmm180 -100.7 147.72 25.69 Favored 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 168.031 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.881 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 32.0 mt -138.29 108.21 4.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 C-N-CA 119.926 -0.71 . . . . 0.0 112.328 -178.395 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 93.1 t -110.41 111.52 36.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.088 0.47 . . . . 0.0 110.762 -178.154 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.742 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 0.6 OUTLIER -115.24 126.2 54.25 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.077 177.357 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 30.8 p -134.22 137.52 28.28 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 113.742 -1.572 . . . . 0.0 111.705 -174.696 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.617 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 92.9 Cg_endo . . . . . 0 N--CA 1.464 -0.231 0 C-N-CA 123.638 2.892 . . . . 0.0 111.937 178.488 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.0 p . . . . . 0 CA--C 1.514 -0.43 0 CA-C-O 120.421 0.153 . . . . 0.0 110.719 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.742 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 38.0 m -145.16 147.97 33.07 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 119.886 -0.725 . . . . 0.0 111.825 177.994 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.881 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 34.9 tt0 -118.54 114.1 22.3 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.957 176.014 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.697 HD12 ' CG2' ' A' ' 64' ' ' VAL . 16.8 mt -97.94 159.49 14.9 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.0 0.429 . . . . 0.0 110.318 176.564 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -123.43 113.63 19.05 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.59 179.253 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.557 HD12 ' CH2' ' A' ' 30' ' ' TRP . 2.6 mt -111.8 154.92 43.88 Favored Pre-proline 0 C--N 1.318 -0.796 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 -176.726 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -65.53 150.21 86.91 Favored 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 121.569 1.512 . . . . 0.0 110.958 175.955 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -45.11 -25.53 0.35 Allowed 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 114.618 -1.173 . . . . 0.0 113.186 178.981 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 5.4 t -103.9 5.01 35.42 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.44 -174.244 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.434 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -74.97 155.99 36.79 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 -179.677 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.493 ' HB3' ' NE ' ' A' ' 32' ' ' ARG . 26.6 p-10 -137.04 12.94 3.09 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.931 -177.32 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.59 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 23.3 p -169.1 133.79 1.49 Allowed 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 119.973 -0.691 . . . . 0.0 111.905 -177.525 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.823 HG12 ' HZ3' ' A' ' 30' ' ' TRP . 3.6 p -116.14 137.16 50.75 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.122 176.744 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 42.8 m -95.84 101.16 12.82 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 168.56 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.666 HD11 HG12 ' A' ' 77' ' ' ILE . 0.2 OUTLIER -76.49 141.13 41.39 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.259 178.65 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.6 t -136.48 170.73 15.57 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -177.432 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 65.1 29.57 11.96 Favored 'General case' 0 C--N 1.327 -0.388 0 O-C-N 123.665 0.603 . . . . 0.0 111.549 -178.155 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.608 ' O ' HG22 ' A' ' 24' ' ' THR . 9.1 mt -78.73 -175.6 4.49 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 174.135 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -126.99 131.99 24.12 Favored Pre-proline 0 C--N 1.32 -0.702 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 177.876 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -64.49 133.65 38.08 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.87 2.38 . . . . 0.0 113.008 -178.214 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 74.92 34.37 53.0 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.947 -0.644 . . . . 0.0 111.649 179.758 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 70.1 t -134.62 139.79 46.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.209 0.528 . . . . 0.0 110.815 -177.042 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.617 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -81.05 121.13 25.69 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.047 -176.053 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -116.66 115.82 26.39 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -175.306 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.544 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 2.6 m-20 -85.55 111.47 20.05 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.547 -0.752 . . . . 0.0 109.752 174.345 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.666 HG12 HD11 ' A' ' 66' ' ' LEU . 5.1 mp -93.47 117.95 38.14 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.602 0 CA-C-O 121.164 0.507 . . . . 0.0 109.748 175.751 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.883 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 24.9 m -109.39 115.14 29.4 Favored 'General case' 0 N--CA 1.428 -1.573 0 CA-C-N 115.25 -0.887 . . . . 0.0 110.545 -179.693 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.546 ' HB ' ' HB ' ' A' ' 91' ' ' VAL . 12.4 mm -95.73 139.88 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 179.537 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.427 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 68.4 m-85 -128.46 112.39 14.32 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.624 -0.262 . . . . 0.0 110.343 179.085 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.401 ' HB1' HG21 ' A' ' 37' ' ' ILE . . . -79.42 109.32 13.67 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 170.874 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.59 HG12 ' C ' ' A' ' 39' ' ' GLY . 11.1 p -99.39 140.77 18.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.756 -173.927 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -122.93 165.2 17.1 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 -178.412 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -47.16 -47.87 23.7 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -176.716 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -130.1 17.63 5.56 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.37 -176.899 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 66.9 mm-40 -142.31 169.58 17.32 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.871 0.367 . . . . 0.0 111.328 -179.023 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -146.72 120.34 9.16 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.088 177.943 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 21.7 m -65.1 157.81 27.56 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.782 179.742 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 21.1 p -55.16 150.12 22.64 Favored Pre-proline 0 N--CA 1.453 -0.294 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.312 176.635 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -77.61 140.28 18.75 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 121.755 1.637 . . . . 0.0 113.548 -173.68 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.883 ' O ' ' HA ' ' A' ' 78' ' ' THR . 4.6 t -81.53 123.42 37.87 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.832 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 167.348 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 4.8 t -119.75 105.38 17.18 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 C-N-CA 119.53 -0.868 . . . . 0.0 109.857 172.452 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.569 HG13 ' HB ' ' A' ' 77' ' ' ILE . 6.4 pt -120.73 111.11 30.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.354 175.897 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.41 ' CD ' ' H ' ' A' ' 94' ' ' GLN . 0.0 OUTLIER -97.22 114.88 26.66 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.806 0.812 . . . . 0.0 110.76 -175.819 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.79 129.39 50.36 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.937 -1.028 . . . . 0.0 109.398 179.44 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.411 ' HA ' ' HA ' ' A' ' 74' ' ' GLN . 36.2 tt0 -89.42 137.82 31.99 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.146 0.498 . . . . 0.0 110.433 179.148 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 41.7 p -71.46 121.61 18.93 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.928 -178.128 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.9 m . . . . . 0 C--N 1.323 -0.561 0 CA-C-O 121.344 0.592 . . . . 0.0 110.15 179.937 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.287 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -63.27 130.59 29.13 Favored 'Trans proline' 0 C--O 1.235 0.346 0 C-N-CA 122.324 2.016 . . . . 0.0 111.96 177.537 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.506 ' HD2' ' O ' ' A' ' 31' ' ' SER . 72.7 Cg_exo -49.54 146.07 15.5 Favored 'Trans proline' 0 C--O 1.237 0.426 0 C-N-CA 122.891 2.394 . . . . 0.0 111.091 172.856 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.429 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 9.4 p-10 -35.76 106.66 0.32 Allowed Pre-proline 0 N--CA 1.466 0.366 0 O-C-N 124.837 1.336 . . . . 0.0 112.541 -169.276 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.65 ' HG2' HG11 ' A' ' 91' ' ' VAL . 34.6 Cg_exo -67.03 150.94 82.64 Favored 'Trans proline' 0 CA--C 1.517 -0.359 0 C-N-CA 123.368 2.712 . . . . 0.0 112.039 179.08 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.2 m -110.35 131.09 55.36 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.804 -178.387 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.465 HG11 HG22 ' A' ' 21' ' ' VAL . 76.0 t -75.67 119.87 24.38 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-N 114.446 -1.252 . . . . 0.0 109.653 173.756 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -86.97 -40.5 14.72 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.324 -174.809 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -136.03 138.5 42.26 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.995 0.426 . . . . 0.0 110.726 -179.776 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.465 HG22 HG11 ' A' ' 18' ' ' VAL . 17.0 t -125.98 125.16 67.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.005 179.825 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -130.58 -157.27 0.81 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.509 0.195 . . . . 0.0 110.475 -179.249 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.439 ' OD1' ' N ' ' A' ' 24' ' ' THR . 1.9 p30 -73.79 -69.43 0.44 Allowed 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 178.411 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.5 HG22 ' O ' ' A' ' 69' ' ' LEU . 67.7 p -114.39 37.12 3.48 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.483 0.659 . . . . 0.0 109.944 -174.335 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.652 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 55.1 m -167.97 131.49 1.64 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.807 -171.295 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.61 ' HB ' HD12 ' A' ' 66' ' ' LEU . 48.8 mt -149.86 140.8 16.81 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.905 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.522 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 36.5 t -116.52 132.12 67.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 119.135 0.879 . . . . 0.0 110.534 -173.822 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.572 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.7 OUTLIER -126.97 145.59 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.23 -178.996 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.505 ' HG2' ' HB3' ' A' ' 63' ' ' SER . 16.9 mtp180 -128.15 121.5 29.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.524 -175.685 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.834 ' HZ3' HG12 ' A' ' 64' ' ' VAL . 38.7 p90 -114.41 148.56 37.53 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.355 -175.65 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.506 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 32.2 t -93.74 97.64 10.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.935 178.136 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.569 ' CD ' ' H ' ' A' ' 32' ' ' ARG . 0.8 OUTLIER -51.43 155.78 2.4 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.376 -0.829 . . . . 0.0 113.007 -175.497 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.676 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 1.5 Cg_endo -85.38 161.99 11.16 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 124.564 3.509 . . . . 0.0 112.656 -172.671 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -74.71 -18.76 60.46 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.6 173.102 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -59.43 138.69 89.04 Favored Pre-proline 0 CA--C 1.518 -0.276 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.041 175.867 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -69.62 113.86 3.49 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 121.008 1.139 . . . . 0.0 109.666 170.814 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.567 HD12 ' HE1' ' A' ' 40' ' ' TYR . 0.7 OUTLIER -118.63 155.11 20.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -176.222 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.466 ' C ' ' HB3' ' A' ' 59' ' ' GLU . 17.2 p -100.96 -26.02 13.87 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -176.921 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.53 ' C ' HG12 ' A' ' 82' ' ' VAL . . . -168.83 -168.59 31.11 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.33 -0.938 . . . . 0.0 111.675 179.432 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.676 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 5.6 m-85 -137.17 132.57 34.14 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 117.105 0.453 . . . . 0.0 111.378 173.359 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 10.0 mmm180 -99.28 148.68 23.89 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 167.807 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.869 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 31.6 mt -139.21 108.32 3.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 C-N-CA 120.065 -0.654 . . . . 0.0 112.043 178.848 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 75.2 t -110.03 110.42 32.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.325 0.584 . . . . 0.0 110.205 179.864 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.71 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 0.4 OUTLIER -111.87 124.47 52.43 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.377 176.338 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.422 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 23.1 t -139.4 135.74 17.31 Favored Pre-proline 0 C--N 1.314 -0.95 0 CA-C-N 113.692 -1.594 . . . . 0.0 110.383 -173.504 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.658 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 50.0 Cg_exo . . . . . 0 C--O 1.234 0.277 0 C-N-CA 123.362 2.708 . . . . 0.0 112.491 174.22 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 9.6 m . . . . . 0 C--O 1.233 0.214 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.71 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 23.3 m -145.61 148.7 33.4 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.876 -0.33 . . . . 0.0 111.5 -175.78 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.869 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 56.2 tt0 -119.16 118.36 31.14 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.235 173.301 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.698 HD12 ' CG2' ' A' ' 64' ' ' VAL . 19.4 mt -100.0 155.84 17.48 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 173.664 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -118.95 113.34 20.86 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 176.91 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.544 HD12 ' CH2' ' A' ' 30' ' ' TRP . 2.1 mt -108.51 156.25 39.03 Favored Pre-proline 0 C--N 1.317 -0.836 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 -177.32 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -54.77 147.07 52.2 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 121.824 1.683 . . . . 0.0 111.29 171.832 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.477 ' HB2' HG13 ' A' ' 37' ' ' ILE . 8.9 pt-20 -48.54 -27.38 2.7 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.959 173.153 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.4 t -96.69 -1.7 46.06 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.334 -175.572 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.454 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -71.41 152.29 43.26 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 -176.619 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.412 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 3.9 p-10 -132.32 11.32 4.54 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -176.21 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.572 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 53.4 p -169.3 133.67 1.41 Allowed 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 119.993 -0.683 . . . . 0.0 111.877 -177.171 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.834 HG12 ' HZ3' ' A' ' 30' ' ' TRP . 3.7 p -114.61 136.37 51.46 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.148 176.034 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 83.1 m -96.14 100.0 11.68 Favored 'General case' 0 N--CA 1.429 -1.514 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 168.669 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.728 HD11 HG12 ' A' ' 77' ' ' ILE . 0.6 OUTLIER -74.13 144.19 45.01 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.143 178.922 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 8.6 t -144.56 166.16 25.95 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 -174.325 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 64.03 32.95 12.57 Favored 'General case' 0 C--N 1.327 -0.393 0 O-C-N 123.775 0.672 . . . . 0.0 110.936 -177.119 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.5 ' O ' HG22 ' A' ' 24' ' ' THR . 7.9 mt -78.42 -176.85 4.95 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 174.573 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -124.64 123.99 25.66 Favored Pre-proline 0 C--N 1.318 -0.793 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 176.812 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -60.53 135.91 63.93 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 122.778 2.319 . . . . 0.0 112.768 -179.328 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.2 33.91 31.09 Favored Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.683 -179.604 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.527 ' CG1' ' HB3' ' A' ' 46' ' ' PRO . 85.5 t -138.26 139.41 41.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 120.8 0.333 . . . . 0.0 110.82 -176.218 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.658 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 1.7 tm0? -82.39 127.53 33.35 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.025 179.348 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -116.67 114.12 23.6 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -173.378 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.465 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 15.9 m120 -85.53 107.39 17.44 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.674 173.415 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.728 HG12 HD11 ' A' ' 66' ' ' LEU . 5.1 mp -91.01 117.07 33.51 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.733 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 176.644 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.895 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 26.1 m -109.15 114.77 28.77 Favored 'General case' 0 N--CA 1.424 -1.734 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.436 -179.146 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.549 ' HB ' ' HB ' ' A' ' 91' ' ' VAL . 13.5 mm -95.31 141.52 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -179.882 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -129.34 111.99 13.4 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.229 179.624 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.404 ' HB1' HG21 ' A' ' 37' ' ' ILE . . . -79.81 114.47 18.76 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 169.761 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.543 HG23 ' HG2' ' A' ' 87' ' ' GLU . 7.1 p -104.36 132.25 51.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 C-N-CA 120.048 -0.661 . . . . 0.0 109.565 -178.687 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.592 ' OE1' ' HB2' ' A' ' 86' ' ' GLN . 1.1 mp0 -113.6 171.33 7.64 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 123.178 0.299 . . . . 0.0 110.751 -177.655 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.418 ' H ' ' HG3' ' A' ' 84' ' ' GLU . 28.8 mt-10 -45.22 -40.92 7.84 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.505 -0.771 . . . . 0.0 112.754 -176.107 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -112.42 -20.47 11.78 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -172.353 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.592 ' HB2' ' OE1' ' A' ' 83' ' ' GLU . 69.5 mt-30 -142.63 178.47 7.6 Favored 'General case' 0 C--N 1.328 -0.329 0 O-C-N 122.091 -0.381 . . . . 0.0 111.523 -170.095 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.543 ' HG2' HG23 ' A' ' 82' ' ' VAL . 50.4 mt-10 -123.17 120.35 32.93 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.449 -0.796 . . . . 0.0 108.976 171.09 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 50.9 m -70.0 178.03 2.9 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -172.625 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -59.31 152.83 51.41 Favored Pre-proline 0 N--CA 1.451 -0.413 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.539 179.028 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -87.0 138.47 4.97 Favored 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 122.53 2.153 . . . . 0.0 114.269 -177.42 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.895 ' O ' ' HA ' ' A' ' 78' ' ' THR . 7.1 t -82.28 125.78 39.88 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.746 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 165.929 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 4.5 t -122.16 107.08 18.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 C-N-CA 119.83 -0.748 . . . . 0.0 110.121 173.276 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.542 HG13 ' HB ' ' A' ' 77' ' ' ILE . 6.5 pt -124.96 114.94 42.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.878 177.449 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.558 ' HB2' ' OE1' ' A' ' 74' ' ' GLN . 11.3 pt20 -100.92 120.78 40.66 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.553 0.692 . . . . 0.0 111.598 -175.077 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.23 132.25 39.48 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.546 178.103 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.51 ' HB2' ' HG2' ' A' ' 74' ' ' GLN . 35.8 tt0 -87.0 142.3 28.04 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.016 0.436 . . . . 0.0 110.259 179.898 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 31.6 p -68.39 134.49 50.3 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.297 -178.102 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 11.8 m . . . . . 0 C--N 1.328 -0.361 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.665 -177.893 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.738 0 N-CA-C 111.88 -0.488 . . . . 0.0 111.88 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.5 m 60.43 57.29 2.88 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.152 0.501 . . . . 0.0 110.47 -178.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 49.1 t-80 -61.32 -35.83 78.46 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.382 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 85.0 mmm -98.9 38.63 1.35 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.168 178.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -108.37 25.07 20.99 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.268 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.9 p -71.36 -39.8 71.06 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.009 0.433 . . . . 0.0 111.309 -178.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.4 m -88.72 -4.17 58.6 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.628 0.728 . . . . 0.0 109.944 178.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 26.9 m -80.38 126.23 30.91 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.823 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -98.07 126.23 41.0 Favored Pre-proline 0 C--N 1.321 -0.634 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 176.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -65.28 145.81 84.61 Favored 'Trans proline' 0 C--O 1.234 0.289 0 C-N-CA 122.36 2.04 . . . . 0.0 112.498 -177.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.3 p-10 -95.94 164.55 12.67 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.268 -178.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -97.37 162.75 21.58 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.806 -179.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -72.86 128.34 13.15 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.264 1.976 . . . . 0.0 111.476 174.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.568 ' HD2' ' O ' ' A' ' 31' ' ' SER . 89.2 Cg_exo -48.33 146.2 10.4 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.837 2.358 . . . . 0.0 111.933 174.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.456 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 9.1 p-10 -36.76 107.12 0.36 Allowed Pre-proline 0 N--CA 1.468 0.446 0 O-C-N 124.806 1.316 . . . . 0.0 112.74 -169.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.634 ' HG2' HG11 ' A' ' 91' ' ' VAL . 27.4 Cg_exo -66.86 152.3 80.71 Favored 'Trans proline' 0 C--O 1.233 0.273 0 C-N-CA 123.62 2.88 . . . . 0.0 112.643 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.8 m -107.05 130.62 54.63 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.987 -177.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.475 HG22 HG12 ' A' ' 28' ' ' VAL . 77.0 t -78.25 122.22 32.76 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-N 114.812 -1.085 . . . . 0.0 109.881 172.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -87.16 -42.08 13.27 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.918 -175.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -134.48 139.07 45.22 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.464 -175.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.447 ' HA ' HG12 ' A' ' 26' ' ' ILE . 61.2 t -130.88 123.78 54.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.472 178.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -133.59 -159.47 0.97 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.11 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 17.7 p-10 -76.37 -57.68 3.72 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.199 0.524 . . . . 0.0 111.262 -178.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.62 HG22 ' O ' ' A' ' 69' ' ' LEU . 33.8 p -119.43 32.81 5.91 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.516 -172.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.627 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 68.4 m -168.07 130.47 1.5 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.201 -173.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.626 ' HB ' HD12 ' A' ' 66' ' ' LEU . 33.1 mt -145.08 141.71 22.86 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.888 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 175.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 40.6 t -116.69 132.93 64.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 C-N-CA 119.71 -0.796 . . . . 0.0 110.17 -175.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.584 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.7 OUTLIER -127.76 147.35 32.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 C-N-CA 120.397 -0.521 . . . . 0.0 110.052 -179.126 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.44 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 20.9 mtp180 -133.29 120.77 21.49 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.203 -174.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.814 ' HZ3' HG12 ' A' ' 64' ' ' VAL . 41.3 p90 -113.23 149.65 33.48 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.343 -173.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.568 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 20.5 m -98.25 98.14 9.44 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.097 178.168 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.645 ' CD ' ' H ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -45.82 156.26 0.45 Allowed Pre-proline 0 CA--C 1.539 0.54 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 -173.49 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.708 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 2.9 Cg_exo -78.57 170.64 17.99 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 124.844 3.696 . . . . 0.0 113.496 -170.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -76.8 -20.96 55.81 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.832 -1.076 . . . . 0.0 109.218 173.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -70.19 137.77 86.91 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.856 175.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.405 ' O ' ' HG2' ' A' ' 83' ' ' GLU . 6.7 Cg_exo -73.5 114.93 4.17 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 121.468 1.446 . . . . 0.0 109.51 167.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.563 HG21 ' HB1' ' A' ' 81' ' ' ALA . 0.2 OUTLIER -111.8 160.44 11.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -174.121 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.4 p -93.23 -32.21 14.45 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.497 ' C ' HG12 ' A' ' 82' ' ' VAL . . . -167.85 -164.56 23.74 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.11 -1.043 . . . . 0.0 111.614 179.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.708 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 6.2 m-85 -140.33 135.52 32.27 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-N 117.111 0.456 . . . . 0.0 111.416 176.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.435 ' C ' HG13 ' A' ' 42' ' ' ILE . 25.1 mtp180 -103.48 151.09 23.24 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 167.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.865 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 29.3 mt -139.54 107.86 3.22 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 C-N-CA 120.312 -0.555 . . . . 0.0 112.112 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 71.2 t -106.3 110.24 30.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.151 0.5 . . . . 0.0 110.704 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.583 ' HA ' ' O ' ' A' ' 76' ' ' ASN . 0.8 OUTLIER -113.28 125.47 54.33 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.661 176.26 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.412 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 26.1 p -139.13 143.88 38.53 Favored Pre-proline 0 C--N 1.317 -0.817 0 CA-C-N 114.007 -1.451 . . . . 0.0 111.792 -173.253 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.564 ' HB3' HG11 ' A' ' 73' ' ' VAL . 4.7 Cg_exo -74.03 137.43 24.07 Favored 'Trans proline' 0 C--O 1.234 0.284 0 C-N-CA 123.082 2.522 . . . . 0.0 111.467 175.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 7.3 m -65.71 -26.92 67.98 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.091 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 19.3 m -99.02 12.33 5.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.206 0.527 . . . . 0.0 110.522 175.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 68.7 157.1 0.14 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.629 -1.169 . . . . 0.0 111.829 -177.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 156.91 -125.46 1.59 Allowed Glycine 0 N--CA 1.445 -0.766 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 -176.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 23.0 m -86.97 117.09 25.46 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 117.228 0.514 . . . . 0.0 110.286 177.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 8.4 p -120.65 146.09 46.76 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.974 175.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.565 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 71.2 m -147.71 148.62 31.19 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.248 -0.581 . . . . 0.0 112.006 -179.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.865 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 41.6 tt0 -114.67 115.41 27.07 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.7 172.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.676 HD12 ' CG2' ' A' ' 64' ' ' VAL . 16.7 mt -96.44 157.97 15.65 Favored 'General case' 0 CA--C 1.513 -0.475 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.038 175.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.438 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 25.0 t-20 -120.21 115.73 24.2 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 178.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.571 HD12 ' CH2' ' A' ' 30' ' ' TRP . 2.5 mt -113.4 156.02 43.83 Favored Pre-proline 0 N--CA 1.443 -0.781 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 -177.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -63.65 150.87 87.43 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 121.687 1.591 . . . . 0.0 111.3 175.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -45.41 -28.54 0.89 Allowed 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 114.738 -1.119 . . . . 0.0 112.972 178.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 10.2 t -104.39 11.21 34.89 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.223 0.535 . . . . 0.0 111.126 -174.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.486 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -75.51 159.92 30.76 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 178.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.572 ' HB3' ' NE ' ' A' ' 32' ' ' ARG . 4.6 p-10 -146.41 17.53 1.34 Allowed 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 120.724 -0.391 . . . . 0.0 112.045 -177.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.584 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 39.3 p -171.4 134.37 0.87 Allowed 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.529 -0.469 . . . . 0.0 111.729 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.814 HG12 ' HZ3' ' A' ' 30' ' ' TRP . 3.2 p -119.17 136.5 56.16 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 CA-C-N 116.358 -0.383 . . . . 0.0 109.992 174.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 63.0 m -95.67 100.47 12.19 Favored 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 168.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.726 HD11 HG12 ' A' ' 77' ' ' ILE . 0.3 OUTLIER -75.03 136.74 41.21 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.167 179.918 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 7.4 t -132.16 164.61 25.94 Favored 'General case' 0 C--N 1.316 -0.856 0 O-C-N 123.705 0.628 . . . . 0.0 109.458 -173.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 26.4 t0 58.71 50.72 8.47 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 123.81 0.694 . . . . 0.0 110.692 -177.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.62 ' O ' HG22 ' A' ' 24' ' ' THR . 11.9 mt -90.18 -176.24 4.79 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 172.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 57.6 tp60 -123.62 125.53 25.98 Favored Pre-proline 0 C--N 1.32 -0.691 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 174.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -62.01 140.77 86.32 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 123.05 2.5 . . . . 0.0 113.269 -178.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 75.57 29.6 59.46 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.918 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.564 HG11 ' HB3' ' A' ' 46' ' ' PRO . 61.0 t -131.42 148.09 32.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.276 0.56 . . . . 0.0 111.145 -176.041 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.554 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -82.81 127.79 33.79 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.412 179.18 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.432 ' CZ ' ' HG3' ' A' ' 46' ' ' PRO . 3.8 m-85 -122.37 116.07 23.39 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.401 0.62 . . . . 0.0 112.521 -176.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.583 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 0.8 OUTLIER -85.92 112.91 21.61 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.597 172.927 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.726 HG12 HD11 ' A' ' 66' ' ' LEU . 5.0 mp -95.79 115.9 36.11 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.597 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 172.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.879 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 21.9 m -108.88 113.6 26.66 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.26 -178.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.542 ' HB ' ' HB ' ' A' ' 91' ' ' VAL . 12.8 mm -95.04 138.41 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.412 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 82.8 m-85 -124.67 111.29 15.42 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.161 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.563 ' HB1' HG21 ' A' ' 37' ' ' ILE . . . -81.05 111.24 17.34 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 171.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.497 HG12 ' C ' ' A' ' 39' ' ' GLY . 7.1 p -104.5 136.72 36.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 C-N-CA 120.021 -0.672 . . . . 0.0 110.717 -175.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.405 ' HG2' ' O ' ' A' ' 36' ' ' PRO . 4.3 tm-20 -121.39 163.28 18.95 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -47.74 -46.59 30.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 118.341 0.519 . . . . 0.0 111.426 -178.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 -89.97 -34.6 15.95 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -170.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -150.77 171.84 16.54 Favored 'General case' 0 C--O 1.222 -0.347 0 C-N-CA 120.619 -0.432 . . . . 0.0 111.528 -168.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -114.57 129.06 56.63 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.321 175.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 17.1 m -66.95 169.33 8.39 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.075 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.5 p -57.76 151.13 43.92 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-O 120.968 0.413 . . . . 0.0 110.784 176.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -84.14 141.6 9.36 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 122.159 1.906 . . . . 0.0 113.989 -174.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.879 ' O ' ' HA ' ' A' ' 78' ' ' THR . 12.5 t -81.93 121.83 35.82 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.717 0 CA-C-N 114.855 -1.066 . . . . 0.0 108.196 168.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 5.9 t -117.87 105.72 18.48 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 C-N-CA 119.552 -0.859 . . . . 0.0 109.897 172.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.588 HG13 ' HB ' ' A' ' 77' ' ' ILE . 8.0 pt -123.26 115.48 45.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.379 176.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.515 ' HB2' ' OE1' ' A' ' 74' ' ' GLN . 5.1 pt20 -103.31 126.46 50.49 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.351 0.596 . . . . 0.0 111.103 -174.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -128.94 134.46 48.22 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.088 177.115 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.5 ' HG2' ' HG2' ' A' ' 74' ' ' GLN . 45.1 mt-10 -86.59 133.12 33.74 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 175.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 37.9 p -72.75 113.85 10.24 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.161 0.505 . . . . 0.0 110.724 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 14.3 m -69.52 -32.19 70.88 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.421 0.629 . . . . 0.0 110.223 -177.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 103.27 -163.38 15.77 Favored Glycine 0 N--CA 1.442 -0.949 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.704 176.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 47.4 m -75.38 127.72 85.68 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 115.448 -0.376 . . . . 0.0 110.539 178.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -47.57 102.81 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 123.467 2.778 . . . . 0.0 113.18 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -102.08 112.51 25.19 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.814 177.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 16.2 m 58.24 42.55 21.72 Favored 'General case' 0 C--N 1.33 -0.245 0 O-C-N 123.776 0.672 . . . . 0.0 110.562 179.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -70.05 105.55 2.92 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.583 -178.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 109.35 119.81 4.24 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.119 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.8 m . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.799 -0.62 . . . . 0.0 110.324 178.855 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.644 0 N-CA-C 111.649 -0.581 . . . . 0.0 111.649 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.2 m -65.76 -45.34 82.93 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.015 0.436 . . . . 0.0 110.459 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 57.2 t60 -84.08 106.0 15.39 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.89 179.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 24.8 mmt -76.38 147.45 38.03 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.216 178.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 108.34 137.5 8.18 Favored Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 111.382 -0.687 . . . . 0.0 111.382 -176.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 84.0 m -147.21 114.1 6.12 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.875 0.369 . . . . 0.0 110.886 -178.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.5 p -99.97 -65.13 0.98 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.182 177.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 44.1 m 68.98 125.15 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.365 0 CA-C-O 121.399 0.619 . . . . 0.0 111.801 176.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -110.21 117.37 51.68 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.481 179.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -76.29 153.06 35.52 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 123.105 2.537 . . . . 0.0 112.466 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -103.69 144.42 31.48 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.462 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.538 ' HB2' ' O ' ' A' ' 89' ' ' THR . . . -74.02 151.83 88.48 Favored Pre-proline 0 C--N 1.319 -0.739 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.803 174.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -56.88 129.03 32.4 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.347 2.031 . . . . 0.0 112.079 174.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.449 ' HD2' ' O ' ' A' ' 31' ' ' SER . 85.5 Cg_exo -46.43 146.82 4.64 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.702 2.268 . . . . 0.0 111.422 171.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -36.79 106.17 0.32 Allowed Pre-proline 0 N--CA 1.472 0.628 0 O-C-N 124.654 1.221 . . . . 0.0 112.694 -168.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.634 ' HG2' HG11 ' A' ' 91' ' ' VAL . 37.9 Cg_exo -65.34 150.58 87.03 Favored 'Trans proline' 0 CA--C 1.52 -0.204 0 C-N-CA 123.501 2.8 . . . . 0.0 112.33 178.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 20.2 m -107.0 130.49 54.63 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.037 -176.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.488 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 82.1 t -83.33 121.37 36.09 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-N 114.435 -1.257 . . . . 0.0 109.908 174.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.532 ' OD1' ' HG3' ' A' ' 20' ' ' GLN . 13.5 t70 -80.96 -48.13 12.71 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.108 -174.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.532 ' HG3' ' OD1' ' A' ' 19' ' ' ASP . 27.5 mt-30 -136.07 140.73 44.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.694 -177.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.525 ' HA ' HG12 ' A' ' 26' ' ' ILE . 6.4 m -126.0 101.33 8.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.159 178.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.406 ' HB3' ' H ' ' A' ' 23' ' ' ASP . 12.3 m-20 -97.65 -160.12 0.78 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.151 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.531 ' CA ' ' HA2' ' A' ' 99' ' ' GLY . 11.5 p-10 -78.86 -52.66 8.0 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.253 0.549 . . . . 0.0 110.622 177.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.747 HG22 ' O ' ' A' ' 69' ' ' LEU . 26.6 p -121.81 34.6 5.13 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.984 -172.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.651 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 66.1 m -169.19 130.43 1.14 Allowed 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.424 -172.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.578 ' HB ' HD12 ' A' ' 66' ' ' LEU . 20.5 mt -144.83 137.39 21.73 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.786 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 177.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 41.1 t -115.67 128.67 72.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 C-N-CA 119.632 -0.827 . . . . 0.0 110.438 -175.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.65 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.7 OUTLIER -125.12 144.65 34.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 C-N-CA 120.546 -0.461 . . . . 0.0 109.916 -177.55 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.531 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 23.0 mtm180 -129.88 121.0 25.82 Favored 'General case' 0 C--N 1.327 -0.393 0 O-C-N 123.239 0.337 . . . . 0.0 110.573 -176.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.734 ' HZ3' HG12 ' A' ' 64' ' ' VAL . 33.8 p90 -107.88 144.58 34.91 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.176 -173.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.449 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 16.1 m -85.64 89.85 7.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.493 178.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.705 ' HD3' ' H ' ' A' ' 32' ' ' ARG . 0.4 OUTLIER -46.07 152.35 0.8 Allowed Pre-proline 0 CA--C 1.538 0.486 0 C-N-CA 124.189 0.996 . . . . 0.0 113.014 -175.549 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.687 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 2.2 Cg_endo -86.03 166.42 9.78 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 124.273 3.315 . . . . 0.0 113.318 -169.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -76.27 -20.86 56.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.319 172.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.32 136.24 91.56 Favored Pre-proline 0 N--CA 1.453 -0.311 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.754 175.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -70.21 113.19 3.37 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 121.072 1.181 . . . . 0.0 109.593 170.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.505 HG22 ' HG2' ' A' ' 83' ' ' GLU . 24.9 pt -117.9 153.42 19.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.797 -174.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.448 ' C ' ' HB3' ' A' ' 59' ' ' GLU . 9.1 p -94.88 -24.4 17.02 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.547 ' C ' HG12 ' A' ' 82' ' ' VAL . . . -174.8 -161.67 24.97 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 119.732 -1.223 . . . . 0.0 113.304 -179.063 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.687 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 41.8 m-85 -139.54 131.49 27.76 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 122.364 0.266 . . . . 0.0 111.25 174.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.408 ' HB2' ' CD1' ' A' ' 80' ' ' TYR . 14.3 mmm-85 -96.21 148.76 22.38 Favored 'General case' 0 CA--C 1.504 -0.812 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 165.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.876 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 28.4 mt -139.0 107.84 3.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 C-N-CA 119.74 -0.784 . . . . 0.0 112.439 -179.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 71.9 t -109.04 109.93 30.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.396 0.617 . . . . 0.0 110.719 179.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.697 ' CZ ' ' HB ' ' A' ' 53' ' ' THR . 0.6 OUTLIER -112.77 125.57 54.48 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.322 176.747 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.4 m -139.97 141.16 26.17 Favored Pre-proline 0 C--N 1.317 -0.842 0 CA-C-N 114.282 -1.326 . . . . 0.0 111.429 -173.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.684 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 59.9 Cg_endo -68.89 156.29 65.84 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 123.66 2.907 . . . . 0.0 112.01 177.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 67.3 m -85.83 -29.71 23.54 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.724 -178.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 89.5 t -115.77 -42.21 3.28 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 C-N-CA 120.796 -0.361 . . . . 0.0 111.578 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -179.82 142.64 0.16 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.446 ' CA ' ' HG3' ' A' ' 46' ' ' PRO . . . 157.76 -160.18 30.48 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.866 -0.683 . . . . 0.0 111.963 -177.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.508 ' O ' ' HE1' ' A' ' 75' ' ' TYR . 19.4 m -94.83 121.6 36.6 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 -177.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.505 ' HA ' ' O ' ' A' ' 44' ' ' TYR . 15.1 m -102.77 139.94 37.69 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 172.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.697 ' HB ' ' CZ ' ' A' ' 44' ' ' TYR . 23.6 m -147.27 153.29 39.58 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 120.61 -0.436 . . . . 0.0 111.13 -179.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.876 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 30.8 tt0 -122.35 112.4 18.06 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 123.025 0.53 . . . . 0.0 109.673 175.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.682 HD12 ' CG2' ' A' ' 64' ' ' VAL . 15.8 mt -97.8 159.97 14.6 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.584 177.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -123.95 114.56 19.95 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.076 179.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.588 HD12 ' CH2' ' A' ' 30' ' ' TRP . 3.8 mt -113.69 154.65 45.68 Favored Pre-proline 0 C--N 1.318 -0.778 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -176.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -61.34 150.56 84.33 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 121.987 1.792 . . . . 0.0 111.18 176.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.448 ' HB3' ' C ' ' A' ' 38' ' ' THR . 11.4 pt-20 -46.26 -30.0 1.84 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.032 -0.985 . . . . 0.0 112.499 176.203 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 7.4 t -99.89 17.37 21.02 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.045 -175.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.476 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -88.48 151.46 22.53 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.531 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 24.6 p-10 -136.58 13.95 3.19 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.871 -177.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.65 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 71.6 p -167.51 134.39 2.25 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.336 -0.546 . . . . 0.0 111.678 -177.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.734 HG12 ' HZ3' ' A' ' 30' ' ' TRP . 4.2 p -115.06 138.72 44.44 Favored 'Isoleucine or valine' 0 C--O 1.243 0.727 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.226 175.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 55.5 m -97.7 100.88 12.28 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.58 169.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.721 HD11 HG12 ' A' ' 77' ' ' ILE . 0.7 OUTLIER -76.46 144.46 39.88 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.2 177.415 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.1 p -141.85 164.74 29.38 Favored 'General case' 0 C--N 1.32 -0.675 0 O-C-N 123.501 0.501 . . . . 0.0 110.955 -172.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 28.8 t70 65.86 26.54 11.12 Favored 'General case' 0 N--CA 1.465 0.294 0 O-C-N 123.923 0.765 . . . . 0.0 110.824 -178.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.747 ' O ' HG22 ' A' ' 24' ' ' THR . 14.9 mt -70.65 -175.01 0.97 Allowed 'General case' 0 C--O 1.222 -0.349 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.948 176.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.456 ' HB2' HG21 ' A' ' 73' ' ' VAL . 16.8 mm-40 -129.27 133.28 24.97 Favored Pre-proline 0 C--N 1.319 -0.719 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 176.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -64.57 128.1 20.43 Favored 'Trans proline' 0 C--O 1.234 0.276 0 C-N-CA 122.921 2.414 . . . . 0.0 112.755 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 90.8 14.95 57.36 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.321 178.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.456 HG21 ' HB2' ' A' ' 70' ' ' GLN . 72.0 t -114.78 141.09 32.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.219 0.533 . . . . 0.0 111.602 -175.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.684 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -80.49 122.26 26.79 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.626 179.238 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.508 ' HE1' ' O ' ' A' ' 51' ' ' SER . 23.8 m-85 -118.17 113.71 21.96 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.377 0.608 . . . . 0.0 112.377 -176.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.552 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 20.5 m-80 -87.28 108.26 18.87 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.681 175.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.721 HG12 HD11 ' A' ' 66' ' ' LEU . 5.4 mp -92.55 115.29 31.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.298 0.571 . . . . 0.0 109.883 176.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.858 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 51.9 m -107.64 115.89 30.95 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.019 179.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.624 ' HB ' ' HB ' ' A' ' 91' ' ' VAL . 19.1 mm -95.91 143.04 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 -178.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.473 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 47.2 m-85 -128.35 111.83 13.77 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 178.091 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.489 ' HB1' HG21 ' A' ' 37' ' ' ILE . . . -79.82 107.96 13.0 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 173.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.547 HG12 ' C ' ' A' ' 39' ' ' GLY . 9.5 p -99.4 135.62 33.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 C-N-CA 120.132 -0.627 . . . . 0.0 110.678 -175.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.505 ' HG2' HG22 ' A' ' 37' ' ' ILE . 4.5 mt-10 -111.06 171.07 7.69 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 175.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -44.64 -47.09 10.47 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 123.797 0.686 . . . . 0.0 112.378 -178.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -106.14 -21.06 13.22 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -169.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -149.61 176.93 10.21 Favored 'General case' 0 C--O 1.219 -0.515 0 CA-C-N 118.696 0.68 . . . . 0.0 111.813 -174.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -117.6 134.36 54.97 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 177.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 10.7 m -73.84 -179.98 3.96 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.832 0.348 . . . . 0.0 111.223 -176.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.538 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 0.8 OUTLIER -61.74 159.43 34.7 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.587 176.176 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -88.78 140.96 4.35 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 122.418 2.079 . . . . 0.0 114.361 -177.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.858 ' O ' ' HA ' ' A' ' 78' ' ' THR . 5.6 t -83.08 128.67 38.5 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.7 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 164.15 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 4.1 t -123.22 106.87 18.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 C-N-CA 119.987 -0.685 . . . . 0.0 110.113 171.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.539 HG13 ' HB ' ' A' ' 77' ' ' ILE . 6.7 pt -126.77 111.48 26.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.895 177.124 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.401 ' HB2' HE22 ' A' ' 74' ' ' GLN . 17.9 pt20 -102.6 120.51 40.67 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.673 0.749 . . . . 0.0 111.524 -175.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.429 ' NE2' HG11 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -128.1 135.9 50.44 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.2 -179.1 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -87.04 146.46 26.09 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 176.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 20.7 p -81.38 120.08 24.51 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.104 178.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 85.7 m -70.17 -31.82 69.48 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.501 0.667 . . . . 0.0 110.58 178.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.531 ' HA2' ' CA ' ' A' ' 23' ' ' ASP . . . 83.59 -137.91 16.88 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.908 178.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 23.3 m -90.53 118.78 68.98 Favored Pre-proline 0 C--N 1.319 -0.748 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 175.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_exo -52.01 105.93 0.13 Allowed 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 123.117 2.545 . . . . 0.0 112.854 -178.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 32.2 tpt180 -148.27 87.9 1.62 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.694 179.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 50.6 m -87.25 62.45 7.26 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.964 -178.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -92.92 8.89 37.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.246 0.546 . . . . 0.0 109.708 177.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -73.51 100.87 1.11 Allowed Glycine 0 N--CA 1.444 -0.82 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.282 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 22.3 m . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.937 -0.554 . . . . 0.0 109.641 177.668 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.597 0 N-CA-C 111.997 -0.441 . . . . 0.0 111.997 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.1 p -84.06 -25.17 30.04 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.03 0.443 . . . . 0.0 110.827 -178.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 41.3 m-70 -85.82 95.49 9.44 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.667 179.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 25.2 ptm -156.86 43.37 0.37 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.483 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -63.05 -31.3 80.24 Favored Glycine 0 N--CA 1.453 -0.228 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.18 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.0 p -66.58 127.35 32.02 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.776 0.322 . . . . 0.0 111.226 177.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 37.6 m -70.97 112.26 6.99 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.445 178.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 53.7 m -73.79 128.97 36.95 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.081 -178.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -105.4 100.05 23.92 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.748 173.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -80.42 174.1 11.65 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.908 2.405 . . . . 0.0 112.741 -177.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -126.11 155.12 42.13 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.012 -178.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -95.91 160.78 29.34 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.509 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -70.58 132.67 22.48 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.479 2.119 . . . . 0.0 111.45 174.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -53.81 159.52 6.92 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.687 2.258 . . . . 0.0 111.314 172.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -39.27 106.24 0.39 Allowed Pre-proline 0 N--CA 1.469 0.491 0 O-C-N 124.313 1.008 . . . . 0.0 111.918 -173.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.556 ' HG2' HG11 ' A' ' 91' ' ' VAL . 38.2 Cg_exo -65.22 144.82 82.45 Favored 'Trans proline' 0 CA--C 1.517 -0.339 0 C-N-CA 122.999 2.466 . . . . 0.0 111.925 178.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 39.6 m -97.91 124.72 42.47 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.665 -177.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.452 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 85.2 t -78.46 118.37 25.52 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-N 114.479 -1.237 . . . . 0.0 109.17 172.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -89.69 -37.13 14.81 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.283 -174.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -134.59 129.66 35.31 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.941 0.401 . . . . 0.0 110.66 -176.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.439 ' HA ' HG12 ' A' ' 26' ' ' ILE . 85.7 t -126.39 120.52 56.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.724 -178.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -125.41 -167.77 1.74 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.813 176.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.521 ' O ' ' HB2' ' A' ' 69' ' ' LEU . 4.1 p-10 -67.28 -59.16 3.65 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.173 0.511 . . . . 0.0 111.331 176.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.688 HG22 ' O ' ' A' ' 69' ' ' LEU . 36.0 p -117.32 36.83 4.08 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.991 -173.019 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.666 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 66.1 m -168.65 130.28 1.29 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.059 -176.229 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.618 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 34.1 mt -148.14 136.63 15.1 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.539 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 176.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.452 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 41.3 t -116.79 127.84 74.31 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.602 0 C-N-CA 120.054 -0.658 . . . . 0.0 110.693 -174.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.626 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.8 OUTLIER -122.52 143.5 35.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -176.97 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.477 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 63.8 mtp180 -130.14 121.01 25.49 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.912 0.387 . . . . 0.0 110.568 -175.349 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.707 ' HZ3' HG12 ' A' ' 64' ' ' VAL . 34.9 p90 -110.69 141.49 43.89 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.504 -173.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 17.6 m -83.63 86.61 7.09 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.02 -0.537 . . . . 0.0 109.725 175.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.442 ' CD ' ' HB3' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -48.28 156.83 0.74 Allowed Pre-proline 0 CA--C 1.541 0.598 0 CA-C-N 114.87 -1.059 . . . . 0.0 113.267 -176.184 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.674 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 3.1 Cg_exo -81.03 169.85 15.8 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 124.341 3.361 . . . . 0.0 113.538 -171.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -91.35 -7.33 51.21 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.662 176.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -69.37 144.08 94.2 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.204 175.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -70.64 113.24 3.45 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 121.071 1.18 . . . . 0.0 109.766 171.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.913 HG22 ' HG3' ' A' ' 83' ' ' GLU . 3.5 pt -119.91 157.56 22.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.403 -173.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.485 HG21 ' HA ' ' A' ' 84' ' ' GLU . 16.6 p -101.29 -22.85 14.51 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -176.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.578 ' C ' HG12 ' A' ' 82' ' ' VAL . . . -177.01 -165.43 32.38 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 119.6 -1.286 . . . . 0.0 112.371 179.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.674 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 6.3 m-85 -139.24 134.38 32.6 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.773 0.32 . . . . 0.0 110.875 173.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.7 mmm180 -100.97 148.07 25.44 Favored 'General case' 0 CA--C 1.501 -0.906 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 165.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.892 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 33.6 mt -138.25 109.53 5.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 C-N-CA 119.881 -0.728 . . . . 0.0 112.319 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 69.9 t -110.77 110.12 31.02 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.525 0 CA-C-O 121.391 0.615 . . . . 0.0 110.695 -179.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.712 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 0.8 OUTLIER -112.46 124.49 52.62 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.428 177.06 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.455 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 17.8 p -139.08 137.17 18.92 Favored Pre-proline 0 C--N 1.314 -0.975 0 CA-C-N 114.135 -1.393 . . . . 0.0 111.525 -173.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.56 ' HG3' ' CZ ' ' A' ' 75' ' ' TYR . 8.0 Cg_exo -69.55 131.15 20.92 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.978 2.452 . . . . 0.0 110.821 174.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 12.6 m -55.39 -33.5 63.52 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.289 -0.869 . . . . 0.0 112.526 -173.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 12.7 m -109.89 -41.15 4.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -175.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 178.63 148.77 0.2 Allowed 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 -175.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.437 ' CA ' ' HG2' ' A' ' 46' ' ' PRO . . . 140.64 -160.61 26.57 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.47 178.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 20.2 m -84.69 122.98 29.85 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.524 0.202 . . . . 0.0 111.446 -177.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.7 p -117.31 140.38 49.63 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 175.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.712 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 29.1 m -146.0 150.23 35.63 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.655 -173.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.892 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 56.6 tt0 -114.93 118.35 33.23 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.935 173.238 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.73 HD12 ' CG2' ' A' ' 64' ' ' VAL . 21.9 mt -100.23 148.34 24.74 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.54 -0.464 . . . . 0.0 109.902 173.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -109.86 114.14 27.46 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 176.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.563 HD12 ' CH2' ' A' ' 30' ' ' TRP . 1.7 mt -109.96 152.51 43.07 Favored Pre-proline 0 N--CA 1.444 -0.766 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 -177.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -60.9 149.2 89.74 Favored 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 121.952 1.768 . . . . 0.0 111.389 176.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.476 ' HB3' ' C ' ' A' ' 38' ' ' THR . 9.6 pt-20 -46.92 -22.78 0.36 Allowed 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 114.848 -1.069 . . . . 0.0 113.019 176.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.2 t -107.3 15.84 24.6 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.135 -176.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.48 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -82.17 164.3 21.36 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.504 -0.317 . . . . 0.0 110.423 -179.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.477 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 4.6 p-10 -149.19 11.27 0.8 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -177.102 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.626 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 21.9 p -168.7 134.11 1.69 Allowed 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.346 -0.542 . . . . 0.0 111.996 -178.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.73 ' CG2' HD12 ' A' ' 55' ' ' LEU . 4.1 p -117.02 136.78 53.08 Favored 'Isoleucine or valine' 0 C--O 1.242 0.673 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.288 176.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 41.9 m -98.93 102.03 13.62 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-O 121.411 0.624 . . . . 0.0 109.795 170.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.667 HD11 HG12 ' A' ' 77' ' ' ILE . 0.2 OUTLIER -79.24 142.22 36.41 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.118 178.422 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.8 t -136.51 169.6 17.42 Favored 'General case' 0 C--N 1.32 -0.681 0 O-C-N 123.274 0.359 . . . . 0.0 110.559 -175.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 58.71 32.99 22.76 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.634 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.688 ' O ' HG22 ' A' ' 24' ' ' THR . 11.8 mt -71.88 -176.39 1.68 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.755 176.111 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -124.56 126.43 25.42 Favored Pre-proline 0 C--N 1.32 -0.714 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 175.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -63.58 132.44 35.48 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.183 2.589 . . . . 0.0 113.62 -176.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 87.92 21.58 45.85 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.311 177.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.495 HG11 ' HB3' ' A' ' 46' ' ' PRO . 18.7 t -125.53 148.2 30.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.328 0.585 . . . . 0.0 111.463 -176.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.48 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 15.0 tp60 -81.48 114.28 20.1 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.937 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.56 ' CZ ' ' HG3' ' A' ' 46' ' ' PRO . 6.1 m-85 -104.83 115.19 29.87 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.291 0.567 . . . . 0.0 112.02 -178.024 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.556 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 14.2 m120 -87.72 105.42 17.36 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.64 175.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.667 HG12 HD11 ' A' ' 66' ' ' LEU . 5.2 mp -91.44 117.27 34.36 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.575 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 175.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.88 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 90.4 m -109.2 115.39 29.92 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.779 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.555 ' HB ' ' HB ' ' A' ' 91' ' ' VAL . 12.4 mm -96.16 121.07 46.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.915 -179.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -108.12 111.11 22.97 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 176.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -80.15 123.61 28.05 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 169.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.578 HG12 ' C ' ' A' ' 39' ' ' GLY . 12.7 p -115.67 134.47 58.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 C-N-CA 120.053 -0.659 . . . . 0.0 110.889 -176.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.913 ' HG3' HG22 ' A' ' 37' ' ' ILE . 8.6 mp0 -112.48 171.61 7.42 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -177.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.485 ' HA ' HG21 ' A' ' 38' ' ' THR . 39.1 mt-10 -42.12 -44.93 3.83 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -174.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -125.66 -13.22 6.51 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.498 -0.481 . . . . 0.0 111.959 -176.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -128.39 173.73 9.94 Favored 'General case' 0 N--CA 1.443 -0.794 0 O-C-N 122.247 -0.283 . . . . 0.0 111.358 -171.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 20.4 mp0 -128.12 127.02 42.26 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.478 176.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 68.1 m -72.56 171.74 11.85 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.873 0.368 . . . . 0.0 111.797 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.2 p -60.61 150.24 75.75 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.327 177.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -85.17 141.2 8.02 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.421 2.08 . . . . 0.0 114.328 -175.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.88 ' O ' ' HA ' ' A' ' 78' ' ' THR . 7.0 t -82.65 129.39 37.53 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.641 0 CA-C-N 114.782 -1.099 . . . . 0.0 108.594 167.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 9.7 t -125.9 106.44 16.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 C-N-CA 120.196 -0.602 . . . . 0.0 110.057 171.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.552 HG13 ' HB ' ' A' ' 77' ' ' ILE . 5.8 pt -121.95 111.39 30.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.048 177.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.687 ' H ' ' NE2' ' A' ' 94' ' ' GLN . 0.7 OUTLIER -96.78 115.36 27.29 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.57 0.7 . . . . 0.0 111.184 -178.801 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.67 131.79 53.97 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.471 177.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -86.79 134.12 33.59 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.214 0.531 . . . . 0.0 110.135 179.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 24.1 p -66.08 120.86 13.92 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.437 178.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.6 m -68.29 -30.69 69.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.342 0.591 . . . . 0.0 110.247 -177.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.78 -150.99 20.28 Favored Glycine 0 N--CA 1.441 -0.985 0 CA-C-N 115.331 -0.849 . . . . 0.0 112.297 175.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.496 HG22 ' H ' ' A' ' 102' ' ' ARG . 40.2 m -106.07 128.76 25.74 Favored Pre-proline 0 C--N 1.316 -0.865 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 100' ' ' THR . 52.0 Cg_exo -55.51 -26.82 56.34 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 123.253 2.635 . . . . 0.0 112.305 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.57 ' HB3' ' OD1' ' A' ' 104' ' ' ASP . 69.3 mtp180 -88.41 121.11 30.43 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.059 175.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 5.1 p -94.2 9.58 37.37 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.104 0.478 . . . . 0.0 111.024 -178.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.57 ' OD1' ' HB3' ' A' ' 102' ' ' ARG . 6.7 p-10 -89.57 175.13 7.4 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.872 177.002 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 141.24 -54.32 0.63 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.911 -0.661 . . . . 0.0 111.93 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 20.7 m . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.828 -0.606 . . . . 0.0 109.818 177.092 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.642 0 N-CA-C 111.738 -0.545 . . . . 0.0 111.738 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 44.4 t 69.17 111.34 0.05 OUTLIER 'General case' 0 C--O 1.233 0.188 0 C-N-CA 123.081 0.552 . . . . 0.0 110.772 -179.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 41.8 m-70 60.42 57.23 2.9 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.486 -179.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.17 75.96 8.13 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.44 -179.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -79.67 -27.35 54.41 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.799 -176.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 13.9 m -88.93 62.12 6.21 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.43 0.633 . . . . 0.0 110.178 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.7 m -82.21 86.22 6.68 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.347 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 24.2 m -89.28 123.09 33.16 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.473 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -119.36 139.56 27.85 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.147 -177.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -67.06 136.94 42.7 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.231 1.954 . . . . 0.0 112.284 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -88.2 164.88 15.43 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.918 178.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -96.3 159.1 32.76 Favored Pre-proline 0 C--N 1.32 -0.687 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.882 -177.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -71.27 129.65 16.32 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 122.35 2.033 . . . . 0.0 111.284 175.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.54 ' HD2' ' O ' ' A' ' 31' ' ' SER . 88.5 Cg_exo -49.31 151.44 6.61 Favored 'Trans proline' 0 C--O 1.234 0.316 0 C-N-CA 122.743 2.295 . . . . 0.0 111.936 173.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -36.63 106.61 0.34 Allowed Pre-proline 0 N--CA 1.469 0.51 0 O-C-N 124.728 1.268 . . . . 0.0 112.324 -171.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.666 ' HG2' HG11 ' A' ' 91' ' ' VAL . 28.1 Cg_exo -68.61 143.76 57.91 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 123.442 2.761 . . . . 0.0 113.046 179.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 94.6 m -96.62 127.7 42.86 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.199 -177.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.44 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 97.3 t -79.27 116.48 23.29 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-N 114.611 -1.177 . . . . 0.0 109.337 173.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -86.95 -37.02 17.97 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.085 -173.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -135.6 136.55 41.13 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.235 -176.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.467 ' HA ' HG12 ' A' ' 26' ' ' ILE . 42.0 t -133.52 115.44 22.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.109 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.401 ' HB3' ' H ' ' A' ' 23' ' ' ASP . 8.2 m-20 -132.41 -160.37 1.04 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.269 179.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.401 ' H ' ' HB3' ' A' ' 22' ' ' ASP . 6.3 p-10 -68.69 -66.59 0.55 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -177.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.609 HG22 ' O ' ' A' ' 69' ' ' LEU . 57.2 p -115.52 36.87 3.77 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.423 0.63 . . . . 0.0 110.582 -172.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.602 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 32.2 p -170.2 131.21 0.97 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.673 -174.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.586 ' HB ' HD12 ' A' ' 66' ' ' LEU . 42.4 mt -145.97 142.07 21.62 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.771 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 178.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 43.6 t -119.67 134.14 64.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 118.859 0.754 . . . . 0.0 110.338 -173.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.544 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.7 OUTLIER -129.11 148.55 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.524 -179.261 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.639 ' HG2' ' OG ' ' A' ' 63' ' ' SER . 29.7 mtm105 -131.36 120.3 22.92 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.554 -177.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.749 ' HZ3' HG12 ' A' ' 64' ' ' VAL . 37.8 p90 -111.14 143.81 41.28 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.832 -175.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.54 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 17.3 t -91.17 96.44 10.58 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 177.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.543 ' CD ' ' H ' ' A' ' 32' ' ' ARG . 1.0 OUTLIER -49.54 158.12 0.86 Allowed Pre-proline 0 C--N 1.327 -0.372 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -173.854 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.692 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 5.1 Cg_exo -79.94 165.56 21.83 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 124.197 3.265 . . . . 0.0 112.534 -173.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -78.92 -10.43 59.81 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.13 -0.941 . . . . 0.0 108.933 172.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -72.23 138.42 81.54 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 114.779 -1.1 . . . . 0.0 111.315 177.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo -66.31 115.05 3.29 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 121.492 1.461 . . . . 0.0 109.738 166.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.54 HD12 ' HE1' ' A' ' 40' ' ' TYR . 0.6 OUTLIER -119.55 154.71 22.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 -177.901 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.412 ' N ' ' O ' ' A' ' 82' ' ' VAL . 9.5 p -95.74 -23.79 16.81 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -178.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.574 ' C ' HG12 ' A' ' 82' ' ' VAL . . . -173.61 -163.02 26.49 Favored Glycine 0 CA--C 1.502 -0.778 0 C-N-CA 119.919 -1.134 . . . . 0.0 111.887 178.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.692 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 6.8 m-85 -141.2 133.8 28.58 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 122.525 0.33 . . . . 0.0 111.156 174.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.5 mmm180 -104.61 149.87 25.16 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 167.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.888 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 33.7 mt -138.88 107.93 3.77 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 C-N-CA 120.123 -0.631 . . . . 0.0 112.106 -178.138 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 66.1 t -107.09 110.13 30.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.422 0.63 . . . . 0.0 110.572 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.645 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 0.5 OUTLIER -110.74 124.62 52.33 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.096 175.517 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.412 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 14.5 t -142.39 139.2 17.28 Favored Pre-proline 0 C--N 1.316 -0.89 0 CA-C-N 113.86 -1.518 . . . . 0.0 110.666 -172.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.704 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 37.2 Cg_exo -63.1 153.49 73.5 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 123.374 2.716 . . . . 0.0 112.585 176.049 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 19.9 t -72.38 -30.76 64.98 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.44 -175.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.3 p -117.72 -42.51 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 120.242 -0.583 . . . . 0.0 112.163 177.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -179.76 152.23 0.48 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.635 0.255 . . . . 0.0 110.523 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.492 ' CA ' ' HG2' ' A' ' 46' ' ' PRO . . . 150.77 -156.26 26.59 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 111.494 -0.642 . . . . 0.0 111.494 -179.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 34.8 t -87.27 122.46 31.07 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.78 0.29 . . . . 0.0 110.809 -178.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 32.7 p -117.44 145.98 43.78 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 176.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.645 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 24.6 m -147.87 152.87 38.34 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.756 -0.377 . . . . 0.0 111.374 -178.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.888 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 34.1 tt0 -116.87 118.36 32.26 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 171.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.7 HD12 ' CG2' ' A' ' 64' ' ' VAL . 20.5 mt -97.13 157.13 16.08 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 174.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -122.35 113.48 19.45 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.564 HD12 ' CH2' ' A' ' 30' ' ' TRP . 3.6 mt -112.0 155.58 43.13 Favored Pre-proline 0 N--CA 1.443 -0.782 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 -175.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -64.36 149.65 89.73 Favored 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 121.656 1.57 . . . . 0.0 110.945 174.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -46.56 -25.94 0.79 Allowed 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 114.722 -1.126 . . . . 0.0 113.123 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 7.9 t -101.55 5.72 41.88 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.915 0.388 . . . . 0.0 111.358 -175.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.455 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -75.95 155.99 34.59 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.433 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 4.9 p-10 -141.3 12.46 2.17 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 120.55 -0.46 . . . . 0.0 112.181 -175.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.639 ' OG ' ' HG2' ' A' ' 29' ' ' ARG . 9.4 m -161.94 135.88 6.6 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.981 -0.288 . . . . 0.0 110.834 -178.051 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.749 HG12 ' HZ3' ' A' ' 30' ' ' TRP . 4.2 p -121.26 135.12 62.45 Favored 'Isoleucine or valine' 0 C--O 1.24 0.605 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 172.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 55.2 m -97.67 100.91 12.31 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-O 121.528 0.68 . . . . 0.0 109.291 169.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.741 HD11 HG12 ' A' ' 77' ' ' ILE . 0.2 OUTLIER -77.52 141.38 39.65 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.22 -0.9 . . . . 0.0 108.958 179.824 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 22.5 t -141.42 169.63 17.25 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -174.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 34.1 t70 64.48 29.87 13.17 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 123.998 0.811 . . . . 0.0 110.307 -178.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.609 ' O ' HG22 ' A' ' 24' ' ' THR . 8.2 mt -75.42 -176.29 3.11 Favored 'General case' 0 N--CA 1.462 0.143 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 175.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -117.96 133.1 23.42 Favored Pre-proline 0 C--N 1.32 -0.689 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 174.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -64.55 128.71 21.85 Favored 'Trans proline' 0 C--O 1.233 0.269 0 C-N-CA 122.666 2.244 . . . . 0.0 112.392 177.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.63 37.52 19.81 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.04 179.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.526 ' CG1' ' HB3' ' A' ' 46' ' ' PRO . 71.5 t -134.82 138.35 49.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.121 0.486 . . . . 0.0 110.805 -178.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.704 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -75.7 121.28 22.27 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.564 -0.743 . . . . 0.0 109.549 -179.997 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.439 ' CE2' HD22 ' A' ' 69' ' ' LEU . 7.6 m-85 -113.92 114.62 26.47 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.308 0.575 . . . . 0.0 112.444 -176.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.482 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 12.2 m120 -88.28 109.21 19.78 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.321 172.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.741 HG12 HD11 ' A' ' 66' ' ' LEU . 4.9 mp -92.15 119.97 40.53 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.621 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 175.038 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.897 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 55.9 m -112.16 115.41 28.8 Favored 'General case' 0 N--CA 1.425 -1.687 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.613 -179.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.53 ' H ' ' HB ' ' A' ' 91' ' ' VAL . 12.6 mm -95.94 136.91 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -124.29 111.73 16.17 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.322 -0.399 . . . . 0.0 109.965 178.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.445 ' HB1' HG21 ' A' ' 37' ' ' ILE . . . -80.04 109.38 14.43 Favored 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 171.063 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.574 HG12 ' C ' ' A' ' 39' ' ' GLY . 10.4 p -100.13 139.73 20.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 C-N-CA 120.029 -0.668 . . . . 0.0 110.754 -174.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.632 ' HG2' ' H ' ' A' ' 84' ' ' GLU . 0.7 OUTLIER -117.56 167.56 11.2 Favored 'General case' 0 N--CA 1.447 -0.583 0 O-C-N 124.005 0.816 . . . . 0.0 108.935 179.265 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.632 ' H ' ' HG2' ' A' ' 83' ' ' GLU . 39.1 mt-10 -40.65 -52.51 2.9 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 28.5 m-80 -123.99 1.49 8.63 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.815 -174.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -134.98 172.02 13.6 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.332 -0.547 . . . . 0.0 111.596 -172.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -136.86 129.14 29.83 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.523 177.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 23.9 m -69.09 162.22 27.4 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.304 176.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.1 p -58.15 151.81 44.57 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.015 0.436 . . . . 0.0 110.265 174.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -82.39 140.6 10.9 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 121.978 1.786 . . . . 0.0 113.727 -173.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.897 ' O ' ' HA ' ' A' ' 78' ' ' THR . 10.7 t -82.27 123.72 38.52 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.728 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 167.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.4 t -121.82 106.71 18.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 C-N-CA 119.76 -0.776 . . . . 0.0 109.936 171.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.574 HG13 ' HB ' ' A' ' 77' ' ' ILE . 6.4 pt -120.47 115.7 47.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.612 177.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -103.83 123.0 46.3 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.467 0.651 . . . . 0.0 111.343 -174.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.34 135.25 42.6 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.711 177.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.49 ' HG3' ' HG2' ' A' ' 74' ' ' GLN . 1.6 mp0 -86.13 135.22 33.69 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.162 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 41.2 p -67.08 124.17 22.32 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.16 0.505 . . . . 0.0 110.303 178.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 14.2 m -69.39 -31.52 69.96 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.142 -174.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.32 -142.74 16.12 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.559 -0.829 . . . . 0.0 111.696 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 15.1 m -141.5 128.22 11.46 Favored Pre-proline 0 C--N 1.318 -0.789 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 178.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo -68.8 58.26 1.12 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.745 2.297 . . . . 0.0 111.576 171.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -91.69 137.81 32.07 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.451 -179.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 17.7 m 62.97 50.68 3.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.486 0.66 . . . . 0.0 109.696 -176.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -76.83 177.65 7.48 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.633 -177.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 86.87 -88.53 1.59 Allowed Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.389 -177.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 15.1 m . . . . . 0 C--O 1.247 0.953 0 CA-C-O 118.637 -0.697 . . . . 0.0 110.056 178.101 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.701 0 N-CA-C 111.9 -0.48 . . . . 0.0 111.9 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.5 m -67.34 -43.41 81.61 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.027 0.442 . . . . 0.0 110.703 -179.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 13.2 t60 -99.24 90.84 4.71 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 178.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 59.6 mtt -76.54 -24.57 53.64 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.864 -176.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 156.04 -102.5 0.22 Allowed Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.849 -0.691 . . . . 0.0 111.855 179.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 15.4 t -107.59 148.47 29.24 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.0 p -70.56 112.96 7.21 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.242 177.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 33.8 m -62.13 120.17 10.36 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 120.949 0.404 . . . . 0.0 110.262 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -146.9 110.98 4.11 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.743 -177.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -79.78 175.15 10.84 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.801 2.334 . . . . 0.0 111.681 175.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -127.24 164.39 21.8 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.328 -176.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -95.9 163.68 20.52 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.343 178.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -71.82 130.11 16.4 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 122.446 2.097 . . . . 0.0 111.626 175.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.629 ' HD2' ' O ' ' A' ' 31' ' ' SER . 88.3 Cg_exo -48.54 154.83 2.57 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.963 2.442 . . . . 0.0 112.32 172.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.423 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 24.5 t70 -39.31 106.36 0.39 Allowed Pre-proline 0 N--CA 1.466 0.372 0 O-C-N 124.652 1.22 . . . . 0.0 112.621 -172.088 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.693 ' HG2' HG11 ' A' ' 91' ' ' VAL . 27.2 Cg_exo -68.92 149.25 72.0 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 123.444 2.763 . . . . 0.0 112.696 178.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.1 m -106.71 132.88 52.19 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.862 -177.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 81.9 t -85.14 121.56 37.16 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 114.63 -1.168 . . . . 0.0 109.78 174.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -94.28 -28.03 15.8 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.181 -174.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -135.79 126.51 27.3 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.406 -175.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.514 ' HA ' HG12 ' A' ' 26' ' ' ILE . 58.1 t -127.96 109.65 20.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.423 177.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.477 ' CG ' ' H ' ' A' ' 23' ' ' ASP . 13.7 t70 -118.68 -157.61 0.69 Allowed 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.477 ' H ' ' CG ' ' A' ' 22' ' ' ASP . 1.1 m-20 -84.23 -56.36 3.69 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.053 0.454 . . . . 0.0 110.286 -179.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.688 HG22 ' O ' ' A' ' 69' ' ' LEU . 22.8 p -114.43 34.5 4.69 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.669 -176.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.634 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 51.1 m -168.34 130.63 1.42 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.152 -172.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.585 ' HB ' HD12 ' A' ' 66' ' ' LEU . 45.3 mt -147.84 138.36 17.2 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.548 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 175.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 47.6 t -118.13 127.96 75.25 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.517 0 O-C-N 121.684 -0.635 . . . . 0.0 110.961 -174.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.602 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.6 OUTLIER -123.72 146.88 28.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.056 -176.61 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.498 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 28.7 mtm180 -133.35 121.88 23.0 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.313 -176.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.721 ' HZ3' HG12 ' A' ' 64' ' ' VAL . 39.4 p90 -111.37 145.13 39.43 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.52 -174.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.629 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 25.4 m -90.83 94.74 9.8 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.311 178.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.584 ' NE ' ' HB3' ' A' ' 62' ' ' ASN . 0.1 OUTLIER -49.0 156.61 0.9 Allowed Pre-proline 0 CA--C 1.537 0.458 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -173.837 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.618 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 5.0 Cg_exo -80.12 167.88 19.36 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 124.126 3.217 . . . . 0.0 112.248 -173.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.438 ' H ' ' NE2' ' A' ' 34' ' ' GLN . 1.9 mp0 -83.14 -11.4 57.97 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 173.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -67.49 147.17 98.81 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 114.333 -1.303 . . . . 0.0 111.481 177.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -75.31 114.4 3.98 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 121.54 1.494 . . . . 0.0 110.283 170.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.582 HG22 ' HG3' ' A' ' 83' ' ' GLU . 1.2 pt -122.61 154.15 27.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -176.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.424 ' C ' ' HB3' ' A' ' 59' ' ' GLU . 19.3 p -99.14 -30.17 12.44 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -176.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.576 ' C ' HG12 ' A' ' 82' ' ' VAL . . . -165.73 -164.13 20.58 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.482 -0.866 . . . . 0.0 111.7 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.618 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 6.6 m-85 -141.95 134.89 28.78 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 117.145 0.473 . . . . 0.0 111.392 175.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 8.9 mmm180 -100.4 150.92 22.12 Favored 'General case' 0 CA--C 1.508 -0.656 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 166.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.89 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 30.4 mt -139.27 108.49 3.7 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 C-N-CA 120.452 -0.499 . . . . 0.0 112.215 177.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 72.7 t -108.69 110.34 31.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.464 0.649 . . . . 0.0 110.804 179.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.648 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 1.0 OUTLIER -112.35 125.67 54.44 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.374 175.773 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 12.4 p -137.79 139.24 25.99 Favored Pre-proline 0 C--N 1.317 -0.822 0 CA-C-N 114.093 -1.412 . . . . 0.0 112.02 -172.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.521 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 72.0 Cg_endo -74.24 142.37 30.35 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 123.482 2.788 . . . . 0.0 111.71 176.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 18.4 m -71.46 -28.91 64.28 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.233 -176.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.7 m -116.94 -40.48 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -178.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -179.84 143.03 0.17 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -178.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.439 ' CA ' ' HG3' ' A' ' 46' ' ' PRO . . . 155.13 -159.88 29.39 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.971 -0.633 . . . . 0.0 111.664 178.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.459 ' O ' ' HE1' ' A' ' 75' ' ' TYR . 27.1 t -94.97 120.67 35.57 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.685 0.279 . . . . 0.0 110.625 -179.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.448 ' HA ' ' O ' ' A' ' 44' ' ' TYR . 22.0 p -107.55 139.5 41.98 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 173.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.648 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 36.8 m -146.95 150.11 34.52 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 120.482 -0.487 . . . . 0.0 111.441 -174.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.89 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 52.5 tt0 -115.34 114.16 24.77 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.55 173.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.682 HD12 ' CG2' ' A' ' 64' ' ' VAL . 23.0 mt -97.08 151.64 19.56 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.46 -0.496 . . . . 0.0 109.667 175.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -116.54 115.81 26.45 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.61 HD12 ' CH2' ' A' ' 30' ' ' TRP . 3.9 mt -113.51 156.96 42.65 Favored Pre-proline 0 C--N 1.319 -0.723 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -176.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -66.16 151.37 83.82 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 121.712 1.608 . . . . 0.0 111.166 175.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.424 ' HB3' ' C ' ' A' ' 38' ' ' THR . 9.2 pt-20 -46.07 -28.01 1.09 Allowed 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.099 -0.955 . . . . 0.0 112.823 177.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.9 t -101.67 12.28 37.42 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.265 0.555 . . . . 0.0 111.246 -175.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.467 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -82.07 159.98 23.31 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.584 ' HB3' ' NE ' ' A' ' 32' ' ' ARG . 28.4 p-10 -146.73 17.19 1.27 Allowed 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -176.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.602 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 21.5 p -169.08 135.73 1.75 Allowed 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.17 -0.612 . . . . 0.0 111.846 -178.54 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.721 HG12 ' HZ3' ' A' ' 30' ' ' TRP . 4.1 p -122.06 136.21 59.67 Favored 'Isoleucine or valine' 0 C--O 1.242 0.682 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.343 175.022 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 39.3 m -98.19 102.01 13.64 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-O 121.531 0.681 . . . . 0.0 109.55 170.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.701 HD11 HG12 ' A' ' 77' ' ' ILE . 0.2 OUTLIER -78.5 139.45 38.67 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.036 179.104 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 22.0 t -136.1 170.05 16.64 Favored 'General case' 0 C--N 1.317 -0.828 0 O-C-N 123.257 0.348 . . . . 0.0 110.224 -174.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 62.52 26.56 15.79 Favored 'General case' 0 C--N 1.331 -0.222 0 O-C-N 123.861 0.725 . . . . 0.0 111.457 -179.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.688 ' O ' HG22 ' A' ' 24' ' ' THR . 16.4 mt -68.17 -175.92 0.66 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.209 0.528 . . . . 0.0 109.887 177.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.55 ' OE1' ' HD2' ' A' ' 71' ' ' PRO . 5.7 tp-100 -126.1 118.9 23.67 Favored Pre-proline 0 C--N 1.319 -0.738 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.149 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.55 ' HD2' ' OE1' ' A' ' 70' ' ' GLN . 19.2 Cg_endo -60.89 134.48 53.68 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.886 2.391 . . . . 0.0 113.033 -177.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.63 23.33 50.72 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.936 -0.65 . . . . 0.0 111.812 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 50.5 t -129.49 146.38 34.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.183 0.516 . . . . 0.0 110.804 -177.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.521 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -82.98 120.16 25.36 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.186 -0.916 . . . . 0.0 109.721 -178.696 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.459 ' HE1' ' O ' ' A' ' 51' ' ' SER . 14.5 m-85 -115.06 113.92 24.68 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.254 0.55 . . . . 0.0 111.949 -176.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.576 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 0.8 OUTLIER -87.22 113.35 22.88 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.936 177.006 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.701 HG12 HD11 ' A' ' 66' ' ' LEU . 5.3 mp -94.68 114.94 32.28 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.615 0 CA-C-O 121.289 0.566 . . . . 0.0 109.618 175.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.843 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 48.4 m -108.52 116.15 31.43 Favored 'General case' 0 N--CA 1.427 -1.615 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.122 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.547 ' HB ' ' HB ' ' A' ' 91' ' ' VAL . 13.0 mm -95.22 143.49 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -129.99 113.12 14.18 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.001 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.33 122.53 25.87 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 106.738 -1.578 . . . . 0.0 106.738 168.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.576 HG12 ' C ' ' A' ' 39' ' ' GLY . 7.5 p -110.49 135.37 49.78 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 C-N-CA 120.153 -0.619 . . . . 0.0 109.97 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.679 ' OE1' ' HG2' ' A' ' 86' ' ' GLN . 4.8 mp0 -115.34 169.87 8.82 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -37.76 -53.09 1.28 Allowed 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -171.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -126.24 7.23 7.12 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.726 -0.389 . . . . 0.0 111.947 -175.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.679 ' HG2' ' OE1' ' A' ' 83' ' ' GLU . 20.3 pm0 -143.79 176.73 9.02 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 120.688 -0.405 . . . . 0.0 111.289 -173.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -136.06 129.89 32.62 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.775 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 67.9 m -76.99 175.78 9.25 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.086 0.47 . . . . 0.0 111.622 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -60.93 152.94 68.02 Favored Pre-proline 0 N--CA 1.451 -0.38 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.283 179.065 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -85.99 141.83 7.4 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.433 2.089 . . . . 0.0 114.204 -177.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.843 ' O ' ' HA ' ' A' ' 78' ' ' THR . 11.8 t -82.51 124.88 39.74 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.718 0 CA-C-N 114.692 -1.14 . . . . 0.0 108.101 166.192 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 14.4 t -120.34 105.24 16.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 C-N-CA 119.385 -0.926 . . . . 0.0 109.904 171.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.57 HG13 ' HB ' ' A' ' 77' ' ' ILE . 10.4 pt -122.04 110.86 28.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.192 177.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.431 ' HB2' ' OE1' ' A' ' 74' ' ' GLN . 11.1 pt20 -100.86 114.6 28.59 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.783 0.801 . . . . 0.0 111.237 -174.093 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.28 126.44 52.16 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.988 -1.005 . . . . 0.0 109.756 178.38 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.457 ' HB2' ' HG2' ' A' ' 74' ' ' GLN . 39.1 tt0 -89.73 130.21 36.03 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 177.039 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 41.6 p -63.66 140.38 58.87 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.319 -177.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.6 m -67.58 -30.74 70.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.633 -173.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 58.07 88.35 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 CA-C-N 115.948 -0.569 . . . . 0.0 113.088 172.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.4 m -81.77 118.52 72.45 Favored Pre-proline 0 C--N 1.313 -0.997 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 -179.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -51.01 111.41 0.55 Allowed 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 122.546 2.164 . . . . 0.0 111.364 178.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 70.3 mtt85 65.9 69.86 0.44 Allowed 'General case' 0 C--O 1.234 0.237 0 O-C-N 123.644 0.59 . . . . 0.0 110.05 -175.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.3 m -58.58 -47.36 84.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.809 -178.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -130.16 113.96 15.11 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.402 179.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 72.21 -112.03 3.85 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.982 -0.628 . . . . 0.0 111.756 -178.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.8 t . . . . . 0 C--O 1.253 1.238 0 CA-C-O 118.795 -0.621 . . . . 0.0 109.79 176.81 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.553 0 N-CA-C 112.126 -0.39 . . . . 0.0 112.126 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.3 m -75.74 -34.52 60.32 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.77 0.319 . . . . 0.0 111.272 -178.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 67.4 t60 -71.16 -38.82 72.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.916 0.389 . . . . 0.0 110.297 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 38.3 tpp -152.06 127.02 9.67 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.18 176.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -160.57 71.42 0.23 Allowed Glycine 0 N--CA 1.445 -0.764 0 N-CA-C 111.216 -0.753 . . . . 0.0 111.216 179.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.3 t -87.71 25.55 1.47 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.345 0.593 . . . . 0.0 111.077 -174.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.9 m -79.48 97.6 6.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.967 175.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.466 ' O ' ' HG3' ' A' ' 86' ' ' GLN . 23.5 m -69.22 133.86 48.48 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.015 -178.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -114.19 88.97 16.0 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-O 120.838 0.352 . . . . 0.0 110.276 175.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -81.52 159.2 19.49 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 122.476 2.117 . . . . 0.0 112.166 -178.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -106.02 152.61 23.14 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.822 -178.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.582 ' HB2' ' O ' ' A' ' 89' ' ' THR . . . -83.28 155.71 66.52 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.164 177.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -62.22 132.68 39.93 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.412 2.074 . . . . 0.0 111.655 173.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.42 ' HD2' ' O ' ' A' ' 31' ' ' SER . 89.0 Cg_exo -49.43 145.6 15.84 Favored 'Trans proline' 0 C--O 1.236 0.383 0 C-N-CA 122.588 2.192 . . . . 0.0 111.188 172.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.425 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 5.5 m-20 -34.98 106.63 0.3 Allowed Pre-proline 0 N--CA 1.469 0.497 0 O-C-N 124.847 1.342 . . . . 0.0 112.693 -169.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.604 ' HG2' HG11 ' A' ' 91' ' ' VAL . 28.0 Cg_exo -66.68 151.51 82.5 Favored 'Trans proline' 0 CA--C 1.519 -0.273 0 C-N-CA 123.534 2.823 . . . . 0.0 112.108 178.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 8.2 m -113.13 131.62 55.77 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.635 -177.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.458 ' HA ' ' HA ' ' A' ' 28' ' ' VAL . 71.6 t -76.05 119.34 23.91 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-N 114.363 -1.29 . . . . 0.0 110.143 174.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -93.81 -28.05 16.11 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.073 -174.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -135.52 132.6 37.49 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.388 -178.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.456 ' HA ' HG12 ' A' ' 26' ' ' ILE . 11.5 t -131.95 104.84 8.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.77 179.312 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -111.75 -163.29 0.84 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.092 177.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.482 ' O ' ' HB2' ' A' ' 69' ' ' LEU . 4.0 p-10 -73.69 -62.42 1.5 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.349 0.595 . . . . 0.0 111.471 176.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.635 HG22 ' O ' ' A' ' 69' ' ' LEU . 35.1 p -111.49 33.43 4.72 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.447 -172.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.691 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 35.6 m -168.88 130.4 1.22 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.897 -171.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.594 ' HB ' HD12 ' A' ' 66' ' ' LEU . 40.5 mt -146.64 140.14 20.16 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.636 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 176.251 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 85.6 t -117.09 129.19 74.04 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.752 0 O-C-N 121.654 -0.654 . . . . 0.0 110.61 -175.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.639 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.8 OUTLIER -121.97 143.44 34.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 C-N-CA 120.32 -0.552 . . . . 0.0 109.608 -178.912 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.496 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 44.6 mtp180 -129.65 121.13 26.41 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.891 0.377 . . . . 0.0 110.5 -174.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.723 ' HZ3' HG12 ' A' ' 64' ' ' VAL . 37.1 p90 -111.54 152.6 27.34 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.566 -174.411 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.42 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 11.7 m -96.81 97.46 9.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.965 178.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.562 ' NE ' ' HB3' ' A' ' 62' ' ' ASN . 0.1 OUTLIER -49.72 156.52 1.19 Allowed Pre-proline 0 CA--C 1.538 0.489 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -173.768 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.613 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 3.0 Cg_exo -84.1 165.55 13.06 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 124.303 3.335 . . . . 0.0 112.638 -173.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -77.91 -18.41 56.17 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.198 173.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.57 143.88 96.11 Favored Pre-proline 0 C--O 1.235 0.334 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.105 175.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.475 ' O ' ' HG2' ' A' ' 83' ' ' GLU . 57.2 Cg_endo -75.86 114.68 3.99 Favored 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 121.321 1.347 . . . . 0.0 109.934 170.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.558 HD12 ' CE1' ' A' ' 40' ' ' TYR . 1.3 pt -118.78 152.43 21.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -175.238 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.46 ' C ' ' HB3' ' A' ' 59' ' ' GLU . 7.7 p -92.15 -30.06 16.16 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.956 0.725 . . . . 0.0 112.956 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.593 ' C ' HG12 ' A' ' 82' ' ' VAL . . . -169.85 -162.14 21.58 Favored Glycine 0 CA--C 1.501 -0.818 0 C-N-CA 119.9 -1.143 . . . . 0.0 111.445 -178.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.613 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 7.2 m-85 -140.86 134.42 30.07 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 117.068 0.434 . . . . 0.0 110.888 173.324 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 -101.91 147.82 26.07 Favored 'General case' 0 CA--C 1.505 -0.762 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 166.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.897 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 34.4 mt -138.67 108.96 4.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 C-N-CA 120.238 -0.585 . . . . 0.0 112.367 -177.274 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 76.6 t -107.37 110.18 30.89 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.448 0 CA-C-O 121.27 0.557 . . . . 0.0 110.6 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.698 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 0.6 OUTLIER -112.62 125.05 53.86 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.34 175.969 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.461 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 13.5 t -140.22 136.03 16.64 Favored Pre-proline 0 C--N 1.31 -1.132 0 CA-C-N 113.941 -1.481 . . . . 0.0 110.297 -174.156 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.586 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 21.6 Cg_exo -64.95 151.19 86.66 Favored 'Trans proline' 0 CA--C 1.518 -0.319 0 C-N-CA 123.014 2.476 . . . . 0.0 111.795 176.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 18.1 m -70.9 -35.75 72.42 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.145 -178.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 91.3 t -117.3 -42.98 3.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -176.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -171.31 142.11 1.67 Allowed 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.876 -0.33 . . . . 0.0 111.114 -175.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.498 ' CA ' ' HG2' ' A' ' 46' ' ' PRO . . . 151.54 -154.87 25.82 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.445 178.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.512 ' O ' ' HE1' ' A' ' 75' ' ' TYR . 29.5 m -95.13 121.82 37.16 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 111.616 0.228 . . . . 0.0 111.616 -177.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.454 ' HA ' ' O ' ' A' ' 44' ' ' TYR . 6.1 m -105.99 135.25 47.77 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 173.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.698 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 55.1 m -146.36 150.53 35.88 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.233 -175.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.897 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 46.7 tt0 -120.7 113.59 20.44 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.914 176.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.707 HD12 ' CG2' ' A' ' 64' ' ' VAL . 20.3 mt -97.17 157.84 15.74 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.461 177.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.484 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 27.4 t-20 -121.87 113.2 19.3 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.362 177.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.56 HD12 ' CH2' ' A' ' 30' ' ' TRP . 3.3 mt -109.98 155.56 41.44 Favored Pre-proline 0 C--N 1.318 -0.784 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -176.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -62.72 148.22 93.68 Favored 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 121.781 1.654 . . . . 0.0 110.959 176.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.46 ' HB3' ' C ' ' A' ' 38' ' ' THR . 8.8 pt-20 -44.96 -24.97 0.26 Allowed 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 114.986 -1.006 . . . . 0.0 113.468 178.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.5 t -105.85 9.07 32.94 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.04 0.447 . . . . 0.0 111.213 -174.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.448 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -76.09 157.28 33.07 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.562 ' HB3' ' NE ' ' A' ' 32' ' ' ARG . 27.9 p-10 -141.6 13.87 2.14 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.445 -0.502 . . . . 0.0 112.231 -178.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.639 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 16.6 m -162.17 133.88 5.4 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 121.951 -0.468 . . . . 0.0 110.698 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.723 HG12 ' HZ3' ' A' ' 30' ' ' TRP . 4.3 p -115.27 135.47 55.14 Favored 'Isoleucine or valine' 0 C--O 1.242 0.708 0 CA-C-O 120.796 0.331 . . . . 0.0 110.184 173.211 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 55.0 m -96.27 101.19 12.8 Favored 'General case' 0 N--CA 1.434 -1.27 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.725 170.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.691 ' O ' ' HA ' ' A' ' 25' ' ' SER . 0.3 OUTLIER -77.82 142.02 38.83 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 177.664 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 10.1 t -138.2 167.97 20.71 Favored 'General case' 0 C--N 1.322 -0.597 0 O-C-N 123.282 0.364 . . . . 0.0 110.779 -173.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 63.96 25.12 13.83 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.574 -179.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.635 ' O ' HG22 ' A' ' 24' ' ' THR . 12.7 mt -69.58 -175.99 0.94 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.012 0.435 . . . . 0.0 110.142 177.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -129.41 127.23 23.08 Favored Pre-proline 0 C--N 1.319 -0.725 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 177.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -64.52 134.77 42.78 Favored 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 122.663 2.242 . . . . 0.0 112.599 -178.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 83.77 30.72 28.62 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.989 -0.625 . . . . 0.0 111.576 -178.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.489 ' CG1' ' HB3' ' A' ' 46' ' ' PRO . 95.6 t -133.23 141.98 43.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.7 0.286 . . . . 0.0 110.518 -177.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.586 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 1.5 tm0? -87.68 122.19 31.04 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.051 -179.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.512 ' HE1' ' O ' ' A' ' 51' ' ' SER . 13.4 m-85 -113.15 113.65 25.67 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.143 -174.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.531 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 13.3 m120 -86.34 106.42 17.38 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.937 177.116 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.654 HG12 HD11 ' A' ' 66' ' ' LEU . 5.3 mp -92.35 119.72 40.36 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.529 0 CA-C-O 121.201 0.524 . . . . 0.0 109.886 177.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.829 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 65.6 m -111.68 118.44 35.65 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.478 177.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.565 ' HB ' ' HB ' ' A' ' 91' ' ' VAL . 12.0 mm -96.12 140.05 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 -128.41 111.51 13.4 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 178.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.432 ' HB1' HG21 ' A' ' 37' ' ' ILE . . . -79.81 110.36 15.09 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 173.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.593 HG12 ' C ' ' A' ' 39' ' ' GLY . 10.8 p -99.44 141.53 16.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 C-N-CA 120.196 -0.602 . . . . 0.0 110.728 -173.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.475 ' HG2' ' O ' ' A' ' 36' ' ' PRO . 9.5 tm-20 -118.31 165.9 13.28 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 -176.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -45.17 -46.76 12.26 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -176.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -126.84 0.1 6.66 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.854 0.359 . . . . 0.0 111.426 -174.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.466 ' HG3' ' O ' ' A' ' 8' ' ' THR . 84.2 mm-40 -134.08 174.09 10.87 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 122.071 -0.393 . . . . 0.0 111.167 -173.073 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -136.9 133.67 35.99 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.433 175.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.7 m -75.9 174.59 9.72 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.495 -178.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.582 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 0.1 OUTLIER -60.48 159.43 24.01 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.704 176.525 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -88.66 134.79 2.84 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 122.243 1.962 . . . . 0.0 113.951 -178.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.829 ' O ' ' HA ' ' A' ' 78' ' ' THR . 10.5 t -82.67 126.58 40.04 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.627 0 CA-C-N 115.133 -0.939 . . . . 0.0 108.59 167.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.6 t -124.62 106.33 16.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 C-N-CA 120.115 -0.634 . . . . 0.0 110.276 174.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.511 HG13 ' HB ' ' A' ' 77' ' ' ILE . 8.3 pt -127.34 116.19 43.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.976 179.063 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.579 ' HB2' ' OE1' ' A' ' 74' ' ' GLN . 3.7 pt20 -99.5 131.41 45.52 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.261 0.553 . . . . 0.0 111.094 -177.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -140.43 129.11 22.98 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.137 178.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.453 ' HB2' ' HG2' ' A' ' 74' ' ' GLN . 38.7 tt0 -86.9 139.95 30.12 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.081 0.467 . . . . 0.0 110.305 177.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 18.7 p -70.56 119.44 14.73 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.314 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.406 ' H ' HG12 ' A' ' 21' ' ' VAL . 19.4 m -71.99 -32.0 66.79 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.247 0.546 . . . . 0.0 110.544 -179.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 110.82 -174.32 16.95 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.099 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 22.2 m -74.88 126.52 88.24 Favored Pre-proline 0 C--N 1.322 -0.621 0 N-CA-C 110.258 -0.275 . . . . 0.0 110.258 178.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -67.95 65.97 0.94 Allowed 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 123.068 2.512 . . . . 0.0 112.469 176.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 43.3 ttp180 -72.57 -49.86 29.46 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.789 177.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 19.4 m 56.34 59.03 3.85 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.415 0.626 . . . . 0.0 110.879 177.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -91.81 -43.4 9.55 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.239 178.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -157.85 131.32 2.82 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 120.889 -0.672 . . . . 0.0 111.968 179.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 5.0 p . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.513 -0.756 . . . . 0.0 110.559 178.03 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.722 0 N-CA-C 111.804 -0.518 . . . . 0.0 111.804 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.1 t -112.53 125.81 54.65 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 13.5 t60 -74.86 -26.16 59.49 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.216 -177.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 90.9 mtp -93.14 177.69 5.98 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.566 178.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 142.64 169.47 12.29 Favored Glycine 0 N--CA 1.445 -0.759 0 N-CA-C 111.421 -0.672 . . . . 0.0 111.421 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 42.5 m -59.51 102.06 0.13 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.004 0.43 . . . . 0.0 110.389 178.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.0 m -83.74 84.58 7.5 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 121.104 0.478 . . . . 0.0 110.336 -179.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 88.7 m -79.48 130.01 35.01 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.219 178.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.405 ' HA ' ' HD2' ' A' ' 10' ' ' PRO . . . 65.95 88.44 0.11 Allowed Pre-proline 0 N--CA 1.463 0.186 0 O-C-N 123.796 0.685 . . . . 0.0 110.995 -179.137 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 9' ' ' ALA . 37.3 Cg_endo -66.54 156.21 66.58 Favored 'Trans proline' 0 C--O 1.238 0.493 0 C-N-CA 122.777 2.318 . . . . 0.0 112.647 -178.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -84.16 160.71 20.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.238 178.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -96.49 158.29 34.0 Favored Pre-proline 0 C--N 1.319 -0.735 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.8 175.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -71.2 138.35 33.15 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.042 1.828 . . . . 0.0 110.788 174.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.571 ' HD2' ' O ' ' A' ' 31' ' ' SER . 18.1 Cg_endo -60.59 160.09 25.61 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 122.371 2.047 . . . . 0.0 110.518 176.147 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.407 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 7.5 p-10 -42.15 107.69 0.55 Allowed Pre-proline 0 N--CA 1.468 0.449 0 O-C-N 124.126 0.891 . . . . 0.0 111.84 -170.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.593 ' HG2' HG11 ' A' ' 91' ' ' VAL . 24.3 Cg_exo -67.5 153.35 76.78 Favored 'Trans proline' 0 CA--C 1.518 -0.291 0 C-N-CA 122.953 2.436 . . . . 0.0 111.756 178.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 61.4 m -111.48 131.11 55.46 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 121.752 0.787 . . . . 0.0 110.87 -178.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.446 ' HA ' ' HA ' ' A' ' 28' ' ' VAL . 79.5 t -80.17 124.55 38.31 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 CA-C-N 114.119 -1.4 . . . . 0.0 110.06 174.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -83.41 -49.21 9.54 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.189 -176.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -136.84 141.94 42.84 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.794 -177.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.521 HG11 ' NE2' ' A' ' 95' ' ' GLN . 27.3 m -129.46 125.72 62.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.041 179.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -125.15 -167.9 1.75 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.057 176.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.518 ' O ' ' HB2' ' A' ' 69' ' ' LEU . 1.6 p-10 -62.54 -64.21 0.99 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.111 0.481 . . . . 0.0 111.824 178.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.655 HG22 ' O ' ' A' ' 69' ' ' LEU . 32.9 p -111.66 35.0 3.83 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.915 -172.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.617 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 52.4 p -169.16 139.38 2.23 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.277 -175.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.616 ' HB ' HD12 ' A' ' 66' ' ' LEU . 12.0 mt -149.89 140.2 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 176.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.435 ' O ' HG13 ' A' ' 18' ' ' VAL . 44.0 t -116.21 128.63 73.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 O-C-N 121.486 -0.759 . . . . 0.0 110.519 -177.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.606 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.7 OUTLIER -124.63 146.05 30.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.072 -176.805 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.467 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 22.3 mtm180 -131.01 121.93 25.92 Favored 'General case' 0 C--N 1.328 -0.359 0 O-C-N 123.305 0.378 . . . . 0.0 110.804 -175.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.781 ' HZ3' HG12 ' A' ' 64' ' ' VAL . 39.8 p90 -114.82 143.32 45.28 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.245 -175.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.571 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 15.9 t -88.95 98.77 11.93 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 177.211 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.604 ' CD ' ' H ' ' A' ' 32' ' ' ARG . 0.1 OUTLIER -51.9 159.26 1.43 Allowed Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 123.71 0.804 . . . . 0.0 113.06 -174.621 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.677 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 3.7 Cg_exo -82.21 166.11 16.51 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 124.116 3.211 . . . . 0.0 112.048 -176.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -87.43 -5.41 58.85 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.541 177.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.409 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . . . -70.89 148.1 94.45 Favored Pre-proline 0 N--CA 1.453 -0.314 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.847 175.02 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.496 ' O ' ' HG3' ' A' ' 83' ' ' GLU . 10.9 Cg_exo -71.76 115.91 4.49 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 121.82 1.68 . . . . 0.0 110.101 169.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.498 HD12 ' HE1' ' A' ' 40' ' ' TYR . 2.4 pt -124.73 153.92 31.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -175.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 18.1 p -94.39 -32.67 13.46 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -176.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.579 ' C ' HG12 ' A' ' 82' ' ' VAL . . . -168.55 -162.79 21.35 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.314 -0.946 . . . . 0.0 111.796 -177.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.677 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 7.1 m-85 -141.78 135.23 29.48 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 122.573 0.349 . . . . 0.0 111.284 174.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.9 mmm180 -100.16 148.4 24.64 Favored 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 167.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.916 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 29.9 mt -139.19 107.74 3.42 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 C-N-CA 120.075 -0.65 . . . . 0.0 112.315 179.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 80.3 t -109.24 110.72 33.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.089 0.471 . . . . 0.0 110.859 -178.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.772 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 1.0 OUTLIER -115.22 128.73 56.34 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.215 178.372 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.454 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 29.8 p -143.11 145.16 31.65 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 114.051 -1.431 . . . . 0.0 112.027 -174.095 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.547 ' HB3' HG11 ' A' ' 73' ' ' VAL . 2.1 Cg_endo -81.07 154.51 19.38 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 123.657 2.904 . . . . 0.0 111.172 175.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 23.2 t -84.61 -31.26 24.37 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.551 179.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 19.7 m -111.14 -33.93 2.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -91.62 -170.1 2.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.464 0.174 . . . . 0.0 110.746 -179.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -116.17 -29.37 2.36 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.022 -1.085 . . . . 0.0 115.535 -167.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.467 ' O ' ' HD3' ' A' ' 46' ' ' PRO . 9.6 t -64.8 113.49 3.83 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 118.974 1.387 . . . . 0.0 111.1 -170.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 13.1 m -123.62 146.48 48.14 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.778 176.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.772 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 21.4 m -146.95 148.12 31.43 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 119.678 -0.809 . . . . 0.0 111.531 177.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.916 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 46.7 tt0 -116.16 117.98 31.58 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.97 172.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.717 HD12 ' CG2' ' A' ' 64' ' ' VAL . 17.9 mt -98.38 156.95 16.5 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.634 -0.426 . . . . 0.0 110.07 174.176 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -120.29 113.93 21.13 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 178.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.566 HD12 ' CH2' ' A' ' 30' ' ' TRP . 2.6 mt -111.27 157.74 38.09 Favored Pre-proline 0 C--N 1.318 -0.796 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -175.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -66.78 150.66 83.36 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 121.769 1.646 . . . . 0.0 111.512 175.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -43.17 -27.44 0.22 Allowed 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 114.435 -1.257 . . . . 0.0 113.397 177.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 5.7 t -104.38 4.89 33.92 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.148 0.499 . . . . 0.0 111.227 -172.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.408 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -75.14 152.42 38.49 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 -178.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.484 ' HB3' ' NE ' ' A' ' 32' ' ' ARG . 27.7 p-10 -135.6 16.28 3.37 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.816 -0.353 . . . . 0.0 111.831 -178.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.606 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 17.8 p -170.17 136.93 1.47 Allowed 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.27 -0.572 . . . . 0.0 112.078 -178.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.781 HG12 ' HZ3' ' A' ' 30' ' ' TRP . 3.9 p -119.8 138.42 50.47 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.337 176.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 50.5 m -98.36 101.43 12.88 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-O 121.334 0.588 . . . . 0.0 109.692 170.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.687 HD11 HG12 ' A' ' 77' ' ' ILE . 0.2 OUTLIER -79.93 145.29 32.72 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.426 178.801 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.468 ' HA ' ' O ' ' A' ' 24' ' ' THR . 17.6 t -139.0 177.91 7.55 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -177.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 65.37 20.84 11.87 Favored 'General case' 0 N--CA 1.468 0.437 0 O-C-N 123.486 0.491 . . . . 0.0 111.977 -178.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.655 ' O ' HG22 ' A' ' 24' ' ' THR . 13.8 mt -72.19 -175.59 1.56 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.182 0.515 . . . . 0.0 110.339 178.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 56.0 tp60 -128.72 128.82 23.5 Favored Pre-proline 0 C--N 1.319 -0.734 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 178.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.9 134.63 54.53 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.951 2.434 . . . . 0.0 113.391 -178.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.13 35.81 26.17 Favored Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 115.868 -0.605 . . . . 0.0 112.405 177.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.547 HG11 ' HB3' ' A' ' 46' ' ' PRO . 42.5 t -134.37 150.43 30.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.04 0.448 . . . . 0.0 111.424 -175.327 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 8.0 tp60 -91.1 105.03 17.53 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.332 179.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.527 ' CZ ' ' HG3' ' A' ' 46' ' ' PRO . 9.9 m-85 -97.38 121.14 38.94 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.79 -178.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.553 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 55.7 m-20 -91.85 111.87 23.57 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.283 176.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.687 HG12 HD11 ' A' ' 66' ' ' LEU . 5.3 mp -94.82 118.4 40.83 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.623 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.971 176.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.905 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 29.5 m -107.91 115.4 30.07 Favored 'General case' 0 N--CA 1.425 -1.684 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.605 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.533 ' HB ' ' HB ' ' A' ' 91' ' ' VAL . 12.5 mm -96.1 137.58 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -126.15 111.75 15.0 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.052 178.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -80.02 112.39 17.28 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 171.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.579 HG12 ' C ' ' A' ' 39' ' ' GLY . 10.9 p -103.64 136.4 36.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 C-N-CA 119.924 -0.711 . . . . 0.0 110.956 -175.123 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.66 ' HG2' ' N ' ' A' ' 84' ' ' GLU . 2.4 tt0 -117.73 166.91 11.87 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 177.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.66 ' N ' ' HG2' ' A' ' 83' ' ' GLU . 28.0 mt-10 -44.02 -48.38 8.78 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 178.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 19.9 m-80 -98.62 -33.87 10.79 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -170.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -145.81 169.49 18.42 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-O 120.904 0.383 . . . . 0.0 111.518 -167.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -114.72 145.78 41.68 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.289 175.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 17.8 m -76.15 169.78 17.55 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.738 178.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.2 p -58.73 146.11 75.87 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.079 173.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -78.26 138.91 16.31 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.134 1.889 . . . . 0.0 113.966 -174.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.905 ' O ' ' HA ' ' A' ' 78' ' ' THR . 9.7 t -81.74 126.5 39.88 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.745 0 CA-C-N 114.828 -1.078 . . . . 0.0 108.174 167.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 15.7 t -123.78 106.06 16.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 C-N-CA 119.766 -0.774 . . . . 0.0 109.912 170.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.565 HG13 ' HB ' ' A' ' 77' ' ' ILE . 6.9 pt -120.0 115.58 47.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.892 178.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -99.44 125.01 45.08 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.273 0.558 . . . . 0.0 111.372 -176.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.521 ' NE2' HG11 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -128.73 131.63 47.91 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.379 178.797 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.41 ' HA ' ' O ' ' A' ' 73' ' ' VAL . 44.1 mt-10 -85.71 127.31 34.48 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.049 0.452 . . . . 0.0 110.218 176.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 46.4 p -69.92 120.65 15.96 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.562 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.9 m -69.71 -31.18 69.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.292 0.568 . . . . 0.0 110.588 -178.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 107.32 -162.5 13.36 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.218 176.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 28.8 m -86.17 122.67 72.37 Favored Pre-proline 0 C--N 1.321 -0.656 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 179.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -50.7 105.42 0.1 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.949 2.433 . . . . 0.0 111.964 178.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 29.6 ptt180 -80.41 149.1 30.28 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.323 -175.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 17.5 m -111.06 17.58 20.26 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.388 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -135.91 151.77 50.33 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.96 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 89.02 -90.94 1.68 Allowed Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.278 -177.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.5 m . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.145 -0.931 . . . . 0.0 109.384 175.309 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.793 0 N-CA-C 111.734 -0.547 . . . . 0.0 111.734 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.7 p -63.79 144.15 57.28 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.802 0.301 . . . . 0.0 110.37 177.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 20.1 t60 -85.82 58.36 5.0 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.229 0.538 . . . . 0.0 110.281 -176.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 15.7 tpt -98.96 97.84 8.96 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.649 177.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 155.39 -161.7 30.64 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.715 -0.755 . . . . 0.0 111.824 -178.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.7 m 62.03 66.15 0.84 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.536 0.684 . . . . 0.0 110.139 -178.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 35.2 m -73.84 105.29 5.05 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.253 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 22.5 m -66.58 122.68 18.14 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.162 -177.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -146.09 86.73 6.95 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.165 178.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.547 ' HG3' ' OE1' ' A' ' 83' ' ' GLU . 88.6 Cg_endo -79.96 -176.76 3.39 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.945 2.43 . . . . 0.0 112.689 -177.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -144.14 154.05 42.76 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.549 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.446 ' HB2' ' O ' ' A' ' 89' ' ' THR . . . -90.73 154.85 45.84 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.292 -178.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.448 ' HB2' ' HB2' ' A' ' 30' ' ' TRP . 26.8 Cg_exo -64.54 128.45 21.25 Favored 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.365 2.044 . . . . 0.0 111.646 178.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.415 ' HD2' ' O ' ' A' ' 31' ' ' SER . 53.5 Cg_exo -53.03 143.52 49.86 Favored 'Trans proline' 0 CA--C 1.512 -0.602 0 C-N-CA 122.517 2.145 . . . . 0.0 111.312 176.169 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -37.05 103.17 0.25 Allowed Pre-proline 0 CA--C 1.515 -0.39 0 O-C-N 125.145 1.528 . . . . 0.0 112.74 -163.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.709 ' CG ' HG11 ' A' ' 91' ' ' VAL . 3.1 Cg_endo -47.62 147.98 6.17 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 123.594 2.863 . . . . 0.0 113.526 169.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 18.4 m -107.6 131.6 54.19 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.021 -0.991 . . . . 0.0 109.789 177.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.483 HG11 HG22 ' A' ' 21' ' ' VAL . 81.2 t -76.52 121.03 27.82 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.41 176.128 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -86.08 -39.06 17.16 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.526 -175.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -135.26 127.96 30.95 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.842 0.354 . . . . 0.0 110.683 -178.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.516 ' HA ' HG12 ' A' ' 26' ' ' ILE . 98.7 t -120.78 115.58 47.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.4 177.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -127.2 -164.17 1.33 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.338 178.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -68.55 -63.01 1.14 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.088 0.471 . . . . 0.0 112.149 -178.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.642 HG22 ' O ' ' A' ' 69' ' ' LEU . 38.7 p -117.81 35.08 4.85 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.812 -171.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.531 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 54.4 p -170.91 132.38 0.87 Allowed 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.496 -173.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.595 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 32.7 mt -145.91 140.82 21.67 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.781 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 178.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.433 ' O ' HG13 ' A' ' 18' ' ' VAL . 39.7 t -117.14 134.11 61.76 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.631 0 C-N-CA 120.064 -0.655 . . . . 0.0 110.084 -176.003 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.638 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.6 OUTLIER -127.06 146.93 32.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 C-N-CA 120.221 -0.591 . . . . 0.0 110.462 -178.643 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.564 ' HG2' ' OG ' ' A' ' 63' ' ' SER . 18.4 mtp180 -128.54 118.94 23.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.549 -177.125 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.764 ' HZ3' HG12 ' A' ' 64' ' ' VAL . 36.4 p90 -110.48 146.11 36.53 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.961 -176.08 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.415 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 20.8 m -92.21 99.92 12.62 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.078 177.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.56 ' NE ' ' HB3' ' A' ' 62' ' ' ASN . 0.1 OUTLIER -46.58 156.98 0.47 Allowed Pre-proline 0 CA--C 1.536 0.419 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -175.222 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.628 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 3.4 Cg_exo -83.34 169.0 12.84 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 124.179 3.253 . . . . 0.0 112.5 -172.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -87.2 -3.43 59.05 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.231 -0.895 . . . . 0.0 108.938 173.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.71 146.87 80.67 Favored Pre-proline 0 N--CA 1.451 -0.416 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.968 175.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -77.84 114.7 3.68 Favored 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 121.371 1.38 . . . . 0.0 110.043 170.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.641 HG22 ' HG3' ' A' ' 83' ' ' GLU . 0.7 OUTLIER -120.25 155.02 23.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.461 -174.494 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.1 p -97.51 -33.79 11.23 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -178.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.414 ' C ' HG12 ' A' ' 82' ' ' VAL . . . -164.74 -169.65 28.62 Favored Glycine 0 C--O 1.222 -0.642 0 C-N-CA 120.075 -1.059 . . . . 0.0 112.16 179.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.628 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 4.6 m-85 -136.56 131.38 33.76 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-N 117.302 0.551 . . . . 0.0 111.674 176.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 37.4 mtm180 -103.98 148.41 26.23 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.029 168.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.867 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 30.4 mt -139.0 109.32 4.37 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 C-N-CA 120.421 -0.511 . . . . 0.0 112.335 -176.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 95.6 t -110.43 110.74 33.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.42 0.629 . . . . 0.0 110.667 179.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.755 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 0.5 OUTLIER -108.17 125.09 51.22 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.191 175.358 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.443 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 6.3 p -144.03 138.4 14.98 Favored Pre-proline 0 C--N 1.315 -0.903 0 CA-C-N 113.864 -1.517 . . . . 0.0 111.301 -173.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.742 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 22.5 Cg_exo -65.52 148.1 87.29 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 123.349 2.699 . . . . 0.0 111.767 175.174 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 10.0 m -69.56 -30.89 68.79 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.726 -177.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.497 ' O ' ' HB2' ' A' ' 49' ' ' GLU . 3.4 p -109.55 -41.82 4.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 120.745 -0.382 . . . . 0.0 111.982 -177.072 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.497 ' HB2' ' O ' ' A' ' 48' ' ' VAL . 34.6 tt0 169.56 148.74 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.328 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.566 ' CA ' ' HG2' ' A' ' 46' ' ' PRO . . . 159.21 -141.83 7.85 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 111.515 -0.634 . . . . 0.0 111.515 177.009 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.58 ' O ' ' HE1' ' A' ' 75' ' ' TYR . 16.5 m -93.95 120.56 34.37 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.873 0.368 . . . . 0.0 110.965 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.457 ' HA ' ' O ' ' A' ' 44' ' ' TYR . 15.0 m -115.19 137.57 51.88 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 176.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.755 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 30.6 m -147.15 154.99 41.76 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.358 -176.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.867 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 33.0 tt0 -124.31 115.4 20.95 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 123.297 0.639 . . . . 0.0 109.902 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.687 HD12 ' CG2' ' A' ' 64' ' ' VAL . 18.4 mt -100.52 160.5 14.29 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 175.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.423 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 17.5 m120 -125.98 121.59 33.51 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 178.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.603 HD12 ' CH2' ' A' ' 30' ' ' TRP . 4.6 mt -118.33 158.9 45.48 Favored Pre-proline 0 C--N 1.318 -0.79 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -176.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -64.48 150.97 87.31 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 121.58 1.52 . . . . 0.0 111.21 175.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.402 ' HB2' HG13 ' A' ' 37' ' ' ILE . 12.8 pt-20 -46.0 -26.75 0.77 Allowed 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 114.924 -1.035 . . . . 0.0 112.77 177.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 7.8 t -103.76 8.21 37.22 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.318 -174.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.484 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -75.0 160.43 30.55 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -179.173 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.56 ' HB3' ' NE ' ' A' ' 32' ' ' ARG . 24.7 p-10 -142.58 10.92 1.86 Allowed 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.473 -0.491 . . . . 0.0 112.323 -179.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.638 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 14.6 m -161.43 133.82 5.94 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 118.476 0.58 . . . . 0.0 111.473 -178.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.764 HG12 ' HZ3' ' A' ' 30' ' ' TRP . 4.1 p -119.56 136.87 55.31 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 173.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 40.4 m -97.44 100.97 12.4 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-O 121.426 0.631 . . . . 0.0 109.711 169.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.7 HD11 HG12 ' A' ' 77' ' ' ILE . 0.2 OUTLIER -78.52 145.14 35.06 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.008 178.045 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.1 t -142.31 173.56 11.42 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -175.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 67.02 23.04 9.86 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 123.907 0.755 . . . . 0.0 111.078 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.642 ' O ' HG22 ' A' ' 24' ' ' THR . 10.3 mt -72.37 -175.77 1.67 Allowed 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 177.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 21.6 mm-40 -125.51 134.12 25.52 Favored Pre-proline 0 C--N 1.322 -0.613 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 176.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -65.8 126.01 15.25 Favored 'Trans proline' 0 CA--C 1.529 0.267 0 C-N-CA 122.502 2.135 . . . . 0.0 112.885 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 86.03 31.77 19.4 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.503 177.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 92.1 t -129.79 145.28 35.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.019 0.438 . . . . 0.0 110.698 -177.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.742 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -80.05 123.75 28.12 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.692 -179.274 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.58 ' HE1' ' O ' ' A' ' 51' ' ' SER . 15.3 m-85 -120.45 114.03 21.2 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.164 0.507 . . . . 0.0 112.119 -176.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.457 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 11.5 m120 -90.33 110.65 21.71 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.371 176.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.7 HG12 HD11 ' A' ' 66' ' ' LEU . 5.1 mp -91.36 116.21 32.07 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.686 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 176.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.868 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 14.9 m -108.86 113.51 26.49 Favored 'General case' 0 N--CA 1.424 -1.751 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.359 -177.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.576 ' H ' ' HB ' ' A' ' 91' ' ' VAL . 10.8 mm -95.13 134.23 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -122.33 111.55 17.04 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.75 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.404 ' HB3' ' HB2' ' A' ' 88' ' ' SER . . . -81.25 131.17 35.28 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 170.07 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.414 HG12 ' C ' ' A' ' 39' ' ' GLY . 7.7 p -118.47 135.37 59.1 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.317 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.641 ' HG3' HG22 ' A' ' 37' ' ' ILE . 4.0 mp0 -115.21 169.95 8.74 Favored 'General case' 0 N--CA 1.448 -0.561 0 O-C-N 123.906 0.754 . . . . 0.0 109.482 -178.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -44.26 -47.88 9.43 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -174.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 30.3 p-10 -129.88 16.39 5.76 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.934 -0.306 . . . . 0.0 111.635 -177.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 77.2 mm-40 -144.65 173.99 11.36 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.763 0.316 . . . . 0.0 111.076 -176.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -140.54 119.9 13.06 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 174.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.404 ' HB2' ' HB3' ' A' ' 81' ' ' ALA . 66.7 m -65.57 167.42 8.97 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.832 0.349 . . . . 0.0 111.574 -177.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.446 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 1.2 p -57.4 160.61 6.84 Favored Pre-proline 0 CA--C 1.536 0.422 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.696 178.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -86.99 133.58 3.48 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 122.259 1.973 . . . . 0.0 113.766 -177.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.868 ' O ' ' HA ' ' A' ' 78' ' ' THR . 44.2 t -82.62 122.73 37.61 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.723 0 CA-C-N 114.936 -1.029 . . . . 0.0 108.622 170.028 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 10.8 t -120.38 106.6 19.07 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 C-N-CA 119.586 -0.846 . . . . 0.0 110.277 174.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.553 HG13 ' HB ' ' A' ' 77' ' ' ILE . 7.7 pt -122.29 113.7 39.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.733 176.394 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -100.4 131.25 46.43 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.395 0.616 . . . . 0.0 111.389 -174.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.71 132.35 34.75 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.572 177.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.491 ' HG2' ' HG2' ' A' ' 74' ' ' GLN . 45.3 mt-10 -89.13 131.8 35.1 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 175.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.402 HG22 HD11 ' A' ' 26' ' ' ILE . 31.4 p -68.5 121.17 15.8 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.47 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.3 m -69.33 -31.6 70.16 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.191 0.52 . . . . 0.0 110.305 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 95.59 -132.38 11.06 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.04 177.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 17.2 m -74.9 120.82 83.47 Favored Pre-proline 0 C--N 1.321 -0.632 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 177.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -50.4 136.97 40.0 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 123.307 2.671 . . . . 0.0 112.802 -177.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 85.0 mtt180 60.9 57.21 2.66 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.178 -177.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.5 m -64.4 -47.09 80.51 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.1 -0.955 . . . . 0.0 111.476 -175.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -66.94 126.04 27.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.943 0.401 . . . . 0.0 110.791 -176.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 143.46 134.13 2.83 Favored Glycine 0 N--CA 1.443 -0.855 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.541 -178.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 19.4 m . . . . . 0 C--O 1.247 0.936 0 CA-C-O 118.359 -0.829 . . . . 0.0 110.593 -179.302 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.685 0 N-CA-C 111.836 -0.505 . . . . 0.0 111.836 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.0 p -92.63 61.89 3.75 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.019 0.438 . . . . 0.0 111.595 -176.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 14.4 p80 -74.76 -24.17 58.65 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.862 0.363 . . . . 0.0 110.3 176.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 43.9 tpp -170.0 72.49 0.07 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.391 178.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 159.59 -152.32 23.23 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.097 -179.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 21.5 m -125.11 128.28 48.19 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.895 0.378 . . . . 0.0 111.362 -176.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.8 m -97.74 73.11 2.31 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 173.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.511 ' O ' ' HD3' ' A' ' 10' ' ' PRO . 5.3 m -63.26 151.19 41.24 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.609 -174.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -97.09 92.22 1.14 Allowed Pre-proline 0 C--N 1.323 -0.553 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 167.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.511 ' HD3' ' O ' ' A' ' 8' ' ' THR . 73.4 Cg_endo -78.69 137.95 14.73 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.33 2.02 . . . . 0.0 112.812 -171.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -86.12 162.11 18.55 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.91 175.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -96.06 155.57 38.08 Favored Pre-proline 0 C--N 1.314 -0.965 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 176.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.479 ' CB ' ' HB2' ' A' ' 30' ' ' TRP . 31.5 Cg_exo -62.47 128.14 22.8 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.017 1.811 . . . . 0.0 111.774 174.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -52.73 138.41 59.48 Favored 'Trans proline' 0 CA--C 1.509 -0.765 0 C-N-CA 122.288 1.992 . . . . 0.0 110.529 172.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -36.52 102.78 0.24 Allowed Pre-proline 0 N--CA 1.465 0.296 0 O-C-N 125.373 1.671 . . . . 0.0 112.443 -161.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.737 ' CG ' HG11 ' A' ' 91' ' ' VAL . 2.8 Cg_endo -46.61 146.14 5.66 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 123.896 3.064 . . . . 0.0 113.855 172.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 11.2 m -104.0 129.97 51.62 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.111 -0.949 . . . . 0.0 110.414 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.475 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 89.3 t -79.46 121.74 33.29 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 114.458 -1.247 . . . . 0.0 109.997 174.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -86.18 -43.17 13.22 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.333 -175.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -135.86 139.35 43.33 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.907 0.384 . . . . 0.0 111.046 -179.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.474 HG22 HG11 ' A' ' 18' ' ' VAL . 40.3 t -129.02 111.49 23.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.327 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -116.94 -157.46 0.66 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 -178.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.445 ' N ' ' HA2' ' A' ' 99' ' ' GLY . 7.0 m-20 -75.53 -64.02 1.16 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.231 0.539 . . . . 0.0 110.234 -179.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.673 HG22 ' O ' ' A' ' 69' ' ' LEU . 42.2 p -112.05 37.62 2.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.072 -175.02 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.625 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 69.6 m -168.43 131.97 1.52 Allowed 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 122.611 0.364 . . . . 0.0 110.834 -172.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.591 ' HB ' HD12 ' A' ' 66' ' ' LEU . 39.8 mt -147.53 138.18 17.42 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.622 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 176.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 39.7 t -117.35 132.54 66.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 118.695 0.68 . . . . 0.0 110.629 -174.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.612 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.7 OUTLIER -127.64 146.07 33.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.544 -177.823 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.531 ' HG2' ' HB3' ' A' ' 63' ' ' SER . 92.8 mtt180 -128.04 120.63 27.89 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 123.625 0.578 . . . . 0.0 110.519 -177.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.692 ' HZ3' HG12 ' A' ' 64' ' ' VAL . 34.7 p90 -113.69 154.11 27.83 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.231 -175.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 24.8 t -101.32 102.16 12.95 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 121.162 0.506 . . . . 0.0 110.5 178.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.587 ' CD ' ' H ' ' A' ' 32' ' ' ARG . 0.1 OUTLIER -53.89 160.46 2.18 Favored Pre-proline 0 CA--C 1.542 0.669 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -174.486 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.673 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 2.3 Cg_endo -84.87 169.44 10.41 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 124.581 3.521 . . . . 0.0 113.024 -175.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 -79.58 -22.25 44.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.609 173.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.502 ' HB1' ' OE2' ' A' ' 83' ' ' GLU . . . -58.77 136.7 86.86 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.171 179.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -66.52 113.45 2.71 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 121.317 1.345 . . . . 0.0 109.723 172.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.684 HG22 ' HG2' ' A' ' 83' ' ' GLU . 6.7 pt -123.55 157.3 29.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.855 -173.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.467 ' C ' ' HB3' ' A' ' 59' ' ' GLU . 18.3 p -101.19 -27.65 13.1 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -176.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.493 ' C ' HG12 ' A' ' 82' ' ' VAL . . . -171.04 -163.27 24.79 Favored Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 119.68 -1.247 . . . . 0.0 112.617 179.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.673 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 6.6 m-85 -141.05 135.64 31.23 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 122.858 0.463 . . . . 0.0 110.851 176.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 27.5 mtp180 -104.69 150.2 24.93 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 167.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.863 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 26.7 mt -139.0 107.94 3.65 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 C-N-CA 120.279 -0.568 . . . . 0.0 112.165 -178.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 69.2 t -105.93 110.78 32.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.323 0.582 . . . . 0.0 110.52 179.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.622 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 0.7 OUTLIER -112.35 125.73 54.51 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.341 176.008 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.438 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 16.1 t -142.75 138.1 15.77 Favored Pre-proline 0 C--N 1.317 -0.832 0 CA-C-N 113.968 -1.469 . . . . 0.0 110.785 -173.433 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.68 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 27.1 Cg_exo -62.91 151.94 81.74 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 123.473 2.782 . . . . 0.0 112.252 175.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 46.6 t -63.79 -31.93 73.26 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.014 -0.993 . . . . 0.0 111.985 -175.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 88.5 t -117.78 -42.77 2.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 C-N-CA 120.554 -0.458 . . . . 0.0 111.94 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 179.12 156.82 0.52 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.718 0.294 . . . . 0.0 110.719 -179.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.451 ' CA ' ' HG2' ' A' ' 46' ' ' PRO . . . 146.88 -144.62 12.85 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.061 -0.59 . . . . 0.0 111.756 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.54 ' O ' ' HE1' ' A' ' 75' ' ' TYR . 64.3 m -89.4 120.06 30.41 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.91 0.385 . . . . 0.0 111.101 -179.238 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.496 ' HA ' ' O ' ' A' ' 44' ' ' TYR . 6.2 p -118.06 140.23 50.06 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 174.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.622 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 40.4 m -147.86 151.18 35.49 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 120.581 -0.447 . . . . 0.0 111.534 -177.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.863 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 39.6 tt0 -116.05 115.09 25.48 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 172.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.688 HD12 ' CG2' ' A' ' 64' ' ' VAL . 17.0 mt -96.58 153.49 17.82 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 175.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -117.37 118.95 33.63 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.592 HD12 ' CH2' ' A' ' 30' ' ' TRP . 3.5 mt -116.25 156.22 47.38 Favored Pre-proline 0 N--CA 1.444 -0.73 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 -176.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -64.31 151.44 85.42 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 122.009 1.806 . . . . 0.0 111.403 176.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.467 ' HB3' ' C ' ' A' ' 38' ' ' THR . 8.9 pt-20 -47.35 -25.06 0.9 Allowed 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 114.548 -1.205 . . . . 0.0 113.431 179.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.9 t -107.54 12.84 27.36 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.185 0.517 . . . . 0.0 111.013 -176.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.496 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -76.86 156.29 32.29 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 178.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.486 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 27.5 p-10 -141.71 14.61 2.13 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -177.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.612 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 13.8 p -168.78 135.12 1.8 Allowed 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.207 -0.597 . . . . 0.0 112.389 -177.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.692 HG12 ' HZ3' ' A' ' 30' ' ' TRP . 4.8 p -120.03 134.2 64.31 Favored 'Isoleucine or valine' 0 C--O 1.24 0.591 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.309 176.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 25.8 m -96.74 101.2 12.76 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-O 121.526 0.679 . . . . 0.0 109.615 169.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.724 HD11 HG12 ' A' ' 77' ' ' ILE . 0.3 OUTLIER -78.71 144.39 35.34 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.105 179.239 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.423 ' HA ' ' O ' ' A' ' 24' ' ' THR . 12.4 p -141.68 168.58 19.41 Favored 'General case' 0 C--N 1.322 -0.601 0 O-C-N 123.338 0.399 . . . . 0.0 110.519 -173.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 64.04 27.82 14.25 Favored 'General case' 0 C--N 1.331 -0.238 0 O-C-N 123.804 0.69 . . . . 0.0 111.18 -178.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.673 ' O ' HG22 ' A' ' 24' ' ' THR . 15.3 mt -70.11 -175.5 0.97 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.181 0.515 . . . . 0.0 109.712 175.166 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 56.2 tp60 -125.0 122.67 25.48 Favored Pre-proline 0 C--N 1.315 -0.896 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 176.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.402 ' HB3' ' OD2' ' A' ' 23' ' ' ASP . 32.8 Cg_endo -63.12 129.53 26.01 Favored 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 122.891 2.394 . . . . 0.0 112.502 -177.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 86.09 33.37 15.01 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 121.098 -0.572 . . . . 0.0 111.949 -178.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.428 ' CG1' ' HB3' ' A' ' 46' ' ' PRO . 98.9 t -135.99 144.42 33.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.113 0.482 . . . . 0.0 110.93 -176.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.68 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -80.51 115.55 20.09 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.868 179.504 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.54 ' HE1' ' O ' ' A' ' 51' ' ' SER . 13.0 m-85 -111.59 114.46 27.54 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.275 0.559 . . . . 0.0 111.961 -177.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.571 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 37.0 m-80 -87.2 113.47 22.96 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.946 175.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.724 HG12 HD11 ' A' ' 66' ' ' LEU . 5.1 mp -93.37 117.41 36.79 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.574 0 CA-C-O 121.226 0.536 . . . . 0.0 109.578 174.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.877 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 62.1 m -110.84 114.86 28.53 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.476 -179.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.565 ' H ' ' HB ' ' A' ' 91' ' ' VAL . 11.5 mm -95.18 143.23 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 -179.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -129.66 111.7 12.94 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 178.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -82.39 121.93 27.35 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 172.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.493 HG12 ' C ' ' A' ' 39' ' ' GLY . 8.5 p -118.1 132.56 67.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 C-N-CA 119.758 -0.777 . . . . 0.0 112.179 -174.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.684 ' HG2' HG22 ' A' ' 37' ' ' ILE . 18.1 mt-10 -99.58 172.46 7.28 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 172.158 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -38.46 -42.8 0.78 Allowed 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -128.34 -20.15 3.74 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -178.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -98.07 167.76 10.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.145 0.497 . . . . 0.0 111.635 -173.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -145.16 121.49 10.92 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.364 175.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 10.6 m -67.38 169.77 8.44 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.325 -178.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 12.1 p -58.05 150.04 53.02 Favored Pre-proline 0 N--CA 1.451 -0.401 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.16 172.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -76.17 137.67 19.45 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 122.017 1.811 . . . . 0.0 113.06 -178.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.877 ' O ' ' HA ' ' A' ' 78' ' ' THR . 53.0 t -82.33 122.77 37.5 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.707 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 169.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.4 t -117.84 106.39 19.77 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 C-N-CA 119.374 -0.93 . . . . 0.0 110.676 174.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.563 HG13 ' HB ' ' A' ' 77' ' ' ILE . 7.5 pt -120.37 111.73 33.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.457 174.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.44 ' HB2' ' NE2' ' A' ' 74' ' ' GLN . 19.8 pt20 -99.88 121.6 41.55 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.479 0.657 . . . . 0.0 111.403 -174.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.35 130.12 47.27 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.452 179.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.458 ' CG ' ' HG2' ' A' ' 74' ' ' GLN . 37.2 mt-10 -85.97 134.17 33.88 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 176.206 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 21.6 p -69.13 114.26 7.24 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.355 0.598 . . . . 0.0 111.441 -177.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.424 ' H ' HG12 ' A' ' 21' ' ' VAL . 6.9 m -69.65 -31.66 69.87 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.838 179.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.445 ' HA2' ' N ' ' A' ' 23' ' ' ASP . . . 60.46 -131.45 49.5 Favored Glycine 0 N--CA 1.441 -1.026 0 CA-C-N 114.622 -1.172 . . . . 0.0 113.164 177.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.439 ' HA ' ' HD3' ' A' ' 101' ' ' PRO . 22.8 m -90.51 123.45 65.31 Favored Pre-proline 0 C--N 1.318 -0.791 0 CA-C-N 115.689 -0.256 . . . . 0.0 110.661 -177.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 100' ' ' THR . 37.3 Cg_exo -60.74 95.15 0.11 Allowed 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.852 2.368 . . . . 0.0 112.485 179.053 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 81.8 mtm180 -89.27 -26.49 21.14 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.657 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 16.8 t -84.46 106.04 15.74 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 177.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -73.82 -28.03 61.41 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.085 -175.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 97.58 -127.07 9.09 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.879 -0.677 . . . . 0.0 111.619 -178.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 18.0 m . . . . . 0 C--O 1.247 0.962 0 CA-C-O 118.75 -0.643 . . . . 0.0 110.123 176.81 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.642 0 N-CA-C 112.051 -0.42 . . . . 0.0 112.051 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.6 p -106.08 -23.81 12.53 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.752 0.311 . . . . 0.0 111.225 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 56.6 m80 -78.77 116.97 19.46 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.569 178.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 24.4 mmt -90.13 -34.63 15.8 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.125 179.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -111.95 141.56 16.73 Favored Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 175.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.3 m -145.17 62.37 1.29 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.479 0.656 . . . . 0.0 110.427 -178.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 46.5 m -79.44 125.16 29.19 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.563 175.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 39.1 m -65.79 119.54 11.41 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.043 0.449 . . . . 0.0 110.535 -179.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -118.61 93.4 45.82 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.355 -177.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.446 ' HG3' ' OE1' ' A' ' 83' ' ' GLU . 66.1 Cg_endo -72.52 169.84 20.83 Favored 'Trans proline' 0 C--O 1.235 0.374 0 C-N-CA 123.015 2.477 . . . . 0.0 112.332 -179.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -121.22 158.28 28.42 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.96 -178.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -92.9 156.24 40.77 Favored Pre-proline 0 C--N 1.32 -0.683 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 176.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -64.4 128.54 21.62 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.186 1.924 . . . . 0.0 111.953 178.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_exo -51.53 147.2 23.65 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.57 2.18 . . . . 0.0 111.094 174.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.43 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 6.9 m-20 -34.4 107.64 0.31 Allowed Pre-proline 0 N--CA 1.47 0.536 0 O-C-N 124.613 1.196 . . . . 0.0 113.016 -168.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.603 ' HG2' HG11 ' A' ' 91' ' ' VAL . 22.2 Cg_exo -68.72 153.34 73.36 Favored 'Trans proline' 0 CA--C 1.52 -0.207 0 C-N-CA 123.478 2.786 . . . . 0.0 111.829 177.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 26.3 m -112.63 133.41 54.68 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.566 0.698 . . . . 0.0 110.975 -177.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.456 HG11 HG22 ' A' ' 21' ' ' VAL . 79.6 t -76.21 121.39 28.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 114.437 -1.256 . . . . 0.0 110.231 175.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -76.55 -50.79 13.02 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.07 -175.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -141.12 142.23 34.12 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.799 -178.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.456 HG22 HG11 ' A' ' 18' ' ' VAL . 57.3 t -121.63 122.74 67.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.924 -177.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -125.58 -167.14 1.65 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.396 177.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.608 ' O ' ' HB2' ' A' ' 69' ' ' LEU . 2.0 p-10 -71.17 -65.17 0.78 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.089 0.471 . . . . 0.0 111.723 177.012 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.599 HG22 ' O ' ' A' ' 69' ' ' LEU . 42.1 p -111.23 34.63 3.96 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.561 -173.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.644 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 73.4 m -169.03 130.64 1.19 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.079 -173.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.585 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 45.0 mt -149.2 140.12 16.93 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.837 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 176.204 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.455 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 43.3 t -116.15 134.37 59.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 C-N-CA 119.834 -0.746 . . . . 0.0 110.166 -174.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.629 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.6 OUTLIER -127.33 146.23 33.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 C-N-CA 120.252 -0.579 . . . . 0.0 109.878 179.851 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.481 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 62.8 mtp180 -130.81 121.24 24.98 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 123.345 0.403 . . . . 0.0 110.472 -175.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.755 ' HZ3' HG12 ' A' ' 64' ' ' VAL . 38.8 p90 -114.1 154.21 28.15 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.369 -173.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 19.7 m -100.01 100.81 11.74 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.469 178.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.604 ' CD ' ' H ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -51.19 157.93 1.42 Allowed Pre-proline 0 CA--C 1.537 0.463 0 C-N-CA 123.482 0.713 . . . . 0.0 112.854 -174.933 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.646 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 3.5 Cg_exo -83.25 163.7 15.08 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 124.244 3.296 . . . . 0.0 112.63 -175.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -73.76 -19.83 60.67 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.322 172.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.415 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . . . -62.98 145.48 96.52 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 114.754 -1.112 . . . . 0.0 111.736 178.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 35' ' ' ALA . 3.1 Cg_exo -74.31 114.84 4.13 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 121.568 1.512 . . . . 0.0 110.085 168.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.532 HD12 ' HE1' ' A' ' 40' ' ' TYR . 0.7 OUTLIER -120.23 153.98 23.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -177.468 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.403 ' N ' ' O ' ' A' ' 82' ' ' VAL . 17.1 p -95.98 -25.31 15.99 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -177.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.561 ' C ' HG12 ' A' ' 82' ' ' VAL . . . -171.55 -164.87 27.92 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 119.944 -1.122 . . . . 0.0 112.235 179.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.646 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 5.8 m-85 -139.75 132.98 29.82 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 122.55 0.34 . . . . 0.0 111.18 173.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 10.8 mmm180 -99.82 151.15 21.61 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 166.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.885 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 37.6 mt -139.48 107.48 3.1 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 C-N-CA 120.134 -0.626 . . . . 0.0 112.162 178.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 71.5 t -108.56 110.33 31.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.392 0.615 . . . . 0.0 110.555 -179.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.635 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 0.6 OUTLIER -110.74 125.25 53.32 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.465 -0.788 . . . . 0.0 109.415 175.359 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.441 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 17.1 p -138.5 137.0 19.51 Favored Pre-proline 0 C--N 1.318 -0.772 0 CA-C-N 113.622 -1.626 . . . . 0.0 111.355 -173.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.657 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 22.0 Cg_exo -65.76 150.38 86.12 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 123.283 2.655 . . . . 0.0 112.224 175.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 23.2 t -70.75 -33.3 70.65 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.635 -175.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 18.1 m -118.32 -40.24 2.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 177.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -176.33 152.26 1.08 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.749 0.309 . . . . 0.0 111.422 -179.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.523 ' CA ' ' HG2' ' A' ' 46' ' ' PRO . . . 149.72 -159.27 28.01 Favored Glycine 0 N--CA 1.449 -0.497 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 -178.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.591 ' O ' ' HE1' ' A' ' 75' ' ' TYR . 31.8 t -94.41 120.63 34.94 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 117.297 0.549 . . . . 0.0 110.936 -178.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 14.8 m -104.13 143.83 32.4 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 176.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.635 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 50.2 m -147.74 148.86 31.43 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.489 -0.484 . . . . 0.0 111.691 -178.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.885 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 45.5 tt0 -115.96 117.13 29.3 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.781 172.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.701 HD12 ' CG2' ' A' ' 64' ' ' VAL . 18.4 mt -97.92 163.43 12.79 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 174.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.404 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 26.3 t-20 -128.96 110.51 12.14 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -178.019 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.585 HD12 ' CH2' ' A' ' 30' ' ' TRP . 3.3 mt -109.35 157.41 37.33 Favored Pre-proline 0 C--N 1.317 -0.844 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -175.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -64.06 149.09 91.18 Favored 'Trans proline' 0 N--CA 1.447 -1.212 0 C-N-CA 121.636 1.557 . . . . 0.0 110.99 175.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -44.02 -26.88 0.32 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.385 -1.279 . . . . 0.0 113.156 178.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 10.8 t -108.05 9.26 28.46 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.465 -173.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.417 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -75.07 161.18 29.65 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 178.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.566 ' HB3' ' NE ' ' A' ' 32' ' ' ARG . 28.3 p-10 -144.12 17.83 1.75 Allowed 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.465 0.542 . . . . 0.0 112.465 -178.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.629 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 17.2 p -169.62 133.76 1.33 Allowed 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.125 -0.63 . . . . 0.0 111.889 178.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.755 HG12 ' HZ3' ' A' ' 30' ' ' TRP . 3.6 p -116.6 138.46 47.12 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.182 176.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 30.0 m -97.94 101.05 12.44 Favored 'General case' 0 N--CA 1.433 -1.299 0 CA-C-O 121.366 0.603 . . . . 0.0 109.457 169.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.688 HD11 HG12 ' A' ' 77' ' ' ILE . 0.3 OUTLIER -77.14 144.19 38.6 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.005 178.327 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 62.1 p -139.62 174.13 10.82 Favored 'General case' 0 C--N 1.319 -0.722 0 O-C-N 123.349 0.406 . . . . 0.0 110.147 -175.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 37.6 t70 61.62 28.52 17.68 Favored 'General case' 0 C--N 1.33 -0.258 0 O-C-N 123.777 0.673 . . . . 0.0 110.715 179.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.608 ' HB2' ' O ' ' A' ' 23' ' ' ASP . 13.9 mt -73.89 -176.2 2.39 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 176.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.584 ' OE1' ' HD2' ' A' ' 71' ' ' PRO . 5.8 tp-100 -132.24 121.31 17.54 Favored Pre-proline 0 C--N 1.318 -0.781 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.584 ' HD2' ' OE1' ' A' ' 70' ' ' GLN . 18.5 Cg_endo -60.62 137.06 71.01 Favored 'Trans proline' 0 C--O 1.235 0.346 0 C-N-CA 122.908 2.405 . . . . 0.0 112.896 -178.005 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.23 26.45 52.18 Favored Glycine 0 N--CA 1.449 -0.463 0 N-CA-C 111.435 -0.666 . . . . 0.0 111.435 -178.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.492 ' HB ' ' O ' ' A' ' 70' ' ' GLN . 77.8 t -131.55 136.02 58.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 120.899 0.38 . . . . 0.0 110.691 -177.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.657 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -80.82 117.53 21.55 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.937 -178.101 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.591 ' HE1' ' O ' ' A' ' 51' ' ' SER . 18.9 m-85 -110.42 116.35 31.27 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.252 0.548 . . . . 0.0 112.184 -176.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.496 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 12.1 m120 -89.73 111.18 22.09 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.683 176.02 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.688 HG12 HD11 ' A' ' 66' ' ' LEU . 5.1 mp -92.0 118.82 38.29 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.632 0 CA-C-O 121.16 0.505 . . . . 0.0 109.836 178.057 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.872 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 21.7 m -110.45 115.3 29.4 Favored 'General case' 0 N--CA 1.428 -1.549 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.131 -179.235 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.56 ' HB ' ' HB ' ' A' ' 91' ' ' VAL . 14.1 mm -95.21 142.5 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.43 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 68.7 m-85 -129.6 112.37 13.64 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.335 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.95 122.88 26.7 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 168.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.561 HG12 ' C ' ' A' ' 39' ' ' GLY . 7.9 p -112.66 136.91 47.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.245 -178.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.512 ' HG3' HG22 ' A' ' 37' ' ' ILE . 1.8 mp0 -114.6 171.21 7.77 Favored 'General case' 0 N--CA 1.446 -0.626 0 O-C-N 123.695 0.622 . . . . 0.0 109.659 -177.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -45.3 -44.74 11.7 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -174.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -117.32 -16.73 10.28 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -175.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.499 ' HB2' ' OE1' ' A' ' 83' ' ' GLU . 45.2 mt-30 -128.4 176.05 8.02 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.474 -0.49 . . . . 0.0 111.625 -169.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.443 ' HG2' HG23 ' A' ' 82' ' ' VAL . 45.8 mt-10 -130.33 125.46 34.74 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.289 -0.869 . . . . 0.0 108.967 171.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 45.9 m -72.61 173.94 8.24 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.048 0.452 . . . . 0.0 111.705 -177.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -60.89 155.74 51.41 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.238 178.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -88.28 142.31 5.24 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 122.423 2.082 . . . . 0.0 114.482 -176.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.872 ' O ' ' HA ' ' A' ' 78' ' ' THR . 7.1 t -82.62 126.42 40.02 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.721 0 CA-C-N 114.662 -1.154 . . . . 0.0 108.175 166.002 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.6 t -120.26 106.73 19.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 C-N-CA 119.768 -0.773 . . . . 0.0 110.081 171.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.545 HG13 ' HB ' ' A' ' 77' ' ' ILE . 7.1 pt -123.5 113.35 37.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.54 176.021 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -99.0 126.02 44.61 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.502 0.667 . . . . 0.0 111.458 -175.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.67 127.92 33.93 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.151 -0.932 . . . . 0.0 109.56 176.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.421 ' HA ' ' HA ' ' A' ' 74' ' ' GLN . 37.4 tt0 -87.26 138.17 31.72 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.076 0.465 . . . . 0.0 110.126 176.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 26.5 p -69.55 117.75 11.56 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.238 -177.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 14.3 m -69.81 -30.6 68.16 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.354 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.4 ' HA2' ' HB3' ' A' ' 71' ' ' PRO . . . 106.35 -157.08 16.04 Favored Glycine 0 N--CA 1.446 -0.666 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.29 175.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.471 HG22 ' H ' ' A' ' 102' ' ' ARG . 25.7 m -97.59 124.76 47.35 Favored Pre-proline 0 C--N 1.319 -0.734 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 176.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -62.0 -23.43 75.77 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.613 2.208 . . . . 0.0 112.127 179.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.471 ' H ' HG22 ' A' ' 100' ' ' THR . 34.9 mtp85 69.39 -160.52 0.17 Allowed 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.668 173.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 58.8 m 59.95 34.74 21.6 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-O 121.421 0.629 . . . . 0.0 110.48 -175.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -114.79 10.13 16.46 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.662 -178.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 126.44 -48.08 0.99 Allowed Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 -174.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 17.6 p . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.115 -0.945 . . . . 0.0 112.253 178.405 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.677 0 N-CA-C 111.87 -0.492 . . . . 0.0 111.87 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.7 p -82.77 -31.66 28.19 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 110.567 -0.16 . . . . 0.0 110.567 178.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 34.0 t-80 57.66 61.16 2.53 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.189 0.519 . . . . 0.0 110.073 176.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 66.4 mtt -106.96 41.72 1.42 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.682 -178.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -75.03 108.57 2.56 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.652 -0.785 . . . . 0.0 111.547 178.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 12.0 t -78.61 128.85 34.06 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.342 0.591 . . . . 0.0 110.779 -176.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.6 p -104.12 126.01 50.89 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.889 177.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.7 m -64.32 117.67 7.57 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.097 0.475 . . . . 0.0 111.07 -177.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -141.96 108.13 5.87 Favored Pre-proline 0 C--N 1.319 -0.753 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.336 -178.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.528 ' HD3' ' NE2' ' A' ' 86' ' ' GLN . 87.9 Cg_endo -88.91 170.44 5.1 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.877 2.384 . . . . 0.0 112.274 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -117.56 160.48 21.18 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.58 176.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.408 ' HB2' ' O ' ' A' ' 89' ' ' THR . . . -95.23 158.86 34.05 Favored Pre-proline 0 C--N 1.316 -0.855 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 177.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.413 ' CB ' ' HB2' ' A' ' 30' ' ' TRP . 30.3 Cg_exo -64.52 126.74 17.45 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 121.886 1.724 . . . . 0.0 111.511 175.267 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.505 ' HD2' ' O ' ' A' ' 31' ' ' SER . 84.9 Cg_exo -47.14 146.95 5.83 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.634 2.223 . . . . 0.0 111.114 171.019 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.419 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 10.2 p-10 -37.71 106.67 0.36 Allowed Pre-proline 0 N--CA 1.465 0.302 0 O-C-N 124.743 1.277 . . . . 0.0 112.594 -169.104 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.583 ' HG2' HG11 ' A' ' 91' ' ' VAL . 33.4 Cg_exo -65.59 152.28 82.23 Favored 'Trans proline' 0 CA--C 1.517 -0.329 0 C-N-CA 123.552 2.835 . . . . 0.0 112.015 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 25.8 m -109.45 128.78 55.41 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.898 -178.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.463 ' HA ' ' HA ' ' A' ' 28' ' ' VAL . 83.6 t -74.92 119.21 22.07 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-N 114.415 -1.266 . . . . 0.0 109.591 173.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -88.0 -40.25 14.02 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.184 -173.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 18.0 mm-40 -136.71 139.41 41.9 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.47 -177.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.47 HG11 ' NE2' ' A' ' 95' ' ' GLN . 33.6 m -130.55 133.75 63.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.15 0.5 . . . . 0.0 111.078 178.166 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -134.84 -162.72 1.28 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.064 178.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -69.01 -68.41 0.4 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.105 0.479 . . . . 0.0 111.579 177.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.685 HG22 ' O ' ' A' ' 69' ' ' LEU . 68.2 p -111.87 39.64 2.34 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.905 -174.239 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.711 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 69.9 m -169.12 131.91 1.28 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.371 -0.832 . . . . 0.0 110.322 -171.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.613 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 17.9 mt -150.38 138.45 14.3 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.893 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 176.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 37.7 t -116.35 131.94 67.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 119.002 0.819 . . . . 0.0 110.587 -173.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.631 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.7 OUTLIER -125.94 145.41 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.039 -178.412 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.499 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 77.3 mtt180 -127.13 121.87 32.61 Favored 'General case' 0 N--CA 1.465 0.293 0 O-C-N 123.629 0.581 . . . . 0.0 110.293 -177.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.757 ' HZ3' HG12 ' A' ' 64' ' ' VAL . 28.1 p90 -112.83 146.8 38.23 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.835 -0.621 . . . . 0.0 112.05 -173.41 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.505 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 15.3 m -87.43 88.63 7.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.482 179.246 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.675 ' HD3' ' H ' ' A' ' 32' ' ' ARG . 0.4 OUTLIER -48.77 156.26 0.91 Allowed Pre-proline 0 CA--C 1.54 0.582 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -174.698 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.706 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 1.6 Cg_endo -85.7 169.26 9.37 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 124.307 3.338 . . . . 0.0 112.428 -173.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -93.86 -5.36 48.19 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.836 177.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -67.88 144.48 97.29 Favored Pre-proline 0 C--O 1.234 0.265 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.041 173.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_exo -70.76 112.72 3.32 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 121.272 1.314 . . . . 0.0 109.898 172.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.611 HD12 ' HE1' ' A' ' 40' ' ' TYR . 5.0 pt -121.36 151.93 24.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.08 -172.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.45 HG21 ' HA ' ' A' ' 84' ' ' GLU . 16.8 p -98.33 -26.78 14.38 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -176.287 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.436 ' O ' HG12 ' A' ' 82' ' ' VAL . . . -173.36 -164.16 28.18 Favored Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 119.575 -1.298 . . . . 0.0 112.582 177.43 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.706 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 6.4 m-85 -138.88 135.4 34.44 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 120.975 0.417 . . . . 0.0 111.041 177.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 4.0 mtm105 -108.95 146.62 33.53 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 169.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.891 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 34.9 mt -138.76 109.58 4.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -174.227 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 75.3 t -109.67 110.54 32.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.297 0.57 . . . . 0.0 110.66 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.662 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 1.1 p90 -114.08 125.76 54.34 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.607 176.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.0 m -137.87 145.29 47.63 Favored Pre-proline 0 C--N 1.313 -1.014 0 CA-C-N 114.077 -1.419 . . . . 0.0 111.164 -173.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.576 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 55.7 Cg_endo -66.42 153.74 76.88 Favored 'Trans proline' 0 N--CA 1.472 0.225 0 C-N-CA 123.443 2.762 . . . . 0.0 111.928 178.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 29.3 t -77.76 -37.65 48.59 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.952 179.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 94.7 t -117.67 -42.37 2.79 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -178.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -171.05 137.21 1.15 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.576 0.227 . . . . 0.0 110.531 -177.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 158.31 -169.12 34.82 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.169 -178.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.427 ' O ' ' HE1' ' A' ' 75' ' ' TYR . 22.9 m -94.74 121.3 36.18 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.633 0.254 . . . . 0.0 111.56 -176.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 7.0 m -97.34 141.89 29.88 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 176.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.662 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 86.4 m -147.02 151.05 36.31 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.332 -178.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.891 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 31.8 tt0 -119.82 122.86 42.29 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.496 175.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.736 HD12 ' CG2' ' A' ' 64' ' ' VAL . 16.9 mt -104.58 157.89 16.86 Favored 'General case' 0 CA--C 1.514 -0.406 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.129 175.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -122.02 114.68 21.29 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 177.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.531 HD12 ' CH2' ' A' ' 30' ' ' TRP . 2.1 mt -111.6 156.8 40.86 Favored Pre-proline 0 C--N 1.317 -0.843 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -175.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -63.24 150.16 89.36 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 121.912 1.742 . . . . 0.0 111.448 176.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.414 ' HB3' ' C ' ' A' ' 38' ' ' THR . 10.3 pt-20 -43.94 -28.74 0.49 Allowed 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 114.59 -1.186 . . . . 0.0 112.98 176.326 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.1 t -106.93 19.28 20.69 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.161 -175.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.486 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -82.15 152.78 26.34 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.181 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.499 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 28.5 p-10 -132.59 5.53 4.01 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -177.028 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.631 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 35.5 p -166.18 134.3 2.9 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 119.905 -0.718 . . . . 0.0 111.869 -175.125 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.757 HG12 ' HZ3' ' A' ' 30' ' ' TRP . 4.7 p -114.53 135.3 54.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.259 175.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 54.3 m -97.4 99.41 10.84 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 121.572 0.701 . . . . 0.0 109.146 169.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.711 ' O ' ' HA ' ' A' ' 25' ' ' SER . 0.7 OUTLIER -73.96 144.54 45.2 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.094 -0.957 . . . . 0.0 108.907 179.05 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.452 ' HA ' ' O ' ' A' ' 24' ' ' THR . 10.6 t -142.35 167.46 22.04 Favored 'General case' 0 C--N 1.318 -0.791 0 O-C-N 123.56 0.537 . . . . 0.0 109.714 -173.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 62.77 27.48 16.1 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 123.881 0.738 . . . . 0.0 111.202 -178.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.685 ' O ' HG22 ' A' ' 24' ' ' THR . 13.6 mt -71.09 -174.92 1.05 Allowed 'General case' 0 C--O 1.225 -0.2 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 173.052 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.498 ' HB2' HG21 ' A' ' 73' ' ' VAL . 67.8 mm-40 -122.99 133.43 24.49 Favored Pre-proline 0 C--N 1.317 -0.846 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 175.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -63.71 126.19 16.98 Favored 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 122.513 2.142 . . . . 0.0 112.125 177.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 82.67 39.42 10.65 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.741 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.498 HG21 ' HB2' ' A' ' 70' ' ' GLN . 72.1 t -136.58 138.13 46.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.039 0.447 . . . . 0.0 110.843 -179.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.576 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -80.93 120.25 24.5 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.719 -179.841 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.526 ' CE2' ' HB3' ' A' ' 69' ' ' LEU . 30.1 m-85 -113.66 117.72 32.34 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.499 0.666 . . . . 0.0 112.44 -178.021 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.463 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 6.9 m120 -85.85 110.74 19.61 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.019 172.274 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.69 HG12 HD11 ' A' ' 66' ' ' LEU . 5.1 mp -92.21 121.89 43.18 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.562 0 CA-C-O 121.064 0.459 . . . . 0.0 109.866 176.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.896 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 48.2 m -111.73 114.57 27.65 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.861 179.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.577 ' HB ' ' HB ' ' A' ' 91' ' ' VAL . 13.5 mm -95.91 130.14 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -117.94 113.07 21.16 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 177.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -88.98 125.46 34.99 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 173.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.436 HG12 ' O ' ' A' ' 39' ' ' GLY . 8.1 p -118.6 133.5 65.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 C-N-CA 120.09 -0.644 . . . . 0.0 112.127 -173.396 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.536 ' HG2' HG22 ' A' ' 37' ' ' ILE . 8.9 mt-10 -100.58 173.6 6.47 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.127 172.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.45 ' HA ' HG21 ' A' ' 38' ' ' THR . 26.0 mt-10 -34.93 -44.55 0.23 Allowed 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -176.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -135.03 2.77 3.12 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -176.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.528 ' NE2' ' HD3' ' A' ' 10' ' ' PRO . 26.3 pt20 -146.45 176.14 10.02 Favored 'General case' 0 C--O 1.218 -0.591 0 CA-C-N 118.939 0.791 . . . . 0.0 111.552 -179.087 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -126.67 154.95 43.38 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.768 -179.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 16.9 m -85.73 -175.27 5.55 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.453 176.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.408 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 1.4 p -62.65 158.69 49.04 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.449 173.219 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -87.33 140.08 5.33 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 122.065 1.843 . . . . 0.0 113.674 -178.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.896 ' O ' ' HA ' ' A' ' 78' ' ' THR . 8.6 t -83.29 125.68 40.09 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.744 0 CA-C-N 114.868 -1.06 . . . . 0.0 108.49 167.216 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 5.9 t -125.03 106.58 16.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 C-N-CA 119.958 -0.697 . . . . 0.0 110.078 171.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.528 HG13 ' HB ' ' A' ' 77' ' ' ILE . 5.9 pt -124.76 116.32 47.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.906 179.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.406 ' HB2' HE22 ' A' ' 74' ' ' GLN . 3.8 pt20 -99.47 129.49 45.65 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.456 0.646 . . . . 0.0 111.332 -175.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.47 ' NE2' HG11 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -140.94 130.84 24.44 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.021 177.177 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.41 ' HA ' ' HA ' ' A' ' 74' ' ' GLN . 39.6 tt0 -92.63 138.12 31.77 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.204 0.526 . . . . 0.0 110.745 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 34.1 p -68.81 124.64 24.24 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.741 -176.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 40.0 m -69.28 -30.05 68.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.503 0.668 . . . . 0.0 110.237 177.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 104.47 -160.42 15.7 Favored Glycine 0 N--CA 1.444 -0.819 0 CA-C-N 115.419 -0.81 . . . . 0.0 112.454 175.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 4.2 m -75.47 130.83 78.71 Favored Pre-proline 0 C--N 1.317 -0.807 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 178.177 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -61.54 121.35 9.46 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 122.096 1.864 . . . . 0.0 111.388 177.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.409 ' N ' ' HD3' ' A' ' 102' ' ' ARG . 0.0 OUTLIER -127.23 -171.3 2.39 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.304 -179.064 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 10.9 t 67.11 26.56 8.84 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.342 0.591 . . . . 0.0 110.151 -179.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -105.57 4.62 30.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.638 177.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 159.38 -149.92 20.04 Favored Glycine 0 N--CA 1.443 -0.843 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.182 -179.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.5 p . . . . . 0 C--O 1.247 0.922 0 CA-C-O 118.376 -0.821 . . . . 0.0 110.667 178.019 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.633 0 N-CA-C 111.88 -0.488 . . . . 0.0 111.88 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 39.2 m -68.62 142.73 55.04 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.481 0.182 . . . . 0.0 110.741 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 25.3 m-70 63.0 40.89 8.82 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.095 -179.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 16.2 tpt -94.53 126.93 40.12 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.596 175.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -87.77 162.16 32.64 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.471 -178.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 14.9 t -80.73 129.43 34.52 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 178.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.8 t -159.06 147.11 17.85 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.374 -176.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 57.2 m -138.4 129.22 26.69 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.064 0.459 . . . . 0.0 110.793 -178.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -111.23 128.55 25.18 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.816 176.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.477 ' HB3' ' OE2' ' A' ' 83' ' ' GLU . 65.9 Cg_endo -73.91 160.31 43.47 Favored 'Trans proline' 0 C--O 1.233 0.272 0 C-N-CA 122.635 2.224 . . . . 0.0 111.693 178.359 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -109.44 145.58 35.94 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.483 ' HB2' ' O ' ' A' ' 89' ' ' THR . . . -79.45 153.88 76.44 Favored Pre-proline 0 C--N 1.319 -0.759 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 175.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -62.23 128.45 23.92 Favored 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.295 1.997 . . . . 0.0 111.787 175.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.496 ' HD2' ' O ' ' A' ' 31' ' ' SER . 86.9 Cg_exo -47.12 140.24 14.37 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.71 2.274 . . . . 0.0 111.349 174.057 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.44 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 5.9 p-10 -33.85 106.96 0.28 Allowed Pre-proline 0 N--CA 1.467 0.396 0 O-C-N 124.929 1.393 . . . . 0.0 112.478 -168.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.564 ' HG2' HG11 ' A' ' 91' ' ' VAL . 39.1 Cg_exo -61.91 152.49 74.64 Favored 'Trans proline' 0 CA--C 1.517 -0.344 0 C-N-CA 123.727 2.951 . . . . 0.0 112.718 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.9 m -107.6 128.27 54.39 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.656 -178.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.468 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 69.5 t -78.46 117.12 23.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-N 114.337 -1.301 . . . . 0.0 109.725 173.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -83.63 -36.89 23.52 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.377 -173.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -135.6 138.38 42.87 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.471 -178.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.495 ' HA ' HG12 ' A' ' 26' ' ' ILE . 6.3 m -129.54 120.33 50.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.205 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.407 ' HB3' ' H ' ' A' ' 23' ' ' ASP . 8.4 m-20 -133.69 -165.33 1.62 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.46 -179.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.571 ' O ' ' HB2' ' A' ' 69' ' ' LEU . 3.3 p-10 -67.77 -65.13 0.73 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.971 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.672 HG22 ' O ' ' A' ' 69' ' ' LEU . 39.7 p -115.33 35.5 4.35 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.876 -172.038 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.689 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 18.6 p -169.79 130.7 1.03 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.787 -174.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.573 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 17.0 mt -146.95 135.97 16.11 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.608 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 177.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.468 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 39.9 t -115.1 129.81 70.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 C-N-CA 120.013 -0.675 . . . . 0.0 110.497 -174.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.663 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.8 OUTLIER -123.76 143.89 35.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.044 -177.544 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.534 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 85.8 mtt180 -128.03 121.63 30.22 Favored 'General case' 0 N--CA 1.465 0.297 0 O-C-N 123.79 0.681 . . . . 0.0 110.314 -177.13 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.674 ' HZ3' HG12 ' A' ' 64' ' ' VAL . 30.2 p90 -111.39 140.5 45.93 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.189 -173.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.496 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 61.8 m -82.51 88.19 6.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.13 175.27 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.437 ' HD3' ' H ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -49.08 156.46 0.96 Allowed Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -175.485 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.658 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 3.4 Cg_exo -80.36 169.26 17.47 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 123.886 3.057 . . . . 0.0 112.846 -174.378 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -86.57 -14.84 41.71 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.139 172.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -57.51 135.25 82.07 Favored Pre-proline 0 CA--C 1.517 -0.309 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.162 173.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -67.33 112.39 2.55 Favored 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 120.937 1.091 . . . . 0.0 109.774 172.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.674 HD12 ' HE1' ' A' ' 40' ' ' TYR . 1.6 pt -118.27 151.43 20.36 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -174.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.466 ' C ' ' HB3' ' A' ' 59' ' ' GLU . 11.0 p -98.56 -30.53 12.45 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -178.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.537 ' C ' HG12 ' A' ' 82' ' ' VAL . . . -162.86 -166.66 22.03 Favored Glycine 0 N--CA 1.438 -1.209 0 C-N-CA 120.153 -1.022 . . . . 0.0 112.044 -177.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.674 ' HE1' HD12 ' A' ' 37' ' ' ILE . 6.3 m-85 -141.54 134.46 28.9 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 122.613 0.365 . . . . 0.0 110.875 174.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.3 mmm180 -102.53 149.41 24.43 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 168.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.879 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 30.7 mt -139.55 108.4 3.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 C-N-CA 120.037 -0.665 . . . . 0.0 112.389 -179.297 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 71.7 t -107.53 110.57 32.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.182 0.515 . . . . 0.0 110.836 179.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.656 ' CZ ' ' HB ' ' A' ' 53' ' ' THR . 1.4 p90 -114.9 127.3 55.62 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.948 176.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.3 p -141.81 137.41 16.11 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 113.718 -1.583 . . . . 0.0 111.754 -175.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.595 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 58.1 Cg_endo -73.88 137.26 24.18 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 123.275 2.65 . . . . 0.0 111.9 176.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 32.5 t -66.7 -22.34 66.07 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.75 -176.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.403 ' O ' ' HB3' ' A' ' 49' ' ' GLU . 16.6 m -108.55 20.45 5.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.702 0.287 . . . . 0.0 111.533 -179.339 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.403 ' HB3' ' O ' ' A' ' 48' ' ' VAL . 45.4 tt0 74.58 144.34 0.08 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.118 178.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 162.36 -128.94 1.96 Allowed Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 -177.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.47 ' O ' ' HD3' ' A' ' 46' ' ' PRO . 27.4 m -90.84 119.64 31.22 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 117.177 0.489 . . . . 0.0 110.77 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.431 ' HA ' ' O ' ' A' ' 44' ' ' TYR . 14.9 m -117.5 141.19 48.65 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 173.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.656 ' HB ' ' CZ ' ' A' ' 44' ' ' TYR . 36.1 m -147.62 149.95 33.49 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 120.111 -0.636 . . . . 0.0 111.563 -179.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.879 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 26.4 tt0 -116.95 112.0 20.39 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.585 174.413 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.709 HD12 ' CG2' ' A' ' 64' ' ' VAL . 23.8 mt -96.09 159.04 15.17 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.072 177.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.455 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 24.7 t-20 -125.2 114.86 19.55 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -179.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.575 HD12 ' CH2' ' A' ' 30' ' ' TRP . 4.4 mt -112.1 157.68 39.1 Favored Pre-proline 0 C--N 1.317 -0.843 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 -176.369 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -68.3 152.54 75.66 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 121.749 1.632 . . . . 0.0 111.06 175.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.466 ' HB3' ' C ' ' A' ' 38' ' ' THR . 11.7 pt-20 -45.62 -27.07 0.71 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.796 -1.093 . . . . 0.0 112.758 176.01 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 11.1 t -101.44 18.74 19.36 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.277 0.561 . . . . 0.0 111.1 -174.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.432 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -93.04 157.92 16.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.394 179.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.534 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 26.6 p-10 -143.05 13.74 1.86 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -178.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.663 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 80.5 p -165.26 134.3 3.4 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 119.876 -0.729 . . . . 0.0 111.936 -177.042 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.709 ' CG2' HD12 ' A' ' 55' ' ' LEU . 3.8 p -117.43 134.81 59.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.346 175.082 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 35.1 m -96.57 101.22 12.8 Favored 'General case' 0 N--CA 1.434 -1.255 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.498 169.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.691 HD11 HG12 ' A' ' 77' ' ' ILE . 0.3 OUTLIER -78.3 144.57 35.98 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.1 178.33 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.405 ' HA ' ' O ' ' A' ' 24' ' ' THR . 13.2 p -138.47 166.58 23.92 Favored 'General case' 0 C--N 1.318 -0.783 0 O-C-N 123.514 0.508 . . . . 0.0 110.826 -173.241 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 64.2 27.1 13.92 Favored 'General case' 0 N--CA 1.463 0.2 0 O-C-N 123.757 0.661 . . . . 0.0 111.679 179.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.672 ' O ' HG22 ' A' ' 24' ' ' THR . 11.1 mt -70.31 -176.16 1.14 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 175.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 57.9 tp60 -127.44 124.05 23.43 Favored Pre-proline 0 C--N 1.32 -0.696 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 177.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -62.62 135.55 53.43 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 123.083 2.522 . . . . 0.0 113.31 -177.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.67 25.21 39.42 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.907 179.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 87.4 t -129.99 148.77 33.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.27 0.557 . . . . 0.0 111.289 -174.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.595 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -87.33 121.5 29.86 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.648 -179.588 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -118.02 116.8 27.63 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.153 0.501 . . . . 0.0 112.24 -174.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.555 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 3.9 m-20 -89.96 113.13 24.72 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.376 176.474 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.691 HG12 HD11 ' A' ' 66' ' ' LEU . 5.1 mp -95.27 118.72 42.1 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.546 0 CA-C-O 121.057 0.455 . . . . 0.0 109.836 174.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.856 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 36.8 m -110.85 115.53 29.68 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.253 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.565 ' HB ' ' HB ' ' A' ' 91' ' ' VAL . 13.8 mm -95.89 145.27 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -179.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.414 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 53.0 m-85 -131.13 111.32 11.87 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 177.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.42 ' HB1' HG21 ' A' ' 37' ' ' ILE . . . -80.71 112.08 17.75 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 172.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.537 HG12 ' C ' ' A' ' 39' ' ' GLY . 7.4 p -106.68 135.54 44.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 C-N-CA 119.718 -0.793 . . . . 0.0 111.019 -174.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.477 ' OE2' ' HB3' ' A' ' 10' ' ' PRO . 4.8 mt-10 -109.05 172.06 7.07 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 177.433 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -44.67 -51.42 9.2 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 123.585 0.553 . . . . 0.0 112.136 178.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 -111.39 -14.19 13.79 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -171.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -135.43 172.81 12.47 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.32 -0.552 . . . . 0.0 111.882 -170.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -128.87 133.61 48.0 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 175.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 13.4 m -78.52 170.84 16.0 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.699 0.285 . . . . 0.0 110.914 -178.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.483 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 0.6 OUTLIER -57.9 158.24 13.24 Favored Pre-proline 0 N--CA 1.449 -0.51 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.767 174.758 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -87.07 138.79 5.04 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 122.067 1.844 . . . . 0.0 113.748 -177.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.856 ' O ' ' HA ' ' A' ' 78' ' ' THR . 5.0 t -82.38 124.26 39.09 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.795 0 CA-C-N 114.707 -1.133 . . . . 0.0 108.397 167.296 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 5.0 t -119.61 106.74 19.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 C-N-CA 119.689 -0.804 . . . . 0.0 109.99 171.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.514 HG13 ' HB ' ' A' ' 77' ' ' ILE . 5.9 pt -126.02 111.7 27.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.788 176.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.09 133.45 43.35 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.158 0.504 . . . . 0.0 110.499 -178.509 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.438 ' NE2' HG11 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -139.26 140.44 37.68 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.094 178.0 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.469 ' HG2' ' HG2' ' A' ' 74' ' ' GLN . 38.3 mt-10 -86.26 146.86 26.34 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.952 0.405 . . . . 0.0 110.427 177.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 40.0 p -82.81 114.86 21.42 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.339 177.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 26.7 m -70.45 -31.43 68.58 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.907 -176.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 104.45 -171.55 19.51 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.469 -0.872 . . . . 0.0 112.535 175.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 86.3 m -79.21 124.34 84.44 Favored Pre-proline 0 C--N 1.32 -0.707 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 178.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -53.55 -38.93 84.1 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 123.025 2.484 . . . . 0.0 111.799 177.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 58.5 ttp180 54.03 67.17 1.05 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.685 174.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 23.1 m -92.26 46.44 1.26 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.308 0.575 . . . . 0.0 110.035 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -83.46 -19.23 36.22 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.718 -177.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -89.48 37.55 3.32 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.62 -176.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 37.3 m . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.313 -0.851 . . . . 0.0 109.566 176.321 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.528 0 N-CA-C 111.918 -0.473 . . . . 0.0 111.918 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.5 m -94.97 -9.45 33.95 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.104 0.478 . . . . 0.0 110.888 -179.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 28.5 m-70 -102.28 45.97 0.94 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.488 -179.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 14.2 tpt -67.39 -39.97 85.64 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.525 -178.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -83.4 82.45 1.67 Allowed Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.051 179.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 43.8 m -137.27 91.83 2.65 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 -179.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.9 m -79.71 87.7 5.22 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.296 0.57 . . . . 0.0 110.879 -178.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 13.3 t -115.6 -6.75 12.21 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.388 0.613 . . . . 0.0 110.351 178.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -78.67 119.15 76.24 Favored Pre-proline 0 C--N 1.315 -0.934 0 CA-C-N 114.783 -1.098 . . . . 0.0 110.862 -179.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.528 ' HG3' ' OE1' ' A' ' 83' ' ' GLU . 98.1 Cg_endo -82.47 175.94 8.41 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 123.113 2.542 . . . . 0.0 112.377 178.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -132.55 161.33 34.1 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.792 179.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -95.23 156.81 37.33 Favored Pre-proline 0 C--N 1.32 -0.71 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.638 176.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.418 ' HB2' ' HB2' ' A' ' 30' ' ' TRP . 23.0 Cg_exo -67.25 127.52 16.81 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.421 2.081 . . . . 0.0 111.999 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.587 ' HD2' ' O ' ' A' ' 31' ' ' SER . 80.0 Cg_exo -46.58 145.54 6.22 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 123.186 2.59 . . . . 0.0 112.174 174.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.426 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 24.2 t70 -35.27 105.37 0.28 Allowed Pre-proline 0 N--CA 1.468 0.44 0 O-C-N 124.884 1.365 . . . . 0.0 112.569 -169.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.651 ' HG2' HG11 ' A' ' 91' ' ' VAL . 23.7 Cg_exo -69.19 149.59 70.68 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 123.58 2.853 . . . . 0.0 112.796 -178.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.5 m -107.47 131.07 54.7 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.735 -177.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.512 HG13 ' O ' ' A' ' 27' ' ' VAL . 72.5 t -73.66 123.72 29.37 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.022 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.062 175.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -83.34 -47.67 11.22 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.845 -174.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -135.48 137.54 42.26 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.11 -178.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.512 HG22 HG11 ' A' ' 18' ' ' VAL . 30.3 t -121.52 115.13 45.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.642 177.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -123.09 -167.55 1.62 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.347 177.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.552 ' O ' ' HB2' ' A' ' 69' ' ' LEU . 1.7 p-10 -70.55 -68.41 0.43 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.145 -0.479 . . . . 0.0 112.043 178.117 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.604 HG22 ' O ' ' A' ' 69' ' ' LEU . 38.1 p -106.72 31.95 4.89 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.699 -172.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.648 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 11.6 p -171.24 132.51 0.81 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.502 -174.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.579 ' HB ' HD12 ' A' ' 66' ' ' LEU . 44.9 mt -145.86 145.0 20.61 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.742 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 177.341 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.512 ' O ' HG13 ' A' ' 18' ' ' VAL . 35.6 t -117.44 137.67 50.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 C-N-CA 120.03 -0.668 . . . . 0.0 109.782 -174.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.64 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.6 OUTLIER -130.68 146.39 34.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 C-N-CA 119.974 -0.69 . . . . 0.0 110.229 178.331 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.481 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 34.9 mtp180 -129.63 120.35 25.09 Favored 'General case' 0 C--N 1.327 -0.402 0 O-C-N 123.623 0.577 . . . . 0.0 110.045 -175.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.753 ' HZ3' HG12 ' A' ' 64' ' ' VAL . 37.1 p90 -113.23 148.93 34.54 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.051 -174.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.587 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 13.6 m -93.7 100.4 12.63 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.936 178.498 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.638 ' NE ' ' HB3' ' A' ' 62' ' ' ASN . 0.1 OUTLIER -53.83 156.26 5.15 Favored Pre-proline 0 CA--C 1.538 0.482 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -174.314 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.65 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 2.4 Cg_endo -83.84 168.51 12.34 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 124.341 3.361 . . . . 0.0 112.474 -174.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -82.49 -16.32 49.22 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.019 172.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -59.62 141.65 88.34 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 114.621 -1.172 . . . . 0.0 111.304 177.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -69.75 112.76 3.16 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 121.035 1.156 . . . . 0.0 109.85 171.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.609 HD12 ' HE1' ' A' ' 40' ' ' TYR . 1.4 pt -121.42 147.33 25.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -176.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 17.4 p -97.39 -20.39 17.84 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -177.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.546 ' C ' HG12 ' A' ' 82' ' ' VAL . . . -173.63 -164.1 28.26 Favored Glycine 0 CA--C 1.501 -0.789 0 C-N-CA 119.877 -1.154 . . . . 0.0 111.957 177.19 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.65 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 6.5 m-85 -139.88 132.84 29.38 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-O 120.849 0.357 . . . . 0.0 111.069 173.644 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 8.7 mmm180 -103.49 149.31 24.97 Favored 'General case' 0 CA--C 1.503 -0.851 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 167.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.885 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 33.8 mt -138.73 108.25 4.11 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 C-N-CA 119.939 -0.705 . . . . 0.0 112.219 -178.512 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 72.0 t -107.94 110.38 31.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.299 0.571 . . . . 0.0 110.396 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.612 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 1.0 OUTLIER -110.64 125.42 53.41 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.328 176.071 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 39.9 p -140.01 135.47 16.43 Favored Pre-proline 0 C--N 1.316 -0.864 0 CA-C-N 113.922 -1.49 . . . . 0.0 111.217 -174.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.543 ' HG2' ' CA ' ' A' ' 50' ' ' GLY . 10.5 Cg_exo -69.71 132.48 23.5 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.815 2.344 . . . . 0.0 111.154 173.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 5.8 p -76.01 -9.22 58.44 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 121.077 -0.249 . . . . 0.0 111.547 -178.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.433 ' O ' ' HB2' ' A' ' 49' ' ' GLU . 15.7 m -117.24 -41.65 2.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 179.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.433 ' HB2' ' O ' ' A' ' 48' ' ' VAL . 45.7 tt0 169.86 138.36 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 122.498 0.319 . . . . 0.0 110.21 -177.3 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.543 ' CA ' ' HG2' ' A' ' 46' ' ' PRO . . . 152.44 -154.22 25.38 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.655 176.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.556 ' O ' ' HE2' ' A' ' 75' ' ' TYR . 39.9 t -93.94 121.61 35.59 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.799 0.333 . . . . 0.0 111.343 -176.325 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.477 ' HA ' ' O ' ' A' ' 44' ' ' TYR . 16.5 m -107.2 135.84 48.04 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 174.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.612 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 58.6 m -147.13 152.34 38.29 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.408 -177.048 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.885 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 33.2 tt0 -116.5 117.5 30.08 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.85 174.129 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.703 HD12 ' CG2' ' A' ' 64' ' ' VAL . 18.3 mt -97.3 158.06 15.65 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 174.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -123.45 111.06 15.88 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.607 -178.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.569 HD12 ' CH2' ' A' ' 30' ' ' TRP . 3.4 mt -109.59 155.55 41.16 Favored Pre-proline 0 N--CA 1.444 -0.771 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -177.152 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -64.35 148.83 90.93 Favored 'Trans proline' 0 N--CA 1.448 -1.172 0 C-N-CA 121.611 1.54 . . . . 0.0 110.635 175.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.467 ' HB2' HG13 ' A' ' 37' ' ' ILE . 8.4 pt-20 -44.04 -27.58 0.39 Allowed 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 114.729 -1.123 . . . . 0.0 113.197 178.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.8 t -103.35 6.99 38.23 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.44 -173.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.421 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -76.41 158.5 31.33 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 178.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.638 ' HB3' ' NE ' ' A' ' 32' ' ' ARG . 29.2 p-10 -141.98 18.29 2.12 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -177.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.64 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 25.5 p -169.76 134.2 1.33 Allowed 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.209 -0.597 . . . . 0.0 111.715 179.288 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.753 HG12 ' HZ3' ' A' ' 30' ' ' TRP . 3.7 p -116.81 137.55 50.31 Favored 'Isoleucine or valine' 0 C--O 1.243 0.728 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.489 176.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 68.3 m -96.92 101.18 12.72 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.579 169.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.678 HD11 HG12 ' A' ' 77' ' ' ILE . 0.2 OUTLIER -80.19 145.38 32.31 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.474 -0.784 . . . . 0.0 108.928 178.647 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 8.8 t -141.06 174.14 10.8 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.27 -174.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 62.78 27.22 15.98 Favored 'General case' 0 C--N 1.329 -0.304 0 O-C-N 123.8 0.688 . . . . 0.0 111.272 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.604 ' O ' HG22 ' A' ' 24' ' ' THR . 10.9 mt -74.65 -176.36 2.77 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.275 -0.421 . . . . 0.0 109.883 177.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 57.3 tp60 -130.35 123.27 20.44 Favored Pre-proline 0 C--N 1.32 -0.709 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -62.0 133.59 45.12 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.961 2.441 . . . . 0.0 113.035 -177.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 87.42 25.24 33.85 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.788 -178.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.505 ' CG1' ' HB3' ' A' ' 46' ' ' PRO . 94.9 t -131.02 142.81 42.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.027 0.441 . . . . 0.0 110.841 -176.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.493 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 10.3 tp60 -86.36 107.45 18.01 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.002 -177.339 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.556 ' HE2' ' O ' ' A' ' 51' ' ' SER . 18.8 m-85 -99.13 119.95 38.69 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.097 0.475 . . . . 0.0 111.69 -177.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.507 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 13.3 m120 -92.72 109.21 20.62 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.418 177.164 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.678 HG12 HD11 ' A' ' 66' ' ' LEU . 5.0 mp -91.76 116.72 33.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.246 0.546 . . . . 0.0 109.642 178.121 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.884 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 81.1 m -108.9 115.81 30.8 Favored 'General case' 0 N--CA 1.427 -1.605 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.441 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.544 ' HB ' ' HB ' ' A' ' 91' ' ' VAL . 13.5 mm -95.12 141.26 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 -179.285 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -128.79 111.79 13.49 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.91 178.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.444 ' HB3' ' OG ' ' A' ' 88' ' ' SER . . . -78.97 119.5 22.22 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 168.212 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.546 HG12 ' C ' ' A' ' 39' ' ' GLY . 7.6 p -106.77 133.87 50.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 C-N-CA 120.092 -0.643 . . . . 0.0 110.049 -178.206 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.528 ' OE1' ' HG3' ' A' ' 10' ' ' PRO . 1.4 mp0 -111.01 170.22 8.24 Favored 'General case' 0 N--CA 1.445 -0.68 0 O-C-N 123.579 0.549 . . . . 0.0 110.068 -178.12 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.441 ' H ' ' HG3' ' A' ' 84' ' ' GLU . 30.7 mt-10 -43.68 -46.99 7.65 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.119 -0.946 . . . . 0.0 112.676 -174.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 -125.12 6.14 7.87 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -174.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -147.81 177.24 9.48 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.854 0.359 . . . . 0.0 111.762 -172.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -133.04 124.41 27.6 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.172 176.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.444 ' OG ' ' HB3' ' A' ' 81' ' ' ALA . 92.9 p -70.81 170.43 12.55 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.908 0.385 . . . . 0.0 111.569 -178.022 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 18.7 p -60.73 153.05 65.37 Favored Pre-proline 0 CA--C 1.531 0.218 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.772 175.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -83.38 144.55 11.59 Favored 'Trans proline' 0 CA--C 1.534 0.499 0 C-N-CA 122.31 2.007 . . . . 0.0 114.712 -175.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.884 ' O ' ' HA ' ' A' ' 78' ' ' THR . 11.7 t -83.49 129.38 37.61 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.581 0 CA-C-N 114.614 -1.176 . . . . 0.0 107.975 163.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.3 t -125.1 106.87 17.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 C-N-CA 120.046 -0.661 . . . . 0.0 110.13 173.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.574 HG13 ' HB ' ' A' ' 77' ' ' ILE . 9.7 pt -125.04 113.14 34.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.259 179.266 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.423 ' HB3' ' ND2' ' A' ' 76' ' ' ASN . 11.1 pt20 -98.72 125.33 44.01 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.558 0.694 . . . . 0.0 111.675 -176.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.98 127.3 35.99 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.389 176.285 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.437 ' HA ' ' HA ' ' A' ' 74' ' ' GLN . 28.8 tt0 -87.17 127.25 35.15 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.34 0.59 . . . . 0.0 109.851 178.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.405 HG22 HD11 ' A' ' 26' ' ' ILE . 22.7 p -59.79 116.88 4.39 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.851 -1.068 . . . . 0.0 111.719 -175.265 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.7 m -69.26 -30.88 69.09 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.281 -178.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 107.88 -169.75 14.75 Favored Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.669 178.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.402 ' HA ' ' HD3' ' A' ' 101' ' ' PRO . 39.8 m -73.47 120.75 82.77 Favored Pre-proline 0 C--N 1.319 -0.751 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 175.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 100' ' ' THR . 48.5 Cg_exo -56.18 92.81 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 123.047 2.498 . . . . 0.0 113.088 -176.283 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 75.2 ttt180 -85.27 -32.57 22.49 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.062 175.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 43.6 t -95.9 146.45 24.57 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.496 176.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -132.25 5.16 4.09 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.429 -179.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -166.2 31.35 0.21 Allowed Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.382 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 97.1 m . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.734 -0.65 . . . . 0.0 110.217 178.514 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.655 0 N-CA-C 111.892 -0.483 . . . . 0.0 111.892 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.4 m -118.41 75.16 1.0 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.067 0.46 . . . . 0.0 110.568 -178.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 23.8 m-70 -136.64 112.61 9.64 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.139 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 95.0 mmm -70.01 104.25 2.5 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 175.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 87.11 61.19 1.6 Allowed Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 -172.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 23.6 m -61.87 124.94 22.15 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.342 -0.429 . . . . 0.0 111.046 -176.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.7 t -84.35 151.03 24.98 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.136 177.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 27.7 m -148.75 118.74 7.16 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.029 0.443 . . . . 0.0 110.205 177.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -148.35 124.32 5.26 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.599 -178.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.491 ' HB3' ' CD ' ' A' ' 83' ' ' GLU . 56.4 Cg_endo -70.47 134.47 26.54 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.229 1.952 . . . . 0.0 112.757 -176.297 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.409 ' O ' ' HB3' ' A' ' 33' ' ' PRO . 7.3 p-10 -84.86 154.46 22.26 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.328 174.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -96.85 162.26 23.65 Favored Pre-proline 0 C--N 1.319 -0.756 0 N-CA-C 109.379 -0.601 . . . . 0.0 109.379 177.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -70.93 127.09 13.22 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 121.811 1.674 . . . . 0.0 111.166 176.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.518 ' HD2' ' O ' ' A' ' 31' ' ' SER . 84.6 Cg_exo -48.16 145.6 10.76 Favored 'Trans proline' 0 CA--C 1.515 -0.443 0 C-N-CA 122.874 2.382 . . . . 0.0 111.401 173.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.429 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 17.3 t70 -35.67 106.37 0.31 Allowed Pre-proline 0 N--CA 1.466 0.335 0 O-C-N 124.939 1.399 . . . . 0.0 111.993 -169.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.589 ' HG2' HG11 ' A' ' 91' ' ' VAL . 27.4 Cg_exo -67.03 146.13 76.05 Favored 'Trans proline' 0 CA--C 1.518 -0.305 0 C-N-CA 123.526 2.818 . . . . 0.0 112.045 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.8 m -105.57 131.46 52.93 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.894 -176.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.407 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 93.4 t -73.12 111.44 7.67 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-N 114.471 -1.24 . . . . 0.0 109.315 173.194 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -78.8 -45.0 21.91 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.277 -171.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -139.31 139.88 37.42 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.437 -178.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.416 HG13 HG12 ' A' ' 26' ' ' ILE . 60.5 t -129.12 132.6 66.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.868 -176.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -132.25 -161.86 1.18 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.765 174.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -71.75 -68.52 0.45 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.087 0.47 . . . . 0.0 112.109 177.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.625 HG22 ' O ' ' A' ' 69' ' ' LEU . 68.6 p -106.99 36.78 2.55 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.216 0.531 . . . . 0.0 111.176 -173.104 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.543 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 19.8 p -172.23 140.75 1.18 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.399 -174.108 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.578 ' HB ' HD12 ' A' ' 66' ' ' LEU . 46.5 mt -149.38 155.91 7.87 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.699 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.32 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 39.7 t -128.17 133.48 66.93 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.572 0 CA-C-N 119.373 0.988 . . . . 0.0 110.206 179.159 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.651 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.7 OUTLIER -125.45 145.16 33.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 C-N-CA 120.197 -0.601 . . . . 0.0 109.924 179.45 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.471 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 20.6 mtp180 -130.24 121.08 25.48 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 123.373 0.421 . . . . 0.0 110.563 -174.403 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.629 ' HZ3' HG12 ' A' ' 64' ' ' VAL . 35.2 p90 -111.98 146.48 37.78 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.734 -175.169 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.518 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 33.0 t -89.99 88.68 7.4 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.333 174.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.579 ' HD3' ' H ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -49.55 155.55 1.33 Allowed Pre-proline 0 CA--C 1.541 0.597 0 CA-C-N 115.151 -0.931 . . . . 0.0 112.77 -174.32 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.717 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 2.8 Cg_exo -75.87 170.0 21.04 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.948 3.099 . . . . 0.0 113.953 -169.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 24.7 tt0 -80.35 -22.65 41.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.705 -1.134 . . . . 0.0 108.523 169.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.8 135.38 78.89 Favored Pre-proline 0 CA--C 1.517 -0.299 0 CA-C-N 114.804 -1.089 . . . . 0.0 111.054 177.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -69.83 113.13 3.29 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 121.099 1.2 . . . . 0.0 109.755 171.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.559 HD12 ' HE1' ' A' ' 40' ' ' TYR . 0.6 OUTLIER -118.44 154.2 20.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -174.409 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.425 ' N ' ' O ' ' A' ' 82' ' ' VAL . 7.3 p -94.4 -33.94 12.96 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -179.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.514 ' C ' HG12 ' A' ' 82' ' ' VAL . . . -162.39 -167.53 22.96 Favored Glycine 0 N--CA 1.438 -1.232 0 C-N-CA 120.036 -1.078 . . . . 0.0 112.419 -177.014 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.717 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 4.6 m-85 -137.9 134.07 34.58 Favored 'General case' 0 C--N 1.319 -0.729 0 O-C-N 123.745 0.321 . . . . 0.0 110.897 174.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.6 mmm180 -104.06 147.71 27.09 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 167.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.887 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 22.7 mt -138.66 108.23 4.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 C-N-CA 119.961 -0.696 . . . . 0.0 111.959 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 72.1 t -111.2 109.41 28.39 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.646 0 CA-C-O 121.364 0.602 . . . . 0.0 110.317 179.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.665 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 0.6 OUTLIER -111.58 125.07 53.54 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.549 177.598 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.428 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 23.1 t -141.98 137.44 15.96 Favored Pre-proline 0 C--N 1.316 -0.881 0 CA-C-N 114.158 -1.383 . . . . 0.0 111.192 -172.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.68 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 15.1 Cg_exo -67.69 153.91 74.75 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 123.276 2.651 . . . . 0.0 111.706 174.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 16.3 m -79.07 -26.13 43.07 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.82 -176.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 94.0 t -117.05 -41.86 2.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -178.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 179.32 146.36 0.19 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.566 0.222 . . . . 0.0 110.634 -178.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.461 ' CA ' ' HG2' ' A' ' 46' ' ' PRO . . . 150.31 -149.32 21.18 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.452 -0.88 . . . . 0.0 112.79 176.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 19.9 m -92.58 121.45 34.03 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.744 0.307 . . . . 0.0 111.163 -176.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.524 ' HA ' ' O ' ' A' ' 44' ' ' TYR . 17.7 m -114.87 136.21 53.35 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 174.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.665 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 89.7 m -147.15 147.47 30.56 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.75 -175.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.887 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 33.4 tt0 -115.39 112.29 22.11 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.892 174.303 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.714 HD12 ' CG2' ' A' ' 64' ' ' VAL . 17.2 mt -98.0 152.99 18.7 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.561 -0.456 . . . . 0.0 109.8 174.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -116.7 118.35 32.31 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 177.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.582 HD12 ' CH2' ' A' ' 30' ' ' TRP . 3.2 mt -115.04 157.17 44.11 Favored Pre-proline 0 N--CA 1.444 -0.766 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -176.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -65.57 150.4 86.62 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 121.826 1.684 . . . . 0.0 110.991 174.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.408 ' HB2' HG13 ' A' ' 37' ' ' ILE . 10.0 pt-20 -47.12 -27.66 1.48 Allowed 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 115.217 -0.902 . . . . 0.0 112.48 177.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.8 t -102.59 15.08 30.3 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.138 -174.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.43 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -83.34 163.58 20.55 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 177.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.471 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 5.2 p-10 -150.08 12.97 0.77 Allowed 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.153 -0.619 . . . . 0.0 112.436 -176.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.651 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 20.1 m -162.89 134.92 5.27 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 117.634 0.197 . . . . 0.0 110.776 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.714 ' CG2' HD12 ' A' ' 55' ' ' LEU . 4.1 p -117.58 138.81 47.05 Favored 'Isoleucine or valine' 0 C--O 1.244 0.802 0 CA-C-O 120.662 0.267 . . . . 0.0 110.508 174.304 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 52.6 m -98.76 101.74 13.25 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-O 121.741 0.782 . . . . 0.0 110.162 171.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.594 HD11 HG12 ' A' ' 77' ' ' ILE . 0.5 OUTLIER -75.66 138.17 41.18 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.067 -0.969 . . . . 0.0 108.896 177.455 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 14.0 p -132.17 159.98 37.4 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 123.193 0.308 . . . . 0.0 111.502 -171.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 64.43 34.26 10.48 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.491 175.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.625 ' O ' HG22 ' A' ' 24' ' ' THR . 14.6 mt -74.34 -175.93 2.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.986 175.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.471 ' HB2' HG21 ' A' ' 73' ' ' VAL . 21.3 mt-30 -124.4 140.3 34.87 Favored Pre-proline 0 C--N 1.317 -0.822 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 172.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.14 125.5 14.19 Favored 'Trans proline' 0 CA--C 1.531 0.353 0 C-N-CA 122.362 2.041 . . . . 0.0 112.601 179.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 88.16 38.24 7.38 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.786 178.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.471 HG21 ' HB2' ' A' ' 70' ' ' GLN . 46.6 t -130.5 144.33 38.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 110.333 -0.247 . . . . 0.0 110.333 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.68 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 43.5 tt0 -88.83 125.42 34.9 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.032 178.195 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.526 ' O ' ' HA ' ' A' ' 94' ' ' GLN . 98.3 m-85 -117.44 121.79 42.01 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.917 0.389 . . . . 0.0 111.236 -179.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.543 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 4.1 m-20 -88.33 106.31 18.15 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 170.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.594 HG12 HD11 ' A' ' 66' ' ' LEU . 5.2 mp -90.1 115.56 29.79 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.768 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 177.26 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.902 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 29.0 m -103.83 113.79 27.57 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 114.779 -1.101 . . . . 0.0 110.222 -177.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.541 ' HB ' ' HB ' ' A' ' 91' ' ' VAL . 12.3 mm -95.34 134.43 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -122.05 111.19 16.72 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.984 179.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.479 ' HB1' HG21 ' A' ' 37' ' ' ILE . . . -82.77 111.85 19.07 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 171.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.514 HG12 ' C ' ' A' ' 39' ' ' GLY . 7.8 p -107.73 133.05 53.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 C-N-CA 119.751 -0.779 . . . . 0.0 110.964 -173.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.543 ' OE1' ' HB2' ' A' ' 86' ' ' GLN . 6.8 mt-10 -107.22 171.11 7.56 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 175.613 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -43.77 -42.21 5.39 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 123.481 0.488 . . . . 0.0 112.14 178.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -123.01 -20.24 5.83 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -173.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.543 ' HB2' ' OE1' ' A' ' 83' ' ' GLU . 16.2 mm100 -123.77 176.33 6.33 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.789 -0.365 . . . . 0.0 111.632 -171.538 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -140.42 126.39 19.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.983 176.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.425 ' OG ' ' HB2' ' A' ' 10' ' ' PRO . 19.7 m -67.04 156.07 37.02 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.206 176.437 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 35.9 p -57.86 146.25 68.11 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.369 177.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -76.36 141.45 22.86 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 122.049 1.833 . . . . 0.0 114.118 -171.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.902 ' O ' ' HA ' ' A' ' 78' ' ' THR . 12.0 t -81.3 130.99 34.92 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.68 0 CA-C-N 114.444 -1.253 . . . . 0.0 108.201 169.392 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 19.0 t -127.52 106.85 15.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 C-N-CA 120.062 -0.655 . . . . 0.0 110.11 172.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.502 ' O ' HG13 ' A' ' 93' ' ' ILE . 43.0 pt -119.95 111.71 33.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.416 -179.44 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.526 ' HA ' ' O ' ' A' ' 75' ' ' TYR . 0.5 OUTLIER -95.59 126.31 40.79 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.297 0.57 . . . . 0.0 111.206 -177.456 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -137.42 131.57 32.18 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.625 179.446 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.483 ' HG2' ' HB2' ' A' ' 74' ' ' GLN . 43.4 mt-10 -92.04 122.02 34.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.695 -0.23 . . . . 0.0 110.842 178.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.425 ' CG2' HD11 ' A' ' 26' ' ' ILE . 1.8 p -56.38 126.11 24.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.189 0.519 . . . . 0.0 112.035 -177.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.0 m -69.36 -30.97 69.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.44 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 100.54 -155.43 19.39 Favored Glycine 0 N--CA 1.443 -0.889 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.429 176.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 25.0 m -103.47 123.9 39.94 Favored Pre-proline 0 C--N 1.32 -0.716 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 178.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -55.94 121.86 10.74 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.51 2.14 . . . . 0.0 111.338 175.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 79.6 mtm180 -85.8 73.73 10.33 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.155 0.503 . . . . 0.0 110.575 -178.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 5.8 p -85.69 -12.41 51.29 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.193 178.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -108.13 150.24 27.46 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.939 178.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -161.5 -54.12 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.142 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.1 p . . . . . 0 C--O 1.248 1.024 0 CA-C-O 119.133 -0.46 . . . . 0.0 110.916 178.975 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.568 0 N-CA-C 112.0 -0.44 . . . . 0.0 112.0 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.3 m -151.27 51.2 0.84 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.015 0.436 . . . . 0.0 110.22 177.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 51.0 t-80 -99.94 72.5 1.7 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.141 -179.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 21.2 ptp -119.23 -21.0 7.74 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.631 179.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -137.74 -56.5 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 177.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.8 p 43.74 65.67 0.97 Allowed 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.846 0.859 . . . . 0.0 113.108 175.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.3 m -74.14 -17.33 60.94 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.156 175.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 25.6 m -67.98 141.05 56.38 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.542 177.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 65.19 72.66 0.46 Allowed Pre-proline 0 N--CA 1.466 0.337 0 O-C-N 123.704 0.627 . . . . 0.0 111.539 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -81.44 153.44 18.16 Favored 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 123.103 2.535 . . . . 0.0 111.45 178.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.489 ' O ' ' HB3' ' A' ' 33' ' ' PRO . 7.3 p-10 -106.03 141.83 36.75 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.295 -0.562 . . . . 0.0 110.507 -177.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.582 ' HB2' ' O ' ' A' ' 89' ' ' THR . . . -72.84 163.43 68.3 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.271 178.399 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -62.91 133.46 41.7 Favored 'Trans proline' 0 C--O 1.235 0.344 0 C-N-CA 122.234 1.956 . . . . 0.0 111.618 175.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -50.82 145.97 22.37 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.424 2.082 . . . . 0.0 110.9 173.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.404 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 13.1 m-20 -36.04 105.96 0.3 Allowed Pre-proline 0 N--CA 1.468 0.447 0 O-C-N 124.759 1.287 . . . . 0.0 112.206 -170.343 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.552 ' HG2' HG11 ' A' ' 91' ' ' VAL . 39.1 Cg_exo -65.23 147.21 87.86 Favored 'Trans proline' 0 CA--C 1.521 -0.173 0 C-N-CA 123.764 2.976 . . . . 0.0 112.517 -179.183 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 26.3 m -102.27 131.11 49.05 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.717 -177.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.469 HG13 ' O ' ' A' ' 27' ' ' VAL . 95.3 t -81.28 121.63 35.04 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 CA-C-N 114.379 -1.282 . . . . 0.0 110.224 177.118 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -88.13 -37.16 16.43 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.417 -174.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -135.62 135.61 40.36 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.343 -177.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.514 ' HA ' HG12 ' A' ' 26' ' ' ILE . 60.8 t -132.86 114.69 22.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.748 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -135.09 -172.22 3.0 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 177.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.542 ' O ' ' HB2' ' A' ' 69' ' ' LEU . 0.6 OUTLIER -57.18 -67.69 0.3 Allowed 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -178.131 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.648 HG22 ' O ' ' A' ' 69' ' ' LEU . 36.1 p -110.52 33.57 4.44 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.482 -172.335 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.616 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 58.4 m -168.04 130.06 1.47 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.544 -175.23 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.578 ' HB ' HD12 ' A' ' 66' ' ' LEU . 29.5 mt -144.48 141.53 23.96 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.733 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 175.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.469 ' O ' HG13 ' A' ' 18' ' ' VAL . 44.8 t -118.89 132.28 69.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.398 -175.16 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.609 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.6 OUTLIER -127.96 146.76 33.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 C-N-CA 119.928 -0.709 . . . . 0.0 110.605 -178.396 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.511 ' HG2' ' HB3' ' A' ' 63' ' ' SER . 93.3 mtt180 -130.65 121.17 25.08 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.479 -176.267 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.724 ' HZ3' HG12 ' A' ' 64' ' ' VAL . 37.7 p90 -112.98 152.97 28.77 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.202 -175.02 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 20.8 t -100.42 101.51 12.48 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.296 -0.411 . . . . 0.0 109.914 178.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.666 ' CD ' ' H ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -50.99 157.68 1.35 Allowed Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 123.99 0.916 . . . . 0.0 113.257 -174.364 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.687 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 2.5 Cg_endo -85.1 166.7 11.05 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 124.561 3.508 . . . . 0.0 113.572 -174.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -75.41 -23.64 57.03 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.845 -1.07 . . . . 0.0 109.369 171.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.39 135.92 76.17 Favored Pre-proline 0 C--O 1.236 0.348 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.292 175.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -68.38 113.9 3.27 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 121.192 1.262 . . . . 0.0 109.336 168.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.596 HG22 ' HG3' ' A' ' 83' ' ' GLU . 0.5 OUTLIER -117.98 152.31 20.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -175.662 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.401 HG21 ' HA ' ' A' ' 84' ' ' GLU . 12.5 p -95.54 -29.06 14.56 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -178.403 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.432 ' C ' HG12 ' A' ' 82' ' ' VAL . . . -168.58 -166.44 27.65 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 119.765 -1.207 . . . . 0.0 112.063 178.125 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.687 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 5.5 m-85 -137.81 131.94 31.9 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-N 117.056 0.428 . . . . 0.0 111.516 176.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 41.9 mtm180 -105.68 148.42 27.42 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 170.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.888 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 32.0 mt -139.6 108.92 3.62 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -176.027 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 78.3 t -109.03 110.58 32.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.24 0.543 . . . . 0.0 110.356 179.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.69 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 1.0 OUTLIER -111.86 124.76 53.04 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.392 177.055 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.3 m -134.95 137.7 27.81 Favored Pre-proline 0 C--N 1.315 -0.932 0 CA-C-N 114.318 -1.31 . . . . 0.0 111.639 -173.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.491 ' HD2' ' OG ' ' A' ' 52' ' ' SER . 73.3 Cg_endo -73.04 134.38 21.31 Favored 'Trans proline' 0 C--O 1.23 0.125 0 C-N-CA 123.379 2.72 . . . . 0.0 111.566 174.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 28.1 t -65.0 -34.98 79.73 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.657 -177.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 16.0 m -115.6 -39.42 2.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -175.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -173.71 146.58 1.29 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 117.885 0.311 . . . . 0.0 110.515 -178.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.456 ' C ' ' HG3' ' A' ' 46' ' ' PRO . . . 139.4 -165.3 25.8 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.235 -179.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 20.3 m -92.79 127.84 38.44 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 111.565 0.209 . . . . 0.0 111.565 -177.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.491 ' OG ' ' HD2' ' A' ' 46' ' ' PRO . 6.7 m -103.22 138.07 40.51 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 170.297 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.69 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 37.7 m -147.25 154.25 40.78 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.683 -0.407 . . . . 0.0 111.578 -176.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.888 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 44.3 tt0 -119.32 117.76 29.42 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.03 176.088 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.7 HD12 ' CG2' ' A' ' 64' ' ' VAL . 17.9 mt -99.67 164.67 11.96 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 173.429 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.508 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 8.0 t30 -135.91 115.83 13.17 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -178.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.561 HD12 ' CH2' ' A' ' 30' ' ' TRP . 5.7 mt -112.87 160.82 29.37 Favored Pre-proline 0 N--CA 1.444 -0.745 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -174.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -64.84 151.01 87.3 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 121.656 1.571 . . . . 0.0 110.841 174.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.446 ' HB2' HG13 ' A' ' 37' ' ' ILE . 10.4 pt-20 -45.49 -29.55 1.17 Allowed 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.095 0.958 . . . . 0.0 112.913 178.386 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 7.1 t -96.58 -0.17 49.11 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.398 -174.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.504 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -69.95 158.88 34.77 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 110.205 -0.295 . . . . 0.0 110.205 -177.51 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.561 ' HB3' ' NE ' ' A' ' 32' ' ' ARG . 3.8 p-10 -143.65 15.14 1.78 Allowed 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -177.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.609 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 36.1 p -168.45 133.63 1.72 Allowed 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.084 -0.646 . . . . 0.0 112.333 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.724 HG12 ' HZ3' ' A' ' 30' ' ' TRP . 4.8 p -118.72 139.47 45.93 Favored 'Isoleucine or valine' 0 C--O 1.243 0.725 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.537 176.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 34.4 m -99.51 103.75 15.52 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.72 170.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.708 HD11 HG12 ' A' ' 77' ' ' ILE . 0.2 OUTLIER -83.38 144.45 29.63 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.465 179.112 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 9.6 t -138.97 170.64 15.61 Favored 'General case' 0 N--CA 1.448 -0.555 0 O-C-N 123.371 0.42 . . . . 0.0 110.296 -174.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 65.24 22.25 12.13 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.052 179.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.648 ' O ' HG22 ' A' ' 24' ' ' THR . 6.5 mt -68.66 -178.45 1.16 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 177.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -124.36 128.06 25.11 Favored Pre-proline 0 C--N 1.32 -0.696 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 176.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -62.16 135.22 53.37 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 123.003 2.468 . . . . 0.0 113.069 -177.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.54 29.34 30.12 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.217 178.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 47.8 t -130.55 147.27 33.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.157 0.503 . . . . 0.0 111.198 -177.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 7.6 tp60 -86.06 109.47 18.85 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.205 178.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.448 ' CE2' HD22 ' A' ' 69' ' ' LEU . 4.2 m-85 -98.97 117.39 33.36 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.144 0.497 . . . . 0.0 111.885 -177.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.446 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 78.4 m-20 -88.06 108.13 19.08 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.025 174.224 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.708 HG12 HD11 ' A' ' 66' ' ' LEU . 5.0 mp -92.12 113.55 27.6 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.692 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 175.11 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.889 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 25.8 m -105.07 113.8 27.61 Favored 'General case' 0 N--CA 1.425 -1.723 0 CA-C-N 114.915 -1.038 . . . . 0.0 109.996 -179.022 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.574 ' H ' ' HB ' ' A' ' 91' ' ' VAL . 15.8 mm -95.05 143.3 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -130.85 111.94 12.56 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.96 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.501 ' HB3' ' OG ' ' A' ' 88' ' ' SER . . . -81.28 125.53 30.45 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 167.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.432 HG12 ' C ' ' A' ' 39' ' ' GLY . 7.5 p -113.36 133.5 59.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 C-N-CA 120.384 -0.526 . . . . 0.0 110.233 -179.095 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.596 ' HG3' HG22 ' A' ' 37' ' ' ILE . 8.2 mp0 -109.07 170.85 7.79 Favored 'General case' 0 N--CA 1.443 -0.819 0 O-C-N 123.912 0.757 . . . . 0.0 108.988 -178.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.401 ' HA ' HG21 ' A' ' 38' ' ' THR . 46.8 mt-10 -42.57 -45.24 4.48 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -172.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -131.16 0.9 4.19 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.029 -0.668 . . . . 0.0 112.624 -177.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.491 ' HG3' ' OE1' ' A' ' 83' ' ' GLU . 29.1 pt20 -136.07 176.04 9.05 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.961 -0.296 . . . . 0.0 110.772 -176.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -130.85 135.12 47.42 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.295 -0.412 . . . . 0.0 109.903 175.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.501 ' OG ' ' HB3' ' A' ' 81' ' ' ALA . 78.5 p -70.64 -178.36 1.8 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.955 0.407 . . . . 0.0 111.1 177.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.582 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 1.4 p -65.9 162.72 42.73 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.746 176.326 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -88.62 137.36 3.43 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 122.129 1.886 . . . . 0.0 113.753 179.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.889 ' O ' ' HA ' ' A' ' 78' ' ' THR . 6.4 t -82.53 126.07 39.97 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.72 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 166.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 10.5 t -124.14 106.77 17.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 C-N-CA 119.964 -0.694 . . . . 0.0 109.79 172.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.575 HG13 ' HB ' ' A' ' 77' ' ' ILE . 9.7 pt -122.98 111.88 31.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.354 178.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.426 ' HB3' ' OD1' ' A' ' 76' ' ' ASN . 3.6 pt20 -98.0 119.82 37.31 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.555 0.693 . . . . 0.0 111.591 -175.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.99 131.51 47.44 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.715 178.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -85.19 134.51 34.16 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.274 178.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.407 HG22 HD11 ' A' ' 26' ' ' ILE . 34.1 p -70.99 114.63 9.24 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.587 179.465 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 18.9 m -68.72 -30.77 69.49 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.443 0.64 . . . . 0.0 110.04 -177.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.449 ' HA2' ' HB3' ' A' ' 23' ' ' ASP . . . 94.68 -120.96 6.58 Favored Glycine 0 N--CA 1.441 -1.016 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.421 174.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 24.1 m -125.37 124.41 25.15 Favored Pre-proline 0 C--N 1.318 -0.789 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.2 92.06 0.06 OUTLIER 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 123.092 2.528 . . . . 0.0 112.73 179.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 66.0 ttt180 66.64 -80.43 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.797 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 18.6 m -132.07 -48.02 0.93 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.751 0.31 . . . . 0.0 111.016 -176.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -92.11 163.96 13.76 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.693 179.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 109.73 47.51 0.84 Allowed Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.675 -0.774 . . . . 0.0 111.196 -177.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.9 t . . . . . 0 C--O 1.252 1.197 0 CA-C-O 119.276 -0.392 . . . . 0.0 109.944 -179.721 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.821 0 N-CA-C 112.068 -0.413 . . . . 0.0 112.068 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 44.2 m -82.84 126.17 32.14 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.95 0.405 . . . . 0.0 110.616 179.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 38.5 t-80 -116.47 -53.95 2.49 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.238 179.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 50.1 ttm -162.13 126.24 3.19 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.473 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 166.97 -115.63 0.64 Allowed Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.079 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 7.5 p -78.45 -19.21 53.63 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.082 0.468 . . . . 0.0 110.935 178.134 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.5 p -99.67 117.49 34.14 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.048 178.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 28.1 m -73.32 143.77 46.81 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 175.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -85.03 112.86 46.41 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-O 120.692 0.282 . . . . 0.0 110.393 179.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.07 172.22 16.79 Favored 'Trans proline' 0 C--O 1.235 0.343 0 C-N-CA 122.886 2.391 . . . . 0.0 111.59 -179.038 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -120.02 158.6 26.46 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.838 0.352 . . . . 0.0 110.366 -179.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.403 ' HB2' ' O ' ' A' ' 89' ' ' THR . . . -95.83 160.75 29.5 Favored Pre-proline 0 C--N 1.318 -0.784 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.348 175.079 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -63.89 130.24 27.04 Favored 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.119 1.879 . . . . 0.0 111.578 178.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.579 ' HD2' ' O ' ' A' ' 31' ' ' SER . 83.5 Cg_exo -47.74 149.74 4.86 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.827 2.351 . . . . 0.0 111.212 171.241 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.421 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 8.1 p-10 -39.62 107.16 0.43 Allowed Pre-proline 0 N--CA 1.468 0.467 0 O-C-N 124.382 1.051 . . . . 0.0 112.336 -169.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.602 ' HG2' HG11 ' A' ' 91' ' ' VAL . 31.4 Cg_exo -65.22 148.17 88.6 Favored 'Trans proline' 0 CA--C 1.516 -0.42 0 C-N-CA 123.381 2.721 . . . . 0.0 112.134 179.071 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 24.9 m -107.41 132.01 53.64 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.655 -178.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.429 HG13 ' O ' ' A' ' 27' ' ' VAL . 77.9 t -79.35 123.26 36.04 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 CA-C-N 114.194 -1.366 . . . . 0.0 110.359 176.323 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.423 ' OD2' ' HG3' ' A' ' 20' ' ' GLN . 26.3 t70 -88.72 -35.83 16.51 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.252 -176.281 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.423 ' HG3' ' OD2' ' A' ' 19' ' ' ASP . 75.8 mt-30 -135.99 134.1 38.22 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.688 -176.303 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.504 ' HA ' HG12 ' A' ' 26' ' ' ILE . 78.7 t -129.97 113.68 27.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.444 178.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -127.2 -166.76 1.64 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.057 178.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.6 -68.33 0.37 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.197 0.522 . . . . 0.0 112.161 178.287 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.633 HG22 ' O ' ' A' ' 69' ' ' LEU . 69.6 p -109.56 36.85 2.81 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.51 -174.047 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.517 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 72.0 p -170.59 134.88 1.12 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.94 -176.391 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.628 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 42.4 mt -148.78 141.44 18.21 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.837 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 177.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.429 ' O ' HG13 ' A' ' 18' ' ' VAL . 47.3 t -118.21 132.24 68.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 118.897 0.771 . . . . 0.0 110.214 -176.275 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.622 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.7 OUTLIER -125.31 146.15 31.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 C-N-CA 119.917 -0.713 . . . . 0.0 110.411 -178.254 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.501 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 83.3 mtt180 -131.15 121.9 25.69 Favored 'General case' 0 C--N 1.329 -0.288 0 O-C-N 123.376 0.423 . . . . 0.0 110.778 -175.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.718 ' HZ3' HG12 ' A' ' 64' ' ' VAL . 30.8 p90 -112.27 141.08 46.42 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.63 -0.713 . . . . 0.0 112.12 -172.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.579 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 62.6 m -80.28 86.11 5.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.848 172.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.586 ' HD3' ' H ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -47.59 151.5 1.45 Allowed Pre-proline 0 CA--C 1.538 0.509 0 CA-C-N 115.144 -0.935 . . . . 0.0 112.243 -177.551 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.688 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 3.3 Cg_exo -79.91 162.95 23.53 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.71 2.94 . . . . 0.0 112.714 -172.155 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -82.68 -13.0 57.19 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.218 172.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.408 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . . . -58.82 145.83 77.48 Favored Pre-proline 0 CA--C 1.52 -0.204 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.043 175.398 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 35' ' ' ALA . 12.4 Cg_exo -69.56 114.42 3.67 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 121.458 1.439 . . . . 0.0 110.304 172.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.67 HD12 ' HE1' ' A' ' 40' ' ' TYR . 3.0 pt -127.73 147.95 32.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 109.381 -0.599 . . . . 0.0 109.381 -177.52 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.512 ' C ' ' HB3' ' A' ' 59' ' ' GLU . 16.3 p -96.92 -29.02 13.93 Favored 'General case' 0 N--CA 1.462 0.173 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -178.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.521 ' C ' HG12 ' A' ' 82' ' ' VAL . . . -165.3 -167.44 25.9 Favored Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 119.937 -1.125 . . . . 0.0 112.175 -178.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.688 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 5.3 m-85 -138.36 134.3 34.02 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 122.444 0.298 . . . . 0.0 111.341 174.225 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.6 mmm180 -103.91 149.76 24.81 Favored 'General case' 0 CA--C 1.504 -0.794 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 166.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.886 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 30.6 mt -139.09 108.58 3.89 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 C-N-CA 120.086 -0.646 . . . . 0.0 112.254 -179.339 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 78.8 t -109.44 110.33 31.69 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.432 0 CA-C-O 121.19 0.519 . . . . 0.0 110.797 -179.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.745 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 1.0 OUTLIER -113.57 126.34 55.18 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.783 176.647 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.9 m -137.4 141.88 35.43 Favored Pre-proline 0 C--N 1.319 -0.756 0 CA-C-N 114.203 -1.362 . . . . 0.0 111.98 -173.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.447 ' HD3' ' O ' ' A' ' 51' ' ' SER . 72.6 Cg_endo -76.78 133.48 14.03 Favored 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 123.581 2.854 . . . . 0.0 112.092 175.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 34.1 t -64.73 -27.37 68.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.455 -177.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.407 ' O ' ' HB2' ' A' ' 49' ' ' GLU . 18.9 m -100.67 17.92 3.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.778 0.323 . . . . 0.0 111.603 -179.502 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.407 ' HB2' ' O ' ' A' ' 48' ' ' VAL . 47.1 mm-40 73.91 157.95 0.2 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.241 -179.445 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 144.49 -135.26 6.06 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 121.025 -0.607 . . . . 0.0 111.779 -177.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.447 ' O ' ' HD3' ' A' ' 46' ' ' PRO . 16.2 m -83.3 119.31 24.43 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.753 0.276 . . . . 0.0 111.091 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 49.8 m -118.44 146.44 44.46 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 173.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.745 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 26.1 m -146.56 148.08 31.79 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 119.834 -0.746 . . . . 0.0 111.763 -178.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.886 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 30.8 tt0 -120.19 113.74 20.88 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.921 175.201 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.715 HD12 ' CG2' ' A' ' 64' ' ' VAL . 19.9 mt -97.29 158.22 15.57 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.321 177.155 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -119.24 116.65 26.72 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 177.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.572 HD12 ' CH2' ' A' ' 30' ' ' TRP . 2.3 mt -114.11 156.23 44.41 Favored Pre-proline 0 C--N 1.317 -0.818 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -177.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -62.25 150.08 88.29 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 121.798 1.665 . . . . 0.0 111.644 176.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.512 ' HB3' ' C ' ' A' ' 38' ' ' THR . 9.4 pt-20 -45.49 -26.63 0.6 Allowed 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 114.573 -1.194 . . . . 0.0 113.102 176.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.2 t -109.32 16.02 22.68 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.333 0.587 . . . . 0.0 110.951 -175.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.509 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -75.59 162.91 27.87 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 177.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.501 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 30.4 p-10 -142.89 4.8 1.5 Allowed 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -176.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.622 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 59.4 p -167.31 133.96 2.26 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 119.861 -0.736 . . . . 0.0 111.928 -176.426 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.718 HG12 ' HZ3' ' A' ' 30' ' ' TRP . 3.5 p -115.54 137.68 48.36 Favored 'Isoleucine or valine' 0 C--O 1.243 0.761 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.47 176.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 24.2 m -93.74 101.46 13.58 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.547 168.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.701 HD11 HG12 ' A' ' 77' ' ' ILE . 0.2 OUTLIER -78.46 144.07 36.11 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 173.542 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.461 ' HA ' ' O ' ' A' ' 24' ' ' THR . 4.3 m -152.79 167.7 28.17 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -177.375 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 68.87 26.22 5.95 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 123.912 0.758 . . . . 0.0 110.394 -174.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.633 ' O ' HG22 ' A' ' 24' ' ' THR . 8.9 mt -72.97 -175.82 1.88 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.792 175.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -123.95 129.2 24.86 Favored Pre-proline 0 C--N 1.322 -0.611 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 174.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -62.54 133.96 45.33 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 123.204 2.603 . . . . 0.0 113.336 -177.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.54 34.88 24.27 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.897 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.414 HG11 ' HB3' ' A' ' 46' ' ' PRO . 58.7 t -134.94 138.95 48.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 120.999 0.428 . . . . 0.0 111.363 -176.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.421 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 18.3 tp60 -75.07 108.88 8.09 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.971 177.466 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -101.63 113.57 26.83 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.311 0.577 . . . . 0.0 111.592 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.581 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 3.7 m-20 -86.91 110.12 19.79 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.437 175.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.701 HG12 HD11 ' A' ' 66' ' ' LEU . 5.3 mp -92.33 118.5 38.01 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.664 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.695 176.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.885 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 28.4 m -109.47 115.63 30.3 Favored 'General case' 0 N--CA 1.426 -1.675 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.397 179.55 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.577 ' HB ' ' HB ' ' A' ' 91' ' ' VAL . 13.3 mm -95.47 137.21 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 -179.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.449 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 74.2 m-85 -124.84 111.35 15.39 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 116.581 -0.282 . . . . 0.0 110.281 179.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.416 ' HB1' HG21 ' A' ' 37' ' ' ILE . . . -80.26 116.89 20.59 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 169.394 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.521 HG12 ' C ' ' A' ' 39' ' ' GLY . 7.7 p -109.12 133.34 54.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 C-N-CA 120.075 -0.65 . . . . 0.0 110.448 -176.457 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -112.98 170.15 8.41 Favored 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 123.258 0.349 . . . . 0.0 110.202 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -46.17 -40.66 11.49 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -175.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 24.2 p-10 -111.46 -21.03 12.0 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -171.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -142.6 175.97 9.39 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.372 -0.531 . . . . 0.0 111.653 -172.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -118.41 120.25 37.01 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.291 -0.868 . . . . 0.0 108.675 173.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 50.8 m -68.9 175.35 3.71 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.161 0.505 . . . . 0.0 112.067 -176.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.403 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 1.0 OUTLIER -60.16 152.33 62.74 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.17 179.352 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -88.63 142.78 5.05 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 C-N-CA 122.261 1.974 . . . . 0.0 114.084 -177.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.885 ' O ' ' HA ' ' A' ' 78' ' ' THR . 6.9 t -82.57 128.11 39.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 114.366 -1.288 . . . . 0.0 108.001 165.404 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.7 t -123.49 105.68 16.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 C-N-CA 119.746 -0.782 . . . . 0.0 110.004 172.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.556 HG13 ' HB ' ' A' ' 77' ' ' ILE . 6.5 pt -122.85 111.79 31.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.935 177.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -95.92 117.51 30.75 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.533 0.683 . . . . 0.0 110.851 -177.144 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.58 127.51 46.47 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.155 176.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -87.15 135.05 33.44 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.147 0.499 . . . . 0.0 110.369 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 34.5 p -69.55 119.59 14.02 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.683 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 10.2 m -69.06 -31.4 70.14 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.437 0.637 . . . . 0.0 110.178 -179.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 108.15 -165.14 12.78 Favored Glycine 0 N--CA 1.442 -0.935 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.279 176.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 56.5 m -82.51 126.06 74.64 Favored Pre-proline 0 C--N 1.32 -0.714 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 178.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -61.52 87.65 0.1 OUTLIER 'Trans proline' 0 C--O 1.233 0.255 0 C-N-CA 122.721 2.281 . . . . 0.0 111.48 175.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 -130.57 17.29 5.33 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.319 -176.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 48.1 t -127.26 95.55 4.31 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.265 -178.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -82.63 146.18 29.26 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.077 178.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.28 -36.79 3.55 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.091 -178.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.5 t . . . . . 0 C--O 1.249 1.038 0 CA-C-O 119.342 -0.361 . . . . 0.0 110.148 -179.945 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.557 0 N-CA-C 111.982 -0.447 . . . . 0.0 111.982 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.6 m -68.09 -28.68 67.56 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 122.852 -0.205 . . . . 0.0 111.368 -179.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 58.9 m-70 54.73 38.63 30.43 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.48 0.657 . . . . 0.0 110.338 -176.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 24.2 ptt? -83.45 -12.82 55.92 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.064 -178.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -163.05 167.51 37.43 Favored Glycine 0 N--CA 1.442 -0.943 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.231 177.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 19.0 m -152.96 80.61 1.21 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.081 0.467 . . . . 0.0 109.752 177.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.0 m -73.25 -37.79 66.22 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.318 -178.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 51.1 m -100.68 121.17 41.19 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.292 178.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -142.96 99.86 5.48 Favored Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.179 -178.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.481 ' HB2' ' OG ' ' A' ' 88' ' ' SER . 66.6 Cg_endo -76.3 144.65 26.35 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.662 2.241 . . . . 0.0 112.121 -179.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -104.74 150.12 25.02 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.755 0.312 . . . . 0.0 110.591 -178.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.698 ' HB2' ' O ' ' A' ' 89' ' ' THR . . . -72.43 153.45 91.95 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.238 175.254 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.426 ' HB3' ' O ' ' A' ' 31' ' ' SER . 46.2 Cg_exo -58.49 135.68 69.25 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.381 2.054 . . . . 0.0 111.142 173.462 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.564 ' HD2' ' O ' ' A' ' 31' ' ' SER . 7.9 Cg_endo -53.39 147.09 38.48 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.072 1.848 . . . . 0.0 110.809 174.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -30.51 106.39 0.23 Allowed Pre-proline 0 N--CA 1.472 0.674 0 O-C-N 124.854 1.346 . . . . 0.0 113.267 -168.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.654 ' HG2' HG11 ' A' ' 91' ' ' VAL . 23.2 Cg_exo -70.25 147.22 59.27 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 123.192 2.595 . . . . 0.0 111.876 176.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 18.5 m -109.88 132.86 53.77 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.803 0.811 . . . . 0.0 110.953 -176.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.513 HG21 ' OE1' ' A' ' 95' ' ' GLN . 95.0 t -79.67 125.58 38.82 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-N 114.2 -1.363 . . . . 0.0 110.056 176.269 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -83.63 -52.51 6.39 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.067 -174.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -136.43 132.11 35.02 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.88 0.372 . . . . 0.0 110.505 -178.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.502 ' HA ' HG12 ' A' ' 26' ' ' ILE . 95.1 t -114.15 122.24 67.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.867 -178.365 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -124.14 -160.34 0.92 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.602 179.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.525 ' O ' ' HB2' ' A' ' 69' ' ' LEU . 1.8 p-10 -73.35 -77.03 0.11 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.129 178.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.652 HG22 ' O ' ' A' ' 69' ' ' LEU . 62.8 p -105.16 34.79 3.06 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.955 -174.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.675 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 75.3 m -168.12 131.01 1.53 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.042 -172.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.579 ' HB ' HD12 ' A' ' 66' ' ' LEU . 28.7 mt -149.2 148.28 15.84 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.89 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 177.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.447 ' O ' HG13 ' A' ' 18' ' ' VAL . 44.2 t -121.58 130.31 74.73 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.59 0 CA-C-N 119.367 0.985 . . . . 0.0 110.888 -176.329 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.622 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.6 OUTLIER -123.9 146.21 29.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 C-N-CA 120.3 -0.56 . . . . 0.0 109.965 -179.629 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.438 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 21.6 mtp180 -129.32 121.0 26.59 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 123.295 0.372 . . . . 0.0 110.602 -174.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.815 ' HZ3' HG12 ' A' ' 64' ' ' VAL . 40.5 p90 -115.05 146.4 41.32 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.641 -174.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.564 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 24.0 t -93.89 97.88 10.68 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.635 177.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.597 ' CD ' ' H ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -46.8 155.67 0.59 Allowed Pre-proline 0 CA--C 1.539 0.533 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -175.445 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.696 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 2.8 Cg_endo -84.5 166.08 12.2 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 124.628 3.552 . . . . 0.0 112.634 -174.299 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -76.54 -22.11 54.81 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.257 -0.883 . . . . 0.0 108.957 170.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -55.22 133.23 69.21 Favored Pre-proline 0 CA--C 1.517 -0.297 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.663 176.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -61.8 116.32 3.37 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 121.554 1.503 . . . . 0.0 110.148 168.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.572 HD12 ' HE1' ' A' ' 40' ' ' TYR . 1.0 OUTLIER -126.76 148.49 31.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -177.544 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.42 ' H ' ' HA ' ' A' ' 83' ' ' GLU . 19.0 p -98.07 -28.81 13.59 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -178.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.52 ' C ' HG12 ' A' ' 82' ' ' VAL . . . -162.83 -166.85 22.32 Favored Glycine 0 N--CA 1.443 -0.892 0 C-N-CA 120.347 -0.93 . . . . 0.0 111.766 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.696 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 5.9 m-85 -139.06 132.57 30.32 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 120.718 0.294 . . . . 0.0 110.932 173.183 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 10.4 mmm180 -102.51 149.91 23.91 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 167.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.878 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 34.0 mt -138.49 107.54 3.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 C-N-CA 120.022 -0.671 . . . . 0.0 111.925 -179.225 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.441 HG22 ' HB2' ' A' ' 54' ' ' GLU . 89.4 t -109.1 110.34 31.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.387 0.613 . . . . 0.0 110.551 -178.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.608 ' CE2' ' HB3' ' A' ' 66' ' ' LEU . 1.2 p90 -113.15 126.02 54.99 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.884 177.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 7.4 m -141.06 138.76 18.26 Favored Pre-proline 0 C--N 1.317 -0.827 0 CA-C-N 113.773 -1.558 . . . . 0.0 110.868 -175.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.477 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 59.5 Cg_endo -71.99 143.95 41.76 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 123.337 2.691 . . . . 0.0 111.749 175.208 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 33.3 m -71.94 -31.79 66.67 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.265 -176.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.498 ' O ' ' HB2' ' A' ' 49' ' ' GLU . 27.7 m -100.69 -40.59 8.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -174.668 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.498 ' HB2' ' O ' ' A' ' 48' ' ' VAL . 39.4 tt0 168.75 148.4 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -178.25 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 142.64 -174.32 23.54 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.206 178.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.444 ' HB2' ' O ' ' A' ' 68' ' ' ASP . 51.0 m -73.46 133.36 43.66 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.844 0.354 . . . . 0.0 111.741 -176.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.0 m -116.53 145.73 43.12 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 174.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.551 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 85.7 m -148.11 147.74 29.85 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.086 -0.645 . . . . 0.0 112.123 -178.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.878 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 30.3 tt0 -112.41 118.29 34.77 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.134 171.286 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.708 HD12 ' CG2' ' A' ' 64' ' ' VAL . 16.5 mt -97.42 160.54 14.26 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 173.209 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -124.77 113.95 18.62 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.728 -179.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.594 HD12 ' CH2' ' A' ' 30' ' ' TRP . 3.2 mt -112.96 157.99 39.07 Favored Pre-proline 0 C--N 1.317 -0.835 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -177.095 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -65.79 150.13 86.24 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 121.76 1.64 . . . . 0.0 111.413 174.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -44.44 -28.72 0.59 Allowed 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 114.887 -1.051 . . . . 0.0 112.859 176.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.8 t -105.29 14.44 28.92 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.251 0.548 . . . . 0.0 111.408 -174.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.437 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -80.02 158.79 26.43 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 176.207 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.531 ' HB3' ' NE ' ' A' ' 32' ' ' ARG . 31.0 p-10 -142.05 17.28 2.1 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 120.619 -0.432 . . . . 0.0 111.96 -177.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.622 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 19.2 p -171.35 134.01 0.86 Allowed 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.268 -0.573 . . . . 0.0 111.847 -179.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.815 HG12 ' HZ3' ' A' ' 30' ' ' TRP . 3.5 p -117.11 136.3 54.71 Favored 'Isoleucine or valine' 0 C--O 1.242 0.7 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.414 176.367 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 20.8 m -95.13 101.36 13.1 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.386 167.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.675 ' O ' ' HA ' ' A' ' 25' ' ' SER . 0.3 OUTLIER -78.14 144.55 36.33 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.9 -1.045 . . . . 0.0 109.555 178.646 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.461 ' O ' ' HB2' ' A' ' 68' ' ' ASP . 14.2 t -140.39 170.17 16.31 Favored 'General case' 0 C--N 1.319 -0.745 0 O-C-N 123.76 0.663 . . . . 0.0 109.271 -176.482 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.461 ' HB2' ' O ' ' A' ' 67' ' ' SER . 3.2 m-20 71.89 20.0 4.6 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 123.803 0.69 . . . . 0.0 112.021 -179.28 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.652 ' O ' HG22 ' A' ' 24' ' ' THR . 6.8 mt -72.79 -177.81 2.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.125 0.488 . . . . 0.0 110.412 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 7.8 tp60 -125.38 122.72 25.07 Favored Pre-proline 0 C--N 1.321 -0.663 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 175.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.61 126.09 15.5 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.698 2.265 . . . . 0.0 112.833 -178.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 95.98 28.78 9.04 Favored Glycine 0 N--CA 1.45 -0.414 0 CA-C-N 115.949 -0.568 . . . . 0.0 112.181 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 36.9 t -134.64 152.17 32.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.048 0.451 . . . . 0.0 110.961 -177.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.477 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 11.6 tp60 -87.84 107.99 18.94 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.663 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.469 ' O ' ' HA ' ' A' ' 94' ' ' GLN . 7.1 m-85 -100.79 130.44 46.81 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.145 0.498 . . . . 0.0 111.876 -179.263 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.52 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 10.8 m120 -103.88 113.48 27.04 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.596 -1.184 . . . . 0.0 109.202 175.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.61 HG12 HD11 ' A' ' 66' ' ' LEU . 3.8 mp -95.07 120.27 44.26 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.814 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 176.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.937 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 25.6 m -109.03 113.46 26.34 Favored 'General case' 0 N--CA 1.424 -1.763 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.225 -179.12 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.54 ' HB ' ' HB ' ' A' ' 91' ' ' VAL . 12.9 mm -94.64 132.38 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -120.32 111.35 17.65 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.044 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.484 ' HB1' HG21 ' A' ' 37' ' ' ILE . . . -81.82 109.58 16.33 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 172.117 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.52 HG12 ' C ' ' A' ' 39' ' ' GLY . 7.2 p -104.66 143.09 16.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 C-N-CA 120.268 -0.573 . . . . 0.0 111.418 -172.069 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.557 ' HG2' ' N ' ' A' ' 84' ' ' GLU . 55.2 tt0 -121.11 168.17 11.85 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 170.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.557 ' N ' ' HG2' ' A' ' 83' ' ' GLU . 27.7 mt-10 -33.27 -50.97 0.32 Allowed 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -176.561 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 28.4 p-10 -111.96 -24.35 10.0 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -171.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -137.38 173.1 12.04 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.558 -170.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -121.36 152.05 39.43 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.968 178.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.481 ' OG ' ' HB2' ' A' ' 10' ' ' PRO . 9.8 m -80.51 179.61 7.65 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.62 175.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.698 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 0.6 OUTLIER -60.02 159.41 20.91 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 173.081 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -88.16 138.7 4.16 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 121.921 1.747 . . . . 0.0 113.365 179.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.937 ' O ' ' HA ' ' A' ' 78' ' ' THR . 13.3 t -83.18 123.38 38.61 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.671 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 165.222 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.0 t -121.09 106.48 18.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 C-N-CA 119.856 -0.738 . . . . 0.0 109.981 172.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.449 HG13 ' HB ' ' A' ' 77' ' ' ILE . 29.9 pt -121.63 117.63 53.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.976 179.033 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.469 ' HA ' ' O ' ' A' ' 75' ' ' TYR . 12.2 pt20 -108.1 128.67 54.89 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.159 0.504 . . . . 0.0 111.618 -175.422 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.545 ' OE1' HG21 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -136.74 153.03 50.97 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.772 171.927 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -97.31 126.14 42.35 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -179.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.436 HG22 HD11 ' A' ' 26' ' ' ILE . 20.1 p -61.12 112.73 2.22 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.417 0.627 . . . . 0.0 111.26 -176.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 11.0 m -70.04 -30.79 68.16 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.864 -176.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 107.64 -168.26 13.93 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.093 177.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 18.3 m -81.19 128.78 69.42 Favored Pre-proline 0 C--N 1.321 -0.665 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 177.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -58.66 92.12 0.07 OUTLIER 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.672 2.248 . . . . 0.0 111.988 176.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 15.1 ptp180 -129.41 19.7 5.76 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.366 -178.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 44.9 m -69.68 -19.48 63.58 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.909 -177.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -109.64 13.6 23.76 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.71 0.767 . . . . 0.0 109.837 178.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -125.42 108.46 1.07 Allowed Glycine 0 N--CA 1.45 -0.369 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.055 -179.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 20.3 m . . . . . 0 C--O 1.251 1.143 0 CA-C-O 118.741 -0.647 . . . . 0.0 110.617 -178.285 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.571 0 N-CA-C 111.835 -0.506 . . . . 0.0 111.835 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.0 p -71.11 -57.48 4.48 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.842 0.353 . . . . 0.0 110.686 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 38.8 m-70 -91.48 124.27 35.52 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.405 -178.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 19.8 ptm -123.2 67.64 0.99 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.987 -176.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -73.75 -77.43 0.63 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.801 -0.714 . . . . 0.0 111.71 178.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.2 p -80.31 59.68 3.5 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.191 0.519 . . . . 0.0 110.577 176.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.5 t -73.47 -20.51 60.68 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.215 -177.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 22.7 m -110.8 125.25 53.37 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.124 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -103.63 119.5 54.53 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.199 179.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -78.17 144.53 21.0 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 122.428 2.085 . . . . 0.0 112.065 -179.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -93.39 164.86 13.04 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.986 179.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.496 ' HB2' ' O ' ' A' ' 89' ' ' THR . . . -97.03 159.84 30.45 Favored Pre-proline 0 C--N 1.32 -0.714 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.132 177.039 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.41 ' HB2' ' HB2' ' A' ' 30' ' ' TRP . 19.9 Cg_exo -67.64 131.43 24.4 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.338 2.026 . . . . 0.0 111.415 175.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.429 ' HD2' ' O ' ' A' ' 31' ' ' SER . 74.6 Cg_exo -50.2 151.78 8.88 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.751 2.301 . . . . 0.0 111.214 172.454 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -36.83 106.37 0.33 Allowed Pre-proline 0 N--CA 1.472 0.658 0 O-C-N 124.443 1.089 . . . . 0.0 112.411 -171.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.587 ' HG2' HG11 ' A' ' 91' ' ' VAL . 37.8 Cg_exo -65.78 149.79 86.54 Favored 'Trans proline' 0 CA--C 1.517 -0.326 0 C-N-CA 123.141 2.561 . . . . 0.0 112.129 177.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 27.4 m -106.38 130.1 54.26 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.585 -178.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.515 HG22 HG12 ' A' ' 28' ' ' VAL . 53.8 t -71.62 121.88 22.67 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-N 114.227 -1.351 . . . . 0.0 110.12 175.072 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -83.78 -46.26 12.42 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.258 -173.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -135.63 137.99 42.44 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.894 -178.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.499 ' HA ' HG12 ' A' ' 26' ' ' ILE . 23.7 t -123.26 121.37 62.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.892 -178.175 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -131.57 -163.05 1.28 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.443 176.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -72.88 -68.9 0.45 Allowed 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.311 0.485 . . . . 0.0 112.311 -178.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.555 HG22 ' O ' ' A' ' 69' ' ' LEU . 38.1 p -110.12 28.84 8.21 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.377 0.608 . . . . 0.0 110.87 -171.407 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.559 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 12.0 p -169.95 134.65 1.32 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.069 -175.477 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.546 ' HB ' HD12 ' A' ' 66' ' ' LEU . 29.0 mt -146.16 155.98 12.27 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.207 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 54.4 t -121.48 140.21 46.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 119.859 1.209 . . . . 0.0 110.253 -177.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.57 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.8 OUTLIER -130.81 149.24 33.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 119.867 -0.733 . . . . 0.0 110.676 176.741 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.505 ' HG2' ' HB3' ' A' ' 63' ' ' SER . 60.8 mtp180 -132.1 120.61 22.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.265 -176.212 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.785 ' HZ3' HG12 ' A' ' 64' ' ' VAL . 32.6 p90 -112.04 144.23 41.74 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.905 -173.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.429 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 21.4 m -85.04 86.55 7.37 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.697 174.535 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.582 ' HD3' ' H ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -52.03 152.87 5.15 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.035 -0.984 . . . . 0.0 112.231 -174.513 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.648 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 4.3 Cg_exo -78.13 160.69 29.78 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 123.615 2.877 . . . . 0.0 113.029 -172.229 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -79.29 -14.8 58.78 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.16 -0.927 . . . . 0.0 108.763 170.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.44 145.28 59.65 Favored Pre-proline 0 CA--C 1.517 -0.292 0 CA-C-N 114.879 -1.055 . . . . 0.0 111.441 175.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -67.45 115.77 3.87 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 121.463 1.442 . . . . 0.0 109.951 170.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.65 HD12 ' HE1' ' A' ' 40' ' ' TYR . 1.4 pt -128.18 146.76 33.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.513 ' C ' ' HB3' ' A' ' 59' ' ' GLU . 26.9 p -93.69 -28.86 15.72 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -178.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.557 ' C ' HG12 ' A' ' 82' ' ' VAL . . . -168.44 -164.04 23.45 Favored Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 120.338 -0.934 . . . . 0.0 111.532 -178.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.65 ' HE1' HD12 ' A' ' 37' ' ' ILE . 5.2 m-85 -140.3 133.98 30.32 Favored 'General case' 0 CA--C 1.513 -0.481 0 CA-C-N 116.929 0.364 . . . . 0.0 111.243 175.202 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.8 mmm180 -106.03 148.35 27.84 Favored 'General case' 0 CA--C 1.505 -0.757 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 167.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.881 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 28.8 mt -138.03 108.55 5.13 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 C-N-CA 120.006 -0.678 . . . . 0.0 112.489 -177.461 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 76.6 t -110.84 111.08 34.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.019 0.438 . . . . 0.0 110.717 -178.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.752 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 1.3 p90 -116.81 126.85 53.68 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.602 0.715 . . . . 0.0 110.474 178.453 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.416 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 25.1 p -149.81 143.93 17.21 Favored Pre-proline 0 C--N 1.319 -0.739 0 CA-C-N 113.698 -1.592 . . . . 0.0 111.183 -175.171 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.593 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 32.4 Cg_exo -59.11 148.78 83.96 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 123.128 2.552 . . . . 0.0 111.808 176.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 20.1 m -61.89 -23.18 66.14 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.466 -0.788 . . . . 0.0 112.534 -172.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 5.5 p -116.08 -42.32 3.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 120.345 -0.542 . . . . 0.0 112.347 -178.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 173.99 147.51 0.06 Allowed 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 110.067 -0.345 . . . . 0.0 110.067 -176.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.487 ' HA3' ' HG2' ' A' ' 46' ' ' PRO . . . 149.42 -162.2 28.98 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.204 174.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 16.1 m -63.45 120.7 12.17 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.932 0.396 . . . . 0.0 111.096 -177.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.8 m -118.77 139.63 51.26 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.272 178.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.752 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 14.6 m -139.56 145.12 38.24 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.548 -0.461 . . . . 0.0 111.376 -177.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.881 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 74.3 tt0 -118.26 124.48 47.95 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 116.042 -0.527 . . . . 0.0 109.615 174.484 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.67 HD12 ' CG2' ' A' ' 64' ' ' VAL . 13.5 mt -106.42 156.79 18.17 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.153 173.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -119.29 115.58 24.46 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.577 178.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.58 HD12 ' CH2' ' A' ' 30' ' ' TRP . 3.5 mt -114.26 158.72 38.94 Favored Pre-proline 0 C--N 1.321 -0.636 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -177.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -69.15 150.0 71.43 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 121.599 1.532 . . . . 0.0 111.226 174.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.513 ' HB3' ' C ' ' A' ' 38' ' ' THR . 10.1 pt-20 -46.48 -25.1 0.61 Allowed 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 114.859 -1.064 . . . . 0.0 113.099 177.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 10.0 t -104.63 15.04 28.79 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.236 -174.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -84.69 162.32 19.73 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 178.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.469 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 27.8 p-10 -142.02 10.42 1.96 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -176.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.57 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 23.0 p -167.42 136.94 2.76 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.77 -177.315 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.785 HG12 ' HZ3' ' A' ' 30' ' ' TRP . 2.8 p -120.64 137.49 54.22 Favored 'Isoleucine or valine' 0 C--O 1.247 0.96 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.801 177.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 42.3 m -90.57 100.94 13.69 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.22 166.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.58 ' HB3' ' CE2' ' A' ' 44' ' ' TYR . 0.5 OUTLIER -76.41 133.52 39.86 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.475 179.352 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 10.7 p -128.37 160.09 33.32 Favored 'General case' 0 N--CA 1.447 -0.583 0 O-C-N 123.878 0.736 . . . . 0.0 110.521 -174.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 65.13 52.03 1.56 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.202 -178.061 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.555 ' O ' HG22 ' A' ' 24' ' ' THR . 6.6 mt -95.1 -175.75 3.62 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 172.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 18.6 mm-40 -127.45 132.77 24.49 Favored Pre-proline 0 C--N 1.321 -0.638 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 175.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -65.57 133.39 34.24 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.879 2.386 . . . . 0.0 112.878 -179.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 77.84 28.99 55.77 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.993 -0.622 . . . . 0.0 111.93 179.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 97.5 t -132.01 141.55 45.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.998 0.428 . . . . 0.0 110.398 -178.099 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.593 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 7.7 tp60 -84.61 111.76 19.83 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.183 -175.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.405 ' CZ ' ' HG3' ' A' ' 46' ' ' PRO . 11.5 m-85 -103.01 127.58 50.2 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.303 0.573 . . . . 0.0 112.011 -176.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.584 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 14.4 m120 -95.72 111.14 23.16 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.278 176.194 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.616 ' HB ' HG13 ' A' ' 93' ' ' ILE . 5.0 mp -92.44 118.09 37.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 176.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.891 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 28.4 m -108.75 113.83 27.12 Favored 'General case' 0 N--CA 1.426 -1.629 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.176 -179.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.58 ' HB ' ' HB ' ' A' ' 91' ' ' VAL . 13.9 mm -95.12 133.5 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -179.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -121.42 111.89 17.86 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.372 179.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.473 ' HB1' HG21 ' A' ' 37' ' ' ILE . . . -81.28 109.17 15.54 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 171.475 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.557 HG12 ' C ' ' A' ' 39' ' ' GLY . 7.4 p -101.09 137.69 27.82 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.604 0 C-N-CA 120.095 -0.642 . . . . 0.0 111.32 -172.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 11.5 tm-20 -117.05 167.41 11.17 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 179.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -46.27 -41.01 12.47 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -174.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 46.3 t-20 -109.38 -32.42 7.17 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -172.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 22.8 pt20 -133.81 176.97 8.09 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.098 -165.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -130.91 135.32 47.57 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 176.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 16.3 m -65.83 170.42 5.39 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.805 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.496 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 1.2 p -54.62 153.66 10.31 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.141 173.434 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -85.93 142.04 7.55 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 121.753 1.635 . . . . 0.0 113.724 -176.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.891 ' O ' ' HA ' ' A' ' 78' ' ' THR . 4.8 t -82.27 123.89 38.69 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.833 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 167.032 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.7 t -120.39 106.04 18.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 C-N-CA 119.862 -0.735 . . . . 0.0 109.961 172.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.616 HG13 ' HB ' ' A' ' 77' ' ' ILE . 7.8 pt -121.02 113.03 38.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.995 176.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.528 ' HB3' ' ND2' ' A' ' 76' ' ' ASN . 11.9 pt20 -99.56 117.66 34.43 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.408 0.623 . . . . 0.0 110.977 -176.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.31 130.63 43.01 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.476 ' HA ' ' HA ' ' A' ' 74' ' ' GLN . 40.4 tt0 -89.23 128.8 35.86 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.338 0.59 . . . . 0.0 111.021 -177.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.452 HG22 HD11 ' A' ' 26' ' ' ILE . 32.8 p -59.19 126.05 26.12 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.148 -178.349 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 10.9 m -69.69 -30.95 68.72 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.472 0.653 . . . . 0.0 109.875 179.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 89.2 -137.31 14.09 Favored Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.86 178.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 21.1 m -130.53 122.14 19.65 Favored Pre-proline 0 C--N 1.317 -0.82 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 178.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_exo -42.97 -63.95 0.29 Allowed 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 123.232 2.622 . . . . 0.0 112.747 -175.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 26.3 ttm180 -148.72 118.51 7.07 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.382 178.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 42.9 m 64.3 -89.94 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.587 179.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -124.88 10.9 8.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.204 0.526 . . . . 0.0 110.349 179.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 142.11 -83.51 0.21 Allowed Glycine 0 N--CA 1.444 -0.787 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.11 179.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.8 t . . . . . 0 C--O 1.248 0.983 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.859 177.77 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.659 0 N-CA-C 111.792 -0.523 . . . . 0.0 111.792 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 31.1 m -83.68 108.53 16.81 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.791 0.329 . . . . 0.0 110.556 -179.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 32.8 m-70 -80.21 81.01 6.56 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.629 -179.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 84.2 mtp -93.36 -0.69 56.52 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.138 -177.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -88.22 -33.53 10.56 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.383 -0.913 . . . . 0.0 112.319 -179.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 13.3 t -88.42 -7.16 57.06 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 111.599 0.222 . . . . 0.0 111.599 -176.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.2 t -158.06 145.66 18.35 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.99 0.424 . . . . 0.0 110.805 -178.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 24.0 m -119.28 127.78 53.54 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.315 179.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -100.39 110.35 59.8 Favored Pre-proline 0 C--N 1.327 -0.396 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 176.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.502 ' HB2' ' OG ' ' A' ' 88' ' ' SER . 48.1 Cg_endo -76.37 135.87 17.1 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 122.282 1.988 . . . . 0.0 112.897 -176.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -87.97 162.38 16.89 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.879 178.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.423 ' HB2' ' O ' ' A' ' 89' ' ' THR . . . -96.92 163.0 21.05 Favored Pre-proline 0 C--N 1.322 -0.608 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 174.193 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.429 ' HB2' ' HB2' ' A' ' 30' ' ' TRP . 19.3 Cg_exo -69.47 128.89 16.96 Favored 'Trans proline' 0 C--O 1.235 0.367 0 C-N-CA 122.27 1.98 . . . . 0.0 111.472 174.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.42 ' HD2' ' O ' ' A' ' 31' ' ' SER . 52.3 Cg_exo -52.45 142.12 49.18 Favored 'Trans proline' 0 CA--C 1.509 -0.736 0 C-N-CA 122.306 2.004 . . . . 0.0 110.806 173.316 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.506 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 2.4 m-20 -35.79 103.16 0.24 Allowed Pre-proline 0 N--CA 1.465 0.291 0 O-C-N 125.069 1.48 . . . . 0.0 112.674 -164.373 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.752 ' CG ' HG11 ' A' ' 91' ' ' VAL . 5.2 Cg_endo -49.7 145.72 17.03 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 123.584 2.856 . . . . 0.0 113.134 169.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.6 m -101.51 131.83 47.46 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.354 179.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.533 HG22 HG12 ' A' ' 28' ' ' VAL . 70.9 t -73.98 112.1 10.26 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 CA-C-N 114.835 -1.075 . . . . 0.0 109.284 172.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -86.51 -36.62 18.88 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.666 -172.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -135.03 140.83 45.92 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.973 -176.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.418 ' HA ' HG12 ' A' ' 26' ' ' ILE . 47.5 t -133.81 139.94 47.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.492 -179.22 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.435 ' CG ' ' H ' ' A' ' 23' ' ' ASP . 12.4 t70 -146.69 -157.69 0.83 Allowed 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -179.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.458 ' HB3' ' HB3' ' A' ' 71' ' ' PRO . 7.0 m-20 -79.5 -70.91 0.48 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.425 0.631 . . . . 0.0 109.935 178.14 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.58 HG22 ' O ' ' A' ' 69' ' ' LEU . 69.7 p -104.71 34.96 2.93 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.775 -174.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.521 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 29.9 m -167.83 137.52 2.65 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 123.139 0.576 . . . . 0.0 110.062 -172.321 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.579 ' HB ' HD12 ' A' ' 66' ' ' LEU . 29.2 mt -153.17 149.76 13.07 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.117 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 177.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.446 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 47.3 t -122.37 137.0 57.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 119.517 1.053 . . . . 0.0 110.186 -176.385 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.56 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.8 OUTLIER -130.19 149.83 33.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 C-N-CA 120.129 -0.629 . . . . 0.0 110.383 179.341 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.453 ' HG2' ' HB3' ' A' ' 63' ' ' SER . 55.1 mtp180 -134.31 120.44 19.92 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.392 -175.142 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.749 ' HZ3' HG12 ' A' ' 64' ' ' VAL . 36.9 p90 -112.56 146.8 37.89 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.742 -173.039 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.42 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 35.5 t -89.24 91.96 8.98 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 173.306 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.508 ' HD3' ' H ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -50.94 153.37 3.07 Favored Pre-proline 0 CA--C 1.54 0.584 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.785 -176.129 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.653 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 5.1 Cg_exo -78.07 162.52 28.85 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 123.879 3.053 . . . . 0.0 112.592 -174.527 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -83.25 -7.74 59.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.405 172.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.33 150.94 70.64 Favored Pre-proline 0 CA--C 1.518 -0.262 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.737 175.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.581 ' O ' ' HG3' ' A' ' 83' ' ' GLU . 12.2 Cg_exo -69.77 114.46 3.71 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 121.128 1.219 . . . . 0.0 109.559 169.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.583 HD12 ' HE1' ' A' ' 40' ' ' TYR . 2.0 pt -128.85 142.59 43.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.454 ' N ' ' O ' ' A' ' 82' ' ' VAL . 12.6 p -92.2 -31.42 15.46 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -178.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.558 ' C ' HG12 ' A' ' 82' ' ' VAL . . . -163.41 -163.95 17.36 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.12 -1.038 . . . . 0.0 111.919 -177.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.653 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 5.4 m-85 -141.05 133.31 28.12 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.785 0.326 . . . . 0.0 111.323 175.419 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.41 ' C ' HG13 ' A' ' 42' ' ' ILE . 10.1 mmm180 -103.7 149.61 24.81 Favored 'General case' 0 CA--C 1.503 -0.832 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 167.128 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.866 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 32.0 mt -138.7 107.08 3.51 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 C-N-CA 119.734 -0.787 . . . . 0.0 112.318 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.418 HG22 ' HB2' ' A' ' 54' ' ' GLU . 74.1 t -108.88 110.18 31.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.19 0.519 . . . . 0.0 110.646 -178.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.778 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 0.5 OUTLIER -110.34 124.9 52.53 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.552 176.019 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 35.6 t -137.34 135.41 19.42 Favored Pre-proline 0 C--N 1.318 -0.8 0 CA-C-N 113.926 -1.488 . . . . 0.0 111.33 -173.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.672 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 50.7 Cg_endo -70.19 130.89 19.57 Favored 'Trans proline' 0 CA--C 1.527 0.156 0 C-N-CA 123.472 2.781 . . . . 0.0 112.005 175.557 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 14.5 m -70.31 -16.81 63.05 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.035 0.445 . . . . 0.0 111.303 -178.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.431 ' CG2' HG13 ' A' ' 73' ' ' VAL . 15.8 m -105.86 16.62 6.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.59 177.601 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.42 ' HB2' ' O ' ' A' ' 48' ' ' VAL . 24.3 mm-40 71.26 161.37 0.23 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.861 -1.063 . . . . 0.0 111.912 -178.379 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 145.3 -134.98 5.76 Favored Glycine 0 N--CA 1.446 -0.64 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 -176.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 27.2 t -93.59 121.26 34.82 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.957 0.379 . . . . 0.0 110.817 179.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.3 p -117.92 143.06 46.67 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.232 176.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.778 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 24.4 m -142.78 147.8 36.11 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.457 -0.497 . . . . 0.0 111.557 -174.588 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.866 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 21.8 tt0 -116.44 122.34 44.49 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.148 172.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.658 HD12 ' CG2' ' A' ' 64' ' ' VAL . 12.8 mt -99.8 160.54 14.23 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.613 -0.435 . . . . 0.0 109.882 172.153 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -122.54 117.66 26.43 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.597 HD12 ' CH2' ' A' ' 30' ' ' TRP . 3.9 mt -116.02 158.2 43.09 Favored Pre-proline 0 C--N 1.318 -0.796 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -177.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -70.71 152.17 64.18 Favored 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 121.298 1.332 . . . . 0.0 111.124 173.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.487 ' HB2' HG13 ' A' ' 37' ' ' ILE . 8.1 pt-20 -43.62 -39.65 3.65 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.548 0.69 . . . . 0.0 111.796 175.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.454 ' N ' ' HG3' ' A' ' 59' ' ' GLU . 9.7 t -88.24 19.07 3.92 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.467 -174.119 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -91.79 164.38 13.72 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 175.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.45 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 30.3 p-10 -149.28 16.08 0.92 Allowed 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -178.243 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.56 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 17.3 p -170.13 134.17 1.21 Allowed 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.446 -0.502 . . . . 0.0 112.017 -179.575 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.749 HG12 ' HZ3' ' A' ' 30' ' ' TRP . 3.2 p -119.52 137.68 52.63 Favored 'Isoleucine or valine' 0 C--O 1.244 0.772 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.347 177.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 42.2 m -94.71 101.49 13.33 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-O 121.573 0.701 . . . . 0.0 109.332 167.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.624 HD11 HG12 ' A' ' 77' ' ' ILE . 0.2 OUTLIER -76.59 139.49 40.68 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.362 178.533 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 14.2 t -134.88 171.04 14.95 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -176.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 64.89 35.19 8.58 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 123.786 0.679 . . . . 0.0 110.795 -179.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.58 ' O ' HG22 ' A' ' 24' ' ' THR . 7.5 mt -85.08 -176.96 6.41 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 174.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 19.6 mm-40 -123.37 132.5 24.28 Favored Pre-proline 0 C--N 1.318 -0.782 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 173.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.458 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . 37.2 Cg_endo -66.74 128.01 18.15 Favored 'Trans proline' 0 C--O 1.234 0.311 0 C-N-CA 122.722 2.281 . . . . 0.0 112.517 179.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 83.49 33.8 21.44 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.991 -0.623 . . . . 0.0 111.851 -179.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.431 HG13 ' CG2' ' A' ' 48' ' ' VAL . 72.1 t -134.84 140.79 44.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.085 0.469 . . . . 0.0 111.047 -176.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.672 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -79.34 118.41 21.23 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.233 -178.481 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -114.32 121.4 43.52 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.095 0.474 . . . . 0.0 112.143 -177.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.574 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 0.8 OUTLIER -88.47 113.38 24.0 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.418 170.669 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.624 HG12 HD11 ' A' ' 66' ' ' LEU . 4.9 mp -92.2 115.47 31.24 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.661 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 173.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.895 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 19.4 m -107.24 113.31 26.64 Favored 'General case' 0 N--CA 1.427 -1.615 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.421 -178.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.574 ' H ' ' HB ' ' A' ' 91' ' ' VAL . 11.3 mm -94.78 136.09 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.022 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.418 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 80.7 m-85 -122.35 110.94 16.28 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.92 179.104 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.481 ' HB1' HG21 ' A' ' 37' ' ' ILE . . . -80.14 107.62 13.07 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 171.001 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.558 HG12 ' C ' ' A' ' 39' ' ' GLY . 7.3 p -99.96 137.61 26.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 C-N-CA 119.854 -0.738 . . . . 0.0 110.572 -173.464 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.644 ' HG2' ' N ' ' A' ' 84' ' ' GLU . 2.1 tt0 -111.85 166.8 10.89 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 124.014 0.821 . . . . 0.0 109.597 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.644 ' N ' ' HG2' ' A' ' 83' ' ' GLU . 34.3 mt-10 -41.23 -53.06 3.27 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 123.008 0.523 . . . . 0.0 111.955 177.107 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -124.53 8.26 8.33 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -173.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -140.41 174.22 10.73 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.025 0.441 . . . . 0.0 111.56 -176.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -136.8 122.26 19.52 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 172.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.502 ' OG ' ' HB2' ' A' ' 10' ' ' PRO . 32.6 m -64.72 168.69 5.82 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.712 0.292 . . . . 0.0 110.951 178.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.423 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 1.1 p -56.09 151.71 24.74 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.768 176.195 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -82.92 136.28 8.06 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 121.985 1.79 . . . . 0.0 113.139 -178.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.895 ' O ' ' HA ' ' A' ' 78' ' ' THR . 54.0 t -82.77 119.03 31.5 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.755 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 169.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.8 t -116.77 105.24 17.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 C-N-CA 119.249 -0.98 . . . . 0.0 109.965 173.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.59 HG13 ' HB ' ' A' ' 77' ' ' ILE . 7.4 pt -118.1 111.59 34.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.438 176.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -101.15 127.69 47.59 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.518 0.675 . . . . 0.0 111.04 -174.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -140.34 134.56 31.09 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.296 -0.866 . . . . 0.0 108.82 -179.224 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.597 ' HG2' ' HG2' ' A' ' 74' ' ' GLN . 47.0 mt-10 -86.61 126.56 34.59 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 120.81 0.338 . . . . 0.0 110.765 178.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.468 HG22 HD11 ' A' ' 26' ' ' ILE . 35.0 p -56.23 119.59 6.21 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.32 179.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 25.6 m -67.93 -30.29 69.57 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.591 -178.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.41 ' HA2' ' HA ' ' A' ' 23' ' ' ASP . . . 89.51 -138.42 14.62 Favored Glycine 0 N--CA 1.432 -1.602 0 CA-C-N 114.794 -1.093 . . . . 0.0 111.016 -179.448 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.406 ' HA ' ' HD3' ' A' ' 101' ' ' PRO . 18.2 m -84.27 118.69 71.82 Favored Pre-proline 0 C--N 1.314 -0.941 0 N-CA-C 110.266 -0.272 . . . . 0.0 110.266 179.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 100' ' ' THR . 35.2 Cg_exo -59.9 100.31 0.14 Allowed 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 123.044 2.496 . . . . 0.0 112.336 -178.222 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 87.4 mtt180 -85.29 -58.54 2.64 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.902 -179.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 10.0 t 54.98 78.02 0.19 Allowed 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.531 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -112.71 158.34 20.17 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.304 -179.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -78.49 81.52 1.34 Allowed Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.143 178.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 34.7 p . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.236 -0.888 . . . . 0.0 112.037 -179.215 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.539 0 N-CA-C 111.841 -0.504 . . . . 0.0 111.841 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.2 m -87.78 70.96 9.63 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.139 0.495 . . . . 0.0 110.483 179.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 22.4 t60 -82.01 65.94 7.37 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.458 0.647 . . . . 0.0 109.708 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 21.6 ptp -124.42 37.83 4.32 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.269 -177.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 85.78 -58.52 4.81 Favored Glycine 0 N--CA 1.45 -0.403 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 -174.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 16.7 p -79.21 78.71 5.67 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 121.133 0.492 . . . . 0.0 110.357 175.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.413 ' O ' ' HB ' ' A' ' 8' ' ' THR . 31.4 p -68.89 160.02 31.49 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.065 -178.104 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.413 ' HB ' ' O ' ' A' ' 7' ' ' THR . 63.4 m 71.89 122.44 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.205 0.526 . . . . 0.0 110.926 -176.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -137.43 120.98 11.73 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.174 179.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.518 ' HA ' ' HB2' ' A' ' 35' ' ' ALA . 83.9 Cg_endo -78.28 176.48 9.89 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.241 1.961 . . . . 0.0 112.097 179.287 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -138.93 161.36 37.52 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -175.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.46 ' HB2' ' O ' ' A' ' 89' ' ' THR . . . -96.32 164.41 18.46 Favored Pre-proline 0 C--N 1.313 -0.997 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 175.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.458 ' HB2' ' HB2' ' A' ' 30' ' ' TRP . 17.4 Cg_exo -70.47 126.99 13.43 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 121.926 1.751 . . . . 0.0 111.062 172.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.709 ' HD2' ' O ' ' A' ' 31' ' ' SER . 95.4 Cg_exo -45.54 147.46 2.78 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.931 2.421 . . . . 0.0 111.858 172.504 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.43 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 29.8 t70 -32.74 105.36 0.24 Allowed Pre-proline 0 N--CA 1.468 0.456 0 O-C-N 125.016 1.448 . . . . 0.0 112.842 -170.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.659 ' HG2' HG11 ' A' ' 91' ' ' VAL . 20.8 Cg_exo -72.24 151.39 54.6 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 123.803 3.002 . . . . 0.0 112.113 177.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 24.0 m -119.68 135.06 54.98 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 121.72 0.771 . . . . 0.0 111.11 -176.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.48 HG22 HG12 ' A' ' 28' ' ' VAL . 71.9 t -77.64 125.41 37.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-N 114.16 -1.382 . . . . 0.0 109.864 174.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -88.05 -47.29 8.63 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.208 -174.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -136.88 145.83 44.82 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 120.978 0.418 . . . . 0.0 110.854 179.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 26.3 m -130.94 139.9 49.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.461 -179.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.411 ' HB3' ' H ' ' A' ' 23' ' ' ASP . 29.2 m-20 -135.34 -153.5 0.52 Allowed 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 175.374 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.448 ' CB ' ' HB3' ' A' ' 71' ' ' PRO . 5.5 m-20 -76.3 -73.47 0.27 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.546 0.689 . . . . 0.0 110.497 178.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.684 HG22 ' O ' ' A' ' 69' ' ' LEU . 35.0 p -102.07 37.01 1.95 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.698 -174.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.689 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 55.3 p -169.55 134.08 1.39 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.14 -173.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.627 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 13.3 mt -150.6 142.08 16.71 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.819 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.441 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 38.6 t -115.96 129.02 73.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 119.184 0.902 . . . . 0.0 110.906 -176.204 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.624 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.7 OUTLIER -123.27 145.71 29.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -177.742 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.445 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 59.5 mtp180 -131.78 122.4 25.74 Favored 'General case' 0 C--N 1.329 -0.298 0 O-C-N 123.254 0.346 . . . . 0.0 110.706 -174.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.72 ' HZ3' HG12 ' A' ' 64' ' ' VAL . 34.5 p90 -114.36 148.42 37.65 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.674 -0.694 . . . . 0.0 112.004 -174.265 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.709 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 24.1 t -92.69 86.47 5.56 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.612 177.119 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.564 ' HD3' ' H ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -43.08 150.96 0.43 Allowed Pre-proline 0 CA--C 1.548 0.869 0 C-N-CA 124.011 0.924 . . . . 0.0 113.39 -176.043 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.746 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 6.3 Cg_exo -78.46 167.79 22.34 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 124.473 3.448 . . . . 0.0 114.9 -164.394 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -68.35 -28.62 67.29 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 114.308 -1.314 . . . . 0.0 109.642 170.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.518 ' HB2' ' HA ' ' A' ' 10' ' ' PRO . . . -61.87 137.43 95.32 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 114.99 -1.005 . . . . 0.0 111.403 -179.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_exo -70.66 115.03 4.04 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 121.394 1.396 . . . . 0.0 109.366 167.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.609 HG22 ' HG3' ' A' ' 83' ' ' GLU . 0.4 OUTLIER -118.64 159.35 19.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -174.745 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.404 ' N ' ' O ' ' A' ' 82' ' ' VAL . 16.7 p -101.47 -27.62 13.03 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -178.452 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -168.04 -168.9 30.83 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 119.879 -1.153 . . . . 0.0 112.365 177.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.746 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 5.0 m-85 -137.5 134.46 35.76 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 121.076 0.465 . . . . 0.0 111.438 177.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.8 mtm180 -112.95 147.54 36.9 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.103 170.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.894 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 27.1 mt -137.98 109.76 6.2 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 C-N-CA 119.886 -0.726 . . . . 0.0 112.841 -173.281 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 97.5 t -110.81 111.16 34.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.086 0.469 . . . . 0.0 110.941 -178.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.829 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 0.9 OUTLIER -115.69 126.65 54.39 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.267 177.366 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.6 p -136.67 138.25 25.88 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-N 113.922 -1.49 . . . . 0.0 111.889 -174.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.48 ' HD3' ' O ' ' A' ' 51' ' ' SER . 94.6 Cg_endo -80.44 143.21 15.23 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 123.611 2.874 . . . . 0.0 111.604 176.043 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 16.4 t -71.02 -28.61 64.52 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.851 -175.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.7 m -114.69 -34.81 2.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -177.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.485 ' HG3' ' HG2' ' A' ' 70' ' ' GLN . 31.1 mm-40 -87.09 -172.75 4.11 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.753 0.311 . . . . 0.0 111.106 -177.227 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -119.94 -11.82 6.8 Favored Glycine 0 N--CA 1.443 -0.889 0 C-N-CA 120.359 -0.924 . . . . 0.0 114.773 -171.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.48 ' O ' ' HD3' ' A' ' 46' ' ' PRO . 7.7 m -78.21 111.4 14.11 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 118.992 1.396 . . . . 0.0 110.168 -178.639 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 28.8 p -123.31 147.21 47.24 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.576 176.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.829 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 12.4 m -140.01 148.72 42.28 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 119.535 -0.866 . . . . 0.0 111.595 -179.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.894 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 37.5 tt0 -122.68 112.15 17.6 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.557 177.269 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.663 HD12 ' CG2' ' A' ' 64' ' ' VAL . 11.7 mt -99.56 164.27 12.15 Favored 'General case' 0 CA--C 1.511 -0.531 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.633 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.417 ' O ' HD23 ' A' ' 57' ' ' LEU . 18.6 t-20 -126.27 118.86 25.99 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.586 179.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.638 HD12 ' CH2' ' A' ' 30' ' ' TRP . 5.3 mt -119.02 159.12 46.11 Favored Pre-proline 0 C--N 1.318 -0.801 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 -178.02 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -65.13 153.44 78.26 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 121.717 1.612 . . . . 0.0 111.258 174.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -49.98 -26.7 4.49 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.074 176.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 10.2 t -101.23 13.63 34.5 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.053 -175.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.514 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -80.34 161.53 24.99 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 178.274 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.445 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 27.7 p-10 -147.73 16.54 1.12 Allowed 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -178.16 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.624 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 19.7 p -171.49 134.42 0.86 Allowed 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.23 -0.588 . . . . 0.0 111.645 179.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.72 HG12 ' HZ3' ' A' ' 30' ' ' TRP . 3.1 p -118.83 137.36 53.06 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.399 176.548 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 52.1 m -95.71 100.82 12.49 Favored 'General case' 0 N--CA 1.433 -1.301 0 CA-C-O 121.573 0.701 . . . . 0.0 109.18 169.035 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.725 ' HB3' ' CE2' ' A' ' 44' ' ' TYR . 0.3 OUTLIER -74.9 141.33 44.14 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.173 178.439 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.438 ' HA ' ' O ' ' A' ' 24' ' ' THR . 9.7 t -136.07 168.97 18.36 Favored 'General case' 0 N--CA 1.444 -0.75 0 O-C-N 123.605 0.566 . . . . 0.0 109.762 -178.126 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 62.92 34.34 14.25 Favored 'General case' 0 CA--C 1.519 -0.234 0 O-C-N 123.787 0.679 . . . . 0.0 111.252 -178.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.684 ' O ' HG22 ' A' ' 24' ' ' THR . 9.4 mt -79.62 -177.21 5.73 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 174.108 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.485 ' HG2' ' HG3' ' A' ' 49' ' ' GLU . 55.7 tp60 -123.33 125.01 26.24 Favored Pre-proline 0 C--N 1.314 -0.947 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 175.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.448 ' HB3' ' CB ' ' A' ' 23' ' ' ASP . 39.4 Cg_endo -65.28 133.97 37.21 Favored 'Trans proline' 0 CA--C 1.53 0.316 0 C-N-CA 123.019 2.48 . . . . 0.0 113.12 -175.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 82.48 35.49 19.83 Favored Glycine 0 N--CA 1.45 -0.386 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.901 -179.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.448 HG21 ' HG3' ' A' ' 49' ' ' GLU . 45.4 t -137.4 149.91 25.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.0 0.428 . . . . 0.0 111.026 -175.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 8.9 tp60 -87.98 111.34 21.38 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.433 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -102.01 123.34 45.72 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.878 -177.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.545 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 74.9 m-20 -93.5 107.6 19.42 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.151 175.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.641 HG12 HD11 ' A' ' 66' ' ' LEU . 5.2 mp -92.69 118.67 38.81 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.596 0 CA-C-O 121.229 0.538 . . . . 0.0 109.717 176.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.844 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 30.0 m -110.16 116.19 31.08 Favored 'General case' 0 N--CA 1.428 -1.553 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.331 179.618 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.539 ' HB ' ' HB ' ' A' ' 91' ' ' VAL . 12.4 mm -95.5 130.79 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -117.53 112.14 20.2 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 177.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.417 ' HB1' HG21 ' A' ' 37' ' ' ILE . . . -82.69 127.61 33.56 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 169.588 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.404 ' O ' ' N ' ' A' ' 38' ' ' THR . 6.5 p -117.59 135.88 56.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 C-N-CA 120.194 -0.603 . . . . 0.0 110.804 -177.265 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.609 ' HG3' HG22 ' A' ' 37' ' ' ILE . 2.4 mp0 -113.37 170.17 8.43 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.403 ' HG3' ' H ' ' A' ' 84' ' ' GLU . 40.6 mt-10 -38.65 -52.65 1.65 Allowed 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -174.102 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -131.09 17.31 5.05 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.943 -0.303 . . . . 0.0 110.814 -176.15 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 18.1 mm-40 -142.19 173.5 11.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.795 0.331 . . . . 0.0 110.915 -176.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -135.81 125.58 25.58 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 175.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.4 ' HB2' ' HB3' ' A' ' 81' ' ' ALA . 47.6 m -73.1 170.5 14.77 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.734 0.302 . . . . 0.0 111.079 178.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.46 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 2.8 p -62.58 153.03 79.37 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 120.973 0.416 . . . . 0.0 111.096 178.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -86.03 140.92 6.97 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.516 2.144 . . . . 0.0 114.387 -177.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.844 ' O ' ' HA ' ' A' ' 78' ' ' THR . 21.0 t -82.33 127.4 39.67 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.624 0 CA-C-N 114.83 -1.077 . . . . 0.0 108.575 167.132 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 11.7 t -121.84 106.9 18.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 C-N-CA 119.935 -0.706 . . . . 0.0 109.884 170.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.579 HG13 ' HB ' ' A' ' 77' ' ' ILE . 8.6 pt -122.58 116.79 49.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.166 178.342 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -100.03 124.96 45.98 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.601 0.715 . . . . 0.0 110.953 -177.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.67 134.25 40.93 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.311 178.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -84.89 137.05 33.37 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.965 0.412 . . . . 0.0 110.037 178.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 25.5 p -71.13 113.0 7.73 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.778 176.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 33.1 m -69.01 -28.91 67.01 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.837 0.827 . . . . 0.0 109.638 -179.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.41 ' HA2' ' HA ' ' A' ' 23' ' ' ASP . . . 87.46 -148.09 21.04 Favored Glycine 0 N--CA 1.436 -1.339 0 CA-C-N 114.7 -1.137 . . . . 0.0 111.877 176.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 4.7 m -68.91 120.16 74.39 Favored Pre-proline 0 C--N 1.316 -0.868 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 178.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -42.2 108.09 0.09 OUTLIER 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 123.787 2.991 . . . . 0.0 113.262 -176.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 7.5 ptm180 -81.7 122.59 27.84 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.768 -178.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 19.6 m -71.69 143.17 49.78 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.559 176.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 62.74 48.51 4.16 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.614 0.721 . . . . 0.0 109.851 -174.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -176.85 -44.82 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.041 -0.981 . . . . 0.0 111.279 -179.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 65.4 m . . . . . 0 C--O 1.248 0.984 0 CA-C-O 118.917 -0.563 . . . . 0.0 109.713 174.594 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.655 0 N-CA-C 111.572 -0.611 . . . . 0.0 111.572 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.0 m 55.65 42.81 29.05 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 120.891 0.377 . . . . 0.0 111.443 178.938 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 45.0 m170 -75.54 128.43 35.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.454 -179.393 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 14.7 tpt 58.49 70.83 0.62 Allowed 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.813 0.816 . . . . 0.0 110.102 -176.704 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 164.95 58.02 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.619 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.93 -177.682 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.8 t -66.77 117.75 9.33 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.338 0.589 . . . . 0.0 111.737 -175.788 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.1 m -82.75 74.47 9.71 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 172.093 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 32.1 m -65.03 123.33 19.21 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.382 -0.826 . . . . 0.0 112.233 -172.33 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -93.83 146.44 31.71 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.906 178.652 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.446 ' HB2' ' OG ' ' A' ' 88' ' ' SER . 74.0 Cg_endo -73.21 150.91 48.33 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 122.515 2.143 . . . . 0.0 111.991 179.899 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.423 ' O ' ' HB3' ' A' ' 33' ' ' PRO . 13.8 p-10 -110.72 157.4 19.79 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.185 -178.622 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -96.39 161.07 28.14 Favored Pre-proline 0 C--N 1.32 -0.716 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.196 177.302 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -68.28 130.91 22.18 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.507 2.138 . . . . 0.0 112.252 177.306 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.401 ' HD2' ' O ' ' A' ' 31' ' ' SER . 74.0 Cg_exo -50.87 151.26 11.52 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.81 2.34 . . . . 0.0 111.572 172.899 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -38.88 106.13 0.37 Allowed Pre-proline 0 N--CA 1.47 0.573 0 O-C-N 124.493 1.121 . . . . 0.0 112.251 -170.552 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.603 ' HG2' HG11 ' A' ' 91' ' ' VAL . 34.3 Cg_exo -64.59 149.68 89.46 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 123.504 2.803 . . . . 0.0 112.691 179.594 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 28.0 m -105.24 129.39 53.62 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.988 -1.006 . . . . 0.0 110.71 -177.423 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.452 ' HA ' ' HA ' ' A' ' 28' ' ' VAL . 70.6 t -81.02 123.31 37.49 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 CA-C-N 114.522 -1.217 . . . . 0.0 110.049 175.639 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -89.39 -37.39 14.88 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.435 -174.756 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -135.05 134.75 40.7 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.851 0.358 . . . . 0.0 110.601 -177.898 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.504 ' HA ' HG12 ' A' ' 26' ' ' ILE . 59.2 t -130.0 117.93 42.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.334 179.184 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.415 ' HB3' ' H ' ' A' ' 23' ' ' ASP . 8.8 m-20 -128.21 -160.76 1.04 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.84 175.405 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.56 ' O ' ' HB2' ' A' ' 69' ' ' LEU . 1.9 m-20 -77.19 -58.4 3.3 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.043 0.449 . . . . 0.0 110.91 -177.718 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.646 HG22 ' O ' ' A' ' 69' ' ' LEU . 34.9 p -113.11 34.42 4.47 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.131 -175.458 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.637 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 75.8 p -169.88 130.94 1.03 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.626 -176.583 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.592 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 43.4 mt -147.17 139.51 18.98 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.624 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 176.841 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.445 ' O ' HG13 ' A' ' 18' ' ' VAL . 39.9 t -118.17 130.13 73.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 118.697 0.681 . . . . 0.0 110.586 -175.702 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.675 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.6 OUTLIER -122.81 145.87 28.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 C-N-CA 120.496 -0.482 . . . . 0.0 110.009 -177.368 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.556 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 29.8 mtm180 -130.81 121.11 24.75 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 123.358 0.411 . . . . 0.0 110.68 -175.946 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.746 ' HZ3' HG12 ' A' ' 64' ' ' VAL . 38.2 p90 -110.26 144.23 39.27 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.608 -173.994 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.401 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 17.6 m -89.31 96.8 10.86 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.027 177.167 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.596 ' NE ' ' HB3' ' A' ' 62' ' ' ASN . 0.1 OUTLIER -45.73 155.85 0.46 Allowed Pre-proline 0 CA--C 1.538 0.515 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -175.105 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.693 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 4.6 Cg_exo -82.95 169.91 12.78 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 124.519 3.479 . . . . 0.0 112.623 -172.416 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -81.21 -18.0 47.65 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.181 174.518 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.417 ' HB2' ' HA ' ' A' ' 10' ' ' PRO . . . -64.18 142.08 98.21 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.499 177.863 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_exo -70.72 115.26 4.15 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 121.487 1.458 . . . . 0.0 109.614 168.432 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.6 HG22 ' HG3' ' A' ' 83' ' ' GLU . 0.8 OUTLIER -121.72 152.15 25.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -174.91 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 11.8 p -98.12 -31.65 12.01 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -177.637 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.452 ' C ' HG12 ' A' ' 82' ' ' VAL . . . -163.15 -164.39 18.09 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.267 -0.968 . . . . 0.0 111.698 177.977 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.693 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 6.4 m-85 -140.32 136.13 32.91 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.848 0.324 . . . . 0.0 111.124 175.162 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 21.6 mtp180 -104.69 151.38 23.77 Favored 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 166.393 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.889 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 32.6 mt -139.59 108.47 3.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 C-N-CA 120.617 -0.433 . . . . 0.0 111.977 -178.491 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 72.6 t -107.77 109.64 28.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.306 0.574 . . . . 0.0 110.194 178.322 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.703 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 0.6 OUTLIER -110.46 125.14 52.97 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.138 175.908 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.1 m -143.17 133.88 12.4 Favored Pre-proline 0 C--N 1.316 -0.874 0 CA-C-N 113.928 -1.487 . . . . 0.0 110.808 -175.379 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.524 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 57.6 Cg_endo -73.95 130.92 14.98 Favored 'Trans proline' 0 C--N 1.333 -0.274 0 C-N-CA 123.108 2.539 . . . . 0.0 111.694 176.162 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 41.7 t -64.02 -24.11 67.59 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.309 -178.621 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.464 ' CG2' HG13 ' A' ' 73' ' ' VAL . 13.7 m -99.59 16.04 3.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.852 0.358 . . . . 0.0 111.167 178.783 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 74.36 152.75 0.13 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.919 -1.037 . . . . 0.0 111.381 178.121 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 155.73 -131.12 2.96 Favored Glycine 0 N--CA 1.448 -0.505 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 -176.366 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.517 ' O ' ' HE2' ' A' ' 75' ' ' TYR . 19.8 m -92.28 119.85 32.26 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 117.245 0.523 . . . . 0.0 110.74 179.705 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 15.5 m -117.98 137.26 52.98 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 176.531 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.703 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 23.5 m -144.77 151.93 39.59 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 120.443 -0.503 . . . . 0.0 111.476 -175.705 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.889 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 51.4 tt0 -121.61 112.44 18.46 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.619 176.251 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.713 HD12 ' CG2' ' A' ' 64' ' ' VAL . 18.1 mt -97.48 163.0 13.05 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.013 176.885 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.513 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 18.5 m120 -129.75 113.27 14.51 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.884 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.556 HD12 ' CH2' ' A' ' 30' ' ' TRP . 3.5 mt -110.98 157.62 38.14 Favored Pre-proline 0 C--N 1.317 -0.831 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -174.431 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -64.59 150.45 88.19 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 121.849 1.699 . . . . 0.0 111.157 175.484 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -48.31 -23.03 0.78 Allowed 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 115.177 -0.919 . . . . 0.0 112.852 177.908 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 5.1 t -99.86 1.6 43.07 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.215 -175.859 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.496 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -76.06 159.57 30.65 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 -176.951 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.596 ' HB3' ' NE ' ' A' ' 32' ' ' ARG . 28.6 p-10 -147.03 18.52 1.24 Allowed 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 120.554 -0.458 . . . . 0.0 112.231 -178.421 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.675 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 23.2 p -169.22 133.65 1.43 Allowed 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.164 -0.615 . . . . 0.0 112.155 -179.9 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.746 HG12 ' HZ3' ' A' ' 30' ' ' TRP . 3.6 p -118.44 137.11 53.46 Favored 'Isoleucine or valine' 0 C--O 1.242 0.673 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.203 176.257 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 61.0 m -97.68 101.98 13.63 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.752 171.65 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.68 HD11 HG12 ' A' ' 77' ' ' ILE . 0.2 OUTLIER -80.59 140.22 35.87 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.362 179.397 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 22.0 t -134.11 168.23 19.21 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 123.438 0.461 . . . . 0.0 110.642 -173.455 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 58.75 31.34 21.09 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.991 -177.811 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.646 ' O ' HG22 ' A' ' 24' ' ' THR . 14.3 mt -69.16 -175.44 0.76 Allowed 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 175.19 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.462 ' CG ' HG21 ' A' ' 106' ' ' THR . 8.6 tt0 -126.87 125.53 24.28 Favored Pre-proline 0 C--N 1.318 -0.772 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 178.407 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -63.52 130.04 27.02 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 123.03 2.486 . . . . 0.0 113.418 -177.346 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 88.18 22.05 43.0 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.774 -179.917 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.464 HG13 ' CG2' ' A' ' 48' ' ' VAL . 86.6 t -127.38 144.26 37.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.145 0.498 . . . . 0.0 111.308 -173.35 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.524 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 15.8 tp60 -88.88 107.18 18.86 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.98 -176.566 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.517 ' HE2' ' O ' ' A' ' 51' ' ' SER . 16.0 m-85 -98.09 117.79 33.24 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.224 0.535 . . . . 0.0 111.64 -178.079 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -90.4 107.9 19.44 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.127 177.629 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.68 HG12 HD11 ' A' ' 66' ' ' LEU . 5.3 mp -91.73 116.4 32.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.294 0.569 . . . . 0.0 109.684 178.988 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.854 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 30.8 m -108.47 115.26 29.77 Favored 'General case' 0 N--CA 1.428 -1.525 0 CA-C-N 115.294 -0.867 . . . . 0.0 110.404 -179.791 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.566 ' HB ' ' HB ' ' A' ' 91' ' ' VAL . 14.3 mm -95.46 144.23 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -179.255 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -131.17 112.12 12.55 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.233 179.374 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -79.02 123.69 27.55 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 169.117 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.452 HG12 ' C ' ' A' ' 39' ' ' GLY . 7.0 p -114.53 135.91 52.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 C-N-CA 120.149 -0.621 . . . . 0.0 110.685 -179.824 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.666 ' OE1' ' HG3' ' A' ' 86' ' ' GLN . 3.9 mp0 -112.28 170.68 8.0 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -179.164 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -38.76 -55.78 1.44 Allowed 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -174.09 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -125.23 9.85 8.01 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -176.233 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.666 ' HG3' ' OE1' ' A' ' 83' ' ' GLU . 3.3 pt20 -143.03 176.49 9.06 Favored 'General case' 0 N--CA 1.447 -0.623 0 O-C-N 122.336 -0.227 . . . . 0.0 111.0 -175.095 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -138.28 136.08 36.12 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.004 178.432 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.446 ' OG ' ' HB2' ' A' ' 10' ' ' PRO . 46.2 m -78.24 175.46 10.18 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.168 178.297 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -63.09 160.69 37.13 Favored Pre-proline 0 CA--C 1.534 0.344 0 CA-C-O 120.973 0.416 . . . . 0.0 111.523 178.614 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -87.85 140.46 5.01 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.302 2.002 . . . . 0.0 114.365 -178.497 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.854 ' O ' ' HA ' ' A' ' 78' ' ' THR . 6.9 t -82.72 127.65 39.47 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.688 0 CA-C-N 114.825 -1.08 . . . . 0.0 108.34 165.863 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.4 t -124.05 106.06 16.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 C-N-CA 120.027 -0.669 . . . . 0.0 109.596 172.476 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.537 HG13 ' HB ' ' A' ' 77' ' ' ILE . 7.7 pt -124.2 112.87 34.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.418 178.674 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -94.07 120.17 33.94 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.315 0.579 . . . . 0.0 111.05 -177.66 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.33 125.37 42.16 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.486 175.482 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.447 ' HA ' ' HA ' ' A' ' 74' ' ' GLN . 40.9 tt0 -90.0 128.08 36.18 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.18 0.514 . . . . 0.0 110.034 179.783 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 40.3 p -59.52 144.71 46.56 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.948 -176.524 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 16.4 m -68.63 -31.98 71.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.342 -171.752 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 58.85 75.3 0.27 Allowed Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.686 -0.769 . . . . 0.0 111.832 178.366 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.448 ' HA ' ' HD3' ' A' ' 101' ' ' PRO . 3.5 m -66.08 131.0 94.41 Favored Pre-proline 0 C--N 1.314 -0.944 0 CA-C-N 114.838 -0.681 . . . . 0.0 110.687 -176.474 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 100' ' ' THR . 21.3 Cg_exo -66.07 74.34 0.35 Allowed 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.796 2.33 . . . . 0.0 112.195 177.369 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.492 ' HA ' ' HE ' ' A' ' 102' ' ' ARG . 3.1 tpm_? -85.54 -53.48 5.15 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.156 -179.13 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 47.4 t -171.27 -48.86 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.137 178.63 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -152.08 -30.99 0.15 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.559 179.215 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 81.97 -84.77 1.47 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.752 175.946 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.462 HG21 ' CG ' ' A' ' 70' ' ' GLN . 8.9 t . . . . . 0 C--O 1.248 0.989 0 CA-C-O 118.51 -0.757 . . . . 0.0 109.953 -176.813 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.814 0 N-CA-C 111.86 -0.496 . . . . 0.0 111.86 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.1 t -155.93 155.54 33.0 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 -179.239 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -125.11 176.85 6.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.875 0.369 . . . . 0.0 110.349 -179.82 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 26.0 ttt -135.67 54.25 1.92 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 176.369 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.39 89.66 1.12 Allowed Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.306 -0.861 . . . . 0.0 112.014 -178.723 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.6 m -85.02 78.42 9.91 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.199 0.523 . . . . 0.0 110.528 -178.76 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.4 p -83.28 -7.15 59.64 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.024 -178.625 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 12.9 t -74.9 -6.82 51.28 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 122.093 0.949 . . . . 0.0 109.703 174.074 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -112.86 88.33 11.56 Favored Pre-proline 0 C--N 1.313 -0.992 0 CA-C-N 114.043 -1.435 . . . . 0.0 109.112 173.834 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.485 ' HG3' ' CD ' ' A' ' 83' ' ' GLU . 87.5 Cg_endo -79.08 158.37 26.89 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 122.953 2.435 . . . . 0.0 112.427 -174.67 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -116.01 171.07 8.02 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -179.708 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.576 ' HB2' ' O ' ' A' ' 89' ' ' THR . . . -96.34 165.48 16.13 Favored Pre-proline 0 C--N 1.316 -0.858 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 178.997 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.469 ' HB2' ' HB2' ' A' ' 30' ' ' TRP . 27.0 Cg_exo -64.64 130.68 27.09 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 121.81 1.674 . . . . 0.0 111.055 171.806 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.567 ' HD2' ' O ' ' A' ' 31' ' ' SER . 71.5 Cg_exo -50.39 155.56 4.86 Favored 'Trans proline' 0 C--O 1.235 0.353 0 C-N-CA 122.524 2.149 . . . . 0.0 111.6 171.415 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -35.7 106.19 0.3 Allowed Pre-proline 0 N--CA 1.472 0.654 0 O-C-N 124.56 1.162 . . . . 0.0 112.437 -171.115 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.628 ' HG2' HG11 ' A' ' 91' ' ' VAL . 24.1 Cg_exo -70.5 145.1 51.94 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 123.162 2.575 . . . . 0.0 112.435 177.518 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.2 m -101.64 131.2 48.0 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.568 0.699 . . . . 0.0 110.814 -177.575 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.498 HG11 HG22 ' A' ' 21' ' ' VAL . 70.6 t -81.01 118.24 28.44 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 CA-C-N 114.658 -1.156 . . . . 0.0 110.061 175.226 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -78.05 -46.63 20.39 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.318 -175.568 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -136.74 140.67 42.77 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.679 -178.193 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.498 HG22 HG11 ' A' ' 18' ' ' VAL . 7.2 t -127.24 114.2 35.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.697 -178.063 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -124.63 -164.96 1.32 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 179.467 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.581 ' O ' ' HB2' ' A' ' 69' ' ' LEU . 4.0 p-10 -70.67 -67.1 0.53 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.073 0.463 . . . . 0.0 112.193 -178.109 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.678 HG22 ' O ' ' A' ' 69' ' ' LEU . 35.2 p -110.3 32.08 5.43 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.004 -173.381 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.706 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 42.3 m -167.71 129.99 1.57 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.194 -171.622 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.732 ' HB ' HD12 ' A' ' 66' ' ' LEU . 44.8 mt -147.37 145.57 18.99 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.924 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 177.398 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 43.7 t -118.67 131.4 71.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 119.22 0.918 . . . . 0.0 110.262 -176.803 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.64 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.6 OUTLIER -127.76 145.77 34.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 C-N-CA 120.096 -0.642 . . . . 0.0 110.318 -179.214 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.48 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 11.1 mtm180 -130.02 121.34 26.28 Favored 'General case' 0 CA--C 1.515 -0.379 0 O-C-N 123.397 0.436 . . . . 0.0 110.302 -175.584 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.733 ' HZ3' HG12 ' A' ' 64' ' ' VAL . 34.6 p90 -111.53 145.8 38.43 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.419 -175.306 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.567 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 12.5 t -90.29 91.81 8.66 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 175.124 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.473 ' HD3' ' H ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -46.1 156.3 0.48 Allowed Pre-proline 0 CA--C 1.542 0.662 0 C-N-CA 124.14 0.976 . . . . 0.0 113.507 -174.426 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.684 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 4.2 Cg_exo -76.27 169.53 21.81 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 123.86 3.04 . . . . 0.0 112.939 -173.754 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -83.74 -15.59 48.03 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.344 174.378 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.98 144.87 99.14 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.122 -0.944 . . . . 0.0 111.423 177.233 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -68.6 115.45 3.92 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 121.612 1.542 . . . . 0.0 109.831 167.274 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.638 HD12 ' HE1' ' A' ' 40' ' ' TYR . 1.1 pt -121.11 155.74 24.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -177.683 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.51 ' C ' ' HB3' ' A' ' 59' ' ' GLU . 21.7 p -104.24 -29.32 10.88 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -177.858 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.522 ' C ' HG12 ' A' ' 82' ' ' VAL . . . -161.7 -167.87 22.77 Favored Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.252 -0.975 . . . . 0.0 111.829 179.853 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.684 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 5.5 m-85 -139.93 131.57 27.25 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 120.803 0.335 . . . . 0.0 111.301 174.347 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.593 ' CZ ' HG11 ' A' ' 82' ' ' VAL . 0.2 OUTLIER -99.55 147.79 24.96 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 168.792 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.891 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 33.0 mt -139.71 107.47 2.93 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 C-N-CA 119.875 -0.73 . . . . 0.0 112.435 -179.582 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 82.5 t -108.47 110.7 32.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.138 0.494 . . . . 0.0 110.825 -178.519 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.751 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 0.8 OUTLIER -113.43 125.56 54.37 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 121.503 0.668 . . . . 0.0 109.985 176.175 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.495 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 13.9 t -140.25 140.53 23.6 Favored Pre-proline 0 C--N 1.319 -0.751 0 CA-C-N 113.717 -1.583 . . . . 0.0 110.69 -174.505 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.633 ' HG3' ' CZ ' ' A' ' 75' ' ' TYR . 2.4 Cg_endo -80.46 148.3 18.34 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 123.605 2.87 . . . . 0.0 111.67 178.57 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 15.0 m -71.35 -30.11 65.78 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.584 179.87 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.9 p -118.18 -40.25 2.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 179.345 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.504 ' HG2' ' CB ' ' A' ' 70' ' ' GLN . 10.2 tp10 -76.77 166.54 23.22 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.598 -0.273 . . . . 0.0 110.31 -179.344 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -115.88 17.64 15.23 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.389 -0.91 . . . . 0.0 114.581 -174.792 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.7 t -93.06 111.72 23.44 Favored 'General case' 0 C--N 1.334 -0.088 0 CA-C-N 118.954 1.377 . . . . 0.0 109.054 174.334 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 22.7 p -123.08 148.16 45.93 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.076 179.576 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.751 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 62.7 m -146.92 145.6 29.86 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 119.922 -0.711 . . . . 0.0 111.588 176.919 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.891 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 41.8 tt0 -116.56 115.75 26.33 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.94 174.532 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.684 HD12 ' CG2' ' A' ' 64' ' ' VAL . 18.8 mt -97.52 161.55 13.72 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 175.855 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.486 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 36.9 t30 -126.12 119.44 27.56 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 177.651 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.573 HD12 ' CH2' ' A' ' 30' ' ' TRP . 4.7 mt -113.96 159.55 35.64 Favored Pre-proline 0 C--N 1.317 -0.822 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 -177.419 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -67.18 151.99 80.39 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 121.534 1.489 . . . . 0.0 111.005 174.66 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.51 ' HB3' ' C ' ' A' ' 38' ' ' THR . 7.0 pt-20 -47.8 -24.75 1.06 Allowed 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.092 -0.958 . . . . 0.0 112.632 177.468 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.9 t -104.6 15.87 27.17 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.09 -174.524 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.428 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -86.81 161.69 18.21 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 178.057 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.48 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 4.3 p-10 -145.31 15.37 1.48 Allowed 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.954 -178.092 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.64 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 26.4 p -168.83 133.88 1.6 Allowed 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.281 -0.568 . . . . 0.0 111.694 -179.016 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.733 HG12 ' HZ3' ' A' ' 30' ' ' TRP . 3.3 p -117.33 139.83 42.72 Favored 'Isoleucine or valine' 0 C--O 1.244 0.81 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.47 177.237 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 47.7 m -97.23 101.14 12.64 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.579 168.391 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.732 HD12 ' HB ' ' A' ' 26' ' ' ILE . 0.3 OUTLIER -76.03 141.9 41.97 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.597 177.924 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.436 ' HA ' ' O ' ' A' ' 24' ' ' THR . 27.3 p -136.62 166.22 24.04 Favored 'General case' 0 N--CA 1.447 -0.595 0 O-C-N 123.819 0.7 . . . . 0.0 110.041 -174.955 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 61.93 38.54 14.32 Favored 'General case' 0 N--CA 1.464 0.227 0 O-C-N 123.688 0.617 . . . . 0.0 111.431 -179.214 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.678 ' O ' HG22 ' A' ' 24' ' ' THR . 8.1 mt -85.04 -176.26 6.12 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 175.459 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.504 ' CB ' ' HG2' ' A' ' 49' ' ' GLU . 58.4 tp60 -126.72 124.69 24.21 Favored Pre-proline 0 C--N 1.32 -0.704 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 176.479 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -62.24 134.54 49.35 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 123.188 2.592 . . . . 0.0 113.498 -178.072 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 86.53 24.27 40.0 Favored Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.363 176.977 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 17.9 t -130.53 149.23 33.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.236 0.541 . . . . 0.0 111.445 -176.232 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.494 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 14.8 tp60 -79.64 108.0 12.85 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.634 179.971 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.633 ' CZ ' ' HG3' ' A' ' 46' ' ' PRO . 4.2 m-85 -101.15 116.52 33.01 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.377 0.608 . . . . 0.0 111.868 -178.708 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.585 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 31.0 m-80 -89.2 109.02 19.94 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.448 177.037 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.678 HG12 HD11 ' A' ' 66' ' ' LEU . 5.2 mp -92.56 116.01 32.73 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.616 0 CA-C-O 121.332 0.586 . . . . 0.0 109.571 175.598 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.874 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 89.2 m -108.82 116.18 31.5 Favored 'General case' 0 N--CA 1.426 -1.639 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.243 179.954 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.558 ' HB ' ' HB ' ' A' ' 91' ' ' VAL . 15.6 mm -95.26 140.59 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 -178.959 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -127.87 113.04 15.4 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 178.776 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.458 ' HB1' HG21 ' A' ' 37' ' ' ILE . . . -84.12 119.65 25.23 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 171.173 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.593 HG11 ' CZ ' ' A' ' 41' ' ' ARG . 7.5 p -110.54 141.22 26.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 C-N-CA 120.237 -0.585 . . . . 0.0 110.204 -175.355 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.604 ' OE1' ' HB2' ' A' ' 86' ' ' GLN . 0.1 OUTLIER -123.28 170.88 9.84 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 123.37 0.419 . . . . 0.0 110.104 177.183 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -34.64 -55.83 0.55 Allowed 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 113.839 1.052 . . . . 0.0 113.839 -171.241 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -123.81 14.72 9.33 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 -174.627 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.604 ' HB2' ' OE1' ' A' ' 83' ' ' GLU . 25.4 mt-30 -146.18 170.81 15.96 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.368 0.604 . . . . 0.0 111.849 -177.298 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -127.38 124.63 39.02 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.113 173.704 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 15.4 m -76.2 -178.52 4.53 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.648 0.261 . . . . 0.0 111.088 -177.635 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.576 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 3.9 p -67.39 154.93 92.07 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-O 120.947 0.403 . . . . 0.0 111.438 -178.378 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -88.2 141.6 5.08 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 122.76 2.307 . . . . 0.0 115.031 179.747 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.874 ' O ' ' HA ' ' A' ' 78' ' ' THR . 8.8 t -83.34 131.59 33.43 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.538 0 CA-C-N 114.678 -1.146 . . . . 0.0 108.271 163.892 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 13.7 t -125.02 106.81 17.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 C-N-CA 119.94 -0.704 . . . . 0.0 110.172 170.178 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.623 HG13 ' HB ' ' A' ' 77' ' ' ILE . 8.2 pt -121.11 111.43 31.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.342 178.185 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -97.23 112.99 24.55 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.659 0.742 . . . . 0.0 111.6 -177.035 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.92 131.54 53.41 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.484 179.77 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -86.47 129.89 34.69 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.046 0.451 . . . . 0.0 110.519 -179.483 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.443 HG22 HD11 ' A' ' 26' ' ' ILE . 20.3 p -60.43 117.68 5.55 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.227 179.626 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.424 ' H ' HG12 ' A' ' 21' ' ' VAL . 39.1 m -70.9 -31.5 68.16 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.039 179.651 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.486 ' HA2' ' CA ' ' A' ' 23' ' ' ASP . . . 66.79 -115.6 7.43 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.193 -0.912 . . . . 0.0 112.678 176.711 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 21.1 m -93.28 121.34 65.51 Favored Pre-proline 0 C--N 1.319 -0.751 0 N-CA-C 110.347 -0.242 . . . . 0.0 110.347 179.0 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -56.23 130.7 41.55 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.532 2.155 . . . . 0.0 111.139 176.207 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 36.5 mmt180 -83.36 49.4 1.56 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.858 0.361 . . . . 0.0 110.895 -175.978 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 17.6 m -67.46 -38.38 84.39 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.316 179.211 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -95.84 167.15 11.43 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.071 177.879 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 78.25 34.1 37.92 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.287 -179.973 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 24.5 m . . . . . 0 C--O 1.25 1.131 0 CA-C-O 118.419 -0.801 . . . . 0.0 110.597 -178.798 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.654 0 N-CA-C 111.849 -0.501 . . . . 0.0 111.849 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 40.1 m -142.24 39.67 1.6 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.84 0.352 . . . . 0.0 110.907 -178.798 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 33.0 t60 -71.43 -43.19 67.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.899 0.38 . . . . 0.0 110.001 177.616 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 52.5 tpp -94.43 -56.53 2.78 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.225 178.333 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -87.97 74.38 2.19 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.009 -179.846 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 12.9 t -99.12 -7.99 25.85 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.407 0.623 . . . . 0.0 110.083 179.604 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.4 HG21 ' HA ' ' A' ' 35' ' ' ALA . 2.6 m 64.47 63.56 0.74 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 114.649 -1.16 . . . . 0.0 111.047 179.07 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 17.1 m -63.09 128.25 34.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.25 177.873 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 66.2 92.42 0.06 OUTLIER Pre-proline 0 C--O 1.235 0.304 0 O-C-N 123.751 0.657 . . . . 0.0 110.383 -175.719 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.402 ' HG3' ' OE1' ' A' ' 83' ' ' GLU . 55.4 Cg_endo -69.07 151.31 73.0 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 122.927 2.418 . . . . 0.0 112.371 -175.425 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.442 ' HB2' ' HB3' ' A' ' 33' ' ' PRO . 1.0 OUTLIER -80.99 153.66 27.33 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.454 178.263 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -96.75 158.79 32.98 Favored Pre-proline 0 C--N 1.312 -1.058 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 163.559 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.456 ' CB ' ' HB2' ' A' ' 30' ' ' TRP . 23.6 Cg_exo -67.35 126.16 14.54 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 121.364 1.376 . . . . 0.0 111.535 176.589 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.42 ' HD2' ' O ' ' A' ' 31' ' ' SER . 76.6 Cg_exo -49.49 145.39 16.56 Favored 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.469 2.112 . . . . 0.0 110.634 171.486 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.402 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 10.1 m-20 -35.95 105.62 0.29 Allowed Pre-proline 0 N--CA 1.47 0.55 0 O-C-N 124.701 1.251 . . . . 0.0 112.329 -169.394 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.597 ' HG2' HG11 ' A' ' 91' ' ' VAL . 31.3 Cg_exo -64.76 155.45 67.25 Favored 'Trans proline' 0 CA--C 1.514 -0.492 0 C-N-CA 123.747 2.965 . . . . 0.0 112.407 -179.81 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 31.6 m -113.77 131.03 56.36 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.806 -178.207 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.511 HG11 HG22 ' A' ' 21' ' ' VAL . 71.4 t -73.26 122.81 26.9 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 114.054 -1.43 . . . . 0.0 109.884 175.051 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -84.47 -41.94 16.09 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.944 -173.847 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -136.22 140.62 43.65 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.163 178.574 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.511 HG22 HG11 ' A' ' 18' ' ' VAL . 39.8 t -123.72 119.46 57.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.468 178.191 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.406 ' HB2' ' O ' ' A' ' 25' ' ' SER . 23.6 m-20 -124.36 -159.06 0.85 Allowed 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 176.95 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.569 ' HB3' ' C ' ' A' ' 99' ' ' GLY . 17.8 p-10 -84.44 -54.41 4.78 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.3 0.571 . . . . 0.0 111.348 179.094 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.599 HG22 ' O ' ' A' ' 69' ' ' LEU . 29.9 p -119.61 29.73 7.44 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.192 -172.409 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.636 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 17.0 p -169.91 130.6 1.01 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.665 -1.152 . . . . 0.0 109.858 -176.097 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.606 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 48.0 mt -148.05 142.22 19.23 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.666 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.765 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.458 ' O ' HG13 ' A' ' 18' ' ' VAL . 44.9 t -115.96 136.21 53.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 C-N-CA 119.858 -0.737 . . . . 0.0 109.933 -175.701 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.642 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.6 OUTLIER -127.13 145.41 34.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 C-N-CA 120.122 -0.631 . . . . 0.0 110.162 179.105 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.48 ' HG2' ' HB3' ' A' ' 63' ' ' SER . 54.8 mtp180 -130.02 120.98 25.61 Favored 'General case' 0 C--N 1.327 -0.408 0 O-C-N 123.535 0.522 . . . . 0.0 110.497 -174.766 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.708 ' HZ3' HG12 ' A' ' 64' ' ' VAL . 35.7 p90 -113.47 149.04 34.84 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.879 -174.052 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.433 ' O ' ' HA ' ' A' ' 13' ' ' PRO . 48.2 m -92.75 88.53 6.28 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.202 175.758 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.526 ' HD3' ' H ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -50.75 159.05 0.99 Allowed Pre-proline 0 CA--C 1.544 0.715 0 CA-C-N 114.99 -1.005 . . . . 0.0 113.404 -175.413 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.729 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 6.4 Cg_exo -74.08 169.33 22.69 Favored 'Trans proline' 0 C--N 1.358 1.032 0 C-N-CA 124.001 3.134 . . . . 0.0 113.332 -172.597 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -91.38 3.88 53.81 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.242 174.842 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.4 ' HA ' HG21 ' A' ' 7' ' ' THR . . . -85.4 151.41 56.22 Favored Pre-proline 0 CA--C 1.515 -0.378 0 CA-C-N 114.683 -1.144 . . . . 0.0 110.532 178.686 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -75.85 114.76 4.01 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 121.446 1.431 . . . . 0.0 109.92 171.728 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.614 HD12 ' HE1' ' A' ' 40' ' ' TYR . 2.6 pt -123.06 157.52 28.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.728 -173.508 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.407 ' H ' ' HA ' ' A' ' 83' ' ' GLU . 6.8 p -91.91 -39.12 11.89 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -178.483 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.436 ' O ' HG12 ' A' ' 82' ' ' VAL . . . -169.45 -162.99 22.72 Favored Glycine 0 N--CA 1.439 -1.11 0 C-N-CA 119.542 -1.313 . . . . 0.0 112.687 -178.98 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.729 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 5.1 m-85 -137.71 135.64 36.63 Favored 'General case' 0 CA--C 1.506 -0.746 0 CA-C-O 120.897 0.38 . . . . 0.0 111.175 178.993 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.6 mtm105 -107.53 147.62 30.31 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 169.987 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.875 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 27.3 mt -139.22 109.74 4.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 C-N-CA 120.17 -0.612 . . . . 0.0 112.471 -174.758 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 78.4 t -111.11 110.34 31.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.578 179.011 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.784 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 0.7 OUTLIER -112.08 124.94 53.51 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.427 176.646 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.431 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 8.1 p -138.02 136.24 19.48 Favored Pre-proline 0 C--N 1.312 -1.039 0 CA-C-N 113.946 -1.479 . . . . 0.0 111.47 -172.394 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.595 ' HB3' HG11 ' A' ' 73' ' ' VAL . 16.1 Cg_exo -64.78 129.46 23.49 Favored 'Trans proline' 0 CA--C 1.519 -0.242 0 C-N-CA 122.929 2.419 . . . . 0.0 110.934 174.905 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 13.6 m -60.31 -26.6 66.66 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.683 -0.689 . . . . 0.0 112.453 -173.538 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.475 ' O ' ' HB3' ' A' ' 49' ' ' GLU . 17.7 m -105.54 -41.94 6.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 120.546 -0.462 . . . . 0.0 111.805 179.675 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.475 ' HB3' ' O ' ' A' ' 48' ' ' VAL . 12.1 pt-20 165.31 157.18 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.534 0.734 . . . . 0.0 109.654 177.212 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 147.05 -143.82 11.83 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.95 178.481 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 45.4 m -91.04 121.64 33.02 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.743 0.271 . . . . 0.0 110.987 -179.709 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.9 m -116.07 145.58 42.9 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 176.021 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.784 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 26.3 m -145.67 154.99 42.71 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 120.53 -0.468 . . . . 0.0 111.493 -175.507 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.875 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 33.3 tt0 -127.46 112.92 15.52 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.603 -179.026 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.708 HD12 ' CG2' ' A' ' 64' ' ' VAL . 17.0 mt -100.86 162.35 12.96 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.455 178.183 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.555 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 2.3 m120 -128.65 115.89 18.74 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 176.837 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.57 HD12 ' CH2' ' A' ' 30' ' ' TRP . 4.6 mt -110.85 156.86 40.04 Favored Pre-proline 0 N--CA 1.441 -0.883 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -175.96 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -63.26 151.22 85.92 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 121.737 1.625 . . . . 0.0 110.989 175.902 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.437 ' HB2' HG13 ' A' ' 37' ' ' ILE . 9.8 pt-20 -45.84 -28.95 1.2 Allowed 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.344 176.707 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.5 t -101.2 19.53 17.44 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.148 -174.834 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.506 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -89.11 161.08 16.7 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 178.635 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.446 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 29.6 p-10 -147.85 15.94 1.09 Allowed 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -177.123 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.642 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 28.0 p -171.32 133.95 0.86 Allowed 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.226 -0.59 . . . . 0.0 111.779 -178.476 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.716 HG11 HG21 ' A' ' 42' ' ' ILE . 3.1 p -117.13 136.77 53.2 Favored 'Isoleucine or valine' 0 C--O 1.24 0.59 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.434 177.146 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 41.3 m -94.57 101.71 13.61 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.668 169.106 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.636 ' O ' ' HA ' ' A' ' 25' ' ' SER . 0.2 OUTLIER -78.8 141.04 38.09 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 177.551 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 10.9 t -137.3 172.65 12.67 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 -177.035 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 60.93 31.58 19.97 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.476 -179.287 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.599 ' O ' HG22 ' A' ' 24' ' ' THR . 10.7 mt -74.42 -176.99 2.89 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 176.917 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 7.7 tp60 -126.15 121.59 23.99 Favored Pre-proline 0 C--N 1.319 -0.741 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 177.5 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.426 ' HB3' ' HA2' ' A' ' 99' ' ' GLY . 12.0 Cg_endo -60.29 135.06 59.33 Favored 'Trans proline' 0 C--O 1.235 0.366 0 C-N-CA 123.001 2.467 . . . . 0.0 113.372 -177.634 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 87.71 17.47 58.23 Favored Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.309 177.323 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.595 HG11 ' HB3' ' A' ' 46' ' ' PRO . 14.1 t -125.62 146.62 31.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 120.816 0.341 . . . . 0.0 110.841 -177.573 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.553 ' OE1' ' HB2' ' A' ' 96' ' ' GLU . 35.0 tp60 -81.05 122.69 27.63 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.782 178.744 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.463 ' CE2' HD22 ' A' ' 69' ' ' LEU . 5.4 m-85 -105.98 116.17 31.48 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 121.599 0.714 . . . . 0.0 111.725 -179.297 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.423 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 16.2 t-20 -90.14 104.1 16.7 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 114.487 -1.233 . . . . 0.0 109.113 177.01 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.623 HG12 HD11 ' A' ' 66' ' ' LEU . 5.3 mp -92.25 116.41 33.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.347 0.594 . . . . 0.0 109.758 177.722 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.84 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 62.1 m -108.3 116.13 31.39 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.09 179.094 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.612 ' HB ' ' HB ' ' A' ' 91' ' ' VAL . 15.5 mm -95.61 141.92 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.831 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -126.94 112.99 15.93 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 179.613 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -89.25 123.1 33.15 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 174.53 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.436 HG12 ' O ' ' A' ' 39' ' ' GLY . 7.3 p -120.63 134.67 63.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 120.02 -0.672 . . . . 0.0 112.258 -173.122 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.611 ' HG2' HG22 ' A' ' 37' ' ' ILE . 6.3 mt-10 -104.59 171.82 7.12 Favored 'General case' 0 N--CA 1.454 -0.261 0 O-C-N 124.146 0.904 . . . . 0.0 109.228 173.607 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -47.68 -39.51 17.56 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 179.081 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -113.36 -29.33 7.26 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -171.343 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -133.32 176.34 8.6 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.553 -0.459 . . . . 0.0 111.683 -170.011 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -134.61 137.78 43.98 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.789 177.717 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 17.7 m -77.64 173.47 12.01 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.828 -179.69 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 14.2 p -61.79 154.63 66.02 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-O 120.918 0.39 . . . . 0.0 110.623 176.567 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -81.64 142.6 12.97 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 122.067 1.845 . . . . 0.0 113.622 -175.463 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.84 ' O ' ' HA ' ' A' ' 78' ' ' THR . 7.1 t -83.18 129.41 37.5 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.771 0 CA-C-N 114.879 -1.055 . . . . 0.0 108.615 168.09 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.9 t -126.27 106.96 16.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.153 175.01 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.547 HG13 ' HB ' ' A' ' 77' ' ' ILE . 8.1 pt -128.17 118.9 49.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.47 178.794 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -103.39 129.93 50.59 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.402 0.62 . . . . 0.0 111.349 -176.877 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.06 130.03 23.19 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.96 176.517 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.553 ' HB2' ' OE1' ' A' ' 74' ' ' GLN . 34.5 tt0 -85.83 136.12 33.44 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.251 0.548 . . . . 0.0 110.093 179.959 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 25.4 p -65.92 124.5 22.67 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.55 179.709 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.4 m -68.57 -31.71 71.1 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.228 -173.292 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.569 ' C ' ' HB3' ' A' ' 23' ' ' ASP . . . 119.56 166.68 13.41 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.001 177.697 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.496 ' N ' ' HB3' ' A' ' 23' ' ' ASP . 24.1 m -68.37 123.11 86.78 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-O 120.379 0.133 . . . . 0.0 110.96 -176.172 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 100' ' ' THR . 35.9 Cg_exo -58.31 101.27 0.12 Allowed 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.974 2.449 . . . . 0.0 112.235 178.826 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 7.8 ptp180 -145.15 171.15 14.93 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.872 -179.96 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 35.8 t -145.25 135.95 24.44 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 177.771 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 71.3 -64.56 0.38 Allowed 'General case' 0 N--CA 1.467 0.391 0 O-C-N 123.911 0.757 . . . . 0.0 112.034 175.508 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -121.15 177.62 16.39 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.339 -178.632 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.7 t . . . . . 0 C--O 1.249 1.041 0 CA-C-O 119.058 -0.496 . . . . 0.0 110.401 -179.814 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.82 0 N-CA-C 111.708 -0.557 . . . . 0.0 111.708 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 28.2 m -79.49 -178.21 6.18 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 178.35 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 62.22 40.39 11.64 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.321 0.581 . . . . 0.0 109.626 -176.665 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 23.0 ptt? -107.03 169.5 8.51 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.106 -175.295 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 104.22 -169.58 17.71 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.952 -0.642 . . . . 0.0 111.632 -179.37 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.0 m -78.62 71.58 5.09 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.279 0.562 . . . . 0.0 110.24 179.279 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.1 p -73.21 -12.91 61.04 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.839 -176.823 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 13.0 t -79.99 -4.48 52.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.734 0.778 . . . . 0.0 110.387 176.189 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -129.37 88.28 51.0 Favored Pre-proline 0 C--N 1.311 -1.084 0 CA-C-N 114.7 -1.137 . . . . 0.0 109.377 175.411 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -64.04 142.36 80.8 Favored 'Trans proline' 0 C--O 1.235 0.372 0 C-N-CA 122.654 2.236 . . . . 0.0 113.337 -173.342 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -90.02 162.82 15.17 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.797 175.646 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -97.04 159.68 30.84 Favored Pre-proline 0 C--N 1.316 -0.854 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.249 177.317 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -68.61 133.14 26.95 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.482 2.122 . . . . 0.0 111.678 175.005 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.77 154.24 21.65 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.321 2.014 . . . . 0.0 110.943 172.91 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -36.45 107.2 0.35 Allowed Pre-proline 0 N--CA 1.468 0.464 0 O-C-N 124.595 1.184 . . . . 0.0 112.445 -172.148 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.622 ' HG2' HG11 ' A' ' 91' ' ' VAL . 36.1 Cg_exo -66.69 150.93 83.53 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 123.09 2.526 . . . . 0.0 112.265 177.712 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 45.8 m -106.93 129.04 54.81 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.872 -179.07 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.473 HG11 HG22 ' A' ' 21' ' ' VAL . 78.2 t -76.99 123.29 33.27 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-N 114.509 -1.223 . . . . 0.0 109.891 173.75 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -91.59 -37.39 13.11 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.341 -174.813 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 13.9 mm-40 -136.17 132.74 36.36 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.788 -178.59 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.485 ' HA ' HG12 ' A' ' 26' ' ' ILE . 46.5 t -124.01 120.1 58.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.388 179.637 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -127.5 -159.98 0.98 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 178.809 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.402 ' HB3' ' HA2' ' A' ' 99' ' ' GLY . 1.8 p-10 -74.48 -72.11 0.3 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 179.162 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.608 HG22 ' O ' ' A' ' 69' ' ' LEU . 69.9 p -105.41 33.57 3.64 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.211 -174.034 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.601 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 68.5 p -169.66 137.16 1.71 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.574 -173.628 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.618 ' HB ' HD12 ' A' ' 66' ' ' LEU . 35.9 mt -150.71 145.68 16.69 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.904 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.783 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.432 ' O ' HG13 ' A' ' 18' ' ' VAL . 41.0 t -118.36 131.85 69.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 119.255 0.934 . . . . 0.0 110.472 -176.062 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.59 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.6 OUTLIER -127.13 146.52 32.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.233 -178.119 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.47 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 20.2 mtm180 -130.69 121.27 25.2 Favored 'General case' 0 C--N 1.329 -0.303 0 O-C-N 123.244 0.34 . . . . 0.0 110.57 -175.856 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.823 ' HZ3' HG12 ' A' ' 64' ' ' VAL . 39.5 p90 -112.06 146.74 37.41 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.103 -175.651 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 24.0 t -92.59 99.09 11.86 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.928 177.548 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.605 ' CD ' ' H ' ' A' ' 32' ' ' ARG . 0.2 OUTLIER -53.49 160.3 1.96 Allowed Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 115.098 -0.955 . . . . 0.0 113.189 -174.261 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.645 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 2.2 Cg_endo -84.93 163.52 11.81 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 124.307 3.338 . . . . 0.0 112.279 -177.254 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -82.73 -6.42 59.39 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.338 172.064 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -66.2 146.79 99.04 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.841 174.557 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -73.94 114.08 3.94 Favored 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 121.165 1.244 . . . . 0.0 109.857 170.213 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.583 HD12 ' HE1' ' A' ' 40' ' ' TYR . 0.8 OUTLIER -120.56 147.79 24.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 -177.455 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.422 ' N ' ' O ' ' A' ' 82' ' ' VAL . 25.4 p -88.89 -30.2 19.05 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -178.335 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.59 ' C ' HG12 ' A' ' 82' ' ' VAL . . . -171.09 -162.3 23.21 Favored Glycine 0 CA--C 1.499 -0.942 0 C-N-CA 120.116 -1.04 . . . . 0.0 111.551 -179.327 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.645 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 6.5 m-85 -140.06 132.6 28.69 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 117.01 0.405 . . . . 0.0 111.155 173.807 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.2 mmm180 -100.7 147.72 25.69 Favored 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 168.031 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.881 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 32.0 mt -138.29 108.21 4.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 C-N-CA 119.926 -0.71 . . . . 0.0 112.328 -178.395 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 93.1 t -110.41 111.52 36.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.088 0.47 . . . . 0.0 110.762 -178.154 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.742 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 0.6 OUTLIER -115.24 126.2 54.25 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.077 177.357 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 30.8 p -134.22 137.52 28.28 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 113.742 -1.572 . . . . 0.0 111.705 -174.696 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.617 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 92.9 Cg_endo -80.52 130.6 7.98 Favored 'Trans proline' 0 N--CA 1.464 -0.231 0 C-N-CA 123.638 2.892 . . . . 0.0 111.937 178.488 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 23.1 t -72.72 -28.0 62.4 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.017 -178.325 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.2 m -117.48 16.48 7.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.173 0.511 . . . . 0.0 112.177 -176.187 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.546 ' HB2' HG11 ' A' ' 73' ' ' VAL . 1.2 tm-20 -149.83 -166.01 2.43 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.239 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -137.4 17.73 3.51 Favored Glycine 0 N--CA 1.443 -0.843 0 C-N-CA 119.283 -1.437 . . . . 0.0 115.034 -174.208 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.598 ' O ' ' HD3' ' A' ' 46' ' ' PRO . 7.7 t -93.37 111.19 22.79 Favored 'General case' 0 C--O 1.225 -0.197 0 CA-C-N 119.265 1.532 . . . . 0.0 109.386 174.278 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.0 p -123.41 148.83 45.73 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.719 -179.341 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.742 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 38.0 m -145.16 147.97 33.07 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 119.886 -0.725 . . . . 0.0 111.825 177.994 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.881 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 34.9 tt0 -118.54 114.1 22.3 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.957 176.014 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.697 HD12 ' CG2' ' A' ' 64' ' ' VAL . 16.8 mt -97.94 159.49 14.9 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.0 0.429 . . . . 0.0 110.318 176.564 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -123.43 113.63 19.05 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.59 179.253 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.557 HD12 ' CH2' ' A' ' 30' ' ' TRP . 2.6 mt -111.8 154.92 43.88 Favored Pre-proline 0 C--N 1.318 -0.796 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 -176.726 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -65.53 150.21 86.91 Favored 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 121.569 1.512 . . . . 0.0 110.958 175.955 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -45.11 -25.53 0.35 Allowed 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 114.618 -1.173 . . . . 0.0 113.186 178.981 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 5.4 t -103.9 5.01 35.42 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.44 -174.244 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.434 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -74.97 155.99 36.79 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 -179.677 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.493 ' HB3' ' NE ' ' A' ' 32' ' ' ARG . 26.6 p-10 -137.04 12.94 3.09 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.931 -177.32 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.59 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 23.3 p -169.1 133.79 1.49 Allowed 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 119.973 -0.691 . . . . 0.0 111.905 -177.525 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.823 HG12 ' HZ3' ' A' ' 30' ' ' TRP . 3.6 p -116.14 137.16 50.75 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.122 176.744 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 42.8 m -95.84 101.16 12.82 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 168.56 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.666 HD11 HG12 ' A' ' 77' ' ' ILE . 0.2 OUTLIER -76.49 141.13 41.39 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.259 178.65 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.6 t -136.48 170.73 15.57 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -177.432 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 65.1 29.57 11.96 Favored 'General case' 0 C--N 1.327 -0.388 0 O-C-N 123.665 0.603 . . . . 0.0 111.549 -178.155 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.608 ' O ' HG22 ' A' ' 24' ' ' THR . 9.1 mt -78.73 -175.6 4.49 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 174.135 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -126.99 131.99 24.12 Favored Pre-proline 0 C--N 1.32 -0.702 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 177.876 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -64.49 133.65 38.08 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.87 2.38 . . . . 0.0 113.008 -178.214 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 74.92 34.37 53.0 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.947 -0.644 . . . . 0.0 111.649 179.758 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.546 HG11 ' HB2' ' A' ' 49' ' ' GLU . 70.1 t -134.62 139.79 46.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.209 0.528 . . . . 0.0 110.815 -177.042 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.617 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -81.05 121.13 25.69 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.047 -176.053 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -116.66 115.82 26.39 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -175.306 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.544 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 2.6 m-20 -85.55 111.47 20.05 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.547 -0.752 . . . . 0.0 109.752 174.345 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.666 HG12 HD11 ' A' ' 66' ' ' LEU . 5.1 mp -93.47 117.95 38.14 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.602 0 CA-C-O 121.164 0.507 . . . . 0.0 109.748 175.751 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.883 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 24.9 m -109.39 115.14 29.4 Favored 'General case' 0 N--CA 1.428 -1.573 0 CA-C-N 115.25 -0.887 . . . . 0.0 110.545 -179.693 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.546 ' HB ' ' HB ' ' A' ' 91' ' ' VAL . 12.4 mm -95.73 139.88 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 179.537 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.427 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 68.4 m-85 -128.46 112.39 14.32 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.624 -0.262 . . . . 0.0 110.343 179.085 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.401 ' HB1' HG21 ' A' ' 37' ' ' ILE . . . -79.42 109.32 13.67 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 170.874 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.59 HG12 ' C ' ' A' ' 39' ' ' GLY . 11.1 p -99.39 140.77 18.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.756 -173.927 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -122.93 165.2 17.1 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 -178.412 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -47.16 -47.87 23.7 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -176.716 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -130.1 17.63 5.56 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.37 -176.899 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 66.9 mm-40 -142.31 169.58 17.32 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.871 0.367 . . . . 0.0 111.328 -179.023 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -146.72 120.34 9.16 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.088 177.943 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 21.7 m -65.1 157.81 27.56 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.782 179.742 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 21.1 p -55.16 150.12 22.64 Favored Pre-proline 0 N--CA 1.453 -0.294 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.312 176.635 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -77.61 140.28 18.75 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 121.755 1.637 . . . . 0.0 113.548 -173.68 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.883 ' O ' ' HA ' ' A' ' 78' ' ' THR . 4.6 t -81.53 123.42 37.87 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.832 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 167.348 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 4.8 t -119.75 105.38 17.18 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 C-N-CA 119.53 -0.868 . . . . 0.0 109.857 172.452 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.569 HG13 ' HB ' ' A' ' 77' ' ' ILE . 6.4 pt -120.73 111.11 30.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.354 175.897 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.41 ' CD ' ' H ' ' A' ' 94' ' ' GLN . 0.0 OUTLIER -97.22 114.88 26.66 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.806 0.812 . . . . 0.0 110.76 -175.819 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.79 129.39 50.36 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.937 -1.028 . . . . 0.0 109.398 179.44 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.411 ' HA ' ' HA ' ' A' ' 74' ' ' GLN . 36.2 tt0 -89.42 137.82 31.99 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.146 0.498 . . . . 0.0 110.433 179.148 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 41.7 p -71.46 121.61 18.93 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.928 -178.128 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.9 m -69.43 -30.87 68.9 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.344 0.592 . . . . 0.0 110.15 179.937 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.402 ' HA2' ' HB3' ' A' ' 23' ' ' ASP . . . 82.59 -114.47 3.84 Favored Glycine 0 N--CA 1.443 -0.898 0 CA-C-N 115.187 -0.915 . . . . 0.0 112.237 177.776 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 4.1 m -98.02 146.52 31.64 Favored Pre-proline 0 C--N 1.316 -0.849 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 177.459 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_exo -64.59 55.65 0.24 Allowed 'Trans proline' 0 C--N 1.356 0.95 0 C-N-CA 123.205 2.603 . . . . 0.0 112.786 176.566 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 17.0 ptp180 -169.8 42.25 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 179.385 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 8.9 m -59.73 -35.35 74.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.108 -174.686 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -104.55 23.74 12.82 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.096 0.474 . . . . 0.0 110.268 177.118 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -82.75 68.05 3.62 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.092 -179.731 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 3.5 t . . . . . 0 C--O 1.245 0.865 0 CA-C-O 119.382 -0.342 . . . . 0.0 110.29 179.362 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.643 0 N-CA-C 111.686 -0.566 . . . . 0.0 111.686 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.1 m -82.84 -19.39 37.67 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.801 0.334 . . . . 0.0 111.395 -177.132 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 49.1 m80 -101.79 -60.51 1.52 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.152 179.577 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 23.7 mmt -78.74 92.24 4.78 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.122 0.487 . . . . 0.0 111.071 -177.009 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.445 ' HA2' ' CB ' ' A' ' 9' ' ' ALA . . . -83.25 61.19 4.81 Favored Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.807 177.068 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 12.8 p -61.48 106.22 0.62 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.634 0.254 . . . . 0.0 110.842 -179.765 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 62.1 p 49.25 52.16 14.95 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.793 -175.41 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 19.4 m 75.99 123.54 0.04 OUTLIER 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.217 -178.186 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.445 ' CB ' ' HA2' ' A' ' 5' ' ' GLY . . . -129.78 94.72 31.01 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.2 175.988 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.603 ' HG3' ' OE1' ' A' ' 83' ' ' GLU . 98.3 Cg_endo -75.97 -178.33 4.28 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 122.981 2.454 . . . . 0.0 112.109 -179.265 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -130.51 154.44 47.78 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.128 -178.203 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -91.11 158.24 41.75 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.76 176.229 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -63.27 130.59 29.13 Favored 'Trans proline' 0 C--O 1.235 0.346 0 C-N-CA 122.324 2.016 . . . . 0.0 111.96 177.537 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.506 ' HD2' ' O ' ' A' ' 31' ' ' SER . 72.7 Cg_exo -49.54 146.07 15.5 Favored 'Trans proline' 0 C--O 1.237 0.426 0 C-N-CA 122.891 2.394 . . . . 0.0 111.091 172.856 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.429 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 9.4 p-10 -35.76 106.66 0.32 Allowed Pre-proline 0 N--CA 1.466 0.366 0 O-C-N 124.837 1.336 . . . . 0.0 112.541 -169.276 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.65 ' HG2' HG11 ' A' ' 91' ' ' VAL . 34.6 Cg_exo -67.03 150.94 82.64 Favored 'Trans proline' 0 CA--C 1.517 -0.359 0 C-N-CA 123.368 2.712 . . . . 0.0 112.039 179.08 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.2 m -110.35 131.09 55.36 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.804 -178.387 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.465 HG11 HG22 ' A' ' 21' ' ' VAL . 76.0 t -75.67 119.87 24.38 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-N 114.446 -1.252 . . . . 0.0 109.653 173.756 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -86.97 -40.5 14.72 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.324 -174.809 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -136.03 138.5 42.26 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.995 0.426 . . . . 0.0 110.726 -179.776 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.465 HG22 HG11 ' A' ' 18' ' ' VAL . 17.0 t -125.98 125.16 67.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.005 179.825 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -130.58 -157.27 0.81 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.509 0.195 . . . . 0.0 110.475 -179.249 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.439 ' OD1' ' N ' ' A' ' 24' ' ' THR . 1.9 p30 -73.79 -69.43 0.44 Allowed 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 178.411 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.5 HG22 ' O ' ' A' ' 69' ' ' LEU . 67.7 p -114.39 37.12 3.48 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.483 0.659 . . . . 0.0 109.944 -174.335 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.652 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 55.1 m -167.97 131.49 1.64 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.807 -171.295 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.61 ' HB ' HD12 ' A' ' 66' ' ' LEU . 48.8 mt -149.86 140.8 16.81 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.905 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.522 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 36.5 t -116.52 132.12 67.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 119.135 0.879 . . . . 0.0 110.534 -173.822 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.572 ' O ' ' HA ' ' A' ' 63' ' ' SER . 0.7 OUTLIER -126.97 145.59 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.23 -178.996 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.505 ' HG2' ' HB3' ' A' ' 63' ' ' SER . 16.9 mtp180 -128.15 121.5 29.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.524 -175.685 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.834 ' HZ3' HG12 ' A' ' 64' ' ' VAL . 38.7 p90 -114.41 148.56 37.53 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.355 -175.65 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.506 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 32.2 t -93.74 97.64 10.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.935 178.136 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.569 ' CD ' ' H ' ' A' ' 32' ' ' ARG . 0.8 OUTLIER -51.43 155.78 2.4 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.376 -0.829 . . . . 0.0 113.007 -175.497 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.676 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 1.5 Cg_endo -85.38 161.99 11.16 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 124.564 3.509 . . . . 0.0 112.656 -172.671 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -74.71 -18.76 60.46 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.6 173.102 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -59.43 138.69 89.04 Favored Pre-proline 0 CA--C 1.518 -0.276 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.041 175.867 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -69.62 113.86 3.49 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 121.008 1.139 . . . . 0.0 109.666 170.814 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.567 HD12 ' HE1' ' A' ' 40' ' ' TYR . 0.7 OUTLIER -118.63 155.11 20.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -176.222 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.466 ' C ' ' HB3' ' A' ' 59' ' ' GLU . 17.2 p -100.96 -26.02 13.87 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -176.921 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.53 ' C ' HG12 ' A' ' 82' ' ' VAL . . . -168.83 -168.59 31.11 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.33 -0.938 . . . . 0.0 111.675 179.432 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.676 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 5.6 m-85 -137.17 132.57 34.14 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 117.105 0.453 . . . . 0.0 111.378 173.359 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 10.0 mmm180 -99.28 148.68 23.89 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 167.807 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.869 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 31.6 mt -139.21 108.32 3.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 C-N-CA 120.065 -0.654 . . . . 0.0 112.043 178.848 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 75.2 t -110.03 110.42 32.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.325 0.584 . . . . 0.0 110.205 179.864 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.71 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 0.4 OUTLIER -111.87 124.47 52.43 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.377 176.338 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.422 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 23.1 t -139.4 135.74 17.31 Favored Pre-proline 0 C--N 1.314 -0.95 0 CA-C-N 113.692 -1.594 . . . . 0.0 110.383 -173.504 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.658 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 50.0 Cg_exo -55.61 148.26 55.0 Favored 'Trans proline' 0 C--O 1.234 0.277 0 C-N-CA 123.362 2.708 . . . . 0.0 112.491 174.22 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 31.4 t -61.8 -42.03 98.49 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.412 -176.75 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.9 m -114.73 -39.24 2.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -178.531 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -176.52 145.36 0.56 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.666 0.269 . . . . 0.0 110.994 -176.948 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.51 ' CA ' ' HG2' ' A' ' 46' ' ' PRO . . . 154.45 -151.68 23.33 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 121.168 -0.539 . . . . 0.0 111.953 176.828 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 39.5 t -92.3 121.87 34.22 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.576 0.188 . . . . 0.0 110.657 -177.745 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 9.6 m -112.07 144.63 41.11 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 178.447 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.71 ' HB ' ' CE2' ' A' ' 44' ' ' TYR . 23.3 m -145.61 148.7 33.4 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.876 -0.33 . . . . 0.0 111.5 -175.78 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.869 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 56.2 tt0 -119.16 118.36 31.14 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.235 173.301 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.698 HD12 ' CG2' ' A' ' 64' ' ' VAL . 19.4 mt -100.0 155.84 17.48 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 173.664 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -118.95 113.34 20.86 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 176.91 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.544 HD12 ' CH2' ' A' ' 30' ' ' TRP . 2.1 mt -108.51 156.25 39.03 Favored Pre-proline 0 C--N 1.317 -0.836 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 -177.32 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -54.77 147.07 52.2 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 121.824 1.683 . . . . 0.0 111.29 171.832 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.477 ' HB2' HG13 ' A' ' 37' ' ' ILE . 8.9 pt-20 -48.54 -27.38 2.7 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.959 173.153 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.4 t -96.69 -1.7 46.06 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.334 -175.572 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.454 ' CB ' ' HB3' ' A' ' 57' ' ' LEU . . . -71.41 152.29 43.26 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 -176.619 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.412 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 3.9 p-10 -132.32 11.32 4.54 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -176.21 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.572 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 53.4 p -169.3 133.67 1.41 Allowed 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 119.993 -0.683 . . . . 0.0 111.877 -177.171 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.834 HG12 ' HZ3' ' A' ' 30' ' ' TRP . 3.7 p -114.61 136.37 51.46 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.148 176.034 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 83.1 m -96.14 100.0 11.68 Favored 'General case' 0 N--CA 1.429 -1.514 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 168.669 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.728 HD11 HG12 ' A' ' 77' ' ' ILE . 0.6 OUTLIER -74.13 144.19 45.01 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.143 178.922 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 8.6 t -144.56 166.16 25.95 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 -174.325 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 64.03 32.95 12.57 Favored 'General case' 0 C--N 1.327 -0.393 0 O-C-N 123.775 0.672 . . . . 0.0 110.936 -177.119 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.5 ' O ' HG22 ' A' ' 24' ' ' THR . 7.9 mt -78.42 -176.85 4.95 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 174.573 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -124.64 123.99 25.66 Favored Pre-proline 0 C--N 1.318 -0.793 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 176.812 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -60.53 135.91 63.93 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 122.778 2.319 . . . . 0.0 112.768 -179.328 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.2 33.91 31.09 Favored Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.683 -179.604 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.527 ' CG1' ' HB3' ' A' ' 46' ' ' PRO . 85.5 t -138.26 139.41 41.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 120.8 0.333 . . . . 0.0 110.82 -176.218 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.658 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 1.7 tm0? -82.39 127.53 33.35 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.025 179.348 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -116.67 114.12 23.6 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -173.378 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.465 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 15.9 m120 -85.53 107.39 17.44 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.674 173.415 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.728 HG12 HD11 ' A' ' 66' ' ' LEU . 5.1 mp -91.01 117.07 33.51 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.733 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 176.644 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.895 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 26.1 m -109.15 114.77 28.77 Favored 'General case' 0 N--CA 1.424 -1.734 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.436 -179.146 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.549 ' HB ' ' HB ' ' A' ' 91' ' ' VAL . 13.5 mm -95.31 141.52 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -179.882 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -129.34 111.99 13.4 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.229 179.624 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.404 ' HB1' HG21 ' A' ' 37' ' ' ILE . . . -79.81 114.47 18.76 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 169.761 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.543 HG23 ' HG2' ' A' ' 87' ' ' GLU . 7.1 p -104.36 132.25 51.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 C-N-CA 120.048 -0.661 . . . . 0.0 109.565 -178.687 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.603 ' OE1' ' HG3' ' A' ' 10' ' ' PRO . 1.1 mp0 -113.6 171.33 7.64 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 123.178 0.299 . . . . 0.0 110.751 -177.655 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.418 ' H ' ' HG3' ' A' ' 84' ' ' GLU . 28.8 mt-10 -45.22 -40.92 7.84 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.505 -0.771 . . . . 0.0 112.754 -176.107 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -112.42 -20.47 11.78 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -172.353 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.592 ' HB2' ' OE1' ' A' ' 83' ' ' GLU . 69.5 mt-30 -142.63 178.47 7.6 Favored 'General case' 0 C--N 1.328 -0.329 0 O-C-N 122.091 -0.381 . . . . 0.0 111.523 -170.095 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.543 ' HG2' HG23 ' A' ' 82' ' ' VAL . 50.4 mt-10 -123.17 120.35 32.93 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.449 -0.796 . . . . 0.0 108.976 171.09 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 50.9 m -70.0 178.03 2.9 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -172.625 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -59.31 152.83 51.41 Favored Pre-proline 0 N--CA 1.451 -0.413 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.539 179.028 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -87.0 138.47 4.97 Favored 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 122.53 2.153 . . . . 0.0 114.269 -177.42 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.895 ' O ' ' HA ' ' A' ' 78' ' ' THR . 7.1 t -82.28 125.78 39.88 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.746 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 165.929 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 4.5 t -122.16 107.08 18.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 C-N-CA 119.83 -0.748 . . . . 0.0 110.121 173.276 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.542 HG13 ' HB ' ' A' ' 77' ' ' ILE . 6.5 pt -124.96 114.94 42.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.878 177.449 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.558 ' HB2' ' OE1' ' A' ' 74' ' ' GLN . 11.3 pt20 -100.92 120.78 40.66 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.553 0.692 . . . . 0.0 111.598 -175.077 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.23 132.25 39.48 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.546 178.103 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.51 ' HB2' ' HG2' ' A' ' 74' ' ' GLN . 35.8 tt0 -87.0 142.3 28.04 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.016 0.436 . . . . 0.0 110.259 179.898 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 31.6 p -68.39 134.49 50.3 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.297 -178.102 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 11.8 m -70.49 -29.25 65.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.665 -177.893 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.407 ' HA3' ' HA ' ' A' ' 23' ' ' ASP . . . -47.68 128.7 15.39 Favored Glycine 0 N--CA 1.452 -0.285 0 CA-C-N 115.156 -0.929 . . . . 0.0 113.812 -179.423 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 84.9 m -89.82 122.17 68.24 Favored Pre-proline 0 C--N 1.32 -0.696 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 172.819 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -54.67 110.4 0.52 Allowed 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.802 2.335 . . . . 0.0 111.883 179.381 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 44.0 ttp180 -149.73 108.93 3.93 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.913 -175.41 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 58.8 p -110.81 -173.03 2.15 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.753 175.433 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 65.94 57.25 0.81 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.184 0.516 . . . . 0.0 111.34 174.333 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -100.41 43.81 1.7 Allowed Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 175.134 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 23.8 p . . . . . 0 C--O 1.25 1.112 0 C-N-CA 123.542 0.737 . . . . 0.0 111.36 -175.203 . . . . . . . . 0 0 . 1 stop_ save_